Citrus Sinensis ID: 040480
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SKB2 | 641 | Leucine-rich repeat recep | yes | no | 0.996 | 0.505 | 0.622 | 1e-119 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.846 | 0.227 | 0.375 | 2e-44 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.689 | 0.187 | 0.412 | 3e-44 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.846 | 0.227 | 0.375 | 5e-44 | |
| Q9LJM4 | 991 | Receptor-like protein kin | no | no | 0.836 | 0.274 | 0.389 | 1e-42 | |
| Q9SYM9 | 355 | Receptor-like serine/thre | no | no | 0.833 | 0.763 | 0.368 | 2e-42 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.833 | 0.267 | 0.382 | 3e-42 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.796 | 0.235 | 0.386 | 4e-42 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.8 | 0.207 | 0.383 | 4e-42 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.855 | 0.238 | 0.356 | 1e-41 |
| >sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 428 bits (1101), Expect = e-119, Method: Compositional matrix adjust.
Identities = 203/326 (62%), Positives = 254/326 (77%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
LI+ A+RG + G +IFSPLI+K EDLAFL+ E+ ASLE IG GGCG+V+KAELPGSN
Sbjct: 311 LIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GK+IAVKKVI P A EL D S+ K+ +IRS+I T IRHRN+LPLLAH+ RP
Sbjct: 371 GKIIAVKKVI-QPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRP 429
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
+ H LVY++M+ GSLQ +L DV G +EL W +RHKIAL +A+GLEYLHM H+ R+IHRD
Sbjct: 430 ECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRD 489
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPANVL+DDDMEARIS F LA MPD +T I T +V GT YIAPE++QT ++KCDI
Sbjct: 490 LKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDI 549
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YSFGV+L +LV+GK P D+FF HT EM +++WMRN++ SENP+ AID KL+ G++EQML
Sbjct: 550 YSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQML 609
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+AC+CTL DP +RPNSKDVR M
Sbjct: 610 LVLKIACYCTLDDPKQRPNSKDVRTM 635
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 113/301 (37%), Positives = 171/301 (56%), Gaps = 26/301 (8%)
Query: 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGE 88
L+ + F + +GSGG GDVYKA+L +G ++A+KK+I S G+
Sbjct: 881 LLEATNGFHNDSLVGSGGFGDVYKAQL--KDGSVVAIKKLIHVS--------------GQ 924
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
G E +++ T +I+HRN++PLL + + LLVY++MK GSL+ VL+D K +L
Sbjct: 925 GD-REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKL 983
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
W +R KIA+ A GL +LH + +IHRD+K +NVL+D+++EAR+S F +A LM
Sbjct: 984 NWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMD 1043
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD--DFFSHTGEM 266
T + + GTP Y+ PEY+Q+ S K D+YS+GV+L L+ GK P D DF G+
Sbjct: 1044 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADF----GDN 1099
Query: 267 DMVRWMRNVMASENPNRAIDSKLLGN--GYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324
++V W++ + A D +LL E ++L LK+AC C +RP V
Sbjct: 1100 NLVGWVK-LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMA 1158
Query: 325 M 325
M
Sbjct: 1159 M 1159
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 102/247 (41%), Positives = 149/247 (60%), Gaps = 23/247 (9%)
Query: 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGE 88
L+ + F + IGSGG GDVYKA L +G +A+KK+I S G+
Sbjct: 876 LLQATNGFHNDSLIGSGGFGDVYKAIL--KDGSAVAIKKLIHVS--------------GQ 919
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
G E +++ T +I+HRN++PLL + D LLVY+FMK GSL+ VL+D K +L
Sbjct: 920 GD-REFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKL 978
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
W +R KIA+ A GL +LH + S +IHRD+K +NVL+D+++EAR+S F +A LM
Sbjct: 979 NWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMD 1038
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD--DFFSHTGEM 266
T + + GTP Y+ PEY+Q+ S K D+YS+GV+L L+ GK P D DF G+
Sbjct: 1039 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDF----GDN 1094
Query: 267 DMVRWMR 273
++V W++
Sbjct: 1095 NLVGWVK 1101
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 178 bits (452), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 113/301 (37%), Positives = 171/301 (56%), Gaps = 26/301 (8%)
Query: 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGE 88
L+ + F + +GSGG GDVYKA+L +G ++A+KK+I S G+
Sbjct: 881 LLEATNGFHNDSLVGSGGFGDVYKAQL--KDGSVVAIKKLIHVS--------------GQ 924
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
G E +++ T +I+HRN++PLL + + LLVY++MK GSL+ VL+D K +L
Sbjct: 925 GD-REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKL 983
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
W +R KIA+ A GL +LH + +IHRD+K +NVL+D+++EAR+S F +A LM
Sbjct: 984 NWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMD 1043
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD--DFFSHTGEM 266
T + + GTP Y+ PEY+Q+ S K D+YS+GV+L L+ GK P D DF G+
Sbjct: 1044 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADF----GDN 1099
Query: 267 DMVRWMRNVMASENPNRAIDSKLLGN--GYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324
++V W++ + A D +LL E ++L LK+AC C +RP V
Sbjct: 1100 NLVGWVK-LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMA 1158
Query: 325 M 325
M
Sbjct: 1159 M 1159
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJM4|IKU2_ARATH Receptor-like protein kinase HAIKU2 OS=Arabidopsis thaliana GN=IKU2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 116/298 (38%), Positives = 160/298 (53%), Gaps = 26/298 (8%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAE--------LIDAYSELGEGKLTE 93
IG GG G+VYK L +G+ +AVK I+ P S+ E L D + G E
Sbjct: 677 IGRGGQGNVYKVSL--RSGETLAVKH--IWCPESSHESFRSSTAMLSDGNNRSNNG---E 729
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
+++ T S I+H N++ L + DS LLVY++M NGSL L++ +G +E+ W R
Sbjct: 730 FEAEVATLSNIKHINVVKLFCSITCEDSKLLVYEYMPNGSLWEQLHE-RRGEQEIGWRVR 788
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID- 212
+AL A GLEYLH VIHRD+K +N+L+D++ RI+ F LA ++ Q D
Sbjct: 789 QALALGAAKGLEYLHHGLDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQRDF 848
Query: 213 -TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271
V GT YIAPEY T ++EK D+YSFGV+L LV GK P + F D+V W
Sbjct: 849 SAPLVKGTLGYIAPEYAYTTKVNEKSDVYSFGVVLMELVTGKKPLETDFGENN--DIVMW 906
Query: 272 MRNVMASENPNRAIDSKLLGNG----YEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+ +V S+ NR + KL+ Y+E L VL +A CT P RP K V M
Sbjct: 907 VWSV--SKETNREMMMKLIDTSIEDEYKEDALKVLTIALLCTDKSPQARPFMKSVVSM 962
|
Modulates the seed size by negatively regulating the cellularization of syncytial endosperm. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (438), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 109/296 (36%), Positives = 161/296 (54%), Gaps = 25/296 (8%)
Query: 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGE 88
F+KK ++ + +GSGG G VY+ + S AVK+ L SE
Sbjct: 68 FMKKTHKLSNKDILGSGGFGTVYRLVIDDST--TFAVKR-----------LNRGTSERDR 114
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
G E+ + + I+HRNI+ L + P +LL+Y+ M NGSL + L+ GR+ L
Sbjct: 115 GFHRELEAM----ADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLH----GRKAL 166
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+W SR++IA+ A G+ YLH +IHRDIK +N+L+D +MEAR+S F LA LM
Sbjct: 167 DWASRYRIAVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDK 226
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268
T + T +V GT Y+APEY T + K D+YSFGV+L L+ G+ P DD F G +
Sbjct: 227 THVST-FVAGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEG-TKL 284
Query: 269 VRWMRNVMASENPNRAIDSKLLGNGYE--EQMLLVLKLACFCTLADPDERPNSKDV 322
V W++ V+ + ID++L G+ + E+M V +A C +P RP +V
Sbjct: 285 VTWVKGVVRDQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEV 340
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (436), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 114/298 (38%), Positives = 168/298 (56%), Gaps = 27/298 (9%)
Query: 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
C IG G G VYKAE+ S+ ++AVKK+ SAA++ D G +
Sbjct: 698 CIKESNMIGMGATGIVYKAEMSRSS-TVLAVKKLW----RSAADIED-------GTTGDF 745
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSL-QAVLYDVSKGRRELEWLSR 153
++ ++RHRNI+ LL + + ++VY+FM NG+L A+ + GR ++W+SR
Sbjct: 746 VGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSR 805
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+ IAL VA GL YLH VIHRDIK N+L+D +++ARI+ F LA +M +
Sbjct: 806 YNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVS- 864
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273
V G+ YIAPEY TL + EK DIYS+GV+L L+ G+ P + F + +D+V W+R
Sbjct: 865 -MVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGES--VDIVEWVR 921
Query: 274 -----NVMASENPNRAIDSKLLGNGY-EEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
N+ E A+D + Y +E+MLLVL++A CT P +RP+ +DV M
Sbjct: 922 RKIRDNISLEE----ALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISM 975
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (435), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 113/292 (38%), Positives = 163/292 (55%), Gaps = 33/292 (11%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE--IRSQII 99
+G G CG VYKAE+ G G++IAVKK+ + GEG ++ R++I
Sbjct: 805 LGRGACGTVYKAEMSG--GEVIAVKKL---------------NSRGEGASSDNSFRAEIS 847
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE--LEWLSRHKIA 157
T +IRHRNI+ L +S+LL+Y++M GSL L +G + L+W +R++IA
Sbjct: 848 TLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQL---QRGEKNCLLDWNARYRIA 904
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY-V 216
L A GL YLH +++HRDIK N+L+D+ +A + F LA L+ L+ +M V
Sbjct: 905 LGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI--DLSYSKSMSAV 962
Query: 217 VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVM 276
G+ YIAPEY T+ ++EKCDIYSFGV+L L+ GK P G D+V W+R +
Sbjct: 963 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGG--DLVNWVRRSI 1019
Query: 277 ASENPN-RAIDSKLLGNGYE--EQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+ P D++L N +M LVLK+A FCT P RP ++V M
Sbjct: 1020 RNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAM 1071
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (435), Expect = 4e-42, Method: Composition-based stats.
Identities = 112/292 (38%), Positives = 167/292 (57%), Gaps = 32/292 (10%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
IGSGG G VYKAEL NG+ IAVKK++ + + + ++ T
Sbjct: 954 IGSGGSGKVYKAEL--KNGETIAVKKILWKDDLMSNK--------------SFNREVKTL 997
Query: 102 SQIRHRNILPLLAHMV-RPDS-HLLVYDFMKNGSLQAVLY--DVSKGRRELEWLSRHKIA 157
IRHR+++ L+ + + D +LL+Y++M NGS+ L+ + +K + L W +R KIA
Sbjct: 998 GTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIA 1057
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP---DGLTQIDTM 214
L +A G+EYLH ++HRDIK +NVL+D ++EA + F LA ++ D T+ +TM
Sbjct: 1058 LGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTM 1117
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274
+ G+ YIAPEY +L +EK D+YS G++L +V GK P + F E DMVRW+
Sbjct: 1118 F-AGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDE--ETDMVRWVET 1174
Query: 275 VM----ASENPNRAIDSKL--LGNGYEEQMLLVLKLACFCTLADPDERPNSK 320
V+ SE + IDS+L L EE VL++A CT + P ERP+S+
Sbjct: 1175 VLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSR 1226
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 107/300 (35%), Positives = 169/300 (56%), Gaps = 22/300 (7%)
Query: 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGE 88
L+ + F++ IGSGG GDVYKA+L ++G ++A+KK+I + G+
Sbjct: 851 LLEATNGFSADSMIGSGGFGDVYKAKL--ADGSVVAIKKLIQVT--------------GQ 894
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD-VSKGRRE 147
G E +++ T +I+HRN++PLL + + LLVY++MK GSL+ VL++ KG
Sbjct: 895 GD-REFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIF 953
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
L+W +R KIA+ A GL +LH +IHRD+K +NVL+D D AR+S F +A L+
Sbjct: 954 LDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSAL 1013
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE-M 266
T + + GTP Y+ PEY+Q+ + K D+YS+GV+L L+ GK P D GE
Sbjct: 1014 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDP--EEFGEDN 1071
Query: 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEE-QMLLVLKLACFCTLADPDERPNSKDVRCM 325
++V W + + + +D +L+ + + ++L LK+A C P +RP V M
Sbjct: 1072 NLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTM 1131
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | ||||||
| 255540437 | 633 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.996 | 0.511 | 0.672 | 1e-127 | |
| 224133744 | 630 | predicted protein [Populus trichocarpa] | 0.996 | 0.514 | 0.671 | 1e-126 | |
| 224119518 | 627 | predicted protein [Populus trichocarpa] | 0.996 | 0.516 | 0.668 | 1e-125 | |
| 356508750 | 636 | PREDICTED: leucine-rich repeat receptor- | 0.996 | 0.509 | 0.659 | 1e-123 | |
| 24421095 | 633 | receptor-like protein kinase [Nicotiana | 0.996 | 0.511 | 0.647 | 1e-123 | |
| 356516603 | 631 | PREDICTED: leucine-rich repeat receptor- | 0.996 | 0.513 | 0.650 | 1e-119 | |
| 449440606 | 643 | PREDICTED: leucine-rich repeat receptor- | 0.996 | 0.503 | 0.622 | 1e-118 | |
| 297822929 | 641 | hypothetical protein ARALYDRAFT_482113 [ | 0.996 | 0.505 | 0.625 | 1e-118 | |
| 15225153 | 641 | putative leucine-rich repeat transmembra | 0.996 | 0.505 | 0.622 | 1e-117 | |
| 16648755 | 641 | At2g31880/F20M17.8 [Arabidopsis thaliana | 0.996 | 0.505 | 0.622 | 1e-117 |
| >gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 461 bits (1186), Expect = e-127, Method: Compositional matrix adjust.
Identities = 220/327 (67%), Positives = 264/327 (80%), Gaps = 3/327 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSP-LIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGS 58
LILA +RGG +D G IFSP LI+K E+LAFL+KED ++LE IG GGCG+VYKAELPGS
Sbjct: 302 LILATIRGGGKDSGPAIFSPHLIKKAENLAFLEKEDGLSNLELIGRGGCGEVYKAELPGS 361
Query: 59 NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR 118
NGKMIA+KK I+ P AAEL + ++L K+ +IRS+I T QIRHRN+LPLLAH+ R
Sbjct: 362 NGKMIAIKK-IVQPPRDAAELTEEDTKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSR 420
Query: 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178
PD H LVY+FMKNGSLQ +L DV +G+REL+WL+RH+IA+ VASGLEYLH HS R+IHR
Sbjct: 421 PDCHCLVYEFMKNGSLQDILSDVEQGKRELDWLARHRIAIGVASGLEYLHTSHSPRIIHR 480
Query: 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCD 238
D+KPANVL+DDDMEARI+ F LA MPD T + T V GT YIAPEYHQTL ++KCD
Sbjct: 481 DLKPANVLLDDDMEARIADFGLAKAMPDANTHVTTSNVAGTVGYIAPEYHQTLKFTDKCD 540
Query: 239 IYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQM 298
IYSFGVLL VLVMGK P D+FF T EM +V+WMRN+M SENP++AID K+ GNG+EEQM
Sbjct: 541 IYSFGVLLGVLVMGKLPSDEFFQTTREMSLVKWMRNIMTSENPSQAIDPKMNGNGFEEQM 600
Query: 299 LLVLKLACFCTLADPDERPNSKDVRCM 325
LLVLK+ACFCTL DP +RPNSKD+RCM
Sbjct: 601 LLVLKIACFCTLDDPRQRPNSKDIRCM 627
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1177), Expect = e-126, Method: Compositional matrix adjust.
Identities = 219/326 (67%), Positives = 262/326 (80%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
++LAAV+GG RD G IFSPLI++ EDLAFL+K+D A+LE IG GGCG+VYKAELPGSN
Sbjct: 300 IVLAAVKGGGRDGGPAIFSPLIKRAEDLAFLEKDDGLANLEVIGKGGCGEVYKAELPGSN 359
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GKMIA+KK II P AAEL + S+L K+ +I+S+I T IRHRN+LPLLAH+ RP
Sbjct: 360 GKMIAIKK-IIQPPKDAAELTEEDSKLLHKKMRQIQSEINTVGHIRHRNLLPLLAHVSRP 418
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
D H LVY+ MKNGSLQ L V++GRREL+WL+RH+IA+ VASGLEYLH+ HS R+IHRD
Sbjct: 419 DCHYLVYELMKNGSLQDALNHVTEGRRELDWLARHRIAVGVASGLEYLHLSHSPRIIHRD 478
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPANVL+DD MEARI+ F LA MPD T I T V GT YIAPEYHQTL ++KCDI
Sbjct: 479 LKPANVLLDDSMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDI 538
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YSFGV+L VLVMGK P D+FF +T EM +V+WMRN+M SENP +AID KL+GNG EEQML
Sbjct: 539 YSFGVVLGVLVMGKLPSDEFFQNTREMSLVKWMRNIMTSENPRQAIDPKLMGNGLEEQML 598
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+ACFCT+ DP +RPNSKDVRCM
Sbjct: 599 LVLKIACFCTIDDPKQRPNSKDVRCM 624
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 453 bits (1165), Expect = e-125, Method: Compositional matrix adjust.
Identities = 218/326 (66%), Positives = 264/326 (80%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
++LAAV+GG RD G IFSPLI+K EDLAFL+K++ A+LE IG GGCG+V+KAELPGSN
Sbjct: 297 IVLAAVKGGGRDVGPAIFSPLIKKAEDLAFLEKDEGLANLEIIGRGGCGEVFKAELPGSN 356
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GKMIAVKK II P AAEL + S++ K+ +I+S+I T IRHRN+LPLLAH+ RP
Sbjct: 357 GKMIAVKK-IIQPPKDAAELSEEDSKVLNKKMRQIQSEINTVGHIRHRNLLPLLAHVSRP 415
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
D H LVY+FMKNGSLQ VL V++G+REL+WL+RHKIA+ VASGLEYLH+ HS ++IHRD
Sbjct: 416 DCHYLVYEFMKNGSLQDVLNQVTEGKRELDWLARHKIAVGVASGLEYLHLSHSPQIIHRD 475
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPANVL+DDDMEARI+ F LA MPD T I T V GT YIAPEYHQTL +EKCDI
Sbjct: 476 LKPANVLLDDDMEARIADFGLAKAMPDAKTHITTSNVAGTVGYIAPEYHQTLKFTEKCDI 535
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YSFGV+L VLVMGK P D FF T E+ +V+WMRN+M SENP++AID KL+G+G EEQML
Sbjct: 536 YSFGVVLGVLVMGKLPSDAFFQSTRELSLVKWMRNIMISENPSQAIDPKLIGHGLEEQML 595
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+ACFCT+ DP +RP+SKDVRCM
Sbjct: 596 LVLKIACFCTIDDPKQRPSSKDVRCM 621
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1150), Expect = e-123, Method: Compositional matrix adjust.
Identities = 215/326 (65%), Positives = 257/326 (78%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
L LA ++G R G I+SPLI+K EDLAFL+KE+ ASLE IG GGCG+VYKAELPGSN
Sbjct: 306 LALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGIASLEIIGRGGCGEVYKAELPGSN 365
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GKMIA+KK I+ P AEL + S++ K+ +IRS+I T QIRHRN+LPLLAH+ RP
Sbjct: 366 GKMIAIKK-IVQPPKDGAELAEEDSKVLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRP 424
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
+ H LVY+FMKNGSLQ L V +G EL+WLSRHKI+L VA+GLEYLHM+H+ R+IHRD
Sbjct: 425 ECHYLVYEFMKNGSLQDTLSKVERGESELDWLSRHKISLGVAAGLEYLHMNHNPRIIHRD 484
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPAN+L+DDDMEARI+ F LA MPD T I T V GT YIAPEYHQ L ++KCDI
Sbjct: 485 LKPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDI 544
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YS+GV+L VLV+GK P DDFF HT EM +V+WMR ++SENP AI+SKLLGNGYEEQML
Sbjct: 545 YSYGVILGVLVIGKLPSDDFFQHTEEMSLVKWMRKTLSSENPKEAINSKLLGNGYEEQML 604
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+ACFCT+ DP ERPNSKDVRCM
Sbjct: 605 LVLKIACFCTMDDPKERPNSKDVRCM 630
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1148), Expect = e-123, Method: Compositional matrix adjust.
Identities = 211/326 (64%), Positives = 262/326 (80%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
L++ VR G D LTI+SPLI+K EDLAFL+KED ASLE IG GGCG+VY+AELPGSN
Sbjct: 303 LVMFFVRKGKTDGSLTIYSPLIKKAEDLAFLEKEDGVASLEMIGKGGCGEVYRAELPGSN 362
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GK+IA+KK I+ PM AAEL + ++ K+ +++S+I QIRHRN+LPLLAHM RP
Sbjct: 363 GKIIAIKK-ILQPPMDAAELAEEDTKALNKKMRQVKSEIQILGQIRHRNLLPLLAHMPRP 421
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
D H LVY++MKNGSLQ +L V++G REL+WL RH+IA+ +A+GLEYLH++HS +IHRD
Sbjct: 422 DCHYLVYEYMKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLEYLHINHSQCIIHRD 481
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPANVL+DDDMEARI+ F LA +PD T + T V GT YIAPEYHQTL ++KCDI
Sbjct: 482 LKPANVLLDDDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDI 541
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YSFGV+LAVLV+GK P D+FF HT EM +V+W+RNVM SE+P RAID KL+G+G+EEQML
Sbjct: 542 YSFGVVLAVLVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAIDPKLIGSGFEEQML 601
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+ACFCTL +P ERPNSKDVRCM
Sbjct: 602 LVLKIACFCTLENPKERPNSKDVRCM 627
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1120), Expect = e-119, Method: Compositional matrix adjust.
Identities = 212/326 (65%), Positives = 253/326 (77%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
L LA ++G R G I+SPLI+K EDLAFL+KE+ ASLE IG GGCG+VYKAELPGSN
Sbjct: 301 LALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGMASLEIIGRGGCGEVYKAELPGSN 360
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GKMIA+KK II P AEL + S++ K+ +IRS+I T QIRHRN+LPLLAH+ RP
Sbjct: 361 GKMIAIKK-IIQPPKEGAELAEEDSKVLNKKMRQIRSEITTVGQIRHRNLLPLLAHVSRP 419
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
H LVY+FMKNGSL L V G EL+WLSRHKIAL VA+GLEYLH++H+ R+IHRD
Sbjct: 420 GCHYLVYEFMKNGSLHDTLSKVEVGEFELDWLSRHKIALGVAAGLEYLHLNHNPRIIHRD 479
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPAN+L+DDDMEARI+ F LA MPD T I T V GT YIAPEYHQ L ++KCDI
Sbjct: 480 LKPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDI 539
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YSFGV+L VLV+GK P +FF HT EM +V+WMR +++SENP AID+KLLGNGYE+QML
Sbjct: 540 YSFGVILGVLVIGKLPSHEFFQHTEEMSLVKWMRKILSSENPKEAIDTKLLGNGYEDQML 599
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+ACFCT+ DP ERPNSKDV CM
Sbjct: 600 LVLKIACFCTMDDPKERPNSKDVWCM 625
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440606|ref|XP_004138075.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] gi|449501343|ref|XP_004161343.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1108), Expect = e-118, Method: Compositional matrix adjust.
Identities = 203/326 (62%), Positives = 256/326 (78%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSP-LIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
L++AA++GGS++ G +IF+P LI+++DLAFL++++ ASL+ IG GGCG+VYKAELP +
Sbjct: 303 LVIAAIKGGSKNSGPSIFAPKLIKRDDLAFLERDNALASLQLIGKGGCGEVYKAELPEKS 362
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GKM A+KK I P AAELI+ S K+ +I+S+I T +IRHRN+LPL+AH+ RP
Sbjct: 363 GKMFAIKK-ITQPPKDAAELIEEESRHMSKKMRQIKSEIRTVGEIRHRNLLPLVAHVPRP 421
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
D H LVY+ MKNGSLQ +L VS G +EL+WL+RH IAL VASGLEYLHM+H+ R+IHRD
Sbjct: 422 DCHYLVYELMKNGSLQDMLNQVSAGVKELDWLTRHNIALGVASGLEYLHMNHTPRIIHRD 481
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPANVL+DD MEARI+ F LA MPD T + V GT YIAPEYHQTL ++KCDI
Sbjct: 482 LKPANVLLDDGMEARIADFGLAKAMPDAQTHMTASNVAGTVGYIAPEYHQTLKFTDKCDI 541
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
Y FGVLL VLV+GK P D+FF +T EM +V+WM+NVM S+NP AID KLLGNG+EEQML
Sbjct: 542 YGFGVLLGVLVIGKLPSDEFFQNTDEMSLVKWMKNVMTSDNPRGAIDPKLLGNGWEEQML 601
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
L LK+ACFCT+ +P ERPNSKDVRCM
Sbjct: 602 LALKIACFCTMDNPKERPNSKDVRCM 627
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297822929|ref|XP_002879347.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] gi|297325186|gb|EFH55606.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1105), Expect = e-118, Method: Compositional matrix adjust.
Identities = 204/326 (62%), Positives = 254/326 (77%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
LI+ A+RG + G +IFSPLI+K EDLAFL+ E+ ASLE IG GGCG+V+KAELPGSN
Sbjct: 311 LIIQAIRGSGKPSGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GK+IAVKKVI P A EL D S+ K+ +IRS+I T QIRHRN+LPLLAH+ RP
Sbjct: 371 GKIIAVKKVI-QPPKDADELTDEDSKFMNKKMRQIRSEISTVGQIRHRNLLPLLAHVSRP 429
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
+ H LVY++M+ GSLQ +L DV G +EL W +RHKIAL +A+GLEYLHM H+ R+IHRD
Sbjct: 430 ECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRD 489
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPANVL+DDDMEARIS F LA +MPD +T I T V GT YIAPE++QT + KCDI
Sbjct: 490 LKPANVLLDDDMEARISDFGLAKVMPDAVTHITTSNVAGTVGYIAPEFYQTHKFTAKCDI 549
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YSFGV+L +LV+GK P D+FF HT EM +++WMRN++ SENP+ AID KL+ G++EQML
Sbjct: 550 YSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMEQGFDEQML 609
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+AC+CTL DP +RPNSKDVR M
Sbjct: 610 LVLKIACYCTLDDPKQRPNSKDVRTM 635
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1101), Expect = e-117, Method: Compositional matrix adjust.
Identities = 203/326 (62%), Positives = 254/326 (77%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
LI+ A+RG + G +IFSPLI+K EDLAFL+ E+ ASLE IG GGCG+V+KAELPGSN
Sbjct: 311 LIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GK+IAVKKVI P A EL D S+ K+ +IRS+I T IRHRN+LPLLAH+ RP
Sbjct: 371 GKIIAVKKVI-QPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRP 429
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
+ H LVY++M+ GSLQ +L DV G +EL W +RHKIAL +A+GLEYLHM H+ R+IHRD
Sbjct: 430 ECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRD 489
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPANVL+DDDMEARIS F LA MPD +T I T +V GT YIAPE++QT ++KCDI
Sbjct: 490 LKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDI 549
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YSFGV+L +LV+GK P D+FF HT EM +++WMRN++ SENP+ AID KL+ G++EQML
Sbjct: 550 YSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQML 609
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+AC+CTL DP +RPNSKDVR M
Sbjct: 610 LVLKIACYCTLDDPKQRPNSKDVRTM 635
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16648755|gb|AAL25569.1| At2g31880/F20M17.8 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1097), Expect = e-117, Method: Compositional matrix adjust.
Identities = 203/326 (62%), Positives = 253/326 (77%), Gaps = 2/326 (0%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
LI+ A+RG + G +IFSPLI+K EDLAFL+ E+ ASLE IG GGCG+V+KAELPGSN
Sbjct: 311 LIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GK+IAVKKVI P A EL D S+ K+ +IRS+I T IRHRN+LPLLAH+ RP
Sbjct: 371 GKIIAVKKVI-QPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRP 429
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
+ H LVY++M+ GSLQ +L DV G +EL W +RHKIAL +A+GLEYLHM H+ R+IHRD
Sbjct: 430 ECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRD 489
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
KPANVL+DDDMEARIS F LA MPD +T I T +V GT YIAPE++QT ++KCDI
Sbjct: 490 SKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDI 549
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YSFGV+L +LV+GK P D+FF HT EM +++WMRN++ SENP+ AID KL+ G++EQML
Sbjct: 550 YSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQML 609
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+AC+CTL DP +RPNSKDVR M
Sbjct: 610 LVLKIACYCTLDDPKQRPNSKDVRTM 635
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | ||||||
| TAIR|locus:2045228 | 641 | SOBIR1 "SUPPRESSOR OF BIR1 1" | 0.996 | 0.505 | 0.622 | 6.3e-108 | |
| TAIR|locus:2024432 | 977 | LRR XI-23 [Arabidopsis thalian | 0.873 | 0.290 | 0.383 | 3.4e-44 | |
| TAIR|locus:2203000 | 355 | AT1G78530 [Arabidopsis thalian | 0.796 | 0.729 | 0.371 | 9.6e-44 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.843 | 0.266 | 0.396 | 2.1e-42 | |
| TAIR|locus:2091206 | 991 | IKU2 "HAIKU2" [Arabidopsis tha | 0.846 | 0.277 | 0.389 | 2.2e-41 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.843 | 0.270 | 0.383 | 6.3e-41 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.701 | 0.385 | 0.386 | 2.3e-40 | |
| TAIR|locus:2058759 | 589 | FEI2 "FEI 2" [Arabidopsis thal | 0.695 | 0.383 | 0.401 | 4.4e-40 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.895 | 0.25 | 0.351 | 6.2e-40 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.796 | 0.235 | 0.386 | 7.1e-40 |
| TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 203/326 (62%), Positives = 254/326 (77%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN 59
LI+ A+RG + G +IFSPLI+K EDLAFL+ E+ ASLE IG GGCG+V+KAELPGSN
Sbjct: 311 LIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370
Query: 60 GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119
GK+IAVKKVI P A EL D S+ K+ +IRS+I T IRHRN+LPLLAH+ RP
Sbjct: 371 GKIIAVKKVI-QPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRP 429
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
+ H LVY++M+ GSLQ +L DV G +EL W +RHKIAL +A+GLEYLHM H+ R+IHRD
Sbjct: 430 ECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRD 489
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KPANVL+DDDMEARIS F LA MPD +T I T +V GT YIAPE++QT ++KCDI
Sbjct: 490 LKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDI 549
Query: 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299
YSFGV+L +LV+GK P D+FF HT EM +++WMRN++ SENP+ AID KL+ G++EQML
Sbjct: 550 YSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQML 609
Query: 300 LVLKLACFCTLADPDERPNSKDVRCM 325
LVLK+AC+CTL DP +RPNSKDVR M
Sbjct: 610 LVLKIACYCTLDDPKQRPNSKDVRTM 635
|
|
| TAIR|locus:2024432 LRR XI-23 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 475 (172.3 bits), Expect = 3.4e-44, P = 3.4e-44
Identities = 114/297 (38%), Positives = 166/297 (55%)
Query: 32 KEDCFASLEK---IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPM-SAAELIDAYSELG 87
++D S+++ IG GGCGDVY+ L +GK +AVK + S + + + +E
Sbjct: 659 EDDIIDSIKEENLIGRGGCGDVYRVVL--GDGKEVAVKHIRCSSTQKNFSSAMPILTER- 715
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE 147
EG+ E +++ T S IRH N++ L + DS LLVY+++ NGSL +L+ K
Sbjct: 716 EGRSKEFETEVQTLSSIRHLNVVKLYCSITSDDSSLLVYEYLPNGSLWDMLHSCKKSN-- 773
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPD 206
L W +R+ IAL A GLEYLH + VIHRD+K +N+L+D+ ++ RI+ F LA IL
Sbjct: 774 LGWETRYDIALGAAKGLEYLHHGYERPVIHRDVKSSNILLDEFLKPRIADFGLAKILQAS 833
Query: 207 GLTQIDTMYVVGTPRYIAP-EYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265
T V GT YIAP EY ++EKCD+YSFGV+L LV GK P + F +
Sbjct: 834 NGGPESTHVVAGTYGYIAPAEYGYASKVTEKCDVYSFGVVLMELVTGKKPIEAEFGES-- 891
Query: 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
D+V W+ N + S+ I K +G Y E + +L++A CT P RP + V
Sbjct: 892 KDIVNWVSNNLKSKESVMEIVDKKIGEMYREDAVKMLRIAIICTARLPGLRPTMRSV 948
|
|
| TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 9.6e-44, Sum P(2) = 9.6e-44
Identities = 101/272 (37%), Positives = 151/272 (55%)
Query: 54 ELPGSNGKMIAVKKVIIYSPMSAAELID-AYSELGEGKLTEIRSQIITASQIRHRNILPL 112
++ GS G + VI S A + ++ SE G E+ + + I+HRNI+ L
Sbjct: 79 DILGSGGFGTVYRLVIDDSTTFAVKRLNRGTSERDRGFHRELEAM----ADIKHRNIVTL 134
Query: 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS 172
+ P +LL+Y+ M NGSL + L+ GR+ L+W SR++IA+ A G+ YLH
Sbjct: 135 HGYFTSPHYNLLIYELMPNGSLDSFLH----GRKALDWASRYRIAVGAARGISYLHHDCI 190
Query: 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT 232
+IHRDIK +N+L+D +MEAR+S F LA LM T + T +V GT Y+APEY T
Sbjct: 191 PHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVST-FVAGTFGYLAPEYFDTGK 249
Query: 233 ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGN 292
+ K D+YSFGV+L L+ G+ P DD F G +V W++ V+ + ID++L G+
Sbjct: 250 ATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTK-LVTWVKGVVRDQREEVVIDNRLRGS 308
Query: 293 GYEE--QMLLVLKLACFCTLADPDERPNSKDV 322
+E +M V +A C +P RP +V
Sbjct: 309 SVQENEEMNDVFGIAMMCLEPEPAIRPAMTEV 340
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 459 (166.6 bits), Expect = 2.1e-42, P = 2.1e-42
Identities = 115/290 (39%), Positives = 169/290 (58%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
IG G G VYKAE+ +AVKK + SP ++ D + E E + +I ++
Sbjct: 720 IGMGAIGIVYKAEVMRRPLLTVAVKK-LWRSPSPQNDIEDHHQE--EDEEDDILREVNLL 776
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL--EWLSRHKIALA 159
+RHRNI+ +L ++ ++VY++M NG+L L+ SK + L +WLSR+ +A+
Sbjct: 777 GGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALH--SKDEKFLLRDWLSRYNVAVG 834
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVV-G 218
V GL YLH +IHRDIK N+L+D ++EARI+ F LA +M L + +T+ +V G
Sbjct: 835 VVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMM---LHKNETVSMVAG 891
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN-VMA 277
+ YIAPEY TL I EK DIYS GV+L LV GK P D F + +D+V W+R V
Sbjct: 892 SYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDS--IDVVEWIRRKVKK 949
Query: 278 SENPNRAIDSKLLGNGYE--EQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+E+ ID+ + G+ E+MLL L++A CT P +RP+ +DV M
Sbjct: 950 NESLEEVIDASIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITM 999
|
|
| TAIR|locus:2091206 IKU2 "HAIKU2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 2.2e-41, P = 2.2e-41
Identities = 115/295 (38%), Positives = 162/295 (54%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELI-DAYSELGEGKLT----EIRS 96
IG GG G+VYK L +G+ +AVK I+ P S+ E + + L +G E +
Sbjct: 677 IGRGGQGNVYKVSL--RSGETLAVKH--IWCPESSHESFRSSTAMLSDGNNRSNNGEFEA 732
Query: 97 QIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI 156
++ T S I+H N++ L + DS LLVY++M NGSL L++ +G +E+ W R +
Sbjct: 733 EVATLSNIKHINVVKLFCSITCEDSKLLVYEYMPNGSLWEQLHE-RRGEQEIGWRVRQAL 791
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDGLTQ-IDTM 214
AL A GLEYLH VIHRD+K +N+L+D++ RI+ F LA I+ D + +
Sbjct: 792 ALGAAKGLEYLHHGLDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQRDFSAP 851
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274
V GT YIAPEY T ++EK D+YSFGV+L LV GK P + F D+V W+ +
Sbjct: 852 LVKGTLGYIAPEYAYTTKVNEKSDVYSFGVVLMELVTGKKPLETDFGENN--DIVMWVWS 909
Query: 275 VMASENPNRAIDSKLLGNG----YEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
V S+ NR + KL+ Y+E L VL +A CT P RP K V M
Sbjct: 910 V--SKETNREMMMKLIDTSIEDEYKEDALKVLTIALLCTDKSPQARPFMKSVVSM 962
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 6.3e-41, P = 6.3e-41
Identities = 113/295 (38%), Positives = 169/295 (57%)
Query: 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
C IG G G VYKAE+ S+ ++AVKK+ SAA++ D G +
Sbjct: 698 CIKESNMIGMGATGIVYKAEMSRSS-TVLAVKKLW----RSAADIED-------GTTGDF 745
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK-GRRELEWLSR 153
++ ++RHRNI+ LL + + ++VY+FM NG+L ++ + GR ++W+SR
Sbjct: 746 VGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSR 805
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+ IAL VA GL YLH VIHRDIK N+L+D +++ARI+ F LA +M +
Sbjct: 806 YNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVSM 865
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273
V G+ YIAPEY TL + EK DIYS+GV+L L+ G+ P + F + +D+V W+R
Sbjct: 866 --VAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGES--VDIVEWVR 921
Query: 274 NVMASE-NPNRAIDSKLLGN-GY-EEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+ + A+D + GN Y +E+MLLVL++A CT P +RP+ +DV M
Sbjct: 922 RKIRDNISLEEALDPNV-GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISM 975
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 390 (142.3 bits), Expect = 2.3e-40, Sum P(2) = 2.3e-40
Identities = 90/233 (38%), Positives = 134/233 (57%)
Query: 85 ELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG 144
+L EG ++ I+HR ++ L + P S LL+YD++ GSL L+ V +G
Sbjct: 338 KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALH-VERG 396
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204
+L+W SR I + A GL YLH S R+IHRDIK +N+L+D ++EAR+S F LA L+
Sbjct: 397 E-QLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 455
Query: 205 PDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264
D + I T+ V GT Y+APEY Q+ +EK D+YSFGVL+ ++ GK P D F G
Sbjct: 456 EDEESHITTI-VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG 514
Query: 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317
+++V W++ +++ + P +D G E L L +A C P+ERP
Sbjct: 515 -LNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDAL-LSIATQCVSPSPEERP 565
|
|
| TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 390 (142.3 bits), Expect = 4.4e-40, Sum P(2) = 4.4e-40
Identities = 94/234 (40%), Positives = 134/234 (57%)
Query: 85 ELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG 144
+L EG ++ I+HR ++ L + P S LL+YD++ GSL L+ K
Sbjct: 336 KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALH---KR 392
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204
+L+W SR I + A GL YLH S R+IHRDIK +N+L+D ++EAR+S F LA L+
Sbjct: 393 GEQLDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 452
Query: 205 PDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264
D + I T+ V GT Y+APEY Q+ +EK D+YSFGVL+ ++ GK P D F G
Sbjct: 453 EDEESHITTI-VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEKG 511
Query: 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML-LVLKLACFCTLADPDERP 317
++V W+ N + SEN + I L G E + L +L +A C + PDERP
Sbjct: 512 -FNIVGWL-NFLISENRAKEIVD-LSCEGVERESLDALLSIATKCVSSSPDERP 562
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 6.2e-40, P = 6.2e-40
Identities = 110/313 (35%), Positives = 173/313 (55%)
Query: 16 TIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMS 75
T PL + L+ + F++ IGSGG GDVYKA+L ++G ++A+KK+I +
Sbjct: 838 TFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKL--ADGSVVAIKKLIQVT--- 892
Query: 76 AAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQ 135
G+G E +++ T +I+HRN++PLL + + LLVY++MK GSL+
Sbjct: 893 -----------GQGD-REFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLE 940
Query: 136 AVLYD-VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
VL++ KG L+W +R KIA+ A GL +LH +IHRD+K +NVL+D D AR
Sbjct: 941 TVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVAR 1000
Query: 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKF 254
+S F +A L+ T + + GTP Y+ PEY+Q+ + K D+YS+GV+L L+ GK
Sbjct: 1001 VSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKK 1060
Query: 255 PFDDFFSHTGE-MDMVRWMRNVMASENPNRAIDSKLLGN-GYEEQMLLVLKLACFCTLAD 312
P D GE ++V W + + + +D +L+ + + ++L LK+A C
Sbjct: 1061 PIDP--EEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDR 1118
Query: 313 PDERPNSKDVRCM 325
P +RP V M
Sbjct: 1119 PFKRPTMIQVMTM 1131
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 7.1e-40, P = 7.1e-40
Identities = 113/292 (38%), Positives = 163/292 (55%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE--IRSQII 99
+G G CG VYKAE+ G G++IAVKK+ + GEG ++ R++I
Sbjct: 805 LGRGACGTVYKAEMSG--GEVIAVKKL---------------NSRGEGASSDNSFRAEIS 847
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE--LEWLSRHKIA 157
T +IRHRNI+ L +S+LL+Y++M GSL L +G + L+W +R++IA
Sbjct: 848 TLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQL---QRGEKNCLLDWNARYRIA 904
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVV 217
L A GL YLH +++HRDIK N+L+D+ +A + F LA L+ L+ +M V
Sbjct: 905 LGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLID--LSYSKSMSAV 962
Query: 218 -GTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVM 276
G+ YIAPEY T+ ++EKCDIYSFGV+L L+ GK P G D+V W+R +
Sbjct: 963 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPL-EQGG--DLVNWVRRSI 1019
Query: 277 ASENPN-RAIDSKLLGNGYE--EQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+ P D++L N +M LVLK+A FCT P RP ++V M
Sbjct: 1020 RNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAM 1071
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00150657 | hypothetical protein (630 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 325 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.003 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-42
Identities = 73/284 (25%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
LEK+G G G VY A + GK++A+K + + + I +I
Sbjct: 4 LEKLGEGSFGKVYLARDKKT-GKLVAIKVIKK--------------KKIKKDRERILREI 48
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+++H NI+ L D LV ++ + G L +L +GR +
Sbjct: 49 KILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR--FYLR 104
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+ S LEYLH S ++HRD+KP N+L+D+D +++ F LA + G VG
Sbjct: 105 QILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVG 158
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
TP Y+APE + DI+S GV+L L+ GK PF G+ ++ + +
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFP------GDDQLLELFKKIG-- 210
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
P E + L+ DP++R +++
Sbjct: 211 -KPKPPFPPPEWDISPEAKDLI---RKLLVK--DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-42
Identities = 90/292 (30%), Positives = 133/292 (45%), Gaps = 39/292 (13%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ L K+GSG G VYKA+ G+ GK++AVK + S+ + EIR
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGT-GKIVAVKILKKR---------SEKSKKDQTARREIR 50
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
I + H NI+ L+ D LV ++ + G L Y G L K
Sbjct: 51 ---ILRR-LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD--YLSRGGP--LSEDEAKK 102
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPDGLTQIDT 213
IAL + GLEYLH S +IHRD+KP N+L+D++ +I+ F LA +L
Sbjct: 103 IALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-- 157
Query: 214 MYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272
VGTP Y+APE K D++S GV+L L+ GK P FS +D ++ +
Sbjct: 158 --FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLI 211
Query: 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324
R ++ D +G EE L+ K DP +RP ++++
Sbjct: 212 RRILGPPLE---FDEPKWSSGSEEAKDLIKKCLNK----DPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-39
Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G GG G VY A GK +A+K + S E + L EI
Sbjct: 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEEL----------LREIE----IL 45
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVA 161
++ H NI+ L + LV ++ + GSL+ +L + +L +I L +
Sbjct: 46 KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQIL 102
Query: 162 SGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
GLEYLH + +IHRD+KP N+L+D D+ + +++ F L+ L+ + + T+ VGTP
Sbjct: 103 EGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTP 157
Query: 221 RYIAPE-YHQTLTISEKCDIYSFGVLLAVL 249
Y+APE SEK DI+S GV+L L
Sbjct: 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 73/285 (25%), Positives = 117/285 (41%), Gaps = 46/285 (16%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E +G G G VY A G+++AVK V + + E ++A + +I
Sbjct: 6 ELLGRGSFGSVYLALD-KDTGELMAVKSVELSG--DSEEELEA-----------LEREIR 51
Query: 100 TASQIRHRNILPLLAHMV-RPDSHLLVY-DFMKNGSLQAVLYDVSKGRRELEWLSRHKI- 156
S ++H NI+ + L ++ +++ GSL ++L K L I
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-------LPEPVIR 104
Query: 157 --ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
+ GL YLH S ++HRDIK AN+L+D D +++ F A + D T T
Sbjct: 105 KYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161
Query: 215 YVVGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273
V GTP ++APE DI+S G + + GK P+ + + + +
Sbjct: 162 SVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAAL-----YK 215
Query: 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318
+ E P I L E+ L+ C DP +RP
Sbjct: 216 IGSSGEPPE--IPEHLS-----EEAKDFLRK-CLRR--DPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-32
Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 52/297 (17%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMI--AVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
+K+G G G+VYK +L G +GK AVK + + + L E R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT------LKEDASEEERKDF----LKEARVM 50
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL-----YDVSKGRRELEWLS 152
++ H N++ LL + LV ++M+ G L L S + L
Sbjct: 51 K----KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKD 106
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
A+ +A G+EYL S + +HRD+ N L+ +D+ +IS F L+ + D D
Sbjct: 107 LLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD-----D 158
Query: 213 TMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDDFFSHTGEM 266
Y T R++APE + + K D++SFGVLL + +G P+ +
Sbjct: 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---- 214
Query: 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323
+++ ++R P +E + +L C DP++RP ++
Sbjct: 215 EVLEYLRKGYRLPKPE---------YCPDE----LYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-31
Identities = 69/235 (29%), Positives = 109/235 (46%), Gaps = 26/235 (11%)
Query: 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
F LEKIG GG G+VYKA GK +A+K + + S + K +I
Sbjct: 1 LFEILEKIGKGGFGEVYKA-RHKRTGKEVAIKVIKLES---------------KEKKEKI 44
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
++I + +H NI+ ++ D +V +F GSL+ +L + ++
Sbjct: 45 INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIA-- 101
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
+ + GLEYLH + +IHRDIK AN+L+ D E ++ F L+ + D +TM
Sbjct: 102 YVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTM 157
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269
VGTP ++APE K DI+S G+ L GK P+ + + +
Sbjct: 158 --VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-ALFKI 209
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 6e-30
Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 32/294 (10%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ L K+G G G+VY A K++A+K + + E+ E+ L +
Sbjct: 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQ--ILASLN 55
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
NI+ L S LV +++ GSL+ +L + + E +
Sbjct: 56 H---------PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF- 105
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLAILMPDGLT----Q 210
I + S LEYLH S +IHRDIKP N+L+D D ++ F LA L+PD +
Sbjct: 106 ILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162
Query: 211 IDTMYVVGTPRYIAPEYHQTLT---ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267
VGTP Y+APE L+ S DI+S G+ L L+ G PF+ + +
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222
Query: 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321
++ + + + + + + L+ KL DP R +S
Sbjct: 223 TLKIILE-LPTPSLASPLSPSNPELISKAASDLLKKLLAK----DPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK---MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+K+G G G+VYK +L G GK +AVK + + + E
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--------------IEEFL 49
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+ ++ H N++ LL + +V ++M+ G L + L K R +L
Sbjct: 50 REARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLS 106
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
AL +A G+EYL S IHRD+ N L+ +++ +IS F L+ + D D Y
Sbjct: 107 FALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-----DDYY 158
Query: 216 VVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL 246
R++APE + + K D++SFGVLL
Sbjct: 159 RKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 31/215 (14%)
Query: 39 LEKIGSGGCGDVYKAEL---PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+K+G G G+VYK L +AVK + + E E
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE--------------EFL 49
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+ ++ H NI+ LL + ++V ++M G L L +EL
Sbjct: 50 REARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLS 107
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
AL +A G+EYL S IHRD+ N L+ +++ +IS F L+ + D D Y
Sbjct: 108 FALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-----DDYY 159
Query: 216 VVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL 246
V R++APE + + K D++SFGVLL
Sbjct: 160 KVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 2e-26
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 39 LEKIGSGGCGDVYKAEL---PGSNGKMIAVKKV-IIYSPMSAAELIDAYSELGEGKLTEI 94
+K+G G G+VYK L +AVK + S E L E
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF-----------LEEA 52
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
++ H NI+ LL + + +V ++M G L L K +L
Sbjct: 53 S----IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLL 105
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
++AL +A G+EYL + +HRD+ N L+ +++ +IS F L+ + + D
Sbjct: 106 QMALQIAKGMEYLESKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYE-----DDY 157
Query: 215 YVVGT-----PRYIAPEYHQTLTISEKCDIYSFGVLL 246
Y +++APE + + K D++SFGVLL
Sbjct: 158 YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ IG G G VYK L G +A+K++ ++ E L I +I
Sbjct: 6 DLIGRGAFGVVYKG-LNLETGDFVAIKQIS-------------LEKIKEEALKSIMQEID 51
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
++H NI+ + + DS ++ ++ +NGSL+ ++ +A+
Sbjct: 52 LLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-------FPESLVAVY 104
Query: 160 VA---SGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV 216
V GL YLH VIHRDIK AN+L D +++ F +A + D + V
Sbjct: 105 VYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--V 159
Query: 217 VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
VGTP ++APE + S DI+S G + L+ G P+ D
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 38/278 (13%)
Query: 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIIT 100
+G G G VYK + GK+ A+KK+ + + + L E+++
Sbjct: 8 VLGQGSSGVVYKVRHKPT-GKIYALKKIHVDGDEEFRKQL----------LRELKTLRSC 56
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK-GRRELEWLSRHKIALA 159
S ++ + +V ++M GSL +L V K L IA
Sbjct: 57 ESP----YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQ 107
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
+ GL+YLH +IHRDIKP+N+LI+ E +I+ F ++ ++ + L Q +T VGT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGT 163
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASE 279
Y++PE Q + S DI+S G+ L +GKFP F G+ M+ +
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP----FLPPGQPSFFELMQAICDGP 219
Query: 280 NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317
P+ L + + + C DP +RP
Sbjct: 220 PPS------LPAEEFSPEFRDFISA---CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 82/295 (27%), Positives = 137/295 (46%), Gaps = 41/295 (13%)
Query: 33 EDCFASLEK---IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG 89
D +SL++ I G G YK + NG VK++ + + ++E+ +++G
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGK-SIKNGMQFVVKEINDVNSIPSSEI----ADMG-- 738
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
+++H NI+ L+ L++++++ +L VL R L
Sbjct: 739 -------------KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLS 778
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
W R KIA+ +A L +LH S V+ ++ P ++ID E + L GL
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLL 832
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269
DT + + Y+APE +T I+EK DIY FG++L L+ GK P D F G +V
Sbjct: 833 CTDTKCFISSA-YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS--IV 889
Query: 270 RWMRNVMASENPNRAIDSKLLGNG--YEEQMLLVLKLACFCTLADPDERPNSKDV 322
W R + + + ID + G+ + +++ V+ LA CT DP RP + DV
Sbjct: 890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 33/226 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+++IG G G VY S+GK+ +K++ + S MS E DA +E+ +I
Sbjct: 5 IKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDL-SNMSEKEREDALNEV----------KI 52
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA- 157
+ ++ H NI+ +V ++ G L + K ++E + +I
Sbjct: 53 L--KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKI---KKQKKEGKPFPEEQILD 107
Query: 158 --LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPD---GLTQI 211
+ + L+YLH S +++HRDIKP N+ + + ++ F ++ +L T
Sbjct: 108 WFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-- 162
Query: 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
VVGTP Y++PE Q + K DI+S G +L L K PF+
Sbjct: 163 ----VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-24
Identities = 56/176 (31%), Positives = 85/176 (48%), Gaps = 22/176 (12%)
Query: 96 SQIITASQIRH----RNILPLLAH--MVR------PDSHL-LVYDFMKNGSLQAVLYDVS 142
+II ++ H RNIL + H +V+ + L LV ++ G L +S
Sbjct: 29 KKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL---FSHLS 85
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
K R E +R A + LEYLH S +I+RD+KP N+L+D D +++ F LA
Sbjct: 86 KEGRFSEERARFYAA-EIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAK 141
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ ++ +T GTP Y+APE + D +S GVLL ++ GK PF
Sbjct: 142 ELSSEGSRTNTF--CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 34/231 (14%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E+ F LEK+G G G VYKA + G+++A+K V + E L
Sbjct: 2 EEVFDILEKLGEGSYGSVYKA-IHKETGQVVAIKVVPV-----------------EEDLQ 43
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWL 151
EI +I Q I+ + ++ L +V ++ GS+ D+ K + L
Sbjct: 44 EIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVMEYCGAGSVS----DIMKITNKT--L 96
Query: 152 SRHKIALAVAS---GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ +IA + GLEYLH S + IHRDIK N+L++++ +A+++ F ++ + D +
Sbjct: 97 TEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
+ +T V+GTP ++APE Q + + K DI+S G+ + GK P+ D
Sbjct: 154 AKRNT--VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 71/294 (24%), Positives = 126/294 (42%), Gaps = 51/294 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
LE IG G G V K S+GK I V K I Y M+ E + Q+
Sbjct: 5 LETIGKGSFGTVRKVRRK-SDGK-ILVWKEIDYGNMTEKE----------------KQQL 46
Query: 99 ITA----SQIRHRNILPLLAHMVRPDSHLL--VYDFMKNGSLQAVLYDVSKGRRELEWLS 152
++ +++H NI+ ++ + L V ++ + G L + + K ++E +++
Sbjct: 47 VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQL---IQKCKKERKYIE 103
Query: 153 RH---KIALAVASGLEYLH--MHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
+I + L H V+HRD+KPAN+ +D + ++ F LA ++
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267
+ Y VGTP Y++PE ++ EK DI+S G L+ L P F+ ++
Sbjct: 164 -SSFAKTY-VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP----FTARNQLQ 217
Query: 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321
+ ++ P R Y ++ V+K DPD+RP++++
Sbjct: 218 LASKIKEGKFRRIPYR----------YSSELNEVIK---SMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-22
Identities = 70/293 (23%), Positives = 132/293 (45%), Gaps = 56/293 (19%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F L KIG G G V+K + ++ ++ A+K++ + S M+ E +A E +
Sbjct: 2 FEILNKIGKGSFGVVFKV-VRKADKRVYAMKQIDL-SKMNRREREEAIDE------ARVL 53
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL------LVYDFMKNGSLQAVLYDVSKGRR--- 146
+++ ++ IR+ +S L +V ++ +NG L +L + +GR
Sbjct: 54 AKLDSSYIIRYY------------ESFLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPE 100
Query: 147 ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
+ W + + + GL +LH S +++HRDIK N+ +D +I +A L+ D
Sbjct: 101 DQVW----RFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153
Query: 207 GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266
+T+ VGTP Y++PE + +EK D+++ GV+L GK PFD
Sbjct: 154 NTNFANTI--VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD-------AN 204
Query: 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319
+ + ++ P + Y +Q+ ++ C D +RP++
Sbjct: 205 NQGALILKIIRGVFPP-------VSQMYSQQLAQLIDQ---CLTKDYRQRPDT 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 69/229 (30%), Positives = 99/229 (43%), Gaps = 30/229 (13%)
Query: 39 LEKIGSGGCGDVYKAE-LPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
+E IG G VY A LP N + +A+K++ +L + + E+R +
Sbjct: 6 IEVIGVGATAVVYAAICLP--NNEKVAIKRI---------DL-EKCQT----SVDELRKE 49
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
+ SQ H N++ V D LV ++ GSL D+ K L IA
Sbjct: 50 VQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIA 105
Query: 158 L---AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL-AILMPDGLTQIDT 213
V GLEYLH + IHRDIK N+L+ +D +I+ F + A L G
Sbjct: 106 TVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162
Query: 214 MY-VVGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF 260
VGTP ++APE Q K DI+SFG+ L G P+ +
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 32/223 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L ++G+G G V K + GK++AVK + E+ E I+ QI
Sbjct: 6 LGELGAGNSGVVSKVLHRPT-GKIMAVKTI--------------RLEINE----AIQKQI 46
Query: 99 ITASQIRHR----NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
+ I H+ I+ + ++M GSL + +GR L
Sbjct: 47 LRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKI-LKEVQGRIPERILG-- 103
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
KIA+AV GL YLH H +IHRD+KP+N+L++ + ++ F ++ + + L +
Sbjct: 104 KIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-- 159
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
VGT Y+APE Q S K DI+S G+ L L G+FP+
Sbjct: 160 --VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-21
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F L+K+G G G VYK + S+ + A+K+V + S MS E DA + EIR
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGS-MSQKEREDA--------VNEIR 51
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
I AS + H NI+ + + +V ++ G L + K R+ + +
Sbjct: 52 ---ILAS-VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR 107
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL--TQIDT 213
I + + GL+ LH +++HRD+K AN+L+ + +I ++ ++ + TQI
Sbjct: 108 IFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-- 162
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
GTP Y+APE + S K DI+S G LL + PF+
Sbjct: 163 ----GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-21
Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 32/279 (11%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+KIG G +VY+A K +A+KKV I+ M A D E+ K
Sbjct: 8 KKIGRGQFSEVYRATCLLDR-KPVALKKVQIFEMMDAKARQDCVKEIDLLK--------- 57
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
Q+ H N++ L + + +V + G L ++ K +R + + K +
Sbjct: 58 ---QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
+ S +E HMH S RV+HRDIKPANV I ++ L T ++ VGT
Sbjct: 115 LCSAVE--HMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASE 279
P Y++PE + K DI+S G LL + + PF + +M++ + + +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLFSLCQKIEQCD 224
Query: 280 NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318
P L Y E++ +L C DPD+RP+
Sbjct: 225 YP------PLPTEHYSEKL---RELVSMCIYPDPDQRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-21
Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 53/292 (18%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F LE IG G G+VYKA +N +++A+K + + E E ++ +I+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTN-QVVAIKVIDL--------------EEAEDEIEDIQ 47
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
+I SQ R I ++ S L ++ ++ GS D+ K + L
Sbjct: 48 QEIQFLSQCRSPYITKYYGSFLK-GSKLWIIMEYCGGGSC----LDLLKPGK----LDET 98
Query: 155 KIA---LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI 211
IA V GLEYLH IHRDIK AN+L+ ++ + +++ F ++ + +++
Sbjct: 99 YIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155
Query: 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271
+T VGTP ++APE + EK DI+S G+ L G+ P D + +R
Sbjct: 156 NTF--VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-------LHPMRV 206
Query: 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLK--LACFCTLADPDERPNSKD 321
+ + + P L GN + + K ++ C DP ERP++K+
Sbjct: 207 LFLIPKNNPP------SLEGNKFSKP----FKDFVSL-CLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 80/302 (26%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG 89
L+ ED ++ +G+G G V K + + M KKV+ I A S +
Sbjct: 2 LRNED-LETISDLGAGNGGSVSKVKHIPTGTVM--AKKVV---------HIGAKSSV--- 46
Query: 90 KLTEIRSQIITASQIRHRNILPLL-----AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG 144
R QI+ QI H P + A + + + +FM GSL + G
Sbjct: 47 -----RKQILRELQIMHECRSPYIVSFYGAFLNENNI-CMCMEFMDCGSLDRIYKKG--G 98
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204
+E L KIA+AV GL YL+ H R++HRDIKP+N+L++ + ++ F ++ +
Sbjct: 99 PIPVEILG--KIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154
Query: 205 PDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF----DDFF 260
+ + VGT Y++PE Q + K D++S G+ + L +GKFPF D
Sbjct: 155 INSIADT----FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
Query: 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320
M ++ ++ ++ P +L + + E + + C L DP ERP +
Sbjct: 211 GQDDPMGILDLLQQIVQEPPP------RLPSSDFPEDLRDFVDA---CLLKDPTERPTPQ 261
Query: 321 DV 322
+
Sbjct: 262 QL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-20
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E +GSG G VY+ L +G AVK+V + + G+ + ++ +I
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEV----------SLADDGQTGQEAVKQLEQEIA 54
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVY-DFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
S+++H NI+ L R + +L ++ + + GSL +L + L +I L
Sbjct: 55 LLSKLQHPNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL 113
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
GLEYLH +HRDIK AN+L+D + +++ F +A + + G
Sbjct: 114 ----GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKG 163
Query: 219 TPRYIAPEY-HQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF 260
+P ++APE Q DI+S G + + GK P+
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-20
Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 44/290 (15%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F K+GSG G+V++ N +A+K I+ S K + +
Sbjct: 8 FTLERKLGSGYFGEVWEGLW--KNRVRVAIK--ILKSDD-------------LLKQQDFQ 50
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++ ++RH++++ L A + ++ + M+ GSL A L +G+ L S
Sbjct: 51 KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQ-VLPVASLID 108
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL-TQIDTM 214
+A VA G+ YL IHRD+ N+L+ +D+ +++ F LA L+ + + D
Sbjct: 109 MACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDDFFSHTGEMDMVRWMR 273
++ APE T S K D++SFG+LL + G+ P+ +H + R
Sbjct: 166 IPY---KWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
Query: 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323
++ P Q + + L C+ A+P++RP+ K +R
Sbjct: 223 MPCPAKCP---------------QEIYKIMLECWA--AEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 43/233 (18%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ +LEKIG G G+VYKA + ++ A+KK+ L + I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEV-AIKKMR----------------LRKQNKELII 63
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL------LVYDFMKNGSLQAVLYDVSKGRRELE 149
++I+ +H NI+ DS+L +V ++M GSL ++
Sbjct: 64 NEILIMKDCKHPNIVDYY------DSYLVGDELWVVMEYMDGGSLTDIITQNFVR----- 112
Query: 150 WLSRHKIA---LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
++ +IA V GLEYLH S VIHRDIK N+L+ D +++ F A +
Sbjct: 113 -MNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168
Query: 207 GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
++ +++ VGTP ++APE + K DI+S G++ + G+ P+
Sbjct: 169 EKSKRNSV--VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 75/296 (25%), Positives = 122/296 (41%), Gaps = 42/296 (14%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ L ++G G G V K L N MI K I P +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLK--NTGMIFALKTITTDPN-----------------PD 41
Query: 94 IRSQIITASQI----RHRNILPLL-AHMVRPDSHL-LVYDFMKNGSLQAVLYDV-SKGRR 146
++ QI+ +I + I+ A + S + + ++ + GSL ++ V +G R
Sbjct: 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR 101
Query: 147 ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
E + KIA +V GL YLH S ++IHRDIKP+N+L+ + ++ F ++
Sbjct: 102 IGEKVL-GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS----G 153
Query: 207 GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD-DFFSHTGE 265
L GT Y+APE Q S D++S G+ L + +FPF + G
Sbjct: 154 ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213
Query: 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321
++++ ++ N NP D G + E+ + C DP RP D
Sbjct: 214 IELLSYIVN---MPNP-ELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 78/283 (27%), Positives = 125/283 (44%), Gaps = 32/283 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F +KIG G VYKA +G+++A+KKV I+ M A D E+ K
Sbjct: 4 FKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK----- 57
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
Q+ H N++ LA + + +V + G L ++ K +R + + K
Sbjct: 58 -------QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ + S LE HMH S R++HRDIKPANV I ++ L T ++
Sbjct: 111 YFVQLCSALE--HMH-SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL- 166
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275
VGTP Y++PE + K DI+S G LL + + PF + +M++ + +
Sbjct: 167 -VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKI 220
Query: 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318
+ P L + Y E++ L C DP++RP+
Sbjct: 221 EKCDYP------PLPADHYSEEL---RDLVSRCINPDPEKRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 5e-20
Identities = 56/248 (22%), Positives = 91/248 (36%), Gaps = 51/248 (20%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI- 94
F + IG G V A+ K A+K I + + E K+ +
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEK-ETNKEYAIK---ILD----KRQL-----IKEKKVKYVK 49
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
+ + H I+ L ++ V ++ NG L + L
Sbjct: 50 IEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-------LDEK 102
Query: 155 KIALAVA---SGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL--- 208
A LEYLH S +IHRD+KP N+L+D DM +I+ F A ++
Sbjct: 103 CTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159
Query: 209 ----------TQIDTMY-----VVGTPRYIAPEYHQTLT---ISEKCDIYSFGVLLAVLV 250
+QI+ VGT Y++PE L + D+++ G ++ ++
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQML 216
Query: 251 MGKFPFDD 258
GK PF
Sbjct: 217 TGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 44/135 (32%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA-VASGLEYLHMHHSARVIHRDIKP 182
LV D + G L+ Y +S+ + E + K + + LEYLH S +IHRDIKP
Sbjct: 77 LVVDLLLGGDLR---YHLSQKVKFSE--EQVKFWICEIVLALEYLH---SKGIIHRDIKP 128
Query: 183 ANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSF 242
N+L+D+ I+ F++A + T + GTP Y+APE S D +S
Sbjct: 129 DNILLDEQGHVHITDFNIATKVTPD-TLTTST--SGTPGYMAPEVLCRQGYSVAVDWWSL 185
Query: 243 GVLLAVLVMGKFPFD 257
GV + GK P+
Sbjct: 186 GVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 33/218 (15%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
++ + +++IGSG GDVYKA + G+++A+K + + E G+
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIAT-GELVAIKVIKL--------------EPGDD-FE 45
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
I+ +I + RH NI+ +R D +V ++ GSLQ +Y V++G LS
Sbjct: 46 IIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGP-----LS 99
Query: 153 RHKIALA---VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
+IA GL YLH IHRDIK AN+L+ +D + +++ F ++ + +
Sbjct: 100 ELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTIS---EKCDIYSFGV 244
+ + +GTP ++APE KCDI++ G+
Sbjct: 157 KRKSF--IGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F +KIG G +VY+A +G +A+KKV I+ M A D E+ K
Sbjct: 4 FRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLK----- 57
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
Q+ H N++ A + + +V + G L ++ K +R + + K
Sbjct: 58 -------QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK 110
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ + S LE++H S RV+HRDIKPANV I ++ L T ++
Sbjct: 111 YFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL- 166
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275
VGTP Y++PE + K DI+S G LL + + PF + +M++ + +
Sbjct: 167 -VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKI 220
Query: 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318
+ P L + Y E++ +L C DP++RP+
Sbjct: 221 EQCDYP------PLPSDHYSEEL---RQLVNMCINPDPEKRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-19
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
IG G GDV + G+ +AVK + S + A L +A
Sbjct: 12 ATIGKGEFGDVMLGDY---RGQKVAVKCLKDDSTAAQAFLAEAS---------------- 52
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
+ +RH N++ LL +++ + +V ++M GSL V Y S+GR + + AL
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL--VDYLRSRGRAVITLAQQLGFALD 110
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
V G+EYL +HRD+ NVL+ +D+ A++S F GL + +
Sbjct: 111 VCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDF--------GLAKEASQGQDSG 159
Query: 220 P---RYIAPEYHQTLTISEKCDIYSFGVLL 246
++ APE + S K D++SFG+LL
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E+ F LE+IG G G+VYK + +++A+K +ID E E ++
Sbjct: 3 EELFTKLERIGKGSFGEVYKG-IDNRTKEVVAIK------------IIDL--EEAEDEIE 47
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+I+ +I SQ I ++ ++ +++ GS +L G E +++
Sbjct: 48 DIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIA 104
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
I + GL+YLH S R IHRDIK ANVL+ + + +++ F +A + D TQI
Sbjct: 105 --TILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIK 157
Query: 213 TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
VGTP ++APE + K DI+S G+ L G+ P D
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 32/232 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
KIG G G VY A + G+++AVK++ I + EI ++
Sbjct: 5 GNKIGGGTFGKVYTA-VNLDTGELMAVKEIRIQDNDPKT-------------IKEIADEM 50
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMK---NGSLQAVLYDVSKGRRELEWLSRHK 155
++H N++ V + VY FM+ G+L+ +L GR E + R
Sbjct: 51 KVLELLKHPNLVKYYGVEVHREK---VYIFMEYCSGGTLEELL---EHGRILDEHVIR-V 103
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
L + GL YLH H ++HRDIKPAN+ +D + ++ F A+ + + T +
Sbjct: 104 YTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160
Query: 216 --VVGTPRYIAPEYHQTLTISEK---CDIYSFGVLLAVLVMGKFPFDDFFSH 262
+ GTP Y+APE DI+S G ++ + GK P+ + +
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 8e-18
Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 25/227 (11%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E+ F LEKIG G G+V+K + K++A+K +ID E E ++
Sbjct: 3 EELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIK------------IIDL--EEAEDEIE 47
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+I+ +I SQ + ++ ++ +++ GS +L ++ +
Sbjct: 48 DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL 107
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
R + GL+YLH S + IHRDIK ANVL+ + E +++ F +A + D TQI
Sbjct: 108 RE-----ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIK 157
Query: 213 TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
VGTP ++APE + K DI+S G+ L G+ P +
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-18
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E IG G G VY A L + G+M+AVK+V + A + + + + +RS+I
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVEL-----PATIAGRHDSRQKDMVKALRSEIE 60
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
T + H NI+ L + + +++ GS+ + L + GR E E L R
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFE-EQLVRF-FTEQ 116
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
V GL YLH S ++HRD+K N+L+D D +IS F ++ D M + G+
Sbjct: 117 VLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 220 PRYIAPE----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
++APE Y Q S K DI+S G ++ + G+ P+ D
Sbjct: 174 VFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E IG G G V + E G+ +AVK I ++A ++ + +
Sbjct: 12 EIIGEGEFGAVLQGEY---TGQKVAVK--NIKCDVTAQAFLEETAVM------------- 53
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
+++ H+N++ LL ++ ++ V + M G+L L ++GR + + + +L
Sbjct: 54 --TKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLD 108
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
VA G+EYL S +++HRD+ N+L+ +D A++S F LA + G+ D +
Sbjct: 109 VAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---DNSKL--P 160
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
++ APE + S K D++S+GVLL V G+ P+
Sbjct: 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G GG G+V ++ + GKM A KK L + +G+ + + I
Sbjct: 1 LGKGGFGEVCACQVKAT-GKMYACKK-----------LDKKRLKKRKGEQMALNEKKIL- 47
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVA 161
++ R I+ L D LV M G L+ +Y+V G A +
Sbjct: 48 EKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQII 105
Query: 162 SGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPR 221
GLE+LH R+++RD+KP NVL+DD RIS LA+ + G GTP
Sbjct: 106 CGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPG 159
Query: 222 YIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
Y+APE Q D ++ G L ++ G+ PF
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 78/246 (31%), Positives = 112/246 (45%), Gaps = 63/246 (25%)
Query: 38 SLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDA---YSELGEGKLTEI 94
+L +GSG G V A + K +A+KK + P +A I A Y EL +L +
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRK-VAIKK--LSRPFQSA--IHAKRTYREL---RLLK- 69
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKGRRE 147
+ H N++ LL + P S L LV M A L ++ K ++
Sbjct: 70 --------HMDHENVIGLL-DVFTPASSLEDFQDVYLVTHLM-----GADLNNIVKCQK- 114
Query: 148 LEWLSRHKIALAVAS---GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204
LS I V GL+Y+H SA +IHRD+KP+N+ +++D E +I F LA
Sbjct: 115 ---LSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168
Query: 205 PDGLTQIDTMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
D +T YV T Y APE Y+QT+ DI+S G ++A L+ GK FP
Sbjct: 169 DDEMTG----YVA-TRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGKTLFP 217
Query: 256 FDDFFS 261
D
Sbjct: 218 GSDHID 223
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-17
Identities = 67/223 (30%), Positives = 115/223 (51%), Gaps = 22/223 (9%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE-IRSQIIT 100
IGSG G VY + S+G+++AVK+V + S A S+ + + + + +I
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSV-------SASSKDRKRSMLDALAREIAL 59
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVY-DFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
+++H NI+ L + D HL ++ +++ GS+ A+L + G E E L R+ +
Sbjct: 60 LKELQHENIVQYLGSSLDAD-HLNIFLEYVPGGSVAALLNNY--GAFE-ETLVRNFVR-Q 114
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY---- 215
+ GL YLH +IHRDIK AN+L+D+ +IS F ++ + T
Sbjct: 115 ILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ G+ ++APE + + + K DI+S G L+ ++ GK PF D
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 65/230 (28%), Positives = 96/230 (41%), Gaps = 34/230 (14%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ L KIG G G VYKA G+++A+KK + + + L EI+
Sbjct: 1 YQKLGKIGEGTYGVVYKAR-DKLTGEIVAIKK------IKLRFESEGIPKTA---LREIK 50
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++ H NI+ LL LV++FM LY + K R+ L
Sbjct: 51 L----LKELNHPNIIKLLDVFRHKGDLYLVFEFMD-----TDLYKLIKDRQRG--LPESL 99
Query: 156 IA---LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDGLTQI 211
I + GL + H S ++HRD+KP N+LI+ + +++ F LA
Sbjct: 100 IKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY- 155
Query: 212 DTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGK--FPFDD 258
T YVV T Y APE S DI+S G + A L+ + FP
Sbjct: 156 -THYVV-TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 33/230 (14%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E+ F LE+IG G G+V+K + +++A+K + + E E ++
Sbjct: 3 EELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDL--------------EEAEDEIE 47
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGS----LQAVLYDVSKGRREL 148
+I+ +I SQ + ++ ++ +++ GS L+A +D E
Sbjct: 48 DIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD------EF 101
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ + K + GL+YLH S + IHRDIK ANVL+ + + +++ F +A + D
Sbjct: 102 QIATMLK---EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-- 153
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
TQI VGTP ++APE Q K DI+S G+ L G+ P D
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-17
Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 27/291 (9%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+A LE +GSG G VYK + ++A+K++ +++P + + +G+ I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGD-----IV 56
Query: 96 SQI-ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
S++ I Q+RH NI+ + D +V D ++ L + + ++
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
I + + L YLH R++HRD+ P N+++ +D + I+ F LA +
Sbjct: 117 NIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLA---KQKQPESKLT 171
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274
VVGT Y PE + EK D+++FG +L + + PF ++ M + +
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF-----YSTNM-LSLATKI 225
Query: 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
V A P L Y E + V+ C D + RP+ V M
Sbjct: 226 VEAVYEP-------LPEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAM 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 9e-17
Identities = 74/311 (23%), Positives = 126/311 (40%), Gaps = 56/311 (18%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLTEIRSQ 97
+ +IG G G VYKA G+++A+KK+ M + EG +T IR +
Sbjct: 4 IAQIGEGTYGQVYKAR-NKKTGELVALKKI----RMENEK---------EGFPITAIR-E 48
Query: 98 IITASQIRHRNILPLLAHMVRPD--SHLLVYDFMK---NGSLQAVLYDVSKGRRELEWLS 152
I ++RH NI+ L + S +V+++M G L + ++ +
Sbjct: 49 IKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQI------ 102
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
+ + GL+YLH S ++HRDIK +N+LI++D +++ F LA +
Sbjct: 103 KC-YMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158
Query: 213 TMYVVGTPRYIAPE--YHQTLTISEKCDIYSFGVLLAVLVMGKFPF---------DDFFS 261
T V+ T Y PE T + D++S G +LA L +GK F + F
Sbjct: 159 TNRVI-TLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216
Query: 262 HTG--------EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADP 313
G + + W N+ + R + + L+ KL DP
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL----DP 272
Query: 314 DERPNSKDVRC 324
+R ++
Sbjct: 273 KKRISADQALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 1e-16
Identities = 72/234 (30%), Positives = 111/234 (47%), Gaps = 53/234 (22%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK--LTEIRSQII 99
IGSG G V A + G+ +A+KK+ + + +L + K L EI+ ++
Sbjct: 8 IGSGAYGVVCSA-VDKRTGRKVAIKKIS-----------NVFDDLIDAKRILREIK--LL 53
Query: 100 TASQIRHRNILPLLAHMVRPDSHL------LVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
+RH NI+ LL ++RP S +V + M + L+ V K + L
Sbjct: 54 --RHLRHENIIGLL-DILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDH 104
Query: 154 HK-IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDGLTQI 211
+ + GL+YLH SA VIHRD+KP+N+L++ + + +I F LA + PD +
Sbjct: 105 IQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
Query: 212 D-TMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
T YVV T Y APE Y + + DI+S G + A L+ K FP
Sbjct: 162 FLTEYVV-TRWYRAPELLLSSSRYTKAI------DIWSVGCIFAELLTRKPLFP 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 44/246 (17%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAEL----PGSNGKMIAVKKVIIYSPMSAAELIDAYSELG 87
+ D ++G G G V+ E P ++ +++AVK + + A + + +EL
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL- 61
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL--------- 138
+ +H NI+ D ++V+++M++G L L
Sbjct: 62 -------------LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAF 108
Query: 139 ---YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195
D G L L +IA+ +ASG+ YL S +HRD+ N L+ D+ +I
Sbjct: 109 LKSPDSPMGELTLSQL--LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKI 163
Query: 196 SGFDLAILMPDGLTQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLV 250
F M + D V G R++ PE + + D++SFGV+L +
Sbjct: 164 GDFG----MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
Query: 251 MGKFPF 256
GK P+
Sbjct: 220 YGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 64/235 (27%), Positives = 101/235 (42%), Gaps = 54/235 (22%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+K+G G VYKA G+++A+KK+ + A + I+ T +R +I
Sbjct: 5 GKKLGEGTYAVVYKAR-DKETGRIVAIKKIKLGERKEAKDGIN---------FTALR-EI 53
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+++H NI+ LL + LV++FM+ L+ V+ D S I L
Sbjct: 54 KLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKS-------------IVL 99
Query: 159 AVA----------SGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
A GLEYLH + ++HRD+KP N+LI D +++ F LA
Sbjct: 100 TPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156
Query: 209 TQIDTMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
++ V T Y APE Y D++S G + A L++ PF
Sbjct: 157 RKMTHQVV--TRWYRAPELLFGARHYGVG------VDMWSVGCIFAELLLRV-PF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 84/288 (29%), Positives = 126/288 (43%), Gaps = 42/288 (14%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G GG G+V ++ + GK+ A KK ++ L + EG + E R I A
Sbjct: 1 LGKGGFGEVSACQMRAT-GKLYACKK------LNKKRL--KKRKGYEGAMVEKR---ILA 48
Query: 102 SQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
H + LA+ + + L LV M G L+ +Y+V + E +
Sbjct: 49 KV--HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE---ENPGFPEPRACFYT 103
Query: 161 A---SGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVV 217
A SGLE+LH R+I+RD+KP NVL+D+D RIS LA+ + DG Q T
Sbjct: 104 AQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158
Query: 218 GTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277
GTP ++APE Q D ++ GV L ++ + P F GE V
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP----FRARGE--------KVEN 206
Query: 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLA-DPDERPNSKDVRC 324
E R ++ + Y ++ K C LA DP++R +D C
Sbjct: 207 KELKQRILNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 26 DLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSE 85
DL+ ++ F +++IGSG GDVYKA + G++ A+K VI P
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKAR-NVNTGELAAIK-VIKLEP------------ 46
Query: 86 LGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGR 145
GE ++ +II +H NI+ +R D + +F GSLQ + Y V+
Sbjct: 47 -GE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI-YHVTGP- 102
Query: 146 RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
LS +IA L+ L+ HS +HRDIK AN+L+ D+ +++ F ++ +
Sbjct: 103 -----LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157
Query: 206 DGLTQIDTMYVVGTPRYIAPE---YHQTLTISEKCDIYSFGV 244
+ + + +GTP ++APE + ++ CDI++ G+
Sbjct: 158 ATIAKRKSF--IGTPYWMAPEVAAVERKGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-16
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 29/233 (12%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSE---LGEGKLTEIRSQI 98
+G GG G+V ++ + GKM A KK + L E L E ++ E +
Sbjct: 1 LGKGGFGEVCAVQVK-NTGKMYACKK------LDKKRLKKKSGEKMALLEKEILEKVNSP 53
Query: 99 ITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
+ LA+ +HL LV M G L+ +Y+V G R LE +
Sbjct: 54 FIVN----------LAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYS 101
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVV 217
+ G+ LH+H S +++RD+KP NVL+DD R+S LA+ + DG T
Sbjct: 102 AQITCGI--LHLH-SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRA 155
Query: 218 GTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270
GT Y+APE + S D ++ G + +V G+ PF D + ++ R
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 64/240 (26%), Positives = 97/240 (40%), Gaps = 40/240 (16%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
F +E IG G G VYKA G+++A+K ++D + E E
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHK-KTGQLVAIK------------IMDIIEDEEEEIKEE 52
Query: 94 IRSQIITASQIRHRNILP------LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG-RR 146
I H NI D LV + GS+ D+ KG R+
Sbjct: 53 YN---ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT----DLVKGLRK 105
Query: 147 ELEWLSRHKIAL---AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL 203
+ + L IA GL YLH + VIHRDIK N+L+ + E ++ F ++
Sbjct: 106 KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162
Query: 204 MPDGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ L + +T +GTP ++APE + + D++S G+ L GK P D
Sbjct: 163 LDSTLGRRNT--FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 64/250 (25%), Positives = 109/250 (43%), Gaps = 37/250 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL-TEIRSQ 97
LE++G G G VYK EL G N ++ + + I E E K+ E R +
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERL-----------SATSVAIKTLKENAEPKVQQEFRQE 58
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL------------YDVSKGR 145
S ++H NI+ LL + ++++++ +G L L +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 146 RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
L+ IA+ +A+G+EYL HH +HRD+ N L+ + + +IS F L+ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 206 DGLTQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDDFF 260
D V R++ PE + + DI+SFGV+L + G P+ F
Sbjct: 176 SA----DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-F 230
Query: 261 SHTGEMDMVR 270
S+ ++M+R
Sbjct: 231 SNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 4e-15
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ EKIG G G VY A + + G+ +A+K++ + + K I
Sbjct: 21 YTRFEKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQ---------------QPKKELII 64
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++I+ + ++ NI+ L + D +V +++ GSL V+ + + +
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--------MDEGQ 116
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
IA L+ L HS +VIHRDIK N+L+ D +++ F + ++ TM
Sbjct: 117 IAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM- 175
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
VGTP ++APE K DI+S G++ +V G+ P+
Sbjct: 176 -VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+K+G G G V + E S GK+I V A L KL++I +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPV----------------AVKCLKSDKLSDIMDDFL 44
Query: 100 TASQI----RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+ I H N++ L +V ++V + GSL L + G + L
Sbjct: 45 KEAAIMHSLDHENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTL--CD 101
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
A+ +A+G+ YL S R IHRD+ N+L+ D + +I F L +P + Y
Sbjct: 102 YAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN----EDHY 154
Query: 216 VVGTPRYI-----APEYHQTLTISEKCDIYSFGVLL 246
V+ + APE +T T S D++ FGV L
Sbjct: 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-15
Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G VYKA+ + A K+I S EL D + EI I++
Sbjct: 13 LGDGAFGKVYKAQ--HKETGLFAAAKIIQIE--SEEELEDF--------MVEI--DILS- 57
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE--LEWLSRHKIALA 159
+ +H NI+ L + ++ +F G+L +++ ++ +G E + ++ R
Sbjct: 58 -ECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ----- 111
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
+ L +LH H +VIHRD+K N+L+ D + +++ F ++ L + DT +GT
Sbjct: 112 MLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGT 166
Query: 220 PRYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPFDD 258
P ++APE T + K DI+S G+ L L + P +
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 54/190 (28%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L +IG G G V+KA G+ +A+KKV A L G + +I
Sbjct: 5 LGRIGEGAHGIVFKA-KDRETGETVALKKV-------------ALRRLEGGIPNQALREI 50
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+H ++ LL +LV ++M L VL D R L
Sbjct: 51 KALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDE---ERPLPEAQVKSYMR 106
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-- 216
+ G+ Y+H + ++HRD+KPAN+LI D +I+ F LA L + +Y
Sbjct: 107 MLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE---EPRLYSHQ 160
Query: 217 VGTPRYIAPE 226
V T Y APE
Sbjct: 161 VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 9e-15
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 49/237 (20%)
Query: 23 EKEDLAFLKKEDCFASLEKIGSGGCGDVYKA--ELPGSN-GKMIAVKKVIIYSPMSAAEL 79
EK L F+K+ +G G G V + G N G+ +AVK + +
Sbjct: 2 EKRHLKFIKQ---------LGEGHFGKVELCRYDPLGDNTGEQVAVKSL---NHSG---- 45
Query: 80 IDAYSELGEGKLTEIRSQIITASQIRHRNILPL--LAHMVRPDSHLLVYDFMKNGSLQAV 137
E ++ +I + H NI+ + S L+ +++ +GSL+
Sbjct: 46 -------EEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDY 98
Query: 138 LYDVSKGRRELEWLSRHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
L +R + ++ ++ + + G++YL S R IHRD+ N+L++ + +
Sbjct: 99 L------QRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVK 149
Query: 195 ISGFDLAILMPDGLTQIDTMYVVGTPR-----YIAPEYHQTLTISEKCDIYSFGVLL 246
IS F LA ++P+ Y V P + APE +T S D++SFGV L
Sbjct: 150 ISDFGLAKVLPED----KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 49/294 (16%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E F L +IG G G VY A +++A+KK + YS + E K
Sbjct: 14 EKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKK-MSYSGKQSNE-----------KWQ 60
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+I ++ Q+RH N + +R + LV ++ GS +L K +E+E +
Sbjct: 61 DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA 119
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
I GL YLH H IHRDIK N+L+ + +++ F A L+ +
Sbjct: 120 ---ICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS--- 170
Query: 213 TMYVVGTPRYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267
VGTP ++APE L + E K D++S G+ L K P F+ M+
Sbjct: 171 ---FVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN----MN 218
Query: 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321
+ + ++ +++P L N + + + C P +RP+S++
Sbjct: 219 AMSALYHIAQNDSPT------LSSNDWSDYFRNFVDS---CLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ EKIG G G VY A + + G+ +A+K++ + ELI
Sbjct: 21 YTRFEKIGQGASGTVYTA-IDVATGQEVAIKQMNL-QQQPKKELI--------------I 64
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++I+ + +H NI+ L + D +V +++ GSL V+ + ++ + R
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE- 123
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
LE+LH + VIHRDIK N+L+ D +++ F + ++ TM
Sbjct: 124 ----CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM- 175
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
VGTP ++APE K DI+S G++ +V G+ P+
Sbjct: 176 -VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 33/228 (14%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL 91
K+D F + ++G+G G V K + S +I +K+I A
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPS--GLIMARKLIHLEIKPA--------------- 45
Query: 92 TEIRSQIITASQIRHRNILPLLAHM---VRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRE 147
IR+QII Q+ H P + D + + + M GSL VL + + E
Sbjct: 46 --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE 103
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
+ K+++AV GL YL H +++HRD+KP+N+L++ E ++ F ++ + D
Sbjct: 104 I----LGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
+ VGT Y++PE Q S + DI+S G+ L L +G++P
Sbjct: 158 MAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 33/228 (14%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL 91
K+D F + ++G+G G V+K S +I +K+I A
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSG--LIMARKLIHLEIKPA--------------- 45
Query: 92 TEIRSQIITASQIRHRNILPLLAHM---VRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRE 147
IR+QII Q+ H P + D + + + M GSL VL + +
Sbjct: 46 --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 103
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
+ K+++AV GL YL H +++HRD+KP+N+L++ E ++ F ++ + D
Sbjct: 104 I----LGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
+ VGT Y++PE Q S + DI+S G+ L + +G++P
Sbjct: 158 MAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L K+G+G G+V++ + +AVK + + M + L E +QI
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGT-MDPKDF-----------LAE--AQI 54
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ ++RH ++ L A + +V + MK GSL L + +L L +A
Sbjct: 55 M--KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAA 110
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDGLT-QIDTMYV 216
VASG+ YL + IHRD+ NVL+ ++ +++ F LA ++ D + +
Sbjct: 111 QVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167
Query: 217 VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256
+ ++ APE S K D++SFG+LL +V G+ P+
Sbjct: 168 I---KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 3e-14
Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 28/222 (12%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ EKIG G G VY A + + G+ +A++++ + + K I
Sbjct: 22 YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQ---------------QPKKELII 65
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++I+ + ++ NI+ L + D +V +++ GSL V+ + + +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--------MDEGQ 117
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL-AILMPDGLTQIDTM 214
IA L+ L HS +VIHRDIK N+L+ D +++ F A + P+ Q
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRS 174
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
+VGTP ++APE K DI+S G++ ++ G+ P+
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-14
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ EKIG G G V+ A + G+ +A+K++ + + K I
Sbjct: 21 YTRYEKIGQGASGTVFTAI-DVATGQEVAIKQINLQK---------------QPKKELII 64
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++I+ ++++ NI+ L + D +V +++ GSL V+ + + +
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--------MDEAQ 116
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
IA L+ L H+ +VIHRDIK NVL+ D +++ F + ++ TM
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM- 175
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
VGTP ++APE K DI+S G++ +V G+ P+
Sbjct: 176 -VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 4e-14
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 50/232 (21%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS-----PMSAAELIDAYSELGEGKLTE 93
LEK+G G G VYKA G+++A+KK+ + + P +A L E
Sbjct: 4 LEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEEGIPSTA--------------LRE 48
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
I +++H NI+ LL + LV+++ L+ L D G +
Sbjct: 49 IS----LLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKS 102
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPDGLTQI 211
I + GL Y H H R++HRD+KP N+LI+ D +++ F LA +P +
Sbjct: 103 --IMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-----L 152
Query: 212 DTM-YVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
T + V T Y APE H + + DI+S G + A ++ GK FP
Sbjct: 153 RTYTHEVVTLWYRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGKPLFP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 38/223 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L+ IG G GDV + G +AVK I + +A + ++
Sbjct: 11 LQTIGKGEFGDVMLGDY---RGNKVAVK--CIKNDATAQAFL---------------AEA 50
Query: 99 ITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
+Q+RH N++ LL +V L +V ++M GSL V Y S+GR L K +
Sbjct: 51 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL--VDYLRSRGRSVLGGDCLLKFS 108
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ--IDTMY 215
L V +EYL + +HRD+ NVL+ +D A++S F GLT+ T
Sbjct: 109 LDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDF--------GLTKEASSTQD 157
Query: 216 VVGTP-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
P ++ APE + S K D++SFG+LL + G+ P+
Sbjct: 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 22/222 (9%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+++G+G Y+A + G ++AVK+V Y +++E + +R +I
Sbjct: 6 QQLGTGAFSSCYQARDVKT-GTLMAVKQVT-YVRNTSSEQEEVVEA--------LRKEIR 55
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVY-DFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+++ H +I+ +L DSH ++ ++M GS+ +L + + ++
Sbjct: 56 LMARLNHPHIIRMLG-ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR 114
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDD-MEARISGFDLAILMPDGLTQIDTM--Y 215
GL YLH ++IHRD+K AN+LID RI+ F A + T
Sbjct: 115 ----GLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
++GT ++APE + CD++S G ++ + K P++
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-14
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 45/229 (19%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
K+G+G G+V+ NG K + MS L E +
Sbjct: 11 ERKLGAGQFGEVWMGTW---NGTTKVAVKTLKPGTMSPEAF-----------LQEAQ--- 53
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
++RH ++ L A + +V ++M GSL L + L L +A
Sbjct: 54 -IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV--DMAA 110
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+A G+ YL S IHRD+ N+L+ +++ +I+ F LA L+ D Y
Sbjct: 111 QIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE------DDEY--- 158
Query: 219 TPR--------YIAPE--YHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256
T R + APE + TI K D++SFG+LL +V G+ P+
Sbjct: 159 TAREGAKFPIKWTAPEAANYGRFTI--KSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-14
Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 38/215 (17%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKM-IAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
EKIG G GDVYK L G +AVK +L L E
Sbjct: 1 EKIGKGNFGDVYKGVL---KGNTEVAVKTC----------RSTLPPDLKRKFLQEAE--- 44
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
Q H NI+ L+ V+ +V + + GSL L K + L +++L
Sbjct: 45 -ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSL 100
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF-------DLAILMPDGLTQI 211
A+G+EYL S IHRD+ N L+ ++ +IS F + DGL QI
Sbjct: 101 DAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157
Query: 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL 246
++ APE + + D++S+G+LL
Sbjct: 158 PI-------KWTAPEALNYGRYTSESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-14
Identities = 67/222 (30%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLTEI 94
F +G GG G+V ++ + GKM A KK+ E GE L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRAT-GKMYACKKL---------EKKRIKKRKGESMALNE- 50
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
QI+ ++ R ++ L D+ LV M G L+ +Y + G E
Sbjct: 51 -KQIL--EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAV 105
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
A + GLE LH R+++RD+KP N+L+DD RIS LA+ +P+G T
Sbjct: 106 FYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IK 159
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
VGT Y+APE + + D ++ G LL ++ G+ PF
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 53/172 (30%), Positives = 86/172 (50%), Gaps = 24/172 (13%)
Query: 93 EIRSQIITASQIRHRNILPLLAHMV------RPDSHL-LVYDFMKNGSLQAVLYDVSKGR 145
IR+QII ++ H P ++V D + + + M GSL VL GR
Sbjct: 41 AIRNQIIRELKVLHECNSP---YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GR 95
Query: 146 RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
L KI++AV GL YL H ++HRD+KP+N+L++ E ++ F ++ +
Sbjct: 96 IPENILG--KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL- 150
Query: 206 DGLTQIDTM--YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
ID+M VGT Y++PE Q + + DI+S G+ L + +G++P
Sbjct: 151 -----IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 64/264 (24%), Positives = 122/264 (46%), Gaps = 36/264 (13%)
Query: 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG 89
L E+ + + ++G G G VYKA+ K V ++AA++ID SE
Sbjct: 1 LNPEEFWEIIGELGDGAFGKVYKAQ-----NKETGV--------LAAAKVIDTKSE---E 44
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
+L + +I + H NI+ LL ++ ++ +F G++ AV+ ++ +
Sbjct: 45 ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP----- 99
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
L+ +I + LE L+ H ++IHRD+K N+L D + +++ F ++ +
Sbjct: 100 -LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264
+ D+ +GTP ++APE T + K D++S G+ L + + P
Sbjct: 159 RRDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH------- 209
Query: 265 EMDMVRWMRNVMASENPNRAIDSK 288
E++ +R + + SE P A S+
Sbjct: 210 ELNPMRVLLKIAKSEPPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIIT 100
KIG G G V A + S+GK++AVKK+ + L + +++
Sbjct: 27 KIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFN---------------EVVI 70
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
+H N++ + + D +V +F++ G+L + V+ R ++ +IA
Sbjct: 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVC 122
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
+ L+ L + H+ VIHRDIK ++L+ D ++S F + + + ++ VGTP
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTP 180
Query: 221 RYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
++APE L + DI+S G+++ +V G+ P+
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 62/247 (25%), Positives = 113/247 (45%), Gaps = 38/247 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
E +G G G VYKA + +++AVK + P+ E++ QI
Sbjct: 6 QEILGHGNGGTVYKAYHLLT-RRILAVKVI----PLDIT--------------VELQKQI 46
Query: 99 ITASQIRHR----NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
++ +I ++ I+ + + +FM GSL DV + E L R
Sbjct: 47 MSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-----DVYRKIPE-HVLGR- 99
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
IA+AV GL YL S +++HRD+KP+N+L++ + ++ F ++ + + I
Sbjct: 100 -IAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKT 152
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274
Y VGT Y+APE D++S G+ L +G+FP+ + G + ++ ++
Sbjct: 153 Y-VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC 211
Query: 275 VMASENP 281
++ + P
Sbjct: 212 IVDEDPP 218
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 36/253 (14%)
Query: 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIIT 100
++G G G VYKA+ K ++AA++I+ SE +L + +I
Sbjct: 19 ELGDGAFGKVYKAK-----NKETGA--------LAAAKVIETKSE---EELEDYMVEIEI 62
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
+ H I+ LL ++ +F G++ A++ ++ +G E + I +
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ------IQVIC 116
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
LE L HS ++IHRD+K NVL+ D + +++ F ++ L + D+ +GTP
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF--IGTP 174
Query: 221 RYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275
++APE T+ + K DI+S G+ L + + P E++ +R + +
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-------ELNPMRVLLKI 227
Query: 276 MASENPNRAIDSK 288
SE P + SK
Sbjct: 228 AKSEPPTLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 71/225 (31%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 42 IGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+G G G V AEL G + A+KK ++ LID + E + E R +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--------LID---DDVECTMVEKRVLAL 51
Query: 100 TASQIRHRNILPLLAHMV---RPDSHLL-VYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
P L H+ + HL V +F+ G L + D KGR +L + +
Sbjct: 52 AWEN-------PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFY- 101
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
A + GL++LH S +I+RD+K NV++D D +I+ F + G + T
Sbjct: 102 -AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF- 156
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF--DD 258
GTP YIAPE Q L + D +SFGVLL +++G+ PF DD
Sbjct: 157 -CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 42 IGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+G G G V AEL G+N + A+KK ++ L D + E + E R +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--------LED---DDVECTMVE-RRVLA 50
Query: 100 TASQIRHRNILPLLAHM---VRPDSHLL-VYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
A + P L H+ + HL V +++ G L + + S GR + +
Sbjct: 51 LAWE------HPFLTHLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFY- 101
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
A + GL++LH +I+RD+K NVL+D D +I+ F + +G + T
Sbjct: 102 -AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF- 156
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
GTP YIAPE + +E D +SFGVLL +++G+ PF
Sbjct: 157 -CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F +EKIG G G VYKA G+++A+KK+ +D +E T IR
Sbjct: 2 FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI----------RLDTETEGVPS--TAIR 48
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+I ++ H NI+ LL + + LV++F+ + L+ + L + +
Sbjct: 49 -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYL 106
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
L GL + H H RV+HRD+KP N+LI+ + +++ F LA G+ +
Sbjct: 107 FQLL--QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 159
Query: 216 VVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGK--FPFD 257
V T Y APE Y+ T DI+S G + A +V + FP D
Sbjct: 160 EVVTLWYRAPEILLGCKYYST-----AVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ +E IGSG G V A + +GK +A+KK+ P + A L E K+
Sbjct: 4 GSRYKPIENIGSGAYGVVCSA-IDTRSGKKVAIKKI----PHAFDVPTLAKRTLRELKIL 58
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHL----LVYDFMKNGSLQAVLYDVSKGRREL 148
+H NI+ + + P + +V D M++ L +++ S
Sbjct: 59 R---------HFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQPLTE 106
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM---P 205
E + L GL+Y+H SA VIHRD+KP+N+L+++D E RI F +A + P
Sbjct: 107 EHIRYFLYQLL--RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 206 DGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLA 247
T Y V T Y APE +L + D++S G + A
Sbjct: 162 TEHKYFMTEY-VATRWYRAPELLLSLPEYTTAIDMWSVGCIFA 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 72/276 (26%), Positives = 114/276 (41%), Gaps = 47/276 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ- 97
L+ I G G VY A+ S G A+K V+ S M A + ++T ++++
Sbjct: 1 LKPISKGAFGSVYLAK-KRSTGDYFAIK-VLKKSDMIA-----------KNQVTNVKAER 47
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
I Q + L D LV +++ G +++ + G +W ++
Sbjct: 48 AIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQY--I 103
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM--Y 215
V G+E LH +IHRDIKP N+LID +++ F GL++
Sbjct: 104 AEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDF--------GLSRNGLENKK 152
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF-----DDFFSHTGEMDMVR 270
VGTP Y+APE + + D +S G ++ + G PF D F + +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-LSRRIN 211
Query: 271 WMRNVMASENP------NRAIDS---KLLG-NGYEE 296
W V +P NR + K LG NGY+E
Sbjct: 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 79/240 (32%), Positives = 110/240 (45%), Gaps = 55/240 (22%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELI--DAYSELGEGKL 91
D + L+++GSG G V A L G +A+KK +Y P + EL AY EL K
Sbjct: 15 DRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKK--LYRPFQS-ELFAKRAYRELRLLK- 69
Query: 92 TEIRSQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKG 144
++H N++ LL + PD L LV FM D+ K
Sbjct: 70 -----------HMKHENVIGLL-DVFTPDLSLDRFHDFYLVMPFMGT--------DLGKL 109
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204
+ E LS +I V L+ L H+A +IHRD+KP N+ +++D E +I F LA
Sbjct: 110 MK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--- 165
Query: 205 PDGLTQID---TMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
Q D T YVV T Y APE H T T+ DI+S G ++A ++ GK F
Sbjct: 166 ----RQTDSEMTGYVV-TRWYRAPEVILNWMHYTQTV----DIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 59/233 (25%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G GG G V ++ S + A+K V + I+
Sbjct: 1 LGVGGFGRVELVKVK-SKNRTFALKCVK-------------------------KRHIVET 34
Query: 102 SQIRH----RNIL-----PLLAHMVRP--DS-HL-LVYDFMKNGSLQAVLYDVSKGRREL 148
Q H + IL P + + R D ++ ++ ++ G L +L D +G +
Sbjct: 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD--RGLFD- 91
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
E+ +R IA V EYLH +I+RD+KP N+L+D + ++ F A + G
Sbjct: 92 EYTARFYIACVV-LAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEK-----CDIYSFGVLLAVLVMGKFPF 256
T GTP Y+APE I K D +S G+LL L+ G+ PF
Sbjct: 148 K---TWTFCGTPEYVAPE-----IILNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183
LV D+ G L+ + +K R H+ L L +H HS +IHRDIK A
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTF---REHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFG 243
N+L+ + ++ F + + ++ GTP Y+APE + S+K D++S G
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG 232
Query: 244 VLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASE-NPNRAIDSKLLGNGYEEQMLLVL 302
VLL L+ K PFD GE +M M +A +P L + E +V
Sbjct: 233 VLLYELLTLKRPFD------GE-NMEEVMHKTLAGRYDP-------LPPSISPEMQEIVT 278
Query: 303 KLACFCTLADPDERPNSK 320
L +DP RP+S
Sbjct: 279 ALLS----SDPKRRPSSS 292
|
Length = 496 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 8e-13
Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 35/234 (14%)
Query: 34 DCFASLEKIGSGGCGDVYKA--ELPGSNGKMIAVKKVIIYSPMSAAELIDAYSE------ 85
+ IG G G+V + +LPG +A+K L S+
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT-----------LKAGSSDKQRLDF 52
Query: 86 LGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGR 145
L E + Q H NI+ L + + +++ ++M+NGSL L +
Sbjct: 53 LTEASIMG---------QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL---REND 100
Query: 146 RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
+ + +ASG++YL + +HRD+ N+L++ ++ ++S F L+ +
Sbjct: 101 GKFTVGQLVGMLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLE 157
Query: 206 DGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
D T R+ APE + D++SFG+++ V+ G+ P+ D
Sbjct: 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-13
Identities = 56/214 (26%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ ++++GSG GDVYKA G++ AVK + + E G+ + I+
Sbjct: 11 YELIQRVGSGTYGDVYKAR-NLHTGELAAVKIIKL--------------EPGD-DFSLIQ 54
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE--WLSR 153
+I + +H NI+ + + + ++ GSLQ + Y V+ EL+ ++ R
Sbjct: 55 QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI-YHVTGPLSELQIAYVCR 113
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+ GL YLH S +HRDIK AN+L+ D+ + +++ F +A + + + +
Sbjct: 114 ETL-----QGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165
Query: 214 MYVVGTPRYIAPE---YHQTLTISEKCDIYSFGV 244
+GTP ++APE + ++ CDI++ G+
Sbjct: 166 F--IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 71/242 (29%), Positives = 104/242 (42%), Gaps = 45/242 (18%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKV-IIYSPMSAAELIDAYSELGEGKLTEIRSQIIT 100
+G G G V KA GK++A+KKV II + G T +R ++
Sbjct: 17 LGEGTYGKVEKAY-DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI-HFTTLR-ELKI 73
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK--GRRELEWLSRHK-IA 157
++I+H NI+ L+ V D LV D M D+ K R+ S+ K I
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA--------SDLKKVVDRKIRLTESQVKCIL 125
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-----ILMPDGLTQID 212
L + +GL LH +HRD+ PAN+ I+ +I+ F LA D L++ +
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 213 TM-------YVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--FPF 256
TM V T Y APE YH D++S G + A L+ GK FP
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFA------VDMWSVGCIFAELLTGKPLFPG 236
Query: 257 DD 258
++
Sbjct: 237 EN 238
|
Length = 335 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
S KIG G G V A + GK +AVKK+ + L +
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHT-GKQVAVKKMDLRKQQRRELLFN-------------- 68
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+++ H N++ + + D +V +F++ G+L + V+ R E ++
Sbjct: 69 -EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIA--T 122
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ L+V L YLH + VIHRDIK ++L+ D ++S F + + + ++
Sbjct: 123 VCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL- 178
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
VGTP ++APE L + DI+S G+++ ++ G+ P+
Sbjct: 179 -VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 49/203 (24%)
Query: 95 RSQIITASQIRH----RNIL-----PLLAHMV---RPDSHL-LVYDFMKNGSLQAVLYDV 141
+S +I +QI H R+IL P + + + + HL LV ++M G L +L +
Sbjct: 36 KSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL--I 93
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLH-MHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
K E +R IA V + L+ +H + IHRDIKP N+LID D +++ F L
Sbjct: 94 RKDVFPEET-ARFYIAELVLA-LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGL 147
Query: 201 AILMPDGLTQIDTMY---------------------------VVGTPRYIAPEYHQTLTI 233
M + + VGTP YIAPE +
Sbjct: 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY 207
Query: 234 SEKCDIYSFGVLLAVLVMGKFPF 256
+CD +S GV+L ++ G PF
Sbjct: 208 GLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-12
Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 36/236 (15%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F +E +G+G G VYK G+ + + ++A +++D + E EI+
Sbjct: 8 FELVELVGNGTYGQVYK-------GRHVKTGQ------LAAIKVMDVTGDEEE----EIK 50
Query: 96 SQI-ITASQIRHRNILPLLAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
+I + HRNI ++ D LV +F GS+ ++ + +
Sbjct: 51 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
EW++ I + GL +LH H +VIHRDIK NVL+ ++ E ++ F ++ + +
Sbjct: 111 EWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165
Query: 209 TQIDTMYVVGTPRYIAPEY-----HQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
+ +T +GTP ++APE + T K D++S G+ + G P D
Sbjct: 166 GRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 38/228 (16%)
Query: 43 GSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITAS 102
+ K + ++AVKK+ L E L ++ +IIT+
Sbjct: 11 EDLMIVHLAKHK---PTNTLVAVKKI---------NLDSCSKE----DLKLLQQEIITSR 54
Query: 103 QIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA--- 159
Q++H NILP + + +V M GS + +L E L IA
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP-----EGLPELAIAFILKD 109
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
V + L+Y+H IHR +K +++L+ D + +SG ++ M + V
Sbjct: 110 VLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV--VHDF 164
Query: 220 PRYI-------APE--YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
P+ +PE +EK DIYS G+ L G PF D
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLTEI 94
F +G GG G+V ++ + GKM A K++ E GE L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRAT-GKMYACKRL---------EKKRIKKRKGESMALNE- 50
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
QI+ ++ + ++ L D+ LV M G L+ +Y++ E E +
Sbjct: 51 -KQIL--EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY 107
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
A + GLE LH + ++RD+KP N+L+DD RIS LA+ +P+G +++
Sbjct: 108 --AAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----ESI 158
Query: 215 Y-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
VGT Y+APE + D + G L+ ++ G+ PF
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L+++G G G VYK L G +A+K++ + EL E K +QI
Sbjct: 6 LDELGKGNYGSVYKV-LHRPTGVTMAMKEIRL--------------ELDESKF----NQI 46
Query: 99 ITASQIRHRNILPLLAHM----VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
I I H+ + P + + + ++M GSL LY +
Sbjct: 47 IMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLR 105
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
+I AV GL++L H+ +IHRD+KP NVL++ + + ++ F ++ + L + +
Sbjct: 106 RITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-- 161
Query: 215 YVVGTPRYIAPEY------HQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
+G Y+APE +Q T + + D++S G+ + + +G++P+
Sbjct: 162 --IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLTEIRSQIIT 100
+G GG G+V ++ + GKM A KK+ E GE L E QI+
Sbjct: 8 LGKGGFGEVCACQVRAT-GKMYACKKL---------EKKRIKKRKGEAMALNE--KQIL- 54
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
++ R ++ L D+ LV M G L+ +Y++ + E + A +
Sbjct: 55 -EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY--AAEI 111
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
GLE LH R+++RD+KP N+L+DD RIS LA+ +P+G T VGT
Sbjct: 112 TCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTV 165
Query: 221 RYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
Y+APE + + D + G L+ ++ GK PF
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 3e-12
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 42/228 (18%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLTEIRSQ 97
++++G G G VY A G+++A+KK + + E L E++S
Sbjct: 4 IKQLGDGTFGSVYLARNK-ETGELVAIKK-----------MKKKFYSWEECMNLREVKS- 50
Query: 98 IITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI 156
+ + H NI+ L + R + L V+++M+ LY + K R+ + S I
Sbjct: 51 LRKLN--EHPNIVKLK-EVFRENDELYFVFEYMEGN-----LYQLMK-DRKGKPFSESVI 101
Query: 157 A---LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPDGLTQI 211
+ GL ++H H HRD+KP N+L+ +I+ F LA I T
Sbjct: 102 RSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD- 157
Query: 212 DTMYVVGTPRYIAPE--YHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
Y V T Y APE T + S DI++ G ++A L + FP
Sbjct: 158 ---Y-VSTRWYRAPEILLRST-SYSSPVDIWALGCIMAELYTLRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 56/239 (23%)
Query: 36 FASLEK---IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ LE+ IGSG G VYK + G++ A+K +IY
Sbjct: 73 LSELERVNRIGSGAGGTVYKV-IHRPTGRLYALK--VIYGNHEDT--------------- 114
Query: 93 EIRSQIITASQI----RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
+R QI +I H N++ ++ +FM GSL+ G
Sbjct: 115 -VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIA 165
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ +A + SG+ YLH H ++HRDIKP+N+LI+ +I+ F G+
Sbjct: 166 DEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADF--------GV 214
Query: 209 TQI--DTM----YVVGTPRYIAPEYHQT-----LTISEKCDIYSFGVLLAVLVMGKFPF 256
++I TM VGT Y++PE T DI+S GV + +G+FPF
Sbjct: 215 SRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 113 LAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRREL-EWLSRHKIALAVASGLEYLHMH 170
L + + +++L LV D+ G L +L SK L E ++R IA V + +H
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLA----IHSI 118
Query: 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAI-LMPDGLTQIDTMYVVGTPRYIAPEYHQ 229
H +HRDIKP NVL+D + R++ F + + DG Q + VGTP YI+PE Q
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SSVAVGTPDYISPEILQ 176
Query: 230 TL-----TISEKCDIYSFGVLLAVLVMGKFPF 256
+ +CD +S GV + ++ G+ PF
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 70/245 (28%), Positives = 111/245 (45%), Gaps = 51/245 (20%)
Query: 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIIT 100
IG GG G+VY A P + +A+KK I +S L L + L E +
Sbjct: 9 LIGKGGMGEVYLAYDPVC-SRRVALKK--IREDLSENPL------LKKRFLREAK----I 55
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYD--FMKNGSLQAVLYDVSKGRRELEWLSRH---- 154
A+ + H I+P+ + + D + Y +++ +L+++L V + E LS+
Sbjct: 56 AADLIHPGIVPVYS--ICSDGDPVYYTMPYIEGYTLKSLLKSV----WQKESLSKELAEK 109
Query: 155 -------KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI---LM 204
I + + +EY+H S V+HRD+KP N+L+ E I + AI L
Sbjct: 110 TSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166
Query: 205 PDGLTQID-----TMY--------VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251
+ L ID Y +VGTP Y+APE + SE DIY+ GV+L ++
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
Query: 252 GKFPF 256
FP+
Sbjct: 227 LSFPY 231
|
Length = 932 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 49/246 (19%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
I+ +DL FLK+ +G+G G V + G I K+I MS E I+
Sbjct: 1 IDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYDVAI---KMIKEGSMSEDEFIE 48
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
E K ++ H ++ L + +V ++M NG L L +
Sbjct: 49 ------EAK---------VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH 93
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
K + + L K V G+ YL S + IHRD+ N L+DD ++S F
Sbjct: 94 GKRFQPSQLLEMCK---DVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDF--- 144
Query: 202 ILMPDGLTQ--IDTMYV--VGTP---RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGK 253
GL++ +D Y VG+ R+ PE S K D+++FGVL+ V +GK
Sbjct: 145 -----GLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199
Query: 254 FPFDDF 259
P++ F
Sbjct: 200 MPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVK----KVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
+G G G V AEL G++ ++ A+K VI+ D + +TE R
Sbjct: 3 LGKGSFGKVMLAELKGTD-EVYAIKVLKKDVILQDD-------DV-----DCTMTEKR-- 47
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
I A +H + L D V +++ G L ++ + + R+ E SR A
Sbjct: 48 -ILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRF-YA 102
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI--LMPDGLTQIDTMY 215
V L +LH H VI+RD+K N+L+D + +++ F + ++ T
Sbjct: 103 AEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT---- 155
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF-----DDFF 260
GTP YIAPE Q L D ++ GVL+ ++ G+ PF DD F
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 73/258 (28%), Positives = 121/258 (46%), Gaps = 47/258 (18%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ +L +GSG G V A K +AVKK + P + LI A E +L +
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQK-VAVKK--LSRPFQS--LIHARRTYRELRLLK-- 69
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYD--FMKNGSLQAVLYDVSKGRRELEWLSR 153
++H N++ LL + P + + ++ ++ + A L ++ K ++ LS
Sbjct: 70 -------HMKHENVIGLL-DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----LSD 117
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+ + L L HSA +IHRD+KP+NV +++D E RI F LA D +T
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG--- 174
Query: 214 MYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDDFFSHTG 264
V T Y APE Y+QT+ DI+S G ++A L+ GK FP +D+
Sbjct: 175 --YVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGKALFPGNDY----- 221
Query: 265 EMDMVRWMRNVMASENPN 282
+D ++ + V+ + +P
Sbjct: 222 -IDQLKRIMEVVGTPSPE 238
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G V AEL G++ ++ AVK + ++I ++ E +TE R + A
Sbjct: 3 LGKGSFGKVLLAELKGTD-ELYAVKVL-------KKDVILQDDDV-ECTMTEKR---VLA 50
Query: 102 SQIRHRNILPLLAHMV----RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
+H P L + D V +++ G L ++ + + R E +R A
Sbjct: 51 LAGKH----PFLTQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARF-YA 102
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID-TMYV 216
+ GL++LH +I+RD+K NVL+D + +I+ F + +G+ T
Sbjct: 103 AEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMC---KEGILGGVTTSTF 156
Query: 217 VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
GTP YIAPE D ++ GVLL ++ G+ PF+
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-12
Identities = 56/235 (23%), Positives = 112/235 (47%), Gaps = 30/235 (12%)
Query: 35 CFASLEKIGSGGCGDVYKA--ELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ IG+G G+V++ ++PG +A+K L Y+E +
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKT-----------LKPGYTE---KQRQ 51
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+ S+ Q H NI+ L + + +++ ++M+NG+L L D + E+ S
Sbjct: 52 DFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-----HDGEFSS 106
Query: 153 RHKIAL--AVASGLEYL-HMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
+ + +A+G++YL M++ +HRD+ N+L++ ++E ++S F L+ ++ D
Sbjct: 107 YQLVGMLRGIAAGMKYLSDMNY----VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162
Query: 210 QIDTMYVVGTP-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDDFFSH 262
T P R+ APE + D++SFG+++ V+ G+ P+ D +H
Sbjct: 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ KIG G G V A S G+ +AVKK+ + L +
Sbjct: 21 LDNFVKIGEGSTGIVCIAT-DKSTGRQVAVKKMDLRKQQRRELLFN-------------- 65
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+++ +H NI+ + + + D +V +F++ G+L + V+ R E ++
Sbjct: 66 -EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIA--T 119
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ LAV L +LH VIHRDIK ++L+ D ++S F + + + ++
Sbjct: 120 VCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL- 175
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
VGTP ++APE L + DI+S G+++ +V G+ P+
Sbjct: 176 -VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-12
Identities = 67/291 (23%), Positives = 130/291 (44%), Gaps = 45/291 (15%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ LE IG G G VY+ GK + +V+ A ++I+ + + +++I+
Sbjct: 3 YQRLELIGRGAYGAVYR-------GKHVPTGRVV------ALKIINLDTP--DDDVSDIQ 47
Query: 96 SQIITASQIRH---RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
++ SQ+R NI ++ ++ ++ + GS++ ++ + ++
Sbjct: 48 REVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM--------KAGPIA 99
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
I++ + L L H VIHRDIK AN+L+ + ++ F +A L+ ++
Sbjct: 100 EKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159
Query: 213 TMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271
T VGTP ++APE K DI+S G+ + + G P+ D +D R
Sbjct: 160 TF--VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-------VDAFRA 210
Query: 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
M + S+ P +L NGY + + + C +P ER +++++
Sbjct: 211 MMLIPKSKPP------RLEDNGYSKLL---REFVAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 62/246 (25%), Positives = 110/246 (44%), Gaps = 37/246 (15%)
Query: 26 DLAFLKK-EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYS 84
DL+ L+ F +E +G+G G VYK + G++ A+K +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKT-GQLAAIKVM---------------- 49
Query: 85 ELGEGKLTEIRSQI-ITASQIRHRNILPLLAHMVRP------DSHLLVYDFMKNGSLQAV 137
++ E + EI+ +I + HRNI ++ D LV +F GS+ +
Sbjct: 50 DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL 109
Query: 138 LYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197
+ + + +W++ I + GL +LH H VIHRDIK NVL+ ++ E ++
Sbjct: 110 VKNTKGNALKEDWIAY--ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVD 164
Query: 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEY-----HQTLTISEKCDIYSFGVLLAVLVMG 252
F ++ + + + +T +GTP ++APE + T + DI+S G+ + G
Sbjct: 165 FGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
Query: 253 KFPFDD 258
P D
Sbjct: 223 APPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 60/240 (25%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L+K+G G G V+KA + +++A+KK+ DA+ + + T R +I
Sbjct: 12 LQKLGKGAYGIVWKA-IDRRTKEVVALKKIF-----------DAFRNATDAQRT-FR-EI 57
Query: 99 ITASQIR-HRNILPLLAHMVRPDSHL---LVYDFMKNGSLQAV-----LYDVSKGRRELE 149
+ ++ H NI+ LL ++++ ++ LV+++M+ L AV L DV
Sbjct: 58 MFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYMET-DLHAVIRANILEDV-------- 107
Query: 150 WLSRHK--IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL---M 204
HK I + L+Y+H S VIHRD+KP+N+L++ D +++ F LA +
Sbjct: 108 ----HKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
Query: 205 PDGLTQIDTMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
+ V T Y APE Y ++ D++S G +L +++GK FP
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRY------TKGVDMWSVGCILGEMLLGKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 45/244 (18%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
I+ +L FLK+ +GSG G V+ + G I K+I MS + I+
Sbjct: 1 IDPSELTFLKE---------LGSGQFGVVHLGKWRGKIDVAI---KMIREGAMSEDDFIE 48
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
E K+ ++ H N++ L + +V ++M NG L L +
Sbjct: 49 ------EAKVM---------MKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE- 92
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
KG+ EWL + V +EYL S IHRD+ N L+ +D ++S F LA
Sbjct: 93 RKGKLGTEWLL--DMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147
Query: 202 ILMPDGLTQIDTMYV--VGTP---RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFP 255
+ +D Y GT ++ PE S K D++SFGVL+ V GK P
Sbjct: 148 RYV------LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
Query: 256 FDDF 259
++ F
Sbjct: 202 YERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG--KLTEIRSQI 98
K+G G G+VY+ + +AVK L E ++ E +
Sbjct: 13 KLGGGQYGEVYEG-VWKKYSLTVAVKT------------------LKEDTMEVEEFLKEA 53
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+I+H N++ LL R ++ +FM G+L L + R+E+ + +A
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMAT 111
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
++S +EYL + IHRD+ N L+ ++ +++ F L+ LM DT
Sbjct: 112 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHA 163
Query: 219 TPRY----IAPEYHQTLTISEKCDIYSFGVLL---AVLVMGKFP 255
++ APE S K D+++FGVLL A M +P
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 20/145 (13%)
Query: 120 DSHL-LVYDFMKNGSLQAVL--YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVI 176
D +L +V ++M G L ++ YD+ + +W + + +A L HS I
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNYDIPE-----KWARFYTAEVVLA-----LDAIHSMGFI 164
Query: 177 HRDIKPANVLIDDDMEARISGFDLAILM-PDGLTQIDTMYVVGTPRYIAPEYHQTL---- 231
HRD+KP N+L+D +++ F + M +G+ + DT VGTP YI+PE ++
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDYISPEVLKSQGGDG 222
Query: 232 TISEKCDIYSFGVLLAVLVMGKFPF 256
+CD +S GV L +++G PF
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 34/227 (14%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
I G G V+ A+ S G + A+K VI + M +D Q++T
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIK-VIKKADMIRKNQVD---------------QVLTE 43
Query: 102 SQIRHRNILPLLAHMV---RPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
I + P + + + +L LV +++ G L ++L +V G + E ++R IA
Sbjct: 44 RDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLD-EDVARIYIA 100
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL--AILMPDGLTQIDTMY 215
V LEYLH + +IHRD+KP N+LID + +++ F L L+ + D
Sbjct: 101 EIVL-ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156
Query: 216 ----VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+VGTP YIAPE S+ D +S G +L ++G PF
Sbjct: 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLTEIRSQIIT 100
+G GG G+V ++ + GKM A KK+ E GE L E R
Sbjct: 8 LGKGGFGEVCACQVRAT-GKMYACKKL---------EKKRIKKRKGEAMALNEKR----I 53
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
++ R ++ L D+ LV M G L+ +Y++ G + A +
Sbjct: 54 LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAEL 111
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
GLE L R+++RD+KP N+L+DD RIS LA+ +P+G T VGT
Sbjct: 112 CCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTV 165
Query: 221 RYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
Y+APE + D + G L+ ++ G+ PF
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 68/228 (29%), Positives = 100/228 (43%), Gaps = 49/228 (21%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG--KLTEIRS 96
L +IG G G VYKA G+ +A+KKV + L E L+ +R
Sbjct: 4 LAEIGEGAYGTVYKARDLN-TGRFVALKKVRV--------------PLSEEGIPLSTLR- 47
Query: 97 QIITASQIR---HRNILPLL--AHMVRPDSHL---LVYDFMKNGSLQAVLYDVSK---GR 145
+I Q+ H NI+ LL H R D L LV++ + L L K
Sbjct: 48 EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP 106
Query: 146 RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA---- 201
++ L R + G+++LH H R++HRD+KP N+L+ D + +I+ F LA
Sbjct: 107 ETIKDLMRQ-----LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
Query: 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVL 249
M LT VV T Y APE + + D++S G + A L
Sbjct: 159 FEMA--LTS-----VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 38/234 (16%)
Query: 37 ASLEKI---GSGGCGDVYKA--ELPGSNGKMIAVKKVII--YSPMSAAELIDAYSELGEG 89
LEKI GSG G VYK G K+ KV+ SP + E++D E
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD------EA 60
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
+ AS + H +++ LL + L+ M G L L V + +
Sbjct: 61 Y--------VMAS-VDHPHVVRLLG-ICLSSQVQLITQLMPLGCL---LDYVRNHKDNIG 107
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
+ +A G+ YL R++HRD+ NVL+ +I+ F LA L+
Sbjct: 108 SQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD-- 162
Query: 210 QIDTMYVVG---TP-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
+ Y P +++A E + K D++S+GV + ++ G P++
Sbjct: 163 --EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 2e-11
Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 31/178 (17%)
Query: 97 QIITASQIRH----RNILPLLAH--MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL-E 149
+I+ Q+ H + IL + H +V L F + +L V+ V G EL
Sbjct: 38 KIVKLKQVEHVLNEKRILQSIRHPFLVN-----LYGSFQDDSNLYLVMEYVPGG--ELFS 90
Query: 150 WLSRHK---------IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
L + A V LEYLH +++RD+KP N+L+D D +I+ F
Sbjct: 91 HLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGF 147
Query: 201 AILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
A + T + GTP Y+APE + + D ++ G+L+ ++ G PF D
Sbjct: 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 28/220 (12%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
++K+G+G G+V+ G+ + K SP S E +QI
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE----------------EAQI 54
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ ++RH ++ L A +V + +V ++M GSL L D +GR L+ + +A
Sbjct: 55 M--KKLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKD-GEGR-ALKLPNLVDMAA 109
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
VA+G+ Y+ IHRD++ AN+L+ D + +I+ F LA L+ D +
Sbjct: 110 QVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAK 164
Query: 219 TP-RYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256
P ++ APE + K D++SFG+LL LV G+ P+
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 23/221 (10%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G VY G+ +AVK+V D S + ++ + +I
Sbjct: 10 LGQGAFGRVYLC-YDVDTGRELAVKQV----------PFDPDSPETKKEVNALECEIQLL 58
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVY-DFMKNGSLQAVLYDVSKGRREL-EWLSRHKIALA 159
++H I+ +R D L ++ ++M GS++ D K L E ++R K
Sbjct: 59 KNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTR-KYTRQ 112
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY-VVG 218
+ G+EYLH + ++HRDIK AN+L D ++ F + + + M V G
Sbjct: 113 ILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
TP +++PE K D++S G + ++ K P+ +F
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK-------IALAVASGLEYLHMHHSARVI 176
L Y F +L V+ + G L L+R++ +A + +H H +
Sbjct: 66 LQYAFQDKDNLYLVM-EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV 124
Query: 177 HRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK 236
HRDIKP NVLID +++ F A + + VGTP YIAPE T+ K
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL-PVGTPDYIAPEVLTTMNGDGK 183
Query: 237 ------CDIYSFGVLLAVLVMGKFPFDDFFSH 262
CD +S GV+ ++ G+ PF + S
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 26/225 (11%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMI--AVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
IG G G VY L S+G+ I AVK + + ++ E ++ + L EG
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL---NRITDLEEVEQF--LKEG-------- 47
Query: 98 IITASQIRHRNILPLLAHMVRPD-SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI 156
I H N+L LL + + S L+V +MK+G L+ + + + +
Sbjct: 48 -IIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---F 103
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG-LTQIDTMY 215
L VA G+EYL S + +HRD+ N ++D+ +++ F LA + D +
Sbjct: 104 GLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160
Query: 216 VVGTP-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
P +++A E QT + K D++SFGVLL ++ G P+ D
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 69/229 (30%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 36 FASLEKIGSGGCGDVYKA--ELPGSNGKMIAVKKVIIYSPMSAAELID-AYSELGEGKLT 92
+ L+ +G G G V A +L G N +A+KK I P S L Y EL KL
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQN---VAIKK--IMKPFSTPVLAKRTYREL---KLL 63
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+ +RH NI+ L + P + + L +L R LE
Sbjct: 64 K---------HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTS-----RPLEKQF 109
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
+ GL+Y+H SA V+HRD+KP+N+LI+++ + +I F LA + +T
Sbjct: 110 IQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG-- 164
Query: 213 TMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGK--FPFDD 258
V T Y APE T + DI+S G + A ++ GK FP D
Sbjct: 165 ---YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 29/228 (12%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F L+ IG G G+V +L ++ K+ A+K + + + AE E R
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNAD-KVFAMKILNKWEMLKRAE---------TACFREER 52
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
++ + L + + +++L LV D+ G L +L R E ++R
Sbjct: 53 DVLVNGDN----QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--RLPEDMARF 106
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI-LMPDGLTQIDT 213
+A V + ++ +H H +HRDIKP N+L+D + R++ F + LM DG Q +
Sbjct: 107 YLAEMVIA-IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--S 160
Query: 214 MYVVGTPRYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPF 256
VGTP YI+PE Q + + +CD +S GV + ++ G+ PF
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 71/262 (27%), Positives = 117/262 (44%), Gaps = 50/262 (19%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS-----PMSAAELIDAYSELGEGK 90
F L +IG G G VY+A S G+++A+KKV + + P+S+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTS-GEIVALKKVRMDNERDGIPISS-------------- 53
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMV--RPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
L EI + +RH NI+ L +V DS LV ++ + L ++L ++ E
Sbjct: 54 LREITLLL----NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSES 108
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ + L + GL+YLH + +IHRD+K +N+L+ D +I+ F LA GL
Sbjct: 109 QVKC---LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA--RTYGL 160
Query: 209 TQIDTMYVVGTPRYIAPEY-----HQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263
V T Y APE T I D+++ G +LA L+ K
Sbjct: 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAI----DMWAVGCILAELLAHK----PLLPGK 212
Query: 264 GEMDMVRWMRNVMASENPNRAI 285
E++ + + ++ + PN +I
Sbjct: 213 SEIEQLDLIIQLLGT--PNESI 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 69/229 (30%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID-AYSELGEGKLTEI 94
+ SL+++GSG G V A + G+ +A+KK + P + AY EL K
Sbjct: 17 YTSLKQVGSGAYGSVCSA-IDKRTGEKVAIKK--LSRPFQSEIFAKRAYRELTLLK---- 69
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
++H N++ LL S DF + + D+ K LS
Sbjct: 70 --------HMQHENVIGLLDVFTSAVSGDEFQDFYL--VMPYMQTDLQKIMGHP--LSED 117
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
K+ V L L HSA +IHRD+KP N+ +++D E +I F LA +T
Sbjct: 118 KVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG---- 173
Query: 215 YVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
YVV T Y APE Y+QT+ DI+S G ++A ++ GK F
Sbjct: 174 YVV-TRWYRAPEVILNWMHYNQTV------DIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L +G G G V K + G+++A+KK +E + + L E++
Sbjct: 6 LGVVGEGAYGVVLKCRNKAT-GEIVAIKK------FKESEDDEDVKKTA---LREVK--- 52
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
Q+RH NI+ L R LV+++++ L+ +L G L +
Sbjct: 53 -VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGG------LPPDAVRS 104
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+ L+ + HS +IHRDIKP N+L+ + ++ F A + T YV
Sbjct: 105 YIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA- 163
Query: 219 TPRYIAPEYHQTLTISEK-----CDIYSFGVLLAVLVMGK--FP 255
T Y APE L + + D+++ G ++A L+ G+ FP
Sbjct: 164 TRWYRAPE----LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 165 EYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIA 224
EYLH S +I+RD+KP N+L+D+ +++ F A +PD T + GTP Y+A
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLA 183
Query: 225 PEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
PE Q+ + D ++ GVLL + G PF D
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIIT 100
K+G G G+V+ G+ I K P E L E +QI+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP--------------EAFLQE--AQIM- 55
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
++RH ++PL A +V + +V +FM GSL L + +L L +A +
Sbjct: 56 -KKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQI 111
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
A G+ Y+ IHRD++ AN+L+ D++ +I+ F LA L+ D + P
Sbjct: 112 ADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFP 166
Query: 221 -RYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256
++ APE + K D++SFG+LL LV G+ P+
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 79 LIDAYSELGEG-------------------KLTEIRSQ---------IITASQIRHRNIL 110
L++ Y ++GEG K+ ++R Q ++ +H+N++
Sbjct: 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVV 81
Query: 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH 170
+ + + ++ +F++ G+L + VS+ R L+ +IA S L+ L
Sbjct: 82 EMYKSYLVGEELWVLMEFLQGGALTDI---VSQTR-----LNEEQIATVCESVLQALCYL 133
Query: 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT 230
HS VIHRDIK ++L+ D ++S F + + + ++ VGTP ++APE
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVISR 191
Query: 231 LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270
+ DI+S G+++ +V G+ P +FS + M R
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPP---YFSDSPVQAMKR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 9e-11
Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 16/148 (10%)
Query: 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178
PD V +F+ G L ++ + K RR E +R A + S L +LH +I+R
Sbjct: 68 PDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAA-EITSALMFLH---DKGIIYR 120
Query: 179 DIKPANVLIDDDMEARISGFDLAIL-MPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKC 237
D+K NVL+D + +++ F + + +G T T GTP YIAPE Q +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 238 DIYSFGVLLAVLVMGKFPF-----DDFF 260
D ++ GVLL ++ G PF DD F
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 38/108 (35%), Positives = 61/108 (56%), Gaps = 11/108 (10%)
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ-IDT 213
KIA+++ LEYLH S VIHRD+KP+NVLI+ + + ++ F ++ + D + + ID
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID- 163
Query: 214 MYVVGTPRYIAPEYHQTLTISE----KCDIYSFGVLLAVLVMGKFPFD 257
G Y+APE + K D++S G+ + L G+FP+D
Sbjct: 164 ---AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 57 GSNGKMIAVKKVII--YSPMS--AAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112
G+ GK+I V++ Y M E+I A E+ LTE R RH + L
Sbjct: 6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAH-TLTESR----VLKNTRHPFLTSL 60
Query: 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS 172
D V +++ G L + +S+ R E +R A + S L+YLH S
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGA-EIVSALDYLH---S 113
Query: 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRYIAPEYHQTL 231
++++RD+K N+++D D +I+ F L +G+T TM GTP Y+APE +
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDN 170
Query: 232 TISEKCDIYSFGVLLAVLVMGKFPF 256
D + GV++ ++ G+ PF
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 9/107 (8%)
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
K+ +A+ L YL H VIHRD+KP+N+L+D ++ F ++ + D + +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS- 174
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDI----YSFGVLLAVLVMGKFPFD 257
G Y+APE + K DI +S G+ L L G+FP+
Sbjct: 175 --AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ ++KIG G G +Y A+ + V K I + M E + E
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEH--CVIKEIDLTKMPVKEKEASKKE---------- 49
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSL-------QAVLYDVSKGRREL 148
+I ++++H NI+ A +V ++ G L + VL+ + L
Sbjct: 50 --VILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ---IL 104
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD-MEARISGFDLAILMPDG 207
W + ++ GL+++H +++HRDIK N+ + + M A++ F +A + D
Sbjct: 105 SWF------VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
+ T VGTP Y++PE Q + K DI+S G +L L K PF+
Sbjct: 156 MELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 43/176 (24%), Positives = 86/176 (48%), Gaps = 11/176 (6%)
Query: 84 SELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK 143
+ L E + + ++I+ S ++H NI+ H + ++ L+ ++ G+L YD
Sbjct: 36 TRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL----YDKIV 91
Query: 144 GRRELEWLSRHKIAL--AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
++ + + + S + Y+H A ++HRDIK N+ + ++ F ++
Sbjct: 92 RQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148
Query: 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
++ + +T VVGTP Y++PE Q + + K DI++ G +L L+ K FD
Sbjct: 149 KILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 19/168 (11%)
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGR-----REL 148
R + + ++++H NI+ D HL +V ++ G L + +G+ L
Sbjct: 46 RKEAVLLAKMKHPNIVAF-KESFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTIL 103
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+W ++ L V H+H RV+HRDIK N+ + + + ++ F A L+
Sbjct: 104 QWFV--QMCLGVQ------HIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
T VGTP Y+ PE + + + K DI+S G +L L K PF
Sbjct: 155 AYACTY--VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 20/145 (13%)
Query: 120 DSHL-LVYDFMKNGSLQAVL--YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVI 176
D +L +V ++M G L ++ YDV + +W + + +A L HS +I
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNYDVPE-----KWAKFYTAEVVLA-----LDAIHSMGLI 164
Query: 177 HRDIKPANVLIDDDMEARISGFDLAILMPD-GLTQIDTMYVVGTPRYIAPEYHQTLT--- 232
HRD+KP N+L+D +++ F + M + G+ + DT VGTP YI+PE ++
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT--AVGTPDYISPEVLKSQGGDG 222
Query: 233 -ISEKCDIYSFGVLLAVLVMGKFPF 256
+CD +S GV L +++G PF
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E F+ L +IG G G VY A ++ +++A+KK + YS + E K
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKK-MSYSGKQSNE-----------KWQ 60
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+I ++ ++RH N + +R + LV ++ GS +L K +E+E +
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA 119
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
+ GL YLH H+ +IHRD+K N+L+ + ++ F A +M
Sbjct: 120 ---VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX--- 170
Query: 213 TMYVVGTPRYIAPEYHQTLTISE-----KCDIYSFGV 244
VGTP ++APE L + E K D++S G+
Sbjct: 171 ---FVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIIT 100
K+G G G+V+ G+ I K SP E L E +Q++
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--------------EAFLQE--AQVM- 55
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
++RH ++ L A +V + +V ++M GSL L L L +A +
Sbjct: 56 -KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQI 111
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
ASG+ Y+ +HRD++ AN+L+ +++ +++ F LA L+ D + P
Sbjct: 112 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP 166
Query: 221 -RYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMAS 278
++ APE + K D++SFG+LL L G+ P+ + + R R
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317
E P D L C C +P+ERP
Sbjct: 227 ECPESLHD-----------------LMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 58/224 (25%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
++K+G+G G+V+ G KV I S + +A+ L E L +
Sbjct: 11 VKKLGAGQFGEVWMGYYNGH-------TKVAIKSLKQGSMSPEAF--LAEANLMK----- 56
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI-- 156
Q++H ++ L A +V + ++ ++M+NGSL L +G + L+ +K+
Sbjct: 57 ----QLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFL-KTPEGIK----LTINKLID 106
Query: 157 -ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG--LTQIDT 213
A +A G+ ++ + IHRD++ AN+L+ + + +I+ F LA L+ D +
Sbjct: 107 MAAQIAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256
+ + ++ APE T + K D++SFG+LL +V G+ P+
Sbjct: 164 KFPI---KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 58/253 (22%), Positives = 96/253 (37%), Gaps = 55/253 (21%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F ++ +G G G V+ L G+ GK+ A+K V+ M K+ +
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT-GKLFALK-VLDKKEMIK-----------RNKVKRVL 49
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++ + + H + L A LV D+ G L +L G+ E ++R
Sbjct: 50 TEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLSEEVARFY 108
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID--- 212
A + LEYLH+ +++RD+KP N+L+ + +S FDL+ +
Sbjct: 109 AAEVLL-ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164
Query: 213 ------------------------TMYVVGTPRYIAPEY-----HQTLTISEKCDIYSFG 243
+ VGT YIAPE H D ++ G
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-----GSAVDWWTLG 219
Query: 244 VLLAVLVMGKFPF 256
+LL ++ G PF
Sbjct: 220 ILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 49/295 (16%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E+ F L +IG G G VY A +N +++AVKK + YS E K
Sbjct: 20 EEIFVGLHEIGHGSFGAVYFATNSHTN-EVVAVKK-MSYSGKQTNE-----------KWQ 66
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+I ++ Q++H N + ++ + LV ++ GS +L K +E+E +
Sbjct: 67 DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA 125
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
I GL YLH H+ +IHRDIK N+L+ + + +++ F A +
Sbjct: 126 ---ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS--- 176
Query: 213 TMYVVGTPRYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267
VGTP ++APE L + E K D++S G+ L K P + M+
Sbjct: 177 ---FVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MN 224
Query: 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ + ++ +++P L N + + +C P ERP S ++
Sbjct: 225 AMSALYHIAQNDSPT------LQSNEWTDSF---RGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 19/140 (13%)
Query: 124 LVYDFMKNGSLQAVL--YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181
+V ++M G L ++ YDV + +W + + +A L HS IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KWARFYTAEVVLA-----LDAIHSMGFIHRDVK 169
Query: 182 PANVLIDDDMEARISGFDLAILM-PDGLTQIDTMYVVGTPRYIAPEYHQTLT----ISEK 236
P N+L+D +++ F + M +G+ + DT VGTP YI+PE ++ +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 237 CDIYSFGVLLAVLVMGKFPF 256
CD +S GV L +++G PF
Sbjct: 228 CDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 46/140 (32%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 124 LVYDFMKNGSLQAVLYDVSK-GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182
LV D+ G L +L SK R E ++R +A V + + H +HRDIKP
Sbjct: 78 LVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLA----IDSVHQLGYVHRDIKP 130
Query: 183 ANVLIDDDMEARISGFDLAI-LMPDGLTQIDTMYVVGTPRYIAPEYHQTL-----TISEK 236
NVL+D + R++ F + L+ DG + + VGTP YI+PE Q + +
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGTPDYISPEILQAMEDGKGRYGPE 188
Query: 237 CDIYSFGVLLAVLVMGKFPF 256
CD +S GV + ++ G+ PF
Sbjct: 189 CDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 57 GSNGKMIAV--KKVIIYSPMSA--AELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112
G+ GK+I V K Y M E+I A E+ +TE R RH + L
Sbjct: 6 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-TVTESR----VLQNTRHPFLTAL 60
Query: 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS 172
D V ++ G L + +S+ R E +R A + S LEYLH S
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLH---S 113
Query: 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRYIAPEYHQTL 231
V++RDIK N+++D D +I+ F L +G++ TM GTP Y+APE +
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 232 TISEKCDIYSFGVLLAVLVMGKFPF 256
D + GV++ ++ G+ PF
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 73/302 (24%), Positives = 122/302 (40%), Gaps = 65/302 (21%)
Query: 38 SLEKI-GSGGCGDVYKAELP---GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
L KI G G G V + +L GS K +AVK M I YSE+ E L+E
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLK-VAVKT------MKLD--IHTYSEI-EEFLSE 51
Query: 94 IRSQIITASQIRHRNILPLL------AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE 147
H N++ L+ + + + +++ FMK+G L + L
Sbjct: 52 A----ACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-----YSR 102
Query: 148 LEWLSRH-------KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
L L K + +A G+EYL + IHRD+ N ++ +DM ++ F L
Sbjct: 103 LGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL 159
Query: 201 AILMPDG----LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFP 255
+ + G +I M V ++IA E + K D+++FGV + + G+ P
Sbjct: 160 SKKIYSGDYYRQGRIAKMPV----KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
Query: 256 FDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDE 315
+ +H ++ ++R+ + P +D + L C ADP +
Sbjct: 216 YPGVENH----EIYDYLRHGNRLKQPEDCLDE-------------LYDLMYSCWRADPKD 258
Query: 316 RP 317
RP
Sbjct: 259 RP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 36 FASLEKIGSGGCGDVYKAE-LPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLTE 93
+ IG G G VYKA+ G +GK A+KK E G +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK------------FKGDKEQYTGISQSA 49
Query: 94 IRSQIITASQIRHRNILPL----LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
R +I +++H N++ L L H + S L++D+ ++ Q + + R +
Sbjct: 50 CR-EIALLRELKHENVVSLVEVFLEHADK--SVYLLFDYAEHDLWQIIKFHRQAKRVSIP 106
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR----ISGFDLAILMP 205
+ + +G+ YLH + V+HRD+KPAN+L+ + R I LA L
Sbjct: 107 PSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 206 DGLTQI-DTMYVVGTPRYIAPEY-----HQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
L + D VV T Y APE H T I DI++ G + A L+ + F
Sbjct: 164 APLKPLADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 39/236 (16%)
Query: 42 IGSGGCGDVYKAELPGSN----GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
+G G G V +AE G + + + V ++ + +L D SE+ KL
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG---- 75
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL-----------YDVSKGRR 146
+H+NI+ LL + ++ ++ G+L+ L +D++K
Sbjct: 76 -------KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 147 E-LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
E L + A VA G+EYL S R IHRD+ NVL+ +D +I+ F LA
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA---- 181
Query: 206 DGLTQIDTMYVVGTPR----YIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
G+ ID R ++APE + + D++SFG+L+ + +G P+
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 67/234 (28%), Positives = 104/234 (44%), Gaps = 41/234 (17%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVI--IYSPMSAAELIDAYSELGEGKLTE 93
+ +L+ IGSG G V A G+ +A+KK+ + A AY EL L +
Sbjct: 18 YQNLKPIGSGAQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAKR---AYREL---VLMK 70
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKGRR 146
+ + H+NI+ LL ++ P L LV + M Q + D+ R
Sbjct: 71 L---------VNHKNIIGLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER- 119
Query: 147 ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
+ +L + G+++LH SA +IHRD+KP+N+++ D +I F LA
Sbjct: 120 -MSYL-----LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170
Query: 207 GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDD 258
T YVV T Y APE + E DI+S G ++ ++ G FP D
Sbjct: 171 SFMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 42 IGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+G G G V+ AEL G+N + A+KK ++ L+D E T + +++
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--------LMDDDVEC-----TMVEKRVL 49
Query: 100 TASQIRHRNILPLLAHM---VRPDSHLL-VYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+ + H P L H+ + +L V +++ G L ++ + + L R
Sbjct: 50 SLAW-EH----PFLTHLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFD--LPRAT 99
Query: 156 I-ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
A + GL++LH S +++RD+K N+L+D D +I+ D + + L T
Sbjct: 100 FYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIA--DFGMCKENMLGDAKTC 154
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
GTP YIAPE + D +SFGVLL +++G+ PF
Sbjct: 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 19/166 (11%)
Query: 104 IRHRNILPLLAHMVR-PDSHLLVYDFMKNGSLQAVLYDVSKGRREL-EWLSRHKI---AL 158
+ H+NILP+L + + ++Y +M G+L+ L G + LS ++ A+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI---LMPDGLTQI-DTM 214
+A G+ YLH VIH+DI N +ID++++ +I+ D A+ L P + D
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT--DNALSRDLFPMDYHCLGDNE 179
Query: 215 YVVGTP-RYIAPEYHQTLTISEKCDIYSFGVLLAVLV-MGKFPFDD 258
P +++A E S D++SFGVLL L+ +G+ P+ +
Sbjct: 180 N---RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 28/182 (15%)
Query: 87 GEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLL-VYDFMKNGSLQAVLYD----- 140
E + R + +++ H NI+ LL P L V++++ +L+ VL
Sbjct: 18 EEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALP 77
Query: 141 -VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARIS 196
GR L+ L ALA A H+ ++HRD+KP N+++ A++
Sbjct: 78 AGETGRLMLQVLD----ALACA---------HNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 197 GFDLAILMP-----DGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251
F + L+P D T T V+GTP Y APE + ++ D+Y++G++ +
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
Query: 252 GK 253
G+
Sbjct: 185 GQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 35/230 (15%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLTEI 94
+ +EKIG G G VYKA G+++A+KK I +E EG T I
Sbjct: 1 YQKVEKIGEGTYGVVYKA-RDKLTGEIVALKK------------IRLETE-DEGVPSTAI 46
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVL---YDVSKGRRELEW 150
R +I ++ H NI+ LL +V ++ L LV++F+ + L+ + ++
Sbjct: 47 R-EISLLKELNHPNIVRLL-DVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIK- 102
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
+ G+ Y H H RV+HRD+KP N+LID + +++ F LA +
Sbjct: 103 ----SYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155
Query: 211 IDTMYVVGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGK--FPFD 257
T VV T Y APE + S DI+S G + A +V + FP D
Sbjct: 156 Y-THEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 54/240 (22%)
Query: 42 IGSGGCGDVYKAELPG---SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+G G G+V+ A+ G G+ + + K + + E +E R ++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-------------ENLQSEFRREL 59
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWL----SRH 154
++ H+N++ LL + H ++ ++ G L+ L +K + E ++
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQ 118
Query: 155 KIALA--VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA----------- 201
K+AL +A G+++L +AR +HRD+ N L+ E ++S L+
Sbjct: 119 KVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL 175
Query: 202 --ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
L+P R++APE Q S K D++SFGVL+ V G+ PF
Sbjct: 176 RNALIP--------------LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 57 GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH- 115
GS GK+ V+K+ A +L A L + L ++R ++ T + R+IL + H
Sbjct: 7 GSFGKVFLVRKIT---GPDAGQLY-AMKVLKKATL-KVRDRVRTKME---RDILAEVNHP 58
Query: 116 -MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH--------KIALA-VASGLE 165
+V+ L Y F G L +L D +G LS+ K LA +A L+
Sbjct: 59 FIVK-----LHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 112
Query: 166 YLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAP 225
+LH S +I+RD+KP N+L+D++ +++ F L+ D + GT Y+AP
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAP 167
Query: 226 EYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
E ++ D +SFGVL+ ++ G PF
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 33/229 (14%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E F L +IG G G VY A +N +++A+KK + YS + E K
Sbjct: 24 EKLFTDLREIGHGSFGAVYFARDVRTN-EVVAIKK-MSYSGKQSNE-----------KWQ 70
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+I ++ +I+H N + +R + LV ++ GS +L K +E+E +
Sbjct: 71 DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA 129
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
I GL YLH H+ +IHRDIK N+L+ + + +++ F A + +
Sbjct: 130 ---ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS--- 180
Query: 213 TMYVVGTPRYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPF 256
VGTP ++APE L + E K D++S G+ L K P
Sbjct: 181 ---FVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 72/311 (23%), Positives = 121/311 (38%), Gaps = 71/311 (22%)
Query: 39 LEKIGSGGCGDVYKAEL----PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL-TE 93
+E++G G VYK L PG + +A+K + + EG L E
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL---------------KDKAEGPLREE 54
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLY------------DV 141
+ + + S+++H NI+ LL + + +++ + + L L D
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF--- 198
+ LE I +A+G+E+L HH V+H+D+ NVL+ D + +IS
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 199 ------DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVM 251
D LM + L I R+++PE S DI+S+GV+L V
Sbjct: 172 REVYAADYYKLMGNSLLPI---------RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY 222
Query: 252 GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLA 311
G P+ + D++ +RN P+ + L L C+
Sbjct: 223 GLQPYCGY----SNQDVIEMIRNRQVLPCPDDC-----------PAWVYTLMLECWNEF- 266
Query: 312 DPDERPNSKDV 322
P RP KD+
Sbjct: 267 -PSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASG 163
++H ++ L + V DF+ G L + + + R E +R A +AS
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAA-EIASA 108
Query: 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRY 222
L YLH S +++RD+KP N+L+D ++ F L +G+ Q DT GTP Y
Sbjct: 109 LGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEY 162
Query: 223 IAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
+APE + D + G +L ++ G PF
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
IG GG G+VY GKM A+K L ++ +G+ + +I+ +
Sbjct: 2 IGRGGFGEVYGCR-KADTGKMYAMKC-----------LDKKRIKMKQGETLALNERIMLS 49
Query: 102 SQIRHRNILPLLAHMV----RPDSHLLVYDFMKNGSLQAVLYDVSK----GRRELEWLSR 153
+ P + M PD + D M G L Y +S+ +E+ +
Sbjct: 50 --LVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH---YHLSQHGVFSEKEMRFY-- 102
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
A + GLE HMH+ V++RD+KPAN+L+D+ RIS LA ++
Sbjct: 103 ---ATEIILGLE--HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKP 152
Query: 214 MYVVGTPRYIAPEYHQTLTISE-KCDIYSFGVLLAVLVMGKFPF 256
VGT Y+APE Q T + D +S G +L L+ G PF
Sbjct: 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-10
Identities = 58/240 (24%), Positives = 112/240 (46%), Gaps = 34/240 (14%)
Query: 26 DLAFLKKEDCFASLEKIGSGGCGDVYKAEL--PGSNGKMIAVKKVIIYSPMSAAELIDAY 83
D++ +K E E IG+G G+V + L PG +A+K L Y
Sbjct: 2 DVSCVKIE------EVIGAGEFGEVCRGRLKLPGKREIFVAIKT-----------LKSGY 44
Query: 84 SELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK 143
+E + + S+ Q H NI+ L + + +++ +FM+NG+L + L +
Sbjct: 45 TE---KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL-RQND 100
Query: 144 GRRELEWLSRHKIALAVASGLEYL-HMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
G+ + L + +A+G++YL M++ +HRD+ N+L++ ++ ++S F L+
Sbjct: 101 GQFTVIQLV--GMLRGIAAGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSR 154
Query: 203 LMPDGLTQIDTMYVVGTP---RYIAPEYHQTLTISEKCDIYSFG-VLLAVLVMGKFPFDD 258
+ D + +G R+ APE + D++S+G V+ V+ G+ P+ D
Sbjct: 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 32/99 (32%), Positives = 56/99 (56%), Gaps = 8/99 (8%)
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
+ LEYLH S +++RD+KP N+L+D + +++ F A + D T + GT
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGT 161
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
P Y+APE Q+ ++ D ++ G+L+ +++G PF D
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
++K+G+G G+V+ +N +AVK + P + + + A+ E E L +
Sbjct: 11 VKKLGAGQFGEVWMGYY--NNSTKVAVKTL---KPGTMS--VQAFLE--EANLMK----- 56
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
++H ++ L A + + + ++ ++M GSL L G+ L L +
Sbjct: 57 ----TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI--DFSA 110
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+A G+ Y+ + IHRD++ ANVL+ + + +I+ F LA ++ D +
Sbjct: 111 QIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAK 165
Query: 219 TP-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
P ++ APE + + K D++SFG+LL ++ GK P+
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 79/301 (26%), Positives = 133/301 (44%), Gaps = 39/301 (12%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ +L +G G G V K + + G+++A+KK + + I + EIR
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKET-GQIVAIKKFLESEDDKMVKKI---------AMREIR 52
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
Q+RH N++ L+ R LV++F+ + VL D+ K L+ K
Sbjct: 53 ----MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRK 104
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ G+E+ H H+ +IHRDIKP N+L+ ++ F A + ++ T Y
Sbjct: 105 YLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDY 160
Query: 216 VVGTPRYIAPEYHQTLTISEK-CDIYSFGVLLAVLVMGK--FPFD---DFFSHTGEM--D 267
V T Y APE T + DI++ G L+ ++ G+ FP D D H + +
Sbjct: 161 -VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN 219
Query: 268 MVRWMRNVMASENPNRAI-------DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320
++ + + +NP A + + L + + LVL LA C DPD+RP+S
Sbjct: 220 LIPRHQEIF-QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 321 D 321
Sbjct: 279 Q 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 62/232 (26%), Positives = 106/232 (45%), Gaps = 48/232 (20%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLTEI 94
+ +EKIG G G VYK G+++A+KK+ + S EG T I
Sbjct: 2 YTKIEKIGEGTYGVVYKGR-NKKTGQIVAMKKIRLESE-------------EEGVPSTAI 47
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
R +I +++H NI+ L +++ L+++F+ + L+ L + KG +++
Sbjct: 48 R-EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKG----QYMDAE 101
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL--AILMPDGLTQID 212
+ + L+ + HS RV+HRD+KP N+LID+ +++ F L A +P ++
Sbjct: 102 LVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VRVY 158
Query: 213 TMYVV-----------GTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK 253
T VV G+PRY P DI+S G + A + K
Sbjct: 159 THEVVTLWYRAPEVLLGSPRYSTP-----------VDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 38/102 (37%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL-MPDGLTQIDTMY 215
A +A GL +LH S +I+RD+K NV++D + +I+ F + M DG+T T
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT---TKT 160
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
GTP YIAPE + D ++FGVLL ++ G+ PF+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI--LMPDGLTQIDTM 214
A +A GL +LH S +I+RD+K NV++D + +I+ F + + T+
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT--- 160
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
GTP YIAPE + D ++FGVLL ++ G+ PFD
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 71/305 (23%), Positives = 127/305 (41%), Gaps = 59/305 (19%)
Query: 39 LEKIGSGGCGDVYKAEL--PG-SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+E++G G +YK L PG + +++A+K + + + E +
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ--------------QWGEFQ 55
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLY------DVSKGRRE-- 147
+ +++ H NI+ LL + + ++++++ G L L DV E
Sbjct: 56 QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115
Query: 148 -----LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA- 201
L+ IA+ +A+G+EYL H +H+D+ N+LI + + +IS L+
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 202 -ILMPDGL-TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
I D Q ++ + R++ PE S DI+SFGV+L + G P+
Sbjct: 173 EIYSADYYRVQPKSLLPI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229
Query: 259 FFSHTGEMDMVRWMRNVMASEN-PNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317
FS+ ++MVR + + SE+ P R + L C P RP
Sbjct: 230 -FSNQEVIEMVRKRQLLPCSEDCPPR-----------------MYSLMTECWQEGPSRRP 271
Query: 318 NSKDV 322
KD+
Sbjct: 272 RFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
IG GG G+VY GKM A+K L ++ +G+ + +I+ +
Sbjct: 2 IGRGGFGEVYGCR-KADTGKMYAMKC-----------LDKKRIKMKQGETLALNERIMLS 49
Query: 102 SQIRHRNILPLLAHMV----RPDSHLLVYDFMKNGSLQAVLYDVSK----GRRELEWLSR 153
+ P + M PD + D M G L Y +S+ E+ +
Sbjct: 50 --LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEAEMRFY-- 102
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
A + GLE HMH+ V++RD+KPAN+L+D+ RIS LA ++
Sbjct: 103 ---AAEIILGLE--HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKP 152
Query: 214 MYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPF 256
VGT Y+APE Q + D +S G +L L+ G PF
Sbjct: 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 22/143 (15%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183
LV++FM++G L L +G+ E L + L V G+ YL S+ VIHRD+
Sbjct: 76 LVFEFMEHGCLSDYL-RAQRGKFSQETLL--GMCLDVCEGMAYLE---SSNVIHRDLAAR 129
Query: 184 NVLIDDDMEARISGFDLAILMPDGLTQI--DTMYVVGTP-----RYIAPEYHQTLTISEK 236
N L+ ++ ++S F G+T+ D Y T ++ +PE S K
Sbjct: 130 NCLVGENQVVKVSDF--------GMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 237 CDIYSFGVLL-AVLVMGKFPFDD 258
D++SFGVL+ V GK P+++
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 66/236 (27%), Positives = 109/236 (46%), Gaps = 41/236 (17%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ + +L +GSG G V A G +AVKK + P + +I A E +L +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK--LSRPFQS--IIHAKRTYRELRLLK 71
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYD--FMKNGSLQAVLYDVSKGRRELEWL 151
++H N++ LL + P L ++ ++ + A L ++ K ++ L
Sbjct: 72 ---------HMKHENVIGLL-DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----L 117
Query: 152 SRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI 211
+ + + L L HSA +IHRD+KP+N+ +++D E +I F LA D +T
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG- 176
Query: 212 DTMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDD 258
V T Y APE Y+QT+ DI+S G ++A L+ G+ FP D
Sbjct: 177 ----YVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 12/203 (5%)
Query: 57 GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHM 116
GS GK++ V+K + A + I + ++T ++ +Q+ I+PL
Sbjct: 4 GSFGKVMQVRKRDT-QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF 62
Query: 117 VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA-LAVASGLEYLHMHHSARV 175
P+ LV F+ G L + + + R +R A L A LE LH V
Sbjct: 63 QSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAELLCA--LENLH---KFNV 114
Query: 176 IHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISE 235
I+RD+KP N+L+D + F L L + +T GTP Y+APE ++
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF--CGTPEYLAPELLLGHGYTK 172
Query: 236 KCDIYSFGVLLAVLVMGKFPFDD 258
D ++ GVLL ++ G PF D
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 15/165 (9%)
Query: 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASG 163
++H ++ L D V D++ G L Y + + R LE +R A +AS
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASA 108
Query: 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI--LMPDGLTQIDTMYVVGTPR 221
L YLH S +++RD+KP N+L+D ++ F L + +G T GTP
Sbjct: 109 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST----FCGTPE 161
Query: 222 YIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266
Y+APE D + G +L ++ G PF + +T EM
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF--YSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 19/144 (13%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEW-LSRHKI---------ALAVASGLEYLHMHHSA 173
L Y F + L V+ + G EL + LSR ++ + S L YLH S
Sbjct: 60 LKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SC 114
Query: 174 RVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRYIAPEYHQTLT 232
V++RD+K N+++D D +I+ F L +G++ TM GTP Y+APE +
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 233 ISEKCDIYSFGVLLAVLVMGKFPF 256
D + GV++ ++ G+ PF
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 36/229 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVI-IYSPMSAAELIDAYSELGEGKLTEIRSQ 97
E IG G G V A + G+ +A+KK+ ++ +S DA L E KL +
Sbjct: 5 QEVIGKGSYGVVCSA-IDTHTGEKVAIKKINDVFEHVS-----DATRILREIKLLRL--- 55
Query: 98 IITASQIRHRNILPLLAHMVRPDSH-----LLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+RH +I+ + M+ P +V++ M++ L+ V K +L
Sbjct: 56 ------LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLT-PE 103
Query: 153 RHKIAL-AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDGLTQ 210
H+ L + L+Y+H +A V HRD+KP N+L + D + +I F LA + D T
Sbjct: 104 HHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 211 IDTMYVVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVMGK--FP 255
I V T Y APE + + DI+S G + A ++ GK FP
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 41/177 (23%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS-----PMSAAELIDAYSELGEGKLTE 93
L K+G G G+VYKA G+++A+KK+++++ P++A L E
Sbjct: 13 LGKLGEGTFGEVYKAR-QIKTGRVVALKKILMHNEKDGFPITA--------------LRE 57
Query: 94 IRSQIITASQIRHRNILPLLAHMV--RPDSHL-------LVYDFMKNGSLQAVLYDVSKG 144
I+ I+ ++H N++PL+ M RPD +V +M + L +L
Sbjct: 58 IK--ILKK--LKHPNVVPLI-DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLL---ENP 108
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+L L + G+ YLH ++HRDIK AN+LID+ +I+ F LA
Sbjct: 109 SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F L ++G GG G V+ A+ + G+++A+K+ M + L KL E+R
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDT-GEIVALKR------MKKSLLF---------KLNEVR 46
Query: 96 SQIITASQI----RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWL 151
++T I + ++ LL + L +++ G + +L + L L
Sbjct: 47 -HVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-------LGVL 98
Query: 152 SRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI 211
S +A E + H IHRD+KP N LID +++ F L+ +T
Sbjct: 99 SEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYA 155
Query: 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
++ VVG+P Y+APE + D +S G +L + G PF
Sbjct: 156 NS--VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 163 GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRY 222
GL+YLH SA ++HRDIKP N+L++ + +I F LA + ++ T VV T Y
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170
Query: 223 IAPEY-----HQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
APE H T + DI+S G + A L+ + F
Sbjct: 171 RAPEILMGSRHYTSAV----DIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 39 LEKIGSGGCGDVYKAE---LPGSNGKM-IAVKKVIIYSPMSAAE--LIDAYSELGEGKLT 92
+ +G G G V KAE L N +AVK + A E L D SE+ K+
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDLVSEMEMMKMI 72
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL---------YDVSK 143
+H+NI+ LL + +V ++ +G+L+ L
Sbjct: 73 G-----------KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 144 GRRELEWLSRHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
R E L++ + A VA G+E+L S + IHRD+ NVL+ +D +I+ F L
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGL 178
Query: 201 AILMPDGLTQIDTMYVVGTPR----YIAPEYHQTLTISEKCDIYSFGVLL 246
A + ID R ++APE + + D++SFGVLL
Sbjct: 179 A----RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 24/191 (12%)
Query: 139 YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198
Y+V K E L KIA+A L YL ++IHRD+KP+N+L+D + ++ F
Sbjct: 97 YEVLKSVIPEEILG--KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDF 152
Query: 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISE---KCDIYSFGVLLAVLVMGKFP 255
++ + D + + T G Y+APE + D++S G+ L + GKFP
Sbjct: 153 GISGQLVDSIAK--TRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
Query: 256 FDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLL-VLKLACFCTLADPD 314
+ + + + V+ + P +L N E + + C + D
Sbjct: 210 YPKW------NSVFDQLTQVVKGDPP-------ILSNSEEREFSPSFVNFINLCLIKDES 256
Query: 315 ERPNSKDVRCM 325
+RP K++
Sbjct: 257 KRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK-LTEI 94
F LEK+G G VYK + G+++A+K++ +DA EG T I
Sbjct: 2 FKQLEKLGEGTYATVYKG-RNRTTGEIVALKEI----------HLDA----EEGTPSTAI 46
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
R +I +++H NI+ L + + +LV+++M L+ + D R L+ +
Sbjct: 47 R-EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYM-DTHGVRGALDPNTVK 103
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL--AILMPDGLTQID 212
+ G+ + H + RV+HRD+KP N+LI+ E +++ F L A +P ++
Sbjct: 104 SFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-----VN 155
Query: 213 TMYV-VGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGK 253
T V T Y AP+ + T S DI+S G ++A ++ G+
Sbjct: 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 6e-09
Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 36 FASLEKIGSGGCGDV---YKAELPGSNGKMIAVKKVIIYSPM-SAAELIDAYSELGEGKL 91
+ +L+ IGSG G V Y A L + +A+KK + P + AY EL
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKK--LSRPFQNQTHAKRAYREL----- 67
Query: 92 TEIRSQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKG 144
+ + H+NI+ LL ++ P L LV + M Q +
Sbjct: 68 -------VLMKCVNHKNIISLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVI------- 112
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204
+ EL+ + + G+++LH SA +IHRD+KP+N+++ D +I F LA
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--R 167
Query: 205 PDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDDFFSH 262
G + + T YVV T Y APE + E DI+S G ++ +V K FP D+
Sbjct: 168 TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 44/149 (29%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178
D V D++ G L + + + R E +R A +AS L YLH S +I+R
Sbjct: 68 ADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARF-YAAEIASALGYLH---SLNIIYR 120
Query: 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRYIAPEYHQTLTISEKC 237
D+KP N+L+D ++ F L +G+ T GTP Y+APE +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC---KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 238 DIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266
D + G +L ++ G PF + T EM
Sbjct: 178 DWWCLGAVLYEMLYGLPPF--YSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASG 163
++H ++ L + V D++ G L + + + R LE +R A VAS
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARF-YAAEVASA 108
Query: 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRY 222
+ YLH S +I+RD+KP N+L+D ++ F L +G+ +T GTP Y
Sbjct: 109 IGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC---KEGVEPEETTSTFCGTPEY 162
Query: 223 IAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
+APE + D + G +L ++ G PF
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-09
Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 25/224 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ ++KIG G G KA L S +GK +K++ I S MS E E
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINI-SKMSPKER------------EE 45
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
R ++ S ++H NI+ + +V D+ + G L Y +R + +
Sbjct: 46 SRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPED 101
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+ V L H+H +++HRDIK N+ + D ++ F +A ++ + T
Sbjct: 102 QILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
+GTP Y++PE + + K DI++ G +L + K F+
Sbjct: 161 --CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 65/229 (28%), Positives = 96/229 (41%), Gaps = 37/229 (16%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPM-SAAELIDAYSELGEGKLTEI 94
+ L+ IGSG G V A G +AVKK + P + AY EL
Sbjct: 23 YQQLKPIGSGAQGIVCAA-FDTVLGINVAVKK--LSRPFQNQTHAKRAYREL-------- 71
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKGRRE 147
+ + H+NI+ LL ++ P L LV + M Q + ++ R
Sbjct: 72 ----VLLKCVNHKNIISLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS 126
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
+ + G+++LH SA +IHRD+KP+N+++ D +I F LA
Sbjct: 127 Y-------LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
T YVV T Y APE + E DI+S G ++ LV G F
Sbjct: 177 FMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 26/170 (15%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183
LV D+M G L + + K R E ++ IA V + LE+LH + +++RD+KP
Sbjct: 73 LVTDYMSGGEL---FWHLQKEGRFSEDRAKFYIAELVLA-LEHLHKYD---IVYRDLKPE 125
Query: 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK-----CD 238
N+L+D I+ D + + T GT Y+APE + + EK D
Sbjct: 126 NILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE----VLLDEKGYTKHVD 179
Query: 239 IYSFGVLLAVLVMGKFPFDDFFSHTGEM------DMVRWMRNVMASENPN 282
+S GVL+ + G PF + T +M VR+ +NV++ E
Sbjct: 180 FWSLGVLVFEMCCGWSPF--YAEDTQQMYRNIAFGKVRFPKNVLSDEGRQ 227
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 57 GSNGKMIAVKKVII--YSPMS--AAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112
G+ GK+I VK+ Y M E+I A E+ LTE R RH + L
Sbjct: 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH-TLTENR----VLQNSRHPFLTAL 60
Query: 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS 172
D V ++ G L + +S+ R E +R A + S L+YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN 116
Query: 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRYIAPEYHQTL 231
V++RD+K N+++D D +I+ F L +G+ TM GTP Y+APE +
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 232 TISEKCDIYSFGVLLAVLVMGKFPF 256
D + GV++ ++ G+ PF
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 40/165 (24%), Positives = 75/165 (45%), Gaps = 9/165 (5%)
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
+++ + H NI+ + + + ++V ++ G+L + R L
Sbjct: 46 AQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-----RCNSLLDE 100
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-DMEARISGFDLAILMPDGLTQID 212
I L LH H+ ++HRD+K N+L+D M +I F ++ ++ ++
Sbjct: 101 DTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSK 157
Query: 213 TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
VVGTP YI+PE + ++K DI++ G +L L K F+
Sbjct: 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 47/173 (27%), Positives = 72/173 (41%), Gaps = 48/173 (27%)
Query: 125 VYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184
V D++ G + ++L + G E E L+R IA + +E +H IHRDIKP N
Sbjct: 79 VMDYIPGGDMMSLL--IRLGIFE-EDLARFYIA-ELTCAIESVH---KMGFIHRDIKPDN 131
Query: 185 VLIDDDMEARISGFDLAI----------LMPDGLTQIDTM-------------------- 214
+LID D +++ F L + D+M
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 215 -----------YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
+VGTP YIAPE ++ CD +S GV+L +++G+ PF
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 75/295 (25%), Positives = 114/295 (38%), Gaps = 62/295 (21%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G VY A S IA+K++ E Y + + +I
Sbjct: 16 LGKGTYGIVYAAR-DLSTQVRIAIKEI--------PERDSRYVQ-------PLHEEIALH 59
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW--LSRHKIALA 159
S ++HRNI+ L + + + GSL A+L +W L ++ +
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL--------RSKWGPLKDNEQTII 111
Query: 160 -----VASGLEYLHMHHSARVIHRDIKPANVLIDD-DMEARISGFD----LAILMPDGLT 209
+ GL+YLH +++HRDIK NVL++ +IS F LA + P T
Sbjct: 112 FYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CT 166
Query: 210 QIDTMYVVGTPRYIAPEY--HQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267
+ T GT +Y+APE DI+S G + + GK PF + M
Sbjct: 167 ETFT----GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF 222
Query: 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
V M +P I L L CF DPD+R ++ D+
Sbjct: 223 KVG-----MFKIHPE--IPESLSAEAKN------FILRCF--EPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 59/247 (23%), Positives = 102/247 (41%), Gaps = 42/247 (17%)
Query: 30 LKKEDCFASLEKIGSGGCGDVYKAE---LPGSNGKMIAVKKVIIYSPMSAAELIDAYSEL 86
+K+ D E +G G G V+ AE L + KM+ K + ++A + +EL
Sbjct: 2 IKRRDIVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 60
Query: 87 GEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQA---------- 136
+ ++H +I+ D ++V+++MK+G L
Sbjct: 61 --------------LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM 106
Query: 137 VLYDVS--KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
+L D + + EL IA +ASG+ YL H +HRD+ N L+ ++ +
Sbjct: 107 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVK 163
Query: 195 ISGFDLAILMPDGLTQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL-AVL 249
I F M + D V G R++ PE + + D++SFGV+L +
Sbjct: 164 IGDFG----MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219
Query: 250 VMGKFPF 256
GK P+
Sbjct: 220 TYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 7/102 (6%)
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI-LMPDGLTQIDTMY 215
A ++ GL +LH +I+RD+K NV++D + +I+ F + M DG+T T
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT---TRT 160
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
GTP YIAPE + D +++GVLL ++ G+ PFD
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 25/175 (14%)
Query: 95 RSQIITASQIRH----RNILPLLAH--------MVRPDSHL-LVYDFMKNGSLQAVLYDV 141
+S+II Q+ H R IL + H + +S+L LV +F+ G L
Sbjct: 66 KSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN 125
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ ++ +I L EYL S +++RD+KP N+L+D D +++ F A
Sbjct: 126 KRFPNDVGCFYAAQIVLI----FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
+ T + GTP YIAPE + + D ++ G+ + +++G PF
Sbjct: 179 -----KVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 40/230 (17%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAE-LIDAYSELGEGKLTEIRSQIIT 100
IG G G V A+ +N K +A+KK+ +A + IDA L E KL
Sbjct: 13 IGRGAYGIVCSAKNSETNEK-VAIKKIA-----NAFDNRIDAKRTLREIKLL-------- 58
Query: 101 ASQIRHRNILPLLAHMVRPDSH------LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
+ H N++ + ++ P +VY+ M L+ + + + L
Sbjct: 59 -RHLDHENVIAI-KDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQ 111
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
+ GL+Y+H SA V+HRD+KP+N+L++ + + +I F LA T
Sbjct: 112 YFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA-RTTSEKGDFMTE 167
Query: 215 YVVGTPRYIAPEYHQTLTISE---KCDIYSFGVLLAVLVMGK--FPFDDF 259
YVV T Y APE L SE D++S G + A L+ K FP D+
Sbjct: 168 YVV-TRWYRAPEL--LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 59/243 (24%), Positives = 110/243 (45%), Gaps = 42/243 (17%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLT 92
D + L +I G G VY+A G+++A+KK+ + EG +T
Sbjct: 5 DEYEKLNRIEEGTYGVVYRA-RDKKTGEIVALKKLK-------------MEKEKEGFPIT 50
Query: 93 EIRSQIITASQIRHRNILPLLAHMV---RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
+R +I +++H NI+ + +V D +V +++++ L++++ + + + E
Sbjct: 51 SLR-EINILLKLQHPNIVTV-KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSE 107
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
+ L + SG+ +LH + ++HRD+K +N+L+++ +I F LA L
Sbjct: 108 ---VKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTISEKC-----DIYSFGVLLAVLVMGKFPFDDFFSHTG 264
T VV T Y APE L + K D++S G + A L+ F
Sbjct: 162 PY-TQLVV-TLWYRAPE----LLLGAKEYSTAIDMWSVGCIFAELLTK----KPLFPGKS 211
Query: 265 EMD 267
E+D
Sbjct: 212 EID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 39/133 (29%), Positives = 60/133 (45%), Gaps = 25/133 (18%)
Query: 123 LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA--------VASGLEYLHMHHSAR 174
L+ +++ GSL ++L +HK+ LA + G+ YLH S
Sbjct: 84 QLIMEYVPLGSL-------------RDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQH 127
Query: 175 VIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRY-IAPEYHQTLTI 233
IHRD+ NVL+D+D +I F LA +P+G +P + A E +
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187
Query: 234 SEKCDIYSFGVLL 246
S D++SFGV L
Sbjct: 188 SYASDVWSFGVTL 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 35/233 (15%)
Query: 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK-----IAL 158
+ H N+L L + +LLV +F G L+ L + R + K +A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL----RSNRGMVAQMAQKDVLQRMAC 107
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL-MPDGLTQIDTMYVV 217
VASGL +LH IH D+ N + D+ +I + LA+ P+ + V
Sbjct: 108 EVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164
Query: 218 GTPRYIAPE----YHQTL---TISEKCDIYSFGV-LLAVLVMGKFPFDDFFSHTGEMDMV 269
R++APE Q L ++K +I+S GV + + P+ D + ++
Sbjct: 165 PL-RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL----SDEQVL 219
Query: 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ + + P +D K YE FC L DP+ RP +++V
Sbjct: 220 KQVVREQDIKLPKPQLDLKYSDRWYEVMQ--------FCWL-DPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 35/213 (16%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E +G G G+V+K L + +AVK + E D EL L+E R
Sbjct: 1 ELLGKGNFGEVFKGTL--KDKTPVAVK--------TCKE--DLPQELKIKFLSEAR---- 44
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
Q H NI+ L+ + +V + + G + L K + EL+ K AL
Sbjct: 45 ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALD 101
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF------DLAILMPDGLTQIDT 213
A+G+ YL S IHRD+ N L+ ++ +IS F D I GL QI
Sbjct: 102 AAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL 246
++ APE S + D++S+G+LL
Sbjct: 159 -------KWTAPEALNYGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 27/195 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ + L KIG G G V+K G+++A+KK + + I L E
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCR-NRETGQIVAIKKFVESEDDPVIKKI---------ALRE 50
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
IR Q++H N++ L+ R LV+++ + VL ++ K R +
Sbjct: 51 IR----MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLI 102
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
KI + + H H IHRD+KP N+LI + ++ F A + LT
Sbjct: 103 KKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARI----LTGPGD 155
Query: 214 MYV--VGTPRYIAPE 226
Y V T Y APE
Sbjct: 156 DYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 42/238 (17%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ L +G G G V+ A + K +AVKK+++ P S L EI+
Sbjct: 7 YMDLRPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHA-----------LREIK 54
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG-----RRELEW 150
II ++ H NI+ + ++ P L D + + + +Y V + LE
Sbjct: 55 --II--RRLDHDNIVKVY-EVLGPSGSDLTED-VGSLTELNSVYIVQEYMETDLANVLEQ 108
Query: 151 --LSRHKIAL---AVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLA-IL 203
LS L + GL+Y+H SA V+HRD+KPANV I+ +D+ +I F LA I+
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165
Query: 204 MPD-----GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
P L++ +PR + + T I D+++ G + A ++ GK F
Sbjct: 166 DPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 20/101 (19%)
Query: 163 GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID---TMYVVGT 219
GL+Y+H SA V+HRD+KP N+L++ D E +I F LA + + T YV T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-T 172
Query: 220 PRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK 253
Y APE Y + + D++S G +LA L+ K
Sbjct: 173 RWYRAPEIMLSFQSYTKAI------DVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 39 LEKIGSGGCGDVYKAE---LPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
++++G G G V L + G+++AVKK+ +A L D E+
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL---QHSTAEHLRDFEREI--------- 56
Query: 96 SQIITASQIRHRNILP---LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+I+ + Q H NI+ + R + L V +++ GSL+ L K R L+
Sbjct: 57 -EILKSLQ--HDNIVKYKGVCYSAGRRNLRL-VMEYLPYGSLRDYL---QKHRERLDHRK 109
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
A + G+EYL S R +HRD+ N+L++ + +I F L ++P Q
Sbjct: 110 LLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP----QDK 162
Query: 213 TMYVVGTPR-----YIAPEYHQTLTISEKCDIYSFGVLL 246
Y V P + APE S D++SFGV+L
Sbjct: 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 11 RDRGLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDV---YKAELPGSNGKMIAVKK 67
RD I LK+ + +L+ IGSG G V Y A L + +A+KK
Sbjct: 6 RDNNFYSVE--IGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKK 56
Query: 68 VIIYSPM-SAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHL--- 123
+ P + AY EL + + H+NI+ LL ++ P L
Sbjct: 57 --LSRPFQNQTHAKRAYREL------------VLMKCVNHKNIIGLL-NVFTPQKSLEEF 101
Query: 124 ----LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
+V + M Q + + EL+ + + G+++LH SA +IHRD
Sbjct: 102 QDVYIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRD 151
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
+KP+N+++ D +I F LA G + + T YVV T Y APE + E DI
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDI 208
Query: 240 YSFGVLLAVLVMGK--FPFDDF 259
+S G ++ ++ G FP D
Sbjct: 209 WSVGCIMGEMIKGGVLFPGTDH 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 22/218 (10%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E+IG G G+V+ L N +AVK P +L L E R
Sbjct: 1 ERIGRGNFGEVFSGRLRADN-TPVAVKSCRETLP----------PDLKAKFLQEAR---- 45
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
Q H NI+ L+ + +V + ++ G L ++G R L+ ++
Sbjct: 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGPR-LKVKELIQMVEN 102
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
A+G+EYL H IHRD+ N L+ + +IS F ++ DG+
Sbjct: 103 AAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
++ APE S + D++SFG+LL +G P+
Sbjct: 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 42 IGSGGCGDVY--KAELPGSNGKMIAVKKVII-YSPMSAAELIDAYSELGEGKLTEIRSQI 98
IG+G G+V + +LPG +A+K + Y+ + + S +G
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG----------- 60
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
Q H NI+ L + + ++V ++M+NGSL A L K + + +
Sbjct: 61 ----QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLR 113
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+ASG++YL +HRD+ N+L++ ++ ++S F L+ ++ D T
Sbjct: 114 GIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 219 TP-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
P R+ APE + D++S+G+++ V+ G+ P+
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 43/247 (17%)
Query: 30 LKKEDCFASLEKIGSGGCGDVYKAE----LPGSNGKMIAVKKVIIYSPMSAAELIDAYSE 85
+K+ D E +G G G V+ AE LP + ++AVK A E
Sbjct: 2 IKRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVK---------------ALKE 45
Query: 86 LGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQ---------A 136
E + + + + ++H++I+ L+V+++M++G L A
Sbjct: 46 ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 105
Query: 137 VLYDVSKGRR--ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
+ + +L IA +ASG+ YL H +HRD+ N L+ + +
Sbjct: 106 KILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVK 162
Query: 195 ISGFDLAILMPDGLTQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL-AVL 249
I F M + D V G R++ PE + + DI+SFGV+L +
Sbjct: 163 IGDFG----MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218
Query: 250 VMGKFPF 256
GK P+
Sbjct: 219 TYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 47/195 (24%), Positives = 90/195 (46%), Gaps = 45/195 (23%)
Query: 23 EKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS-----PMSAA 77
++ + F + + L KIG G G+V+KA +++A+KKV++ + P++A
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKAR-HKKTKQIVALKKVLMENEKEGFPITA- 58
Query: 78 ELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL------AHMVRPD--SHLLVYDFM 129
L EI+ I+ ++H N++ L+ A S LV++F
Sbjct: 59 -------------LREIK--IL--QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC 101
Query: 130 KN---GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186
++ G L + E++ + + + +GL Y+H +++HRD+K AN+L
Sbjct: 102 EHDLAGLLSNKNVKFTLS--EIKKVMKM-----LLNGLYYIH---RNKILHRDMKAANIL 151
Query: 187 IDDDMEARISGFDLA 201
I D +++ F LA
Sbjct: 152 ITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 86/322 (26%), Positives = 130/322 (40%), Gaps = 87/322 (27%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGE-GKLTEIRSQ 97
L KIG G +V KA+ GK A+K + + L + L EI++
Sbjct: 4 LGKIGEGTFSEVLKAQ-SRKTGKYYAIKC-----------MKKHFKSLEQVNNLREIQA- 50
Query: 98 IITASQIR----HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAV-------LYDVSKGRR 146
+R H NIL L+ ++D K G L V LY++ KGR+
Sbjct: 51 ------LRRLSPHPNILRLIEV---------LFD-RKTGRLALVFELMDMNLYELIKGRK 94
Query: 147 ELEWLSRHKIAL---AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL 203
L ++ + L+ HMH + + HRDIKP N+LI DD +++ F
Sbjct: 95 RP--LPEKRVKSYMYQLLKSLD--HMHRNG-IFHRDIKPENILIKDD-ILKLADFGSCRG 148
Query: 204 MPDGLTQIDTMYVVGTPRYIAPEYHQTLT---ISEKCDIYSFG-VLLAVLVMGKFPFDDF 259
+ T Y + T Y APE LT K DI++ G V +L + FP
Sbjct: 149 IYS--KPPYTEY-ISTRWYRAPEC--LLTDGYYGPKMDIWAVGCVFFEILSL--FP---L 198
Query: 260 FSHTGEMDMVRWMRNVMAS--------ENPNRAID-----------SKLLGNGYEEQMLL 300
F T E+D + + +V+ + +R ++ KLL N E + L
Sbjct: 199 FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDL 258
Query: 301 VLKLACFCTLADPDERPNSKDV 322
+ KL + DPDER +K
Sbjct: 259 LKKLLAY----DPDERITAKQA 276
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 70/290 (24%), Positives = 111/290 (38%), Gaps = 49/290 (16%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIY-SPMSAAELIDAYSELGEGKLTEIRSQI 98
E +G G G VY + G++IAVK+V + S + AAE Y +L E ++
Sbjct: 6 EVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAE--KEYEKLQE--------EV 53
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
++H NI+ L + ++ + +F+ GS+ ++L L K
Sbjct: 54 DLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTK 109
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANV---------LIDDDMEARISGFDLAILMPDGLT 209
+ G+ YLH + V+HRDIK NV LID R++ L + L
Sbjct: 110 QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269
+ GTP ++APE K DI+S G + + GK P MD +
Sbjct: 167 SMH-----GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL-------ASMDRL 214
Query: 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319
M + A + + C D ERP++
Sbjct: 215 AAMFYIGAHRGLMPRLPDSFSAAAID--------FVTSCLTRDQHERPSA 256
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 65/251 (25%), Positives = 104/251 (41%), Gaps = 63/251 (25%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
D + LEKIG G G VYKA + GK++A+KK E
Sbjct: 1 DAYEKLEKIGEGTYGKVYKAR-DKNTGKLVALKKT----------------------RLE 37
Query: 94 IRSQIITASQIRHRNILPLLA---HMVRPDSHLLVYDFMKNGSLQAVLYDV--------- 141
+ + I + +R ++L +L+ ++VR LL + ++ + + LY V
Sbjct: 38 MDEEGIPPTALREISLLQMLSESIYIVR----LLDVEHVEEKNGKPSLYLVFEYLDSDLK 93
Query: 142 ----SKGR---RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA- 193
S GR R L + + G+ + H H V+HRD+KP N+L+D
Sbjct: 94 KFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLL 150
Query: 194 RISGFDL--AILMPDG--LTQIDTMYVVGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAV 248
+I+ L A +P +I T++ Y APE + S DI+S G + A
Sbjct: 151 KIADLGLGRAFSIPVKSYTHEIVTLW------YRAPEVLLGSTHYSTPVDIWSVGCIFAE 204
Query: 249 LVMGK--FPFD 257
+ + FP D
Sbjct: 205 MSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 17/138 (12%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRH---KIALAVASGLEYLHMHHSARVIHRDI 180
V +F+ G L ++ + + R+ E +R +I+LA L+ H +I+RD+
Sbjct: 73 FVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA-------LNFLHERGIIYRDL 122
Query: 181 KPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRYIAPEYHQTLTISEKCDI 239
K NVL+D + +++ + + +G+ DT GTP YIAPE + D
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMC---KEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 240 YSFGVLLAVLVMGKFPFD 257
++ GVL+ ++ G+ PFD
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 42 IGSGGCGDVYKAELPGSN----GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
+G G G V AE G + ++ V ++ S + +L D SE+ K+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG---- 81
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL---------YDVSKGRREL 148
+H+NI+ LL + ++ ++ G+L+ L Y + +
Sbjct: 82 -------KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 149 EWLSRHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
E LS + A VA G+EYL S + IHRD+ NVL+ +D +I+ F LA
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLA---- 187
Query: 206 DGLTQIDTMYVVGTPR----YIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
+ ID R ++APE + + D++SFGVLL + +G P+
Sbjct: 188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 66/254 (25%), Positives = 105/254 (41%), Gaps = 37/254 (14%)
Query: 20 PLIEKEDL--AFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAA 77
PL K + +F D + +E IG G G V+K L NG AVK
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKV-LNKKNGSKAAVK----------- 49
Query: 78 ELIDAYSELGEGKLTEIRSQI-ITASQIRHRNILPLLAHMVRPDSH-----LLVYDFMKN 131
++D ++ E EI ++ I + H N++ + D LV +
Sbjct: 50 -ILDPIHDIDE----EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNG 104
Query: 132 GSLQAVLYDVSKG-RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190
GS+ D+ KG + E + IA + L L H + IHRD+K N+L+ +
Sbjct: 105 GSVT----DLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE 160
Query: 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEY---HQTL--TISEKCDIYSFGVL 245
++ F ++ + T++ VGTP ++APE Q L T +CD++S G+
Sbjct: 161 GGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218
Query: 246 LAVLVMGKFPFDDF 259
L G P D
Sbjct: 219 AIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 69/299 (23%), Positives = 133/299 (44%), Gaps = 53/299 (17%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
++IG+G G V +E+ G V +V++ + A + L +G I
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTG----VARVVVKELKANASSKEQNEFLQQGDPYRI----- 51
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
++H NIL L V +LLV+++ + G L++ L RR + L ++A
Sbjct: 52 ----LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS--GFDLAILMPDGLTQIDTMYVV 217
+A+G+ ++H H+ +H D+ N + D+ ++ G + D + D V
Sbjct: 108 IAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV- 163
Query: 218 GTPRYIAPE----YHQTLTISEK---CDIYSFGVLLAVLVMGKFPFDDF---FSHTGEMD 267
R++APE +H L +E+ ++++ GV L L F++ +SH + +
Sbjct: 164 -PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQPYSHLSDRE 216
Query: 268 MVRWMRNVMASENPNRAIDSKL----LGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ + +V+ + KL L Y E+ VL+ FC L+ P++R +++V
Sbjct: 217 V---LNHVIKDQ------QVKLFKPQLELPYSERWYEVLQ---FCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 37/235 (15%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ +L IG G G V A G +A+KK+ SP + + L EI+
Sbjct: 7 YQNLSYIGEGAYGMVCSA-THKPTGVKVAIKKI---SPFE-------HQTFCQRTLREIK 55
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSH------LLVYDFMKNGSLQAVLYDVSKGRRELE 149
I+ + +H NI+ +L ++RP S +V + M + LY + K +
Sbjct: 56 --ILR--RFKHENIIGILD-IIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQH--- 102
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDGL 208
LS I + L L HSA V+HRD+KP+N+L++ + + +I F LA I P+
Sbjct: 103 -LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161
Query: 209 -TQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGK--FPFDDF 259
T T Y V T Y APE ++ DI+S G +LA ++ + FP D+
Sbjct: 162 HTGFLTEY-VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 123 LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182
LV +++ G L ++ + + R+ E +R A + L +LH +I+RD+K
Sbjct: 72 FLVIEYVNGGDL---MFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGIIYRDLKL 124
Query: 183 ANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRYIAPEYHQTLTISEKCDIYS 241
NVL+D D +++ + + +GL DT GTP YIAPE + D ++
Sbjct: 125 DNVLLDADGHIKLTDYGMC---KEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181
Query: 242 FGVLLAVLVMGKFPFD 257
GVL+ ++ G+ PFD
Sbjct: 182 LGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ + +IG G G V+KA + G+ +A+K+V + + E G L+ IR
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-----------GEEGM-PLSTIR 50
Query: 96 SQII--TASQIRHRNILPL-----LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
+ H N++ L ++ R LV++ + + L L V +
Sbjct: 51 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT 109
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
E + + + GL++LH H RV+HRD+KP N+L+ + +++ F LA +
Sbjct: 110 ETIK--DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--- 161
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLA 247
Q+ VV T Y APE + + D++S G + A
Sbjct: 162 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 22/126 (17%)
Query: 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF--------DLAILMPDGLTQIDTM- 214
LEYLH + ++HRD+KP N+LI +++ F L + +G + DT
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 215 ----YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF-----DDFFSHTGE 265
V GTP YIAPE + D ++ G++L ++G PF ++ F
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230
Query: 266 MDMVRW 271
D + W
Sbjct: 231 -DDIEW 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 35/237 (14%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
D + +E IG G G VYK +G + AVK ++D S++ E E
Sbjct: 22 DTWEIIETIGKGTYGKVYKVT-NKKDGSLAAVK------------ILDPISDVDE----E 64
Query: 94 IRSQI-ITASQIRHRNILPLLAHMVRPDSHL-----LVYDFMKNGSLQAVLYDVSK-GRR 146
I ++ I S H N++ + D + LV + GS+ ++ + G+R
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 147 ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
L I+ + L L H+ R+IHRD+K N+L+ + ++ F ++ +
Sbjct: 125 ----LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 207 GLTQIDTMYVVGTPRYIAPEY-----HQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ +T VGTP ++APE + +CD++S G+ L G P D
Sbjct: 181 TRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 33/122 (27%), Positives = 48/122 (39%), Gaps = 36/122 (29%)
Query: 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAI-LMPDGLTQIDTMY-------------- 215
H IHRDIKP N+L+D ++S F L L T+ +
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177
Query: 216 ---------------------VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKF 254
VGTP YIAPE +++CD +S GV++ +++G
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237
Query: 255 PF 256
PF
Sbjct: 238 PF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 71/235 (30%), Positives = 108/235 (45%), Gaps = 40/235 (17%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLT 92
D + +EKIG G G VYKA +N + IA+KK+ + + EG T
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRL-------------EQEDEGVPST 47
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWL 151
IR +I +++H NI+ L +V + L LV++++ D+ K
Sbjct: 48 AIR-EISLLKEMQHGNIVR-LQDVVHSEKRLYLVFEYLD--------LDLKKHMDSSPDF 97
Query: 152 SRH----KIAL-AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA-RISGFDLAILMP 205
+++ K L + G+ Y H H RV+HRD+KP N+LID A +++ F LA
Sbjct: 98 AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF- 153
Query: 206 DGLTQIDTMYVVGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGK--FPFD 257
G+ + V T Y APE + S DI+S G + A +V K FP D
Sbjct: 154 -GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 43/169 (25%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++ +T Q H NI+ L + R ++ ++V ++M NG+L + L K +L
Sbjct: 55 AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMG 111
Query: 156 IALAVASGLEYL-HMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
+ +ASG++YL M + +H+ + VL++ D+ +ISGF + + +
Sbjct: 112 MLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEAI 162
Query: 215 YVVGTPR----YIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
Y + + + APE Q S D++SFG+++ V+ G+ P+ D
Sbjct: 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 123 LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182
V +++ G L ++ + + R+ E +R A ++ L YLH +I+RD+K
Sbjct: 72 FFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKL 124
Query: 183 ANVLIDDDMEARISGFDLAILMPDGLTQIDTM-YVVGTPRYIAPEYHQTLTISEKCDIYS 241
NVL+D + +++ + + +GL DT GTP YIAPE + D ++
Sbjct: 125 DNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 242 FGVLLAVLVMGKFPFD 257
GVL+ ++ G+ PFD
Sbjct: 182 LGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 38/228 (16%)
Query: 39 LEKIGSGGCGDVYKAE-LPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
L+ +G GG G V++ + G++ I KV+ K T +R+Q
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVL-------------------KKATIVRNQ 41
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
TA RNIL + H D L+Y F G L +L +S G + L R I
Sbjct: 42 KDTAHTKAERNILEAVKHPFIVD---LIYAFQTGGKLYLILEYLSGGELFMH-LEREGIF 97
Query: 158 LA---------VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ ++ LE+LH +I+RD+KP N+L+D +++ F L
Sbjct: 98 MEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
T T GT Y+APE + D +S G L+ ++ G PF
Sbjct: 155 TVTHTF--CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 22/142 (15%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183
+V +FM+NG L L +G+ + L + V G+EYL + IHRD+
Sbjct: 76 IVTEFMENGCLLNYLRQ-RQGKLSKDMLL--SMCQDVCEGMEYLERNS---FIHRDLAAR 129
Query: 184 NVLIDDDMEARISGFDLAILMPDGLTQ--IDTMYVVGTP-----RYIAPEYHQTLTISEK 236
N L+ ++S F G+T+ +D Y + ++ PE S K
Sbjct: 130 NCLVSSTGVVKVSDF--------GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 237 CDIYSFGVLL-AVLVMGKFPFD 257
D++SFGVL+ V GK PF+
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 29/212 (13%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+++G G G V K +GK + V A + + K E +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEV----------AVKTLKQEHIAAGKK--EFLREAS 48
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
+Q+ H I+ L+ + + + +LV + G L L K RRE+ ++A
Sbjct: 49 VMAQLDHPCIVRLIG-VCKGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQ 103
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
VA G+ YL S +HRD+ NVL+ + +A+IS F ++ + G Y T
Sbjct: 104 VAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG----SDYYRATT 156
Query: 220 ----P-RYIAPEYHQTLTISEKCDIYSFGVLL 246
P ++ APE S K D++S+GV L
Sbjct: 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 40/234 (17%)
Query: 41 KIGSGGCGDVYKAEL----PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRS 96
++G G G V+ AE P + ++AVK L DA + +
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKT-----------LKDA----SDNARKDFHR 56
Query: 97 QIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQ---------AVLYDVSKGRRE 147
+ + ++H +I+ V D ++V+++MK+G L AVL E
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
L IA +A+G+ YL H +HRD+ N L+ +++ +I F M
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG----MSRD 169
Query: 208 LTQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
+ D V G R++ PE + + D++S GV+L + GK P+
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 23/167 (13%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ LEKIG G G V+KA+ + +++A+K+V L D EG +
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRET-HEIVALKRV---------RLDDD----DEGVPSSAL 47
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
+I +++H+NI+ L ++ D L LV+++ L+ +D G +++
Sbjct: 48 REICLLKELKHKNIV-RLYDVLHSDKKLTLVFEYCDQ-DLKK-YFDSCNG--DIDPEIVK 102
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ GL + H H+ V+HRD+KP N+LI+ + E +++ F LA
Sbjct: 103 SFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 64/234 (27%), Positives = 95/234 (40%), Gaps = 41/234 (17%)
Query: 42 IGSGGCGDVYKAEL-----PGSNGKMIAVKKVIIYSPMSAAELIDAYSE-LGEGKLTEIR 95
+GSG G+VY+ PGS +AVK + E L E L
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKT------LRKGATDQEKKEFLKEAHLM--- 53
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
S H NI+ LL + + ++ + M+ G L + L D R L+ +
Sbjct: 54 ------SNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE 107
Query: 156 ---IALAVASGLEYLHMHHSARVIHRDIKPANVLI-----DDDMEARISGFDLAILMPDG 207
I L VA G YL H IHRD+ N L+ D D +I F LA
Sbjct: 108 LLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA----RD 160
Query: 208 LTQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
+ + D G R++APE + + D++SFGVL+ +L +G+ P+
Sbjct: 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 50/214 (23%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 40 EKIGSGGCGDVY-KAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+++G G G VY + + + V K I ++ E + A E +Q+
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----------AQL 55
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL------EWLS 152
+ S++ H I+ A + D+ ++ ++ + L L ++ + L EW
Sbjct: 56 L--SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF- 112
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
I L + G+ Y+H R++HRD+K N+ + +++ +I F ++ L+ G +
Sbjct: 113 ---IQLLL--GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLA 162
Query: 213 TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL 246
T + GTP Y++PE + K DI+S G +L
Sbjct: 163 TTFT-GTPYYMSPEALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS-----PMSAAELIDAYSELGEGKLTEIR 95
+IG G G VYKA P S G +A+K V + + P+S + L
Sbjct: 7 EIGVGAYGTVYKARDPHS-GHFVALKSVRVQTNEDGLPLSTVREVALLKRL--------- 56
Query: 96 SQIITASQIRHRNILPLL--AHMVRPDSHL---LVYDFMKNGSLQAVLYDVSKGRRELEW 150
H NI+ L+ R D LV++ + + L+ L V E
Sbjct: 57 ------EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAET 109
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
+ + GL++LH + ++HRD+KP N+L+ + +++ F LA + Q
Sbjct: 110 IK--DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQ 161
Query: 211 IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLA 247
+ VV T Y APE T + D++S G + A
Sbjct: 162 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 57/269 (21%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLT 92
D F + +IG G G VYKA G+++A+KKV + + EG +T
Sbjct: 7 DKFDIIGQIGEGTYGQVYKAR-DKDTGELVALKKVRLDNEK-------------EGFPIT 52
Query: 93 EIRSQIITASQIRHRNILPL----------LAHMVRPDSHLLVYDFMKN---GSLQAVLY 139
IR +I Q+ HRNI+ L L + LV+++M + G L++ L
Sbjct: 53 AIR-EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV 111
Query: 140 DVSKGRRELEWLSRHKIAL--AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197
S+ H + + GL Y H + +HRDIK +N+L+++ + +++
Sbjct: 112 HFSE---------DHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLAD 159
Query: 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK-----CDIYSFGVLLAVLVMG 252
F LA L ++ T V+ T Y PE L + E+ D++S G +L L
Sbjct: 160 FGLARLYNSEESRPYTNKVI-TLWYRPPE----LLLGEERYGPAIDVWSCGCILGEL--- 211
Query: 253 KFPFDDFFSHTGEMDMVRWMRNVMASENP 281
F F E+ + + + S P
Sbjct: 212 -FTKKPIFQANQELAQLELISRLCGSPCP 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 4e-07
Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLL--VYDFMKNGSLQAVLY 139
+Y L E + +++ ++ +++H+NI+ + + + L + +F G L +
Sbjct: 47 SYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ 106
Query: 140 DVSKGRRELEWLSRHKIALAVASGLEYLHM----HHSARVIHRDIKPANVLIDDDME--- 192
K ++E + I + L Y H + RV+HRD+KP N+ + +
Sbjct: 107 KCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166
Query: 193 ------ARISGFDLAILMPDGLTQ---IDTM--YVVGTPRYIAPEY--HQTLTISEKCDI 239
++G +A + GL++ I++M VGTP Y +PE H+T + +K D+
Sbjct: 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDM 226
Query: 240 YSFGVLLAVLVMGKFPF 256
++ G ++ L GK PF
Sbjct: 227 WALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 26/227 (11%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F L +G G G V AE + G++ A+K + I A E+ E + E R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT-GELYAIKAL-------KKGDIIARDEV-ESLMCEKR 51
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLY-DVSKGRRELEWLSRH 154
TA+ RH ++ L A D V ++ G L ++ DV R + +
Sbjct: 52 I-FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY---- 106
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID-T 213
A V GL+YLH + ++++RD+K N+L+D + +I+ F L +G+ D T
Sbjct: 107 --AACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRT 158
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF--DD 258
GTP ++APE + + D + GVL+ +++G+ PF DD
Sbjct: 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL 91
K D + LEK+G G VYK + NGK++A+K +I E G
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGK-SKVNGKLVALK------------VIRLQEEEGT-PF 48
Query: 92 TEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWL 151
T IR + ++H NI+ L + ++ LV++++ Q + K L
Sbjct: 49 TAIREASLLKG-LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYM----DKHPGGLHPE 103
Query: 152 SRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ + GL Y+H + ++HRD+KP N+LI D E +++ F LA
Sbjct: 104 NVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 37/156 (23%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASG 163
++H ++ L A + + +++ +FM GSL L ++ L L + +A G
Sbjct: 58 LQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEG 114
Query: 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG--LTQIDTMYVVGTPR 221
+ ++ + IHRD++ AN+L+ + +I+ F LA ++ D + + + +
Sbjct: 115 MAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---K 168
Query: 222 YIAPEYHQTLTISEKCDIYSFGVLLA-VLVMGKFPF 256
+ APE + + K D++SFG+LL ++ G+ P+
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 27/223 (12%)
Query: 40 EKIGSGGCGDVYKAE---LPGSNGKMIAVKKVIIYSPMSAAELI--DAYSELGEGKLTEI 94
EK+G G G+V+ E L + K A + A +++ DA E L E+
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLY-------DVSKGRRE 147
+ I+ S++ NI LL ++ ++M+NG L L ++ +
Sbjct: 71 K--IL--SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
L + + +A +ASG+ YL S +HRD+ N L+ + +I+ F M
Sbjct: 127 LSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFG----MSRN 179
Query: 208 LTQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL 246
L D V G R++A E + K D+++FGV L
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 47/187 (25%), Positives = 86/187 (45%), Gaps = 25/187 (13%)
Query: 88 EGKLTEIRSQIITASQI-RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL-------- 138
E L+++ S++ I +H+NI+ LL + ++ ++ G+L+ L
Sbjct: 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120
Query: 139 ---YDVSKGRRE-LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
YD+++ E + + VA G+EYL S + IHRD+ NVL+ ++ +
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMK 177
Query: 195 ISGFDLAILMPDGLTQIDTMYVVGTPR----YIAPEYHQTLTISEKCDIYSFGVLL-AVL 249
I+ F LA + ID R ++APE + + D++SFGVL+ +
Sbjct: 178 IADFGLA----RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233
Query: 250 VMGKFPF 256
+G P+
Sbjct: 234 TLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 3/169 (1%)
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE 147
E + RS++ + H I+ D LL+ ++ G L + + +E
Sbjct: 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---QIKQRLKE 162
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
+++ L + L HS +++HRD+K AN+ + ++ F + D
Sbjct: 163 HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
++ GTP Y+APE + S+K D++S GV+L L+ PF
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 33/108 (30%), Positives = 59/108 (54%), Gaps = 17/108 (15%)
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
+ A VA+G++YL + IHRD+ NVL+ +++ ++I+ F GL++ + +
Sbjct: 123 QFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADF--------GLSRGEEV 171
Query: 215 YVVGT-----PRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
YV T R++A E + K D++SFGVLL ++ +G P+
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 1/97 (1%)
Query: 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI-LMPDGLTQIDTMYVVGTPRY 222
LE + HS ++HRDIK AN+L D ++ F + L L+ V GTP +
Sbjct: 116 LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 223 IAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
++PE K DI+S G + ++ K P+ +F
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G+VY G+ +AVK+V P D S+ ++ + +I
Sbjct: 10 LGRGAFGEVYLC-YDADTGRELAVKQV----PF------DPDSQETSKEVNALECEIQLL 58
Query: 102 SQIRHRNILPLLAHMVRPDSHLL--VYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
+RH I+ + P+ L ++M GS++ D K L +
Sbjct: 59 KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQ 114
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY---- 215
+ G+ YLH S ++HRDIK AN+L D ++ F + +I T+
Sbjct: 115 ILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS-------KRIQTICMSGT 164
Query: 216 ----VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
V GTP +++PE K D++S + ++ K P+ ++
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 9e-07
Identities = 45/149 (30%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178
H+L+ D++K+G L +D+ K +L KI + L LH H+ +IH
Sbjct: 81 LKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHN 133
Query: 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPR-------YIAPEYHQTL 231
DIK NVL D + RI L GL +I +GTP Y +PE +
Sbjct: 134 DIKLENVLYDRAKD-RI------YLCDYGLCKI-----IGTPSCYDGTLDYFSPEKIKGH 181
Query: 232 TISEKCDIYSFGVLLAVLVMGKFPFDDFF 260
D ++ GVL L+ GK PF +
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 24/169 (14%)
Query: 105 RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL---------YDVSKGRRELEWLSRHK 155
+H+NI+ LL + ++ ++ G+L+ L Y + E L+
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 156 I---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
+ A VA G+EYL S + IHRD+ NVL+ +D +I+ F LA + ID
Sbjct: 136 LVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLA----RDVHNID 188
Query: 213 TMYVVGTPR----YIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
R ++APE + + D++SFGVLL + +G P+
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 47/197 (23%), Positives = 75/197 (38%), Gaps = 52/197 (26%)
Query: 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
D+ V D++ G + ++L + +L ++ AV S H IHRD
Sbjct: 74 DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVES-------VHKMGFIHRD 126
Query: 180 IKPANVLIDDDMEARIS------GF----DLAILMPDGLTQIDTM--------------- 214
IKP N+LID D +++ GF D + D+M
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 215 --------------------YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKF 254
+VGTP YIAPE ++ CD +S GV+L +++G+
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 246
Query: 255 PFDDFFSHTGEMDMVRW 271
PF +M ++ W
Sbjct: 247 PFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 20/162 (12%)
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKG-- 144
E K E +Q++ SQ++H NI+ D L +V F + G L L + KG
Sbjct: 42 ERKAAEQEAQLL--SQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE-QKGKL 98
Query: 145 ---RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ +EW + +A L+YLH H ++HRD+K NV + ++ +A
Sbjct: 99 LPENQVVEWF------VQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIA 149
Query: 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFG 243
++ + T+ +GTP Y++PE + K D+++ G
Sbjct: 150 RVLENQCDMASTL--IGTPYYMSPELFSNKPYNYKSDVWALG 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 36/227 (15%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSP-MSAAELI--DAYSELGEGKLTEIRS 96
EK+G G G+V+ E G + P + A +++ D L EI+
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK- 69
Query: 97 QIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK- 155
S++++ NI+ LL V D ++ ++M+NG L L +RE+E H
Sbjct: 70 ---IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-----SQREIESTFTHAN 121
Query: 156 ------------IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL 203
+A+ +ASG++YL S +HRD+ N L+ + +I+ F
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFG---- 174
Query: 204 MPDGLTQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL 246
M L D + G R++A E + D+++FGV L
Sbjct: 175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 61/248 (24%), Positives = 104/248 (41%), Gaps = 58/248 (23%)
Query: 42 IGSGGCGDVYKA---ELPGSNG-KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
+G G G V KA L G G +AVK ++ S++EL D SE K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVK--MLKENASSSELRDLLSEFNLLK------- 58
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL------------------- 138
Q+ H +++ L + LL+ ++ K GSL++ L
Sbjct: 59 -----QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNS 113
Query: 139 -YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197
Y + R L A ++ G++YL +++HRD+ NVL+ + + +IS
Sbjct: 114 SYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISD 170
Query: 198 FDLAILMPDGLTQI---DTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLLAVL 249
F GL++ + YV + +++A E + + D++SFGVLL +
Sbjct: 171 F--------GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222
Query: 250 V-MGKFPF 256
V +G P+
Sbjct: 223 VTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 40/166 (24%), Positives = 67/166 (40%), Gaps = 40/166 (24%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183
L+ +F+ G + +L + + L+ + +A + + H IHRDIKP
Sbjct: 78 LIMEFLPGGDMMTLLM-------KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD 130
Query: 184 NVLIDDDMEARISGFDLAI----------------LMPDGLT--------QIDT------ 213
N+L+D ++S F L +P T + +T
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 214 ---MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
VGTP YIAPE ++ CD +S GV++ +++G PF
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 34/231 (14%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSN--GKMIAVK---KVIIYSPMSAAELIDAYSELGEGK 90
F L +G+G G V+ G + GK+ A+K K I AE
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH----------- 50
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELE 149
T Q++ A +R L L + + D+ L L+ D++ G L LY +RE
Sbjct: 51 -TRTERQVLEA--VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHF 102
Query: 150 WLSRHKIALA-VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDG 207
S ++ +A + L++LH +I+RDIK N+L+D + ++ F L+ + +
Sbjct: 103 TESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTI--SEKCDIYSFGVLLAVLVMGKFPF 256
+ + GT Y+APE + + + D +S GVL L+ G PF
Sbjct: 160 EERAYSF--CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 49/207 (23%), Positives = 78/207 (37%), Gaps = 40/207 (19%)
Query: 50 VYKAELPGSNGKMIAVKK------VIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ 103
V K PGS G++ K V++ LI+A +
Sbjct: 70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEA----------------MLLQN 113
Query: 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD-VSKGRRELEWLSRHKIALAVAS 162
+ H +++ + +V +V + LY ++K R L I +
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSD-----LYTYLTKRSRPLPIDQALIIEKQILE 168
Query: 163 GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA---ILMPDGLTQIDTMYVVGT 219
GL YLH R+IHRD+K N+ I+D + I A ++ P L + GT
Sbjct: 169 GLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG------LAGT 219
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLL 246
APE + K DI+S G++L
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVL 246
|
Length = 357 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 43/180 (23%), Positives = 84/180 (46%), Gaps = 20/180 (11%)
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSK 143
++ + S+ + + H N++ L+ ++ S +++ FMK+G L + L
Sbjct: 43 EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRL 102
Query: 144 GRRELEWLSRH--KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
G ++ K +ASG+EYL S IHRD+ N +++++M ++ F L+
Sbjct: 103 GDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS 159
Query: 202 ILMPDG----LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
+ +G +I M V ++IA E + K D++SFGV + + G+ P+
Sbjct: 160 KKIYNGDYYRQGRIAKMPV----KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 40/166 (24%), Positives = 63/166 (37%), Gaps = 40/166 (24%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183
L+ +F+ G + +L + + LS +A + + H IHRDIKP
Sbjct: 78 LIMEFLPGGDMMTLLM-------KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPD 130
Query: 184 NVLIDDDMEARISGFDLAILM---------------PDGLTQIDTM-------------- 214
N+L+D ++S F L + P M
Sbjct: 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRR 190
Query: 215 ----YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
VGTP YIAPE ++ CD +S GV++ +++G PF
Sbjct: 191 QLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 9e-06
Identities = 40/152 (26%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRR-ELEWLSRHKIALAVAS 162
++H N+L L +LLV +F G L+ L K + + ++A +A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 163 GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL--MPDGLTQIDTMYVVGTP 220
GL +LH ++ IH D+ N L+ D+ +I + L+ D D ++V P
Sbjct: 112 GLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV---P 165
Query: 221 -RYIAPEY----HQTLTI---SEKCDIYSFGV 244
R+IAPE H L + +++ +++S GV
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 48/223 (21%), Positives = 87/223 (39%), Gaps = 31/223 (13%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE-IRSQI 98
IG G GDVY+ + IAV + + E +
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVA-------------VKTCKNCTSPSVREKFLQEA 58
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
Q H +I+ L+ ++ + +V + G L++ L + L+ S +
Sbjct: 59 YIMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSY 114
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+++ L YL S R +HRDI NVL+ ++ F L+ + D ++ Y
Sbjct: 115 QLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-----ESYYKAS 166
Query: 219 TPR----YIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
+ ++APE + D++ FGV + +L++G PF
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 8/134 (5%)
Query: 127 DFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186
++M GS++ D K L K + G+ YLH S ++HRDIK AN+L
Sbjct: 86 EYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANIL 138
Query: 187 IDDDMEARISGFDLAI-LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVL 245
D ++ F + L ++ V GTP +++PE K D++S G
Sbjct: 139 RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCT 198
Query: 246 LAVLVMGKFPFDDF 259
+ ++ K P+ ++
Sbjct: 199 VVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 17/108 (15%)
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
A VA G++YL + IHRD+ N+L+ ++ A+I+ F GL++ +
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF--------GLSRGQEV 164
Query: 215 YVVGT-----PRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
YV T R++A E + D++S+GVLL ++ +G P+
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 24/171 (14%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK- 90
K + + L+K+G G VYK ++ ++A+K++ + E EG
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTD-NLVALKEIRL--------------EHEEGAP 48
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
T IR ++ ++H NI+ L + S LV++++ + L+ L D
Sbjct: 49 CTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNS------ 100
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
++ H + L + L L+ H +V+HRD+KP N+LI++ E +++ F LA
Sbjct: 101 INMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 53/231 (22%), Positives = 99/231 (42%), Gaps = 17/231 (7%)
Query: 57 GSNGKMIAVKKVIIYSP--MSAAELIDAYSELGEGKLTE-IRSQIITASQIRHRNILPLL 113
G+ GK+ V+KV + + A +++ + + + K TE R++ IR L L
Sbjct: 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 70
Query: 114 AHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS 172
+ + D+ L L+ D++ G L L + E ++ + + L H
Sbjct: 71 HYAFQTDTKLHLILDYINGGELFTHL-------SQRERFKEQEVQIYSGEIVLALEHLHK 123
Query: 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ--T 230
+I+RDIK N+L+D + ++ F L+ + + GT Y+AP+ +
Sbjct: 124 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGD 182
Query: 231 LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENP 281
+ D +S GVL+ L+ G PF + ++ R ++ SE P
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 52/183 (28%)
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVV-G 218
VA G+++L S IHRD+ NVL+ D A+I F LA + + D+ YVV G
Sbjct: 221 VAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN-----DSNYVVKG 272
Query: 219 TPR----YIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDDFFSHTGEMDMVRWMR 273
R ++APE + + D++S+G+LL + +GK P+
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY----------------- 315
Query: 274 NVMASENPNRAIDSK---LLGNGYE--------EQMLLVLKLACFCTLADPDERPNSKDV 322
P ++SK ++ GY+ ++ ++K+ C +P ERP +
Sbjct: 316 -------PGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKM---CWNLEPTERPTFSQI 365
Query: 323 RCM 325
+
Sbjct: 366 SQL 368
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 41 KIGSGGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
K+G G G VYKA+ G + K A+K++ G G +I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-----------------EGTGISMSACREIA 50
Query: 100 TASQIRHRNILPL----LAHMVRPDSHLLVYDFMKNGSLQAV-LYDVSKGRRELEWLSRH 154
+++H N++ L L+H R L++D+ ++ + + SK ++ L R
Sbjct: 51 LLRELKHPNVIALQKVFLSHSDR--KVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRS 108
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR----ISGFDLAILMPDGLTQ 210
+ + L+ +H H+ V+HRD+KPAN+L+ + R I+ A L L
Sbjct: 109 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 211 I-DTMYVVGTPRYIAPEY-----HQTLTISEKCDIYSFGVLLAVLV 250
+ D VV T Y APE H T I DI++ G + A L+
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 38/150 (25%), Positives = 54/150 (36%), Gaps = 45/150 (30%)
Query: 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAI---------------------------- 202
H IHRDIKP N+LID ++S F L+
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 203 -LMPDGLT-------QIDT---------MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVL 245
+ D + QI T VGTP YIAPE ++CD +S G +
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 246 LAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275
+ ++G PF SH ++ W +
Sbjct: 238 MFECLIGWPPFCSENSHETYRKIINWRETL 267
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 53/234 (22%)
Query: 42 IGSGGCGDVYKAE----LPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
IG G G V++A LP M+AVK ++ SA D E
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAA---------- 60
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS--------------- 142
++ H NI+ LL L++++M G L L S
Sbjct: 61 --LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 143 ---KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199
L + IA VA+G+ YL +HRD+ N L+ ++M +I+ F
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFG 175
Query: 200 LA--ILMPD--GLTQIDTMYVVGTPRYIAPE---YHQTLTISEKCDIYSFGVLL 246
L+ I D ++ D + + R++ PE Y++ T S D++++GV+L
Sbjct: 176 LSRNIYSADYYKASENDAIPI----RWMPPESIFYNRYTTES---DVWAYGVVL 222
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 41 KIGSGGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
K+G G G VYKA+ G + + A+K++ G G +I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-----------------EGTGISMSACREIA 50
Query: 100 TASQIRHRNILPL----LAHMVRPDSHLLVYDFMKNGSLQAV-LYDVSKGRRELEWLSRH 154
+++H N++ L L+H R L++D+ ++ + + SK ++ L R
Sbjct: 51 LLRELKHPNVISLQKVFLSHADR--KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 108
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR----ISGFDLAILMPDGLTQ 210
+ + L+ +H H+ V+HRD+KPAN+L+ + R I+ A L L
Sbjct: 109 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 211 I-DTMYVVGTPRYIAPEY-----HQTLTISEKCDIYSFGVLLAVLV 250
+ D VV T Y APE H T I DI++ G + A L+
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 27/226 (11%)
Query: 42 IGSGGCGDVYKAELPGSNGKM-IAVKKVIIYSPMSAAELIDAYSELGE-GKLTEIRSQII 99
IG G G V KA + +M A+K++ Y+ S + D EL KL + I
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI--- 156
HR L LA P +LL DF++ + + LS ++
Sbjct: 73 LLGACEHRGYL-YLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV 216
A VA G++YL + IHRD+ N+L+ ++ A+I+ F GL++ +YV
Sbjct: 130 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF--------GLSRGQEVYV 178
Query: 217 VGT-----PRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
T R++A E + D++S+GVLL ++ +G P+
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 26/172 (15%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK- 90
K + + LEK+G G V+K + ++A+K++ + E EG
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTE-NLVALKEIRL--------------EHEEGAP 48
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELE 149
T IR ++ ++H NI+ L +V D L LV++++ + L+ + D
Sbjct: 49 CTAIR-EVSLLKDLKHANIVTL-HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN------ 99
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+S H + + + L L H +V+HRD+KP N+LI++ E +++ F LA
Sbjct: 100 IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 24/222 (10%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F L +G G G V K + +++A+KK + + E+ E L E++
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETK-EIVAIKKF---------KDSEENEEVKETTLRELK 52
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++ NI+ L R LV+++++ L+ +L ++ G + K
Sbjct: 53 ----MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNG------VPPEK 101
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ + ++ +H H ++HRDIKP N+LI + ++ F A + +G T Y
Sbjct: 102 VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
V T Y +PE + D++S G +L L G+ FP
Sbjct: 162 -VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 12/92 (13%)
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
V+ G++YL + +HRD+ NVL+ A+IS F L+ L + Y T
Sbjct: 104 VSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLS----KALGADENYYKAKT 156
Query: 220 P-----RYIAPEYHQTLTISEKCDIYSFGVLL 246
++ APE S K D++SFGVL+
Sbjct: 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 4/67 (5%)
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
V +GL LH ++HRDIKP N+L+ D + +I F A+ M G+ + +Y +
Sbjct: 318 VLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLD 373
Query: 220 PRYIAPE 226
PRY PE
Sbjct: 374 PRYSPPE 380
|
Length = 507 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 57 GSNGKMIAVKKVIIYSP--MSAAELIDAYSELGEGKLTE-IRSQIITASQIRHRNILPLL 113
G+ GK+ V+KV + + A +++ + + + K E R++ +R L L
Sbjct: 11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTL 70
Query: 114 AHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS 172
+ + ++ L L+ D++ G + LY + +I LA LE+LH
Sbjct: 71 HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLH---K 123
Query: 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID--TMYVVGTPRYIAPEYHQT 230
+++RDIK N+L+D + ++ F L+ + L++ T GT Y+APE +
Sbjct: 124 LGIVYRDIKLENILLDSEGHVVLTDFGLS---KEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 231 LTISEKC-DIYSFGVLLAVLVMGKFPF 256
K D +S G+L+ L+ G PF
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 14/161 (8%)
Query: 106 HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL-YDVSKGRRELEWLSRHKIALAVASGL 164
H NI+P A + + +V FM GS + ++ G EL + I V L
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---AIAYILQGVLKAL 114
Query: 165 EYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM-----YVVGT 219
+Y+H H V HR +K +++LI D + +SG + M + ++ + Y V
Sbjct: 115 DYIH--HMGYV-HRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKV 171
Query: 220 PRYIAPE-YHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDD 258
+++PE Q L K DIYS G+ L G PF D
Sbjct: 172 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 17/173 (9%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRS--- 96
EK+G G G+V+ E G M K ++ A L E R+
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFM---DKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 97 -QIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD-------VSKGRREL 148
+I S+++ NI+ LLA + D ++ ++M+NG L L +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ + +A +ASG++YL S +HRD+ N L+ + +I+ F ++
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 28/234 (11%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
D L +G G G+VY+ G +G + ++ + P S +E E +
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE----QDES------D 55
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE----LE 149
+ + S+ H+NI+ L+ ++ + M G L++ L + ++ R E L
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE-NRPRPERPSSLT 114
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD---DMEARISGFDLA--ILM 204
A VA G +YL IHRDI N L+ A+I+ F +A I
Sbjct: 115 MKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171
Query: 205 PDGLTQID-TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
+ M + +++ PE + K D++SFGVLL + +G P+
Sbjct: 172 ASYYRKGGRAMLPI---KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 28/169 (16%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ +LEK+G G VYK + NG+++A+K + M E + T IR
Sbjct: 7 YLNLEKLGEGSYATVYKG-ISRINGQLVALKVI----SMKTEEGV---------PFTAIR 52
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+ ++H NI+ L + ++ V+++M Q ++ + L +
Sbjct: 53 EASLL-KGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMI-------QHPGGLHPYN 104
Query: 156 IAL---AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ L + GL Y+H H ++HRD+KP N+LI E +++ F LA
Sbjct: 105 VRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 65/298 (21%), Positives = 119/298 (39%), Gaps = 54/298 (18%)
Query: 42 IGSGGCGDVYKAELPGSNGKM--IAVK--KVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
+G G G V +A+L +G +AVK K I+S E + + + E +
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRR--ELEWLSRHK 155
I + + R + LP+ +++ FMK+G L L G L + +
Sbjct: 67 IGVSLRSRAKGRLPI---------PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ +ASG+EYL S IHRD+ N +++++M ++ F L+ + G Y
Sbjct: 118 FMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-----DYY 169
Query: 216 VVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDDFFSHTGEMDMV 269
G +++A E + D+++FGV + ++ G+ P+
Sbjct: 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---------- 219
Query: 270 RWMRNVMASENPNRAIDSKLLGNGYEEQ----MLLVLKLACFCTLADPDERPNSKDVR 323
N I + L+ +Q + V +L C C +P RP+ + +R
Sbjct: 220 -----------ENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLR 266
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 9e-05
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 87 GEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGR 145
G EI ++ + H I+ LL + P + L LV GSL L V + R
Sbjct: 49 GRQTFQEITDHMLAMGSLDHAYIVRLLG--ICPGASLQLVTQLSPLGSL---LDHVRQHR 103
Query: 146 RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILM 204
L+ + +A G+ YL H R++HR++ N+L+ D +I+ F +A +L
Sbjct: 104 DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160
Query: 205 PDGLTQIDTMYV---VGTP-RYIAPEYHQTLTISEKCDIYSFGVLL 246
PD D Y TP +++A E + + D++S+GV +
Sbjct: 161 PD-----DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 23/150 (15%)
Query: 106 HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLE 165
H NI+ LL L++ ++ G L L K L + VA G+
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMA 155
Query: 166 YLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPDGLTQIDTMYVV-GTPR- 221
+L S IHRD+ NVL+ +I F LA I+ D+ YVV G R
Sbjct: 156 FLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN-------DSNYVVKGNARL 205
Query: 222 ---YIAPE--YHQTLTISEKCDIYSFGVLL 246
++APE ++ T + D++S+G+LL
Sbjct: 206 PVKWMAPESIFNCVYTF--ESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM---PDGLTQIDT 213
+ VA G+E+L S + IHRD+ N+L+ ++ +I F LA + PD + + D
Sbjct: 179 SFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
+ +++APE + + D++SFGVLL + +G P+
Sbjct: 236 RLPL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 33/106 (31%), Positives = 58/106 (54%), Gaps = 14/106 (13%)
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM---PDGLTQIDT 213
+ VA G+E+L S + IHRD+ N+L+ ++ +I F LA + PD + + D
Sbjct: 185 SFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 214 MYVVGTPRYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
+ +++APE + + TI + D++SFGVLL + +G P+
Sbjct: 242 RLPL---KWMAPETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 49/231 (21%)
Query: 39 LEKIGSGGCGDVYKAEL-----PGSN-GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
L++I G G K EL G N G+ +AVK + P E G +
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KP-----------ESGGNHIA 51
Query: 93 EIRSQIITASQIRHRNILPL--LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
+++ +I + H NI+ + + L+ +F+ +GSL+ L + + ++
Sbjct: 52 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINL 108
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
+ K A+ + G++YL S + +HRD+ NVL++ + + +I F GLT+
Sbjct: 109 KQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDF--------GLTK 157
Query: 211 -IDT---MYVVGTPR-----YIAPE--YHQTLTISEKCDIYSFGVLLAVLV 250
I+T Y V + APE I+ D++SFGV L L+
Sbjct: 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS--DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 42/173 (24%), Positives = 80/173 (46%), Gaps = 28/173 (16%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK- 90
K + + L+K+G G V+K ++A+K++ + E EG
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGR-SKLTENLVALKEIRL--------------EHEEGAP 47
Query: 91 LTEIRSQIITASQIRHRNILPL--LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
T IR ++ ++H NI+ L + H R LV++++ + L+ L +
Sbjct: 48 CTAIR-EVSLLKNLKHANIVTLHDIIHTER--CLTLVFEYLDS-DLKQYLDNCGN----- 98
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+S H + + + L L H +++HRD+KP N+LI++ E +++ F LA
Sbjct: 99 -LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 46/182 (25%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK- 90
K + + L+K+G G VYK G+++A+K++ + E EG
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGR-SKLTGQLVALKEIRL--------------EHEEGAP 47
Query: 91 LTEIRSQIITAS---QIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRR 146
T IR AS ++H NI+ L ++ L LV++++ D+ +
Sbjct: 48 FTAIRE----ASLLKDLKHANIV-TLHDIIHTKKTLTLVFEYLDT--------DLKQ--- 91
Query: 147 ELEW----LSRHKIAL---AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199
++ LS H + L + GL Y H RV+HRD+KP N+LI + E +++ F
Sbjct: 92 YMDDCGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGELKLADFG 148
Query: 200 LA 201
LA
Sbjct: 149 LA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 47/204 (23%), Positives = 88/204 (43%), Gaps = 50/204 (24%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F ++ I G G VY +N K+ AVK + A++I+ +
Sbjct: 6 FVIVKPISRGAFGKVYLGR-KKNNSKLYAVKV------VKKADMIN----------KNMV 48
Query: 96 SQIITASQIRHRNIL-----PLLAHMVRPDSHL----LVYDFMKNGSLQAVL-----YDV 141
Q+ R+ L P + H+ LV +++ G ++++L +D
Sbjct: 49 HQVQA-----ERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD- 102
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
E ++ I+ VA L+YLH H +IHRD+KP N+LI ++ +++ F L+
Sbjct: 103 -------EEMAVKYIS-EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
Query: 202 ILMPDGLTQIDTMYVVGTPRYIAP 225
+ + +++ M ++ TP P
Sbjct: 152 KVTLN--RELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 37/161 (22%), Positives = 74/161 (45%), Gaps = 18/161 (11%)
Query: 94 IRSQIITASQIRHRNILPLLAHMV---RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
+R +++ ++I H+ P + M+ ++ +LV + G L L S + E+
Sbjct: 38 VRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL---SGKKDEITV 94
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
+ ++ V+ G++YL +HRD+ NVL+ + A+IS F L+ L
Sbjct: 95 SNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLS----KALGA 147
Query: 211 IDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL 246
D+ Y + ++ APE S + D++S+G+ +
Sbjct: 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 20/150 (13%)
Query: 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL--EWLSRHKIALAVASGLE 165
N++ L ++V DS LV + G L + + E W + +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL------D 99
Query: 166 YLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ--IDTMYVVGTPRYI 223
LH ++ RD+ P N+L+DD +++ F + D ++ MY
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------- 149
Query: 224 APEYHQTLTISEKCDIYSFGVLLAVLVMGK 253
APE +E CD +S G +L L+ GK
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 56/247 (22%), Positives = 97/247 (39%), Gaps = 28/247 (11%)
Query: 24 KEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPM--SAAELID 81
K D FL F ++ + +G G ++ L S + A + V + LI
Sbjct: 141 KHDDEFLAH---FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIA 197
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLV--------YDFMKNGS 133
+ G ++ ++I+ ++ H NIL + + + ++ Y FM + +
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA 257
Query: 134 LQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193
R L +R I + +EY+H ++IHRDIK N+ ++ D
Sbjct: 258 FDW-------KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD--G 304
Query: 194 RISGFDLAILMPDGLTQIDTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMG 252
+I D MP + Y VGT +PE E DI+S G++L ++
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364
Query: 253 KF-PFDD 258
F P D
Sbjct: 365 DFCPIGD 371
|
Length = 501 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 61/317 (19%), Positives = 120/317 (37%), Gaps = 68/317 (21%)
Query: 17 IFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSA 76
I S I+K +K+ D + +YK K+VII +
Sbjct: 15 IESDDIDKYTSVLIKENDQNS------------IYKGIFNN--------KEVIIRTFKKF 54
Query: 77 AELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHL----LVYDFMKNG 132
+ ++ E ++ +R I NIL + ++ L L+ ++ G
Sbjct: 55 HKGHKVLIDITENEIKNLRR-------IDSNNILKIYGFIIDIVDDLPRLSLILEYCTRG 107
Query: 133 SLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192
L+ VL ++L + ++ +A+ GL L+ + + ++++ + L+ ++ +
Sbjct: 108 YLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYK 161
Query: 193 ARISGFDL-AILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251
+I L IL ++ M V + + TI K DIYS GV+L +
Sbjct: 162 LKIICHGLEKILSSPPFKNVNFM--VYFSYKMLNDIFSEYTI--KDDIYSLGVVLWEIFT 217
Query: 252 GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLL--VLKLACF-- 307
GK PF++ + D+ ++ ++ L L++ C
Sbjct: 218 GKIPFEN-LTTKEIYDL--------------------IINKNNSLKLPLDCPLEIKCIVE 256
Query: 308 -CTLADPDERPNSKDVR 323
CT D +RPN K++
Sbjct: 257 ACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 47/241 (19%)
Query: 32 KEDCFASLEKIGSGGCGDVYKA-ELP-GSNGKMIAVKKVI--IYSPMSAAELIDAYSELG 87
KE ++ +GSG G VYK +P G K+ K++ P + E +D
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD------ 58
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE 147
+I AS + H +++ LL + P L V M +G L
Sbjct: 59 --------EALIMAS-MDHPHLVRLLGVCLSPTIQL-VTQLMPHGCL------------- 95
Query: 148 LEWLSRHKIALA----------VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197
L+++ HK + +A G+ YL R++HRD+ NVL+ +I+
Sbjct: 96 LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITD 152
Query: 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
F LA L+ + + +++A E + + D++S+GV + ++ G P+
Sbjct: 153 FGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
Query: 257 D 257
D
Sbjct: 213 D 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL 91
KE F ++ +GSG G VYK L G+ + + P++ EL +A S
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 53
Query: 92 TEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLY---DVSKGRREL 148
EI + + + + ++ LL + + L+ M G L + D + L
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL 112
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
W + +A G+ YL ++HRD+ NVL+ +I+ F LA L L
Sbjct: 113 NW------CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL----L 159
Query: 209 TQIDTMYVV---GTP-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFD 257
+ Y P +++A E + + D++S+GV + ++ G P+D
Sbjct: 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 32/108 (29%), Positives = 55/108 (50%), Gaps = 18/108 (16%)
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM---PDGLTQIDT 213
+ VA G+E+L S + IHRD+ N+L+ ++ +I F LA + PD + +
Sbjct: 180 SFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK--- 233
Query: 214 MYVVGTPR----YIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
G+ R ++APE + + D++SFGVLL + +G P+
Sbjct: 234 ----GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 20/182 (10%)
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE 147
E L ++++++ + RH NI+ ++ FM GS ++L
Sbjct: 40 EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP---- 95
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD-LAILMPD 206
E +S I + L L+ H IHR+IK +++LI D +SG L L+ +
Sbjct: 96 -EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154
Query: 207 G--------LTQIDTMYVVGTPRYIAPE-YHQTLT-ISEKCDIYSFGVLLAVLVMGKFPF 256
G Q T + +++PE Q L + K DIYS G+ L G+ PF
Sbjct: 155 GQKAKVVYDFPQFSTSVL----PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
Query: 257 DD 258
D
Sbjct: 211 QD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 18/41 (43%), Positives = 27/41 (65%)
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
+VGTP YIAPE ++ CD +S GV+L +++G+ PF
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 31/235 (13%)
Query: 32 KEDCFASLEKIGSGGCGDVYKA-ELP-GSNGKMIAVKKVII--YSPMSAAELID-AYSEL 86
KE ++ +GSG G VYK +P G N K+ KV+ SP + E++D AY
Sbjct: 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA 64
Query: 87 GEGKLTEIRS-QIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGR 145
G G R I S ++ L + P LL Y + + +
Sbjct: 65 GVGSPYVCRLLGICLTSTVQ-------LVTQLMPYGCLLDYVRENKDRIGS--------Q 109
Query: 146 RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
L W + +A G+ YL R++HRD+ NVL+ +I+ F LA L+
Sbjct: 110 DLLNW------CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160
Query: 206 DGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDDF 259
T+ +++A E + + D++S+GV + ++ G P+D
Sbjct: 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 39 LEKIGSGGCGDVY----KAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
L ++G G G VY + + G +AVK V S E I+ +E
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNE--------- 59
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV------SKGRREL 148
+ ++ H ++ LL + + L+V + M +G L++ L + + GR
Sbjct: 60 -ASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
++A +A G+ YL+ + + +HRD+ N ++ D +I F M +
Sbjct: 117 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDI 169
Query: 209 TQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLL 246
+ D G R++APE + + D++SFGV+L
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 26/169 (15%)
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL--YDVSKGRRE------------ 147
S+++ NI+ LL V D ++ ++M+NG L L + +
Sbjct: 74 SRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLP 133
Query: 148 -LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
+ + S +AL +ASG++YL S +HRD+ N L+ +++ +I+ F M
Sbjct: 134 AISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG----MSR 186
Query: 207 GLTQIDTMYVVGTP----RYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251
L D + G R++A E + D+++FGV L ++M
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 42/166 (25%), Positives = 65/166 (39%), Gaps = 47/166 (28%)
Query: 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL--AILMPDGLTQIDTMYVVGTPR 221
L L HS ++HRD+KP N++ + DL A + G+ I +++ PR
Sbjct: 265 LFALDGLHSTGIVHRDVKPQNIIFSEG-SGSFKIIDLGAAADLRVGINYIPKEFLL-DPR 322
Query: 222 YIAPEYH----QT------------------LTISEKCDIYSFGVLLAVLVMGKFP---- 255
Y APE + QT L + ++ DIYS G++ L M FP
Sbjct: 323 YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF--LQMA-FPNLRS 379
Query: 256 ------FDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYE 295
F+ D+V W + V +P+ L G+E
Sbjct: 380 DSNLIQFNRQLKRNDY-DLVAWRKLVEPRASPD-------LRRGFE 417
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.22 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.16 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.79 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.7 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.16 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.95 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.7 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.62 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.59 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.44 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.39 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.34 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.26 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.13 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.09 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.88 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.87 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.78 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.67 | |
| PLN02236 | 344 | choline kinase | 96.66 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.65 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.54 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.5 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.04 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.35 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.11 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.99 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.6 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.14 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.93 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.6 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.37 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.3 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.22 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-52 Score=343.46 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=218.1
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++.+.++.||+|..|+||+|+ ...+++.+|+|.+.. ...+...+++.+|+++++..+||+||
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~-Hk~t~~i~AlK~I~~--------------~~~~~~~~Qi~rEl~il~~~~spyIV 140 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVR-HKPTGKIYALKVILL--------------NIDPALQKQILRELEILRSCQSPYIV 140 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEE-EcCCCeEEEEEeecc--------------cCCHHHHHHHHHHHHHHhhCCCCCee
Confidence 344578889999999999999996 567889999999832 34456788999999999999999999
Q ss_pred ccccceecCCc-eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 111 PLLAHMVRPDS-HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 111 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
.+|+.|..++. .+++||||++|+|.+.+.. .+.+++....+++.+++.||.|||. .++|+||||||+|+|++.
T Consensus 141 ~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNs 214 (364)
T KOG0581|consen 141 GFYGAFYSNGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNS 214 (364)
T ss_pred eEeEEEEeCCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeecc
Confidence 99999999995 9999999999999999943 3669999999999999999999993 269999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
.|.|||||||.+..+.+.. ...+.||..|||||.+.+..|+.++||||||+.++|+.+|+.||... .....+..
T Consensus 215 kGeVKicDFGVS~~lvnS~----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~ 288 (364)
T KOG0581|consen 215 KGEVKICDFGVSGILVNSI----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIF 288 (364)
T ss_pred CCCEEeccccccHHhhhhh----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHH
Confidence 9999999999998877652 12268999999999999999999999999999999999999999764 23345566
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+.+..+...+.+..+.. ....++.++|..||++||.+|||+.|+++
T Consensus 289 ~Ll~~Iv~~ppP~lP~~---------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 289 ELLCAIVDEPPPRLPEG---------EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHhcCCCCCCCcc---------cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 66666665544432221 12333999999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=349.86 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=207.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.+.|.+.+.||+|+||.|-+| ++..+++.||||++....-... +. .........+|+++|++++|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla-~e~~tgk~vAiKIi~krk~~~~-------s~-~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLA-YEKKTGKQVAIKIINKRKSTGC-------SR-AIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEE-EEcccCcEEEeeeeehhhcccc-------cc-cccchhhhHHHHHHHHhcCCCCEEE
Confidence 3567999999999999999999 7889999999999832110000 00 1123344679999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC-
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD- 190 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~- 190 (325)
++++++..+..|+||||+.||.|.+++ ..+..+.+..-..++.|++.|+.||| ++||+||||||+|||++.+
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~ 313 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDA 313 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCC
Confidence 999999999999999999999999999 45566888888899999999999999 9999999999999999865
Q ss_pred --CCceeeccccceecCCCCccccceeecCCcccccccccccCCC---CCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 191 --MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI---SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 191 --~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~---~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
-.+||+|||+|....... ...++|||+.|.|||++.+... +.++|+||+||++|-+++|.+||.+.....
T Consensus 314 e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-- 388 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-- 388 (475)
T ss_pred cceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--
Confidence 668999999998776433 2334799999999999987653 347899999999999999999998754322
Q ss_pred chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.+ ++..+..... +..+....++.++||.+||..||++|||++|+|+
T Consensus 389 -sl~e---QI~~G~y~f~-------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 -SLKE---QILKGRYAFG-------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -cHHH---HHhcCccccc-------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 2222 2222322211 1223445556999999999999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=358.19 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=215.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
.+|...+.||+|||+.+|.++ +..+|+.||+|++ .+..-......+++.+|+++-++|+|||||+++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~-~~~tge~~A~KvV------------pk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~ 84 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEAR-DLDTGEVVAVKVV------------PKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFY 84 (592)
T ss_pred ceeeeeeeeccCcceEEEEEE-EcCCCcEEEEEEe------------ehHHhcCcchHHHHHHHHHHHHhcCCCcEEeee
Confidence 789999999999999999996 5578999999999 333445567788999999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
++|++.+++|+|+|+|..++|..++ ..+..+++.++..++.||+.||.||| +++|+|||||..|+|++++-+|
T Consensus 85 ~~FEDs~nVYivLELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~V 157 (592)
T KOG0575|consen 85 HFFEDSNNVYIVLELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNV 157 (592)
T ss_pred eEeecCCceEEEEEecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcE
Confidence 9999999999999999999999998 46678999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
||+|||+|..+........ ..|||+.|.|||++.....+..+||||+||++|.||.|++||.. ..+.+...
T Consensus 158 KIgDFGLAt~le~~~Erk~--TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-------k~vkety~ 228 (592)
T KOG0575|consen 158 KIGDFGLATQLEYDGERKK--TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-------KTVKETYN 228 (592)
T ss_pred EecccceeeeecCcccccc--eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-------chHHHHHH
Confidence 9999999999886544333 37999999999999998999999999999999999999999964 23344344
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+......... . ......+||.++|+.||.+|||+++||+
T Consensus 229 ~Ik~~~Y~~P~---~--------ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 229 KIKLNEYSMPS---H--------LSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHhcCccccc---c--------cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 43333222111 1 1112889999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-53 Score=335.54 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=215.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
.-..|+++++||.|.||.||+++ ...+++.+|.|.+ .+.......+..+..|+.+|++|+||||++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~-~~~~g~l~a~K~i-------------~f~~md~k~rq~~v~Ei~lLkQL~HpNIVq 82 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQ-CLLDGKLVALKKI-------------QFGMMDAKARQDCVKEISLLKQLNHPNIVQ 82 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEee-eccCcchhhhhhc-------------chhhccHHHHHHHHHHHHHHHhcCCchHHH
Confidence 34679999999999999999996 5678999999998 244566677889999999999999999999
Q ss_pred ccc-ceecCCc-eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEec
Q 040480 112 LLA-HMVRPDS-HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANVLID 188 (325)
Q Consensus 112 ~~~-~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~nil~~ 188 (325)
+++ .+..++. +++|||+|.+|+|.+.+..+...+..+++.++|+++.|++.||+++|+... .-|+||||||-|||++
T Consensus 83 Yy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~ 162 (375)
T KOG0591|consen 83 YYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT 162 (375)
T ss_pred HHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc
Confidence 998 5555555 899999999999999999988999999999999999999999999995322 2399999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.+|.+||+|||+++.+......... .+|||.|++||.+...+|+.++||||+||++|+|..-++||.+. +.
T Consensus 163 ~~gvvKLGDfGL~r~l~s~~tfA~S--~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~ 233 (375)
T KOG0591|consen 163 ANGVVKLGDFGLGRFLSSKTTFAHS--LVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NL 233 (375)
T ss_pred CCCceeeccchhHhHhcchhHHHHh--hcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cH
Confidence 9999999999999988765543332 69999999999999999999999999999999999999999652 44
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhh
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (325)
....+.+..+..++.+ .+-.++.+..||..|+..||+.||+.-.+
T Consensus 234 ~~L~~KI~qgd~~~~p---------~~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 234 LSLCKKIEQGDYPPLP---------DEHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred HHHHHHHHcCCCCCCc---------HHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 4444444444322211 12234448899999999999999985433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=336.29 Aligned_cols=204 Identities=28% Similarity=0.477 Sum_probs=182.9
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|.+.+.||.|+||+||+|++. .++..||||.+. ...+....++.+..|+.+|+.++|||||
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~-~~~~~VAIK~i~-------------~~~l~~k~~e~L~~Ei~iLkel~H~nIV 72 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHK-KSGTEVAIKCIA-------------KKKLNKKLVELLLSEIKILKELKHPNIV 72 (429)
T ss_pred cccccceehhhccCcceEEEEEeEec-cCCceEEeeeeh-------------hhccCHHHHHHHHHHHHHHHhcCCccee
Confidence 45678999999999999999999754 555999999982 2334556788899999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
.+++.+.+++.+|+|||||+||+|.+++ ...+.+++.++..++.|++.|+++|| +++||||||||.|||++..
T Consensus 73 ~l~d~~~~~~~i~lVMEyC~gGDLs~yi----~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~ 145 (429)
T KOG0595|consen 73 RLLDCIEDDDFIYLVMEYCNGGDLSDYI----RRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTT 145 (429)
T ss_pred eEEEEEecCCeEEEEEEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccC
Confidence 9999999999999999999999999999 44557999999999999999999999 8999999999999999854
Q ss_pred ------CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 191 ------MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 191 ------~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
..+||+|||+++.+..+..... .+|++.|||||++..++|+.|+|+||+|+++|+|++|+.||..
T Consensus 146 ~~~~~~~~LKIADFGfAR~L~~~~~a~t---lcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 146 ARNDTSPVLKIADFGFARFLQPGSMAET---LCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCCCCCceEEecccchhhhCCchhHHHH---hhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 4579999999999886654433 6999999999999999999999999999999999999999975
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=334.15 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=211.3
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
....+.|++++.||+|+||+||.++ ...+++.+|+|.+ .+..-.........+.|..+|..++||+|
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vr-k~dt~kiYAmKvl------------~K~~iv~~~e~~~~~~Er~IL~~v~hPFi 87 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVR-KKDTGKIYAMKVL------------KKKKIVEKKEVRHTKAERNILSKIKHPFI 87 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEE-EcccCceeehhhh------------hhhHhhhhhhHHHHHHHHHHHHhCCCCcE
Confidence 3456899999999999999999997 4588999999988 33333444678899999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++++..|++.+.+|+|+||+.||.|...+ +....+++..+..++..|+.||.||| ++|||||||||+|||++.
T Consensus 88 v~l~ysFQt~~kLylVld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~ 160 (357)
T KOG0598|consen 88 VKLIYSFQTEEKLYLVLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDE 160 (357)
T ss_pred eeeEEecccCCeEEEEEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecC
Confidence 99999999999999999999999999999 45677999999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
+|+++|+|||++........... .++||+.|+|||++.+.+|+.++|.||||+++|+|++|.+||.. .+..
T Consensus 161 ~GHi~LtDFgL~k~~~~~~~~t~--tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-------~~~~ 231 (357)
T KOG0598|consen 161 QGHIKLTDFGLCKEDLKDGDATR--TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-------EDVK 231 (357)
T ss_pred CCcEEEeccccchhcccCCCccc--cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-------ccHH
Confidence 99999999999986655443333 37999999999999999999999999999999999999999965 2334
Q ss_pred HHHHHHhhhCCC-Ccc-cchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC
Q 040480 270 RWMRNVMASENP-NRA-IDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318 (325)
Q Consensus 270 ~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (325)
.+...+...+.. ... ... ..+++++++|..||++|..
T Consensus 232 ~~~~~I~~~k~~~~p~~ls~------------~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 232 KMYDKILKGKLPLPPGYLSE------------EARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred HHHHHHhcCcCCCCCccCCH------------HHHHHHHHHhccCHHHhcC
Confidence 555555555521 111 121 1889999999999999973
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=318.24 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=208.1
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.|+.+.++|+|+||+||+|+ +..+|+.||||++.- +...+...+-.++|+++|++++|||+|.++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCr-nk~TgqIVAIKkF~E-------------sedd~~VkKIAlREIrmLKqLkH~NLVnLi 67 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCR-NKDTGQIVAIKKFVE-------------SEDDPVVKKIALREIRMLKQLKHENLVNLI 67 (396)
T ss_pred cHHhhhhccccCcceEEEEec-cCCcccEEEEEeecc-------------CCccHHHHHHHHHHHHHHHhcccchHHHHH
Confidence 468999999999999999995 778999999999831 222334556689999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
++|......++|||||+. ++.+.++. ....++.....+++.|++.|+.|+| +++++||||||+||+++.+|.+
T Consensus 68 EVFrrkrklhLVFE~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvv 140 (396)
T KOG0593|consen 68 EVFRRKRKLHLVFEYCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVV 140 (396)
T ss_pred HHHHhcceeEEEeeecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcE
Confidence 999999999999999987 66666643 4445888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCC-CCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 194 RISGFDLAILMPD-GLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 194 ~l~dfg~~~~~~~-~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
||||||+|+.... +..... .+.|.+|.|||++.| .+|+..+||||+||++.||++|.+-|.+.+ +.+....
T Consensus 141 KLCDFGFAR~L~~pgd~YTD---YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S----DiDQLy~ 213 (396)
T KOG0593|consen 141 KLCDFGFARTLSAPGDNYTD---YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS----DIDQLYL 213 (396)
T ss_pred EeccchhhHhhcCCcchhhh---hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc----hHHHHHH
Confidence 9999999998774 332222 477899999999998 579999999999999999999999997532 2222222
Q ss_pred HHHHhhhC-----------------CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASE-----------------NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+......- ..+.+..+.-+...+++....+.+++.+||+.||.+|++.+++++
T Consensus 214 I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 214 IRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22211110 011222222233344555556899999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=339.16 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=214.2
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCC
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRN 108 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 108 (325)
....++|.+.+.||.|+|++|++|+ +..+++.||||++ ++.....+.....+.+|-.+|.+| .||.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~-~~~t~keYAiKVl------------~K~~Iike~KvkYV~~Ek~~l~~L~~hPg 135 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAR-EKATGKEYAIKVL------------DKRYIIKEKKVKYVTREKEALTQLSGHPG 135 (604)
T ss_pred cCChhhcchhheeccccceeEEEee-ecCCCceeeHhhh------------hHHHHHhhcccchhhHHHHHHHHhhCCCC
Confidence 4567899999999999999999995 6779999999988 444556667778889999999999 7999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|++++..|.++..+|+|+||+++|+|.+++.+. +.+++.+...++.+|+.||.||| ++|||||||||+|||++
T Consensus 136 ivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd 208 (604)
T KOG0592|consen 136 IVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLD 208 (604)
T ss_pred eEEEEEEeecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEc
Confidence 999999999999999999999999999999553 56999999999999999999999 89999999999999999
Q ss_pred CCCCceeeccccceecCCCCcc---------cc--ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 040480 189 DDMEARISGFDLAILMPDGLTQ---------ID--TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~---------~~--~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
++++++|+|||.+..+...... .. ...++||..|.+||++.....+..+|+|+|||++|+|+.|.+||.
T Consensus 209 ~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr 288 (604)
T KOG0592|consen 209 KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR 288 (604)
T ss_pred CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence 9999999999999877543222 11 134799999999999999999999999999999999999999996
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
... . ....+.++........-.+ +.+.+||.+.|..||.+|+|+.+|-
T Consensus 289 a~N----e---yliFqkI~~l~y~fp~~fp-----------~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 289 AAN----E---YLIFQKIQALDYEFPEGFP-----------EDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred ccc----H---HHHHHHHHHhcccCCCCCC-----------HHHHHHHHHHHccCccccccHHHHh
Confidence 522 1 2223333333222211111 2289999999999999999998874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=335.09 Aligned_cols=252 Identities=32% Similarity=0.483 Sum_probs=200.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcE-EEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKM-IAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
....+.+.+|.|+||+||+|.|. |.. ||+|.+... .........+.+|+.+|++++|||||++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~-------------~~~~~~~~~f~~E~~il~~l~HpNIV~f 104 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDP-------------DFDDESRKAFRREASLLSRLRHPNIVQF 104 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC---CceeEEEEEecch-------------hcChHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 33444556999999999999984 555 999988321 1111226789999999999999999999
Q ss_pred ccceecCC-ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceEecCC
Q 040480 113 LAHMVRPD-SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR-VIHRDIKPANVLIDDD 190 (325)
Q Consensus 113 ~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~-ivH~dl~~~nil~~~~ 190 (325)
++++.+.. ..++||||+++|+|.+++... .+..++...+..++.|++.|++||| +++ ||||||||+|+|++.+
T Consensus 105 ~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~ 179 (362)
T KOG0192|consen 105 YGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLK 179 (362)
T ss_pred EEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCC
Confidence 99999888 799999999999999999543 4678999999999999999999999 778 9999999999999999
Q ss_pred C-CceeeccccceecCCCCccccceeecCCcccccccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 191 M-EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ--TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 191 ~-~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~--~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+ ++||+|||+++...... ...+...||+.|+|||++. ...|+.++||||||+++|+|+||..||.+... ..
T Consensus 180 ~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~ 253 (362)
T KOG0192|consen 180 GKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQ 253 (362)
T ss_pred CCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HH
Confidence 7 99999999998766532 1122257899999999999 56899999999999999999999999976432 11
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+. ........++..+.. ++..+..|+.+||+.||+.||++.+++.
T Consensus 254 ~~--~~v~~~~~Rp~~p~~----------~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 254 VA--SAVVVGGLRPPIPKE----------CPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HH--HHHHhcCCCCCCCcc----------CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11 111222333322211 2233899999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=328.41 Aligned_cols=268 Identities=28% Similarity=0.355 Sum_probs=215.1
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...+.|+.+++||+|+||.||+|+ +..+++.||+|++. +....+.......+|+.+|++|.||||+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr-~~~tgkivALKKvr-------------~d~~~~~~~~t~~REI~ILr~l~HpNIi 179 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKAR-DLETGKIVALKKVR-------------FDNEKEGFPITAIREIKILRRLDHPNII 179 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEee-ecccCcEEEEEEee-------------cccCCCcchHHHHHHHHHHHhcCCCccc
Confidence 366789999999999999999995 77899999999993 2334556778899999999999999999
Q ss_pred ccccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 111 PLLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 111 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++.+..... ..+|+|||||+. +|.-++. ...-.+++.++..++.|++.||+||| ++||+|||||.+|||++
T Consensus 180 kL~eivt~~~~~siYlVFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLid 252 (560)
T KOG0600|consen 180 KLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILID 252 (560)
T ss_pred ceeeEEEecCCceEEEEEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEc
Confidence 999998877 689999999987 8888872 24557999999999999999999999 99999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.+|.+||+|||+|+.+....... .+..+-|.+|.|||++.|.. |+.++|+||.|||+.||+.|++.|.+. ...+
T Consensus 253 n~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~----tEve 327 (560)
T KOG0600|consen 253 NNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR----TEVE 327 (560)
T ss_pred CCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc----cHHH
Confidence 99999999999999776554332 33356799999999999874 999999999999999999999999752 2333
Q ss_pred HHHHHHHHhhhCCCCcccchhhc---------------CCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLL---------------GNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+.+..+...+....|.-.++. ...+...+....+|+..+|..||.+|.|+.++|+
T Consensus 328 Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 328 QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 34444444443333332211111 1112333345789999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=300.92 Aligned_cols=265 Identities=25% Similarity=0.351 Sum_probs=216.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
.+|...++||+|.||+||+|+ +..+++.||||++.+. ...........+|++.|+.++|+||+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~-d~~t~~~VAIKKIkl~-------------~~kdGi~~talREIK~Lqel~h~nIi~Li 67 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKAR-DTETGKRVAIKKIKLG-------------NAKDGINRTALREIKLLQELKHPNIIELI 67 (318)
T ss_pred chhhhhhhhcCcceEEEEEEE-ecCCCcEEEEEEeecc-------------ccccCccHHHHHHHHHHHHccCcchhhhh
Confidence 589999999999999999996 6778999999999543 22233355789999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.|...+.+.+|+||++. +|...+.+ ....++...+..++.+++.|++||| ++.|+||||||.|++++.+|.+
T Consensus 68 D~F~~~~~l~lVfEfm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~l 140 (318)
T KOG0659|consen 68 DVFPHKSNLSLVFEFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQL 140 (318)
T ss_pred hhccCCCceEEEEEeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcE
Confidence 999999999999999976 99999843 5567888999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
||+|||+++.+........ ..+-|.+|.|||++.|. .|+..+||||.||++.||+-+.+-|.+ ..+.+....+
T Consensus 141 KiADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~I 214 (318)
T KOG0659|consen 141 KIADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKI 214 (318)
T ss_pred EeecccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHH
Confidence 9999999998775443322 23668899999988876 489999999999999999999988765 3344444455
Q ss_pred HHHhhhCCCCcccchhhcCC--------------chHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 273 RNVMASENPNRAIDSKLLGN--------------GYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
-+....+.+..|.+....++ ....+..+..||+.+||..||.+|+|+.|+|++
T Consensus 215 f~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 215 FRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 55555555544443322222 234555568999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=331.13 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=203.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.+.+.+.||+|-||.||.|.|+ ....||+|.+.. .....+.+.+|+.+|++|+|++||+++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~----------------~~m~~~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKE----------------GSMSPEAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc--CCCcccceEEec----------------cccChhHHHHHHHHHHhCcccCeEEEE
Confidence 45667889999999999999985 445799998832 234456778999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++..+..+||||||++.|+|.+++.. ..+..+.......++.||++|++||+ ++++|||||.++||||+++..+
T Consensus 268 gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~v 342 (468)
T KOG0197|consen 268 GVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVV 342 (468)
T ss_pred EEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceE
Confidence 999999999999999999999999965 45677889999999999999999999 8999999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 272 (325)
||+|||+++........... ...-+..|+|||.+....++.+|||||||+++|||+| |+.|+.... ..++.+.+
T Consensus 343 KIsDFGLAr~~~d~~Y~~~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms----n~ev~~~l 417 (468)
T KOG0197|consen 343 KISDFGLARLIGDDEYTASE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS----NEEVLELL 417 (468)
T ss_pred EEcccccccccCCCceeecC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC----HHHHHHHH
Confidence 99999999954433322221 1123568999999999999999999999999999998 999987633 23444444
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
.+..+-+.|.. ++..+.+||..||+.+|++|||++.+.
T Consensus 418 e~GyRlp~P~~-------------CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 418 ERGYRLPRPEG-------------CPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred hccCcCCCCCC-------------CCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 43333333322 333489999999999999999998764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=327.21 Aligned_cols=274 Identities=37% Similarity=0.621 Sum_probs=227.7
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcch-HHHHHHHHHHHhccCC
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK-LTEIRSQIITASQIRH 106 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~e~~~l~~l~h 106 (325)
.+..++++|.-.+.||+|+||.||+|... ++..||||.+.... .. ..++..|+.++.+++|
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~----------------~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNS----------------GQGEREFLNEVEILSRLRH 130 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCC----------------CcchhHHHHHHHHHhcCCC
Confidence 34568899999999999999999999875 44899999872211 11 3459999999999999
Q ss_pred CCccccccceecCC-ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 107 RNILPLLAHMVRPD-SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 107 ~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
||+++++|+|.+.+ ..++|+||++.|+|.+.+...... .++|..+.+|+.+++.||+|||......|+|||||++||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 99999999999999 499999999999999999542221 789999999999999999999987667899999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceee-cCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYV-VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~-~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
|+|++..+||+|||++........ ..... .||.+|++||+......+.++||||||+++.|+++|+.+.+...+ ..
T Consensus 209 LLD~~~~aKlsDFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~ 285 (361)
T KOG1187|consen 209 LLDEDFNAKLSDFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RG 285 (361)
T ss_pred eECCCCCEEccCccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cc
Confidence 999999999999999955443111 11112 789999999999988899999999999999999999988875432 23
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhc-CCchH-HHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLL-GNGYE-EQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+..|.............+|+.+. ..... .+...+..+...|++.+|.+||++.|+++
T Consensus 286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 34488888887877778888888876 33332 57777999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=327.77 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=207.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~ 111 (325)
.++|.++++||.|+||.||+|+ ...++..||||++.. .....+.+. -.||+..|++++ ||||++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~-~~~~~~~VAIK~MK~-------------Kf~s~ee~~-nLREvksL~kln~hpniik 73 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAK-SKETGELVAIKKMKK-------------KFYSWEECM-NLREVKSLRKLNPHPNIIK 73 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEee-ecCCCceeeHHHHHh-------------hhccHHHHH-HHHHHHHHHhcCCCCcchh
Confidence 4789999999999999999995 678888999998731 122222222 367899999998 999999
Q ss_pred cccceecCC-ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 112 LLAHMVRPD-SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 112 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
+.+++.+.+ .+|+|||||+. +|.+.+.. .+..+++..+..|+.||+.||+|+| .+|+.|||+||+|||+...
T Consensus 74 L~Evi~d~~~~L~fVfE~Md~-NLYqLmK~---R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~ 146 (538)
T KOG0661|consen 74 LKEVIRDNDRILYFVFEFMDC-NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGN 146 (538)
T ss_pred hHHHhhccCceEeeeHHhhhh-hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEeccc
Confidence 999999888 89999999965 99999955 3778999999999999999999999 8899999999999999988
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
..+||+|||+|+.......... .+.|.+|.|||++... .|+.+.||||+||+++|+.+-++-|.+.. ..+..
T Consensus 147 ~~iKiaDFGLARev~SkpPYTe---YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s----E~Dqi 219 (538)
T KOG0661|consen 147 DVIKIADFGLAREVRSKPPYTE---YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS----EIDQI 219 (538)
T ss_pred ceeEecccccccccccCCCcch---hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc----HHHHH
Confidence 8999999999998877655444 4789999999987654 58999999999999999999999997522 22222
Q ss_pred HHHHHHhhhCCCCcccc----------------hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 270 RWMRNVMASENPNRAID----------------SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
--+..+...+....+.. +.....-..+...++.+||.+|+.+||.+||||.|+|++
T Consensus 220 ~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 220 YKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 22222222222111111 000111123455669999999999999999999999874
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=316.81 Aligned_cols=248 Identities=26% Similarity=0.428 Sum_probs=213.5
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
-+|++.+.||+|.||+|-+| ++...|+.||||.+ ++.....+....++++|++||+.|+||||++++
T Consensus 53 HRyE~~etLGkGTYGKVk~A-~e~~sgR~VAiKsI------------rKdkIkdeqDlvhIRREIeIMSsLNHPhII~Iy 119 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLA-YEHKSGREVAIKSI------------RKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIY 119 (668)
T ss_pred hHHHHHHHhcCCcccceeeh-hhccCCcEeehhhh------------hhhhcccHHHHHHHHHHHHHHhhcCCCceeehh
Confidence 48999999999999999999 67788999999988 344445567788999999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
++|...+...+||||..+|.|.+++ ...+.+++..+..++.||..|+.||| .++++|||||.+|||++.++++
T Consensus 120 EVFENkdKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~Ni 192 (668)
T KOG0611|consen 120 EVFENKDKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNI 192 (668)
T ss_pred hhhcCCceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCe
Confidence 9999999999999999999999999 45667999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTIS-EKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~-~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
||+|||++..+..... ...+||++.|.+||+++|.+|. +.+|.||||+++|.|+.|..||++. +....+
T Consensus 193 KIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-------Dhk~lv 262 (668)
T KOG0611|consen 193 KIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-------DHKRLV 262 (668)
T ss_pred eeeccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-------hHHHHH
Confidence 9999999987765443 2337999999999999999884 7899999999999999999999763 223344
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
+++..+...+..-+.. ..-||++||.+||+.|-|+++|.
T Consensus 263 rQIs~GaYrEP~~PSd------------A~gLIRwmLmVNP~RRATieDiA 301 (668)
T KOG0611|consen 263 RQISRGAYREPETPSD------------ASGLIRWMLMVNPERRATIEDIA 301 (668)
T ss_pred HHhhcccccCCCCCch------------HHHHHHHHHhcCcccchhHHHHh
Confidence 4444444333222222 66799999999999999999885
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=327.98 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=214.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
....|...++||+|+.|.||.|. ...+++.||||.+. .......+-+..|+.+|+..+|+|||.
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~-~~~~~~~VaiK~m~---------------l~~Q~~keLilnEi~Vm~~~~H~NiVn 334 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVAR-KISTKQEVAIKRMD---------------LRKQPKKELLLNEILVMRDLHHPNIVN 334 (550)
T ss_pred hhhhhcchhhhccccccceeeee-eccCCceEEEEEEE---------------eccCCchhhhHHHHHHHHhccchHHHH
Confidence 45679999999999999999994 66778889999983 233456778999999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+...+.++.||||++||+|.+.+ ....+++.++..|+..++.||+||| .+||+|||||.+||+++.+|
T Consensus 335 fl~Sylv~deLWVVMEym~ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g 406 (550)
T KOG0578|consen 335 FLDSYLVGDELWVVMEYMEGGSLTDVV-----TKTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDG 406 (550)
T ss_pred HHHHhcccceeEEEEeecCCCchhhhh-----hcccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCC
Confidence 999999999999999999999999998 4455899999999999999999999 99999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.+||+|||++.......... ...+||+.|+|||+.....|++++||||||++++||+.|.+||-... ..+.
T Consensus 407 ~vKltDFGFcaqi~~~~~KR--~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------PlrA 477 (550)
T KOG0578|consen 407 SVKLTDFGFCAQISEEQSKR--STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRA 477 (550)
T ss_pred cEEEeeeeeeeccccccCcc--ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-------hHHH
Confidence 99999999998877665432 33799999999999999999999999999999999999999996422 2333
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++.+-..+.+....+.. ....|.+++.+||+.|+++|+|+.|+|+
T Consensus 478 lyLIa~ng~P~lk~~~k--------lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 478 LYLIATNGTPKLKNPEK--------LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHhhcCCCCcCCccc--------cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 34434444443333322 2333999999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=325.14 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=205.2
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCC
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRN 108 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~ 108 (325)
....++|.+.+.||.|+||+|++|. ...++..||+|++..... .... ......+.+|+.+++.+. |||
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~-~~~t~~~vAiKii~~~~~---------~~~~-~~~~~~i~rEi~~~~~~~~Hpn 81 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAK-HRLTGEKVAIKIIDRKKV---------SSKS-QKLDELIKREISILRRLRSHPN 81 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEee-eccCCCeEEEEEechhcc---------cccc-cccchhhHHHHHHHHHhccCCC
Confidence 3456899999999999999999995 567789999996521100 0011 123456678999999999 999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++......|+||||+.||+|.+++. ...++.+..+..++.|++.|++||| ++||+||||||+|++++
T Consensus 82 I~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld 154 (370)
T KOG0583|consen 82 IIRLLEVFATPTKIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLD 154 (370)
T ss_pred EeEEEEEEecCCeEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEec
Confidence 9999999999999999999999999999993 3567888999999999999999999 88999999999999999
Q ss_pred CC-CCceeeccccceecC-CCCccccceeecCCcccccccccccCC-CC-CccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 189 DD-MEARISGFDLAILMP-DGLTQIDTMYVVGTPRYIAPEYHQTLT-IS-EKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 189 ~~-~~~~l~dfg~~~~~~-~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~-~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
.+ +++||+|||++.... ... .....+||+.|+|||++.+.. |+ .++||||+|+++|.|++|..||++.
T Consensus 155 ~~~~~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~----- 226 (370)
T KOG0583|consen 155 GNEGNLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS----- 226 (370)
T ss_pred CCCCCEEEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----
Confidence 99 999999999999874 222 223369999999999999987 75 7899999999999999999999862
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+.......+....... +..+. ...+.+|+.+||..||.+|+|+.+++.
T Consensus 227 --~~~~l~~ki~~~~~~~---p~~~~-------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 227 --NVPNLYRKIRKGEFKI---PSYLL-------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --cHHHHHHHHhcCCccC---CCCcC-------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 2222222222222211 11110 122899999999999999999999873
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=315.73 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=199.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
..+|...+.||+|+||.||++. +..++...|||.+... .....+.+.+|+.+|++++|||||++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~-~~~~g~~~AvK~v~~~---------------~~~~~~~l~~Ei~iL~~l~~p~IV~~ 79 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLAT-NKKTGELMAVKSVELE---------------DSPTSESLEREIRILSRLNHPNIVQY 79 (313)
T ss_pred cchhhhhccccCccceEEEEEE-ecCCCcceeeeeeecc---------------cchhHHHHHHHHHHHHhCCCCCEEee
Confidence 5679999999999999999996 4455899999988321 11126779999999999999999999
Q ss_pred ccceecCC--ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC-
Q 040480 113 LAHMVRPD--SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD- 189 (325)
Q Consensus 113 ~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~- 189 (325)
++...... ..+++|||+++|+|.+++... .+ .+++..+..+..|+++||.||| ++|++||||||+|||++.
T Consensus 80 ~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~ 153 (313)
T KOG0198|consen 80 YGSSSSRENDEYNIFMEYAPGGSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPS 153 (313)
T ss_pred CCccccccCeeeEeeeeccCCCcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCC
Confidence 99755544 589999999999999999542 22 6999999999999999999999 999999999999999999
Q ss_pred CCCceeeccccceecCCC-CccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDG-LTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~-~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
++.+||+|||.+...... ..........||+.|+|||++.+. ....++|||||||++.+|+||+.||... ..
T Consensus 154 ~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~ 227 (313)
T KOG0198|consen 154 NGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FE 227 (313)
T ss_pred CCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cc
Confidence 799999999999876641 111122236899999999999953 2335999999999999999999999763 11
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+...+......+ .++.. .+.+..+++.+|+..||++|||++++|.
T Consensus 228 ~~~~~~~ig~~~~~P-~ip~~--------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 228 EAEALLLIGREDSLP-EIPDS--------LSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred hHHHHHHHhccCCCC-CCCcc--------cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 222222222222111 12211 2223889999999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=298.07 Aligned_cols=241 Identities=23% Similarity=0.329 Sum_probs=205.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||.|+||.|-+++ .+.++..+|+|++ ++..-+.....++...|..+|+.+.||++++++
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr-~k~~g~yYAmKvL------------~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~ 110 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVR-EKHSGNYYAMKVL------------DKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLY 110 (355)
T ss_pred hhhhheeeeccCccceEEEEE-EccCCceeehhhc------------CHHHHHHHHHHHHHhhHHHHHhhccCceeEEEE
Confidence 579999999999999999997 5567999999998 344445556788999999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+.+.+|+||||.+||.|..++ ..-+++++..+..++.+++.|++||| +++|++|||||+|||++.+|.+
T Consensus 111 ~t~~d~~~lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~i 183 (355)
T KOG0616|consen 111 GTFKDNSNLYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHI 183 (355)
T ss_pred EeeccCCeEEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcE
Confidence 9999999999999999999999999 44566999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
||+|||++..+... +...|||+.|+|||++...++..++|.||||+++|||+.|.+||.+... .....
T Consensus 184 KitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~ 251 (355)
T KOG0616|consen 184 KITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYE 251 (355)
T ss_pred EEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHH
Confidence 99999999876543 4447999999999999999999999999999999999999999965322 33333
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (325)
.+..+.......... ++.+|+.++|+.|-.+|.
T Consensus 252 KI~~~~v~fP~~fs~-----------~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 252 KILEGKVKFPSYFSS-----------DAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHHhCcccCCcccCH-----------HHHHHHHHHHhhhhHhhh
Confidence 444433322111111 189999999999999994
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=322.54 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=206.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++++.||+|+||.||+|+ ...+|..+|+|++.. ..-.....+..++.|-.+|....+|.||+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLar-Kk~Tg~iyAmK~LkK------------S~M~~~~Qv~hV~aERdiL~~~ds~~vVK 205 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLAR-KKDTGEIYAMKILKK------------SEMLKKNQVEHVRAERDILAEVDSPWVVK 205 (550)
T ss_pred CcccchhheeeccccceeEEEEE-EccCCcEEeeecccH------------HHHHhhhhHHHHHHHHHHhhhcCCCcEEE
Confidence 45789999999999999999996 678999999999832 22334456788999999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
++..|.+...+|+||||++||++..++ .....+++..+..++.+++.|+..+| ..|++||||||+|+|++..|
T Consensus 206 LyYsFQD~~~LYLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~G 278 (550)
T KOG0605|consen 206 LYYSFQDKEYLYLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKG 278 (550)
T ss_pred EEEEecCCCeeEEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCC
Confidence 999999999999999999999999999 55677999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCC----------------C------Ccc----ccce-------------------eecCCccccccc
Q 040480 192 EARISGFDLAILMPD----------------G------LTQ----IDTM-------------------YVVGTPRYIAPE 226 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~----------------~------~~~----~~~~-------------------~~~g~~~~~aPE 226 (325)
++||.|||++.-... . ... .... ..+|||.|+|||
T Consensus 279 HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPE 358 (550)
T KOG0605|consen 279 HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPE 358 (550)
T ss_pred CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchH
Confidence 999999999953211 0 000 0000 037999999999
Q ss_pred ccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHh
Q 040480 227 YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLAC 306 (325)
Q Consensus 227 ~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 306 (325)
++.+..|+..+|.||||||+||||.|.+||....+.+.-..+..|............. .+..|||.
T Consensus 359 Vll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s--------------~eA~DLI~ 424 (550)
T KOG0605|consen 359 VLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLS--------------DEAKDLIT 424 (550)
T ss_pred HHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCccc--------------HHHHHHHH
Confidence 9999999999999999999999999999998755543334444444333322222111 23899999
Q ss_pred hhcCCCCCCCCC
Q 040480 307 FCTLADPDERPN 318 (325)
Q Consensus 307 ~~l~~dP~~Rps 318 (325)
+||+ ||+.|..
T Consensus 425 rll~-d~~~RLG 435 (550)
T KOG0605|consen 425 RLLC-DPENRLG 435 (550)
T ss_pred HHhc-CHHHhcC
Confidence 9999 9999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=310.23 Aligned_cols=273 Identities=26% Similarity=0.384 Sum_probs=214.4
Q ss_pred hhHHHHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc
Q 040480 24 KEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ 103 (325)
Q Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 103 (325)
..+..|-...+.|++...||.|.-++||+|.. ...+..||||++.+. . -....+.+.+|+..|+.
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c-~p~~e~VAIK~inLE-------------k-c~~~ld~l~kE~~~msl 80 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARC-IPTNEVVAIKIINLE-------------K-CNNDLDALRKEVQTMSL 80 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeee-cccCCEEEEEEeehh-------------h-hhhhHHHHHHHHHHhhh
Confidence 44556666778999999999999999999964 456699999998321 1 12337789999999999
Q ss_pred cCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 104 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+.||||++++..|..+..+|+||+|+.+|++.+.+..... ..+++..+..|+.+++.||.||| .+|.+|||+|+.
T Consensus 81 ~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAg 155 (516)
T KOG0582|consen 81 IDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAG 155 (516)
T ss_pred cCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccc
Confidence 9999999999999999999999999999999999976433 34999999999999999999999 889999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccc--eeecCCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCc
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDT--MYVVGTPRYIAPEYHQT--LTISEKCDIYSFGVLLAVLVMGKFPFDDF 259 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~ 259 (325)
|||++.+|.|+|+|||.+..+......... ..+.||++|+|||++.. ..|+.|+||||||++..||.+|..||...
T Consensus 156 nILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 156 NILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred cEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 999999999999999999876654432222 33689999999998543 36999999999999999999999999753
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
-+ .+.+.....+..+ ...-.....+........+.+++..||+.||.+|||++++++
T Consensus 236 pP-------mkvLl~tLqn~pp-~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 236 PP-------MKVLLLTLQNDPP-TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred Ch-------HHHHHHHhcCCCC-CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 22 1111111212221 110001111122233346999999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=325.97 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=212.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..+-|.+.+.||.|+-|.|-+|+ +..+|+.+|||++... ..........+.+|+.+|+.+.|||+++
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlak-h~~TGqlaaiKii~k~------------~~~s~s~~~~IerEIviMkLi~HpnVl~ 76 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAK-HAETGQLAAIKIIPKR------------SELSSSQPAGIEREIVIMKLIEHPNVLR 76 (786)
T ss_pred cccceeccccccCCCCceehhhh-cccccceeEEEeeccc------------cccccccccchhhhhHHHHHhcCCCeee
Confidence 45789999999999999999996 6789999999998422 1334455667899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+|++|.++.++|+|+||++||.|++++ ...+.+++..+.+++.|++.|+.||| ..+|+||||||+|++++..+
T Consensus 77 LydVwe~~~~lylvlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~ 149 (786)
T KOG0588|consen 77 LYDVWENKQHLYLVLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKN 149 (786)
T ss_pred eeeeeccCceEEEEEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhccc
Confidence 999999999999999999999999999 56778999999999999999999999 77999999999999999998
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTIS-EKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~-~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.+||+|||+|.....+..... -||++.|.|||++.|.+|. .++||||.|+|+|.||+|+.||++ .++..
T Consensus 150 nIKIADFGMAsLe~~gklLeT---SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-------dNir~ 219 (786)
T KOG0588|consen 150 NIKIADFGMASLEVPGKLLET---SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-------DNIRV 219 (786)
T ss_pred CEeeeccceeecccCCccccc---cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-------ccHHH
Confidence 899999999987655544333 4999999999999999985 789999999999999999999975 22333
Q ss_pred HHHHHhhhCCC-CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENP-NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+..++.+... +..+.+ +..+|+.+||.+||..|.|++||++
T Consensus 220 LLlKV~~G~f~MPs~Is~------------eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 220 LLLKVQRGVFEMPSNISS------------EAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHHHHcCcccCCCcCCH------------HHHHHHHHHhccCccccccHHHHhh
Confidence 33444433322 222222 2899999999999999999999974
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=316.49 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=211.8
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.....|+.++.||+|+||.||+| .+..+++.||+|++-+ ...+...+.+.+|+.++++++++||.
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~-~d~~t~k~vAiKii~L--------------e~~~deIediqqei~~Ls~~~~~~it 74 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKA-IDNKTKKVVAIKIIDL--------------EEAEDEIEDIQQEISVLSQCDSPNIT 74 (467)
T ss_pred Ccccccccchhccccccceeeee-eeccccceEEEEEech--------------hhcchhhHHHHHHHHHHHhcCcchHH
Confidence 45678999999999999999999 4778999999999832 23445678899999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++|+.+..+..++++||||.||++.+.+ .....+.+..+.-++.+++.|+.||| .++.+|+|||+.||++..+
T Consensus 75 ~yygsyl~g~~LwiiMey~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~ 147 (467)
T KOG0201|consen 75 EYYGSYLKGTKLWIIMEYCGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSES 147 (467)
T ss_pred hhhhheeecccHHHHHHHhcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEecc
Confidence 9999999999999999999999999999 44455588888889999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
|.++|+|||.+.......... ..++||+.|||||++.+..|+.++||||||++.++|.+|.+|+.+..+-
T Consensus 148 g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------- 217 (467)
T KOG0201|consen 148 GDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------- 217 (467)
T ss_pred CcEEEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------
Confidence 999999999999887765544 3479999999999999999999999999999999999999999875541
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+.....+.. .++.+-+ .....+.++|..||++||+.||||.++|+
T Consensus 218 --rvlflIpk~---~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 218 --RVLFLIPKS---APPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --eEEEeccCC---CCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 111111111 1111111 23334899999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=317.62 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=212.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|.+.+.||+|+||.||+|+ .+.+.+.||+|.+. .....+...+.+.+|+++++.++||||+.++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgr-rK~t~~~vAik~i~-------------K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~ 67 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGR-RKYTIQVVAIKFID-------------KSGRNEKELKNLRQEVRILRSLKHPNIVEML 67 (808)
T ss_pred cchhHHHHhcCCccceeeecc-cccceeEEEEEEeh-------------hcCCchHHHHHHHHHHHHHHhcCCcchhhHH
Confidence 579999999999999999995 66788999999882 1234456678899999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
++|+...+.++|+||+.| +|..++ ..+..+++..+..+..+++.||.||| +.+|+|||+||.||++..++.+
T Consensus 68 esfEt~~~~~vVte~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~ 139 (808)
T KOG0597|consen 68 ESFETSAHLWVVTEYAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTL 139 (808)
T ss_pred HhhcccceEEEEehhhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCce
Confidence 999999999999999977 999999 45677999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|++|||+++.+..... ..+...||+.|+|||+..+++|+..+|+|||||++||++.|++|| ...++.+..+
T Consensus 140 KlcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF-------~a~si~~Lv~ 210 (808)
T KOG0597|consen 140 KLCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF-------YARSITQLVK 210 (808)
T ss_pred eechhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc-------hHHHHHHHHH
Confidence 9999999998765432 223357999999999999999999999999999999999999999 3345566666
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+...+..... +....+..++..+|.+||.+|.|-.+++.
T Consensus 211 ~I~~d~v~~p~-----------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 211 SILKDPVKPPS-----------TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHhcCCCCCcc-----------cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 66554433211 22233899999999999999999887764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=297.46 Aligned_cols=271 Identities=22% Similarity=0.277 Sum_probs=208.4
Q ss_pred HHHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC
Q 040480 27 LAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH 106 (325)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 106 (325)
+.-....+.|+++++|++|+||.||+|+ +..+++.||+|++.- ....+...-.-.+|+.+|.+.+|
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRak-dk~t~eIVALKr~km-------------ekek~GFPItsLREIniLl~~~H 134 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAK-DKKTDEIVALKRLKM-------------EKEKEGFPITSLREINILLKARH 134 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEec-cCCcceeEEeeeccc-------------ccccCCCcchhHHHHHHHHhcCC
Confidence 4445577899999999999999999995 778889999999832 22233334456899999999999
Q ss_pred CCccccccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040480 107 RNILPLLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 107 ~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~n 184 (325)
||||.+-++.+.. +.+|+|||||+. +|...+..+ ..++......-++.|++.|++||| .+.|+|||||++|
T Consensus 135 ~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SN 207 (419)
T KOG0663|consen 135 PNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSN 207 (419)
T ss_pred CCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhh
Confidence 9999999988654 569999999987 999999654 357889999999999999999999 8899999999999
Q ss_pred eEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 185 VLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
+|++..|.+||+|||+|+.+...... .+..+-|.+|.|||++.+.+ |+.+.|+||+|||+.+|+++++-|.+.
T Consensus 208 LLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~---- 281 (419)
T KOG0663|consen 208 LLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK---- 281 (419)
T ss_pred eeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC----
Confidence 99999999999999999988765332 22356689999999988865 899999999999999999999999753
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcC----------------CchHH--HHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLG----------------NGYEE--QMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~--~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+....+-+....+....+..-..++ ..+.. ..+.-++|+..+|..||.+|.|+++.|+
T Consensus 282 sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 282 SEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 2222222222222222211111100000 00111 2244789999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=288.31 Aligned_cols=265 Identities=24% Similarity=0.328 Sum_probs=208.7
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
....++||++.+.||.|||+-||+++ .-.+++.+|+|++.+.+ .+..+..++|++..++++|||
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~-~~s~~~~YAlKkI~c~~---------------~~~~e~~~rEid~~rkf~s~~ 79 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVK-GLSTGHLYALKKILCHS---------------QEDIEEALREIDNHRKFNSPN 79 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeec-ccCcccchhhheeeccc---------------hHHHHHHHHHHHHHHhhCCcc
Confidence 34467899999999999999999996 56788999999985432 356778999999999999999
Q ss_pred ccccccceecCCc-----eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 109 ILPLLAHMVRPDS-----HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 109 i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+++++++...+.. .|++++|...|+|.+.++.....+..+++..++.|+.++++||.+||.. ...+.|+||||.
T Consensus 80 vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~ 158 (302)
T KOG2345|consen 80 VLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPA 158 (302)
T ss_pred hHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcc
Confidence 9999998865544 8999999999999999988877888999999999999999999999944 224999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCcccc-------ceeecCCccccccccccc---CCCCCccchhhHHHHHHHHHhCC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQID-------TMYVVGTPRYIAPEYHQT---LTISEKCDIYSFGVLLAVLVMGK 253 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~-------~~~~~g~~~~~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~ 253 (325)
||++++++.+++.|||.++...-...... ......|..|.|||++.- ...++++|||||||++|.|+.|.
T Consensus 159 NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~ 238 (302)
T KOG2345|consen 159 NILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGE 238 (302)
T ss_pred eeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcC
Confidence 99999999999999999986543221111 011245889999998864 45789999999999999999999
Q ss_pred CCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 254 FPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 254 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.||+...+..+...+.-.. ..-.++.. .-.++.+.++|.+||+.||.+||++.+++.
T Consensus 239 sPfe~~~~~GgSlaLAv~n--------~q~s~P~~------~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 239 SPFERIYQQGGSLALAVQN--------AQISIPNS------SRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred CcchHHhhcCCeEEEeeec--------cccccCCC------CCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 9998654432222221110 00011110 002334899999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=308.97 Aligned_cols=266 Identities=26% Similarity=0.370 Sum_probs=200.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
.-+.|++.+.||+|.||+|-+| ++..+++.||+|++....-.... .............+...+|+.+|+++.|||||+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLa-r~~~~~~l~AiKil~K~~~~~~~-~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLA-RDEVDGKLYAIKILPKKELRRQY-GFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ehhheehhhhhcCCccceEEEE-eecCCCcEEEEEeechhhhhhhc-ccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 4578999999999999999999 67888999999998432211000 000001112234568999999999999999999
Q ss_pred cccceecC--CceEEEEEcccCCCHHHHHhhhcccccc-cChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 112 LLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRE-LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 112 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++++..+. +.+|+|+|||..|.+... ..... ++..++++++.+++.||+||| .+||+||||||+|+|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence 99998765 578999999998876533 34445 899999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCcccc---ceeecCCcccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 189 DDMEARISGFDLAILMPDGLTQID---TMYVVGTPRYIAPEYHQTLT----ISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
++|.+||+|||.+..+..+..... .....||+.|+|||...+.. .+.+.||||+|+++|+|+.|+.||-+..
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~- 323 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF- 323 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-
Confidence 999999999999988754422211 11258999999999876632 3578999999999999999999996521
Q ss_pred CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
..+....+...+.. .+.. .+..+.+.+||.+||++||+.|.++.+|.
T Consensus 324 ------~~~l~~KIvn~pL~-fP~~--------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 324 ------ELELFDKIVNDPLE-FPEN--------PEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred ------HHHHHHHHhcCccc-CCCc--------ccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 12222222222111 1111 12334489999999999999999998874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=316.66 Aligned_cols=262 Identities=22% Similarity=0.317 Sum_probs=197.4
Q ss_pred hhhcCcccccccccCcceeEEEEEe----cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-C
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAEL----PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-R 105 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 105 (325)
...++|++.+.||+|+||.||+|.+ +..++..||+|.+... ........+.+|+.++..+ +
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~~ 69 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--------------ATASEHKALMSELKILIHIGN 69 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--------------cchHHHHHHHHHHHHHHHhcc
Confidence 4557899999999999999999964 2234578999987311 1122345688999999999 8
Q ss_pred CCCccccccceecCC-ceEEEEEcccCCCHHHHHhhhccc----------------------------------------
Q 040480 106 HRNILPLLAHMVRPD-SHLLVYDFMKNGSLQAVLYDVSKG---------------------------------------- 144 (325)
Q Consensus 106 h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~---------------------------------------- 144 (325)
||||+++++.+...+ ..+++|||+++|+|.+++......
T Consensus 70 h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (338)
T cd05102 70 HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRF 149 (338)
T ss_pred CcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccc
Confidence 999999999877644 578999999999999998642110
Q ss_pred ------------------ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCC
Q 040480 145 ------------------RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206 (325)
Q Consensus 145 ------------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 206 (325)
...++......++.|++.||.||| ++||+|+||||+||+++.++.++|+|||++.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 150 QPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 124667788889999999999999 88999999999999999999999999999976543
Q ss_pred CCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCccc
Q 040480 207 GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAI 285 (325)
Q Consensus 207 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (325)
...........++..|+|||++.+..++.++||||||+++|+|++ |..||..... ..... ...........
T Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~---~~~~~---~~~~~~~~~~~-- 298 (338)
T cd05102 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---NEEFC---QRLKDGTRMRA-- 298 (338)
T ss_pred CcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc---cHHHH---HHHhcCCCCCC--
Confidence 322222222345678999999998889999999999999999997 9999975321 11111 11111111110
Q ss_pred chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 286 DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
+ ...+..+.+|+.+||+.||++|||+.+++++
T Consensus 299 ~--------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~ 330 (338)
T cd05102 299 P--------ENATPEIYRIMLACWQGDPKERPTFSALVEI 330 (338)
T ss_pred C--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 1122348999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=308.90 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=198.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|. +..+++.+|+|.+... ..........+.+|+.+++.++||||++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 67 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVR-DRISEHYYALKVMAIP------------EVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67 (291)
T ss_pred CCceeeeeeecCCCeEEEEEE-EcCCCCEEEEEEEEHH------------HHhhhHHHHHHHHHHHHHHhCCCCcHhhhH
Confidence 479999999999999999995 5567889999988321 111123355688899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+.+..++||||+++++|.+++. ....++......++.|++.||+||| ++|++|+||+|+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~ 140 (291)
T cd05612 68 WTEHDQRFLYMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHI 140 (291)
T ss_pred hhhccCCeEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCE
Confidence 99999999999999999999999983 3456888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++....... ....|++.|+|||++.+..++.++||||||+++|+|++|..||.... ... ...
T Consensus 141 kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~----~~~---~~~ 208 (291)
T cd05612 141 KLTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----PFG---IYE 208 (291)
T ss_pred EEEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHH---HHH
Confidence 999999987654321 12468999999999999889999999999999999999999996522 111 122
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
.+...... ++.. ....+.+|+.+||+.||.+||+ ++++++
T Consensus 209 ~i~~~~~~---~~~~--------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 209 KILAGKLE---FPRH--------LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHhCCcC---CCcc--------CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 22222111 1100 1123889999999999999995 888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=292.71 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=209.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.+.|++.+.||+|.|+.||++ ....+|+.+|+|++- ........-+++.+|+.+-+.++||||+++
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc-~~~~tg~~fa~kiin-------------~~k~~~~~~e~l~rEarIC~~LqHP~IvrL 75 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKIIN-------------TKKLSARDFQKLEREARICRKLQHPNIVRL 75 (355)
T ss_pred chhhhHHHHHccCchHHHHHH-HhccchHHHHHHHhh-------------hhhhccccHHHHHHHHHHHHhcCCCcEeeh
Confidence 468999999999999999999 677889999999872 233344567889999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec---C
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID---D 189 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~---~ 189 (325)
.+.+......|+|+|++.|++|..-+- .+..+++..+...+.|++++|.|+| .++|||||+||.|+++- .
T Consensus 76 ~~ti~~~~~~ylvFe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~ 148 (355)
T KOG0033|consen 76 HDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAK 148 (355)
T ss_pred hhhhcccceeEEEEecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccC
Confidence 999999999999999999999988773 3355888889999999999999999 99999999999999995 3
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
..-+||+|||++..+..+..... +.||+.|+|||+++..+|+-.+|||+.|+++|-|+.|.+||.+. ....+.
T Consensus 149 ~A~vKL~~FGvAi~l~~g~~~~G---~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~----~~~rly 221 (355)
T KOG0033|consen 149 GAAVKLADFGLAIEVNDGEAWHG---FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLY 221 (355)
T ss_pred CCceeecccceEEEeCCcccccc---ccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc----cHHHHH
Confidence 45689999999999884444333 68999999999999999999999999999999999999999763 223333
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+ .+..+.... + +..+++..+...+|+++||..||.+|.|+.|+|+
T Consensus 222 e---~I~~g~yd~---~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 222 E---QIKAGAYDY---P----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred H---HHhccccCC---C----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 3 223222211 1 1122333444899999999999999999999885
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=307.49 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=197.8
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
.|++.+.||+|+||.||+|. ...+++.||+|.+... ..........+.+|+.+++.+.|++|+++++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~-~~~~~~~~avK~~~~~------------~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~ 67 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKK------------RIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67 (285)
T ss_pred CceEEEEEecCCCEEEEEEE-EecCCceEEEEEeeHh------------hhhhhhhHHHHHHHHHHHHhcCCCcEEEEEE
Confidence 47889999999999999995 5567889999987311 1111122345778999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+...+..++|+||+++++|.+.+... ....+++..+..++.|++.||.||| +++++|+||||+||++++++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~k 142 (285)
T cd05631 68 AYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIR 142 (285)
T ss_pred EEccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEE
Confidence 999999999999999999999887432 2345888899999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||++......... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||............ ..
T Consensus 143 l~Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~----~~ 215 (285)
T cd05631 143 ISDLGLAVQIPEGETV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV----DR 215 (285)
T ss_pred EeeCCCcEEcCCCCee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH----HH
Confidence 9999999875433221 1246899999999999989999999999999999999999999753321111111 11
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
...... ...+. .....+.+|+.+||+.||.+||+ ++++++
T Consensus 216 ~~~~~~--~~~~~--------~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 216 RVKEDQ--EEYSE--------KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred Hhhccc--ccCCc--------cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111111 01111 11223889999999999999997 677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=298.64 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=202.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
..+|...+.||.|+||.|+.|. +..+++.||+|++. .........++..+|+.+++.++|+||+.+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~-~~~t~~~VAIKKi~-------------~~F~~~~~akRtlRElklLr~~~HeNIi~l 86 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAK-DKRTGEKVAIKKIL-------------NPFENQIDAKRTLRELKLLRHLRHENIIGL 86 (359)
T ss_pred cceecccccccCcceeeEEEEE-EcCCCCEeehhhhh-------------hhhhchHHHHHHHHHHHHHHHhcCCCcceE
Confidence 4566668999999999999994 67788999999982 123445567889999999999999999999
Q ss_pred ccceec-----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 113 LAHMVR-----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 113 ~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
.+++.. -+.+|+|+|++ +.+|.+.+ ..++.++...+..++.|++.||.|+| +.+++||||||+|+++
T Consensus 87 ~di~~p~~~~~f~DvYiV~elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~ 158 (359)
T KOG0660|consen 87 LDIFRPPSRDKFNDVYLVFELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLL 158 (359)
T ss_pred EeecccccccccceeEEehhHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheee
Confidence 998865 35689999999 45999998 45566999999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCccc-----
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS----- 261 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~----- 261 (325)
+.+..+|++|||+|+...........+..+.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+.+.
T Consensus 159 n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 159 NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 999999999999999886543333334457789999999764 45799999999999999999999999965221
Q ss_pred -------CCCcchHHHH----HHH-Hhhh-CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 -------HTGEMDMVRW----MRN-VMAS-ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 -------~~~~~~~~~~----~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+... .+. +... ..+..++. ..+ .+.....++|+.+||.+||.+|+|++|+|+
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~-~~f----p~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFS-SIF----PNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHH-HHc----CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0011111110 001 1111 11111111 112 223334889999999999999999999985
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=313.89 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=212.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|+.++.+|+|+||.+++++ ....++.+++|++... ...+..+....+|+.++++++||||+.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvr-hk~~~~~~vlK~I~l~-------------~~t~~~r~~A~~E~~lis~~~hP~iv~y 68 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVR-HKSDDKLYVLKKINLE-------------KLTEPERRSAIQEMDLLSKLLHPNIVEY 68 (426)
T ss_pred cchhhhhhhcCccccchhhhhh-hccCCceEEEEEEecc-------------ccCchhhHHHHHHHHHHHhccCCCeeee
Confidence 4689999999999999999996 4456679999999543 2333455588999999999999999999
Q ss_pred ccceecCCc-eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 113 LAHMVRPDS-HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 113 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
.+.|..++. .++||+||+||++.+.+.+. .+..+++..+..|+.|++.|+.||| +..|+|||||+.|||++.++
T Consensus 69 ~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~ 143 (426)
T KOG0589|consen 69 KDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDK 143 (426)
T ss_pred ccchhcCCceEEEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccC
Confidence 999999988 99999999999999999663 3577999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.|+|+|||++........... ...||+.|++||.+.+.+|..++|+|||||++|+|++-+++|... +....
T Consensus 144 ~VkLgDfGlaK~l~~~~~~a~--tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-------~m~~L 214 (426)
T KOG0589|consen 144 KVKLGDFGLAKILNPEDSLAS--TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-------NMSEL 214 (426)
T ss_pred ceeecchhhhhhcCCchhhhh--eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-------chHHH
Confidence 999999999998877653222 268999999999999999999999999999999999999999652 22222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
+..+......+ .+ .....++..||..||..+|..||++.++|..
T Consensus 215 i~ki~~~~~~P--lp--------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ILKINRGLYSP--LP--------SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhccCCC--CC--------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33333332111 11 1122339999999999999999999999863
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=312.37 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=200.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.+|+|.+.. ...........+.+|+.+++.++||||+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 83 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAK-HKGTGEYYAIKCLKK------------REILKMKQVQHVAQEKSILMELSHPFIVNM 83 (329)
T ss_pred chheEEEEEEEecCCeEEEEEE-ECCCCCEEEEEEEEH------------HHHhhhhhHHHHHHHHHHHHhCCCCCCCcE
Confidence 4789999999999999999996 556788999999831 111222345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+...+..|+||||+.+++|.+++. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~ 156 (329)
T PTZ00263 84 MCSFQDENRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGH 156 (329)
T ss_pred EEEEEcCCEEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCC
Confidence 999999999999999999999999984 3456888889999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++....... ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+... ....
T Consensus 157 ~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~ 224 (329)
T PTZ00263 157 VKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIY 224 (329)
T ss_pred EEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHH
Confidence 9999999997654322 124789999999999998899999999999999999999999965221 1222
Q ss_pred HHHhhhCCC-CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 273 RNVMASENP-NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
..+...... +... ...+.+|+.+||+.||.+||+ +++++.
T Consensus 225 ~~i~~~~~~~p~~~------------~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 225 EKILAGRLKFPNWF------------DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHhcCCcCCCCCC------------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 222222111 1111 123889999999999999997 577653
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=311.74 Aligned_cols=251 Identities=20% Similarity=0.254 Sum_probs=201.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|.+.+.||.|+||.||+|.+....+..||+|.+... ..........+.+|+.+++.++||||++
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~Iv~ 95 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS------------KIIKQKQVDHVFSERKILNYINHPFCVN 95 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHH------------HhhhhhhHHHHHHHHHHHHhCCCCCCcc
Confidence 4468999999999999999999766555678999988311 1122334567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..|+||||+.+++|.+++. ....+++..+..++.|++.||.||| ++|++||||||+||+++.++
T Consensus 96 ~~~~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~ 168 (340)
T PTZ00426 96 LYGSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDG 168 (340)
T ss_pred eEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCC
Confidence 9999999999999999999999999984 3456888999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++....... ....||+.|+|||++.+..++.++|+|||||++|+|++|..||..... ...
T Consensus 169 ~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~ 236 (340)
T PTZ00426 169 FIKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------LLI 236 (340)
T ss_pred CEEEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------HHH
Confidence 99999999997654321 225789999999999988899999999999999999999999965221 111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
...+...... ++.. ....+.+++.+||+.||++|+ |++++++
T Consensus 237 ~~~i~~~~~~---~p~~--------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 237 YQKILEGIIY---FPKF--------LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHHhcCCCC---CCCC--------CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1222221111 1110 112278999999999999995 8888764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=304.83 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=199.1
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|+ +..+++.+|+|.+... .........+.+|+.+++.++||||++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~avK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 66 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCR-HKETKEIVAIKKFKDS-------------EENEEVKETTLRELKMLRTLKQENIVELK 66 (287)
T ss_pred CCceEEEEecccCCEEEEEEE-ECCCCcEEEEEEEecc-------------cccccchhhHHHHHHHHHhCCCccccchh
Confidence 479999999999999999996 5567889999988321 11223455678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..++||||++++.+.... .....++...+..++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~ 139 (287)
T cd07848 67 EAFRRRGKLYLVFEYVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVL 139 (287)
T ss_pred hhEecCCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcE
Confidence 9999999999999999987665443 23456888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++......... ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... ..... +.
T Consensus 140 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~---~~~~~-~~ 214 (287)
T cd07848 140 KLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI---DQLFT-IQ 214 (287)
T ss_pred EEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHH-HH
Confidence 99999999875433221 112246788999999999888999999999999999999999999753211 01111 11
Q ss_pred HHhh------------hCCCC-cccch-----hhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMA------------SENPN-RAIDS-----KLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~------------~~~~~-~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... ..... ...+. ..........+..+.+|+.+||+.||++|||++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 215 KVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00000 00000 0000001123345999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.55 Aligned_cols=245 Identities=21% Similarity=0.281 Sum_probs=193.9
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecC
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 119 (325)
+.||+|+||.||+|. +..+++.+|+|.+.. ...........+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~lG~G~~g~Vy~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 67 (323)
T cd05571 1 KLLGKGTFGKVILVR-EKATGKYYAMKILKK------------EVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH 67 (323)
T ss_pred CeeeeCCCeEEEEEE-ECCCCCEEEEEEEEH------------HHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC
Confidence 468999999999995 556789999999831 1112223455678899999999999999999999999
Q ss_pred CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccc
Q 040480 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199 (325)
Q Consensus 120 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg 199 (325)
+..|+||||+++++|.+++. ....+++..+..++.|++.||+||| ++||+|+||||+||+++.++.++|+|||
T Consensus 68 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG 140 (323)
T cd05571 68 DRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFG 140 (323)
T ss_pred CEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999999999998883 3456889999999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhC
Q 040480 200 LAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASE 279 (325)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 279 (325)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..... ..+....
T Consensus 141 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~---~~~~~~~ 211 (323)
T cd05571 141 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLF---ELILMEE 211 (323)
T ss_pred CCcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC----HHHHH---HHHHcCC
Confidence 9875332211 1223578999999999999899999999999999999999999996421 11111 1111111
Q ss_pred CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 280 NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
. .++. .....+.+|+.+||+.||++|| ++.++++
T Consensus 212 ~---~~p~--------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 I---RFPR--------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred C---CCCC--------CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1 1111 1122388999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=312.54 Aligned_cols=256 Identities=19% Similarity=0.249 Sum_probs=201.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|+ +..+++.||+|++... ..........+..|+.++..++||||++++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~-~~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~ 67 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAK-KKDTGEIVALKRMKKS------------LLFKLNEVRHVLTERDILTTTKSEWLVKLL 67 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEE-ECCCCCEEEEEEEEHH------------HHhhhhHHHHHHHHHHHHHhCCCCCCccEE
Confidence 479999999999999999996 5567889999998311 111223456788899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..|+||||+++++|.+++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~ 140 (333)
T cd05600 68 YAFQDDEYLYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHI 140 (333)
T ss_pred EEEEcCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCE
Confidence 99999999999999999999999983 3456888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||..... .+....+.
T Consensus 141 kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~ 211 (333)
T cd05600 141 KLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP----NETWENLK 211 (333)
T ss_pred EEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH----HHHHHHHH
Confidence 9999999976543 11224789999999999998999999999999999999999999965321 11111111
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+...++. ......+.+++.+||..+|.+|||++++++
T Consensus 212 ~~~~~~~~~~~~~~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 212 YWKETLQRPVYDDPR------FNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred hccccccCCCCCccc------cccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 111000011000000 112334889999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=279.29 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=208.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
+.++|++.+.||+|.||.||+|+ ...++..||+|+++. ..-.......++.+|+++.+.|+||||++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlar-ekks~~IvalKVlfK------------sqi~~~~v~~qlrREiEIqs~L~hpnilr 86 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAR-EKKSLFIVALKVLFK------------SQILKTQVEHQLRREIEIQSHLRHPNILR 86 (281)
T ss_pred chhhccccccccCCccccEeEee-eccCCcEEEEeeeeH------------HHHHHhcchhhhhheeEeecccCCccHHh
Confidence 45789999999999999999996 456778899999842 22333455678999999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+|++|.+....|+++||...|++...+++ +....+++...+.++.|++.|+.|+| .++|+||||||+|+|++..+
T Consensus 87 lY~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~ 161 (281)
T KOG0580|consen 87 LYGYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAG 161 (281)
T ss_pred hhhheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCC
Confidence 99999999999999999999999999954 34566999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.+|++|||-+...... .....+||..|.|||...+...+..+|+|++|++.|+++.|.+||.... ..+..
T Consensus 162 ~lkiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----~~etY-- 231 (281)
T KOG0580|consen 162 ELKIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----HSETY-- 231 (281)
T ss_pred CeeccCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----hHHHH--
Confidence 9999999999765522 2334799999999999999999999999999999999999999997532 11222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+++.+..... + +.......|+|.+|+..+|.+|.+..|++.
T Consensus 232 -krI~k~~~~~---p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 232 -KRIRKVDLKF---P--------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -HHHHHccccC---C--------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 2222211111 1 112223889999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=307.52 Aligned_cols=200 Identities=26% Similarity=0.442 Sum_probs=173.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+++ +..++..+|+|.+... ........+.+|+.++++++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~a~k~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 68 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQ-HKPSGLIMARKLIHLE--------------IKPAIRNQIIRELQVLHECNSPYIVGF 68 (331)
T ss_pred cccceEEEeecCCCCEEEEEEE-ECCCCcEEEEEEeecc--------------cCHHHHHHHHHHHHHHHHCCCCCCCeE
Confidence 5789999999999999999996 5567888999987321 122345678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEecCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA-RVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~ivH~dl~~~nil~~~~~ 191 (325)
++++...+..++||||+++++|.+++. ....++...+..++.|++.||.||| ++ +++|+||||+||+++.++
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~ 141 (331)
T cd06649 69 YGAFYSDGEISICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRG 141 (331)
T ss_pred EEEEEECCEEEEEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCC
Confidence 999999999999999999999999984 3345888999999999999999999 54 699999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
.++|+|||++........ ....|+..|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus 142 ~~kl~Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 142 EIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cEEEccCccccccccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999876543221 124689999999999998899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=313.58 Aligned_cols=261 Identities=21% Similarity=0.223 Sum_probs=196.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|+||.||+|. +..+++.||+|.. ....+.+|+.+++.++||||+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~-d~~~~~~vaiK~~---------------------~~~~~~~E~~il~~l~HpnIv~~ 148 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACI-DNKTCEHVVIKAG---------------------QRGGTATEAHILRAINHPSIIQL 148 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEE-ECCCCCEEEEech---------------------hhhhhHHHHHHHHhCCCCCCCCE
Confidence 4689999999999999999995 6678899999964 12345789999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++......++|+|++. ++|..++. ....++...+..++.|++.||.||| ++||+||||||+||+++.++.
T Consensus 149 ~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~ 220 (391)
T PHA03212 149 KGTFTYNKFTCLILPRYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGD 220 (391)
T ss_pred eEEEEECCeeEEEEecCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCC
Confidence 999999999999999995 58888873 3356888899999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||-..............+
T Consensus 221 vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l 299 (391)
T PHA03212 221 VCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI 299 (391)
T ss_pred EEEEeCCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHH
Confidence 99999999865332211 11122578999999999999899999999999999999999998864322211111111111
Q ss_pred HHHhh-hCCCC--cccc-------------------hhh--cCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMA-SENPN--RAID-------------------SKL--LGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~-~~~~~--~~~~-------------------~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+.. ....+ .+.. +.. ........+..+.+|+.+||+.||++|||++|+|+
T Consensus 300 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 300 KLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 11110 00000 0000 000 00011233456899999999999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=315.79 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=204.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
..++|.++++||+|.||+|++++.. .+++.+|||.+. +..-+....++..+.|..++.... ||+++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k-~~~e~yAIK~LK------------K~~Il~~d~Ve~~~~EkrI~~la~~HPFL~ 432 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELK-GTNEYYAIKVLK------------KGDILQRDEVESLMCEKRIFELANRHPFLV 432 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEc-CCCcEEEEEEee------------ccceeccccHHHHHHHHHHHHHhccCCeEe
Confidence 5578999999999999999999764 566799999983 333455677888999988888875 99999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
+++..|...+++|+||||+.||++..+ .....+++..+..++..++.||.||| .+||+|||||.+|||+|.+
T Consensus 433 ~L~~~fQT~~~l~fvmey~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~e 504 (694)
T KOG0694|consen 433 NLFSCFQTKEHLFFVMEYVAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTE 504 (694)
T ss_pred ecccccccCCeEEEEEEecCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEccc
Confidence 999999999999999999999994433 35577999999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
|++||+|||++...-.... .+.+++||+.|+|||++.+..|+.++|.|||||++|+|+.|..||.+.+. .++..
T Consensus 505 Gh~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE----ee~Fd 578 (694)
T KOG0694|consen 505 GHVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE----EEVFD 578 (694)
T ss_pred CcEEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHH
Confidence 9999999999986554333 44558999999999999999999999999999999999999999986332 22222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
.+. ......+.+... +..+|++++|.+||++|..+
T Consensus 579 sI~--~d~~~yP~~ls~------------ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 SIV--NDEVRYPRFLSK------------EAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHh--cCCCCCCCcccH------------HHHHHHHHHhccCcccccCC
Confidence 211 112222222222 28899999999999999977
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=321.32 Aligned_cols=257 Identities=19% Similarity=0.257 Sum_probs=203.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
...|.+.+.||+|++|.||+|.....++..||+|.+... .......+.+|+.+++.++||||+++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---------------~~~~~~~~~~E~~~l~~l~Hpniv~~ 130 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---------------DERQAAYARSELHCLAACDHFGIVKH 130 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---------------CHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 345999999999999999999654444778888876221 12234467789999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+...+..|+||||+++++|.+++.........++...+..++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 131 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~ 207 (478)
T PTZ00267 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGI 207 (478)
T ss_pred EEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCc
Confidence 99999999999999999999999988654444556888899999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++...............+||+.|+|||++.+..++.++|||||||++|+|++|..||.... . ....
T Consensus 208 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----~---~~~~ 280 (478)
T PTZ00267 208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----Q---REIM 280 (478)
T ss_pred EEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----H---HHHH
Confidence 99999999987654332222233578999999999999899999999999999999999999996421 1 1222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........... +. .....+.++|.+||..||++|||++++++
T Consensus 281 ~~~~~~~~~~~--~~--------~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 281 QQVLYGKYDPF--PC--------PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhCCCCCC--Cc--------cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 22222221111 10 11123899999999999999999999874
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=304.83 Aligned_cols=264 Identities=18% Similarity=0.268 Sum_probs=196.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|++.+.||.|+||.||+|. +..++..||+|.+.... .......+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~niv~~ 68 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGR-SKLTENLVALKEIRLEH--------------EEGAPCTAIREVSLLKNLKHANIVTL 68 (288)
T ss_pred cccceEeeEEecCCCEEEEEEE-ECCCCCEEEEEEecccc--------------cCCcchhHHHHHHHHHhCCCCCEeeE
Confidence 4679999999999999999995 55678899999883211 11223456789999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..++||||+++ +|.+++.. ....++...+..++.|++.||.||| ++||+|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~ 141 (288)
T cd07871 69 HDIIHTERCLTLVFEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGE 141 (288)
T ss_pred EEEEcCCCeEEEEEeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCC
Confidence 9999999999999999976 89888743 2345788888999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||++......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .+....
T Consensus 142 ~kl~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~----~~~~~~ 215 (288)
T cd07871 142 LKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV----KEELHL 215 (288)
T ss_pred EEECcCcceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 999999999765432221 112467889999998865 4588999999999999999999999965321 111111
Q ss_pred HHHHhhhCCCCcc------------cchhhcCCc----hHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRA------------IDSKLLGNG----YEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~------------~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+....+ ..+...... .......+.+|+.+||+.||.+|||++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111100000 000000000 0112234889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=292.14 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=206.6
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.|++++.||+|.-|+||+|+.. .++..+|+|++ ++..-.......+...|-+||+.+.||.++.+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~-~t~~~fAmKVm------------dK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELR-GTNCLFAMKVM------------DKESLASRKKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEec-CCCceEEEEEe------------cHHHHhhhhHHHHHHHHHHHHHhcCCCccchhh
Confidence 57999999999999999999754 45589999998 333333456677888999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
..+..+...|++||||+||+|....++ +....+++..+..++..++.||+||| .+|||+|||||+|||+.++|++
T Consensus 144 a~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHI 218 (459)
T KOG0610|consen 144 ASFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHI 218 (459)
T ss_pred heeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcE
Confidence 999999999999999999999999865 66778999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCC-------------------------------c-c----------------------ccceeecCC
Q 040480 194 RISGFDLAILMPDGL-------------------------------T-Q----------------------IDTMYVVGT 219 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~-------------------------------~-~----------------------~~~~~~~g~ 219 (325)
.|.||+++....... . . .+...++||
T Consensus 219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT 298 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT 298 (459)
T ss_pred EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence 999999986432100 0 0 001115789
Q ss_pred cccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHH
Q 040480 220 PRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML 299 (325)
Q Consensus 220 ~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (325)
-.|+|||++.|..-+.++|.|+||+++|||++|..||-+.... +...++..........+ ....
T Consensus 299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~-------~Tl~NIv~~~l~Fp~~~---------~vs~ 362 (459)
T KOG0610|consen 299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-------ETLRNIVGQPLKFPEEP---------EVSS 362 (459)
T ss_pred cccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch-------hhHHHHhcCCCcCCCCC---------cchh
Confidence 9999999999999999999999999999999999999764432 22333333222211111 2333
Q ss_pred HHHHHHhhhcCCCCCCCCC----hhhhh
Q 040480 300 LVLKLACFCTLADPDERPN----SKDVR 323 (325)
Q Consensus 300 ~l~~li~~~l~~dP~~Rps----~~ell 323 (325)
.+.|||+++|.+||.+|.. +.||-
T Consensus 363 ~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 363 AAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred HHHHHHHHHhccChhhhhccccchHHhh
Confidence 4899999999999999998 66653
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=304.64 Aligned_cols=245 Identities=22% Similarity=0.289 Sum_probs=192.5
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecC
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 119 (325)
+.||+|+||.||+++ +..++..||+|.+.. ...........+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~lG~G~~g~Vy~~~-~~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~ 67 (323)
T cd05595 1 KLLGKGTFGKVILVR-EKATGRYYAMKILRK------------EVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 67 (323)
T ss_pred CeeeeCCCEEEEEEE-ECCCCCEEEEEEEEH------------HHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 468999999999996 556789999999831 1111223455677899999999999999999999999
Q ss_pred CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccc
Q 040480 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199 (325)
Q Consensus 120 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg 199 (325)
+..|+||||+++++|..++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||
T Consensus 68 ~~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 140 (323)
T cd05595 68 DRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG 140 (323)
T ss_pred CEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccH
Confidence 99999999999999988883 3446889999999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhC
Q 040480 200 LAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASE 279 (325)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 279 (325)
++......... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..... . .....+....
T Consensus 141 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~---~~~~~~~~~~ 211 (323)
T cd05595 141 LCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----E---RLFELILMEE 211 (323)
T ss_pred HhccccCCCCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----H---HHHHHHhcCC
Confidence 98753322211 1124689999999999998999999999999999999999999964221 1 1111111111
Q ss_pred CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 280 NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
.. ++. .....+.+++.+||+.||++|| ++.++++
T Consensus 212 ~~---~p~--------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 IR---FPR--------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CC---CCC--------CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11 111 1122388999999999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=300.75 Aligned_cols=265 Identities=22% Similarity=0.336 Sum_probs=192.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc---CCCCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI---RHRNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~ 110 (325)
++|++.+.||+|+||.||+|+....++..+|+|.+..... .........+|+.+++.+ .||||+
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~hpniv 67 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-------------EEGMPLSTIREVAVLRHLETFEHPNVV 67 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-------------CCCchHHHHHHHHHHHhhcccCCCCcc
Confidence 4799999999999999999976555678899998743211 111223344555555554 699999
Q ss_pred cccccee-----cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 111 PLLAHMV-----RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 111 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
++++++. .....++||||+++ +|.+++... ....+++..+..++.|++.||.||| ++|++|+||||+||
T Consensus 68 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Ni 141 (290)
T cd07862 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNI 141 (290)
T ss_pred eEEEEEecccCCCCCcEEEEEccCCC-CHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHE
Confidence 9999874 34568999999964 899988542 2345888899999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
+++.++.++|+|||++........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 142 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~---- 214 (290)
T cd07862 142 LVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---- 214 (290)
T ss_pred EEcCCCCEEEccccceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH----
Confidence 999999999999999976554321 2224689999999999888899999999999999999999999975321
Q ss_pred chHHHHHHHHhhhCCCCcc-----cchhh--------cCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRA-----IDSKL--------LGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~-----~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....+........+..+ .+... ......+....+.+|+.+||+.||++|||+.|+++
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 215 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1122111111111100000 00000 00001123345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=320.70 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=204.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|. +..+++.||+|.+... .........+.+|+..+..++|+|+++
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~-~~~~g~~vAvK~i~~~-------------~~~~~~~~~~~~Ei~~l~~~~h~~iv~ 95 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAK-RVSDGEPFAVKVVDME-------------GMSEADKNRAQAEVCCLLNCDFFSIVK 95 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEE-EcCCCCEEEEEEEecc-------------cCCHHHHHHHHHHHHHHhcCCCCcEEE
Confidence 45799999999999999999995 5567899999998322 122234556788999999999999999
Q ss_pred cccceecCC--------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 112 LLAHMVRPD--------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 112 ~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+++.+...+ ..++||||+++++|.+++.........+++..+..++.|++.||.||| +++|+|+||||+
T Consensus 96 ~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~ 172 (496)
T PTZ00283 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSA 172 (496)
T ss_pred eecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHH
Confidence 887765432 368999999999999999665455567899999999999999999999 889999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
||+++.++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 173 NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--- 249 (496)
T PTZ00283 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--- 249 (496)
T ss_pred HEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---
Confidence 99999999999999999986654332222233578999999999999899999999999999999999999996421
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............... .++ ..+..+.+++.+||+.||.+|||+.++++
T Consensus 250 ----~~~~~~~~~~~~~~~--~~~--------~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 250 ----MEEVMHKTLAGRYDP--LPP--------SISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred ----HHHHHHHHhcCCCCC--CCC--------CCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 122222222222111 111 11233899999999999999999999875
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=314.50 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=201.5
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|+ +..+++.||+|++.. ...........+..|+.++..++||||++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 67 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVR-DKDTGQVYAMKVLRK------------SDMIKRNQIAHVRAERDILADADSPWIVKLY 67 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEE-ECCCCCEEEEEEEEH------------HHHhhccHHHHHHHHHHHHHhcCCCCccchh
Confidence 479999999999999999996 556789999999831 1112224556788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+.+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~ 140 (350)
T cd05573 68 YSFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHI 140 (350)
T ss_pred hheecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCE
Confidence 999999999999999999999999843 356889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCC---------------------------ccccceeecCCcccccccccccCCCCCccchhhHHHHH
Q 040480 194 RISGFDLAILMPDGL---------------------------TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL 246 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~---------------------------~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il 246 (325)
+|+|||++....... .........||+.|+|||++.+..++.++|||||||++
T Consensus 141 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 220 (350)
T cd05573 141 KLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220 (350)
T ss_pred EeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhh
Confidence 999999997654432 00111224689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-hhhhhc
Q 040480 247 AVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-SKDVRC 324 (325)
Q Consensus 247 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~ 324 (325)
|+|++|+.||..... ......+..... ....+.. . ..+..+.+||.+||. ||.+||+ ++++++
T Consensus 221 ~ell~g~~Pf~~~~~-------~~~~~~i~~~~~-~~~~p~~--~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 221 YEMLYGFPPFYSDTL-------QETYNKIINWKE-SLRFPPD--P----PVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred hhhccCCCCCCCCCH-------HHHHHHHhccCC-cccCCCC--C----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 999999999975321 111111111000 0000000 0 022338899999997 9999999 999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=311.65 Aligned_cols=265 Identities=20% Similarity=0.257 Sum_probs=201.3
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEe----cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAEL----PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ 103 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 103 (325)
.+....++|++.+.||+|+||.||+|++ ...++..||+|++.... .......+.+|+.+++.
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--------------~~~~~~~~~~Ei~il~~ 94 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--------------HLTEREALMSELKVLSY 94 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--------------CcHHHHHHHHHHHHHHH
Confidence 4444567899999999999999999964 23456789999873211 11234567889999999
Q ss_pred c-CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc---------------------------------------
Q 040480 104 I-RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK--------------------------------------- 143 (325)
Q Consensus 104 l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------------------------- 143 (325)
+ +||||+++++++...+..++||||+++|+|.+++.....
T Consensus 95 l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (375)
T cd05104 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPG 174 (375)
T ss_pred hcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCC
Confidence 9 899999999999999999999999999999999854211
Q ss_pred --------------------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 144 --------------------------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 144 --------------------------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
....+++..+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~ 251 (375)
T cd05104 175 VSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGR 251 (375)
T ss_pred cccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCC
Confidence 0124677788899999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ......
T Consensus 252 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---~~~~~~ 328 (375)
T cd05104 252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---DSKFYK 328 (375)
T ss_pred cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---hHHHHH
Confidence 999999999986654332221112234567999999999899999999999999999998 8899865321 112222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
... .......+ . ..+..+.+|+.+||+.||++|||+.+++++
T Consensus 329 ~~~---~~~~~~~~-------~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 329 MIK---EGYRMLSP-------E---CAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHH---hCccCCCC-------C---CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 211 11111100 0 012238999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=303.06 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=197.4
Q ss_pred hcCcccccccccCcceeEEEEEecC---------------CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHH
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPG---------------SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 97 (325)
.++|++.++||+|+||.||+|.+.. .++..||+|.+... ........+.+|
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E 69 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--------------ANKNARNDFLKE 69 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--------------CCHHHHHHHHHH
Confidence 4789999999999999999997532 13347999987321 112234568899
Q ss_pred HHHHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc---------------cccccChhhHHHHHHHHHH
Q 040480 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK---------------GRRELEWLSRHKIALAVAS 162 (325)
Q Consensus 98 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~ 162 (325)
+.+++.++||||+++++++.+.+..++||||+.+++|.+++..... ....+++.....++.|++.
T Consensus 70 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 149 (304)
T cd05096 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIAS 149 (304)
T ss_pred HHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999854221 1124667788899999999
Q ss_pred HHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhH
Q 040480 163 GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSF 242 (325)
Q Consensus 163 ~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dvwsl 242 (325)
||.||| +.|++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||
T Consensus 150 al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 226 (304)
T cd05096 150 GMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226 (304)
T ss_pred HHHHHH---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHH
Confidence 999999 88999999999999999999999999999986544332222222345778999999988889999999999
Q ss_pred HHHHHHHHh--CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 243 GVLLAVLVM--GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 243 G~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
|+++|+|++ +..||..... ..................... ....++..+.+|+.+||+.||++|||+.
T Consensus 227 G~~l~el~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 227 GVTLWEILMLCKEQPYGELTD----EQVIENAGEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred HHHHHHHHHccCCCCCCcCCH----HHHHHHHHHHhhhcccccccc------CCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 999999987 5577765322 122222211111110000000 0001223489999999999999999999
Q ss_pred hhhc
Q 040480 321 DVRC 324 (325)
Q Consensus 321 ell~ 324 (325)
+|.+
T Consensus 297 ~i~~ 300 (304)
T cd05096 297 DIHA 300 (304)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=302.79 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=191.7
Q ss_pred cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCc
Q 040480 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS 121 (325)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 121 (325)
||+|+||.||+|. +..+++.||+|.+.. ...........+.+|+.++++++||||+++++.+...+.
T Consensus 1 lg~G~~g~Vy~~~-~~~~~~~~aiK~i~~------------~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 67 (312)
T cd05585 1 IGKGSFGKVMQVR-KRDTQRIYALKTIRK------------AHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK 67 (312)
T ss_pred CCcCCCeEEEEEE-ECCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCe
Confidence 6999999999996 556788999998831 111222345677889999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 122 HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
.|+||||+++++|.+++. ....+++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++
T Consensus 68 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~ 140 (312)
T cd05585 68 LYLVLAFINGGELFHHLQ----REGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLC 140 (312)
T ss_pred EEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECccc
Confidence 999999999999999984 3456889999999999999999999 889999999999999999999999999998
Q ss_pred eecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCC
Q 040480 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENP 281 (325)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..............
T Consensus 141 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~~~~~~~~~~~ 211 (312)
T cd05585 141 KLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEMYRKILQEPLR 211 (312)
T ss_pred ccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCC
Confidence 75432221 1223578999999999999899999999999999999999999996521 11222222222111
Q ss_pred CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC---hhhhhc
Q 040480 282 NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN---SKDVRC 324 (325)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~ 324 (325)
.+. .....+.+++.+||+.||.+||+ +.+++.
T Consensus 212 ---~~~--------~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 212 ---FPD--------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ---CCC--------cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 111 11223889999999999999985 556553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=304.19 Aligned_cols=245 Identities=20% Similarity=0.305 Sum_probs=193.5
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecC
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 119 (325)
+.||+|+||.||+++ +..+++.||+|.+... ..........+.+|+.+++.+.||||+++++.+...
T Consensus 1 ~~lG~G~~g~Vy~~~-~~~~~~~~avK~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 67 (328)
T cd05593 1 KLLGKGTFGKVILVR-EKASGKYYAMKILKKE------------VIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK 67 (328)
T ss_pred CeeeeCCCEEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC
Confidence 468999999999995 5677899999998321 112233456778899999999999999999999999
Q ss_pred CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccc
Q 040480 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199 (325)
Q Consensus 120 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg 199 (325)
+..++||||+++++|.+++. ....+++..+..++.|++.||.||| ++||+|+||||+||+++.++.++|+|||
T Consensus 68 ~~~~lv~Ey~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG 140 (328)
T cd05593 68 DRLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFG 140 (328)
T ss_pred CEEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCc
Confidence 99999999999999988883 3456889999999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhC
Q 040480 200 LAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASE 279 (325)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 279 (325)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... . .....+....
T Consensus 141 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~---~~~~~~~~~~ 211 (328)
T cd05593 141 LCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----E---KLFELILMED 211 (328)
T ss_pred CCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----H---HHHHHhccCC
Confidence 9875332211 11224789999999999988899999999999999999999999965211 1 1111111111
Q ss_pred CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 280 NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
. .++.. ....+.+++.+||+.||++|| ++.++++
T Consensus 212 ~---~~p~~--------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 212 I---KFPRT--------LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred c---cCCCC--------CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 1 11111 122388999999999999997 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=289.65 Aligned_cols=269 Identities=23% Similarity=0.284 Sum_probs=205.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC-ccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN-ILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~ 111 (325)
-..|..+++||+|+||+||+|+ ...+|+.||+|++.+.. ..+.......+|+.+++.++|+| |+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar-~~~~g~~VALKkirl~~-------------~~EG~P~taiREisllk~L~~~~~iv~ 75 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKAR-SKRTGKFVALKKIRLEF-------------EEEGVPSTAIREISLLKRLSHANHIVR 75 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEE-EecCCCEEEEEEEeccc-------------cccCCCchhhHHHHHHHHhCCCcceEE
Confidence 4668889999999999999995 66788999999995432 11234556799999999999999 999
Q ss_pred cccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++++...+ ..++|+||++. +|..++.........++...+..++.|++.||+||| +++|+||||||.|+
T Consensus 76 L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNl 151 (323)
T KOG0594|consen 76 LHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNL 151 (323)
T ss_pred EEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceE
Confidence 999998877 78999999966 999999664432245777889999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+++++|.+||+|||+|+...-.... .+..++|.+|.|||++.+. .|+...||||+|||+.+|++++.-|.+...
T Consensus 152 Li~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--- 226 (323)
T KOG0594|consen 152 LISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--- 226 (323)
T ss_pred EECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---
Confidence 9999999999999999965533322 2224778999999999987 689999999999999999999999876322
Q ss_pred cchHHHHHHHHhhhCCCCcccchh----hc--------CCc-hH---HHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSK----LL--------GNG-YE---EQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~----~~--------~~~-~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
.+...-+......+....|.... .. ... .. +......+++.+||+.+|.+|.|+..++.+
T Consensus 227 -~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 227 -IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred -HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 22222222233222221111100 00 000 11 111358899999999999999999998863
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.21 Aligned_cols=200 Identities=25% Similarity=0.451 Sum_probs=171.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.++||.|+||.||++. +..++..+|+|.+... ........+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~~a~k~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 68 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVS-HKPSGLIMARKLIHLE--------------IKPAIRNQIIRELQVLHECNSPYIVGF 68 (333)
T ss_pred hhhhheeccccCCCCEEEEEEE-ECCCCcEEEEEEeecc--------------cCHHHHHHHHHHHHHHHHCCCCcccce
Confidence 4789999999999999999996 4567788999987321 122334568899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEecCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA-RVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~ivH~dl~~~nil~~~~~ 191 (325)
++++...+..++||||+++++|.+++.. ...++......++.|++.||.||| +. +++|+||||+||+++.++
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~ 141 (333)
T cd06650 69 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRG 141 (333)
T ss_pred eEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCC
Confidence 9999999999999999999999999843 345888889999999999999999 53 799999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
.++|+|||++........ ....|+..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 142 ~~kL~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 142 EIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred CEEEeeCCcchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999875533211 124688899999999988899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=313.23 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=195.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.|++++.||+|+||+||+|+ +..+++.+|+|.+.. ...........+.+|+.+++.++||||++++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~-~~~~~~~~aiK~i~~------------~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~ 67 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLAC-KVDTHALYAMKTLRK------------KDVLNRNQVAHVKAERDILAEADNEWVVKLY 67 (381)
T ss_pred CCceEEEEEeecCCEEEEEEE-ECCCCCEEEEEEEEH------------HHhhhhHHHHHHHHHHHHHHhcCCCCeeeeE
Confidence 468999999999999999996 566789999999831 1112234456789999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+.+..|+||||+++++|.+++. ....+++..+..++.|++.||.||| +.||+||||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~ 140 (381)
T cd05626 68 YSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHI 140 (381)
T ss_pred EEEecCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCE
Confidence 99999999999999999999999984 3345888888999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCc---------------------------------------------cccceeecCCccccccccc
Q 040480 194 RISGFDLAILMPDGLT---------------------------------------------QIDTMYVVGTPRYIAPEYH 228 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~---------------------------------------------~~~~~~~~g~~~~~aPE~~ 228 (325)
+|+|||++........ ........||..|+|||++
T Consensus 141 kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 220 (381)
T cd05626 141 KLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220 (381)
T ss_pred EEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH
Confidence 9999998753311000 0000124689999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhh
Q 040480 229 QTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFC 308 (325)
Q Consensus 229 ~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 308 (325)
.+..++.++|||||||++|+|++|..||..... ... ...+...... ...+.. . .....+.+|+.+|
T Consensus 221 ~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~---~~~i~~~~~~-~~~~~~--~----~~s~~~~dli~~l 286 (381)
T cd05626 221 LRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP----TET---QLKVINWENT-LHIPPQ--V----KLSPEAVDLITKL 286 (381)
T ss_pred cCCCCCCccceeehhhHHHHHHhCCCCCcCCCH----HHH---HHHHHccccc-cCCCCC--C----CCCHHHHHHHHHH
Confidence 988899999999999999999999999975321 111 1111110100 000000 0 0112378888885
Q ss_pred c--CCCCCCCCChhhhhc
Q 040480 309 T--LADPDERPNSKDVRC 324 (325)
Q Consensus 309 l--~~dP~~Rps~~ell~ 324 (325)
+ ..+|..||+++++++
T Consensus 287 l~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 287 CCSAEERLGRNGADDIKA 304 (381)
T ss_pred ccCcccccCCCCHHHHhc
Confidence 5 556666999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=302.19 Aligned_cols=242 Identities=21% Similarity=0.289 Sum_probs=187.9
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHH---hccCCCCcccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA---SQIRHRNILPL 112 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~i~~~ 112 (325)
|++.+.||+|+||.||+|. +..+++.||+|.+... ..........+.+|..++ +.++||||+++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~ 67 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAE-YKKTGELYAIKALKKG------------DIIARDEVESLMCEKRIFETANSERHPFLVNL 67 (324)
T ss_pred CeEEEEEeecCCEEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhccccCCCChhce
Confidence 7889999999999999996 5567889999998321 111122344566665544 56789999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..|+||||+++++|...+. ...+++..+..++.|++.||.||| ++|++|+||||+||+++.++.
T Consensus 68 ~~~~~~~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~ 139 (324)
T cd05589 68 FACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGF 139 (324)
T ss_pred eeEEEcCCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCc
Confidence 999999999999999999999988872 346899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .. ..
T Consensus 140 ~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~---~~ 210 (324)
T cd05589 140 VKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EE---VF 210 (324)
T ss_pred EEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HH---HH
Confidence 99999999864332211 12235789999999999998999999999999999999999999965221 11 11
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (325)
..+...... .+. ..+..+.+++.+||+.||.+||+
T Consensus 211 ~~i~~~~~~---~p~--------~~~~~~~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 211 DSIVNDEVR---YPR--------FLSREAISIMRRLLRRNPERRLG 245 (324)
T ss_pred HHHHhCCCC---CCC--------CCCHHHHHHHHHHhhcCHhHcCC
Confidence 222221111 010 01223889999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=308.92 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=199.1
Q ss_pred HhhhcCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI- 104 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 104 (325)
....++|++.+.||+|+||.||+|.+. ..++..||+|.+... ........+.+|+.+++.+
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~il~~l~ 99 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--------------AHTDEREALMSELKILSHLG 99 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC--------------CCHHHHHHHHHHHHHHHhhc
Confidence 345678999999999999999999642 223457999987321 1122345688999999999
Q ss_pred CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc-----------------------------------------
Q 040480 105 RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK----------------------------------------- 143 (325)
Q Consensus 105 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------- 143 (325)
+||||+++++.+...+..++||||+++|+|.+++.....
T Consensus 100 ~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (374)
T cd05106 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSD 179 (374)
T ss_pred cCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccc
Confidence 899999999999999999999999999999999854210
Q ss_pred -------------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 144 -------------------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 144 -------------------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
....+++..+.+++.|++.||.||| ++|++||||||+||++++++.++|+||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~Df 256 (374)
T cd05106 180 TYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDF 256 (374)
T ss_pred cccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeec
Confidence 0124677788999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMA 277 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
|++................++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ....... .
T Consensus 257 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~---~ 330 (374)
T cd05106 257 GLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVK---R 330 (374)
T ss_pred eeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHH---c
Confidence 99976544322211112234567999999988889999999999999999997 999997532211 1111111 1
Q ss_pred hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
...... +. ..+..+.+++.+||+.||.+|||+.+++++
T Consensus 331 ~~~~~~--~~--------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 331 GYQMSR--PD--------FAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred ccCccC--CC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111100 00 012238999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=310.98 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=195.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|. +..+++.+|+|++.. ...........+..|+.++..++||+|++++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~ 67 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQ-KKDTGHVYAMKILRK------------ADMLEKEQVGHIRAERDILVEADSLWVVKMF 67 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEE-ECCCCCEEEEEEEEH------------HHHHHhhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 479999999999999999995 556788999999831 1112223456788899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+....|+||||+++++|.+++. ....++...+..++.|++.||.||| ++||+||||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~v 140 (363)
T cd05628 68 YSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHV 140 (363)
T ss_pred EEEecCCeEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCE
Confidence 99999999999999999999999984 3456899999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCcc---------------------------------ccceeecCCcccccccccccCCCCCccchh
Q 040480 194 RISGFDLAILMPDGLTQ---------------------------------IDTMYVVGTPRYIAPEYHQTLTISEKCDIY 240 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~---------------------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dvw 240 (325)
+|+|||++......... ......+||+.|+|||++.+..++.++|+|
T Consensus 141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~Dvw 220 (363)
T cd05628 141 KLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220 (363)
T ss_pred EEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhh
Confidence 99999998754321100 001124789999999999998999999999
Q ss_pred hHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcC--CCCCCCCC
Q 040480 241 SFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTL--ADPDERPN 318 (325)
Q Consensus 241 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dP~~Rps 318 (325)
||||++|+|++|..||..... . .....+...... ..+++.. . ....+.+++.+|+. .++..||+
T Consensus 221 SlGvil~ell~G~~Pf~~~~~----~---~~~~~i~~~~~~-~~~p~~~--~----~s~~~~~li~~l~~~~~~r~~r~~ 286 (363)
T cd05628 221 SLGVIMYEMLIGYPPFCSETP----Q---ETYKKVMNWKET-LIFPPEV--P----ISEKAKDLILRFCCEWEHRIGAPG 286 (363)
T ss_pred hhHHHHHHHHhCCCCCCCCCH----H---HHHHHHHcCcCc-ccCCCcC--C----CCHHHHHHHHHHcCChhhcCCCCC
Confidence 999999999999999965321 1 111222211110 0111100 0 11226777777664 23345689
Q ss_pred hhhhhc
Q 040480 319 SKDVRC 324 (325)
Q Consensus 319 ~~ell~ 324 (325)
++|+++
T Consensus 287 ~~ei~~ 292 (363)
T cd05628 287 VEEIKT 292 (363)
T ss_pred HHHHhC
Confidence 999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=313.23 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=198.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|+ +..+++.||+|.+... ..........+.+|+.++..++||||++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~E~~il~~l~h~~iv~~~ 67 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQ-KKDTGHIYAMKKLRKS------------EMLEKEQVAHVRAERDILAEADNPWVVKLY 67 (364)
T ss_pred CCceEEEEEEecCCEEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhCCCCCCcceE
Confidence 479999999999999999996 5567889999998311 111223455678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+.+..|+||||+.+++|.+++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~ 140 (364)
T cd05599 68 YSFQDENYLYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHI 140 (364)
T ss_pred EEEEcCCeEEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCE
Confidence 99999999999999999999999984 3446899999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccc------------------------------------cceeecCCcccccccccccCCCCCcc
Q 040480 194 RISGFDLAILMPDGLTQI------------------------------------DTMYVVGTPRYIAPEYHQTLTISEKC 237 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~------------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~ 237 (325)
+|+|||++.......... ......||+.|+|||++.+..++.++
T Consensus 141 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 220 (364)
T cd05599 141 KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220 (364)
T ss_pred EEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCee
Confidence 999999987543211100 00113689999999999998999999
Q ss_pred chhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC
Q 040480 238 DIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317 (325)
Q Consensus 238 DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (325)
|+|||||++|+|++|..||..... ......+...... ...+... .....+.+||.+|+. +|.+|+
T Consensus 221 DiwSlG~il~el~~G~~Pf~~~~~-------~~~~~~i~~~~~~-~~~~~~~------~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 221 DWWSLGVIMYEMLVGYPPFCSDNP-------QETYRKIINWKET-LQFPDEV------PLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred eeecchhHHHHhhcCCCCCCCCCH-------HHHHHHHHcCCCc-cCCCCCC------CCCHHHHHHHHHHcc-CHhhcC
Confidence 999999999999999999965321 1111222111111 0111100 112237899999997 999999
Q ss_pred C---hhhhhc
Q 040480 318 N---SKDVRC 324 (325)
Q Consensus 318 s---~~ell~ 324 (325)
+ +.++++
T Consensus 286 ~~~~~~~ll~ 295 (364)
T cd05599 286 GNNGVNEIKS 295 (364)
T ss_pred CCCCHHHHhc
Confidence 8 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=297.58 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=198.3
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||+|+||.||++. +..+++.||+|.+... ..........+.+|+.+++.++||||+++++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~------------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKK------------RIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67 (285)
T ss_pred CceEEEEEecCCCeEEEEEE-EcCCCceEEEEEEehh------------hhhhhhhHHHHHHHHHHHHhcCCCCEeeeee
Confidence 58899999999999999995 5567889999988311 0111122345678999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+..++..++||||+++++|.+.+.. .....+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~ 142 (285)
T cd05605 68 AYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred eecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEE
Confidence 99999999999999999999988743 23346889999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||++......... ....|+..|+|||++.+..++.++|+||+|+++|+|++|..||...... ........
T Consensus 143 l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~----~~~~~~~~ 215 (285)
T cd05605 143 ISDLGLAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK----VKREEVER 215 (285)
T ss_pred EeeCCCceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh----hHHHHHHH
Confidence 9999999765433221 1246889999999999888999999999999999999999999753211 11111111
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
........ .+ ...+..+.+|+.+||+.||.+|| +++++++
T Consensus 216 ~~~~~~~~--~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 216 RVKEDQEE--YS--------EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred Hhhhcccc--cC--------cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11111110 01 11223388999999999999999 7878864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=306.43 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=192.8
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|+||.||+|. +..++..||+|.+... .........+.+|+.+++.++||||+++++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 66 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKINDV-------------FEHVSDATRILREIKLLRLLRHPDIVEIKH 66 (338)
T ss_pred CeEEEEEEeecCCeEEEEEE-ECCCCCEEEEEEechh-------------hccchhHHHHHHHHHHHHhCCCCCEeeecc
Confidence 68999999999999999995 5677899999987311 111223456789999999999999999999
Q ss_pred ceecC-----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 115 HMVRP-----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 115 ~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++... ...|+||||+. ++|.+++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 67 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~ 138 (338)
T cd07859 67 IMLPPSRREFKDIYVVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANA 138 (338)
T ss_pred eEeccCCCCCceEEEEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECC
Confidence 87543 24799999995 58988883 3446889999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCcc-ccceeecCCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 190 DMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQT--LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
++.++|+|||++......... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||..... .
T Consensus 139 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~----~ 214 (338)
T cd07859 139 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV----V 214 (338)
T ss_pred CCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh----H
Confidence 999999999999754322111 11122468999999998865 5688999999999999999999999965321 1
Q ss_pred hHHHHHHHHhhhC--------------------CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASE--------------------NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+....... ....... ...........+.+++.+||+.||++|||++|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP---FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCc---hHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1111111000000 0000000 00000112234789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=314.10 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=195.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|.+.+.||.|+||+||+|+ +..+++.||+|.+... ..........+.+|+.+++.++||||++++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~E~~il~~l~hp~iv~~~ 67 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQ-KKDTGKIYAMKTLLKS------------EMFKKDQLAHVKAERDVLAESDSPWVVSLY 67 (377)
T ss_pred CCceEeEEEeecCCEEEEEEE-ECCCCCEEEEEEEEHH------------HHHHhHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 479999999999999999995 5678889999988321 111223456788899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+.+..|+||||+++++|.+++. ....+++..+..++.|++.||.||| ++||+||||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~ 140 (377)
T cd05629 68 YSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHI 140 (377)
T ss_pred EEEEcCCeeEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCE
Confidence 99999999999999999999999984 3456888889999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCc------------cc---------------------------------cceeecCCccccccccc
Q 040480 194 RISGFDLAILMPDGLT------------QI---------------------------------DTMYVVGTPRYIAPEYH 228 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~------------~~---------------------------------~~~~~~g~~~~~aPE~~ 228 (325)
+|+|||++..+..... .. ......||+.|+|||++
T Consensus 141 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 220 (377)
T cd05629 141 KLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF 220 (377)
T ss_pred EEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH
Confidence 9999999863321000 00 00013689999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhh
Q 040480 229 QTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFC 308 (325)
Q Consensus 229 ~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 308 (325)
.+..++.++|+|||||++|+|++|..||..... .+.. ..+...... ...+.. ......+.+|+.+|
T Consensus 221 ~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~---~~i~~~~~~-~~~p~~------~~~s~~~~dli~~l 286 (377)
T cd05629 221 LQQGYGQECDWWSLGAIMFECLIGWPPFCSENS----HETY---RKIINWRET-LYFPDD------IHLSVEAEDLIRRL 286 (377)
T ss_pred ccCCCCCceeeEecchhhhhhhcCCCCCCCCCH----HHHH---HHHHccCCc-cCCCCC------CCCCHHHHHHHHHH
Confidence 998899999999999999999999999965321 1111 111111100 000100 01122388999999
Q ss_pred cCCCCCCC---CChhhhhc
Q 040480 309 TLADPDER---PNSKDVRC 324 (325)
Q Consensus 309 l~~dP~~R---ps~~ell~ 324 (325)
|. +|.+| +|+.++++
T Consensus 287 L~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hc-CHhhcCCCCCHHHHhc
Confidence 97 77776 59988875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=296.16 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=194.7
Q ss_pred cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCc
Q 040480 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS 121 (325)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 121 (325)
||+|+||+||+++ +..+++.+|+|.+... ..........+..|+.+++.++||||+++.+.+.....
T Consensus 1 lg~G~~g~Vy~~~-~~~~~~~~avK~~~~~------------~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 67 (280)
T cd05608 1 LGKGGFGEVSACQ-MRATGKLYACKKLNKK------------RLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD 67 (280)
T ss_pred CCCCCceeEEEEE-EccCCcEEEEEeeeHH------------HHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe
Confidence 6999999999995 5567889999987311 11111234567789999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 122 HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
.++||||+++++|.+.+.........+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||.+
T Consensus 68 ~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 144 (280)
T cd05608 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA 144 (280)
T ss_pred EEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccc
Confidence 99999999999999888554445567899999999999999999999 889999999999999999999999999999
Q ss_pred eecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCC
Q 040480 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENP 281 (325)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||......... ...........
T Consensus 145 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~-- 217 (280)
T cd05608 145 VELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS-- 217 (280)
T ss_pred eecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC--
Confidence 765543322 12246889999999999989999999999999999999999999753221111 11111111111
Q ss_pred CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 282 NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
...+ ...+..+.+++.+||+.||++|| +++++++
T Consensus 218 -~~~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 218 -VTYP--------DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -CCCc--------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1111 11223488999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=299.05 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=195.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||.|+||.||+|+ +..+++.+|+|.+.... .......+.+|+.+++.++||||++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~niv~ 67 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGK-SKVNGKLVALKVIRLQE--------------EEGTPFTAIREASLLKGLKHANIVL 67 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEE-ECCCCCEEEEEEecccc--------------ccccchhHHHHHHHHhhCCCCCcCe
Confidence 45789999999999999999996 55678899999873211 1122345678999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+....++||||+. ++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 68 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~ 140 (303)
T cd07869 68 LHDIIHTKETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTG 140 (303)
T ss_pred EEEEEecCCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence 9999999999999999996 478777743 3345888889999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||++......... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||..... ......
T Consensus 141 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~ 215 (303)
T cd07869 141 ELKLADFGLARAKSVPSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLE 215 (303)
T ss_pred CEEECCCCcceeccCCCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHH
Confidence 9999999998754332211 1124678899999987654 578899999999999999999999975321 111111
Q ss_pred HHHHHhhhCCCCc--------ccchh-h---cCCchH------HHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNR--------AIDSK-L---LGNGYE------EQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~--------~~~~~-~---~~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............. ...+. . ...... .....+.+|+.+||+.||++|||+.|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 216 RIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1111111100000 00000 0 000000 01234789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=300.59 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=209.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
-...|++.+.||+|.||.||+|+ ...+|+.+|+|.+... ..........+.+|+.+|+++. ||||+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~-~~~tg~~~A~K~i~k~------------~~~~~~~~~~v~~Ev~il~~l~~hpniv 99 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCR-EKSTGKEVACKVIPKR------------KLRGKEDREDVRREVAILQQLSGHPNIV 99 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEE-ecCCCceeEEEEeehh------------hccccccHHHHHHHHHHHHhccCCCCEE
Confidence 34689999999999999999995 6677999999998321 2222235678999999999998 99999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
.+++.+.+....++|||++.||.|.+.+... .+++..+..++.|++.++.||| +.|++|+|+||+|+++...
T Consensus 100 ~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~ 171 (382)
T KOG0032|consen 100 QLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASK 171 (382)
T ss_pred EEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccc
Confidence 9999999999999999999999999999553 3999999999999999999999 8899999999999999633
Q ss_pred ----CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 191 ----MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 191 ----~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+.++++|||++...... ......+||+.|+|||++.+.+|+..+||||+|+++|.|++|.+||......
T Consensus 172 ~~~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---- 244 (382)
T KOG0032|consen 172 DEGSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---- 244 (382)
T ss_pred cCCCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh----
Confidence 47999999999987762 2233479999999999999999999999999999999999999999763321
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ...+..+.. .+....+.+....+.++|..|+..||.+|+|+.++|+
T Consensus 245 ~~---~~~i~~~~~-------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 245 EI---FLAILRGDF-------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HH---HHHHHcCCC-------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11 112222222 1122333444555899999999999999999999985
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=300.25 Aligned_cols=245 Identities=22% Similarity=0.266 Sum_probs=192.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC-CCccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH-RNILPLL 113 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~ 113 (325)
+|++.+.||+|+||.||+|+ +..+++.||+|.+... ..........+..|..++..+.| ++|++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~avK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~ 67 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKD------------VIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67 (324)
T ss_pred CceEEEEEeeccCeEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhcCCCCceeeeE
Confidence 58999999999999999996 5567789999998321 11122345667888889998876 5688899
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..|+||||+++++|.+++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 140 (324)
T cd05587 68 SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHI 140 (324)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCE
Confidence 99999999999999999999999883 3445888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++........ ......||..|+|||++.+..++.++|+||||+++|+|++|+.||.... ..... .
T Consensus 141 kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~~~~~---~ 211 (324)
T cd05587 141 KIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----EDELF---Q 211 (324)
T ss_pred EEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHH---H
Confidence 9999999875432221 1223578999999999999899999999999999999999999996522 11122 2
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
.+...... .+. .....+.+++.+||..||.+|++.
T Consensus 212 ~i~~~~~~---~~~--------~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 212 SIMEHNVS---YPK--------SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHcCCCC---CCC--------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 22211111 111 012238899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=313.32 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=194.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||+|+||.||+|+ +..+++.+|+|.+.. ...........+.+|+.++++++||||++++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~-~~~~~~~~aiK~i~~------------~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~ 67 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLAR-KVDTKALYAMKTLRK------------KDVLLRNQVAHVKAERDILAEADNEWVVRLY 67 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEE-ECCCCCEEEEEEEeH------------HHhhhHHHHHHHHHHHHHHHhCCCCcCCeEE
Confidence 469999999999999999995 556788999998831 1111223456788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+.+..|+||||+++++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++.+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~ 140 (382)
T cd05625 68 YSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHI 140 (382)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999843 345888889999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCc---------------------------------------------cccceeecCCccccccccc
Q 040480 194 RISGFDLAILMPDGLT---------------------------------------------QIDTMYVVGTPRYIAPEYH 228 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~---------------------------------------------~~~~~~~~g~~~~~aPE~~ 228 (325)
+|+|||++........ ........||+.|+|||++
T Consensus 141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 220 (382)
T cd05625 141 KLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220 (382)
T ss_pred EEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh
Confidence 9999999753211000 0001124689999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhh
Q 040480 229 QTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFC 308 (325)
Q Consensus 229 ~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 308 (325)
.+..++.++|||||||++|+|++|..||..... .. ....+...... ...+.. ......+.+++.+|
T Consensus 221 ~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~---~~~~i~~~~~~-~~~p~~------~~~s~~~~~li~~l 286 (382)
T cd05625 221 LRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP----LE---TQMKVINWQTS-LHIPPQ------AKLSPEASDLIIKL 286 (382)
T ss_pred cCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH----HH---HHHHHHccCCC-cCCCCc------ccCCHHHHHHHHHH
Confidence 998999999999999999999999999965321 11 11111111110 000000 01112277888887
Q ss_pred cCCCCCCCCC---hhhhhc
Q 040480 309 TLADPDERPN---SKDVRC 324 (325)
Q Consensus 309 l~~dP~~Rps---~~ell~ 324 (325)
+ .||.+|++ ++++++
T Consensus 287 ~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred c-cCHhHcCCCCCHHHHhc
Confidence 5 59999997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=281.50 Aligned_cols=259 Identities=27% Similarity=0.382 Sum_probs=214.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 112 (325)
+.|.-.+.||.|..++|.++. ...++..+|+|++.........+.. ....+.-.+|+.+|+++ .||+|+++
T Consensus 17 ~~y~pkeilgrgvss~vrRci-~k~t~~e~a~kii~~~at~~~~e~~-------~~~~EaT~~Ev~ILRqv~GHP~II~l 88 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCI-HKETGKEFAVKIIDVTATTESGETP-------YEMREATRQEISILRQVMGHPYIIDL 88 (411)
T ss_pred hhcChHHHhcccchhhhhhhh-hcccccceeEEEEEecccccCCccH-------HHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence 567888999999999999994 6678888999999777654443321 13345678899999998 59999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
.+++..+...++|+|.++.|.|.+++ .+.-.++++...+|+.|+++|++||| .++||||||||+||+++++-+
T Consensus 89 ~D~yes~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 89 QDVYESDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMN 161 (411)
T ss_pred eeeccCcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccc
Confidence 99999999999999999999999999 45667999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccC------CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL------TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~------~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
++|.|||+++....+..... .|||++|+|||.+... .|+..+|+||+|+++|.|+.|.+||-. .
T Consensus 162 i~isDFGFa~~l~~GekLre---lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-------R 231 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGEKLRE---LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-------R 231 (411)
T ss_pred eEEeccceeeccCCchhHHH---hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-------H
Confidence 99999999998887765444 6999999999987642 477889999999999999999999943 2
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...-.++.+..++.... ..-+.+......+||.+||+.||.+|.|++|+|+
T Consensus 232 kQmlMLR~ImeGkyqF~-------speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 232 KQMLMLRMIMEGKYQFR-------SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHHHHhcccccC-------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 33344555555544321 2234445555899999999999999999999875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=302.81 Aligned_cols=257 Identities=21% Similarity=0.273 Sum_probs=196.5
Q ss_pred CcccccccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILP 111 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~ 111 (325)
+|++.+.||+|+||.||+++.. ..+++.+|+|.+... ...........+..|+.+++.++ ||+|++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-----------~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~ 69 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKA-----------ALVQKAKTVEHTRTERNVLEHVRQSPFLVT 69 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHH-----------HHhhhhhHHHHHHHHHHHHHhccCCCCccc
Confidence 5899999999999999999643 246789999988311 01112234556788999999995 899999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+...+..++||||+++++|.+++. ....+++..+..++.|++.||.||| ++|++||||||+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 70 LHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEG 142 (332)
T ss_pred EEEEEecCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCC
Confidence 9999999999999999999999999983 3456889999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||++......... ......||..|+|||.+.+.. ++.++||||||+++|+|++|..||............
T Consensus 143 ~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-- 219 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-- 219 (332)
T ss_pred CEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--
Confidence 9999999999765432221 112257899999999988754 788999999999999999999999753322111111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
...+....... +. .....+.+++.+||+.||++|| +++++++
T Consensus 220 -~~~~~~~~~~~---~~--------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 220 -SRRILKCDPPF---PS--------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -HHHHhcCCCCC---CC--------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 12222111111 10 0122388999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=299.54 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=188.3
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|+ +..+++.||+|.+.. ...........+..|..++..+ .||||+++++.+..
T Consensus 1 ~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 67 (320)
T cd05590 1 RVLGKGSFGKVMLAR-LKESGRLYAVKVLKK------------DVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT 67 (320)
T ss_pred CeeeeCCCeEEEEEE-EcCCCCEEEEEEEEH------------HHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc
Confidence 468999999999996 556788999998831 1112223455667777888766 69999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+++++|.+++. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~iv~Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~Df 140 (320)
T cd05590 68 PDRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADF 140 (320)
T ss_pred CCEEEEEEcCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeC
Confidence 999999999999999998883 3346889999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++........ ......||+.|+|||.+.+..++.++|+||||+++|+|++|..||.... .... ...+...
T Consensus 141 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~----~~~~---~~~i~~~ 211 (320)
T cd05590 141 GMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN----EDDL---FEAILND 211 (320)
T ss_pred CCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHH---HHHHhcC
Confidence 99875432221 1222578999999999998889999999999999999999999996522 1112 2222221
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
.... +. .....+.+++.+||+.||.+||++
T Consensus 212 ~~~~---~~--------~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 212 EVVY---PT--------WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCC---CC--------CCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111 10 012238899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=313.47 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=195.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.|++.+.||+|+||.||+|+ +..+++.+|+|.+.. ...........+.+|+.+++.+.||||++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~-~~~~~~~~avK~~~~------------~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~ 67 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVR-KVDTNALYAMKTLRK------------ADVLMRNQAAHVKAERDILAEADNEWVVKLY 67 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEE-ECCCCCEEEEEEEcH------------HHHHhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence 479999999999999999996 556789999998821 1112223456788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+..++..|+||||+++++|.+++.. ...++...+..++.|++.||.||| ++||+||||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~i 140 (376)
T cd05598 68 YSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHI 140 (376)
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCE
Confidence 999999999999999999999999843 345888888999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCc-----------------------------------------cccceeecCCcccccccccccCC
Q 040480 194 RISGFDLAILMPDGLT-----------------------------------------QIDTMYVVGTPRYIAPEYHQTLT 232 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~-----------------------------------------~~~~~~~~g~~~~~aPE~~~~~~ 232 (325)
+|+|||++..+..... ........||+.|+|||++.+..
T Consensus 141 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 220 (376)
T cd05598 141 KLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220 (376)
T ss_pred EEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC
Confidence 9999999753210000 00011246899999999999999
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCC
Q 040480 233 ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLAD 312 (325)
Q Consensus 233 ~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 312 (325)
++.++|||||||++|+|++|..||..... .+. ...+...... ...+. .......+.+++.+|+ .+
T Consensus 221 ~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~---~~~i~~~~~~-~~~~~------~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 221 YTQLCDWWSVGVILYEMLVGQPPFLADTP----AET---QLKVINWETT-LHIPS------QAKLSREASDLILRLC-CG 285 (376)
T ss_pred CCcceeeeeccceeeehhhCCCCCCCCCH----HHH---HHHHhccCcc-ccCCC------CCCCCHHHHHHHHHHh-cC
Confidence 99999999999999999999999975321 111 1111111100 00000 0011223778888876 59
Q ss_pred CCCCC---Chhhhhc
Q 040480 313 PDERP---NSKDVRC 324 (325)
Q Consensus 313 P~~Rp---s~~ell~ 324 (325)
|.+|+ |+.++++
T Consensus 286 p~~R~~~~t~~ell~ 300 (376)
T cd05598 286 AEDRLGKNGADEIKA 300 (376)
T ss_pred HhhcCCCCCHHHHhC
Confidence 99999 8888874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=302.82 Aligned_cols=245 Identities=21% Similarity=0.282 Sum_probs=192.1
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecC
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 119 (325)
+.||+|+||.||++. +..+++.+|+|.+... ..........+..|+.++..++||||+++++.+...
T Consensus 1 ~~lG~G~~g~V~~~~-~~~~~~~~a~K~~~~~------------~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~ 67 (325)
T cd05594 1 KLLGKGTFGKVILVK-EKATGRYYAMKILKKE------------VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH 67 (325)
T ss_pred CeeeeCCCEEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC
Confidence 468999999999995 5568899999998321 111223455677889999999999999999999999
Q ss_pred CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEecCCCCceeecc
Q 040480 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 120 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
+..|+||||+++++|..++. ....+++..+..++.|++.||.||| + +|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~lv~E~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Df 140 (325)
T cd05594 68 DRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDF 140 (325)
T ss_pred CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecC
Confidence 99999999999999998883 3456889999999999999999999 6 69999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++......... .....||..|+|||++.+..++.++||||||+++|+|++|..||.... .... ...+...
T Consensus 141 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~----~~~~---~~~i~~~ 211 (325)
T cd05594 141 GLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKL---FELILME 211 (325)
T ss_pred CCCeecCCCCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC----HHHH---HHHHhcC
Confidence 998754322211 122468999999999998889999999999999999999999996421 1111 1111111
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
... ++. . ....+.+|+.+||+.||++|+ ++.++++
T Consensus 212 ~~~---~p~-----~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 212 EIR---FPR-----T---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCC---CCC-----C---CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 111 110 0 112388999999999999997 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=306.90 Aligned_cols=196 Identities=25% Similarity=0.387 Sum_probs=171.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-C-----CC
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-H-----RN 108 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~ 108 (325)
+|++++.||+|+||.|-+| ++..+++.||||++. .......+...|+.+|..++ | -|
T Consensus 187 rY~V~e~LGkGtFGQVvk~-~d~~T~e~VAIKIiK----------------N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n 249 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKA-YDHKTGEIVAIKIIK----------------NKKRFLRQAQIEIRILELLNKHDPDDKYN 249 (586)
T ss_pred EEEEEEEecccccceeEEE-EecCCCcEEEEEeec----------------cChHHHHHHHHHHHHHHHHhccCCCCCee
Confidence 8999999999999999999 788999999999983 23355667788899999886 3 39
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
+|+++++|...+++|+|+|.+. .+|.+++.. ..-..++...+..++.|++.+|.+|| ..+|||+||||+|||+.
T Consensus 250 ~Vrm~d~F~fr~HlciVfELL~-~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~ 323 (586)
T KOG0667|consen 250 IVRMLDYFYFRNHLCIVFELLS-TNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLK 323 (586)
T ss_pred EEEeeeccccccceeeeehhhh-hhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeec
Confidence 9999999999999999999995 599999954 34456999999999999999999999 88999999999999997
Q ss_pred C--CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 189 D--DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 189 ~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+ ...|||+|||.++....... ..+-+..|.|||++.|.+|+.+.||||||||+.||++|.+-|.+
T Consensus 324 ~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 324 DPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 4 45799999999987665433 23557789999999999999999999999999999999888865
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=292.45 Aligned_cols=259 Identities=27% Similarity=0.392 Sum_probs=205.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||.|+||.||+|+ ...++..+|+|.+.... .........+.+|+.+++.++||||++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~-~~~~~~~~~iK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 68 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRAT-CLLDRKPVALKKVQIFE------------MMDAKARQDCVKEIDLLKQLNHPNVIKYL 68 (267)
T ss_pred cceeeeeeeccCCCeeEEEEE-EeCCCCEEEEEEeeccc------------cCCHHHHHHHHHHHHHHHhCCCcceeeee
Confidence 689999999999999999996 55678899999873211 11223445678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..++++||+++++|.+++.........++......++.|++.||.||| +++++|+||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~ 145 (267)
T cd08228 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVV 145 (267)
T ss_pred eeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCE
Confidence 9999999999999999999999988654444556888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||.+.......... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... ........
T Consensus 146 ~l~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-----~~~~~~~~ 218 (267)
T cd08228 146 KLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLFSLCQ 218 (267)
T ss_pred EECccccceeccchhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc-----ccHHHHHH
Confidence 999999988765432211 12467889999999988888999999999999999999999985422 11222222
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+... .......+.+++.+||+.+|++|||+.++++
T Consensus 219 ~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 219 KIEQCDYPPLP---------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHhcCCCCCCC---------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 22222211111 1122344899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=298.22 Aligned_cols=248 Identities=20% Similarity=0.266 Sum_probs=192.5
Q ss_pred ccccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccce
Q 040480 39 LEKIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHM 116 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 116 (325)
++.||+|+||.||+++.. ..+++.+|+|.+... ...........+..|+.+++.++||||+++++.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~-----------~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~ 69 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA-----------TIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF 69 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHH-----------HHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE
Confidence 368999999999999643 246789999988311 0011122345677899999999999999999999
Q ss_pred ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceee
Q 040480 117 VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS 196 (325)
Q Consensus 117 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~ 196 (325)
..++..|+||||+++++|.+++. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++.++|+
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~ 142 (323)
T cd05584 70 QTGGKLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLT 142 (323)
T ss_pred ecCCeEEEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEe
Confidence 99999999999999999999883 3455778888899999999999999 8899999999999999999999999
Q ss_pred ccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHh
Q 040480 197 GFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVM 276 (325)
Q Consensus 197 dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 276 (325)
|||++......... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.
T Consensus 143 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~ 213 (323)
T cd05584 143 DFGLCKESIHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKIL 213 (323)
T ss_pred eCcCCeecccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHH
Confidence 99998754332221 1224689999999999988899999999999999999999999965221 11222222
Q ss_pred hhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
..... .++. ....+.+++.+||+.||++|| +++++++
T Consensus 214 ~~~~~---~~~~--------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 214 KGKLN---LPPY--------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred cCCCC---CCCC--------CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 22111 1111 112388999999999999999 7777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=299.46 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=191.1
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|+ +..+++.+|+|.+.. ...........+..|..++..+ +||||+++++.+..
T Consensus 1 ~~lG~G~~g~Vy~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~ 67 (321)
T cd05591 1 KVLGKGSFGKVMLAE-LKGTDEVYAIKVLKK------------DVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT 67 (321)
T ss_pred CccccCCCeEEEEEE-ECCCCCEEEEEEEeH------------HHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc
Confidence 469999999999996 456788999999831 1112233455667788888765 79999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+++++|...+. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Df 140 (321)
T cd05591 68 KDRLFFVMEYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADF 140 (321)
T ss_pred CCeEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeec
Confidence 999999999999999998883 3446888899999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++......... .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||.... .. .....+...
T Consensus 141 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~----~~---~~~~~i~~~ 211 (321)
T cd05591 141 GMCKEGILNGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN----ED---DLFESILHD 211 (321)
T ss_pred ccceecccCCcc--ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC----HH---HHHHHHHcC
Confidence 998754322221 122478999999999999899999999999999999999999996522 11 122222222
Q ss_pred CCC-CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-------Chhhhhc
Q 040480 279 ENP-NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-------NSKDVRC 324 (325)
Q Consensus 279 ~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~ell~ 324 (325)
... +... ...+.+++.+||+.||++|| ++.++++
T Consensus 212 ~~~~p~~~------------~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 212 DVLYPVWL------------SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCCC------------CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111 1111 12388999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=299.48 Aligned_cols=252 Identities=20% Similarity=0.268 Sum_probs=192.3
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|+ +..+++.||+|.+... ..........+..|..++..+ +||||+++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~-~~~~~~~~aiK~i~~~------------~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~ 67 (329)
T cd05588 1 RVIGRGSYAKVLLVE-LKKTRRIYAMKVIKKE------------LVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT 67 (329)
T ss_pred CeEeeCCCeEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc
Confidence 468999999999996 5567889999998321 111223455678888999888 69999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+++++|.+++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Df 140 (329)
T cd05588 68 ESRLFFVIEFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDY 140 (329)
T ss_pred CCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcC
Confidence 999999999999999998883 3456899999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC-cchHHHHHHHHhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG-EMDMVRWMRNVMA 277 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~ 277 (325)
|++........ ......||..|+|||++.+..++.++|+||||+++|+|++|+.||........ ......+......
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 218 (329)
T cd05588 141 GMCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL 218 (329)
T ss_pred ccccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH
Confidence 99864322111 12235789999999999998999999999999999999999999964322111 1111122222221
Q ss_pred hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC------hhhhh
Q 040480 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN------SKDVR 323 (325)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~ell 323 (325)
..... .+.. ....+.+++.+||+.||.+||| +++++
T Consensus 219 ~~~~~--~p~~--------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 219 EKQIR--IPRS--------LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred cCCCC--CCCC--------CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 11111 1110 1123889999999999999998 45665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=294.18 Aligned_cols=242 Identities=19% Similarity=0.297 Sum_probs=189.9
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceec-
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR- 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 118 (325)
..+|+|++|.||+|.+ +++.||+|.+.... .......+.+.+|+.++++++||||+++++++.+
T Consensus 26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFH------------KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred eEEeeCCceEEEEEEE---CCEEEEEEeccccc------------cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 4689999999999986 68899999883211 1111234678899999999999999999998876
Q ss_pred ---CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEecCCCCce
Q 040480 119 ---PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 119 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~nil~~~~~~~~ 194 (325)
....++||||+++|+|.+++. ....+++.....++.+++.|+.+|| + .+++|+||+|+||++++++.++
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEE
Confidence 346899999999999999994 3456888899999999999999999 5 3888999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT--LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
|+|||++........ ...|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..+. .
T Consensus 164 l~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~----~~~~---~ 231 (283)
T PHA02988 164 IICHGLEKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT----TKEI---Y 231 (283)
T ss_pred EcccchHhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC----HHHH---H
Confidence 999999876543221 2367889999999876 678999999999999999999999997532 1122 2
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+...... ...+. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 232 ~~i~~~~~~-~~~~~--------~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 232 DLIINKNNS-LKLPL--------DCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHhcCCC-CCCCC--------cCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 222211111 11110 12334899999999999999999999985
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=303.60 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=192.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|++.+.||.|+||.||+|+ +..+++.||+|.+... ........+.+|+.+++.++|+||+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 137 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVI-HRPTGRLYALKVIYGN--------------HEDTVRRQICREIEILRDVNHPNVVKC 137 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEE-ECCCCCEEEEEEEecC--------------CcHHHHHHHHHHHHHHHhCCCCCccee
Confidence 4678899999999999999996 4567889999987321 112334578899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..++||||+.+++|.+.. ..+...+..++.|++.||.||| ++|++|+||||+||++++++.
T Consensus 138 ~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~ 206 (353)
T PLN00034 138 HDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKN 206 (353)
T ss_pred eeEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCC
Confidence 99999999999999999999886432 2456677889999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
++|+|||++......... .....|+..|+|||.+.. ...+.++|||||||++|+|++|+.||..... .+
T Consensus 207 ~kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~ 280 (353)
T PLN00034 207 VKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GD 280 (353)
T ss_pred EEEcccccceeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----cc
Confidence 999999999865433221 112478999999998743 2345689999999999999999999973221 11
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
................. ......+.+||.+||+.||++|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 281 WASLMCAICMSQPPEAP----------ATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHHhccCCCCCC----------CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111111111100 112233899999999999999999999985
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=319.97 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=207.8
Q ss_pred cCcccccccccCcceeEEEEEecCC----CCcEEEEEEEcccCCCcHHHHHHHHHhhCc-chHHHHHHHHHHHhccCCCC
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGS----NGKMIAVKKVIIYSPMSAAELIDAYSELGE-GKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~ 108 (325)
++-...+.||+|+||+||+|+..+- ....||||.+. +... ..+.+|++|+++++.++|||
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LK---------------d~a~~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALK---------------DKAENQARQDFRREAELLAELQHPN 550 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhc---------------ccccHHHHHHHHHHHHHHHhccCCC
Confidence 4566788999999999999976433 23569999872 2233 36889999999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcc------c----ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------G----RRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------~----~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
||+++|++...+..++|+||++.|+|.+++..... . ..+++..+.+.|+.||+.|+.||- ++..|||
T Consensus 551 IVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHR 627 (774)
T KOG1026|consen 551 IVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHR 627 (774)
T ss_pred eEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCccccc
Confidence 99999999999999999999999999999975431 1 233888899999999999999999 7789999
Q ss_pred CCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 040480 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFD 257 (325)
Q Consensus 179 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~ 257 (325)
||-.+|.||+++-.|||+|||+++..-..+.........-+.+|||||.+...+||.+|||||||+++||+++ |+.||.
T Consensus 628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred chhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 9999999999999999999999986654443333222233678999999999999999999999999999998 999997
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
+. .+.++++.++....-. +.++++..+.+||..||+.+|.+|||++||-
T Consensus 708 gl----Sn~EVIe~i~~g~lL~-------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 708 GL----SNQEVIECIRAGQLLS-------------CPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cc----chHHHHHHHHcCCccc-------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 64 3345555555433222 2234455599999999999999999999984
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=297.12 Aligned_cols=244 Identities=23% Similarity=0.344 Sum_probs=186.8
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc-cCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ-IRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|+ ...+++.||+|.+... .............|..++.. .+||||+++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~-~~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~ 67 (316)
T cd05592 1 KVLGKGSFGKVMLAE-LKGTNEFFAIKALKKD------------VVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT 67 (316)
T ss_pred CeeeeCCCeEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc
Confidence 469999999999996 4567889999988321 11112233444555556654 479999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..++||||+++++|.+++. ....++...+..++.|++.||.||| ++||+|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Df 140 (316)
T cd05592 68 KEHLFFVMEYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADF 140 (316)
T ss_pred CCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccC
Confidence 999999999999999998883 3446888999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++........ ......||..|+|||.+.+..++.++||||||+++|+|++|..||.... ..... ..+...
T Consensus 141 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~----~~~~~---~~i~~~ 211 (316)
T cd05592 141 GMCKENMNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED----EDELF---DSILND 211 (316)
T ss_pred cCCeECCCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC----HHHHH---HHHHcC
Confidence 99976433221 1223578999999999999889999999999999999999999997522 11111 122111
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh-hhh
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK-DVR 323 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell 323 (325)
. +. .+ .. ....+.+++.+||+.||.+||++. +++
T Consensus 212 ~-~~--~~-----~~---~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 212 R-PH--FP-----RW---ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred C-CC--CC-----CC---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 10 11 01 122378999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=297.63 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=191.6
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 118 (325)
+.||+|+||+||+|. ...++..+|+|.+.. ...........+..|..++..+ +||||+++++++..
T Consensus 1 ~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~ 67 (318)
T cd05570 1 KVLGKGSFGKVLLAE-LKGTDELYAVKVLKK------------DVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT 67 (318)
T ss_pred CeeeeCCCeEEEEEE-ECCCCCEEEEEEEEH------------HHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc
Confidence 469999999999995 556788999998831 1112223455677888888877 69999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+++++|...+. ....+++..+..++.|++.||.||| +++++|+||||+||++++++.++|+||
T Consensus 68 ~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Df 140 (318)
T cd05570 68 KDRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADF 140 (318)
T ss_pred CCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEeccc
Confidence 999999999999999998883 3346899999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++......... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.... ..... ..+...
T Consensus 141 g~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~~---~~i~~~ 211 (318)
T cd05570 141 GMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDELF---QSILED 211 (318)
T ss_pred CCCeecCcCCCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHHH---HHHHcC
Confidence 998753222211 122468999999999999999999999999999999999999996422 11111 111111
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh-----hhhhc
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS-----KDVRC 324 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~ 324 (325)
... .+. .....+.+|+.+||+.||.+|||+ .++++
T Consensus 212 ~~~---~~~--------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 212 EVR---YPR--------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCC---CCC--------cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111 110 112238999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=296.75 Aligned_cols=243 Identities=25% Similarity=0.325 Sum_probs=188.3
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc-cCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ-IRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|+ +..+++.||+|.+... .............|..++.. ..||+|+++++.+..
T Consensus 1 ~~lg~G~~g~V~~~~-~~~~~~~~avK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 67 (316)
T cd05620 1 KVLGKGSFGKVLLAE-LKGKGEYFAVKALKKD------------VVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT 67 (316)
T ss_pred CeeeeCCCeEEEEEE-ECCCCCEEEEEEEEHH------------HhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe
Confidence 479999999999996 5567889999998321 11112234456667777765 489999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+.+++|.+++. ....++...+..++.|++.||+||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Df 140 (316)
T cd05620 68 KEHLFFVMEFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADF 140 (316)
T ss_pred CCEEEEEECCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCcc
Confidence 999999999999999998883 3456888899999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.... ..... ..+...
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~~~~~---~~~~~~ 211 (316)
T cd05620 141 GMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----EDELF---ESIRVD 211 (316)
T ss_pred CCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHH---HHHHhC
Confidence 99875322211 1223578999999999999899999999999999999999999996422 11222 221111
Q ss_pred CC-CCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh-hhh
Q 040480 279 EN-PNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK-DVR 323 (325)
Q Consensus 279 ~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell 323 (325)
.. .+... ...+.+++.+||+.||++||++. +++
T Consensus 212 ~~~~~~~~------------~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 TPHYPRWI------------TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCC------------CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11 11111 12388999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=291.39 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=190.2
Q ss_pred cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCc
Q 040480 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS 121 (325)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 121 (325)
||+|+||.||+++ ...+++.+|+|.+... ..........+..|+.+++.++||||+++++.+.....
T Consensus 1 lg~G~~g~Vy~~~-~~~~~~~~a~K~~~~~------------~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~ 67 (277)
T cd05607 1 LGKGGFGEVCAVQ-VKNTGKMYACKKLDKK------------RLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTH 67 (277)
T ss_pred CCCCCceEEEEEE-EccCCcEEEEEEEcHH------------HhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCe
Confidence 6999999999996 4567899999988211 11111223445678999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 122 HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
.++||||+++++|.+.+.. .....++...+..++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||++
T Consensus 68 ~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~ 142 (277)
T cd05607 68 LCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLA 142 (277)
T ss_pred EEEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceee
Confidence 9999999999999988743 23345788888899999999999999 889999999999999999999999999998
Q ss_pred eecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCC
Q 040480 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENP 281 (325)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
......... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||......... .............
T Consensus 143 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~ 216 (277)
T cd05607 143 VELKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK---EELKRRTLEDEVK 216 (277)
T ss_pred eecCCCcee---eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH---HHHHHHhhccccc
Confidence 766543221 2246889999999998888999999999999999999999999753221111 1111211111111
Q ss_pred CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 282 NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
. . . ......+.+|+.+||+.||++||++.|++
T Consensus 217 ~---~----~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 217 F---E----H---QNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred c---c----c---ccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 0 0 0 11223389999999999999999996644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=307.21 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=199.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|.+.+.||+|+||+||+|. +..+++.+|+|.+... ..........+.+|+.+++.++||||++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~ 67 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVR-EKATGDIYAMKVMKKS------------VLLAQETVSFFEEERDILSISNSPWIPQLQ 67 (330)
T ss_pred CCceEEEEEEeccCEEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhCCCCCCccee
Confidence 479999999999999999995 5567889999998321 111223456688899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+.+..++||||+++++|.+++... ...+++..+..++.|++.||.||| +++++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~ 141 (330)
T cd05601 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHI 141 (330)
T ss_pred eEEecCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCE
Confidence 9999999999999999999999998542 346889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ------TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~------~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+|+|||++......... ......||+.|+|||++. +..++.++||||||+++|+|++|..||.....
T Consensus 142 kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------ 214 (330)
T cd05601 142 KLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------ 214 (330)
T ss_pred EeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------
Confidence 99999999876543322 122246899999999886 45578899999999999999999999965221
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+....... ..+.. ......+.+|+.+||+ ||.+|||++++++
T Consensus 215 -~~~~~~i~~~~~~~-~~~~~------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 215 -AKTYNNIMNFQRFL-KFPED------PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -HHHHHHHHcCCCcc-CCCCC------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11122222111110 00000 0112238899999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=306.52 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=197.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.+|+|.+.. ...........+.+|+.+++.++||||++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVR-HKSSQKVYAMKLLSK------------FEMIKRSDSAFFWEERDIMAFANSPWVVQ 107 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEE-ECCCCCEEEEEEEEH------------HHhhhhhhHHHHHHHHHHHHhCCCCCEee
Confidence 56789999999999999999996 456788999998831 11112233456788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+.++...|+||||+++++|.+++. ...++...+..++.|++.||.||| +++|+||||||+||++++++
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~ 179 (370)
T cd05621 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHG 179 (370)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCC
Confidence 9999999999999999999999999983 235788889999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT----ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.++|+|||++......... ......||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 180 ~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------ 252 (370)
T cd05621 180 HLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------ 252 (370)
T ss_pred CEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------
Confidence 9999999999876432211 112357899999999987643 67899999999999999999999965221
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCC--CCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPD--ERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~--~Rps~~ell~ 324 (325)
......+....... .++.. ......+.+++.+||..+|. .|+|+.|+++
T Consensus 253 -~~~~~~i~~~~~~~-~~p~~------~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 253 -VGTYSKIMDHKNSL-NFPED------VEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred -HHHHHHHHhCCccc-CCCCc------ccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 11122222211111 01110 01123378899999985554 3889999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=315.37 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=199.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
..-+++|.+.|.+|||+.||+|+. ...+..+|+|++.+. .+.....+++|+.+|++|+ |+|||
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~-~~~~~~~AlKrm~~~---------------de~~L~~v~~EI~~MK~L~gh~nIV 98 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQD-VKGGKKYALKRMYVN---------------DEEALNAVKREIDIMKLLSGHKNIV 98 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEe-cCCCceeeeeeeecC---------------CHHHHHHHHHHHHHHHHhcCCCcee
Confidence 446789999999999999999974 444589999998532 4567788999999999997 99999
Q ss_pred ccccce-ec---C---CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 111 PLLAHM-VR---P---DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 111 ~~~~~~-~~---~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
.+++.. .. . -.++++||||.||.|-+++......+ |++.++++|+.|+++|+++||++ +..|+|||||-+
T Consensus 99 ~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiE 175 (738)
T KOG1989|consen 99 SYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIE 175 (738)
T ss_pred eEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhh
Confidence 999933 21 1 23679999999999999997654443 99999999999999999999977 667999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccc-cc------eeecCCcccccccc---cccCCCCCccchhhHHHHHHHHHhCC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQI-DT------MYVVGTPRYIAPEY---HQTLTISEKCDIYSFGVLLAVLVMGK 253 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~------~~~~g~~~~~aPE~---~~~~~~~~~~DvwslG~il~~ll~g~ 253 (325)
|||++.++..||||||.++......... .. -...-|+.|.|||. ..+.++++|+|||||||++|.|++..
T Consensus 176 NvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t 255 (738)
T KOG1989|consen 176 NVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFT 255 (738)
T ss_pred heEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhC
Confidence 9999999999999999997544332111 00 00245899999995 46788999999999999999999999
Q ss_pred CCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 254 FPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 254 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.||+.... .. ++.+.... ++ .+.....|.+||..||+.||.+||++.++++
T Consensus 256 ~PFe~sg~----la-------Ilng~Y~~---P~------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 256 TPFEESGK----LA-------ILNGNYSF---PP------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred CCcCcCcc----ee-------EEeccccC---CC------CccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 99986322 11 11111111 11 1234444999999999999999999999874
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=290.68 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=204.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|. ...++..+++|.+.... .........+.+|+.+++.+.||||++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~-~~~~~~~~~vK~~~~~~------------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~ 68 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRAT-CLLDGVPVALKKVQIFD------------LMDAKARADCIKEIDLLKQLNHPNVIKYY 68 (267)
T ss_pred chhhhhhhhcccCCeEEEEEe-ecCCCceEEEEeeeehh------------hhhHHHHHHHHHHHHHHHHccCCchhhhh
Confidence 579999999999999999996 45678899999873211 11223446788899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..++++||+++++|.+++.........+++.....++.|++.+|.||| ++|++|+||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~ 145 (267)
T cd08229 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVV 145 (267)
T ss_pred heeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCE
Confidence 9999999999999999999999998654445567899999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||.+.......... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... .+......
T Consensus 146 ~l~dfg~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~ 218 (267)
T cd08229 146 KLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCK 218 (267)
T ss_pred EECcchhhhccccCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc-----chHHHHhh
Confidence 999999987654332211 12467889999999988889999999999999999999999986421 11222222
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+... .......+.+++.+||+.||.+|||+.+|++
T Consensus 219 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 219 KIEQCDYPPLP---------SDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hhhcCCCCCCC---------cccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 22211111110 0122334899999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=299.11 Aligned_cols=245 Identities=22% Similarity=0.264 Sum_probs=191.3
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLL 113 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 113 (325)
+|++.+.||+|+||.||+|. +..+++.+|+|.+... .............|..++..+ .|++|++++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~ 67 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKD------------VVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67 (323)
T ss_pred CceEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhccCCCeEeeEE
Confidence 58899999999999999996 5567889999988321 111223344566677777766 479999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..++||||+++++|.+.+. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~ 140 (323)
T cd05616 68 SCFQTMDRLYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHI 140 (323)
T ss_pred EEEecCCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcE
Confidence 99999999999999999999998883 3345888999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++......... .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.... ..... .
T Consensus 141 kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~---~ 211 (323)
T cd05616 141 KIADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELF---Q 211 (323)
T ss_pred EEccCCCceecCCCCCc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC----HHHHH---H
Confidence 99999998754322211 122578999999999999999999999999999999999999996522 11222 2
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
.+...... .+. .....+.+++.+||+.||.+|++.
T Consensus 212 ~i~~~~~~---~p~--------~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 212 SIMEHNVA---YPK--------SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHhCCCC---CCC--------cCCHHHHHHHHHHcccCHHhcCCC
Confidence 22221111 111 112238899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=310.70 Aligned_cols=262 Identities=20% Similarity=0.273 Sum_probs=191.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. ...+++.||+|++.. ......+|+.+++.++||||++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~-~~~~~~~vAiK~i~~-------------------~~~~~~~Ei~il~~l~h~niv~ 123 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIKKVLQ-------------------DPQYKNRELLIMKNLNHINIIF 123 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEE-ECCCCCEEEEEEEec-------------------CcchHHHHHHHHHhcCCCCCcc
Confidence 34579999999999999999995 556788999998721 1122346899999999999999
Q ss_pred cccceecC--------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 112 LLAHMVRP--------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 112 ~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+++++... ..+++||||+++ +|.+++.........++...+..++.|++.||.||| +++|+||||||+
T Consensus 124 l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~ 199 (440)
T PTZ00036 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQ 199 (440)
T ss_pred eeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHH
Confidence 98876432 246789999976 788877655455667899999999999999999999 889999999999
Q ss_pred ceEecCCC-CceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 184 NVLIDDDM-EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 184 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
||+++.++ .+||+|||++.......... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+...
T Consensus 200 NILl~~~~~~vkL~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 200 NLLIDPNTHTLKLCDFGSAKNLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred HEEEcCCCCceeeeccccchhccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999664 69999999998664432221 24678999999987664 689999999999999999999999965321
Q ss_pred CCCcchHHHHHHHHhhhCC-----------CCcccch----hhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASEN-----------PNRAIDS----KLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+..... ....+. ....++. ..........+..+.+||.+||+.||.+|||+.|+++
T Consensus 277 ---~~~~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 277 ---VDQLVRIIQ-VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred ---HHHHHHHHH-HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 111111111 110000 0000000 0000000112345899999999999999999999985
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=303.98 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=199.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.+|+|.+.. ...........+.+|+.+++.++||||++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~il~~~~h~~iv~ 107 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVR-HKSSKQVYAMKLLSK------------FEMIKRSDSAFFWEERDIMAHANSEWIVQ 107 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEE-ECCCCCEEEEEEEEH------------HHhhhhhhHHHHHHHHHHHHhCCCCCcce
Confidence 45789999999999999999996 556788999999831 11112233455778999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+.+.+..|+||||+++++|.+++. ...++...+..++.|++.||+||| ++||+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~ 179 (370)
T cd05596 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSG 179 (370)
T ss_pred EEEEEecCCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCC
Confidence 9999999999999999999999999883 235788888899999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL----TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~----~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.++|+|||.+......... ......||+.|+|||.+.+. .++.++|+|||||++|+|++|..||.....
T Consensus 180 ~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------ 252 (370)
T cd05596 180 HLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------ 252 (370)
T ss_pred CEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------
Confidence 9999999999765433221 11224789999999988654 378899999999999999999999965321
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCC--CCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDE--RPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~ 324 (325)
......+....... .++.. ...+..+.+||.+||+.+|.+ |||++++++
T Consensus 253 -~~~~~~i~~~~~~~-~~~~~------~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 253 -VGTYSKIMDHKNSL-TFPDD------IEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -HHHHHHHHcCCCcC-CCCCc------CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11122222211111 11110 011233889999999999988 999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.37 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=188.0
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc-cCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ-IRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||+||+|+ +..+++.||+|.+... .............|..++.. +.||||+++++++.+
T Consensus 1 ~~lG~G~~g~Vy~~~-~~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~ 67 (316)
T cd05619 1 KMLGKGSFGKVFLAE-LKGTNQFFAIKALKKD------------VVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT 67 (316)
T ss_pred CeeeeCCCEEEEEEE-ECCCCCEEEEEEEEHH------------HhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe
Confidence 469999999999996 5567889999998321 11112233445666667765 489999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..++||||+++++|.+++. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df 140 (316)
T cd05619 68 KENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADF 140 (316)
T ss_pred CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccC
Confidence 999999999999999999983 3346888889999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++........ ......||..|+|||.+.+..++.++|+|||||++|+|++|..||.... ....... +...
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~---i~~~ 211 (316)
T cd05619 141 GMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD----EEELFQS---IRMD 211 (316)
T ss_pred CcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC----HHHHHHH---HHhC
Confidence 99875432221 1122578999999999999889999999999999999999999996522 1122221 1111
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh-hhh
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK-DVR 323 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell 323 (325)
... .+. . ....+.+++.+||+.||.+||++. +++
T Consensus 212 ~~~---~~~-----~---~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 212 NPC---YPR-----W---LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCC---CCc-----c---CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111 110 0 122388999999999999999996 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=298.08 Aligned_cols=251 Identities=20% Similarity=0.256 Sum_probs=207.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.+-|.+.+.||+|-|++|-+|+ ...+|+.||||++..+ .+......++.+|++.|+.++|||||++
T Consensus 17 AGLYDLekTlG~GHFAVVKLAr-HVFTGekVAVKviDKT-------------KlD~~st~hlfqEVRCMKLVQHpNiVRL 82 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLAR-HVFTGEKVAVKVIDKT-------------KLDTLSTGHLFQEVRCMKLVQHPNIVRL 82 (864)
T ss_pred eeeehhhhhhcCCceehhhhhh-hhcccceeEEEEeccc-------------ccchhhhhHHHHHHHHHHHhcCcCeeee
Confidence 3568899999999999999995 5689999999998322 2333445689999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC-CC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-DM 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~-~~ 191 (325)
|++...+..+|+|+|.=++|+|.++|.+. ...+.+..+.+++.||+.|+.|+| ...+|||||||+|+.+.+ -|
T Consensus 83 YEViDTQTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlG 156 (864)
T KOG4717|consen 83 YEVIDTQTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLG 156 (864)
T ss_pred eehhcccceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecC
Confidence 99999999999999999999999999763 445999999999999999999999 556999999999998875 48
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTIS-EKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~-~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
-|||+|||++..+..+... +..||+..|.|||++.|..|+ +++||||||+|+|.|++|++||..... .+
T Consensus 157 lVKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-------SE 226 (864)
T KOG4717|consen 157 LVKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-------SE 226 (864)
T ss_pred ceEeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-------hh
Confidence 8999999999887766543 336999999999999999986 679999999999999999999975322 11
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.++...+. ....-+.++.++||.+||..||.+|.|.+||..
T Consensus 227 TLTmImDCKY-----------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 227 TLTMIMDCKY-----------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhhhcccc-----------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2223332222 222344556999999999999999999999863
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=298.24 Aligned_cols=241 Identities=24% Similarity=0.312 Sum_probs=186.2
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHH-HHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI-ITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||+||+|. +..+++.||+|.+... ..........+..|. .+++.++||||+++++.+..
T Consensus 1 ~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~ 67 (323)
T cd05575 1 KVIGKGSFGKVLLAK-HKADGKFYAVKVLQKK------------AILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT 67 (323)
T ss_pred CeeeeCCCeEEEEEE-ECCCCCEEEEEEEEHH------------HHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe
Confidence 468999999999995 5677899999998321 111112223444444 35678899999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..++||||+++++|..++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Df 140 (323)
T cd05575 68 ADKLYFVLDYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDF 140 (323)
T ss_pred CCEEEEEEcCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEecc
Confidence 999999999999999999883 3456888899999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+...
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~ 211 (323)
T cd05575 141 GLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------TAEMYDNILNK 211 (323)
T ss_pred CCCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcC
Confidence 99865432221 1222478999999999999899999999999999999999999996521 12222222222
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
.... .+ .....+.+++.+||+.||.+||++.
T Consensus 212 ~~~~---~~--------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 212 PLRL---KP--------NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCC---CC--------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1111 11 0122388999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=288.37 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=205.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||.|+||.||+|. ...+++.+|+|.+.... .........+.+|+.++++++|+++++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~ik~~~~~~------------~~~~~~~~~~~~ei~~l~~~~~~~i~~~~ 68 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAI-CLLDGRVVALKKVQIFE------------MMDAKARQDCLKEIDLLKQLDHPNVIKYL 68 (267)
T ss_pred CceeeeeeeccCCceEEEEEE-EcCCCCEEEEEEeeccc------------ccchhhHHHHHHHHHHHHhCCCCCeeeee
Confidence 689999999999999999996 45678899999873221 11223356788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..+++|||+++++|.+++.........++...+..++.+++.||.+|| +.|++|+||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~ 145 (267)
T cd08224 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVV 145 (267)
T ss_pred eeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcE
Confidence 9999999999999999999999998655455566899999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||.+.......... ....++..|.|||.+.+..++.++|+||||+++|+|++|..||.... ........
T Consensus 146 ~l~d~~~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~ 218 (267)
T cd08224 146 KLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCK 218 (267)
T ss_pred EEeccceeeeccCCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHh
Confidence 999999987654432211 12467888999999988889999999999999999999999985422 12222222
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
.......+..+ .......+.+++.+||..+|.+|||+.+|+++
T Consensus 219 ~~~~~~~~~~~---------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~ 261 (267)
T cd08224 219 KIEKCDYPPLP---------ADHYSEELRDLVSRCINPDPEKRPDISYVLQV 261 (267)
T ss_pred hhhcCCCCCCC---------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22211111110 01223348899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=297.89 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=189.2
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|+ +..+++.+|+|.+... ..........+..|..++.++ +||||+++++++..
T Consensus 1 ~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~ 67 (329)
T cd05618 1 RVIGRGSYAKVLLVR-LKKTERIYAMKVVKKE------------LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 67 (329)
T ss_pred CeeeeCCCeEEEEEE-ECCCCCEEEEEEEEhh------------HhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe
Confidence 469999999999995 5567889999998321 111223455677888888776 79999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..++||||+++++|..++. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~Df 140 (329)
T cd05618 68 ESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDY 140 (329)
T ss_pred CCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeC
Confidence 999999999999999988873 3456899999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc-chHHHHHHHHhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE-MDMVRWMRNVMA 277 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~ 277 (325)
|++........ ......||..|+|||++.+..++.++|+||||+++|+|++|..||......... .....+......
T Consensus 141 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~ 218 (329)
T cd05618 141 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 218 (329)
T ss_pred CccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh
Confidence 99875332211 112257899999999999989999999999999999999999999643221111 111122222111
Q ss_pred hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
..... ++. .....+.+++.+||+.||.+|||+
T Consensus 219 ~~~~~--~p~--------~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 219 EKQIR--IPR--------SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred cCCCC--CCC--------CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11111 111 011238899999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=305.58 Aligned_cols=261 Identities=20% Similarity=0.206 Sum_probs=199.1
Q ss_pred hcCcccccccccCcceeEEEEEec-CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..+|++.+.||.|+||.||+|... ..++..||+|.+.. .....+|+.++++++||||++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~--------------------~~~~~~E~~il~~l~h~~iv~ 150 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG--------------------GKTPGREIDILKTISHRAIIN 150 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccc--------------------cccHHHHHHHHHhcCCCCccc
Confidence 357999999999999999999643 23567899997621 123457999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+......+++||++. ++|.+++ .....+++..+..++.|++.||.||| ++||+|+||||+||+++.++
T Consensus 151 ~~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~ 222 (392)
T PHA03207 151 LIHAYRWKSTVCMVMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPE 222 (392)
T ss_pred eeeeEeeCCEEEEEehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCC
Confidence 9999999999999999996 5888887 33456899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++................||..|+|||++.+..++.++|||||||++|+|++|+.||...........+...
T Consensus 223 ~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i 302 (392)
T PHA03207 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302 (392)
T ss_pred CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHH
Confidence 99999999997665443333333357899999999999989999999999999999999999999664432222222222
Q ss_pred HHHHhhhC----------------------CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASE----------------------NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ .+....+..... ......+.++|.+||..||++|||+.|+++
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 303 IRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK---YGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhc---cCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 21111000 000000000000 011234788999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=305.51 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=205.6
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
.|....+...+...||+|.||+||+|+|. -.||||++.... ......+.|+.|+..+++-+|.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh----GdVAVK~Lnv~~-------------pt~~qlqaFKnEVa~lkkTRH~ 448 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH----GDVAVKLLNVDD-------------PTPEQLQAFKNEVAVLKKTRHE 448 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc----cceEEEEEecCC-------------CCHHHHHHHHHHHHHHhhcchh
Confidence 34455677889999999999999999984 359999985433 2334677899999999999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
||+-+.+++..... .+|+.+|.|.+|..++.. .+..++......|+.|++.|+.||| .++|+|+|||..|||+
T Consensus 449 NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl 521 (678)
T KOG0193|consen 449 NILLFMGACMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFL 521 (678)
T ss_pred hheeeehhhcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEE
Confidence 99999999988777 999999999999999833 3456888888999999999999999 9999999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL---TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
.++++|||+|||++...............-|...|+|||+++.+ +|++.+||||||+++|||++|..||....
T Consensus 522 ~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~---- 597 (678)
T KOG0193|consen 522 HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN---- 597 (678)
T ss_pred ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC----
Confidence 99999999999999876554332222223567789999998754 58999999999999999999999997311
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+++. .++=.+.. ..-......++++++.+|+..||.++|++||++.+|+.
T Consensus 598 ~dqIi---fmVGrG~l------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 598 RDQII---FMVGRGYL------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhheE---EEeccccc------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11111 11111111 11112334556666999999999999999999999986
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=296.59 Aligned_cols=248 Identities=21% Similarity=0.258 Sum_probs=190.5
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|+ ...+++.+|+|.+... ..........+..|..++.++ +||+|+++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 67 (327)
T cd05617 1 RVIGRGSYAKVLLVR-LKKNDQIYAMKVVKKE------------LVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT 67 (327)
T ss_pred CeeeeCCCeEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe
Confidence 479999999999995 5567889999998321 111223456678888888888 59999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+++++|..++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Df 140 (327)
T cd05617 68 TSRLFLVIEYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDY 140 (327)
T ss_pred CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEecc
Confidence 999999999999999998883 3456899999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.......... ...........
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~ 217 (327)
T cd05617 141 GMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILE 217 (327)
T ss_pred ccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHh
Confidence 99875322211 1223578999999999999899999999999999999999999996433221111 11112222211
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
.... .+.. .+..+.+++.+||+.||.+||++.
T Consensus 218 ~~~~--~p~~--------~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 218 KPIR--IPRF--------LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCC--CCCC--------CCHHHHHHHHHHhccCHHHcCCCC
Confidence 1111 1110 112278999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=289.91 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=196.6
Q ss_pred hcCcccccccccCcceeEEEEEecC--CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPG--SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|++.+.||+|+||.||+|.+.. ..+..+|+|.+... ........+.+|+.++++++||||+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~iv 69 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG--------------CSDKQRRGFLAEALTLGQFDHSNIV 69 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC--------------CCHHHHHHHHHHHHHHhcCCCCCcC
Confidence 4789999999999999999996543 34578999987321 1112345688899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++||||+++++|.+++.. ....+++.....++.|++.||+||| ++|++|+||+|+||+++.+
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~ 143 (266)
T cd05064 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSD 143 (266)
T ss_pred eEEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCC
Confidence 999999999999999999999999999843 2346889999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
+.++++|||.+......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||..... .+..
T Consensus 144 ~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~~~ 218 (266)
T cd05064 144 LVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QDVI 218 (266)
T ss_pred CcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHH
Confidence 99999999987653222111 1111234568999999998899999999999999999775 9999965321 1222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. .+......+ .+ ...+..+.+++.+||+.+|.+|||+++|++
T Consensus 219 ~---~~~~~~~~~--~~--------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 219 K---AVEDGFRLP--AP--------RNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred H---HHHCCCCCC--CC--------CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 2 221111111 11 112334889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=289.08 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=199.6
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
-.|+-.+.+|.|+||.||+|.. ..+++.+|||++.. ..+.-.+|+.+|+.+.|||||++.
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~-~e~~~~vAIKKv~~-------------------d~r~knrEl~im~~l~HpNIV~L~ 83 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKL-RETEEEVAIKKVLQ-------------------DKRYKNRELQIMRKLDHPNIVRLL 83 (364)
T ss_pred EEEEeeEEEeecccceEEEEEE-cCCCceeEEEEecC-------------------CCCcCcHHHHHHHhcCCcCeeeEE
Confidence 4688899999999999999965 45589999999831 112346788999999999999998
Q ss_pred cceecCC-----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 114 AHMVRPD-----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 114 ~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
.+|.... ...+||||++. +|.+.+......+..++...+.-+..|+++||+||| +.||+||||||.|+|+|
T Consensus 84 ~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD 159 (364)
T KOG0658|consen 84 YFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVD 159 (364)
T ss_pred EEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEc
Confidence 8775432 34689999987 999999776667888999999999999999999999 78999999999999999
Q ss_pred CC-CCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 189 DD-MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 189 ~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
.+ |.+||+|||.|.....+..+.. ...|..|.|||++.|. .|+.+.||||.||++.||+-|++-|.+.+ ...
T Consensus 160 ~~tg~LKicDFGSAK~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s---~~d 233 (364)
T KOG0658|consen 160 PDTGVLKICDFGSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS---SVD 233 (364)
T ss_pred CCCCeEEeccCCcceeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC---HHH
Confidence 65 8899999999998877666544 3457789999998876 48999999999999999999999997632 222
Q ss_pred hHHHHHHHHhhhCC--------CC--cccchhhcCC-----chHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASEN--------PN--RAIDSKLLGN-----GYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~--------~~--~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++...++ +...+. +. ....+..... .......+..+|+.++|..+|.+|.++.|+++
T Consensus 234 QL~eIik-~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 234 QLVEIIK-VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHHHH-HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 2222222 111111 00 0000111111 11233445899999999999999999999886
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=290.52 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=200.0
Q ss_pred hcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
.++|.+.+.||+|+||.||+|.... .++..+|+|.+... ........+.+|+.+++.+.|||
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~~~~ 69 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--------------ASNDARKDFEREAELLTNFQHEN 69 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--------------CCHHHHHHHHHHHHHHHhcCCCC
Confidence 4679999999999999999996532 34578999987311 11123567889999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhc----------ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS----------KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
|+++++++......+++|||+++++|.+++.... .....+++..+..++.|++.++.+|| ++|++|+
T Consensus 70 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~ 146 (280)
T cd05049 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHR 146 (280)
T ss_pred chheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecc
Confidence 9999999999999999999999999999996431 12345778888999999999999999 8899999
Q ss_pred CCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 040480 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFD 257 (325)
Q Consensus 179 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~ 257 (325)
||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.
T Consensus 147 dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 147 DLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred ccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999875533222111112345678999999999899999999999999999998 999986
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... ..... .+..+...... ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~----~~~~~---~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 227 GLSN----EEVIE---CITQGRLLQRP----------RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCH----HHHHH---HHHcCCcCCCC----------CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5321 22222 22211111100 012233899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=299.32 Aligned_cols=243 Identities=22% Similarity=0.281 Sum_probs=190.8
Q ss_pred ccccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccce
Q 040480 39 LEKIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHM 116 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 116 (325)
++.||+|+||.||+++.. ..++..+|+|.+... .........+..|+.++++++||||+++++.+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 67 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-------------TLKVRDRVRTKMERDILAEVNHPFIVKLHYAF 67 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHH-------------HhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 367999999999999642 346789999998321 11122344567899999999999999999999
Q ss_pred ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceee
Q 040480 117 VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS 196 (325)
Q Consensus 117 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~ 196 (325)
...+..|+||||+++++|.+++. ....+++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 68 ~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~ 140 (318)
T cd05582 68 QTEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140 (318)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEe
Confidence 99999999999999999999883 3456899999999999999999999 8899999999999999999999999
Q ss_pred ccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHh
Q 040480 197 GFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVM 276 (325)
Q Consensus 197 dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 276 (325)
|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... .. .....+.
T Consensus 141 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~----~~---~~~~~i~ 211 (318)
T cd05582 141 DFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD----RK---ETMTMIL 211 (318)
T ss_pred eccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC----HH---HHHHHHH
Confidence 9999876543321 1222578999999999998889999999999999999999999996522 11 1122222
Q ss_pred hhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhh
Q 040480 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321 (325)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (325)
..... ++. .....+.+|+.+||+.||++|||+.+
T Consensus 212 ~~~~~---~p~--------~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 212 KAKLG---MPQ--------FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred cCCCC---CCC--------CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 21111 110 01223889999999999999999654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=285.42 Aligned_cols=258 Identities=20% Similarity=0.313 Sum_probs=200.5
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|.+.+.||.|++|.||+|. +..+++.+++|.+....... ........+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~-~~~~~~~~~lk~~~~~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 70 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCY-DVDTGRELAVKQVPFDPDSP----------ETKKEVNALECEIQLLKNLQHERIVQYY 70 (263)
T ss_pred CcccccceecCCCceEEEEEE-EcCCCcEEEEEEEeecccch----------hhHHHHHHHHHHHHHHHhCCCCCeeeeE
Confidence 579999999999999999995 55678899999874322111 0112345688899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++..+...++++||+++++|.+.+.. ...++......++.|++.||.+|| ..|++|+||+|+||++++++.+
T Consensus 71 ~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 71 GCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred EEEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 999999999999999999999999843 345888888999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCcccc-ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQID-TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||.+........... .....++..|+|||...+..++.++|+||||+++|+|++|+.||..... ... .
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~---~ 216 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAA---I 216 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHH---H
Confidence 9999999876543221111 0123567889999999998899999999999999999999999964211 111 1
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
....... .....+ ......+.+++.+||..+|.+|||+.++++.
T Consensus 217 ~~~~~~~-~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 217 FKIATQP-TNPQLP--------SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHhccC-CCCCCC--------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111111 111111 1122238899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=292.24 Aligned_cols=255 Identities=30% Similarity=0.486 Sum_probs=197.9
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH 115 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 115 (325)
|++.+.||+|+||+||++. +..+++.+|+|.+.... ..........+|+.+++.++||||++++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~-~~~~~~~~~~K~~~~~~-------------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~ 66 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAK-NKKNGQKVAVKIIDKSE-------------IEEEEREENIREIKILRRLRHPNIVQILDV 66 (260)
T ss_dssp EEEEEEEEEESSEEEEEEE-ETTTTEEEEEEEEESTT-------------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEE
T ss_pred CEEeEEEEeCCCEEEEEEE-ECCCCeEEEEEEecccc-------------ccccccchhhhhhhcccccccccccccccc
Confidence 7899999999999999996 55677899999984321 111222234558999999999999999999
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCcee
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l 195 (325)
+......+++||++++++|.+++. ....++...+..++.|++.||.+|| +.+++|+||+|+||++++++.++|
T Consensus 67 ~~~~~~~~~v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l 139 (260)
T PF00069_consen 67 FQDDNYLYIVMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKL 139 (260)
T ss_dssp EEESSEEEEEEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEE
T ss_pred cccccccccccccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 999999999999999999999994 4566899999999999999999999 779999999999999999999999
Q ss_pred eccccceecCCCCccccceeecCCcccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 196 SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 196 ~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
+|||.+....... .......++..|.|||... +..++.++|+||||+++|+|++|..||... ...+.......
T Consensus 140 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~----~~~~~~~~~~~ 213 (260)
T PF00069_consen 140 IDFGSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES----NSDDQLEIIEK 213 (260)
T ss_dssp SSGTTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS----SHHHHHHHHHH
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccc----cchhhhhhhhh
Confidence 9999998652211 1222257788999999998 778999999999999999999999999763 11112222221
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... .........+.+++.+||+.||++|||+.++++
T Consensus 214 ~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 214 ILKRPLPSSS-------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHTHHHHHT-------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccccc-------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111000000 000000134999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=286.14 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=195.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||++++. .+..+|+|.+.. .......+.+|+.+++.++||||++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 65 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINE----------------GAMSEEDFIEEAKVMMKLSHPKLVQLY 65 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec--cCceEEEEeccc----------------CCccHHHHHHHHHHHHHCCCCCceeEE
Confidence 57899999999999999999753 456799997621 112245678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..+++|||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++|+||+|+||+++.++.+
T Consensus 66 ~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~ 139 (256)
T cd05114 66 GVCTQQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVV 139 (256)
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeE
Confidence 999999999999999999999998843 2235788889999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||.+........... ....++..|+|||...+..++.++|+||||+++|+|++ |+.||.... ..+..
T Consensus 140 kl~d~g~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~~~~~--- 211 (256)
T cd05114 140 KVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----NYEVV--- 211 (256)
T ss_pred EECCCCCccccCCCceecc-CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHH---
Confidence 9999999876543222111 11234567999999988889999999999999999999 899996522 11222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
..+........+ . . .+..+.+++.+||+.||.+|||+.+++++
T Consensus 212 ~~i~~~~~~~~~---~----~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~ 254 (256)
T cd05114 212 EMISRGFRLYRP---K----L---ASMTVYEVMYSCWHEKPEGRPTFAELLRA 254 (256)
T ss_pred HHHHCCCCCCCC---C----C---CCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 222222211111 0 0 11238999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=299.52 Aligned_cols=266 Identities=25% Similarity=0.299 Sum_probs=193.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||+|+||.||+|. +..++..+|+|.+... .........+.+|+.+++.++||||++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~ 84 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAF-DTVLGINVAVKKLSRP-------------FQNQTHAKRAYRELVLLKCVNHKNIIS 84 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEE-EcCCCceeEEEEeccc-------------ccchhHHHHHHHHHHHHHhCCCCCEee
Confidence 34899999999999999999995 5677899999988321 112233456778999999999999999
Q ss_pred cccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++++.... ..|+||||+++ +|.+.+. ..++...+..++.|++.||.||| ++||+||||||+||
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NI 154 (359)
T cd07876 85 LLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 154 (359)
T ss_pred eeeeeccCCCccccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHE
Confidence 999886543 47999999976 6766652 23778888899999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
+++.++.++|+|||++........ .....||..|+|||.+.+..++.++||||||+++|+|++|..||........-
T Consensus 155 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 231 (359)
T cd07876 155 VVKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW 231 (359)
T ss_pred EECCCCCEEEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999975433221 11246788999999999999999999999999999999999999753210000
Q ss_pred -----------chH----HHHHHHHhhhCCCCcccc-hhhc--------CCchHHHHHHHHHHHhhhcCCCCCCCCChhh
Q 040480 266 -----------MDM----VRWMRNVMASENPNRAID-SKLL--------GNGYEEQMLLVLKLACFCTLADPDERPNSKD 321 (325)
Q Consensus 266 -----------~~~----~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (325)
... .................. .... ..........+.+|+.+||+.||++|||+.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 311 (359)
T cd07876 232 NKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311 (359)
T ss_pred HHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence 000 000000000000000000 0000 0000112234889999999999999999999
Q ss_pred hhc
Q 040480 322 VRC 324 (325)
Q Consensus 322 ll~ 324 (325)
+++
T Consensus 312 ~l~ 314 (359)
T cd07876 312 ALR 314 (359)
T ss_pred Hhc
Confidence 985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=304.50 Aligned_cols=239 Identities=29% Similarity=0.407 Sum_probs=196.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
.-.-++.||.|+.|.||+|+. .++.||||++ +.+. ..+++-|++|+||||+.+.+
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl---~netVAVKKV---------------~elk-------ETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRL---HNETVAVKKV---------------RELK-------ETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred HhhhhhhhccCcccceeeeec---cCceehhHHH---------------hhhh-------hhhHHHHHhccCcceeeEee
Confidence 344467899999999999987 6788999987 2222 23466688899999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
+|.....+|||||||..|.|...+ ..+..+.......|..+|+.|+.||| ...|||||||.-||||+.+..||
T Consensus 180 VCtqsPcyCIiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 180 VCTQSPCYCIIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred eecCCceeEEeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEE
Confidence 999999999999999999999999 56677888889999999999999999 77999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||-+........... +.||..|||||+++..+.++++||||||+++|+||||..||.+.+.....+.+-.
T Consensus 253 IsDFGTS~e~~~~STkMS---FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs---- 325 (904)
T KOG4721|consen 253 ISDFGTSKELSDKSTKMS---FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS---- 325 (904)
T ss_pred eccccchHhhhhhhhhhh---hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC----
Confidence 999999988776654444 7999999999999999999999999999999999999999976443211111110
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....- .-...+++.|.=|+++||+-.|..|||+++++.
T Consensus 326 ----NsL~L--------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~ 363 (904)
T KOG4721|consen 326 ----NSLHL--------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILL 363 (904)
T ss_pred ----Ccccc--------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHH
Confidence 00000 111234445788999999999999999999874
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=289.79 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=197.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
.|++.+.||+|+||.||++. +..+++.+|+|.+... ..........+..|+.+++.++|++++.+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~-~~~~~~~~avK~~~~~------------~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~ 67 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKK------------RIKKRKGESMALNEKQILEKVNSRFVVSLAY 67 (285)
T ss_pred CceeeEEeecCCCeEEEEEE-EcCCCceEEEEEEehh------------hccchHHHHHHHHHHHHHHhCCCCCeeeeeE
Confidence 47888999999999999995 5667889999987321 1111122345678999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+...+..++||||+.+++|.+++... ....++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~ 142 (285)
T cd05630 68 AYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIR 142 (285)
T ss_pred EEecCCEEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEE
Confidence 999999999999999999999988432 2345888899999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||++......... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..................
T Consensus 143 l~Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~ 219 (285)
T cd05630 143 ISDLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 219 (285)
T ss_pred EeeccceeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh
Confidence 9999998765433221 1246889999999999888999999999999999999999999753221111111111110
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
.. . ... ......+.+|+.+||+.||++||| ++|+++
T Consensus 220 ~~----~--~~~--------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 VQ----E--EYS--------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hh----h--hcC--------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00 0 000 011223889999999999999999 778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.44 Aligned_cols=269 Identities=20% Similarity=0.279 Sum_probs=203.4
Q ss_pred hhHHHHHhhhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHH
Q 040480 24 KEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99 (325)
Q Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 99 (325)
+.+..+....++|++.+.||.|+||.||+|.+.. .++..||+|.+... ......+.+.+|+.
T Consensus 27 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--------------~~~~~~~~~~~Ei~ 92 (400)
T cd05105 27 PYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--------------ARSSEKQALMSELK 92 (400)
T ss_pred CCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--------------CChHHHHHHHHHHH
Confidence 4455555667889999999999999999997532 23357999987321 11223457889999
Q ss_pred HHhccC-CCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc-----------------------------------
Q 040480 100 TASQIR-HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK----------------------------------- 143 (325)
Q Consensus 100 ~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------- 143 (325)
+++.+. ||||+++++++...+..|+||||+++|+|.+++.....
T Consensus 93 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (400)
T cd05105 93 IMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFE 172 (400)
T ss_pred HHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhc
Confidence 999996 99999999999999999999999999999998854210
Q ss_pred ---------------------------------------------------------cccccChhhHHHHHHHHHHHHHH
Q 040480 144 ---------------------------------------------------------GRRELEWLSRHKIALAVASGLEY 166 (325)
Q Consensus 144 ---------------------------------------------------------~~~~~~~~~~~~i~~~l~~~l~~ 166 (325)
....+++..+..++.|++.||.|
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 252 (400)
T cd05105 173 NKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEF 252 (400)
T ss_pred ccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 01236677788999999999999
Q ss_pred HHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHH
Q 040480 167 LHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL 246 (325)
Q Consensus 167 lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il 246 (325)
|| +.+++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++
T Consensus 253 LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil 329 (400)
T cd05105 253 LA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329 (400)
T ss_pred HH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHH
Confidence 99 889999999999999999999999999999865443322222223567789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 247 AVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 247 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
|+|++ |..||...... ..... ......... .+ ...+..+.+++.+||+.||++|||+.++.++
T Consensus 330 ~ellt~g~~P~~~~~~~---~~~~~---~~~~~~~~~--~~--------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 330 WEIFSLGGTPYPGMIVD---STFYN---KIKSGYRMA--KP--------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHHHHCCCCCCcccchh---HHHHH---HHhcCCCCC--CC--------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 99997 99998653221 11111 111111111 00 1123348999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=289.90 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=198.9
Q ss_pred cCcccccccccCcceeEEEEEecCC----CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGS----NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
++|++.+.||.|+||.||+|..... ....+++|.+... ........+.+|+.+++.++||||
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--------------~~~~~~~~~~~ei~~l~~l~h~~i 70 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--------------AEPKVQQEFRQEAELMSDLQHPNI 70 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--------------CCHHHHHHHHHHHHHHHhcCCccc
Confidence 5799999999999999999975322 2267999987311 112234568889999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIH 177 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH 177 (325)
+++++++......+++|||+++++|.+++..... ....++...+..++.|++.||.||| +++++|
T Consensus 71 ~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H 147 (283)
T cd05048 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVH 147 (283)
T ss_pred ceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 9999999998999999999999999999854311 1145778888999999999999999 889999
Q ss_pred cCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 040480 178 RDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256 (325)
Q Consensus 178 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~ 256 (325)
+||||+||++++++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus 148 ~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~ 227 (283)
T cd05048 148 RDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227 (283)
T ss_pred cccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999976543322222222356778999999988889999999999999999998 99998
Q ss_pred CCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 257 DDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..... .+... .+....... . ....+..+.+|+.+||+.||.+|||+.++++
T Consensus 228 ~~~~~----~~~~~---~i~~~~~~~--~--------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 228 YGFSN----QEVIE---MIRSRQLLP--C--------PEDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred CCCCH----HHHHH---HHHcCCcCC--C--------cccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 65321 12222 221111111 1 1122344999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=283.26 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=201.7
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||+|++|.||+|. ...+++.+++|.+... .........+.+|+.+++.++|||++++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~-~~~~~~~~~~k~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVV-RKADKRVYAMKQIDLS-------------KMNRREREEAIDEARVLAKLDSSYIIRYYE 66 (256)
T ss_pred CceEeEEecCCCCeEEEEEE-EcCCCcEEEEEEeehh-------------hCCHHHHHHHHHHHHHHHhcCCCCeehhee
Confidence 48889999999999999995 5567889999987321 122345567888999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+...+..++|+||+++++|.+++... ....++...+..++.+++.||.||| +.|++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~ 141 (256)
T cd08529 67 SFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVK 141 (256)
T ss_pred eeccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEE
Confidence 999999999999999999999998542 2356888889999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||.+.......... ....|+..|+|||+..+..++.++|+||||+++|+|++|..||.... ... ....
T Consensus 142 l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~---~~~~ 212 (256)
T cd08529 142 IGDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN----QGA---LILK 212 (256)
T ss_pred EcccccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHH---HHHH
Confidence 99999988665433221 22467889999999998889999999999999999999999996432 111 1111
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+.. . ......+.+++.+||+.+|++||++.++++
T Consensus 213 ~~~~~~~~~--~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 213 IIRGVFPPV--S--------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHcCCCCCC--c--------cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 111111110 0 012234899999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=289.98 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=197.7
Q ss_pred cCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
.+|.+.+.||+|+||+||++... ..++..+|+|.+. .........+.+|+.++++++||||
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~---------------~~~~~~~~~~~~e~~~l~~l~h~~i 69 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK---------------DASDNARKDFHREAELLTNLQHEHI 69 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecC---------------CcCHHHHHHHHHHHHHHHhCCCCCc
Confidence 57899999999999999999642 2345668899772 1122345678899999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhc---------ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS---------KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDI 180 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl 180 (325)
+++++++...+..++++||+++++|.+++.... .....+++..+..++.|++.||+||| ++|++|+||
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dl 146 (288)
T cd05093 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDL 146 (288)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccc
Confidence 999999999999999999999999999985422 12235889999999999999999999 889999999
Q ss_pred CCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCc
Q 040480 181 KPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDF 259 (325)
Q Consensus 181 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~ 259 (325)
||+||++++++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 147 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 147 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred CcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999875543222111112345678999999998889999999999999999998 89998643
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. .... ..+........ + . ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 227 ~~----~~~~---~~i~~~~~~~~--~-----~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 227 SN----NEVI---ECITQGRVLQR--P-----R---TCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CH----HHHH---HHHHcCCcCCC--C-----C---CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 21 1111 12222211110 0 0 11223899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=290.07 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=191.0
Q ss_pred ccccccccCcceeEEEEEec---CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 37 ASLEKIGSGGCGDVYKAELP---GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
.+.+.||.|.||.||+|.+. ...+..|+||.+.. .......+.+.+|+..+++++||||++++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~ni~~~~ 67 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--------------SSSEEEEEEFLNEIQILRKLRHPNIVKLY 67 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--------------TSSHHHHHHHHHHHHHHHTHSBTTBE-EE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--------------ccccccceeeeeccccccccccccccccc
Confidence 35688999999999999886 23457899998821 11223467889999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..++|+||+++++|.+++... ....++...+..|+.|++.||.||| +++++|++|+++||+++.++.+
T Consensus 68 g~~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~ 142 (259)
T PF07714_consen 68 GFCIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQV 142 (259)
T ss_dssp EEEESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEE
T ss_pred cccccccccccccccccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccc
Confidence 9999888899999999999999999542 2456899999999999999999999 7799999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 272 (325)
||+|||++....................|+|||.+.+..++.++||||||+++|++++ |..||.+. ...+. .
T Consensus 143 Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~----~~~~~---~ 215 (259)
T PF07714_consen 143 KLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY----DNEEI---I 215 (259)
T ss_dssp EEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS----CHHHH---H
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccc---c
Confidence 9999999987743322222222355678999999998889999999999999999999 78998653 12222 2
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............. ..+..+.+++.+||..||++|||+.++++
T Consensus 216 ~~~~~~~~~~~~~----------~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 216 EKLKQGQRLPIPD----------NCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHTTEETTSBT----------TSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccceecc----------chhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2222222221111 01222889999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=286.86 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=198.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.++||.|+||.||+|... ++..+|+|.+.. .....+.+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~ 65 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKP----------------GTMSVQAFLEEANLMKTLQHDKLVR 65 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccC----------------CchhHHHHHHHHHHHHhCCCCCeee
Confidence 4578999999999999999999753 556799998631 1123457889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+...+..++++||+++++|.+++... ....++......++.|++.||+||| +.+++|+||+|+||+++.++
T Consensus 66 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~ 140 (261)
T cd05072 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESL 140 (261)
T ss_pred EEEEEcCCCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCC
Confidence 999999999999999999999999998542 2345778888899999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+.......... .....++..|+|||...+..++.++|+||||+++|+|++ |..||.... ......
T Consensus 141 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~ 215 (261)
T cd05072 141 MCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS----NSDVMS 215 (261)
T ss_pred cEEECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC----HHHHHH
Confidence 99999999998765432211 111234667999999988889999999999999999998 999996522 112222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
.. ......+. . ...+..+.+++.+||..||++|||+++++++
T Consensus 216 ~~---~~~~~~~~--~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 257 (261)
T cd05072 216 AL---QRGYRMPR--M--------ENCPDELYDIMKTCWKEKAEERPTFDYLQSV 257 (261)
T ss_pred HH---HcCCCCCC--C--------CCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 21 11111110 0 0122338899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.19 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=194.5
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||+|+||.||+|. +..+++.||+|.+... .........+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 66 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVT-DPRDGKRVALKKMPNV-------------FQNLVSCKRVFRELKMLCFFKHDNVLSALD 66 (372)
T ss_pred CCcccceeeeCCCEEEEEEE-ECCCCCEEEEEecccc-------------ccchHHHHHHHHHHHHHHhCCCCCcCCHhh
Confidence 47899999999999999995 5567899999987311 011123456789999999999999999999
Q ss_pred ceecCC-----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 115 HMVRPD-----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 115 ~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++...+ ..|+|+||+.+ +|.+.+ .....++...+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 67 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~ 138 (372)
T cd07853 67 ILQPPHIDPFEEIYVVTELMQS-DLHKII----VSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNS 138 (372)
T ss_pred eecCCCccccceEEEEeecccc-CHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECC
Confidence 998776 78999999964 788777 34456899999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
++.++|+|||++.......... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||..... ...
T Consensus 139 ~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~ 213 (372)
T cd07853 139 NCVLKICDFGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP----IQQ 213 (372)
T ss_pred CCCEEeccccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH----HHH
Confidence 9999999999998654332211 1123578899999998774 478999999999999999999999965321 111
Q ss_pred HHHHHHH--------------------hhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNV--------------------MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+... ......... .... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 214 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS-LPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc-hHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 1111100 000000000 0000 0001112344889999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=289.43 Aligned_cols=259 Identities=18% Similarity=0.308 Sum_probs=196.9
Q ss_pred hhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||.||+|.+.. .++..+|+|.+... ........+.+|+.+++.++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--------------~~~~~~~~~~~e~~~l~~l~~~ 69 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--------------ASMRERIEFLNEASVMKEFNCH 69 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--------------CCHHHHHHHHHHHHHHHhCCCC
Confidence 56789999999999999999996532 24567999986211 0112334678899999999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhccc------ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG------RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~ 181 (325)
||+++++++......++||||+++++|.+++...... ...++...+..++.|++.||.||| +.|++|+|||
T Consensus 70 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlk 146 (277)
T cd05062 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLA 146 (277)
T ss_pred CeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcc
Confidence 9999999999999999999999999999998543211 223566778889999999999999 8899999999
Q ss_pred CCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcc
Q 040480 182 PANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFF 260 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~ 260 (325)
|+||++++++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 147 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 147 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred hheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999875543322211111244678999999998889999999999999999998 788986421
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. .............. + ...+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ----~~---~~~~~~~~~~~~~~--~--------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 227 ----NE---QVLRFVMEGGLLDK--P--------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred ----HH---HHHHHHHcCCcCCC--C--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 11122222211110 0 011234899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=319.79 Aligned_cols=258 Identities=20% Similarity=0.314 Sum_probs=198.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++++.||.|+||+||+|+ +..++..+|+|.+... .........+..|+.+++++.||||+++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAk-dk~tg~~vAlKvIk~~-------------~l~e~~~~~~~~EI~IL~~L~HPNIVrl 77 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVK-HKRTQEFFCWKAISYR-------------GLKEREKSQLVIEVNVMRELKHKNIVRY 77 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEE-ECCCCeEEEEEEEecc-------------ccCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence 3789999999999999999996 5567889999987322 1222345678899999999999999999
Q ss_pred ccceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCceE
Q 040480 113 LAHMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHH----SARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~----~~~ivH~dl~~~nil 186 (325)
++++.. ...+|+||||+++++|.+++.........+++..++.|+.||+.||.|||... ..+|+|+||||+|||
T Consensus 78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 998854 35689999999999999999665444567999999999999999999999431 146999999999999
Q ss_pred ecC-----------------CCCceeeccccceecCCCCccccceeecCCccccccccccc--CCCCCccchhhHHHHHH
Q 040480 187 IDD-----------------DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT--LTISEKCDIYSFGVLLA 247 (325)
Q Consensus 187 ~~~-----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~--~~~~~~~DvwslG~il~ 247 (325)
++. .+.++|+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 964 234899999999765433221 22478999999998864 35789999999999999
Q ss_pred HHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 248 VLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 248 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+|++|..||.... ........+......... ..+..+.+||..||+.+|.+|||+.++|.
T Consensus 235 ELLTGk~PF~~~~------~~~qli~~lk~~p~lpi~-----------~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 235 ELCSGKTPFHKAN------NFSQLISELKRGPDLPIK-----------GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHCCCCCCcCC------cHHHHHHHHhcCCCCCcC-----------CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999999996421 112222222221111100 01223899999999999999999999984
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.68 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=196.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.+|+|.+.. ...........+.+|+.+++.++||||++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~-~~~~~~~~aiK~i~~------------~~~~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVR-HKSTRKVYAMKLLSK------------FEMIKRSDSAFFWEERDIMAFANSPWVVQ 107 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEE-ECCCCcEEEEEEEEH------------HHhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 56899999999999999999996 556788999998731 11112233456788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+...+..++||||+++++|.+++.. ..++...+..++.|++.||.||| ++||+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCC
Confidence 99999999999999999999999999832 34788888899999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT----ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.++|+|||++......... ......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.....
T Consensus 180 ~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------ 252 (371)
T cd05622 180 HLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------ 252 (371)
T ss_pred CEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------
Confidence 9999999999876433221 112357899999999987643 78899999999999999999999964221
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCC--CCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDE--RPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~ 324 (325)
......+........ ++. .......+.++|.+||..++.. ||+++++++
T Consensus 253 -~~~~~~i~~~~~~~~-~~~------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 253 -VGTYSKIMNHKNSLT-FPD------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred -HHHHHHHHcCCCccc-CCC------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 122222222111110 010 0112233889999999843432 778888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=303.49 Aligned_cols=264 Identities=20% Similarity=0.198 Sum_probs=195.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
...+|.+.+.||+|+||.||+|. +..+++.||+|.. ......+|+.++++++||||++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~-~~~~~~~vavK~~---------------------~~~~~~~E~~iL~~L~HpnIv~ 224 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESS-HPDYPQRVVVKAG---------------------WYASSVHEARLLRRLSHPAVLA 224 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEE-ECCCCCEEEEecc---------------------cccCHHHHHHHHHHCCCCCCCc
Confidence 35589999999999999999996 5566788999954 1123467999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++|++++. ++|.+++.. ....+++..+..++.|++.||.||| ++||+|+||||+||+++.++
T Consensus 225 l~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~ 297 (461)
T PHA03211 225 LLDVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPE 297 (461)
T ss_pred EEEEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCC
Confidence 9999999999999999995 588888733 2346899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC----Ccch
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT----GEMD 267 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~----~~~~ 267 (325)
.++|+|||++................||..|+|||++.+..++.++|||||||++|+|++|..|+-...... ....
T Consensus 298 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~ 377 (461)
T PHA03211 298 DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ 377 (461)
T ss_pred CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHH
Confidence 999999999976543322222223568999999999999999999999999999999999876543221111 1112
Q ss_pred HHHHHHHHhhhCCCCccc-----------------chhhcCCc---hHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAI-----------------DSKLLGNG---YEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+.+.+............. .+...... .......+.+||.+||+.||.+|||+.|+|+
T Consensus 378 l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 378 ILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 222222211100000000 00000000 0112234889999999999999999999986
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=285.37 Aligned_cols=255 Identities=21% Similarity=0.322 Sum_probs=198.6
Q ss_pred hcCcccccccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|.+.+.||+|+||+||+|.+... +...+|+|.+... ........+..|+.+++.++||||+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~ 68 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--------------SSDKQRLDFLTEASIMGQFDHPNII 68 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC--------------CChHHHHHHHHHHHHHHhCCCCCcc
Confidence 46799999999999999999976433 3467999987321 1122345678899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++.+...+..+++|||+++++|.+++.. ....++...+..++.|++.|+.||| +++++|+||+|+||+++++
T Consensus 69 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~ 142 (266)
T cd05033 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSN 142 (266)
T ss_pred eEeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCC
Confidence 999999999999999999999999999843 2346889999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||++................++..|+|||...+..++.++|+||||+++|+|++ |..||.... ....
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~----~~~~- 217 (266)
T cd05033 143 LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDV- 217 (266)
T ss_pred CCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC----HHHH-
Confidence 9999999999987652222111111234568999999998889999999999999999998 999986422 1112
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+......+.. .+.+..+.+++.+||+.+|++||++.++++
T Consensus 218 --~~~~~~~~~~~~~----------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 218 --IKAVEDGYRLPPP----------MDCPSALYQLMLDCWQKDRNERPTFSQIVS 260 (266)
T ss_pred --HHHHHcCCCCCCC----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1222211111111 112234899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=305.13 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=195.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|+ +..+++.+|+|.+.. ...........+..|+.++..++||+|++++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~ 67 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQ-KKDTGHIYAMKILRK------------ADMLEKEQVAHIRAERDILVEADGAWVVKMF 67 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEE-ECCCCCEEEEEEEEH------------HHHhhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 478999999999999999996 556788999999831 1112234456788899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+.+..|+||||+++++|.+++. ....++...+..++.|++.||.||| ++|++||||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~v 140 (360)
T cd05627 68 YSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHV 140 (360)
T ss_pred EEEEcCCEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCE
Confidence 99999999999999999999999983 3456889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCcc---------------------------------ccceeecCCcccccccccccCCCCCccchh
Q 040480 194 RISGFDLAILMPDGLTQ---------------------------------IDTMYVVGTPRYIAPEYHQTLTISEKCDIY 240 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~---------------------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dvw 240 (325)
+|+|||++......... .......||+.|+|||++.+..++.++|+|
T Consensus 141 kL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 220 (360)
T cd05627 141 KLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 220 (360)
T ss_pred EEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceec
Confidence 99999998644221100 001124689999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC--
Q 040480 241 SFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-- 318 (325)
Q Consensus 241 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-- 318 (325)
||||++|+|++|..||..... ......+..... ...+++.. .....+.+||.+|+ .||.+|++
T Consensus 221 SlGvilyel~tG~~Pf~~~~~-------~~~~~~i~~~~~-~~~~p~~~------~~s~~~~~li~~l~-~~p~~R~~~~ 285 (360)
T cd05627 221 SLGVIMYEMLIGYPPFCSETP-------QETYRKVMNWKE-TLVFPPEV------PISEKAKDLILRFC-TDSENRIGSN 285 (360)
T ss_pred cccceeeecccCCCCCCCCCH-------HHHHHHHHcCCC-ceecCCCC------CCCHHHHHHHHHhc-cChhhcCCCC
Confidence 999999999999999965322 111122221111 00111100 01123788888876 59999995
Q ss_pred -hhhhhc
Q 040480 319 -SKDVRC 324 (325)
Q Consensus 319 -~~ell~ 324 (325)
++++++
T Consensus 286 ~~~ei~~ 292 (360)
T cd05627 286 GVEEIKS 292 (360)
T ss_pred CHHHHhc
Confidence 566653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=294.00 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=185.2
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHH-HHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI-ITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|+ +..+++.+|+|.+... ..........+..|. .+++.++||||+++++.+.+
T Consensus 1 ~~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~ 67 (321)
T cd05603 1 KVIGKGSFGKVLLAK-RKSDGSFYAVKVLQKK------------TILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT 67 (321)
T ss_pred CeeeeCCCEEEEEEE-ECCCCCEEEEEEEEHH------------HHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc
Confidence 479999999999996 5567889999988311 111112233444444 46788999999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+++++|...+. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Df 140 (321)
T cd05603 68 AEKLYFVLDYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDF 140 (321)
T ss_pred CCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccC
Confidence 999999999999999988873 3456888888999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++........ ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.... .......+...
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~ 211 (321)
T cd05603 141 GLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDNILHK 211 (321)
T ss_pred CCCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-------HHHHHHHHhcC
Confidence 99875322211 1222578999999999998889999999999999999999999996521 12222222222
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
... .+. .....+.+++.+||+.||.+||++.
T Consensus 212 ~~~---~~~--------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 PLQ---LPG--------GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCC---CCC--------CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111 111 0122388999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=293.55 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=194.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCC---CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSN---GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
..++|++.+.||+|+||.||+|++.... ...||+|.+... ........+.+|+.+++.++|||
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~n 70 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--------------TSPKANKEILDEAYVMASVDNPH 70 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence 4578999999999999999999754222 234899987311 11233456888999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++... ..+++++|+++|+|.+++.. ....++......++.|++.||+||| ++|++|+||||+||+++
T Consensus 71 iv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~ 143 (316)
T cd05108 71 VCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVK 143 (316)
T ss_pred CCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEec
Confidence 99999988764 57899999999999999843 2345788888999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.. ..+
T Consensus 144 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~----~~~ 219 (316)
T cd05108 144 TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASE 219 (316)
T ss_pred CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHH
Confidence 999999999999987654332222111234567999999998899999999999999999997 999996521 112
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ...... .++ . +...+.+++.+||..||.+|||+.+++.
T Consensus 220 ~~~~~~---~~~~~~--~~~----~----~~~~~~~li~~cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 220 ISSILE---KGERLP--QPP----I----CTIDVYMIMVKCWMIDADSRPKFRELII 263 (316)
T ss_pred HHHHHh---CCCCCC--CCC----C----CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222111 111111 011 0 1123889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=295.42 Aligned_cols=262 Identities=21% Similarity=0.311 Sum_probs=197.0
Q ss_pred hhhcCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-C
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-R 105 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 105 (325)
...++|++.+.||+|+||.||+|... ..+++.||+|++... ........+..|+.++.++ .
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~--------------~~~~~~~~~~~E~~~~~~l~~ 69 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG--------------ATASEYKALMTELKILIHIGH 69 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC--------------CCHHHHHHHHHHHHHHHhhcc
Confidence 34568999999999999999999532 234578999987311 1112345677899999999 7
Q ss_pred CCCccccccceecC-CceEEEEEcccCCCHHHHHhhhcc-----------------------------------------
Q 040480 106 HRNILPLLAHMVRP-DSHLLVYDFMKNGSLQAVLYDVSK----------------------------------------- 143 (325)
Q Consensus 106 h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------- 143 (325)
||||+++++.+... ...++++||+++++|.+++.....
T Consensus 70 h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (337)
T cd05054 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIE 149 (337)
T ss_pred CcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccccccccc
Confidence 99999999987654 568899999999999999853211
Q ss_pred ----------------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCC
Q 040480 144 ----------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207 (325)
Q Consensus 144 ----------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 207 (325)
....+++..+..++.|++.||.||| ++||+|+||||+||++++++.++|+|||++......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~ 226 (337)
T cd05054 150 DKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 226 (337)
T ss_pred CcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence 0135788889999999999999999 889999999999999999999999999999876443
Q ss_pred CccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccc
Q 040480 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAID 286 (325)
Q Consensus 208 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (325)
..........++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..... ......... .+
T Consensus 227 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~~~---~~~~~~~~~--~~ 298 (337)
T cd05054 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEFCR---RLKEGTRMR--AP 298 (337)
T ss_pred cchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHHHH---HHhccCCCC--CC
Confidence 32222222345678999999999899999999999999999998 99999652211 11111 111111110 00
Q ss_pred hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 287 SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
......+.+++.+||+.+|++||++.|++++
T Consensus 299 --------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 299 --------EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred --------ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112338999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=284.80 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=197.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
..+|.+.+.||.|+||.||+|. ...++..+|+|.+.. .......+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~-~~~~~~~~~~K~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGV-WKKYSLTVAVKTLKE----------------DTMEVEEFLKEAAVMKEIKHPNLVQL 67 (263)
T ss_pred hHHeEEeeecCCcccceEEEEE-EecCCceEEEEEecC----------------CchHHHHHHHHHHHHHhCCCCChhhe
Confidence 3568999999999999999996 445678899998721 12234567889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..+++|||+++++|.+++... ....++...+..++.|++.+|++|| ++|++|+||+|+||++++++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~ 142 (263)
T cd05052 68 LGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHL 142 (263)
T ss_pred EEEEcCCCCcEEEEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCc
Confidence 99999999999999999999999998442 2345888889999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+.......... .....++..|+|||...+..++.++||||||+++|+|++ |..||.... . ...
T Consensus 143 ~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~----~---~~~ 214 (263)
T cd05052 143 VKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----L---SQV 214 (263)
T ss_pred EEeCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----H---HHH
Confidence 9999999997665432211 111233567999999998889999999999999999998 999986421 1 111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............ + ...+..+.+++.+||+.||++|||+.++++
T Consensus 215 ~~~~~~~~~~~~--~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 215 YELLEKGYRMER--P--------EGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHCCCCCCC--C--------CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 122221111110 0 112234899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=293.41 Aligned_cols=242 Identities=24% Similarity=0.292 Sum_probs=185.2
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHH-HHHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ-IITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||+||+|+ +..+++.+|+|.+... ..........+..| ..+++.+.||||+++++.+..
T Consensus 1 ~~lg~G~fg~V~~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~ 67 (325)
T cd05602 1 KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKK------------AILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT 67 (325)
T ss_pred CeeeeCCCeEEEEEE-ECCCCCEEEEEEEEHH------------HHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc
Confidence 469999999999996 5567789999998321 11111122233333 445678899999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+.+++|.+++. ....++...+..++.|++.||.||| ++|++||||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~Df 140 (325)
T cd05602 68 ADKLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDF 140 (325)
T ss_pred CCeEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccC
Confidence 999999999999999999883 3445778888889999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... . .....+...
T Consensus 141 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~---~~~~~i~~~ 211 (325)
T cd05602 141 GLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----A---EMYDNILNK 211 (325)
T ss_pred CCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----H---HHHHHHHhC
Confidence 99875432211 12235789999999999998999999999999999999999999964221 1 112222221
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhh
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (325)
.... .+ +....+.+++.+||+.||.+||++.+
T Consensus 212 ~~~~---~~--------~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 212 PLQL---KP--------NITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CcCC---CC--------CCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 1111 11 11223889999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=292.80 Aligned_cols=246 Identities=21% Similarity=0.259 Sum_probs=191.8
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPLL 113 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 113 (325)
+|++.+.||+|+||.||+|+ +..+++.||+|++.. ...........+..|..+++.+. |++|++++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~ 67 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKK------------DVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67 (323)
T ss_pred CceEEEEEEecCCeEEEEEE-ECCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHHhccCCCchhhee
Confidence 47889999999999999996 556788999998831 11112234456777888888776 57888899
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..|+||||+++++|.+++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~i 140 (323)
T cd05615 68 SCFQTVDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHI 140 (323)
T ss_pred eEEecCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCE
Confidence 99999999999999999999999883 3356889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++......... .....||..|+|||++.+..++.++|+||||+++|+|++|..||.... .... ..
T Consensus 141 kL~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~~~~---~~ 211 (323)
T cd05615 141 KIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED----EDEL---FQ 211 (323)
T ss_pred EEeccccccccCCCCcc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHH---HH
Confidence 99999998754322211 122468999999999999889999999999999999999999996532 1111 22
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
.+...... .+. .....+.+++.+||+.||.+|++..
T Consensus 212 ~i~~~~~~---~p~--------~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 212 SIMEHNVS---YPK--------SLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred HHHhCCCC---CCc--------cCCHHHHHHHHHHcccCHhhCCCCC
Confidence 22221111 010 0112388999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=288.11 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=197.8
Q ss_pred cCcccccccccCcceeEEEEEec---CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELP---GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
++|++.+.||+|+||+||+|.+. ...+..+++|.+... ........+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~niv 70 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--------------NNPQQWGEFQQEASLMAELHHPNIV 70 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--------------CCHHHHHHHHHHHHHHhhCCCCCee
Confidence 57899999999999999999642 235578999987321 1123345678899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhc-------------ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS-------------KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIH 177 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH 177 (325)
++++++......+++|||+++++|.+++.... .....++......++.|++.||.||| ++|++|
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H 147 (283)
T cd05090 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVH 147 (283)
T ss_pred eEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeeh
Confidence 99999999999999999999999999984321 01234778888899999999999999 889999
Q ss_pred cCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 040480 178 RDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256 (325)
Q Consensus 178 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~ 256 (325)
+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus 148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~ 227 (283)
T cd05090 148 KDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227 (283)
T ss_pred hccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999986644332222222345678999999988889999999999999999998 99998
Q ss_pred CCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 257 DDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... .....+ ......... .+ ...+..+.+++.+||+.||.+||++.+|++
T Consensus 228 ~~~~----~~~~~~---~~~~~~~~~--~~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 228 YGFS----NQEVIE---MVRKRQLLP--CS--------EDCPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred CCCC----HHHHHH---HHHcCCcCC--CC--------CCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 6421 112222 221111111 01 011223889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=292.19 Aligned_cols=264 Identities=19% Similarity=0.277 Sum_probs=196.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|.+.+.||+|+||.||+|. +..++..+|+|.+.... .......+.+|+.+++.++||||+++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 69 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGR-SKLTENLVALKEIRLEH--------------EEGAPCTAIREVSLLKDLKHANIVTL 69 (309)
T ss_pred CCceEEEEEecccCCEEEEEEE-ecCCCCeEEEEEeeccc--------------cCCcchhHHHHHHHHHhCCCCCcceE
Confidence 3689999999999999999995 55678889999873221 11223356789999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++..++..++||||+++ +|.+++.. ....++...+..++.|++.||.||| ++|++||||+|+||+++.++.
T Consensus 70 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~ 142 (309)
T cd07872 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGE 142 (309)
T ss_pred EEEEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999976 88887743 2345788888999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+.......... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .+....
T Consensus 143 ~kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~----~~~~~~ 216 (309)
T cd07872 143 LKLADFGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV----EDELHL 216 (309)
T ss_pred EEECccccceecCCCcccc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHH
Confidence 9999999987644322211 12357889999998765 4578999999999999999999999965322 111111
Q ss_pred HHHHhhhCCCCcc-------------cc---hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRA-------------ID---SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~-------------~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+ .+ +.............+.+|+.+||+.||.+|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 217 IFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 1111111000000 00 00000001122344889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=283.68 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=196.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|++|.||+|.+. +++.||+|.+... ......+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~----------------~~~~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPG----------------TMDPKDFLAEAQIMKKLRHPKLIQL 66 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCC----------------cccHHHHHHHHHHHHHCCCCCccce
Confidence 467999999999999999999643 4567999987321 1234567889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..++++||+++++|.+++... ....++...+..++.|++.|+.+|| ++|++|+||+|+||+++.++.
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~ 141 (261)
T cd05068 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNI 141 (261)
T ss_pred eEEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCC
Confidence 99999999999999999999999998542 2346888999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||++........... .....+..|+|||...+..++.++|+||||+++|+|++ |..||.... ......
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~- 215 (261)
T cd05068 142 CKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT----NAEVLQ- 215 (261)
T ss_pred EEECCcceEEEccCCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH-
Confidence 99999999987653221111 11122457999999998889999999999999999999 999996422 111121
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....... .+ ...+..+.+++.+||+.||.+||++.++++
T Consensus 216 --~~~~~~~~~--~~--------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 216 --QVDQGYRMP--CP--------PGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --HHHcCCCCC--CC--------CcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111110 00 112234899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=289.15 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=198.7
Q ss_pred hcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
..+|.+.+.||+|+||.||+|+... .++..+++|.+.. ........+.+|+.+++.++|||
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~ 68 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---------------PTLAARKDFQREAELLTNLQHEH 68 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC---------------ccHHHHHHHHHHHHHHhcCCCCC
Confidence 4678999999999999999997432 2446688887621 11233456888999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVI 176 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~iv 176 (325)
|+++++++...+..++||||+++++|.+++..... ....+++..+..++.|++.|++||| ++|++
T Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~ 145 (291)
T cd05094 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFV 145 (291)
T ss_pred cceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 99999999999999999999999999999954221 1234788889999999999999999 88999
Q ss_pred ecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCC
Q 040480 177 HRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFP 255 (325)
Q Consensus 177 H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p 255 (325)
|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus 146 H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 225 (291)
T cd05094 146 HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225 (291)
T ss_pred ecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976543322222222355778999999998889999999999999999998 9999
Q ss_pred CCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 256 FDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|..... ....+ ........... ...+..+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~----~~~~~---~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 226 WFQLSN----TEVIE---CITQGRVLERP----------RVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCH----HHHHH---HHhCCCCCCCC----------ccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 865321 11221 11111111100 012233889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=284.83 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=196.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|. +..++..+|+|.+.... .......+.+|+.+++++.||||++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~-~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 65 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAY-HLLTRRILAVKVIPLDI--------------TVELQKQIMSELEILYKCDSPYIIGFY 65 (279)
T ss_pred CcchheeeeccCCCeEEEEEE-EcCCCcEEEEEEEecCC--------------ChHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 468899999999999999995 55678889999873211 122345688899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..++|+||+++++|..+. .++......++.|++.||.||| +.|++|+||+|+||+++.++.+
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~ 134 (279)
T cd06619 66 GAFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQV 134 (279)
T ss_pred EEEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCE
Confidence 9999999999999999999886542 3677788899999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++........ ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.................
T Consensus 135 ~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 210 (279)
T cd06619 135 KLCDFGVSTQLVNSIA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ 210 (279)
T ss_pred EEeeCCcceecccccc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH
Confidence 9999999976543221 224788899999999988899999999999999999999999975332222211111111
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... .. . ......+.+++.+||+.||.+||+++++++
T Consensus 211 ~~~~~~~~~-~~-----~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 211 CIVDEDPPV-LP-----V---GQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred HHhccCCCC-CC-----C---CcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111111110 00 0 011223889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=297.20 Aligned_cols=200 Identities=26% Similarity=0.367 Sum_probs=166.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||+|+||.||+|. +..+++.+|+|++... .........+.+|+.+++.++||||++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~ii~ 87 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAY-DAILERNVAIKKLSRP-------------FQNQTHAKRAYRELVLMKCVNHKNIIG 87 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEE-ECCCCcEEEEEEeCcc-------------ccCchhHHHHHHHHHHHHhcCCCCccc
Confidence 45799999999999999999994 6677889999987321 112233456778999999999999999
Q ss_pred cccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++++... ...|+||||+++ +|.+.+. ..++...+..++.|++.||.||| ++||+|+||||+||
T Consensus 88 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NI 157 (364)
T cd07875 88 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 157 (364)
T ss_pred cceeecccccccccCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHE
Confidence 99877543 357999999976 7777762 23778888899999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+++.++.++|+|||++......... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 ll~~~~~~kL~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 158 VVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred EECCCCcEEEEeCCCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999765433221 224678999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=291.02 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=189.4
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc---cCCCCccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ---IRHRNILP 111 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~~i~~ 111 (325)
+|++.+.||+|+||+||+|. +..+++.+|+|.+..... .........+|+.+++. +.||||++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~-~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~h~ni~~ 66 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKAR-DPHSGHFVALKSVRVQTN-------------EDGLPLSTVREVALLKRLEAFDHPNIVR 66 (288)
T ss_pred CceEeeEEeecCCeEEEEEE-ECCCCcEEEEEEeccCcC-------------CCCCchHHHHHHHHHHHhhhcCCCCeee
Confidence 58999999999999999996 556789999998843211 11112233445555554 47999999
Q ss_pred cccceec-----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 112 LLAHMVR-----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 112 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
+++++.. ....++++||+.+ +|.+++... ....++...+..++.|++.||.||| ++|++|+||||+||+
T Consensus 67 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nil 140 (288)
T cd07863 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENIL 140 (288)
T ss_pred eeeeeccccCCCCceEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 9998754 2457999999975 888888432 2345889999999999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
++.++.++|+|||++......... ....|+..|+|||++.+..++.++|+||||+++|+|++|.+||..... .
T Consensus 141 i~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~ 213 (288)
T cd07863 141 VTSGGQVKLADFGLARIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----A 213 (288)
T ss_pred ECCCCCEEECccCccccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----H
Confidence 999999999999999766433221 124678899999999888899999999999999999999999964221 1
Q ss_pred hHHHHHHHHhhhCCCC----------cccc---hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPN----------RAID---SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~----------~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+....+.......... .... ............+.+.+++.+||+.||++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 214 DQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111000000 0000 00000111123345889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=288.46 Aligned_cols=255 Identities=23% Similarity=0.380 Sum_probs=197.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..+++.+|+|++... .......+.+|+.++++++||||++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~-~~~~~~~~aik~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~ii~ 70 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKAR-NLHTGELAAVKIIKLE---------------PGDDFSLIQQEIFMVKECKHCNIVA 70 (267)
T ss_pred chhhcchhheeecCCCeEEEEEE-ECCCCeEEEEEEEecC---------------ccchHHHHHHHHHHHHhcCCCCeee
Confidence 45689999999999999999996 4567889999987321 1123345778999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++|+||+++++|.+++. ....++...+..++.|++.|+.||| +.|++|+|++|+||+++.++
T Consensus 71 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~ 143 (267)
T cd06646 71 YFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNG 143 (267)
T ss_pred eeEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCC
Confidence 9999999999999999999999999883 3346888899999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||++......... .....|+..|+|||.+. ...++.++|+||||+++|+|++|..||............
T Consensus 144 ~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~ 221 (267)
T cd06646 144 DVKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred CEEECcCccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee
Confidence 9999999999866432221 12246788999999874 334678999999999999999999998643221110000
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+.... .....+..+.+++.+||+.||++|||++++++
T Consensus 222 ------~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 222 ------SKSNFQPPKLK-------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred ------ecCCCCCCCCc-------cccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 00000000000 01112334899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=289.47 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=200.7
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
.....+|++.+.||+|+||.||+|. +..++..+++|.+... .......+.+|+.+++.+.|||+
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~~v~ik~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~v 79 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAM-DVATGQEVAIRQMNLQ---------------QQPKKELIINEILVMRENKNPNI 79 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEE-ECCCCcEEEEEEEecC---------------CcchHHHHHHHHHHHHhCCCCCE
Confidence 3466799999999999999999995 5667889999987321 12234567889999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++.+......++||||+++++|.+++. ...++......++.|++.||.||| ++|++|+||+|+||+++.
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~ 151 (296)
T cd06654 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGM 151 (296)
T ss_pred eeEEEEEEeCCEEEEeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcC
Confidence 999999999999999999999999999883 235788889999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||.+......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... . .
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~--~ 223 (296)
T cd06654 152 DGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----L--R 223 (296)
T ss_pred CCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----H--H
Confidence 999999999998754432211 1124678899999999888889999999999999999999999965322 0 1
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. .........+....+ ......+.+++.+||..||++|||+.++++
T Consensus 224 ~-~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 224 A-LYLIATNGTPELQNP--------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred h-HHHHhcCCCCCCCCc--------cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1 111111111110001 112234889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=294.64 Aligned_cols=241 Identities=24% Similarity=0.300 Sum_probs=186.0
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHH-HHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI-ITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|+ +..+++.+|+|.+... ..........+..|. .+++.++||||+++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~ 67 (325)
T cd05604 1 KVIGKGSFGKVLLAK-RKLDGKCYAVKVLQKK------------IVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT 67 (325)
T ss_pred CceeeCCCeEEEEEE-ECCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec
Confidence 468999999999995 5677899999998321 111122333444444 35677899999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+++++|..++. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~Df 140 (325)
T cd05604 68 TEKLYFVLDFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDF 140 (325)
T ss_pred CCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeec
Confidence 999999999999999988883 3456889999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
|++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+...
T Consensus 141 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~~~~~ 211 (325)
T cd05604 141 GLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-------VAEMYDNILHK 211 (325)
T ss_pred CCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-------HHHHHHHHHcC
Confidence 99865332211 1222578999999999999899999999999999999999999996522 11122222221
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
.... .+ . ....+.+++.+||+.||.+||++.
T Consensus 212 ~~~~---~~----~----~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 212 PLVL---RP----G----ASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CccC---CC----C----CCHHHHHHHHHHhccCHHhcCCCC
Confidence 1111 11 0 112278999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=300.79 Aligned_cols=257 Identities=27% Similarity=0.349 Sum_probs=201.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCC---cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNG---KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
.-++-.+.++||+|+||.||+|.+...++ ..||+|.... ........+.+++.|.++|++++|||
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~------------~~~~~~~~~~e~m~EArvMr~l~H~N 222 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG------------SSELTKEQIKEFMKEARVMRQLNHPN 222 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc------------cccccHHHHHHHHHHHHHHHhCCCCC
Confidence 34455566999999999999998875544 3389998732 12244577889999999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|++++|++..+..+++|||+|+||+|.+++.+. ...++..+...++.+.+.||+||| +++++||||-.+|+|++
T Consensus 223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~ 296 (474)
T KOG0194|consen 223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYS 296 (474)
T ss_pred EEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheec
Confidence 999999999999999999999999999999552 226999999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
.++.+||+|||+++........... .--+..|+|||.+....+++++||||||+++||+++ |..||.+... .+
T Consensus 297 ~~~~vKISDFGLs~~~~~~~~~~~~--~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~ 370 (474)
T KOG0194|consen 297 KKGVVKISDFGLSRAGSQYVMKKFL--KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----YE 370 (474)
T ss_pred CCCeEEeCccccccCCcceeecccc--ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----HH
Confidence 9999999999998765422111111 123568999999999999999999999999999999 8889976332 22
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+..++. ....+...+. ..+..+..++.+||..||++|||+.++.+
T Consensus 371 v~~kI~--~~~~r~~~~~----------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 371 VKAKIV--KNGYRMPIPS----------KTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHH--hcCccCCCCC----------CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 222221 1111111110 22333888999999999999999998864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=298.18 Aligned_cols=266 Identities=23% Similarity=0.278 Sum_probs=194.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||+|+||.||+|. +..+++.+|+|.+... .........+.+|+.+++.++||||++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~ 80 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAY-DAVLDRNVAIKKLSRP-------------FQNQTHAKRAYRELVLMKCVNHKNIIS 80 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEE-ecCCCceEEEEEeCCc-------------ccChHHHHHHHHHHHHHHHhCCCchhc
Confidence 44799999999999999999994 6677889999987321 112233456778999999999999999
Q ss_pred cccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++++... ...|+||||+++ +|.+.+. ..++...+..++.|++.||.||| ++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Ni 150 (355)
T cd07874 81 LLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 150 (355)
T ss_pred eeeeeeccccccccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHE
Confidence 99987543 346999999976 6776662 23778888999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
+++.++.++|+|||++......... ....||..|+|||++.+..++.++|+||||+++|+|++|+.||.........
T Consensus 151 ll~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 227 (355)
T cd07874 151 VVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_pred EECCCCCEEEeeCcccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999765433221 1246789999999999989999999999999999999999999653210000
Q ss_pred chHHH---------------HHHHHhhhC-CCCcccchhhc--------CCchHHHHHHHHHHHhhhcCCCCCCCCChhh
Q 040480 266 MDMVR---------------WMRNVMASE-NPNRAIDSKLL--------GNGYEEQMLLVLKLACFCTLADPDERPNSKD 321 (325)
Q Consensus 266 ~~~~~---------------~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (325)
..... ......... .......+... ..........+.+|+.+||+.||++|||+.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~e 307 (355)
T cd07874 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307 (355)
T ss_pred HHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHH
Confidence 00000 000000000 00000000000 0001112335889999999999999999999
Q ss_pred hhc
Q 040480 322 VRC 324 (325)
Q Consensus 322 ll~ 324 (325)
+++
T Consensus 308 ll~ 310 (355)
T cd07874 308 ALQ 310 (355)
T ss_pred Hhc
Confidence 986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=296.16 Aligned_cols=194 Identities=21% Similarity=0.257 Sum_probs=162.5
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
....+|++.+.||+|+||.||+|. +..++..||+|... ......|+.++++++||||+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~valK~~~---------------------~~~~~~E~~~l~~l~h~~iv 120 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKIGQ---------------------KGTTLIEAMLLQNVNHPSVI 120 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEE-ECCCCceEEEEeCC---------------------ccccHHHHHHHHhCCCCCCc
Confidence 345689999999999999999996 45567889999641 11224588899999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++......++|+|++.+ +|.+++.. ....+++..+..++.|++.||.||| ++||+||||||+||+++.+
T Consensus 121 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~ 193 (357)
T PHA03209 121 RMKDTLVSGAITCMVLPHYSS-DLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDV 193 (357)
T ss_pred ChhheEEeCCeeEEEEEccCC-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence 999999999999999999965 88888743 3456889999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~ 256 (325)
+.++|+|||.+........ .....||..|+|||++.+..++.++|+||||+++|+|+++..|+
T Consensus 194 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 194 DQVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCEEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999999875332221 12246899999999999989999999999999999999855443
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=286.91 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=196.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
.|++.+.||.|+||+||+|. +..+++.+|+|.+... ..........+.+|+.+++.++|++++.+.+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~ 67 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQ-VRATGKMYACKRLEKK------------RIKKRKGESMALNEKQILEKVNSQFVVNLAY 67 (285)
T ss_pred CceEEEEEecCCCeEEEEEE-ECCCCcEEEEEEeehh------------hhhhhhHHHHHHHHHHHHHHcCCcCceeEEE
Confidence 47888999999999999996 4567889999987321 1111123345678999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+..++..++++||+.+++|.+.+... ....+++..+..++.|++.||.||| ++||+|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~k 142 (285)
T cd05632 68 AYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred EEecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEE
Confidence 999999999999999999999888432 2346899999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||++......... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... .........
T Consensus 143 l~Dfg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~---~~~~~~~~~ 216 (285)
T cd05632 143 ISDLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK---VKREEVDRR 216 (285)
T ss_pred EecCCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHh
Confidence 9999998765432221 1246889999999999888999999999999999999999999653211 011111111
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
...... .... .....+.+|+.+||+.||++||| +.++++
T Consensus 217 ~~~~~~---~~~~--------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 217 VLETEE---VYSA--------KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred hhcccc---ccCc--------cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111111 1111 11223789999999999999999 556553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=283.47 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=195.5
Q ss_pred cccccccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
|.+.+.||+|+||.||+|..... .+..+|+|.+... .........+.+|+..++.++||||++++
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 67 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-------------IHTYSEIEEFLSEAACMKDFDHPNVMKLI 67 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC-------------cCCHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 67889999999999999975432 3478999987321 11223356788999999999999999999
Q ss_pred cceecCCc------eEEEEEcccCCCHHHHHhhhc--ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 114 AHMVRPDS------HLLVYDFMKNGSLQAVLYDVS--KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 114 ~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+.+..... .++++||+++++|..++.... .....++......++.|++.||.||| +.+++|+||||+||
T Consensus 68 ~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Ni 144 (273)
T cd05035 68 GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNC 144 (273)
T ss_pred eeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheE
Confidence 98765544 799999999999999985432 12346888889999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~ 264 (325)
++++++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 145 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---- 220 (273)
T cd05035 145 MLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---- 220 (273)
T ss_pred EECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----
Confidence 999999999999999986654332222212234668999999988889999999999999999999 889986522
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..... ........... + ...+..+.+++.+||+.||.+|||+.++++
T Consensus 221 ~~~~~---~~~~~~~~~~~--~--------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 221 NHEIY---DYLRHGNRLKQ--P--------EDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred HHHHH---HHHHcCCCCCC--C--------cCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12222 22222211111 1 112234899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=282.21 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=190.4
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecC
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 119 (325)
+.||+|+||.||+|+ +..+++.+|+|.+.. .........+.+|+.+++.+.||||+++++++...
T Consensus 1 ~~lg~g~~g~vy~~~-~~~~~~~~a~k~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 65 (252)
T cd05084 1 ERIGRGNFGEVFSGR-LRADNTPVAVKSCRE--------------TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 65 (252)
T ss_pred CccCcccCccEEEEE-EecCCceEEEEecCc--------------cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 478999999999996 455788899997621 11223456788999999999999999999999999
Q ss_pred CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccc
Q 040480 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199 (325)
Q Consensus 120 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg 199 (325)
...++||||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||
T Consensus 66 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 139 (252)
T cd05084 66 QPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFG 139 (252)
T ss_pred CCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccc
Confidence 999999999999999999842 2345788899999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 200 LAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
.+.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .... ......
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~~---~~~~~~ 212 (252)
T cd05084 140 MSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----QQTR---EAIEQG 212 (252)
T ss_pred cCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----HHHH---HHHHcC
Confidence 9875443211111111122456999999988889999999999999999997 8889864221 1111 111111
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
... ..+ ...+..+.+++.+||+.||++|||+.+++++
T Consensus 213 ~~~--~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 213 VRL--PCP--------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred CCC--CCc--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 111 1112348999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=292.02 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=203.1
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HR 107 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ 107 (325)
+-.....|++++.||.||.+.||++.- .+..-+|+|++. ..........-+..|+.+|.+|+ |.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~--s~~~iyalkkv~-------------~~~~D~qtl~gy~nEI~lL~KLkg~~ 420 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLN--SDKQIYALKKVV-------------LLEADNQTLDGYRNEIALLNKLKGHD 420 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeec--CCCcchhhhHHH-------------HhhcCHHHHHHHHHHHHHHHHhcCCc
Confidence 334667899999999999999999953 344668888762 23344566788999999999996 79
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+|++++++-..++.+|+|||+= ..+|..++... ....+.-....++.||+.++.++| ..||||.||||-|+++
T Consensus 421 ~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl 493 (677)
T KOG0596|consen 421 KIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL 493 (677)
T ss_pred eEEEEeeeeccCceEEEEeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE
Confidence 9999999999999999999965 56999999542 222343478889999999999999 7799999999999998
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCC-----------CCCccchhhHHHHHHHHHhCCCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-----------ISEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-----------~~~~~DvwslG~il~~ll~g~~p~ 256 (325)
-. |.+||+|||+|..........-...++||..|+|||.+.... .+.++||||||||+|+|+.|+.||
T Consensus 494 Vk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf 572 (677)
T KOG0596|consen 494 VK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF 572 (677)
T ss_pred Ee-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence 74 589999999999888777776666689999999999875322 457899999999999999999999
Q ss_pred CCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 257 DDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+... ...........+...++-...+..++ ++++++.||..||++|||+.++|+
T Consensus 573 ~~~~---------n~~aKl~aI~~P~~~Iefp~~~~~~~-----li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 573 GQII---------NQIAKLHAITDPNHEIEFPDIPENDE-----LIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHH---------HHHHHHHhhcCCCccccccCCCCchH-----HHHHHHHHHhcCcccCCCcHHHhc
Confidence 7521 12223333333333222222222221 899999999999999999999986
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=285.58 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=197.1
Q ss_pred cCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
.+|.+.++||+|+||.||+++.. ..++..+++|.+. .........+.+|+.+++.++||||
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~---------------~~~~~~~~~~~~e~~~l~~l~h~~i 69 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK---------------EASESARQDFQREAELLTVLQHQHI 69 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecC---------------cCCHHHHHHHHHHHHHHhcCCCCCC
Confidence 57889999999999999999642 2345678888762 1222345678899999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcc-----------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK-----------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
+++++++...+..++++||+++++|.+++..... ....+++..+..++.|++.|++||| ++|++|+
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~ 146 (280)
T cd05092 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHR 146 (280)
T ss_pred ceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 9999999999999999999999999999854321 1135788889999999999999999 8899999
Q ss_pred CCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 040480 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFD 257 (325)
Q Consensus 179 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~ 257 (325)
||+|+||++++++.++|+|||++................++..|+|||...+..++.++|+||||+++|+|++ |..||.
T Consensus 147 dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 147 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred cccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999999999976543322111112344678999999998889999999999999999998 999986
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... ..... ..........+ . ..+..+.+++.+||+.||.+||++.++++
T Consensus 227 ~~~~----~~~~~---~~~~~~~~~~~--~--------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 227 QLSN----TEAIE---CITQGRELERP--R--------TCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCCH----HHHHH---HHHcCccCCCC--C--------CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4221 11111 11111111100 0 11223889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=281.67 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=199.0
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|+||.||+++ +..++..+|+|.+.... .....+.+..|+.+++.++||||+++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~-~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 65 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQ-HVNSDQKYAMKEIRLPK--------------SSSAVEDSRKEAVLLAKMKHPNIVAFKE 65 (255)
T ss_pred CceEEEEeeccCCeEEEEEE-EcCCCceEEEEEEEcCc--------------chHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 58899999999999999996 55678899999873211 1123456778899999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+...+..++++||+++++|.+++.. .....++......++.|++.||.+|| ++|++|+||+|+||++++++.++
T Consensus 66 ~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~ 140 (255)
T cd08219 66 SFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVK 140 (255)
T ss_pred EEEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEE
Confidence 99999999999999999999998843 23345788889999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
++|||.+......... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.... .......
T Consensus 141 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~ 211 (255)
T cd08219 141 LGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILK 211 (255)
T ss_pred EcccCcceeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHHH
Confidence 9999999766443221 112467889999999998889999999999999999999999996421 1111222
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ .+. .....+.+++.+||+.||++|||+.+++.
T Consensus 212 ~~~~~~~~--~~~--------~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 212 VCQGSYKP--LPS--------HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HhcCCCCC--CCc--------ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 22111111 111 11223889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=282.78 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=198.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||.|+||.||+|... .+..+++|.+... .......+..|+.+++.++||||++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~--~~~~~~~k~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~ 66 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWK--NRVRVAIKILKSD---------------DLLKQQDFQKEVQALKRLRHKHLIS 66 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEec--CCCcEEEEecccc---------------chhhHHHHHHHHHHHhcCCCcchhh
Confidence 3467999999999999999999754 2788999987321 1223456788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++......++||||+++++|.+++... ....++...+..++.|++.|+.||| ++|++|+||+|+||+++.++
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~ 141 (261)
T cd05148 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDL 141 (261)
T ss_pred eeeeEecCCCeEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCc
Confidence 999999999999999999999999999542 3345788889999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+........... ...++..|+|||...+..++.++|+||||+++|+|++ |..||.... ..+...
T Consensus 142 ~~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----~~~~~~ 215 (261)
T cd05148 142 VCKVADFGLARLIKEDVYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----NHEVYD 215 (261)
T ss_pred eEEEccccchhhcCCcccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----HHHHHH
Confidence 999999999976543221111 1245678999999988889999999999999999998 899996532 112222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..........+ ...+..+.+++.+||+.||.+|||+.++++
T Consensus 216 ---~~~~~~~~~~~----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 216 ---QITAGYRMPCP----------AKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---HHHhCCcCCCC----------CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 12221111110 111233889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=291.99 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=192.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||.|+||.||+|. +..+++.||+|.+... .........+.+|+.+++.++||||++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~ 78 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAY-DTRLRQKVAVKKLSRP-------------FQSLIHARRTYRELRLLKHMKHENVIG 78 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEE-ECCCCCEEEEEEeCch-------------hhhhHHHHHHHHHHHHHHhcCCCchhh
Confidence 45789999999999999999995 5567889999987311 111123445778999999999999999
Q ss_pred cccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++++... ...|++++++ +++|.+++ ....++...+..++.|++.||.||| ++||+|+||||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Ni 149 (343)
T cd07878 79 LLDVFTPATSIENFNEVYLVTNLM-GADLNNIV-----KCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNV 149 (343)
T ss_pred hhhhhcccccccccCcEEEEeecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhE
Confidence 99987543 3468999988 67898877 2346899999999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+++.++.++|+|||++....... ....|+..|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 150 l~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--- 221 (343)
T cd07878 150 AVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY--- 221 (343)
T ss_pred EECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH---
Confidence 99999999999999997654321 22468899999999876 4688999999999999999999999964221
Q ss_pred cchHHHHHHHHhhhCCCC-----------------cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPN-----------------RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+............... ...+..............+.+|+.+||+.||.+|||+.|+++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 222 -IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred -HHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111111000000000 000000000000111223789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=284.54 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=198.5
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...+.|++++.||+|+||.||+|+ +..+++.+++|.+.. ........+.+|+.+++.++||||+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~-~~~~~~~~~~k~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~ 72 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAK-NKETGALAAAKVIET---------------KSEEELEDYMVEIEILATCNHPYIV 72 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEE-ECCCCceEEEEEecc---------------CCHHHHHHHHHHHHHHHhCCCCcEe
Confidence 345789999999999999999996 556778999998732 1223456788899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++.+..++..++||||+++++|...+.. ....++...+..++.|++.++.+|| +.+++|+||+|+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~ 146 (292)
T cd06644 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLD 146 (292)
T ss_pred eeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCC
Confidence 999999999999999999999999887733 2345889999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
+.++|+|||.+........ ......++..|+|||.+. ...++.++|+||||+++|+|++|..||.....
T Consensus 147 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---- 220 (292)
T cd06644 147 GDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---- 220 (292)
T ss_pred CCEEEccCccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----
Confidence 9999999998875433211 112246788999999874 33467899999999999999999999865321
Q ss_pred chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+....+ ......+.+++.+||..||++||+++++++
T Consensus 221 ---~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 221 ---MRVLLKIAKSEPPTLSQP--------SKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---HHHHHHHhcCCCccCCCC--------cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111112221111111111 111223889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=286.40 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=197.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.+|+|.+.... ......+.+|+.+++.++||||++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~-~~~~~~~~~ik~~~~~~---------------~~~~~~~~~e~~~~~~l~h~~ii~ 70 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKAR-NVNTGELAAIKVIKLEP---------------GEDFAVVQQEIIMMKDCKHSNIVA 70 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEE-EcCCCcEEEEEEEecCc---------------hhHHHHHHHHHHHHHhCCCCCeee
Confidence 44689999999999999999995 55678899999873221 122345678899999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+...+..++++||+++++|.+++. ....++...+..++.|++.++.||| +.|++|+||+|+||+++.++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~ 143 (267)
T cd06645 71 YFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNG 143 (267)
T ss_pred EEEEEEeCCEEEEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence 9999999999999999999999999883 3456899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||.+........ ......|+..|+|||.+. ...++.++|+||||+++|+|++|..||...... ..
T Consensus 144 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~----~~ 217 (267)
T cd06645 144 HVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RA 217 (267)
T ss_pred CEEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch----hh
Confidence 999999999876543222 112246889999999874 445788999999999999999999998643211 10
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. .........+....+. ...+..+.+++.+||..||++|||++++++
T Consensus 218 ~--~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 218 L--FLMTKSNFQPPKLKDK-------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred H--HhhhccCCCCCccccc-------CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 0000111111100000 011223889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=286.54 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=197.6
Q ss_pred cCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
.+|++.+.||.|+||.||+|.+.. ..+..+|+|.+.... .......+.+|..++..++||||
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~e~~~~~~l~h~~i 70 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--------------EGPLREEFKHEAMMRSRLQHPNI 70 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--------------CHHHHHHHHHHHHHHhcCCCCCc
Confidence 568999999999999999997532 235789999873211 11234568889999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhc------------ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS------------KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIH 177 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH 177 (325)
+++++++...+..++++||+.+++|.+++.... .....++...+..++.|++.||.|+| ++|++|
T Consensus 71 v~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H 147 (283)
T cd05091 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVH 147 (283)
T ss_pred CeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccc
Confidence 999999999999999999999999999984211 11235778888999999999999999 889999
Q ss_pred cCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 040480 178 RDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256 (325)
Q Consensus 178 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~ 256 (325)
+||||+||++++++.++|+|||++................+++.|+|||...+..++.++||||||+++|+|++ |..||
T Consensus 148 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 227 (283)
T cd05091 148 KDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227 (283)
T ss_pred cccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999876543322222222345678999999988889999999999999999998 88888
Q ss_pred CCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 257 DDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..... ......+....... .+ .+.+..+.+|+.+||+.+|.+||++.+|++
T Consensus 228 ~~~~~-------~~~~~~i~~~~~~~--~~--------~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 228 CGYSN-------QDVIEMIRNRQVLP--CP--------DDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred CCCCH-------HHHHHHHHcCCcCC--CC--------CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 65221 12222222222111 11 112233889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.61 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=200.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
...+|++.+.||.|++|.||+|. +..+++.+++|.+... .......+.+|+.+++.++|||+++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~-~~~~~~~v~iK~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~ 80 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAI-DVATGQEVAIKQINLQ---------------KQPKKELIINEILVMKELKNPNIVN 80 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEE-EcCCCcEEEEEEEecc---------------cCchHHHHHHHHHHHHhcCCCceee
Confidence 45679999999999999999995 5677889999987321 1233456788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+......++|+||+++++|.+++. ...+++..+..++.+++.++++|| +.|++|+||+|+||+++.++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~ 152 (296)
T cd06655 81 FLDSFLVGDELFVVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDG 152 (296)
T ss_pred eeeeEecCceEEEEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence 9999999999999999999999999883 235889999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...
T Consensus 153 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~ 223 (296)
T cd06655 153 SVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRA 223 (296)
T ss_pred CEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHH
Confidence 9999999998765433221 1124678899999999888899999999999999999999999965322 111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.........+....+ ......+.++|.+||..||.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 224 LYLIATNGTPELQNP--------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHhcCCcccCCc--------ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111111111110000 112223889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=285.40 Aligned_cols=259 Identities=19% Similarity=0.304 Sum_probs=199.1
Q ss_pred hhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||.||+|.+.. .++..+|+|.+... ........+.+|+.+++.+.||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--------------~~~~~~~~~~~e~~~l~~~~~~ 69 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--------------ASMRERIEFLNEASVMKEFNCH 69 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc--------------cCHHHHHHHHHHHHHHHhCCCC
Confidence 34689999999999999999997542 23478999987311 1112344678899999999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhccc------ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG------RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~ 181 (325)
||+++++++......++||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||+
T Consensus 70 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~ 146 (277)
T cd05032 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLA 146 (277)
T ss_pred ceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccC
Confidence 9999999999999999999999999999998543221 224677888999999999999999 8899999999
Q ss_pred CCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcc
Q 040480 182 PANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFF 260 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~ 260 (325)
|+||+++.++.++|+|||++................++..|+|||...+..++.++|+||||+++|++++ |..||....
T Consensus 147 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 147 ARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred hheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999999999999999999876544322212222356778999999988889999999999999999998 999986421
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... .......... +.. .+..+.+++.+||+.+|++|||+.++++
T Consensus 227 ----~~~~~~---~~~~~~~~~~--~~~--------~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 227 ----NEEVLK---FVIDGGHLDL--PEN--------CPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ----HHHHHH---HHhcCCCCCC--CCC--------CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 112222 2221111111 100 1234899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=280.93 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=195.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|.+.+.||.|+||.||+|++. .+..+|+|.+... ......+.+|+.+++.++||||+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~----------------~~~~~~~~~e~~~l~~l~h~~i~~~ 64 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG----------------SMSEDEFIEEAKVMMKLSHEKLVQL 64 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCC----------------cccHHHHHHHHHHHhcCCCCCeeeE
Confidence 357899999999999999999753 3456999987311 1223567889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..+++|||+.+++|.+++.. ....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.
T Consensus 65 ~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~ 138 (256)
T cd05113 65 YGVCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGC 138 (256)
T ss_pred EEEEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCC
Confidence 9999988899999999999999999843 2236888999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+......... ......++..|.|||...+..++.++|+||||+++|+|++ |..||..... ....
T Consensus 139 ~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~-- 211 (256)
T cd05113 139 VKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETV-- 211 (256)
T ss_pred EEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHH--
Confidence 999999998765433221 1111234567999999988889999999999999999998 9999864221 1111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............. ..+..+.+++.+||+.||.+|||+.++++
T Consensus 212 -~~~~~~~~~~~~~----------~~~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 212 -EKVSQGLRLYRPH----------LASEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred -HHHhcCCCCCCCC----------CCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1222221111000 01233899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=287.87 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=200.3
Q ss_pred HhhhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI- 104 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 104 (325)
....++|++.+.||+|+||.||++.+.. .....+|+|.+... ........+.+|+.++..+
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--------------~~~~~~~~~~~E~~~l~~l~ 73 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--------------ATEKDLSDLVSEMEMMKMIG 73 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC--------------CCHHHHHHHHHHHHHHHhhc
Confidence 3455789999999999999999997542 23467999987321 1123345688899999999
Q ss_pred CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhc------------ccccccChhhHHHHHHHHHHHHHHHHhcCC
Q 040480 105 RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS------------KGRRELEWLSRHKIALAVASGLEYLHMHHS 172 (325)
Q Consensus 105 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~ 172 (325)
+||||+++++++...+..+++|||+++++|.+++.... .....+++..+..++.|++.||.||| +
T Consensus 74 ~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~ 150 (293)
T cd05053 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---S 150 (293)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---H
Confidence 79999999999999999999999999999999985421 23456888889999999999999999 8
Q ss_pred CCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-
Q 040480 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM- 251 (325)
Q Consensus 173 ~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~- 251 (325)
.+++|+||+|+||+++.++.++|+|||.+................++..|+|||...+..++.++||||||+++|++++
T Consensus 151 ~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 151 KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcC
Confidence 8999999999999999999999999999986654332222222234567999999988889999999999999999997
Q ss_pred CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 252 GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 252 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|..||.... ..+... ..........+ ...+..+.+|+.+||..||++|||+.++++
T Consensus 231 g~~p~~~~~----~~~~~~---~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 231 GGSPYPGIP----VEELFK---LLKEGYRMEKP----------QNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred CCCCCCCCC----HHHHHH---HHHcCCcCCCC----------CCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 999986421 111121 11111111111 011233889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=285.48 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=197.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||++. +..++..+|+|.+... ........+.+|++++++++||||++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~~~a~k~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 65 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVL-HRPSGLIMARKLIHLE--------------IKPAIRNQIIRELKVLHECNSPYIVGFY 65 (308)
T ss_pred CCceEEeeccCCCCeEEEEEE-EcCCCeEEEEEEeccc--------------cCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 469999999999999999996 4566788999987321 1223455688899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEecCCCC
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~nil~~~~~~ 192 (325)
+.+..++..++|+||+++++|.+++.. ...++...+..++.|++.||.||| + .+++|+||+|+||+++.++.
T Consensus 66 ~~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~ 138 (308)
T cd06615 66 GAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGE 138 (308)
T ss_pred EEEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCc
Confidence 999999999999999999999999843 356888999999999999999999 5 48999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||.+........ ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... .......
T Consensus 139 ~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~ 210 (308)
T cd06615 139 IKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMF 210 (308)
T ss_pred EEEccCCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHhh
Confidence 99999999865433211 224678899999999888899999999999999999999999854221 1111100
Q ss_pred HHHhhhCC-CCc--------------------------ccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASEN-PNR--------------------------AIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~-~~~--------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ ... ...+... .......+.+++.+||..||++|||+.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred cCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 000 0000000 0012334889999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=286.72 Aligned_cols=265 Identities=20% Similarity=0.291 Sum_probs=195.7
Q ss_pred hcCcccccccccCcceeEEEEEecC---------------CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHH
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPG---------------SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 97 (325)
.++|++.+.||.|+||.||++.+.. .+...+|+|.+... ........+.+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--------------~~~~~~~~~~~E 69 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--------------ANKNARNDFLKE 69 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--------------CCHHHHHHHHHH
Confidence 4679999999999999999985321 12346899987311 122335678899
Q ss_pred HHHHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhccc-------ccccChhhHHHHHHHHHHHHHHHHhc
Q 040480 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG-------RRELEWLSRHKIALAVASGLEYLHMH 170 (325)
Q Consensus 98 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lh~~ 170 (325)
+.+++.++||||+++++++...+..+++|||+++++|.+++...... ...++...+..++.|++.||.|||
T Consensus 70 ~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-- 147 (296)
T cd05095 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-- 147 (296)
T ss_pred HHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--
Confidence 99999999999999999999999999999999999999998553211 124667789999999999999999
Q ss_pred CCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHH
Q 040480 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLV 250 (325)
Q Consensus 171 ~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (325)
+.|++|+||||+||+++.++.++|+|||++................++..|++||...+..++.++|+||||+++|+|+
T Consensus 148 -~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~ 226 (296)
T cd05095 148 -SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226 (296)
T ss_pred -HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHH
Confidence 8899999999999999999999999999987654332211111123456899999888888999999999999999999
Q ss_pred h--CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 251 M--GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 251 ~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+ |..||..... ....................+. . ..++..+.+|+.+||+.||++|||+.++++
T Consensus 227 ~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 227 TLCKEQPYSQLSD----EQVIENTGEFFRDQGRQVYLPK---P---ALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HhCCCCCccccCh----HHHHHHHHHHHhhccccccCCC---C---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8 7788864322 1111111111110000000000 0 011234889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.12 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=203.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
+.++|++.+.||+|+||+||++. ...++..+|+|.+... ........+.+|+.+++.++||||++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~-~~~~~~~~a~k~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i~~ 67 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVK-HIPTGTVMAKKVVHIG--------------AKSSVRKQILRELQIMHECRSPYIVS 67 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEE-EcCCCcEEEEEEEEec--------------CcchHHHHHHHHHHHHHHcCCCCcce
Confidence 34789999999999999999995 4567888999987321 11234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+...+..++|+||+++++|.+++.. ...++......++.+++.+|.|||.. .+++|+||+|+||++++++
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~ 141 (284)
T cd06620 68 FYGAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRG 141 (284)
T ss_pred EeeeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCC
Confidence 99999999999999999999999988833 34688999999999999999999932 4899999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC----Ccch
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT----GEMD 267 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~----~~~~ 267 (325)
.++|+|||++........ ....|+..|+|||.+.+..++.++|+||||+++|++++|..||....... ....
T Consensus 142 ~~~l~d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~ 217 (284)
T cd06620 142 QIKLCDFGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG 217 (284)
T ss_pred cEEEccCCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhH
Confidence 999999999865432221 12467889999999888888999999999999999999999997543321 1112
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
+............+... . ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 218 ILDLLQQIVQEPPPRLP--S-------SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HHHHHHHHhhccCCCCC--c-------hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 22333322222111100 0 1123348899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=280.88 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=194.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+.. .......+.+|+.+++.++||||++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIRE----------------GAMSEDDFIEEAKVMMKLSHPNLVQLY 65 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec--CCccEEEEEecc----------------CCCCHHHHHHHHHHHHhCCCCCEEEEE
Confidence 56899999999999999999653 456799998721 112234577899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..++|+||+++++|.+++.. ....+++..+..++.|++.|+++|| ++|++|+||+|+||+++.++.+
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~ 139 (256)
T cd05059 66 GVCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVV 139 (256)
T ss_pred EEEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcE
Confidence 999999999999999999999999843 2336888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||.+........... ....++..|+|||...+..++.++|+||||+++|+|++ |..||..... .+..
T Consensus 140 kl~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~--- 211 (256)
T cd05059 140 KVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----SEVV--- 211 (256)
T ss_pred EECCcccceeccccccccc-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----HHHH---
Confidence 9999999876543221111 11123457999999998889999999999999999998 8999864221 1111
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
...........+ . ..+..+.+++.+||+.+|++|||+.+++++
T Consensus 212 ~~~~~~~~~~~~-------~---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 212 ESVSAGYRLYRP-------K---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHcCCcCCCC-------C---CCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 121111111110 0 122348999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=287.80 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=201.0
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
....++|++.+.||.|+||.||+|. +..++..||+|.+... .....+.+.+|+.+++.++||||
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~-~~~~~~~vaiK~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~i 78 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAI-DIATGQEVAIKQMNLQ---------------QQPKKELIINEILVMRENKNPNI 78 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEE-ECCCCCEEEEEEEecC---------------ccchHHHHHHHHHHHHhCCCCCE
Confidence 4466899999999999999999995 5667889999988321 11234567888999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++.+...+..++||||+++++|.+++. ...++...+..++.|++.+|.+|| +.|++|+||+|+||+++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~ 150 (297)
T cd06656 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGM 150 (297)
T ss_pred eeEEEEEecCCEEEEeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECC
Confidence 999999999999999999999999999983 245788889999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||.+.......... ....+++.|+|||...+..++.++|+||||+++|++++|..||.........
T Consensus 151 ~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---- 224 (297)
T cd06656 151 DGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---- 224 (297)
T ss_pred CCCEEECcCccceEccCCccCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe----
Confidence 9999999999987654332211 1246788999999999888999999999999999999999999653221110
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+... .....+..+.+++.+||..||++|||++++++
T Consensus 225 ---~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 225 ---YLIATNGTPELQ--------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---eeeccCCCCCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111111100 01112233789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=282.79 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=192.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCc----EEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||+||+|.+. .++. .+++|.+.. .........+..|+.+++.+.||
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~~~~~~~~k~~~~--------------~~~~~~~~~~~~~~~~l~~l~h~ 69 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWI-PEGDSIKIPVAIKTIQD--------------RSGRQTFQEITDHMLAMGSLDHA 69 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEc-CCCCceeeEEEEeeccc--------------ccchHHHHHHHHHHHHHhcCCCC
Confidence 3468999999999999999999753 3333 477776521 11112345677788888999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
||+++++++. ....++++||+++++|.+++.. ....+++.....++.|++.||.||| +++++|+||||+||++
T Consensus 70 ~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili 142 (279)
T cd05111 70 YIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILL 142 (279)
T ss_pred CcceEEEEEC-CCccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEE
Confidence 9999999775 4567899999999999999843 3346888999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcc
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEM 266 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~ 266 (325)
++++.++|+|||.+................++..|+|||...+..++.++||||||+++|++++ |..||..... .
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~ 218 (279)
T cd05111 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----H 218 (279)
T ss_pred cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----H
Confidence 9999999999999986644332222222456778999999988889999999999999999998 9999965321 1
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ......... . .+...+.+++.+||..||.+|||+.|+++
T Consensus 219 ~~~~~~---~~~~~~~~~---~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 219 EVPDLL---EKGERLAQP---Q-------ICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHH---HCCCcCCCC---C-------CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111111 111111110 0 01223788999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=279.99 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=195.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.++||+|+||.||+|.. .+++.+|+|.+.. .......+.+|+.+++.++|||+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~--~~~~~~a~K~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~~ 65 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY--NGHTKVAIKSLKQ----------------GSMSPEAFLAEANLMKQLQHPRLVR 65 (260)
T ss_pred chHHceeeeeeccCccceEEeeec--CCCceEEEEEecC----------------CCCcHHHHHHHHHHHHhcCCcCeee
Confidence 457899999999999999999964 3567899998731 1123456788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++ ..+..++++||+.+++|.+++... ....++......++.|++.+|+||| +.|++|+||+|+||+++.++
T Consensus 66 ~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~ 139 (260)
T cd05067 66 LYAVV-TQEPIYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETL 139 (260)
T ss_pred EEEEE-ccCCcEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCC
Confidence 99876 456789999999999999998442 3346788889999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+........... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||.... ......
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~ 214 (260)
T cd05067 140 CCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT----NPEVIQ 214 (260)
T ss_pred CEEEccCcceeecCCCCcccc-cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC----hHHHHH
Confidence 999999999976653222111 11244678999999988889999999999999999998 999996422 112222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ........ + ...+..+.+++.+||+.||++|||++++++
T Consensus 215 ~~---~~~~~~~~--~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 215 NL---ERGYRMPR--P--------DNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HH---HcCCCCCC--C--------CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 11111110 0 111234999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=282.01 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=191.8
Q ss_pred cccccccccCcceeEEEEEecCCCC-cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNG-KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+.+.+.||+|+||.||+|++..... ..+|+|.+... .........+.+|..+++.++||||+++++
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-------------ICTRSEMEDFLSEAVCMKEFDHPNVMRLIG 67 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-------------cCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4578899999999999997543322 36899987321 112234567888999999999999999998
Q ss_pred ceecC------CceEEEEEcccCCCHHHHHhhhc--ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 115 HMVRP------DSHLLVYDFMKNGSLQAVLYDVS--KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 115 ~~~~~------~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
.+... ...++++||+.+++|.+++.... .....+++.....++.|++.||.||| +++++|+||||+||+
T Consensus 68 ~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil 144 (272)
T cd05075 68 VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCM 144 (272)
T ss_pred EEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheE
Confidence 76432 24689999999999999874322 22345788899999999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGE 265 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~ 265 (325)
+++++.++|+|||++................++..|++||...+..++.++|+||||+++|+|++ |..||.... .
T Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~ 220 (272)
T cd05075 145 LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE----N 220 (272)
T ss_pred EcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC----H
Confidence 99999999999999987654332111112345678999999998889999999999999999999 889986421 1
Q ss_pred chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... ........... +. ..+..+.+++.+||+.||++|||+.++++
T Consensus 221 ~~~~---~~~~~~~~~~~--~~--------~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 221 SEIY---DYLRQGNRLKQ--PP--------DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred HHHH---HHHHcCCCCCC--CC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1222 22222221110 10 12233899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=282.83 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=196.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
++-|++.+.||+|+||.||+|. +..++..+++|.+... .......+.+|+.+++.+.|||++++
T Consensus 4 ~~~~~i~~~lg~g~~g~v~~~~-~~~~~~~~~~k~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~ii~~ 67 (282)
T cd06643 4 EEFWEIIGELGDGAFGKVYKAQ-NKETGVLAAAKVIDTK---------------SEEELEDYMVEIDILASCDHPNIVKL 67 (282)
T ss_pred HHHHHHHhhcccCCCeEEEEEE-ECCCCeEEEEEEeCCC---------------CHHHHHHHHHHHHHHHHCCCCCeeeE
Confidence 4458899999999999999996 4567788899987321 12335567889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+...+..++|+||+++++|...+.. ....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.
T Consensus 68 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~ 141 (282)
T cd06643 68 LDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGD 141 (282)
T ss_pred EEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCC
Confidence 9999999999999999999999887733 2356889999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
++|+|||++......... .....++..|+|||++. +..++.++|+||||+++|+|++|..||.....
T Consensus 142 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------ 213 (282)
T cd06643 142 IKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------ 213 (282)
T ss_pred EEEccccccccccccccc--cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------
Confidence 999999998765332211 12246788999999874 34577899999999999999999999865321
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+....+. ..+..+.+++.+||+.||.+|||+.++++
T Consensus 214 -~~~~~~~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 214 -MRVLLKIAKSEPPTLAQPS--------RWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -HHHHHHHhhcCCCCCCCcc--------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111111111111 11234899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=314.80 Aligned_cols=258 Identities=23% Similarity=0.376 Sum_probs=205.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCc----EEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
.++-.+.+.||+|+||.||.|.+....+. .||+|.+.. .........+.+|..+|+.+.|||
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--------------~~~~~~~~~Fl~Ea~~m~~f~HpN 756 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--------------LSSEQEVSDFLKEALLMSKFDHPN 756 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--------------cCCHHHHHHHHHHHHHHhcCCCcc
Confidence 34566778899999999999998877665 488888731 223466788999999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcc---cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK---GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
|+++++++.+....++++|||.||+|..++++... ....++......++.|++.|++||+ +++.|||||..+|+
T Consensus 757 iv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNC 833 (1025)
T KOG1095|consen 757 IVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNC 833 (1025)
T ss_pred eeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhhe
Confidence 99999999999999999999999999999976421 2567888899999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~ 264 (325)
|+++...|||+|||+|+...............-+..|+|||.+....++.++||||||+++||+++ |..||.+..+
T Consensus 834 LL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--- 910 (1025)
T KOG1095|consen 834 LLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--- 910 (1025)
T ss_pred eecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---
Confidence 999999999999999994433332222111123468999999999999999999999999999999 9999986433
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.++ +.....+.+...+ ..+++.+.++|..||+.+|++||++..|++
T Consensus 911 -~~v---~~~~~~ggRL~~P----------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 911 -FEV---LLDVLEGGRLDPP----------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -HHH---HHHHHhCCccCCC----------CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 222 2222333322111 123334889999999999999999998874
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=281.93 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=195.3
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
.+.+.|++.+.||+|+||.||+|. ...+++.+|+|.+... ......+..|+.++..+ +|||+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~-~~~~~~~~aik~~~~~----------------~~~~~~~~~e~~~l~~~~~h~~i 65 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGR-HVKTGQLAAIKVMDVT----------------GDEEEEIKQEINMLKKYSHHRNI 65 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEE-EcCCCcEEEEEEEEcC----------------CccHHHHHHHHHHHHHhcCCCCe
Confidence 467889999999999999999995 4567889999987321 12345677888888888 69999
Q ss_pred cccccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 110 LPLLAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 110 ~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+++++.+... ...++++||+++++|.+++.. .....+++..+..++.|++.|+.||| +++++|+||+|+
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~ 140 (272)
T cd06637 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQ 140 (272)
T ss_pred eeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHH
Confidence 9999988653 457999999999999999854 22346888889999999999999999 889999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----LTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
||++++++.++|+|||++......... .....|+..|+|||++.+ ..++.++|+||||+++|+|++|..||..
T Consensus 141 nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 141 NVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred HEEECCCCCEEEccCCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999999999998765432221 222568889999998763 3578899999999999999999999964
Q ss_pred cccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 259 FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ..... ........ ... . ...+..+.+|+.+||..||.+|||+.++++
T Consensus 219 ~~~------~~~~~-~~~~~~~~--~~~----~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 219 MHP------MRALF-LIPRNPAP--RLK----S---KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCH------HHHHH-HHhcCCCC--CCC----C---CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 321 11111 11111100 000 0 012234899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=291.98 Aligned_cols=258 Identities=23% Similarity=0.275 Sum_probs=194.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||++. ...+++.||+|.+.. ...........+.+|..++..++|+||++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 67 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVK-MKNTGQVYAMKILNK------------WEMLKRAETACFREERDVLVNGDRRWITNLH 67 (331)
T ss_pred CCceEEEEEEecCCeEEEEEE-ECCCCCEEEEEEEEH------------HHHhhhhhHHHHHHHHHHHHhCCCCCCCceE
Confidence 479999999999999999995 456788999999831 1112223455678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+.+..|+||||+++++|.+++.. ....+++..+..++.|++.||.||| +++++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~ 141 (331)
T cd05597 68 YAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHI 141 (331)
T ss_pred EEEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCE
Confidence 999999999999999999999999843 2345888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
+|+|||++......... ......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.....
T Consensus 142 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------- 213 (331)
T cd05597 142 RLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------- 213 (331)
T ss_pred EEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------
Confidence 99999998765433221 1122468999999999863 3478899999999999999999999964211
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCC--CCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPD--ERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~--~Rps~~ell~ 324 (325)
......+....... ..+.. ....+..+.+++.+||+.+++ .||++.++++
T Consensus 214 ~~~~~~i~~~~~~~-~~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 214 VETYGKIMNHKEHF-QFPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred HHHHHHHHcCCCcc-cCCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 11112222111100 01110 011233378899998865443 3789988874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=281.37 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=200.2
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||.|++|.||+|. +..++..+|+|.+... ........+.+|+.+++.++|||+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 65 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAI-DKRTNQVVAIKVIDLE--------------EAEDEIEDIQQEIQFLSQCRSPYITKYY 65 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEE-ECCCCeEEEEEEeecc--------------ccchHHHHHHHHHHHHHHcCCCCeeeee
Confidence 479999999999999999996 5567889999987321 1123345678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+....++|+||+++++|.+++.. ..++......++.|++.++.+|| +++++|+||+|+||++++++.+
T Consensus 66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~ 137 (274)
T cd06609 66 GSFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDV 137 (274)
T ss_pred EEEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCE
Confidence 999999999999999999999999832 26889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... . ....
T Consensus 138 ~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----~---~~~~ 208 (274)
T cd06609 138 KLADFGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----M---RVLF 208 (274)
T ss_pred EEcccccceeecccccc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----H---HHHH
Confidence 99999999877644221 1224678889999999988899999999999999999999999965321 1 1111
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.....+... . . ..+..+.+++.+||..||++|||++++++
T Consensus 209 ~~~~~~~~~~~-~-----~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 209 LIPKNNPPSLE-G-----N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HhhhcCCCCCc-c-----c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111111100 0 0 02233889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=282.37 Aligned_cols=255 Identities=21% Similarity=0.288 Sum_probs=194.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCC---cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNG---KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
..++|++.+.||+|+||+||+|++...+. ..||+|.+... ........+.+|+.+++.+.|||
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--------------~~~~~~~~~~~e~~~l~~~~~~~ 70 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--------------TSPKANKEILDEAYVMAGVGSPY 70 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--------------CCHHHHHHHHHHHHHHHhcCCCC
Confidence 45789999999999999999997543322 25899987321 11223456788899999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++.. ...+++++|+++|+|.+++.. ....++......++.|++.||.||| +++++|+||||+||+++
T Consensus 71 i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~ 143 (279)
T cd05109 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVK 143 (279)
T ss_pred CceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 9999998865 457899999999999999843 2346889999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
+++.++|+|||++................++..|+|||...+..++.++||||||+++|+|++ |..||.... ...
T Consensus 144 ~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~ 219 (279)
T cd05109 144 SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----ARE 219 (279)
T ss_pred CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHH
Confidence 999999999999987654322211111234567999999988889999999999999999998 899986422 122
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ....... +. ..+..+.+++.+||+.||++||++.++++
T Consensus 220 ~~~~~~---~~~~~~~--~~--------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 220 IPDLLE---KGERLPQ--PP--------ICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHH---CCCcCCC--Cc--------cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222221 1111111 10 11233889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.92 Aligned_cols=258 Identities=25% Similarity=0.334 Sum_probs=195.6
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.++||+|+||.||+|. +..+++.||+|.+.... ........++.+|+.+++.++||||++++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~-d~~tg~~VAIK~I~~~l------------~~~e~~~~rflrEi~ILs~L~HPNIVkl~ 68 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAY-DPVCSRRVALKKIREDL------------SENPLLKKRFLREAKIAADLIHPGIVPVY 68 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEE-ECCCCcEEEEEEECccc------------ccCHHHHHHHHHHHHHHHhCCCcCcCeEE
Confidence 689999999999999999995 56678999999983211 11123345788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhccc-------ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG-------RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
+++.+.+..+++|||++|++|.+++...... ....+...+..++.|++.||.||| ++|++||||||+||+
T Consensus 69 ~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNIL 145 (932)
T PRK13184 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNIL 145 (932)
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEE
Confidence 9999999999999999999999998643211 123455677889999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCc----------------cccceeecCCcccccccccccCCCCCccchhhHHHHHHHHH
Q 040480 187 IDDDMEARISGFDLAILMPDGLT----------------QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLV 250 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~----------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (325)
++.++.++|+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 Ld~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELL 225 (932)
T PRK13184 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225 (932)
T ss_pred EcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHH
Confidence 99999999999999986521100 00111246899999999999999999999999999999999
Q ss_pred hCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhh
Q 040480 251 MGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322 (325)
Q Consensus 251 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (325)
+|..||...... ... . .... ..+... ....+.+..+.+++.+||+.||++||+..+.
T Consensus 226 TG~~PF~~~~~~----ki~-~-~~~i--~~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~ee 282 (932)
T PRK13184 226 TLSFPYRRKKGR----KIS-Y-RDVI--LSPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQE 282 (932)
T ss_pred HCCCCCCCcchh----hhh-h-hhhc--cChhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999652211 110 0 0000 000000 0011223348899999999999999875543
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=285.03 Aligned_cols=262 Identities=20% Similarity=0.257 Sum_probs=200.1
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ 103 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 103 (325)
.+-...++|++.+.||+|+||.||++.+. ..++..+|+|.+... ........+.+|+.++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~ 94 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--------------AHSSEREALMSELKIMSH 94 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc--------------CChHHHHHHHHHHHHHHh
Confidence 34445578999999999999999999642 234567999987311 112334578899999999
Q ss_pred c-CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 104 I-RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 104 l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
+ +||||+++++.+...+..+++|||+++++|.+++... ....+++.....++.|++.||.||| +++++|+||+|
T Consensus 95 l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp 169 (302)
T cd05055 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA 169 (302)
T ss_pred ccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhcc
Confidence 9 7999999999999999999999999999999998431 2233788999999999999999999 88999999999
Q ss_pred CceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCccc
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFS 261 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~ 261 (325)
+||+++.++.++++|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 170 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 170 RNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred ceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 999999999999999999976544322111122345678999999988889999999999999999998 9999865321
Q ss_pred CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... ......... + . .....+.+++.+||..+|++|||+.++++
T Consensus 250 ---~~~~~~~---~~~~~~~~~--~-----~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 250 ---DSKFYKL---IKEGYRMAQ--P-----E---HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---hHHHHHH---HHcCCcCCC--C-----C---CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1111111 111111110 0 0 11223899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=295.93 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=204.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
.++.|.-++.||.|+||.||-| .+..+...||||++.-.. .........+..|+..|.+++|||++.
T Consensus 24 PEklf~dLrEIGHGSFGAVYfA-rd~~n~evVAIKKMsySG------------KQs~EKWqDIlKEVrFL~~l~HPntie 90 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSG------------KQSNEKWQDILKEVRFLRQLRHPNTIE 90 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEe-eccCccceeeeeeccccc------------cccHHHHHHHHHHHHHHHhccCCCccc
Confidence 5667999999999999999999 577888999999983221 122245567899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+-+.|..+...++|||||-| +-.+.+. ....++.+..+..|+.+.+.||+||| +.+.||||||..||++++.|
T Consensus 91 YkgCyLre~TaWLVMEYClG-SAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g 163 (948)
T KOG0577|consen 91 YKGCYLREHTAWLVMEYCLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPG 163 (948)
T ss_pred ccceeeccchHHHHHHHHhc-cHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCC
Confidence 99999999999999999966 8888884 35667999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT---LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.|||+|||.+........ ++||+.|+|||++.. +.|+-++||||||+++.+|...++|.-+. +.
T Consensus 164 ~VKLaDFGSAsi~~PAns------FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-------NA 230 (948)
T KOG0577|consen 164 LVKLADFGSASIMAPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NA 230 (948)
T ss_pred eeeeccccchhhcCchhc------ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-------hH
Confidence 999999999987665433 689999999998753 46899999999999999999999997542 22
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...++++-....|.-. ..+....|..++.+||++-|.+|||.++++.
T Consensus 231 MSALYHIAQNesPtLq---------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 231 MSALYHIAQNESPTLQ---------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHhcCCCCCC---------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3333333322222111 1233444899999999999999999999874
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=284.68 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=194.7
Q ss_pred CcccccccccCcceeEEEEEecCC----CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGS----NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
+|++.+.||+|+||.||+|..... ....+++|.+... ........+.+|+.+++.+.||||+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv 66 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--------------ASSSELRDLLSEFNLLKQVNHPHVI 66 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC--------------CCHHHHHHHHHHHHHHhhCCCCCEe
Confidence 478999999999999999964321 2256888876311 1112346788899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcc--------------------cccccChhhHHHHHHHHHHHHHHHHhc
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK--------------------GRRELEWLSRHKIALAVASGLEYLHMH 170 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~~l~~lh~~ 170 (325)
++++.+...+..++++||+.+++|.+++..... ....++...+..++.|++.+|.|||
T Consensus 67 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-- 144 (290)
T cd05045 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-- 144 (290)
T ss_pred eEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--
Confidence 999999999999999999999999999854211 1234778888999999999999999
Q ss_pred CCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHH
Q 040480 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLV 250 (325)
Q Consensus 171 ~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (325)
+.+++|+||+|+||++++++.++|+|||++................++..|+|||...+..++.++|+||||+++|+|+
T Consensus 145 -~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~ 223 (290)
T cd05045 145 -EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223 (290)
T ss_pred -HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHH
Confidence 8899999999999999999999999999987653332211112234567899999988888999999999999999999
Q ss_pred h-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 251 M-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 251 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+ |..||.... ...+..... ....... + ...+..+.+++.+||+.||++||++.++++
T Consensus 224 t~g~~p~~~~~----~~~~~~~~~---~~~~~~~--~--------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 224 TLGGNPYPGIA----PERLFNLLK---TGYRMER--P--------ENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred hcCCCCCCCCC----HHHHHHHHh---CCCCCCC--C--------CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8 999996421 112222111 1111110 0 112234889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=294.94 Aligned_cols=272 Identities=21% Similarity=0.284 Sum_probs=204.1
Q ss_pred cccchhHHHHHhhhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHH
Q 040480 20 PLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95 (325)
Q Consensus 20 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (325)
|...+.+..+....++|.+.+.||+|+||.||+|.+.. .++..||+|++... ........+.
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--------------~~~~~~~~~~ 88 (401)
T cd05107 23 PMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST--------------ARSSEKQALM 88 (401)
T ss_pred CCCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC--------------CChhHHHHHH
Confidence 33345555566677889999999999999999997532 34568999998321 1122345688
Q ss_pred HHHHHHhccC-CCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc-------------------------------
Q 040480 96 SQIITASQIR-HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------------------------- 143 (325)
Q Consensus 96 ~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------- 143 (325)
.|+.++..+. ||||+++++.+...+..++|+||+.+|+|.+++.....
T Consensus 89 ~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (401)
T cd05107 89 SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHV 168 (401)
T ss_pred HHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccch
Confidence 9999999997 99999999999999999999999999999999854211
Q ss_pred ---------------------------------------------------------------cccccChhhHHHHHHHH
Q 040480 144 ---------------------------------------------------------------GRRELEWLSRHKIALAV 160 (325)
Q Consensus 144 ---------------------------------------------------------------~~~~~~~~~~~~i~~~l 160 (325)
....++......++.|+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 248 (401)
T cd05107 169 SLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQV 248 (401)
T ss_pred hhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHH
Confidence 01235556678899999
Q ss_pred HHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchh
Q 040480 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIY 240 (325)
Q Consensus 161 ~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dvw 240 (325)
+.||.||| +++++|+||||+||++++++.++|+|||++................++..|+|||.+.+..++.++|+|
T Consensus 249 ~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 325 (401)
T cd05107 249 ANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVW 325 (401)
T ss_pred HHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHH
Confidence 99999999 889999999999999999999999999999765332221111123567789999999888899999999
Q ss_pred hHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 241 SFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 241 slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
|||+++|+|++ |..||..... .+. ....+........ +. .....+.+|+.+||..+|.+||++
T Consensus 326 slGvil~e~l~~g~~P~~~~~~----~~~--~~~~~~~~~~~~~--p~--------~~~~~l~~li~~cl~~~P~~RPs~ 389 (401)
T cd05107 326 SFGILLWEIFTLGGTPYPELPM----NEQ--FYNAIKRGYRMAK--PA--------HASDEIYEIMQKCWEEKFEIRPDF 389 (401)
T ss_pred HHHHHHHHHHHcCCCCCCCCCc----hHH--HHHHHHcCCCCCC--CC--------CCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999998 8899864221 111 1111111111111 00 112338999999999999999999
Q ss_pred hhhhc
Q 040480 320 KDVRC 324 (325)
Q Consensus 320 ~ell~ 324 (325)
++|++
T Consensus 390 ~ell~ 394 (401)
T cd05107 390 SQLVH 394 (401)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=285.34 Aligned_cols=199 Identities=26% Similarity=0.371 Sum_probs=158.1
Q ss_pred ccccccCcceeEEEEEec-CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccccee
Q 040480 39 LEKIGSGGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMV 117 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 117 (325)
.++||+|+||+||+|+.. ..+++.+|+|.+... .....+.+|+.+++.++||||+++++.+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 68 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----------------GISMSACREIALLRELKHPNVISLQKVFL 68 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-----------------CCcHHHHHHHHHHHhcCCCCCcceeeeEe
Confidence 468999999999999753 246688999987311 12335678999999999999999999885
Q ss_pred c--CCceEEEEEcccCCCHHHHHhhhcc-----cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---
Q 040480 118 R--PDSHLLVYDFMKNGSLQAVLYDVSK-----GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI--- 187 (325)
Q Consensus 118 ~--~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~--- 187 (325)
. ....++++||+.+ +|.+++..... ....++...+..++.|++.||.||| ++|++|+||||+||++
T Consensus 69 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~ 144 (317)
T cd07868 69 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGE 144 (317)
T ss_pred cCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecC
Confidence 4 4567899999865 88888743211 1235888889999999999999999 8899999999999999
Q ss_pred -cCCCCceeeccccceecCCCCcc-ccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 188 -DDDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 188 -~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+.++.++|+|||++......... .......||+.|+|||++.+. .++.++|+|||||++|+|++|.+||..
T Consensus 145 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 145 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 45578999999999866433211 112234778999999988764 588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.39 Aligned_cols=264 Identities=19% Similarity=0.278 Sum_probs=196.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|++.+.||.|+||.||+|. +..++..||+|.+.... .......+.+|+.+++.++||||+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~-~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~nI~~~ 69 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGR-SKLTDNLVALKEIRLEH--------------EEGAPCTAIREVSLLKDLKHANIVTL 69 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEE-EcCCCcEEEEEEEeccc--------------ccCchhHHHHHHHHHHhcCCCCcceE
Confidence 4689999999999999999995 55677899999873221 11223456789999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..++|+||+++ +|.+++.. ....++...+..++.|++.||.||| +.|++|+||+|+||+++.++.
T Consensus 70 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~ 142 (301)
T cd07873 70 HDIIHTEKSLTLVFEYLDK-DLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGE 142 (301)
T ss_pred EEEEecCCeEEEEEecccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCc
Confidence 9999999999999999975 89888743 2345788889999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||++.......... ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .+....
T Consensus 143 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~----~~~~~~ 216 (301)
T cd07873 143 LKLADFGLARAKSIPTKTY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV----EEQLHF 216 (301)
T ss_pred EEECcCcchhccCCCCCcc--cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 9999999987543322111 113567889999987654 478899999999999999999999965321 111111
Q ss_pred HHHHhhhCCCCcc------------cchhhcC----CchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRA------------IDSKLLG----NGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~------------~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+ ..+.... .........+.+||.+||+.||.+|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 217 IFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111111100000 0000000 001122334889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=280.69 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=209.9
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
..++.|.++.+||+|+||.||+|. ...+|..+|+|.+.+ +....++..|+.+|.+...|++|
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAI-H~EsG~v~AIK~VPV-----------------~sDLQEIIKEISIMQQC~S~yVV 91 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAI-HRESGHVLAIKKVPV-----------------DTDLQEIIKEISIMQQCKSKYVV 91 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHH-HhccCcEEEEEecCc-----------------cchHHHHHHHHHHHHHcCCchhh
Confidence 356789999999999999999994 668899999998843 35678899999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++|+.+..+..+++|||||..|+..+.+.. .+.++++..+..++...+.||.||| ...-+|||||..||+++.+
T Consensus 92 KYYGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~ 165 (502)
T KOG0574|consen 92 KYYGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTD 165 (502)
T ss_pred hhhhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEccc
Confidence 999999999999999999999999999843 5678999999999999999999999 5578999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
|..||+|||.+..+.......++ ..||+.|+|||++..-.|.-++|+||||++..+|..|++||.+..+
T Consensus 166 G~AKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP--------- 234 (502)
T KOG0574|consen 166 GIAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP--------- 234 (502)
T ss_pred chhhhhhccccchhhhhHHhhCc--cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---------
Confidence 99999999999876554333232 5899999999999988899999999999999999999999987544
Q ss_pred HHHHHhhhC-CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASE-NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++.+...+ .++..+ ...+....++.+++++||.++|++|-|+-++++
T Consensus 235 -MRAIFMIPT~PPPTF------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 235 -MRAIFMIPTKPPPTF------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -cceeEeccCCCCCCC------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11111111 111111 112334445899999999999999999998875
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=292.65 Aligned_cols=244 Identities=20% Similarity=0.223 Sum_probs=183.6
Q ss_pred cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc---CCCCccccccceec
Q 040480 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI---RHRNILPLLAHMVR 118 (325)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~ 118 (325)
||+|+||+||+|+ +..+++.||+|.+... .............|..++... .||+|++++..+..
T Consensus 1 lG~G~~g~Vy~~~-~~~~~~~~avK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~ 67 (330)
T cd05586 1 IGKGTFGQVYQVR-KKDTRRIYAMKVLSKK------------EIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT 67 (330)
T ss_pred CCCCCceEEEEEE-ECCCCCEEEEEEEeHH------------HHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec
Confidence 7999999999995 5677889999998311 111112233444555555544 69999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..|+||||+.+++|.+++. ....+++..+..++.|++.||+||| ++||+|+||||+||+++.++.++|+||
T Consensus 68 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Df 140 (330)
T cd05586 68 DSDLYLVTDYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDF 140 (330)
T ss_pred CCeEEEEEcCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecC
Confidence 999999999999999998883 3456899999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhh
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
|++......... .....||..|+|||.+.+. .++.++||||||+++|+|++|..||.... .......+..
T Consensus 141 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-------~~~~~~~i~~ 211 (330)
T cd05586 141 GLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-------TQQMYRNIAF 211 (330)
T ss_pred CcCcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-------HHHHHHHHHc
Confidence 998754322221 1225789999999988764 47899999999999999999999996421 1111222221
Q ss_pred hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC----Chhhhhc
Q 040480 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP----NSKDVRC 324 (325)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~ell~ 324 (325)
.... ++. . .....+.+++.+||+.||.+|| ++.++++
T Consensus 212 ~~~~---~~~----~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 212 GKVR---FPK----N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCC---CCC----c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1111 010 0 0122378999999999999998 5666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=282.35 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=199.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||.|+||.||+|.. ..++..+|+|.+... .......+..|+.+++.++||||++
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~i~~ 66 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQH-KETGLFAAAKIIQIE---------------SEEELEDFMVEIDILSECKHPNIVG 66 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEE-cCCCcEEEEEEEeeC---------------CHHHHHHHHHHHHHHHhCCCCceeE
Confidence 356899999999999999999964 457789999987321 1234456788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+..+...++||||+++++|.+++.. ....++...+..++.|++.+|.||| +++++|+||+|+||+++.++
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~ 140 (280)
T cd06611 67 LYEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDG 140 (280)
T ss_pred EEEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCC
Confidence 99999999999999999999999999844 2346889999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
.++|+|||.+........ ......++..|+|||.+. ...++.++|+||||+++|+|++|..||.....
T Consensus 141 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~----- 213 (280)
T cd06611 141 DVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP----- 213 (280)
T ss_pred CEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----
Confidence 999999998865543222 112246788999999874 33467899999999999999999999965321
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+....+ ......+.+++.+||+.||.+|||+.++++
T Consensus 214 --~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 214 --MRVLLKILKSEPPTLDQP--------SKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred --HHHHHHHhcCCCCCcCCc--------ccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 111222222211111111 111223889999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=283.79 Aligned_cols=265 Identities=19% Similarity=0.280 Sum_probs=198.7
Q ss_pred hcCcccccccccCcceeEEEEEecCC---------------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHH
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGS---------------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~---------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 97 (325)
.++|++.+.||+|+||.||+|..... .+..+|+|.+... ........+.+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~--------------~~~~~~~~~~~e 69 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD--------------ASDNAREDFLKE 69 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc--------------cCHHHHHHHHHH
Confidence 46899999999999999999965322 2245899987321 112345678899
Q ss_pred HHHHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc-------cccccChhhHHHHHHHHHHHHHHHHhc
Q 040480 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK-------GRRELEWLSRHKIALAVASGLEYLHMH 170 (325)
Q Consensus 98 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~~l~~lh~~ 170 (325)
+.++++++||||+++++++..++..++++|++++++|.+++..... ....++...+..++.|++.||.|||
T Consensus 70 ~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH-- 147 (296)
T cd05051 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-- 147 (296)
T ss_pred HHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 9999999999999999999999999999999999999999855321 1235889999999999999999999
Q ss_pred CCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHH
Q 040480 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLV 250 (325)
Q Consensus 171 ~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (325)
+.+++|+||||+||+++.++.++|+|||.+................++..|+|||...+..++.++||||||+++|+|+
T Consensus 148 -~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 226 (296)
T cd05051 148 -SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226 (296)
T ss_pred -HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHH
Confidence 8899999999999999999999999999987654332222222234567899999988888999999999999999999
Q ss_pred h--CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 251 M--GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 251 ~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+ +..||.... .....................+ .....+..+.+++.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 227 TLCREQPYEHLT----DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hcCCCCCCCCcC----hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 8 667875422 1112211111111101000000 00112234899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=285.41 Aligned_cols=264 Identities=21% Similarity=0.276 Sum_probs=195.1
Q ss_pred hcCcccccccccCcceeEEEEEecCC-------------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHH
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGS-------------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 99 (325)
.++|++.+.||+|+||.||+|..... ....||+|.+... ........+.+|+.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~ei~ 69 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--------------VTKTARNDFLKEIK 69 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--------------CCHHHHHHHHHHHH
Confidence 46899999999999999999964211 1235899987321 11223456889999
Q ss_pred HHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc--------cccccChhhHHHHHHHHHHHHHHHHhcC
Q 040480 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK--------GRRELEWLSRHKIALAVASGLEYLHMHH 171 (325)
Q Consensus 100 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~~l~~lh~~~ 171 (325)
++++++|||++++++++...+..++||||+++++|.+++..... ....+++.....++.|++.||.|||
T Consensus 70 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--- 146 (295)
T cd05097 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--- 146 (295)
T ss_pred HHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---
Confidence 99999999999999999999999999999999999999854211 1124677888999999999999999
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~ 251 (325)
+.|++|+||+|+||+++.++.++|+|||++................++..|+|||...+..++.++|+||||+++|+|++
T Consensus 147 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 147 SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHH
Confidence 88999999999999999999999999999976543322111112344678999999988889999999999999999998
Q ss_pred --CCCCCCCcccCCCcchHHHHHHHHhhh-CC-CCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 252 --GKFPFDDFFSHTGEMDMVRWMRNVMAS-EN-PNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 252 --g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
+..||..... ............. .. .....++ ..+..+.+|+.+||+.||++|||+++++++
T Consensus 227 ~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 227 LCKEQPYSLLSD----EQVIENTGEFFRNQGRQIYLSQTP--------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred cCCCCCCcccCh----HHHHHHHHHhhhhccccccCCCCC--------CCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5677754221 1111111111110 00 0000000 112239999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=278.72 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=189.1
Q ss_pred cccccCcceeEEEEEec-CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|.+. ..++..+|+|++... .........+..|+.+++.+.||||+++++++.
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 66 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-------------NNDPALKDELLREANVMQQLDNPYIVRMIGICE- 66 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCC-------------CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-
Confidence 36899999999999653 345788999987321 112234567888999999999999999999775
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..++||||+++++|.+++. ....++......++.|++.||.+|| ++|++|+||+|+||+++.++.++|+||
T Consensus 67 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Df 139 (257)
T cd05116 67 AESWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDF 139 (257)
T ss_pred CCCcEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCC
Confidence 456789999999999999983 3346888999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHh
Q 040480 199 DLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVM 276 (325)
Q Consensus 199 g~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 276 (325)
|.+.......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... .......+ .
T Consensus 140 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~i---~ 212 (257)
T cd05116 140 GLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK----GNEVTQMI---E 212 (257)
T ss_pred ccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH---H
Confidence 9997664432211 1111234578999999888888999999999999999998 999996532 12222222 2
Q ss_pred hhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... .+. ..+..+.++|.+||+.||++|||+.+|.+
T Consensus 213 ~~~~~~--~~~--------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 213 SGERME--CPQ--------RCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCC--CCC--------CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 211111 111 12233899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=275.19 Aligned_cols=252 Identities=19% Similarity=0.310 Sum_probs=198.2
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|++|.||++. +..+++.+|+|.+... .........+.+|+.+++.++|||++++.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~~k~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVR-HRTDGKQYVIKKLNLR-------------NASRRERKAAEQEAQLLSQLKHPNIVAYRE 66 (257)
T ss_pred CceEEEEecCCCCeEEEEEE-EcCCCcEEEEEEEehh-------------hcCHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 58999999999999999996 4566788999998321 122234556788999999999999999998
Q ss_pred ceec-CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 115 HMVR-PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 115 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
.+.. ....++++||+++++|.+++.. .....+++..+..++.+++.++.+|| +.|++|+||+|+||+++.++.+
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~ 141 (257)
T cd08223 67 SWEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNII 141 (257)
T ss_pred eecCCCCEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcE
Confidence 8764 4457999999999999999854 22345889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++......... .....+++.|+|||...+..++.++|+||||+++++|++|..||.... ......
T Consensus 142 ~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-------~~~~~~ 212 (257)
T cd08223 142 KVGDLGIARVLENQCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSLVY 212 (257)
T ss_pred EEecccceEEecccCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHH
Confidence 99999999766433221 122467889999999999889999999999999999999999986421 112222
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+.. ....+..+.+++.+||+.||++|||+.++++
T Consensus 213 ~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 213 RIIEGKLPPM----------PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHhcCCCCC----------ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 2222221110 0122234899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=281.67 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=198.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||++. +..+++.+|+|.+... ..........+.+|+.+++++.||||++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~-~~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 67 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVR-HKGSGKYYALKILSKA------------KIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67 (290)
T ss_pred CceEEEEEeecCCCeEEEEEE-EcCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhCCCCCcccee
Confidence 479999999999999999996 4557889999987311 111223456788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..+++|||+++++|.+++.. ...++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.+
T Consensus 68 ~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~ 140 (290)
T cd05580 68 GSFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYI 140 (290)
T ss_pred eEEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999843 356889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++...... .....++..|+|||.+.+...+.++|+||||+++|+|++|..||.... . .....
T Consensus 141 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~---~~~~~ 208 (290)
T cd05580 141 KITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----P---IQIYE 208 (290)
T ss_pred EEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----H---HHHHH
Confidence 99999998765443 122467889999999988888999999999999999999999996522 1 11111
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
........ ++.. ....+.+++.+||..||.+|| +++++++
T Consensus 209 ~~~~~~~~---~~~~--------~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 209 KILEGKVR---FPSF--------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHhcCCcc---CCcc--------CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11111111 1110 122388999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=277.85 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=201.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|+||.||+|. +..+++.+++|.+... .......+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~-~~~~~~~~~ik~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~i~~~ 65 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKAR-DIATGELVAIKVIKLE---------------PGDDFEIIQQEISMLKECRHPNIVAY 65 (262)
T ss_pred ccceEEEEEecCCCceEEEEeE-ecCCCCEEEEEEEEcC---------------chhhHHHHHHHHHHHHhCCCCChhce
Confidence 4689999999999999999996 4456788999988321 11245678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+...+..+++|||+++++|.+++.. ....++...+..++.|++.+|.||| +.+++|+||+|+||+++.++.
T Consensus 66 ~~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~ 139 (262)
T cd06613 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGD 139 (262)
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCC
Confidence 9999999999999999999999998843 2356889999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL---TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++|+|||.+......... .....++..|+|||...+. .++.++|+||||+++|+|++|..||..... ...
T Consensus 140 ~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~----~~~- 212 (262)
T cd06613 140 VKLADFGVSAQLTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----MRA- 212 (262)
T ss_pred EEECccccchhhhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHH-
Confidence 999999998765443211 1224678889999998776 788999999999999999999999965321 111
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
............. .......+..+.+++.+||..||.+|||+.+++..
T Consensus 213 --~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 213 --LFLISKSNFPPPK------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --HHHHHhccCCCcc------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111000000 00112234458999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=278.23 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=203.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|+||.||+|. +..++..+|+|.+... .........+..|+.+++.++||||+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~~k~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDYG-------------NMTEKEKQQLVSEVNILRELKHPNIVRYYD 66 (265)
T ss_pred CceeeeeeccCCCeEEEEee-ecCCCCEEEEEEEecc-------------cCCHHHHHHHHHHHHHHHhcCCCccceeee
Confidence 58899999999999999995 5567788999987321 122334567888999999999999999999
Q ss_pred ceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEecCC
Q 040480 115 HMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHH--SARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 115 ~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~~ivH~dl~~~nil~~~~ 190 (325)
.+.. ....++++||+++++|.+++.........+++..+..++.|++.||.+||..+ +.+++|+||+|+||+++++
T Consensus 67 ~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~ 146 (265)
T cd08217 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN 146 (265)
T ss_pred eeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC
Confidence 7754 44579999999999999999765455667899999999999999999999553 5689999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||.+.......... ....++..|+|||...+..++.++|+||||+++|+|++|..||.... .. .
T Consensus 147 ~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~---~ 217 (265)
T cd08217 147 NNVKLGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QL---Q 217 (265)
T ss_pred CCEEEecccccccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HH---H
Confidence 999999999998765443211 12467889999999988889999999999999999999999997532 11 1
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
..........+ ..+ ...+..+.+++.+||+.+|++|||+.+|+++
T Consensus 218 ~~~~~~~~~~~--~~~--------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 218 LASKIKEGKFR--RIP--------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHhcCCCC--CCc--------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222111111 111 1122348999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=277.84 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=201.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|+||.||+|. +..++..+|+|.+... ........+.+.+|+.++++++||||+++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~-~~~~~~~~~ik~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 67 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQ-KRDTKKMFAMKYMNKQ------------KCVEKGSVRNVLNERRILQELNHPFLVNLWY 67 (258)
T ss_pred CceEEEEeccCCCceEEEEE-EccCCcEEEEEEEehh------------hhcchhHHHHHHHHHHHHHhCCCCChHHHHH
Confidence 58999999999999999996 5567889999988311 1112235678899999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+......++|+||+.+++|.+++.. ...++...+..++.|++.+|.||| +++++|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~ 140 (258)
T cd05578 68 SFQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVH 140 (258)
T ss_pred hhcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEE
Confidence 99999999999999999999999833 356889999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||.+......... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... .... ...
T Consensus 141 l~d~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~-~~~ 212 (258)
T cd05578 141 ITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQ-IRA 212 (258)
T ss_pred EeecccccccCCCccc---cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHH-HHH
Confidence 9999998876543221 1246788899999998888999999999999999999999999754321 1111 111
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh--hhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS--KDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~ell~ 324 (325)
.... .....+. ..+..+.+++.+||+.||.+||++ .|+++
T Consensus 213 ~~~~--~~~~~~~--------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 213 KQET--ADVLYPA--------TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred Hhcc--ccccCcc--------cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1111 1111111 112348899999999999999999 88865
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=279.05 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=193.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|... ++..+|+|.+... ......+.+|+.++++++||++++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~----------------~~~~~~~~~E~~~l~~l~~~~i~~ 65 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPG----------------TMSPESFLEEAQIMKKLRHDKLVQ 65 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec--CCceeEEEEecCC----------------CCCHHHHHHHHHHHHhcCCCceEE
Confidence 3468999999999999999999643 5567999987321 112346888999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++. ....+++|||+++++|.+++... ....++...+..++.+++.||.||| +.+++|+||+|+||++++++
T Consensus 66 ~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~ 139 (260)
T cd05070 66 LYAVVS-EEPIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGL 139 (260)
T ss_pred EEeEEC-CCCcEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCc
Confidence 998774 45689999999999999998542 2345788899999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+........... ....++..|+|||...+..++.++|+||||+++|+|++ |..||.... ..+..
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~~~~- 213 (260)
T cd05070 140 VCKIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NREVL- 213 (260)
T ss_pred eEEeCCceeeeeccCcccccc-cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HHHHH-
Confidence 999999999986544322111 11234567999999988889999999999999999999 899996532 11222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............ ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 214 --~~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 214 --EQVERGYRMPCP----------QDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --HHHHcCCCCCCC----------CcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 222211111110 112233899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=282.17 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=199.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCC---CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGS---NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
..++|++.+.||+|+||.||+|.+... .+..+++|.+.. .........+.+|+.+++.+.|||
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~n 69 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD--------------HASEIQVTLLLQESCLLYGLSHQN 69 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC--------------CCCHHHHHHHHHHHHHHHhCCCCC
Confidence 357899999999999999999976542 267889998621 122344567888999999999999
Q ss_pred ccccccceec-CCceEEEEEcccCCCHHHHHhhhccc----ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 109 ILPLLAHMVR-PDSHLLVYDFMKNGSLQAVLYDVSKG----RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 109 i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
|+++++++.. ....+++++|+++++|.+++...... ...++...+..++.|++.||.||| +++++|+||+|+
T Consensus 70 i~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~ 146 (280)
T cd05043 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAAR 146 (280)
T ss_pred CCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHh
Confidence 9999998765 46789999999999999998553222 156889999999999999999999 889999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSH 262 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~ 262 (325)
||++++++.++|+|||++..+.............++..|+|||++.+..++.++||||||+++|++++ |..||....
T Consensus 147 nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-- 224 (280)
T cd05043 147 NCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-- 224 (280)
T ss_pred hEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--
Confidence 99999999999999999976543322111112345667999999988889999999999999999998 999996522
Q ss_pred CCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 263 TGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+...... ........ ...+..+.+++.+||+.||++|||+.++++
T Consensus 225 --~~~~~~~~~---~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 225 --PFEMAAYLK---DGYRLAQP----------INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --HHHHHHHHH---cCCCCCCC----------CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 122222211 11111100 112234899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=300.63 Aligned_cols=259 Identities=19% Similarity=0.236 Sum_probs=184.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC------
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR------ 105 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------ 105 (325)
..++|++.+.||+|+||+||+|. +..+++.||||++... .........|+.+++.++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~-~~~~~~~vAvK~i~~~----------------~~~~~~~~~e~~~l~~l~~~~~~~ 189 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAW-DRKRKEYCAVKIVRNV----------------PKYTRDAKIEIQFMEKVRQADPAD 189 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEE-EcCCCeEEEEEEEecc----------------hhhHHHHHHHHHHHHHHhhcCccc
Confidence 35789999999999999999995 5567889999998311 011223344555555543
Q ss_pred CCCccccccceecC-CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCC
Q 040480 106 HRNILPLLAHMVRP-DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPA 183 (325)
Q Consensus 106 h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~ 183 (325)
|++++++++++... ...++||+++ +++|.+++.. ...+++..+..++.|++.||.||| + .||+||||||+
T Consensus 190 ~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~ 261 (467)
T PTZ00284 190 RFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPE 261 (467)
T ss_pred CcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHH
Confidence 45688888887654 4688999988 6688888843 356889999999999999999999 6 49999999999
Q ss_pred ceEecCCC----------------CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHH
Q 040480 184 NVLIDDDM----------------EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLA 247 (325)
Q Consensus 184 nil~~~~~----------------~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~ 247 (325)
|||++.++ .+||+|||.+...... .....||..|+|||++.+..++.++|||||||++|
T Consensus 262 NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ 336 (467)
T PTZ00284 262 NILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336 (467)
T ss_pred HEEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHH
Confidence 99998665 4899999987543221 12357899999999999999999999999999999
Q ss_pred HHHhCCCCCCCcccCCCcchHHHHHHHHhhhC---------------------CCCcccchhhc-----CCch--HHHHH
Q 040480 248 VLVMGKFPFDDFFSHTGEMDMVRWMRNVMASE---------------------NPNRAIDSKLL-----GNGY--EEQML 299 (325)
Q Consensus 248 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~-----~~~~--~~~~~ 299 (325)
+|++|+.||..... .+....+....... .......+... .... .....
T Consensus 337 elltG~~pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (467)
T PTZ00284 337 ELYTGKLLYDTHDN----LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDD 412 (467)
T ss_pred HHHhCCCCCCCCCh----HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchH
Confidence 99999999965321 11111111111000 00000000000 0000 01123
Q ss_pred HHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 300 LVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 300 ~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.+||.+||++||++|||++|+|+
T Consensus 413 ~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 413 LLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHHHHHhCCcChhhCCCHHHHhc
Confidence 4789999999999999999999985
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=278.81 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=193.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.++||+|+||.||+|++. .+..+|+|.+.. .......+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~----------------~~~~~~~~~~E~~~l~~l~~~~i~~ 65 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKP----------------GTMSPEAFLQEAQVMKKLRHEKLVQ 65 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEec--CCceEEEEeccc----------------CccCHHHHHHHHHHHHhCCCCCcce
Confidence 3467999999999999999999753 334699998731 1112346788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+. ....++||||+++++|.+++... ....+++..+..++.|++.||.+|| +.+++|+||+|+||++++++
T Consensus 66 ~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~ 139 (262)
T cd05071 66 LYAVVS-EEPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENL 139 (262)
T ss_pred EEEEEC-CCCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCC
Confidence 998764 45689999999999999999542 2345788888999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+.......... .....++..|+|||...+..++.++|+||||+++|+|++ |..||..... ....
T Consensus 140 ~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~~~~- 213 (262)
T cd05071 140 VCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVL- 213 (262)
T ss_pred cEEeccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----HHHH-
Confidence 99999999997654332211 111245667999999988889999999999999999999 8889864321 1111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... . ....+..+.+++.+|++.||.+|||+.++++
T Consensus 214 --~~~~~~~~~~--~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 214 --DQVERGYRMP--C--------PPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred --HHHhcCCCCC--C--------ccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1111111110 0 1123344899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=279.63 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=199.7
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
.+.++|++.+.||+|++|.||+|. +..+++.+++|.+... ......+.+|+.+++++ .||||
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~~k~~~~~----------------~~~~~~~~~e~~~l~~~~~h~~i 65 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKAR-HKKTGQLVAIKIMDII----------------EDEEEEIKEEYNILRKYSNHPNI 65 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEE-ECCCCcEEEEEEEecC----------------chhHHHHHHHHHHHHHhcCCCCh
Confidence 356899999999999999999996 4456788999987321 12345688999999998 69999
Q ss_pred cccccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 110 LPLLAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 110 ~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+++++.+.... ..++||||+++++|.+++......+..++...+..++.|++.||.||| +.+++|+||+|+
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ 142 (275)
T cd06608 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQ 142 (275)
T ss_pred heEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHH
Confidence 99999986644 489999999999999998654444567899999999999999999999 889999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----LTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
||++++++.++|+|||.+......... .....|+..|+|||.+.. ..++.++|+||||+++|+|++|..||..
T Consensus 143 ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 143 NILLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred HEEEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 999999999999999998765433221 122467889999998754 2467889999999999999999999964
Q ss_pred cccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 259 FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ............+.. .........+.+++.+||..||++|||+.++++
T Consensus 221 ~~~-------~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 221 MHP-------MRALFKIPRNPPPTL--------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cch-------HHHHHHhhccCCCCC--------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 221 111111111111110 011123345899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=287.77 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=195.2
Q ss_pred HhhhcCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI- 104 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 104 (325)
....++|++.+.||+|+||.||+|.+. ..+++.||+|.+... ........+.+|+.++..+
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~ 68 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--------------ATHSEHRALMSELKILIHIG 68 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC--------------CChHHHHHHHHHHHHHHhcc
Confidence 345679999999999999999999642 245688999988321 1122345688899999999
Q ss_pred CCCCccccccceecC-CceEEEEEcccCCCHHHHHhhhcc----------------------------------------
Q 040480 105 RHRNILPLLAHMVRP-DSHLLVYDFMKNGSLQAVLYDVSK---------------------------------------- 143 (325)
Q Consensus 105 ~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~---------------------------------------- 143 (325)
+||||+++++.+... ...+++|||+++++|.+++.....
T Consensus 69 ~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (343)
T cd05103 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSA 148 (343)
T ss_pred CCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccc
Confidence 689999999987654 457899999999999999854210
Q ss_pred -----------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecccc
Q 040480 144 -----------------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200 (325)
Q Consensus 144 -----------------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~ 200 (325)
....++......++.|++.||+||| ++|++|+||||+||+++.++.++|+|||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~ 225 (343)
T cd05103 149 SSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGL 225 (343)
T ss_pred cccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEeccc
Confidence 0123567777889999999999999 88999999999999999999999999999
Q ss_pred ceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhC
Q 040480 201 AILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASE 279 (325)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 279 (325)
+................++..|+|||...+..++.++|+||||+++|+|++ |..||..... ..... .......
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~---~~~~~~~ 299 (343)
T cd05103 226 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEFC---RRLKEGT 299 (343)
T ss_pred ccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc---cHHHH---HHHhccC
Confidence 876533222111112244667999999988889999999999999999997 9999865321 11111 1111111
Q ss_pred CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 280 NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+ . . ....+.+++..||+.||++|||+.++++
T Consensus 300 ~~~~~--~-----~---~~~~~~~~~~~cl~~~p~~Rps~~eil~ 334 (343)
T cd05103 300 RMRAP--D-----Y---TTPEMYQTMLDCWHGEPSQRPTFSELVE 334 (343)
T ss_pred CCCCC--C-----C---CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11110 0 0 1123889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=283.59 Aligned_cols=265 Identities=24% Similarity=0.301 Sum_probs=194.9
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|++|.||+|. +..++..||+|.+... .........+.+|+.+++.+.|||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGR-NKKTGQIVAMKKIRLE-------------SEEEGVPSTAIREISLLKELQHPNIVCLQD 66 (285)
T ss_pred CceEeeEecccCceEEEEEE-ECCCCcEEEEEEeccc-------------cccCCchHHHHHHHHHHHhcCCCCEeeeEE
Confidence 48899999999999999995 5567889999987321 112233456788999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++..++..++||||+. ++|.+++.... .+..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~ 141 (285)
T cd07861 67 VLMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIK 141 (285)
T ss_pred EEeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEE
Confidence 9999999999999997 58888874422 2356889999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|+|||++......... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ........
T Consensus 142 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~---~~~~~~~~ 216 (285)
T cd07861 142 LADFGLARAFGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI---DQLFRIFR 216 (285)
T ss_pred ECcccceeecCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHH
Confidence 9999998765432211 1113567889999987654 4688999999999999999999999642210 11111110
Q ss_pred HHhhhCCCC---------------cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPN---------------RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ..... ..................+.++|.+||+.||.+|||+.+++.
T Consensus 217 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 217 ILG-TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhC-CCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 00000 000000000001112334789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.15 Aligned_cols=259 Identities=23% Similarity=0.267 Sum_probs=192.5
Q ss_pred cCc-ccccccccCcceeEEEEEec---CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 34 DCF-ASLEKIGSGGCGDVYKAELP---GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 34 ~~y-~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
++| .+.+.||+|+||+||++.++ ..++..+|+|.+.... .......+.+|+.+++.++||||
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~i 68 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--------------GQQNTSGWKKEINILKTLYHENI 68 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--------------ChHHHHHHHHHHHHHHhCCCCCE
Confidence 455 89999999999999987643 2356789999873211 11234567889999999999999
Q ss_pred cccccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 110 LPLLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 110 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+++++++... ...+++|||+++++|.+++.. ..+++..+..++.|++.||.||| +++++|+||||+||++
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili 140 (283)
T cd05080 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLL 140 (283)
T ss_pred eeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEE
Confidence 9999987653 457899999999999999832 35899999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccc-ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC--
Q 040480 188 DDDMEARISGFDLAILMPDGLTQID-TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG-- 264 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~-- 264 (325)
++++.++|+|||++........... .....++..|+|||...+..++.++|+||||+++|+|++|..||........
T Consensus 141 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~ 220 (283)
T cd05080 141 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM 220 (283)
T ss_pred cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh
Confidence 9999999999999986654322111 1112345679999999888899999999999999999999999864321100
Q ss_pred ------cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 ------EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
................. ......+..+.+++.+||+.||++|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 221 IGPKQGQMTVVRLIELLERGMRL----------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcccccccchhhhhhhhhcCCCC----------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000000000000000 001112234899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=284.70 Aligned_cols=268 Identities=21% Similarity=0.297 Sum_probs=197.2
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|. +..+++.+|+|.+.... ........+.+|+.++++++|||+++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~iK~~~~~~-------------~~~~~~~~~~~e~~~l~~~~h~~i~~~~ 66 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCR-NRETGQIVAIKKFVESE-------------DDPVIKKIALREIRMLKQLKHPNLVNLI 66 (286)
T ss_pred CceeeeeeecccCCeEEEEEE-ECCCCcEEEEEEEeecc-------------cCccccHHHHHHHHHHHhCCCCCEeeee
Confidence 479999999999999999996 45678899999873211 1112234578899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++......++|+||+++++|..+. .....+++..+..++.|++.+|.||| ++|++|+||+|+||+++.++.+
T Consensus 67 ~~~~~~~~~~~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~ 139 (286)
T cd07847 67 EVFRRKRKLHLVFEYCDHTVLNELE----KNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQI 139 (286)
T ss_pred eEEeeCCEEEEEEeccCccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcE
Confidence 9999999999999999998777766 23345899999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||++......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||................
T Consensus 140 ~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (286)
T cd07847 140 KLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL 217 (286)
T ss_pred EECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999999876543321 112356788999998876 457889999999999999999999997532211110011000
Q ss_pred HHH-------hhhC------CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNV-------MASE------NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~-------~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... .... .....................+.+|+.+||+.||++|||+.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0000 000000000000011122445889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.79 Aligned_cols=255 Identities=20% Similarity=0.376 Sum_probs=197.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||+|+||.||+|. +..++..+|+|.+... ........+.+|+.++++++||||++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~-~~~~~~~~a~k~~~~~--------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 65 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVL-HRPTGVTMAMKEIRLE--------------LDESKFNQIIMELDILHKAVSPYIVDFY 65 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEE-EcCCCcEEEEEEeecc--------------cCHHHHHHHHHHHHHHHhcCCCcHHhhh
Confidence 478999999999999999996 4567889999987321 1223356788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..++|+||+++++|.+++... .....+++..+..++.|++.+|.|||. +.+++|+||+|+||+++.++.+
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~ 142 (286)
T cd06622 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQV 142 (286)
T ss_pred hheecCCeEEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCE
Confidence 9999999999999999999998888431 113468999999999999999999992 2499999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCC------CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT------ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~------~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+|+|||.+......... ...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ..
T Consensus 143 ~l~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~ 214 (286)
T cd06622 143 KLCDFGVSGNLVASLAK----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----AN 214 (286)
T ss_pred EEeecCCcccccCCccc----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hh
Confidence 99999998765432221 235778899999886543 47899999999999999999999965221 11
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............+. .+ .+....+.+++.+||+.+|.+||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 215 IFAQLSAIVDGDPPT--LP--------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHhhcCCCC--CC--------cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 222222222211111 11 113344889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=282.56 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=196.0
Q ss_pred hhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||.||+|.... ..+..||+|.+... ........+.+|+.+++.+.||
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~e~~~l~~l~~~ 69 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--------------ASLRERIEFLNEASVMKGFTCH 69 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc--------------CCHHHHHHHHHHHHHHHhCCCC
Confidence 45789999999999999999996432 23567999986211 1112234577899999999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhccc------ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG------RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~ 181 (325)
||+++++++...+..++||||+++++|.+++...... ...++...+..++.|++.||.||| +++++|+|||
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dik 146 (288)
T cd05061 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLA 146 (288)
T ss_pred CeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCC
Confidence 9999999999999999999999999999999653211 233456677889999999999999 8899999999
Q ss_pred CCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcc
Q 040480 182 PANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFF 260 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~ 260 (325)
|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 147 p~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 147 ARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred hheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999875543222111111244667999999988889999999999999999998 788986421
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ................ ...+..+.+++.+||+.||++|||+.++++
T Consensus 227 ~-------~~~~~~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 227 N-------EQVLKFVMDGGYLDQP----------DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred H-------HHHHHHHHcCCCCCCC----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1 1122222222111110 011234999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=276.44 Aligned_cols=252 Identities=19% Similarity=0.330 Sum_probs=200.3
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||+|+||.+|++. +..+++.+|+|.+... .........+.+|+.+++.++||||+++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~-~~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVK-SKEDGKQYVIKEINIS-------------KMSPKEREESRKEVAVLSNMKHPNIVQYQE 66 (256)
T ss_pred CceEEEEeccCCceEEEEEE-EcCCCCEEEEEEEEhH-------------hCChHHHHHHHHHHHHHHhCCCCCeeeeEe
Confidence 58999999999999999996 4567889999987321 112234457889999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+...+..++|+||+.+++|.+.+.. .....++......++.|++.++.+|| +++++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~ 141 (256)
T cd08218 67 SFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIK 141 (256)
T ss_pred eecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999998843 22335788888999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
++|||.+.......... ....|+..|+|||...+..++.++|+||||+++++|++|..||.... . ......
T Consensus 142 l~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~---~~~~~~ 212 (256)
T cd08218 142 LGDFGIARVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----M---KNLVLK 212 (256)
T ss_pred EeeccceeecCcchhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC----H---HHHHHH
Confidence 99999997664432211 12357888999999988889999999999999999999999986421 1 122222
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+... ......+.++|.+||+.+|.+||++.++++
T Consensus 213 ~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 213 IIRGSYPPVS----------SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HhcCCCCCCc----------ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2222221111 112233899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=277.91 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=200.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||+|++|.||+|. +..++..+|+|.+......... ........+.+.+|+.++++++||||+++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~-~~~~~~~~~~k~~~~~~~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGM-NASSGELMAVKQVELPSVSASS------KDRKRSMLDALAREIALLKELQHENIVQYLG 73 (267)
T ss_pred CccccceeecCCCeEEEEEE-ecCCCcEEEEEEecCCCcccch------hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 58899999999999999995 5567789999988543322111 0111123457888999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++...+..++++||+++++|.+++.. ...++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 74 SSLDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred EEEeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEE
Confidence 99999999999999999999999943 355888889999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCcc----ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 195 ISGFDLAILMPDGLTQ----IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~----~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
|+|||.+......... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~--- 219 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQ--- 219 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HH---
Confidence 9999998866532111 111123578889999999888889999999999999999999999975221 11
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..........+. .+ ...+..+.+++.+||+.||.+||++.++++
T Consensus 220 ~~~~~~~~~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 220 AIFKIGENASPE--IP--------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHhccCCCc--CC--------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111111111111 01 112234889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=284.94 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=196.1
Q ss_pred hcCcccccccccCcceeEEEEEecCC------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-C
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGS------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-R 105 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 105 (325)
.++|.+.+.||+|+||.||+|.+... +...+|+|.+... ........+..|+.+++.+ +
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~~ 82 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--------------ATEKDLSDLISEMEMMKMIGK 82 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC--------------CChHHHHHHHHHHHHHHHhcC
Confidence 36899999999999999999975321 2356999987311 1223345688899999999 7
Q ss_pred CCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcCCC
Q 040480 106 HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHHSA 173 (325)
Q Consensus 106 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~ 173 (325)
||||+++++++...+..++|+||+++++|.+++..... ....++...+..++.|++.||.||| ++
T Consensus 83 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~ 159 (307)
T cd05098 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SK 159 (307)
T ss_pred CCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 99999999999999999999999999999999954321 1234788889999999999999999 88
Q ss_pred CeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-C
Q 040480 174 RVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-G 252 (325)
Q Consensus 174 ~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g 252 (325)
|++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 160 gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g 239 (307)
T cd05098 160 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239 (307)
T ss_pred CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999876543222111111234568999999988889999999999999999998 8
Q ss_pred CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 253 KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 253 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..||.... ................ + ...+..+.+|+.+||..+|++|||+.++++
T Consensus 240 ~~p~~~~~-------~~~~~~~~~~~~~~~~--~--------~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 240 GSPYPGVP-------VEELFKLLKEGHRMDK--P--------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred CCCCCcCC-------HHHHHHHHHcCCCCCC--C--------CcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 88885411 1111222211111111 0 112234889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=281.86 Aligned_cols=258 Identities=22% Similarity=0.318 Sum_probs=197.7
Q ss_pred hcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
.++|++.+.||+|+||.||+|.... .++..+|+|.+... ........+.+|+.+++.+.|||
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~ei~~l~~l~h~~ 69 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--------------ASADMQADFQREAALMAEFDHPN 69 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC--------------cCHHHHHHHHHHHHHHHhcCCCc
Confidence 4689999999999999999997532 35678999987321 11123456888999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhc------------------ccccccChhhHHHHHHHHHHHHHHHHhc
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS------------------KGRRELEWLSRHKIALAVASGLEYLHMH 170 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~~l~~lh~~ 170 (325)
|+++++++......++++||+++++|.+++.... .....+++..+..++.|++.||.+||
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH-- 147 (288)
T cd05050 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS-- 147 (288)
T ss_pred hheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--
Confidence 9999999999999999999999999999996421 11234677888999999999999999
Q ss_pred CCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHH
Q 040480 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLV 250 (325)
Q Consensus 171 ~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (325)
+++++|+||+|+||+++.++.++|+|||.+.................+..|+|||...+..++.++||||||+++|+|+
T Consensus 148 -~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 148 -ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226 (288)
T ss_pred -hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHH
Confidence 8899999999999999999999999999987654332211111123456799999998888999999999999999999
Q ss_pred h-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 251 M-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 251 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+ |..||..... .+............. + ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~p~~~~~~-------~~~~~~~~~~~~~~~--~--------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 227 SYGMQPYYGMAH-------EEVIYYVRDGNVLSC--P--------DNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred hCCCCCCCCCCH-------HHHHHHHhcCCCCCC--C--------CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7 8888854211 122222222211110 0 012233899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=285.89 Aligned_cols=203 Identities=25% Similarity=0.353 Sum_probs=164.5
Q ss_pred ccccccccC--cceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 37 ASLEKIGSG--GCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 37 ~~~~~lg~G--~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+++++||+| +|++||++. ...+++.||+|.+... .........+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 66 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLAR-YKPTGEYVTVRRINLE-------------ACTNEMVTFLQGELHVSKLFNHPNIVPYRA 66 (327)
T ss_pred ChhhhccccccceEEEEEEe-ecccCcEEEEEEechh-------------hccHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 357889999 788999995 5678899999988321 112234556788999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++..++..++|+||+++++|.+++... ....+++..+..++.|++.||.||| +++++|+||||+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~ 141 (327)
T cd08227 67 TFIADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVY 141 (327)
T ss_pred EEEECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEE
Confidence 999999999999999999999998442 2234888899999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCcc-----ccceeecCCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 195 ISGFDLAILMPDGLTQ-----IDTMYVVGTPRYIAPEYHQT--LTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~-----~~~~~~~g~~~~~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+.||+........... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 142 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 142 LSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred EcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 9999865443221110 01112345677999999876 4588999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=283.19 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=199.4
Q ss_pred hhhcCcccccccccCcceeEEEEEecC------CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPG------SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI 104 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 104 (325)
....+|.+.+.||+|+||.||+|++.. .++..+|+|.+.. .........+.+|+.+++.+
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~--------------~~~~~~~~~~~~E~~~l~~l 77 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD--------------DATEKDLSDLVSEMEMMKMI 77 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccc--------------ccchHHHHHHHHHHHHHHhh
Confidence 456789999999999999999997421 2345789997621 11123456788999999999
Q ss_pred -CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcC
Q 040480 105 -RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHH 171 (325)
Q Consensus 105 -~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~ 171 (325)
.||||+++++.+...+..+++|||+++++|.+++..... ....++...+..++.|++.||.|||
T Consensus 78 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--- 154 (304)
T cd05101 78 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--- 154 (304)
T ss_pred ccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---
Confidence 799999999999999999999999999999999965321 1235677788899999999999999
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~ 251 (325)
++|++|+||||+||+++.++.++|+|||.+................++..|+|||++.+..++.++||||||+++|+|++
T Consensus 155 ~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 155 SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred HCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence 88999999999999999999999999999987654332222222345678999999988889999999999999999998
Q ss_pred -CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 252 -GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 252 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|..||.... ................. ...+..+.+++.+||+.+|.+|||+.++++
T Consensus 235 ~g~~p~~~~~-------~~~~~~~~~~~~~~~~~----------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 235 LGGSPYPGIP-------VEELFKLLKEGHRMDKP----------ANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred CCCCCcccCC-------HHHHHHHHHcCCcCCCC----------CCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 788885421 12222222222111110 122334899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=273.89 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=201.6
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|+||.||.++ +..++..+++|.+... .........+.+|+.++++++|+||+++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~-~~~~~~~~~~k~~~~~-------------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~ 66 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLT-------------RLSEKERRDALNEIVILSLLQHPNIIAYYN 66 (256)
T ss_pred CceEeeEecccCCceEEEEE-EcCCCcEEEEEEEeec-------------ccchhHHHHHHHHHHHHHhCCCCCeeEEEe
Confidence 58999999999999999996 5567888999987322 122234556789999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++.+.+..+++|||+++++|.+++... ....++...+..++.|++.++.+|| +.|++|+||+|+||++++++.++
T Consensus 67 ~~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~k 141 (256)
T cd08221 67 HFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIK 141 (256)
T ss_pred EEecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEE
Confidence 999999999999999999999998542 2356888999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||.+......... .....++..|.|||...+..++.++|+||||+++|+|++|..||.... .......
T Consensus 142 l~d~~~~~~~~~~~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~ 212 (256)
T cd08221 142 LGDFGISKILGSEYSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVK 212 (256)
T ss_pred ECcCcceEEccccccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHH
Confidence 9999999866443321 122467889999999988888999999999999999999999986421 1122222
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+......... ...+..+.+++.+||+.||.+|||+.++++
T Consensus 213 ~~~~~~~~~~----------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 213 IVQGNYTPVV----------SVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred HHcCCCCCCc----------cccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 2222111111 112233889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=287.13 Aligned_cols=258 Identities=22% Similarity=0.279 Sum_probs=195.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+++. ..+++.+|+|.+.. ...........+.+|..++..++|++|++++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 67 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKL-KNADKVFAMKILNK------------WEMLKRAETACFREERDVLVNGDNQWITTLH 67 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEE-CCCCCEEEEEEEeH------------HHHHHhhHHHHHHHHHHHHhhCCCCCEeeEE
Confidence 4799999999999999999964 56678899998821 1112223345578889999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+.+.+..++||||+++++|.+++.. ....+++..+..++.|++.||.||| +++++||||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~ 141 (332)
T cd05623 68 YAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHI 141 (332)
T ss_pred EEEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCE
Confidence 999999999999999999999999943 2345888889999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
+|+|||++......... ......||+.|+|||++. ...++.++|+||||+++|+|++|+.||.... .
T Consensus 142 kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-------~ 213 (332)
T cd05623 142 RLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-------L 213 (332)
T ss_pred EEeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-------H
Confidence 99999998754332211 112247899999999886 3457889999999999999999999996421 1
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCC--CCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPD--ERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~--~Rps~~ell~ 324 (325)
......+..... ...++. ........+.+|+.+|++.+|. .|++++++++
T Consensus 214 ~~~~~~i~~~~~-~~~~p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 214 VETYGKIMNHKE-RFQFPA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred HHHHHHHhCCCc-cccCCC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 222222222111 111111 1112234488899998866444 4688888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=285.17 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=197.6
Q ss_pred HHhhhcCcccccccccCcceeEEEEEec------CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHh
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELP------GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITAS 102 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 102 (325)
+....++|.+.+.||+|+||.||+|+.. ......+|+|.+... ........+..|+.+++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~E~~~l~ 72 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--------------ATDKDLADLISEMELMK 72 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--------------CChHHHHHHHHHHHHHH
Confidence 3445578999999999999999999642 123457899986311 11223456788999999
Q ss_pred cc-CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHh
Q 040480 103 QI-RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHM 169 (325)
Q Consensus 103 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~ 169 (325)
.+ .||||+++++++...+..++++||+++++|.+++..... ....++......++.|++.||.|||
T Consensus 73 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH- 151 (314)
T cd05099 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE- 151 (314)
T ss_pred hccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH-
Confidence 99 599999999999998999999999999999999965321 1245788888999999999999999
Q ss_pred cCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHH
Q 040480 170 HHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVL 249 (325)
Q Consensus 170 ~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~l 249 (325)
++|++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 152 --~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el 229 (314)
T cd05099 152 --SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229 (314)
T ss_pred --HCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHH
Confidence 889999999999999999999999999999765432221111112334579999999888899999999999999999
Q ss_pred Hh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 250 VM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 250 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++ |..||.... ....... ......... + ...+..+.+++.+||..||++|||+.++++
T Consensus 230 ~~~g~~p~~~~~----~~~~~~~---~~~~~~~~~--~--------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 230 FTLGGSPYPGIP----VEELFKL---LREGHRMDK--P--------SNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HhCCCCCCCCCC----HHHHHHH---HHcCCCCCC--C--------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99 888985421 1122221 111111110 0 111223889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=296.80 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=204.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..+-|+|+..||.|+||+||+|. +..++...|.|.+ ....+...+.++-|++||+.+.||+|++
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~-nket~~lAAaKvI---------------etkseEELEDylVEIeILa~CdHP~ivk 93 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAV-NKETKLLAAAKVI---------------ETKSEEELEDYLVEIEILAECDHPVIVK 93 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhh-cccchhhhhhhhh---------------cccchhHHhhhhhhhhhhhcCCChHHHH
Confidence 45668899999999999999994 5567777777776 2334466788999999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.|..++.++++.|||.||.....+-. -+..+.+..+..++.|++.||.||| ++.|+|||||+.|||++.+|
T Consensus 94 Ll~ayy~enkLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldG 167 (1187)
T KOG0579|consen 94 LLSAYYFENKLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDG 167 (1187)
T ss_pred HHHHHhccCceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecC
Confidence 99999999999999999999998888744 3556999999999999999999999 99999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
.++|+|||.+....... .....+.||++|+|||+.. ..+|+.++||||||+++.+|..+.+|.....+
T Consensus 168 dirLADFGVSAKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----- 240 (1187)
T KOG0579|consen 168 DIRLADFGVSAKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----- 240 (1187)
T ss_pred cEeeecccccccchhHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----
Confidence 99999999986544322 2233479999999999865 45789999999999999999999999765322
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.+..+.+..++.-.-+ ......|.|++.+||.+||..||+++++++
T Consensus 241 --MRVllKiaKSePPTLlqP--------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 241 --MRVLLKIAKSEPPTLLQP--------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --HHHHHHHhhcCCCcccCc--------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 222222222222211111 122333889999999999999999999985
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=282.85 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=193.8
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|+||.||+|. +..+++.+|+|.+.... ........+.+|+.+++.++||||+++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~-~~~~g~~~~~k~~~~~~-------------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 66 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAK-NRETHEIVALKRVRLDD-------------DDEGVPSSALREICLLKELKHKNIVRLYD 66 (284)
T ss_pred CceeEEEecccCCeEEEEEE-ECCCCcEEEEEEeeccc-------------ccccCccchhHHHHHHHhcCCCCeeeHHH
Confidence 58999999999999999996 55678899999883221 11223345677999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++.+....++++||+.+ +|.+++.. ....+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~ 139 (284)
T cd07839 67 VLHSDKKLTLVFEYCDQ-DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELK 139 (284)
T ss_pred HhccCCceEEEEecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEE
Confidence 99999999999999975 78877743 2456899999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|+|||.+.......... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..|+..... .......+.
T Consensus 140 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~---~~~~~~~~~ 214 (284)
T cd07839 140 LADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIF 214 (284)
T ss_pred ECccchhhccCCCCCCc--CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC---HHHHHHHHH
Confidence 99999987654322211 1235678899999887644 68899999999999999999988643211 111111111
Q ss_pred HHhhhCC----------CCcccchhhc-----CCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASEN----------PNRAIDSKLL-----GNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~----------~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... +.....+... ..........+.+++.+||+.||.+|||++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 215 RLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 1000000 0000000000 0001123345889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=287.31 Aligned_cols=258 Identities=22% Similarity=0.262 Sum_probs=195.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+++ ...+++.+|+|.+.. ...........+.+|..++..+.|++|++++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~ 67 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVK-MKHTERIYAMKILNK------------WEMLKRAETACFREERNVLVNGDCQWITTLH 67 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEeH------------HHHHhhHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 579999999999999999996 556788999998821 1111223345678889999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..|+||||+.+++|.+++.. ....+++..+..++.|++.||.||| ++||+|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~ 141 (331)
T cd05624 68 YAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHI 141 (331)
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCE
Confidence 999999999999999999999999943 2346888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
+|+|||++......... ......|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||.....
T Consensus 142 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------- 213 (331)
T cd05624 142 RLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------- 213 (331)
T ss_pred EEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------
Confidence 99999999765443221 1122468999999998875 4578899999999999999999999964221
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCC--CCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDE--RPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~ 324 (325)
......+..... ....+ ....+.+..+.+++.+||+.++.. |++++++++
T Consensus 214 ~~~~~~i~~~~~-~~~~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 214 VETYGKIMNHEE-RFQFP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHHHcCCC-cccCC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 111222221111 00111 111122344889999999865543 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=285.10 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=192.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCc--EEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGK--MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
++|++.+.||+|+||.||+|.+. .++. .+++|.+.. .........+.+|+.++.++ +||||+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~-~~~~~~~~~ik~~~~--------------~~~~~~~~~~~~Ei~~l~~l~~h~~iv 71 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKE--------------YASKDDHRDFAGELEVLCKLGHHPNII 71 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEc-cCCceeeEEEEEecc--------------cCCHHHHHHHHHHHHHHHHhcCCCCcc
Confidence 68999999999999999999754 3443 457776521 11123345778899999999 899999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
++++++...+..++|+||+++++|.+++..... ....++...+..++.|++.|+.||| ++|++|+
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~ 148 (303)
T cd05088 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHR 148 (303)
T ss_pred eEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 999999999999999999999999999854221 1235788899999999999999999 8899999
Q ss_pred CCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 040480 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFD 257 (325)
Q Consensus 179 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~ 257 (325)
||+|+||+++.++.++|+|||++........ .....++..|+|||...+..++.++||||||+++|+|++ |..||.
T Consensus 149 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 149 DLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred ccchheEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 9999999999999999999999863321111 111233567999999988888999999999999999998 999986
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... .+.. ...........+ ...+..+.+|+.+||+.+|++|||++++++
T Consensus 226 ~~~~----~~~~---~~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 275 (303)
T cd05088 226 GMTC----AELY---EKLPQGYRLEKP----------LNCDDEVYDLMRQCWREKPYERPSFAQILV 275 (303)
T ss_pred cCCh----HHHH---HHHhcCCcCCCC----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4221 1111 111111111110 011223889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.65 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=194.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
..++|++.+.||+|+||.||+|. +..+++.+|+|.+... ......+..|+.+++.+ +||||+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~-~~~~~~~~~ik~~~~~----------------~~~~~~~~~e~~~l~~l~~h~~i~ 78 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVL-NKKNGSKAAVKILDPI----------------HDIDEEIEAEYNILKALSDHPNVV 78 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEE-ECCCCceeEEEeeccc----------------cchHHHHHHHHHHHHHHhcCCCee
Confidence 56899999999999999999996 4567889999986211 11224567788888888 699999
Q ss_pred cccccee-----cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 111 PLLAHMV-----RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 111 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
++++++. ..+..+++|||+++++|.+++.........+++..+..++.|++.||.||| +.+++|+||+|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~ni 155 (286)
T cd06638 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNI 155 (286)
T ss_pred eeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhE
Confidence 9999874 345689999999999999988543334456888889999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCcc
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----LTISEKCDIYSFGVLLAVLVMGKFPFDDFF 260 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~ 260 (325)
+++.++.++|+|||.+......... .....|+..|+|||.+.. ..++.++|+||||+++|+|++|..||....
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 156 LLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EECCCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999998765433221 112468889999998753 347889999999999999999999986532
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ...........+. ...+ . .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~-------~~~~~~~~~~~~~-~~~~----~---~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 234 PM-------RALFKIPRNPPPT-LHQP----E---LWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred hh-------HHHhhccccCCCc-ccCC----C---CcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 21 1111111111111 0011 0 11223889999999999999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=273.91 Aligned_cols=251 Identities=19% Similarity=0.326 Sum_probs=198.7
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||+|+||.||+|. +..++..+|+|.+... .........+.+|+.+++.++|||++++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCR-RKADQKLVIIKQIPVE-------------QMTKDERLAAQNECQVLKLLSHPNIIEYYE 66 (256)
T ss_pred CceEEEEecccCceEEEEEE-EcCCCcEEEEEEEecc-------------ccccHHHHHHHHHHHHHhhCCCCchhheee
Confidence 58999999999999999995 5567889999988322 122334567889999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC-Cc
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM-EA 193 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~-~~ 193 (325)
.+...+..++|+||+++++|.+++... ....+++..+..++.+++.++.+|| ++|++|+||+|+||+++.++ .+
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~ 141 (256)
T cd08220 67 NFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVV 141 (256)
T ss_pred eEecCCEEEEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 999999999999999999999999542 2345788899999999999999999 88999999999999998654 57
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||.+.......... ...++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ... ..
T Consensus 142 ~l~d~~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~---~~ 211 (256)
T cd08220 142 KIGDFGISKILSSKSKAY---TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL----PAL---VL 211 (256)
T ss_pred EEccCCCceecCCCcccc---ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch----HHH---HH
Confidence 999999998765432211 24678899999999988889999999999999999999999965221 111 11
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... .+. .....+.+++.+||..||.+|||+.++++
T Consensus 212 ~~~~~~~~~--~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 212 KIMSGTFAP--ISD--------RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHhcCCCC--CCC--------CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111111 110 11223889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=281.56 Aligned_cols=250 Identities=23% Similarity=0.416 Sum_probs=194.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.|.....||+|+||.||++. +..++..+|+|.+.. ......+.+.+|+.+++.++|||+++++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~vaiK~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~ii~~~ 85 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIAT-EKHTGKQVAVKKMDL---------------RKQQRRELLFNEVVIMRDYHHENVVDMY 85 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEE-ECCCCCEEEEEEEec---------------chHHHHHHHHHHHHHHHhCCCCcHHHHH
Confidence 344556789999999999995 556788999998721 1123345688899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..++|+||+++++|.+++. ...++...+..++.|++.++.||| +++++|+||+|+||++++++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~ 157 (292)
T cd06658 86 NSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRI 157 (292)
T ss_pred HheecCCeEEEEEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCE
Confidence 99999999999999999999998872 245888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++......... .....|+..|+|||...+..++.++|+||||+++|+|++|..||..... ........
T Consensus 158 kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~ 231 (292)
T cd06658 158 KLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMRRIR 231 (292)
T ss_pred EEccCcchhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 99999998754332221 1224678899999999888899999999999999999999999964221 11111111
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ . .......+.+++.+||..||.+|||++++++
T Consensus 232 ---~~~~~~~~-~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 232 ---DNLPPRVK-D-------SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ---hcCCCccc-c-------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11111000 0 0012223889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=276.47 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=197.6
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||+|+||.||+|.. .+++.+|+|.+....... .........+.+|+.+++.++|+||+++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~~---------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 69 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNV---------LAAEKEYEKLQEEVDLLKSLKHVNIVQYLG 69 (265)
T ss_pred CccccceEeccCCeEEEEEEE--cCCCeEEEEEeecCccch---------hhHHHHHHHHHHHHHHHHhcCCCCEeeEee
Confidence 588999999999999999964 367889999874321110 011123457889999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++...+..++++||+++++|.+++.. ...++...+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~ 142 (265)
T cd06631 70 TCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIK 142 (265)
T ss_pred EeecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEE
Confidence 99999999999999999999999833 345788889999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCc----cccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 195 ISGFDLAILMPDGLT----QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 195 l~dfg~~~~~~~~~~----~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
|+|||.+........ ........|+..|+|||...+..++.++|+||||+++|+|++|..||..... ...
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~ 216 (265)
T cd06631 143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR------LAA 216 (265)
T ss_pred eccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh------HHH
Confidence 999999876432111 1111224578899999999988889999999999999999999999964221 111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..............+ . .....+.+++.+||+.+|.+|||+.++++
T Consensus 217 -~~~~~~~~~~~~~~~-----~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 217 -MFYIGAHRGLMPRLP-----D---SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -HHHhhhccCCCCCCC-----C---CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111101100111 1 12233889999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=279.21 Aligned_cols=258 Identities=23% Similarity=0.305 Sum_probs=195.3
Q ss_pred hcCcccccccccCcceeEEEEEecCC----CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGS----NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
.++|.+.+.||+|++|.||+|.+... ++..+++|.+... ........+.+|+.+++.++|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--------------~~~~~~~~~~~e~~~l~~l~~~~ 70 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--------------CSEQDESDFLMEALIMSKFNHQN 70 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence 46799999999999999999976431 4577899976211 11123346788999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcc---cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK---GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
|+++++++.+.+..+++|||+++++|.+++..... ....+++..+..++.|++.+++||| +++++|+||+|+||
T Consensus 71 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~ni 147 (277)
T cd05036 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNC 147 (277)
T ss_pred EeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheE
Confidence 99999999999999999999999999999854321 1235788889999999999999999 88999999999999
Q ss_pred EecCCC---CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCccc
Q 040480 186 LIDDDM---EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFS 261 (325)
Q Consensus 186 l~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~ 261 (325)
+++.++ .++|+|||++.................+..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 148 l~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 148 LLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred EEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 998654 589999999986533222111111233467999999988889999999999999999997 9999965321
Q ss_pred CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ...+....... .+. ..+..+.+++.+||+.||++|||+.++++
T Consensus 228 ----~~~---~~~~~~~~~~~--~~~--------~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 228 ----QEV---MEFVTGGGRLD--PPK--------GCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred ----HHH---HHHHHcCCcCC--CCC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111 12222111111 111 11233889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=279.98 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=198.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.+.|+..+.||+|+||.||+|. +..++..+|+|.+... ........+.+|+.+++.+.||||+++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~-~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLE--------------EAEDEIEDIQQEITVLSQCDSPYITRY 67 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEE-EcCCCeEEEEEEeccc--------------cchHHHHHHHHHHHHHHcCCCCccHhh
Confidence 3568889999999999999995 5567789999987311 112334678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+...+..++|+||+++++|.+++. ...++...+..++.|++.|+.||| +++++|+||+|+||++++++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~ 139 (277)
T cd06642 68 YGSYLKGTKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGD 139 (277)
T ss_pred hcccccCCceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCC
Confidence 999999999999999999999999882 346888899999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++++|||++......... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...
T Consensus 140 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~--- 210 (277)
T cd06642 140 VKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVL--- 210 (277)
T ss_pred EEEccccccccccCcchh--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHH---
Confidence 999999998765433221 12246788899999999888999999999999999999999998643221 111
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+ .. ....+..+.+++.+||+.+|.+|||+.++++
T Consensus 211 ~~~~~~~~~--~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 211 FLIPKNSPP--TL--------EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred hhhhcCCCC--CC--------CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111111110 00 1122334889999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.06 Aligned_cols=264 Identities=23% Similarity=0.387 Sum_probs=202.6
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc-cCCCCccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ-IRHRNILPLL 113 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~ 113 (325)
.|++.+.||+|+||.||+|.....+++.+|+|.+......... ...........+.+|+.++.. +.||||++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~-----~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGK-----DKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccccc-----ccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence 4889999999999999999866547789999987543221110 001122345567778887764 7899999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEecCCCC
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~nil~~~~~~ 192 (325)
+++...+..++++||+++++|.+++.........++...++.++.|++.+|.+|| . .+++|+||+|+||+++.++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCc
Confidence 9999999999999999999999998665455567899999999999999999999 5 58999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||.+....... ......|+..|+|||...+..++.++|+||||+++|+|++|..||.... .....
T Consensus 153 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-------~~~~~ 222 (269)
T cd08528 153 VTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------MLSLA 222 (269)
T ss_pred EEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-------HHHHH
Confidence 9999999998755433 1223467889999999998889999999999999999999999986421 11111
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
.........+ ... . .....+.+++.+||+.||++||++.|+..+
T Consensus 223 ~~~~~~~~~~--~~~----~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 223 TKIVEAVYEP--LPE----G---MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHhhccCCc--CCc----c---cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 1211111111 000 0 112338899999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=275.82 Aligned_cols=251 Identities=28% Similarity=0.446 Sum_probs=201.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|+||.||+|.. ..++..+++|.+... .....+.+|+.+++.++||||+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~-~~~~~~~~~k~~~~~-----------------~~~~~~~~e~~~~~~l~~~~i~~~ 63 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIH-KETGQVVAIKVVPVE-----------------EDLQEIIKEISILKQCDSPYIVKY 63 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEE-cCCCcEEEEEEeecH-----------------HHHHHHHHHHHHHHhCCCCcEeee
Confidence 57899999999999999999964 456788999987211 115678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+......|+++||+++++|.+++.. ....+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.
T Consensus 64 ~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~ 137 (256)
T cd06612 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQ 137 (256)
T ss_pred eeeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCc
Confidence 9999999999999999999999999843 3456899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .. .
T Consensus 138 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~----~~---~ 208 (256)
T cd06612 138 AKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM----RA---I 208 (256)
T ss_pred EEEcccccchhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh----hh---h
Confidence 999999998866543221 12245788999999999888999999999999999999999999753221 00 1
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............ ........+.+++.+||+.||++|||+.++++
T Consensus 209 ~~~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 209 FMIPNKPPPTLS--------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhccCCCCCCC--------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111111110000 01122334899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=278.59 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=185.5
Q ss_pred cccccCcceeEEEEEecC-CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPG-SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|.+.. .++..+|+|.+.... .......+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 66 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--------------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE 66 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--------------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 468999999999997532 345679999873211 11223467889999999999999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcc-cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeec
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSK-GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~d 197 (325)
....++||||+++++|.+++..... .....+...+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|
T Consensus 67 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~d 143 (269)
T cd05087 67 VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGD 143 (269)
T ss_pred CCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECC
Confidence 8999999999999999999854322 2234566777889999999999999 88999999999999999999999999
Q ss_pred cccceecCCCCccccceeecCCcccccccccccC-------CCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-------TISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 198 fg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-------~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
||.+................++..|+|||++.+. .++.++|+||||+++|+|++ |..||..... ....
T Consensus 144 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~~~~ 219 (269)
T cd05087 144 YGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD----EQVL 219 (269)
T ss_pred ccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh----HHHH
Confidence 9998654333222222224567789999987642 35789999999999999996 9999965322 1111
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... .......... +. .... ....+.+++..|+ .+|++|||+++|++
T Consensus 220 ~~~---~~~~~~~~~~-~~-~~~~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 220 TYT---VREQQLKLPK-PR-LKLP---LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHH---hhcccCCCCC-Cc-cCCC---CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 111 1111110000 00 0011 1122788999998 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=275.60 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=196.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||.|+||.||+|... ++..+|+|.+.. .......+.+|+.+++.++||||++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~ 65 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKP----------------GTMSPEAFLQEAQIMKKLRHDKLVQ 65 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecC----------------CccCHHHHHHHHHHHhhCCCCCEee
Confidence 3478999999999999999999643 457799998732 1123456888999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++......++++||+++++|.+++... ....++......++.+++.|+.+|| +++++|+||+|+||+++.++
T Consensus 66 ~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~ 140 (261)
T cd05034 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENL 140 (261)
T ss_pred eeeeeecCCceEEEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCC
Confidence 999999889999999999999999999542 2345888899999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |+.||.... .....
T Consensus 141 ~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----~~~~~- 214 (261)
T cd05034 141 VCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT----NREVL- 214 (261)
T ss_pred CEEECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----HHHHH-
Confidence 9999999998766432111 1111234567999999998889999999999999999998 999995421 11111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...........+ . ..+..+.+++.+||+.||.+||++.++++
T Consensus 215 --~~~~~~~~~~~~--~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 215 --EQVERGYRMPRP--P--------NCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --HHHHcCCCCCCC--C--------CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 222211111110 0 11234899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.90 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=191.2
Q ss_pred cCcccccccccCcceeEEEEEecCCCC--cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
++|++.+.||+|+||.||+|... .++ ..+++|.+... ........+.+|+.+++++ +||||+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~E~~~l~~l~~hp~iv 66 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIK-KDGLKMNAAIKMLKEF--------------ASENDHRDFAGELEVLCKLGHHPNII 66 (297)
T ss_pred ccceeeeeecCCCcceEEEEEec-CCCCcceeEEEEcccc--------------CCHHHHHHHHHHHHHHHhhcCCCchh
Confidence 57999999999999999999653 333 34788876210 1112345678899999999 699999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
++++++...+..++++||+++++|.+++..... ....++...+..++.|++.||.+|| ++|++|+
T Consensus 67 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~ 143 (297)
T cd05089 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHR 143 (297)
T ss_pred heEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 999999999999999999999999999854211 1235788889999999999999999 8899999
Q ss_pred CCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 040480 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFD 257 (325)
Q Consensus 179 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~ 257 (325)
||||+||++++++.++|+|||++........ ......+..|+|||...+..++.++||||||+++|+|++ |..||.
T Consensus 144 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 144 DLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred cCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999864322111 111123457999999988889999999999999999997 999996
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... .+. ............ + ...+..+.+|+.+||+.||.+|||++++++
T Consensus 221 ~~~~----~~~---~~~~~~~~~~~~--~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 221 GMTC----AEL---YEKLPQGYRMEK--P--------RNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred CCCH----HHH---HHHHhcCCCCCC--C--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5321 111 111111111110 0 012233889999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=276.92 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=200.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|+..+.||.|++|.||+|. +..++..+|+|.+... ........+.+|+++++.++||||++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~-~~~~~~~~~~k~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 65 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCR-LKNTGMIFALKTITTD--------------PNPDLQKQILRELEINKSCKSPYIVKYY 65 (287)
T ss_pred CceEEEEEeccCCceEEEEEE-ECCCCeEEEEEEEecC--------------CchHHHHHHHHHHHHHHhCCCCCeeeee
Confidence 478999999999999999996 4557889999987321 1113456688899999999999999999
Q ss_pred cceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 114 AHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 114 ~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++... +..++||||+++++|.+++.........++...+..++.|++.+|.||| +.|++|+||+|+||+++.++
T Consensus 66 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~ 142 (287)
T cd06621 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKG 142 (287)
T ss_pred eEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCC
Confidence 988653 4689999999999999988654445566888899999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccC-CCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSH-TGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~-~~~~~~~~ 270 (325)
.++|+|||++......... ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....+...
T Consensus 143 ~~~l~dfg~~~~~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (287)
T cd06621 143 QVKLCDFGVSGELVNSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218 (287)
T ss_pred eEEEeeccccccccccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH
Confidence 9999999998654432211 235678899999998888999999999999999999999999764321 11122222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+.. ....+. ..... .........+.+++.+||..||.+|||+.|+++
T Consensus 219 ~~~---~~~~~~--~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 219 YIV---NMPNPE--LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHh---cCCchh--hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 211 111111 00000 000112344899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=278.61 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=196.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
..++|++.+.||+|+||.||+|. +..+++.+|+|.+... ......+..|+.++..+ +|||++
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~-~~~~~~~~aik~~~~~----------------~~~~~~~~~e~~~l~~l~~h~ni~ 82 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVT-NKKDGSLAAVKILDPI----------------SDVDEEIEAEYNILQSLPNHPNVV 82 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEE-ECCCCCEEEEEEeccc----------------ccHHHHHHHHHHHHHHhcCCCCeE
Confidence 46889999999999999999995 5567889999987211 12234566788888888 799999
Q ss_pred ccccceecC-----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 111 PLLAHMVRP-----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 111 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
++++++... +..++|+||+++++|.+++.........+++..+..++.|++.||.+|| +.+++|+||+|+||
T Consensus 83 ~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~ni 159 (291)
T cd06639 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNI 159 (291)
T ss_pred EEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHE
Confidence 999988653 3589999999999999988654344566889999999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCcc
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-----TISEKCDIYSFGVLLAVLVMGKFPFDDFF 260 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-----~~~~~~DvwslG~il~~ll~g~~p~~~~~ 260 (325)
+++.++.++|+|||.+.......... ....|+..|+|||.+... .++.++|+||||+++|+|++|+.||....
T Consensus 160 li~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 160 LLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred EEcCCCCEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 99999999999999987654332211 123678889999987543 26789999999999999999999996532
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ............+... . .......+.++|.+||+.||++|||+.++++
T Consensus 238 ~-------~~~~~~~~~~~~~~~~-~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 238 P-------VKTLFKIPRNPPPTLL-H-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H-------HHHHHHHhcCCCCCCC-c-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 1111111111111100 0 0112234899999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=277.48 Aligned_cols=254 Identities=20% Similarity=0.354 Sum_probs=195.6
Q ss_pred cCcccccccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
++|++.+.||+|+||.||+|...... +..||+|.+... ........+..|+.+++.++||||++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~ni~~ 69 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--------------YTEKQRRDFLSEASIMGQFDHPNIIH 69 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--------------CCHHHHHHHHHHHHHHHhCCCcCcce
Confidence 56899999999999999999754332 246999987321 12234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++......++|+||+++++|.+++.. ....++...+..++.|++.||.+|| ++|++|+||+|+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~ 143 (269)
T cd05065 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNL 143 (269)
T ss_pred EEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCC
Confidence 99999999999999999999999999843 2345888899999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCcccccee-ec--CCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 192 EARISGFDLAILMPDGLTQIDTMY-VV--GTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~-~~--g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
.++|+|||.+.............. .. .+..|+|||...+..++.++||||||+++|++++ |..||..... .+
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~ 219 (269)
T cd05065 144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QD 219 (269)
T ss_pred cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HH
Confidence 999999999876543322111111 11 1347999999998889999999999999999886 9999865221 12
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+. .....+. + .+.+..+.+++.+||..+|.+||++.+++.
T Consensus 220 ~~~~i~---~~~~~~~--~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 220 VINAIE---QDYRLPP--P--------MDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHH---cCCcCCC--c--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222221 1111111 0 112233889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=282.42 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=195.5
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|. +..+++.+|+|.+... .........+.+|+.+++.++||||++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~-~~~~~~~~~iK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 66 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCK-HKETGQIVAIKKFLES-------------EDDKMVKKIAMREIRMLKQLRHENLVNLI 66 (286)
T ss_pred CceeEeeeeccCCCeEEEEEE-ECCCCCEEEEEeHhhc-------------cCcchhhHHHHHHHHHHHhcCCcchhhHH
Confidence 479999999999999999996 4456889999986211 11112345678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++..++..++|+||+++++|..+. .....+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.+
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~ 139 (286)
T cd07846 67 EVFRRKKRLYLVFEFVDHTVLDDLE----KYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVV 139 (286)
T ss_pred HhcccCCeEEEEEecCCccHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcE
Confidence 9999999999999999998887766 23345889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||++......... .....++..|+|||...+. .++.++|+||||+++|+|++|..||..... .+.....
T Consensus 140 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~ 213 (286)
T cd07846 140 KLCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHI 213 (286)
T ss_pred EEEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHH
Confidence 99999998765443221 1123578889999987653 467899999999999999999999864221 1110000
Q ss_pred HHHhhhC-----------------CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASE-----------------NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... ..................+..+.+++.+||+.||++||++.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 214 IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 000000000000001123345899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.26 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=199.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.+.|+..+.||.|+||.||+|. +..++..+|+|.+... ........+.+|+.+++.+.||||+++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~-~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLE--------------EAEDEIEDIQQEITVLSQCDSPYVTKY 67 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEE-EccCCEEEEEEEEecc--------------ccHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 4678899999999999999995 4556788999987321 112335678889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+.+....++||||+++++|.+++. ...++......++.|++.++.+|| +.+++|+||+|+||+++.++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~ 139 (277)
T cd06640 68 YGSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGD 139 (277)
T ss_pred EEEEEECCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCC
Confidence 999999999999999999999999883 245788888999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++++|||.+......... .....++..|.|||.+.+..++.++|+||||+++|+|++|..||...... ...
T Consensus 140 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~--- 210 (277)
T cd06640 140 VKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVL--- 210 (277)
T ss_pred EEEcccccceeccCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hHh---
Confidence 999999999766543221 11245788899999998888999999999999999999999999653221 111
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ .......+..+.+++.+||+.+|.+||++.++++
T Consensus 211 ~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 211 FLIPKNNP----------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhhcCCC----------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 11111111 1112234445889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.67 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=194.6
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCC
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRN 108 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 108 (325)
..+.+.|++.+.||.|+||.||+|. +..+++.+|+|.+.. .......+..|+.+++.+ .|||
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~-~~~~~~~~a~K~~~~----------------~~~~~~~~~~e~~~l~~~~~h~~ 74 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGR-HVKTGQLAAIKVMDV----------------TEDEEEEIKLEINMLKKYSHHRN 74 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEE-EcCCCcEEEEEEEec----------------ChHHHHHHHHHHHHHHHhcCCCc
Confidence 4567899999999999999999996 456788999998732 112345577888888888 6999
Q ss_pred ccccccceec------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 109 ILPLLAHMVR------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 109 i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
|+++++++.. ....+++|||+++++|.+++... ....+++..+..++.|++.|+.||| +.+++|+||+|
T Consensus 75 i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~ 149 (282)
T cd06636 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKG 149 (282)
T ss_pred EEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCH
Confidence 9999998853 45689999999999999998542 2345778888899999999999999 88999999999
Q ss_pred CceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCC
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
+||++++++.++|+|||.+......... .....|+..|+|||.+. +..++.++|+||||+++|+|++|..||.
T Consensus 150 ~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 150 QNVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred HHEEECCCCCEEEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 9999999999999999998755322111 12246788999999875 3457889999999999999999999996
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..... .. ........... .. . ...+..+.++|.+||+.||.+|||+.|+++
T Consensus 228 ~~~~~------~~-~~~~~~~~~~~--~~----~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 228 DMHPM------RA-LFLIPRNPPPK--LK----S---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccCHH------hh-hhhHhhCCCCC--Cc----c---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 53211 10 01111111100 00 0 112234899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=277.95 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=201.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||.|+||+||+|. ...++..+++|.+... ........+.+|+.+++.++|+|+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAI-CLPNNEKVAIKRIDLE--------------KCQTSVDELRKEVQAMSQCNHPNVVKYY 65 (267)
T ss_pred CcceeeeeecCCCCeEEEEEE-EcCCCcEEEEEEeccC--------------CcchHHHHHHHHHHHHHhcCCCCEEEEE
Confidence 479999999999999999996 4457889999987311 1112456788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..++++|++++++|.+++..... ...+++..+..++.|++.||.+|| ++|++|+||+|+||++++++.+
T Consensus 66 ~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~ 141 (267)
T cd06610 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSV 141 (267)
T ss_pred EEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCE
Confidence 999999999999999999999999854211 245888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccc--cceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 194 RISGFDLAILMPDGLTQI--DTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+|+|||++.......... ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||...... . .
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~--~ 215 (267)
T cd06610 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----K--V 215 (267)
T ss_pred EEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----h--h
Confidence 999999997665433221 12224678899999988776 6889999999999999999999999653221 1 1
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.........+. .... ......+..+.+++.+||+.||++|||+.++++
T Consensus 216 -~~~~~~~~~~~--~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 216 -LMLTLQNDPPS--LETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -HHHHhcCCCCC--cCCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111111111 0000 001223344899999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=274.16 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=197.0
Q ss_pred cccccCcceeEEEEEecC--CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccccee
Q 040480 40 EKIGSGGCGDVYKAELPG--SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMV 117 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 117 (325)
+.||+|+||.||+|.... ..+..+++|.+.... .......+.+|+..+..+.|+|++++++++.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 66 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--------------SEEERKDFLKEARVMKKLGHPNVVRLLGVCT 66 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc--------------chhHHHHHHHHHHHHhhcCCCChheeeeeec
Confidence 479999999999997542 227889999873211 1113567889999999999999999999999
Q ss_pred cCCceEEEEEcccCCCHHHHHhhhccc-----ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 118 RPDSHLLVYDFMKNGSLQAVLYDVSKG-----RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
.....+++|||+++++|.+++...... ...+++..+..++.|++.||++|| +++++|+||+|+||++++++.
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~ 143 (262)
T cd00192 67 EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLV 143 (262)
T ss_pred CCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCc
Confidence 999999999999999999999553211 467899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+................++..|+|||...+..++.++|+||||+++|+|++ |..||.... ....
T Consensus 144 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~--- 216 (262)
T cd00192 144 VKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----NEEV--- 216 (262)
T ss_pred EEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----HHHH---
Confidence 99999999987665432222222456788999999988889999999999999999999 699997631 1112
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........... .+ ...+..+.+++.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 259 (262)
T cd00192 217 LEYLRKGYRLP--KP--------EYCPDELYELMLSCWQLDPEDRPTFSELVE 259 (262)
T ss_pred HHHHHcCCCCC--CC--------ccCChHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22222111111 00 111334899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=274.87 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=192.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|++|.||+|.+. .+..+|+|.+... ......+.+|+.+++.++|||++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~----------------~~~~~~~~~E~~~l~~l~h~~i~~~ 66 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPG----------------TMMPEAFLQEAQIMKKLRHDKLVPL 66 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccC----------------CccHHHHHHHHHHHHhCCCCCeeeE
Confidence 467999999999999999999753 3346899976211 1223567889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++. .+..+++|||+.+++|.+++... ....+++..+..++.|++.||.||| +.|++|+||+|+||++++++.
T Consensus 67 ~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~ 140 (260)
T cd05069 67 YAVVS-EEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLV 140 (260)
T ss_pred EEEEc-CCCcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCe
Confidence 98775 45689999999999999998542 2334788888999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+.......... .....++..|+|||...+..++.++|+||||+++|+|++ |..||..... .....
T Consensus 141 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~- 214 (260)
T cd05069 141 CKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REVLE- 214 (260)
T ss_pred EEECCCccceEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH-
Confidence 9999999997654332211 111235667999999988889999999999999999999 8999965221 11211
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... .+ ...+..+.+++.+||..||.+||+++++++
T Consensus 215 --~~~~~~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 215 --QVERGYRMP--CP--------QGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred --HHHcCCCCC--CC--------cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111111111 00 112234899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=273.70 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=191.9
Q ss_pred cccccCcceeEEEEEecCCCC--cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccccee
Q 040480 40 EKIGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMV 117 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 117 (325)
+.||+|++|.||+|.+...++ ..+|+|.+.... .......+.+|+.++++++||||+++++.+.
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 66 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK--------------LSDIMDDFLKEAAIMHSLDHENLIRLYGVVL 66 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcc--------------cHHHHHHHHHHHHHHhhcCCCCccceeEEEc
Confidence 468999999999998654344 368999873211 0044567889999999999999999999988
Q ss_pred cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeec
Q 040480 118 RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~d 197 (325)
. ...++++||+++++|.+++..... ..+++..+..++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|
T Consensus 67 ~-~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~d 140 (257)
T cd05040 67 T-HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGD 140 (257)
T ss_pred C-CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecc
Confidence 8 889999999999999999854221 46888999999999999999999 88999999999999999999999999
Q ss_pred cccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHH
Q 040480 198 FDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNV 275 (325)
Q Consensus 198 fg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 275 (325)
||++.......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||.... ..+... ..
T Consensus 141 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~---~~ 213 (257)
T cd05040 141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS----GSQILK---KI 213 (257)
T ss_pred ccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHH---HH
Confidence 99998764422111 1112356778999999988889999999999999999998 999986421 112221 11
Q ss_pred hhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ...+ ...+..+.+++.+||+.+|++|||+.++++
T Consensus 214 ~~~~~~-~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 214 DKEGER-LERP--------EACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HhcCCc-CCCC--------ccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 111110 0000 112234889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=276.84 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=196.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|++.+.||+|+||.||+|.+...+ +..+|+|.+... ........+..|+.++++++||||+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~ 68 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--------------YTEKQRRDFLSEASIMGQFDHPNII 68 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC--------------CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 468999999999999999999754332 347899987321 1122345788899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..+++|||+++++|.+++.. ....++......++.|++.|+.+|| +++++|+||+|+||+++.+
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~ 142 (267)
T cd05066 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSN 142 (267)
T ss_pred eEEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCC
Confidence 999999999999999999999999999843 2345788889999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccc-eeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchH
Q 040480 191 MEARISGFDLAILMPDGLTQIDT-MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~-~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 268 (325)
+.++++|||.+............ ....++..|+|||.+.+..++.++|+||||+++|++++ |..||..... .+.
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~ 218 (267)
T cd05066 143 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDV 218 (267)
T ss_pred CeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHH
Confidence 99999999999866543221111 11122457999999998889999999999999999886 9999965321 112
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... +......+.. ...+..+.+++.+||+.+|.+|||+.++++
T Consensus 219 ~~~---~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 219 IKA---IEEGYRLPAP----------MDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHH---HhCCCcCCCC----------CCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 221 1111111110 112234889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.54 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=198.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|.+.+.||+|+||.||++. +..++..+++|.+... .....+.+.+|+.+++.++|||+++
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~v~iK~~~~~---------------~~~~~~~~~~e~~~l~~l~hp~i~~ 80 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAI-DVATGQEVAIKQMNLQ---------------QQPKKELIINEILVMRENKHPNIVN 80 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEE-EcCCCCEEEEEEeccc---------------cchHHHHHHHHHHHHhhcCCCCeee
Confidence 45799999999999999999995 5567788999987211 1223456788899999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+...+..++|+||+++++|.+++. ...++...+..++.|++.|+.+|| ++|++|+||+|+||+++.++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~ 152 (293)
T cd06647 81 YLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDG 152 (293)
T ss_pred hhheeeeCCcEEEEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCC
Confidence 9999999999999999999999999983 235778888999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++.......... ....++..|+|||.+.+..++.++|+||||+++|++++|..||........
T Consensus 153 ~~kL~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------- 223 (293)
T cd06647 153 SVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------- 223 (293)
T ss_pred CEEEccCcceeccccccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-------
Confidence 99999999887654332211 124678889999999888889999999999999999999999965322110
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.........+... ........+.+++.+||+.+|.+||++++++.
T Consensus 224 ~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 224 LYLIATNGTPELQ--------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred eeehhcCCCCCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001111111100 01112234889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=273.89 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=188.6
Q ss_pred cccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccccee
Q 040480 40 EKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMV 117 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 117 (325)
+.||+|+||.||+|.+...+ +..+|+|.+.... .......+..|+.+++.+.|||++++++++.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 66 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--------------IAAGKKEFLREASVMAQLDHPCIVRLIGVCK 66 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEeccccc--------------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEc
Confidence 47999999999999765443 3789999873211 1124457888999999999999999999765
Q ss_pred cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeec
Q 040480 118 RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~d 197 (325)
....++|+||+++++|.+++.. ...+++..+..++.|++.++.+|| .++++|+||+|+||+++.++.++|+|
T Consensus 67 -~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~d 138 (257)
T cd05060 67 -GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISD 138 (257)
T ss_pred -CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecc
Confidence 4568999999999999999943 336889999999999999999999 88999999999999999999999999
Q ss_pred cccceecCCCCcccc-ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHH
Q 040480 198 FDLAILMPDGLTQID-TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNV 275 (325)
Q Consensus 198 fg~~~~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 275 (325)
||.+........... .....++..|+|||...+..++.++|+||||+++|+|++ |..||..... .+......
T Consensus 139 f~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~-- 212 (257)
T cd05060 139 FGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLE-- 212 (257)
T ss_pred ccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHH--
Confidence 999986643322111 111223467999999988889999999999999999998 9999965321 22222221
Q ss_pred hhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... .+ ...+..+.+++.+||..||++|||+.++++
T Consensus 213 -~~~~~~--~~--------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 213 -SGERLP--RP--------EECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -cCCcCC--CC--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111111 01 011234889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.47 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=183.8
Q ss_pred cccccCcceeEEEEEecC-CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPG-SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|.... .....+++|.+... ........+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--------------~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~ 66 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--------------ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE 66 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc--------------CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC
Confidence 368999999999996432 24457888876211 112334567889999999999999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhccc-ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeec
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKG-RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~d 197 (325)
....++||||+++++|.+++...... ....+......++.|++.||+||| +++++|+||||+||+++.++.++|+|
T Consensus 67 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~d 143 (269)
T cd05042 67 SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGD 143 (269)
T ss_pred CCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEec
Confidence 99999999999999999999653321 233466778899999999999999 88999999999999999999999999
Q ss_pred cccceecCCCCccccceeecCCccccccccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-------LTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 198 fg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-------~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
||++................++..|+|||+... ..++.++|+||||+++|+|++ |..||..... .+..
T Consensus 144 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~ 219 (269)
T cd05042 144 YGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQVL 219 (269)
T ss_pred cccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHH
Confidence 999865433221111112345667999998643 346789999999999999999 7888865321 1111
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
...........+ .+ ... ......+.+++..|+ .||++|||+++|+++
T Consensus 220 ---~~~~~~~~~~~~-~~-~~~---~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 220 ---KQVVREQDIKLP-KP-QLD---LKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred ---HHHhhccCccCC-CC-ccc---ccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 111111111100 00 001 112233677888888 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=278.16 Aligned_cols=254 Identities=23% Similarity=0.386 Sum_probs=191.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHH-HHhccCCCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII-TASQIRHRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~ 112 (325)
++|++.+.||+|+||.||+|. +..+++.||+|.+.... .......+..|+. .++.+.||||+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~-~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~e~~~~~~~~~~~~iv~~ 65 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMR-HVPTGTIMAVKRIRATV--------------NSQEQKRLLMDLDISMRSVDCPYTVTF 65 (283)
T ss_pred CCceEEEEecccCCeEEEEEE-EcCCCcEEEEEEEecCC--------------CcHHHHHHHHHHHHHHHHcCCCCeeee
Confidence 479999999999999999996 55678999999873211 1111223344444 3566789999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEecCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA-RVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~ivH~dl~~~nil~~~~~ 191 (325)
++++..++..+++|||++ ++|.+++.........+++..+..++.|++.||.||| ++ +++|+||+|+||+++.++
T Consensus 66 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~ 141 (283)
T cd06617 66 YGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNG 141 (283)
T ss_pred eEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCC
Confidence 999999999999999997 4888888654444567899999999999999999999 76 999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCccccccccccc----CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT----LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .
T Consensus 142 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~-- 213 (283)
T cd06617 142 QVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---P-- 213 (283)
T ss_pred CEEEeecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---C--
Confidence 999999999876543221 122467888999998765 4468899999999999999999999964211 1
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... .........+.. +. . ..+..+.+++.+||..+|.+|||+.++++
T Consensus 214 ~~~-~~~~~~~~~~~~--~~----~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 214 FQQ-LKQVVEEPSPQL--PA----E---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHH-HHHHHhcCCCCC--Cc----c---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 111111111111 10 0 12234899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=274.03 Aligned_cols=247 Identities=28% Similarity=0.398 Sum_probs=196.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||.|+||.||+|.. .++.+|+|.+... .....++..|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~----------------~~~~~~~~~e~~~l~~l~~~~i~~ 64 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDD----------------STAAQAFLAEASVMTTLRHPNLVQ 64 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe---cCcEEEEEEeccc----------------hhHHHHHHHHHHHHHhcCCcceee
Confidence 356899999999999999999964 5788999988321 113567888999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+++++|.+++... ....+++..+..++.|++.+|.||| +.|++|+||+|+||+++.++
T Consensus 65 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~ 139 (256)
T cd05039 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDL 139 (256)
T ss_pred eEEEEcCCCCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCC
Confidence 999999899999999999999999998442 2236889999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+........ ...++..|.|||.+.+..++.++|+||||+++|++++ |..||.... .....
T Consensus 140 ~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~- 209 (256)
T cd05039 140 VAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVV- 209 (256)
T ss_pred CEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC----HHHHH-
Confidence 999999999976633221 1234567999999988888999999999999999997 999986421 11111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... .+ ...+..+.+++.+||..+|++|||++++++
T Consensus 210 --~~~~~~~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 210 --PHVEKGYRME--AP--------EGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --HHHhcCCCCC--Cc--------cCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1111111111 00 111234889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=282.07 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=199.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|. +..+++.||+|.+... .........+.+|+.+++.++|+||++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~-~~~~~~~v~vK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 66 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCR-NKATGEIVAIKKFKES-------------EDDEDVKKTALREVKVLRQLRHENIVNLK 66 (288)
T ss_pred CceeEEEEecccCCeeEEEEE-eCCCCcEEEEehhhhh-------------cccccchhHHHHHHHHHHhcCCCCeeehh
Confidence 479999999999999999995 5556889999987211 11233456788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..++++||++++.+.... .....++...+..++.|++.|+.+|| .++++|+||+|+||++++++.+
T Consensus 67 ~~~~~~~~~~iv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~ 139 (288)
T cd07833 67 EAFRRKGRLYLVFEYVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVL 139 (288)
T ss_pred heEEECCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCE
Confidence 9999999999999999986666554 23445889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||.+.......... .....++..|+|||...+. .++.++|+||||+++|+|++|..||..... .+.....
T Consensus 140 kl~d~g~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~ 214 (288)
T cd07833 140 KLCDFGFARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD----IDQLYLI 214 (288)
T ss_pred EEEeeecccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 999999987665443211 1124677889999999887 788999999999999999999999965321 1111111
Q ss_pred HHHhhhCCC--------C---------cccchhhcCCch-HHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 273 RNVMASENP--------N---------RAIDSKLLGNGY-EEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 273 ~~~~~~~~~--------~---------~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
........+ . ...........+ ...+..+.+++.+||..||++|||+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 215 QKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 111100000 0 000000000000 1124558999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=278.55 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=199.0
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||.|+||.||+|. +..+++.+|+|.+......... .........+.+..|+.+++.++|||++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~-~~~~~~~~a~K~~~~~~~~~~~-----~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 75 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLAL-NVTTGEMMAVKQVELPATIAGR-----HDSRQKDMVKALRSEIETLKDLDHLNIVQYLG 75 (272)
T ss_pred ceeecceecccCceEEEEEe-ecCCCceeeeeeeechhhhhcc-----cchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence 57889999999999999995 5567889999987432111000 00001123457888999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++...+..++|+||+++++|.+++.. ...++...+..++.|++.+|.+|| +++++|+||+|+||+++.++.++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 76 FETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EeccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEE
Confidence 99999999999999999999999843 256888899999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT--ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|||.+................|+..|+|||...... ++.++|+||||+++|++++|..||..... ....
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~- 221 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAM- 221 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHH-
Confidence 99999987654332222222346788999999887654 78899999999999999999999854211 1111
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ......+.. .....+..+.+++.+||..||.+|||++++++
T Consensus 222 ~~~~~~-~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 222 FKLGNK-RSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHhhcc-ccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 111111111 11123345899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=274.07 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=193.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
.+|++.+.||+|+||.||+|. +..++..+++|.+....... ........+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~-~~~~~~~~~~k~~~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 70 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCY-DVDTGRELAAKQVQFDPESP----------ETSKEVSALECEIQLLKNLQHERIVQYY 70 (266)
T ss_pred CCccccceecCCCCEEEEEEE-EcCCCcEEEEEEeecCcCCc----------hhHHHHHHHHHHHHHHHHcCCCCeeeEE
Confidence 579999999999999999995 55678899999874321100 1112445688899999999999999999
Q ss_pred cceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 114 AHMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 114 ~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+.+.. ....++++||+++++|.+++.. ...++......++.|++.+|.+|| +.+++|+||+|+||+++.++
T Consensus 71 ~~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~ 143 (266)
T cd06651 71 GCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAG 143 (266)
T ss_pred EEEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCC
Confidence 98765 3567899999999999999833 345788888999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCc-cccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLT-QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~-~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~ 217 (266)
T cd06651 144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAA 217 (266)
T ss_pred CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHH
Confidence 999999999876543211 1111224578899999999988899999999999999999999999965311 111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... .... .......+.+++ +||..+|++|||++|+++
T Consensus 218 -~~~~~~~~~-~~~~--------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 -IFKIATQPT-NPQL--------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -HHHHhcCCC-CCCC--------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111111111 0000 111222367777 688899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=275.51 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=201.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||.|++|.||+|. +..+++.+++|.+.... .......+.+|+.+++.+.||||++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~-~~~~~~~~~ik~~~~~~--------------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 65 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVL-HRPTGKIMAVKTIRLEI--------------NEAIQKQILRELDILHKCNSPYIVGFY 65 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEE-EcCCCcEEEEEEEeccc--------------ChHHHHHHHHHHHHHHHCCCCchhhhh
Confidence 468899999999999999995 55678899999873221 123456778899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEecCCCC
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~nil~~~~~~ 192 (325)
+.+...+..++++||+++++|.+++... ...++......++.|++.++.+|| + .+++|+||+|+||+++.++.
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~ 139 (265)
T cd06605 66 GAFYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQ 139 (265)
T ss_pred eeeecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999999998442 256888899999999999999999 7 89999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||.+.......... ..++..|+|||...+..++.++|+||||+++|+|++|..||..... .........
T Consensus 140 ~~l~d~g~~~~~~~~~~~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~ 213 (265)
T cd06605 140 IKLCDFGVSGQLVNSLAKT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELL 213 (265)
T ss_pred EEEeecccchhhHHHHhhc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHH
Confidence 9999999986553221111 4678899999999988899999999999999999999999975322 111222223
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+..... .....+.++|.+||..||++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 214 QYIVNEPPPRLPSG---------KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHhcCCCCCCChh---------hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 32222221111100 12334889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=275.88 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=196.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|+..+.||+|+||.||+|...... ...+++|.+... ........+..|+.+++.++|||++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~ 69 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--------------YTEKQRQDFLSEASIMGQFSHHNII 69 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc--------------CCHHHHHHHHHHHHHHhcCCCCCee
Confidence 468899999999999999999754322 247899987321 1123345678899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++.+++...+..++||||+++++|.+++.. ....++......++.|++.|+.+|| +.|++|+||+|+||+++.+
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~ 143 (268)
T cd05063 70 RLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSN 143 (268)
T ss_pred EEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCC
Confidence 999999999999999999999999999843 2356888899999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccce-eecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTM-YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~-~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 268 (325)
+.++++|||++............. ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ....
T Consensus 144 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~----~~~~ 219 (268)
T cd05063 144 LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS----NHEV 219 (268)
T ss_pred CcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC----HHHH
Confidence 999999999998665432221111 1122457999999988889999999999999999997 999996422 1122
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+......+.. .+.+..+.+++.+||+.+|++||++.++++
T Consensus 220 ---~~~i~~~~~~~~~----------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 220 ---MKAINDGFRLPAP----------MDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ---HHHHhcCCCCCCC----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2222221111111 012234889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=274.57 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=194.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||++.+. .+..+++|.+.. .......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~ 65 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKP----------------GSMSVEAFLAEANVMKTLQHDKLVK 65 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec--CCccEEEEecCC----------------ChhHHHHHHHHHHHHHhcCCCCcce
Confidence 4578999999999999999999643 455699997621 1123456888999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+.. ...++++||+++++|.+++... ....++...+..++.|++.||.+|| +.|++|+||+|+||+++.++
T Consensus 66 ~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~ 139 (260)
T cd05073 66 LHAVVTK-EPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 139 (260)
T ss_pred EEEEEcC-CCeEEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCC
Confidence 9998877 7789999999999999999542 2345777888899999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.... ......
T Consensus 140 ~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~ 214 (260)
T cd05073 140 VCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIR 214 (260)
T ss_pred cEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC----HHHHHH
Confidence 9999999999765432211 1111234567999999988889999999999999999998 999996422 111222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ....... . ...+..+.+++.+||+.||++||++.++++
T Consensus 215 ~~~---~~~~~~~--~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 215 ALE---RGYRMPR--P--------ENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHh---CCCCCCC--c--------ccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 111 1111110 0 112234889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=298.61 Aligned_cols=283 Identities=18% Similarity=0.225 Sum_probs=191.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCC--CcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSP--MSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|++++.||+|+||+||+|.+....+...+.|.+..... ....................+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 36899999999999999999976544444444332211100 0001111111122233456788999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhc-ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS-KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++++++...+..|++++++.+ +|.+++.... ..........+..++.|++.||.||| ++||+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 999999999999999999955 7777763321 11222345567789999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCC-CCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKF-PFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~-p~~~~~~~~~~~~~ 268 (325)
++.++|+|||++.......... .....||..|+|||++.+..++.++|||||||++|+|++|.. |+..... .....+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHHHHH
Confidence 9999999999998765432211 112478999999999999999999999999999999999875 4443211 111111
Q ss_pred HHHHHHHhhhCCCCcccchh--------------hcCCch------HHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSK--------------LLGNGY------EEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.+... ......++.. ...... ......+.+++.+||+.||++|||+.|+++
T Consensus 381 ~~~~~~~---~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSL---SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhc---ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111110 0000000000 000000 011234778899999999999999999986
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=280.03 Aligned_cols=254 Identities=20% Similarity=0.276 Sum_probs=193.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||++. +..+++.|++|.+... ..........+.+|+.+++.++||||++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~-~~~~~~~v~ik~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 67 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVR-HKETRQRFAMKKINKQ------------NLILRNQIQQVFVERDILTFAENPFVVSMF 67 (305)
T ss_pred CCceEeeEeecCCCeeEEEEE-ECCCCcEEEEEEeehh------------hhhhHHHHHHHHHHHHHHHhCCCCCeeeeE
Confidence 479999999999999999995 5567889999987311 111123345778899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+..++..++||||+++++|.+++.. ...+++..+..++.|++.|+.||| +++++|+||+|+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~ 140 (305)
T cd05609 68 CSFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHI 140 (305)
T ss_pred EEEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCE
Confidence 999999999999999999999999833 346888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCc-------------cccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcc
Q 040480 194 RISGFDLAILMPDGLT-------------QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF 260 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~-------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~ 260 (325)
+|+|||.+........ ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus 141 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 141 KLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred EEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998863211000 000111356778999999988889999999999999999999999996421
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhh
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (325)
. .................. ...+..+.+++.+||+.||++||++.++
T Consensus 221 ~-------~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~~ 267 (305)
T cd05609 221 P-------EELFGQVISDDIEWPEGD--------EALPADAQDLISRLLRQNPLERLGTGGA 267 (305)
T ss_pred H-------HHHHHHHHhcccCCCCcc--------ccCCHHHHHHHHHHhccChhhccCccCH
Confidence 1 122222222111100000 0122338999999999999999995443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=273.00 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=191.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-.+|.+.+.||+|+||.||++.. .+..+++|.+.. ......+.+|+.+++.++|++++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~-----------------~~~~~~~~~e~~~l~~l~~~~i~~~ 64 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKN-----------------DATAQAFLAEASVMTQLRHSNLVQL 64 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCC-----------------CchHHHHHHHHHHHHhCCCCCeeeE
Confidence 35899999999999999999965 577899998721 1234567889999999999999999
Q ss_pred cccee-cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 113 LAHMV-RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 113 ~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
++++. ..+..++++||+++++|.+++.. .....+++.....++.|++.+|++|| ++|++|+||+|+||+++.++
T Consensus 65 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~ 139 (256)
T cd05082 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDN 139 (256)
T ss_pred EEEEEcCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCC
Confidence 98754 45678999999999999999843 22335788888999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||++........ ...++..|+|||+..+..++.++|+||||+++|+|++ |..||.... ..+...
T Consensus 140 ~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~~~~~~ 210 (256)
T cd05082 140 VAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVP 210 (256)
T ss_pred cEEecCCccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHH
Confidence 999999999875443221 1233567999999988889999999999999999997 999986421 112222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....... .. ...+..+.+++.+||+.||++|||+.++++
T Consensus 211 ---~~~~~~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 211 ---RVEKGYKMD--AP--------DGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---HHhcCCCCC--CC--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 221111110 00 112234889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=278.19 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=198.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|++|.||+|. +..++..+|+|.+.... ........+.+|+.++++++||||+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~vK~~~~~~-------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAK-DRETGETVALKKVALRR-------------LEGGIPNQALREIKALQACQHPYVVKLLD 66 (286)
T ss_pred CceEEeecccCCCcEEEEEE-ECCCCceEEEEEEEccc-------------ccchhhHHHHHHHHHHHhCCCCCCcceee
Confidence 58999999999999999996 45568899999884321 11233457888999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++......++|+||+ +++|.+++.. ....++...+..++.|++.+|+||| +.|++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~ 139 (286)
T cd07832 67 VFPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLK 139 (286)
T ss_pred EEecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEE
Confidence 999999999999999 9999998843 2356899999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|+|||.+........ .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||.... .........
T Consensus 140 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~----~~~~~~~~~ 214 (286)
T cd07832 140 IADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN----DIEQLAIVF 214 (286)
T ss_pred EeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC----HHHHHHHHH
Confidence 999999986654322 111124678899999988654 46889999999999999999988885422 111111111
Q ss_pred HHhhhCCCCcc-------------cc---hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRA-------------ID---SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~-------------~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..........+ .+ .........+....+.+++.+||+.||++|||++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 215 RTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11100000000 00 00000011123356899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=279.45 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=195.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
..|.....||.|+||.||+|. +..++..+|+|.+... .......+.+|+.+++.+.|||+++++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~-~~~~~~~v~iK~~~~~---------------~~~~~~~~~~e~~~l~~l~hp~i~~~~ 84 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAR-EKHSGRQVAVKMMDLR---------------KQQRRELLFNEVVIMRDYQHQNVVEMY 84 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEE-EcCCCCEEEEEEEEec---------------ccchHHHHHHHHHHHHhCCCCchhhhh
Confidence 446667789999999999995 5567889999987211 112345678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+...+..++++||+++++|.+++ ....++...+..++.|++.||.+|| +++++|+||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~iv~e~~~~~~L~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~ 156 (297)
T cd06659 85 KSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRV 156 (297)
T ss_pred hheeeCCeEEEEEecCCCCCHHHHH-----hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcE
Confidence 9999999999999999999999877 2345888999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||++......... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ... ..
T Consensus 157 kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~---~~ 227 (297)
T cd06659 157 KLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQA---MK 227 (297)
T ss_pred EEeechhHhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH---HH
Confidence 99999998654432211 1224688899999999888899999999999999999999999964221 111 11
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............ .......+.+++.+||+.+|.+||+++++++
T Consensus 228 ~~~~~~~~~~~~--------~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 228 RLRDSPPPKLKN--------AHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHhccCCCCccc--------cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 111111111000 0111233889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=272.61 Aligned_cols=246 Identities=20% Similarity=0.263 Sum_probs=187.4
Q ss_pred ccccCcceeEEEEEecCC-CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecC
Q 040480 41 KIGSGGCGDVYKAELPGS-NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119 (325)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 119 (325)
.||+|+||.||+|.+... ++..+|+|.+... ........+.+|+.++++++||||+++++.+. .
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~ 66 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--------------NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-A 66 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--------------cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-C
Confidence 489999999999975433 3556999987321 11233457889999999999999999999775 4
Q ss_pred CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccc
Q 040480 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199 (325)
Q Consensus 120 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg 199 (325)
...++||||+++++|.+++.. ....+++..+..++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||
T Consensus 67 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg 140 (257)
T cd05115 67 EALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFG 140 (257)
T ss_pred CCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCC
Confidence 578999999999999998843 3456899999999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCCcccc-ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhh
Q 040480 200 LAILMPDGLTQID-TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMA 277 (325)
Q Consensus 200 ~~~~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
.+........... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||..... .+. ...+..
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~---~~~~~~ 213 (257)
T cd05115 141 LSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PEV---MSFIEQ 213 (257)
T ss_pred ccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HHH---HHHHHC
Confidence 9975543322111 111223568999999988889999999999999999996 9999965321 122 222222
Q ss_pred hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..... .+ ..++..+.+++.+||..||++||++.++++
T Consensus 214 ~~~~~--~~--------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 GKRLD--CP--------AECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CCCCC--CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22111 11 112234889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=273.79 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=199.4
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|+..+.||+|++|.||++. +..++..+|+|.+........ ........+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~-~~~~~~~~alk~~~~~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 70 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQAR-DVKTGTLMAVKQVTYVRNTSS---------EQEEVVEALRKEIRLMARLNHPHIIRMLG 70 (268)
T ss_pred CccccceecCcCceEEEEEE-EcCCCcEEEEEEeecccCCch---------hHHHHHHHHHHHHHHHHHcCCCceehhhc
Confidence 58889999999999999996 567788999998743221110 01124567889999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC-Cc
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM-EA 193 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~-~~ 193 (325)
++.+.+..++|+||+++++|.+++.. ...+++.....++.|++.||.+|| ++|++|+||+|+||+++.++ .+
T Consensus 71 ~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~ 143 (268)
T cd06630 71 ATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRL 143 (268)
T ss_pred eeccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999843 345788899999999999999999 88999999999999998765 58
Q ss_pred eeeccccceecCCCCccc--cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 194 RISGFDLAILMPDGLTQI--DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
+|+|||.+.......... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~ 219 (268)
T cd06630 144 RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLAL 219 (268)
T ss_pred EEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHH
Confidence 999999997665432111 11224578899999999888889999999999999999999999964321 111111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... ... .......+.+++.+||..||.+|||+.++++
T Consensus 220 ~~~~~~~~~~-~~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 IFKIASATTA-PSI--------PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHhccCCC-CCC--------chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1111111111 011 1122234889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=273.25 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=198.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|+..+.||+|++|.||+|. ...++..+++|.+...... .........+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~-~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~ 69 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGL-NLDDGDFFAVKEVSLADDG----------QTGQEAVKQLEQEIALLSKLQHPNIVQYLG 69 (258)
T ss_pred CccccceeeecCCceEEEEE-EcCCCcEEEEEEEEEcccc----------ccchHHHHHHHHHHHHHHhcCCCCchheee
Confidence 58889999999999999995 4557889999987432211 011234567889999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++......++++||+++++|.+++.. ...++......++.|++.++.+|| +.|++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 70 TEREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred eEecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999843 345788888999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|+|||.+........ .....|+..|+|||...... ++.++|+||||+++|+|++|..||..... .....
T Consensus 143 l~d~~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~ 212 (258)
T cd06632 143 LADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVF 212 (258)
T ss_pred EccCccceecccccc---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHH
Confidence 999999876544331 12246788899999887766 88999999999999999999999965321 11111
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ....++. .....+.+++.+||+.+|.+|||+.++++
T Consensus 213 ~~~~~~-~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 213 KIGRSK-ELPPIPD--------HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHhcc-cCCCcCC--------CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111101 1111111 12233889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=273.16 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=194.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|+||.||+|.+. .+..+|+|.+... ......+..|+.+++++.||+++++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~----------------~~~~~~~~~e~~~l~~l~~~~i~~~ 64 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREG----------------AMSEEDFIEEAQVMMKLSHPKLVQL 64 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCC----------------CCCHHHHHHHHHHHHhCCCCCeeeE
Confidence 467999999999999999999653 4678999987311 1223457889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++......++++||+++++|.+++.. ....+++..+..++.+++.++++|| +.+++|+||+|+||+++.++.
T Consensus 65 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~ 138 (256)
T cd05112 65 YGVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQV 138 (256)
T ss_pred EEEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCe
Confidence 9999999999999999999999998843 2345788888999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+........... ....++..|+|||...+..++.++|+||||+++|+|++ |..||.... .....
T Consensus 139 ~~l~d~g~~~~~~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~-- 211 (256)
T cd05112 139 VKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS----NSEVV-- 211 (256)
T ss_pred EEECCCcceeecccCccccc-CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC----HHHHH--
Confidence 99999999876543222111 11234568999999988889999999999999999998 999986422 11112
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... .+.. .+..+.+|+.+||+.+|++|||+.++++
T Consensus 212 -~~~~~~~~~~---~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 212 -ETINAGFRLY---KPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred -HHHhCCCCCC---CCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2211111111 0110 1233899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=283.52 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=197.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCC------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGS------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI- 104 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 104 (325)
...+|.+.+.||+|+||.||+|++... .+..+|+|.+.. .........+.+|+.+++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~E~~~l~~l~ 75 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD--------------DATDKDLSDLVSEMEMMKMIG 75 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc--------------ccCHHHHHHHHHHHHHHHhhc
Confidence 346799999999999999999964321 224689997621 11223456788999999999
Q ss_pred CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcCC
Q 040480 105 RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHHS 172 (325)
Q Consensus 105 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~ 172 (325)
+||||+++++.+...+..++++||+++++|.+++..... ....++...+..++.|++.||.||| +
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~ 152 (334)
T cd05100 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---S 152 (334)
T ss_pred CCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---H
Confidence 799999999999999999999999999999999854321 2234777788899999999999999 8
Q ss_pred CCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-
Q 040480 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM- 251 (325)
Q Consensus 173 ~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~- 251 (325)
+|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 153 ~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 8999999999999999999999999999976544322212211234567999999998889999999999999999998
Q ss_pred CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 252 GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 252 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|..||.... .......+......... ...+..+.+++.+||+.+|++|||+.++++
T Consensus 233 g~~p~~~~~-------~~~~~~~~~~~~~~~~~----------~~~~~~l~~li~~cl~~~p~~Rps~~ell~ 288 (334)
T cd05100 233 GGSPYPGIP-------VEELFKLLKEGHRMDKP----------ANCTHELYMIMRECWHAVPSQRPTFKQLVE 288 (334)
T ss_pred CCCCCCCCC-------HHHHHHHHHcCCCCCCC----------CCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 888886421 12222222221111111 011223889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=281.09 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=199.6
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|++|.||+|. +..+++.+|+|.+..... ........+..|+.+++.+.||||++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~-~~~~~~~~aiK~~~~~~~------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 67 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVR-LKGTGKLFALKVLDKKEM------------IKRNKVKRVLTEQEILATLDHPFLPTLY 67 (316)
T ss_pred CceEEeeeecCCccEEEEEEE-EcCCCcEEEEEEEecccc------------chHHHHHHHHHHHHHHHhCCCCCchhhe
Confidence 479999999999999999995 455789999998843210 1112456788899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+......+++|||+.+++|.+++.. .....+++.....++.|++.+|+||| +.|++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~ 142 (316)
T cd05574 68 ASFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHI 142 (316)
T ss_pred eeeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCE
Confidence 999999999999999999999999843 23356888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccc---------------------------cceeecCCcccccccccccCCCCCccchhhHHHHH
Q 040480 194 RISGFDLAILMPDGLTQI---------------------------DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL 246 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~---------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il 246 (325)
+|+|||++.......... ......|+..|+|||.+.+..++.++|+||||+++
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll 222 (316)
T cd05574 143 MLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222 (316)
T ss_pred EEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHH
Confidence 999999987543221100 01123578889999999988899999999999999
Q ss_pred HHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC----hhhh
Q 040480 247 AVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN----SKDV 322 (325)
Q Consensus 247 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~el 322 (325)
|+|++|..||..... . ............. +. ....+..+.+++.+||+.||++||| ++++
T Consensus 223 ~~l~~g~~pf~~~~~---~----~~~~~~~~~~~~~---~~------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 223 YEMLYGTTPFKGSNR---D----ETFSNILKKEVTF---PG------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred HHHhhCCCCCCCCch---H----HHHHHHhcCCccC---CC------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 999999999965321 1 1111111111110 00 0012334999999999999999999 8888
Q ss_pred hc
Q 040480 323 RC 324 (325)
Q Consensus 323 l~ 324 (325)
++
T Consensus 287 l~ 288 (316)
T cd05574 287 KQ 288 (316)
T ss_pred Hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=279.24 Aligned_cols=198 Identities=27% Similarity=0.395 Sum_probs=157.2
Q ss_pred cccccCcceeEEEEEec-CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 118 (325)
.+||+|+||.||+|+.. ..++..+|+|.+.. ......+.+|+.+++.++||||+++++++..
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~-----------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-----------------TGISMSACREIALLRELKHPNVIALQKVFLS 69 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecC-----------------CCCcHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 57999999999999753 23567899998721 1123457789999999999999999998853
Q ss_pred --CCceEEEEEcccCCCHHHHHhhhc-----ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe----
Q 040480 119 --PDSHLLVYDFMKNGSLQAVLYDVS-----KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---- 187 (325)
Q Consensus 119 --~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~---- 187 (325)
+...++++||+.+ +|.+++.... .....+++..+..++.|++.||.||| +++++|+||||+||++
T Consensus 70 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~ 145 (317)
T cd07867 70 HSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEG 145 (317)
T ss_pred cCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCC
Confidence 4568999999865 7887774321 12235788889999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCcc-ccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+.++.++|+|||++......... .......||..|+|||.+.+. .++.++||||||+++|+|++|..||..
T Consensus 146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 45678999999999866443221 112224678899999988764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=275.95 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=192.9
Q ss_pred hcCcccccccccCcceeEEEEEe---cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAEL---PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..+|++.+.||.|+||.||+|.+ +..++..||+|.+.. ........+.+|+.+++.++||||
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i 67 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH---------------STAEHLRDFEREIEILKSLQHDNI 67 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc---------------CCHHHHHHHHHHHHHHHhCCCCCe
Confidence 46899999999999999999975 344678999998732 122335578899999999999999
Q ss_pred cccccceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 110 LPLLAHMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 110 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+++++++.. ....++|+||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++|+||||+||++
T Consensus 68 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili 141 (284)
T cd05081 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILV 141 (284)
T ss_pred eEEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEE
Confidence 999987643 3468999999999999999843 2345888899999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccc-ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccC----
Q 040480 188 DDDMEARISGFDLAILMPDGLTQID-TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSH---- 262 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~---- 262 (325)
++++.++|+|||++........... .....++..|+|||...+..++.++|+||||+++|+|++|..|+......
T Consensus 142 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~ 221 (284)
T cd05081 142 ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM 221 (284)
T ss_pred CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh
Confidence 9999999999999987644322111 11112344699999998888999999999999999999987765432100
Q ss_pred ----CC-cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 263 ----TG-EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 263 ----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ................... ....+..+.+|+.+||..+|++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 222 MGNDKQGQMIVYHLIELLKNNGRLPA----------PPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cccccccccchHHHHHHHhcCCcCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 0000001111111111000 0112234899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=274.84 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=195.6
Q ss_pred cCcccccccccCcceeEEEEEec---CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELP---GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.-|.+++.||+|+||.||+|+++ ..++..+|+|.+.... .......+.+|+.+++.+.|||++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~i~ 69 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--------------GGNHIADLKKEIEILRNLYHENIV 69 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--------------cHHHHHHHHHHHHHHHhCCCCCee
Confidence 45799999999999999999754 3467889999873211 123345688999999999999999
Q ss_pred ccccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 111 PLLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 111 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++++++... ...++||||+++++|.+++.. ....+++..+..++.|++.+|.||| ++|++|+||+|+||+++
T Consensus 70 ~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~ 143 (284)
T cd05079 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVE 143 (284)
T ss_pred eeeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEc
Confidence 999988765 568999999999999999843 2235788899999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc------
Q 040480 189 DDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS------ 261 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~------ 261 (325)
.++.++|+|||++......... .......++..|+|||...+..++.++|+||||+++|+|++++.|+.....
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~ 223 (284)
T cd05079 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI 223 (284)
T ss_pred CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhc
Confidence 9999999999999865433221 111123556789999998888899999999999999999998766432110
Q ss_pred --CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 --HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..................... .+ ...+..+.+|+.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 224 GPTHGQMTVTRLVRVLEEGKRLP--RP--------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred ccccccccHHHHHHHHHcCccCC--CC--------CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011111112222111111111 00 112334999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=271.88 Aligned_cols=239 Identities=21% Similarity=0.259 Sum_probs=181.1
Q ss_pred cccccCcceeEEEEEecCC-----------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 40 EKIGSGGCGDVYKAELPGS-----------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
+.||+|+||.||+|.+... ....+++|.+.. ........+.+|+.+++.++|||
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~---------------~~~~~~~~~~~~~~~l~~l~hp~ 65 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP---------------SHRDISLAFFETASMMRQVSHKH 65 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh---------------hhhhHHHHHHHHHHHHHhCCCCC
Confidence 4689999999999975322 123588887621 11223446788889999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++......+++|||+++++|..++.. ....++...+..++.|++.|+.||| +++++|+||+|+||+++
T Consensus 66 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~ 139 (262)
T cd05077 66 IVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLA 139 (262)
T ss_pred EeeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEe
Confidence 99999999999999999999999999888732 3345888899999999999999999 88999999999999998
Q ss_pred CCCC-------ceeeccccceecCCCCccccceeecCCcccccccccc-cCCCCCccchhhHHHHHHHHH-hCCCCCCCc
Q 040480 189 DDME-------ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-TLTISEKCDIYSFGVLLAVLV-MGKFPFDDF 259 (325)
Q Consensus 189 ~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~DvwslG~il~~ll-~g~~p~~~~ 259 (325)
.++. ++++|||.+....... ...++..|+|||.+. +..++.++||||||+++|+|+ .|..||...
T Consensus 140 ~~~~~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 140 REGIDGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred cCCccCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 6654 8999999986543221 135677899999886 456889999999999999998 588887642
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. .+.. ......... . .. ....+.+|+.+||+.||++||++.+|++
T Consensus 214 ~~----~~~~----~~~~~~~~~---~----~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 214 TL----AEKE----RFYEGQCML---V----TP----SCKELADLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred ch----hHHH----HHHhcCccC---C----CC----ChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 21 1111 111111110 0 00 1123889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=269.92 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=189.2
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecC
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 119 (325)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 64 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDL--------------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR 64 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcC--------------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC
Confidence 47899999999999643 57889999863211 112234678899999999999999999999999
Q ss_pred CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccc
Q 040480 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199 (325)
Q Consensus 120 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg 199 (325)
+..++||||+++++|.+++.. ....+++..+..++.+++.+|.++| ++|++|+||+|+||+++.++.++|+|||
T Consensus 65 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g 138 (250)
T cd05085 65 QPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFG 138 (250)
T ss_pred CccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCc
Confidence 999999999999999998843 2345788889999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 200 LAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
++......... ......++..|+|||+..+..++.++|+||||+++|++++ |..||..... ... .......
T Consensus 139 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----~~~---~~~~~~~ 210 (250)
T cd05085 139 MSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----QQA---REQVEKG 210 (250)
T ss_pred cceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----HHH---HHHHHcC
Confidence 98754432211 1111233567999999988889999999999999999998 9999965321 111 1111111
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... .+ ...+..+.+++.+||..+|++|||+.++++
T Consensus 211 ~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 211 YRMS--CP--------QKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CCCC--CC--------CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1111 00 012234899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=278.33 Aligned_cols=262 Identities=25% Similarity=0.328 Sum_probs=194.2
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|++|.||+|+ +..++..+|+|.+... .........+.+|+.++++++||||+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 66 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKIRLD-------------TETEGVPSTAIREISLLKELNHPNIVKLLD 66 (284)
T ss_pred CceeeeeecCCCceEEEEEE-ECCCCCEEEEEEcccc-------------ccccccchHHHHHHHHHHhcCCCCCcchhh
Confidence 58899999999999999996 5567889999987321 111223456888999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++.+.+..++||||+. ++|.+++.. .....++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~ 140 (284)
T cd07860 67 VIHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIK 140 (284)
T ss_pred hcccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEE
Confidence 9999999999999996 588888744 23456888999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|+|||.+......... .....++..|+|||...+.. ++.++|+||||+++|+|++|+.||..... .....+...
T Consensus 141 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~ 215 (284)
T cd07860 141 LADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFR 215 (284)
T ss_pred EeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHH
Confidence 9999998755432211 11235678899999877644 58889999999999999999999964221 111111111
Q ss_pred HHhhhCCCCccc-----------------chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAI-----------------DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+.... ...............+.++|.+||+.||.+|||++++++
T Consensus 216 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 216 ---TLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ---HhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 000000000112234789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=273.72 Aligned_cols=239 Identities=18% Similarity=0.254 Sum_probs=180.4
Q ss_pred cccccCcceeEEEEEecC-----------------------CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHH
Q 040480 40 EKIGSGGCGDVYKAELPG-----------------------SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRS 96 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~-----------------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (325)
..||+|+||.||+|.... .....+++|.+.. ........+.+
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~---------------~~~~~~~~~~~ 65 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP---------------SHRDIALAFFE 65 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh---------------HHHHHHHHHHH
Confidence 369999999999996421 1124588887621 11123456788
Q ss_pred HHHHHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 040480 97 QIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVI 176 (325)
Q Consensus 97 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~iv 176 (325)
|+.+++.++||||+++++++......++||||+++++|..++.. ....++...+..++.|++.||.||| +++++
T Consensus 66 ~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ii 139 (274)
T cd05076 66 TASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLE---DKNLV 139 (274)
T ss_pred HHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---cCCcc
Confidence 89999999999999999999999999999999999999988843 3456888899999999999999999 88999
Q ss_pred ecCCCCCceEecCCC-------CceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHH
Q 040480 177 HRDIKPANVLIDDDM-------EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAV 248 (325)
Q Consensus 177 H~dl~~~nil~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ 248 (325)
|+||||+||+++..+ .++++|||.+........ ..++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 140 H~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~e 213 (274)
T cd05076 140 HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213 (274)
T ss_pred CCCCCcccEEEeccCcccCccceeeecCCccccccccccc------cccCCcccCchhhcCCCCCCcHHHHHHHHHHHHH
Confidence 999999999997543 379999998754332211 246778999998865 457899999999999999
Q ss_pred HH-hCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 249 LV-MGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 249 ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++ +|..||..... ........ .......... ..+.+++.+||+.+|++|||+.++++
T Consensus 214 l~~~g~~p~~~~~~----~~~~~~~~---~~~~~~~~~~------------~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 214 ICFDGEVPLKERTP----SEKERFYE---KKHRLPEPSC------------KELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred HHhCCCCCccccCh----HHHHHHHH---hccCCCCCCC------------hHHHHHHHHHcccChhhCcCHHHHHH
Confidence 85 69999865322 11111111 1111111111 12889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=288.83 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=207.6
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
....+.|.+.+.||.|.|++|.+|. +..++..||+|.+.. ...+.....++.+|+.+|+.++||||
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~-~~~t~~~VaiK~idk-------------t~ln~~~~~k~~rev~imk~l~HPnI 117 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLAR-HILTGTEVAIKIIDK-------------TQLNPSKRQKLGREVDIMKSLNHPNI 117 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeE-ecCCCceEEEEEehh-------------cccChHHHHHHHHHHHHHHhcCCcce
Confidence 3466889999999999999999995 567789999998832 23344555669999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++++++...+..+|+||||+.+|.+.+++ ...+...+..+..++.|+..|++||| +++|||||||++|++++.
T Consensus 118 vkl~~v~~t~~~lylV~eya~~ge~~~yl----~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~ 190 (596)
T KOG0586|consen 118 VKLFSVIETEATLYLVMEYASGGELFDYL----VKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDE 190 (596)
T ss_pred eeeeeeeeecceeEEEEEeccCchhHHHH----HhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhccccc
Confidence 99999999999999999999999999999 34455666889999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
+-++||+|||++..+........ ++|++.|.|||++.+.+| ++.+|+||+|+++|.|+.|..||++....+-....
T Consensus 191 ~mnikIaDfgfS~~~~~~~~lqt---~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv 267 (596)
T KOG0586|consen 191 NMNIKIADFGFSTFFDYGLMLQT---FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV 267 (596)
T ss_pred ccceeeeccccceeecccccccc---cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh
Confidence 99999999999998886544333 699999999999999886 58899999999999999999999864332222111
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
. ......+..+..+ ..+||+++|..+|.+|++++++-
T Consensus 268 l------~gk~rIp~~ms~d------------ce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 268 L------RGKYRIPFYMSCD------------CEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred e------eeeecccceeech------------hHHHHHHhhccCccccCCHHHhh
Confidence 1 1111112222211 78899999999999999999874
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=271.72 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=202.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||.|++|.||+|+ +..+++.+++|++.... .......+..|+..+..++|||+++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~-~~~~~~~~~vk~~~~~~--------------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVR-HKPTGKIYALKKIHVDG--------------DEEFRKQLLRELKTLRSCESPYVVKCY 65 (264)
T ss_pred CcceeeeeeeecCCeEEEEEE-EcCCCcEEEEEEeccCc--------------chHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 468999999999999999996 44578899999873221 113456788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEecCCCC
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~nil~~~~~~ 192 (325)
+.+...+..++++||+++++|.+++.. ...++......++.|++.++.+|| + .+++|+||+|+||+++.++.
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~ 138 (264)
T cd06623 66 GAFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGE 138 (264)
T ss_pred EEEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCC
Confidence 999999999999999999999999943 366899999999999999999999 8 89999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .......
T Consensus 139 ~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~ 212 (264)
T cd06623 139 VKIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELM 212 (264)
T ss_pred EEEccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHH
Confidence 9999999998765433322 124578889999999988899999999999999999999999976432 1112222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+. .+. . ..+..+.+++.+||..+|++|||+.++++
T Consensus 213 ~~~~~~~~~~--~~~----~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 213 QAICDGPPPS--LPA----E---EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHHhcCCCCC--CCc----c---cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 2222111111 110 0 02234899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=290.42 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=200.1
Q ss_pred hhcCc-ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 32 KEDCF-ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 32 ~~~~y-~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
..++| +....||+|+|-+||+| .|..+|..||--.+.. ..-...+...+++..|+.+|+.|+||||+
T Consensus 37 p~gRy~k~~evLGrGafKtVYka-~De~~giEVAWnqvk~-----------~d~~q~~~~leR~~~Ev~lLKsL~H~NIi 104 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKA-FDEEEGIEVAWNQVKI-----------RDVTQSPEELERLYSEVHLLKSLKHPNII 104 (632)
T ss_pred CCCceeehhhhcccccceeeeec-cccccchhhHHHHHhH-----------HHhhcChHHHHHHHHHHHHHccCCCCcee
Confidence 34455 44568999999999999 5678888777554411 11112334568999999999999999999
Q ss_pred ccccceecCCc--eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 111 PLLAHMVRPDS--HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 111 ~~~~~~~~~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++|.+|.+... ..+|+|.+..|+|..|..++ +..+.+.+..|+.||+.||.|||++ ..+|+|||||.+||||+
T Consensus 105 rfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFin 179 (632)
T KOG0584|consen 105 RFYDSWVDTDNKTINFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVN 179 (632)
T ss_pred eeeeheecCCCceeeeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEc
Confidence 99999988766 78999999999999999554 4478889999999999999999987 56899999999999998
Q ss_pred C-CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 189 D-DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
. -|.|||+|+|+|+......... ..|||.|||||... ..|.+.+||||||+++.||+|+.+||.....
T Consensus 180 G~~G~VKIGDLGLAtl~r~s~aks----vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------ 248 (632)
T KOG0584|consen 180 GNLGEVKIGDLGLATLLRKSHAKS----VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------ 248 (632)
T ss_pred CCcCceeecchhHHHHhhccccce----eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------
Confidence 5 4999999999998766543222 48999999999988 6899999999999999999999999965322
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.++..+.+..+..|..... ...- .++++|.+||.. .++|||+.|+|+
T Consensus 249 ~AQIYKKV~SGiKP~sl~k------V~dP---evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 249 PAQIYKKVTSGIKPAALSK------VKDP---EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHHHHcCCCHHHhhc------cCCH---HHHHHHHHHhcC-chhccCHHHHhh
Confidence 2333444444433321111 0011 188999999999 999999999985
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=274.27 Aligned_cols=255 Identities=21% Similarity=0.306 Sum_probs=195.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCC---CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSN---GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
..++|++.+.||+|+||.||+|.+.... ...+|+|.+.... .......+.+|+.+++.++|||
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~ 70 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--------------SPKANKEILDEAYVMASVDHPH 70 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 4578999999999999999999754322 2368898763221 1234567888999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++.. ...++++||+++++|.+++.. ....+++..+..++.|++.||+||| +++++|+||+|+||+++
T Consensus 71 i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~ 143 (279)
T cd05057 71 VVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVK 143 (279)
T ss_pred cceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEc
Confidence 9999998887 788999999999999999843 2345889999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
.++.++|+|||.+................++..|+|||......++.++|+||||+++|++++ |..||..... .+
T Consensus 144 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~ 219 (279)
T cd05057 144 TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VE 219 (279)
T ss_pred CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HH
Confidence 999999999999986653322211111223567999999888888999999999999999998 9999965321 12
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+.... ........ +.. ....+.+++.+||..||.+|||+.++++
T Consensus 220 ~~~~~---~~~~~~~~--~~~--------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 220 IPDLL---EKGERLPQ--PPI--------CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHH---hCCCCCCC--CCC--------CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22221 11111110 100 1122889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=271.68 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=195.2
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
.+|++.+.||+|+||.||+|. +..++..||+|.+....... ........+.+|+.+++.+.||||++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~-~~~~~~~v~ik~~~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 70 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCY-DADTGRELAVKQVQFDPESP----------ETSKEVNALECEIQLLKNLLHERIVQYY 70 (265)
T ss_pred CcceEeeEEecCCceEEEEEE-EcCCCcEEEEEEeecCcCCc----------ccHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 579999999999999999995 56778999999873221100 1112356788899999999999999999
Q ss_pred cceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 114 AHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 114 ~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+.+.+. ...++++||+++++|.+++.. ...++......++.|++.+|.+|| +++++|+||+|+||+++.++
T Consensus 71 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~ 143 (265)
T cd06652 71 GCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVG 143 (265)
T ss_pred eEeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCC
Confidence 987653 467899999999999999843 244788888999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+......... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... ....
T Consensus 144 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~ 217 (265)
T cd06652 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE------AMAA 217 (265)
T ss_pred CEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc------hHHH
Confidence 9999999998765432111 11122457889999999988888999999999999999999999996421 1111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... .... .......+.+++.+|+. +|.+||+++++++
T Consensus 218 -~~~~~~~~~-~~~~--------~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 218 -IFKIATQPT-NPVL--------PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -HHHHhcCCC-CCCC--------chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111111111 1111 11223347889999994 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=270.28 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=202.9
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|+||.||++. +..+++.+++|.+... .........+.+|+.+++.++||||+++.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~-~~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLG-------------SMSQKEREDAVNEIRILASVNHPNIISYKE 66 (256)
T ss_pred CceEeeeecCCCceeEEEEE-ECCCCCEEEEEEEehh-------------hccHHHHHHHHHHHHHHHhCCCCCchhhhh
Confidence 58899999999999999996 5567889999987321 112234556778999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++......++|+||+++++|.+++.........++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~k 143 (256)
T cd08530 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVK 143 (256)
T ss_pred hhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEE
Confidence 999999999999999999999998664444567888999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||.+......... ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......
T Consensus 144 l~d~g~~~~~~~~~~~----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~ 212 (256)
T cd08530 144 IGDLGISKVLKKNMAK----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-------QDLRYK 212 (256)
T ss_pred EeeccchhhhccCCcc----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 9999999776554211 13578899999999988899999999999999999999999965321 111111
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+. .......++.+++.+||+.+|++|||+.++++
T Consensus 213 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 213 VQRGKYPP----------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HhcCCCCC----------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111111 11123344899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=274.23 Aligned_cols=250 Identities=23% Similarity=0.383 Sum_probs=196.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
..|...+.||.|++|.||++. +..++..+++|.+... .......+.+|+.+++.+.|||+++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~~~iK~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~vv~~~ 82 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIAT-DKSTGRQVAVKKMDLR---------------KQQRRELLFNEVVIMRDYQHPNIVEMY 82 (285)
T ss_pred HhhhcceEeccCCCeEEEEEE-ECCCCCEEEEEEEecc---------------chhHHHHHHHHHHHHHHcCCCChheEE
Confidence 356667899999999999995 5567788999987211 112345678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..++++||+.+++|.+++.. ..++...+..++.|++.++++|| ++|++|+||+|+||+++.++.+
T Consensus 83 ~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 154 (285)
T cd06648 83 SSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRV 154 (285)
T ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcE
Confidence 999999999999999999999999832 45888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|+|||.+.......... ....|+..|+|||...+..++.++|+||||+++|+|++|..||..... .....
T Consensus 155 ~l~d~g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~ 225 (285)
T cd06648 155 KLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMK 225 (285)
T ss_pred EEcccccchhhccCCccc--ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHH
Confidence 999999886544322111 124678899999999888899999999999999999999999864211 12222
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+..... ...+..+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 226 RIRDNLPPKLKNL--------HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHhcCCCCCccc--------ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2222211110000 012233899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=271.23 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=191.3
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|++.+.||+|+||.||++.. +++.+|+|.+.. ......+.+|+.+++.++|||++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~-----------------~~~~~~~~~e~~~l~~~~~~~i~~~ 64 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKC-----------------DVTAQAFLEETAVMTKLHHKNLVRL 64 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc---CCCceEEEeecC-----------------cchHHHHHHHHHHHHhCCCCCcCeE
Confidence 46799999999999999999963 677899998721 1123567889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+... ..+++|||+.+++|.+++... ....++......++.|++.|+.+|| +.|++|+||+|+||+++.++.
T Consensus 65 ~~~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~ 138 (254)
T cd05083 65 LGVILHN-GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGV 138 (254)
T ss_pred EEEEcCC-CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCc
Confidence 9987654 579999999999999998542 2345788888999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+........ ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ....
T Consensus 139 ~kl~Dfg~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~-- 207 (254)
T cd05083 139 AKVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KEVK-- 207 (254)
T ss_pred EEECCCccceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HHHH--
Confidence 99999999875433211 1233567999999988889999999999999999997 9999865321 1111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... . ....+..+.+++.+||+.+|++||++.+++.
T Consensus 208 -~~~~~~~~~~-~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 208 -ECVEKGYRME-P---------PEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -HHHhCCCCCC-C---------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111111111 0 0112334889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=273.67 Aligned_cols=258 Identities=22% Similarity=0.370 Sum_probs=196.1
Q ss_pred hcCcccccccccCcceeEEEEEecCC----CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGS----NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
.++|++.+.||.|+||.||+|+.... +.+.+++|.+... ........+.+|+.++++++|||
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~ 69 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--------------KDENLQSEFRRELDMFRKLSHKN 69 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--------------cchHHHHHHHHHHHHHHhcCCcc
Confidence 37899999999999999999975322 3467888876211 11124567889999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhccc-----ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG-----RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
|+++++++......++||||+++++|.+++...... ...+++..+..++.|++.+|.||| +.+++|+||+|+
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~ 146 (275)
T cd05046 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAAR 146 (275)
T ss_pred eeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccc
Confidence 999999999989999999999999999998543211 125889999999999999999999 889999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSH 262 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~ 262 (325)
||+++.++.++++|||++......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||....
T Consensus 147 Nili~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-- 223 (275)
T cd05046 147 NCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-- 223 (275)
T ss_pred eEEEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--
Confidence 999999999999999998644322111 1111245667999999888888999999999999999998 888985421
Q ss_pred CCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 263 TGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ...... ...... ...+..+.+++.+||+.||.+|||+.++++
T Consensus 224 --~~~~~~---~~~~~~-~~~~~~--------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 224 --DEEVLN---RLQAGK-LELPVP--------EGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred --hHHHHH---HHHcCC-cCCCCC--------CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111111 111111 110000 012234899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=273.20 Aligned_cols=256 Identities=19% Similarity=0.283 Sum_probs=183.3
Q ss_pred cccccCcceeEEEEEecCC-CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGS-NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||++++... ....+++|.+... ........+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~--------------~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 66 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN--------------ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE 66 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC--------------CChHHHHHHHHHHHHHhccCCcchhheEEEecC
Confidence 3699999999999975322 2345667765211 111234678889999999999999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
....++||||+++++|.+++..........+......++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 67 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Df 143 (268)
T cd05086 67 AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDY 143 (268)
T ss_pred CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEeccc
Confidence 99999999999999999999654333345667777899999999999999 889999999999999999999999999
Q ss_pred ccceecCCCCccccceeecCCccccccccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-------LTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-------~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
|++................++..|+|||++.. ..++.++|+||||+++|+|++ |..||..... .+
T Consensus 144 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~--- 216 (268)
T cd05086 144 GIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD----RE--- 216 (268)
T ss_pred ccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH----HH---
Confidence 98754322111111122467888999998743 235789999999999999997 5678754221 11
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
............ ...+..... ....+.+++..|| .+|++|||+.+++++
T Consensus 217 ~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 217 VLNHVIKDQQVK-LFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred HHHHHHhhcccc-cCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 112212111111 111111111 1223778999999 689999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=268.99 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=189.8
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecC
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 119 (325)
++||.|+||.||+|... . ++.+++|.+.... .......+..|+.+++++.||||+++++++...
T Consensus 1 ~~lg~g~~g~v~~~~~~-~-~~~v~~K~~~~~~--------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 64 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK-G-NTEVAVKTCRSTL--------------PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK 64 (251)
T ss_pred CccccCCCceEEEEEEe-C-CCcEEEEeccccC--------------CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Confidence 47999999999999653 3 8899999873211 112456788899999999999999999999999
Q ss_pred CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccc
Q 040480 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199 (325)
Q Consensus 120 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg 199 (325)
...++|+||+++++|.+++.. ....++......++.+++.+|.+|| +++++|+||+|+||+++.++.++|+|||
T Consensus 65 ~~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g 138 (251)
T cd05041 65 QPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFG 138 (251)
T ss_pred CCeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeecc
Confidence 999999999999999999843 2345788888999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhh
Q 040480 200 LAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMAS 278 (325)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .... ......
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~~~---~~~~~~ 211 (251)
T cd05041 139 MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQTR---ERIESG 211 (251)
T ss_pred ccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----HHHH---HHHhcC
Confidence 9876543222111111223557999999988889999999999999999998 8888865321 1111 111111
Q ss_pred CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... .+ ...+..+.+++.+||+.+|.+|||+.|+++
T Consensus 212 ~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 YRMP--AP--------QLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CCCC--CC--------ccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1110 00 112234899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=278.25 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=192.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCC---cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNG---KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
+.++|+..+.||+|+||.||+|.+..... ..+|+|.+... ........+.+|+.+++.+.|||
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~e~~~~~~l~h~n 70 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--------------TGPKANVEFMDEALIMASMDHPH 70 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc--------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence 56789999999999999999996533222 25788876311 11222346788999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++... ..+++++|+++++|.+++.. ....++...+..++.|++.||.||| +++++|+||+|+||+++
T Consensus 71 iv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~ 143 (303)
T cd05110 71 LVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVK 143 (303)
T ss_pred cccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeec
Confidence 99999988654 56799999999999999843 2335788889999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
.++.++|+|||++................++..|+|||...+..++.++||||||+++|+|++ |..||.... ...
T Consensus 144 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~ 219 (303)
T cd05110 144 SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----TRE 219 (303)
T ss_pred CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHH
Confidence 999999999999986654332222222345678999999998889999999999999999997 899986521 111
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ....... +. .....+.+++.+||..||++||+++++++
T Consensus 220 ~~~~~~---~~~~~~~--~~--------~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 220 IPDLLE---KGERLPQ--PP--------ICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred HHHHHH---CCCCCCC--CC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222211 1111110 00 01223889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=273.74 Aligned_cols=249 Identities=25% Similarity=0.436 Sum_probs=194.8
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC---CCCccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR---HRNILP 111 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~ 111 (325)
.|++.+.||.|+||.||+|. +..+++.+|+|.+.... .......+.+|+.+++.+. |||+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~-~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~e~~~l~~l~~~~~~~vi~ 66 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGK-HVPTGRVVALKIINLDT--------------PDDDVSDIQREVALLSQLRQSQPPNITK 66 (277)
T ss_pred hhhhhhheeccCCceEEEEE-EcCCCcEEEEEEecCCC--------------CchhHHHHHHHHHHHHHhccCCCCCeee
Confidence 58899999999999999996 45678899999873211 1223456778888888886 999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++......+++|||+++++|.+++.. ..+++..+..++.|++.+|.+|| +.|++|+||+|+||+++.++
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~ 138 (277)
T cd06917 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTG 138 (277)
T ss_pred EeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCC
Confidence 99999999999999999999999998832 36888999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+.......... ....|+..|+|||...+ ..++.++|+||||+++|+|++|..||..... ..
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~ 209 (277)
T cd06917 139 NVKLCDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-------FR 209 (277)
T ss_pred CEEEccCCceeecCCCcccc--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-------hh
Confidence 99999999998765443221 22468889999998764 4568899999999999999999999965321 11
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... +. ..... ..+..+.+++.+||+.||++||++.+++.
T Consensus 210 ~~~~~~~~~-~~-----~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 210 AMMLIPKSK-PP-----RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred hhhccccCC-CC-----CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111111111 10 00011 12234889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.68 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=194.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||+|+||.||+|. +..+++.+|+|.+... .........+.+|+.+++.++||||++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~ 79 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAY-DTVTGQNVAIKKLSRP-------------FQNVTHAKRAYRELVLMKLVNHKNIIG 79 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEE-ECCCCCEEEEEecCcc-------------ccChhHHHHHHHHHHHHHhcCCCCCcc
Confidence 45789999999999999999995 5667889999987211 111233456778999999999999999
Q ss_pred cccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++++... ...|+|+||+.+ +|.+.+.. .++...+..++.|++.||++|| ++|++|+||||+||
T Consensus 80 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Ni 149 (353)
T cd07850 80 LLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 149 (353)
T ss_pred eeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHE
Confidence 99987544 357999999965 88887722 2788888999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 150 l~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---- 222 (353)
T cd07850 150 VVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---- 222 (353)
T ss_pred EECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH----
Confidence 999999999999999986544322 1123578899999999998999999999999999999999999964321
Q ss_pred chHHHHHHHHh-------------------hhCCCC--ccc----chhh----cCCchHHHHHHHHHHHhhhcCCCCCCC
Q 040480 266 MDMVRWMRNVM-------------------ASENPN--RAI----DSKL----LGNGYEEQMLLVLKLACFCTLADPDER 316 (325)
Q Consensus 266 ~~~~~~~~~~~-------------------~~~~~~--~~~----~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~R 316 (325)
......+.... ...... ..+ +... ...........+.+++.+||+.||++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 302 (353)
T cd07850 223 IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302 (353)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhC
Confidence 00000000000 000000 000 0000 000011234458899999999999999
Q ss_pred CChhhhhc
Q 040480 317 PNSKDVRC 324 (325)
Q Consensus 317 ps~~ell~ 324 (325)
||+.|+|+
T Consensus 303 ~t~~eiL~ 310 (353)
T cd07850 303 ISVDDALQ 310 (353)
T ss_pred cCHHHHhc
Confidence 99999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=276.90 Aligned_cols=265 Identities=21% Similarity=0.294 Sum_probs=193.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|++|.||+|. +..+++.||+|.+.... .......+.+|+.++++++||||+++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~-~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~i~~~ 68 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGR-SKLTGQLVALKEIRLEH--------------EEGAPFTAIREASLLKDLKHANIVTL 68 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEE-EcCCCcEEEEEEEeccc--------------ccCCchhHHHHHHHHhhCCCcceeeE
Confidence 4789999999999999999995 55678899999873211 11122345679999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..++||||+.+ +|.+++.. ....++...+..++.|++.||.||| +++++|+||+|+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~ 141 (291)
T cd07844 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGE 141 (291)
T ss_pred EEEEecCCeEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCC
Confidence 9999999999999999975 89888743 2346788899999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+.......... ....++..|+|||...+ ..++.++|+||||+++|+|++|..||..... ..+....
T Consensus 142 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~ 216 (291)
T cd07844 142 LKLADFGLARAKSVPSKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD---VEDQLHK 216 (291)
T ss_pred EEECccccccccCCCCccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHH
Confidence 9999999986543221111 11245778999998765 4578899999999999999999999965321 1111111
Q ss_pred HHHHhhhCCCCcc----------------cchhhcCCchHHH--HHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRA----------------IDSKLLGNGYEEQ--MLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~~--~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............. ..+.......... ...+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 217 IFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 1111110000000 0000000000001 134789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=275.62 Aligned_cols=266 Identities=24% Similarity=0.299 Sum_probs=195.6
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||.|++|.||+|. +..+++.||+|.+....... ........+..|+.+++.++|+||+++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~-~~~~~~~v~iK~~~~~~~~~----------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~ 69 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKAR-DKETGRIVAIKKIKLGERKE----------AKDGINFTALREIKLLQELKHPNIIGLLD 69 (298)
T ss_pred CceeeeeeeeccccEEEEEE-ECCCCcEEEEEEEecccccc----------ccchhhHHHHHHHHHHhhcCCCCChhhhh
Confidence 58899999999999999995 55568899999984322110 01223445678999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++.+.+..++||||+ +++|.+++.. ....+++..+..++.|++.||.||| ++|++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 70 VFGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred eeecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEE
Confidence 999999999999999 8899999843 1136889999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|+|||++.......... ....++..|.|||.+.+ ..++.++|+||||+++|+|++|.+||..... .+......
T Consensus 143 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~~~~~~~~ 216 (298)
T cd07841 143 LADFGLARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----IDQLGKIF 216 (298)
T ss_pred EccceeeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----HHHHHHHH
Confidence 99999998765432211 11345778999998754 4578899999999999999999888764221 11111111
Q ss_pred HHhhhCCCCc---------cc-----chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNR---------AI-----DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~---------~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... .. ...............+.+++.+||+.||++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 217 EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred HHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1000000000 00 000000011223455899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=277.71 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=195.5
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|.+.+.||+|+||.||+|. ...+++.||+|.+.... .........+.+|+.+++.++|||++
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~-~~~~~~~v~iK~~~~~~------------~~~~~~~~~~~~Ei~~l~~l~h~niv 78 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSG------------KQSNEKWQDIIKEVRFLQQLRHPNTI 78 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEE-EcCCCcEEEEEEEeccc------------cCcHHHHHHHHHHHHHHHhCCCCCEE
Confidence 355789999999999999999996 45578899999873221 11123345688899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++.+.+...+..++|+||+.+ ++.+.+.. ....+++..+..++.|++.+|.||| +.+++|+||+|+||+++.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~ 151 (307)
T cd06607 79 EYKGCYLREHTAWLVMEYCLG-SASDILEV---HKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEP 151 (307)
T ss_pred EEEEEEEeCCeEEEEHHhhCC-CHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCC
Confidence 999999999999999999975 77777632 2345889999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+.++|+|||++....... ...++..|+|||.+. ...++.++||||||+++|+|++|..||.....
T Consensus 152 ~~~kL~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------ 219 (307)
T cd06607 152 GTVKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------ 219 (307)
T ss_pred CCEEEeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------
Confidence 999999999987544321 135678899999874 34578899999999999999999999864211
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+. .. .......+.+++.+||+.||++|||+.++++
T Consensus 220 -~~~~~~~~~~~~~~--~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 220 -MSALYHIAQNDSPT--LS-------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred -HHHHHHHhcCCCCC--CC-------chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11111111111111 00 1113344899999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=269.22 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=196.0
Q ss_pred cccccccccCcceeEEEEEecCCC---CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSN---GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
+++.+.||.|+||.||++++.... +..+|+|.+.... .......+..|+.++..+.|+||+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~e~~~l~~l~~~~i~~~ 66 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--------------DEQQIEEFLREARIMRKLDHPNIVKL 66 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--------------ChHHHHHHHHHHHHHHhcCCCchheE
Confidence 467889999999999999764322 4889999873211 11145678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+...+..+++|||+++++|.+++.... ...+++..+..++.|++.++++|| +.+++|+||+|+||+++.++.
T Consensus 67 ~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~ 141 (258)
T smart00219 67 LGVCTEEEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLV 141 (258)
T ss_pred EEEEcCCCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCe
Confidence 999999999999999999999999984421 112889999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+............ ...++..|+|||...+..++.++|+||||+++++|++ |..||... .......
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~~~~~~~- 215 (258)
T smart00219 142 VKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----SNEEVLE- 215 (258)
T ss_pred EEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHH-
Confidence 999999999876544221111 1235778999999988889999999999999999998 78888642 1112222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
........... . ..+..+.+++.+||+.||++|||+.+++++
T Consensus 216 --~~~~~~~~~~~--~--------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 216 --YLKKGYRLPKP--E--------NCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred --HHhcCCCCCCC--C--------cCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 22222111110 0 123348999999999999999999999863
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.40 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=199.0
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||+|+||.||+|. ...+++.+++|.+.... ........+..|+.+++.++|+||+++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~~ik~~~~~~-------------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~ 66 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAV-NLDTGELMAVKEIRIQD-------------NDPKTIKEIADEMKVLELLKHPNLVKYYG 66 (264)
T ss_pred CceeeeEeecCCCcEEEEEE-ECCCCcEEEEEEEECcc-------------cchHHHHHHHHHHHHHHhCCCCChhheee
Confidence 68999999999999999995 45567899999984321 11235678899999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.....+..++|+||+++++|.+++. ....++...+..++.+++.|+.+|| +.|++|+||+|+||++++++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~k 139 (264)
T cd06626 67 VEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIK 139 (264)
T ss_pred eEecCCEEEEEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999983 3345788889999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCcccc--ceeecCCcccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 195 ISGFDLAILMPDGLTQID--TMYVVGTPRYIAPEYHQTLT---ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
|+|||.+........... .....++..|+|||.+.+.. .+.++|+||||+++|++++|..||..... . .
T Consensus 140 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~---~ 213 (264)
T cd06626 140 LGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---E---F 213 (264)
T ss_pred EcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---h---H
Confidence 999999987654332211 11235678999999988766 78999999999999999999999965321 1 1
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...........+. .+.. ......+.+++.+||+.||.+|||+.+++.
T Consensus 214 ~~~~~~~~~~~~~--~~~~------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 214 QIMFHVGAGHKPP--IPDS------LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHhcCCCCC--CCcc------cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111111111 1110 111233789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=273.45 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=190.0
Q ss_pred cccccCcceeEEEEEecC-----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 40 EKIGSGGCGDVYKAELPG-----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+.||+|+||.||+|++.. .++..+++|.+... ........+.+|+.+++.++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--------------ATDQEKKEFLKEAHLMSNFNHPNIVKLLG 66 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc--------------cchhhHHHHHHHHHHHHhcCCCCeeeEee
Confidence 468999999999997532 22367888876211 11233556888999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcc---cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSK---GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
++...+..+++|||+++++|.+++..... ....+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~ 143 (269)
T cd05044 67 VCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKG 143 (269)
T ss_pred eecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCC
Confidence 99999999999999999999999964322 2234778888999999999999999 88999999999999999877
Q ss_pred -----CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCc
Q 040480 192 -----EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGE 265 (325)
Q Consensus 192 -----~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~ 265 (325)
.++++|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .
T Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~----~ 219 (269)
T cd05044 144 YDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN----N 219 (269)
T ss_pred CCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC----H
Confidence 899999999875543322111112345678999999998889999999999999999998 999986422 1
Q ss_pred chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+... .+....... .....+..+.+++.+||..+|.+||++.++++
T Consensus 220 ~~~~~---~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 220 QEVLQ---HVTAGGRLQ----------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHH---HHhcCCccC----------CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11111 111111110 01112344889999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=279.20 Aligned_cols=273 Identities=23% Similarity=0.284 Sum_probs=196.1
Q ss_pred CcccccccccCcceeEEEEEecCC-CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGS-NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+|++.+.||+|+||.||+|..... ++..+|+|.+.... .........+.+|+.+++.++||||++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 68 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDK------------EQYTGISQSACREIALLRELKHENVVSLV 68 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccc------------ccccCccHHHHHHHHHHHhcCCCCccceE
Confidence 588999999999999999965332 68899999984211 01123345678899999999999999999
Q ss_pred cceecC--CceEEEEEcccCCCHHHHHhhhccc-ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC-
Q 040480 114 AHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKG-RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD- 189 (325)
Q Consensus 114 ~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~- 189 (325)
+++... ...++|+||+++ +|.+.+...... ...++...++.++.|++.||.||| +++++|+||+|+||+++.
T Consensus 69 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~ 144 (316)
T cd07842 69 EVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGE 144 (316)
T ss_pred EEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCC
Confidence 999888 789999999975 777776443332 236888999999999999999999 889999999999999998
Q ss_pred ---CCCceeeccccceecCCCCc-cccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 190 ---DMEARISGFDLAILMPDGLT-QIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 190 ---~~~~~l~dfg~~~~~~~~~~-~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
++.++|+|||++........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||........
T Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 224 (316)
T cd07842 145 GPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK 224 (316)
T ss_pred CCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccc
Confidence 89999999999886543322 1111224668889999987664 578899999999999999999999975433220
Q ss_pred cc------hHHHHHHHHhhhCC--------------------CCcccchhhcCCch---HHHHHHHHHHHhhhcCCCCCC
Q 040480 265 EM------DMVRWMRNVMASEN--------------------PNRAIDSKLLGNGY---EEQMLLVLKLACFCTLADPDE 315 (325)
Q Consensus 265 ~~------~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~ 315 (325)
.. ........ ..... .....+........ ......+.+++.+||+.||++
T Consensus 225 ~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 303 (316)
T cd07842 225 KSNPFQRDQLERIFEV-LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTK 303 (316)
T ss_pred ccchhHHHHHHHHHHH-hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCccc
Confidence 00 11111100 00000 00000000000000 022335889999999999999
Q ss_pred CCChhhhhc
Q 040480 316 RPNSKDVRC 324 (325)
Q Consensus 316 Rps~~ell~ 324 (325)
|||+.|+++
T Consensus 304 Rps~~eil~ 312 (316)
T cd07842 304 RITAEEALE 312 (316)
T ss_pred CcCHHHHhc
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=278.77 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=207.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..+.|+..++||+|+||.||-++ ...+|+.+|.|.+ ++.+............|-.++..++.++||.
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acq-vraTGKMYAcKkL------------~KKRiKkr~ge~maLnEk~iL~kV~s~FiVs 249 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQ-VRATGKMYACKKL------------DKKRIKKRKGETMALNEKQILEKVSSPFIVS 249 (591)
T ss_pred cccceeeeEEEecccccceeEEE-EecchhhHHHHHH------------HHHHHHHhhhhHHhhHHHHHHHHhccCcEEE
Confidence 55789999999999999999996 4688999999987 3333333344556778889999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+-..+...+.+|+|+..|+||+|.-.|..+ .+..+++..+..++.+|+.||.+|| +.+||+||+||+|||+|+.|
T Consensus 250 laYAfeTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~G 324 (591)
T KOG0986|consen 250 LAYAFETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHG 324 (591)
T ss_pred EeeeecCCCceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCC
Confidence 999999999999999999999999988553 4467999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
++.|.|+|+|..+..+..... ..||.+|||||++.+..|+.+.|.|||||++|+|+.|+.||..........++.+.
T Consensus 325 hvRISDLGLAvei~~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr 401 (591)
T KOG0986|consen 325 HVRISDLGLAVEIPEGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR 401 (591)
T ss_pred CeEeeccceEEecCCCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH
Confidence 999999999998877655433 48999999999999999999999999999999999999999764332222222221
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
... . ... .+ +...++..+|....|.+||.+|....
T Consensus 402 ~~~----~--~~e-----y~---~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLE----D--PEE-----YS---DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred Hhc----c--hhh-----cc---cccCHHHHHHHHHHHccCHHHhccCC
Confidence 111 1 111 11 22233488899999999999998654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=269.02 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=197.8
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||+|+||.||+|. ...++..+|+|.+.. ..........+.+|+.+++.++|+||+++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~-~~~~~~~~~ik~~~~-------------~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~ 66 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAK-AKSDSEHCVIKEIDL-------------TKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66 (257)
T ss_pred CceEEEEecCCCcceEEEEE-EcCCCceEEEEEeeH-------------hhccchhhHHHHHHHHHHHhCCCCChhhhhh
Confidence 58899999999999999995 556778899998732 1122234456788999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC-c
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME-A 193 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~-~ 193 (325)
.+......++++||+++++|.+++.. .....+++.....++.|++.+|.||| +.+++|+||+|+||++++++. +
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~ 141 (257)
T cd08225 67 SFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVA 141 (257)
T ss_pred eeccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeE
Confidence 99999999999999999999999844 22335788899999999999999999 889999999999999998764 6
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+++|||.+.......... ....|+..|+|||...+..++.++|+||||+++++|++|..||.... ......
T Consensus 142 ~l~d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~ 212 (257)
T cd08225 142 KLGDFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVL 212 (257)
T ss_pred EecccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHH
Confidence 999999987664332211 12357889999999888889999999999999999999999986421 122222
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... ..+ ..+..+.+++.+||..+|++|||+.++++
T Consensus 213 ~~~~~~~~~--~~~--------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 213 KICQGYFAP--ISP--------NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHhcccCCC--CCC--------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 222221111 111 11233899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=269.92 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=191.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.+.+.....||+|+||.||+|+ +..++..+++|.+... .......+.+|+.+++.++|+||+++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~v~~k~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~ 70 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAAR-DLSTQVRIAIKEIPER---------------DSRYVQPLHEEIALHSYLKHRNIVQY 70 (268)
T ss_pred cccCCceEEEecCCceEEEEeE-ecCCCcEEEEEEecCC---------------CHHHHHHHHHHHHHHHhcCCCCeeee
Confidence 3445555689999999999996 4457788999987321 12234578899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhccccccc--ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC-
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL--EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD- 189 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~--~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~- 189 (325)
++++...+..++++||+++++|.+++... ...+ +...+..++.|++.||+||| ++|++|+||+|+||+++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~ 144 (268)
T cd06624 71 LGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTY 144 (268)
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCC
Confidence 99999999999999999999999998432 1234 67778889999999999999 889999999999999986
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT--ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
++.++|+|||.+......... .....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ..
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~----~~ 218 (268)
T cd06624 145 SGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE----PQ 218 (268)
T ss_pred CCeEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC----hh
Confidence 678999999998765432221 11235788999999886543 78899999999999999999999864221 11
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+...... ..+ .++ ......+.+++.+||+.+|.+|||+.++++
T Consensus 219 ~~~~~~~~~~-~~~--~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 219 AAMFKVGMFK-IHP--EIP--------ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhHhhhhhhc-cCC--CCC--------cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1111110000 000 011 112233889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=270.61 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=198.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.+-|++.+.||.|+||.||+|. +..++..+|+|.+... ........+.+|+.+++.+.||||+++
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~-~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~iv~~ 67 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLE--------------EAEDEIEDIQQEITVLSQCDSPYVTKY 67 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEE-ECCCCcEEEEEEeccc--------------cchHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3568899999999999999995 5567889999986211 111234578889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+...+..++|+||+++++|.+++. ...++...+..++.+++.++.+|| ..|++|+||+|+||+++.++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~ 139 (277)
T cd06641 68 YGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGE 139 (277)
T ss_pred EEEEEeCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCC
Confidence 999999999999999999999999883 345888899999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++++|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....
T Consensus 140 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~ 210 (277)
T cd06641 140 VKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVL 210 (277)
T ss_pred EEEeecccceecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHH
Confidence 999999998765443221 1224678889999999888889999999999999999999999864221 1111
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+.....+. .+ ...+..+.+++.+||+.+|.+||++.++++
T Consensus 211 ~~~~~~~~~~--~~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 211 FLIPKNNPPT--LE--------GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHHhcCCCCC--CC--------cccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111111110 11 112233889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=271.21 Aligned_cols=239 Identities=18% Similarity=0.258 Sum_probs=179.8
Q ss_pred cccccCcceeEEEEEecCC------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 40 EKIGSGGCGDVYKAELPGS------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.||.|+||.||+|..... ....+++|.+. .........+..|..+++.+.|||+++++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~---------------~~~~~~~~~~~~e~~~l~~~~h~~iv~~~ 65 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD---------------KSHRNYSESFFEAASMMSQLSHKHLVLNY 65 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhc---------------chhHHHHHHHHHHHHHHHhCCCCChhhee
Confidence 4689999999999965322 12347777651 11123345678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC-
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME- 192 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~- 192 (325)
+++...+..++||||+++++|.+++.. ....+++..+..++.|++.||+||| ++|++|+||||+||+++.++.
T Consensus 66 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~ 139 (258)
T cd05078 66 GVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDR 139 (258)
T ss_pred eEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEeccccc
Confidence 999999999999999999999999843 2335788888999999999999999 889999999999999987665
Q ss_pred -------ceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCC-CCCCCcccCC
Q 040480 193 -------ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGK-FPFDDFFSHT 263 (325)
Q Consensus 193 -------~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~-~p~~~~~~~~ 263 (325)
++++|||.+....... ...++..|+|||++.+ ..++.++|+||||+++|+|++|. .||.....
T Consensus 140 ~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-- 211 (258)
T cd05078 140 KTGNPPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-- 211 (258)
T ss_pred ccCCCceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--
Confidence 5899999886543321 1356788999999876 35789999999999999999985 56543211
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..... ..... . ..+.. ....+.+|+.+||+.||++|||++++++
T Consensus 212 --~~~~~----~~~~~-~--~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 212 --QKKLQ----FYEDR-H--QLPAP--------KWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred --HHHHH----HHHcc-c--cCCCC--------CcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111 11111 0 01100 1123889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=267.33 Aligned_cols=254 Identities=23% Similarity=0.398 Sum_probs=203.5
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||.|+||.||++. +..++..+++|.+.... ........+.+|+++++.++|||++++.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~ik~~~~~~-------------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~ 66 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLSN-------------MSEKEREDALNEVKILKKLNHPNIIKYYE 66 (258)
T ss_pred CceEEeeeccCCCeEEEEEE-EcCCCcEEEEEEeeccc-------------CChHHHHHHHHHHHHHHhcCCCChhheEE
Confidence 58899999999999999996 44578899999983321 12244567888999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+......++++||+++++|.+.+.........++...+..++.+++.|+.+|| +.|++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~ 143 (258)
T cd08215 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVK 143 (258)
T ss_pred EEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEE
Confidence 999999999999999999999999654333577999999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||.+........ ......|++.|+|||...+..++.++|+||+|+++++|++|..||.... . ......
T Consensus 144 l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~---~~~~~~ 214 (258)
T cd08215 144 LGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----L---LELALK 214 (258)
T ss_pred ECCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----H---HHHHHH
Confidence 999999987655431 1122467888999999988889999999999999999999999986522 1 112222
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ .+. .....+.+++.+||..+|++|||+.++++
T Consensus 215 ~~~~~~~~--~~~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 215 ILKGQYPP--IPS--------QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HhcCCCCC--CCC--------CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22111111 111 12234899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=277.45 Aligned_cols=266 Identities=25% Similarity=0.336 Sum_probs=195.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||.|+||.||+|. +..++..||+|.+.... ..........+|+.++++++|+|+++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~i~~ 70 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRAR-DTTSGEIVALKKVRMDN-------------ERDGIPISSLREITLLLNLRHPNIVE 70 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEE-ECCCCcEEEEEEEEecc-------------CCCCCcchhhHHHHHHHhCCCCCCcc
Confidence 45789999999999999999996 55678899999884221 11122234567899999999999999
Q ss_pred cccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 112 LLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 112 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++... +..++|+||+.+ +|.+++.. ....+++..+..++.|++.||.||| +.|++|+||+|+||+++.
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~ 143 (309)
T cd07845 71 LKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTD 143 (309)
T ss_pred eEEEEecCCCCeEEEEEecCCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 99988755 468999999965 88888743 2356889999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
++.++|+|||.+.......... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ...
T Consensus 144 ~~~~kL~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~----~~~ 217 (309)
T cd07845 144 KGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE----IEQ 217 (309)
T ss_pred CCCEEECccceeeecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHH
Confidence 9999999999998765432111 11245778999998865 4578999999999999999999999965221 112
Q ss_pred HHHHHHHhhhCCCCc-------------ccchh---hcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNR-------------AIDSK---LLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~-------------~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............... ..... ............+.++|.+||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 218 LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred HHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 211111111100000 00000 000000112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.77 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=193.2
Q ss_pred hcCcccccccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|.+.+.||+|+||.||+|.+... +...+++|...... .....+.+.+|+.+++.+.||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--------------~~~~~~~~~~e~~~l~~~~h~~i~ 70 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--------------SPSVREKFLQEAYIMRQFDHPHIV 70 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--------------CHHHHHHHHHHHHHHHhCCCCchh
Confidence 46799999999999999999975433 23568889763211 123455788899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.+ ...++||||+++++|.+++.. ....++...+..++.+++.||.+|| +.+++|+||+|+||+++.+
T Consensus 71 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~ 143 (270)
T cd05056 71 KLIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSP 143 (270)
T ss_pred ceeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecC
Confidence 99998765 567899999999999999843 2335888999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||++............ ...++..|+|||.+.+..++.++|+||||+++|++++ |..||..... .+..
T Consensus 144 ~~~~l~d~g~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~ 218 (270)
T cd05056 144 DCVKLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVI 218 (270)
T ss_pred CCeEEccCceeeecccccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH----HHHH
Confidence 99999999998765443221111 1234567999999988889999999999999999986 9999965321 1111
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ......... .+. ..+..+.+++.+|+..+|.+|||+.++++
T Consensus 219 ~---~~~~~~~~~--~~~--------~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 219 G---RIENGERLP--MPP--------NCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred H---HHHcCCcCC--CCC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 111111111 010 11234899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=273.01 Aligned_cols=267 Identities=23% Similarity=0.284 Sum_probs=193.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~ 112 (325)
++|++.+.||+|+||.||+|. +..+++.||+|.+... .........+.+|+.+++.+. ||||+++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~-~~~~~~~v~lK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~~~~~i~~~ 66 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKAR-DKNTGKLVALKKTRLE-------------MDEEGIPPTALREISLLQMLSESIYIVRL 66 (295)
T ss_pred CCceEeeEecccCCeEEEEEE-ECCCCcEEEEEeehhh-------------ccccCCchHHHHHHHHHHHccCCCCccce
Confidence 479999999999999999996 4567889999987321 111223456788999999995 6999999
Q ss_pred ccceecCCc-----eEEEEEcccCCCHHHHHhhhccc-ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRPDS-----HLLVYDFMKNGSLQAVLYDVSKG-RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++..... .|++|||+.+ +|.+++...... ...+++..+..++.|++.||.||| +++++|+||+|+||+
T Consensus 67 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil 142 (295)
T cd07837 67 LDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLL 142 (295)
T ss_pred eeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEE
Confidence 998877665 8999999986 898888543322 346899999999999999999999 889999999999999
Q ss_pred ecC-CCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 187 IDD-DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 187 ~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
++. ++.++|+|||.+.......... ....+++.|.|||.+.+ ..++.++|+||||+++|+|++|..||......
T Consensus 143 ~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-- 218 (295)
T cd07837 143 VDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-- 218 (295)
T ss_pred EecCCCeEEEeecccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--
Confidence 998 8899999999987653322111 11245778999998765 45789999999999999999999999652210
Q ss_pred cchHHHHHHHHhhhCCCCcc--------------cchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRA--------------IDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ ....+....+ ..+.............+.++|.+||+.||.+|||+.+++.
T Consensus 219 -~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 219 -QQLLHIFK-LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred -HHHHHHHH-HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11111111 0000000000 0000000001123344889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.08 Aligned_cols=248 Identities=27% Similarity=0.358 Sum_probs=189.0
Q ss_pred cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCc
Q 040480 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS 121 (325)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 121 (325)
||+|+||+||+|. +..+++.+|+|.+... ..........+..|+.+++.++||||+++++.+...+.
T Consensus 1 lg~g~~g~vy~~~-~~~~~~~~~ik~~~~~------------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 67 (277)
T cd05577 1 LGKGGFGEVCACQ-VKATGKMYACKKLDKK------------RLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD 67 (277)
T ss_pred CCCCCceeEEEEE-EcCCCcEEEEEEEehh------------hhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe
Confidence 6899999999995 5667899999987321 11111234456779999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 122 HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
.|+|+||+++++|.+++... ....++...+..++.|++.+|.||| +.|++|+||+|+||++++++.++|+|||.+
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~ 142 (277)
T cd05577 68 LCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA 142 (277)
T ss_pred EEEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcch
Confidence 99999999999999998542 2236888999999999999999999 889999999999999999999999999998
Q ss_pred eecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCC
Q 040480 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENP 281 (325)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+. .......
T Consensus 143 ~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~-- 214 (277)
T cd05577 143 VELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTLEMA-- 214 (277)
T ss_pred hhhccCCc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hcccccc--
Confidence 76543211 112356788999999988888999999999999999999999996533211111111 1111100
Q ss_pred CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 282 NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
...+ ......+.+++.+||+.||.+|| ++.++++
T Consensus 215 -~~~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 215 -VEYP--------DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -ccCC--------ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0000 01123388999999999999999 6665764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=268.58 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=193.6
Q ss_pred cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCc
Q 040480 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS 121 (325)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 121 (325)
||.|++|.||+|. +..++..+|+|.+.... .........+.+|+.+++.++||||+++++.+.+...
T Consensus 1 lg~g~~~~v~~~~-~~~~~~~~~iK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 67 (262)
T cd05572 1 LGVGGFGRVELVK-VKSKNRTFALKCVKKRH------------IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY 67 (262)
T ss_pred CCCCCceEEEEEE-ECCCCcEEEEEEEehhc------------chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc
Confidence 6999999999996 45568899999883211 1112344678899999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 122 HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
.++++||+++++|.+++.. ...++...+..++.|++.||.+|| +++++|+||+|+||+++.++.++|+|||.+
T Consensus 68 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~ 140 (262)
T cd05572 68 IYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFA 140 (262)
T ss_pred cEEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcc
Confidence 9999999999999999833 345888899999999999999999 889999999999999999999999999999
Q ss_pred eecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCC
Q 040480 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENP 281 (325)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... +.............
T Consensus 141 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~- 211 (262)
T cd05572 141 KKLKSGQK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNG- 211 (262)
T ss_pred cccCcccc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCC-
Confidence 87654321 1124678899999998888889999999999999999999999975332 11222222221111
Q ss_pred CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 282 NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
....+.. ....+.+++.+||+.||++||+ +.|+++
T Consensus 212 ~~~~~~~--------~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 212 KLEFPNY--------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCcc--------cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1111111 1233899999999999999999 888875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=261.48 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=197.0
Q ss_pred hcCcccc-cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 33 EDCFASL-EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 33 ~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
.++|.+. ++||-|-.|+|-.+ ....+++.+|+|++ ....+.++|+++--.. .|||||
T Consensus 60 tedY~is~qvLG~GinGkV~~C-~~k~T~ekfALKvL--------------------~Ds~KARrEVeLHw~~s~h~~iV 118 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQC-VHKRTQEKFALKVL--------------------LDSPKARREVELHWMASGHPHIV 118 (400)
T ss_pred hhhheehhhhhccccCCceEEE-EeccchhhhHHHHH--------------------hcCHHHHhHhhhhhhhcCCCceE
Confidence 3456554 47999999999999 57788999999987 2334556666543333 599999
Q ss_pred ccccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 111 PLLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 111 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
.+++++.+ ...+.+|||.++||.|.+.+++ .....+++..+..|+.||..|+.||| +.+|.||||||+|+|
T Consensus 119 ~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLL 193 (400)
T KOG0604|consen 119 SIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLL 193 (400)
T ss_pred EeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhhee
Confidence 99998864 3457899999999999999965 45567999999999999999999999 889999999999999
Q ss_pred ec---CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 187 ID---DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 187 ~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
.. .+..+||+|||++.......... ..+-|+.|.|||++...+|+..+|+||+|+++|-|++|.+||=......
T Consensus 194 yt~t~~na~lKLtDfGFAK~t~~~~~L~---TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a 270 (400)
T KOG0604|consen 194 YTTTSPNAPLKLTDFGFAKETQEPGDLM---TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_pred eecCCCCcceEecccccccccCCCcccc---CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence 96 45678999999998765432222 2467999999999999999999999999999999999999995433322
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... +......... ...-++.+++...++|+.+|..+|++|.|+.+++.
T Consensus 271 ispgMk----~rI~~gqy~F------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 271 ISPGMK----RRIRTGQYEF------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CChhHH----hHhhccCccC------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 222222 2222222211 12335677788999999999999999999999863
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=272.41 Aligned_cols=263 Identities=24% Similarity=0.314 Sum_probs=197.2
Q ss_pred hcCcccccccccCcceeEEEEEecC---CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPG---SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
...|++.+.||+|+||.||+|+++. .++..+|+|.+.... .......+.+|+.+++.+.||||
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~ei~~l~~l~~~~i 68 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--------------EEQHRSDFEREIEILRTLDHENI 68 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc--------------chHHHHHHHHHHHHHHhCCCCCh
Confidence 3578899999999999999997642 356889999873211 00245678999999999999999
Q ss_pred cccccceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 110 LPLLAHMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 110 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+++++++.. ....++++||+++++|.+++.. ....++......++.|++.||.+|| +.|++|+||+|+||++
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~ 142 (284)
T cd05038 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILV 142 (284)
T ss_pred heEEeeeecCCCCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEE
Confidence 999998876 5578999999999999999843 2235888899999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccc-ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc-
Q 040480 188 DDDMEARISGFDLAILMPDGLTQID-TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE- 265 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~- 265 (325)
+.++.++|+|||.+........... .....++..|+|||...+..++.++|+||||+++|+|++|..|+.........
T Consensus 143 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~ 222 (284)
T cd05038 143 ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM 222 (284)
T ss_pred cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc
Confidence 9999999999999987653222111 11123355699999998888999999999999999999999998643211100
Q ss_pred -------chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 266 -------MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 266 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
.................. + ...+..+.+++.+||+.||.+|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 223 IGIAQGQMIVTRLLELLKEGERLPR--P--------PSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred cccccccccHHHHHHHHHcCCcCCC--C--------ccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 001111111111111100 0 1122348899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=269.90 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=185.5
Q ss_pred cccccCcceeEEEEEecCCCC--cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccccce
Q 040480 40 EKIGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHM 116 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 116 (325)
+.||+|+||.||+|+.. .++ ..+++|.+.. .........+.+|+.++..+ .||||+++++++
T Consensus 1 ~~lg~g~~g~v~~~~~~-~~~~~~~~~~k~~~~--------------~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 65 (270)
T cd05047 1 DVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKE--------------YASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 65 (270)
T ss_pred CcCCCCCCceEEEEEEc-CCCCeeEEEEEEccc--------------cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE
Confidence 46899999999999754 334 3468887621 01123345678899999999 799999999999
Q ss_pred ecCCceEEEEEcccCCCHHHHHhhhc------------ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040480 117 VRPDSHLLVYDFMKNGSLQAVLYDVS------------KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 117 ~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~n 184 (325)
...+..+++|||+++++|.+++.... .....++...+..++.|++.|++||| +.|++|+||+|+|
T Consensus 66 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~n 142 (270)
T cd05047 66 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARN 142 (270)
T ss_pred ecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccce
Confidence 99999999999999999999985422 11234788889999999999999999 8899999999999
Q ss_pred eEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCC
Q 040480 185 VLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHT 263 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~ 263 (325)
|++++++.++|+|||++........ ......+..|+|||+..+..++.++|+||||+++|+|++ |..||.....
T Consensus 143 ili~~~~~~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-- 217 (270)
T cd05047 143 ILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-- 217 (270)
T ss_pred EEEcCCCeEEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--
Confidence 9999999999999999853221111 111223557999999988889999999999999999997 9999964211
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+. ............. ......+.+|+.+||+.||.+|||+.++++
T Consensus 218 --~~~---~~~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 218 --AEL---YEKLPQGYRLEKP----------LNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred --HHH---HHHHhCCCCCCCC----------CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 111 1111111111100 012233889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=264.86 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=201.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|..++.||+|.||+|-+++ ...+++.+|+|++ .+.-......+.+-..|.++|...+||.+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~r-EKat~k~YAiKIl------------kKeviiakdEVAHTlTE~RVL~~~~HPFLt~L 233 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCR-EKATGKLYAIKIL------------KKEVIIAKDEVAHTLTENRVLQNCRHPFLTSL 233 (516)
T ss_pred cchhhHHHHhcCCccceEEEEe-ecccCceeehhhh------------hhhheeehHHhhhhhhHHHHHHhccCcHHHHh
Confidence 3679999999999999999995 7789999999987 23233445667778889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
...|..++.+|+||||.+||.|.-.+ .....+++.....+...|+.||-||| +++||+||+|.+|.+++.+|+
T Consensus 234 KYsFQt~drlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGH 306 (516)
T KOG0690|consen 234 KYSFQTQDRLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGH 306 (516)
T ss_pred hhhhccCceEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCc
Confidence 99999999999999999999998888 44566899999999999999999999 899999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+||+|||++..-...... ...+|||+.|+|||++....|..++|.|.+|+++|+|++|+.||-.. ....+.+.+
T Consensus 307 IKitDFGLCKE~I~~g~t--~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~----dh~kLFeLI 380 (516)
T KOG0690|consen 307 IKITDFGLCKEEIKYGDT--TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK----DHEKLFELI 380 (516)
T ss_pred eEeeecccchhcccccce--eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc----chhHHHHHH
Confidence 999999999765443332 23489999999999999999999999999999999999999999542 112222222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (325)
.. .....+. ...+ +...|+..+|.+||.+|..
T Consensus 381 l~-ed~kFPr-~ls~------------eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 381 LM-EDLKFPR-TLSP------------EAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred Hh-hhccCCc-cCCH------------HHHHHHHHHhhcChHhhcC
Confidence 11 1111111 1111 1788999999999999974
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=270.06 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=199.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~ 112 (325)
++|.+.+.||+|+||.||+|+ +..++..+|+|.+... ..........+.+|..+++++. ||||+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~-~~~~~~~~~ik~~~~~------------~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~ 67 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAK-EKETNKEYAIKILDKR------------QLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67 (280)
T ss_pred CCceEeeeecCCCceEEEEEE-EcCCCCEEEEEEechH------------hccchHHHHHHHHHHHHHHhcccCCCchhH
Confidence 479999999999999999996 4567889999987321 1112233467888999999998 9999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+...+..++|||++.+++|.+++.. ...++...+..++.|++.+|.+|| +.|++|+||+|+||+++.++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~ 140 (280)
T cd05581 68 YYTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMH 140 (280)
T ss_pred HHHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCC
Confidence 9999999999999999999999999843 346999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCcc------------------ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCC
Q 040480 193 ARISGFDLAILMPDGLTQ------------------IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKF 254 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~ 254 (325)
++++|||.+......... .......++..|+|||...+..++.++|+||||++++++++|..
T Consensus 141 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~ 220 (280)
T cd05581 141 IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220 (280)
T ss_pred EEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCC
Confidence 999999999865443221 11122456788999999888888999999999999999999999
Q ss_pred CCCCcccCCCcchHHHHHHHHhhhCC-CCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh----hhhhc
Q 040480 255 PFDDFFSHTGEMDMVRWMRNVMASEN-PNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS----KDVRC 324 (325)
Q Consensus 255 p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~ell~ 324 (325)
||.... .... ......... .+..+ +..+.+++.+||+.||.+|||+ +++++
T Consensus 221 p~~~~~----~~~~---~~~~~~~~~~~~~~~------------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 221 PFRGSN----EYLT---FQKILKLEYSFPPNF------------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCCcc----HHHH---HHHHHhcCCCCCCcc------------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 997532 1111 111111111 11111 2338899999999999999999 88875
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=269.80 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=191.8
Q ss_pred cccccccccCcceeEEEEEecC--CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPG--SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
|.+.+.||+|+||.||+|.+.. .++..+|+|.+... .......+.+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 67 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-------------IFSSSDIEEFLREAACMKEFDHPNVIKLI 67 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc-------------cCChHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 6788999999999999996543 35688999987321 11223456688899999999999999999
Q ss_pred cceecCC------ceEEEEEcccCCCHHHHHhhhc--ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 114 AHMVRPD------SHLLVYDFMKNGSLQAVLYDVS--KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 114 ~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++.... ..+++++|+.+++|.+++.... .....++......++.|++.||+||| +.+++|+||+|+||
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~ni 144 (273)
T cd05074 68 GVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNC 144 (273)
T ss_pred EEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhE
Confidence 9875432 2478899999999998874321 12235788888999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~ 264 (325)
+++.++.++++|||.+................++..|++||...+..++.++||||||+++|+|++ |..||.....
T Consensus 145 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--- 221 (273)
T cd05074 145 MLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--- 221 (273)
T ss_pred EEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---
Confidence 999999999999999886543322111112244567999999988888999999999999999999 8899864221
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+... ........... ...+..+.+++.+||+.+|++|||+.++++
T Consensus 222 -~~~~~---~~~~~~~~~~~----------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 222 -SEIYN---YLIKGNRLKQP----------PDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -HHHHH---HHHcCCcCCCC----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11221 11111111110 011234899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=271.63 Aligned_cols=263 Identities=21% Similarity=0.278 Sum_probs=192.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
+.++|.+.+.||+|+||.||+|. +..++..+|+|.+.... .......+.+|+.+++.++|+||++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~ni~~ 67 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGI-SRINGQLVALKVISMKT--------------EEGVPFTAIREASLLKGLKHANIVL 67 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEE-EcCCCcEEEEEEecccC--------------cCCCcHHHHHHHHHHHhcCCCCEeE
Confidence 45789999999999999999995 55677899999873211 1122335578899999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++|+||+. ++|.+++.. ....++...+..++.|++.||.||| +.|++|+||+|+||+++.++
T Consensus 68 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~ 140 (291)
T cd07870 68 LHDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLG 140 (291)
T ss_pred EEEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCC
Confidence 9999999999999999996 577776632 2345677788889999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||++.......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ..+
T Consensus 141 ~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~------~~~ 212 (291)
T cd07870 141 ELKLADFGLARAKSIPSQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD------VFE 212 (291)
T ss_pred cEEEeccccccccCCCCCCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh------HHH
Confidence 99999999987543322111 123568899999998764 478899999999999999999999964321 111
Q ss_pred HHHHHhhh-CCCC--------------cccchhhcCCch------HHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMAS-ENPN--------------RAIDSKLLGNGY------EEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~-~~~~--------------~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+.. +.+. ............ ......+.+++.+|++.||.+|||+.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 11111110 0000 000000000000 001234889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=270.97 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=200.8
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...+.|++.+.||+|++|.||+|.+ ..++..+++|.+.... .....+..|+++++.++|+|++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~----------------~~~~~~~~e~~~l~~l~~~~i~ 78 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATD-RATGKEVAIKKMRLRK----------------QNKELIINEILIMKDCKHPNIV 78 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEE-ccCCcEEEEEEEecCc----------------hhHHHHHHHHHHHHHCCCCCee
Confidence 3567899999999999999999964 4567889999883211 1356678899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++.+......++++||+++++|.+++.... ..++...+..++.|++.+|++|| +.|++|+||+|+||+++.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~ 152 (286)
T cd06614 79 DYYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKD 152 (286)
T ss_pred EEEEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCC
Confidence 99999999999999999999999999995421 36889999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... . .
T Consensus 153 ~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----~---~ 223 (286)
T cd06614 153 GSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----L---R 223 (286)
T ss_pred CCEEECccchhhhhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----H---H
Confidence 99999999998655433211 1223567889999999888899999999999999999999999864221 1 1
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..........+.... ....+..+.+++.+||+.+|.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 224 ALFLITTKGIPPLKN--------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHhcCCCCCcc--------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111111111111000 1112334899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=301.24 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=195.9
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
-+.-++|+.++.||+||||.||+++ +.-+|+.||||++.++. ......++.+|++.+++++||||
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVR-NKlDGr~YAIKKIpl~~--------------s~~~~skI~rEVk~LArLnHpNV 539 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVR-NKLDGREYAIKKIPLKA--------------SDKLYSKILREVKLLARLNHPNV 539 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEe-ecccchhhhhhhccCch--------------HHHHHHHHHHHHHHHhhcCCcce
Confidence 4566789999999999999999996 77899999999984331 33567789999999999999999
Q ss_pred cccccceec-----------------------------------------------------------------------
Q 040480 110 LPLLAHMVR----------------------------------------------------------------------- 118 (325)
Q Consensus 110 ~~~~~~~~~----------------------------------------------------------------------- 118 (325)
|+++..|..
T Consensus 540 VRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e 619 (1351)
T KOG1035|consen 540 VRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEE 619 (1351)
T ss_pred eeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcc
Confidence 999987753
Q ss_pred ----------------------------------------C--------CceEEEEEcccCCCHHHHHhhhccccccc-C
Q 040480 119 ----------------------------------------P--------DSHLLVYDFMKNGSLQAVLYDVSKGRREL-E 149 (325)
Q Consensus 119 ----------------------------------------~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~-~ 149 (325)
+ ..+||=||||+..++.+++. .+... .
T Consensus 620 ~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~----~N~~~~~ 695 (1351)
T KOG1035|consen 620 NDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIR----RNHFNSQ 695 (1351)
T ss_pred cccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHH----hcccchh
Confidence 0 12367789998866666662 22222 4
Q ss_pred hhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecC----------------CCCccccc
Q 040480 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP----------------DGLTQIDT 213 (325)
Q Consensus 150 ~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~----------------~~~~~~~~ 213 (325)
....++++.+|++||+|+| ++|||||||||.|||+++++.|||+|||++.... .+......
T Consensus 696 ~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~ 772 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL 772 (1351)
T ss_pred hHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence 6678999999999999999 8899999999999999999999999999998721 01111133
Q ss_pred eeecCCcccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhc
Q 040480 214 MYVVGTPRYIAPEYHQTLT---ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLL 290 (325)
Q Consensus 214 ~~~~g~~~~~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
+...||..|.|||++.+.. |+.|+|+||||++++||+. ||+ ..++-+..+.....+..+.. +.+.
T Consensus 773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~------TsMERa~iL~~LR~g~iP~~---~~f~ 840 (1351)
T KOG1035|consen 773 TSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG------TSMERASILTNLRKGSIPEP---ADFF 840 (1351)
T ss_pred ccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC------chHHHHHHHHhcccCCCCCC---cccc
Confidence 4478999999999987765 9999999999999999985 464 33444444444443333322 2222
Q ss_pred CCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 291 GNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 291 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..... .=.++|.+|++.||.+||||.|+|.
T Consensus 841 ~~~~~----~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 841 DPEHP----EEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccch----HHHHHHHHHhcCCCccCCCHHHHhh
Confidence 22222 2467999999999999999999985
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.49 Aligned_cols=271 Identities=21% Similarity=0.275 Sum_probs=195.8
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
.+....++|++.+.||+|+||.||+|. +..+++.+|+|.+.... ..........+|+.++++++||
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~aik~~~~~~-------------~~~~~~~~~~~e~~~l~~l~h~ 71 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKAR-HKKTKQIVALKKVLMEN-------------EKEGFPITALREIKILQLLKHE 71 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEE-ECCCCcEEEEEEEeccC-------------CcCCchhHHHHHHHHHHhCCCC
Confidence 355566789999999999999999996 55678999999873211 1112234556789999999999
Q ss_pred CccccccceecCC--------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 040480 108 NILPLLAHMVRPD--------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179 (325)
Q Consensus 108 ~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~d 179 (325)
||+++++++.... ..++|+||+.+ +|.+.+.. ....+++..+..++.|++.||+||| ++|++|+|
T Consensus 72 ~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~d 144 (310)
T cd07865 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRD 144 (310)
T ss_pred CccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 9999999876544 35999999965 78877732 3346899999999999999999999 88999999
Q ss_pred CCCCceEecCCCCceeeccccceecCCCCcc--ccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCC
Q 040480 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 180 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~ 256 (325)
|+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||
T Consensus 145 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 145 MKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred CCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999765432221 111223567889999987664 3688999999999999999999998
Q ss_pred CCcccCCCcchHHHHHHHHhhhCCCCcccchh----------hcCCc---h------HHHHHHHHHHHhhhcCCCCCCCC
Q 040480 257 DDFFSHTGEMDMVRWMRNVMASENPNRAIDSK----------LLGNG---Y------EEQMLLVLKLACFCTLADPDERP 317 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~---~------~~~~~~l~~li~~~l~~dP~~Rp 317 (325)
..... ......+..... ..+....+.. ..... . ......+.+||.+||+.||.+||
T Consensus 225 ~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~ 299 (310)
T cd07865 225 QGNTE----QHQLTLISQLCG-SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299 (310)
T ss_pred CCCCH----HHHHHHHHHHhC-CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc
Confidence 65321 111111121111 1000000000 00000 0 00123377999999999999999
Q ss_pred Chhhhhc
Q 040480 318 NSKDVRC 324 (325)
Q Consensus 318 s~~ell~ 324 (325)
|++++++
T Consensus 300 t~~e~l~ 306 (310)
T cd07865 300 DADTALN 306 (310)
T ss_pred CHHHHhc
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=267.17 Aligned_cols=248 Identities=24% Similarity=0.315 Sum_probs=183.6
Q ss_pred cccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccccee
Q 040480 40 EKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMV 117 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 117 (325)
+.||+|+||.||+|.+... .+..+|+|.+... ........+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 66 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--------------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL 66 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--------------CCHHHHHHHHHHHHHHccCCCCCcceEEEEee
Confidence 4689999999999975322 3467999986211 11233567888999999999999999999765
Q ss_pred -cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceee
Q 040480 118 -RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS 196 (325)
Q Consensus 118 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~ 196 (325)
.++..++++||+.+++|.+++.. .....+......++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 67 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~ 140 (262)
T cd05058 67 PSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVA 140 (262)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEEC
Confidence 45568999999999999999843 2233566677889999999999999 8899999999999999999999999
Q ss_pred ccccceecCCCCcc--ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCcccCCCcchHHHHHH
Q 040480 197 GFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMG-KFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 197 dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++| .+||.... ......
T Consensus 141 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~ 213 (262)
T cd05058 141 DFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITV 213 (262)
T ss_pred CccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHH
Confidence 99998754332111 011112456689999999888899999999999999999995 56664321 112222
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........... . ..+..+.+++.+||..+|++||++.++++
T Consensus 214 ~~~~~~~~~~~-------~---~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 214 YLLQGRRLLQP-------E---YCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHhcCCCCCCC-------C---cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22222111100 0 11223889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=280.71 Aligned_cols=263 Identities=23% Similarity=0.310 Sum_probs=195.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|+||.||+|. +..+++.||+|.+... .........+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~-~~~~~~~valK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 69 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAI-DTRSGKKVAIKKIPHA-------------FDVPTLAKRTLRELKILRHFKHDNIIAI 69 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEE-EcCCCCEEEEEEeccc-------------cccccchHHHHHHHHHHHhcCCCCccCH
Confidence 4789999999999999999995 5567889999987321 1112335567789999999999999999
Q ss_pred ccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 113 LAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 113 ~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++++.. ....++|+||+. ++|.+++ .....++...+..++.|++.||.||| +++++|+||+|+||+++
T Consensus 70 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~ 141 (334)
T cd07855 70 RDILRPPGADFKDVYVVMDLME-SDLHHII----HSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVN 141 (334)
T ss_pred HHhccccCCCCceEEEEEehhh-hhHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEc
Confidence 988753 346899999996 5888887 33455899999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCcccc--ceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 189 DDMEARISGFDLAILMPDGLTQID--TMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
.++.++|+|||.+........... .....|+..|.|||.+.+ ..++.++|+||||+++|+|++|+.||......
T Consensus 142 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--- 218 (334)
T cd07855 142 EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--- 218 (334)
T ss_pred CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH---
Confidence 999999999999976543322111 112467889999998765 45789999999999999999999999653211
Q ss_pred chHHHHHHHHhh--------------------hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMA--------------------SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........... ........+ ........+..+.++|.+||+.||.+|||++++++
T Consensus 219 -~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 219 -HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVP---WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred -HHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCC---HHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11110000000 000000000 00011223455999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=266.27 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=202.0
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||+|++|.||+|. +..+++.+++|.+.... ........+.+|+.++++++||||+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~-~~~~~~~~~ik~~~~~~-------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLAL-DKDTGELMAVKSVELSG-------------DSEEELEALEREIRILSSLQHPNIVRYYG 66 (260)
T ss_pred CceeeeEeeecCceEEEEEE-ECCCCcEEEEEEeeccc-------------cchHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence 47888999999999999995 45578899999873321 11245678899999999999999999999
Q ss_pred ceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 115 HMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 115 ~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
.+... +..++++||+++++|.+++.. ...+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~ 139 (260)
T cd06606 67 SERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGV 139 (260)
T ss_pred EEecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCC
Confidence 99888 889999999999999999843 237899999999999999999999 789999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||.+................++..|.|||...+...+.++|+||||+++++|++|..||.... ......
T Consensus 140 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~ 213 (260)
T cd06606 140 VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAAL 213 (260)
T ss_pred EEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHH
Confidence 99999999987765543111222467889999999988889999999999999999999999997533 111111
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ ...++ ...+..+.+++.+|+..||.+||++.++++
T Consensus 214 ~~~~~~~~-~~~~~--------~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 214 YKIGSSGE-PPEIP--------EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HhccccCC-CcCCC--------cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111011 11111 111334899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=270.65 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=196.0
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|++|.||+|+ +..++..+|+|.+.... .......+.+|+.++++++||||+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 65 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGR-NRTTGEIVALKEIHLDA--------------EEGTPSTAIREISLMKELKHENIVRLHD 65 (284)
T ss_pred CceEeeeeccCCceEEEEEE-ECCCCeEEEEEEecccc--------------cccchHHHHHHHHHHHhhcCCCEeeeee
Confidence 58999999999999999996 55678899999884221 1123455678999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++...+..++|+||+++ +|.+++.... ....+++..+..++.|++.||.||| +.|++|+||+|+||++++++.++
T Consensus 66 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~ 140 (284)
T cd07836 66 VIHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELK 140 (284)
T ss_pred eEeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEE
Confidence 99999999999999986 8888874322 2346899999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|+|||.+.......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .+......
T Consensus 141 l~d~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~ 214 (284)
T cd07836 141 LADFGLARAFGIPVNTF--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN----EDQLLKIF 214 (284)
T ss_pred EeecchhhhhcCCcccc--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHH
Confidence 99999997554322111 113567889999987654 468899999999999999999999975322 11111111
Q ss_pred HHhhhCCC---------C---c---ccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENP---------N---R---AIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~---------~---~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+.. . . .................+.+++.+||+.||.+||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 215 RIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11000000 0 0 00000000111123445889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=266.13 Aligned_cols=245 Identities=20% Similarity=0.244 Sum_probs=186.4
Q ss_pred hhcCccccccc--ccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc-cCCCC
Q 040480 32 KEDCFASLEKI--GSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ-IRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~l--g~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~ 108 (325)
..+.|++.+.+ |.|+||.||++. +..++..+|+|.+.... ... . |...... .+|||
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~~~~k~~~~~~-------------~~~--~-----e~~~~~~~~~h~~ 70 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLK-HKPTQKLFVQKIIKAKN-------------FNA--I-----EPMVHQLMKDNPN 70 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEE-EcCCCcEEEEEEEehhh-------------cch--h-----hHHHHHHhhcCCC
Confidence 34677777776 999999999995 56678889999873210 000 0 1111111 16999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++++++.+...+..++||||+++++|.+++.. ...+++..+..++.|++.||.+|| +.|++|+||+|+||+++
T Consensus 71 iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 71 FIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYD 143 (267)
T ss_pred EEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEe
Confidence 99999999999999999999999999999833 337899999999999999999999 88999999999999999
Q ss_pred CCC-CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 189 DDM-EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.++ .++|+|||.+........ ..++..|+|||++.+..++.++|+||||+++|+|++|..||..... ....
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~ 215 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTPSC------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELD 215 (267)
T ss_pred CCCCeEEEecCccceecCCCcc------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhh
Confidence 888 999999999876543221 3578899999999988899999999999999999999999974322 1111
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-hhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-SKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~ 324 (325)
...+..... ... ... ......+.+++.+||+.||.+||+ ++++++
T Consensus 216 ~~~~~~~~~--~~~--~~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 216 LESLLKRQQ--KKL--PFI--------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHhhc--ccC--Ccc--------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 222222111 100 000 112233899999999999999996 599875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=273.62 Aligned_cols=261 Identities=26% Similarity=0.323 Sum_probs=193.1
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH 115 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 115 (325)
|++.+.||.|++|.||+|. +..++..+|+|++... .........+.+|+.+++.++|||+++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~-~~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~ 66 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKAR-DKLTGEIVALKKIRLE-------------TEDEGVPSTAIREISLLKELNHPNIVRLLDV 66 (283)
T ss_pred CchheEecCCCCeEEEEEE-EcCCCCEEEEEEeecc-------------cccccchhHHHHHHHHHHhcCCCCccCHhhe
Confidence 6789999999999999996 5567889999987321 1112234567789999999999999999999
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCcee
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l 195 (325)
+.+.+..++++||++ ++|.+++... ....+++..+..++.|++.+|.||| +++++|+||+|+||+++.++.++|
T Consensus 67 ~~~~~~~~iv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l 140 (283)
T cd07835 67 VHSENKLYLVFEFLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKL 140 (283)
T ss_pred eccCCeEEEEEeccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEE
Confidence 999999999999995 5899888432 2236889999999999999999999 889999999999999999999999
Q ss_pred eccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 196 SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 196 ~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
+|||.+.......... ....++..|+|||++.+. .++.++|+||||+++|+|++|..||..... ..........
T Consensus 141 ~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~ 215 (283)
T cd07835 141 ADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIFRT 215 (283)
T ss_pred eecccccccCCCcccc--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHH
Confidence 9999997654322111 113557889999987654 468899999999999999999999964221 0111111110
Q ss_pred HhhhCCCCc-----------------ccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNR-----------------AIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+.. .................+.+++.+||+.||.+|||++++++
T Consensus 216 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 216 ---LGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ---hCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 00000000011122234889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=272.16 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=195.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|+||.||+|+ +..+++.+++|.+.... ........+.+|+.++++++||||+++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~ik~~~~~~-------------~~~~~~~~~~~e~~~l~~l~h~ni~~~ 69 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRAR-DKKTGEIVALKKLKMEK-------------EKEGFPITSLREINILLKLQHPNIVTV 69 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEE-ECCCCcEEEEEEEeecc-------------ccccchhhHHHHHHHHHhcCCCCEEEE
Confidence 3689999999999999999996 45668899999884221 112233456789999999999999999
Q ss_pred ccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 113 LAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 113 ~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++... +..|+|+||+.+ +|.+.+.. ....++......++.|++.||.||| +.+++|+||+|+||+++.+
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~ 142 (293)
T cd07843 70 KEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNR 142 (293)
T ss_pred EEEEEecCCCcEEEEehhcCc-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCC
Confidence 9988877 889999999975 89888843 2335899999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||.+.......... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ....
T Consensus 143 ~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~----~~~~ 216 (293)
T cd07843 143 GILKICDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE----IDQL 216 (293)
T ss_pred CcEEEeecCceeeccCCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHH
Confidence 999999999998765432211 1235678899999887643 68899999999999999999999965321 1111
Q ss_pred HHHHHHhhhCCC-----------------CcccchhhcCCchHH--HHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENP-----------------NRAIDSKLLGNGYEE--QMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............ ........ ...... ....+.++|.+||+.||++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHHhCCCchHHHHHhhccchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 111000000000 00000000 011111 2445889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=270.85 Aligned_cols=269 Identities=14% Similarity=0.160 Sum_probs=184.3
Q ss_pred hcCcccccccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|.+.+.||+|+||+||+|.+.... +..+|+|...........+. .............+...+..+.|++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~----~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMET----LVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHH----HHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 478999999999999999999754221 45677775422221110000 000011112233444556677899999
Q ss_pred ccccceecCC----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 111 PLLAHMVRPD----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 111 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++.+.... ..+++++++.. ++.+.+.. ....+...+..++.|++.||.||| +++++||||||+||+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nil 158 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIM 158 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 9998665443 34678887744 67666632 223567778899999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcc-----ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQ-----IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
++.++.++|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999866432111 111224689999999999999999999999999999999999999976422
Q ss_pred CCCcchH--HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 262 HTGEMDM--VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 262 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
....... .............. ...++.+.+++..|+..+|++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 239 NGNLIHAAKCDFIKRLHEGKIKI------------KNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred chHHHHHhHHHHHHHhhhhhhcc------------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 1111110 11112222111111 0112348899999999999999999999863
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=270.17 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=193.1
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH 115 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 115 (325)
|....+||+|+||.||++. ...++..+|+|.+.. ........+.+|+.+++.++|+|++++++.
T Consensus 22 ~~~~~~lg~g~~g~v~~~~-~~~~~~~v~iK~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 85 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIAT-VKSSGKLVAVKKMDL---------------RKQQRRELLFNEVVIMRDYQHENVVEMYNS 85 (292)
T ss_pred hhhHHHcCCCCCeEEEEEE-EcCCCeEEEEEEecc---------------cchhHHHHHHHHHHHHHhcCCcchhheeeE
Confidence 3345789999999999995 456788999998721 112345568889999999999999999999
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCcee
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l 195 (325)
+...+..+++|||+++++|.+++. ...+++..+..++.|++.++++|| +.|++|+||+|+||++++++.++|
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l 157 (292)
T cd06657 86 YLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKL 157 (292)
T ss_pred EEeCCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999998772 335788889999999999999999 889999999999999999999999
Q ss_pred eccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHH
Q 040480 196 SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275 (325)
Q Consensus 196 ~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 275 (325)
+|||.+......... .....|+..|+|||...+..++.++|+||||+++|+|++|..||.... .........
T Consensus 158 ~dfg~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~----~~~~~~~~~-- 229 (292)
T cd06657 158 SDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIR-- 229 (292)
T ss_pred cccccceeccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHH--
Confidence 999988755432211 122467889999999888888999999999999999999999986421 111111111
Q ss_pred hhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... ....+..+.+++.+||+.||.+||++.++++
T Consensus 230 -~~~~~~~~~--------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 230 -DNLPPKLKN--------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -hhCCcccCC--------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 111111000 0112223889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=277.98 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=192.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..++..||+|.+... ........+.+|+.+++.++||||+++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~-~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~niv~~ 68 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSAT-HKPTGVKVAIKKISPF--------------EHQTFCQRTLREIKILRRFKHENIIGI 68 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEE-EcCCCCeEEEEEeccc--------------ccchhHHHHHHHHHHHHhCCCCCcCch
Confidence 4789999999999999999995 5567889999987311 112234567789999999999999999
Q ss_pred ccceecC-----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 113 LAHMVRP-----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 113 ~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
++++... ...++++||+.+ +|.+.+ ....+++..+..++.|++.||.+|| +.|++|+||+|+||++
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-----~~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill 139 (336)
T cd07849 69 LDIIRPPSFESFNDVYIVQELMET-DLYKLI-----KTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLL 139 (336)
T ss_pred hheeecccccccceEEEEehhccc-CHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEE
Confidence 9876544 357999999965 887777 3346889999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccc-cceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 188 DDDMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
+.++.++|+|||++.......... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.....
T Consensus 140 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---- 215 (336)
T cd07849 140 NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---- 215 (336)
T ss_pred CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 999999999999987654322211 1112467889999998654 4688999999999999999999999965221
Q ss_pred chHHHHHHHHhhhCCCCcc--------------c---chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRA--------------I---DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~--------------~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
................... . ...............+.+++.+||+.||++|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111111111100000000 0 000000001122344889999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=293.78 Aligned_cols=255 Identities=21% Similarity=0.370 Sum_probs=210.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..+.-.|.++||.|.||.|++|++.... ...||||.++ ....+..+..|..|..||-++.||||
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK--------------~GytekqrrdFL~EAsIMGQFdHPNI 692 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLK--------------AGYTEKQRRDFLSEASIMGQFDHPNI 692 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeec--------------cCccHHHHhhhhhhhhhcccCCCCcE
Confidence 4567788999999999999999875433 3679999984 23445667889999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++.++........+|+|||++|+|..+++. .++.+...+...++..|+.|+.||- ++++|||||.++|||++.
T Consensus 693 IrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNs 766 (996)
T KOG0196|consen 693 IRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNS 766 (996)
T ss_pred EEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeecc
Confidence 9999999999999999999999999999965 4456999999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecC--CcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcc
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVG--TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEM 266 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g--~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~ 266 (325)
+-.+|+.|||+++....... ...+...| +.+|.|||.+...++|.++||||+|++|||.++ |..||.+..+
T Consensus 767 nLvCKVsDFGLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----- 840 (996)
T KOG0196|consen 767 NLVCKVSDFGLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----- 840 (996)
T ss_pred ceEEEeccccceeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----
Confidence 99999999999997765542 22222333 458999999999999999999999999999886 9999977543
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..-+..+..+.+.+.+++ ++..|.+|+..||++|-..||++.+|+.
T Consensus 841 --QdVIkaIe~gyRLPpPmD----------CP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 841 --QDVIKAIEQGYRLPPPMD----------CPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred --HHHHHHHHhccCCCCCCC----------CcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 233333334444443333 3444999999999999999999999975
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=271.45 Aligned_cols=258 Identities=22% Similarity=0.361 Sum_probs=193.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~ 112 (325)
++|+..+.||+|+||.||++. +..++..+|+|.+.... .......+..|+.++.++. ||||+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~e~~~l~~~~~~~~iv~~ 68 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKML-HKPSGTIMAVKRIRSTV--------------DEKEQKRLLMDLDVVMRSSDCPYIVKF 68 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEE-ECCCCCEEEEEEehhcc--------------ChHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 456778899999999999996 55678999999873211 1133456788888898886 9999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhc-ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVS-KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
++++...+..+++|||+.. ++.++..... .....+++.....++.|++.||+|||. +.+++|+||+|+||+++.++
T Consensus 69 ~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~ 145 (288)
T cd06616 69 YGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNG 145 (288)
T ss_pred eeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCC
Confidence 9999999999999999864 6665543211 233568999999999999999999992 24999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL---TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||++.......... ...|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||.... ..
T Consensus 146 ~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~ 216 (288)
T cd06616 146 NIKLCDFGISGQLVDSIAKT---RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SV 216 (288)
T ss_pred cEEEeecchhHHhccCCccc---cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hH
Confidence 99999999987654332221 23578889999998776 68899999999999999999999996532 12
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+.. . .......+..+.+|+.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~--~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 217 FDQLTQVVKGDPPIL--S----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHhhhcCCCCCcC--C----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222222221111111 0 1111123334899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=263.07 Aligned_cols=250 Identities=28% Similarity=0.425 Sum_probs=200.1
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||+|++|.||+++ +..+++.+++|.+.... ........+.+|+++++++.|||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~ik~~~~~~-------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGL-NLETGDFVAIKQISLEK-------------IKEEALKSIMQEIDLLKNLKHPNIVKYIG 66 (254)
T ss_pred CceeeeEEcccCCeEEEEEE-EcCCCcEEEEEEecccc-------------cCHHHHHHHHHHHHHHHhCCCCCccEEEE
Confidence 58899999999999999995 55677889999984321 11235567899999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++...+..++++||+++++|.+++.. ...+++..+..++.|++.++.+|| +.|++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~ 139 (254)
T cd06627 67 SIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVK 139 (254)
T ss_pred EEEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999843 356899999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||.+.......... ....++..|+|||...+..++.++|+||||+++|+|++|..||..... .......
T Consensus 140 l~d~~~~~~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~ 211 (254)
T cd06627 140 LADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRI 211 (254)
T ss_pred EeccccceecCCCcccc--cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH
Confidence 99999998765543321 124678899999998887888999999999999999999999965321 1111111
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ..+. .....+.+++.+||..+|++|||+.+++.
T Consensus 212 -~~~~~~--~~~~--------~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 -VQDDHP--PLPE--------GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -hccCCC--CCCC--------CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111111 1111 11233889999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=262.62 Aligned_cols=250 Identities=30% Similarity=0.466 Sum_probs=199.3
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
.|++.+.||+|++|.||++. +..+++.+++|.+... .......+.+|+.+++.++||+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~~k~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 64 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKAR-HKRTGKEVAIKVIKLE---------------SKEKKEKIINEIQILKKCKHPNIVKYYG 64 (253)
T ss_pred CceeeeeeccCCceEEEEEE-ECCCCcEEEEEEeccc---------------chhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 47889999999999999996 4457888999988321 1135567889999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+......++++||+++++|.+++.. ....++...+..++.|++.++.+|| ++|++|+||+|+||+++.++.++
T Consensus 65 ~~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~ 138 (253)
T cd05122 65 SYLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVK 138 (253)
T ss_pred EEecCCeEEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEE
Confidence 99999999999999999999999843 2256899999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||.+........ .....++..|+|||...+..++.++|+||||+++|+|++|..||..... .... ..
T Consensus 139 l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~---~~ 208 (253)
T cd05122 139 LIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----MKAL---FK 208 (253)
T ss_pred Eeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----HHHH---HH
Confidence 999999977655432 1224678899999999888889999999999999999999999965321 1111 11
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+..... ......+.+++.+||+.||++|||+.++++
T Consensus 209 ~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 209 IATNGPPGLRNP--------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHhcCCCCcCcc--------cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111110000 001234899999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.85 Aligned_cols=245 Identities=27% Similarity=0.371 Sum_probs=198.6
Q ss_pred ccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCC
Q 040480 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPD 120 (325)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 120 (325)
+||+|.||+||-|+ +..++..+|||.+ ..........++.|+.+-++++|.|||++++.+..++
T Consensus 582 VLGKGTYG~VYA~R-D~~tqvrIaIKEI---------------pekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG 645 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAAR-DMDTQVRIAIKEI---------------PEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG 645 (1226)
T ss_pred EeecCceeEEEeec-cccceeEEEeeec---------------ccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC
Confidence 69999999999995 7788899999988 2334456778999999999999999999999999999
Q ss_pred ceEEEEEcccCCCHHHHHhhhccccccc--ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec-CCCCceeec
Q 040480 121 SHLLVYDFMKNGSLQAVLYDVSKGRREL--EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISG 197 (325)
Q Consensus 121 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~--~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~-~~~~~~l~d 197 (325)
.+-+.||-++||+|.+.+.... +++ .+.++..+..||++||.||| .+.|||||||-+|++++ -.|.+||.|
T Consensus 646 f~kIFMEqVPGGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISD 719 (1226)
T KOG4279|consen 646 FFKIFMEQVPGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISD 719 (1226)
T ss_pred eEEEEeecCCCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecc
Confidence 9999999999999999996533 345 77888899999999999999 88999999999999998 568889999
Q ss_pred cccceecCCCCccccceeecCCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHH
Q 040480 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275 (325)
Q Consensus 198 fg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 275 (325)
||-+..+.... ..+..+-||..|+|||++... .|+.++|||||||++.+|.||++||-...+....+ .+.
T Consensus 720 FGTsKRLAgin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-----FkV- 791 (1226)
T KOG4279|consen 720 FGTSKRLAGIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-----FKV- 791 (1226)
T ss_pred cccchhhccCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-----hhh-
Confidence 99998765433 334447899999999998765 48899999999999999999999997654322221 111
Q ss_pred hhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.-.....+++ .........+|.+|+..||.+||++.++|+
T Consensus 792 -GmyKvHP~iP--------eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 -GMYKVHPPIP--------EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -cceecCCCCc--------HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1111111222 223344889999999999999999999875
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=270.91 Aligned_cols=265 Identities=25% Similarity=0.285 Sum_probs=191.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||.|++|.||+|. +..+++.+|+|.+... .........+.+|+.+++.++||||++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~-~~~~~~~~~iK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 67 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKAR-DRVTNETIALKKIRLE-------------QEDEGVPSTAIREISLLKEMQHGNIVRLQ 67 (294)
T ss_pred CceEEEEEecCCCCEEEEEEE-ecCCCcEEEEEehhhc-------------cccccchHHHHHHHHHHHhccCCCEeeEE
Confidence 579999999999999999996 5567889999987321 11223345678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC-CCC
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-DME 192 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~-~~~ 192 (325)
+++......++|+||+++ +|.+.+.. .....++...+..++.|++.||.||| +++++|+||+|+||+++. ++.
T Consensus 68 ~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~ 141 (294)
T PLN00009 68 DVVHSEKRLYLVFEYLDL-DLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNA 141 (294)
T ss_pred EEEecCCeEEEEEecccc-cHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCE
Confidence 999999999999999965 78877733 22233577788899999999999999 889999999999999985 456
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||++.......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .+....
T Consensus 142 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~----~~~~~~ 215 (294)
T PLN00009 142 LKLADFGLARAFGIPVRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE----IDELFK 215 (294)
T ss_pred EEEcccccccccCCCcccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 8999999997554321111 113567889999987664 578899999999999999999999965321 111110
Q ss_pred HHHHhhhCCCCcc---------------cchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRA---------------IDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+....+ ................+.+++.+||+.||++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000000000 0000000001112334889999999999999999999985
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=267.59 Aligned_cols=262 Identities=26% Similarity=0.344 Sum_probs=197.1
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH 115 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 115 (325)
|++.+.||.|++|.||+|. +..+++.+++|.+... .........+.+|+.+++.++||+|++++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~-~~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 66 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKAR-DKLTGEIVAIKKIKLR-------------FESEGIPKTALREIKLLKELNHPNIIKLLDV 66 (283)
T ss_pred CccceeeecCCCceEEEEE-cCCCCcEEEEEEeccc-------------cccchhHHHHHHHHHHHHHhcCCCcchHHHh
Confidence 6788999999999999995 5567889999987321 1111345577889999999999999999999
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCcee
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l 195 (325)
+...+..++++||+.+ +|.+.+.. ....++...+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++|
T Consensus 67 ~~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l 139 (283)
T cd05118 67 FRHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKL 139 (283)
T ss_pred hccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEE
Confidence 9999999999999976 88888743 2346889999999999999999999 889999999999999999999999
Q ss_pred eccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 196 SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 196 ~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
+|||.+........ ......++..|.|||.+.+. .++.++|+||||+++|+|++|+.||..... .+.......
T Consensus 140 ~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~ 213 (283)
T cd05118 140 ADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE----IDQLFKIFR 213 (283)
T ss_pred eeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH
Confidence 99999987655431 11123567789999988776 688999999999999999999999964221 111111111
Q ss_pred HhhhCCCCc-------------cc---chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNR-------------AI---DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~-------------~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+.. .. ..........+....+.++|.+||+.||.+||++++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 214 TLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000000 00 000001112234556999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=264.98 Aligned_cols=237 Identities=21% Similarity=0.313 Sum_probs=182.0
Q ss_pred cccccCcceeEEEEEecCCCC---------cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 40 EKIGSGGCGDVYKAELPGSNG---------KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
+.||+|+||.||+|.+..... ..+++|.+.. .......+.+|+.+++.++||||+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~ 64 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----------------DHRDSLAFFETASLMSQLSHKHLV 64 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeecccc----------------chhhHHHHHHHHHHHHcCCCcchh
Confidence 478999999999997643321 3477776521 111156788899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.. ...++|+||+++++|.+++... ...++...+..++.|++.||.||| ++|++|+||||+||+++.+
T Consensus 65 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~ 137 (259)
T cd05037 65 KLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARY 137 (259)
T ss_pred heeeEEec-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecC
Confidence 99998887 7789999999999999998542 226888899999999999999999 8899999999999999987
Q ss_pred C-------CceeeccccceecCCCCccccceeecCCcccccccccccC--CCCCccchhhHHHHHHHHHh-CCCCCCCcc
Q 040480 191 M-------EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVM-GKFPFDDFF 260 (325)
Q Consensus 191 ~-------~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~--~~~~~~DvwslG~il~~ll~-g~~p~~~~~ 260 (325)
+ .++|+|||++....... ...++..|+|||++.+. .++.++|+||||+++|+|++ |..||....
T Consensus 138 ~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 138 GLNEGYVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ccccCCceeEEeCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 7 79999999997654411 13456789999998876 68899999999999999999 577775532
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ........ ...... .+. ...+.+++.+||..+|.+|||+.++++
T Consensus 212 ~----~~~~~~~~---~~~~~~--~~~----------~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 212 S----SEKERFYQ---DQHRLP--MPD----------CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred c----hhHHHHHh---cCCCCC--CCC----------chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 11111111 111000 000 033889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=278.82 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=205.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
+-+...+.++||+|-||.|.+|+.. ....||+|++.... ....+..+..|+++|.+++||||+.
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a--------------~~~~r~~F~kEIkiLsqLkhPNIve 599 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDA--------------TKNARNDFLKEIKILSRLKHPNIVE 599 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec--CceEEEEeecCccc--------------chhHHHHHHHHHHHHhccCCCCeeE
Confidence 4467889999999999999999874 46899999984221 1223578999999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
++++|..++.+++++||+..|+|.+++...... ........+|+.||+.|++||. +.++|||||.++|+|++.++
T Consensus 600 LvGVC~~DePicmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~ 674 (807)
T KOG1094|consen 600 LLGVCVQDDPLCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEF 674 (807)
T ss_pred EEeeeecCCchHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcc
Confidence 999999999999999999999999999653322 2455556779999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCcccCCCcchHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM--GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~--g~~p~~~~~~~~~~~~~~ 269 (325)
++||+|||+++-+-.+..........-+.+|+|||.+...++|.++|+|+||+++||+++ ...||.+... .++.
T Consensus 675 ~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vv 750 (807)
T KOG1094|consen 675 TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVV 750 (807)
T ss_pred cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHH
Confidence 999999999997666555444434455789999999999999999999999999999886 6789876432 2333
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
+-.......+... .......-++..+.+++.+||..|.++|||++++.
T Consensus 751 en~~~~~~~~~~~------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 751 ENAGEFFRDQGRQ------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred HhhhhhcCCCCcc------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 3222222222111 11111223344488999999999999999999874
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=272.73 Aligned_cols=260 Identities=21% Similarity=0.324 Sum_probs=190.0
Q ss_pred ccccccC--cceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccce
Q 040480 39 LEKIGSG--GCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHM 116 (325)
Q Consensus 39 ~~~lg~G--~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 116 (325)
...||.| +||+||+|+ +..+++.||+|.+... .......+.+.+|+.+++.++||||+++++++
T Consensus 3 ~~~ig~g~~~~~~v~~a~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~ 68 (328)
T cd08226 3 QVEIGRGFCNLTSVYLAR-HTPTGTLVTVRITDLE-------------NCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF 68 (328)
T ss_pred HHHhCCcccCceeEEEEE-EcCCCcEEEEEEeccc-------------cCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE
Confidence 4567776 999999995 5678899999987321 11223456788899999999999999999999
Q ss_pred ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceee
Q 040480 117 VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS 196 (325)
Q Consensus 117 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~ 196 (325)
...+..++|+||+.+++|.+++.... ...+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++++
T Consensus 69 ~~~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~ 143 (328)
T cd08226 69 TTGSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLS 143 (328)
T ss_pred ecCCceEEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEe
Confidence 99999999999999999999885432 235888888999999999999999 8899999999999999999999999
Q ss_pred ccccceecCCCCccc-----cceeecCCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 197 GFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 197 dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
||+.+.......... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||...... .
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~------~ 217 (328)
T cd08226 144 GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT------Q 217 (328)
T ss_pred chHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH------H
Confidence 997654332211110 01112345679999998764 4788999999999999999999999753211 0
Q ss_pred HHHHHHhhhCCC-C-----------------------------------cccchhhcCCchHHHHHHHHHHHhhhcCCCC
Q 040480 270 RWMRNVMASENP-N-----------------------------------RAIDSKLLGNGYEEQMLLVLKLACFCTLADP 313 (325)
Q Consensus 270 ~~~~~~~~~~~~-~-----------------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 313 (325)
. .......... + ..................+.+|+.+||+.||
T Consensus 218 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 296 (328)
T cd08226 218 M-LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP 296 (328)
T ss_pred H-HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCc
Confidence 0 0000000000 0 0000001111123345568999999999999
Q ss_pred CCCCChhhhhc
Q 040480 314 DERPNSKDVRC 324 (325)
Q Consensus 314 ~~Rps~~ell~ 324 (325)
++|||++|+++
T Consensus 297 ~~Rpta~e~l~ 307 (328)
T cd08226 297 EKRPSASSLLS 307 (328)
T ss_pred ccCCCHHHHhh
Confidence 99999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=258.58 Aligned_cols=274 Identities=24% Similarity=0.303 Sum_probs=201.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCC---cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNG---KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
..|++...||+|.||.||+|.-.+.++ +.+|+|++.-. ...........+|+.+++.++|||++
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~-------------kd~tGiS~SAcREiaL~REl~h~nvi 90 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGE-------------KDGTGISMSACREIALLRELKHPNVI 90 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhcc-------------CCCCCcCHHHHHHHHHHHHhcCCcch
Confidence 579999999999999999994333332 36899987311 11224456789999999999999999
Q ss_pred ccccceec-CCceEEEEEcccCCCHHHHHhhhcc-cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 111 PLLAHMVR-PDSHLLVYDFMKNGSLQAVLYDVSK-GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 111 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
.+..++.. +..+++++||.+. +|.+.|.-... ....++......|++|++.|+.||| ++=|+||||||.|||+.
T Consensus 91 ~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvm 166 (438)
T KOG0666|consen 91 SLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVM 166 (438)
T ss_pred hHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEe
Confidence 99999987 7789999999987 89998854332 2356888889999999999999999 77899999999999998
Q ss_pred CC----CCceeeccccceecCCCCccc-cceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccC
Q 040480 189 DD----MEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSH 262 (325)
Q Consensus 189 ~~----~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~ 262 (325)
.+ |.|||+|+|+++.+.+.-... .....+-|.+|.|||++.|.. ||.+.||||+|||+.||++-.+.|......
T Consensus 167 gdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k 246 (438)
T KOG0666|consen 167 GDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK 246 (438)
T ss_pred ccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence 66 999999999999876544322 222245588999999998865 999999999999999999999988643221
Q ss_pred C-----CcchHHHHHHHHhhhCCCCcccchhhcCCc-----------h-----HH-------HHHHHHHHHhhhcCCCCC
Q 040480 263 T-----GEMDMVRWMRNVMASENPNRAIDSKLLGNG-----------Y-----EE-------QMLLVLKLACFCTLADPD 314 (325)
Q Consensus 263 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~-----~~-------~~~~l~~li~~~l~~dP~ 314 (325)
. -..+...-+-.+...+....|.+-...+.. + .+ -.....+|+.+||..||.
T Consensus 247 ~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~ 326 (438)
T KOG0666|consen 247 IKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPI 326 (438)
T ss_pred cccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCch
Confidence 1 111222222223333332222222111111 0 00 111277899999999999
Q ss_pred CCCChhhhhc
Q 040480 315 ERPNSKDVRC 324 (325)
Q Consensus 315 ~Rps~~ell~ 324 (325)
+|.|++++++
T Consensus 327 kRIta~qAle 336 (438)
T KOG0666|consen 327 KRITAEQALE 336 (438)
T ss_pred hhccHHHHhc
Confidence 9999999875
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=271.66 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=193.2
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
..|...+.||+|+||.||++. +..++..+|+|.+.... .........+..|+.+++.++|||+++++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~-~~~~~~~valK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 91 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSG------------KQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91 (317)
T ss_pred hhhhhhheeccCCCeEEEEEE-EcCCCcEEEEEEEecCC------------CCchHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 458899999999999999996 45578899999873211 11223345688899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++......++|+||+.+ +|.+.+.. ....+++..+..++.+++.++.+|| +++++|+||+|+||+++.++.+
T Consensus 92 ~~~~~~~~~~lv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~ 164 (317)
T cd06635 92 GCYLREHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQV 164 (317)
T ss_pred EEEeeCCeEEEEEeCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCE
Confidence 999999999999999976 77777632 3455888999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+|+|||++....... ...|+..|+|||.+. ...++.++|+||||+++|+|++|..||.... ...
T Consensus 165 kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~ 231 (317)
T cd06635 165 KLADFGSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMS 231 (317)
T ss_pred EEecCCCccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-------HHH
Confidence 999999886543321 236788899999873 4467899999999999999999999986521 111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..........+... .......+.+++.+||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 232 ALYHIAQNESPTLQ---------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred HHHHHHhccCCCCC---------CccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 11222222111100 0112234899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=267.86 Aligned_cols=259 Identities=24% Similarity=0.261 Sum_probs=189.5
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPLLA 114 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 114 (325)
|++.+.||+|+||.||+|+ +..++..+|+|.+.... .........+|+.+++++. |||++++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~-~~~~~~~~aik~~~~~~--------------~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 65 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQ-SRKTGKYYAIKCMKKHF--------------KSLEQVNNLREIQALRRLSPHPNILRLIE 65 (282)
T ss_pred CceEeeccccccceEEEEE-EcCCCcEEEEEEehhcc--------------CCchhhhHHHHHHHHhhcCCCCCccceEE
Confidence 6789999999999999996 45678899999873211 1111223346778888885 999999999
Q ss_pred ceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 115 HMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 115 ~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++.+. +..++|+||+.+ +|.+.+.. ....+++..+..++.|++.||.+|| +.|++|+||+|+||+++. +.
T Consensus 66 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~ 137 (282)
T cd07831 66 VLFDRKTGRLALVFELMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DI 137 (282)
T ss_pred EEecCCCCcEEEEEecCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CC
Confidence 99887 889999999975 78777733 2346899999999999999999999 889999999999999999 99
Q ss_pred ceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||.+........... ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .+....
T Consensus 138 ~kl~dfg~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~----~~~~~~ 210 (282)
T cd07831 138 LKLADFGSCRGIYSKPPYTE---YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE----LDQIAK 210 (282)
T ss_pred eEEEecccccccccCCCcCC---CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH----HHHHHH
Confidence 99999999976643322211 356889999997644 4568899999999999999999999965321 122222
Q ss_pred HHHHhhhCC------------CCcccchhhc---CCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASEN------------PNRAIDSKLL---GNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~------------~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... .....+.... .......+..+.++|.+||+.||++|||++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 211111000 0000000000 0001123456999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=284.22 Aligned_cols=275 Identities=20% Similarity=0.268 Sum_probs=213.7
Q ss_pred CCCCceeeccccchhHHHHHhhhcCcccccccccCcceeEEEEEecCCCCc--EEEEEEEcccCCCcHHHHHHHHHhhCc
Q 040480 11 RDRGLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGK--MIAVKKVIIYSPMSAAELIDAYSELGE 88 (325)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~ 88 (325)
.+++.++..+.. .+++.-+..++...+.+.||+|+||+|++|.|+..+|+ .||||.+.... ..
T Consensus 88 ~h~~~t~~~~~p-~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~--------------l~ 152 (1039)
T KOG0199|consen 88 SHPAQTNSVANP-SIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS--------------LN 152 (1039)
T ss_pred cccccccCCCCc-CCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc--------------cc
Confidence 334444444333 34445556677888899999999999999999887764 59999873221 11
Q ss_pred chHHHHHHHHHHHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHH
Q 040480 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLH 168 (325)
Q Consensus 89 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh 168 (325)
.....|.+|+.+|.+|+|||++++|++..+ ....+|||.++.|+|.+.+.+ .....+.......++.||+.|+.||.
T Consensus 153 ~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLe 229 (1039)
T KOG0199|consen 153 AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLE 229 (1039)
T ss_pred hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHh
Confidence 256789999999999999999999998877 677899999999999999966 45566888888999999999999999
Q ss_pred hcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccc-eeecCCcccccccccccCCCCCccchhhHHHHHH
Q 040480 169 MHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT-MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLA 247 (325)
Q Consensus 169 ~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~ 247 (325)
++++|||||..+|+++-....|||+|||+.+.+......... ....-...|+|||.++..+++.++|||+||+++|
T Consensus 230 ---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiW 306 (1039)
T KOG0199|consen 230 ---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIW 306 (1039)
T ss_pred ---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHH
Confidence 999999999999999998889999999999977654332211 1112245799999999999999999999999999
Q ss_pred HHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 248 VLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 248 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
||++ |..||-+... ...+..+-++..... ...+++++.+++..||..+|.+|||+..|.
T Consensus 307 EMFtyGEePW~G~~g-------~qIL~~iD~~erLpR----------Pk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 307 EMFTYGEEPWVGCRG-------IQILKNIDAGERLPR----------PKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred hhhccCCCCCCCCCH-------HHHHHhccccccCCC----------CCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 9998 8899976322 222222222222221 223556699999999999999999999874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=276.35 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=193.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|.+.+.||.|+||+||+|+ +..++..||+|.+... .........+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 69 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAK-NSETNEKVAIKKIANA-------------FDNRIDAKRTLREIKLLRHLDHENVIAI 69 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEE-ecCCCCeEEEEEeccc-------------ccccchhHHHHHHHHHHHhcCCCCccch
Confidence 4689999999999999999995 5678899999987321 1112234566789999999999999999
Q ss_pred ccceecC-----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 113 LAHMVRP-----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 113 ~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
++++... ...|+++||+. ++|.+++. ....++......++.|++.||.||| +++++|+||+|+||++
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~ 141 (337)
T cd07858 70 KDIMPPPHREAFNDVYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLL 141 (337)
T ss_pred HHheecccccccCcEEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEE
Confidence 9987654 34799999996 58888873 3456899999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .
T Consensus 142 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~ 215 (337)
T cd07858 142 NANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY----V 215 (337)
T ss_pred cCCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh----H
Confidence 9999999999999976543321 1112356888999998764 4588999999999999999999999965311 1
Q ss_pred hHHHHHHHHhhhCCCC------------------cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPN------------------RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
................ ....... .....+....+.+++.+||+.||++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 1111111100000000 0000000 0001123344889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=267.30 Aligned_cols=245 Identities=25% Similarity=0.298 Sum_probs=181.4
Q ss_pred ccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHH---HHHHhccCCCCcccccccee
Q 040480 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ---IITASQIRHRNILPLLAHMV 117 (325)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~ 117 (325)
.||+|+||.||++. +..+++.+|+|.+....... ........++ ..++....||+|+.+++.+.
T Consensus 1 ~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 67 (279)
T cd05633 1 IIGRGGFGEVYGCR-KADTGKMYAMKCLDKKRIKM------------KQGETLALNERIMLSLVSTGDCPFIVCMTYAFH 67 (279)
T ss_pred CcccCCCeEEEEEE-ECCCCcEEEEEEEEcccccc------------chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe
Confidence 48999999999995 55678899999873221100 0111112222 23344457999999999999
Q ss_pred cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeec
Q 040480 118 RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~d 197 (325)
..+..++||||+++++|.+++. ....+++..+..++.|++.||.||| +++++|+||||+||++++++.++|+|
T Consensus 68 ~~~~~~lv~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~d 140 (279)
T cd05633 68 TPDKLCFILDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISD 140 (279)
T ss_pred cCCeEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999999998883 3346899999999999999999999 88999999999999999999999999
Q ss_pred cccceecCCCCccccceeecCCcccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHh
Q 040480 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVM 276 (325)
Q Consensus 198 fg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 276 (325)
||++........ ....|+..|+|||... +..++.++|+||||+++|+|++|..||...... . ... .....
T Consensus 141 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~--~~~-~~~~~ 211 (279)
T cd05633 141 LGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--D--KHE-IDRMT 211 (279)
T ss_pred CCcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc--C--HHH-HHHHh
Confidence 999875543221 1236889999999876 456789999999999999999999999653221 1 111 11111
Q ss_pred hhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
... ....+ ...+..+.+++.+||+.||.+|| |+.++++
T Consensus 212 ~~~--~~~~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 212 LTV--NVELP--------DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred hcC--CcCCc--------cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 000 00001 11223388999999999999999 5888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=265.08 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=191.7
Q ss_pred cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCc
Q 040480 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS 121 (325)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 121 (325)
||.|+||.||++. +..+++.+++|.+... ..........+.+|+.+++.++||||+++++.+.....
T Consensus 1 lg~g~~~~vy~~~-~~~~~~~~~~k~~~~~------------~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 67 (265)
T cd05579 1 ISKGAYGRVFLAK-KKSTGDIYAIKVIKKA------------DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN 67 (265)
T ss_pred CCCCCceEEEEEE-ECCCCCEEEEEEecch------------hhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcE
Confidence 6899999999996 5566889999987321 11112445678889999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 122 HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
.|+++||+++++|.+++.. ...++...+..++.|++.+|.+|| .++++|+||+|+||++++++.++|+|||++
T Consensus 68 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~ 140 (265)
T cd05579 68 LYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLS 140 (265)
T ss_pred EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccc
Confidence 9999999999999999843 236899999999999999999999 889999999999999999999999999998
Q ss_pred eecCCCCc------cccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHH
Q 040480 202 ILMPDGLT------QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275 (325)
Q Consensus 202 ~~~~~~~~------~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 275 (325)
........ ........++..|+|||.......+.++|+||||+++|++++|..||..... . ......
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~---~~~~~~ 213 (265)
T cd05579 141 KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----E---EIFQNI 213 (265)
T ss_pred hhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----H---HHHHHH
Confidence 75543321 1112224577889999999888889999999999999999999999965321 1 111222
Q ss_pred hhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh---hhhhc
Q 040480 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS---KDVRC 324 (325)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~ 324 (325)
.......... . ..+..+.+++.+||+.+|.+|||+ .++++
T Consensus 214 ~~~~~~~~~~---~------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 214 LNGKIEWPED---V------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred hcCCcCCCcc---c------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1111111000 0 012348999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=264.00 Aligned_cols=256 Identities=19% Similarity=0.299 Sum_probs=195.6
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
.+|++.+.||+|+||.||+|+ +..++..+|+|.+...... .........+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 70 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCY-DADTGRELAVKQVPFDPDS----------QETSKEVNALECEIQLLKNLRHDRIVQYY 70 (264)
T ss_pred CceeeeeeEccCCCeEEEEEE-EcCCCCEEEEEEEecCccc----------chhhHHHHHHHHHHHHHHHcCCCCcceEE
Confidence 579999999999999999995 5567889999987322110 11123456788999999999999999999
Q ss_pred cceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 114 AHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 114 ~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+.+.+. ...++++||+++++|.+++.. ...++......++.|++.||.+|| +.|++|+||+|+||+++.++
T Consensus 71 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~ 143 (264)
T cd06653 71 GCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAG 143 (264)
T ss_pred EEEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCC
Confidence 988664 457899999999999999842 345788888999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~ 217 (264)
T cd06653 144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAA 217 (264)
T ss_pred CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHH
Confidence 9999999999865432111 111124578899999999988889999999999999999999999965211 111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+.. ...+ ....+.+.+++.+||+ +|..||++.+++.
T Consensus 218 -~~~~~~~~~~-~~~p--------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 -IFKIATQPTK-PMLP--------DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HHHHHcCCCC-CCCC--------cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111111 1111 1122338899999999 5799999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=254.73 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=193.7
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPLL 113 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 113 (325)
..+++..||.|+-|.||++++ ..++...|||.+..+ -+.+..+++...++++.... +|+||+.+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~-rs~~~iiAVK~M~rt--------------~Nkee~kRILmDldvv~~s~dcpyIV~c~ 157 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRF-RSTGHIIAVKQMRRT--------------GNKEENKRILMDLDVVLKSHDCPYIVQCF 157 (391)
T ss_pred HhhhHHhhcCCCccceEEEEE-cccceEEEEEeeccc--------------CCHHHHHHHHHhhhHHhhccCCCeeeeee
Confidence 345567799999999999975 467889999998322 23345566777777776665 89999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
++|..+..+++.||.+.. .+...+.. ..+++++..+.++...++.||.||...| ||+|||+||+|||+++.|.+
T Consensus 158 GyFi~n~dV~IcMelMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gni 231 (391)
T KOG0983|consen 158 GYFITNTDVFICMELMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNI 231 (391)
T ss_pred eEEeeCchHHHHHHHHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCE
Confidence 999999999999998844 66666633 4556999999999999999999999755 99999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL---TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
||||||++..+........ ..|.+.|+|||.+... .|+.++||||||+++++|.||+.||... ..+...
T Consensus 232 KlCDFGIsGrlvdSkAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c-----~tdFe~ 303 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSKAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC-----KTDFEV 303 (391)
T ss_pred Eeecccccceeeccccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC-----CccHHH
Confidence 9999999987765444333 4789999999988654 5889999999999999999999999752 222222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+..+.....+.-..... ...++.+++..||.+|+.+||...++++
T Consensus 304 -ltkvln~ePP~L~~~~g--------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 304 -LTKVLNEEPPLLPGHMG--------FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -HHHHHhcCCCCCCcccC--------cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 22222211111111110 2234899999999999999999999875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=276.94 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=192.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
.++|++.+.||+|+||.||+|. +..++..+|+|.+... .........+.+|+.+++++ +||||++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~vK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~~h~ni~~ 71 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAI-DRRTKEVVALKKIFDA-------------FRNATDAQRTFREIMFLQELGDHPNIVK 71 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEE-EcCCCeEEEEEeeccc-------------cCcchhhhhhhHHHHHHHHhcCCCCccc
Confidence 4789999999999999999995 5567889999987321 11112344567899999999 9999999
Q ss_pred cccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 112 LLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 112 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++... ...++|+||+++ +|.+++.. ..+++.....++.|++.||.||| +.|++|+||+|+||+++.
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~ 142 (337)
T cd07852 72 LLNVIKAENDKDIYLVFEYMET-DLHAVIRA-----NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNS 142 (337)
T ss_pred eeeeeccCCCceEEEEeccccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcC
Confidence 99987654 357999999975 89888732 26788888899999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCcc---ccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 190 DMEARISGFDLAILMPDGLTQ---IDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~---~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
++.++|+|||.+......... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......
T Consensus 143 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~--- 219 (337)
T cd07852 143 DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL--- 219 (337)
T ss_pred CCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH---
Confidence 999999999999865443221 12222467889999998755 45788999999999999999999999653221
Q ss_pred chHHHHHHHH--------------------hhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNV--------------------MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... ........... ......+.+..+.+++.+||+.||.+|||+.++++
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 220 -NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP---LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred -HHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccc---hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 110000000 00000000000 00001112345899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=272.08 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=192.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|+||.||+|. +..++..+|+|.+.... ..........+|+.+++.++||||+++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~ik~~~~~~-------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 72 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKAR-QIKTGRVVALKKILMHN-------------EKDGFPITALREIKILKKLKHPNVVPL 72 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEE-ECCCCcEEEEEEEEecc-------------CCCCcchhHHHHHHHHHhcCCCCccch
Confidence 5799999999999999999996 55678889999874321 111122345788999999999999999
Q ss_pred ccceecCC--------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040480 113 LAHMVRPD--------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 113 ~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~n 184 (325)
++.+.... ..++|++|+.+ +|...+.. ....++...+..++.|++.||.||| ++|++|+||+|+|
T Consensus 73 ~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~n 145 (311)
T cd07866 73 IDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAAN 145 (311)
T ss_pred hhheecccccccccCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence 99875443 46999999965 67776632 3446899999999999999999999 8899999999999
Q ss_pred eEecCCCCceeeccccceecCCCCcccc---------ceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCC
Q 040480 185 VLIDDDMEARISGFDLAILMPDGLTQID---------TMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKF 254 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~~~~~~~---------~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~ 254 (325)
|++++++.++|+|||++........... .....++..|+|||...+. .++.++|+||||+++|+|++|+.
T Consensus 146 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 146 ILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred EEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 9999999999999999976543221111 1123567789999987654 47899999999999999999999
Q ss_pred CCCCcccCCCcchHHHHHHHHhhhCCCCcc-----------------cchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC
Q 040480 255 PFDDFFSHTGEMDMVRWMRNVMASENPNRA-----------------IDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317 (325)
Q Consensus 255 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (325)
||..... ....+..........+... .++. ...........+.+++.+||+.||++||
T Consensus 226 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 226 ILQGKSD----IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT-LEERFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred CCCCCCH----HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCcc-HHHHcccCChhHHHHHHHHcccCcccCc
Confidence 9965222 1111111111111100000 0000 0000111224588999999999999999
Q ss_pred Chhhhhc
Q 040480 318 NSKDVRC 324 (325)
Q Consensus 318 s~~ell~ 324 (325)
|+.+++.
T Consensus 301 t~~ell~ 307 (311)
T cd07866 301 TASDALE 307 (311)
T ss_pred CHHHHhc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.54 Aligned_cols=262 Identities=25% Similarity=0.348 Sum_probs=195.3
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH 115 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 115 (325)
|++.+.||.|++|.||+|. ...+++.+|+|.+.... ........+.+|+.+++.++|||+++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~-~~~~~~~~~~K~~~~~~-------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 66 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKAR-NKKTGELVALKKIRMEN-------------EKEGFPITAIREIKLLQKLRHPNIVRLKEI 66 (287)
T ss_pred CeeeEEeccCCCeEEEEEE-ECCCCeEEEEEEEeccc-------------ccccchHHHHHHHHHHHhccCCCeeeheee
Confidence 6789999999999999995 55667899999984321 112334567889999999999999999999
Q ss_pred eecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 116 MVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 116 ~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+... +..++|+||+++ +|.+++.. ....+++..+..++.|++.||++|| +.|++|+||+|+||++++++.+
T Consensus 67 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~ 139 (287)
T cd07840 67 VTSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVL 139 (287)
T ss_pred EecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCE
Confidence 9888 889999999975 88888732 2246889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||.+......... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .......
T Consensus 140 ~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~----~~~~~~~ 214 (287)
T cd07840 140 KLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE----LEQLEKI 214 (287)
T ss_pred EEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH
Confidence 99999999876554321 1122356778999997765 3578999999999999999999999965321 1111111
Q ss_pred HHHhhhCCCC-----------------cccchhhcCCchHH-HHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPN-----------------RAIDSKLLGNGYEE-QMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... ....... ...... ++..+.+++.+||+.||.+|||++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 215 FELCGSPTDENWPGVSKLPWFENLKPKKPYKRRL-REFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHhCCCchhhccccccchhhhhccccccchhHH-HHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111110000 0000000 001111 2455899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=262.98 Aligned_cols=242 Identities=24% Similarity=0.304 Sum_probs=180.9
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHH-HHhccCCCCcccccccee
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII-TASQIRHRNILPLLAHMV 117 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~ 117 (325)
++.||.|+||.||+|. +..+++.+|+|.+.... .........+..|.. +.....|||++++++.+.
T Consensus 1 ~~~l~~g~~~~v~~a~-~~~~~~~vavK~~~~~~------------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 67 (260)
T cd05611 1 LKPISKGAFGSVYLAK-KRSTGDYFAIKVLKKSD------------MIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ 67 (260)
T ss_pred CccCCcCCCeeEEEEE-ecCCCCeEEEEEecchh------------hhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE
Confidence 3679999999999995 55678899999873211 000111122333333 344568999999999999
Q ss_pred cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeec
Q 040480 118 RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~d 197 (325)
..+..|+++||+++++|.+++. ....++...+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|
T Consensus 68 ~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 140 (260)
T cd05611 68 SKDYLYLVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTD 140 (260)
T ss_pred cCCeEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEee
Confidence 9999999999999999999983 3346888999999999999999999 88999999999999999999999999
Q ss_pred cccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhh
Q 040480 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277 (325)
Q Consensus 198 fg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
||.+...... ....++..|+|||...+..++.++|+||||+++|+|++|..||.... ..... .....
T Consensus 141 fg~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~---~~~~~ 207 (260)
T cd05611 141 FGLSRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET----PDAVF---DNILS 207 (260)
T ss_pred cccceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC----HHHHH---HHHHh
Confidence 9998754331 12357888999999988888999999999999999999999996422 11111 11111
Q ss_pred hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
..... +.. .....+..+.+++.+||+.||++|||+.
T Consensus 208 ~~~~~---~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 208 RRINW---PEE----VKEFCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred cccCC---CCc----ccccCCHHHHHHHHHHccCCHHHccCCC
Confidence 11100 000 0011233489999999999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=268.72 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=191.5
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.|...+.||+|+||+||+|+ +..++..+++|.+.... .........+..|+.+++.++|||+++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~v~ik~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 87 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFAT-NSHTNEVVAVKKMSYSG------------KQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87 (313)
T ss_pred HHhhcceeeccCCCeEEEEEE-ECCCCcEEEEEEEeccc------------cCchHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 347778899999999999995 55678899999873211 11123345678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+....|+||||+.+ ++.+.+.. ....+++..+..++.|++.++.||| ++|++|+||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~ 160 (313)
T cd06633 88 GCYLKEHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQV 160 (313)
T ss_pred EEEEeCCEEEEEEecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCE
Confidence 999999999999999965 77777632 3456888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+|+|||.+...... ....|+..|+|||.+. ...++.++|+||||+++|+|++|..||..... ..
T Consensus 161 kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~ 227 (313)
T cd06633 161 KLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS 227 (313)
T ss_pred EEeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HH
Confidence 99999988543221 1246788899999874 34578899999999999999999999865221 11
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..........+... .. .....+.+++.+||+.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~------~~---~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 228 ALYHIAQNDSPTLQ------SN---EWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHhcCCCCCC------cc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111111110 00 11223889999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=269.50 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=193.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
....|...+.||+|+||.||+|+ +..++..+++|.+.... .........+.+|+.+++.++|+|+++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~~~ik~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~i~~ 79 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSG------------KQSNEKWQDIIKEVRFLQKLRHPNTIQ 79 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEE-EcCCCcEEEEEEEeccc------------ccChHHHHHHHHHHHHHHhCCCCCccc
Confidence 44568889999999999999996 45677889999873211 111223456778999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+.+++......++|+||+.+ ++.+.+.. ....++...+..++.|++.++.+|| +.+++|+||+|+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~ 152 (308)
T cd06634 80 YRGCYLREHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPG 152 (308)
T ss_pred EEEEEEcCCeeEEEEEccCC-CHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCC
Confidence 99999999999999999974 78777632 3345888899999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||++....... ...++..|+|||.+. ...++.++||||||+++|+|++|..||.....
T Consensus 153 ~~kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------- 219 (308)
T cd06634 153 LVKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------- 219 (308)
T ss_pred cEEECCcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------
Confidence 99999999987654321 235788999999874 34578899999999999999999999865211
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+... .......+.+||.+||+.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 220 MSALYHIAQNESPALQ---------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred HHHHHHHhhcCCCCcC---------cccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 1111111111111100 0112233889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=272.30 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=189.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||.|+||.||+|. +..+++.||+|.+.... ....+.+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~-~~~~~~~v~iK~i~~~~---------------~~~~~~~~~Ei~~l~~l~h~~i~~~ 67 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAV-DSDCDKRVAVKKIVLTD---------------PQSVKHALREIKIIRRLDHDNIVKV 67 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEE-ECCCCcEEEEEEEecCC---------------CchHHHHHHHHHHHHhcCCCcchhh
Confidence 4799999999999999999995 66778999999883221 1344667889999999999999999
Q ss_pred ccceecC--------------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 113 LAHMVRP--------------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 113 ~~~~~~~--------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
++.+... ...++|+||+.+ +|.+++. ...++...+..++.|++.||.||| +.|++|+
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~ 138 (342)
T cd07854 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLSEEHARLFMYQLLRGLKYIH---SANVLHR 138 (342)
T ss_pred HhhhcccccccccccccccccceEEEEeecccc-cHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 9876544 357899999974 8888772 245888999999999999999999 8899999
Q ss_pred CCCCCceEec-CCCCceeeccccceecCCCCccc-cceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCC
Q 040480 179 DIKPANVLID-DDMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFP 255 (325)
Q Consensus 179 dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p 255 (325)
||+|+||+++ +++.++++|||.+.......... ......++..|.|||.+.+ ..++.++|+||||+++|+|++|..|
T Consensus 139 dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 218 (342)
T cd07854 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218 (342)
T ss_pred CCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999997 45678999999997654322111 1112356788999997654 4578899999999999999999999
Q ss_pred CCCcccCCCcchHHHHHHH------------------Hhh-hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCC
Q 040480 256 FDDFFSHTGEMDMVRWMRN------------------VMA-SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDER 316 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~------------------~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 316 (325)
|....... ........ ... ............ .......+.+++.+||+.||.+|
T Consensus 219 f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~R 291 (342)
T cd07854 219 FAGAHELE---QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDL----LPGVNPEALDFLEQILTFNPMDR 291 (342)
T ss_pred CCCCCHHH---HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHH----ccCCCHHHHHHHHHHhCCCchhc
Confidence 96432100 00000000 000 000000000000 01122348899999999999999
Q ss_pred CChhhhhc
Q 040480 317 PNSKDVRC 324 (325)
Q Consensus 317 ps~~ell~ 324 (325)
||++++++
T Consensus 292 ~t~~ell~ 299 (342)
T cd07854 292 LTAEEALM 299 (342)
T ss_pred cCHHHHhC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.48 Aligned_cols=267 Identities=25% Similarity=0.317 Sum_probs=194.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||.|+||.||+|. ...+++.||+|.+.... ........+.+|+.+++.++|||+++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~v~iK~~~~~~-------------~~~~~~~~~~~e~~~~~~l~h~~i~~ 70 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKAR-DKDTGELVALKKVRLDN-------------EKEGFPITAIREIKILRQLNHRNIVN 70 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEE-ECCCCcEEEEEEEeecc-------------cccCchHHHHHHHHHHHhCCCCCeee
Confidence 45789999999999999999996 45678899999874221 11223345678999999999999999
Q ss_pred cccceecCC----------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040480 112 LLAHMVRPD----------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181 (325)
Q Consensus 112 ~~~~~~~~~----------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~ 181 (325)
+++++.+.. ..++++||+++ ++.+.+.. ....+++..+..++.|++.||+||| +.|++|+||+
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~ 143 (302)
T cd07864 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIK 143 (302)
T ss_pred eeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 999887654 78999999976 77776632 2346889999999999999999999 8899999999
Q ss_pred CCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcc
Q 040480 182 PANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFF 260 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~ 260 (325)
|+||++++++.++|+|||.+........... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 144 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 144 CSNILLNNKGQIKLADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred HHHEEECCCCcEEeCcccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999976644332111 112456789999987653 46889999999999999999999996421
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchh----------------hcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSK----------------LLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+........+....+.. .........+..+.+++.+||+.||.+|||+.++++
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 223 ----ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ----hHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112122222221111111000000 000001112345899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=307.05 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=204.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.-+|.-...||.|.||.||.| .+..+|+..|+|-+... .........+.+|+.++..++|||+|++
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYta-vN~~tGellAvKEI~iq-------------~~~~k~~~~i~eEm~vlE~lnHpNlV~Y 1299 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTA-VNLDTGELLAVKEIKIQ-------------DSDHKTFKLIAEEMKVLEGLNHPNLVRY 1299 (1509)
T ss_pred eeeeccccccCCcceeeeEEe-ecCCccchhhhhhhhcC-------------ccccccCcchHHHHHHHHhccCcccccc
Confidence 347888889999999999999 68899999999987322 2224556778999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
+++-+..+..++.||||.+|+|.+.+ ..+...++.....+..|++.|++||| +.|||||||||.||+++.+|-
T Consensus 1300 yGVEvHRekv~IFMEyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~ 1372 (1509)
T KOG4645|consen 1300 YGVEVHREKVYIFMEYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGL 1372 (1509)
T ss_pred CceeecHHHHHHHHHHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCc
Confidence 99999999999999999999999999 44555777777889999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCc--cccceeecCCcccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 193 ARISGFDLAILMPDGLT--QIDTMYVVGTPRYIAPEYHQTLT---ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~--~~~~~~~~g~~~~~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+|++|||.|........ ........||+.|||||++.+.. -..++|||||||++.||+||+.||...+. .+.
T Consensus 1373 iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~a 1449 (1509)
T KOG4645|consen 1373 IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWA 1449 (1509)
T ss_pred EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhH
Confidence 99999999987765421 11122258999999999988754 34689999999999999999999987543 222
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+ +.++-.+..|. ++.+ ...+-.+++..||..||++|.++.|+++
T Consensus 1450 I---My~V~~gh~Pq--~P~~--------ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1450 I---MYHVAAGHKPQ--IPER--------LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred H---HhHHhccCCCC--Cchh--------hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2 22222222221 1111 2333789999999999999999999875
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=263.19 Aligned_cols=256 Identities=18% Similarity=0.306 Sum_probs=194.9
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|.+.+.||+|+||.||++.. ...+..+++|.+.... ...........+.+|+.+++.++||||+++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~-~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKD-KKAVAEERLKVLKEIP----------VGELNPNETVQANQEAQLLSKLDHPAIVKFHA 69 (260)
T ss_pred CceeeeeecCCCCceEEEEEe-cCCCCcceEEEecccc----------ccccCcchHHHHHHHHHHHHhCCCCcHHHHHH
Confidence 689999999999999999964 3444455555542110 01112233445677889999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++.+....++|+||+++++|.+.+.........+++..+..++.|++.||.+|| +.|++|+||+|+||+++. +.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 70 SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred HHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEe
Confidence 999999999999999999999998655455567999999999999999999999 889999999999999975 5699
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||.+.......... ....|+..|+|||...+..++.++|+||||+++|+|++|..||.... .......
T Consensus 146 l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~ 216 (260)
T cd08222 146 IGDFGVSRLLMGSCDLA--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLR 216 (260)
T ss_pred ecccCceeecCCCcccc--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHH
Confidence 99999987654332211 12457888999999888888999999999999999999999985421 1112222
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+. . ....+..+.++|.+||+.||++||++.++++
T Consensus 217 ~~~~~~~~--~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 217 IVEGPTPS--L--------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHcCCCCC--C--------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 22111111 0 1122334899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=265.43 Aligned_cols=255 Identities=21% Similarity=0.259 Sum_probs=192.6
Q ss_pred CcccccccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
+|++.+.||+|++|.||+++.. ..++..+|+|.+... ...........+..|+.++.++ .||+|++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~-----------~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~ 69 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKA-----------TIVQKAKTAEHTRTERQVLEAVRRCPFLVT 69 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehH-----------HHHhhhhHHHHHHHHHHHHHhccCCcchhh
Confidence 4889999999999999999643 235688999987311 0011123445678899999999 5899999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+......++||||+++++|.+++. ....++......++.|++.+|.+|| +.+++|+||+|+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 70 LHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEG 142 (288)
T ss_pred hheeeecCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCC
Confidence 9999999999999999999999999883 2345888889999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT--ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
.++|+|||++......... ......|+..|+|||...+.. .+.++|+||||+++|+|++|..||....... ...
T Consensus 143 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~ 218 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQS 218 (288)
T ss_pred CEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHH
Confidence 9999999998765433221 111245788999999987654 6789999999999999999999996422111 111
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhh
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (325)
...........+... .....+.+++.+||+.||++|||+.++
T Consensus 219 ~~~~~~~~~~~~~~~-----------~~~~~l~~li~~~l~~~p~~R~t~~~~ 260 (288)
T cd05583 219 EISRRILKSKPPFPK-----------TMSAEARDFIQKLLEKDPKKRLGANGA 260 (288)
T ss_pred HHHHHHHccCCCCCc-----------ccCHHHHHHHHHHhcCCHhhccCcchH
Confidence 212222221111100 011238899999999999999997655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=264.43 Aligned_cols=257 Identities=22% Similarity=0.301 Sum_probs=193.6
Q ss_pred CcccccccccCcceeEEEEEecC--CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPG--SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
+|++.+.||.|+||.||+|.... .++..+|+|.+.... ........+.+.+|+.+++++ +|++|++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~-----------~~~~~~~~~~~~~e~~~l~~l~~~~~i~~ 69 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKAT-----------IVQKAKTTEHTRTERQVLEHIRQSPFLVT 69 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhh-----------hhhcchHHHHHHHHHHHHHhcccCCChhc
Confidence 48899999999999999996432 367889999873110 111223456678899999999 5899999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++.+..+...++|+||+++++|.+++.. ...++...+..++.|++.||.+|| +.|++|+||+|+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 70 LHYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 142 (290)
T ss_pred eeeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCC
Confidence 99999998999999999999999999843 345788888999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
.++|+|||++......... ......|+..|+|||...+. .++.++|+||||+++|+|++|..||...... ....
T Consensus 143 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~ 218 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQA 218 (290)
T ss_pred CEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHH
Confidence 9999999998765432211 11124678899999988753 4678999999999999999999999642211 1122
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
...........+. +. .....+.+++.+||+.||.+|| ++++++.
T Consensus 219 ~~~~~~~~~~~~~---~~--------~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 219 EISRRILKSEPPY---PQ--------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHhhccCCCC---Cc--------cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 2222222211111 10 0122388999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=254.47 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=199.1
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 118 (325)
+.||.|+++.|-.+ ..-.++..+|||++. ....-.+.++.+|++++.+.+ |+||++++++|.+
T Consensus 84 e~LGeGAyasVqtc-v~i~t~~EYAVKiid---------------Kq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 84 ELLGEGAYASVQTC-VSIQTGKEYAVKIID---------------KQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred HHhcCccceeeeee-eeeccchhhhhhhhh---------------cCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 47999999999988 567789999999882 223345678899999999996 9999999999999
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC---cee
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME---ARI 195 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~---~~l 195 (325)
+..+|+|||-+.||+|...| .....+++.++.++..+++.||.+|| .+||.|||+||+|||...... +||
T Consensus 148 d~~FYLVfEKm~GGplLshI----~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHI----QKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHH----HHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceee
Confidence 99999999999999999999 45667999999999999999999999 999999999999999976544 699
Q ss_pred eccccceec--CCCCc---cccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCc-----c
Q 040480 196 SGFDLAILM--PDGLT---QIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDDF-----F 260 (325)
Q Consensus 196 ~dfg~~~~~--~~~~~---~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~-----~ 260 (325)
+||.+..-. ..... .......+|+..|||||+.. ...|+.++|+||||+++|-|++|.+||.+. .
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 999887532 22111 11222358899999999754 234788999999999999999999999653 1
Q ss_pred cCCCc---chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGE---MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+. .........++.+.... + ...+.....+..+|++.+|..|+..|.++.++++
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeF---P----dkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEF---P----DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcC---C----hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11222 22333444444444332 2 2234445556889999999999999999998875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=274.37 Aligned_cols=269 Identities=23% Similarity=0.345 Sum_probs=212.9
Q ss_pred CCCCceeeccccchhHHHHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcch
Q 040480 11 RDRGLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK 90 (325)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~ 90 (325)
+++-+.-.+|..|.=+ +.+ .+-...++||-|-||.||.|.|. .-.-.||||.+ ....+.
T Consensus 248 nKptvygvSPn~DkWE---meR-tdItMkhKLGGGQYGeVYeGvWK-kyslTvAVKtL----------------KEDtMe 306 (1157)
T KOG4278|consen 248 NKPTVYGVSPNADKWE---MER-TDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTL----------------KEDTME 306 (1157)
T ss_pred CCCceeeecCCcchhh---ccc-hheeeeeccCCCcccceeeeeee-ccceeeehhhh----------------hhcchh
Confidence 3444666677664322 222 34567889999999999999764 33457999987 234467
Q ss_pred HHHHHHHHHHHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc
Q 040480 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH 170 (325)
Q Consensus 91 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~ 170 (325)
.++|..|..+|+.++|||+|+++++|..+..+|||+|||..|+|.+++.... +..++....+.++.||..|++||.
T Consensus 307 veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLE-- 382 (1157)
T KOG4278|consen 307 VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLE-- 382 (1157)
T ss_pred HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHH--
Confidence 8899999999999999999999999999999999999999999999997643 355788888999999999999999
Q ss_pred CCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHH
Q 040480 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLV 250 (325)
Q Consensus 171 ~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (325)
.++.|||||..+|.|+.++..||++|||+++.+.......... .--+..|.|||-+....++.++|||+||+++|++.
T Consensus 383 -kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIA 460 (1157)
T KOG4278|consen 383 -KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIA 460 (1157)
T ss_pred -HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHH
Confidence 8899999999999999999999999999999876543322211 12256799999999999999999999999999999
Q ss_pred h-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 251 M-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 251 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
| |-.||.+. .-.+++..+....+-..+. .++..+.+||..||+++|.+||++.|+-
T Consensus 461 TYGMsPYPGi----dlSqVY~LLEkgyRM~~Pe-------------GCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 461 TYGMSPYPGI----DLSQVYGLLEKGYRMDGPE-------------GCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred hcCCCCCCCc----cHHHHHHHHhccccccCCC-------------CCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 8 88898762 2234444444333333322 2333388999999999999999999874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=271.67 Aligned_cols=264 Identities=26% Similarity=0.320 Sum_probs=197.7
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
+|++.+.||.|++|.||+|+ +..++..+|+|.+.... ........+.+|+.+++.++||||+++.+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~-~~~~~~~~~iK~~~~~~-------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAV-DKRTGRKVAIKKISNVF-------------DDLIDAKRILREIKLLRHLRHENIIGLLD 66 (330)
T ss_pred CceeeeeecCCCCeEEEEEE-eCCCCcEEEEEeecccc-------------ccchhhhhHHHHHHHHHhcCCcchhhhhh
Confidence 68999999999999999996 55668899999873211 11234567888999999999999999999
Q ss_pred ceecCC-----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 115 HMVRPD-----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 115 ~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++.... ..|++++|+.+ +|.+.+. ....+++..+..++.+++.||.+|| +.|++|+||+|+||+++.
T Consensus 67 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~ 138 (330)
T cd07834 67 ILRPPSPEDFNDVYIVTELMET-DLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNS 138 (330)
T ss_pred hhcccCcccccceEEEecchhh-hHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence 988775 78999999975 8888873 3347899999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCcc-ccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .+
T Consensus 139 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~----~~ 214 (330)
T cd07834 139 NCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY----ID 214 (330)
T ss_pred CCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH----HH
Confidence 999999999999876554310 111123568889999999887 789999999999999999999999965321 11
Q ss_pred HHHHHHHHhhhCCCCccc--c---------------hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAI--D---------------SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~--~---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+............. . ...........+..+.+++.+||+.||.+|||++++++
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 215 QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111111111110000000 0 00000011123445899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=261.95 Aligned_cols=248 Identities=26% Similarity=0.293 Sum_probs=183.1
Q ss_pred ccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCC
Q 040480 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPD 120 (325)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 120 (325)
.||+|+||.||+|. +..+++.||+|.+......... .............+++...||+|+.+++.+...+
T Consensus 1 ~ig~g~~g~Vy~~~-~~~~~~~vaiK~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 70 (278)
T cd05606 1 IIGRGGFGEVYGCR-KADTGKMYAMKCLDKKRIKMKQ---------GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 70 (278)
T ss_pred CcccCCCeEEEEEE-EecCCCEEEEEEeeccccccch---------hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 48999999999995 5567889999987422111000 0001111122334455567999999999999999
Q ss_pred ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecccc
Q 040480 121 SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200 (325)
Q Consensus 121 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~ 200 (325)
..++|+||+.|++|.+++. ....+++..+..++.|++.|+.||| +++++|+||+|+||+++.++.++|+|||.
T Consensus 71 ~~~~v~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~ 143 (278)
T cd05606 71 KLSFILDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 143 (278)
T ss_pred EEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcC
Confidence 9999999999999998883 3456899999999999999999999 88999999999999999999999999999
Q ss_pred ceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhC
Q 040480 201 AILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASE 279 (325)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 279 (325)
+........ ....|+..|+|||.+.+. .++.++|+||+|+++|+|++|..||...... .. ........ ..
T Consensus 144 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-~~---~~~~~~~~-~~ 214 (278)
T cd05606 144 ACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DK---HEIDRMTL-TM 214 (278)
T ss_pred ccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-ch---HHHHHHhh-cc
Confidence 875533221 124688999999998744 5889999999999999999999999753221 11 11111111 11
Q ss_pred CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 280 NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
.. ..+. ..+..+.+++.+||..||.+|| ++.++++
T Consensus 215 ~~--~~~~--------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 AV--ELPD--------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC--CCCC--------cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 1110 1123389999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=262.52 Aligned_cols=263 Identities=25% Similarity=0.337 Sum_probs=191.5
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc---CCCCcccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI---RHRNILPL 112 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~ 112 (325)
|++.+.||+|+||.||+|++ ..++..+|+|.+..... .......+.+|+.+++++ .|||++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~-~~~~~~~aiK~~~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~ 66 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARD-LNTGRFVALKKVRVPLS-------------EEGIPLSTLREIALLKQLESFEHPNIVRL 66 (287)
T ss_pred CeEEEEecccCceEEEEEEE-CCCCCEEEEEEeccccc-------------cchhhhhHHHHHHHHHHhhccCCCCcceE
Confidence 67889999999999999975 45688999999843221 111223444566665554 69999999
Q ss_pred ccceecCCc-----eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 113 LAHMVRPDS-----HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 113 ~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
++.+...+. .++++||+++ +|.+++... ....+++..+..++.|++.||.+|| +.+++|+||+|+||++
T Consensus 67 ~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili 140 (287)
T cd07838 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILV 140 (287)
T ss_pred EEEEeeccCCCCceeEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEE
Confidence 999988776 8999999975 898887432 2235889999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+.++.++|+|||.+........... ..++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ..
T Consensus 141 ~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~ 214 (287)
T cd07838 141 TSDGQVKIADFGLARIYSFEMALTS---VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQ 214 (287)
T ss_pred ccCCCEEEeccCcceeccCCccccc---ccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HH
Confidence 9999999999999987654332211 34678899999999888999999999999999999999998753221 11
Q ss_pred HHHHHHHHhhhCC---C-C--------cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASEN---P-N--------RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~---~-~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............. + . ..................+.+++.+||+.||.+||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 215 LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1111111000000 0 0 000000001112233455889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=263.72 Aligned_cols=259 Identities=18% Similarity=0.258 Sum_probs=201.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--CC---
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR--HR--- 107 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~--- 107 (325)
.++|.+++.+|+|.||.|-.+ ++..++..||||++. . .....+..+.|++++.++. .|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec-~D~~~~~~vAlKIik------------~----V~kYreAa~iEi~vLqki~~~DP~g~ 150 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVEC-WDRETKEHVALKIIK------------N----VDKYREAALIEIEVLQKINESDPNGK 150 (415)
T ss_pred ccceehhhhhcCCcccceEEE-eecCCCceehHHHHH------------H----HHHHhhHHHHHHHHHHHHHhcCCCCc
Confidence 679999999999999999999 777779999999872 1 2245567788899999983 23
Q ss_pred -CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 108 -NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 108 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
-++++.+++...++.|+|+|.+ |.++.+++.. +.-.+++...+..+..|+++++++|| +.+++|.||||+||+
T Consensus 151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENIL 224 (415)
T KOG0671|consen 151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENIL 224 (415)
T ss_pred eEEEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEE
Confidence 4678888899999999999988 6699999943 45567889999999999999999999 889999999999999
Q ss_pred ecC--------------------CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHH
Q 040480 187 IDD--------------------DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL 246 (325)
Q Consensus 187 ~~~--------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il 246 (325)
+.. +..++|+|||.++.-.... ...+.|..|.|||++.+-+++.++||||+|||+
T Consensus 225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL 299 (415)
T ss_pred EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence 842 3458999999998765543 234678899999999999999999999999999
Q ss_pred HHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCccc---------------------------------chhhcCCc
Q 040480 247 AVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAI---------------------------------DSKLLGNG 293 (325)
Q Consensus 247 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~ 293 (325)
.|+.+|..-|.... +.+....+.++.. +.|..-+ +....-..
T Consensus 300 ~ElytG~~LFqtHe----n~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~ 374 (415)
T KOG0671|consen 300 VELYTGETLFQTHE----NLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ 374 (415)
T ss_pred EEeeccceecccCC----cHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc
Confidence 99999999997532 2222233333332 1111000 00011112
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 294 YEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 294 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.+...|+||+.+||.+||.+|+|+.|+|+
T Consensus 375 ~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 375 DDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred CcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 3455556999999999999999999999985
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=271.21 Aligned_cols=277 Identities=25% Similarity=0.263 Sum_probs=195.1
Q ss_pred hcCccc-ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhC-cchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFAS-LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELG-EGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~-~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|.. .+.||.|+||+||+|. +..+++.||+|.+............ ..... ......+.+|+.+++.++||||+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~-~~~~~~~vaiK~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAY-DTLTGKIVAIKKVKIIEISNDVTKD--RQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEE-ECCCCCeEEEEEeeccccccccccc--hhhhcccccchhHHHHHHHHHhCCCccee
Confidence 467765 5779999999999995 5567889999987432211100000 00000 01122577899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..+++|||+.+ +|.+++. ....++......++.|++.||.+|| +.|++|+||+|+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMAS-DLKKVVD----RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSK 155 (335)
T ss_pred eeeEEEecCCcEEEEEecccc-CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCC
Confidence 999999999999999999974 8988883 3456889999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCc------------cccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 040480 191 MEARISGFDLAILMPDGLT------------QIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~------------~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
+.++|+|||.+........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999976552110 0111113457789999988764 36889999999999999999999997
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcc--------------cchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRA--------------IDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
.... ......+...........+ ..+.............+.+++.+||+.||++|||+++++
T Consensus 236 ~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 236 GENE----IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCH----HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 5321 1111111111111110000 000000001112234588999999999999999999998
Q ss_pred c
Q 040480 324 C 324 (325)
Q Consensus 324 ~ 324 (325)
.
T Consensus 312 ~ 312 (335)
T PTZ00024 312 K 312 (335)
T ss_pred c
Confidence 5
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=263.73 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=189.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
.-++|++.+.||+|+||.||+|.+ ..+++.+|+|.+.... .......+..|+.++... .||||+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~avK~~~~~~--------------~~~~~~~~~~e~~~~~~~~~~~~i~ 77 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRF-KKTGHVMAVKQMRRTG--------------NKEENKRILMDLDVVLKSHDCPYIV 77 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEE-CCCCeEEEEEEEeccC--------------ChHHHHHHHHHHHHHHhccCCCchH
Confidence 457899999999999999999964 4568899999983211 112233455566555555 499999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEecC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANVLIDD 189 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~nil~~~ 189 (325)
++++++......|++|||+.+ ++.+.+.. ....+++..+..++.|++.++.||| + .|++|+||+|+||++++
T Consensus 78 ~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~ 150 (296)
T cd06618 78 KCYGYFITDSDVFICMELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDA 150 (296)
T ss_pred hhheeeecCCeEEEEeeccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcC
Confidence 999999999999999999854 77777643 2346888889999999999999999 5 48999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT----ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
++.++|+|||.+........... ..++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... .
T Consensus 151 ~~~~kL~dfg~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~ 224 (296)
T cd06618 151 SGNVKLCDFGISGRLVDSKAKTR---SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---E 224 (296)
T ss_pred CCCEEECccccchhccCCCcccC---CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---H
Confidence 99999999999876543222211 35677899999987654 78899999999999999999999964211 1
Q ss_pred chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+..... . .....+.+|+.+||+.||.+|||+.++++
T Consensus 225 ---~~~~~~~~~~~~~~~~~~-----~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 225 ---FEVLTKILQEEPPSLPPN-----E---GFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred ---HHHHHHHhcCCCCCCCCC-----C---CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111222222211111100 0 12234899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=255.12 Aligned_cols=274 Identities=23% Similarity=0.299 Sum_probs=206.0
Q ss_pred HHHHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC
Q 040480 26 DLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR 105 (325)
Q Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 105 (325)
.-.+....+.|+-..++|+|.||.||+|+ ...+++.||+|++ .+....+..-....+|+.++..++
T Consensus 9 ~~P~~~~~~~yek~~kigqGtfgeVFkAr-~~n~~kkvalkkv-------------lmeneKeGfpitalreikiL~~lk 74 (376)
T KOG0669|consen 9 YEPFCDEVSKYEKLAKIGQGTFGEVFKAR-SKNTGKKVALKKV-------------LMENEKEGFPITALREIKILQLLK 74 (376)
T ss_pred cCCceecchHHHHHHhcCCchHHHHHHHh-hcCccchhHHHHH-------------HHhccccCCcHHHHHHHHHHHHhc
Confidence 33456677899999999999999999996 5567778999875 223334455667889999999999
Q ss_pred CCCccccccceec--------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 040480 106 HRNILPLLAHMVR--------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIH 177 (325)
Q Consensus 106 h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH 177 (325)
|+|++.+++.|.. ...+|+||.+|+. +|.-.+. .....++..++.+++.++..||+|+| ...|+|
T Consensus 75 Henv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilH 147 (376)
T KOG0669|consen 75 HENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILH 147 (376)
T ss_pred chhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHH---HhhHHh
Confidence 9999999998853 2347999999977 8888883 23467999999999999999999999 889999
Q ss_pred cCCCCCceEecCCCCceeeccccceecCCCCc--cccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCC
Q 040480 178 RDIKPANVLIDDDMEARISGFDLAILMPDGLT--QIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKF 254 (325)
Q Consensus 178 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~ 254 (325)
||+|+.|++++.++.++|+|||+++.+..... ..+.++.+-|.+|.+||.+.|. .|+++.|+|+-||++.+|+++.+
T Consensus 148 RDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 148 RDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred hcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 99999999999999999999999987654332 2333445668999999988876 48999999999999999999999
Q ss_pred CCCCcccCCCcchHHHHHHHHhhhCCCCcccchh------------hcCCc---hHHHHH------HHHHHHhhhcCCCC
Q 040480 255 PFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSK------------LLGNG---YEEQML------LVLKLACFCTLADP 313 (325)
Q Consensus 255 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~---~~~~~~------~l~~li~~~l~~dP 313 (325)
.+.+.. .......+......-.++.|...+ +.... ..+..+ ...+|+.++|..||
T Consensus 228 imqgnt----eqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP 303 (376)
T KOG0669|consen 228 IMQGNT----EQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDP 303 (376)
T ss_pred cccCCh----HHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCc
Confidence 886522 122222333332222211111100 00000 111111 47899999999999
Q ss_pred CCCCChhhhhc
Q 040480 314 DERPNSKDVRC 324 (325)
Q Consensus 314 ~~Rps~~ell~ 324 (325)
.+||++++++.
T Consensus 304 ~kR~~ad~aln 314 (376)
T KOG0669|consen 304 TKRIDADQALN 314 (376)
T ss_pred ccCcchHhhhc
Confidence 99999999874
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=268.35 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=192.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
.+++|++.+.||.|+||.||+|. +..+++.+|+|.+... .........+..|+.+++.++||||++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpniv~ 73 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSAR-DQLTGQNVAIKKIMKP-------------FSTPVLAKRTYRELKLLKHLRHENIIS 73 (328)
T ss_pred cccceEEEEeecccCCeEEEEEE-ECCCCCEEEEEEeccc-------------ccccchhHHHHHHHHHHHhcCCCCeee
Confidence 56789999999999999999995 6678899999987321 111233456778999999999999999
Q ss_pred cccceec-CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 112 LLAHMVR-PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 112 ~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
+.+++.. ....++++||+ +++|.+++. ...++......++.|++.||.+|| +++++|+||+|+||+++++
T Consensus 74 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 74 LSDIFISPLEDIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINEN 144 (328)
T ss_pred EeeeEecCCCcEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCC
Confidence 9998865 55789999998 558888772 345788888899999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.
T Consensus 145 ~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~ 219 (328)
T cd07856 145 CDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT 219 (328)
T ss_pred CCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999987543221 12356778999998765 568899999999999999999999996532100000000
Q ss_pred HH--------HHHHhhh--------CCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RW--------MRNVMAS--------ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~--------~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+. ....... .......+.. .........+.++|.+||+.+|++|||+++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFS---EKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHH---HHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000000 0000000000 000112344899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=269.44 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=192.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|.+.+.||+|+||.||+|. +..++..||+|.+... .........+.+|+.+++.++||||++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~ 78 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSAL-DRRTGAKVAIKKLYRP-------------FQSELFAKRAYRELRLLKHMKHENVIG 78 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEE-ECCCCcEEEEEEeccc-------------ccchHHHHHHHHHHHHHHhcCCCCccc
Confidence 35789999999999999999995 5667899999987311 011223456788999999999999999
Q ss_pred cccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++.+.... ..++|+||+ +++|.+++. ...+++..+..++.|++.||.||| +.|++|+||+|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Ni 149 (343)
T cd07880 79 LLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNL 149 (343)
T ss_pred eeeeecCCccccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHE
Confidence 999887554 358999998 669988872 346889999999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+++.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.....
T Consensus 150 ll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--- 221 (343)
T cd07880 150 AVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--- 221 (343)
T ss_pred EEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 99999999999999987554321 12356888999998775 3578899999999999999999999965321
Q ss_pred cchHHHHHHHHhhhCCC-Ccc-------------------cchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENP-NRA-------------------IDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~-~~~-------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... .......... ... ................+.+++.+||+.||.+|||+.++++
T Consensus 222 -~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 222 -LDQ---LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred -HHH---HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000000000 000 0000000011122334889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=262.44 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=191.1
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPLLA 114 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 114 (325)
|.+.+.||.|++|+||+|+ ...+++.+++|.+.... .........+|+..++.+. |||++++++
T Consensus 1 y~~~~~ig~g~~g~v~~~~-~~~~~~~~~ik~~~~~~--------------~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 65 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLAR-NKETGELVAIKKMKKKF--------------YSWEECMNLREVKSLRKLNEHPNIVKLKE 65 (283)
T ss_pred CeeheeeccCCceEEEEEE-ECCCCcEEEEEEehhhc--------------cchhHHHHHHHHHHHHhccCCCCchhHHH
Confidence 6789999999999999996 45567889999873211 1111223456788888998 999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.+..++..++||||+ +++|.+.+... ....+++..+..++.|++.+|.||| +++++|+||+|+||+++.++.++
T Consensus 66 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~ 139 (283)
T cd07830 66 VFRENDELYFVFEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVK 139 (283)
T ss_pred HhhcCCcEEEEEecC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEE
Confidence 999999999999999 67998888432 2246889999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|+|||.+.......... ...++..|+|||.+. +..++.++|+||||+++++|++|..||..... .+......
T Consensus 140 l~d~~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~----~~~~~~~~ 212 (283)
T cd07830 140 IADFGLAREIRSRPPYT---DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE----IDQLYKIC 212 (283)
T ss_pred EeecccceeccCCCCcC---CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh----HHHHHHHH
Confidence 99999997654432211 135788899999774 44578999999999999999999999965321 11111111
Q ss_pred HHhhhCCC-------------Ccc---cchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENP-------------NRA---IDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~-------------~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ ... ................+.+++.+||+.||++|||++|++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 213 SVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 10000000 000 0000000001112345899999999999999999999985
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=270.78 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=192.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||.|++|.||+|. +..++..+|+|.+... .........+.+|+.+++.+.|||+++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~-~~~~~~~~aiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~ 78 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAF-DTKTGRKVAIKKLSRP-------------FQSAIHAKRTYRELRLLKHMDHENVIG 78 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEE-ECCCCcEEEEEecccc-------------cchhhHHHHHHHHHHHHHhccCCCHHH
Confidence 35789999999999999999996 5567889999987321 011123455678999999999999999
Q ss_pred cccceecCCc------eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRPDS------HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+.+++..... .++|+||+ +++|.+++. ...+++..+..++.|++.||.+|| +.|++|+||+|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Ni 149 (343)
T cd07851 79 LLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNI 149 (343)
T ss_pred HHHHhhccccccccccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHe
Confidence 9998866554 89999998 569998883 246899999999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+++.++.++|+|||.+....... ....++..|+|||...+ ..++.++|+||||+++|+|++|+.||.....
T Consensus 150 ll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--- 221 (343)
T cd07851 150 AVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--- 221 (343)
T ss_pred EECCCCCEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---
Confidence 99999999999999997654321 12356788999998765 3578899999999999999999999964221
Q ss_pred cchHHHHHHHHhhhCCCCcccchhh-------------------cCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKL-------------------LGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+..... .+...+.... ...........+.+++.+||+.||.+|||+.++++
T Consensus 222 -~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 222 -IDQLKRIMNLVG--TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred -HHHHHHHHHhcC--CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 111111111110 0000000000 00000112345899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=255.36 Aligned_cols=243 Identities=25% Similarity=0.313 Sum_probs=191.7
Q ss_pred cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCc
Q 040480 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS 121 (325)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 121 (325)
||.|+||.||++.. ..+++.+++|.+... ..........+..|+.++++++|||++++++.+.....
T Consensus 1 lg~G~~~~v~~~~~-~~~~~~~~~k~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 67 (250)
T cd05123 1 LGKGSFGKVLLVRK-KDTGKLYAMKVLKKK------------KIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEK 67 (250)
T ss_pred CCCCCceEEEEEEE-CCCCcEEEEEEeehh------------hhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCe
Confidence 69999999999964 456789999987321 11222345678889999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 122 HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
.+++|||+++++|.+++. ....++......++.|++.++.++| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 68 ~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~ 140 (250)
T cd05123 68 LYLVLEYAPGGELFSHLS----KEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLA 140 (250)
T ss_pred eEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcc
Confidence 999999999999999983 3346889999999999999999999 789999999999999999999999999999
Q ss_pred eecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCC
Q 040480 202 ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENP 281 (325)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
........ ......++..|.|||...+...+.++|+||||+++|++++|..||..... .............
T Consensus 141 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~ 211 (250)
T cd05123 141 KELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDPLR 211 (250)
T ss_pred eecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCCC
Confidence 87654321 11224678899999999888889999999999999999999999964221 1111222211111
Q ss_pred CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh---hhhhc
Q 040480 282 NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS---KDVRC 324 (325)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~ 324 (325)
.+.. .+..+.+++.+||..||++|||+ ++++.
T Consensus 212 ---~~~~--------~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 212 ---FPEF--------LSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred ---CCCC--------CCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 1111 02238899999999999999999 77764
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=277.71 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=198.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
+..|...+.||+|+||.||+++ +..+|+.||||.+.. .. ....++...+|++++++++|||||++
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgr-nketG~~vAvK~~~~------------~~--~~r~~e~~~~EieilkKLnh~NIVk~ 76 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGR-NKETGRLVAVKTFNK------------ES--SLRPRERWCREIEILKKLNHPNIVKL 76 (732)
T ss_pred CcceeehhhhcCCccceeeeec-ccccccchhHHhhhh------------hc--ccchHHHHHHHHHHHHHcCchhhhhh
Confidence 3567888899999999999995 678999999998721 11 23457789999999999999999999
Q ss_pred ccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
+++-.... ...+|||||.||+|...+++-.+ ...+++...+.++.++..|+.||| ..||+||||||.||+
T Consensus 77 f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIv 152 (732)
T KOG4250|consen 77 FDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIV 152 (732)
T ss_pred cccCCccccCcccccceEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEE
Confidence 99766544 46899999999999999965433 345899999999999999999999 789999999999999
Q ss_pred ec--CCCC--ceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 187 ID--DDME--ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 187 ~~--~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
+. ++|. -||+|||.|+....+..... ..||..|++||.... ..|+..+|.|||||++|++.||..||.....
T Consensus 153 l~~Gedgq~IyKLtDfG~Arel~d~s~~~S---~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 153 LQIGEDGQSIYKLTDFGAARELDDNSLFTS---LVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred EeecCCCceEEeeecccccccCCCCCeeee---ecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 95 3343 49999999999887764333 699999999999884 7899999999999999999999999976554
Q ss_pred CCCcchHHHHHHHHhhhCCCC------------cccchhh--cCCchHHHHHHHHHHHhhhcCCCCCCCC
Q 040480 262 HTGEMDMVRWMRNVMASENPN------------RAIDSKL--LGNGYEEQMLLVLKLACFCTLADPDERP 317 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (325)
..... +.+.+....+... ..+...+ ...-.......+-.++..+|..||++|-
T Consensus 230 pk~~~---~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 230 PKNNK---EIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ccccc---hhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 33222 2222222111110 0000000 1111234444577888889999999987
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=267.53 Aligned_cols=263 Identities=24% Similarity=0.340 Sum_probs=191.1
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
....++|++.+.||+|+||.||+|. +..+++.||+|.+... .........+.+|+.++++++||||
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~Ei~~l~~l~h~~i 78 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAF-DTKTGLRVAVKKLSRP-------------FQSIIHAKRTYRELRLLKHMKHENV 78 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEE-EcCCCeEEEEEEecCc-------------chhhHHHHHHHHHHHHHHHcCCCcc
Confidence 3356899999999999999999995 5567889999987321 0111224467789999999999999
Q ss_pred cccccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 110 LPLLAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 110 ~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+++++++... ...+++++++ +++|.+.+. ...+++..+..++.|++.||.||| ++|++|+||+|+
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~ 149 (345)
T cd07877 79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPS 149 (345)
T ss_pred cceeeeeeecccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChH
Confidence 9999887543 3467888877 679988772 235888999999999999999999 889999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSH 262 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~ 262 (325)
||++++++.++|+|||++....... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.....
T Consensus 150 NIll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~- 223 (345)
T cd07877 150 NLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH- 223 (345)
T ss_pred HEEEcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 9999999999999999987543221 12467888999998766 4678899999999999999999999964221
Q ss_pred CCcchHHHHHHHHhhhCCCC-----------------cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 263 TGEMDMVRWMRNVMASENPN-----------------RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...............+. ...+..............+.++|.+||+.||.+|||+.++++
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 224 ---IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred ---HHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 11111110000000000 000000000000112334889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=263.13 Aligned_cols=261 Identities=23% Similarity=0.282 Sum_probs=188.2
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH 115 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 115 (325)
|.+.+.+|.|+++.|+++. .+++.+|+|++... .........+.+|+.+++.++||||+++++.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~---~~~~~~avK~~~~~-------------~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~ 67 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHK---PTNTLVAVKKINLD-------------SCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67 (314)
T ss_pred hhhhHhhcCCceEEEEEec---CCCCEEEEEEEecc-------------ccchhHHHHHHHHHHHHHhcCCcchhhhhhe
Confidence 3444555555555555443 37899999998321 1223456779999999999999999999999
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCcee
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l 195 (325)
+...+..+++|||+++++|.+++... ....++......++.|++.||.||| +++|+|+||+|+||+++.++.+++
T Consensus 68 ~~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl 142 (314)
T cd08216 68 FIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVL 142 (314)
T ss_pred eecCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEE
Confidence 99999999999999999999998542 2345788888999999999999999 889999999999999999999999
Q ss_pred eccccceecCCCCcc-----ccceeecCCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 196 SGFDLAILMPDGLTQ-----IDTMYVVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 196 ~dfg~~~~~~~~~~~-----~~~~~~~g~~~~~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
+||+.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .
T Consensus 143 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~------~ 216 (314)
T cd08216 143 SGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA------T 216 (314)
T ss_pred ecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH------H
Confidence 999988755322111 111223466789999998663 578899999999999999999999975321 0
Q ss_pred HHHHHHHhhhCCCC---------c--------------ccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPN---------R--------------AIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~---------~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ ..... . .................+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 217 QMLLEKVR-GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHHHHHHh-ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 11111110 00000 0 00000000111223345889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=262.43 Aligned_cols=262 Identities=26% Similarity=0.333 Sum_probs=195.1
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH 115 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 115 (325)
|++.+.||.|++|.||+|+ ...+++.+|+|.+.... ........+..|+.+++.++|+|+++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~-~~~~~~~~~iK~~~~~~-------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 66 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKAR-DKKTGEIVALKKIRLDN-------------EEEGIPSTALREISLLKELKHPNIVKLLDV 66 (282)
T ss_pred CeeehcccccCcceEEEee-ecCCCcEEEEEEecccc-------------ccccccHHHHHHHHHHHhcCCCCHHHHHhh
Confidence 6778999999999999996 45668899999884221 122334567789999999999999999999
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCcee
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l 195 (325)
+...+..++|+||+.+ +|.+++... ...++...+..++.|++.+|++|| ++|++|+||+|+||++++++.++|
T Consensus 67 ~~~~~~~~~v~e~~~~-~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l 139 (282)
T cd07829 67 IHTERKLYLVFEYCDM-DLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKL 139 (282)
T ss_pred hhcCCceEEEecCcCc-CHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEE
Confidence 9999999999999975 899998432 246889999999999999999999 889999999999999999999999
Q ss_pred eccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 196 SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 196 ~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
+|||.+.......... ....++..|+|||.+.+. .++.++|+||||+++|++++|..||..... .+....+..
T Consensus 140 ~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~ 213 (282)
T cd07829 140 ADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE----IDQLFKIFQ 213 (282)
T ss_pred ecCCcccccCCCcccc--CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHH
Confidence 9999987654432211 113456789999988766 788999999999999999999999965221 111111111
Q ss_pred HhhhCCCC---------------cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPN---------------RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ ..................+.+++.+||..||++||++++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 10000000 000000000111112345999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=267.75 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=188.5
Q ss_pred CcccccccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
+|++.+.||+|+||.||++.. ..+ +..+|+|.+... .........+.+|+.+++.+ +||||++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~-~~~~~~~~~aiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 66 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARN-AETSEEETVAIKKITNV-------------FSKKILAKRALRELKLLRHFRGHKNITC 66 (332)
T ss_pred CceEEEEccccCCeEEEEEEe-CCCCcCceEEEEEeccc-------------cccchhHHHHHHHHHHHHHhcCCCChhe
Confidence 588999999999999999965 344 778999987311 01112345677889999988 5999999
Q ss_pred cccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 112 LLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 112 ~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+++.... ....+++++++. ++|.+.+. ....++...+..++.|++.||.||| ++|++|+||+|+||++
T Consensus 67 ~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili 138 (332)
T cd07857 67 LYDMDIVFPGNFNELYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLV 138 (332)
T ss_pred eeeeeeeccccCCcEEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEE
Confidence 9986432 245788899885 58988883 4456889999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCcc--ccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+.++.++|+|||.+......... .......|+..|+|||...+ ..++.++|+||||+++|+|++|..||.....
T Consensus 139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~--- 215 (332)
T cd07857 139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--- 215 (332)
T ss_pred cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---
Confidence 99999999999999865432221 11122467889999998765 4678999999999999999999999965321
Q ss_pred cchHHHHHHHHhhhCCC-----------------CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENP-----------------NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............+.. ....+..............+.+++.+||+.||.+|||+.+++.
T Consensus 216 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 216 -VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred -HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111100000000000 0000000000011112334889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=269.91 Aligned_cols=259 Identities=25% Similarity=0.334 Sum_probs=189.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|.+.+.||+|+||.||+|. +..+++.+|+|.+... .........+.+|+.+++.+.||||+++
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~niv~~ 79 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAI-DKRTGEKVAIKKLSRP-------------FQSEIFAKRAYRELTLLKHMQHENVIGL 79 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEE-eCCCCcEEEEEEecCc-------------cccccchhHHHHHHHHHHhcCCCCccch
Confidence 4689999999999999999995 4567889999987321 1112234567889999999999999999
Q ss_pred ccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++.... ..++|+||+.. +|.... ...++...+..++.|++.||.||| +++++|+||+|+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIl 149 (342)
T cd07879 80 LDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLA 149 (342)
T ss_pred hheecccccCCCCceEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEE
Confidence 99886543 45899999864 776654 235888899999999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
++.++.++|+|||++....... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.....
T Consensus 150 l~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---- 220 (342)
T cd07879 150 VNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---- 220 (342)
T ss_pred ECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 9999999999999987543221 12356788999998766 4578899999999999999999999965221
Q ss_pred chHHHHHHHHhhhCCC-----------------CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENP-----------------NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...............+ ...................+.+++.+||+.||.+|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111111110000000 0000000000001122334889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.19 Aligned_cols=257 Identities=29% Similarity=0.464 Sum_probs=195.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
....|...+.||+|+||.||+|+ ...++..||+|.+.... . ....|+..+++++||||++
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~~vavK~~~~~~---------------~----~~~~~~~~l~~l~HpnIv~ 747 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGK-SIKNGMQFVVKEINDVN---------------S----IPSSEIADMGKLQHPNIVK 747 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEE-ECCCCcEEEEEEccCCc---------------c----ccHHHHHHHhhCCCCCcce
Confidence 34567788899999999999996 44578899999873110 0 1123467888999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..++||||+++++|.+++. .+++..+..++.|++.|++|||..++.+++|||+||+||+++.++
T Consensus 748 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~ 820 (968)
T PLN00113 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820 (968)
T ss_pred EEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC
Confidence 9999999999999999999999999983 278889999999999999999966677999999999999999888
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
..++. ++........ ....++..|+|||+..+..++.++||||||+++|||++|+.||..... .......|
T Consensus 821 ~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~ 891 (968)
T PLN00113 821 EPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEW 891 (968)
T ss_pred ceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHH
Confidence 77765 5544322211 113568899999999998999999999999999999999999954322 23345555
Q ss_pred HHHHhhhCCCCcccchhhcC--CchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLG--NGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+............++.... .....+...+.+++.+||+.||++|||++|+++
T Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred HHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 54433222222222222211 122345556889999999999999999999986
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=271.95 Aligned_cols=249 Identities=21% Similarity=0.328 Sum_probs=197.2
Q ss_pred ccccccccCcceeEEEEEecCC-CC--cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 37 ASLEKIGSGGCGDVYKAELPGS-NG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
...+.||.|-||.||.|.+... .| -.||||...... .....+.+.+|..+|+++.||||++++
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--------------t~d~tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--------------TPDDTEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--------------ChhhHHHHHHHHHHHHhCCCcchhhee
Confidence 3456799999999999988654 33 348888774222 234467899999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
|++.+. ..++|||.++-|.|..+++. ....++..+...++.|++.+|+||| +...|||||..+||++....-|
T Consensus 458 Gv~~e~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 458 GVCVEQ-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCV 530 (974)
T ss_pred eeeecc-ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCccee
Confidence 988764 67999999999999999954 4556888899999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 272 (325)
||+|||+++.+.......... ..-+..|+|||-++...++.++|||-||+++||++. |..||.+..+. +++--+
T Consensus 531 KLaDFGLSR~~ed~~yYkaS~-~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----DVI~~i 605 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKASR-GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----DVIGHI 605 (974)
T ss_pred eecccchhhhccccchhhccc-cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----ceEEEe
Confidence 999999999887665544431 122568999999999999999999999999999997 99999863332 222111
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+ +.+ ....++++..+..|+.+||..||.+||++.|+.+
T Consensus 606 En---GeR----------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 606 EN---GER----------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred cC---CCC----------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 11 111 1122234444889999999999999999998854
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=261.59 Aligned_cols=250 Identities=22% Similarity=0.247 Sum_probs=197.3
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCC
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRN 108 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~ 108 (325)
+.+..+|.++.+||+|+||+|-+|. ...+.+.+|||++... -.......+--+.|-++|+... -|.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLae-rkgtdELyAiKiLkKD------------ViiQdDDvectm~EKrvLAL~~kppF 411 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAE-RKGTDELYAIKILKKD------------VIIQDDDVECTMVEKRVLALPGKPPF 411 (683)
T ss_pred ceeecccceEEEeccCccceeeeec-ccCcchhhhhhhhccc------------eeeecCcccceehhhhheecCCCCch
Confidence 3466789999999999999999995 5567788999987422 1122233444456666777664 689
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
+++++..+..-+.+|+||||++||+|...++ +-+.+.+..+..++..++.||-+|| ++||++||||.+|||++
T Consensus 412 L~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd 484 (683)
T KOG0696|consen 412 LVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLD 484 (683)
T ss_pred HHHHHHHhhhhhheeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEec
Confidence 9999999999999999999999999999994 4455888888899999999999999 99999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.+|++||+|||++..-...... +..++||+.|+|||++..++|+.++|.||+|+++|+|+.|++||++.+. .++
T Consensus 485 ~eGHiKi~DFGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----~el 558 (683)
T KOG0696|consen 485 SEGHIKIADFGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DEL 558 (683)
T ss_pred cCCceEeeecccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----HHH
Confidence 9999999999999765544433 3348999999999999999999999999999999999999999987432 223
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
.+ .+......- + .. .+.+..+++...|.+.|.+|...
T Consensus 559 F~---aI~ehnvsy---P-----Ks---lSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 559 FQ---AIMEHNVSY---P-----KS---LSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred HH---HHHHccCcC---c-----cc---ccHHHHHHHHHHhhcCCccccCC
Confidence 22 222222211 1 11 11237789999999999999754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=265.32 Aligned_cols=265 Identities=23% Similarity=0.304 Sum_probs=203.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
+++|-+++.||+|+|+.||+| .+-...+.||+|+-.+.. .......+...+...+|..|-+.|.||.||++
T Consensus 462 n~RYLlLhLLGrGGFSEVyKA-FDl~EqRYvAvKIHqlNK--------~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKl 532 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKA-FDLTEQRYVAVKIHQLNK--------NWRDEKKENYHKHACREYRIHKELDHPRIVKL 532 (775)
T ss_pred HHHHHHHHHhccccHHHHHHh-cccchhheeeEeeehhcc--------chhhHhhhhHHHHHHHHHhhhhccCcceeeee
Confidence 468999999999999999999 577788999999864432 11112233456688999999999999999999
Q ss_pred cccee-cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC--
Q 040480 113 LAHMV-RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-- 189 (325)
Q Consensus 113 ~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~-- 189 (325)
|+++. +.+.+|-|+|||+|-+|.-++ .....++++.+..|+.|++.||.||... +.+|+|.||||.|||+..
T Consensus 533 YDyfslDtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 533 YDYFSLDTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCc
Confidence 99996 456789999999999999988 5566799999999999999999999977 779999999999999964
Q ss_pred -CCCceeeccccceecCCCCcccc-----ceeecCCcccccccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCc
Q 040480 190 -DMEARISGFDLAILMPDGLTQID-----TMYVVGTPRYIAPEYHQTL----TISEKCDIYSFGVLLAVLVMGKFPFDDF 259 (325)
Q Consensus 190 -~~~~~l~dfg~~~~~~~~~~~~~-----~~~~~g~~~~~aPE~~~~~----~~~~~~DvwslG~il~~ll~g~~p~~~~ 259 (325)
-|.+||+|||++..+........ +....||++|+|||++.-. +++.++||||.|+|+|.++.|+.||+..
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 47899999999998765443321 2335799999999987533 4678999999999999999999999753
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
.. ...++.........+..+++.- .+..+..++|++||+...++|...-++.
T Consensus 688 qs------QQdILqeNTIlkAtEVqFP~KP------vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 688 QS------QQDILQENTILKATEVQFPPKP------VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hh------HHHHHhhhchhcceeccCCCCC------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 22 1111221111222222222221 1122278899999999999998877764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=287.69 Aligned_cols=255 Identities=25% Similarity=0.314 Sum_probs=204.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++++.||+|+||.|.++++ ..+++.||.|++ .+..-.......-|..|-.+|..-..+=|++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~-k~t~~VYAMK~l------------nK~eMlKr~~tA~F~EERDimv~~ns~Wiv~ 139 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRH-KSTEKVYAMKIL------------NKWEMLKRAETACFREERDIMVFGNSEWIVQ 139 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEe-eccccchhHHHh------------hHHHHhhchhHHHHHHHhHHHHcCCcHHHHH
Confidence 567899999999999999999964 567889999987 1212233345567888999999989999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
++..|.+++++|+||||++||+|...+.++. .+++..+..++..|+.||..+| +.|+|||||||+|||++..|
T Consensus 140 LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 140 LHYAFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred HHHHhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccC
Confidence 9999999999999999999999999995432 5999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+++|+|||.+..+...+.- .....+|||.|.|||++.. ..|+..+|.||+|+++|+|+.|..|| ...
T Consensus 213 HikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF-------Yad 284 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF-------YAD 284 (1317)
T ss_pred cEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc-------hHH
Confidence 9999999999888754432 2233689999999998763 35889999999999999999999999 444
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC---hhhh
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN---SKDV 322 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~el 322 (325)
.++.....+......... |. ..++++...+||++.++ +|+.|.. ++++
T Consensus 285 slveTY~KIm~hk~~l~F-P~------~~~VSeeakdLI~~ll~-~~e~RLgrngiedi 335 (1317)
T KOG0612|consen 285 SLVETYGKIMNHKESLSF-PD------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDI 335 (1317)
T ss_pred HHHHHHHHHhchhhhcCC-Cc------ccccCHHHHHHHHHHhc-ChhhhcccccHHHH
Confidence 556655655555332221 11 11244558888888875 6777877 5554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=229.70 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=200.6
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
.|.-.++||+|.||+||+|+ +..+.+.||+|.+.+.. ..+.......+|+-+++.++|.||+++++
T Consensus 3 ~ydkmekigegtygtvfkar-n~~t~eivalkrvrldd-------------ddegvpssalreicllkelkhknivrl~d 68 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKAR-NRETHEIVALKRVRLDD-------------DDEGVPSSALREICLLKELKHKNIVRLHD 68 (292)
T ss_pred chHHHHhhcCCcceeeEecc-cCCccceEEEEEEeccC-------------CCCCCcHHHHHHHHHHHHhhhcceeehhh
Confidence 56678899999999999995 66788999999985432 23345667899999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
+...+..+-+|+|||.. +|..++.+ .++.++......++.|++.||.++| ++++.|||+||.|.+++.+|+.|
T Consensus 69 vlhsdkkltlvfe~cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelk 141 (292)
T KOG0662|consen 69 VLHSDKKLTLVFEFCDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_pred hhccCceeEEeHHHhhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEE
Confidence 99999999999999966 89888844 5667999999999999999999999 88999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|||+++.++-...... ...-|.+|.+|.++.|.+ |+.+.|+||-||++.++.. |++-|.+.+ ...++.+ +
T Consensus 142 ladfglarafgipvrcys--aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d---vddqlkr-i 215 (292)
T KOG0662|consen 142 LADFGLARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKR-I 215 (292)
T ss_pred ecccchhhhcCCceEeee--ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc---HHHHHHH-H
Confidence 999999987765432221 135588999999998876 7889999999999999997 666665421 1122222 2
Q ss_pred HHHhhhCCCCcccchhhcCC-----------ch----HHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGN-----------GY----EEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~-----------~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+....+......++ .+ ++....-++|+.+.|.-+|..|.+++.+++
T Consensus 216 f~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 216 FRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22222222211111111111 11 122223578999999999999999998875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=271.68 Aligned_cols=241 Identities=22% Similarity=0.276 Sum_probs=189.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHh-ccCCCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITAS-QIRHRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~ 110 (325)
..+.|++...+|.|+|+.|-.+. ...+++..++|++... ......|+.++. .-.||||+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~-~~~t~~~~~vkii~~~-------------------~~~~~~e~~~~~~~~~h~niv 379 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCE-SSPTDQEPAVKIISKR-------------------ADDNQDEIPISLLVRDHPNIV 379 (612)
T ss_pred cchhhccccccCCCCccceeeee-ccccccchhheecccc-------------------ccccccccchhhhhcCCCcce
Confidence 46789999999999999999995 6677888999988321 111233333333 33699999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe-cC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI-DD 189 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~-~~ 189 (325)
++.+.+.+..+.|+|||.+.|+-+.+.+. ....+. ..+..|+.+|+.++.||| .+|+|||||||+|||+ +.
T Consensus 380 ~~~~v~~~~~~~~~v~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~ 451 (612)
T KOG0603|consen 380 KSHDVYEDGKEIYLVMELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGS 451 (612)
T ss_pred eecceecCCceeeeeehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCC
Confidence 99999999999999999999998888883 223333 777889999999999999 8899999999999999 68
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
.++++|+|||.+........ ..+-|..|.|||+.....|++++|+||||+++|+|++|+.||...- .. .
T Consensus 452 ~g~lrltyFG~a~~~~~~~~-----tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P---~~---~ 520 (612)
T KOG0603|consen 452 AGHLRLTYFGFWSELERSCD-----TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP---AG---I 520 (612)
T ss_pred CCcEEEEEechhhhCchhhc-----ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC---ch---H
Confidence 89999999999987766511 1244788999999999999999999999999999999999996521 11 3
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+...++..++.. ...++..++|+.+||++||.+||++.+++.
T Consensus 521 ei~~~i~~~~~s-------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 521 EIHTRIQMPKFS-------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHhhcCCccc-------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 333333322222 223334899999999999999999999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=257.39 Aligned_cols=258 Identities=28% Similarity=0.391 Sum_probs=195.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc--cCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ--IRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~ 110 (325)
.....+.+.+|+|.||.||+|++ +++.||||++ .......+..|-+|++. ++|+||+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL---~~~~VAVKif------------------p~~~kqs~~~Ek~Iy~lp~m~h~nIl 267 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL---DNRLVAVKIF------------------PEQEKQSFQNEKNIYSLPGMKHENIL 267 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc---cCceeEEEec------------------CHHHHHHHHhHHHHHhccCccchhHH
Confidence 45667788999999999999987 5689999998 22445667777777764 4799999
Q ss_pred ccccceecCC----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc------CCCCeEecCC
Q 040480 111 PLLAHMVRPD----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH------HSARVIHRDI 180 (325)
Q Consensus 111 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~------~~~~ivH~dl 180 (325)
++++.-.... ..++|++|.+.|+|.+++ ....+++....+++..|+.||+|||+. ++.+|+||||
T Consensus 268 ~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDl 342 (534)
T KOG3653|consen 268 QFIGAEKRGTADRMEYWLVTEFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDL 342 (534)
T ss_pred HhhchhccCCccccceeEEeeeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccc
Confidence 9998765544 689999999999999999 557799999999999999999999965 3567999999
Q ss_pred CCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCC-CC-----CccchhhHHHHHHHHHhCCC
Q 040480 181 KPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-IS-----EKCDIYSFGVLLAVLVMGKF 254 (325)
Q Consensus 181 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~-----~~~DvwslG~il~~ll~g~~ 254 (325)
|..|||+..+.++.|+|||+|..+............+||.+|||||++.+.- +. .+.||||+|.++|||++...
T Consensus 343 kSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 343 KSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred cccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 9999999999999999999999998777666666689999999999988753 22 35899999999999998664
Q ss_pred CCC-C-------ccc-C-CCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 255 PFD-D-------FFS-H-TGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 255 p~~-~-------~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
-+. + ... . .....+.+....+...+..+.. +..-... .....+.+.+..||+.||+.|.|+.
T Consensus 423 ~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~-p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 423 DADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKI-PDAWRKH---AGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCC-hhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhH
Confidence 331 0 000 0 1112223322222222222211 1111111 3334489999999999999999975
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=281.75 Aligned_cols=150 Identities=24% Similarity=0.370 Sum_probs=130.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|.+.++||.|+||+||+|. +..+++.||+|++... ..........+..|+.+++.++||||+++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~-~~~~~~~vAiKvi~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~ 69 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGR-KKNNSKLYAVKVVKKA------------DMINKNMVHQVQAERDALALSKSPFIVHL 69 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEE-ECCCCcEEEEEEEehh------------hccCHHHHHHHHHHHHHHHhcCCCCcCeE
Confidence 3689999999999999999995 5567899999998321 11122334678889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
+..+...+..|+||||+.+++|.+++.. ...++...++.++.|++.||.||| ..+|+|+||||+|||++.++.
T Consensus 70 ~~~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~ 142 (669)
T cd05610 70 YYSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGH 142 (669)
T ss_pred EEEEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCC
Confidence 9999999999999999999999999843 345788889999999999999999 789999999999999999999
Q ss_pred ceeeccccce
Q 040480 193 ARISGFDLAI 202 (325)
Q Consensus 193 ~~l~dfg~~~ 202 (325)
++|+|||++.
T Consensus 143 vkL~DFGls~ 152 (669)
T cd05610 143 IKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCc
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=265.94 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=202.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
+-+++.++..||-|+||.|=++...+.. ..+|+|.+ .+..-......+++..|-.+|.....|.|++
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~-~~fAlKil------------kK~hIVdtkQqeHv~sEr~Im~~~~s~fIvr 484 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQK-ATFALKIL------------KKKHIVDTKQQEHVFSERNIMMECRSDFIVR 484 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccc-hHHHHHHH------------hHhhccchhHHHHHHhHHHHHHhcCchHHHH
Confidence 4467888899999999999999764332 24777776 2333445566788999999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+|..|.++..+|++||-|-||.|...+ ..++.++..+...++..+++|+.||| ++|||+|||||+|.+++.+|
T Consensus 485 LYrTfrd~kyvYmLmEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~G 557 (732)
T KOG0614|consen 485 LYRTFRDSKYVYMLMEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRG 557 (732)
T ss_pred HHHHhccchhhhhhHHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCC
Confidence 999999999999999999999999999 45677999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
-+||.|||++.....+.. +..++||+.|.|||++.+..-+.++|.||||+++|+|++|.+||...++ +..+..
T Consensus 558 y~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----mktYn~ 630 (732)
T KOG0614|consen 558 YLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----MKTYNL 630 (732)
T ss_pred ceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----HHHHHH
Confidence 999999999998876654 3448999999999999999999999999999999999999999976332 333322
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (325)
+......-.-+.. ..+...+||+++...+|.+|..
T Consensus 631 ILkGid~i~~Pr~------------I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 631 ILKGIDKIEFPRR------------ITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHhhhhhhhcccc------------cchhHHHHHHHHHhcCcHhhhc
Confidence 2221111111111 1122778999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=272.56 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=208.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
..+-|+|.+.+|.|.+|.||+++ ...+++..|+|++.. ....-+++..|..+++.+. |||++
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k-~~~~~~~aa~kI~~~----------------~~d~deEiE~eynil~~~~~hpnv~ 79 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGR-HVKTGQLAAIKIMDP----------------TEDEEEEIELEYNMLKKYSHHPNVA 79 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEe-eeecCceeeeEeecC----------------CccccHHHHHHHHHHHhccCCCCcc
Confidence 66789999999999999999995 567888899998733 3344566778888888885 89999
Q ss_pred cccccee-----cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 111 PLLAHMV-----RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 111 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
.+++++. .++++++|||||.||+..+++.... +..+.+..+..|+..++.|+.+|| +..++|||+|-.||
T Consensus 80 ~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~Ni 154 (953)
T KOG0587|consen 80 TFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNV 154 (953)
T ss_pred eEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceE
Confidence 9999885 4578999999999999999997765 677999999999999999999999 88999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCC-----CCCccchhhHHHHHHHHHhCCCCCCCcc
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-----ISEKCDIYSFGVLLAVLVMGKFPFDDFF 260 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-----~~~~~DvwslG~il~~ll~g~~p~~~~~ 260 (325)
+++.++.|||+|||.+..+........+ ..||+.|+|||++...+ |+..+|+||||++..+|.-|.+|+.+..
T Consensus 155 LLT~e~~VKLvDFGvSaQldsT~grRnT--~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 155 LLTENAEVKLVDFGVSAQLDSTVGRRNT--FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred EEeccCcEEEeeeeeeeeeecccccccC--cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 9999999999999999887765443333 68999999999987653 6778999999999999999999998765
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+ ++.....++ .+. +. -....+..+.|.++|..||.+|-+.||+..++|+
T Consensus 233 P----------mraLF~IpR--NPP-Pk--Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 233 P----------MRALFLIPR--NPP-PK--LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred h----------hhhhccCCC--CCC-cc--ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 4 122222111 111 11 1223455566999999999999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=249.11 Aligned_cols=220 Identities=21% Similarity=0.189 Sum_probs=171.1
Q ss_pred CcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCceEE
Q 040480 45 GGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLL 124 (325)
Q Consensus 45 G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 124 (325)
|.+|.||++. +..+++.+|+|.+.... ...++...+....||||+++++++......++
T Consensus 4 g~~~~v~~~~-~~~~~~~~~~K~i~~~~--------------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l 62 (237)
T cd05576 4 GVIDKVLLVM-DTRTQQTFILKGLRKSS--------------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFL 62 (237)
T ss_pred cccceEEEEE-EccCCcEEEEEeecchh--------------------hhhhHHHHHHhcCCCceeehhhheecCCeEEE
Confidence 8999999995 67788999999883211 12223334445569999999999999999999
Q ss_pred EEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceec
Q 040480 125 VYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204 (325)
Q Consensus 125 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~ 204 (325)
+|||+++++|.+++.. ...+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++++|||.+...
T Consensus 63 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~ 135 (237)
T cd05576 63 VLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV 135 (237)
T ss_pred EEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcc
Confidence 9999999999999843 335888999999999999999999 889999999999999999999999999987655
Q ss_pred CCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcc
Q 040480 205 PDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRA 284 (325)
Q Consensus 205 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (325)
..... ...++..|+|||...+..++.++|+||+|+++|+|++|..|+....... .... ...
T Consensus 136 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~--~~~ 196 (237)
T cd05576 136 EDSCD-----GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT--TLN 196 (237)
T ss_pred ccccc-----cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc--ccC
Confidence 43221 1245667999999988888999999999999999999998875311100 0000 000
Q ss_pred cchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 285 IDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
.+ . .....+.+++.+||+.||.+|||+
T Consensus 197 ~~-----~---~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 197 IP-----E---WVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred Cc-----c---cCCHHHHHHHHHHccCCHHHhcCC
Confidence 00 0 112238899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=265.19 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=200.1
Q ss_pred Ccccc--cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 35 CFASL--EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 35 ~y~~~--~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-|++. +.||.|-||+||-|+ ...+|+.||||++ ++.++- ......++.|+.||.++.||.||.+
T Consensus 563 vYQif~devLGSGQFG~VYgg~-hRktGrdVAvKvI------------dKlrFp-~kqesqlR~EVaILq~l~HPGiV~l 628 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGK-HRKTGRDVAVKVI------------DKLRFP-TKQESQLRNEVAILQNLHHPGIVNL 628 (888)
T ss_pred HHHhhhHhhccCCcceeeecce-ecccCceeeeeee------------ecccCC-CchHHHHHHHHHHHHhcCCCCeeEE
Confidence 45553 589999999999995 5678999999998 333332 2344789999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC--
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD-- 190 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~-- 190 (325)
...++..+..+.|||-+.| +..+++-. ...+++++..-..++.||+.||.||| -++|+|+||||+||++...
T Consensus 629 e~M~ET~ervFVVMEKl~G-DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~ 702 (888)
T KOG4236|consen 629 ECMFETPERVFVVMEKLHG-DMLEMILS--SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASP 702 (888)
T ss_pred EEeecCCceEEEEehhhcc-hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCC
Confidence 9999999999999999966 66666633 46678999999999999999999999 8899999999999999743
Q ss_pred -CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 191 -MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 -~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
..+||||||+++.......... ..||+.|+|||+++...|...-|+||.|+|+|.-++|..||... .++-
T Consensus 703 FPQvKlCDFGfARiIgEksFRrs---VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd------EdIn 773 (888)
T KOG4236|consen 703 FPQVKLCDFGFARIIGEKSFRRS---VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED------EDIN 773 (888)
T ss_pred CCceeeccccceeecchhhhhhh---hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc------cchh
Confidence 6789999999998876654333 58999999999999999999999999999999999999999642 1222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
..+.+.---.. +..+.+.....++||..+|+..-++|-|.+.-+
T Consensus 774 dQIQNAaFMyP----------p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 774 DQIQNAAFMYP----------PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHhhccccccC----------CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 22221111111 122333444589999999999999999987654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=247.28 Aligned_cols=262 Identities=22% Similarity=0.370 Sum_probs=202.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
...+.+-+..||.|+||+|++.. .+.+|+..|||.+... ..+....++..|.+...+- ++||||
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~-hk~sg~~mAVKrIr~~--------------n~~keq~rll~e~d~~mks~~cp~IV 126 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKML-HKPSGKLMAVKRIRSN--------------NIEKEQKRLLMEHDTVMKSSNCPNIV 126 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhh-cCccCcEEEEEEeeec--------------cchHHHHHHHHHHHHHHhhcCCcHHH
Confidence 44455667789999999999995 5678899999998422 2235566777777665544 689999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhh-hcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYD-VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++|+....++..++.||.++- +|..+... ....+..+++.....|....+.||.||.. ...|+|||+||+|||++.
T Consensus 127 kfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 127 KFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDR 203 (361)
T ss_pred HHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEec
Confidence 999999999999999999954 77666532 23456779998889999999999999986 448999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.|.+||||||.+..+..... .+...|...|+|||.+... .|+.++|+||||+++||+.||..|+.. -.+
T Consensus 204 ~G~vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~------w~s 274 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK------WDS 274 (361)
T ss_pred CCCEeeecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch------HHH
Confidence 99999999999976544322 2224788899999988643 489999999999999999999999954 233
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
+.+.+..+..+..+....+.... .....+..+|..||.+|-..||+..+++.+
T Consensus 275 vfeql~~Vv~gdpp~l~~~~~~~-----~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 275 VFEQLCQVVIGDPPILLFDKECV-----HYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHHHcCCCCeecCccccc-----ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 55556666655554433333222 222338899999999999999999998753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=241.21 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=199.1
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHR 107 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 107 (325)
+...-++|.++++||+|+|++|-++++ ..+.+.+|+|++. +.-....+.+.-...|-.+..+. +||
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~-~~t~qiyamkvvk------------kel~nddedidwvqtek~vfe~asn~p 311 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRL-KKTDQIYAMKVVK------------KELVNDDEDIDWVQTEKHVFEQASNNP 311 (593)
T ss_pred cccccccceeeeeecCcchhhhhheeh-cccceeeehhhHH------------HHhcCCcccchhHHhhHHHHHhccCCC
Confidence 333556899999999999999999964 4677889999872 22223334555566666666665 589
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
.+|-+...|..+..+++|.||++||+|.-.+ +....+++..+..+...+..||.||| ++||++||||.+|+++
T Consensus 312 flvglhscfqtesrlffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvll 384 (593)
T KOG0695|consen 312 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLL 384 (593)
T ss_pred eEEehhhhhcccceEEEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEE
Confidence 9999999999999999999999999998777 44566999999999999999999999 9999999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+..|++||+|+|++..-...... +..++||+.|.|||++++..|..++|.|+||+++++|+.|+.||+--.......+
T Consensus 385 daeghikltdygmcke~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n 462 (593)
T KOG0695|consen 385 DAEGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN 462 (593)
T ss_pred ccCCceeecccchhhcCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc
Confidence 99999999999999765443332 3348999999999999999999999999999999999999999974332222222
Q ss_pred HHHHHHHHhhhCCCC--cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 268 MVRWMRNVMASENPN--RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
-..++.++.-..... +...-+ ...+++.-|++||.+|...
T Consensus 463 tedylfqvilekqiriprslsvk------------as~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 463 TEDYLFQVILEKQIRIPRSLSVK------------ASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred hhHHHHHHHhhhcccccceeehh------------hHHHHHHhhcCCcHHhcCC
Confidence 223333322222211 111111 4568888999999999754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=270.67 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=203.5
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEecCC------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHH
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAELPGS------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 101 (325)
.|....++..+.+.||.|+||.|++|..... ....||||.+... ......+.+..|+.+|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~--------------~~~~~~~~~~~El~~m 355 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKEN--------------ASSSEKKDLMSELNVL 355 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccc--------------cCcHHHHHHHHHHHHH
Confidence 4444445557888999999999999975422 2467999987321 2225677899999999
Q ss_pred hccC-CCCccccccceecCCceEEEEEcccCCCHHHHHhhhc---cc-------c--cccChhhHHHHHHHHHHHHHHHH
Q 040480 102 SQIR-HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS---KG-------R--RELEWLSRHKIALAVASGLEYLH 168 (325)
Q Consensus 102 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~-------~--~~~~~~~~~~i~~~l~~~l~~lh 168 (325)
+.+. ||||+.+++.+...+..++|+||+..|+|.++++... .- . ..++......+..|++.|++||+
T Consensus 356 ~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~ 435 (609)
T KOG0200|consen 356 KELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA 435 (609)
T ss_pred HHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh
Confidence 9995 9999999999999999999999999999999997644 00 1 23888889999999999999999
Q ss_pred hcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeec--CCcccccccccccCCCCCccchhhHHHHH
Q 040480 169 MHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVV--GTPRYIAPEYHQTLTISEKCDIYSFGVLL 246 (325)
Q Consensus 169 ~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~--g~~~~~aPE~~~~~~~~~~~DvwslG~il 246 (325)
+.+++||||-.+||++.++..+|++|||+++............ .. -+..|+|||.+....|+.++||||||+++
T Consensus 436 ---~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 436 ---SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILL 511 (609)
T ss_pred ---hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHH
Confidence 8899999999999999999999999999998655443332111 11 13469999999999999999999999999
Q ss_pred HHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 247 AVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 247 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
||+++ |..||.+.. ...++.++++...+...+... ..++.+++..||+.+|++||++.++.+
T Consensus 512 ~EifsLG~~PYp~~~---~~~~l~~~l~~G~r~~~P~~c-------------~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIP---PTEELLEFLKEGNRMEQPEHC-------------SDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhhCCCCCCCCCC---cHHHHHHHHhcCCCCCCCCCC-------------CHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99998 889996511 133343333333322222222 223889999999999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=265.59 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=202.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCC---CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSN---GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
++......++||+|+||+||+|.|--.. +-+||+|++. .....+...++..|+.+|..+.|||
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~--------------~~t~~~~s~e~LdeAl~masldHpn 759 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLI--------------EFTSPKASIELLDEALRMASLDHPN 759 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEee--------------ccCCchhhHHHHHHHHHHhcCCCch
Confidence 5666777889999999999999885442 2469999873 2334456778999999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++++++++.... .-+|++|++.|+|.++++. .+..+..+..+.|..||+.|+.||| .+.+|||||-.+|||+.
T Consensus 760 l~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVk 832 (1177)
T KOG1025|consen 760 LLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVK 832 (1177)
T ss_pred HHHHhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeec
Confidence 999999988765 8899999999999999965 5667889999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
+...+|+.|||++...............--.+.|+|-|.+....++.++||||||+++||++| |..|+++... .+
T Consensus 833 sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----~e 908 (1177)
T KOG1025|consen 833 SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----EE 908 (1177)
T ss_pred CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----HH
Confidence 999999999999988776554433322222567999999999999999999999999999998 9999976332 22
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
+...++...+-..+ +.+..++.-++.+||..|+..||+++++.
T Consensus 909 I~dlle~geRLsqP-------------piCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 909 IPDLLEKGERLSQP-------------PICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred hhHHHhccccCCCC-------------CCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 22222211111111 12333388899999999999999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=257.22 Aligned_cols=221 Identities=23% Similarity=0.379 Sum_probs=185.2
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
-|..++.||-|+||+|.++. +..+...+|.|.+ ++..-+........+.|-+||+....+-||++|.
T Consensus 630 mFvkik~iGvGAFGeV~Lv~-KvDT~~lYAmKTL------------rKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVR-KVDTRALYAMKTL------------RKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred ceEEEeeecccccceeEEEe-ecchhhHHHHhhh------------HHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 36667789999999999995 5667888999987 2333344456778899999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
.|.+.+.+|+||+|++||++..++..+ .-|++..+..++..+..|+++.| +.|.|||||||+|||||.+|++|
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCcee
Confidence 999999999999999999999999654 44888899999999999999999 88999999999999999999999
Q ss_pred eeccccceecCC--CCc------ccc--------------------------------ceeecCCcccccccccccCCCC
Q 040480 195 ISGFDLAILMPD--GLT------QID--------------------------------TMYVVGTPRYIAPEYHQTLTIS 234 (325)
Q Consensus 195 l~dfg~~~~~~~--~~~------~~~--------------------------------~~~~~g~~~~~aPE~~~~~~~~ 234 (325)
|+|||+++=+.+ ... ..+ ....+||+.|+|||++....++
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 999999973321 000 000 0013699999999999999999
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHH
Q 040480 235 EKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275 (325)
Q Consensus 235 ~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 275 (325)
..+|.||.|+|+|+|+.|+.||....+.+....+..|..-+
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l 890 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFL 890 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcc
Confidence 99999999999999999999999887777777777665543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=241.85 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=190.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc--CCCCccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI--RHRNILP 111 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~ 111 (325)
.+-.+.+.+|+|.||.||+|.| .|+.||||++.- ..-..+.+|.+++... +|+||+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w---rGe~VAVKiF~s------------------rdE~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW---RGEDVAVKIFSS------------------RDERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred heeEEEEEecCccccceeeccc---cCCceEEEEecc------------------cchhhhhhHHHHHHHHHhccchhhh
Confidence 3577889999999999999998 688999999821 2234577788888755 8999999
Q ss_pred cccceecCC----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCC
Q 040480 112 LLAHMVRPD----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH-----HSARVIHRDIKP 182 (325)
Q Consensus 112 ~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-----~~~~ivH~dl~~ 182 (325)
+++.-..++ ++++|++|.+.|||.|++ ...+++.....+++..++.||+|||.. .+..|.|||||.
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 988654433 479999999999999999 447799999999999999999999954 345699999999
Q ss_pred CceEecCCCCceeeccccceecCCC--CccccceeecCCcccccccccccCC----C--CCccchhhHHHHHHHHHhC--
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDG--LTQIDTMYVVGTPRYIAPEYHQTLT----I--SEKCDIYSFGVLLAVLVMG-- 252 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~g~~~~~aPE~~~~~~----~--~~~~DvwslG~il~~ll~g-- 252 (325)
.|||+..++.+.|+|+|+|...... .........+||.+|+|||++...- + -..+||||||.++||+.-.
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999999999876543 2233344479999999999986532 1 1359999999999998752
Q ss_pred --------CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhh
Q 040480 253 --------KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322 (325)
Q Consensus 253 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (325)
+.||-+..+ .+.+..+. +.+.-.......+++. .. ...+...+.+||+.||..||.-|.|+-.+
T Consensus 425 ~ggi~eey~~Pyyd~Vp--~DPs~eeM-rkVVCv~~~RP~ipnr--W~-s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVP--SDPSFEEM-RKVVCVQKLRPNIPNR--WK-SDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cCCEehhhcCCcccCCC--CCCCHHHH-hcceeecccCCCCCcc--cc-cCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 357765443 22222222 2222222222222211 11 12445558899999999999999997543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=262.85 Aligned_cols=265 Identities=21% Similarity=0.261 Sum_probs=164.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCC----CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSN----GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||.||+|.+ ..+ +..||+|++..... .+....+ .+....+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~-~~~~~~~~~~vAvK~~~~~~~-----------------~e~~~~e--~l~~~~~~ 189 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASL-VNKQSKKEGKYVLKKATEYGA-----------------VEIWMNE--RVRRACPN 189 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEE-cCCccccCcEEEEEEecccch-----------------hHHHHHH--HHHhhchh
Confidence 567999999999999999999964 345 78899998732110 0001111 11111122
Q ss_pred Cccccccc------eecCCceEEEEEcccCCCHHHHHhhhcc----------------cccccChhhHHHHHHHHHHHHH
Q 040480 108 NILPLLAH------MVRPDSHLLVYDFMKNGSLQAVLYDVSK----------------GRRELEWLSRHKIALAVASGLE 165 (325)
Q Consensus 108 ~i~~~~~~------~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~~l~ 165 (325)
++..+... .......++|+||+.+++|.+++..... .........+..++.|++.||.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~ 269 (566)
T PLN03225 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALD 269 (566)
T ss_pred hHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHH
Confidence 22222111 2355678999999999999998843110 0001122345679999999999
Q ss_pred HHHhcCCCCeEecCCCCCceEecC-CCCceeeccccceecCCCCccccceeecCCcccccccccccC-------------
Q 040480 166 YLHMHHSARVIHRDIKPANVLIDD-DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL------------- 231 (325)
Q Consensus 166 ~lh~~~~~~ivH~dl~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~------------- 231 (325)
||| +++|+||||||+|||++. ++.+||+|||++.......... .....+++.|+|||.+...
T Consensus 270 yLH---~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~ 345 (566)
T PLN03225 270 GLH---STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 345 (566)
T ss_pred HHH---HCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccc
Confidence 999 889999999999999985 5789999999997654332221 2235788999999965322
Q ss_pred ---------CCCCccchhhHHHHHHHHHhCCCCCCCccc------CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHH
Q 040480 232 ---------TISEKCDIYSFGVLLAVLVMGKFPFDDFFS------HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEE 296 (325)
Q Consensus 232 ---------~~~~~~DvwslG~il~~ll~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (325)
.++.++|||||||++|+|+++..|++.... .....+...|........... ....-...+.
T Consensus 346 ~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~d~ 421 (566)
T PLN03225 346 ALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPD----LRRGFEVLDL 421 (566)
T ss_pred cccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchh----hhhhhhhccc
Confidence 234567999999999999997766542100 000011111111111000000 0000000001
Q ss_pred HHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 297 QMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 297 ~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+|+.+||+.||++|||+.++++
T Consensus 422 ~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 422 DGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred cchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 1123568999999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=233.46 Aligned_cols=240 Identities=28% Similarity=0.400 Sum_probs=187.8
Q ss_pred cceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCceEEE
Q 040480 46 GCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLV 125 (325)
Q Consensus 46 ~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 125 (325)
+||.||+|.. ..+++.+++|.+..... ......+.+|+..++.++|+|++++++.+......+++
T Consensus 1 ~~g~v~~~~~-~~~~~~~~~k~~~~~~~--------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 65 (244)
T smart00220 1 SFGKVYLARD-KKTGKLVAIKVIKKEKI--------------KKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLV 65 (244)
T ss_pred CceEEEEEEE-CCCCcEEEEEEeccccc--------------ccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEE
Confidence 5899999964 45678999998832210 11157888999999999999999999999999999999
Q ss_pred EEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecC
Q 040480 126 YDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205 (325)
Q Consensus 126 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~ 205 (325)
+|++.+++|.+++.. ...++......++.+++.++.+|| +.+++|+||+|+||+++.++.++++|||.+....
T Consensus 66 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~ 138 (244)
T smart00220 66 MEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLD 138 (244)
T ss_pred EeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeec
Confidence 999999999999843 223788899999999999999999 7899999999999999999999999999998776
Q ss_pred CCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCccc
Q 040480 206 DGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAI 285 (325)
Q Consensus 206 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (325)
..... ....++..|+|||...+..++.++|+||||++++++++|..||.... ...................
T Consensus 139 ~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~------~~~~~~~~~~~~~~~~~~~ 209 (244)
T smart00220 139 PGGLL---TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD------QLLELFKKIGKPKPPFPPP 209 (244)
T ss_pred ccccc---ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHhccCCCCccc
Confidence 54311 12467888999999988888999999999999999999999986421 1111122222222111110
Q ss_pred chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 286 DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ..+..+.+++.+||..+|++||++.++++
T Consensus 210 ~~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 EW--------KISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cc--------cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00 02233899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=226.37 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=196.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
..++|++.+++|+|.++.||.|. +-.+++.++||++. +...+.+.+|+.+|..+. ||||+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~-~~~~~eK~ViKiLK------------------PVkkkKIkREikIL~nL~gg~NIi 96 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGI-NITNNEKCVIKILK------------------PVKKKKIKREIKILQNLRGGPNII 96 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccc-ccCCCceEEEeeec------------------hHHHHHHHHHHHHHHhccCCCCee
Confidence 56789999999999999999994 56678889999883 356678999999999997 99999
Q ss_pred ccccceecCC--ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 111 PLLAHMVRPD--SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 111 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
+++++..+.. ...+++||+++.+..... ..++...+...+.+++.||.||| ++||+|||+||.|++++
T Consensus 97 ~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmId 166 (338)
T KOG0668|consen 97 KLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMID 166 (338)
T ss_pred ehhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeec
Confidence 9999997764 578999999998887776 34778888999999999999999 99999999999999999
Q ss_pred -CCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 189 -DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 189 -~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+.-+++|+|||++.....+..... ...+..|-.||++.. +.|+.+-|+|||||++..|++.+.||-... .+..
T Consensus 167 h~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~--dN~D 241 (338)
T KOG0668|consen 167 HELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYD 241 (338)
T ss_pred hhhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC--CCHH
Confidence 556799999999988776654433 456777889998764 458899999999999999999999985422 1222
Q ss_pred hHHHHHHH------------HhhhCC----------CCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRN------------VMASEN----------PNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~------------~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++++..+. ....-. +...+........-.-...+.+||+.++|..|-.+|||+.|+..
T Consensus 242 QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 242 QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 33322211 000000 00000000001111122234889999999999999999999753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=238.61 Aligned_cols=135 Identities=25% Similarity=0.379 Sum_probs=113.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-----C
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-----H 106 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h 106 (325)
..++|.+.++||-|-|++||+| |+..+.+.||+|+... .+...+....|+++|++++ |
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLa-wDtq~~r~VAlKVvKS----------------AqhYtEaAlDEIklL~~v~~~Dp~~ 138 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLA-WDTQNKRYVALKVVKS----------------AQHYTEAALDEIKLLQQVREGDPND 138 (590)
T ss_pred cCceEEEEEeccccccceeEEE-eeccCCeEEEEEEEeh----------------hhHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3479999999999999999999 8989999999999831 2234556778889998883 2
Q ss_pred ---CCccccccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 040480 107 ---RNILPLLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179 (325)
Q Consensus 107 ---~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~d 179 (325)
.+||++++.|.. ..++|+|+|++ |.+|..+|... .-+.++.....+|+.|++.||-|||..+ ||+|.|
T Consensus 139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTD 213 (590)
T KOG1290|consen 139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTD 213 (590)
T ss_pred CCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccC
Confidence 379999998864 45789999999 66999999653 4455889999999999999999999866 999999
Q ss_pred CCCCceEec
Q 040480 180 IKPANVLID 188 (325)
Q Consensus 180 l~~~nil~~ 188 (325)
|||+|||+.
T Consensus 214 lKPENvLl~ 222 (590)
T KOG1290|consen 214 LKPENVLLC 222 (590)
T ss_pred CCcceeeee
Confidence 999999983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=244.63 Aligned_cols=261 Identities=21% Similarity=0.240 Sum_probs=198.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC------
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH------ 106 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------ 106 (325)
.++|++....|+|-|++|.+|. +...+..||||++.. ++.-.+.=..|+++|++|+.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~-D~~r~~~vAiKIIRn----------------NE~M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRAR-DQARGQEVAIKIIRN----------------NEVMHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred cceeEEEeccccceeeeeeecc-ccCCCCeeEEEEeec----------------chHHhhhhhHHHHHHHHhhccCchhh
Confidence 4588899999999999999995 666777999999932 22333445678999999952
Q ss_pred CCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 107 RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 107 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
-++++++..|...+++|+|||-+ ..+|.+.+.++ +.+-.+.......++.|++.||.+|. +-||+|+||||+|||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNIL 568 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceE
Confidence 38999999999999999999988 55999999775 34556788888899999999999999 669999999999999
Q ss_pred ecCC-CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 187 IDDD-MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 187 ~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
+++. ..+||||||.|..........- .-+..|.|||++.|-+|+...|+||.||++|+|.||+..|.+..+
T Consensus 569 VNE~k~iLKLCDfGSA~~~~eneitPY----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN---- 640 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENEITPY----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN---- 640 (752)
T ss_pred eccCcceeeeccCccccccccccccHH----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc----
Confidence 9976 4569999999987665443211 224468999999999999999999999999999999999976332
Q ss_pred chHHHHHHHHhhhCCCC-------------------------------------cccc-----hhh-----cCCchHHHH
Q 040480 266 MDMVRWMRNVMASENPN-------------------------------------RAID-----SKL-----LGNGYEEQM 298 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~-------------------------------------~~~~-----~~~-----~~~~~~~~~ 298 (325)
.++....-. ++++.+. ...+ ..+ ++.......
T Consensus 641 N~MLrl~me-~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~ 719 (752)
T KOG0670|consen 641 NQMLRLFME-LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIV 719 (752)
T ss_pred HHHHHHHHH-hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHH
Confidence 222222111 1111110 0000 000 112224555
Q ss_pred HHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 299 LLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 299 ~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..|.+|+.+||..||++|.|..++|+
T Consensus 720 ~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 720 QQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHHHhccChhhcCCHHHHhc
Confidence 67999999999999999999999885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=258.49 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=188.1
Q ss_pred cccccccccCcce-eEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccc
Q 040480 36 FASLEKIGSGGCG-DVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLL 113 (325)
Q Consensus 36 y~~~~~lg~G~~g-~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 113 (325)
|.-.+.+|.|+.| .||+|.+ .++.||||.+ -........+|+..+..- +||||++++
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y---e~R~VAVKrl------------------l~e~~~~A~rEi~lL~eSD~H~NviRyy 569 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY---EGREVAVKRL------------------LEEFFDFAQREIQLLQESDEHPNVIRYY 569 (903)
T ss_pred eccHHHcccCCCCcEEEEEee---CCceehHHHH------------------hhHhHHHHHHHHHHHHhccCCCceEEEE
Confidence 4444678999997 6899987 7889999976 123455678899888877 599999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC---C
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD---D 190 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~---~ 190 (325)
+.-.++...|+..|.|.. +|.+++.................++.|++.||++|| +.+||||||||.|||++. +
T Consensus 570 c~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~ 645 (903)
T KOG1027|consen 570 CSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSAD 645 (903)
T ss_pred eeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCC
Confidence 999999999999999965 999999552011111111455788999999999999 789999999999999985 3
Q ss_pred --CCceeeccccceecCCCCcccc-ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCcccCCCcc
Q 040480 191 --MEARISGFDLAILMPDGLTQID-TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMG-KFPFDDFFSHTGEM 266 (325)
Q Consensus 191 --~~~~l~dfg~~~~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g-~~p~~~~~~~~~~~ 266 (325)
..++|.|||++..+..+..... .....||.+|.|||++....-+.++||+||||++|+.++| ..||++...++.
T Consensus 646 ~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-- 723 (903)
T KOG1027|consen 646 GTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-- 723 (903)
T ss_pred cceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--
Confidence 4579999999998876554333 3335789999999999998888899999999999999984 899987443211
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++..+........+. .++ +..+||.+|++.||..||++.++|.
T Consensus 724 -------NIl~~~~~L~~L~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 724 -------NILTGNYTLVHLEPL------PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------hhhcCccceeeeccC------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 122222222111111 111 3889999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=245.78 Aligned_cols=278 Identities=21% Similarity=0.302 Sum_probs=180.6
Q ss_pred hhcCcccccccccCcceeEEEEEec---------------CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHH
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELP---------------GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRS 96 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (325)
..++|.+.++||+|+||+||+|.+. ...++.||||.+.........++... ........+....
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e-~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKT-GTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhh-hhhhhcccchhHH
Confidence 4678999999999999999999531 12346799999854322111111100 0011112334556
Q ss_pred HHHHHhccCCCCc-----cccccceec--------CCceEEEEEcccCCCHHHHHhhhcc--------------------
Q 040480 97 QIITASQIRHRNI-----LPLLAHMVR--------PDSHLLVYDFMKNGSLQAVLYDVSK-------------------- 143 (325)
Q Consensus 97 e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~-------------------- 143 (325)
|+.++.+++|.++ +++++++.. .+..++|+||+.+++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766544 566666543 3568999999999999998853211
Q ss_pred cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccc
Q 040480 144 GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYI 223 (325)
Q Consensus 144 ~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~ 223 (325)
....+++..+..++.|++.+|.|+| +++++|+||||+||+++.++.++|+|||++......... ......+++.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 0122455678889999999999999 889999999999999999999999999999755432211 111123478999
Q ss_pred cccccccCCC----------------------CCccchhhHHHHHHHHHhCCC-CCCCcccCCC-----cchHHHHHHHH
Q 040480 224 APEYHQTLTI----------------------SEKCDIYSFGVLLAVLVMGKF-PFDDFFSHTG-----EMDMVRWMRNV 275 (325)
Q Consensus 224 aPE~~~~~~~----------------------~~~~DvwslG~il~~ll~g~~-p~~~~~~~~~-----~~~~~~~~~~~ 275 (325)
|||.+..... ..+.|+||+||++++|+++.. ||........ ..+...|..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-- 455 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-- 455 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence 9998754321 234799999999999999875 7653211100 111111111
Q ss_pred hhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCC---CCCCChhhhhc
Q 040480 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADP---DERPNSKDVRC 324 (325)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~ell~ 324 (325)
......... ..+.......+|+.+||..+| .+|+|++|+|+
T Consensus 456 ~~~~~~~~~--------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 YKGQKYDFS--------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hcccCCCcc--------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111111100 111223348899999999866 78999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=232.32 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=202.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCC----CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGS----NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
...|++....+.+|.||.||.|.|... +.+.|.+|.+. ....+-....+..|..++..+.||
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk--------------~~AS~iQv~~~L~es~lly~~sH~ 347 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK--------------QHASQIQVNLLLQESMLLYGASHP 347 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH--------------hcccHHHHHHHHHHHHHHhcCcCC
Confidence 445688888899999999999976532 22445555431 222334567788999999999999
Q ss_pred Cccccccceec-CCceEEEEEcccCCCHHHHHhhhc----ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 108 NILPLLAHMVR-PDSHLLVYDFMKNGSLQAVLYDVS----KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 108 ~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
|+..+.++... ....+.++++...|+|+.++.-.. ...+.+...+...++.|++.|++||| +.|++|.||..
T Consensus 348 nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAa 424 (563)
T KOG1024|consen 348 NLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAA 424 (563)
T ss_pred CccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhh
Confidence 99999998754 456788999999999999996322 23455777777889999999999999 88999999999
Q ss_pred CceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCccc
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFS 261 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~ 261 (325)
+|.++++.-.+||+|=.+++.+...+...-......+..|++||.+....|+.++|+||||+++|||+| |+.|+.+.++
T Consensus 425 RNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 425 RNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred hcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 999999999999999999998766655444333455778999999999999999999999999999998 9999976333
Q ss_pred CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.++..+++...+...+. +++++++.++.-||..+|++||+++|+++
T Consensus 505 ----fEm~~ylkdGyRlaQP~-------------NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 505 ----FEMEHYLKDGYRLAQPF-------------NCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ----HHHHHHHhccceecCCC-------------CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 34444444333333332 34445999999999999999999999863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=212.86 Aligned_cols=209 Identities=25% Similarity=0.402 Sum_probs=174.1
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHR 107 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 107 (325)
|....+...-+..||+|++|.|=+.++ ..+|...|+|.+.. ..+.....++.+|+.+.... .+|
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh-~~sg~imAvKri~~--------------tvn~q~q~r~L~dldi~~r~~~CP 105 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRH-IQSGTIMAVKRIRA--------------TVNSQEQKRLLMDLDIIMRTVDCP 105 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheee-ccCCeEEEEeeehh--------------hcChHHHHHHHHhhhhhccCCCCC
Confidence 334555666677899999999888753 46889999998842 23445566777777776655 689
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
++|.+|+.....+..++.||.++. +|..+..+....+...++..+.+|+..+..||.|||+ ...++|||+||+|||+
T Consensus 106 f~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLI 182 (282)
T KOG0984|consen 106 FTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILI 182 (282)
T ss_pred eEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEE
Confidence 999999999999999999999965 9999888888889999999999999999999999996 4589999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCccccccccccc----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT----LTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~----~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+.+|.+|+||||.+..+....... ...|...|+|||.+.. ..|+.++||||||+++.||.+++.||+.
T Consensus 183 n~~GqVKiCDFGIsG~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 183 NYDGQVKICDFGISGYLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccCCcEEEcccccceeehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 999999999999998766543322 2467788999998754 3688999999999999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=228.88 Aligned_cols=260 Identities=25% Similarity=0.340 Sum_probs=196.7
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.-..+|.-++.+|.|.- .|..+ .+...+++||+|++... .......++..+|..++..++|+||+
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a-~D~v~~~~v~ikk~~~p-------------f~n~~~akra~rel~l~~~v~~~nii 78 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAA-FDQVLGRPVAIKKLSRP-------------FQNQTHAKRAYRELKLMKCVNHKNII 78 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEec-chhhccCceehhhhcCc-------------cccCccchhhhhhhhhhhhhccccee
Confidence 34578999999999999 67777 67788999999987322 22234566788999999999999999
Q ss_pred ccccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040480 111 PLLAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 111 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~n 184 (325)
+++.++.-. ...|+|||++.. +|.+.+. ..++-.++..++.|++.|+.||| +.||+||||||+|
T Consensus 79 ~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsn 148 (369)
T KOG0665|consen 79 SLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSN 148 (369)
T ss_pred eeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCccc
Confidence 999988644 356999999965 9998883 34777889999999999999999 9999999999999
Q ss_pred eEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 185 VLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
|++..+..+||.|||+++....... .+....+..|.|||++.+..+.+.+||||+||++.+|+.|..-|.+.
T Consensus 149 ivv~~~~~lKi~dfg~ar~e~~~~~---mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----- 220 (369)
T KOG0665|consen 149 IVVNSDCTLKILDFGLARTEDTDFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----- 220 (369)
T ss_pred ceecchhheeeccchhhcccCcccc---cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-----
Confidence 9999999999999999986554411 12246677899999999999999999999999999999999988532
Q ss_pred cchHHHHHHHHhhhCCCC---------------------------cccchhhcCCc---hHHHHHHHHHHHhhhcCCCCC
Q 040480 265 EMDMVRWMRNVMASENPN---------------------------RAIDSKLLGNG---YEEQMLLVLKLACFCTLADPD 314 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~ 314 (325)
..+.+|.+.....+.+. ..++...+... ..-....+.+|+.+||..||+
T Consensus 221 -d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe 299 (369)
T KOG0665|consen 221 -DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPE 299 (369)
T ss_pred -hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChh
Confidence 22222222221111110 00000000000 111223488999999999999
Q ss_pred CCCChhhhhc
Q 040480 315 ERPNSKDVRC 324 (325)
Q Consensus 315 ~Rps~~ell~ 324 (325)
+|.|++++|+
T Consensus 300 ~Risv~daL~ 309 (369)
T KOG0665|consen 300 KRISVDDALR 309 (369)
T ss_pred hcccHHHHhc
Confidence 9999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-34 Score=227.03 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=189.3
Q ss_pred ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccce
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHM 116 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 116 (325)
+--+.||-|+||+||.++ +..+++.|++|++.. -..+-...+.+.+|+.++..++|.|++..+++.
T Consensus 56 ~PDRPIGYGAFGVVWsVT-DPRdgrrvalkK~pn-------------vfq~L~s~krvFre~kmLcfFkHdNVLSaLDIL 121 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVT-DPRSGKRVALKKMPN-------------VFQNLASCKRVFREIKMLSSFRHDNVLSLLDIL 121 (449)
T ss_pred CCCCcccccceeEEEecc-CCCCccchhHhhcch-------------HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhc
Confidence 345689999999999995 667889999999832 122234567889999999999999999998876
Q ss_pred ecCC-----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 117 VRPD-----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 117 ~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
.-.. ..|.++|.+.. +|...+ .+.+.++...+.-++.||+.||.||| +.+|.||||||.|.+++.+.
T Consensus 122 QPph~dfFqEiYV~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNC 193 (449)
T KOG0664|consen 122 QPANPSFFQELYVLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNC 193 (449)
T ss_pred CCCCchHHHHHHHHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCc
Confidence 5433 34677887754 777777 66778999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.+||+|||+++........ ..+...-|..|.|||++.|. .|+.+.||||.||++.|++..+.-|....+ .+..+
T Consensus 194 vLKICDFGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P----iqQL~ 268 (449)
T KOG0664|consen 194 ILKICDFGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP----IEQLQ 268 (449)
T ss_pred eEEecccccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh----HHHHH
Confidence 9999999999876654332 11223447789999999886 489999999999999999999888854221 11111
Q ss_pred HHHHHh------------h-------hCCCCcccchhhcC-CchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVM------------A-------SENPNRAIDSKLLG-NGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~------------~-------~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.... . ......+..+.+.. ....+......+++.+++.+||++|.+.++.+.
T Consensus 269 lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 269 MIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 111111 0 01111111111111 111122223678889999999999999888763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-33 Score=241.04 Aligned_cols=206 Identities=26% Similarity=0.345 Sum_probs=172.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC---CCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR---HRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~ 108 (325)
.-..|..++.||.|+||.|++|.++ .+...|+||.++.-+ .-.....+....-.+-.|+.||+.++ |+|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K-~n~~eVViK~I~KeR-------IL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHK-ENNYEVVIKMIFKER-------ILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred ccccceeeeeccccccceEEEeeec-ccceEEEeeehhhhh-------hhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 3356999999999999999999654 557889999884211 11111222333445778999999997 999
Q ss_pred ccccccceecCCceEEEEEcc-cCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 109 ILPLLAHMVRPDSHLLVYDFM-KNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
|++++++|++++..|++||.. +|.+|.++| .....+++..+..|+.|++.|+++|| ++||||||||-+|+.+
T Consensus 631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenviv 703 (772)
T KOG1152|consen 631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIV 703 (772)
T ss_pred hhhhhheeecCCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEE
Confidence 999999999999999999976 356899998 45667999999999999999999999 9999999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~ 256 (325)
+.+|-++|+|||.+.....+.. ..++||..|.|||++.|.+| ...-|||+||+++|.++....||
T Consensus 704 d~~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ecCCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9999999999999987766543 23689999999999999887 45689999999999999998887
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=242.32 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=204.6
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
....+|+.+.++|.|++|.||+++ +..+++..|+|.+.+. ......-+.+|+.+++..+||||+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaR-d~~s~elaavkvVkLe---------------p~dd~~~iqqei~~~~dc~h~niv 75 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKAR-DKRSGELAAVKVVKLE---------------PGDDFSGIQQEIGMLRDCRHPNIV 75 (829)
T ss_pred CCccchhheeeecCCcccchhhhc-ccccCchhhheeeecc---------------CCccccccccceeeeecCCCcChH
Confidence 466789999999999999999996 6678899999998543 234456678889999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
.+++.+...+.+++.||||.||+|.+.. ...+.+++.++..++...+.+++||| ++|-+|||||--||++++.
T Consensus 76 ay~gsylr~dklwicMEycgggslQdiy----~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~ 148 (829)
T KOG0576|consen 76 AYFGSYLRRDKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDE 148 (829)
T ss_pred HHHhhhhhhcCcEEEEEecCCCccccee----eecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeeccc
Confidence 9999999999999999999999999887 45677999999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
|.++++|||.+........... .+.||+.|+|||+.. ...|...+|+|++|++..++-.-++|..+..+
T Consensus 149 gDvklaDfgvsaqitati~Krk--sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------ 220 (829)
T KOG0576|consen 149 GDVKLADFGVSAQITATIAKRK--SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------ 220 (829)
T ss_pred CceeecccCchhhhhhhhhhhh--cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------
Confidence 9999999999976654433222 268999999999653 44588999999999999999988888644322
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....-+-.....++...+. ......|-++++.++.++|++|||++.+|+
T Consensus 221 mr~l~LmTkS~~qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 221 MRALFLMTKSGFQPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHhhccCCCCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111222222222222221 112223788999999999999999998774
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=206.12 Aligned_cols=211 Identities=33% Similarity=0.506 Sum_probs=177.7
Q ss_pred cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCCc
Q 040480 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS 121 (325)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 121 (325)
||.|.+|.||++.. ..+++.+++|.+...... .....+.+|+..++.+.|++++++++++.....
T Consensus 1 l~~g~~~~v~~~~~-~~~~~~~~~K~~~~~~~~--------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 65 (215)
T cd00180 1 LGEGGFGTVYLARD-KKTGKKVAIKIIKKEDSS--------------SLLEELLREIEILKKLNHPNIVKLYGVFEDENH 65 (215)
T ss_pred CCcCCceEEEEEEe-cCCCcEEEEEEeccccch--------------hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Confidence 68999999999964 345889999988322110 035678999999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC-CCCceeecccc
Q 040480 122 HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-DMEARISGFDL 200 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~-~~~~~l~dfg~ 200 (325)
.++++|++++++|.+++... ...++......++.+++.++.+|| +.|++|+||+|.||+++. ++.++|+|||.
T Consensus 66 ~~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~ 139 (215)
T cd00180 66 LYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGL 139 (215)
T ss_pred EEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCc
Confidence 99999999989999998432 145888899999999999999999 889999999999999999 89999999999
Q ss_pred ceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhC
Q 040480 201 AILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASE 279 (325)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 279 (325)
+........ ......+...|.+||..... ..+.++|+|++|++++++
T Consensus 140 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------ 187 (215)
T cd00180 140 SKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------ 187 (215)
T ss_pred eEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------
Confidence 987655431 11113567789999998876 778999999999999999
Q ss_pred CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 280 NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+.+++.+|++.||.+||++.++++
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence 11889999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=217.19 Aligned_cols=200 Identities=24% Similarity=0.343 Sum_probs=164.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~ 108 (325)
-.+.|.++++||.|.|++||++.+... .++.||+|.+..+ ....++..|+++|..+. +.|
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----------------s~p~ri~~El~~L~~~gG~~n 96 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----------------SSPSRILNELEMLYRLGGSDN 96 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----------------cCchHHHHHHHHHHHhccchh
Confidence 567899999999999999999965432 6788999988443 34456889999999995 799
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++.+.+..+++..+|+||++.....++... ++...+..+++.++.||.++| .+||||||+||+|++.+
T Consensus 97 i~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n 166 (418)
T KOG1167|consen 97 IIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYN 166 (418)
T ss_pred hhcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccc
Confidence 99999999999999999999999998888833 778889999999999999999 99999999999999998
Q ss_pred C-CCCceeeccccceecCCC-------C------cc-----------------------------ccceeecCCcccccc
Q 040480 189 D-DMEARISGFDLAILMPDG-------L------TQ-----------------------------IDTMYVVGTPRYIAP 225 (325)
Q Consensus 189 ~-~~~~~l~dfg~~~~~~~~-------~------~~-----------------------------~~~~~~~g~~~~~aP 225 (325)
. .+.-.|+|||++...... . .. .......||++|.||
T Consensus 167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP 246 (418)
T KOG1167|consen 167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP 246 (418)
T ss_pred cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence 4 467799999999721000 0 00 000113689999999
Q ss_pred cccccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 226 EYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 226 E~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
|++... ..+.++||||-|+|+..++++..||-.
T Consensus 247 EvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 247 EVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred HHHhhccCcCCccceeeccceeehhhcccccccc
Confidence 987654 468899999999999999999999954
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=204.11 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=184.1
Q ss_pred cccchhHHHHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHH
Q 040480 20 PLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99 (325)
Q Consensus 20 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 99 (325)
..|...++..+.-.+.|.|.+.||+|.||.+-+|++ ..++..+++|-+.. .......+.+|.-
T Consensus 10 h~I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eH-r~s~t~ivlKavp~----------------p~tt~~dF~rEfh 72 (378)
T KOG1345|consen 10 HLIPMEELKKVDLEDVYTINKQLGEGRFGKILLAEH-RQSKTRIVLKAVPR----------------PQTTQADFVREFH 72 (378)
T ss_pred cccccccccccchhhhhhHHHHhcccceeeEEeeec-cCCceEEEeeccCc----------------chhhHHHHHHHhc
Confidence 456667777778889999999999999999999975 45667788997631 1234556666665
Q ss_pred HHhcc-CCCCccccccce-ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 040480 100 TASQI-RHRNILPLLAHM-VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIH 177 (325)
Q Consensus 100 ~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH 177 (325)
.--.| .|.||+.-|+.. ...+..++++||++-|+|.+-+ ....+.+.....++.|++.|+.|+| +.++||
T Consensus 73 Y~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMH---sknlVH 144 (378)
T KOG1345|consen 73 YSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMH---SKNLVH 144 (378)
T ss_pred cceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhh---ccchhh
Confidence 54445 478999887754 5566777899999999999888 3455777788899999999999999 999999
Q ss_pred cCCCCCceEec--CCCCceeeccccceecCCCCccccceeecCCcccccccccccC-----CCCCccchhhHHHHHHHHH
Q 040480 178 RDIKPANVLID--DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-----TISEKCDIYSFGVLLAVLV 250 (325)
Q Consensus 178 ~dl~~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-----~~~~~~DvwslG~il~~ll 250 (325)
||||.+|||+- +...+||||||..+..+....... -+..|.+||..... ...+.+|+|+||+++|.++
T Consensus 145 RdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~-----~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl 219 (378)
T KOG1345|consen 145 RDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLE-----YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL 219 (378)
T ss_pred cccccceEEEecCCccEEEeeecccccccCceehhhh-----hhcccCCcHHHhhccccceEecccccchheeeeeeeee
Confidence 99999999995 446799999999987655433222 24468888865432 2357899999999999999
Q ss_pred hCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC
Q 040480 251 MGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318 (325)
Q Consensus 251 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (325)
+|+.||..... ++...|....+....... .++.+..-.+ .+.++.++-|..+|++|=.
T Consensus 220 tG~~PWQka~~----~d~~Y~~~~~w~~rk~~~--~P~~F~~fs~----~a~r~Fkk~lt~~~~drck 277 (378)
T KOG1345|consen 220 TGKFPWQKASI----MDKPYWEWEQWLKRKNPA--LPKKFNPFSE----KALRLFKKSLTPRFKDRCK 277 (378)
T ss_pred cCCCcchhhhc----cCchHHHHHHHhcccCcc--CchhhcccCH----HHHHHHHHhcCCcccccch
Confidence 99999984322 222222222222221110 1111111111 2667888888899988843
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=202.16 Aligned_cols=200 Identities=31% Similarity=0.448 Sum_probs=167.5
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH 115 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 115 (325)
|.+.+.||.|++|.||++.. ..+++.+++|.+...... .....+.+|+..++.++|+|++++++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~~--------------~~~~~~~~e~~~~~~~~~~~i~~~~~~ 65 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARD-KGTGELVAVKVLKKEKTE--------------KQREEFLREIRILKKLKHPNIVKLYGV 65 (225)
T ss_pred CceeeEeecCCCeEEEEEEE-cCCCcEEEEEeeccccch--------------HHHHHHHHHHHHHHhCCCCChhhheee
Confidence 67788999999999999964 455788999998432110 145678889999999999999999999
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccc-cChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE-LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
+......++++|++++++|.+++... .. ++......++.+++.++.+|| +.+++|+|++|+||+++.++.++
T Consensus 66 ~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~ 138 (225)
T smart00221 66 FEDPEPLYLVMEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVK 138 (225)
T ss_pred eecCCceEEEEeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999998432 22 788889999999999999999 77999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCccccccccc-ccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYH-QTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~-~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
|+|||.+......... ......++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 139 l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 139 LADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 9999999876554311 11224667889999998 666778899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=236.73 Aligned_cols=194 Identities=14% Similarity=0.184 Sum_probs=136.9
Q ss_pred CC-CCccccccce-------ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 040480 105 RH-RNILPLLAHM-------VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVI 176 (325)
Q Consensus 105 ~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~iv 176 (325)
+| +||+.+++++ .....++.++|++ +++|.+++.. ....++...+..++.|++.||.||| ++||+
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 45 6788888876 2334577888987 5599999942 2455899999999999999999999 88999
Q ss_pred ecCCCCCceEecC-------------------CCCceeeccccceecCCCCc--------------cccceeecCCcccc
Q 040480 177 HRDIKPANVLIDD-------------------DMEARISGFDLAILMPDGLT--------------QIDTMYVVGTPRYI 223 (325)
Q Consensus 177 H~dl~~~nil~~~-------------------~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~g~~~~~ 223 (325)
||||||+|||++. ++.++++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 34566677776653211000 00011135788999
Q ss_pred cccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHH
Q 040480 224 APEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLK 303 (325)
Q Consensus 224 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 303 (325)
|||++.+..++.++|||||||++|+|++|..|+.... ... ........+.. .. .......+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~---~~~~~~~~~~~-----~~-----~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTM---SSLRHRVLPPQ-----IL-----LNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHH---HHHHHhhcChh-----hh-----hcCHHHHH
Confidence 9999999999999999999999999999988864311 111 11111111110 00 01112567
Q ss_pred HHhhhcCCCCCCCCChhhhhc
Q 040480 304 LACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 304 li~~~l~~dP~~Rps~~ell~ 324 (325)
++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=184.73 Aligned_cols=162 Identities=20% Similarity=0.225 Sum_probs=120.2
Q ss_pred CCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccc
Q 040480 132 GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI 211 (325)
Q Consensus 132 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 211 (325)
|+|.+++.. .+..+++..++.++.|++.||.||| +++ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc---
Confidence 588888843 2456999999999999999999999 556 999999999999998 99987654322
Q ss_pred cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcC
Q 040480 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLG 291 (325)
Q Consensus 212 ~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (325)
..|++.|+|||++.+..++.++||||||+++|+|++|..||..... ....................
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~---- 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE------LSAILEILLNGMPADDPRDR---- 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch------hcHHHHHHHHHhccCCcccc----
Confidence 2578999999999999999999999999999999999999964321 11111111111111111000
Q ss_pred CchHHHHH--HHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 292 NGYEEQML--LVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 292 ~~~~~~~~--~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ .+.+++.+||..||.+|||+.++++
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~ 164 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLA 164 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHH
Confidence 01112222 4899999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=188.99 Aligned_cols=202 Identities=23% Similarity=0.311 Sum_probs=172.7
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~ 112 (325)
-.|++.++||+|.||+++.|+ +--++++||||.- -......+++.|....+.|. .++|.++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~-Nl~nne~VAIKfE-----------------PrkS~APQLrdEYr~YKlL~g~~GIP~v 89 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGK-NLYNNEPVAIKFE-----------------PRKSEAPQLRDEYRTYKLLGGTEGIPQV 89 (449)
T ss_pred ccceeccccccCcceeeeccc-ccccCceEEEEec-----------------cccCCcchHHHHHHHHHHHcCCCCCCce
Confidence 369999999999999999994 6678999999964 22344557788888888886 5999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC--
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD-- 190 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~-- 190 (325)
+.+....-+..+|+|.+ |.+|.+++ ..++..++.++...++.||+.-++++| .+.+|+|||||+|+||...
T Consensus 90 YYFGqeG~~NiLVidLL-GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~ 162 (449)
T KOG1165|consen 90 YYFGQEGKYNILVIDLL-GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGT 162 (449)
T ss_pred eeeccccchhhhhhhhh-CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCC
Confidence 99888888899999988 88999998 347788999999999999999999999 8889999999999999733
Q ss_pred ---CCceeeccccceecCCCCccccc-----eeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcc
Q 040480 191 ---MEARISGFDLAILMPDGLTQIDT-----MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF 260 (325)
Q Consensus 191 ---~~~~l~dfg~~~~~~~~~~~~~~-----~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~ 260 (325)
..+.++|||++..+......... ....||.+||+-..+.|.+.+.+.|+-|||.++++.|-|..||.+..
T Consensus 163 k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 163 KDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred CCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 45799999999877655443332 22579999999999999999999999999999999999999998744
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=194.34 Aligned_cols=204 Identities=24% Similarity=0.294 Sum_probs=162.2
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC----CCCcc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR----HRNIL 110 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~ 110 (325)
+|.+.++||+|+||.||+|.........+|+|...... ......+..|..++..+. .+++.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~---------------~~~~~~l~~E~~vl~~l~~~~~~~~~~ 83 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKEL---------------GSKPSVLKIEIQVLKKLEKKNGPSHFP 83 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecc---------------cCCCccchhHHHHHHHHhhhcCCCCCC
Confidence 89999999999999999997543334678888763211 111115667777777775 26888
Q ss_pred ccccce-ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 111 PLLAHM-VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 111 ~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
.+++.. ......++||+.+ |.+|.+...... ...++..+...++.|++.+|.++| +.|++||||||.|+++..
T Consensus 84 ~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~ 157 (322)
T KOG1164|consen 84 KLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQ 157 (322)
T ss_pred EEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecC
Confidence 888888 4777889999988 789999875432 577999999999999999999999 889999999999999985
Q ss_pred C-----CCceeeccccceecC--CCCc----ccc--ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 040480 190 D-----MEARISGFDLAILMP--DGLT----QID--TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 190 ~-----~~~~l~dfg~~~~~~--~~~~----~~~--~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~ 256 (325)
. ..+++.|||+++.+. .... ... ...+.||..|.|+.++.+...+.+.|+||++.++.+++.|..||
T Consensus 158 ~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 158 SSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred CCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 4 358999999998332 1111 111 12356999999999999999999999999999999999999999
Q ss_pred CCc
Q 040480 257 DDF 259 (325)
Q Consensus 257 ~~~ 259 (325)
...
T Consensus 238 ~~~ 240 (322)
T KOG1164|consen 238 EAL 240 (322)
T ss_pred ccc
Confidence 653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=178.34 Aligned_cols=209 Identities=25% Similarity=0.312 Sum_probs=172.9
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC-
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH- 106 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h- 106 (325)
.-+...+.|.++++||.|+||.+|.|. .-.+|..||||.-. ....-..+..|..+...+++
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~-~i~~ge~VAiK~Es-----------------~~a~hpqL~yEskvY~iL~~g 70 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGI-SITSGEEVAIKLES-----------------SKAKHPQLLYESKVYRILQGG 70 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeee-eccCCceEEEEeec-----------------ccCCCcchhHHHHHHHHhccC
Confidence 345567899999999999999999995 56789999999752 11233456778888888875
Q ss_pred CCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 107 RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 107 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
..|+.+..+..+.+...+||+.+ |.+|.+.+.- ....++.++.+-++.|++.-++|+| .++.+||||||+|++
T Consensus 71 ~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFL 143 (341)
T KOG1163|consen 71 VGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFL 143 (341)
T ss_pred CCCchhhhhccccccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCcccee
Confidence 78899998899999999999988 8899999854 4566999999999999999999999 889999999999999
Q ss_pred ecCC---CCceeeccccceecCCCCccc-----cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 187 IDDD---MEARISGFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 187 ~~~~---~~~~l~dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+.-+ ..+.++|||++..+....... ......||.+|.|-..+.+-..+...|+-|+|.++.+..-|..||.+
T Consensus 144 MGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 144 MGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred eccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 9743 568999999998765433322 22335789999998888888889999999999999999999999987
Q ss_pred ccc
Q 040480 259 FFS 261 (325)
Q Consensus 259 ~~~ 261 (325)
...
T Consensus 224 lka 226 (341)
T KOG1163|consen 224 LKA 226 (341)
T ss_pred cch
Confidence 543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=192.17 Aligned_cols=172 Identities=20% Similarity=0.195 Sum_probs=128.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|.+.+.||+|+||+||+|.+...++..+|||++...... .........+.+|+.++++++|+|++.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~----------~~~~~~~~~~~~E~~iL~~L~h~~iv~ 85 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW----------WSKPLARHLAAREIRALKTVRGIGVVP 85 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc----------cccHHHHHHHHHHHHHHHhccCCCCCc
Confidence 4578999999999999999999765557778899986311000 001123556899999999999999885
Q ss_pred -cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEecC
Q 040480 112 -LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDI-KPANVLIDD 189 (325)
Q Consensus 112 -~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl-~~~nil~~~ 189 (325)
++. .+..|+||||++|++|.. . .. .. ...++.+++.+|.+|| ++||+|||| ||+||+++.
T Consensus 86 ~l~~----~~~~~LVmE~~~G~~L~~-~----~~---~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~ 147 (365)
T PRK09188 86 QLLA----TGKDGLVRGWTEGVPLHL-A----RP---HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGP 147 (365)
T ss_pred EEEE----cCCcEEEEEccCCCCHHH-h----Cc---cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcC
Confidence 443 245799999999999962 2 11 01 1467889999999999 889999999 999999998
Q ss_pred CCCceeeccccceecCCCCcccc------ceeecCCcccccccccccC
Q 040480 190 DMEARISGFDLAILMPDGLTQID------TMYVVGTPRYIAPEYHQTL 231 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~------~~~~~g~~~~~aPE~~~~~ 231 (325)
++.++|+|||++..+........ .....++..|++||.+...
T Consensus 148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 89999999999997654332111 1234677789999987643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=206.63 Aligned_cols=262 Identities=20% Similarity=0.234 Sum_probs=186.0
Q ss_pred ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccce
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHM 116 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 116 (325)
.....+|.|++|.|+.+. .....+..+.|..... ... ..........+..|+.+-..+.|||++......
T Consensus 321 ~~~~~~g~ga~g~~~~~~-~~~~~~~~~~~~~r~~-~~~--------~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~ 390 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAK-RRSDLKSFPEKEFRVR-VKP--------TESERKYNYNITSEFCIGSSLSHPNIIETLDIV 390 (601)
T ss_pred CccceeeecccCceEEEE-ecCCCccchhhhhhcc-cCC--------cccHHHHhhhhhhheeecccccCCchhhhHHHH
Confidence 456688999999777774 3333333444433111 000 000111222277778888889999998888877
Q ss_pred ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceee
Q 040480 117 VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS 196 (325)
Q Consensus 117 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~ 196 (325)
.+....+-+||||++ +|...+ .....+....+..++.|++.|+.|+| ..|+.|||+|++|+++..++.+|++
T Consensus 391 ~~~~~~~~~mE~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~ 462 (601)
T KOG0590|consen 391 QEIDGILQSMEYCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKII 462 (601)
T ss_pred hhcccchhhhhcccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEe
Confidence 777766666999999 999998 33346888888999999999999999 8899999999999999999999999
Q ss_pred ccccceecCCCCcc--ccceeecCCcccccccccccCCCCC-ccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 197 GFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQTLTISE-KCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 197 dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~~~~-~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
|||.+..+...... ......+|+..|.|||...+..|.+ ..||||.|++++.|++|+.||-......... . .
T Consensus 463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~---~ 537 (601)
T KOG0590|consen 463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--K---T 537 (601)
T ss_pred ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--h---h
Confidence 99999877655444 3344478999999999999998875 5999999999999999999996533211110 0 0
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
. ...................+..-+.+|.+||+.||.+|.|+++|++.
T Consensus 538 ~----~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 538 N----NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred h----ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0 00000000000111223344457889999999999999999999863
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=178.10 Aligned_cols=239 Identities=19% Similarity=0.232 Sum_probs=150.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC-------
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH------- 106 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------- 106 (325)
-.......||.|+++.||.++ +..+++.+|+|.+........ ...+.+++|.-....+.+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~-d~~t~~~~avkvf~~~~~~~~------------~~~~~~~~e~l~~~~~~~~~~p~~a 78 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVT-DVETGEEFAVKVFLLPADASA------------NEYEQLKEEQLAITLFPGVKNPKEA 78 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEE-ETTTTEEEEEEEEEESSTTHT------------THHHHHHHHHHGGGGSTT--SHHHH
T ss_pred eEEEEccccccCCceEEEEEE-EccCCceEEEEEEecccccch------------HHHHHHHHHHHHhhhhccCCCHHHH
Confidence 345677889999999999995 678899999999876552222 223344444333322211
Q ss_pred ---CCccccccceec------------CC-----ceEEEEEcccCCCHHHHHhhhccc---ccccChhhHHHHHHHHHHH
Q 040480 107 ---RNILPLLAHMVR------------PD-----SHLLVYDFMKNGSLQAVLYDVSKG---RRELEWLSRHKIALAVASG 163 (325)
Q Consensus 107 ---~~i~~~~~~~~~------------~~-----~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~ 163 (325)
-.++-.++...- .. +.+++|+-+. ++|.+.+...... ...+.......+..|++..
T Consensus 79 ~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~l 157 (288)
T PF14531_consen 79 YRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRL 157 (288)
T ss_dssp HHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred HHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHH
Confidence 112222222211 11 2367788774 4898886543222 2334445556788999999
Q ss_pred HHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCccccccccccc--------CCCCC
Q 040480 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT--------LTISE 235 (325)
Q Consensus 164 l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~--------~~~~~ 235 (325)
+++|| +.|++|+||+|+|++++++|.++|+||+.....+..... ...+..|.|||.... -.++.
T Consensus 158 vA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~ 229 (288)
T PF14531_consen 158 VANLH---SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTF 229 (288)
T ss_dssp HHHHH---HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-H
T ss_pred HHHHh---hcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeee
Confidence 99999 889999999999999999999999999888765543221 123467889996543 24788
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCC
Q 040480 236 KCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDE 315 (325)
Q Consensus 236 ~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 315 (325)
+.|.|+||+++|.|+++..||+.......... ....+. +.++.+.+||..+|+.||.+
T Consensus 230 ~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~ 287 (288)
T PF14531_consen 230 ATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPED 287 (288)
T ss_dssp HHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGG
T ss_pred ccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCccc
Confidence 99999999999999999999986433211111 223333 67777999999999999998
Q ss_pred C
Q 040480 316 R 316 (325)
Q Consensus 316 R 316 (325)
|
T Consensus 288 R 288 (288)
T PF14531_consen 288 R 288 (288)
T ss_dssp S
T ss_pred C
Confidence 8
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=173.78 Aligned_cols=246 Identities=22% Similarity=0.349 Sum_probs=181.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+...++.+|.....|..|+|+| .|..++.|++. .+.......+.+..|.-.++-+.||||+.++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw---qgndivakil~-------------vr~~t~risrdfneefp~lrifshpnilpvl 253 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW---QGNDIVAKILN-------------VREVTARISRDFNEEFPALRIFSHPNILPVL 253 (448)
T ss_pred hhhhhhhhhccCCCcccccccc---cCcchhhhhhh-------------hhhcchhhcchhhhhCcceeeecCCchhhhh
Confidence 3455667888999999999998 56677788762 2333444556788888889999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+....++.++..|++.|+|...+.+ +..-..+..++.+++.+++.|++|||+. ..-|--.-|+...++++++-+.
T Consensus 254 gacnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedlta 330 (448)
T KOG0195|consen 254 GACNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTA 330 (448)
T ss_pred hhccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhh
Confidence 999999999999999999999999943 4555677788899999999999999976 3334455688899999988665
Q ss_pred ee--eccccceecCCCCccccceeecCCcccccccccccCCCC---CccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 194 RI--SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTIS---EKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 194 ~l--~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~---~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
+| +|-.++.... ...-.+.|++||.+...+.+ .++|+|||++++|++.|...||.+..+-+....+
T Consensus 331 rismad~kfsfqe~---------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 331 RISMADTKFSFQEV---------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred heecccceeeeecc---------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 54 3322221100 01236789999998876643 5799999999999999999999876553333222
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
. ..+-++. +++. ....+.+|+.-|++.||.+||.+..++
T Consensus 402 a------leglrv~--ippg--------is~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 402 A------LEGLRVH--IPPG--------ISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred h------hcccccc--CCCC--------ccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1 2222211 1111 112278899999999999999998876
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-22 Score=176.40 Aligned_cols=261 Identities=29% Similarity=0.392 Sum_probs=191.7
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC-Ccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR-NILPLLA 114 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~ 114 (325)
|.+.+.||.|+||.||++... ..+++|.+.... .........+.+|..+++.+.|+ +++++.+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~------------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 65 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKL------------ESKSKEVERFLREIQILASLNHPPNIVKLYD 65 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhh------------ccchhHHHHHHHHHHHHHHccCCcceeeEEE
Confidence 788899999999999999643 778899873211 11112466788899999999988 7999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC-Cc
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM-EA 193 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~-~~ 193 (325)
.+......+++++++.++++.+.+...... ..++......++.|++.++.++| +.+++|||+||+||+++..+ .+
T Consensus 66 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~ 141 (384)
T COG0515 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVV 141 (384)
T ss_pred EEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeE
Confidence 997777789999999999999666321111 26888889999999999999999 88999999999999999888 79
Q ss_pred eeeccccceecCCCCccc----cceeecCCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 194 RISGFDLAILMPDGLTQI----DTMYVVGTPRYIAPEYHQT---LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~----~~~~~~g~~~~~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+++|||.+.......... ......|+..|.+||...+ ...+...|+||+|++++++++|..||..........
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~ 221 (384)
T COG0515 142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS 221 (384)
T ss_pred EEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHH
Confidence 999999998655443221 2234688999999999887 578889999999999999999999975432210011
Q ss_pred hHHHHHHHHhhhCCC--CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 267 DMVRWMRNVMASENP--NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
.... .......+ ......... ......+.+++..|+..+|..|.+..+..
T Consensus 222 ~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 222 QTLK---IILELPTPSLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred HHHH---HHHhcCCcccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 1221 11111211 000010000 11223478999999999999999887654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=176.85 Aligned_cols=264 Identities=20% Similarity=0.259 Sum_probs=174.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCC----------------------------------CCcEEEEEEEcccCCCcH-
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGS----------------------------------NGKMIAVKKVIIYSPMSA- 76 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~----------------------------------~~~~vavK~~~~~~~~~~- 76 (325)
..++|+|...||+|+.+.||.++..+. ..-++|||+++..+..+.
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 567899999999999999999864320 013588998887776543
Q ss_pred HHHHHHHHhhCcchHHHHHH-H--HHHHhc--------cCCCCccccccceec---------------------------
Q 040480 77 AELIDAYSELGEGKLTEIRS-Q--IITASQ--------IRHRNILPLLAHMVR--------------------------- 118 (325)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~-e--~~~l~~--------l~h~~i~~~~~~~~~--------------------------- 118 (325)
..+...+...........+. | ....+. -+||||+++...|.+
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 23333322211111111111 1 111111 259999999988754
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec--CC--CCce
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID--DD--MEAR 194 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~--~~--~~~~ 194 (325)
....|+||..++. +|.+++. ....+.....-++.|+++|+.||| .+||.|||+|.+||++. ++ ..++
T Consensus 315 ~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred CceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEE
Confidence 2246899999876 9999983 244667778889999999999999 88999999999999995 22 3469
Q ss_pred eeccccceecCCCCccc----cceeecCCcccccccccccCCC------CCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 195 ISGFDLAILMPDGLTQI----DTMYVVGTPRYIAPEYHQTLTI------SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~----~~~~~~g~~~~~aPE~~~~~~~------~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
++|||.+---....... ...-..|....+|||+....+. -.++|.|+.|.+.||+++...||=... +.
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--em 463 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--EM 463 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--hh
Confidence 99999986444322111 1111456778899998776543 258999999999999999999995411 11
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
..+...+... .-+..+ +.++..+++|+...|+.||++|+|..
T Consensus 464 ~L~~r~Yqe~--qLPalp------------~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 464 LLDTRTYQES--QLPALP------------SRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eechhhhhhh--hCCCCc------------ccCChHHHHHHHHHhcCCccccCCcc
Confidence 1111111111 111111 11222388999999999999999964
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=197.04 Aligned_cols=248 Identities=23% Similarity=0.248 Sum_probs=177.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
...|...+.||.+.|=+|.+|+++ .|. |+||++....+.-.. ....+...+++ .+.+++||++.+
T Consensus 22 ~~e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~sL-----------~~~~qrL~~ik-~~l~~~pn~lPf 86 (1431)
T KOG1240|consen 22 SVECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTISL-----------RPFKQRLEEIK-FALMKAPNCLPF 86 (1431)
T ss_pred ccceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCCCc-----------hHHHHHHHHHH-HHhhcCCcccch
Confidence 337888999999999999999753 444 889998655432221 12223333344 556689999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
.-+.+.+...|+|=+|..+ +|.|.+ ..+.-+...++.-|+.|++.||.-+| ..||+|||||.+|||++.=+.
T Consensus 87 qk~~~t~kAAylvRqyvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW 158 (1431)
T KOG1240|consen 87 QKVLVTDKAAYLVRQYVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNW 158 (1431)
T ss_pred HHHHHhhHHHHHHHHHHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeech
Confidence 8888888889999999977 999998 55566777788889999999999999 889999999999999998888
Q ss_pred ceeeccccceec-CCCCccccceeecCC----cccccccccccC----------C-CCCccchhhHHHHHHHHHh-CCCC
Q 040480 193 ARISGFDLAILM-PDGLTQIDTMYVVGT----PRYIAPEYHQTL----------T-ISEKCDIYSFGVLLAVLVM-GKFP 255 (325)
Q Consensus 193 ~~l~dfg~~~~~-~~~~~~~~~~~~~g~----~~~~aPE~~~~~----------~-~~~~~DvwslG~il~~ll~-g~~p 255 (325)
+.|+||..-... -..+.....+++..| .+|.|||.+... + .+++.||||+||++.||++ |++|
T Consensus 159 ~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl 238 (1431)
T KOG1240|consen 159 LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL 238 (1431)
T ss_pred hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence 999999766422 111222222223333 369999976431 1 5688999999999999998 7888
Q ss_pred CCCcc----cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 256 FDDFF----SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 256 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|.-.. ...+..+....++.+ ... .++.++..|++.||.+|.|+++.|+
T Consensus 239 F~LSQL~aYr~~~~~~~e~~Le~I---ed~------------------~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 239 FTLSQLLAYRSGNADDPEQLLEKI---EDV------------------SLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred ccHHHHHhHhccCccCHHHHHHhC---cCc------------------cHHHHHHHHHccCchhccCHHHHHH
Confidence 85310 000011111111110 000 1889999999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-23 Score=165.97 Aligned_cols=180 Identities=11% Similarity=0.086 Sum_probs=130.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||.|+||.||++. + ++..+|+|.+....+........ -.....+.+|+..+.++.||+|..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~-~--~~~~~iiKvf~~~~~~~~~~~~~------f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLID-T--DYGKYILKVFAPKVKRTERFLKS------FVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEe-c--CCCcEEEEEechhcCchHHHHHh------hhhhHHHHHHHHHHHHHHHCCCCc
Confidence 57899999999999999999974 3 46679999884332222111000 001233678888999999999999
Q ss_pred cccceecC--------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 112 LLAHMVRP--------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 112 ~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+..++... +..+++|||++|.+|.+... ++. ....+++.++..+| ..|++|+|++|+
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~ 164 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH---QHGMVSGDPHKG 164 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH---HcCCccCCCChH
Confidence 98876533 35789999999999987741 222 24568899999999 889999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHH
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLV 250 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (325)
||+++.++ ++|+|||.......... ...+.....+..++|+||||+++....
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999888 99999998865422111 011333344667899999999876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=156.94 Aligned_cols=155 Identities=18% Similarity=0.169 Sum_probs=109.3
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHH--HH---HHHHh------hCcchHHHHHHHHHHHhccCCC
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAE--LI---DAYSE------LGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~---~~~~~------~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
...||+|+||.||+|.. . +|+.||+|++....+..... .. ..+.. ...........|+..+..+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~-~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATT-A-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEEC-C-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 56899999999999964 3 78999999986543211110 00 00000 0001122345688999999887
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceE
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYL-HMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~l-h~~~~~~ivH~dl~~~nil 186 (325)
++.....+.. ...++||||++|+++..... ....++......++.|++.+|.++ | +.|++|+||||+||+
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIl 150 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLL 150 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEE
Confidence 7644333222 23489999999877765431 234688888999999999999999 7 779999999999999
Q ss_pred ecCCCCceeeccccceecC
Q 040480 187 IDDDMEARISGFDLAILMP 205 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~ 205 (325)
++ ++.++|+|||++....
T Consensus 151 i~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred EE-CCcEEEEEccccccCC
Confidence 98 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=187.90 Aligned_cols=201 Identities=21% Similarity=0.259 Sum_probs=160.1
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
..+..|.|.+.+|+|+||+||+|... +++.+|+|+-....+ .++ .-+.+++..+. . .--+.|+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~---WEf---------YI~~q~~~RLk-~--~~~~~~~ 757 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNP---WEF---------YICLQVMERLK-P--QMLPSIM 757 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCc---eee---------eehHHHHHhhc-h--hhhcchH
Confidence 35678999999999999999999754 399999998643321 111 11222222222 0 0135678
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec--
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID-- 188 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~-- 188 (325)
.+...+...+..++|++|.+.|+|.++++ ....+++.....+..||+..+.+|| ..+|||+||||+|+|+.
T Consensus 758 ~~~~a~~~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 758 HISSAHVFQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRRE 830 (974)
T ss_pred HHHHHHccCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecc
Confidence 88888888899999999999999999994 6667888888999999999999999 88999999999999995
Q ss_pred -----CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 040480 189 -----DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255 (325)
Q Consensus 189 -----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p 255 (325)
....++|+|||.+..+............++|-.+-++|...|.+++..+|.|.|+.+++.||+|++.
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 2355899999999877654444444456889999999999999999999999999999999999854
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=154.63 Aligned_cols=157 Identities=17% Similarity=0.145 Sum_probs=111.4
Q ss_pred cccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHH-----HH------HhhCcchHHHHHHHHHHHhccCC
Q 040480 38 SLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID-----AY------SELGEGKLTEIRSQIITASQIRH 106 (325)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-----~~------~~~~~~~~~~~~~e~~~l~~l~h 106 (325)
+...||+|++|.||+|... +|+.||||++....+........ .. .............|...+..+.+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE 78 (190)
T ss_pred CCceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3578999999999999643 78999999986543211110000 00 00000112334678899999988
Q ss_pred CCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCce
Q 040480 107 RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANV 185 (325)
Q Consensus 107 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~ni 185 (325)
+++.....+... ..++||||++|+++..... ....++......++.|++.++.++| . .|++|+||||+||
T Consensus 79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NI 149 (190)
T cd05145 79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNI 149 (190)
T ss_pred CCCCCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhE
Confidence 887554443332 2489999999875544321 2235677788999999999999999 6 8999999999999
Q ss_pred EecCCCCceeeccccceecCC
Q 040480 186 LIDDDMEARISGFDLAILMPD 206 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~ 206 (325)
+++ ++.++|+|||++.....
T Consensus 150 ll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE-CCCEEEEEcccceecCC
Confidence 999 78999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-23 Score=181.52 Aligned_cols=229 Identities=23% Similarity=0.276 Sum_probs=174.2
Q ss_pred ccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcccccccee
Q 040480 41 KIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPLLAHMV 117 (325)
Q Consensus 41 ~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 117 (325)
.+|+|+||.|+++..- ...+.-+|.|...... ........-..|..++...+ ||.++++...+.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t-------------~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq 67 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKAT-------------LKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ 67 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccc-------------cccccccccccHHHHHhhccCCCceeeeeeeec
Confidence 4799999999988421 1234567777653221 11111225566677778776 999999999999
Q ss_pred cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeec
Q 040480 118 RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~d 197 (325)
.+...++++++..|+.|...+ .....+...........++.++.++| +.+++|+|+|++||+++.+|++++.|
T Consensus 68 t~~kl~l~ld~~rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~td 140 (612)
T KOG0603|consen 68 TDGKLYLILDFLRGGDLFTRL----SKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTD 140 (612)
T ss_pred cccchhHhhhhcccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCC
Confidence 999999999999999998877 33445677777778888999999999 88999999999999999999999999
Q ss_pred cccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhh
Q 040480 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277 (325)
Q Consensus 198 fg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
||.+...-..... +||..|+|||+++ ....++|.||||+++++|++|..||.. ....++.+
T Consensus 141 fglske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~ 201 (612)
T KOG0603|consen 141 FGLSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILK 201 (612)
T ss_pred chhhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhh
Confidence 9999865544332 8899999999999 347889999999999999999999975 22333333
Q ss_pred hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
..... +. .....+.+++..++..+|..|.-.
T Consensus 202 ~~~~~---p~--------~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 AELEM---PR--------ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hccCC---ch--------hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 22211 11 112227889999999999998765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=168.50 Aligned_cols=210 Identities=22% Similarity=0.369 Sum_probs=156.5
Q ss_pred HhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCe-EecC
Q 040480 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARV-IHRD 179 (325)
Q Consensus 101 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~i-vH~d 179 (325)
|+++.|.|+.++++.+.+....+.|.+||..|+|.+.+.. ....+++.+...++.+++.|+.|+|. -.| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeee
Confidence 3567899999999999999999999999999999999954 45678899999999999999999994 343 9999
Q ss_pred CCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCC-------CCCccchhhHHHHHHHHHhC
Q 040480 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-------ISEKCDIYSFGVLLAVLVMG 252 (325)
Q Consensus 180 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-------~~~~~DvwslG~il~~ll~g 252 (325)
++..|.+++....+|+.|||+.................-..-|.|||.+++.. .+.+.|+||||++++++++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999997664311111111112245799999987742 46779999999999999999
Q ss_pred CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 253 KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 253 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
..||+.........++...++. ....+..+ ...... +....+..++..||..+|.+||+++++-
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~--~~~~~~rP---~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK--GGSNPFRP---SIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred cCccccccccCChHHHHHHHHh--cCCCCcCc---chhhhh--hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 9999875443333333333222 01111111 111110 2233589999999999999999998874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=147.67 Aligned_cols=190 Identities=17% Similarity=0.113 Sum_probs=133.9
Q ss_pred ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC-CCccccccc
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH-RNILPLLAH 115 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~ 115 (325)
.+...|+.|+||+||.+.. .+.+++.+.+.... .....-....+.+|+.+|+++.| +++++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~-----------~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~ 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG---GERKFVRRDLSAAP-----------WWLRGVAWWLARREALALRQLDGLPRTPRLLHW 70 (218)
T ss_pred ccceeecCCCcceEEEeec---CCceeeecccccch-----------hhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE
Confidence 4567899999999998742 67777766552110 00001112257899999999964 789998875
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEecCCCCce
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDI-KPANVLIDDDMEAR 194 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl-~~~nil~~~~~~~~ 194 (325)
+..+++|+|+.|.+|.+... . ....++.|+..+|.++| .+||+|+|| ||+||+++.++.++
T Consensus 71 ----~~~~lvmeyI~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~ 132 (218)
T PRK12274 71 ----DGRHLDRSYLAGAAMYQRPP----R-------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPA 132 (218)
T ss_pred ----cCEEEEEeeecCccHHhhhh----h-------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEE
Confidence 45799999999988865431 0 11347788999999999 889999999 79999999999999
Q ss_pred eeccccceecCCCCcc----c-c------ceeecCCcccccccccccC-CCC-CccchhhHHHHHHHHHhCCCCCCC
Q 040480 195 ISGFDLAILMPDGLTQ----I-D------TMYVVGTPRYIAPEYHQTL-TIS-EKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~----~-~------~~~~~g~~~~~aPE~~~~~-~~~-~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
|+|||++......... . . ......++.+++|+..... ..+ ...+.++-|+-+|.++|+..++-.
T Consensus 133 LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 133 VIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred EEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 9999999865543321 0 0 0012245566666643322 122 457888999999999999988654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.4e-22 Score=171.71 Aligned_cols=173 Identities=25% Similarity=0.375 Sum_probs=126.4
Q ss_pred eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 122 HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
+|+.|++|.-.+|.+++... ......+....+.++.|++.++.| ++.+|+|+||.||+...+..++|+|||+.
T Consensus 331 lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 46778888888888888421 223346677788899999999988 48999999999999999999999999999
Q ss_pred eecCCCC----ccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHh
Q 040480 202 ILMPDGL----TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVM 276 (325)
Q Consensus 202 ~~~~~~~----~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 276 (325)
....... .....+...||..|++||.+.++.|+.++|+||||+++++++. -..++.. ......+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence 8876655 2334455789999999999999999999999999999999997 3333321 11111111
Q ss_pred hhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhh
Q 040480 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321 (325)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (325)
.+ .+++....+.. + =..|+.+++...|.+||++.+
T Consensus 474 ~g-----~ip~~~~~d~p-~----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DG-----IIPPEFLQDYP-E----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cC-----CCChHHhhcCc-H----HHHHHHHhcCCCcccCchHHH
Confidence 12 22222211111 1 346899999999999996654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=147.06 Aligned_cols=166 Identities=16% Similarity=0.120 Sum_probs=115.3
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHH--HHH---HHHH--hhC--cchHHHHHHHH
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAA--ELI---DAYS--ELG--EGKLTEIRSQI 98 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~---~~~~--~~~--~~~~~~~~~e~ 98 (325)
.+....--|.+.+.||+|++|.||+|.++..++..||+|.+......... ... ..+. ... ......+..|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 34444457999999999999999999535568899999998543321100 000 0000 000 01123467889
Q ss_pred HHHhccCCC--CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC-e
Q 040480 99 ITASQIRHR--NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR-V 175 (325)
Q Consensus 99 ~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~-i 175 (325)
..+.++.+. .++++++. ...++||||++|.+|.... .............++.|++.++.+|| ..| +
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~i 170 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLY---KEGEL 170 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHH---hcCCE
Confidence 999988753 23344432 2358999999998876654 12334555566789999999999999 889 9
Q ss_pred EecCCCCCceEecCCCCceeeccccceecC
Q 040480 176 IHRDIKPANVLIDDDMEARISGFDLAILMP 205 (325)
Q Consensus 176 vH~dl~~~nil~~~~~~~~l~dfg~~~~~~ 205 (325)
+|+||+|+||+++ ++.++|+|||.+....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 8899999999986433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-19 Score=142.19 Aligned_cols=135 Identities=17% Similarity=0.188 Sum_probs=100.3
Q ss_pred cccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-----CCCCcccc
Q 040480 38 SLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-----RHRNILPL 112 (325)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~ 112 (325)
-.+.||+|+||.||. +. .+.. .+||++.... ....+.+.+|+.+++.+ .||||+++
T Consensus 6 ~~~~LG~G~~~~Vy~--hp-~~~~-k~IKv~~~~~---------------~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~ 66 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HP-EDAQ-RCIKIVYHRG---------------DGGDKEIRRELKYYAHLSRRLIDWSGIPRY 66 (210)
T ss_pred CcceecCCCceEEEE--CC-CCcC-eEEEEEeccc---------------cchHHHHHHHHHHHHHhhccCCCCccccee
Confidence 356899999999995 22 2333 3799873211 12345689999999999 57999999
Q ss_pred ccceecCC---ceE-EEEEc--ccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCce
Q 040480 113 LAHMVRPD---SHL-LVYDF--MKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGL-EYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 113 ~~~~~~~~---~~~-lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l-~~lh~~~~~~ivH~dl~~~ni 185 (325)
++++.++. ..+ +|+|| +.+++|.+++.. ..+++. ..++.+++.++ .||| +++|+|+||||+||
T Consensus 67 yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NI 136 (210)
T PRK10345 67 YGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNI 136 (210)
T ss_pred eEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHE
Confidence 99998874 333 78999 557899999933 224444 35677777777 8999 88999999999999
Q ss_pred EecCC----CCceeeccccc
Q 040480 186 LIDDD----MEARISGFDLA 201 (325)
Q Consensus 186 l~~~~----~~~~l~dfg~~ 201 (325)
+++.. +.++|+||+-+
T Consensus 137 Ll~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 137 LCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEeccCCCCCcEEEEECCCC
Confidence 99742 37999995444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.2e-18 Score=138.84 Aligned_cols=143 Identities=17% Similarity=0.257 Sum_probs=112.9
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceec
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 118 (325)
++.||+|++|.||+|.+ .+..+++|............. .......+.+|+.++..+.|++++....++..
T Consensus 1 ~~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELD-------ERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred CcccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHH-------HHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 36799999999999975 677899997643322111100 01123467889999999999988877777777
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..+++|||++|++|.+.+.. . .. ....++.+++.+|.++| +.+++|+|++|.||+++ ++.++++||
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf 138 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDF 138 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEEC
Confidence 7888999999999999998832 1 11 67789999999999999 88999999999999999 788999999
Q ss_pred cccee
Q 040480 199 DLAIL 203 (325)
Q Consensus 199 g~~~~ 203 (325)
|.+..
T Consensus 139 ~~a~~ 143 (211)
T PRK14879 139 GLAEF 143 (211)
T ss_pred CcccC
Confidence 98854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.4e-19 Score=163.86 Aligned_cols=215 Identities=23% Similarity=0.263 Sum_probs=140.4
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
..+++|..++.+-.|++|.||.++ +..+.+.+|.|+-. ..-+.+. ++.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvr-h~~trqrfa~kiNk---------------------q~lilRn--ilt~a~npfvv 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVR-HKETRQRFAMKINK---------------------QNLILRN--ILTFAGNPFVV 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeee-ccccccchhhcccc---------------------cchhhhc--cccccCCccee
Confidence 356789999999999999999996 44566777775420 0001110 12222233322
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
|+=...+ ..-+.++. +++.+++|+| +.||+|||+||+|.++..-
T Consensus 136 ---------------------gDc~tll----k~~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~m 179 (1205)
T KOG0606|consen 136 ---------------------GDCATLL----KNIGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSM 179 (1205)
T ss_pred ---------------------chhhhhc----ccCCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeec
Confidence 1222222 11122333 2367899999 9999999999999999999
Q ss_pred CCceeeccccceecCCC--------Ccc-----ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 040480 191 MEARISGFDLAILMPDG--------LTQ-----IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~--------~~~-----~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
|++|++|||++..-... ... ......+||+.|.|||++..+.|...+|.|++|+|+|+.+-|+.||.
T Consensus 180 GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 180 GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 99999999998642110 000 01112489999999999999999999999999999999999999998
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
+..+.+--..++... ...+ ...+..+.+..+++.++|+.+|.+|.-..
T Consensus 260 Gdtpeelfg~visd~-----i~wp----------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 260 GDTPEELFGQVISDD-----IEWP----------EEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred CCCHHHHHhhhhhhh-----cccc----------ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 743311111111100 0001 11111222388999999999999997543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=135.37 Aligned_cols=138 Identities=17% Similarity=0.251 Sum_probs=105.7
Q ss_pred ccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecCC
Q 040480 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPD 120 (325)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 120 (325)
.||+|+||.||+|.+ .+..+++|............ .......++.+|+.++..+.++++....-++...+
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 70 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPEL-------DERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD 70 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchH-------HHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC
Confidence 479999999999974 56789999864322111000 00122456788999999998887665555556667
Q ss_pred ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecccc
Q 040480 121 SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200 (325)
Q Consensus 121 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~ 200 (325)
..+++|||++|++|.+.+.. .. . .++.+++.+|.++| +.|++|+|++|.||+++ ++.++++|||.
T Consensus 71 ~~~lv~e~~~g~~l~~~~~~----~~-~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 71 NKTIVMEYIEGKPLKDVIEE----GN-D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred CCEEEEEEECCccHHHHHhh----cH-H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCC
Confidence 78999999999999988732 11 1 78999999999999 88999999999999999 78999999999
Q ss_pred cee
Q 040480 201 AIL 203 (325)
Q Consensus 201 ~~~ 203 (325)
+..
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-17 Score=131.74 Aligned_cols=152 Identities=16% Similarity=0.142 Sum_probs=108.7
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHh--------hCcchHHHHHHHHHHHhccCC
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSE--------LGEGKLTEIRSQIITASQIRH 106 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h 106 (325)
.|.+.+.||+|+||.||++... +++.+|||.+....+.. ......... ...........|..++..+.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSF-RKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchh-hhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 3889999999999999999643 78999999875433111 110000000 000122346778888888877
Q ss_pred CC--ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040480 107 RN--ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 107 ~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~n 184 (325)
++ ++.+++ ....+++|||++|++|..... ......++.+++.++.++| ..|++|+||+|.|
T Consensus 93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~N 155 (198)
T cd05144 93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAY---KHGIIHGDLSEFN 155 (198)
T ss_pred cCCCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHH---HCCCCcCCCCccc
Confidence 64 344333 345689999999998876541 0234678899999999999 7899999999999
Q ss_pred eEecCCCCceeeccccceecCC
Q 040480 185 VLIDDDMEARISGFDLAILMPD 206 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~ 206 (325)
|++++++.++|+|||.+.....
T Consensus 156 ill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=154.11 Aligned_cols=144 Identities=19% Similarity=0.237 Sum_probs=111.2
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
..|...+.||+|+||+||++.+ .+..+++|+......... ..........+.+|+.+++.++|++++...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~---~~~~~v~k~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEY---LGRDAVIKERVPKGYRHP-------ELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred cccCccceeccCCcEEEEEEee---cCccceeEEEecccccch-------hHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3456688999999999999975 344455554422111000 000112345688999999999999998877
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
.+.......++||||++|++|.+++. ....++.+++.+|.+|| +.|++|+|+||+||++ .++.+
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcE
Confidence 77777778899999999999999883 34578999999999999 8899999999999999 57789
Q ss_pred eeecccccee
Q 040480 194 RISGFDLAIL 203 (325)
Q Consensus 194 ~l~dfg~~~~ 203 (325)
+|+|||++..
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-18 Score=158.63 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=190.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
....|.+.+.||+|+|+.|-.......+...+|.|.+.... ........+..|..+-+.+. |+|++
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-------------~~~~~~~~i~~e~~~~~~~s~h~n~~ 84 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-------------KSEDSSEHIDTETDIQKKLSKHSNTV 84 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-------------CccchhhhcCcccccccccccccccc
Confidence 46789999999999999998886444455667777653221 11233444555666666666 99999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
.+++.....+..++++++..|+++.+.+.. ......+.......+.|+..++.|+|. ..++.|+|++|+|.+++..
T Consensus 85 ~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s 160 (601)
T KOG0590|consen 85 HMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDES 160 (601)
T ss_pred ccCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccC
Confidence 999999999999999999999999888731 111145666777899999999999994 4489999999999999999
Q ss_pred C-CceeeccccceecCC-CCccccceeecC-CcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 191 M-EARISGFDLAILMPD-GLTQIDTMYVVG-TPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 191 ~-~~~l~dfg~~~~~~~-~~~~~~~~~~~g-~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+ ..++.|||++..+.. ..........+| ++.|.|||...+. ...+..|+||.|+++..+++|..|+.........
T Consensus 161 ~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~- 239 (601)
T KOG0590|consen 161 GSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR- 239 (601)
T ss_pred CCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-
Confidence 8 999999999998776 444444444678 9999999998885 3467899999999999999999999764432211
Q ss_pred hHHHHHHHHhh-hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 267 DMVRWMRNVMA-SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 267 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
...|...... ...+ +........+++.+++..+|.+|.+.+++-
T Consensus 240 -~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 240 -YSSWKSNKGRFTQLP------------WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -ceeecccccccccCc------------cccCChhhhhcccccccCCchhcccccccc
Confidence 1111111000 0111 111112277899999999999999998763
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.1e-16 Score=127.48 Aligned_cols=148 Identities=18% Similarity=0.157 Sum_probs=103.5
Q ss_pred ccccc-cCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc--cccccc
Q 040480 39 LEKIG-SGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI--LPLLAH 115 (325)
Q Consensus 39 ~~~lg-~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~ 115 (325)
...|| .|+.|+||.+.. ++..++||.+.... -...+..............+.+|+.++..+.|+++ +.+++.
T Consensus 36 ~~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~--~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~ 110 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGG--LIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAA 110 (239)
T ss_pred CceeecCCCCccEEEEEe---CCceEEEEEeeEcc--hHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEee
Confidence 34677 899999999964 46789999773110 00000000000112345678899999999988775 666665
Q ss_pred eecCCc----eEEEEEcccC-CCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 116 MVRPDS----HLLVYDFMKN-GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 116 ~~~~~~----~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
...... .++|+|+++| .+|.+++.. ..++.. .+.+++.++.+|| ..||+|+||+|.|||++.+
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPD 178 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCC
Confidence 433222 3599999997 689888732 233432 4678999999999 8899999999999999988
Q ss_pred CCceeecccccee
Q 040480 191 MEARISGFDLAIL 203 (325)
Q Consensus 191 ~~~~l~dfg~~~~ 203 (325)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 8999999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.3e-16 Score=124.47 Aligned_cols=153 Identities=20% Similarity=0.161 Sum_probs=96.7
Q ss_pred cccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHH----HHHhhCc-----chHHHHHHHHHHHhccCCC-
Q 040480 38 SLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID----AYSELGE-----GKLTEIRSQIITASQIRHR- 107 (325)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~~~~-----~~~~~~~~e~~~l~~l~h~- 107 (325)
+.+.||+|+||.||+|... ++..||+|.+............. ....... ........|...+..+.+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG 78 (187)
T ss_pred CCcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence 3578999999999999643 78899999875432211111000 0000000 0011123445555555433
Q ss_pred -CccccccceecCCceEEEEEcccCCCHHH-HHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCc
Q 040480 108 -NILPLLAHMVRPDSHLLVYDFMKNGSLQA-VLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPAN 184 (325)
Q Consensus 108 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~n 184 (325)
.+.++++. ...+++|||++++.+.. .+... . .. .....++.+++.++.++| . ++++|+||+|+|
T Consensus 79 ~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~N 145 (187)
T cd05119 79 VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYN 145 (187)
T ss_pred CCCCceEec----CCCEEEEEEeCCCCccChhhhhh-h----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhh
Confidence 23444432 24689999999843321 11110 0 11 556789999999999999 6 899999999999
Q ss_pred eEecCCCCceeeccccceecCC
Q 040480 185 VLIDDDMEARISGFDLAILMPD 206 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~ 206 (325)
|+++ ++.++++|||.+.....
T Consensus 146 ili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 146 ILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEEE-CCcEEEEECcccccccC
Confidence 9999 88999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=117.77 Aligned_cols=134 Identities=19% Similarity=0.189 Sum_probs=107.5
Q ss_pred cccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC--CCccccccc
Q 040480 38 SLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH--RNILPLLAH 115 (325)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~ 115 (325)
+.+.||.|.++.||++.. ++..+++|...... . ...+..|..+++.+.+ .++++++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~---~~~~~~iK~~~~~~----------------~-~~~~~~e~~~~~~l~~~~~~~p~~~~~ 61 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT---KDEDYVLKINPSRE----------------K-GADREREVAILQLLARKGLPVPKVLAS 61 (155)
T ss_pred cceecccccccceEEEEe---cCCeEEEEecCCCC----------------c-hhHHHHHHHHHHHHHHcCCCCCeEEEE
Confidence 467899999999999975 33789999862111 1 3467788888888876 588898888
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCcee
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l 195 (325)
....+..++++||+++..+... +......++.+++.+++.+|..+..+++|+|++|+||++++.+.+++
T Consensus 62 ~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l 130 (155)
T cd05120 62 GESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGI 130 (155)
T ss_pred cCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEE
Confidence 8888889999999988766432 34455678899999999999654468999999999999999889999
Q ss_pred eccccce
Q 040480 196 SGFDLAI 202 (325)
Q Consensus 196 ~dfg~~~ 202 (325)
+||+.+.
T Consensus 131 ~Df~~~~ 137 (155)
T cd05120 131 IDWEYAG 137 (155)
T ss_pred Eeccccc
Confidence 9999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.3e-15 Score=123.33 Aligned_cols=201 Identities=18% Similarity=0.290 Sum_probs=142.1
Q ss_pred HhccCCCCccccccceecCC-----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCe
Q 040480 101 ASQIRHRNILPLLAHMVRPD-----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARV 175 (325)
Q Consensus 101 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~i 175 (325)
+-++-|.|+++++.+|.+.. ...+++||+..|++.+++..+......+......+|+.|++.||+|||.. ...+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 33456999999999997654 36889999999999999999888888899999999999999999999987 7789
Q ss_pred EecCCCCCceEecCCCCceeeccccceecCCC---CccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhC
Q 040480 176 IHRDIKPANVLIDDDMEARISGFDLAILMPDG---LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMG 252 (325)
Q Consensus 176 vH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g 252 (325)
+|+++..+.|++..++-+|++-- ........ ..........+.++|.+||.=.....+-++|||+||+...+|..+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999998877776421 11111110 011111113456789999986666677899999999999999887
Q ss_pred CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 253 KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 253 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
...-.... ........+.+... .....+ =++++.+|++-.|..||++.+++
T Consensus 279 Eiq~tnse---S~~~~ee~ia~~i~------~len~l-----------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 279 EIQSTNSE---SKVEVEENIANVII------GLENGL-----------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred eeccCCCc---ceeehhhhhhhhee------eccCcc-----------ccCcCcccccCCCCCCcchhhhh
Confidence 75432211 11111111111110 001110 24588999999999999999876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.3e-14 Score=123.68 Aligned_cols=255 Identities=19% Similarity=0.166 Sum_probs=176.8
Q ss_pred hcCccccccccc--CcceeEEEEEec-CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCC
Q 040480 33 EDCFASLEKIGS--GGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRN 108 (325)
Q Consensus 33 ~~~y~~~~~lg~--G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~ 108 (325)
...+.+.+.+|. |.+|.||.+... ..++..+|+|.-.... ........-.++...-+.+. |++
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-------------s~p~~~~~k~~~~~s~~~i~~~~~ 179 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-------------SPPLDSKRKLREFLSHHKIDSHEN 179 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-------------CCccccccccchhhcccccCcccc
Confidence 367888999999 999999999642 4466788888732111 11111112233444444443 899
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCc
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVAS----GLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~----~l~~lh~~~~~~ivH~dl~~~n 184 (325)
.++.+..+...+..++-+|.+. .+|..+... ....++....+..+.+... |+.++| +.+++|.|++|.|
T Consensus 180 ~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~ 252 (524)
T KOG0601|consen 180 PVRDSPAWEGSGILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPAN 252 (524)
T ss_pred ccccCcccccCCcceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhh
Confidence 9999999999999999999985 588877732 2333777788888888888 999999 8899999999999
Q ss_pred eEecCC-CCceeeccccceecCCCCccccc---eeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcc
Q 040480 185 VLIDDD-MEARISGFDLAILMPDGLTQIDT---MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF 260 (325)
Q Consensus 185 il~~~~-~~~~l~dfg~~~~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~ 260 (325)
|+...+ ..++++|||+............. ....|...|++||...+ -++...|++++|.++.+...+..+.....
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 999988 88899999999887665432221 11256778999999877 56889999999999999888776653320
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
. ..+ .. .....+..++.... ...+...+.+|++.+|..|+++..+..+
T Consensus 332 ~--~~W-----~~------~r~~~ip~e~~~~~----s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 332 N--SSW-----SQ------LRQGYIPLEFCEGG----SSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred C--CCc-----cc------cccccCchhhhcCc----chhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0 000 00 00000111111111 1125558999999999999999887653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.4e-13 Score=119.56 Aligned_cols=157 Identities=18% Similarity=0.192 Sum_probs=97.3
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhh-------------------CcchHH------H
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSEL-------------------GEGKLT------E 93 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~------~ 93 (325)
.+.||.|++|.||+|+.. +|+.||||+..+................ ...... .
T Consensus 122 ~~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred CcceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 357999999999999864 7899999998543221111111110000 000011 2
Q ss_pred HHHHHHHHhcc----CCCCccccccce-ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHH-HHHHH
Q 040480 94 IRSQIITASQI----RHRNILPLLAHM-VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVAS-GLEYL 167 (325)
Q Consensus 94 ~~~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~l~~l 167 (325)
+.+|...+.++ ++.+-+.+-.++ ......++||||++|++|.+...... ... ....++..++. .+..+
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHH
Confidence 44444444444 232222322222 23345799999999999988763211 111 23345555554 35677
Q ss_pred HhcCCCCeEecCCCCCceEecCCCCceeeccccceecCC
Q 040480 168 HMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206 (325)
Q Consensus 168 h~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 206 (325)
| ..|++|+|++|.||+++.++.++++|||++.....
T Consensus 274 ~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 L---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred H---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 77999999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-12 Score=117.84 Aligned_cols=150 Identities=17% Similarity=0.239 Sum_probs=115.0
Q ss_pred chHHHHHHHHHHHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHH
Q 040480 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLH 168 (325)
Q Consensus 89 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh 168 (325)
.......+.+..++.++||||+++++.++..+..|+|+|-+. .|..++.. +........+.||+.||.+||
T Consensus 51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~ 121 (690)
T KOG1243|consen 51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEEVCLGLFQILAALSFLN 121 (690)
T ss_pred hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHHHHHHHHHHHHHHHHHh
Confidence 345667788889999999999999999999999999999873 67777743 335566678999999999998
Q ss_pred hcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHH
Q 040480 169 MHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAV 248 (325)
Q Consensus 169 ~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ 248 (325)
. ..+++|++++...|++++.|..+|++|.++............ ..--..|..|+.+.... ...|.|.||+++++
T Consensus 122 ~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~--~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~e 195 (690)
T KOG1243|consen 122 D--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS--LYLIESFDDPEEIDPSE--WSIDSWGLGCLIEE 195 (690)
T ss_pred c--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc--chhhhcccChhhcCccc--cchhhhhHHHHHHH
Confidence 5 448999999999999999999999999988765433221110 11122355666433322 45799999999999
Q ss_pred HHhCC
Q 040480 249 LVMGK 253 (325)
Q Consensus 249 ll~g~ 253 (325)
++.|.
T Consensus 196 l~ng~ 200 (690)
T KOG1243|consen 196 LFNGS 200 (690)
T ss_pred HhCcc
Confidence 99993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.6e-12 Score=100.59 Aligned_cols=154 Identities=14% Similarity=0.086 Sum_probs=100.2
Q ss_pred ccccccCcceeEEEEEecCC-----CCcEEEEEEEcccCCCcH---HHHHHHHHh-----hCcchHHH----HHHHHHHH
Q 040480 39 LEKIGSGGCGDVYKAELPGS-----NGKMIAVKKVIIYSPMSA---AELIDAYSE-----LGEGKLTE----IRSQIITA 101 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~-----~~~~vavK~~~~~~~~~~---~~~~~~~~~-----~~~~~~~~----~~~e~~~l 101 (325)
...||.|.-+.||.|..... .+..+|||+.... ..+. ..+...... ........ ..+|...|
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~-~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L 80 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTT-LNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL 80 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEecc-ceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 45789999999999953211 3478999987532 2111 111100000 01112223 34888888
Q ss_pred hccCC--CCccccccceecCCceEEEEEcccCCCHHH-HHhhhcccccccChhhHHHHHHHHHHHHHHH-HhcCCCCeEe
Q 040480 102 SQIRH--RNILPLLAHMVRPDSHLLVYDFMKNGSLQA-VLYDVSKGRRELEWLSRHKIALAVASGLEYL-HMHHSARVIH 177 (325)
Q Consensus 102 ~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~l-h~~~~~~ivH 177 (325)
+++.. -+++.++.+ ...++||||+.+..+.. .+ ....++......+..+++.++..+ | ..|++|
T Consensus 81 ~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVH 148 (197)
T cd05146 81 KRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVH 148 (197)
T ss_pred HHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 88853 355666653 56789999997643321 12 112244455667889999999988 8 779999
Q ss_pred cCCCCCceEecCCCCceeeccccceecCC
Q 040480 178 RDIKPANVLIDDDMEARISGFDLAILMPD 206 (325)
Q Consensus 178 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 206 (325)
+||++.||++. ++.++++|||.+.....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999999997 46799999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.8e-12 Score=96.05 Aligned_cols=138 Identities=19% Similarity=0.243 Sum_probs=104.7
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceecC
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRP 119 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 119 (325)
..+++|+-+.+|.+.+ -+.++++|.-.......+.-... -...+..+|..++++++--.|.-..=+..+.
T Consensus 2 ~~i~~GAEa~i~~~~~---~g~~av~K~Ri~K~YR~p~LD~k-------lrr~Rt~~Earil~~a~~~GV~~P~v~dvD~ 71 (204)
T COG3642 2 DLIKQGAEAIIYLTDF---LGLPAVVKERIPKRYRHPELDEK-------LRRERTRREARILAKAREAGVPVPIVYDVDP 71 (204)
T ss_pred chhhCCcceeEEeeec---cCcceEEEeecCcccCChHHHHH-------HHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC
Confidence 4578999999999966 45557788765544444322211 2345678889999988766666666667778
Q ss_pred CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccc
Q 040480 120 DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199 (325)
Q Consensus 120 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg 199 (325)
+...++|||++|..|.+.+... ...++..+-.-+.-|| ..||+|+||.++||+++.++ +.++|||
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECC
Confidence 8888999999999999898432 1456667777788999 88999999999999998765 9999999
Q ss_pred cce
Q 040480 200 LAI 202 (325)
Q Consensus 200 ~~~ 202 (325)
++.
T Consensus 137 Lg~ 139 (204)
T COG3642 137 LGE 139 (204)
T ss_pred ccc
Confidence 985
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-12 Score=119.59 Aligned_cols=159 Identities=15% Similarity=0.097 Sum_probs=92.5
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHh-------------------hCcchHHHHH
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSE-------------------LGEGKLTEIR 95 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~ 95 (325)
.|.. +.||.|++|.||+|+.. .+|+.||||++.+.-............. ...+..+.+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~-~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLK-DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEEC-CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 4665 78999999999999754 4589999999864321111111000000 0001122233
Q ss_pred HHHH------HHhcc----CCCCccccccceec-CCceEEEEEcccCCCHHHHHhhhcccc---cccChhhHHHHHHHHH
Q 040480 96 SQII------TASQI----RHRNILPLLAHMVR-PDSHLLVYDFMKNGSLQAVLYDVSKGR---RELEWLSRHKIALAVA 161 (325)
Q Consensus 96 ~e~~------~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~---~~~~~~~~~~i~~~l~ 161 (325)
+|++ -+.++ .+.+.+.+-.++.+ ....++||||+.|+++.+.-.- ...+ ..+.......++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHHH
Confidence 3333 22222 23333333333322 3456799999999999875311 1111 1222223333334432
Q ss_pred HHHHHHHhcCCCCeEecCCCCCceEecCCC----CceeeccccceecCC
Q 040480 162 SGLEYLHMHHSARVIHRDIKPANVLIDDDM----EARISGFDLAILMPD 206 (325)
Q Consensus 162 ~~l~~lh~~~~~~ivH~dl~~~nil~~~~~----~~~l~dfg~~~~~~~ 206 (325)
..|++|+|++|.||+++.++ .++++|||++.....
T Consensus 278 ----------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ----------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45999999999999999887 899999999987654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.4e-11 Score=92.98 Aligned_cols=151 Identities=17% Similarity=0.191 Sum_probs=109.9
Q ss_pred cccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccccee
Q 040480 38 SLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMV 117 (325)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 117 (325)
.+..+-||+-+.|+++.+ .|+..+||.-+.....++.-.- .-...+..+|++++.++.--.|.-.--++.
T Consensus 11 ~l~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~-------kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~ 80 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQ-------KLTRKRTKQEARLLAKCRALGIPAPRLIFI 80 (229)
T ss_pred cceeeeccceeeEeeecc---CCceeEEeecccccccchHHHH-------HHHHHHHHHHHHHHHHHHHhCCCCceEEEE
Confidence 577889999999999976 7888899987655544432111 123456788888888886555555445566
Q ss_pred cCCceEEEEEcccC-CCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC---Cc
Q 040480 118 RPDSHLLVYDFMKN-GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM---EA 193 (325)
Q Consensus 118 ~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~---~~ 193 (325)
+.....++|||++| .++.+++...-. ......-...++..+-+.+.-|| ..+++|+||..+||++..++ .+
T Consensus 81 D~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~ 155 (229)
T KOG3087|consen 81 DTYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITP 155 (229)
T ss_pred ecCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCce
Confidence 77778899999987 588888865322 12222233578888888999999 88999999999999997553 34
Q ss_pred eeecccccee
Q 040480 194 RISGFDLAIL 203 (325)
Q Consensus 194 ~l~dfg~~~~ 203 (325)
.++|||++..
T Consensus 156 ~lIdfgls~~ 165 (229)
T KOG3087|consen 156 ILIDFGLSSV 165 (229)
T ss_pred EEEeecchhc
Confidence 8999999853
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=4e-12 Score=100.23 Aligned_cols=127 Identities=20% Similarity=0.242 Sum_probs=88.9
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc-ccccccee
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI-LPLLAHMV 117 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~ 117 (325)
.+.|+.|.++.||+++. .+..+++|...... ........|..+++.+.+.++ ++++...
T Consensus 3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~----------------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~- 62 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGT----------------ELLINRENEAENSKLAAEAGIGPKLYYFD- 62 (170)
T ss_pred eeecCCcccCceEEEEE---CCeEEEEEeCCCCc----------------ccccCHHHHHHHHHHHHHhCCCCceEEEe-
Confidence 45789999999999975 47789999752111 011234567777777654333 4444432
Q ss_pred cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceEecCCCC
Q 040480 118 RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR-----VIHRDIKPANVLIDDDME 192 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~-----ivH~dl~~~nil~~~~~~ 192 (325)
....++||||++|.++.+.- . ....++.+++.++..|| ..+ ++|+|++|.||+++ ++.
T Consensus 63 -~~~~~lv~e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~ 125 (170)
T cd05151 63 -PETGVLITEFIEGSELLTED---------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGR 125 (170)
T ss_pred -CCCCeEEEEecCCCcccccc---------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCe
Confidence 33458999999998765320 1 11345678999999999 555 59999999999999 668
Q ss_pred ceeeccccce
Q 040480 193 ARISGFDLAI 202 (325)
Q Consensus 193 ~~l~dfg~~~ 202 (325)
++++||+.+.
T Consensus 126 ~~liDf~~a~ 135 (170)
T cd05151 126 LWLIDWEYAG 135 (170)
T ss_pred EEEEeccccc
Confidence 9999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.3e-12 Score=113.18 Aligned_cols=247 Identities=18% Similarity=0.214 Sum_probs=170.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
...+|..+..||.|.|+.|+.+.....++..|++|...........++ .-..|+.+...+ .|.+++
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-------------~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-------------FSLGEVILEAILGSHLPSV 329 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-------------cchhhhhHhhHhhcccccC
Confidence 456789999999999999999975547788899997643332222211 112233333333 488899
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
..+..|...++.|+=.|||+++++...+ .....+.....+++..|++.++.++| ++..+|.|++|+||++..+
T Consensus 330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~ 402 (524)
T KOG0601|consen 330 GKNSSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISND 402 (524)
T ss_pred CCCCCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccc
Confidence 9999999989999999999998888776 33445777788899999999999999 8899999999999999876
Q ss_pred -CCceeeccccceecCCCCccccceeecCCcccc--cccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 191 -MEARISGFDLAILMPDGLTQIDTMYVVGTPRYI--APEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 191 -~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~--aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+..++.||+....+...... ..+..++. +|.......+-.++|++|||..+.+..++..--.....
T Consensus 403 ~~~~~~~~~~~~t~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------ 471 (524)
T KOG0601|consen 403 GFFSKLGDFGCWTRLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------ 471 (524)
T ss_pred hhhhhccccccccccceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCccccc------
Confidence 77799999988653322211 12233344 55555666678899999999999999888743222111
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|. .+..+..+... .....+..+...++..++.-||++.++..
T Consensus 472 ---~~-~i~~~~~p~~~-----------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 472 ---SL-TIRSGDTPNLP-----------GLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ---ce-eeecccccCCC-----------chHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 00 00111111111 01122667788899999999999887653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.8e-12 Score=117.77 Aligned_cols=257 Identities=23% Similarity=0.255 Sum_probs=171.7
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
+....+.+.+.+.+..|+++.++.+. ....+...+.|..... .......++.+.++-.+.-...+|.
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~-pa~sgh~~~~~v~~~a------------p~i~~~~~~s~r~~s~~~i~p~~P~ 865 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPAS-PAGSGHTRPSKVHGLA------------PKIRTNDYESIRSKSNILITPRSPA 865 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCC-ccccccccchhhhccc------------hhhccccccccCCccCccccCCCCc
Confidence 34456778899999999999999884 4445544444443111 1112222333444434444445677
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++.....+......+++++|+.+++|...+.. -...+..-.......+..++++|| +..+.|+|++|.|.+..
T Consensus 866 v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 866 VVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIA 938 (1205)
T ss_pred eecccCCCCCCCCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhc
Confidence 77777777777889999999999999888732 223444445556666778899999 77799999999999999
Q ss_pred CCCCceeeccccceecCCC--------Ccc---------------------ccceeecCCcccccccccccCCCCCccch
Q 040480 189 DDMEARISGFDLAILMPDG--------LTQ---------------------IDTMYVVGTPRYIAPEYHQTLTISEKCDI 239 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~--------~~~---------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv 239 (325)
.++..++.||+........ ... .......||+.|.+||...+......+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 9999999999843321110 000 00112467899999999999988999999
Q ss_pred hhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 240 wslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
|+.|+++++.++|.+||...... +...++.....+. ............+++...+..+|.+|..+
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq-------~~f~ni~~~~~~~--------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQ-------QIFENILNRDIPW--------PEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchh-------hhhhccccCCCCC--------CCCccccChhhhhhhhhhhccCchhccCc
Confidence 99999999999999999764331 1112222111111 11111122227789999999999999877
Q ss_pred h
Q 040480 320 K 320 (325)
Q Consensus 320 ~ 320 (325)
.
T Consensus 1084 ~ 1084 (1205)
T KOG0606|consen 1084 K 1084 (1205)
T ss_pred c
Confidence 5
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.8e-09 Score=92.96 Aligned_cols=132 Identities=17% Similarity=0.310 Sum_probs=100.2
Q ss_pred eEEEEEcccCCCHHHHHhh---hcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 122 HLLVYDFMKNGSLQAVLYD---VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 122 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
..++|+.+.+..--..+.. ..++-....+....+....++.+.+.|| +.|.+-+|++++|+|+++++.|.|+|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence 5688888876422222211 1233445778889999999999999999 779999999999999999999999997
Q ss_pred ccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhC-CCCCCCc
Q 040480 199 DLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMG-KFPFDDF 259 (325)
Q Consensus 199 g~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g-~~p~~~~ 259 (325)
+.-....++..... .+|...|++||... +..-+...|.|.||+++++++.| +.||.+.
T Consensus 162 Dsfqi~~ng~~~~c---pVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 162 DSFQINANGTLHLC---PVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cceeeccCCceEec---ccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 66655443332222 47889999999765 33446789999999999999986 9999763
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.3e-10 Score=91.20 Aligned_cols=152 Identities=17% Similarity=0.163 Sum_probs=105.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHh--------hCcchHHHHHHHHHHHhc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSE--------LGEGKLTEIRSQIITASQ 103 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~e~~~l~~ 103 (325)
...-+.+...||-|.-|.||.|.. ..+.++|+|.-.. ...+++.......- .-.-.+....+|.++|..
T Consensus 89 r~~ve~iG~~IGvGKEsdVY~~~~--~~g~~~~vKfHR~-GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~ 165 (304)
T COG0478 89 RGIVEAIGTKIGVGKESDVYVAID--PKGRKVAVKFHRL-GRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR 165 (304)
T ss_pred cChHHhhccccccCccceEEEEEC--CCCCEEEEEEeec-CchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence 334677889999999999999964 3688999996432 22222222211111 111234567889999998
Q ss_pred cCCC--CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040480 104 IRHR--NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181 (325)
Q Consensus 104 l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~ 181 (325)
|... .+++.++ .+...+|||+++|..|...- ++......++..+++-+..+- ..|+||+|++
T Consensus 166 L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~---~~GiVHGDlS 229 (304)
T COG0478 166 LYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAY---RRGIVHGDLS 229 (304)
T ss_pred hhhcCCCCCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHH---HcCccccCCc
Confidence 8654 6666664 35568999999986554332 244555667777777777666 6699999999
Q ss_pred CCceEecCCCCceeeccccce
Q 040480 182 PANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~ 202 (325)
+-||+++++|.++++||--+.
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred hheEEEecCCCEEEEeCcccc
Confidence 999999999999999996654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.4e-10 Score=92.00 Aligned_cols=142 Identities=18% Similarity=0.216 Sum_probs=95.7
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC--CCcccccccee
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH--RNILPLLAHMV 117 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~ 117 (325)
+.|+.|..+.+|+++.. +++.+++|...... .......+..|..+++.+.+ .++++++.+..
T Consensus 4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~--------------~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~ 67 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGA--------------LLPSAHDVAREYRVLRALAGTGVPVPKVLALCE 67 (223)
T ss_pred eecCCCccceEEEEEec--CCcceEEEeCCCcc--------------cCcccccHHHHHHHHHHhhCCCCCCCCEEEECC
Confidence 57899999999999753 35789999762111 00123467888888888865 34566776665
Q ss_pred cC---CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc------------------------
Q 040480 118 RP---DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH------------------------ 170 (325)
Q Consensus 118 ~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~------------------------ 170 (325)
.. +..++||||++|.++.+.+. ...++......++.+++.+|..||..
T Consensus 68 ~~~~~~~~~~v~e~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (223)
T cd05154 68 DPSVLGTPFYVMERVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARW 142 (223)
T ss_pred CCCccCCceEEEEEeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHH
Confidence 53 25689999999887765441 01233344444555555555555532
Q ss_pred -----------------------------CCCCeEecCCCCCceEecC--CCCceeeccccce
Q 040480 171 -----------------------------HSARVIHRDIKPANVLIDD--DMEARISGFDLAI 202 (325)
Q Consensus 171 -----------------------------~~~~ivH~dl~~~nil~~~--~~~~~l~dfg~~~ 202 (325)
....++|+|+.+.||+++. ++.+.++||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 143 RRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 1356899999999999998 5668999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.6e-09 Score=84.63 Aligned_cols=140 Identities=19% Similarity=0.201 Sum_probs=83.5
Q ss_pred eEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHH------------HhhCcchHHHHHHHHHHHhccCCC--Ccccccc
Q 040480 49 DVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAY------------SELGEGKLTEIRSQIITASQIRHR--NILPLLA 114 (325)
Q Consensus 49 ~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~ 114 (325)
.||.|.. .++..+|+|...... .++....... ............+|...|..+..- ++++++.
T Consensus 1 ~Vy~~~~--~~~~~~a~K~~r~~~-~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~ 77 (188)
T PF01163_consen 1 DVYHAID--PDGEEVAVKIYRTGR-TSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD 77 (188)
T ss_dssp EEEEEEE--CTTEEEEEEEE-S----SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred CEEEEEC--CCCCEEEEEEeccCc-eEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence 3888853 367799999876432 2222111000 001112245678899999999765 4666664
Q ss_pred ceecCCceEEEEEccc--CCCHHHHHhhhcccccccChhhHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 115 HMVRPDSHLLVYDFMK--NGSLQAVLYDVSKGRRELEWLSRHKIALAVASGL-EYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l-~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+ ....+||||++ |..+.... . ..++......++.+++..+ ..+| ..|++|+||++.||+++++
T Consensus 78 ~----~~~~ivME~I~~~G~~~~~l~-~-----~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~- 143 (188)
T PF01163_consen 78 Y----NRNVIVMEYIGEDGVPLPRLK-D-----VDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG- 143 (188)
T ss_dssp E----ETTEEEEE--EETTEEGGCHH-H-----CGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-
T ss_pred E----eCCEEEEEecCCCccchhhHH-h-----ccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-
Confidence 3 24579999998 65554433 1 1122445566777877744 4467 8899999999999999987
Q ss_pred CceeeccccceecC
Q 040480 192 EARISGFDLAILMP 205 (325)
Q Consensus 192 ~~~l~dfg~~~~~~ 205 (325)
.++++|||.+....
T Consensus 144 ~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 144 KVYIIDFGQAVDSS 157 (188)
T ss_dssp CEEE--GTTEEETT
T ss_pred eEEEEecCcceecC
Confidence 89999999886544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.2e-09 Score=92.88 Aligned_cols=171 Identities=19% Similarity=0.256 Sum_probs=125.7
Q ss_pred ceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccccee----cCCce
Q 040480 47 CGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMV----RPDSH 122 (325)
Q Consensus 47 ~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~ 122 (325)
..+.|++ +.+.+|..|++|+++..+... ......-.++++++.|+|+|++.+++. .+..+
T Consensus 289 ~~Ttyk~-~s~~DG~~YvLkRlhg~r~~~---------------~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Sl 352 (655)
T KOG3741|consen 289 SITTYKA-TSNVDGNAYVLKRLHGDRDQS---------------TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSL 352 (655)
T ss_pred cceeEee-eeccCCceeeeeeeccccccC---------------cccchHHHHHHHHhccCceeehhhhhhhhccCcceE
Confidence 3588999 677899999999984332111 112233456788899999999999886 34467
Q ss_pred EEEEEcccC-CCHHHHHhhhc-----------ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 123 LLVYDFMKN-GSLQAVLYDVS-----------KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 123 ~lv~e~~~~-~~L~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++|++|+++ ++|.++..... ..+...++..+|.++.|+..||.++| +.|+.-+-|.+.+|+++.+
T Consensus 353 vlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~ 429 (655)
T KOG3741|consen 353 VLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGK 429 (655)
T ss_pred EEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCc
Confidence 899999985 46766653311 12345777899999999999999999 8899999999999999988
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p 255 (325)
..++|..+|..-....... +-+. ...+-|.=.||.++..|.+|..-
T Consensus 430 ~RIriS~C~i~Dvl~~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 430 MRIRISGCGIMDVLQEDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ceEEEecccceeeecCCCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 8888888877654433320 1111 13457999999999999999644
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1e-08 Score=86.16 Aligned_cols=144 Identities=15% Similarity=0.127 Sum_probs=93.3
Q ss_pred eeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc--cccccceec-----CC
Q 040480 48 GDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI--LPLLAHMVR-----PD 120 (325)
Q Consensus 48 g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~-----~~ 120 (325)
..|+++++ +|+.+.||...... -.+......... .-.....+|...+..+..-+| +.++.+... ..
T Consensus 36 rrvvr~~~---~g~~~~vKr~~~~~---~~~~~k~l~~~~-~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 36 RRTLRFEL---AGKSYFLKWHRGTG---WGEIFKNLLSLR-MPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred ceEEEEEE---CCEEEEEEEecCCc---HHHHhhhhcccc-cccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33556655 57789999762211 111111111000 111236677777777743333 333444432 23
Q ss_pred ceEEEEEcccCC-CHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC-------CCC
Q 040480 121 SHLLVYDFMKNG-SLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-------DME 192 (325)
Q Consensus 121 ~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~-------~~~ 192 (325)
..++|+|++++. +|.+++.... ....+......++.+++..+..|| ..|++|+|++++|||++. +..
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 478999999886 7988884321 233555667789999999999999 889999999999999975 467
Q ss_pred ceeecccccee
Q 040480 193 ARISGFDLAIL 203 (325)
Q Consensus 193 ~~l~dfg~~~~ 203 (325)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998853
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=8.2e-10 Score=100.41 Aligned_cols=149 Identities=21% Similarity=0.248 Sum_probs=99.0
Q ss_pred HHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCcccccee-------ecCCcccccccccccCC
Q 040480 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY-------VVGTPRYIAPEYHQTLT 232 (325)
Q Consensus 160 l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~-------~~g~~~~~aPE~~~~~~ 232 (325)
++.|+.++|. +.++||++|.|++|.++.++.+|+++|+++.............+ ......|.+||++.+..
T Consensus 108 v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3388999996 55899999999999999999999999998865443211111111 12245799999999988
Q ss_pred CCCccchhhHHHHHHHHH-hCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCC
Q 040480 233 ISEKCDIYSFGVLLAVLV-MGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLA 311 (325)
Q Consensus 233 ~~~~~DvwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 311 (325)
.+.++|++|+|+++|.+. .|+.-+..... ........... .... .....+.+.++.+=+.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~-----~~~~--------~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLL-----NAGA--------FGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhccc-----cccc--------ccccccCcHHHHHHHHHHhcC
Confidence 899999999999999998 45554433211 11111110000 0000 000123344488888999999
Q ss_pred CCCCCCChhhhhc
Q 040480 312 DPDERPNSKDVRC 324 (325)
Q Consensus 312 dP~~Rps~~ell~ 324 (325)
++.-||++.+++.
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.8e-08 Score=78.83 Aligned_cols=107 Identities=20% Similarity=0.251 Sum_probs=79.7
Q ss_pred HHHHHHHHHHHhccCCC--CccccccceecC----CceEEEEEcccCC-CHHHHHhhhcccccccChhhHHHHHHHHHHH
Q 040480 91 LTEIRSQIITASQIRHR--NILPLLAHMVRP----DSHLLVYDFMKNG-SLQAVLYDVSKGRRELEWLSRHKIALAVASG 163 (325)
Q Consensus 91 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 163 (325)
.....+|...+..+..- .++.++.+.... ...++|+|++++. +|.+++... ...+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 34567777766666432 234455544432 2358999999874 788888432 125666778899999999
Q ss_pred HHHHHhcCCCCeEecCCCCCceEecCCC---Cceeeccccceec
Q 040480 164 LEYLHMHHSARVIHRDIKPANVLIDDDM---EARISGFDLAILM 204 (325)
Q Consensus 164 l~~lh~~~~~~ivH~dl~~~nil~~~~~---~~~l~dfg~~~~~ 204 (325)
+.-|| ..|++|+|+++.|||++.++ .+.++||+.+...
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 88999999999999999887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.6e-07 Score=74.98 Aligned_cols=144 Identities=16% Similarity=0.059 Sum_probs=100.0
Q ss_pred ccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC--Cccccccceec--
Q 040480 43 GSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR--NILPLLAHMVR-- 118 (325)
Q Consensus 43 g~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~-- 118 (325)
|.||.+.|++..+ .|+.+-+|.....-..+ .. .+-....+.+|...+.++..- +++++......
T Consensus 27 ~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s-------~r--~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~ 94 (216)
T PRK09902 27 RRNGMSGVQCVER---NGKKLYVKRMTHHLFHS-------VR--YPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKI 94 (216)
T ss_pred CCCCcceEEEEEe---CCcEEEEEeccCccccc-------cc--CCCCchHHHHHHHHHHHHHHcCCCCCccceeeeecc
Confidence 5588888999876 44578888763221111 00 033456788999988888532 24554421111
Q ss_pred --CCceEEEEEcccC-CCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC--c
Q 040480 119 --PDSHLLVYDFMKN-GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME--A 193 (325)
Q Consensus 119 --~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~--~ 193 (325)
.-..++|+|-++| .+|.+++.. ..-.+.+...+..++.+++..+.-|| ..|+.|+|+.+.||+++.++. +
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeE
Confidence 1235799997753 588888733 12234677777899999999999999 889999999999999986666 8
Q ss_pred eeecccccee
Q 040480 194 RISGFDLAIL 203 (325)
Q Consensus 194 ~l~dfg~~~~ 203 (325)
.++||..++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999977653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.70 E-value=7e-07 Score=71.65 Aligned_cols=153 Identities=12% Similarity=0.090 Sum_probs=96.6
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
.-..-+++|.+.+.+.......|.+-.. ++..+++|...... ...+.............++......+.....-
T Consensus 25 ~~~i~~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~---~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~ 98 (229)
T PF06176_consen 25 GEKILDNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREEN---RRPERRFKSFFKGSEYSRLINNTDKIRNEGFT 98 (229)
T ss_pred HHHHHhCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhh---hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence 3334778999999999999888888765 67889999763222 11222222233333444444444444433322
Q ss_pred Ccccccccee-----cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 108 NILPLLAHMV-----RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 108 ~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
....++-... .....+++|||++|..|.+... ++. .+...+.+++.-+| ..|++|+|+.|
T Consensus 99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hp 163 (229)
T PF06176_consen 99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHP 163 (229)
T ss_pred ccccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHH---HcCCccCCCCc
Confidence 3333222222 2234568999999988766541 222 24455667789999 88999999999
Q ss_pred CceEecCCCCceeeccccce
Q 040480 183 ANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~ 202 (325)
.|++++++ .++++||+...
T Consensus 164 gNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 164 GNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CcEEEECC-cEEEEECcccc
Confidence 99999855 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.1e-07 Score=70.44 Aligned_cols=132 Identities=15% Similarity=0.188 Sum_probs=92.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc-c
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP-L 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~ 112 (325)
..-+..+.|++|++|.||++.+ .+..+|+|+-. .+..+..+..|.+++..++..++.. +
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~---~~~~~a~Kvrr-----------------~ds~r~~l~kEakiLeil~g~~~~p~v 81 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEW---RGGEVALKVRR-----------------RDSPRRNLEKEAKILEILAGEGVTPEV 81 (201)
T ss_pred hhhhhhhhhhcccccEEEEeec---cCceEEEEEec-----------------CCcchhhHHHHHHHHHHhhhcCCCceE
Confidence 3455677899999999999987 56689999752 3345667888999888887655533 3
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCceEecCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK-PANVLIDDDM 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~-~~nil~~~~~ 191 (325)
+.+.. .++.|||+.|.+|.+.... .+ .+-...+++...-|. ..||-|+.|+ |...++..++
T Consensus 82 y~yg~----~~i~me~i~G~~L~~~~~~-------~~----rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~ 143 (201)
T COG2112 82 YFYGE----DFIRMEYIDGRPLGKLEIG-------GD----RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDR 143 (201)
T ss_pred EEech----hhhhhhhhcCcchhhhhhc-------cc----HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCC
Confidence 33322 2355999999888877622 11 223344555566677 7799999998 5555555555
Q ss_pred Cceeecccccee
Q 040480 192 EARISGFDLAIL 203 (325)
Q Consensus 192 ~~~l~dfg~~~~ 203 (325)
.+.|+||..++.
T Consensus 144 ~~~iIDFd~At~ 155 (201)
T COG2112 144 DVYIIDFDSATF 155 (201)
T ss_pred cEEEEEccchhh
Confidence 899999999873
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.7e-07 Score=83.18 Aligned_cols=156 Identities=15% Similarity=0.176 Sum_probs=92.4
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCc--------------------------HHHHHHHHHhhCcchHHH
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMS--------------------------AAELIDAYSELGEGKLTE 93 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~ 93 (325)
+.++.++-|.||+|++. +|+.||||+..+.-... ...+.+.+...-.. --.
T Consensus 131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~-ElD 207 (517)
T COG0661 131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE-ELD 207 (517)
T ss_pred CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH-HhC
Confidence 57889999999999886 59999999876332211 11111111110000 012
Q ss_pred HHHHHHHHhcc----C-CCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHH
Q 040480 94 IRSQIITASQI----R-HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLH 168 (325)
Q Consensus 94 ~~~e~~~l~~l----~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh 168 (325)
+.+|..-+.++ + .|++.=..=++...+...++|||++|..+.+...- .....+.+.+...+.+.. +..+-
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~ 282 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLL 282 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHH
Confidence 33444333333 2 23332222223345667899999999988888522 112344333333222222 12222
Q ss_pred hcCCCCeEecCCCCCceEecCCCCceeeccccceecCC
Q 040480 169 MHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206 (325)
Q Consensus 169 ~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 206 (325)
..|.+|+|..|.||+++.+|.+.+.|||+......
T Consensus 283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33999999999999999999999999999976654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.7e-06 Score=71.22 Aligned_cols=140 Identities=11% Similarity=0.110 Sum_probs=81.3
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC--Ccccccccee
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR--NILPLLAHMV 117 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 117 (325)
..||+|..+.||+. .+..+++|.... ......+.+|.++++.+..- .+++++.+..
T Consensus 7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~-----------------~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~ 64 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----KTGKWMLKLYNP-----------------GFDKETIKREFDASRKVFSLGIPTPHPFDLVE 64 (226)
T ss_pred eeecCCCCcceeEe-----cCCCEEEEeCCC-----------------CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEe
Confidence 57899999999985 244577887521 11234467788888877532 3567777777
Q ss_pred cCCceEEEEEcccCCC-HHHHH--------------hh----hccc-ccccChhhH-HHHHHH----------HHH-HHH
Q 040480 118 RPDSHLLVYDFMKNGS-LQAVL--------------YD----VSKG-RRELEWLSR-HKIALA----------VAS-GLE 165 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~-L~~~~--------------~~----~~~~-~~~~~~~~~-~~i~~~----------l~~-~l~ 165 (325)
..+...+||++++|.+ +...+ .. .... ....+.... ..+..+ +.. ...
T Consensus 65 ~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~ 144 (226)
T TIGR02172 65 DGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARA 144 (226)
T ss_pred cCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHH
Confidence 7777889999999863 21111 11 0000 000111110 011000 001 111
Q ss_pred HHHhc-CCCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 166 YLHMH-HSARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 166 ~lh~~-~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
+|... ....++|+|+.|.||++++++ +.++||+.+.
T Consensus 145 ~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 145 FIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 22211 134679999999999999887 9999998874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.6e-07 Score=72.63 Aligned_cols=161 Identities=19% Similarity=0.201 Sum_probs=90.3
Q ss_pred hhhcCcccccc---cccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHH---HH---HHHhhCc----chHHHHHHH
Q 040480 31 KKEDCFASLEK---IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAEL---ID---AYSELGE----GKLTEIRSQ 97 (325)
Q Consensus 31 ~~~~~y~~~~~---lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~---~~~~~~~----~~~~~~~~e 97 (325)
.-.++..+... |.+|.-+.||+|.. .++..+|+|+..... ...... .. .+..... ....-...|
T Consensus 42 ~L~~rg~i~~~~g~istGKEA~Vy~a~~--~~~~~~avKiyr~~t-~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kE 118 (268)
T COG1718 42 RLLSRGVITELVGCISTGKEANVYLAET--GDGRYVAVKIYRTST-SEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKE 118 (268)
T ss_pred HHhcCCceeeeEeeecCCcceEEEeecc--CCCceEEEEEEehhh-hhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHH
Confidence 34445555554 55688889999953 467899999875322 111110 00 0000000 001112334
Q ss_pred HHHHhccCC--CCccccccceecCCceEEEEEcccCC-CHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC
Q 040480 98 IITASQIRH--RNILPLLAHMVRPDSHLLVYDFMKNG-SLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR 174 (325)
Q Consensus 98 ~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ 174 (325)
..-|.++.. =.+++.+.. ....+||||+... .-.-.+ ..-.+.......+..++++.+.-|.. ..+
T Consensus 119 f~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~ 187 (268)
T COG1718 119 FRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYK--EAG 187 (268)
T ss_pred HHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHH--hcC
Confidence 444444422 122333322 1346899998543 111111 11123333566778888888887772 269
Q ss_pred eEecCCCCCceEecCCCCceeeccccceecCC
Q 040480 175 VIHRDIKPANVLIDDDMEARISGFDLAILMPD 206 (325)
Q Consensus 175 ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 206 (325)
+||+||+.-|||+. ++.++++||+-+....+
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 99999999999999 78999999999876553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.3e-07 Score=85.72 Aligned_cols=187 Identities=21% Similarity=0.192 Sum_probs=129.7
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC-ccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN-ILPLL 113 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~ 113 (325)
-|...+-+++|+++++++.+ ...+ +.+..+.+ .......-++++|.+++||| .+..+
T Consensus 243 ws~~fh~fvK~altknpKkR-ptae-klL~h~fv--------------------s~~l~~rl~~eLLdK~n~P~~~v~~~ 300 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKR-PTAE-KLLQHPFV--------------------SQTLSRRLAIELLDKVNNPNPVVRYL 300 (829)
T ss_pred chHHHHHHHHHHhcCCCccC-CChh-hheeceee--------------------ccchhhHHHHHHHHHccCCCCccccc
Confidence 35666778999999999985 3222 22334443 11145677789999999999 77777
Q ss_pred cceecCCceEEEEEcccCC-CHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 114 AHMVRPDSHLLVYDFMKNG-SLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
+.+..+...++.++++.++ +..... ....-.+.......+...-..+++++| +-.-+|+| ||+..+ +.
T Consensus 301 ~d~~~E~~~~i~~~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~ 369 (829)
T KOG0576|consen 301 EDYDGEDYLWIPMRICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EE 369 (829)
T ss_pred ccCCcccccchhhhhhcCCccccccC---ChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cc
Confidence 7777888889999999776 221111 011122333344455556667788888 44447887 666554 67
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
.+..+|+....+.... ......+++.|+|||+.....+....|+|++|.-..++.-|-+|-.
T Consensus 370 ~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 370 VKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 8999999987776554 2233678999999999999899999999999987777877777753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.4e-05 Score=60.79 Aligned_cols=106 Identities=20% Similarity=0.243 Sum_probs=79.5
Q ss_pred HHHHHHHhccCC-CCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC
Q 040480 95 RSQIITASQIRH-RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA 173 (325)
Q Consensus 95 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~ 173 (325)
..|..++..+++ +++++++|+|- .+++.||...+++....... ..-...++..+.+|+.++++.+.+++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 346667777775 69999999884 36789999866553210000 1112478999999999999999999954335
Q ss_pred CeEecCCCCCceEecCCCCceeeccccceecC
Q 040480 174 RVIHRDIKPANVLIDDDMEARISGFDLAILMP 205 (325)
Q Consensus 174 ~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~ 205 (325)
.+.-+|++++|+-++++++++++|.+.+....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 58889999999999999999999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=2e-05 Score=65.23 Aligned_cols=78 Identities=13% Similarity=0.157 Sum_probs=51.4
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC--Cccccccce
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR--NILPLLAHM 116 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~ 116 (325)
++.|+.|..+.||++..+ +..+++|.... ......+..|..+++.+... .+++++...
T Consensus 2 i~~l~~G~~n~~~~v~~~---~~~~vlK~~~~-----------------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~ 61 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD---DGRYVLKFYRP-----------------PDAAERLRREAAVLRQLAEHGIPVPRVLAFD 61 (239)
T ss_dssp EEEEEESSSSEEEEEEET---TSEEEEEEESS-----------------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEE
T ss_pred CccCCCCCeeeEEEEEEC---CcEEEEEEeCC-----------------CCCHHHHHHHHHHHHHHHhcCCCCceEEeec
Confidence 457899999999999753 35899998621 02345566777777776432 355666533
Q ss_pred ---ecCCceEEEEEcccCCCHHH
Q 040480 117 ---VRPDSHLLVYDFMKNGSLQA 136 (325)
Q Consensus 117 ---~~~~~~~lv~e~~~~~~L~~ 136 (325)
......+++|++++|..+..
T Consensus 62 ~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 62 TSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp EETEETSEEEEEEEEESSEEHHH
T ss_pred ccccccccceEEEEEeccccccc
Confidence 23334689999999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=2e-05 Score=65.81 Aligned_cols=76 Identities=9% Similarity=0.040 Sum_probs=49.4
Q ss_pred ccccCcc-eeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccccccceec
Q 040480 41 KIGSGGC-GDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPLLAHMVR 118 (325)
Q Consensus 41 ~lg~G~~-g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 118 (325)
.|..|.+ +.||+... .+..+++|..... . ...+.+|+.+++.+. +-.+++++.....
T Consensus 5 ~~~~g~~~~~v~~~~~---~~~~~~vk~~~~~-----------------~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 63 (244)
T cd05150 5 RVTEGQSGATVYRLDG---KNPGLYLKIAPSG-----------------P-TYELEREAERLRWLAGKLPVPEVIDYGSD 63 (244)
T ss_pred ecCCCCCcCeEEEEcC---CCCcEEEEecCCC-----------------c-ccchHHHHHHHHHHHhcCCCCeEEEEEec
Confidence 3455555 78999953 3467888875211 0 224556777776663 3446677776666
Q ss_pred CCceEEEEEcccCCCHHHH
Q 040480 119 PDSHLLVYDFMKNGSLQAV 137 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~ 137 (325)
.+..++||++++|.++...
T Consensus 64 ~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 64 DGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCccEEEEEeeCCccHhHh
Confidence 6678999999999877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.6e-05 Score=72.56 Aligned_cols=155 Identities=14% Similarity=0.111 Sum_probs=88.6
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHh----------------hCcchHHHHHHH------
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSE----------------LGEGKLTEIRSQ------ 97 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~e------ 97 (325)
+.|+..+.|.|++|+.. +|+.||||+.++.-..-.......... ...+..+.+..|
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 57999999999999876 599999998753221110000000000 000111122222
Q ss_pred ----HHHHhccCCCC------ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHH
Q 040480 98 ----IITASQIRHRN------ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYL 167 (325)
Q Consensus 98 ----~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~l 167 (325)
-+..+.++|-+ |++++- .......++|||++|..+.+.-. . ....++...+..-+.+...-.-+.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~-i--~~~gi~~~~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDA-I--DKRGISPHDILNKLVEAYLEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHH-H--HHcCCCHHHHHHHHHHHHHHHHHh
Confidence 22233334444 334332 23345789999999987766631 1 122344444433333333223333
Q ss_pred HhcCCCCeEecCCCCCceEecC----CCCceeeccccceecCC
Q 040480 168 HMHHSARVIHRDIKPANVLIDD----DMEARISGFDLAILMPD 206 (325)
Q Consensus 168 h~~~~~~ivH~dl~~~nil~~~----~~~~~l~dfg~~~~~~~ 206 (325)
| |.+|+|-.|.||+++. +..+.+.|||+......
T Consensus 320 ~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 T-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred c-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3 8999999999999994 56789999999876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.8e-05 Score=62.89 Aligned_cols=142 Identities=18% Similarity=0.288 Sum_probs=91.2
Q ss_pred hhcCcccccccccCcc-eeEEEEEecCCCCcEEEEEEEcc---cCCCcHH-HHHHHH--HhhCcchHHHHHHHHHHHhcc
Q 040480 32 KEDCFASLEKIGSGGC-GDVYKAELPGSNGKMIAVKKVII---YSPMSAA-ELIDAY--SELGEGKLTEIRSQIITASQI 104 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~-g~v~~~~~~~~~~~~vavK~~~~---~~~~~~~-~~~~~~--~~~~~~~~~~~~~e~~~l~~l 104 (325)
.+..++.++.||.|.- |.||+++. +|+.+|+|.+.- ..+.... ...... ..........+..|.+...+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 4589999999999999 99999986 788999999332 2211110 000000 000113345788888888888
Q ss_pred C---CCCc--cccccceecC------------------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHH
Q 040480 105 R---HRNI--LPLLAHMVRP------------------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVA 161 (325)
Q Consensus 105 ~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~ 161 (325)
+ +.++ ++++++..-. ....||.||.+... .+.... +.+|.
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~ 174 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQML 174 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHH
Confidence 5 3455 8888876322 11256777665532 123333 33455
Q ss_pred HHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 162 SGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 162 ~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
+-+..+| ..||+-+|+++.|.. .-+|+|||.+
T Consensus 175 ~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 5577788 889999999999987 2389999865
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.8e-05 Score=60.92 Aligned_cols=141 Identities=14% Similarity=0.191 Sum_probs=90.7
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcH---HHHHHHHHhhCcchHHHHHHHHHHHhccC------CCCc
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSA---AELIDAYSELGEGKLTEIRSQIITASQIR------HRNI 109 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i 109 (325)
...||+|+.-.||.-- .....+||+......... ..+.... ..........+|+.-...+. +.+|
T Consensus 6 ~~~i~~G~~R~cy~HP----~dp~~cIKV~~~~~~~~~~~~~~~~k~~--~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i 79 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP----DDPNLCIKVMRPDRGERRRPFKRWLKRL--RPKSRYRQNRRELRYYKQLSLRRGVDWSHI 79 (199)
T ss_pred CcccccCCCceEEECC----CCCCeEEEEEccccccccccchhHHHhh--cccchhHHHHHHHHHHHHHhhccCCccccc
Confidence 3578999999998652 455688998865441111 1111111 11223455666666666555 7899
Q ss_pred cccccceecCCceEEEEEcccC------CCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKN------GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
.+++|+..++....+|+|.+.+ .+|.+++ ....++. .....+.++ ..+|- ...|+.+|++|.
T Consensus 80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-----~~~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~ 147 (199)
T PF10707_consen 80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYL-----KEGGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPH 147 (199)
T ss_pred ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHH-----HcCCccH-HHHHHHHHH---HHHHH---HcCCeecCCCcc
Confidence 9999999999999999998642 4677777 2233554 444444544 44555 557999999999
Q ss_pred ceEecCC--C--Cceeec
Q 040480 184 NVLIDDD--M--EARISG 197 (325)
Q Consensus 184 nil~~~~--~--~~~l~d 197 (325)
||++... + .++|+|
T Consensus 148 NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 148 NIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cEEEEecCCCceEEEEEe
Confidence 9999733 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.97 E-value=9.4e-05 Score=72.66 Aligned_cols=82 Identities=7% Similarity=0.129 Sum_probs=53.8
Q ss_pred cccccccCcceeEEEEEecCCC-CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCC--ccccc
Q 040480 38 SLEKIGSGGCGDVYKAELPGSN-GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRN--ILPLL 113 (325)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~ 113 (325)
-++.++.|.+..+|+.+..... ...+++|+.... ........+.+|..+++.+. |++ +++++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~--------------~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~ 107 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPG--------------KLLQSAHAVEREYQVLRALGEHTDVPVPKVY 107 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCC--------------ccCccHHHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 3677899999999998654221 146777764210 00112345778888898885 554 47777
Q ss_pred cceecC---CceEEEEEcccCCC
Q 040480 114 AHMVRP---DSHLLVYDFMKNGS 133 (325)
Q Consensus 114 ~~~~~~---~~~~lv~e~~~~~~ 133 (325)
.++.+. +..|+||||++|..
T Consensus 108 ~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 108 CLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred EEecCCCcCCCceEEEEecCCcc
Confidence 766554 46799999998854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.96 E-value=8.1e-05 Score=61.81 Aligned_cols=31 Identities=23% Similarity=0.356 Sum_probs=25.8
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..+++|+|+.+.|++++++...-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4569999999999999876556799998873
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.95 E-value=2.7e-05 Score=75.72 Aligned_cols=198 Identities=19% Similarity=0.181 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHhccCCCCccccccceecCCce----EEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHH
Q 040480 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSH----LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEY 166 (325)
Q Consensus 91 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~ 166 (325)
......|...+....|+|++.++.+....... ....+++...++...+ ..-...+..+.+.+..++.+|+.+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHH
Confidence 33445566777788899999998877654333 3445677777787777 445568888888899999999999
Q ss_pred HHhcCCCCeEecCCCCC---ceEecCCCCceee--ccccceecCCCCccccceeecCCcccccccccccCCCCC--ccch
Q 040480 167 LHMHHSARVIHRDIKPA---NVLIDDDMEARIS--GFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISE--KCDI 239 (325)
Q Consensus 167 lh~~~~~~ivH~dl~~~---nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~--~~Dv 239 (325)
+| +..+.|.-+..+ +.-++..+.+... ||+.+........... ..-+..+.+||......++. ..|+
T Consensus 302 ~h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 302 LH---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HH---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHH
Confidence 99 444444444444 2333344444444 7777665544322211 23345577788766655544 4799
Q ss_pred hhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 240 YSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 240 wslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
|++|.....+..|..+-..... ... +....... .+.+...+|+..++++|+++
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~------~~~------------------~l~~~~~~---~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAV------PVS------------------LLDVLSTS---ELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccc------hhh------------------hhccccch---hhhhhhhhhcchhhhhccch
Confidence 9999999999887755321100 000 00000000 16788899999999999999
Q ss_pred hhhhcC
Q 040480 320 KDVRCM 325 (325)
Q Consensus 320 ~ell~~ 325 (325)
.+++.+
T Consensus 429 ~~ll~~ 434 (1351)
T KOG1035|consen 429 LELLTH 434 (1351)
T ss_pred hhhhhc
Confidence 998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=7.8e-05 Score=63.16 Aligned_cols=152 Identities=14% Similarity=0.143 Sum_probs=95.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHH-----HHhhCc---chHHHHHHHHHHHhc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDA-----YSELGE---GKLTEIRSQIITASQ 103 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~~~~e~~~l~~ 103 (325)
+..-+.+.+.||-|.-+.||.+-+ ..|.+.++|.-.+- ..+++.+..+ .+.... -.+-...+|...|+.
T Consensus 90 R~~v~svGnqIGVGKESDIY~v~d--~~G~~~~lK~HRLG-RtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka 166 (465)
T KOG2268|consen 90 RGSVESVGNQIGVGKESDIYVVAD--EEGNPLILKLHRLG-RTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA 166 (465)
T ss_pred cchhhhhccccccccccceEEEec--CCCCchhHHHHhhh-hhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence 455788899999999999999954 46788888853221 1111111111 111000 112245667777777
Q ss_pred cCC--CCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040480 104 IRH--RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181 (325)
Q Consensus 104 l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~ 181 (325)
|.. -.+++.+ +.+..++|||++.|-.|.+.- . ......+...+...+--|- +.|+||+|++
T Consensus 167 L~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~-------~---v~d~~~ly~~lm~~Iv~la---~~GlIHgDFN 229 (465)
T KOG2268|consen 167 LYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVR-------H---VEDPPTLYDDLMGLIVRLA---NHGLIHGDFN 229 (465)
T ss_pred HHHcCCCCCCcc----cccceeeHHHhhcccceeeee-------e---cCChHHHHHHHHHHHHHHH---HcCceecccc
Confidence 743 3444444 345678999999887665432 1 1122334455555555566 7799999999
Q ss_pred CCceEecCCCCceeecccccee
Q 040480 182 PANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~~ 203 (325)
-=||++.++++++++||--...
T Consensus 230 EFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 230 EFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred hheeEEecCCCEEEeechHhhc
Confidence 9999999999999999966543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00089 Score=59.59 Aligned_cols=83 Identities=16% Similarity=0.160 Sum_probs=50.1
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC---CCCccccccc
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR---HRNILPLLAH 115 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~ 115 (325)
.+.||.|.+..||++... .+++.++||.-........ ..-....++...|.+.|..+. ..++++++.+
T Consensus 31 ~~elggGn~N~VyrV~~~-~g~~svIVKqa~p~~r~~g--------~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDT-EGGKSVIVKQALPYVRVVG--------ESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeC-CCCeEEEEEecCccccccc--------ccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 457899999999999642 2225899997421110000 000123445566666666652 2456777765
Q ss_pred eecCCceEEEEEcccCC
Q 040480 116 MVRPDSHLLVYDFMKNG 132 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~ 132 (325)
+....++|||++++.
T Consensus 102 --D~~~~~lVME~L~~~ 116 (401)
T PRK09550 102 --DEELAVTVMEDLSDH 116 (401)
T ss_pred --CCCCCEEEEecCCCc
Confidence 446678999999763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0011 Score=54.91 Aligned_cols=31 Identities=13% Similarity=0.318 Sum_probs=26.9
Q ss_pred CCCeEecCCCCCceEecC-CCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDD-DMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~-~~~~~l~dfg~~~ 202 (325)
..+++|+|+.+.||+++. ++.+.++||..+.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 347999999999999997 5789999998773
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.001 Score=57.25 Aligned_cols=78 Identities=9% Similarity=0.032 Sum_probs=51.1
Q ss_pred ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC---CCccccc
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH---RNILPLL 113 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~ 113 (325)
.-.+.||.|..+.||.... ++..+++|.... ......+..|...++.+.. -.+++++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~---~~~~~~~k~~~~-----------------~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~ 76 (297)
T PRK10593 17 SRVECISEQPYAALWALYD---SQGNPMPLMARS-----------------FSTPGVAQQEAWKLSMLARSGTVRMPTVY 76 (297)
T ss_pred heeeecCCccceeEEEEEc---CCCCEEEEEecc-----------------cccchHHHHHHHHHHHHccCCCCCcCcEE
Confidence 3355799999999999853 223466676410 0112356777777776642 3677777
Q ss_pred cceec---CCceEEEEEcccCCCH
Q 040480 114 AHMVR---PDSHLLVYDFMKNGSL 134 (325)
Q Consensus 114 ~~~~~---~~~~~lv~e~~~~~~L 134 (325)
+++.. .+..++|||+++|.++
T Consensus 77 ~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 77 GVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred EEeccCCcCCCeEEEEeccCCEec
Confidence 76643 3668999999998654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00057 Score=57.54 Aligned_cols=29 Identities=14% Similarity=0.308 Sum_probs=25.5
Q ss_pred CCeEecCCCCCceEecCCCCceeeccccce
Q 040480 173 ARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 173 ~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..++|+|+.|.||++++++ +.++||+.+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 3589999999999999876 7899998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00095 Score=57.48 Aligned_cols=143 Identities=17% Similarity=0.181 Sum_probs=78.2
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC--Cccccccce
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR--NILPLLAHM 116 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~ 116 (325)
.+.+..|....+|+... ++..+++|.... .....+..|+.++..+... .+++++...
T Consensus 19 i~~i~~G~~n~~y~v~~---~~~~~vLr~~~~------------------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~ 77 (296)
T cd05153 19 FEGISAGIENTNYFVTT---DSGRYVLTLFEK------------------VSAEELPFFLALLDHLAERGLPVPRPIADR 77 (296)
T ss_pred eecccCccccceEEEEe---CCCcEEEEEcCC------------------CChHhccHHHHHHHHHHHCCCCCCccccCC
Confidence 55677788889999854 345688887621 1123445555666655322 244444321
Q ss_pred ------ecCCceEEEEEcccCCCHHH-----------HHhhhccccccc----------ChhhH----------HHHHHH
Q 040480 117 ------VRPDSHLLVYDFMKNGSLQA-----------VLYDVSKGRREL----------EWLSR----------HKIALA 159 (325)
Q Consensus 117 ------~~~~~~~lv~e~~~~~~L~~-----------~~~~~~~~~~~~----------~~~~~----------~~i~~~ 159 (325)
...+..++++++++|..+.. .+.........+ .+... ......
T Consensus 78 ~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 157 (296)
T cd05153 78 DGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRAL 157 (296)
T ss_pred CCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHH
Confidence 22345689999998865421 111111000000 00000 001111
Q ss_pred HHHHHHHHHh----cCCCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 160 VASGLEYLHM----HHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 160 l~~~l~~lh~----~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
+..++..+.. ....+++|+|+.|.|+++++++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 158 LADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2223334332 114579999999999999987767899998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0033 Score=54.47 Aligned_cols=31 Identities=39% Similarity=0.528 Sum_probs=27.5
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..+++|+|+.+.|++++.++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5789999999999999988767899998874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0053 Score=53.47 Aligned_cols=31 Identities=32% Similarity=0.396 Sum_probs=26.5
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..+++|+|+.|.||+++.+...-++||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4589999999999999966555899998874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0032 Score=54.96 Aligned_cols=80 Identities=11% Similarity=0.104 Sum_probs=46.9
Q ss_pred ccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--CC-Ccccccccee
Q 040480 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR--HR-NILPLLAHMV 117 (325)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~ 117 (325)
.+|.|....||++.. ...++.++||.=.. ..+.....-+...++...|...|+... .| .+++++. .
T Consensus 2 EigdGnlN~VfrV~~-~~g~~svIVKQAlp--------~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~ 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYD-QEGDRAAIVKQALP--------YVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F 70 (370)
T ss_pred cCCCCceEEEEEEEc-CCCCeeEEEEEcCH--------HHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence 579999999999963 33336899996421 111111111233455566777776553 24 4555553 4
Q ss_pred cCCceEEEEEcccC
Q 040480 118 RPDSHLLVYDFMKN 131 (325)
Q Consensus 118 ~~~~~~lv~e~~~~ 131 (325)
++....+|||+++.
T Consensus 71 D~e~~~~vMEdL~~ 84 (370)
T TIGR01767 71 DTEMAVTVMEDLSH 84 (370)
T ss_pred ccccceehHhhCcc
Confidence 55566789999843
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00016 Score=72.53 Aligned_cols=163 Identities=10% Similarity=0.068 Sum_probs=113.2
Q ss_pred HHHHHHHHHhccCCCCccccccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc
Q 040480 93 EIRSQIITASQIRHRNILPLLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH 170 (325)
Q Consensus 93 ~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~ 170 (325)
-...|....+...|+++...+.-.... ...+.+++++.+|.+.+.+.+.....+.+..........+......-+|..
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 334444455556788877765544332 345788999999999999976544444455444444444435555665644
Q ss_pred CC--CCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHH
Q 040480 171 HS--ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAV 248 (325)
Q Consensus 171 ~~--~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ 248 (325)
.+ .-.+|+++++-|.++..+..++++++|+.+...+...... ...+++.|+.|++...-.++.++|+|..|+.+|.
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~G--l~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFG--LELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhh--hhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 32 2378999999999999999999999999983332222111 1456777888898888788888999999999999
Q ss_pred HHhCCCCCC
Q 040480 249 LVMGKFPFD 257 (325)
Q Consensus 249 ll~g~~p~~ 257 (325)
...|..+|.
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 888887763
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0023 Score=56.63 Aligned_cols=80 Identities=13% Similarity=0.004 Sum_probs=49.1
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--CC-Cccccccc
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR--HR-NILPLLAH 115 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~ 115 (325)
.+.||.|...-||++.. ...++.++||.=.. ..+ ....-+-..++...|..+|+... .| .+++++.
T Consensus 34 ~~eigdGnlN~VfrV~~-~~~~~svIVKQAlp--------~vR-v~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~- 102 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWD-EQKNISVIVKQAGD--------TAR-ISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL- 102 (409)
T ss_pred eeEcCCCceEEEEEEee-CCCCceEEEEeccH--------hhc-cCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-
Confidence 55789999999999964 22356799996321 111 11111234566777777777653 34 4555653
Q ss_pred eecCCceEEEEEccc
Q 040480 116 MVRPDSHLLVYDFMK 130 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~ 130 (325)
.++....+|||+++
T Consensus 103 -~D~e~~~~vMEdL~ 116 (409)
T PRK12396 103 -FDSVMNCCVMEDLS 116 (409)
T ss_pred -ECcHHhhHHHHhCc
Confidence 45556678888884
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0062 Score=52.60 Aligned_cols=31 Identities=19% Similarity=0.345 Sum_probs=27.3
Q ss_pred CCCeEecCCCCCceEecCC----CCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDD----MEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~----~~~~l~dfg~~~ 202 (325)
...++|+|+.+.||+++++ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4579999999999999974 789999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.015 Score=51.74 Aligned_cols=81 Identities=9% Similarity=0.103 Sum_probs=47.3
Q ss_pred cccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC---CCCcccccc
Q 040480 38 SLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR---HRNILPLLA 114 (325)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~ 114 (325)
..+.+|.|....||+... .+..++||.-..........+ +-...+...|...|+.+. ..++++++.
T Consensus 36 ~~~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga~w--------pl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~ 104 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGESW--------PMTKERAYFEATALREHGRLCPDHVPEVYH 104 (418)
T ss_pred eEEEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCccc--------cCCccHHHHHHHHHHHhhhcCCCCCCeEEE
Confidence 356789999999999963 345688997531111000000 012333344455555443 247777887
Q ss_pred ceecCCceEEEEEcccC
Q 040480 115 HMVRPDSHLLVYDFMKN 131 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~ 131 (325)
++. +..+++||++++
T Consensus 105 ~de--d~~vlvME~L~~ 119 (418)
T PLN02756 105 FDR--TMALIGMRYLEP 119 (418)
T ss_pred ECC--CCCEEEEeecCC
Confidence 665 456788999966
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.013 Score=50.54 Aligned_cols=33 Identities=27% Similarity=0.505 Sum_probs=28.7
Q ss_pred CCeEecCCCCCceEecCCCCceeeccccceecC
Q 040480 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205 (325)
Q Consensus 173 ~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~ 205 (325)
..++|+|+.+.|++++.++-+-|.||+.+..-.
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 469999999999999988889999999986543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.022 Score=49.37 Aligned_cols=31 Identities=16% Similarity=0.287 Sum_probs=27.9
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..+++|+|+.+.|++++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 5589999999999999998899999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.012 Score=51.24 Aligned_cols=158 Identities=16% Similarity=0.169 Sum_probs=89.9
Q ss_pred ccccccccCcceeEEEEEecCCCCcEEEEEEEccc--CCCcHHHHH-------HHHHhhCcc--hHHHHHHHHHHHhccC
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIY--SPMSAAELI-------DAYSELGEG--KLTEIRSQIITASQIR 105 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~-------~~~~~~~~~--~~~~~~~e~~~l~~l~ 105 (325)
.+-.+|..|.-+.||.|. ..+|..+|||+..-. .-.+....+ ..++.-++. .......|++-|+++.
T Consensus 147 ~inGCiSTGKEANVYHat--~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT--EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred ecccccccCccceeEeee--cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 344467789999999994 357888999986410 000000000 001111111 1122334555555554
Q ss_pred CCCccccccceecCCceEEEEEcccCCC-HHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040480 106 HRNILPLLAHMVRPDSHLLVYDFMKNGS-LQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 106 h~~i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~n 184 (325)
...|+-.--+.. ....+||+++.... ..-.+ .+..++...+..+-.+++.-+.-|.+.+ ++||.||+--|
T Consensus 225 ~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN 295 (520)
T KOG2270|consen 225 NAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFN 295 (520)
T ss_pred hcCCCCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhh
Confidence 444332222111 23468999985311 11111 2334666667777778877777777644 89999999999
Q ss_pred eEecCCCCceeeccccceecCC
Q 040480 185 VLIDDDMEARISGFDLAILMPD 206 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~ 206 (325)
+|+-+ |.++++|-+-+.....
T Consensus 296 ~Lyhd-G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 296 LLYHD-GKLYIIDVSQSVEHDH 316 (520)
T ss_pred heEEC-CEEEEEEccccccCCC
Confidence 99875 5789999887765443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.021 Score=50.35 Aligned_cols=32 Identities=22% Similarity=0.410 Sum_probs=27.0
Q ss_pred CCCeEecCCCCCceEecC-CCCceeecccccee
Q 040480 172 SARVIHRDIKPANVLIDD-DMEARISGFDLAIL 203 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~-~~~~~l~dfg~~~~ 203 (325)
...++|+|+++.||++++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 446899999999999986 46799999988753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.023 Score=48.47 Aligned_cols=75 Identities=17% Similarity=0.286 Sum_probs=43.9
Q ss_pred ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc---CCCCccccc
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI---RHRNILPLL 113 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~ 113 (325)
+-.+.++-|....+|+.. .+++.+.||.-. ......+..|..-|+.+ ..-.+++++
T Consensus 20 ~~~~~v~GG~i~~a~~~~---~~~~~~FvK~~~------------------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi 78 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD---TDGGSYFVKVNS------------------ESGRDMFEGEAEGLKALAEANPIRVPKVI 78 (288)
T ss_dssp -EEEEE--SSSSEEEEEE---TTS-EEEEEEEE------------------GGGCCHHHHHHHHHHHHCHTTTSBS--EE
T ss_pred eeeEecCCCChhheEEEE---CCCccEEEEecC------------------hhhHHHHHHHHHHHHHHHhcCCCCCCeEE
Confidence 345578889999999985 477889999862 12223445555555555 345678888
Q ss_pred cceecCCceEEEEEcccCC
Q 040480 114 AHMVRPDSHLLVYDFMKNG 132 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~ 132 (325)
.+....+..++++||++.+
T Consensus 79 ~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 79 AWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE-SSCCEEEEE-----
T ss_pred EEEeecCCceEEEEeecCC
Confidence 8888777889999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.082 Score=45.79 Aligned_cols=30 Identities=27% Similarity=0.383 Sum_probs=26.0
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..+++|+|+.+.||+++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 468999999999999987 678999998763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.032 Score=47.50 Aligned_cols=30 Identities=27% Similarity=0.563 Sum_probs=25.0
Q ss_pred CCeEecCCCCCceEecCCCC-ceeeccccce
Q 040480 173 ARVIHRDIKPANVLIDDDME-ARISGFDLAI 202 (325)
Q Consensus 173 ~~ivH~dl~~~nil~~~~~~-~~l~dfg~~~ 202 (325)
..++|+|+.|.||++++++. .-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 35899999999999997555 4699998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.07 Score=46.72 Aligned_cols=31 Identities=13% Similarity=0.321 Sum_probs=26.4
Q ss_pred CeEecCCCCCceEecC-CCCceeeccccceec
Q 040480 174 RVIHRDIKPANVLIDD-DMEARISGFDLAILM 204 (325)
Q Consensus 174 ~ivH~dl~~~nil~~~-~~~~~l~dfg~~~~~ 204 (325)
-.+|+|+.+.||++++ ++.++++||..+...
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 4899999999999975 478999999998543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.57 Score=40.96 Aligned_cols=29 Identities=28% Similarity=0.357 Sum_probs=24.8
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..+++|+|+.+.||+++ + .+.++||+.+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 56799999999999995 3 58899998874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.098 Score=47.73 Aligned_cols=163 Identities=19% Similarity=0.252 Sum_probs=88.1
Q ss_pred HHHHHHHHHhccCCCCccccccceecC-CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcC
Q 040480 93 EIRSQIITASQIRHRNILPLLAHMVRP-DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHH 171 (325)
Q Consensus 93 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~ 171 (325)
.+.-...+++.+.|++..+++.+.... ....+|+|++ +.+|.+...... +-... + + -|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-----l~~~s---~-------~--~~--- 86 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-----LKDES---L-------L--AH--- 86 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-----cchhh---h-------c--cc---
Confidence 445556788888999998888766543 3467889998 459999883211 11000 0 0 12
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~ 251 (325)
++.|-+ + .+.+| .+. |. | |- +..+++||||+|.++.++.-
T Consensus 87 --~~~~~~-----~-------~~~td-~~~-----------------t~-~--~~-----~~~pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 87 --GVLHLN-----I-------IYITD-HFL-----------------TK-Y--PS-----PIGPKSDVWSLGFIILELYL 126 (725)
T ss_pred --ccceeh-----h-------hhccc-ccc-----------------cc-C--CC-----CCCcchhhhhHHHHHHHHHH
Confidence 332221 1 22333 000 00 0 00 11249999999999999998
Q ss_pred CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccc-hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 252 GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAID-SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 252 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
|..-+... ...+....+.+-...+.... ..........+.+.+.++..+|+-..|..||...+..
T Consensus 127 ~~~l~~~~-------~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 127 GISLEAEL-------TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred hhHHHHHH-------HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 87665331 11122222222211111100 0000112234445588999999999999999766653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.024 Score=45.83 Aligned_cols=86 Identities=13% Similarity=0.062 Sum_probs=55.3
Q ss_pred HHHHHHHHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC
Q 040480 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA 173 (325)
Q Consensus 94 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~ 173 (325)
+..+.++++++. .|+++.. ...-...+++|+|-..... ...++..=+.+|.-+|+. +.
T Consensus 105 y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i~-----------------~~N~i~agi~~L~~fH~~-~~ 162 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKIN-----------------FSNFITAGIKDLMDFHSE-NQ 162 (308)
T ss_pred hhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcccc-----------------hhHHHHHhHHHHHHhhcc-CC
Confidence 345556666543 4566553 1233456888988542110 011222223567778865 67
Q ss_pred CeEecCCCCCceEecCCCCceeeccccc
Q 040480 174 RVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 174 ~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
+.+|+|..|+|||.+..|.+||.|-+.-
T Consensus 163 ~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 163 HCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CeecCCCChhheeecCCCCEEecChhhh
Confidence 8999999999999999999999997654
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.3 Score=42.78 Aligned_cols=106 Identities=16% Similarity=0.167 Sum_probs=66.1
Q ss_pred cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeec
Q 040480 118 RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~d 197 (325)
+....|++|++- |+++... ..-...+...++.+.+..+.-+.. +-..-|+|+...||+++ +|.|.|+|
T Consensus 297 e~~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLID 364 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLID 364 (488)
T ss_pred CceEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEE
Confidence 344567788865 4455322 224456667788777666666653 45688999999999999 89999999
Q ss_pred cccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHH
Q 040480 198 FDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFG 243 (325)
Q Consensus 198 fg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG 243 (325)
|-+++.-..... .....+--|..+.|.. +..-+||-+.
T Consensus 365 fklsRl~~~q~~-------isy~rldhp~lF~G~d-d~QFeIYrlM 402 (488)
T COG5072 365 FKLSRLSYSQGI-------ISYNRLDHPDLFNGVD-DYQFEIYRLM 402 (488)
T ss_pred eeeeecccCCce-------eeccccCchhhhcCcc-ceeeeHHHHH
Confidence 999983322211 1111233455555433 5566676653
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.14 E-value=1 Score=36.96 Aligned_cols=75 Identities=15% Similarity=0.228 Sum_probs=47.4
Q ss_pred cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHH---HHhccCCCCccccccce
Q 040480 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII---TASQIRHRNILPLLAHM 116 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~~i~~~~~~~ 116 (325)
+.+--|.--..|...+ ...++.+|.- .......+..|+. .|+.-+.-.+.+++.+.
T Consensus 22 ~~v~gG~inea~~v~d---g~~~~FvK~n------------------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G 80 (286)
T COG3001 22 EEVSGGDINEAWRLRD---GTDPFFVKCN------------------QREQLSMFTAEADGLELLARSNTITVPKVIAVG 80 (286)
T ss_pred cccCCccccceeEeec---CCcceEEEec------------------chhhHHHHHHHHHHHHHHHhcCCccccceEEec
Confidence 3445566666676643 5567888863 1112233344433 34443455678888888
Q ss_pred ecCCceEEEEEcccCCCHH
Q 040480 117 VRPDSHLLVYDFMKNGSLQ 135 (325)
Q Consensus 117 ~~~~~~~lv~e~~~~~~L~ 135 (325)
...++.|+|+||++.+.+.
T Consensus 81 ~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 81 ASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCCCeeEEEEeeccCCCCC
Confidence 9999999999999875554
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.93 E-value=0.1 Score=45.07 Aligned_cols=55 Identities=24% Similarity=0.252 Sum_probs=35.2
Q ss_pred hhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceEecCCC------------------CceeeccccceecC
Q 040480 151 LSRHKIALAVASGLEYLHMH-HSARVIHRDIKPANVLIDDDM------------------EARISGFDLAILMP 205 (325)
Q Consensus 151 ~~~~~i~~~l~~~l~~lh~~-~~~~ivH~dl~~~nil~~~~~------------------~~~l~dfg~~~~~~ 205 (325)
.-...++.|++.-.--.... +....+|.||||+|||+-+.. .++|.||++++...
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 34566788876443223222 244789999999999995432 25777887776543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.12 Score=43.69 Aligned_cols=47 Identities=21% Similarity=0.257 Sum_probs=34.3
Q ss_pred HHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecccccee
Q 040480 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 156 i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~ 203 (325)
.+..+-..+.-.+.. ..-++|+|+.|+|++.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344444444444421 13599999999999999999999999988854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.37 E-value=0.51 Score=42.22 Aligned_cols=30 Identities=23% Similarity=0.196 Sum_probs=25.1
Q ss_pred CCeEecCCCCCceEecCCCCceeecccccee
Q 040480 173 ARVIHRDIKPANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 173 ~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~ 203 (325)
...+|.|+-+.||+.++ +.++++||..+..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 56899999999998764 4699999988853
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.30 E-value=0.57 Score=41.79 Aligned_cols=61 Identities=21% Similarity=0.220 Sum_probs=37.5
Q ss_pred ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 121 SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 121 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
...++-+|..|.++..++.. ...++....++..-...|+--+-. -.+.+|.|+.|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence 34567778888888888832 223333344444444444332221 23799999999999995
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.22 E-value=0.07 Score=42.24 Aligned_cols=29 Identities=17% Similarity=0.244 Sum_probs=25.5
Q ss_pred CeEecCCCCCceEecCCCCceeecccccee
Q 040480 174 RVIHRDIKPANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 174 ~ivH~dl~~~nil~~~~~~~~l~dfg~~~~ 203 (325)
-.+|+|+.|.|+++++++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998776 89999999854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 325 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 4e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-81
Identities = 97/290 (33%), Positives = 154/290 (53%), Gaps = 18/290 (6%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
D F++ +G GG G VYK L +G ++AVK++ +G +
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEER--------------TQGGELQ 73
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
++++ S HRN+L L + P LLVY +M NGS+ + L + + + L+W R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+IAL A GL YLH H ++IHRD+K AN+L+D++ EA + F LA LM T + T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM-VRWM 272
V GT +IAPEY T SEK D++ +GV+L L+ G+ FD + M + W+
Sbjct: 194 A-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ ++ + +D L GN +E++ ++++A CT + P ERP +V
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-66
Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 23/290 (7%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ F IG G G VYK L +G +A+K+ S G E
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKR------------RTPESSQGI---EE 81
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
++I T S RH +++ L+ + +L+Y +M+NG+L+ LY + W R
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG-LTQID 212
+I + A GL YL H+ +IHRD+K N+L+D++ +I+ F ++ + T +
Sbjct: 142 LEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 213 TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272
T+ V GT YI PEY ++EK D+YSFGV+L ++ + +++ W
Sbjct: 199 TV-VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEWA 256
Query: 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ + +D L E + A C ++RP+ DV
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-65
Identities = 88/284 (30%), Positives = 125/284 (44%), Gaps = 26/284 (9%)
Query: 41 KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIIT 100
K+G GG G VYK + N +AVKK L E + +I
Sbjct: 38 KMGEGGFGVVYKGYV---NNTTVAVKK-----------LAAMVDITTEELKQQFDQEIKV 83
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
++ +H N++ LL D LVY +M NGSL L G L W R KIA
Sbjct: 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGA 142
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
A+G+ +LH +H IHRDIK AN+L+D+ A+IS F LA + T +VGT
Sbjct: 143 ANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199
Query: 221 RYIAPEYHQTLT--ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
Y+APE L I+ K DIYSFGV+L ++ G D H ++ +
Sbjct: 200 AYMAPEA---LRGEITPKSDIYSFGVVLLEIITGLPAVD---EHREPQLLLDIKEEIEDE 253
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
E K + + + + +A C ++RP+ K V
Sbjct: 254 EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-56
Identities = 72/317 (22%), Positives = 116/317 (36%), Gaps = 51/317 (16%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
LE G G V+KA+L + +AVK I+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL---LNEYVAVK---IFPIQDKQSW------------- 63
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSH----LLVYDFMKNGSLQAVLYDVSKGRREL 148
+ ++ + ++H NIL + R S L+ F + GSL L +
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVV 118
Query: 149 EWLSRHKIALAVASGLEYLHMHHSA-------RVIHRDIKPANVLIDDDMEARISGFDLA 201
W IA +A GL YLH + HRDIK NVL+ +++ A I+ F LA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 202 ILMPDGLTQIDTMYVVGTPRYIAPEY-----HQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
+ G + DT VGT RY+APE + + D+Y+ G++L L
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 257 DD--------FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFC 308
D F G+ + M+ V+ + + + M ++ + C
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH---AGMAMLCETIEEC 295
Query: 309 TLADPDERPNSKDVRCM 325
D + R ++ V
Sbjct: 296 WDHDAEARLSAGCVGER 312
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-47
Identities = 62/220 (28%), Positives = 113/220 (51%), Gaps = 20/220 (9%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
EKIG+G G V++AE +G +AVK ++ + ++ E ++
Sbjct: 43 EKIGAGSFGTVHRAEW---HGSDVAVKILME-------------QDFHAERVNEFLREVA 86
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
++RH NI+ + + +P + +V +++ GSL +L+ S R +L+ R +A
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYD 145
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
VA G+ YLH + + ++HR++K N+L+D ++ F L+ L T + + GT
Sbjct: 146 VAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGT 202
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
P ++APE + +EK D+YSFGV+L L + P+ +
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-46
Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 38/240 (15%)
Query: 21 LIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELI 80
+I+ +++ E +G G G V KA+ K +A+K++
Sbjct: 4 MIDYKEIEVE---------EVVGRGAFGVVCKAKW---RAKDVAIKQI------------ 39
Query: 81 DAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD 140
E + ++ S++ H NI+ L + P LV ++ + GSL VL+
Sbjct: 40 -----ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHG 92
Query: 141 VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME-ARISGFD 199
++ L + G+ YLH +IHRD+KP N+L+ +I F
Sbjct: 93 -AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151
Query: 200 LAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
A + +T G+ ++APE + SEKCD++S+G++L ++ + PFD+
Sbjct: 152 TACDIQTHMTN-----NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-46
Identities = 70/317 (22%), Positives = 117/317 (36%), Gaps = 60/317 (18%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E IG G G VYK L + + +AVK ++S + + E I
Sbjct: 19 ELIGRGRYGAVYKGSL---DERPVAVK---VFSFANRQNF-----------INEK--NIY 59
Query: 100 TASQIRHRNILPLLAHMVRPDSH-----LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
+ H NI + R + LLV ++ NGSL L +W+S
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSC 114
Query: 155 KIALAVASGLEYLHM------HHSARVIHRDIKPANVLIDDDMEARISGFDLAILM---- 204
++A +V GL YLH H+ + HRD+ NVL+ +D IS F L++ +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 205 --PDGLTQIDTMYVVGTPRYIAPEY-------HQTLTISEKCDIYSFGVLL---AVLVMG 252
G + VGT RY+APE + ++ D+Y+ G++ +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 253 KFPFDD-------FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLA 305
FP + F + G M+ +++ E N + + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN--SLAVRSLKETI 292
Query: 306 CFCTLADPDERPNSKDV 322
C D + R ++
Sbjct: 293 EDCWDQDAEARLTAQXA 309
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-45
Identities = 60/243 (24%), Positives = 95/243 (39%), Gaps = 40/243 (16%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
I+ + L FL K+ G+++K G I VK + +
Sbjct: 7 IDFKQLNFL---------TKLNENHSGELWKGRW---QGNDIVVKVLKV----------- 43
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLL-AHMVRPDSHL-LVYDFMKNGSLQAVLY 139
+ K + + H N+LP+L A P H L+ +M GSL VL+
Sbjct: 44 --RDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH 101
Query: 140 DVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199
+ ++ K AL +A G+ +LH + + +V+ID+DM ARIS D
Sbjct: 102 E--GTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMAD 158
Query: 200 LAILMPDGLTQIDTMYVVGTPRYIAPE---YHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
+ + + P ++APE T D++SF VLL LV + PF
Sbjct: 159 VKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
Query: 257 DDF 259
D
Sbjct: 212 ADL 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-45
Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 40/246 (16%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
I+ +L E IG GG G VY+A G +AVK ++ I+
Sbjct: 4 IDFAELTLE---------EIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIE 51
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
+R + + ++H NI+ L ++ + LV +F + G L VL
Sbjct: 52 -----------NVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-- 98
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR------- 194
+ + A+ +A G+ YLH +IHRD+K +N+LI +E
Sbjct: 99 ---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155
Query: 195 -ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK 253
I+ F LA + M G ++APE + S+ D++S+GVLL L+ G+
Sbjct: 156 KITDFGLAREW----HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
Query: 254 FPFDDF 259
PF
Sbjct: 212 VPFRGI 217
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-44
Identities = 55/227 (24%), Positives = 112/227 (49%), Gaps = 27/227 (11%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
++IG GG G V+K L + ++A+K +I+ E+I+ K E + ++
Sbjct: 25 KQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIE--------KFQEFQREVF 75
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
S + H NI+ L M P +V +F+ G L L ++W + ++ L
Sbjct: 76 IMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLD 130
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLID-----DDMEARISGFDLAILMPDGLTQIDTM 214
+A G+EY+ + + ++HRD++ N+ + + A+++ F L+ ++
Sbjct: 131 IALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG---- 185
Query: 215 YVVGTPRYIAPE--YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
++G +++APE + + +EK D YSF ++L ++ G+ PFD++
Sbjct: 186 -LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-43
Identities = 68/308 (22%), Positives = 121/308 (39%), Gaps = 51/308 (16%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
LE +G G G+V++ G+ +AVK S+ + + E TE+ +
Sbjct: 13 LECVGKGRYGEVWRGSW---QGENVAVKI------FSSRDEKSWFRE------TELYNT- 56
Query: 99 ITASQIRHRNILPLLA----HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
+RH NIL +A L+ + + GSL L L+ +S
Sbjct: 57 ---VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCL 108
Query: 155 KIALAVASGLEYLHMHHSAR-----VIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
+I L++ASGL +LH+ + HRD+K N+L+ + + I+ LA++
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 210 QIDT--MYVVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD--- 258
Q+D VGT RY+APE ++ DI++FG++L +
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
Query: 259 ----FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPD 314
F+ MR V+ + I ++ + + ++K C +P
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE---CWYQNPS 285
Query: 315 ERPNSKDV 322
R + +
Sbjct: 286 ARLTALRI 293
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-43
Identities = 71/334 (21%), Positives = 119/334 (35%), Gaps = 60/334 (17%)
Query: 14 GLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSP 73
GL + + + + ++IG G G+V+ + G+ +AVK
Sbjct: 26 GLPLLVQRTIAKQIQMV---------KQIGKGRYGEVWMGKW---RGEKVAVKV------ 67
Query: 74 MSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS----HLLVYDFM 129
E + E TEI +RH NIL +A ++ L+ D+
Sbjct: 68 FFTTEEASWFRE------TEIYQT----VLMRHENILGFIAADIKGTGSWTQLYLITDYH 117
Query: 130 KNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHM-----HHSARVIHRDIKPAN 184
+NGSL L L+ S K+A + SGL +LH + HRD+K N
Sbjct: 118 ENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 185 VLIDDDMEARISGFDLAILMPDGLTQID--TMYVVGTPRYIAPE------YHQTLTISEK 236
+L+ + I+ LA+ ++D VGT RY+ PE
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232
Query: 237 CDIYSFGVLLAVLVMGKFPFDD-------FFSHTGEMDMVRWMRNVMASENPNRAIDSKL 289
D+YSFG++L + + MR ++ + + ++
Sbjct: 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW 292
Query: 290 LGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323
+ QM KL C +P R + V+
Sbjct: 293 SSDECLRQM---GKLMTECWAHNPASRLTALRVK 323
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-41
Identities = 62/292 (21%), Positives = 119/292 (40%), Gaps = 53/292 (18%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E +G G G K + G+++ +K++I + + L E+ +++
Sbjct: 16 EVLGKGCFGQAIKVTHRET-GEVMVMKELIRFDEETQRTF-----------LKEV--KVM 61
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
+ H N+L + + + + +++K G+L+ ++ + W R A
Sbjct: 62 --RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKD 116
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT------ 213
+ASG+ YLH S +IHRD+ N L+ ++ ++ F LA LM D TQ +
Sbjct: 117 IASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 214 ------MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE-- 265
VVG P ++APE + EK D++SFG++L ++ D+ T +
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317
+++ ++ P + C DP++RP
Sbjct: 234 LNVRGFLDRYCPPNCPPS-----------------FFPITVRCCDLDPEKRP 268
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-41
Identities = 73/334 (21%), Positives = 123/334 (36%), Gaps = 60/334 (17%)
Query: 14 GLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSP 73
GL + + E IG G G+V++ + G+ +AVK
Sbjct: 31 GLPLLVQRTIARTIVLQ---------ESIGKGRFGEVWRGKW---RGEEVAVKI------ 72
Query: 74 MSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDS----HLLVYDFM 129
S+ E + E EI +RH NIL +A + + LV D+
Sbjct: 73 FSSREERSWFRE------AEIYQT----VMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122
Query: 130 KNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR-----VIHRDIKPAN 184
++GSL L R + K+AL+ ASGL +LHM + HRD+K N
Sbjct: 123 EHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177
Query: 185 VLIDDDMEARISGFDLAILMPDGLTQIDTM--YVVGTPRYIAPE------YHQTLTISEK 236
+L+ + I+ LA+ ID + VGT RY+APE + ++
Sbjct: 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 237 CDIYSFGVLLAVLVMGKFPFDD-------FFSHTGEMDMVRWMRNVMASENPNRAIDSKL 289
DIY+ G++ + ++ V MR V+ + I ++
Sbjct: 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 297
Query: 290 LGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323
M +++ C A+ R + ++
Sbjct: 298 QSCEALRVMAKIMRE---CWYANGAARLTALRIK 328
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 65/291 (22%), Positives = 112/291 (38%), Gaps = 57/291 (19%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
++IGSG G VYK + +G +AVK + + + +L ++++
Sbjct: 29 GQRIGSGSFGTVYKGKW---HGD-VAVKMLNV-------------TAPTPQQLQAFKNEV 71
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ RH NIL + +V + + SL L+ + E IA
Sbjct: 72 GVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIAR 127
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
A G++YLH +IHRD+K N+ + +D +I F LA + G
Sbjct: 128 QTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 219 TPRYIAPE---YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275
+ ++APE + S + D+Y+FG++L L+ G+ P+ + + D + M
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIEM--- 237
Query: 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLAC---------FCTLADPDERP 317
+G G L ++ C C DERP
Sbjct: 238 --------------VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-38
Identities = 48/232 (20%), Positives = 94/232 (40%), Gaps = 36/232 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
E IG G G VY +G+ +A++ + I E +L + ++
Sbjct: 38 GELIGKGRFGQVYHGRW---HGE-VAIRLIDI-------------ERDNEDQLKAFKREV 80
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ Q RH N++ + + P ++ K +L +V+ + L+ +IA
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQ 137
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPDGLTQIDTMY- 215
+ G+ YLH ++H+D+K NV D+ + I+ F L + + D +
Sbjct: 138 EIVKGMGYLHAKG---ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 216 VVGTPRYIAPEYHQTLTI---------SEKCDIYSFGVLLAVLVMGKFPFDD 258
G ++APE + L+ S+ D+++ G + L ++PF
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 55/223 (24%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE-IRSQIIT 100
+G G VY+AE + G +A+K +I + + + + +++++
Sbjct: 19 LGKGSFAGVYRAESIHT-GLEVAIK--MIDK-----------KAMYKAGMVQRVQNEVKI 64
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
Q++H +IL L + + LV + NG + L ++ + E +RH + +
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH-QI 121
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
+G+ YLH H ++HRD+ +N+L+ +M +I+ F LA + + T+ GTP
Sbjct: 122 ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTP 176
Query: 221 RYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
YI+PE H + D++S G + L++G+ PFD
Sbjct: 177 NYISPEIATRSAH-----GLESDVWSLGCMFYTLLIGRPPFDT 214
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 44/230 (19%), Positives = 91/230 (39%), Gaps = 21/230 (9%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKV--IIYSPMSAAELIDAYSELGEGKLTEIRS 96
+ + G + E + K A+KK + + + K + ++
Sbjct: 36 IRTLNQGKFNKIILCE---KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92
Query: 97 QIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI 156
++ + I++ L + D ++Y++M+N S+ +D + + I
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK--FDEYFFVLDKNYTCFIPI 150
Query: 157 ALA------VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
+ V + Y+H + HRD+KP+N+L+D + ++S F + M D +
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 211 IDTMYVVGTPRYIAPE--YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
GT ++ PE +++ K DI+S G+ L V+ PF
Sbjct: 209 --GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE-IRSQIIT 100
+G G G+VY A + ++A+K +++ ++L + + +R ++
Sbjct: 17 LGKGKFGNVYLAREK-QSKFILALK--VLFK-----------AQLEKAGVEHQLRREVEI 62
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
S +RH NIL L + L+ ++ G++ L K + E + I +
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITE-L 118
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
A+ L Y H VIHRDIKP N+L+ E +I+ F ++ P + GT
Sbjct: 119 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDL--CGTL 171
Query: 221 RYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
Y+ PE + EK D++S GVL ++GK PF+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 34/241 (14%), Positives = 69/241 (28%), Gaps = 27/241 (11%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSE-LGEGKLTEIRSQI 98
+G +A G+ V + + E L L I++Q
Sbjct: 84 TVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDF----------------MKNGSLQAVLYDVS 142
+R L+ + + D + VL S
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
+ L +R ++ L V L LH ++H ++P ++++D ++GF+ +
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
P A H ++ D ++ G+ + + P
Sbjct: 260 RDGASAVSPIGR-GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 258 D 258
D
Sbjct: 319 D 319
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 40/288 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+KIG G +VY+A +G +A+KKV I+ M A D E+ +
Sbjct: 37 EKKIGRGQFSEVYRA-ACLLDGVPVALKKVQIFDLMDAKARADCIKEI----------DL 85
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE----WLSRH 154
+ Q+ H N++ A + + +V + G L ++ K +R + W
Sbjct: 86 L--KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW---- 139
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
K + + S LE++H RV+HRDIKPANV I ++ L T +
Sbjct: 140 KYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS- 195
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274
+VGTP Y++PE + K DI+S G LL + + PF + +M++ +
Sbjct: 196 -LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKK 249
Query: 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ + P L + Y E++ ++ + C DP++RP+ V
Sbjct: 250 IEQCDYP------PLPSDHYSEELRQLVNM-CINP--DPEKRPDVTYV 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 60/313 (19%), Positives = 118/313 (37%), Gaps = 65/313 (20%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F + +G G G V KA + + A+KK+ E KL+ I
Sbjct: 8 FEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKI----------------RHTEEKLSTIL 50
Query: 96 SQIITASQIRHRNI------------LPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVS 142
S+++ + + H+ + V+ S L + ++ +NG+L ++ S
Sbjct: 51 SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HS 108
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
+ + ++ + L Y+H +IHRD+KP N+ ID+ +I F LA
Sbjct: 109 ENLNQQRDEYW-RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164
Query: 203 LMPDGLTQIDTMY------------VVGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAVL 249
+ L + +GT Y+A E T +EK D+YS G++ +
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 250 VMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCT 309
+ M+ V ++ + + + N + + ++ L
Sbjct: 225 IYP--FSTG-------MERVNILKKLR---SVSIEFPPDFDDNKMKVEKKIIRLLID--- 269
Query: 310 LADPDERPNSKDV 322
DP++RP ++ +
Sbjct: 270 -HDPNKRPGARTL 281
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE-IRSQIIT 100
+G GG ++ + ++ A K I+ S L + E + +I
Sbjct: 49 LGKGGFAKCFEISDADT-KEVFAGK--IVPK-----------SLLLKPHQREKMSMEISI 94
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL-EWLSRHKIALA 159
+ H++++ D +V + + SL ++ K R+ L E +R+ +
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLR-Q 149
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
+ G +YLH + VIHRD+K N+ +++D+E +I F LA + + + GT
Sbjct: 150 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGT 204
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
P YIAPE S + D++S G ++ L++GK PF+
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE-IRSQIIT 100
+G G G+VY A N ++A+K +++ S+L + + +R +I
Sbjct: 22 LGKGKFGNVYLAREK-QNKFIMALK--VLFK-----------SQLEKEGVEHQLRREIEI 67
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD-VSKGRRELEWLSRHKIALA 159
S +RH NIL + + L+ +F G L Y + K R E S +
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFME-E 122
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT 219
+A L Y H VIHRDIKP N+L+ E +I+ F ++ P + TM GT
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--TM--CGT 175
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
Y+ PE + T EK D++ GVL ++G PFD
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 61/232 (26%), Positives = 106/232 (45%), Gaps = 28/232 (12%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ + L IG+G G K S+GK++ K+ + Y M+ AE SE+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKE-LDYGSMTEAEKQMLVSEV------- 56
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLL--VYDFMKNGSLQAVLYDVSKGRRELE-- 149
++ +++H NI+ ++ + L V ++ + G L +V+ +K R+ L+
Sbjct: 57 ---NLL--RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 150 --WLSRHKIALAVASGLEYLHMHHSA--RVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
++ + L+ H V+HRD+KPANV +D ++ F LA ++
Sbjct: 112 FVL----RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167
Query: 206 DGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
+ T VGTP Y++PE ++ +EK DI+S G LL L PF
Sbjct: 168 HDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 34/313 (10%), Positives = 73/313 (23%), Gaps = 60/313 (19%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E + G V+ + A+K + +E +L +
Sbjct: 68 EPLRVGDRSVVFLVRDVER-LEDFALK------------VFTMGAENSRSELERLHEATF 114
Query: 100 TASQIRHRNILPLLAHM--------------------------VRPDSHLLVYDFMK--N 131
A+++ + ++LL+
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 132 GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191
L + L V R + L+ H + + L S ++H P N+ I D
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDG 231
Query: 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEY--HQTLTISEKCDIYSFGVLLAVL 249
+ + Y E+ T T + + + G+ + +
Sbjct: 232 RLMLGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 250 VMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCT 309
PF + ++ + L+ + F
Sbjct: 287 WCLFLPFGLVTPGIKGS-----WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF-- 339
Query: 310 LADPDERPNSKDV 322
D R +
Sbjct: 340 --DRRRRLLPLEA 350
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 57/292 (19%), Positives = 116/292 (39%), Gaps = 44/292 (15%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ + L+KIG G G + +G+ +K+ I S MS+ E ++ E+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVK-STEDGRQYVIKE-INISRMSSKEREESRREV------- 74
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE---W 150
++ + ++H NI+ S +V D+ + G L + KG E
Sbjct: 75 ---AVL--ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQIL 128
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
+ + L+++H +++HRDIK N+ + D ++ F +A ++ +
Sbjct: 129 ----DWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181
Query: 211 IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270
+GTP Y++PE + + K DI++ G +L L K F+ M
Sbjct: 182 ARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-------SMKN 232
Query: 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ +++ P + Y + ++ F +P +RP+ +
Sbjct: 233 LVLKIISGSFPP-------VSLHYSYDLRSLVS-QLFKR--NPRDRPSVNSI 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-31
Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 35/239 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
++K+G GG V E +G A+K+++ + E + +
Sbjct: 34 IQKLGEGGFSYVDLVE-GLHDGHFYALKRILCHEQQ---------------DREEAQREA 77
Query: 99 ITASQIRHRNILPLLAHMVRPDSH----LLVYDFMKNGSLQAVLYDVSKGRREL-EWLSR 153
H NIL L+A+ +R L+ F K G+L + + L E
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA---ILMPDGLTQ 210
+ L + GLE +H + HRD+KP N+L+ D+ + + + +G Q
Sbjct: 138 -WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 211 I----DTMYVVGTPRYIAPE---YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSH 262
D T Y APE I E+ D++S G +L ++ G+ P+D F
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G GG ++ + ++ A K ++ S + + ++ +I
Sbjct: 23 LGKGGFAKCFEISDADT-KEVFAGK-IVPKSLLLKPHQRE-----------KMSMEISIH 69
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL-EWLSRHKIALAV 160
+ H++++ D +V + + SL ++ K R+ L E +R+ + +
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLR-QI 124
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDGLTQIDTMYVVGT 219
G +YLH + VIHRD+K N+ +++D+E +I F LA + DG + + GT
Sbjct: 125 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVL--CGT 178
Query: 220 PRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
P YIAPE S + D++S G ++ L++GK PF+
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 55/241 (22%), Positives = 95/241 (39%), Gaps = 37/241 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L++IGSGG V++ ++ A+K V + E L R++I
Sbjct: 14 LKQIGSGGSSKVFQVL--NEKKQIYAIKYVNL-------------EEADNQTLDSYRNEI 58
Query: 99 ITASQIRH--RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI 156
++++ I+ L + + +V + N L + L K + W +
Sbjct: 59 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSID-PWERKS-Y 113
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV 216
+ + +H H ++H D+KPAN LI D M ++ F +A M T +
Sbjct: 114 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 217 VGTPRYIAPE-----------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265
VGT Y+ PE IS K D++S G +L + GK PF + +
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 266 M 266
+
Sbjct: 230 L 230
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 37/241 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L++IGSGG V++ ++ A+K V + E L R++I
Sbjct: 33 LKQIGSGGSSKVFQVL--NEKKQIYAIKYVNL-------------EEADNQTLDSYRNEI 77
Query: 99 ITASQIRHRN--ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI 156
++++ + I+ L + + +V + N L + L K + W +
Sbjct: 78 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKS-Y 132
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV 216
+ + +H H ++H D+KPAN LI D M ++ F +A M T +
Sbjct: 133 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 217 VGTPRYIAPE-----------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265
VGT Y+ PE IS K D++S G +L + GK PF + +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 266 M 266
+
Sbjct: 249 L 249
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 35/247 (14%), Positives = 80/247 (32%), Gaps = 38/247 (15%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK-LTEIRSQI 98
+G +A + G+ V + + E+ + L I++Q
Sbjct: 79 TVLGQEDPYAYLEATDQET-GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137
Query: 99 ITASQIRHRNILPLLAHMVRPD--------------SHLLVYDFMK--NGSLQAVLYDVS 142
+R L+ + S +Y M+ + VL S
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
+ L +R ++ L V L LH + ++H ++P ++++D ++GF+
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL- 253
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPEY-----------HQTLTISEKCDIYSFGVLLAVLVM 251
+ DG + + + PE + ++ D ++ G+++ +
Sbjct: 254 -VRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 252 GKFPFDD 258
P
Sbjct: 309 ADLPITK 315
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 56/287 (19%), Positives = 107/287 (37%), Gaps = 44/287 (15%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+IG G VYK L +A ++ +L + + + +
Sbjct: 32 IEIGRGSFKTVYKG-LDTETTVEVAWCELQD-------------RKLTKSERQRFKEEAE 77
Query: 100 TASQIRHRNILPLL---AHMVRPDSHLLVY-DFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++H NI+ V+ +++ + M +G+L+ L K + ++
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRS 133
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLAILMPDGLTQIDTM 214
+ GL++LH + +IHRD+K N+ I +I LA L
Sbjct: 134 WCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAK 188
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274
V+GTP ++APE ++ E D+Y+FG+ + + ++P+ E +
Sbjct: 189 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY-------SECQNAAQIYR 240
Query: 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321
+ S + D E ++ C + DER + KD
Sbjct: 241 RVTSGVKPASFDKVA----IPEVKEIIEG--CIRQ--NKDERYSIKD 279
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 37/241 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L++IGSGG V++ ++ A+K V E L R++I
Sbjct: 61 LKQIGSGGSSKVFQVL--NEKKQIYAIKYV-------------NLEEADNQTLDSYRNEI 105
Query: 99 ITASQIRH--RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI 156
++++ I+ L + + +V + N L + L K + W +
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSID-PWERKS-Y 160
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV 216
+ + +H H ++H D+KPAN LI D M ++ F +A M T +
Sbjct: 161 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 217 VGTPRYIAPE-----------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265
VG Y+ PE IS K D++S G +L + GK PF + +
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 266 M 266
+
Sbjct: 277 L 277
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 59/309 (19%), Positives = 114/309 (36%), Gaps = 60/309 (19%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F ++ +G GG G V++A+ + A+K++ + P E
Sbjct: 7 FEPIQCLGRGGFGVVFEAKN-KVDDCNYAIKRIRL--PNRELAREKVMRE---------- 53
Query: 96 SQIITASQIRHRNIL---------PLLAHMVRPDSHLLVY---DFMKNGSLQAVLYDVSK 143
+ +++ H I+ + + +Y + +L+ + +
Sbjct: 54 --VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRC 110
Query: 144 GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI-------- 195
E E I L +A +E+LH S ++HRD+KP+N+ D ++
Sbjct: 111 TIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167
Query: 196 --SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK 253
+ ++ VGT Y++PE + S K DI+S G++L L+
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225
Query: 254 FPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADP 313
PF +M+ VR + +V + P L Y + ++V P
Sbjct: 226 -PFS------TQMERVRTLTDVRNLKFP------PLFTQKYPCEYVMVQD----MLSPSP 268
Query: 314 DERPNSKDV 322
ERP + ++
Sbjct: 269 MERPEAINI 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 70/327 (21%), Positives = 132/327 (40%), Gaps = 52/327 (15%)
Query: 21 LIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELI 80
L +K+ + LK +D F + ++G+G G V+K S G ++A K +
Sbjct: 21 LTQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPS-GLVMARKLI------------ 66
Query: 81 DAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD 140
+ E+ +I ++ + I+ + + M GSL VL
Sbjct: 67 --HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124
Query: 141 VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
GR + L K+++AV GL YL H +++HRD+KP+N+L++ E ++ F +
Sbjct: 125 A--GRIPEQILG--KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 201 AILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF 260
+ + D + ++ VGT Y++PE Q S + DI+S G+ L + +G++P
Sbjct: 179 SGQLID--SMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234
Query: 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQ--MLLVLKLACF----------- 307
+ E+ + A P + L + + + +L +
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
Query: 308 -------------CTLADPDERPNSKD 321
C + +P ER + K
Sbjct: 295 GVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 23 EKEDLAFLKKEDCFASLEKIGSGGCGDVYKA-ELPGSNGKMIAVKKVIIYSPMSAAELID 81
+ L + D + E IGSG V A P + +A+K++ +
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAP--KKEKVAIKRINL----------- 50
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL-YD 140
E + + E+ +I SQ H NI+ V D LV + GS+ ++ +
Sbjct: 51 ---EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHI 107
Query: 141 VSKGRRELEWLSRHKIAL---AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197
V+KG + L IA V GLEYLH + IHRD+K N+L+ +D +I+
Sbjct: 108 VAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIAD 164
Query: 198 FDLAILMPDGLTQIDTMY---VVGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGK 253
F ++ + G VGTP ++APE Q K DI+SFG+ L G
Sbjct: 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
Query: 254 FPFDDF 259
P+ +
Sbjct: 225 APYHKY 230
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E+ F LEKIG G G+V+K + K++A+K + + E E ++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDL--------------EEAEDEIE 65
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+I+ +I SQ + ++ ++ +++ GS D+ + L
Sbjct: 66 DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGP----LD 117
Query: 153 RHKIAL---AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
+IA + GL+YLH S + IHRDIK ANVL+ + E +++ F +A + D
Sbjct: 118 ETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ +T VGTP ++APE + K DI+S G+ L G+ P +
Sbjct: 175 KRNTF--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 49/243 (20%), Positives = 87/243 (35%), Gaps = 43/243 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+ GG VY+A+ +G+ A+K+++ E K I ++
Sbjct: 33 RRVLAEGGFAFVYEAQ-DVGSGREYALKRLLSNE---------------EEKNRAIIQEV 76
Query: 99 ITASQIR-HRNILPLLAHMVRPDSH-------LLVYDFMKNGSLQAVLYDVSKGRR--EL 148
++ H NI+ + L+ + G L L +
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA---ILMP 205
L KI ++++H +IHRD+K N+L+ + ++ F A P
Sbjct: 137 TVL---KIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 206 DGLTQI-------DTMYVVGTPRYIAPE---YHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
D + + TP Y PE + I EK DI++ G +L +L + P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 256 FDD 258
F+D
Sbjct: 253 FED 255
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 55/305 (18%), Positives = 107/305 (35%), Gaps = 52/305 (17%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
F LEKIGSG G V+K + +G + A+K+ + + +A L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC-VKRLDGCIYAIKR-SKKPLAGSVDEQNA--------LR 59
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVY-DFMKNGSLQAVLYDVSKGRRELEWL 151
E+ A +H +++ + D H+L+ ++ GSL + + + +
Sbjct: 60 EVY---AHAVLGQHSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115
Query: 152 SRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI 211
+ L V GL Y+H S ++H DIKP+N+ I + + +
Sbjct: 116 ELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 212 -------------DTMYVVGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
G R++A E + T K DI++ + + +
Sbjct: 173 FKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
Query: 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317
+ G+ + P + ++ +LK+ DP+ RP
Sbjct: 233 N-----GDQ-----WHEIRQGRLPR-------IPQVLSQEFTELLKV-MIHP--DPERRP 272
Query: 318 NSKDV 322
++ +
Sbjct: 273 SAMAL 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 7e-27
Identities = 52/240 (21%), Positives = 91/240 (37%), Gaps = 36/240 (15%)
Query: 33 EDCFASLEKIGSGGC--GDVYKA-ELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG 89
C+ L IG G V A P G+ + V+++ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKP--TGEYVTVRRINL-------------EACSNE 68
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
+T ++ ++ + H NI+P A + + +V FM GS + ++
Sbjct: 69 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG---- 124
Query: 150 WLSRHKIAL---AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
++ IA V L+Y+H +HR +K +++LI D + +SG + M
Sbjct: 125 -MNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180
Query: 207 GLTQIDTMYV-----VGTPRYIAPE-YHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDF 259
+ ++ V +++PE Q L K DIYS G+ L G PF D
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 58/321 (18%), Positives = 117/321 (36%), Gaps = 49/321 (15%)
Query: 6 VRGGSRDRGLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAV 65
+ + D + + ++ D + ++ ++G G G+V++ G AV
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM-KDKQTGFQCAV 88
Query: 66 KKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLV 125
KKV L ++ E+ + + I+PL VR + +
Sbjct: 89 KKV----------------RLEVFRVEELV----ACAGLSSPRIVPLYG-AVREGPWVNI 127
Query: 126 Y-DFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184
+ + ++ GSL ++ + E + + GLEYLH + R++H D+K N
Sbjct: 128 FMELLEGGSLGQLI---KQMGCLPEDRALY-YLGQALEGLEYLH---TRRILHGDVKADN 180
Query: 185 VLIDDD-MEARISGFDLAILMPD---GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIY 240
VL+ D A + F A+ + G + + Y+ GT ++APE K DI+
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
Query: 241 SFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLL 300
S ++ ++ G P+ + + + P R I
Sbjct: 241 SSCCMMLHMLNGCHPW-------TQYFRGPLCLKIASEPPPIREIPPSC-----APLTAQ 288
Query: 301 VLKLACFCTLADPDERPNSKD 321
++ +P R ++ +
Sbjct: 289 AIQE-GLRK--EPVHRASAME 306
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 62/297 (20%), Positives = 119/297 (40%), Gaps = 45/297 (15%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL 91
K D + ++G G G V K S G+++AVK++ + + +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPS-GQIMAVKRI--------------RATVNSQEQ 49
Query: 92 TEIRSQI-ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL-- 148
+ + I+ + + + R + + M + SL V + +
Sbjct: 50 KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE 108
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ L KIA+++ LE+LH VIHRD+KP+NVLI+ + ++ F ++ + D +
Sbjct: 109 DILG--KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164
Query: 209 TQIDTMYVVGTPRYIAPE----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264
+ D G Y+APE S K DI+S G+ + L + +FP+D +
Sbjct: 165 AK-DI--DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW---GT 218
Query: 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321
++ V+ +P +L + + + + C + ERP +
Sbjct: 219 PFQQ---LKQVVEEPSP------QLPADKFSAEFVDFTSQ---CLKKNSKERPTYPE 263
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 43/227 (18%), Positives = 78/227 (34%), Gaps = 26/227 (11%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ F L ++G G G+V+K +G++ AVK+ + + +E+
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKR-SMSPFRGPKDRARKLAEV------ 107
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE-WL 151
+H + L L + SLQ E + W
Sbjct: 108 -----GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW- 160
Query: 152 SRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI 211
L +LH S ++H D+KPAN+ + ++ F L + +
Sbjct: 161 ---GYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAG 213
Query: 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ G PRY+APE Q + D++S G+ + +
Sbjct: 214 EVQ--EGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 31/234 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ L +IG G G V K S G+++AVK++ + E + +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPS-GQIMAVKRIRS--------------TVDEKEQKQ 66
Query: 94 IRSQI-ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL---YDVSKGRRELE 149
+ + + I+ + R + + M + S Y V E
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEE 125
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
L KI LA L +L + ++IHRDIKP+N+L+D ++ F ++ + D +
Sbjct: 126 ILG--KITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181
Query: 210 QIDTMYVVGTPRYIAPE----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
+ G Y+APE + D++S G+ L L G+FP+ +
Sbjct: 182 KTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 51/278 (18%), Positives = 106/278 (38%), Gaps = 39/278 (14%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ + +G G +V++ G + A+K + + ++ + ++
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHK-KTGDLFAIK--VFNN--------ISFLRPVDVQMR 56
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHL--LVYDFMKNGSLQAVLYDVSKGRRELEW 150
E +++ ++ H+NI+ L A + L+ +F GSL VL + S E
Sbjct: 57 EF--EVL--KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI----DDDMEARISGFDLAILMPD 206
+ V G+ +L + ++HR+IKP N++ D +++ F A + D
Sbjct: 113 EFLIVLR-DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 207 GLTQIDTMYVVGTPRYIAPEYHQTLTI--------SEKCDIYSFGVLLAVLVMGKFPFDD 258
Q ++Y GT Y+ P+ ++ + D++S GV G PF
Sbjct: 169 D-EQFVSLY--GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 259 FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEE 296
F ++ M ++ + + NG +
Sbjct: 226 FEGPRRNKEV---MYKIITGKPSGAISGVQKAENGPID 260
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 51/278 (18%), Positives = 106/278 (38%), Gaps = 39/278 (14%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ + +G G +V++ G + A+K + + ++ + ++
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHK-KTGDLFAIK--VFNN--------ISFLRPVDVQMR 56
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHL--LVYDFMKNGSLQAVLYDVSKGRRELEW 150
E +++ ++ H+NI+ L A + L+ +F GSL VL + S E
Sbjct: 57 EF--EVL--KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI----DDDMEARISGFDLAILMPD 206
+ V G+ +L + ++HR+IKP N++ D +++ F A + D
Sbjct: 113 EFLIVLR-DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 207 GLTQIDTMYVVGTPRYIAPEYHQTLTI--------SEKCDIYSFGVLLAVLVMGKFPFDD 258
Q ++Y GT Y+ P+ ++ + D++S GV G PF
Sbjct: 169 D-EQFVSLY--GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 259 FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEE 296
F ++ M ++ + + NG +
Sbjct: 226 FEGPRRNKEV---MYKIITGKPSGAISGVQKAENGPID 260
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 35/239 (14%)
Query: 40 EKIGSGGCGDVYKA--ELPG--------SNGKMIAVKKVIIYSPMSAAELIDAYSELGEG 89
++IG G G V A E S K+I P G
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRP-DSHL-LVYDFMKNGSLQAVLYDVSKGRRE 147
+ ++ +I ++ H N++ L+ + P + HL +V++ + G + +V +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG----PVMEVPTLKPL 134
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
E +R + G+EYLH ++IHRDIKP+N+L+ +D +I+ F ++
Sbjct: 135 SEDQAR-FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISE--------KCDIYSFGVLLAVLVMGKFPFDD 258
+ VGTP ++APE ++SE D+++ GV L V G+ PF D
Sbjct: 191 DALLSN--TVGTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 32/229 (13%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E+ F LEK+G G G VYKA G+++A+K+V + E L
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAI-HKETGQIVAIKQVPV-----------------ESDLQ 69
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
EI +I Q +++ + +V ++ GS+ ++ +K E E
Sbjct: 70 EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE--- 126
Query: 153 RHKIALAVAS---GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
IA + S GLEYLH R IHRDIK N+L++ + A+++ F +A + D +
Sbjct: 127 ---IATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ +T+ +GTP ++APE Q + + DI+S G+ + GK P+ D
Sbjct: 181 KRNTV--IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 46/240 (19%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F +E IGSGG G V+KA+ +GK +K+ + Y+ A E++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHR-IDGKTYVIKR-VKYNNEKA--------------EREVK 56
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV----SKGRREL-EW 150
+ +++ H NI+ D + S L+ KG L +W
Sbjct: 57 AL----AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKG--TLEQW 110
Query: 151 LSRHK-----------IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199
+ + + + + G++Y+H S ++I+RD+KP+N+ + D + +I F
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFG 167
Query: 200 LA-ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
L L DG GT RY++PE + ++ D+Y+ G++LA L+ +
Sbjct: 168 LVTSLKNDGKRTR----SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 58/265 (21%), Positives = 98/265 (36%), Gaps = 41/265 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
E++G+GG G V + + G+ +A+K+ EL +I
Sbjct: 19 KERLGTGGFGYVLRWIHQDT-GEQVAIKQ------------CR--QELSPKNRERWCLEI 63
Query: 99 ITASQIRHRNILPLLA------HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL--EW 150
++ H N++ + D LL ++ + G L+ L E
Sbjct: 64 QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEG 121
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR---ISGFDLAILMPDG 207
R ++ ++S L YLH + +IHRD+KP N+++ + I A + G
Sbjct: 122 PIRTLLS-DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267
VGT +Y+APE + + D +SFG L + G PF
Sbjct: 178 -ELCTEF--VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL------PNWQ 228
Query: 268 MVRWMRNVMASENPNRAIDSKLLGN 292
V+W V N + + L G
Sbjct: 229 PVQWHGKVREKSNEHIVVYDDLTGA 253
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 35/234 (14%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ + + ++G G G VYKA G + A K + S E +L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKA-KNKETGALAAAKVIETKS---------------EEELE 61
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+ +I + H I+ LL ++ +F G++ A++ ++ +G E +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ--- 118
Query: 153 RHKIALAVAS---GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
I + L +LH S R+IHRD+K NVL+ + + R++ F ++ L
Sbjct: 119 ---IQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPFDD 258
+ D+ +GTP ++APE T+ + K DI+S G+ L + + P +
Sbjct: 173 KRDSF--IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 42/241 (17%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
F +E +G+G G VYK G++ A+K + ++ +
Sbjct: 23 AGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVM----------------DVTGDEEE 65
Query: 93 EIRSQIITASQI-RHRNILP-----LLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGR 145
EI+ +I + HRNI + + D L LV +F GS+ ++ +
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 125
Query: 146 RELEWLSRHKIALAVAS---GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
L IA GL +LH H VIHRDIK NVL+ ++ E ++ F ++
Sbjct: 126 -----LKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPFD 257
+ + + +T +GTP ++APE + K D++S G+ + G P
Sbjct: 178 QLDRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235
Query: 258 D 258
D
Sbjct: 236 D 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
E F+ L +IG G G VY A N +++A+KK + + K
Sbjct: 53 EKLFSDLREIGHGSFGAVYFA-RDVRNSEVVAIKK------------MSYSGKQSNEKWQ 99
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+I ++ ++RH N + +R + LV ++ GS +L K +E+E
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVE--- 155
Query: 153 RHKIALAVAS---GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
IA GL YLH S +IHRD+K N+L+ + ++ F A +M
Sbjct: 156 ---IAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----A 205
Query: 210 QIDTMYVVGTPRYIAPE---YHQTLTISEKCDIYSFGV 244
++ VGTP ++APE K D++S G+
Sbjct: 206 PANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 30/230 (13%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+L ++GSG CG V+K + G +IAVK++ + + I
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKT-GHVIAVKQM--------------RRSGNKEENKRIL 71
Query: 96 SQI-ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
+ + I+ + + + M + + + E L
Sbjct: 72 MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPE-RILG-- 127
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
K+ +A+ L YL H VIHRD+KP+N+L+D+ + ++ F ++ + D +
Sbjct: 128 KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DR 183
Query: 215 YVVGTPRYIAPEYHQTLTISE-----KCDIYSFGVLLAVLVMGKFPFDDF 259
G Y+APE ++ + D++S G+ L L G+FP+ +
Sbjct: 184 S-AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 26/226 (11%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ + EKIG G G VY A + + G+ +A++++ + K
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA-MDVATGQEVAIRQM----NLQQQP-----------KKE 62
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
I ++I+ + ++ NI+ L + D +V +++ GSL V V++ + ++
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIA 119
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
+ LE+LH S +VIHRDIK N+L+ D +++ F + ++
Sbjct: 120 A--VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 213 TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
TM VGTP ++APE K DI+S G++ ++ G+ P+ +
Sbjct: 175 TM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 32/229 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+ +GSG G V+ A K + VK I + I+ + KL ++ +I
Sbjct: 29 MSPLGSGAFGFVWTAVDK-EKNKEVVVK-FIKKEKVLEDCWIE------DPKLGKVTLEI 80
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEWLSRHKI 156
S++ H NI+ +L LV + +G L+ R + E L+ +
Sbjct: 81 AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLD-EPLASYIF 136
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV 216
+ S + YL + +IHRDIK N++I +D ++ F A + G T
Sbjct: 137 R-QLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYT--F 189
Query: 217 VGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
GT Y APE Y + +++S GV L LV + PF +
Sbjct: 190 CGTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFCEL 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 52/226 (23%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
S KIG G G V A +G+ +AVK + + + +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLA-REKHSGRQVAVKMM----DLRKQQ-----------RRE 87
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+ ++++ +H N++ + + + ++ +F++ G+L + VS+ R E ++
Sbjct: 88 LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIA 144
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
+ AV L YLH + VIHRDIK ++L+ D ++S F + + +
Sbjct: 145 T--VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199
Query: 213 TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
++ VGTP ++APE + + DI+S G+++ +V G+ P+
Sbjct: 200 SL--VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 53/230 (23%), Positives = 85/230 (36%), Gaps = 34/230 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT-EIRSQ 97
+G GG G V+ ++ +A+K VI + + + E+
Sbjct: 36 GPLLGKGGFGTVFAGHRL-TDRLQVAIK-VIPRNRVLGWSPLS-----DSVTCPLEVALL 88
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEWLSRHK 155
+ H ++ LL + +LV + L+D KG E SR
Sbjct: 89 WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLG-EGPSR-C 143
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM-EARISGFDLAILMPDGLTQIDTM 214
V + +++ H V+HRDIK N+LID A++ F L+ D
Sbjct: 144 FFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTD- 197
Query: 215 YVVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
GT Y PE YH + ++S G+LL +V G PF+
Sbjct: 198 -FDGTRVYSPPEWISRHQYH-----ALPATVWSLGILLYDMVCGDIPFER 241
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 52/230 (22%), Positives = 82/230 (35%), Gaps = 40/230 (17%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
+ EDL ++ IG G G+V+ L N +AVK +
Sbjct: 111 LNHEDLVLGEQ---------IGRGNFGEVFSGRLRADNTL-VAVK--SCRETLPPDLKAK 158
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
L E R Q H NI+ L+ + +V + ++ G L
Sbjct: 159 F--------LQEAR----ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--- 203
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
L + ++ A+G+EYL IHRD+ N L+ + +IS F ++
Sbjct: 204 RTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS 260
Query: 202 ILMPDGLTQIDTMYVVGTPRYI-----APEYHQTLTISEKCDIYSFGVLL 246
D G R + APE S + D++SFG+LL
Sbjct: 261 REEAD-----GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 4e-24
Identities = 63/339 (18%), Positives = 118/339 (34%), Gaps = 75/339 (22%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELI--------------- 80
F ++ +G GG G V++A+ + A+K++ + + A E +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 81 ------------DAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDF 128
+ + E + + S S + + + P S
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 129 MKNGSLQAVLY---------------DVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA 173
++ S + LY + + E I + +A +E+LH S
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SK 183
Query: 174 RVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYV----------VGTPRYI 223
++HRD+KP+N+ D ++ F L M + + VGT Y+
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 224 APEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNR 283
+PE S K DI+S G++L L+ M+ VR + +V + P
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ---------MERVRIITDVRNLKFP-- 292
Query: 284 AIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
L Y ++ ++V + P ERP + D+
Sbjct: 293 ----LLFTQKYPQEHMMVQDMLSP----SPTERPEATDI 323
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 27/224 (12%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+G G G VY SN IA+K++ E + +I
Sbjct: 28 VVLGKGTYGIVYAG-RDLSNQVRIAIKEI---------------PERDSRYSQPLHEEIA 71
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVY-DFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
++H+NI+ L + + ++ + + GSL A+L ++ E
Sbjct: 72 LHKHLKHKNIVQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTK 129
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDM-EARISGFDLAILMPDGLTQIDTMYVV 217
+ GL+YLH +++HRDIK NVLI+ +IS F + + +T
Sbjct: 130 QILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--T 184
Query: 218 GTPRYIAPE--YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
GT +Y+APE + DI+S G + + GK PF +
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-24
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L+ IG G V A + G+ +A+K II ++L L ++ ++
Sbjct: 20 LKTIGKGNFAKVKLARHILT-GREVAIK--II-----------DKTQLNPTSLQKLFREV 65
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR-RELEWLSRHK 155
+ H NI+ L + + L+ ++ G + +D V+ GR +E E +R K
Sbjct: 66 RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKE--ARSK 119
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ S ++Y H ++HRD+K N+L+D DM +I+ F + G ++D
Sbjct: 120 FR-QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAF- 173
Query: 216 VVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
G P Y APE Y + D++S GV+L LV G PFD
Sbjct: 174 -CGAPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDG 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 33/229 (14%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ +GSG CG+V A K +A++ +I + +A TEI +I+
Sbjct: 141 KTLGSGACGEVKLAFER-KTCKKVAIR-IISKRKFAIGSAREADPA--LNVETEI--EIL 194
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR-RELEWLSRHKI 156
++ H I+ + D ++ V + M+ G L +D V R +E +
Sbjct: 195 --KKLNHPCIIKIKNFFDAEDYYI-VLELMEGGEL----FDKVVGNKRLKEAT--CKL-Y 244
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQIDT 213
+ ++YLH + +IHRD+KP NVL+ ++D +I+ F + ++ +
Sbjct: 245 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SL 297
Query: 214 MY-VVGTPRYIAPE---YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
M + GTP Y+APE T + D +S GV+L + + G PF +
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-24
Identities = 55/233 (23%), Positives = 87/233 (37%), Gaps = 36/233 (15%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F + +G G G + + + + +AVK I+ S A+ E+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGM--FDNRDVAVK-RILPECFSFAD-------------REV- 68
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
Q++ S H N++ + + +LQ + K L L
Sbjct: 69 -QLLRESD-EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYV--EQKDFAHLG-LEPIT 122
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLI-----DDDMEARISGFDLAILMPDGLTQ 210
+ SGL +LH S ++HRD+KP N+LI ++A IS F L + G
Sbjct: 123 LLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 211 IDTMY-VVGTPRYIAPEY---HQTLTISEKCDIYSFGVLLA-VLVMGKFPFDD 258
V GT +IAPE + DI+S G + V+ G PF
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 33/229 (14%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ +GSG CG+V A K +A+K II S A ++ TEI +I+
Sbjct: 16 KTLGSGACGEVKLAFE-RKTCKKVAIK--II-SKRKFAIGSAREADPALNVETEI--EIL 69
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR-RELEWLSRHKI 156
++ H I+ + D ++ V + M+ G L +D V R +E +
Sbjct: 70 K--KLNHPCIIKIKNFFDAEDYYI-VLELMEGGEL----FDKVVGNKRLKEAT--CKL-Y 119
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQIDT 213
+ ++YLH + +IHRD+KP NVL+ ++D +I+ F + ++ +
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SL 172
Query: 214 MY-VVGTPRYIAPE---YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
M + GTP Y+APE T + D +S GV+L + + G PF +
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 60/257 (23%), Positives = 100/257 (38%), Gaps = 50/257 (19%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+GSGG G VY S+ +A+K + + I + EL T + ++
Sbjct: 48 GPLLGSGGFGSVYSGI-RVSDNLPVAIK--HV-----EKDRISDWGELP--NGTRVPMEV 97
Query: 99 ITASQIRHR--NILPLLAHMVRPDSHLLVYDFMKN-GSLQAVLYDVSKGRRELEWLSRHK 155
+ ++ ++ LL RPDS +L+ + + L + +G + E L+R
Sbjct: 98 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD--FITERGALQ-EELAR-S 153
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLAILMPDGLTQIDTM 214
V + + H V+HRDIK N+LID + E ++ F L+ D +
Sbjct: 154 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTD- 207
Query: 215 YVVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD---------- 258
GT Y PE YH ++S G+LL +V G PF+
Sbjct: 208 -FDGTRVYSPPEWIRYHRYH-----GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 261
Query: 259 ---FFSHTGEMDMVRWM 272
S + ++RW
Sbjct: 262 FRQRVS-SECQHLIRWC 277
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 2e-23
Identities = 32/241 (13%), Positives = 70/241 (29%), Gaps = 36/241 (14%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSN----GKMIAVKKVIIYSPMSAAELIDAYSELGE 88
+G G VY+A N + +K A + Y
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV------QKPANPWEFY----- 112
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL--YDVSKGRR 146
T++ ++ + + + + +LV + G+L + Y + +
Sbjct: 113 -IGTQLMERL---KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168
Query: 147 ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA-----------RI 195
+ L A+ + +E +H +IH DIKP N ++ + +
Sbjct: 169 MPQGLVI-SFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224
Query: 196 SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
+I M T + E + + D + + ++ G +
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
Query: 256 F 256
Sbjct: 285 K 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E +G G V + K AVK II + + EL E L E+ I
Sbjct: 23 EILGRGVSSVVRRCIHK-PTCKEYAVK--IIDVTGGGSFSAEEVQELREATLKEVD---I 76
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
H NI+ L LV+D MK G L +D K +E + R
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRA 132
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
+ + LH + ++HRD+KP N+L+DDDM +++ F + + G + +
Sbjct: 133 -----LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG----EKL 180
Query: 215 Y-VVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
V GTP Y+APE ++ D++S GV++ L+ G PF
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 47/232 (20%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+G GG GDVY+AE +++A+K ++ +S+ D T ++ +
Sbjct: 39 RRLVGRGGMGDVYEAEDT-VRERIVALK--LMSETLSS----DPVF------RTRMQREA 85
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV---SKGRRELEWLSRH- 154
TA +++ +++P ++DF G + LY G L R
Sbjct: 86 RTAGRLQEPHVVP-------------IHDF---GEIDGQLYVDMRLINGVDLAAMLRRQG 129
Query: 155 --------KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
I + S L+ H HRD+KP N+L+ D A + F +A D
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186
Query: 207 -GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
LTQ VGT Y+APE + + DIY+ +L + G P+
Sbjct: 187 EKLTQ--LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 43/241 (17%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
+E+ D+ K +G G G+VY+ + +AVK + M E
Sbjct: 217 MERTDITMKHK---------LGGGQYGEVYEGVWKKYSLT-VAVK-TLKEDTMEVEEF-- 263
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
L E +I+H N++ LL R ++ +FM G+L L
Sbjct: 264 ---------LKEAA----VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--R 308
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
R+E+ + +A ++S +EYL + IHR++ N L+ ++ +++ F L+
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLS 365
Query: 202 ILMPDGLTQIDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFP 255
LM Y ++ APE S K D+++FGVLL + G P
Sbjct: 366 RLMTGD------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
Query: 256 F 256
+
Sbjct: 420 Y 420
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-23
Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 29/223 (13%)
Query: 39 LEKIGSGGCGDVYKAE---LPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
++K+G GG VY AE L +A+K I+ P E L
Sbjct: 16 VDKLGGGGMSTVYLAEDTIL----NIKVAIK--AIFIPPREKEET----------LKRFE 59
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++ +SQ+ H+NI+ ++ D + LV ++++ +L + + L +
Sbjct: 60 REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAIN 115
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD-GLTQIDTM 214
+ G+++ H ++HRDIKP N+LID + +I F +A + + LTQ T
Sbjct: 116 FTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TN 170
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
+V+GT +Y +PE + E DIYS G++L +++G+ PF+
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ IG G V + + G AVK ++ + + + E+ E E I
Sbjct: 100 DVIGRGVSSVVRRCVHR-ATGHEFAVK-IMEVTAERLSP--EQLEEVREATRRETH---I 152
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
H +I+ L+ LV+D M+ G L +D K +E + R
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRS 208
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
+ + +LH ++ ++HRD+KP N+L+DD+M+ R+S F + + G + +
Sbjct: 209 -----LLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG----EKL 256
Query: 215 Y-VVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ GTP Y+APE ++ D+++ GV+L L+ G PF
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-22
Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G V E + G +AVK +++ + +I+ +I
Sbjct: 19 LGVGTFGKVKIGEHQLT-GHKVAVK------------ILNRQKIRSLDVVGKIKREIQNL 65
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGR-RELEWLSRHKIALAV 160
RH +I+ L + P +V +++ G L Y GR E+E +R +
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD--YICKHGRVEEME--ARRLFQ-QI 120
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
S ++Y H H V+HRD+KP NVL+D M A+I+ F L+ +M DG + T G+P
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT--SCGSP 174
Query: 221 RYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
Y APE Y + DI+S GV+L L+ G PFDD
Sbjct: 175 NYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLPFDD 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 44/234 (18%), Positives = 84/234 (35%), Gaps = 56/234 (23%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
I GG G +Y A NG+ + +K +++S AE + E +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHS--GDAEAQAMA-------MAERQF-- 132
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDF--MKNGSLQAVLY------------DVSKG 144
+++ H +I V+ +++F + V Y
Sbjct: 133 --LAEVVHPSI-------VQ------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ 177
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204
+ + L + L YLH S +++ D+KP N+++ ++ + ++ +
Sbjct: 178 KLPVAEAIA--YLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231
Query: 205 PDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFD 257
Y+ GTP + APE T + DIY+ G LA L + +
Sbjct: 232 ----NS--FGYLYGTPGFQAPE--IVRTGPTVATDIYTVGRTLAALTLDLPTRN 277
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-22
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 41/227 (18%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G+V A + +AVK I+ +D I+ +I
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVK--IV----DMKRAVDC--------PENIKKEICIN 59
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK----IA 157
+ H N++ H + L ++ G L E ++ +
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD--RIEPDIGMP-EPDAQRFFHQLM- 115
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVV 217
+G+ YLH + HRDIKP N+L+D+ +IS F LA + + +
Sbjct: 116 ----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 218 GTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
GT Y+APE +H +E D++S G++L ++ G+ P+D
Sbjct: 169 GTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 5e-22
Identities = 68/325 (20%), Positives = 117/325 (36%), Gaps = 80/325 (24%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
++ S + +G G G V G+ +AVK++ LID L
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQGS--FQGRPVAVKRM----------LIDFCDIA----LM 57
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
EI +++T S H N++ + + N +LQ ++ SK +
Sbjct: 58 EI--KLLTES-DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLV--ESKNVSDENLKL 111
Query: 153 RHKIALA-----VASGLEYLHMHHSARVIHRDIKPANVLID-------------DDMEAR 194
+ + +ASG+ +LH ++IHRD+KP N+L+ +++
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 195 ISGFDLA-ILMPDGLTQIDTMY-VVGTPRYIAPE-------YHQTLTISEKCDIYSFGVL 245
IS F L L + + GT + APE ++ DI+S G +
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 246 L-AVLVMGKFPFDD-------FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQ 297
+L GK PF D +D ++ + + A D L+ Q
Sbjct: 229 FYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAE---ATD--LI-----SQ 278
Query: 298 MLLVLKLACFCTLADPDERPNSKDV 322
M+ DP +RP + V
Sbjct: 279 MIDH----------DPLKRPTAMKV 293
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 5e-22
Identities = 50/243 (20%), Positives = 104/243 (42%), Gaps = 34/243 (13%)
Query: 24 KEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKM-IAVKKV-IIYSPMSAAELID 81
K+ FLK+++ + ++G G G V + ++ +A+K + E+
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM-- 383
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
+ E ++ Q+ + I+ L+ + + ++ +LV + G L L
Sbjct: 384 ----MREAQIM---------HQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL--- 426
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
R E+ + ++ V+ G++YL + +HR++ NVL+ + A+IS F L+
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLS 483
Query: 202 ILMPDGLTQIDTMYVVGT----P-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFP 255
+ D+ Y + P ++ APE S + D++S+GV + L G+ P
Sbjct: 484 KALGAD----DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
Query: 256 FDD 258
+
Sbjct: 540 YKK 542
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 7e-22
Identities = 59/258 (22%), Positives = 108/258 (41%), Gaps = 37/258 (14%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNG 60
L + +GL + I +E L K +G G G+V+ G+
Sbjct: 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVK---------LGQGCFGEVWMGTWNGT-- 291
Query: 61 KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPD 120
+A+K + MS L E + ++RH ++ L A +V +
Sbjct: 292 TRVAIK-TLKPGTMSPEAF-----------LQEAQ----VMKKLRHEKLVQLYA-VVSEE 334
Query: 121 SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDI 180
+V ++M GSL L + + L +A +ASG+ Y+ + +HRD+
Sbjct: 335 PIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 181 KPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP-RYIAPEYHQTLTISEKCDI 239
+ AN+L+ +++ +++ F LA L+ D P ++ APE + K D+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 447
Query: 240 YSFGVLL-AVLVMGKFPF 256
+SFG+LL + G+ P+
Sbjct: 448 WSFGILLTELTTKGRVPY 465
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-22
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 41/227 (18%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G+V A + +AVK I+ +D I+ +I
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVK--IV----DMKRAVDC--------PENIKKEICIN 59
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK----IA 157
+ H N++ H + L ++ G L E ++ +
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD--RIEPDIGMP-EPDAQRFFHQLM- 115
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVV 217
+G+ YLH + HRDIKP N+L+D+ +IS F LA + + +
Sbjct: 116 ----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 218 GTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
GT Y+APE +H +E D++S G++L ++ G+ P+D
Sbjct: 169 GTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 48/245 (19%), Positives = 101/245 (41%), Gaps = 42/245 (17%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKM-IAVKKV-IIYSPMSAAEL 79
+++++L ++G G G V + ++ +A+K + E+
Sbjct: 6 LKRDNLLIADI--------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM 57
Query: 80 IDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLY 139
+ E ++ Q+ + I+ L+ + + ++ +LV + G L L
Sbjct: 58 ------MREAQIM---------HQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL- 100
Query: 140 DVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFD 199
R E+ + ++ V+ G++YL + +HRD+ NVL+ + A+IS F
Sbjct: 101 --VGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG 155
Query: 200 LAILMPDGLTQIDTMYVVGT----P-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGK 253
L+ + D+ Y + P ++ APE S + D++S+GV + L G+
Sbjct: 156 LSKALGAD----DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 254 FPFDD 258
P+
Sbjct: 212 KPYKK 216
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 37/258 (14%)
Query: 1 LILAAVRGGSRDRGLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNG 60
L + +GL + I +E L K +G G G+V+ G+
Sbjct: 160 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVK---------LGQGCFGEVWMGTWNGTTR 210
Query: 61 KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPD 120
I K + MS L E + ++RH ++ L A +V +
Sbjct: 211 VAI---KTLKPGTMSPEAF-----------LQEAQ----VMKKLRHEKLVQLYA-VVSEE 251
Query: 121 SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDI 180
+V ++M GSL L + + L +A +ASG+ Y+ + +HRD+
Sbjct: 252 PIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 181 KPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP-RYIAPEYHQTLTISEKCDI 239
+ AN+L+ +++ +++ F LA L+ D P ++ APE + K D+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 364
Query: 240 YSFGVLL-AVLVMGKFPF 256
+SFG+LL + G+ P+
Sbjct: 365 WSFGILLTELTTKGRVPY 382
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 29/103 (28%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI-DTM 214
+ L + H + +IHRD+KPAN++I ++ F +A + D + T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257
V+GT +Y++PE + ++ + D+YS G +L ++ G+ PF
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 59/259 (22%), Positives = 104/259 (40%), Gaps = 32/259 (12%)
Query: 8 GGSRDRGLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKK 67
G G + +D+ F ED + E IG G V + G+ AVK
Sbjct: 1 GSPGISGGGGGILDMADDDVLF---EDVYELCEVIGKGPFSVVRRCINR-ETGQQFAVK- 55
Query: 68 VIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYD 127
++ + +++ + E E I ++H +I+ LL +V++
Sbjct: 56 IVDVAKFTSSPGLST-----EDLKREA--SIC--HMLKHPHIVELLETYSSDGMLYMVFE 106
Query: 128 FMKNGSLQAVLYD--VSKGRREL---EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182
FM L V + E ++ H + L Y H ++ +IHRD+KP
Sbjct: 107 FMDGADL----CFEIVKRADAGFVYSEAVASH-YMRQILEALRYCHDNN---IIHRDVKP 158
Query: 183 ANVLI---DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDI 239
VL+ ++ ++ GF +AI + + VGTP ++APE + + D+
Sbjct: 159 HCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDV 216
Query: 240 YSFGVLLAVLVMGKFPFDD 258
+ GV+L +L+ G PF
Sbjct: 217 WGCGVILFILLSGCLPFYG 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 69/224 (30%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G V + G +AVK +++ + +IR +I
Sbjct: 24 LGVGTFGKVKVGK-HELTGHKVAVK------------ILNRQKIRSLDVVGKIRREIQNL 70
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGR-RELEWLSRHKIALAV 160
RH +I+ L + P +V +++ G L Y GR E E SR +
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD--YICKNGRLDEKE--SRRLFQQIL 126
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
SG++Y H H V+HRD+KP NVL+D M A+I+ F L+ +M DG + T G+P
Sbjct: 127 -SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT--SCGSP 179
Query: 221 RYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
Y APE Y + DI+S GV+L L+ G PFDD
Sbjct: 180 NYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGTLPFDD 218
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
K+GSG G+V + + A+K VI S D ++ E EI ++I
Sbjct: 42 RKLGSGAYGEVLLCKEK-NGHSEKAIK-VIKKSQFDKGRYSDD-NKNIEKFHEEIYNEIS 98
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEWLSRH--- 154
+ H NI+ L LV +F + G L ++ +++ +
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHK-----FDECDAA 149
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
I + SG+ YLH H+ ++HRDIKP N+L+ + + +I F L+
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 212 DTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
D +GT YIAPE Y +EKCD++S GV++ +L+ G PF
Sbjct: 207 D---RLGTAYYIAPEVLKKKY------NEKCDVWSCGVIMYILLCGYPPFGG 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 9e-21
Identities = 54/261 (20%), Positives = 83/261 (31%), Gaps = 56/261 (21%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
IG G G V A + A+K ++ + + D + I++++
Sbjct: 32 GAIGQGSYGVVRVAIEN-QTRAIRAIK-IMNKNKIRQINPKD---------VERIKTEVR 80
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSL-------------QAVLYDVSKGRR 146
++ H NI L LV + G L + + V
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 147 ELEWLSRHKIALA-----------------------VASGLEYLHMHHSARVIHRDIKPA 183
+ I + + S L YLH + HRDIKP
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPE 197
Query: 184 NVLIDDDMEAR--ISGFDLAILMPDGLTQIDTMY--VVGTPRYIAPE--YHQTLTISEKC 237
N L + + F L+ GTP ++APE + KC
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 238 DIYSFGVLLAVLVMGKFPFDD 258
D +S GVLL +L+MG PF
Sbjct: 258 DAWSAGVLLHLLLMGAVPFPG 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 20/176 (11%)
Query: 96 SQIITASQIRH----RNILPLLAH--MVR-------PDSHLLVYDFMKNGSLQAVLYDVS 142
II +++ + R+++ L H V+ + + KNG L +
Sbjct: 66 RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---R 122
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
K E +R A + S LEYLH +IHRD+KP N+L+++DM +I+ F A
Sbjct: 123 KIGSFDETCTRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK 178
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
++ Q VGT +Y++PE + + D+++ G ++ LV G PF
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 53/237 (22%), Positives = 88/237 (37%), Gaps = 54/237 (22%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
+G G G V + AVK I+ +L ++ +I
Sbjct: 13 LGEGSYGKVKEVL-DSETLCRRAVK--IL----KKKKLRRI-----PNGEANVKKEIQLL 60
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQA---VLYDVSKGRREL-EWLSRHKIA 157
++RH+N++ L D + N Q V+ G +E+ + + +
Sbjct: 61 RRLRHKNVIQL-------------VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP 107
Query: 158 LAVA--------SGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
+ A GLEYLH ++H+DIKP N+L+ +IS +A +
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL-HPFA 163
Query: 210 QIDTMYVV-GTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
DT G+P + PE + K DI+S GV L + G +PF+
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFS-----GFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 57/248 (22%), Positives = 100/248 (40%), Gaps = 48/248 (19%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKM-IAVK--KVIIYSPMSAAE 78
++++ L KE +GSG G V K +AVK K P E
Sbjct: 13 LDRKLLTLEDKE--------LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 79 LIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL 138
L L E + Q+ + I+ ++ + +S +LV + + G L L
Sbjct: 65 L------LAEANVM---------QQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL 108
Query: 139 YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198
+ R ++ + ++ V+ G++YL + +HRD+ NVL+ A+IS F
Sbjct: 109 ----QQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161
Query: 199 DLAILMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLV 250
L+ + + Y T P ++ APE + + K D++SFGVL+
Sbjct: 162 GLSKALRAD----ENYYKAQTHGKWPVKWYAPECINYYKFSS--KSDVWSFGVLMWEAFS 215
Query: 251 MGKFPFDD 258
G+ P+
Sbjct: 216 YGQKPYRG 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 50/233 (21%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+G G G+V K + + AVK VI + + E+ +++
Sbjct: 28 CMLGKGSFGEVLKCK-DRITQQEYAVK-VINKASAKNKDTSTILREV----------ELL 75
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
++ H NI+ L + S +V + G L +D + + R + + +
Sbjct: 76 --KKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQ 129
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
V SG+ Y+H H+ ++HRD+KP N+L+ + D + +I F L+
Sbjct: 130 -----VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---- 177
Query: 212 DTMY-VVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
M +GT YIAPE Y EKCD++S GV+L +L+ G PF
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPFYG 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 55/247 (22%)
Query: 20 PLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKM-IAVKKVIIYSPMSAAE 78
P+++ D+ F IG G G V KA + +M A+K++ Y+ S +
Sbjct: 20 PVLDWNDIKFQDV---------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDD 68
Query: 79 LIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL 138
D EL E+ ++ H NI+ LL L ++ +G+L L
Sbjct: 69 HRDFAGEL------EVLCKLG-----HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117
Query: 139 YDVSKGRRELEWLSRH------------KIALAVASGLEYLHMHHSARVIHRDIKPANVL 186
+ + + A VA G++YL IHRD+ N+L
Sbjct: 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 174
Query: 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDI 239
+ ++ A+I+ F GL++ +YV T P R++A E + T D+
Sbjct: 175 VGENYVAKIADF--------GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT--NSDV 224
Query: 240 YSFGVLL 246
+S+GVLL
Sbjct: 225 WSYGVLL 231
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 47/243 (19%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
+E+ D+ K +G G G+VY+ + +AVK + M E
Sbjct: 10 MERTDITMKHK---------LGGGQYGEVYEGVWKKYSLT-VAVK-TLKEDTMEVEEF-- 56
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
L E + +I+H N++ LL R ++ +FM G+L L
Sbjct: 57 ----LKEAAVM---------KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--R 101
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
R+E+ + +A ++S +EYL + IHRD+ N L+ ++ +++ F L+
Sbjct: 102 ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 158
Query: 202 ILMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGK 253
LM Y P ++ APE + +I K D+++FGVLL + G
Sbjct: 159 RLMTGD------TYTAHAGAKFPIKWTAPESLAYNKFSI--KSDVWAFGVLLWEIATYGM 210
Query: 254 FPF 256
P+
Sbjct: 211 SPY 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 39/227 (17%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAE---LPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGE 88
+E + ++G G G V L + G ++AVK++ P +
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF--------- 71
Query: 89 GKLTEIRSQIITASQIRHRNILPLLA--HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRR 146
EI QI+ + I+ + S LV +++ +G L+ L + R
Sbjct: 72 --QREI--QIL--KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRA 122
Query: 147 ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
L+ + + G+EYL S R +HRD+ N+L++ + +I+ F LA L+P
Sbjct: 123 RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179
Query: 207 GLTQIDTMYVVGTP-----RYIAPE--YHQTLTISEKCDIYSFGVLL 246
YVV P + APE + + D++SFGV+L
Sbjct: 180 D----KDYYVVREPGQSPIFWYAPESLSDNIFSR--QSDVWSFGVVL 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-20
Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 47/242 (19%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
I+ +L F+++ IGSG G V+ + +A+K I MS +
Sbjct: 5 IDPSELTFVQE---------IGSGQFGLVHLGYWLNKD--KVAIK-TIREGAMSEEDF-- 50
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
+ E ++ ++ H ++ L + LV +FM++G L L
Sbjct: 51 ----IEEAEV---------MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--- 94
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
R + + L V G+ YL VIHRD+ N L+ ++ ++S F +
Sbjct: 95 RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMT 151
Query: 202 ILMPDGLTQIDTMYVVGT---P-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGKF 254
+ D D P ++ +PE + K D++SFGVL+ V GK
Sbjct: 152 RFVLD-----DQYTSSTGTKFPVKWASPEVFSFSRYSS--KSDVWSFGVLMWEVFSEGKI 204
Query: 255 PF 256
P+
Sbjct: 205 PY 206
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-20
Identities = 60/244 (24%), Positives = 90/244 (36%), Gaps = 63/244 (25%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN---GKMIAVKKV-IIYSPMSAA 77
K L ++ +G G G V +N G+M+AVK + P +
Sbjct: 28 FHKRYLKKIRD---------LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS 78
Query: 78 ELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA--HMVRPDSHLLVYDFMKNGSLQ 135
EI I+ + H +I+ S LV +++ GSL
Sbjct: 79 GW-----------KQEI--DIL--RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL- 122
Query: 136 AVLYDVSKGRRELEWLSRHKIALA--------VASGLEYLHMHHSARVIHRDIKPANVLI 187
++L RH I LA + G+ YLH + IHRD+ NVL+
Sbjct: 123 ------------RDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLL 167
Query: 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSF 242
D+D +I F LA +P+G Y V + APE + D++SF
Sbjct: 168 DNDRLVKIGDFGLAKAVPEG----HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223
Query: 243 GVLL 246
GV L
Sbjct: 224 GVTL 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-20
Identities = 52/236 (22%), Positives = 87/236 (36%), Gaps = 45/236 (19%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGK---MIAVKKV-IIYSPMSAA 77
EK L ++ +G G G V +AVK + A
Sbjct: 18 FEKRFLKRIRD---------LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 68
Query: 78 ELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA--HMVRPDSHLLVYDFMKNGSLQ 135
+L EI +I+ + H NI+ + L+ +F+ +GSL+
Sbjct: 69 DL-----------KKEI--EIL--RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 136 AVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195
L K + ++ + K A+ + G++YL S + +HRD+ NVL++ + + +I
Sbjct: 114 EYL---PKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKI 167
Query: 196 SGFDLAILMPDGLTQIDTMYVVGTPRYI-----APEYHQTLTISEKCDIYSFGVLL 246
F L + Y V R APE D++SFGV L
Sbjct: 168 GDFGLTKAIETD----KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 62/232 (26%), Positives = 94/232 (40%), Gaps = 47/232 (20%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+G G G+V + G+ AVK VI + ++ + ++
Sbjct: 32 RVLGKGSFGEVILCKDK-ITGQECAVK-VISKRQVKQKTDKES-----------LLREVQ 78
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEWLSRHKIA 157
Q+ H NI+ L LV + G L +D +S+ R S A
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKR-----FSEVDAA 129
Query: 158 L---AVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
V SG+ Y+H + ++HRD+KP N+L+ D RI F L+
Sbjct: 130 RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186
Query: 212 DTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
D +GT YIAPE Y EKCD++S GV+L +L+ G PF+
Sbjct: 187 D---KIGTAYYIAPEVLHGTY------DEKCDVWSTGVILYILLSGCPPFNG 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 7e-20
Identities = 54/234 (23%), Positives = 99/234 (42%), Gaps = 51/234 (21%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E++G G V + + G A K +I +SA + E +I
Sbjct: 12 EELGKGAFSVVRRCVHK-TTGLEFAAK-IINTKKLSARDFQKLEREA----------RIC 59
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
+++H NI+ L + H LV+D + G L ++ V++ + +
Sbjct: 60 R--KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQ 113
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
+ + Y H + ++HR++KP N+L+ +++ F LAI + D
Sbjct: 114 -----ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---- 161
Query: 212 DTMY-VVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ + GTP Y++PE Y S+ DI++ GV+L +L++G PF D
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPY------SKPVDIWACGVILYILLVGYPPFWD 209
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 48/232 (20%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+K+GSG G+V A+K +I + +S + E+ ++
Sbjct: 43 KKLGSGAYGEVLLCRDK-VTHVERAIK-IIRKTSVSTSSNSKLLEEV----------AVL 90
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEWLSRHKIA 157
+ H NI+ L ++ LV + K G L +D + + + + A
Sbjct: 91 --KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMK-----FNEVDAA 139
Query: 158 L---AVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
+ V SG+ YLH H+ ++HRD+KP N+L+ + D +I F L+ + +
Sbjct: 140 VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196
Query: 212 DTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ +GT YIAPE Y EKCD++S GV+L +L+ G PF
Sbjct: 197 E---RLGTAYYIAPEVLRKKY------DEKCDVWSIGVILFILLAGYPPFGG 239
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 60/234 (25%), Positives = 93/234 (39%), Gaps = 29/234 (12%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVK-KVIIYSPMSAAELIDAYSELGEGK 90
E LEK+G G G V + E +GK ++V K + +S E +D + + E
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF--IREVN 73
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
+ HRN++ L +V +V + GSL L K +
Sbjct: 74 AM---------HSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQGHFLL 120
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
+ + A+ VA G+ YL IHRD+ N+L+ +I F L +P
Sbjct: 121 GTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN--- 174
Query: 211 IDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
D YV+ + APE +T T S D + FGV L + G+ P+
Sbjct: 175 -DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 54/233 (23%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMI--AVKKV-IIYSPMSAAELIDAYSELGEGK 90
+ + +G+G G+V L + K I A+K + + Y+ + LGE
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF------LGEAS 98
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
+ Q H NI+ L + + ++V ++M+NGSL + L K +
Sbjct: 99 IM---------GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTV 146
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
+ + +ASG++YL +HRD+ N+LI+ ++ ++S F L ++ D
Sbjct: 147 IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED---D 200
Query: 211 IDTMYV-VGT--P-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
+ Y G P R+ +PE + D++S+G++L V+ G+ P+ +
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 48/232 (20%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+G G G+V K + + AVK VI + + E+ +++
Sbjct: 28 CMLGKGSFGEVLKCKDR-ITQQEYAVK-VINKASAKNKDTSTILREV----------ELL 75
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEWLSRHKIA 157
++ H NI+ L + S +V + G L +D + + R S H A
Sbjct: 76 --KKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKR-----FSEHDAA 124
Query: 158 L---AVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
V SG+ Y+H H+ ++HRD+KP N+L+ + D + +I F L+
Sbjct: 125 RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 212 DTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
D +GT YIAPE Y EKCD++S GV+L +L+ G PF
Sbjct: 182 D---RIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPFYG 224
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 42/229 (18%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
I +E L KK +G+G G+V+ A + K + MS
Sbjct: 185 IPRESLKLEKK---------LGAGQFGEVWMATYNKHTKVAV---KTMKPGSMSVEAF-- 230
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
L E ++H ++ L A +V + ++ +FM GSL L
Sbjct: 231 ---------LAEAN----VMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK-- 274
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
S + + +A G+ ++ + IHRD++ AN+L+ + +I+ F LA
Sbjct: 275 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331
Query: 202 ILMPDGLTQIDTMYV-VGT--P-RYIAPEYHQTLTISEKCDIYSFGVLL 246
++ D + G P ++ APE + + K D++SFG+LL
Sbjct: 332 RVIED-----NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-19
Identities = 57/232 (24%), Positives = 84/232 (36%), Gaps = 50/232 (21%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
IG G G+V A G+ A K I + + EI +I+
Sbjct: 15 NTIGRGSWGEVKIAVQKGT-RIRRAAK-KIPKYFVEDVDRF----------KQEI--EIM 60
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
+ H NI+ L LV + G L ++ V K + + +
Sbjct: 61 --KSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKD 114
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
V S + Y H + V HRD+KP N L D ++ F LA G
Sbjct: 115 -----VLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 212 DTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
VGTP Y++P+ Y +CD +S GV++ VL+ G PF
Sbjct: 167 T---KVGTPYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPPFSA 209
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 40/235 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMI--AVK--KVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +G G G V + L +G + AVK K+ S E L E
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF------LSEAACM-- 90
Query: 95 RSQIITASQIRHRNILPLLA-----HMVRPDSHLLVYDFMKNGSLQAVL--YDVSKGRRE 147
H N++ LL +++ FMK G L L + G +
Sbjct: 91 -------KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
+ + K + +A G+EYL + +HRD+ N ++ DDM ++ F L+ +
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS- 199
Query: 208 LTQIDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
Y G ++IA E + K D+++FGV + + G P+
Sbjct: 200 ----GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 46/229 (20%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
+ ++L L+ IG G GDV + G +AVK I + +A
Sbjct: 190 LNMKELKLLQT---------IGKGEFGDVMLGDY---RGNKVAVK--CIKNDATAQAF-- 233
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYD 140
L E +Q+RH N++ LL +V L +V ++M GSL L
Sbjct: 234 ---------LAEAS----VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-- 278
Query: 141 VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
S+GR L K +L V +EYL ++ +HRD+ NVL+ +D A++S F
Sbjct: 279 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF-- 333
Query: 201 AILMPDGLTQIDTMYVVGT--P-RYIAPEYHQTLTISEKCDIYSFGVLL 246
GLT+ + P ++ APE + S K D++SFG+LL
Sbjct: 334 ------GLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 376
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-19
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 37/219 (16%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMI--AVKKV-IIYSPMSAAELIDAYSELGEGKLTEIR 95
E IG G G VY L ++GK I AVK + I ++ L EG +
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF------LTEGIIM--- 80
Query: 96 SQIITASQIRHRNILPLLAHMVRPDS-HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
H N+L LL +R + L+V +MK+G L+ +
Sbjct: 81 ------KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLI 131
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
L VA G++YL S + +HRD+ N ++D+ +++ F LA M D
Sbjct: 132 GFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----KEY 183
Query: 215 YVVGT------P-RYIAPEYHQTLTISEKCDIYSFGVLL 246
Y V P +++A E QT + K D++SFGVLL
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 39/228 (17%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E++G G V + + G A K +I +SA + E +I
Sbjct: 35 EELGKGAFSVVRRCVHK-TTGLEFAAK-IINTKKLSARDFQKLEREA----------RIC 82
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
+++H NI+ L + H LV+D + G L ++ V++ + +
Sbjct: 83 --RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQ 136
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
+ + Y H + ++HR++KP N+L+ +++ F LAI + D
Sbjct: 137 -----ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---- 184
Query: 212 DTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ + GTP Y++PE + S+ DI++ GV+L +L++G PF D
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 52/232 (22%), Positives = 92/232 (39%), Gaps = 35/232 (15%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
D + E++G+G G V++ + G A K ++ S E +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERAT-GNNFAAK-FVMTPHESDKETV----------RK 203
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
EI Q + S +RH ++ L + +++Y+FM G L K E +S
Sbjct: 204 EI--QTM--SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL------FEKVADEHNKMS 253
Query: 153 RHKIALA---VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI--SGFDLAILMPDG 207
+ V GL ++H ++ +H D+KP N++ + F L +
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310
Query: 208 LTQIDTMYV-VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
++ V GT + APE + + D++S GVL +L+ G PF
Sbjct: 311 ----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 40/231 (17%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKM-IAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
L+++G+G G V + G+ +A+K +I MS E + E K+
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKW---RGQYDVAIK-MIKEGSMSEDEF------IEEAKV- 72
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+ H ++ L + ++ ++M NG L L + R +
Sbjct: 73 --------MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQ 121
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
++ V +EYL +HRD+ N L++D ++S F L+ + D D
Sbjct: 122 LLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-----D 173
Query: 213 TMYV-VGT--P-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
VG+ P R+ PE + + K DI++FGVL+ + +GK P+
Sbjct: 174 EYTSSVGSKFPVRWSPPEVLMYSKFSS--KSDIWAFGVLMWEIYSLGKMPY 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 64/229 (27%), Positives = 89/229 (38%), Gaps = 28/229 (12%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ F+ IG GG G+VY GKM A+K + + E L E
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKC------LDKKRIKMKQGE--TLALNE 239
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
R + S I+ + PD + D M G L Y +S+ E R
Sbjct: 240 -RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL---HYHLSQHGVFSEADMR 295
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
A + GLE++H V++RD+KPAN+L+D+ RIS LA
Sbjct: 296 FYAA-EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--A 349
Query: 214 MYVVGTPRYIAPEYHQTLTISEK----CDIYSFGVLLAVLVMGKFPFDD 258
VGT Y+APE L D +S G +L L+ G PF
Sbjct: 350 S--VGTHGYMAPE---VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 44/235 (18%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAE---LPGSNGKMIAVKKVIIYSPMSAAE 78
E+ L FL++ +G G G V L + G+++AVKK+ + +
Sbjct: 7 FEERHLKFLQQ---------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 57
Query: 79 LIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA--HMVRPDSHLLVYDFMKNGSLQA 136
EI +I+ ++H NI+ + + L+ +++ GSL+
Sbjct: 58 F-----------EREI--EIL--KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102
Query: 137 VLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS 196
L K + ++ + + + G+EYL + R IHRD+ N+L++++ +I
Sbjct: 103 YL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG 156
Query: 197 GFDLAILMPDGLTQIDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL 246
F L ++P + V P + APE S D++SFGV+L
Sbjct: 157 DFGLTKVLPQD----KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 36/236 (15%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
ED + E++GSG V K S G A K I A+ + E+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCR-EKSTGLEYAAK-FIKKRQSRASRRGVSREEI----ER 64
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEW 150
E+ I+ Q+ H N++ L +L+ + + G L +D K
Sbjct: 65 EV--SIL--RQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKES----- 111
Query: 151 LSRHKIALA---VASGLEYLHMHHSARVIHRDIKPANVLI----DDDMEARISGFDLAIL 203
LS + + G+ YLH + H D+KP N+++ ++ F LA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 204 MPDGLTQIDTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ DG + GTP ++APE + + D++S GV+ +L+ G PF
Sbjct: 169 IEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 39 LEKIGSGGCGDVYKAEL--PGSNGKMIAVKKV-IIYSPMSAAELIDAYSELGEGKLTEIR 95
+ IGSG G+V L PG +A+K + Y+ + L E +
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF------LSEASIM--- 104
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
Q H NI+ L + R ++V ++M+NGSL L + +
Sbjct: 105 ------GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVG 155
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ V +G+ YL +HRD+ NVL+D ++ ++S F L+ ++ D D Y
Sbjct: 156 MLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED---DPDAAY 209
Query: 216 V-VGT--P-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
G P R+ APE +T + D++SFGV++ VL G+ P+ +
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSS--ASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVK----KVIIYSPMSAAELIDAYSELGEG 89
D F +G GG G+V+ ++ + GK+ A K K + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT-GKLYACKKLNKKRLK--------------KRKGY 229
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
+ + +I+ +++ R I+ L LV M G ++ +Y+V + +
Sbjct: 230 QGAMVEKKIL--AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 150 WLSRHKIALA-VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
R A + SGLE+LH +I+RD+KP NVL+DDD RIS LA+ + G
Sbjct: 288 -EPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
T+ GTP ++APE D ++ GV L ++ + PF
Sbjct: 344 TKTKGY--AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 57/230 (24%), Positives = 91/230 (39%), Gaps = 41/230 (17%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
K+GSG GDV+ E S G +K I S + +E+ +++
Sbjct: 28 RKLGSGAFGDVHLVEERSS-GLERVIK--TINKDRSQVPMEQIEAEI----------EVL 74
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
+ H NI+ + + +V + + G L L + + + LS +A
Sbjct: 75 --KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL---LERIVSAQARGKALSEGYVAEL 129
Query: 160 ---VASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQIDT 213
+ + L Y H H V+H+D+KP N+L +I F LA L +
Sbjct: 130 MKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN- 185
Query: 214 MYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
GT Y+APE + KCDI+S GV++ L+ G PF
Sbjct: 186 --AAGTALYMAPEVFKRDV------TFKCDIWSAGVVMYFLLTGCLPFTG 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 29/229 (12%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVK----KVIIYSPMSAAELIDAYSELGEG 89
+ F +G GG G+V ++ + GKM A K K I +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIK--------------KRKGE 228
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
+ QI+ ++ R ++ L D+ LV M G L+ +Y + + E
Sbjct: 229 AMALNEKQIL--EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-E 285
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
+ A + GLE LH R+++RD+KP N+L+DD RIS LA+ +P+G T
Sbjct: 286 ARAVFYAA-EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
I VGT Y+APE + + D ++ G LL ++ G+ PF
Sbjct: 342 -IKGR--VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-19
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 44/235 (18%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAE---LPGSNGKMIAVKKVIIYSPMSAAE 78
E+ L FL++ +G G G V L + G+++AVKK+ + +
Sbjct: 38 FEERHLKFLQQ---------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 88
Query: 79 LIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSH--LLVYDFMKNGSLQA 136
EI +I+ ++H NI+ L+ +++ GSL+
Sbjct: 89 F-----------EREI--EIL--KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133
Query: 137 VLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS 196
L K + ++ + + + G+EYL + R IHRD+ N+L++++ +I
Sbjct: 134 YL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG 187
Query: 197 GFDLAILMPDGLTQIDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL 246
F L ++P Y V P + APE S D++SFGV+L
Sbjct: 188 DFGLTKVLPQD----KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-19
Identities = 57/236 (24%), Positives = 92/236 (38%), Gaps = 36/236 (15%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
ED + E++GSG V K S G A K I A+ E+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCR-EKSTGLEYAAK-FIKKRQSRASRRGVCREEI----ER 64
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEW 150
E+ I+ Q+ H NI+ L +L+ + + G L +D K
Sbjct: 65 EV--SIL--RQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKES----- 111
Query: 151 LSRHKIALA---VASGLEYLHMHHSARVIHRDIKPANVLI----DDDMEARISGFDLAIL 203
LS + + G+ YLH + H D+KP N+++ ++ F LA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 204 MPDGLTQIDTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ DG + GTP ++APE + + D++S GV+ +L+ G PF
Sbjct: 169 IEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-19
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE-IRSQIIT 100
+G G G V A + +A+K I + L + + + +I
Sbjct: 17 LGEGSFGKVKLAT-HYKTQQKVALK--FI-----------SRQLLKKSDMHMRVEREISY 62
Query: 101 ASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAV 160
+RH +I+ L + P ++V ++ G L Y V K R E R +
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFD--YIVEKKRMT-EDEGRRFFQ-QI 117
Query: 161 ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTP 220
+EY H H ++HRD+KP N+L+DD++ +I+ F L+ +M DG + T G+P
Sbjct: 118 ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKT--SCGSP 171
Query: 221 RYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
Y APE Y + D++S G++L V+++G+ PFDD
Sbjct: 172 NYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-19
Identities = 60/236 (25%), Positives = 110/236 (46%), Gaps = 37/236 (15%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKM---IAVKKVIIYSPMSAAELIDAYSELGEGK 90
C + IG+G G+VYK L S+GK +A+K L Y+E
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-----------LKAGYTEKQRVD 92
Query: 91 -LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
L E I+ Q H NI+ L + + +++ ++M+NG+L L + E
Sbjct: 93 FLGEA--GIM--GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFS 145
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
L + +A+G++YL + +HRD+ N+L++ ++ ++S F L+ ++ D
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED--- 199
Query: 210 QIDTMYV-VGT--P-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
+ Y G P R+ APE ++ T D++SFG+++ V+ G+ P+ +
Sbjct: 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTS--ASDVWSFGIVMWEVMTYGERPYWE 253
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-19
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E +GSG +V+ + GK+ A+K I SP + EI ++
Sbjct: 15 EVLGSGAFSEVFLVK-QRLTGKLFALK-CIKKSPAFRDSSL----------ENEI--AVL 60
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
+I+H NI+ L + LV + G L +D + +G ++ + +
Sbjct: 61 --KKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQ 114
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
V S ++YLH + ++HRD+KP N+L +++ + I+ F L+ + +G+
Sbjct: 115 -----VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166
Query: 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
GTP Y+APE S+ D +S GV+ +L+ G PF +
Sbjct: 167 ----ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-19
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 49/243 (20%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKM-IAVKKVIIYSPMSAAELI 80
+++E++ LK+ +GSG G V + G+ +AVK +I MS E
Sbjct: 5 LKREEITLLKE---------LGSGQFGVVKLGKW---KGQYDVAVK-MIKEGSMSEDEF- 50
Query: 81 DAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD 140
E + ++ H ++ + +V +++ NG L L
Sbjct: 51 -----FQEAQT---------MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-- 94
Query: 141 VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
+ LE ++ V G+ +L H IHRD+ N L+D D+ ++S F +
Sbjct: 95 -RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGM 150
Query: 201 AILMPDGLTQIDTMYV-VGT--P-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGK 253
+ D D VGT P ++ APE ++ + K D+++FG+L+ V +GK
Sbjct: 151 TRYVLD-----DQYVSSVGTKFPVKWSAPEVFHYFKYSS--KSDVWAFGILMWEVFSLGK 203
Query: 254 FPF 256
P+
Sbjct: 204 MPY 206
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 54/232 (23%)
Query: 42 IGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA 101
IGSG G + +++AVK I ID ++ +II
Sbjct: 28 IGSGNFGVARLMRDKLT-KELVAVK--YI----ERGAAIDEN----------VQREIINH 70
Query: 102 SQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR-RELEWLSRHK--- 155
+RH NI+ ++ P ++ ++ G L Y+ + GR E E +R
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDE--ARFFFQQ 124
Query: 156 -IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR--ISGFDLAILMPDGLTQID 212
+ SG+ Y H + HRD+K N L+D R I F + +Q
Sbjct: 125 LL-----SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 175
Query: 213 TMYVVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ VGTP YIAPE Y + D++S GV L V+++G +PF+D
Sbjct: 176 S--TVGTPAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYPFED 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 55/236 (23%), Positives = 96/236 (40%), Gaps = 36/236 (15%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
ED + E++GSG V K GK A K I +S++ + E+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCR-QKGTGKEYAAK-FIKKRRLSSSRRGVSREEI----ER 57
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RE 147
E+ I+ +IRH NI+ L +L+ + + G L +D K E
Sbjct: 58 EV--NIL--REIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDE 109
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI----DDDMEARISGFDLAIL 203
+ + G+ YLH + H D+KP N+++ + ++ F +A
Sbjct: 110 ATQFLKQ-----ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 204 MPDGLTQIDTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ G + + GTP ++APE + + D++S GV+ +L+ G PF
Sbjct: 162 IEAG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 49/237 (20%), Positives = 96/237 (40%), Gaps = 37/237 (15%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAEL--PGSNGKM-IAVKKV-IIYSPMSAAELIDAYSELG 87
KE L+ +GSG G V+K G + K+ + +K + S +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV------TD 64
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE 147
+ H +I+ LL + S LV ++ GSL + +G
Sbjct: 65 HMLAI---------GSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQ-HRGALG 113
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
+ L + +A G+ YL H ++HR++ NVL+ + +++ F +A L+P
Sbjct: 114 PQLLL--NWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP- 167
Query: 208 LTQIDTMYVVGT----P-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
D ++ + P +++A E + + D++S+GV + ++ G P+
Sbjct: 168 ----DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAEL--PGSNGKM-IAVK--KVIIYSPMSAAELIDAYSEL 86
KE F ++ +GSG G VYK G K+ +A+K + SP + E+ L
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEI------L 65
Query: 87 GEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRR 146
E + + + + ++ LL + + L+ M G L + + +
Sbjct: 66 DEAYVM---------ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKD 112
Query: 147 ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
+ + +A G+ YL R++HRD+ NVL+ +I+ F LA L+
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 207 GLTQIDTMYVVG---TP-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
+ Y P +++A E + + D++S+GV + ++ G P+D
Sbjct: 170 E----EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 48/228 (21%), Positives = 89/228 (39%), Gaps = 43/228 (18%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
++G G G V+ AE + ++AVK + S + D E
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREA-------- 94
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL-----------YDVSK 143
+++ + ++H++I+ L+V+++M++G L L
Sbjct: 95 --ELL--TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150
Query: 144 GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL 203
L +A VA+G+ YL H +HRD+ N L+ + +I F ++
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRD 207
Query: 204 MPDGLTQIDTMYVVGT----P-RYIAPEYHQTLTISEKCDIYSFGVLL 246
+ Y VG P R++ PE + + D++SFGV+L
Sbjct: 208 IYS-----TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 55/218 (25%), Positives = 83/218 (38%), Gaps = 37/218 (16%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMI--AVKKV-IIYSPMSAAELIDAYSELGEGKLTEIRS 96
IG G G VY E I A+K + I L EG L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF------LREGLLM---- 76
Query: 97 QIITASQIRHRNILPLLAHMVRPDSHLL-VYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+ H N+L L+ M+ P+ + +M +G L + +R
Sbjct: 77 -----RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLIS 128
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
L VA G+EYL + +HRD+ N ++D+ +++ F LA + D Y
Sbjct: 129 FGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD-----REYY 180
Query: 216 VVGTP-------RYIAPEYHQTLTISEKCDIYSFGVLL 246
V ++ A E QT + K D++SFGVLL
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 52/236 (22%), Positives = 96/236 (40%), Gaps = 36/236 (15%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+D + + E++GSG V K S G A K I ++ + ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCR-EKSTGLQYAAK-FIKKRRTKSSRRGVSREDI----ER 63
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEW 150
E+ I+ +I+H N++ L +L+ + + G L +D K
Sbjct: 64 EV--SIL--KEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKES----- 110
Query: 151 LSRHKIALA---VASGLEYLHMHHSARVIHRDIKPANVLI----DDDMEARISGFDLAIL 203
L+ + + +G+ YLH + H D+KP N+++ +I F LA
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 204 MPDGLTQIDTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ G + + GTP ++APE + + D++S GV+ +L+ G PF
Sbjct: 168 IDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 49/233 (21%), Positives = 90/233 (38%), Gaps = 37/233 (15%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
D + LE++GSG G V++ + G++ K I +
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAK-FINTPYPLDKYTV----------KN 97
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEW 150
EI I+ +Q+ H ++ L +L+ +F+ G L +D ++
Sbjct: 98 EI--SIM--NQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAED----YK 145
Query: 151 LSRHKIALA---VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI--SGFDLAILMP 205
+S ++ GL+++H H ++H DIKP N++ + + + F LA +
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202
Query: 206 DGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
T + APE + D+++ GVL VL+ G PF
Sbjct: 203 PDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-18
Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 47/242 (19%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
+ +E L +++ +G+G G+V+ G +AVK + MS
Sbjct: 10 VPRETLKLVER---------LGAGQFGEVWMGYYNGHT--KVAVK-SLKQGSMSPDAF-- 55
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV 141
L E L Q++H+ ++ L A +V + ++ ++M+NGSL L
Sbjct: 56 ----LAEANL---------MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK-- 99
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ +L +A +A G+ ++ + IHRD++ AN+L+ D + +I+ F LA
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 156
Query: 202 ILMPDGLTQIDTMYV-VGT--P-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGKF 254
L+ D + G P ++ APE + T TI K D++SFG+LL ++ G+
Sbjct: 157 RLIED-----NEYTAREGAKFPIKWTAPEAINYGTFTI--KSDVWSFGILLTEIVTHGRI 209
Query: 255 PF 256
P+
Sbjct: 210 PY 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMI--AVKKV-IIYSPMSAAELIDAYSELGEGKLTEIR 95
E IG G G VY L ++GK I AVK + I ++ L EG +
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF------LTEGIIM--- 144
Query: 96 SQIITASQIRHRNILPLLAHMVRPDS-HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
H N+L LL +R + L+V +MK+G L+ +
Sbjct: 145 ------KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLI 195
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
L VA G+++L S + +HRD+ N ++D+ +++ F LA M +
Sbjct: 196 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDS 249
Query: 215 YVVGT----P-RYIAPEYHQTLTISEKCDIYSFGVLL 246
T P +++A E QT + K D++SFGVLL
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 48/227 (21%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E++G G V + G+ A +I +SA + E +I
Sbjct: 17 EELGKGAFSVVRRCV-KVLAGQEYAAM-IINTKKLSARDHQKLEREA----------RIC 64
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
++H NI+ L + H L++D + G L ++ V++ + +
Sbjct: 65 --RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQ 118
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
+ + + H V+HR++KP N+L+ +++ F LAI +
Sbjct: 119 -----ILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
GTP Y++PE + + D+++ GV+L +L++G PF D
Sbjct: 171 FG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 43/236 (18%), Positives = 88/236 (37%), Gaps = 37/236 (15%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMI--AVKKV-IIYSPMSAAELIDAYSELGE 88
+ +G G G+VY+ G+ I AVK + + + + E
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF------MSE 63
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
+ + H +I+ L+ ++ + ++ + G L L + + L
Sbjct: 64 AVIM---------KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYL---ERNKNSL 110
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ L+ +L + + YL + +HRDI N+L+ ++ F L+ +
Sbjct: 111 KVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI---- 163
Query: 209 TQIDTMYVVGT----P-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
D Y + P ++++PE + D++ F V + +L GK PF
Sbjct: 164 --EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-18
Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
++G G G V+ AE + ++AVK + + A D E
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREA-------- 68
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL------------YDVS 142
+++ + ++H +I+ D ++V+++MK+G L L
Sbjct: 69 --ELL--TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
+ + EL IA +ASG+ YL H +HRD+ N L+ ++ +I F ++
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 203 LMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL 246
+ D Y VG P R++ PE ++ T + D++SFGV+L
Sbjct: 182 DVYST----DY-YRVGGHTMLPIRWMPPESIMYRKFTT--ESDVWSFGVIL 225
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 39/231 (16%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ E +G G G V+K E + G +A K +I M E + EI
Sbjct: 91 VSKTEILGGGRFGQVHKCEET-ATGLKLAAK-IIKTRGMKDKEEV----------KNEI- 137
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEWLSR 153
++ +Q+ H N++ L + +LV +++ G L +D + + L+
Sbjct: 138 -SVM--NQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDES----YNLTE 186
Query: 154 HKIALA---VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI--SGFDLAILMPDGL 208
L + G+ ++H + ++H D+KP N+L + +I F LA
Sbjct: 187 LDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242
Query: 209 TQIDTMYV-VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ + V GTP ++APE +S D++S GV+ +L+ G PF
Sbjct: 243 ---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 56/239 (23%), Positives = 90/239 (37%), Gaps = 40/239 (16%)
Query: 28 AFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELG 87
F + D + +G G K S + AVK +I + +
Sbjct: 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKS-NQAFAVK-IISKRMEANTQ--------- 53
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR 145
EI + + H NI+ L LV + + G L ++ K
Sbjct: 54 ----KEI--TALKLCE-GHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKH 102
Query: 146 ---RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFD 199
E ++ R + S + ++H V+HRD+KP N+L +D++E +I F
Sbjct: 103 FSETEASYIMRK-----LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFG 154
Query: 200 LAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
A L P + T T Y APE E CD++S GV+L ++ G+ PF
Sbjct: 155 FARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 41/235 (17%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ +L+ IGSG G V A + +A+KK + P A E L
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKK--LSRPFQ--NQTHAKRAYRELVLM--- 78
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKGRREL 148
+ H+NI+ LL ++ P L +V + M + +L V+ + EL
Sbjct: 79 ------KCVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELM-DANLCQVI------QMEL 124
Query: 149 EWLSRHKIALA--VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
+ L + G+++LH SA +IHRD+KP+N+++ D +I F LA
Sbjct: 125 D--HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTA 177
Query: 207 GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDDF 259
G + + T YVV T Y APE + E DI+S G ++ ++ G FP D
Sbjct: 178 GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-18
Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 41/236 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMI--AVK--KVIIYSPMSAAELIDAYSELGEGKLTEI 94
+G G G V +A+L +G + AVK K I + E L E
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF------LREAACM-- 79
Query: 95 RSQIITASQIRHRNILPLLA------HMVRPDSHLLVYDFMKNGSLQAVL--YDVSKGRR 146
+ H ++ L+ R +++ FMK+G L A L + +
Sbjct: 80 -------KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 147 ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
L + + + +A G+EYL S IHRD+ N ++ +DM ++ F L+ +
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 207 GLTQIDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
Y G +++A E + D+++FGV + ++ G+ P+
Sbjct: 190 -----GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ +L+ IGSG G V A + +A+KK + P A E L
Sbjct: 64 YQNLKPIGSGAQGIVCAA-YDAVLDRNVAIKK--LSRPFQ--NQTHAKRAYRELVLM--- 115
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKGRREL 148
+ H+NI+ LL ++ P L LV + M + +L V+ + EL
Sbjct: 116 ------KCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVI------QMEL 161
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ + + G+++LH SA +IHRD+KP+N+++ D +I F LA
Sbjct: 162 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 216
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDDF 259
+ + T YVV T Y APE + E DI+S G ++ +V K FP D+
Sbjct: 217 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 44/223 (19%), Positives = 89/223 (39%), Gaps = 37/223 (16%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
++G G G VY+ G +A+K V + S E I+ +E
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEA-------- 79
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL------YDVSKGRREL 148
++ + +++ LL + + L++ + M G L++ L +
Sbjct: 80 --SVM--KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
++A +A G+ YL+ + +HRD+ N ++ +D +I F + + +
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-- 190
Query: 209 TQIDTMYVVGT----P-RYIAPEYHQTLTISEKCDIYSFGVLL 246
Y G P R+++PE + + D++SFGV+L
Sbjct: 191 ---TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 27/191 (14%)
Query: 96 SQIITASQIRH----RNILPLLAH--MVR-------PDSHLLVYDFMKNGSLQAVLYDVS 142
+ + +++R+ I+ L H +V + +V D + G L Y +
Sbjct: 51 QKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL---RYHLQ 107
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
+ E + I + L+YL +IHRD+KP N+L+D+ I+ F++A
Sbjct: 108 QNVHFKEETVKLFIC-ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAA 163
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI---SEKCDIYSFGVLLAVLVMGKFPFDDF 259
++P TQI TM GT Y+APE + S D +S GV L+ G+ P+
Sbjct: 164 MLPRE-TQITTM--AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI- 219
Query: 260 FSHTGEMDMVR 270
S T ++V
Sbjct: 220 RSSTSSKEIVH 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 49/246 (19%), Positives = 91/246 (36%), Gaps = 46/246 (18%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMI--AVKKV-IIYSPMSAAE 78
I++E + + IG G GDV++ + A+K S +
Sbjct: 387 IQRERIELGRC---------IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 79 LIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL 138
L E Q H +I+ L+ ++ + ++ + G L++ L
Sbjct: 438 F------LQEALTM---------RQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL 481
Query: 139 YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198
+ L+ S A +++ L YL +HRDI NVL+ + ++ F
Sbjct: 482 Q---VRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 535
Query: 199 DLAILMPDGLTQIDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMG 252
L+ M D+ Y + +++APE + D++ FGV + +L+ G
Sbjct: 536 GLSRYME------DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 253 KFPFDD 258
PF
Sbjct: 590 VKPFQG 595
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 48/233 (20%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK------MIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ +G G G V AE G + +AVK + + +L D SE+
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEM------ 137
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL---------YDVSK 143
E+ I +H+NI+ LL + ++ ++ G+L+ L Y
Sbjct: 138 EMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 144 GRRELEWLSR---HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
R E ++ +A G+EYL IHRD+ NVL+ ++ +I+ F L
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 249
Query: 201 AILMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL 246
A + + Y T P +++APE + + T + D++SFGVL+
Sbjct: 250 ARDINN-----IDYYKKTTNGRLPVKWMAPEALFDRVYTH--QSDVWSFGVLM 295
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 48/236 (20%), Positives = 88/236 (37%), Gaps = 37/236 (15%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMI--AVKKV-IIYSPMSAAELIDAYSELGE 88
+ + IG G GDV++ + A+K S + L E
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF------LQE 66
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
Q H +I+ L+ ++ + ++ + G L++ L + L
Sbjct: 67 ALTM---------RQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL---QVRKYSL 113
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ S A +++ L YL +HRDI NVL+ + ++ F L+ M
Sbjct: 114 DLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME--- 167
Query: 209 TQIDTMYVVGT----P-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
D+ Y + P +++APE + D++ FGV + +L+ G PF
Sbjct: 168 ---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 51/242 (21%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
+ ++L L+ IG G GDV + G +AVK I + +A
Sbjct: 18 LNMKELKLLQT---------IGKGEFGDVMLGDY---RGNKVAVK--CIKNDATAQAF-- 61
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYD 140
L E + +Q+RH N++ LL +V L +V ++M GSL L
Sbjct: 62 ----LAEASV---------MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR- 107
Query: 141 VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
S+GR L K +L V +EYL ++ +HRD+ NVL+ +D A++S F L
Sbjct: 108 -SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 163
Query: 201 A--ILMPDGLTQIDTMYVVGTP-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGKF 254
++ P ++ APE + + K D++SFG+LL + G+
Sbjct: 164 TKEASSTQDTGKL--------PVKWTAPEALREKKFST--KSDVWSFGILLWEIYSFGRV 213
Query: 255 PF 256
P+
Sbjct: 214 PY 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 48/233 (20%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK------MIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ +G G G V AE G + +AVK + + +L D SE+
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEM------ 91
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
E+ I +H+NI+ LL + ++ ++ G+L+ L E +
Sbjct: 92 EMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 153 RH------------KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
+A G+EYL IHRD+ NVL+ ++ +I+ F L
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 203
Query: 201 AILMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL 246
A + + Y T P +++APE + + T + D++SFGVL+
Sbjct: 204 ARDINN-----IDYYKKTTNGRLPVKWMAPEALFDRVYTH--QSDVWSFGVLM 249
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 70/241 (29%), Positives = 107/241 (44%), Gaps = 53/241 (21%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ +L +GSG G V A + G +AVKK + P +I A E +L
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKK--LSRPFQ--SIIHAKRTYRELRLL--- 82
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKGRREL 148
++H N++ LL + P L LV M A L ++ K ++
Sbjct: 83 ------KHMKHENVIGLL-DVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQK-- 128
Query: 149 EWLSRHKIALAV---ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
L+ + + GL+Y+H SA +IHRD+KP+N+ +++D E +I F LA
Sbjct: 129 --LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
Query: 206 DGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDD 258
D +T YV T Y APE H T+ DI+S G ++A L+ G+ FP D
Sbjct: 184 DEMTG----YVA-TRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGRTLFPGTD 234
Query: 259 F 259
Sbjct: 235 H 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 59/234 (25%), Positives = 84/234 (35%), Gaps = 54/234 (23%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E IG G + + AVK +I S E EI I
Sbjct: 28 EDIGVGSYSVCKRCIHK-ATNMEFAVK-IIDKSKRDPTE--------------EIE---I 68
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
+H NI+ L +V + MK G L D + + RE +
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFT 124
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA----RISGFDLAILMPDGLTQ 210
+ +EYLH V+HRD+KP+N+L D+ RI F A +
Sbjct: 125 -----ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 211 IDTMYVVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ T T ++APE Y CDI+S GVLL ++ G PF +
Sbjct: 177 LMT--PCYTANFVAPEVLERQGY------DAACDIWSLGVLLYTMLTGYTPFAN 222
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 51/233 (21%), Positives = 87/233 (37%), Gaps = 48/233 (20%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +G+G G V +A G +AVK + + E SEL ++
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSEL------KV 79
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
S + H NI+ LL L++ ++ G L L +
Sbjct: 80 LSYLG-----NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 155 --------------KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
+ VA G+ +L S IHRD+ N+L+ +I F L
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 201 AILMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL 246
A + + D+ YVV P +++APE ++ T + D++S+G+ L
Sbjct: 192 ARDIKN-----DSNYVVKGNARLPVKWMAPESIFNCVYTF--ESDVWSYGIFL 237
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 72/241 (29%), Positives = 104/241 (43%), Gaps = 54/241 (22%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ S +GSG G V A + +G+ +A+KK + P I A E L
Sbjct: 26 YVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKK--LSRPFQ--SEIFAKRAYRELLLL--- 77
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKGRREL 148
++H N++ LL + P S L LV FM Q L + +
Sbjct: 78 ------KHMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLK--- 122
Query: 149 EWLSRHKIALAV---ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
S KI V GL+Y+H SA V+HRD+KP N+ +++D E +I F LA
Sbjct: 123 --FSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 206 DGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDD 258
+T YVV T Y APE H T+ DI+S G ++A ++ GK F D
Sbjct: 178 AEMTG----YVV-TRWYRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGKTLFKGKD 228
Query: 259 F 259
+
Sbjct: 229 Y 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 40/234 (17%)
Query: 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ + E +G G G V++ S+ K K + +
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCV-ETSSKKTYMAK-FVKVKGTDQVLV-----------KK 50
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEW 150
EI I+ + RHRNIL L + +++++F+ + ++ +
Sbjct: 51 EI--SIL--NIARHRNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFE---- 98
Query: 151 LSRHKIALA---VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA--RISGFDLAILMP 205
L+ +I V L++LH H+ + H DI+P N++ + +I F A +
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 206 DGLTQIDTMYV-VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
G D + P Y APE HQ +S D++S G L+ VL+ G PF
Sbjct: 156 PG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 47/232 (20%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +G G G V +A+ G + +AVK + + + +E SEL +I
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSEL------KI 83
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLV-YDFMKNGSLQAVLYDVSKGRRELEWLSR 153
I H N++ LL +P L+V +F K G+L L +
Sbjct: 84 LIHIG-----HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 154 H------------KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ VA G+E+L S + IHRD+ N+L+ + +I F LA
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 202 ILMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL 246
+ D YV P +++APE + + TI + D++SFGVLL
Sbjct: 196 RDIYK-----DPDYVRKGDARLPLKWMAPETIFDRVYTI--QSDVWSFGVLL 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 37/223 (16%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +G G G+VY+ ++ G +AVK + S + +D E
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEA-------- 125
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
II S+ H+NI+ + ++ ++ + M G L++ L + + L+
Sbjct: 126 --LII--SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 155 ---KIALAVASGLEYLHMHHSARVIHRDIKPANVLID---DDMEARISGFDLAILMPDGL 208
+A +A G +YL +H IHRDI N L+ A+I F +A +
Sbjct: 182 DLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-- 236
Query: 209 TQIDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL 246
Y G +++ PE + K D +SFGVLL
Sbjct: 237 ---AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 49/244 (20%)
Query: 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK 90
+E + + IG+G G VY+A+L S G+++A+KKV L D K
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKV----------LQDK-----RFK 94
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSK 143
E+ QI+ ++ H NI+ L + LV D++ ++ V S+
Sbjct: 95 NREL--QIM--RKLDHCNIVRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSR 148
Query: 144 GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA-RISGFDLA- 201
++ L + + L Y+H S + HRDIKP N+L+D D ++ F A
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
Query: 202 ILMPDGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGK--F 254
L+ + + Y+ + Y APE T +I D++S G +LA L++G+ F
Sbjct: 206 QLVRG---EPNVSYIC-SRYYRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIF 257
Query: 255 PFDD 258
P D
Sbjct: 258 PGDS 261
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 54/237 (22%), Positives = 91/237 (38%), Gaps = 45/237 (18%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ +G G V + AVK +I P + E+ +++
Sbjct: 19 DVLGEGAHARVQTCINL-ITSQEYAVK-IIEKQPGHIRSRV----------FREV--EML 64
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR---RELEWLSRH 154
Q HRN+L L+ D LV++ M+ GS+ + E + +
Sbjct: 65 YQCQ-GHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQD 119
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
VAS L++LH + HRD+KP N+L + +I FDL +
Sbjct: 120 -----VASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 212 DT-----MYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ G+ Y+APE + ++CD++S GV+L +L+ G PF
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-17
Identities = 43/243 (17%), Positives = 90/243 (37%), Gaps = 57/243 (23%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKM------IAVKKVIIYSPMS 75
I EDL F + +G G ++K + +K
Sbjct: 5 IRNEDLIFNES---------LGQGTFTKIFKGVRREVGDYGQLHETEVLLKV-------- 47
Query: 76 AAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQ 135
L A+ E ++ S++ H++++ V D ++LV +F+K GSL
Sbjct: 48 ---LDKAHRNYSESFFEAA--SMM--SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100
Query: 136 AVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR- 194
L K + + L + ++A +A+ + +L + +IH ++ N+L+ + + +
Sbjct: 101 TYL---KKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKT 154
Query: 195 -------ISGFDLAILMPDGLTQIDTMYVVGTP-RYIAPE---YHQTLTISEKCDIYSFG 243
+S ++I + + ++ PE + L + D +SFG
Sbjct: 155 GNPPFIKLSDPGISITVLP-----KDILQE--RIPWVPPECIENPKNLNL--ATDKWSFG 205
Query: 244 VLL 246
L
Sbjct: 206 TTL 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 34/223 (15%), Positives = 70/223 (31%), Gaps = 57/223 (25%)
Query: 39 LEKIGSGGCGDVYKAE---LPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
L G ++A L + +A+ +D L + L E
Sbjct: 36 LIFHGGVPPLQFWQALDTAL----DRQVALT------------FVDPQGVLPDDVLQETL 79
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
S+ + S+I + +L + L+V ++++ GSLQ V + +
Sbjct: 80 SRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIR 133
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
++A+ + H V P+ V + D +
Sbjct: 134 AMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDV---------------------- 168
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
V+ P + + + DI G L L++ ++P +
Sbjct: 169 VLAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPE 204
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 51/237 (21%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAEL--PGSNGKM-IAVKKV-IIYSPMSAAELIDAYSELG 87
KE F ++ +GSG G VYK G K+ +A+K++ SP + E+ L
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI------LD 66
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE 147
E + + + + ++ LL + + L+ M G L + + +
Sbjct: 67 EAYVM---------ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDN 113
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
+ + +A G+ YL R++HRD+ NVL+ +I+ F LA L+
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA- 169
Query: 208 LTQIDTMYVVGT----P-RYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDD 258
+ P +++A E + + D++S+GV + ++ G P+D
Sbjct: 170 ----EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 37/223 (16%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +G G G+VY+ ++ G +AVK + S + +D E
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEA-------- 84
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
II S+ H+NI+ + ++ ++ + M G L++ L + + L+
Sbjct: 85 --LII--SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 155 ---KIALAVASGLEYLHMHHSARVIHRDIKPANVLID---DDMEARISGFDLAILMPDGL 208
+A +A G +YL +H IHRDI N L+ A+I F +A +
Sbjct: 141 DLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-- 195
Query: 209 TQIDTMYVVGTP-----RYIAPEYHQTLTISEKCDIYSFGVLL 246
+ Y G +++ PE + K D +SFGVLL
Sbjct: 196 ---ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 59/254 (23%), Positives = 103/254 (40%), Gaps = 45/254 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +G+G G V +A G + +AVK + S A E SEL +I
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSEL------KI 102
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL----------YDVSKG 144
S + +H NI+ LL L++ ++ G L L +
Sbjct: 103 MSHLG-----QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204
+ VA G+ +L S IHRD+ NVL+ + A+I F LA +
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 205 PDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL-AVLVMGKFPF 256
+ D+ Y+V P +++APE + T+ + D++S+G+LL + +G P+
Sbjct: 215 MN-----DSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEIFSLGLNPY 267
Query: 257 DDFFSHTGEMDMVR 270
++ +V+
Sbjct: 268 PGILVNSKFYKLVK 281
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 71/243 (29%), Positives = 104/243 (42%), Gaps = 57/243 (23%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ L+ +GSG G V A + G G +A+KK +Y P + A E +L
Sbjct: 27 YRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKK--LYRPFQ--SELFAKRAYRELRLL--- 78
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKGRREL 148
+RH N++ LL + PD L LV FM L + K +
Sbjct: 79 ------KHMRHENVIGLL-DVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEK-- 124
Query: 149 EWLSRHKIALAV---ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMP 205
L +I V GL Y+H +A +IHRD+KP N+ +++D E +I F LA
Sbjct: 125 --LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179
Query: 206 DGLTQIDTMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--FPF 256
+T YVV T Y APE Y ++ DI+S G ++A ++ GK F
Sbjct: 180 SEMTG----YVV-TRWYRAPEVILNWMRY------TQTVDIWSVGCIMAEMITGKTLFKG 228
Query: 257 DDF 259
D
Sbjct: 229 SDH 231
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 57/240 (23%), Positives = 92/240 (38%), Gaps = 43/240 (17%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
++G G VY+ + K A+K + +R++I
Sbjct: 59 SELGRGATSIVYRCK-QKGTQKPYALKVL------KKTVDKKI-----------VRTEIG 100
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRRELEWLSRHKIA 157
++ H NI+ L P LV + + G L +D V KG S A
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGY-----YSERDAA 151
Query: 158 LAV---ASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQI 211
AV + YLH + ++HRD+KP N+L D +I+ F L+ ++
Sbjct: 152 DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---- 204
Query: 212 DTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270
M V GTP Y APE + + D++S G++ +L+ G PF D +
Sbjct: 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL 264
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 55/246 (22%), Positives = 93/246 (37%), Gaps = 47/246 (19%)
Query: 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK 90
K+ D F G G G V + S G +A+KKVI + EL +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVI-------QDPRFRNRELQIMQ 71
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSH-------LLVYDFMKNGSLQAVLYDVSK 143
+ + H NI+ L ++ +V +++ +L + +
Sbjct: 72 DL---------AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYR 121
Query: 144 GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLA- 201
+ + + + LH S V HRDIKP NVL++ D ++ F A
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 202 ILMPDGLTQIDTMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK- 253
L P + + Y+ + Y APE Y T + DI+S G + A +++G+
Sbjct: 181 KLSPS---EPNVAYIC-SRYYRAPELIFGNQHY--TTAV----DIWSVGCIFAEMMLGEP 230
Query: 254 -FPFDD 258
F D+
Sbjct: 231 IFRGDN 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 48/233 (20%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK------MIAVKKVIIYSPMSAAELIDAYSELGEGKLT 92
+ +G G G V AE G + +AVK + S + +L D SE+
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEM------ 125
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL------------YD 140
E+ I +H+NI+ LL + ++ ++ G+L+ L
Sbjct: 126 EMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 141 VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
+L A VA G+EYL IHRD+ NVL+ +D +I+ F L
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGL 237
Query: 201 AILMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL 246
A + Y T P +++APE + + T + D++SFGVLL
Sbjct: 238 ARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTH--QSDVWSFGVLL 283
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 59/267 (22%), Positives = 101/267 (37%), Gaps = 74/267 (27%)
Query: 22 IEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELID 81
+ + F + + L KIG G G+V+KA G+ +A+KKV+ M +
Sbjct: 5 YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKA-RHRKTGQKVALKKVL----MENEK--- 56
Query: 82 AYSELGEG-KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHL--------LVYDFMKNG 132
EG +T +R +I ++H N++ L+ S LV+DF +
Sbjct: 57 ------EGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-- 107
Query: 133 SLQAVLYDVSKGRRELEWLSRHKIALAVA----------SGLEYLHMHHSARVIHRDIKP 182
+D++ LS + ++ +GL Y+H + +++HRD+K
Sbjct: 108 ------HDLAG------LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKA 152
Query: 183 ANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPR-----YIAPE-------YHQT 230
ANVLI D +++ F LA Y T R Y PE Y
Sbjct: 153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRY---TNRVVTLWYRPPELLLGERDY--- 206
Query: 231 LTISEKCDIYSFGVLLAVLVMGK--FP 255
D++ G ++A +
Sbjct: 207 ---GPPIDLWGAGCIMAEMWTRSPIMQ 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-16
Identities = 52/190 (27%), Positives = 90/190 (47%), Gaps = 38/190 (20%)
Query: 20 PLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS-----PM 74
+E+L F + + LEK+G G G VYKA+ S G+++A+K++ + + P
Sbjct: 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAEDEGIPS 64
Query: 75 SAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSL 134
+A IR +I ++ H NI+ L+ + LV++FM+ L
Sbjct: 65 TA-----------------IR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DL 105
Query: 135 QAVLYDVSKGRRELEWLSRHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191
+ VL + G L +I + G+ + H H R++HRD+KP N+LI+ D
Sbjct: 106 KKVLDENKTG------LQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDG 156
Query: 192 EARISGFDLA 201
+++ F LA
Sbjct: 157 ALKLADFGLA 166
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 30/172 (17%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK-LT 92
+ + L+K+G G VYK + ++A+K++ + E EG T
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRL--------------EHEEGAPCT 46
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
IR ++ ++H NI+ L + S LV++++ L+ L D ++
Sbjct: 47 AIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI------IN 98
Query: 153 RHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
H + + GL Y H +V+HRD+KP N+LI++ E +++ F LA
Sbjct: 99 MHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 60/246 (24%), Positives = 95/246 (38%), Gaps = 50/246 (20%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT--E 93
+ I SG G V S G +A+K+ +++ +S ++ S+ K E
Sbjct: 24 YTVQRFISSGSYGAVCAGV--DSEGIPVAIKR--VFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHL------LVYDFMKNGSLQAVLYDVSKGRRE 147
IR + H NIL L + LV + M + L V +R
Sbjct: 80 IRLL----NHFHHPNILGLR-DIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRI 129
Query: 148 LEWLSRHKIALAV---ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-IL 203
+ +S I + GL LH A V+HRD+ P N+L+ D+ + I F+LA
Sbjct: 130 V--ISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 204 MPDGLTQIDTMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--F 254
D T YV Y APE + + + D++S G ++A + K F
Sbjct: 185 TADANK---THYVT-HRWYRAPELVMQFKGFTKLV------DMWSAGCVMAEMFNRKALF 234
Query: 255 PFDDFF 260
F+
Sbjct: 235 RGSTFY 240
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 29/183 (15%)
Query: 96 SQIITASQIRH----RNILPLLAH--MVR------PDSHL-LVYDFMKNGSLQAVLYDVS 142
+++ ++ R++L + D++L LV D+ G L L +S
Sbjct: 110 WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL---LTLLS 166
Query: 143 KGRRELEWLSRHKIALA-VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
K L + LA + ++ +H H +HRDIKP N+L+D + R++ F
Sbjct: 167 KFEDRLP-EEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 202 -ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK-----CDIYSFGVLLAVLVMGKFP 255
LM DG Q VGTP YI+PE Q + + CD +S GV + ++ G+ P
Sbjct: 223 LKLMEDGTVQSSVA--VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
Query: 256 FDD 258
F
Sbjct: 281 FYA 283
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 49/234 (20%), Positives = 93/234 (39%), Gaps = 59/234 (25%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK-LTEIRSQ 97
+ K+G G +V++A + +N + + VK + + + E K L +R
Sbjct: 41 VRKLGRGKYSEVFEA-INITNNEKVVVKIL---------KPVKKKKIKREIKILENLRG- 89
Query: 98 IITASQIRHRNILPLLAHMVRPDSH---LLVYDFMKNGSLQAVLYDVSKG--RRELEWLS 152
NI+ L +V+ LV++ + N + + ++ R + +
Sbjct: 90 --------GPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL 140
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLAILMPDGLTQI 211
+ L+Y H S ++HRD+KP NV+ID + + R+ + LA +
Sbjct: 141 K---------ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPG 184
Query: 212 DTM--YVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256
V + + PE Y +L D++S G +LA ++ K PF
Sbjct: 185 QEYNVRVA-SRYFKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEPF 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 50/243 (20%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL 91
+E + + + IG+G G V++A+L S+ +A+KKV L D K
Sbjct: 38 REIAYTNCKVIGNGSFGVVFQAKLVESD--EVAIKKV----------LQDK-----RFKN 80
Query: 92 TEIRSQIITASQIRHRNILPLLAHMVRPDSHL-------LVYDFMKNGSLQAVLYDVSKG 144
E+ QI+ ++H N++ L + LV +++ ++ +K
Sbjct: 81 REL--QIM--RIVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL 134
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM-EARISGFDLA-I 202
++ + L + L Y+H S + HRDIKP N+L+D ++ F A I
Sbjct: 135 KQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
L+ + + Y+ + Y APE + T I DI+S G ++A L+ G+ FP
Sbjct: 192 LIAG---EPNVSYIC-SRYYRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQPLFP 243
Query: 256 FDD 258
+
Sbjct: 244 GES 246
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 66/240 (27%), Positives = 100/240 (41%), Gaps = 55/240 (22%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT--E 93
+ +L IG G G V A N +A+KK I + + T E
Sbjct: 29 YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKK------------ISPFEHQTYCQRTLRE 75
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHL------LVYDFMKNGSLQAVLYDVSKGRRE 147
I+ + RH NI+ + ++R + +V D M + LY + K +
Sbjct: 76 IKIL----LRFRHENIIGIN-DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQH- 124
Query: 148 LEWLSRHKIALAV---ASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--I 202
LS I + GL+Y+H SA V+HRD+KP+N+L++ + +I F LA
Sbjct: 125 ---LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
T T YV T Y APE T +I DI+S G +LA ++ + FP
Sbjct: 179 DPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNRPIFP 233
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 44/189 (23%)
Query: 96 SQIITASQIRH----RNILPLLAH--MVR------PDSHL-LVYDFMKNGSLQAVLYDVS 142
++I S R+I+ +V+ D +L +V ++M G L
Sbjct: 105 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-------- 156
Query: 143 KGRRELEWLSRHKIALAVA--------SGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
+ +S + + A L+ +H IHRD+KP N+L+D +
Sbjct: 157 -----VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK 208
Query: 195 ISGFDLAI-LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK----CDIYSFGVLLAVL 249
++ F + + +G+ + DT VGTP YI+PE ++ CD +S GV L +
Sbjct: 209 LADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 250 VMGKFPFDD 258
++G PF
Sbjct: 267 LVGDTPFYA 275
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-16
Identities = 56/265 (21%), Positives = 107/265 (40%), Gaps = 56/265 (21%)
Query: 15 LTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPM 74
L P++ + L+++D F L+ IG G +V ++ + G++ A+K M
Sbjct: 43 LQWAEPIVVRLKEVRLQRDD-FEILKVIGRGAFSEVAVVKMKQT-GQVYAMKI------M 94
Query: 75 SAAELIDAYSELGEGKLTEIRSQIITASQIRH----RNILPLLAH--MVR------PDSH 122
+ + ++ ++ R++L + + +++
Sbjct: 95 NKWD-------------------MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135
Query: 123 L-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181
L LV ++ G L +L G R ++R +A + ++ +H +HRDIK
Sbjct: 136 LYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLA-EIVMAIDSVHRLG---YVHRDIK 189
Query: 182 PANVLIDDDMEARISGFDLAI-LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK---- 236
P N+L+D R++ F + L DG + VGTP Y++PE Q +
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA--VGTPDYLSPEILQAVGGGPGTGSY 247
Query: 237 ---CDIYSFGVLLAVLVMGKFPFDD 258
CD ++ GV + G+ PF
Sbjct: 248 GPECDWWALGVFAYEMFYGQTPFYA 272
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 52/242 (21%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS-----PMSAAELIDAYSELGE 88
+ + +IG G G V+KA + G+ +A+K+V + + P+S
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST------------ 58
Query: 89 GKLTEIRSQIITASQIRHRNILPLL--AHMVRPDSHL---LVYDFMKNGSLQAVLYDVSK 143
+ E+ + + H N++ L + R D LV++ + L L V +
Sbjct: 59 --IREV-AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPE 114
Query: 144 GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-- 201
E + + + GL++LH H RV+HRD+KP N+L+ + +++ F LA
Sbjct: 115 PGVPTETIK--DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 202 ILMPDGLTQIDTMYVVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGK-- 253
LT VV T Y APE Y + D++S G + A + K
Sbjct: 170 YSFQMALTS-----VVVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRRKPL 218
Query: 254 FP 255
F
Sbjct: 219 FR 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-16
Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLT 92
+ L+ +G G VYKA + +++A+KK+ + SE +G T
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKI----------KLGHRSEAKDGINRT 58
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+R +I ++ H NI+ LL + LV+DFM+ L+ ++ D S L+
Sbjct: 59 ALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV------LT 110
Query: 153 RHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
I L GLEYLH H ++HRD+KP N+L+D++ +++ F LA
Sbjct: 111 PSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 41/227 (18%), Positives = 88/227 (38%), Gaps = 34/227 (14%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+++G G V + S G+ A K + G+ EI +I
Sbjct: 35 KELGRGKFAVVRQCI-SKSTGQEYAAK--FL-----------KKRRRGQDCRAEILHEIA 80
Query: 100 TASQIRHR-NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ ++ L +L+ ++ G + ++ E +S + +
Sbjct: 81 VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP-----ELAEMVSENDVIR 135
Query: 159 A---VASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQID 212
+ G+ YLH ++ ++H D+KP N+L+ + +I F ++ +
Sbjct: 136 LIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA----C 188
Query: 213 TMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ ++GTP Y+APE I+ D+++ G++ +L+ PF
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 63/243 (25%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +G G G V KA G+ +AVK + + S +EL D SE
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEF-------- 77
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL---------YDVSKGR 145
++ Q+ H +++ L + LL+ ++ K GSL+ L Y S G
Sbjct: 78 --NVL--KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 146 RELEWLSRH-----------KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
R L A ++ G++YL ++HRD+ N+L+ + + +
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMK 190
Query: 195 ISGFDLAILMPDGLT----QIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFG 243
IS F GL+ + D+ YV + P +++A E + T + D++SFG
Sbjct: 191 ISDF--------GLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTT--QSDVWSFG 239
Query: 244 VLL 246
VLL
Sbjct: 240 VLL 242
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 47/229 (20%), Positives = 89/229 (38%), Gaps = 42/229 (18%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ +G G G V + G+ A+K ++ SP + E+
Sbjct: 35 QVLGLGVNGKVLECFHR-RTGQKCALK-LLYDSPKARQEV-----------------DHH 75
Query: 100 TASQIRHRNILPLLA----HMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRREL-EWLS 152
+ +I+ +L L++ + M+ G L + +G + E +
Sbjct: 76 WQAS-GGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREA 130
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLT 209
I + + +++LH H+ + HRD+KP N+L + D +++ F A
Sbjct: 131 AE-IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185
Query: 210 QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
TP Y+APE + CD++S GV++ +L+ G PF
Sbjct: 186 ---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 52/231 (22%), Positives = 93/231 (40%), Gaps = 47/231 (20%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+E++G G VYK L G +A+K + + E
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEA-------- 63
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL------------YDVS 142
+ ++++H N++ LL + + +++ + +G L L D
Sbjct: 64 --MLR--ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
+ LE + +A+G+EYL HH V+H+D+ NVL+ D + +IS L
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 203 LMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL 246
+ D Y + P R++APE + +I DI+S+GV+L
Sbjct: 177 EVYAA----DY-YKLLGNSLLPIRWMAPEAIMYGKFSI--DSDIWSYGVVL 220
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 57/238 (23%), Positives = 92/238 (38%), Gaps = 53/238 (22%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +GSG G V A G + +AVK + ++E SEL ++
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSEL------KM 101
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL---------------- 138
+Q+ H NI+ LL L++++ G L L
Sbjct: 102 MTQLG-----SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 139 ---YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195
+ + L + A VA G+E+L +HRD+ NVL+ +I
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKI 213
Query: 196 SGFDLAILMPDGLTQIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFGVLL 246
F LA + D+ YVV P +++APE + TI K D++S+G+LL
Sbjct: 214 CDFGLARDIMS-----DSNYVVRGNARLPVKWMAPESLFEGIYTI--KSDVWSYGILL 264
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK-LT 92
F LEK+G+G VYK L + G +A+K+V + + EG T
Sbjct: 5 SQFKQLEKLGNGTYATVYKG-LNKTTGVYVALKEVKL--------------DSEEGTPST 49
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
IR +I +++H NI+ L + + LV++FM + L+ + + G
Sbjct: 50 AIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLEL 107
Query: 153 RH--KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ GL + H + +++HRD+KP N+LI+ + ++ F LA
Sbjct: 108 NLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 56/243 (23%), Positives = 93/243 (38%), Gaps = 63/243 (25%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ IG G G V++A PG M+AVK + + SA D E
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREA-------- 101
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVL---------------- 138
++ ++ + NI+ LL L++++M G L L
Sbjct: 102 --ALM--AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 139 ----YDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
S G L + IA VA+G+ YL +HRD+ N L+ ++M +
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 214
Query: 195 ISGFDLAILMPDGLT----QIDTMYVVGT----P-RYIAPE--YHQTLTISEKCDIYSFG 243
I+ F GL+ D Y P R++ PE ++ T + D++++G
Sbjct: 215 IADF--------GLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTT--ESDVWAYG 263
Query: 244 VLL 246
V+L
Sbjct: 264 VVL 266
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 62/248 (25%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
+ L+ +G GG G V+ A + K +A+KK+++ P S A E+ K+
Sbjct: 13 YMDLKPLGCGGNGLVFSA-VDNDCDKRVAIKKIVLTDPQSVKH---ALREI---KII--- 62
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHL---------------LVYDFMKNGSLQAVLYD 140
++ H NI+ + ++ P +V ++M + L +
Sbjct: 63 ------RRLDHDNIVKVF-EILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLAN 110
Query: 141 VSKGRRELEWLSRHKIALAV---ASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARIS 196
V + L L + GL+Y+H SA V+HRD+KPAN+ I+ +D+ +I
Sbjct: 111 VLEQGP----LLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163
Query: 197 GFDLA--ILMPDGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVL 249
F LA + + +V T Y +P + T I D+++ G + A +
Sbjct: 164 DFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEM 218
Query: 250 VMGK--FP 255
+ GK F
Sbjct: 219 LTGKTLFA 226
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 6e-15
Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 36/176 (20%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS-----PMSAAELIDAYSELGE 88
+ F +EKIG G G VYKA G+++A+KK+ + + P +A
Sbjct: 3 ENFQKVEKIGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVPSTA------------ 49
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
IR +I ++ H NI+ LL + + LV++F+ + L+ + +
Sbjct: 50 -----IR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTG--- 99
Query: 149 EWLSRHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ I + GL + H H RV+HRD+KP N+LI+ + +++ F LA
Sbjct: 100 --IPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 6e-15
Identities = 60/251 (23%), Positives = 99/251 (39%), Gaps = 62/251 (24%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT--E 93
F +G G G V A G+++A+KK I+ + + T E
Sbjct: 13 FQLKSLLGEGAYGVVCSA-THKPTGEIVAIKK------------IEPFDKPLFALRTLRE 59
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHL------LVYDFMKNGSLQAVLYDVSKGRRE 147
I+ +H NI+ + ++ RPDS ++ + M Q L+ V +
Sbjct: 60 IKIL----KHFKHENIITIF-NIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQM- 108
Query: 148 LEWLSR-HK--IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--- 201
LS H ++ LH + VIHRD+KP+N+LI+ + + ++ F LA
Sbjct: 109 ---LSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 202 ------ILMPDGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVLV 250
P G +V T Y APE + + D++S G +LA L
Sbjct: 163 DESAADNSEPTGQQSGMVEFVA-TRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELF 217
Query: 251 MGK--FPFDDF 259
+ + FP D+
Sbjct: 218 LRRPIFPGRDY 228
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-15
Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK-LT 92
+ LEKIG G G V+KA +++A+K+V + + EG +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKA-KNRETHEIVALKRV----RLDDDD---------EGVPSS 47
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+R +I +++H+NI+ L + LV++F L+ + L
Sbjct: 48 ALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD------LD 99
Query: 153 RHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+ + GL + H V+HRD+KP N+LI+ + E +++ F LA
Sbjct: 100 PEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 43/232 (18%), Positives = 89/232 (38%), Gaps = 47/232 (20%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ +G G G V + + + A+K ++ + E+ +
Sbjct: 68 QVLGLGINGKVLQIFNKRT-QEKFALK------------MLQDCPKARR----EVE---L 107
Query: 100 TASQIRHRNILPLLA----HMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGRR---ELEW 150
+ +I+ ++ L+V + + G L + +G + E E
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTERE- 162
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDG 207
+I ++ ++YLH + + HRD+KP N+L + +++ F A
Sbjct: 163 --ASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 208 LTQIDTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+++ TP Y+APE + CD++S GV++ +L+ G PF
Sbjct: 218 ----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 42/233 (18%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLT 92
+ + +L +G G G V K G+++A+KK + S+ + K
Sbjct: 25 EKYENLGLVGEGSYGMVMKCR-NKDTGRIVAIKKFLE-------------SDDDKMVKKI 70
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWL 151
+R +I Q+RH N++ LL + + LV++F+ + ++ L G L++
Sbjct: 71 AMR-EIKLLKQLRHENLVNLL-EVCKKKKRWYLVFEFVDH-TILDDLELFPNG---LDYQ 124
Query: 152 SRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI 211
K + +G+ + H H +IHRDIKP N+L+ ++ F A +
Sbjct: 125 VVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181
Query: 212 DTMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
V T Y APE Y + D+++ G L+ + MG+ FP
Sbjct: 182 -DDEVA-TRWYRAPELLVGDVKY------GKAVDVWAIGCLVTEMFMGEPLFP 226
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 37/176 (21%), Positives = 74/176 (42%), Gaps = 37/176 (21%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLT--E 93
+ IG+G G V +A +++A+KK++ + +L + K E
Sbjct: 55 YEIRHLIGTGSYGHVCEA-YDKLEKRVVAIKKIL-----------RVFEDLIDCKRILRE 102
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHL------LVYDFMKNGSLQAVLYDVSKGRRE 147
I +++ H +++ +L +V P +V + + + +
Sbjct: 103 IAIL----NRLNHDHVVKVL-DIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVY 152
Query: 148 LEWLSRHK--IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
L H + + G++Y+H SA ++HRD+KPAN L++ D ++ F LA
Sbjct: 153 LT--ELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 50/251 (19%), Positives = 95/251 (37%), Gaps = 41/251 (16%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAE--------------LID 81
++ + +G+G G V + S GK A+KKV+ E L+D
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIES-GKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 82 AYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHL-----LVYDFMKNGSLQA 136
+ G+ + + N + V + ++ +++ + +L
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126
Query: 137 VLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARI 195
VL + R + + + ++H S + HRDIKP N+L++ D ++
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKL 183
Query: 196 SGFDLA-ILMPDGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIYSFGVLLAVL 249
F A L+P + Y+ + Y APE T +I D++S G + L
Sbjct: 184 CDFGSAKKLIPS---EPSVAYIC-SRFYRAPELMLGATEYTPSI----DLWSIGCVFGEL 235
Query: 250 VMGK--FPFDD 258
++GK F +
Sbjct: 236 ILGKPLFSGET 246
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 52/238 (21%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG-KLT 92
+ + + KIG G G V+K G+++A+KK + SE K
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCR-NRDTGQIVAIKKFLE-------------SEDDPVIKKI 48
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWL 151
+R +I Q++H N++ LL + R L LV+++ + ++ L +G +
Sbjct: 49 ALR-EIRMLKQLKHPNLVNLL-EVFRRKRRLHLVFEYCDH-TVLHELDRYQRG------V 99
Query: 152 SRHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPD 206
H + + + H H IHRD+KP N+LI ++ F A + P
Sbjct: 100 PEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP- 155
Query: 207 GLTQIDTMYVVGTPRYIAPE-------YHQTLTISEKCDIYSFGVLLAVLVMGK--FP 255
+ V T Y +PE Y D+++ G + A L+ G +P
Sbjct: 156 --SDYYDDEVA-TRWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGVPLWP 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 5e-14
Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 38/176 (21%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS-----PMSAAELIDAYSELGE 88
+ + LEKIG G G VYKA+ + G+ A+KK+ + P +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTT------------ 47
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
IR +I +++H NI+ L + +LV++ + L+ +L G
Sbjct: 48 -----IR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG---- 96
Query: 149 EWLSRHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
L L + +G+ Y H RV+HRD+KP N+LI+ + E +I+ F LA
Sbjct: 97 --LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 29/178 (16%)
Query: 98 IITASQIRH----RNILPLLAHMVRP-----------DSHL-LVYDFMKNGSLQAVLYDV 141
I+ ++ H +L H P L V ++ G L + +
Sbjct: 186 IVAKDEVAHTLTENRVLQNSRH---PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHL 239
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
S+ R E +R A + S L+YLH + V++RD+K N+++D D +I+ F L
Sbjct: 240 SRERVFSEDRARFYGA-EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLC 296
Query: 202 ILMPDGLTQIDTMYVV-GTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+G+ TM GTP Y+APE + D + GV++ ++ G+ PF +
Sbjct: 297 ---KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 66/257 (25%), Positives = 106/257 (41%), Gaps = 52/257 (20%)
Query: 23 EKEDLAFLKKEDCFASL-EKIGSGGCGDVYKA-ELPGSNGKMIAVKKVIIYS-PMSAAEL 79
K + ED F K+G G G VYKA G + K A+K++ MSA
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--- 65
Query: 80 IDAYSELGEGKLTEIRSQIITASQIRHRNILPLL-AHMVRPDSHL-LVYDFMKNGSLQAV 137
R +I +++H N++ L + D + L++D+ ++ L +
Sbjct: 66 --------------CR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHI 109
Query: 138 L--YDVSKGRRELEWLSRHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192
+ + SK ++ L R + + G+ YLH + V+HRD+KPAN+L+ +
Sbjct: 110 IKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGP 166
Query: 193 AR----ISGFDLA---ILMPDGLTQIDTMYVVGTPRYIAPE-----YHQTLTISEKCDIY 240
R I+ A L +D VV T Y APE H T I DI+
Sbjct: 167 ERGRVKIADMGFARLFNSPLKPLADLDP--VVVTFWYRAPELLLGARHYTKAI----DIW 220
Query: 241 SFGVLLAVLVMGK--FP 255
+ G + A L+ + F
Sbjct: 221 AIGCIFAELLTSEPIFH 237
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 55/248 (22%), Positives = 92/248 (37%), Gaps = 62/248 (25%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYS--------PMSAAELIDAYSE 85
+ + +IG G G VYKA +G +A+K V + + P+S
Sbjct: 9 SRYEPVAEIGVGAYGTVYKA-RDPHSGHFVALKSVRVPNGGGGGGGLPIST--------- 58
Query: 86 LGEGKLTEIRSQIITASQIRHRNILPLL-----AHMVRPDSHLLVYDFMKNGSLQAVLYD 140
+ E+ + + H N++ L+ + R LV++ + L+ L
Sbjct: 59 -----VREV-ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK 111
Query: 141 VSKGRRELEWLSRHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISG 197
L I GL++LH + ++HRD+KP N+L+ +++
Sbjct: 112 APP-----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163
Query: 198 FDLA--ILMPDGLTQIDTMYVVGTPRYIAPE------YHQTLTISEKCDIYSFGVLLAVL 249
F LA LT VV T Y APE Y + D++S G + A +
Sbjct: 164 FGLARIYSYQMALTP-----VVVTLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEM 212
Query: 250 VMGK--FP 255
K F
Sbjct: 213 FRRKPLFC 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 46/204 (22%), Positives = 77/204 (37%), Gaps = 35/204 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
IG G G VY A + K +A+KK + +LID L E +
Sbjct: 31 KHLIGRGSYGYVYLAYDK-NTEKNVAIKK--VNRMFE--DLIDCKRILREITIL------ 79
Query: 99 ITASQIRHRNILPLLAHMVRPDSHL------LVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
++++ I+ L ++ PD L +V + + L + K L
Sbjct: 80 ---NRLKSDYIIRLY-DLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT--E 128
Query: 153 RHK--IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPDGL 208
H I + G ++H + +IHRD+KPAN L++ D ++ F LA I
Sbjct: 129 EHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLT 232
++ + P + LT
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLT 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-13
Identities = 37/165 (22%), Positives = 72/165 (43%), Gaps = 30/165 (18%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK-LT 92
D + + K+G G G+VYKA + +A+K++ + E EG T
Sbjct: 34 DRYRRITKLGEGTYGEVYKAI-DTVTNETVAIKRI----RLEHEE---------EGVPGT 79
Query: 93 EIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
IR ++ +++HRNI+ L + + L++++ + D+ K + +S
Sbjct: 80 AIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVS 130
Query: 153 RHKI---ALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
I + +G+ + H R +HRD+KP N+L+ +
Sbjct: 131 MRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASE 172
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVK---KVIIYSPMSAAELIDAYSELGEGK 90
F L +G G G V +E G+ ++ AVK K +++ ++ E
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT-DELYAVKILKK----------DVVIQDDDV-ECT 388
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
+ E R + A + + L + D V +++ G L +Y + + R E
Sbjct: 389 MVEKR---VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEP 442
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPDGL 208
+ A +A GL +L +I+RD+K NV++D + +I+ F + +
Sbjct: 443 HAVFYAA-EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
T+ T GTP YIAPE + D ++FGVLL ++ G+ PF+
Sbjct: 499 TK--TF--CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 25/176 (14%)
Query: 96 SQIITASQIRH----RNILPLLAH--MVR-------PDSHLLVYDFMKNGSLQAVLYDVS 142
+++ QI H + IL + +V+ + +V +++ G + + L
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---R 133
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
+ R E +R A + EYLH +I+RD+KP N+LID +++ F A
Sbjct: 134 RIGRFSEPHARFYAA-QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+ T + GTP +APE + ++ D ++ GVL+ + G PF
Sbjct: 190 RVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 70/256 (27%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK-LTEI 94
+ ++K+G G G V+K+ + G+++AVKK I+ DA E LTE+
Sbjct: 11 YELVKKLGKGAYGIVWKS-IDRRTGEVVAVKK--IFDAFQ--NSTDAQRTFREIMILTEL 65
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHL---LVYDFMKNGSLQAVLYDVSKGRRELEWL 151
H NI+ LL +++R D+ LV+D+M + L+ V + L
Sbjct: 66 SG---------HENIVNLL-NVLRADNDRDVYLVFDYM-----ETDLHAVIRANI----L 106
Query: 152 SR-HK--IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA------- 201
HK + + ++YLH S ++HRD+KP+N+L++ + +++ F L+
Sbjct: 107 EPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 202 -------------ILMPDGLTQIDTMYVVGTPRYIAPE-------YHQTLTISEKCDIYS 241
D I T YV T Y APE Y T I D++S
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVA-TRWYRAPEILLGSTKY--TKGI----DMWS 216
Query: 242 FGVLLAVLVMGK--FP 255
G +L ++ GK FP
Sbjct: 217 LGCILGEILCGKPIFP 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 8e-12
Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 35/181 (19%)
Query: 96 SQIITASQIRH----RNILPLLAH--MVR-------PDSHLLVYDFMKNGSLQAVLYDVS 142
++ Q+ H R +L ++ H ++R ++ D+++ G L ++L
Sbjct: 42 EIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---R 98
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
K +R +++ A V LEYLH +I+RD+KP N+L+D + +I+ F A
Sbjct: 99 KSQRFPNPVAKFYAA-EVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 154
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK-----CDIYSFGVLLAVLVMGKFPFD 257
+PD T + GTP YIAPE +S K D +SFG+L+ ++ G PF
Sbjct: 155 YVPDV-----TYTLCGTPDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204
Query: 258 D 258
D
Sbjct: 205 D 205
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 55/260 (21%), Positives = 98/260 (37%), Gaps = 64/260 (24%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGS--NGKMIAV----KKVIIYSPMSAAELIDAYSELG 87
+ F L+ +G+G G V+ GK+ A+ K I+ ++
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-----------QKAKTT 102
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRP-----------DSHL-LVYDFMKNGSLQ 135
E TE R +L + P ++ L L+ D++ G L
Sbjct: 103 EHTRTE-------------RQVLEHIRQ--SPFLVTLHYAFQTETKLHLILDYINGGEL- 146
Query: 136 AVLYDVSKGRRELEWLSRHKIALA-VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194
+S+ R E +I + + LE+LH +I+RDIK N+L+D +
Sbjct: 147 --FTHLSQRERFTE--HEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVV 199
Query: 195 ISGFDLA-ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK-----CDIYSFGVLLAV 248
++ F L+ + D + GT Y+AP+ + + D +S GVL+
Sbjct: 200 LTDFGLSKEFVADETERAYDF--CGTIEYMAPD---IVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 249 LVMGKFPFDDFFSHTGEMDM 268
L+ G PF + ++
Sbjct: 255 LLTGASPFTVDGEKNSQAEI 274
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 24/175 (13%)
Query: 98 IITASQIRH----RNILPLLAH--MVR------PDSHL-LVYDFMKNGSLQAVLYDVSKG 144
II ++ H +L H + L V ++ G L + +S+
Sbjct: 43 IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRE 99
Query: 145 RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILM 204
R E +R A + S LEYLH V++RDIK N+++D D +I+ F L
Sbjct: 100 RVFTEERARFYGA-EIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC--- 152
Query: 205 PDGLTQIDTMYVV-GTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+G++ TM GTP Y+APE + D + GV++ ++ G+ PF +
Sbjct: 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 52/230 (22%), Positives = 95/230 (41%), Gaps = 31/230 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVK----KVIIYSPMSAAELIDAYSELGEG 89
+ F + +G G G V+ AE + + A+K V++ ++ E
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVL-----------MDDDV-EC 63
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
+ E R + + H + + ++ V +++ G L +Y + +
Sbjct: 64 TMVEKR---VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDL 117
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDGL 208
+ A + GL++LH +++RD+K N+L+D D +I+ F + M
Sbjct: 118 SRATFYAA-EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
T GTP YIAPE + D +SFGVLL +++G+ PF
Sbjct: 174 K---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 14/142 (9%)
Query: 120 DSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA-VASGLEYLHMHHSARVIH 177
+ L L+ DF++ G L +SK E K LA +A L++LH +I+
Sbjct: 98 EGKLYLILDFLRGGDL---FTRLSKEVMFTE--EDVKFYLAELALALDHLHSLG---IIY 149
Query: 178 RDIKPANVLIDDDMEARISGFDLA-ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK 236
RD+KP N+L+D++ +++ F L+ + GT Y+APE ++
Sbjct: 150 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 237 CDIYSFGVLLAVLVMGKFPFDD 258
D +SFGVL+ ++ G PF
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQG 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 33/137 (24%), Positives = 60/137 (43%), Gaps = 13/137 (9%)
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA-VASGLEYLHMHHSARVIHRDIKP 182
L+ +++ G L + + +E LA ++ L +LH +I+RD+KP
Sbjct: 98 LILEYLSGGEL---FMQLEREGIFME--DTACFYLAEISMALGHLHQKG---IIYRDLKP 149
Query: 183 ANVLIDDDMEARISGFDLA-ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYS 241
N++++ +++ F L + DG T GT Y+APE + D +S
Sbjct: 150 ENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGTIEYMAPEILMRSGHNRAVDWWS 206
Query: 242 FGVLLAVLVMGKFPFDD 258
G L+ ++ G PF
Sbjct: 207 LGALMYDMLTGAPPFTG 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 120 DSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA-VASGLEYLHMHHSARVIH 177
L V D++ G L Y + + R LE R + A +AS L YLH + +++
Sbjct: 111 ADKLYFVLDYINGGEL---FYHLQRERCFLE--PRARFYAAEIASALGYLHSLN---IVY 162
Query: 178 RDIKPANVLIDDDMEARISGFDLA--ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISE 235
RD+KP N+L+D ++ F L + + T T GTP Y+APE
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS--TF--CGTPEYLAPEVLHKQPYDR 218
Query: 236 KCDIYSFGVLLAVLVMGKFPFDD 258
D + G +L ++ G PF
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYS 241
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 31/230 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVK---KVIIYSPMSAAELIDAYSELGEGK 90
D F + +G G G V A + + G + AVK K ++I ++ E
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKET-GDLYAVKVLKK----------DVILQDDDV-ECT 70
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
+TE R I + H + L PD V +F+ G L ++ + K RR E
Sbjct: 71 MTEKR---ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEA 124
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPDGL 208
+R A + S L +LH +I+RD+K NVL+D + +++ F + +
Sbjct: 125 RARFYAA-EIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
T T GTP YIAPE Q + D ++ GVLL ++ G PF+
Sbjct: 181 TA--TF--CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVK---KVIIYSPMSAAELIDAYSELGEGK 90
F L +G G G V +E G+ ++ AVK K +++ ++ E
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGT-DELYAVKILKK----------DVVIQDDDV-ECT 67
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
+ E R + A + + L + D V +++ G L +Y + + R E
Sbjct: 68 MVEKR---VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEP 121
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA--ILMPDGL 208
+ A +A GL +L +I+RD+K NV++D + +I+ F + +
Sbjct: 122 HAVFYAA-EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
T+ T GTP YIAPE + D ++FGVLL ++ G+ PF+
Sbjct: 178 TK--TF--CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 17/150 (11%)
Query: 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRH---KIALAVASGLEYLHMHH 171
+ F++ SL V + + ++L+ + VA G+E+L
Sbjct: 154 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 210
Query: 172 SARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGT----P-RYIAPE 226
S + IHRD+ N+L+ + +I F LA + D YV P +++APE
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-----DPDYVRKGDARLPLKWMAPE 265
Query: 227 YHQTLTISEKCDIYSFGVLL-AVLVMGKFP 255
+ + D++SFGVLL + +G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 41/141 (29%), Positives = 70/141 (49%), Gaps = 14/141 (9%)
Query: 120 DSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178
+S L V +++ G L ++ + + R+ E +R A ++ L YLH +I+R
Sbjct: 82 ESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLALNYLHERG---IIYR 134
Query: 179 DIKPANVLIDDDMEARISGFDLA--ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK 236
D+K NVL+D + +++ + + L P T T GTP YIAPE +
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--TF--CGTPNYIAPEILRGEDYGFS 190
Query: 237 CDIYSFGVLLAVLVMGKFPFD 257
D ++ GVL+ ++ G+ PFD
Sbjct: 191 VDWWALGVLMFEMMAGRSPFD 211
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 3e-10
Identities = 37/259 (14%), Positives = 66/259 (25%), Gaps = 44/259 (16%)
Query: 23 EKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDA 82
+ + EKIG G G+V++ + +A+K + I P
Sbjct: 9 GPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 83 YSE--LGEGKLTEIRSQIITASQIRHRNILPLLAHMV----RPDSHLLVYDFM--KNGSL 134
E L E +++ S + R + L + P L +D GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 135 QAVLYDVSK-------------------GRRELEWLSRHKIALAVASGLEYLHMHHSARV 175
+ + I + + L S R
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL--AVAEASLRF 183
Query: 176 IHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT---------MYVVGTPRYIAPE 226
HRD+ NVL+ ++ + + G +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 227 YHQTL---TISEKCDIYSF 242
+ L + DIY
Sbjct: 244 MDEDLFTGDGDYQFDIYRL 262
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 41/141 (29%), Positives = 70/141 (49%), Gaps = 14/141 (9%)
Query: 120 DSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178
+S L V +++ G L ++ + + R+ E +R A ++ L YLH +I+R
Sbjct: 125 ESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLALNYLHERG---IIYR 177
Query: 179 DIKPANVLIDDDMEARISGFDLA--ILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK 236
D+K NVL+D + +++ + + L P T T GTP YIAPE +
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--TF--CGTPNYIAPEILRGEDYGFS 233
Query: 237 CDIYSFGVLLAVLVMGKFPFD 257
D ++ GVL+ ++ G+ PFD
Sbjct: 234 VDWWALGVLMFEMMAGRSPFD 254
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 43/240 (17%), Positives = 79/240 (32%), Gaps = 44/240 (18%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
IG GG G +Y A++ S V+ P L E + I
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 100 TASQIRHRNILPLL----AHMVRPDSH-LLVYD---------FMKNG---SLQAVLYDVS 142
++++ + P H S+ ++ D + N S + VL
Sbjct: 101 RTRKLKYLGV-PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL---- 155
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI--SGFDL 200
+++L + LEY+H H +H DIK +N+L++ ++ + L
Sbjct: 156 ------------QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGL 200
Query: 201 AILMPDGLTQIDTMY-----VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
A GT + + + H + S + D+ G + + G P
Sbjct: 201 AYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 56/258 (21%), Positives = 99/258 (38%), Gaps = 52/258 (20%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR--- 95
+ K+G G V+ A N +A+K I+ Y+E EI+
Sbjct: 24 VRKLGWGHFSTVWLA-KDMVNNTHVAMK--IVRG-------DKVYTEAA---EDEIKLLQ 70
Query: 96 ----SQIITASQIRHRNILPLL---AHMVRPDSHL-LVYDFM-KNGSLQAVLYDVSKGRR 146
+ + +IL LL H H+ +V++ + +N L + K
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN------LLALIKKYE 124
Query: 147 E----LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD------DMEARIS 196
L ++ +I+ + GL+Y+H +IH DIKP NVL++ ++ +I+
Sbjct: 125 HRGIPLIYV--KQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIA 180
Query: 197 GFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK--F 254
A + T + T Y +PE DI+S L+ L+ G F
Sbjct: 181 DLGNACWYDEHYTN----SIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235
Query: 255 PFDDFFSHTGEMDMVRWM 272
D+ S+T + D + +
Sbjct: 236 EPDEGHSYTKDDDHIAQI 253
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 47/274 (17%), Positives = 92/274 (33%), Gaps = 50/274 (18%)
Query: 7 RGGSRDRGLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVK 66
+ P E + L ++ + +KIGSGG G +Y A P + + A
Sbjct: 11 VDLGTENLYFQSMPFPEGKVLDDMEGNQ-WVLGKKIGSGGFGLIYLAF-PTNKPEKDARH 68
Query: 67 KVIIYSPMSAAELIDA---YSELGEGKLTEIRSQIITASQIRHRNILPLL---AHMVRPD 120
V + L Y + + + + I Q+ + I +
Sbjct: 69 VVKV-EYQENGPLFSELKFYQRVAKK---DCIKKWIERKQLDYLGIPLFYGSGLTEFKGR 124
Query: 121 SH-LLVYD---------FMKNG--SLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLH 168
S+ +V + +NG VL ++ + + LEY+H
Sbjct: 125 SYRFMVMERLGIDLQKISGQNGTFKKSTVL----------------QLGIRMLDVLEYIH 168
Query: 169 MHHSARVIHRDIKPANVLIDDDMEARI--SGFDLAILMPDGLTQIDTMY-----VVGTPR 221
+ +H DIK AN+L+ ++ + + L+ GT
Sbjct: 169 ENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIE 225
Query: 222 YIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
+ + + H+ + +S + D+ G + + GK P
Sbjct: 226 FTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 51/250 (20%), Positives = 91/250 (36%), Gaps = 56/250 (22%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR--S 96
L+ IG G G V KA + +A+K ++ + + EIR
Sbjct: 102 LKVIGKGSFGQVVKA-YDHKVHQHVALK--MVRN-------EKRFHRQA---AEEIRILE 148
Query: 97 QIITASQIRHRNILPLLAH-MVRPDSHL-LV--------YDFMKNGSLQAVLYDVSKGRR 146
+ + N++ +L + R +H+ + Y+ +K Q + +
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFR--NHICMTFELLSMNLYELIKKNKFQGFSLPLVR--- 203
Query: 147 ELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI--DDDMEARISGFDLAILM 204
K A ++ L+ LH R+IH D+KP N+L+ ++ F +
Sbjct: 204 --------KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252
Query: 205 PDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDDFFSH 262
+ Y+ + Y APE D++S G +LA L+ G P +D
Sbjct: 253 HQRVYT----YIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED---- 303
Query: 263 TGEMDMVRWM 272
E D + M
Sbjct: 304 --EGDQLACM 311
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 54/231 (23%), Positives = 82/231 (35%), Gaps = 46/231 (19%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAEL-IDAYSELGEGKLTEIRSQI 98
KIGSG GD+Y + G+ +A+K + + + Y + G I
Sbjct: 15 RKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGI---PTI 70
Query: 99 ITASQIRHRNIL------PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
N++ P L + S SL+ VL
Sbjct: 71 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF--------SLKTVL-------------- 108
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA---RISGFDLAILMPDGLT 209
+A + S +EY+H + IHRD+KP N L+ + I F LA D T
Sbjct: 109 --LLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
Query: 210 QIDTMY-----VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
Y + GT RY + H + S + D+ S G +L +G P
Sbjct: 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 39/233 (16%), Positives = 78/233 (33%), Gaps = 30/233 (12%)
Query: 40 EKIGSGGCGDVYKAE--LPGSNGKMIAVKKVII-YSPMSAAELIDAYSELGEGKLTEIRS 96
G +Y+A + +K + + K ++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN- 106
Query: 97 QIITASQIRHRNILPLLAHMVRPDSH-LLVYDFMKNG-SLQAVLYDVSKGRRELEWLSRH 154
+ I + V D + LV + G SLQ+ L K LS
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHV-----LSER 159
Query: 155 ---KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI--SGFDLAILMPDGLT 209
++A + LE+LH + +H ++ N+ +D + ++++ +G+ A
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 210 QIDTMYV-------VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
+ YV G +I+ + H+ S + D+ S G + + G P
Sbjct: 217 HVA--YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 55/249 (22%), Positives = 95/249 (38%), Gaps = 42/249 (16%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
D + IG G G V KA + +A+K II + A+ E
Sbjct: 54 DRYEIDSLIGKGSFGQVVKA-YDRVEQEWVAIK--IIKN-------KKAFLNQA---QIE 100
Query: 94 IR--SQIITASQIRHRNILPLLAH-MVRPDSHL-LVYDFMKNGSLQAVLYDVSK--GRRE 147
+R + I+ L H M R +HL LV++ L LYD+ + R
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFR--NHLCLVFE-----MLSYNLYDLLRNTNFRG 153
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL--AILMP 205
+ K A + + L +L +IH D+KP N+L+ + + I D + +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212
Query: 206 DGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDDFFSHT 263
+ Q Y+ + Y +PE + D++S G +L + G+ F +
Sbjct: 213 QRIYQ----YIQ-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN----- 262
Query: 264 GEMDMVRWM 272
E+D + +
Sbjct: 263 -EVDQMNKI 270
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 37/233 (15%), Positives = 77/233 (33%), Gaps = 70/233 (30%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ +G G G V + + A+K + + E+ +
Sbjct: 24 QVLGLGINGKVLQIFNK-RTQEKFALKM------------LQDCPKARR----EVE---L 63
Query: 100 TASQIRHRNILPLLA----HMVRPDSHLLVYDFMKNGSLQAVLYD--VSKGR-----REL 148
+ +I+ ++ L+V + + G L + +G RE
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREA 119
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMP 205
+ + + ++YLH + + HRD+KP N+L + +++ F A
Sbjct: 120 SEIMKS-----IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA---- 167
Query: 206 DGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
+Y + CD++S GV++ +L+ G PF
Sbjct: 168 --------------KETTGEKY------DKSCDMWSLGVIMYILLCGYPPFYS 200
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 53/231 (22%), Positives = 79/231 (34%), Gaps = 46/231 (19%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAEL-IDAYSELGEGKLTEIRSQI 98
KIGSG G++Y + +A+K + + Y L G +
Sbjct: 13 RKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGI---PNV 68
Query: 99 ITASQIRHRNIL------PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
N+L P L + S L SL+ VL
Sbjct: 69 RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKL--------SLKTVL-------------- 106
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR---ISGFDLAILMPDGLT 209
+A + + +E++H +HRDIKP N L+ A I F LA D T
Sbjct: 107 --MLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
Query: 210 QIDTMY-----VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
Y + GT RY + H + S + D+ S G +L + G P
Sbjct: 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 42/230 (18%), Positives = 76/230 (33%), Gaps = 42/230 (18%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAEL-IDAYSELGEGKLTEIRSQI 98
+IG G G +++ N + +A+K S Y L +
Sbjct: 16 RRIGEGSFGVIFEGT-NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGI---PNV 71
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNG---SLQAVLYDVSKGRRELEWLSRHK 155
Q N+L + ++ P L G S++ V
Sbjct: 72 YYFGQEGLHNVLVI--DLLGPS---LEDLLDLCGRKFSVKTVA----------------M 110
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR-----ISGFDLAILMPDGLTQ 210
A + + ++ +H +++RDIKP N LI + F + D +T+
Sbjct: 111 AAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
Query: 211 IDTMY-----VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255
Y + GT RY++ H S + D+ + G + + G P
Sbjct: 168 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 57/315 (18%), Positives = 98/315 (31%), Gaps = 82/315 (26%)
Query: 17 IFSPLIEKEDLAFLKKE--------DCFAS----LEKIGSGGCGDVYKAELPGSNGKMIA 64
+ S E+ED K D F + K+G G V+ + K +A
Sbjct: 8 LGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSW-DIQGKKFVA 66
Query: 65 VKKVIIYSPMSAAELIDAYSELGEGKLTEIR-SQIITASQIRHRN---ILPLLAH--MVR 118
+K V+ + E L EIR + + S N ++ LL +
Sbjct: 67 MK-VVK-----------SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114
Query: 119 PD-SHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVI 176
+ +H+ +V++ + + L + S + + I V GL+YLH R+I
Sbjct: 115 VNGTHICMVFEVLGH-HLLKWI-IKSNYQGLPLPCVKK-IIQQVLQGLDYLHTK--CRII 169
Query: 177 HRDIKPANVLID-DDMEARISGFDLAILMPDGLTQIDTMYV------------------- 216
H DIKP N+L+ ++ R + G V
Sbjct: 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229
Query: 217 ------------------------VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMG 252
+ T +Y + E + DI+S + L G
Sbjct: 230 AEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289
Query: 253 KFPFDDFFSHTGEMD 267
+ F+ D
Sbjct: 290 DYLFEPHSGEEYTRD 304
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 57/274 (20%), Positives = 95/274 (34%), Gaps = 86/274 (31%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR--S 96
++ +G G G V + + G+ +AVK I+ + +D Y E +EI+
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVK--IVKN-------VDRYCEAA---RSEIQVLE 66
Query: 97 QIITASQIRHRNILPLLAH--------MVRPDSHLL---VYDFMK-NG----SLQAVLYD 140
+ T + +L +V LL YDF+K NG L +
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIV---FELLGLSTYDFIKENGFLPFRLDHI--- 120
Query: 141 VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD----MEARIS 196
K+A + + +L HS ++ H D+KP N+L
Sbjct: 121 -------------RKMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 197 GFDLAILMPDGLTQID---------TMY-VVGTPRYIAPE------YHQTLTISEKCDIY 240
D L+ + +D +V T Y APE + S+ CD++
Sbjct: 165 KRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVW 218
Query: 241 SFGVLLAVLVMGK--FPFDDFFSHTGEMDMVRWM 272
S G +L +G FP D + + M
Sbjct: 219 SIGCILIEYYLGFTVFPTHD------SKEHLAMM 246
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 44/268 (16%), Positives = 78/268 (29%), Gaps = 74/268 (27%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR--S 96
+ +G G G V + +A+K II + + Y E EI
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALK--IIRN-------VGKYREAA---RLEINVLK 71
Query: 97 QIITASQIRHRNILPLLAH-MVRPDSHL-LV--------YDFMKNG-----SLQAVLYDV 141
+I + + + H+ + ++F+K L V
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFH--GHMCIAFELLGKNTFEFLKENNFQPYPLPHV---- 125
Query: 142 SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA 201
+A + L +L H ++ H D+KP N+L + + +
Sbjct: 126 ------------RHMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKS 170
Query: 202 ILMPDGLTQ----ID-----------TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLL 246
D T V T Y PE L ++ CD++S G +L
Sbjct: 171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCIL 229
Query: 247 AVLVMGK--FPFDDFFSHTGEMDMVRWM 272
G F + + + M
Sbjct: 230 FEYYRGFTLFQTHE------NREHLVMM 251
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 30/182 (16%), Positives = 54/182 (29%), Gaps = 66/182 (36%)
Query: 125 VYDFMKNG-----SLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179
+Y+ + ++ + + + L YL + H D
Sbjct: 122 LYEIITRNNYNGFHIEDI----------------KLYCIEILKALNYLR---KMSLTHTD 162
Query: 180 IKPANVLIDDDMEARISGFDLAILMPDGLTQ----------ID-----------TMYVVG 218
+KP N+L+DD + + + ID +
Sbjct: 163 LKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIIN- 221
Query: 219 TPRYIAPE------YHQTLTISEKCDIYSFGVLLAVLVMGK--FPFDDFFSHTGEMDMVR 270
T +Y APE + D++SFG +LA L G F + M+ +
Sbjct: 222 TRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTGSLLFRTHE------HMEHLA 269
Query: 271 WM 272
M
Sbjct: 270 MM 271
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.13 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.52 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.46 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.45 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.32 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.87 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.14 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.99 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-59 Score=397.43 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=211.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|+ +..+++.||+|++.. ...........+.+|+.++++++||||++
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~-~~~~~~~~AiK~i~k------------~~~~~~~~~~~~~~E~~il~~l~HpnIv~ 96 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLAR-ELATSREYAIKILEK------------RHIIKENKVPYVTRERDVMSRLDHPFFVK 96 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHTTCCCTTBCC
T ss_pred CccccEEEEEEecccCeEEEEEE-ECCCCCEEEEEEEEH------------HHCCCHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34679999999999999999995 667899999999831 11223345678999999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+++..|+||||++||+|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++
T Consensus 97 l~~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g 169 (311)
T 4aw0_A 97 LYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDM 169 (311)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTS
T ss_pred EEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCC
Confidence 99999999999999999999999999943 456999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.+||+|||+|..+............+||+.|+|||++.+..|+.++|||||||++|+|++|..||... .. ...
T Consensus 170 ~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~---~~~ 242 (311)
T 4aw0_A 170 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NE---GLI 242 (311)
T ss_dssp CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SH---HHH
T ss_pred CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CH---HHH
Confidence 99999999999876554444444579999999999999999999999999999999999999999652 12 222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
...+...... ++.. .+..+.+||.+||+.||++|||++|++
T Consensus 243 ~~~i~~~~~~---~p~~--------~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 243 FAKIIKLEYD---FPEK--------FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHTCCC---CCTT--------CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHcCCCC---CCcc--------cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 3333333221 1111 122389999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-59 Score=403.16 Aligned_cols=254 Identities=20% Similarity=0.338 Sum_probs=203.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|++++.||+|+||+||+|+ +..+++.||||++.... ......+.+.+|+.++++++||||+++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~-~~~~~~~vAiK~i~~~~-------------~~~~~~~~~~~E~~il~~l~HpnIV~~ 88 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVK-STEDGRQYVIKEINISR-------------MSSKEREESRREVAVLANMKHPNIVQY 88 (350)
T ss_dssp CCCEEEEEEC------CEEEEE-ETTTCCEEEEEEEECTT-------------SCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceEEeEEEecCCCeEEEEEE-ECCCCCEEEEEEEehHH-------------CCHHHHHHHHHHHHHHHHCCCCCCCcE
Confidence 3689999999999999999995 56788999999984321 223346678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..|+|||||+||+|.+++.. .....+++..+..++.|++.||.||| ++||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~ 163 (350)
T 4b9d_A 89 RESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGT 163 (350)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCC
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCC
Confidence 9999999999999999999999999954 23445788899999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||... +.....
T Consensus 164 vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~ 234 (350)
T 4b9d_A 164 VQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-------SMKNLV 234 (350)
T ss_dssp EEECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHH
T ss_pred EEEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-------CHHHHH
Confidence 99999999987643221 122358999999999999999999999999999999999999999652 122333
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+.....+..+ . ..+..+.+||.+||+.||++|||++|+++
T Consensus 235 ~~i~~~~~~~~~--~--------~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 235 LKIISGSFPPVS--L--------HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHTCCCCCC--T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCCCC--c--------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 344443332211 1 11233899999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=398.75 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=206.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.|+++++||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+++.++||||++++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~-~~~tg~~vAiK~i~~~---------------~~~~~~~~~~Ei~il~~l~HpnIV~l~ 137 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIAT-VRSSGKLVAVKKMDLR---------------KQQRRELLFNEVVIMRDYQHENVVEMY 137 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEGG---------------GCSSGGGGHHHHHHHHHCCCTTBCCEE
T ss_pred HhcEEeEEeecCcCeEEEEEE-ECCCCCEEEEEEEecC---------------chhHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 569999999999999999995 5678999999998422 122344578999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+++.+|+|||||+||+|.+++. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++.+
T Consensus 138 ~~~~~~~~~~ivmEy~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~v 209 (346)
T 4fih_A 138 NSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRV 209 (346)
T ss_dssp EEEEETTEEEEEECCCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCE
Confidence 99999999999999999999999983 245999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
||+|||++......... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+. ... ....
T Consensus 210 Kl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~---~~~~ 280 (346)
T 4fih_A 210 KLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPL---KAMK 280 (346)
T ss_dssp EECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHH---HHHH
T ss_pred EEecCcCceecCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHH---HHHH
Confidence 99999999877554322 22368999999999999999999999999999999999999999652 222 2223
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.....+..... ...+..+.+||.+||+.||++|||++|+++
T Consensus 281 ~i~~~~~~~~~~~--------~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 281 MIRDNLPPRLKNL--------HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHSSCCCCSCG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHcCCCCCCCcc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3333222211111 112234899999999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-58 Score=391.08 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=205.2
Q ss_pred cCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
++|.+.+.||+|+||+||+|++.. .++..||||.+.. ......+.+.+|+.++++++||||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---------------~~~~~~~~f~~E~~il~~l~HpnI 77 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---------------ASDNARKDFHREAELLTNLQHEHI 77 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS---------------CCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC---------------CChHHHHHHHHHHHHHHhCCCCCC
Confidence 578999999999999999998642 3578899999832 122345678999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhc---------ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS---------KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDI 180 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl 180 (325)
|++++++.+.+..|+||||+++|+|.+++.... .....+++..+..++.|++.||.||| +++|+||||
T Consensus 78 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDl 154 (299)
T 4asz_A 78 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDL 154 (299)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCcc
Confidence 999999999999999999999999999996532 22456899999999999999999999 789999999
Q ss_pred CCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCc
Q 040480 181 KPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDF 259 (325)
Q Consensus 181 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~ 259 (325)
||+|||+++++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 155 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 155 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999986654433333333578999999999999999999999999999999998 89999753
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ..++ ...+..+.....+ . .++..+.+|+.+||+.||++|||+++|++
T Consensus 235 ~----~~~~---~~~i~~~~~~~~p--~--------~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 235 S----NNEV---IECITQGRVLQRP--R--------TCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp C----HHHH---HHHHHHTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----HHHH---HHHHHcCCCCCCC--c--------cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 2222 3333333322211 1 12234899999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=381.58 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=191.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|+ +..+++.||+|.+.... .........+.+|+.+++.++||||+++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~-~~~~~~~vAiK~i~~~~------------~~~~~~~~~~~~Ei~il~~l~HpnIv~~ 78 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAY-HTTTGQKVALKIINKKV------------LAKSDMQGRIEREISYLRLLRHPHIIKL 78 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEE-CTTTCCEEEEEEEECC------------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred eeCeEEEEEEecCcCeEEEEEE-ECCCCCEEEEEEEeHHH------------cCCHHHHHHHHHHHHHHHHCCCCCCCeE
Confidence 4789999999999999999995 66788999999984221 1112345678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..|+||||+ +|+|.+++. ....+++..+..++.|++.||.||| ++||+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~~ivmEy~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~ 150 (275)
T 3hyh_A 79 YDVIKSKDEIIMVIEYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLN 150 (275)
T ss_dssp EEEEECSSEEEEEEECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCC
T ss_pred EEEEEECCEEEEEEeCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCC
Confidence 99999999999999999 569999984 3456999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
+||+|||+|......... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+. . ....
T Consensus 151 vkl~DFGla~~~~~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~----~---~~~~ 220 (275)
T 3hyh_A 151 VKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----S---IPVL 220 (275)
T ss_dssp EEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----S---HHHH
T ss_pred EEEeecCCCeecCCCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC----C---HHHH
Confidence 999999999866543322 23589999999999998876 57999999999999999999999652 1 2222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+....... +.. .+..+.+||.+||+.||++|||++|+++
T Consensus 221 ~~~i~~~~~~~---p~~--------~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 221 FKNISNGVYTL---PKF--------LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHHTCCCC---CTT--------SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCC---CCC--------CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 33333332221 111 1223899999999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=400.02 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=206.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.+.|+++++||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~-~~~tg~~vAiK~i~~~---------------~~~~~~~~~~Ei~il~~l~HpnIV~l 213 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIAT-VRSSGKLVAVKKMDLR---------------KQQRRELLFNEVVIMRDYQHENVVEM 213 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEST---------------TCSSGGGHHHHHHHHHHCCCTTBCCE
T ss_pred hHhcEeeeEeccCcCcEEEEEE-ECCCCCEEEEEEEecc---------------chhHHHHHHHHHHHHHhCCCCCCCce
Confidence 3579999999999999999995 5678899999998432 12234567899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+.+|+|||||+||+|.+++. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++.
T Consensus 214 ~~~~~~~~~~~iVmEy~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~ 285 (423)
T 4fie_A 214 YNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGR 285 (423)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCC
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCC
Confidence 999999999999999999999999983 245999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+||+|||++......... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+. ... ...
T Consensus 286 vKl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~---~~~ 356 (423)
T 4fie_A 286 VKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPL---KAM 356 (423)
T ss_dssp EEECCCTTCEECCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHH---HHH
T ss_pred EEEecCccceECCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHH---HHH
Confidence 999999999877544322 22368999999999999999999999999999999999999999652 222 222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+.....+...... ..+..+.+||.+||+.||++|||++|+|+
T Consensus 357 ~~i~~~~~~~~~~~~--------~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 357 KMIRDNLPPRLKNLH--------KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHSCCCCCSCTT--------SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCCCCCcccc--------cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 333322222111111 11233899999999999999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-57 Score=381.25 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=198.6
Q ss_pred cCc-ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 34 DCF-ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 34 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
++| ++.++||+|+||+||+|. +..++..||+|.+... .......+.+.+|+.++++++|||||++
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~-~~~~~~~vAiK~i~~~-------------~~~~~~~~~~~~E~~il~~l~HpnIV~~ 90 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGL-DTETTVEVAWCELQDR-------------KLTKSERQRFKEEAEMLKGLQHPNIVRF 90 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEGG-------------GSCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CceEEeeeEEecCcCcEEEEEE-ECCCCeEEEEEEEchh-------------hCCHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 455 778889999999999995 5678899999998421 2233445678999999999999999999
Q ss_pred ccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceE
Q 040480 113 LAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR--VIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~--ivH~dl~~~nil 186 (325)
++++.+ ++..|+||||++||+|.+++.. ...+++..+..++.|++.||.||| +++ |+||||||+|||
T Consensus 91 ~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NIL 163 (290)
T 3fpq_A 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp EEEEEEEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEE
T ss_pred EEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhhee
Confidence 998865 3458999999999999999943 456899999999999999999999 767 999999999999
Q ss_pred ec-CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 187 ID-DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 187 ~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
++ .++.+||+|||+|....... ....+||+.|+|||++.+ +|+.++|||||||++|+|++|+.||.+..
T Consensus 164 l~~~~g~vKl~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----- 233 (290)
T 3fpq_A 164 ITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----- 233 (290)
T ss_dssp ESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----
T ss_pred EECCCCCEEEEeCcCCEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----
Confidence 97 47899999999997543322 223589999999999876 69999999999999999999999996421
Q ss_pred chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+.....+ ...+. .. +..+.+||.+||+.||++|||++|+++
T Consensus 234 -~~~~~~~~i~~~~~~-~~~~~----~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 234 -NAAQIYRRVTSGVKP-ASFDK----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -SHHHHHHHHTTTCCC-GGGGG----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cHHHHHHHHHcCCCC-CCCCc----cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122222333332222 11111 11 123889999999999999999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-57 Score=390.47 Aligned_cols=257 Identities=20% Similarity=0.306 Sum_probs=199.3
Q ss_pred hcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
.+++.+.++||+|+||+||+|++.. .++..||||++.. ......+.+.+|+.++++++|||
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---------------~~~~~~~~f~~E~~il~~l~Hpn 104 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---------------ASESARQDFQREAELLTMLQHQH 104 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC---------------CSHHHHHHHHHHHHHHTTCCCTT
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc---------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence 3578889999999999999998642 3578899999831 22334567999999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcc-----------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK-----------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIH 177 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH 177 (325)
||++++++.+.+..|+||||+++|+|.+++..... ....+++..+..++.|++.||.||| +++|+|
T Consensus 105 IV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiH 181 (329)
T 4aoj_A 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVH 181 (329)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred CCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeec
Confidence 99999999999999999999999999999965321 2346899999999999999999999 789999
Q ss_pred cCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 040480 178 RDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256 (325)
Q Consensus 178 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~ 256 (325)
|||||+|||+++++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 182 RDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf 261 (329)
T 4aoj_A 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261 (329)
T ss_dssp SCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCC
Confidence 99999999999999999999999987655443333334579999999999999999999999999999999999 89999
Q ss_pred CCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 257 DDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... ..++. ..+..+.....+ . .++..+.+|+.+||+.||++|||++||++
T Consensus 262 ~~~~----~~~~~---~~i~~g~~~~~p--~--------~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 262 YQLS----NTEAI---DCITQGRELERP--R--------ACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp CSSC----HHHHH---HHHHHTCCCCCC--T--------TCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred CCCC----HHHHH---HHHHcCCCCCCc--c--------cccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 7532 22222 333333322211 1 12233899999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-58 Score=394.83 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=201.0
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
+....+.|++.++||+|+||+||+|+ +..+++.||||++... ....+|+.+++.++|||
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~-~~~~g~~vAiK~i~~~--------------------~~~~~E~~il~~l~Hpn 111 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMK-DKQTGFQCAVKKVRLE--------------------VFRVEELVACAGLSSPR 111 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEETT--------------------TCCTHHHHTTTTCCCTT
T ss_pred hhcchhheEeCcEeccCCCeEEEEEE-ECCCCCEEEEEEECHH--------------------HhHHHHHHHHHhCCCCC
Confidence 33345678999999999999999995 5678899999998321 01246899999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
||++++++.+++.+|+||||++||+|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+|||++
T Consensus 112 IV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~ 184 (336)
T 4g3f_A 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLS 184 (336)
T ss_dssp BCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEC
T ss_pred CCcEEEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEe
Confidence 99999999999999999999999999999943 356999999999999999999999 88999999999999999
Q ss_pred CCC-CceeeccccceecCCCCccc---cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 189 DDM-EARISGFDLAILMPDGLTQI---DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 189 ~~~-~~~l~dfg~~~~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
.++ .+||+|||++.......... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......
T Consensus 185 ~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~- 263 (336)
T 4g3f_A 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP- 263 (336)
T ss_dssp TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-
T ss_pred CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-
Confidence 887 69999999998775433221 1223579999999999999999999999999999999999999997643321
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+. ..+.....+...+++ ..+..+.+||.+||+.||.+|||+.|+++
T Consensus 264 ---~~---~~i~~~~~~~~~~~~--------~~s~~~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 264 ---LC---LKIASEPPPIREIPP--------SCAPLTAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp ---CH---HHHHHSCCGGGGSCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HH---HHHHcCCCCchhcCc--------cCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 11 112222221111111 12233899999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=388.49 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=206.1
Q ss_pred cCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
+++++.++||+|+||+||+|++. ..+++.||||.+... ......+.+.+|+.++++++||||
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~--------------~~~~~~~~f~~E~~il~~l~HpNI 91 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--------------AEGPLREEFRHEAMLRARLQHPNV 91 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC---------------CCC-CHHHHHHHHHHHHHCCCTTB
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc--------------cChHHHHHHHHHHHHHHhCCCCCC
Confidence 56888999999999999999863 346688999998321 122345679999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIH 177 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH 177 (325)
+++++++.+++..++||||+++|+|.+++..... ....+++..+..++.|++.||+||| +++|+|
T Consensus 92 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiH 168 (308)
T 4gt4_A 92 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVH 168 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred CCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCC
Confidence 9999999999999999999999999999954221 1346889999999999999999999 789999
Q ss_pred cCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 040480 178 RDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPF 256 (325)
Q Consensus 178 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~ 256 (325)
|||||+|||+++++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||
T Consensus 169 RDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf 248 (308)
T 4gt4_A 169 KDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248 (308)
T ss_dssp SCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654433333334578999999999999999999999999999999998 89999
Q ss_pred CCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 257 DDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.. ..++. ..+..+...+. + .+++..+.+|+.+||+.||++|||+.||++
T Consensus 249 ~~~~----~~~~~---~~i~~~~~~~~--p--------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 249 CGYS----NQDVV---EMIRNRQVLPC--P--------DDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp TTCC----HHHHH---HHHHTTCCCCC--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC----HHHHH---HHHHcCCCCCC--c--------ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7532 22333 33333332221 1 112334899999999999999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=381.70 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=196.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..+++++.++||+|+||+||+|++. ..||||.+.... ......+.+.+|+.++++++||||++
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~-------------~~~~~~~~f~~E~~il~~l~HpNIV~ 96 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVD-------------PTPEQFQAFRNEVAVLRKTRHVNILL 96 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCSS-------------CCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecC-------------CCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 4478899999999999999999753 369999874321 12234567999999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++. ++..++||||+++|+|.+++.. ....+++..+..++.|++.||+||| +++|+||||||+|||+++++
T Consensus 97 l~g~~~-~~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~ 169 (307)
T 3omv_A 97 FMGYMT-KDNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGL 169 (307)
T ss_dssp EEEEEC-SSSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTE
T ss_pred EEEEEE-CCeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCC
Confidence 999775 4678999999999999999943 3456999999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL---TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.+||+|||+|...............+||+.|+|||++.+. +|+.++|||||||++|+|+||+.||.+... ..
T Consensus 170 ~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----~~- 244 (307)
T 3omv_A 170 TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----RD- 244 (307)
T ss_dssp EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HH-
T ss_pred cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----HH-
Confidence 9999999999876544333333446899999999998643 589999999999999999999999975321 11
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+......+.. + ....+++..+.+|+.+||+.||++|||+.||++
T Consensus 245 -~~~~~~~~~~~~p~~--~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 245 -QIIFMVGRGYASPDL--S----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp -HHHHHHHTTCCCCCS--T----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred -HHHHHHhcCCCCCCc--c----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 111112222111110 0 111123344899999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-57 Score=385.13 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=196.6
Q ss_pred hcCcccccccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|++++.||+|+||+||+|+.. ..+++.||+|++.... ........+.+|+.++++++||||+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------------~~~~~~~~~~~E~~il~~l~HpnIv 89 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT-------------LKVRDRVRTKMERDILVEVNHPFIV 89 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEE-------------EEEEECC------CCCCCCCCTTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHH-------------cChHHHHHHHHHHHHHHHCCCCCCC
Confidence 368999999999999999999753 3467899999984211 1122234678899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.+++..|+||||++||+|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+|||++.+
T Consensus 90 ~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~ 162 (304)
T 3ubd_A 90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEE 162 (304)
T ss_dssp CEEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTT
T ss_pred eEEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCC
Confidence 999999999999999999999999999943 456999999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.+||+|||+|......... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.... . ..
T Consensus 163 g~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~---~~ 233 (304)
T 3ubd_A 163 GHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD----R---KE 233 (304)
T ss_dssp SCEEEESSEEEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----H---HH
T ss_pred CCEEecccccceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC----H---HH
Confidence 99999999999865433222 223689999999999999999999999999999999999999996521 1 22
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh-----hhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS-----KDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~ 324 (325)
....+....... +.. .+..+.+||.+||+.||++|||+ +|+++
T Consensus 234 ~~~~i~~~~~~~---p~~--------~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 234 TMTMILKAKLGM---PQF--------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHCCCCC---CTT--------SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHcCCCCC---CCc--------CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 233333322211 111 12238999999999999999995 56653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=376.78 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=207.0
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCC----CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGS----NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR 105 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 105 (325)
-..-++|++.+.||+|+||+||+|++... +++.||||.+... ......+.+.+|+.+++++.
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~--------------~~~~~~~~~~~E~~il~~l~ 125 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--------------ATHSEHRALMSELKILIHIG 125 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT--------------CCHHHHHHHHHHHHHHHHHC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc--------------cChHHHHHHHHHHHHHHHcC
Confidence 33457899999999999999999976432 3468999998321 12234567899999999997
Q ss_pred C-CCccccccceecC-CceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcC
Q 040480 106 H-RNILPLLAHMVRP-DSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHH 171 (325)
Q Consensus 106 h-~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~ 171 (325)
| ||||++++++... +.+++|||||++|+|.+++..... ....+++..+..++.|++.||.|||
T Consensus 126 hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--- 202 (353)
T 4ase_A 126 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 202 (353)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---
T ss_pred CCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---
Confidence 6 8999999998764 568999999999999999965322 1345888999999999999999999
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~ 251 (325)
+++|+||||||+|||+++++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+|
T Consensus 203 ~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 203 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred hCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh
Confidence 88999999999999999999999999999987765544334444678999999999999999999999999999999998
Q ss_pred -CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 252 -GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 252 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|..||.+... ...+.. .+..+.....+ . .++..+.+|+.+||+.||++|||+.||++
T Consensus 283 ~G~~Pf~~~~~---~~~~~~---~i~~g~~~~~p--~--------~~~~~~~~li~~c~~~dP~~RPt~~eil~ 340 (353)
T 4ase_A 283 LGASPYPGVKI---DEEFCR---RLKEGTRMRAP--D--------YTTPEMYQTMLDCWHGEPSQRPTFSELVE 340 (353)
T ss_dssp TSCCSSTTCCC---SHHHHH---HHHHTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCH---HHHHHH---HHHcCCCCCCC--c--------cCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999975322 112222 22222222111 0 11223899999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=367.90 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=188.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||+|+||+||+|+ +..+++.||||++.... .....+.+.+|+.++++++||||++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~-~~~~~~~vAiK~i~~~~--------------~~~~~~~~~~E~~il~~l~HpnIV~~~ 69 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAK-NKVDDCNYAIKRIRLPN--------------RELAREKVMREVKALAKLEHPGIVRYF 69 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEE-ETTTCCEEEEEEEEECS--------------SHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhCEEeeEEecCCCeEEEEEE-ECCCCCEEEEEEEeccC--------------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 569999999999999999995 56788999999984321 123346788999999999999999999
Q ss_pred cceecCC------------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040480 114 AHMVRPD------------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181 (325)
Q Consensus 114 ~~~~~~~------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~ 181 (325)
+++.+.+ .+|+|||||++|+|.+++... ......+...+..++.|++.||.||| ++||+|||||
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlK 145 (299)
T 4g31_A 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLK 145 (299)
T ss_dssp EEEEEEC----------CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred EEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCc
Confidence 9987554 369999999999999999432 11123445567889999999999999 8899999999
Q ss_pred CCceEecCCCCceeeccccceecCCCCcc----------ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh
Q 040480 182 PANVLIDDDMEARISGFDLAILMPDGLTQ----------IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~ 251 (325)
|+|||++.++.+||+|||+|......... ...+..+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 146 p~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 146 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp GGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred HHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 99999999999999999999876543221 11223579999999999999999999999999999999996
Q ss_pred CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 252 GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 252 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
||.. ..+.......+.....++ ...+....+.+||.+||+.||.+|||+.|+++
T Consensus 226 ---Pf~~------~~~~~~~~~~~~~~~~p~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 ---PFST------QMERVRTLTDVRNLKFPP----------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---CCSS------HHHHHHHHHHHHTTCCCH----------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCC------ccHHHHHHHHHhcCCCCC----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7743 122222222222222211 11222334678999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=365.95 Aligned_cols=263 Identities=25% Similarity=0.307 Sum_probs=193.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
.+|.+.++||+|+||+||+|++ +++.||||++... .........|+..+.+++||||++++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~----------------~~~~~~~e~Ei~~~~~l~HpNIv~l~ 63 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR----------------EERSWFREAEIYQTVMLRHENILGFI 63 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGG----------------GHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECcc----------------chhhHHHHHHHHHHhcCCCCCCCcEE
Confidence 4688999999999999999986 6889999998311 11112233466667788999999999
Q ss_pred cceecCC----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCc
Q 040480 114 AHMVRPD----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH-----HSARVIHRDIKPAN 184 (325)
Q Consensus 114 ~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-----~~~~ivH~dl~~~n 184 (325)
+++..++ ..|+||||+++|+|.+++. ...+++..+.+++.|++.||+|||.. ++.+|+||||||+|
T Consensus 64 g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~N 138 (303)
T 3hmm_A 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp EEEEEECSSSEEEEEEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGG
T ss_pred EEEEecCCCceEEEEEecCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCccc
Confidence 9997654 4799999999999999993 34588999999999999999999932 12399999999999
Q ss_pred eEecCCCCceeeccccceecCCCCcc--ccceeecCCcccccccccccC------CCCCccchhhHHHHHHHHHhCCCCC
Q 040480 185 VLIDDDMEARISGFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQTL------TISEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~------~~~~~~DvwslG~il~~ll~g~~p~ 256 (325)
||++.++.+||+|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|||+||..||
T Consensus 139 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 139 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred EEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 99999999999999999876543322 122235799999999998764 3678999999999999999998877
Q ss_pred CCcccCC--------CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 257 DDFFSHT--------GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 257 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... ...........+.... ....++.... ..+.+..+.+|+.+||+.||++|||+.||++
T Consensus 219 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~rp~~p~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK-LRPNIPNRWQ---SCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-CCCCCCGGGG---SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred CccccccccchhcccccchHHHHHHHHhccc-CCCCCCcccc---chHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 5322111 1112222222222221 1111221111 1234556899999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=371.17 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=200.1
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||+|+||+||+|+ +..+++.||||++... .........+.+|+.+|+.++||||++++
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~-~~~t~~~vAiK~i~~~-------------~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 119 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSAR-RRLTGQQVAIKKIPNA-------------FDVVTNAKRTLRELKILKHFKHDNIIAIK 119 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEETTT-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCeEEEEEEecccCeEEEEEE-ECCCCCEEEEEEECcc-------------ccchHHHHHHHHHHHHHHhcCCCCcceEe
Confidence 579999999999999999995 6678999999998321 11223456788999999999999999999
Q ss_pred cceec------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 114 AHMVR------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 114 ~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+++.. .+.+|+||||++ |+|.+++ .....+++..+..++.|++.||.||| ++||+||||||+|||+
T Consensus 120 ~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~ 191 (398)
T 4b99_A 120 DILRPTVPYGEFKSVYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLV 191 (398)
T ss_dssp EECCCSSCTTTCCCEEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEE
T ss_pred eeeecccccccCCEEEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCcccccc
Confidence 98653 367899999996 5899998 44567999999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCc--cccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLT--QIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+.++.+||+|||++..+..... .......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+. .
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~----~ 267 (398)
T 4b99_A 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK----N 267 (398)
T ss_dssp CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS----S
T ss_pred CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC----C
Confidence 9999999999999986643221 1222336899999999998875 4689999999999999999999999752 2
Q ss_pred cchHHHHHHHHhhhCCCCccc--------------c---hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAI--------------D---SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~--------------~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+....+............. + +.............+.+||.+||+.||++|||++|+|+
T Consensus 268 ~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 268 YVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 222222222211111100000 0 00000000112334889999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=360.44 Aligned_cols=199 Identities=23% Similarity=0.374 Sum_probs=168.4
Q ss_pred hcCcccccccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
.++|++.+.||+|+||+||+|+.. ..+++.||+|.+... ....++.+|+.+++.+ .||||
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----------------~~~~~~~~E~~~l~~~~~h~nI 82 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----------------SHPIRIAAELQCLTVAGGQDNV 82 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----------------SCHHHHHHHHHHHHHTCSBTTB
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----------------cCHHHHHHHHHHHHHhcCCCCC
Confidence 478999999999999999999753 245788999988321 2334678899999988 69999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.+.+..|+||||+++++|.+++. .+++..+..++.|++.||.||| ++||+||||||+|||++.
T Consensus 83 v~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~ 152 (361)
T 4f9c_A 83 MGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNR 152 (361)
T ss_dssp CCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEET
T ss_pred ceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeC
Confidence 999999999999999999999999999982 3889999999999999999999 889999999999999987
Q ss_pred C-CCceeeccccceecCCCCcc--------------------------ccceeecCCcccccccccccC-CCCCccchhh
Q 040480 190 D-MEARISGFDLAILMPDGLTQ--------------------------IDTMYVVGTPRYIAPEYHQTL-TISEKCDIYS 241 (325)
Q Consensus 190 ~-~~~~l~dfg~~~~~~~~~~~--------------------------~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dvws 241 (325)
+ +.+||+|||+|+........ ......+||+.|+|||++.+. .++.++||||
T Consensus 153 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWS 232 (361)
T 4f9c_A 153 RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232 (361)
T ss_dssp TTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred CCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhh
Confidence 6 78999999999865432211 111224799999999998875 4899999999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 040480 242 FGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 242 lG~il~~ll~g~~p~~~ 258 (325)
+||++|+|++|+.||..
T Consensus 233 lG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 233 AGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHHHTCSSSSC
T ss_pred hHHHHHHHHHCCCCCCC
Confidence 99999999999999954
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=376.39 Aligned_cols=256 Identities=26% Similarity=0.290 Sum_probs=201.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|++++.||+|+||+||+|+ +..+++.||+|++.... ...............++.+++.++||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~-~~~tg~~~AiK~i~K~~---------i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l 257 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCR-KADTGKMYAMKCLDKKR---------IKMKQGETLALNERIMLSLVSTGDCPFIVCM 257 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEHHH---------HHHTTCHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred hHHeEEEEEEecccCeEEEEEE-ECCCCCEEEEEEEeHHH---------cchhhhHHHHHHHHHHHHHHhhCCCCCEeEE
Confidence 4689999999999999999996 56789999999983210 0111111223334455677888899999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+.+|+||||++||+|.+++.. ...+++..+..++.||+.||.||| ++||+||||||+|||++.+|.
T Consensus 258 ~~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~ 330 (689)
T 3v5w_A 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH 330 (689)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCC
Confidence 9999999999999999999999999943 456999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
+||+|||+|........ ...+||+.|+|||++. +..|+.++|+|||||++|+|++|..||..... .+....
T Consensus 331 vKL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~----~~~~~i 402 (689)
T 3v5w_A 331 VRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEI 402 (689)
T ss_dssp EEECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC----CCHHHH
T ss_pred EEecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHH
Confidence 99999999987654332 2358999999999986 45799999999999999999999999975322 122222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
...+....... +.. .+..+.+||.+||+.||.+|++ ++||++
T Consensus 403 ~~~i~~~~~~~---p~~--------~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 403 DRMTLTMAVEL---PDS--------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHCCCCC---CTT--------SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHhhcCCCCCC---Ccc--------CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 23332222211 111 1123899999999999999998 577754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=375.38 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=206.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|. +..+++.||+|.+... .....+.+.+|+.+|+.++||||++++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~-~~~tg~~~AiK~i~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~ 220 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVT-ERATGNNFAAKFVMTP---------------HESDKETVRKEIQTMSVLRHPTLVNLH 220 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEECC---------------SHHHHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred cccEEEEEEeeccCeEEEEEE-ECCCCCEEEEEEEecc---------------chhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence 689999999999999999995 6678999999998421 123346788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC--C
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD--M 191 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~--~ 191 (325)
+++.+.+.+|+||||++||+|.+++.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.+ +
T Consensus 221 ~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~ 294 (573)
T 3uto_A 221 DAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSN 294 (573)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCC
T ss_pred EEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCC
Confidence 999999999999999999999999832 3456999999999999999999999 8899999999999999854 8
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.+||+|||++..+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.. . ...
T Consensus 295 ~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~----~---~~~ 364 (573)
T 3uto_A 295 ELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----D---DET 364 (573)
T ss_dssp CEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----H---HHH
T ss_pred CEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----H---HHH
Confidence 899999999998765433 223689999999999999999999999999999999999999996522 1 222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+....... +.... ......+.+||.+||+.||.+|||+.|+|+
T Consensus 365 ~~~i~~~~~~~---~~~~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 365 LRNVKSCDWNM---DDSAF----SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHTTCCCC---CSGGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCC---Ccccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33333322211 11111 112234889999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=333.28 Aligned_cols=252 Identities=23% Similarity=0.388 Sum_probs=205.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|. +..+++.||+|.+... .....+.+.+|+.+++.++||||++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~---------------~~~~~~~~~~E~~~l~~l~hp~iv~ 81 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAM-DVATGQEVAIRQMNLQ---------------QQPKKELIINEILVMRENKNPNIVN 81 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEE-BTTTCCEEEEEEEEGG---------------GCSCHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhceeeeeeeccCCCeEEEEEE-ECCCCcEEEEEEeecc---------------cccHHHHHHHHHHHHhcCCCCCCCe
Confidence 45789999999999999999995 6678899999998322 2233556889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+++++|.+++.. ..++...+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~ 153 (297)
T 3fxz_A 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDG 153 (297)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred EeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCC
Confidence 99999999999999999999999999843 35889999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...
T Consensus 154 ~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~ 224 (297)
T 3fxz_A 154 SVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRA 224 (297)
T ss_dssp CEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHH
T ss_pred CEEEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHH
Confidence 9999999999876544332 2235789999999999999999999999999999999999999965221 111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.........+....+. ..+..+.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 225 LYLIATNGTPELQNPE--------KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHCSCCCSCGG--------GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhCCCCCCCCcc--------ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1222222222211111 12233889999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=337.90 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=205.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.||+|++... .........+.+|+.+++.++||||++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpnIv~ 78 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLAR-HILTGREVAIKIIDKT-------------QLNPTSLQKLFREVRIMKILNHPNIVK 78 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEGG-------------GSCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccCCEEEEEEEeeCCCEEEEEEE-ECCCCCEEEEEEEEhh-------------cCCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 35789999999999999999995 5578899999998321 122344567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..|+||||+++++|.+++.. ...+++..+..++.|++.||.||| ++|++||||||+||+++.++
T Consensus 79 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~ 151 (328)
T 3fe3_A 79 LFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADM 151 (328)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTS
T ss_pred EEEEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCC
Confidence 99999999999999999999999999943 356899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTIS-EKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~-~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||++......... ...+||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.. ...
T Consensus 152 ~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~ 221 (328)
T 3fe3_A 152 NIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKE 221 (328)
T ss_dssp CEEECSTTCCGGGSSSCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHH
T ss_pred CEEEeeccCceecCCCCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHH
Confidence 9999999999866544322 225799999999999888765 78999999999999999999997522 122
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+.......... .+..+.+|+.+||+.||.+|||++|+++
T Consensus 222 ~~~~i~~~~~~~p~~-----------~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 222 LRERVLRGKYRIPFY-----------MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHHHCCCCCCTT-----------SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCCCCCCCC-----------CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222333222211110 1123889999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=336.04 Aligned_cols=272 Identities=27% Similarity=0.448 Sum_probs=219.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.+++.++||||++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~ 99 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL--RDGAKVALKRRTPE---------------SSQGIEEFETEIETLSFCRHPHLVS 99 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC--TTCCEEEEEECCSC---------------CSSHHHHHHHHHHGGGSCCCTTBCC
T ss_pred HHhccCccceeecCCCeeEEEEEE--CCCCEEEEEEeccc---------------ChHHHHHHHHHHHHHHhCCCCCEee
Confidence 568999999999999999999974 36889999987321 2234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+++++|.+++.........+++..+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~ 176 (321)
T 2qkw_B 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENF 176 (321)
T ss_dssp EEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTC
T ss_pred EEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCC
Confidence 999999999999999999999999998543333446889999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ......+
T Consensus 177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~ 255 (321)
T 2qkw_B 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEW 255 (321)
T ss_dssp CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHH
T ss_pred CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHH
Confidence 999999999987554333222333568999999999988899999999999999999999999997654432 2334444
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..............++........+.+..+.+++.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 308 (321)
T 2qkw_B 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308 (321)
T ss_dssp THHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33333333333333333334445677778999999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=330.53 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=204.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|+ +..+++.||+|.+.. ...........+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~-~~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l 70 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVR-EKATGRYYAMKILRK------------EVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHSCCCTTBCCE
T ss_pred hHHeEEEEEEecCCCeEEEEEE-ECCCCCEEEEEEEeH------------HHhhhhhHHHHHHHHHHHHHhCCCCcCcce
Confidence 4789999999999999999996 557789999999831 111223456678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..|+||||++|++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~ 143 (337)
T 1o6l_A 71 KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 143 (337)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCC
Confidence 9999999999999999999999999843 356899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++......... ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... .. ...
T Consensus 144 vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~---~~~ 214 (337)
T 1o6l_A 144 IKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HE---RLF 214 (337)
T ss_dssp EEECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HH---HHH
T ss_pred EEEeeccchhhcccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----HH---HHH
Confidence 999999999764332221 223578999999999999999999999999999999999999996521 11 222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
..+...... ++. ..+..+.+||.+||+.||++|| +++|+++
T Consensus 215 ~~i~~~~~~---~p~--------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 215 ELILMEEIR---FPR--------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHCCCC---CCT--------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHcCCCC---CCC--------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 222222111 111 0122389999999999999999 8888875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=331.89 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=207.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|. +..+++.||+|.+....... .........+.+|+.++++++||||+++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~-~~~~~~~~avK~i~~~~~~~---------~~~~~~~~~~~~E~~il~~l~hpnIv~l 80 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRA---------SRRGVCREEIEREVSILRQVLHPNIITL 80 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEBCSSTT---------CSSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhceEEeeEEeeCcCEEEEEEE-ECCCCCEEEEEEEEcccccc---------ccchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence 4689999999999999999996 55778999999985432111 0011235678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC-
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM- 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~- 191 (325)
++++.+.+..++||||++|++|.+++ .....+++..+..++.|++.||.||| ++||+|+||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~ 153 (361)
T 2yab_A 81 HDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNI 153 (361)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTS
T ss_pred EEEEEeCCEEEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCC
Confidence 99999999999999999999999999 34557999999999999999999999 88999999999999998776
Q ss_pred ---CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 ---EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ---~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||++......... ....||+.|+|||++.+..++.++|+||||+++|+|++|..||.... .
T Consensus 154 ~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~----~--- 223 (361)
T 2yab_A 154 PIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----K--- 223 (361)
T ss_dssp SSCCEEECCCSSCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----H---
T ss_pred CccCEEEEecCCceEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----H---
Confidence 7999999999876554322 22579999999999999899999999999999999999999996521 1
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+...... ++..... ..+..+.+||.+||..||.+|||+.|+++
T Consensus 224 ~~~~~~i~~~~~~---~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 224 QETLANITAVSYD---FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHTTCCC---CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCC---CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222233222221 1111111 12234889999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=328.83 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=194.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|++ ++..||+|++.... ........+.+|+.++++++||||++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~hp~iv~ 98 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQD-------------FHAERVNEFLREVAIMKRLRHPNIVL 98 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCC-------------CSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ChhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCC-------------CCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 457899999999999999999975 67889999984321 12234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEecC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR--VIHRDIKPANVLIDD 189 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~--ivH~dl~~~nil~~~ 189 (325)
+++++...+..++||||+++++|.+++... .....+++..+..++.|++.||.||| ++| ++|+||||+||+++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~ 174 (309)
T 3p86_A 99 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDK 174 (309)
T ss_dssp EEEEECSTTCCEEEEECCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECT
T ss_pred EEEEEEECCceEEEEecCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeC
Confidence 999999999999999999999999999432 11234889999999999999999999 888 999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .....
T Consensus 175 ~~~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~----~~~~~ 248 (309)
T 3p86_A 175 KYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN----PAQVV 248 (309)
T ss_dssp TCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC----HHHHH
T ss_pred CCcEEECCCCCCccccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHH
Confidence 999999999999754433221 222578999999999999999999999999999999999999997532 11222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..... .... ...+. ..+..+.+||.+||+.||.+|||+.++++
T Consensus 249 ~~~~~--~~~~--~~~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 249 AAVGF--KCKR--LEIPR--------NLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHH--SCCC--CCCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHh--cCCC--CCCCc--------cCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111 1111 11111 11223899999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=335.02 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=199.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
.++|++.+.||+|+||+||+|+ +..+++.||+|++.. ...........+..|..+++.+ +||||++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~-~~~~~~~~AvK~~~~------------~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~ 88 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLAR-VKETGDLYAVKVLKK------------DVILQDDDVECTMTEKRILSLARNHPFLTQ 88 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEH------------HHHHHHTTHHHHHHHHHHHHHTTTCTTBCC
T ss_pred hhheEEEEEEeeCCCEEEEEEE-EcCCCCEEEEEEEEH------------HHhcchhHHHHHHHHHHHHHhccCCCceee
Confidence 4799999999999999999996 556789999999831 1112234566788899999988 6999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+||+++.++
T Consensus 89 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g 161 (353)
T 3txo_A 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEG 161 (353)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTS
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCC
Confidence 99999999999999999999999999943 356999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++........ .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... . ...
T Consensus 162 ~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~---~~~ 232 (353)
T 3txo_A 162 HCKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN----E---DDL 232 (353)
T ss_dssp CEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS----H---HHH
T ss_pred CEEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC----H---HHH
Confidence 999999999975433222 2223589999999999999889999999999999999999999996522 1 222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh------hhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS------KDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~ 324 (325)
...+.......... ....+.+||.+||+.||.+||++ +++++
T Consensus 233 ~~~i~~~~~~~p~~-----------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 233 FEAILNDEVVYPTW-----------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHCCCCCCTT-----------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHcCCCCCCCC-----------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 22333222211110 11238899999999999999998 66654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=333.34 Aligned_cols=279 Identities=34% Similarity=0.586 Sum_probs=222.5
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
+....++|++.+.||+|+||.||+|++ .+++.||+|.+.... .......+.+|+.+++.++|||
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~ 88 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRLKEER--------------TQGGELQFQTEVEMISMAVHRN 88 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECC--SSSCCEEEEECCC-------------------CCCHHHHHHHGGGTCCCTT
T ss_pred HHHHhhccccceeEecCCCcEEEEEEe--cCCCEEEEEEecccc--------------CchHHHHHHHHHHHHHhccCCC
Confidence 445778999999999999999999964 368899999984211 0111225789999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++...+..++||||+.+++|.+++.........+++..+..++.|++.||.|||..+..|++|+||||+||+++
T Consensus 89 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168 (326)
T ss_dssp BCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred ccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence 99999999999999999999999999999966555556699999999999999999999933333999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc-CCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS-HTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~-~~~~~~ 267 (325)
.++.++|+|||++.......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp TTCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 99999999999998765433322 2224689999999999888899999999999999999999999963221 122233
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+..............+..............+.+++.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 304 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence 444444444444444444444455566777888999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=333.69 Aligned_cols=273 Identities=25% Similarity=0.300 Sum_probs=206.3
Q ss_pred ccchhHHHHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHH
Q 040480 21 LIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIIT 100 (325)
Q Consensus 21 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 100 (325)
..++.+-++....++|++.+.||+|+||+||+|++ .++.||||++... .........|+.+
T Consensus 11 ~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~----------------~~~~~~~~~E~~~ 71 (322)
T 3soc_A 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQ----------------DKQSWQNEYEVYS 71 (322)
T ss_dssp ---CCCCCEEETTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECGG----------------GHHHHHHHHHHHT
T ss_pred ccccCccccccchhhchhhheecccCceEEEEEEE---CCCEEEEEEeecC----------------chHHHHHHHHHHH
Confidence 34444445556778999999999999999999975 4789999998321 1223345568888
Q ss_pred HhccCCCCccccccceecCCc----eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC---
Q 040480 101 ASQIRHRNILPLLAHMVRPDS----HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA--- 173 (325)
Q Consensus 101 l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~--- 173 (325)
+++++||||+++++++..... .++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH---~~~~~ 143 (322)
T 3soc_A 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLH---EDIPG 143 (322)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHT---CCEEE
T ss_pred HhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---hhccc
Confidence 999999999999999987543 6999999999999999933 45899999999999999999999 77
Q ss_pred -------CeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccC-----CCCCccchhh
Q 040480 174 -------RVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-----TISEKCDIYS 241 (325)
Q Consensus 174 -------~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-----~~~~~~Dvws 241 (325)
|++|+||||+||+++.++.+||+|||++................||+.|+|||++.+. .++.++||||
T Consensus 144 l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws 223 (322)
T 3soc_A 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223 (322)
T ss_dssp ETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHH
T ss_pred cccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHH
Confidence 9999999999999999999999999999877654443333335789999999998873 4567899999
Q ss_pred HHHHHHHHHhCCCCCCCcccCCCc---------chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCC
Q 040480 242 FGVLLAVLVMGKFPFDDFFSHTGE---------MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLAD 312 (325)
Q Consensus 242 lG~il~~ll~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 312 (325)
||+++|+|++|+.||......... .....+.......... ........ ....+..+.+|+.+||+.|
T Consensus 224 lG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~l~~li~~cl~~d 299 (322)
T 3soc_A 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR-PVLRDYWQ---KHAGMAMLCETIEECWDHD 299 (322)
T ss_dssp HHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCC-CCCCGGGG---SSHHHHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCC-CCcccccc---ccchHHHHHHHHHHHccCC
Confidence 999999999999999754321111 1122222222221111 11111111 1234455999999999999
Q ss_pred CCCCCChhhhhc
Q 040480 313 PDERPNSKDVRC 324 (325)
Q Consensus 313 P~~Rps~~ell~ 324 (325)
|++|||+.++++
T Consensus 300 P~~Rps~~ell~ 311 (322)
T 3soc_A 300 AEARLSAGCVGE 311 (322)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=329.22 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=207.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|. +..+++.||+|++... ..........+.+.+|+.+++.++||||+++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~----------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 91 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCI-NRETGQQFAVKIVDVA----------KFTSSPGLSTEDLKREASICHMLKHPHIVEL 91 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEHH----------HHHTSSSCCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceEEeeEEeeCCCEEEEEEE-ECCCCCEEEEEEEEhh----------hccccccchHHHHHHHHHHHHhCCCCCCCcE
Confidence 4689999999999999999995 5677899999998321 1111122346778999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..|+||||+++++|.+.+.........+++..+..++.|++.||.||| ++||+|+||||+||+++.++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp EEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSST
T ss_pred EEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCC
Confidence 99999999999999999999999988665445556899999999999999999999 889999999999999986554
Q ss_pred ---ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 193 ---ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 193 ---~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++|+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||... ..
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~--- 238 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-----KE--- 238 (351)
T ss_dssp TCCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-----HH---
T ss_pred CCcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-----HH---
Confidence 999999999877653321 12257899999999999989999999999999999999999999652 11
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+....... ++... ...+..+.+||.+||+.||++|||+.++++
T Consensus 239 ~~~~~i~~~~~~~---~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 239 RLFEGIIKGKYKM---NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHTCCCC---CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCC---Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1222222222211 11111 112234899999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=332.71 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=203.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|.+.. ...........+.+|+.+++.++||||+++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~-~~~~~~~~AiK~~~~------------~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l 80 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQ-KNDTKKMYAMKYMNK------------QKCVERNEVRNVFKELQIMQGLEHPFLVNL 80 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hHHeEEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEeh------------hhcccHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3789999999999999999996 567789999999831 111223456778999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+..|+||||+.|++|.+++. ....++...+..++.|++.||.||| ++||+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ 153 (384)
T 4fr4_A 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGH 153 (384)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCC
Confidence 999999999999999999999999993 4456999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT---LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++|+|||++........ ....+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||..... ....
T Consensus 154 vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~ 226 (384)
T 4fr4_A 154 VHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSK 226 (384)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHH
T ss_pred EEEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHH
Confidence 99999999987654332 223589999999999874 4588999999999999999999999975322 1122
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-hhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-SKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~ 324 (325)
............. +. ..+..+.+||.+||+.||.+||+ ++++++
T Consensus 227 ~~~~~~~~~~~~~---p~--------~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 227 EIVHTFETTVVTY---PS--------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHCCCCC---CT--------TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHhhcccCC---CC--------cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 2222222211111 10 01123899999999999999998 676653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=326.16 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=205.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.+|+|.+... ......+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~~a~K~~~~~----------------~~~~~~~~~E~~~l~~l~hpnIv~~ 66 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVK----------------GTDQVLVKKEISILNIARHRNILHL 66 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECCC----------------THHHHHHHHHHHHHHHSCCTTBCCE
T ss_pred hhceEeeeEEecCCCeEEEEEE-ECCCCcEEEEEEEecC----------------cccHHHHHHHHHHHHhCCCCCCCeE
Confidence 4789999999999999999995 5678899999988321 2234567899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC--C
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD--D 190 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~--~ 190 (325)
++++.+.+..++||||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++|+||||+||+++. +
T Consensus 67 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~ 140 (321)
T 1tki_A 67 HESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRS 140 (321)
T ss_dssp EEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSC
T ss_pred eEEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCC
Confidence 9999999999999999999999999832 3346899999999999999999999 889999999999999986 7
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... . ..
T Consensus 141 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~---~~ 210 (321)
T 1tki_A 141 STIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----N---QQ 210 (321)
T ss_dssp CCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----H---HH
T ss_pred CCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC----H---HH
Confidence 8999999999987755432 223578999999999999888999999999999999999999996522 1 22
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+....... +.... ...+..+.+|+.+||..||.+|||+.|+++
T Consensus 211 ~~~~i~~~~~~~---~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 211 IIENIMNAEYTF---DEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHHTCCCC---CHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCC---Chhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 222333222221 11111 112334899999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=323.00 Aligned_cols=249 Identities=26% Similarity=0.367 Sum_probs=203.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|.+.. ...........+.+|..+++.++||||+++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~ 71 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIR-SRHNGRYYAMKVLKK------------EIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHSCCBTTBCCE
T ss_pred hHHcEEEEEEeeCCCEEEEEEE-ECCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHhhCCCCCCceE
Confidence 4789999999999999999996 556789999999831 111122345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+....|+||||+++++|.+++.. ...++...+..++.|++.||.||| ++||+||||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~ 144 (318)
T 1fot_A 72 WGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGH 144 (318)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSC
T ss_pred eEEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCC
Confidence 9999999999999999999999999943 456899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++...... ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... . ....
T Consensus 145 ~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~---~~~~ 212 (318)
T 1fot_A 145 IKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----T---MKTY 212 (318)
T ss_dssp EEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----H---HHHH
T ss_pred EEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----H---HHHH
Confidence 999999999875432 123578999999999999999999999999999999999999996521 1 2222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
..+....... +.. ....+.+|+.+||+.||.+|| +++++++
T Consensus 213 ~~i~~~~~~~---p~~--------~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 213 EKILNAELRF---PPF--------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHCCCCC---CTT--------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHhCCCCC---CCC--------CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 2222222111 110 112389999999999999999 8888864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=335.43 Aligned_cols=256 Identities=20% Similarity=0.236 Sum_probs=198.4
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
...++|++.+.||+|+||+||+|+ ...+++.||+|++.... .........+..|..++.++ +||||
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~-~~~~~~~~AvK~~~k~~------------~~~~~~~~~~~~E~~il~~~~~hp~I 115 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVR-LKKTDRIYAMRVVKKEL------------VNDDEDIDWVQTEKHVFEQASNHPFL 115 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEEGGG------------TC----CCHHHHHHHHHHHHTTCTTB
T ss_pred CChhHcEEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEEhhh------------ccCHHHHHHHHHHHHHHHhcCCCCCc
Confidence 355789999999999999999996 55678999999984221 11122334577888888877 79999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.+.+..|+||||+++++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+||+++.
T Consensus 116 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~ 188 (396)
T 4dc2_A 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDS 188 (396)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECT
T ss_pred CeeEEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECC
Confidence 9999999999999999999999999999843 356999999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc--ch
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE--MD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~--~~ 267 (325)
++.++|+|||++........ .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||......... ..
T Consensus 189 ~g~ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~ 266 (396)
T 4dc2_A 189 EGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266 (396)
T ss_dssp TSCEEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC
T ss_pred CCCEEEeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh
Confidence 99999999999975333222 222368999999999999999999999999999999999999999643221111 11
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
.......+....... +.. ....+.+||.+||+.||.+||++
T Consensus 267 ~~~~~~~i~~~~~~~---p~~--------~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 267 EDYLFQVILEKQIRI---PRS--------LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHHHCCCCC---CTT--------SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHHHhccccCC---CCc--------CCHHHHHHHHHHhcCCHhHcCCC
Confidence 111222222222111 110 11238999999999999999996
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=324.90 Aligned_cols=254 Identities=24% Similarity=0.450 Sum_probs=204.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|. +..+++.||+|.+.. ........+.+|+.++++++||||++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~~va~K~~~~---------------~~~~~~~~~~~E~~~l~~l~hp~iv~ 71 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVT-HRETGEVMVMKELIR---------------FDEETQRTFLKEVKVMRCLEHPNVLK 71 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEE-ETTTCCEEEEEEESC---------------CCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ChhHeeccceecCCCCEEEEEEE-ECCCCcEEEEEEecc---------------CCHHHHHHHHHHHHHHHhCCCcCccc
Confidence 46899999999999999999995 556789999998732 22345667899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..++||||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~ 145 (310)
T 3s95_A 72 FIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENK 145 (310)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTS
T ss_pred EEEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCC
Confidence 99999999999999999999999999954 3456899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCcccc------------ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q 040480 192 EARISGFDLAILMPDGLTQID------------TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~------------~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~ 259 (325)
.++|+|||.+........... .....||+.|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 146 NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 999999999987654332211 11357899999999999999999999999999999999999998764
Q ss_pred ccCCCc--chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGE--MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ........ ...+ ...++ .+.+|+.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~----~~~~-~~~~~------------~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 226 LPRTMDFGLNVRGFLD----RYCP-PNCPP------------SFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp SCBCTTSSBCHHHHHH----HTCC-TTCCT------------THHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhHHHHhhhhhcccc----ccCC-CCCCH------------HHHHHHHHHccCChhhCcCHHHHHH
Confidence 332221 11221111 1111 11111 2899999999999999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=328.90 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=202.6
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
...++|++.+.||+|+||.||+|+ +..+++.||+|.+.. ...........+..|..++..+ +||||
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~-~~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~E~~il~~~~~hp~i 80 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAE-FKKTNQFFAIKALKK------------DVVLMDDDVECTMVEKRVLSLAWEHPFL 80 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEE-ETTTTEEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHHHTTCTTB
T ss_pred CChHHeEEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEEh------------HHhhhhhhHHHHHHHHHHHHhcCCCCCC
Confidence 356899999999999999999996 456789999999831 1111223456678888888876 89999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.+.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+||+++.
T Consensus 81 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~ 153 (345)
T 1xjd_A 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDK 153 (345)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECT
T ss_pred CcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECC
Confidence 9999999999999999999999999999943 346899999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||++......... ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... ....
T Consensus 154 ~g~vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~- 226 (345)
T 1xjd_A 154 DGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEEL- 226 (345)
T ss_dssp TSCEEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH-
T ss_pred CCCEEEeEChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----HHHH-
Confidence 999999999999764332221 223689999999999999999999999999999999999999996522 1222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh-hhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK-DVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 324 (325)
...+....... +. . .+..+.+||.+||+.||++||++. ++++
T Consensus 227 --~~~i~~~~~~~---p~-----~---~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 227 --FHSIRMDNPFY---PR-----W---LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp --HHHHHHCCCCC---CT-----T---SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --HHHHHhCCCCC---Cc-----c---cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 22222221111 10 0 122389999999999999999998 7764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=340.56 Aligned_cols=255 Identities=19% Similarity=0.291 Sum_probs=203.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|. +..+++.+|+|.+.... ........+.+|+.+++.++||||+++
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~-~~~~~~~~a~K~i~~~~-------------~~~~~~~~~~~E~~il~~l~hpnIv~l 75 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCV-KVLAGQEYAAMIINTKK-------------LSARDHQKLEREARICRLLKHPNIVRL 75 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEE-ETTTTEEEEEEEEESCS-------------CHHHHHHHHHHHHHHHHHCCBTTBCCE
T ss_pred cCCeEEEEEeccCCCeEEEEEE-ECCCCcEEEEEEEEccc-------------CCHHHHHHHHHHHHHHHhCCCcCCCeE
Confidence 5789999999999999999995 66788999999984321 112335578899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec---C
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID---D 189 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~---~ 189 (325)
++++.+.+..|+||||+.+++|.+.+. ....+++..+..++.|++.||.||| ++||+||||||+||+++ .
T Consensus 76 ~~~~~~~~~~~lv~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~ 148 (444)
T 3soa_A 76 HDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLK 148 (444)
T ss_dssp EEEEECSSEEEEEECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSST
T ss_pred EEEEEECCEEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCC
Confidence 999999999999999999999999984 3456999999999999999999999 88999999999999998 4
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.+||+|||++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ....
T Consensus 149 ~~~vkL~DFG~a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~----~~~~- 221 (444)
T 3soa_A 149 GAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED----QHRL- 221 (444)
T ss_dssp TCCEEECCCSSCBCCCTTCCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHH-
T ss_pred CCcEEEccCceeEEecCCCcee--ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc----HHHH-
Confidence 5789999999997665433221 22579999999999999899999999999999999999999996522 2222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+........ ... ....+..+.+||.+||+.||.+|||+.|+|+
T Consensus 222 --~~~i~~~~~~~~---~~~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 222 --YQQIKAGAYDFP---SPE----WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --HHHHHHTCCCCC---TTT----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHHhCCCCCC---ccc----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222222221111 000 0112233899999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=330.87 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=200.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..+++.||+|++.. ...........+.+|+.+++.++||||++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~-~~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 73 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLAT-HYKTQQKVALKFISR------------QLLKKSDMHMRVEREISYLKLLRHPHIIK 73 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCSHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCCEEEEEEEecCCCeEEEEEE-ECCCCCEEEEEEEeh------------HHccchhHHHHHHHHHHHHHhCCCCCCCe
Confidence 34789999999999999999996 557889999999831 11111223457889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+ +|+|.+++.. ...+++..+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 74 l~~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~ 145 (336)
T 3h4j_B 74 LYDVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNL 145 (336)
T ss_dssp EEEEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTC
T ss_pred EEEEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCC
Confidence 999999999999999999 6689998843 356999999999999999999999 77999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||++......... ...+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........
T Consensus 146 ~~kl~DFG~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--- 219 (336)
T 3h4j_B 146 NVKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--- 219 (336)
T ss_dssp CEEECCSSCTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---
T ss_pred CEEEEEeccceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---
Confidence 9999999999866544322 22579999999999988776 6899999999999999999999976432111100
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+. ..+..+.+|+.+||+.||.+|||++|+++
T Consensus 220 -------i~~~~~~~p~--------~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 220 -------VNSCVYVMPD--------FLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -------CCSSCCCCCT--------TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -------HHcCCCCCcc--------cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000000010 11223889999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=331.77 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=204.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|.+.... ........+.+|+.+++.++||||+++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~~avK~~~~~~-------------~~~~~~~~~~~E~~il~~l~hpnIv~~ 93 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTKK-------------LSARDFQKLEREARICRKLQHPNIVRL 93 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEETTT-------------CCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccCeEEeeEEecCCCeEEEEEE-ECCCCCEEEEEEEEccc-------------CCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4689999999999999999995 56778999999984221 122345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC--
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD-- 190 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~-- 190 (325)
++++.+.+..|+||||+.+++|.+.+ .....+++..+..++.|++.||.||| ++||+|+||||+||+++.+
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~ 166 (362)
T 2bdw_A 94 HDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAK 166 (362)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHH----TTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSST
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCC
Confidence 99999999999999999999999998 34456899999999999999999999 8899999999999999854
Q ss_pred -CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 191 -MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 -~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..
T Consensus 167 ~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~--- 236 (362)
T 2bdw_A 167 GAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QH--- 236 (362)
T ss_dssp TCCEEECCCTTCBCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HH---
T ss_pred CCCEEEeecCcceEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HH---
Confidence 45999999999876543322 22578999999999999899999999999999999999999996522 12
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+........ .. .....+..+.+||.+||+.||++|||+.++++
T Consensus 237 ~~~~~i~~~~~~~~---~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 237 RLYAQIKAGAYDYP---SP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHHHHHTCCCCC---TT----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhCCCCCC---cc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22222222221110 00 01112234899999999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=329.78 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=201.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|. +..+++.||+|++.... .....+.+.+|+.+++.++||||+++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~~--------------~~~~~~~~~~E~~~l~~l~hpnIv~~ 70 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAV-NRVTEEAVAVKIVDMKR--------------AVDCPENIKKEICINKMLNHENVVKF 70 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEECC---------------------CHHHHHHHHHHCCCTTBCCE
T ss_pred hhhceeeeEEecCCCEEEEEEE-ECCCCcEEEEEEEEccc--------------ccchHHHHHHHHHHHHhCCCCCCCeE
Confidence 4789999999999999999995 55678999999984321 11223567889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+..|+||||+++++|.+++ .....++...+..++.|++.||.||| ++|++|+||||+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~ 143 (323)
T 3tki_A 71 YGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDN 143 (323)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred EEEEecCCeEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCC
Confidence 99999999999999999999999888 44556999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ......+
T Consensus 144 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~ 221 (323)
T 3tki_A 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDW 221 (323)
T ss_dssp EEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHH
T ss_pred EEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHH
Confidence 99999999986643333222333578999999999988765 77899999999999999999999753221 1111111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... .......+.+|+.+||+.||++|||++|+++
T Consensus 222 ----~~~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 222 ----KEKKTYLNP---------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----HTTCTTSTT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hcccccCCc---------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111100 0112233889999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=333.11 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=193.9
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
....++|++.+.||+|+||+||+|+ +..+++.||+|++... ......+.+|+.+++.++||||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~----------------~~~~~~~~~E~~~l~~l~hpni 78 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMR-DKLTKELVAVKYIERG----------------AAIDENVQREIINHRSLRHPNI 78 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEE-ETTTCCEEEEEEEESS----------------TTSCHHHHHHHHHHHHCCCTTB
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEE-ECCCCcEEEEEEEecC----------------ccccHHHHHHHHHHHhCCCCCC
Confidence 3456899999999999999999995 5678899999998321 1223467899999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++||+||||||+||+++.
T Consensus 79 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~ 151 (361)
T 3uc3_A 79 VRFKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDG 151 (361)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECS
T ss_pred CcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcC
Confidence 9999999999999999999999999999843 346999999999999999999999 889999999999999987
Q ss_pred CCC--ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCc-cchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 190 DME--ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEK-CDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 190 ~~~--~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~-~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
++. +||+|||++......... ....||+.|+|||++.+..++.+ +||||||+++|+|++|..||.......
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--- 225 (361)
T 3uc3_A 152 SPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--- 225 (361)
T ss_dssp SSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC---
T ss_pred CCCceEEEeecCccccccccCCC---CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH---
Confidence 665 999999998744332221 22478999999999988777655 899999999999999999997643322
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+......... .. ..+..+.+||.+||+.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~-~~--------~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 226 DYRKTIQRILSVKYSIPD-DI--------RISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CHHHHHHHHHTTCCCCCT-TS--------CCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHhcCCCCCCC-cC--------CCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 222222332222211110 00 01123889999999999999999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=332.14 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=205.5
Q ss_pred hhcCcccccccccCcceeEEEEEecC------CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPG------SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI- 104 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 104 (325)
..++|++.+.||+|+||.||+|++.. .++..||+|.+... ........+.+|+.+++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~ 144 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--------------ATEKDLSDLVSEMEMMKMIG 144 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--------------CBHHHHHHHHHHHHHHHHSC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--------------cCHHHHHHHHHHHHHHHHhc
Confidence 45789999999999999999997532 34567999987321 1223456789999999999
Q ss_pred CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcCC
Q 040480 105 RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHHS 172 (325)
Q Consensus 105 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~ 172 (325)
+||||+++++++...+..|+||||+++++|.+++..... ....++...+..++.|++.||.||| +
T Consensus 145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~ 221 (370)
T 2psq_A 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---S 221 (370)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---h
Confidence 899999999999999999999999999999999965321 1235788899999999999999999 8
Q ss_pred CCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-
Q 040480 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM- 251 (325)
Q Consensus 173 ~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~- 251 (325)
+||+|+||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++
T Consensus 222 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~ 301 (370)
T 2psq_A 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 301 (370)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcC
Confidence 8999999999999999999999999999987655433323333466789999999999899999999999999999999
Q ss_pred CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 252 GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 252 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|..||.... ........ ........ +. ..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 302 g~~p~~~~~----~~~~~~~~---~~~~~~~~--~~--------~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 302 GGSPYPGIP----VEELFKLL---KEGHRMDK--PA--------NCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp SCCSSTTCC----GGGHHHHH---HTTCCCCC--CT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCC----HHHHHHHH---hcCCCCCC--CC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999997532 22222222 22221111 10 11223899999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=324.15 Aligned_cols=264 Identities=25% Similarity=0.346 Sum_probs=201.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|++. +++.||+|++... .........+.+|+.+++.++||||+++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 84 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLD-------------AEDEGIPSTAIREISLLKELHHPNIVSL 84 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC-------------------CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecc-------------cccchhhHHHHHHHHHHHHcCCCCEeee
Confidence 478999999999999999999753 5889999998321 1122345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+..++||||+++ +|.+.+.. ....++...+..++.|++.||.||| ++||+|+||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~ 157 (311)
T 3niz_A 85 IDVIHSERCLTLVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGA 157 (311)
T ss_dssp EEEECCSSCEEEEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCC
T ss_pred eeEEccCCEEEEEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCC
Confidence 9999999999999999986 88888743 3445899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
++|+|||++......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... .+....
T Consensus 158 ~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~ 231 (311)
T 3niz_A 158 LKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD----DDQLPK 231 (311)
T ss_dssp EEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST----TTHHHH
T ss_pred EEEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh----HHHHHH
Confidence 999999999876543222 122478999999999876 4689999999999999999999999976332 222222
Q ss_pred HHHHhhhCCCCcccchh----------------hcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSK----------------LLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+........+..+.... ............+.+||.+||+.||++|||++|+++
T Consensus 232 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 232 IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22222222211110000 000000112234889999999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=325.91 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=199.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|++.... .........+.+|..+++++ +||||++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~-~~~~~~~~aiK~~~~~~------------~~~~~~~~~~~~E~~~l~~~~~hp~iv~ 74 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVR-LKKTDRIYAMKVVKKEL------------VNDDEDIDWVQTEKHVFEQASNHPFLVG 74 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEEGGG------------SCSHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred hhheEEEEEEEecCCeEEEEEE-ECCCCCEEEEEEEEhHH------------hcchHHHHHHHHHHHHHHhcCCCCccCe
Confidence 4789999999999999999996 45678999999984221 11223456788899999887 8999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..|+||||+++++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+||+++.++
T Consensus 75 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g 147 (345)
T 3a8x_A 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEG 147 (345)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTS
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCC
Confidence 99999999999999999999999999843 346899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc--chHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE--MDMV 269 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~--~~~~ 269 (325)
.++|+|||++........ .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||......... ....
T Consensus 148 ~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 225 (345)
T 3a8x_A 148 HIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225 (345)
T ss_dssp CEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHH
T ss_pred CEEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHH
Confidence 999999999976433222 122358999999999999999999999999999999999999999653221111 1111
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
.....+...... ++. ..+..+.+||.+||+.||.+||++
T Consensus 226 ~~~~~i~~~~~~---~p~--------~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 226 YLFQVILEKQIR---IPR--------SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHCCCC---CCT--------TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHcCCCC---CCC--------CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 122222222111 111 012238899999999999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=321.81 Aligned_cols=267 Identities=19% Similarity=0.258 Sum_probs=207.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
+++|++.+.||+|+||+||+|. +..+++.||+|++... ........+.+|+.+++.++||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 72 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGR-HKKTGDLFAIKVFNNI--------------SFLRPVDVQMREFEVLKKLNHKNIVKL 72 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEECGG--------------GGGSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEE-ECCCCcEEEEEEeccc--------------cccchHHHHHHHHHHHHhcCCCCcceE
Confidence 5789999999999999999996 5567889999998321 112335667899999999999999999
Q ss_pred ccceecCC--ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---
Q 040480 113 LAHMVRPD--SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI--- 187 (325)
Q Consensus 113 ~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~--- 187 (325)
++++.... ..++||||+++++|.+++.... ....++...+..++.|++.||.||| ++||+|+||||+||++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 148 (319)
T 4euu_A 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIG 148 (319)
T ss_dssp EEEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEEC
T ss_pred EEEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEecc
Confidence 99887655 7799999999999999995432 2233899999999999999999999 8899999999999999
Q ss_pred -cCCCCceeeccccceecCCCCccccceeecCCcccccccccc--------cCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 188 -DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ--------TLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 188 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~--------~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+.++.++|+|||++.......... ...||+.|+|||++. +..++.++||||||+++|+|++|..||..
T Consensus 149 ~~~~~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 149 EDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp TTSCEEEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCCceEEEccCCCceecCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 677789999999998765543322 247899999999876 46789999999999999999999999975
Q ss_pred cccCCCcchHHHHHHHHhhhCCCCccc--------------chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 259 FFSHTGEMDMVRWMRNVMASENPNRAI--------------DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... ......+.......... ...............+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 226 FEGPRRN---KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp TTCGGGC---HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCccchh---HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 4332222 22223333322211100 000111223566677999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=325.55 Aligned_cols=249 Identities=19% Similarity=0.240 Sum_probs=203.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|.+.. ...........+.+|+.+++.++||||+++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 106 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVK-HKESGNHYAMKILDK------------QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred HHHCEEEEEeecCcCcEEEEEE-ECCCCCEEEEEEEEh------------HHhccHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4689999999999999999996 556789999999831 111223446778899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+..|+||||+++++|.+++.. ...++...+..++.|++.||.||| ++||+||||||+||+++.++.
T Consensus 107 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~ 179 (350)
T 1rdq_E 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGY 179 (350)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCC
Confidence 9999999999999999999999999943 345899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++....... ...+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... . ....
T Consensus 180 ~kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~---~~~~ 247 (350)
T 1rdq_E 180 IQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----P---IQIY 247 (350)
T ss_dssp EEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----H---HHHH
T ss_pred EEEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC----H---HHHH
Confidence 9999999998764321 22578999999999999999999999999999999999999996521 1 2222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
..+....... +. ..+..+.+||.+||+.||.+||+ ++++++
T Consensus 248 ~~i~~~~~~~---p~--------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 248 EKIVSGKVRF---PS--------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHCCCCC---CT--------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHcCCCCC---CC--------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2333222111 11 01223899999999999999998 788764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=327.21 Aligned_cols=254 Identities=21% Similarity=0.253 Sum_probs=202.2
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
...++|++.+.||+|+||.||+|+ +..+++.||+|.+.. ...........+..|..++..+ +||+|
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~-~~~~~~~~AiK~~~~------------~~~~~~~~~~~~~~E~~~l~~~~~hp~i 83 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSE-RKGTDELYAVKILKK------------DVVIQDDDVECTMVEKRVLALPGKPPFL 83 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEE-ETTEEEEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHTCTTCCTTB
T ss_pred CchHHcEEEEEEeeCCCEEEEEEE-ECCCCCEEEEEEEEH------------HHhhcchHHHHHHHHHHHHHhcCCCCEE
Confidence 456899999999999999999996 456788999999831 1111234466788899999988 79999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.+.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+||+++.
T Consensus 84 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~ 156 (353)
T 2i0e_A 84 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDS 156 (353)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECT
T ss_pred eeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcC
Confidence 9999999999999999999999999999943 345899999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||++........ .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... . .
T Consensus 157 ~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~---~ 227 (353)
T 2i0e_A 157 EGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----E---D 227 (353)
T ss_dssp TSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----H---H
T ss_pred CCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC----H---H
Confidence 99999999999976433222 1223589999999999999999999999999999999999999996522 1 2
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh-----hhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS-----KDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~ 324 (325)
.....+....... +. ..+..+.+||.+||+.||.+||++ +++++
T Consensus 228 ~~~~~i~~~~~~~---p~--------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 228 ELFQSIMEHNVAY---PK--------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHHHCCCCC---CT--------TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHHhCCCCC---CC--------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2222333222111 11 112238999999999999999964 66653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=323.69 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=184.6
Q ss_pred cCcccc---cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCc
Q 040480 34 DCFASL---EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNI 109 (325)
Q Consensus 34 ~~y~~~---~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i 109 (325)
++|++. +.||+|+||.||+|. +..+++.||+|++. ........+|+.+++.+. ||||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~------------------~~~~~~~~~e~~~l~~l~~h~ni 68 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCV-HKKSNQAFAVKIIS------------------KRMEANTQKEITALKLCEGHPNI 68 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEE-ETTTCCEEEEEEEE------------------GGGHHHHHHHHHHHHHTTTCTTB
T ss_pred hccccccCCCccccCCCeEEEEEE-ECCCCCEEEEEEEC------------------hhhhhhHHHHHHHHHHhcCCCCe
Confidence 345554 789999999999995 55678999999982 123456778999999997 9999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.+....|+||||+++++|.+++. ....+++..+..++.|++.||.||| ++||+|+||||+||+++.
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~ 141 (325)
T 3kn6_A 69 VKLHEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTD 141 (325)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC
T ss_pred eEEEEEEEcCCEEEEEEEccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEec
Confidence 999999999999999999999999999994 3456999999999999999999999 889999999999999986
Q ss_pred CC---CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 190 DM---EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 190 ~~---~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
++ .++|+|||++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 142 ~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 219 (325)
T 3kn6_A 142 ENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT 219 (325)
T ss_dssp ----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC
T ss_pred CCCcccEEEeccccceecCCCCCcc--cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc
Confidence 65 79999999998665433221 22478999999999999999999999999999999999999997644322223
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+....... +. ......+..+.+||.+||+.||.+|||++++++
T Consensus 220 ~~~~~~~~i~~~~~~~---~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 220 SAVEIMKKIKKGDFSF---EG----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CHHHHHHHHTTTCCCC---CS----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cHHHHHHHHHcCCCCC---Cc----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 3334444433332221 11 111223344899999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=323.84 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=205.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..++..||+|.+........ ........+.+|+.+++.++||||+++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~hp~iv~~ 79 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSS---------RRGVSREDIEREVSILKEIQHPNVITL 79 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEE-ETTTCCEEEEEEEEBCCSTTC---------SSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceEeceEEeeCCCeEEEEEE-ECCCCcEEEEEEEEccccccc---------cchhhHHHHHHHHHHHHhCCCCCCCcE
Confidence 3679999999999999999995 557789999999854321110 111245678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC-
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM- 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~- 191 (325)
++++...+..++||||+++++|.+++ .....+++..+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 80 ~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 80 HEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHH----TTSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSS
T ss_pred EEEEEeCCEEEEEEEcCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCC
Confidence 99999999999999999999999999 34456999999999999999999999 88999999999999998877
Q ss_pred ---CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 ---EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ---~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~-- 223 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQ-- 223 (326)
T ss_dssp SSCCEEECCCTTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HH--
T ss_pred CCCCEEEEECCCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HH--
Confidence 7999999999876543322 22478999999999999899999999999999999999999996521 11
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+...... .+..... ..+..+.+|+.+||+.||++|||+.++++
T Consensus 224 -~~~~~~~~~~~~---~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 224 -ETLANVSAVNYE---FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -HHHHHHHHTCCC---CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHhcCCC---cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112222222111 1111111 12234889999999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=320.44 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=202.5
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
.|...+.||+|+||.||+|+ +..+++.||||.+... .....+.+.+|+.+++.++||||+++++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~-~~~~g~~vavK~~~~~---------------~~~~~~~~~~E~~~l~~l~h~niv~~~~ 109 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAR-EKHSGRQVAVKMMDLR---------------KQQRRELLFNEVVIMRDYQHFNVVEMYK 109 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEETT---------------TCCSHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhhccEEeccCCCeEEEEEE-ECCCCcEEEEEEEecc---------------chhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 48888899999999999996 4567899999998321 2234567889999999999999999999
Q ss_pred ceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCce
Q 040480 115 HMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR 194 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~ 194 (325)
++...+..++||||+++++|.+++. ...+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++
T Consensus 110 ~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k 181 (321)
T 2c30_A 110 SYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVK 181 (321)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEE
T ss_pred EEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEE
Confidence 9999999999999999999999983 346899999999999999999999 78999999999999999999999
Q ss_pred eeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHH
Q 040480 195 ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 195 l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
|+|||++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... . ......
T Consensus 182 l~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~----~---~~~~~~ 252 (321)
T 2c30_A 182 LSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS----P---VQAMKR 252 (321)
T ss_dssp ECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----H---HHHHHH
T ss_pred EeeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----H---HHHHHH
Confidence 99999998765433221 23578999999999999899999999999999999999999996522 1 122222
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+.....+..... ...+..+.+++.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 253 LRDSPPPKLKNS--------HKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHSSCCCCTTG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhcCCCCCcCcc--------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222222211111 111233889999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.42 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=205.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|.+.+.||+|+||.||+|+ +..+++.||+|++.. ...........+.+|+.+++.++||||++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~-~~~~g~~vAvK~i~~------------~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~ 80 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGK-HELTGHKVAVKILNR------------QKIRSLDVVGKIRREIQNLKLFRHPHIIK 80 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTTHHHHHHHHHHHTTCCCTTBCC
T ss_pred eecCEEEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEEh------------hhccCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 34789999999999999999996 556789999999831 11112234567899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..|+||||+++++|.+++ .....+++..+..++.|++.||.||| ++||+||||||+||+++.++
T Consensus 81 l~~~~~~~~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~ 153 (476)
T 2y94_A 81 LYQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHM 153 (476)
T ss_dssp EEEEEECSSEEEEEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTC
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCC
Confidence 999999999999999999999999998 34566999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||++......... ...+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.. ....
T Consensus 154 ~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~-- 224 (476)
T 2y94_A 154 NAKIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH----VPTL-- 224 (476)
T ss_dssp CEEECCCSSCEECCTTCCB---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS----SHHH--
T ss_pred CeEEEeccchhhccccccc---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC----HHHH--
Confidence 9999999999876543322 22579999999999988765 689999999999999999999997532 1122
Q ss_pred HHHHHhhhCCCC-cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPN-RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+....... ... ...+.+|+.+||+.||.+|||++++++
T Consensus 225 -~~~i~~~~~~~p~~~------------s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 225 -FKKICDGIFYTPQYL------------NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -HHHHHTTCCCCCTTC------------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHhcCCcCCCccC------------CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 22222222111 111 123899999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=319.12 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=201.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|+ +..+++.||+|.+.... ........+.+|+.++++++||||++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 67 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAK-NRETHEIVALKRVRLDD-------------DDEGVPSSALREICLLKELKHKNIVRLH 67 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEE-ETTTCCEEEEEEEESSC-------------SSTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCceeeeEecCCCCeEEEEEE-ECCCCceEEEEeeeccC-------------CcCCcchHHHHHHHHHhcCCCCCEeeEE
Confidence 589999999999999999996 55778999999984322 2223456788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+.+..++||||+++ ++.+.+.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~ 140 (292)
T 3o0g_A 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGEL 140 (292)
T ss_dssp EEEEETTEEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred eEEEeCCEEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 999999999999999976 66666532 3456999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||.+.......... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||... ....+....+
T Consensus 141 kl~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~---~~~~~~~~~i 215 (292)
T 3o0g_A 141 KLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRI 215 (292)
T ss_dssp EECCCTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC---SSHHHHHHHH
T ss_pred EEeecccceecCCccccc--cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC---CCHHHHHHHH
Confidence 999999998765332221 2247899999999988766 799999999999999999988886331 1122222222
Q ss_pred HHHhhhCCCCcccch---------------hhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDS---------------KLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...........+... .............+.+|+.+||+.||++|||++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 222211111110000 0000111123344889999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=334.41 Aligned_cols=216 Identities=25% Similarity=0.370 Sum_probs=180.8
Q ss_pred hHHHHHhhhcCcccccccccC--cceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHh
Q 040480 25 EDLAFLKKEDCFASLEKIGSG--GCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITAS 102 (325)
Q Consensus 25 ~~~~~~~~~~~y~~~~~lg~G--~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 102 (325)
+...++...++|++.+.||+| +||.||+|+ +..+++.||+|++... .........+.+|+.+++
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~-~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~ 81 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLAR-YKPTGEYVTVRRINLE-------------ACSNEMVTFLQGELHVSK 81 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEE-ETTTCCEEEEEEEEGG-------------GSCHHHHHHHHHHHHHHH
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEE-EcCCCCEEEEEEeccc-------------ccChHHHHHHHHHHHHHH
Confidence 334456678899999999999 999999996 5567899999998421 122345667889999999
Q ss_pred ccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 103 QIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 103 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
.++||||+++++++.+.+..++||||+++++|.+++... ....+++..+..++.|++.||.||| ++||+||||||
T Consensus 82 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp 156 (389)
T 3gni_B 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKA 156 (389)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred hCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 999999999999999999999999999999999999542 2355899999999999999999999 88999999999
Q ss_pred CceEecCCCCceeeccccceecCCCCc-----cccceeecCCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCC
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDGLT-----QIDTMYVVGTPRYIAPEYHQT--LTISEKCDIYSFGVLLAVLVMGKFP 255 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~g~~~~~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p 255 (325)
+||+++.++.++|+|||.+........ ........||..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 157 ~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 236 (389)
T 3gni_B 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236 (389)
T ss_dssp GGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred HHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999865432211 111122478899999999987 5789999999999999999999999
Q ss_pred CCCc
Q 040480 256 FDDF 259 (325)
Q Consensus 256 ~~~~ 259 (325)
|.+.
T Consensus 237 f~~~ 240 (389)
T 3gni_B 237 FKDM 240 (389)
T ss_dssp TTTC
T ss_pred CCCC
Confidence 9753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=321.18 Aligned_cols=268 Identities=25% Similarity=0.338 Sum_probs=189.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.... .......+.+|+.+++.++||||++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~hp~iv~ 67 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGL-NKTTGVYVALKEVKLDS--------------EEGTPSTAIREISLMKELKHENIVR 67 (317)
T ss_dssp ----------------CEEEEEE-CSSSCCEEEEEEEECCS--------------TTCSCHHHHHHHHHHTTCCBTTBCC
T ss_pred cccceeEeeEECCCCCEEEEEEE-ECCCCcEEEEEEeeccc--------------ccccHHHHHHHHHHHHhcCCCCcce
Confidence 45789999999999999999995 56778999999984321 1123456788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcc--cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK--GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++...+..++||||+++ +|.+++..... ....++...+..++.|++.||.||| ++||+|+||||+||+++.
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~ 143 (317)
T 2pmi_A 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINK 143 (317)
T ss_dssp EEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECT
T ss_pred EEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcC
Confidence 99999999999999999985 99999865322 2245888899999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
++.+||+|||++.......... ....||+.|+|||++.+. .++.++||||||+++|+|++|..||.... ..+.
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~ 217 (317)
T 2pmi_A 144 RGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN----DEEQ 217 (317)
T ss_dssp TCCEEECCCSSCEETTSCCCCC--CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHH
T ss_pred CCCEEECcCccceecCCCcccC--CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHH
Confidence 9999999999998765332211 224789999999998764 58999999999999999999999997532 2222
Q ss_pred HHHHHHHhhhCCCCcccc--------------------hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAID--------------------SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+...........+.. ..............+.+|+.+||+.||++|||++|+++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 218 LKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 222222211111100000 00000000112334899999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=328.66 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=208.2
Q ss_pred hhHHHHHhhhcCcccccccccCcceeEEEEEe----cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHH
Q 040480 24 KEDLAFLKKEDCFASLEKIGSGGCGDVYKAEL----PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99 (325)
Q Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 99 (325)
.+...+....++|++.+.||+|+||.||+|++ +..+++.||+|.+... ........+.+|+.
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~ 77 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--------------ATHSEHRALMSELK 77 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--------------CCHHHHHHHHHHHH
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--------------CCHHHHHHHHHHHH
Confidence 34455666789999999999999999999974 3456689999998321 12233567899999
Q ss_pred HHhcc-CCCCccccccceecCCc-eEEEEEcccCCCHHHHHhhhccc---------------------------------
Q 040480 100 TASQI-RHRNILPLLAHMVRPDS-HLLVYDFMKNGSLQAVLYDVSKG--------------------------------- 144 (325)
Q Consensus 100 ~l~~l-~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~--------------------------------- 144 (325)
+++++ +||||+++++++...+. .++||||+++++|.+++......
T Consensus 78 ~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (359)
T 3vhe_A 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSIT 157 (359)
T ss_dssp HHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------
T ss_pred HHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccC
Confidence 99999 78999999999887654 89999999999999999653221
Q ss_pred -----------------------------ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCcee
Q 040480 145 -----------------------------RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195 (325)
Q Consensus 145 -----------------------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l 195 (325)
...+++..+..++.|++.||.||| ++||+|+||||+||+++.++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl 234 (359)
T 3vhe_A 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKI 234 (359)
T ss_dssp --------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred ccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEE
Confidence 122888899999999999999999 889999999999999999999999
Q ss_pred eccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHH
Q 040480 196 SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRN 274 (325)
Q Consensus 196 ~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 274 (325)
+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||..... ........
T Consensus 235 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~-- 309 (359)
T 3vhe_A 235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEFCRRL-- 309 (359)
T ss_dssp CCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SHHHHHHH--
T ss_pred EeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch---hHHHHHHH--
Confidence 99999987654443333334577889999999999899999999999999999998 9999975322 11122211
Q ss_pred HhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+ . ..+..+.+++.+||+.||.+|||+.++++
T Consensus 310 -~~~~~~~~~--~--------~~~~~l~~li~~~l~~dP~~Rps~~ell~ 348 (359)
T 3vhe_A 310 -KEGTRMRAP--D--------YTTPEMYQTMLDCWHGEPSQRPTFSELVE 348 (359)
T ss_dssp -HHTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HcCCCCCCC--C--------CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111111111 0 01123899999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=321.77 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=198.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..++..||+|.+..... ........+.+|+.++++++||||+++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~------------~~~~~~~~~~~e~~~l~~l~hp~iv~~ 76 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAE-DTILNIKVAIKAIFIPPR------------EKEETLKRFEREVHNSSQLSHQNIVSM 76 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEE-ETTTCSEEEEEEEECCSS------------CCHHHHHHHHHHHHHHTTCCBTTBCCE
T ss_pred hccEEEEEEEccCCCEEEEEEE-ECCCCCeEEEEEeccCcc------------ccHHHHHHHHHHHHHHhcCCCCCCceE
Confidence 4789999999999999999995 566789999999843321 122345678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||||+||+++.++.
T Consensus 77 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~ 149 (294)
T 4eqm_A 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKT 149 (294)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSC
T ss_pred EEeeeeCCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCC
Confidence 9999999999999999999999999943 346899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++......... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ....
T Consensus 150 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~ 221 (294)
T 4eqm_A 150 LKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIA 221 (294)
T ss_dssp EEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHH
T ss_pred EEEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHH
Confidence 999999999765433221 12224789999999999999999999999999999999999999965221 1111
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-Chhhhh
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-NSKDVR 323 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell 323 (325)
........+.. ..... .+.+..+.+++.+||+.||.+|| ++++++
T Consensus 222 ~~~~~~~~~~~--~~~~~----~~~~~~l~~li~~~l~~dp~~R~~~~~~l~ 267 (294)
T 4eqm_A 222 IKHIQDSVPNV--TTDVR----KDIPQSLSNVILRATEKDKANRYKTIQEMK 267 (294)
T ss_dssp HHHHSSCCCCH--HHHSC----TTSCHHHHHHHHHHSCSSGGGSCSSHHHHH
T ss_pred HHHhhccCCCc--chhcc----cCCCHHHHHHHHHHhcCCHhHccccHHHHH
Confidence 11111111111 11111 11223489999999999999999 666554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=316.89 Aligned_cols=254 Identities=21% Similarity=0.340 Sum_probs=203.3
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
|....++|++.+.||+|+||.||+|.+. ++..||+|++.. .....+.+.+|+.++++++|||
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~----------------~~~~~~~~~~E~~~l~~l~h~~ 66 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIRE----------------GAMSEEDFIEEAEVMMKLSHPK 66 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECT----------------TSBCHHHHHHHHHHHHTCCCTT
T ss_pred EEeChhhceeeheecCCCccEEEEEEec--CCCeEEEEEecc----------------cccCHHHHHHHHHHHHhCCCCC
Confidence 4456689999999999999999999754 577899999832 1123456889999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++.+.+..++||||+++++|.+++.. ....++...+..++.|++.||.+|| ++|++|+||||+||+++
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~ 140 (269)
T 4hcu_A 67 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVG 140 (269)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred EeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEc
Confidence 99999999999999999999999999999843 3446899999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ...
T Consensus 141 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~----~~~ 215 (269)
T 4hcu_A 141 ENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSE 215 (269)
T ss_dssp GGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHH
T ss_pred CCCCEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC----HHH
Confidence 9999999999999765443221 1112356778999999998899999999999999999999 999996522 122
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ...+........+ . ..+..+.+++.+||+.||++|||+.++++
T Consensus 216 ~---~~~~~~~~~~~~~---~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 259 (269)
T 4hcu_A 216 V---VEDISTGFRLYKP---R-------LASTHVYQIMNHCWRERPEDRPAFSRLLR 259 (269)
T ss_dssp H---HHHHHTTCCCCCC---T-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H---HHHHhcCccCCCC---C-------cCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2 2222222111111 0 01223899999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=318.92 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=196.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHH-----------HHhhCcchHHHHHHHHHH
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDA-----------YSELGEGKLTEIRSQIIT 100 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~e~~~ 100 (325)
..++|++.+.||+|+||.||+|. +..+++.||+|.+..........+... .........+.+.+|+.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEE-ETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEE-ECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45789999999999999999995 567889999999854321110000000 000111234578999999
Q ss_pred HhccCCCCccccccceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 101 ASQIRHRNILPLLAHMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 101 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
++.++||||+++++++.+ .+..++||||+++++|.++. ....+++..+..++.|++.||.||| ++|++|+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 999999999999999876 56789999999999998754 3456999999999999999999999 7899999
Q ss_pred CCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCC---CCCccchhhHHHHHHHHHhCCCC
Q 040480 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT---ISEKCDIYSFGVLLAVLVMGKFP 255 (325)
Q Consensus 179 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~p 255 (325)
||||+||+++.++.++|+|||++......... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|..|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999999999999999999876543322 12257899999999988765 37789999999999999999999
Q ss_pred CCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 256 FDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|.... . ......+....... +..+ ..+..+.+|+.+||+.||++|||+.|+++
T Consensus 240 f~~~~----~---~~~~~~~~~~~~~~-~~~~--------~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDER----I---MCLHSKIKSQALEF-PDQP--------DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSS----H---HHHHHHHHHCCCCC-CSSS--------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCcc----H---HHHHHHHhcccCCC-CCcc--------ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 96521 1 11122222211111 1000 11223899999999999999999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=332.23 Aligned_cols=258 Identities=21% Similarity=0.306 Sum_probs=201.6
Q ss_pred hcCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
.++|++.+.||+|+||+||+|++. ..++..||+|.+... ........+.+|+.+++.++|||
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~hpn 135 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--------------CSEQDELDFLMEALIISKFNHQN 135 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--------------CCHHHHHHHHHHHHHHHHCCCTT
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--------------cChhhHHHHHHHHHHHHhCCCCC
Confidence 478999999999999999999753 345678999987311 12233456888999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcc---cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK---GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
|+++++++......++||||+++++|.+++..... ....++...+..++.|++.||.||| ++||+||||||+||
T Consensus 136 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI 212 (367)
T 3l9p_A 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNC 212 (367)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred CCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhE
Confidence 99999999999999999999999999999965432 2245888899999999999999999 88999999999999
Q ss_pred EecCCC---CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCccc
Q 040480 186 LIDDDM---EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFS 261 (325)
Q Consensus 186 l~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~ 261 (325)
+++.++ .++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~- 291 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS- 291 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 999554 599999999975433222222223467889999999998899999999999999999998 999996522
Q ss_pred CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. .....+......... ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 292 ---~~---~~~~~i~~~~~~~~~----------~~~~~~l~~li~~~l~~dP~~Rps~~eil~ 338 (367)
T 3l9p_A 292 ---NQ---EVLEFVTSGGRMDPP----------KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338 (367)
T ss_dssp ---HH---HHHHHHHTTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HH---HHHHHHHcCCCCCCC----------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 12 222222222221111 011223889999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=314.14 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=203.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|++... .........+.+|+.+++.++||||+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 70 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTK-------------KLSARDFQKLEREARICRKLQHPNIVRL 70 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEGG-------------GCCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhhhhhhcCcCCeEEEEEE-EcCCCceEEEEEeecc-------------cCCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence 4789999999999999999995 5577889999998422 1223345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++...+..++||||+++++|.+.+.. ...++...+..++.|++.||.||| ++|++|+||+|+||+++.++.
T Consensus 71 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~ 143 (284)
T 3kk8_A 71 HDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAK 143 (284)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSST
T ss_pred EEEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCC
Confidence 9999999999999999999999998843 355899999999999999999999 889999999999999986655
Q ss_pred ---ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 193 ---ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 193 ---~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++|+|||.+.......... ...|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .....
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~ 216 (284)
T 3kk8_A 144 GAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLY 216 (284)
T ss_dssp TCCEEECCCTTCEECCSSCBCC---CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH
T ss_pred CCcEEEeeceeeEEcccCcccc---CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc----hhHHH
Confidence 9999999998765443322 2478999999999999999999999999999999999999996522 12222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............ .. ....+..+.+|+.+||+.||++|||++|+++
T Consensus 217 ---~~~~~~~~~~~~---~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 217 ---AQIKAGAYDYPS---PE----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---HHHHHTCCCCCT---TT----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---HHHHhccccCCc---hh----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 222222111100 00 0111233889999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=318.79 Aligned_cols=263 Identities=26% Similarity=0.357 Sum_probs=197.3
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|+. .+++.+|+|++.... ........+.+|+.+++.++||||++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 66 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEK-------------EDEGIPSTTIREISILKELKHSNIVKLY 66 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSS-------------GGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred ccchhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccc-------------cccccchhHHHHHHHHHhcCCCCEeeee
Confidence 5899999999999999999975 468899999984321 1122345678999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..++||||+++ +|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 67 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 139 (288)
T 1ob3_A 67 DVIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGEL 139 (288)
T ss_dssp EEEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred eEEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCE
Confidence 999999999999999976 89888843 3356889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||.+......... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.... ..+....+
T Consensus 140 kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~ 213 (288)
T 1ob3_A 140 KIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRI 213 (288)
T ss_dssp EECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHH
T ss_pred EEeECccccccCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH
Confidence 99999999765432221 1224789999999998764 58999999999999999999999997532 12222212
Q ss_pred HHHhhhCCCCccc--------chhh-------cCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAI--------DSKL-------LGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~--------~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...........+. ++.. ........+..+.+|+.+||+.||++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111111110000 0000 00001112334889999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=313.19 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=202.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|++. ++..||+|.+... ......+.+|+.++++++||||++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~----------------~~~~~~~~~E~~~l~~l~h~~i~~ 67 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEG----------------SMSEDEFFQEAQTMMKLSHPKLVK 67 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBT----------------TBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred chhheeeeeeeccCCCceEEEEEec--CceeEEEEEeccC----------------CCcHHHHHHHHHHHHhCCCCCEee
Confidence 5689999999999999999999754 5678999998321 123456889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~ 141 (268)
T 3sxs_A 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDL 141 (268)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTC
T ss_pred EEEEEccCCceEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCC
Confidence 99999999999999999999999999954 2345899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+........... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... . .
T Consensus 142 ~~~l~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~---~ 213 (268)
T 3sxs_A 142 CVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----S---E 213 (268)
T ss_dssp CEEECCTTCEEECCTTCEEEC-CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----H---H
T ss_pred CEEEccCccceecchhhhhcc-cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----H---H
Confidence 999999999987655432221 22355678999999999889999999999999999999 9999965321 1 1
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............+ . . .+..+.+++.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~---~----~---~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 214 VVLKVSQGHRLYRP---H----L---ASDTIYQIMYSCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp HHHHHHTTCCCCCC---T----T---SCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCCCC---C----c---ChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11222222211111 0 0 1123889999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=313.79 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=200.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..++..||+|.+... ..........+.+|+.+++.++||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 73 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAR-EKQSKFILALKVLFKA------------QLEKAGVEHQLRREVEIQSHLRHPNILR 73 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEHH------------HHHHHTCHHHHHHHHHHHTTCCCTTBCC
T ss_pred ecccEEEeeEEecCCCeEEEEEE-EccCCcEEEEEEEecc------------ccchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 34789999999999999999995 5567889999998321 1111233567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~ 146 (279)
T 3fdn_A 74 LYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAG 146 (279)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTS
T ss_pred hhheEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCC
Confidence 99999999999999999999999999843 345899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... ....
T Consensus 147 ~~~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~--- 215 (279)
T 3fdn_A 147 ELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQET--- 215 (279)
T ss_dssp CEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHH---
T ss_pred CEEEEeccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc----HHHH---
Confidence 999999999865433221 22478999999999999899999999999999999999999996421 1111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+......... ..+..+.+|+.+||+.||.+|||++|+++
T Consensus 216 ~~~~~~~~~~~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 216 YKRISRVEFTFPD-----------FVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHHHTCCCCCT-----------TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCC-----------cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1222221111110 01123889999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=326.72 Aligned_cols=253 Identities=20% Similarity=0.268 Sum_probs=203.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.+|+|.+... .......+.+|+.+++.++||||+++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~-~~~~~~~~a~K~~~~~---------------~~~~~~~~~~E~~il~~l~hpnIv~~ 113 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCV-EKATGRVFVAKFINTP---------------YPLDKYTVKNEISIMNQLHHPKLINL 113 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEECC---------------SHHHHHHHHHHHHHHTTCCSTTBCCE
T ss_pred ccceEEEEEEecCCCEEEEEEE-ECCCCCEEEEEEeccc---------------chhhHHHHHHHHHHHHhCCCcCCCeE
Confidence 3689999999999999999995 5677889999988321 11234568899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC--C
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD--D 190 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~--~ 190 (325)
++++.+....++||||+.+++|.+++.. ....+++..+..++.|++.||.||| ++||+|+||||+||+++. +
T Consensus 114 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~ 187 (387)
T 1kob_A 114 HDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKA 187 (387)
T ss_dssp EEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTC
T ss_pred EEEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCC
Confidence 9999999999999999999999998832 3346899999999999999999999 889999999999999974 4
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .. .
T Consensus 188 ~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~---~ 257 (387)
T 1kob_A 188 SSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DL---E 257 (387)
T ss_dssp CCEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HH---H
T ss_pred CceEEEecccceecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC----HH---H
Confidence 67999999999877554322 22578999999999999899999999999999999999999997522 11 2
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+....... +... ....+..+.+||.+||+.||++|||+.++++
T Consensus 258 ~~~~i~~~~~~~---~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 258 TLQNVKRCDWEF---DEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHHHHCCCCC---CSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCCC---Cccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 222222222111 0000 1112233899999999999999999999985
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=322.65 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=200.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|++.+.||+|+||.||+|.+... .+..||||.+... ........+.+|+.+++.++||||
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i 112 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--------------YTERQRRDFLSEASIMGQFDHPNI 112 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--------------CCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--------------CCHHHHHHHHHHHHHHHhCCCCCC
Confidence 457899999999999999999975422 3456999998321 122345678999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.+.+..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++||+|+||||+||+++.
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~ 186 (325)
T 3kul_A 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDS 186 (325)
T ss_dssp CCEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred CcEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECC
Confidence 9999999999999999999999999999843 3356899999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
++.++|+|||++.......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.... ..+
T Consensus 187 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~----~~~ 262 (325)
T 3kul_A 187 NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----NRD 262 (325)
T ss_dssp TCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC----HHH
T ss_pred CCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC----HHH
Confidence 9999999999998765432221 1122355778999999998899999999999999999999 999996532 122
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ..+......... . ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 263 ~~---~~~~~~~~~~~~--~--------~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 263 VI---SSVEEGYRLPAP--M--------GCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HH---HHHHTTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---HHHHcCCCCCCC--C--------CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22 222222211111 0 11233899999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=314.53 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=199.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..++..+|+|.+... ........+.+|+.+++.++||||+++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~hp~iv~~ 85 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVE-ERSSGLERVIKTINKD--------------RSQVPMEQIEAEIEVLKSLDHPNIIKI 85 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEGG--------------GCCSCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhheeecceeccCCCeEEEEEE-EccCCceEEEEEeecc--------------ccchhHHHHHHHHHHHHhCCCchHHhH
Confidence 3789999999999999999996 5567889999998421 122345778999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec---C
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID---D 189 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~---~ 189 (325)
++++.+....++||||+++++|.+.+.........++...+..++.|++.||.||| ++|++|+||||+||+++ .
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~ 162 (285)
T 3is5_A 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSP 162 (285)
T ss_dssp EEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSST
T ss_pred HHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCC
Confidence 99999999999999999999999999765555677999999999999999999999 88999999999999994 5
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||++......... ....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... .....
T Consensus 163 ~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~----~~~~~ 234 (285)
T 3is5_A 163 HSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEVQ 234 (285)
T ss_dssp TCCEEECCCCCCCC-------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH
T ss_pred CCCEEEEeeecceecCCcccC---cCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCC----HHHHH
Confidence 578999999999765543322 22578999999998864 68899999999999999999999996522 11111
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... .... .. ....+.+|+.+||+.||++|||+.|+++
T Consensus 235 ---~~~~~~~~~~-~~~~---~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 235 ---QKATYKEPNY-AVEC---RP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---HHHHHCCCCC-CC-----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---hhhccCCccc-cccc---Cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111 0000 00 1123889999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=338.06 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=205.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|++.. ...........+.+|..+++.++||||+++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~-~~~tg~~vAiK~l~k------------~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 250 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQ-MKATGKLYACKKLNK------------KRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhheEEEEEEeeCCCeEEEEEE-ECCCCcEEEEEEEEh------------HHhhhhHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 4789999999999999999996 456789999999831 111222345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+..|+||||++|++|.+++.........+++..+..++.|++.||.||| ++||+||||||+||+++.++.
T Consensus 251 ~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~ 327 (543)
T 3c4z_A 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGN 327 (543)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSC
T ss_pred EEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCC
Confidence 99999999999999999999999999654444567999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++......... ....+||+.|+|||++.+..++.++|+|||||++|+|++|..||......... ....
T Consensus 328 vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~~~ 402 (543)
T 3c4z_A 328 VRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELK 402 (543)
T ss_dssp EEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HHHH
T ss_pred EEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HHHH
Confidence 999999999876544322 22258999999999999999999999999999999999999999764322222 2222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
..+....... +. ..+..+.+||.+||+.||.+||++
T Consensus 403 ~~i~~~~~~~---p~--------~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 403 QRVLEQAVTY---PD--------KFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHHCCCCC---CT--------TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred HHHhhcccCC---Cc--------ccCHHHHHHHHHhccCCHhHCCCC
Confidence 2332222111 11 112238899999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=328.48 Aligned_cols=261 Identities=25% Similarity=0.306 Sum_probs=207.1
Q ss_pred HhhhcCcccccccccCcceeEEEEEecC------CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPG------SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ 103 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 103 (325)
....++|++.+.||+|+||.||+|++.. ..+..||+|++... ........+.+|+.+++.
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~ 130 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--------------ATEKDLSDLISEMEMMKM 130 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--------------CCHHHHHHHHHHHHHHHH
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--------------cCHHHHHHHHHHHHHHHH
Confidence 3455799999999999999999997532 23367999998321 122345678899999999
Q ss_pred c-CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhc
Q 040480 104 I-RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMH 170 (325)
Q Consensus 104 l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~ 170 (325)
+ +||||+++++++...+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||
T Consensus 131 l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-- 208 (382)
T 3tt0_A 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-- 208 (382)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred hcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--
Confidence 9 899999999999999999999999999999999965331 1245899999999999999999999
Q ss_pred CCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHH
Q 040480 171 HSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLV 250 (325)
Q Consensus 171 ~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (325)
++||+|+||||+||+++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 209 -~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (382)
T 3tt0_A 209 -SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287 (382)
T ss_dssp -HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred -hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence 7899999999999999999999999999998765543333333346788999999999999999999999999999999
Q ss_pred h-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 251 M-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 251 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+ |..||.... ..+ ....+........+ . ..+..+.+|+.+||+.||++|||+.++++
T Consensus 288 t~g~~p~~~~~----~~~---~~~~~~~~~~~~~~--~--------~~~~~l~~li~~~l~~dP~~Rps~~ell~ 345 (382)
T 3tt0_A 288 TLGGSPYPGVP----VEE---LFKLLKEGHRMDKP--S--------NCTNELYMMMRDCWHAVPSQRPTFKQLVE 345 (382)
T ss_dssp TTSCCSSTTCC----HHH---HHHHHHTTCCCCCC--S--------SCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCC----HHH---HHHHHHcCCCCCCC--c--------cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9 999996522 122 22222222221111 0 11223899999999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=332.74 Aligned_cols=257 Identities=22% Similarity=0.294 Sum_probs=202.8
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
....++|++.+.||+|+||.||+|++ ..+++.||+|.+... ........+.+|+.++++++||||
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~hpni 174 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRL-RADNTLVAVKSCRET--------------LPPDLKAKFLQEARILKQYSHPNI 174 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEECCTT--------------SCHHHHTTTTHHHHHHTTCCCTTB
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEE-ecCCeEEEEEEcccc--------------CCHHHHHHHHHHHHHHHhCCCCCE
Confidence 34567899999999999999999964 457889999987321 112234467889999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++...+..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 175 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~ 248 (377)
T 3cbl_A 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTE 248 (377)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred EEEEEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcC
Confidence 9999999999999999999999999999953 2345889999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 268 (325)
++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 249 ~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~~ 324 (377)
T 3cbl_A 249 KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQT 324 (377)
T ss_dssp TCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HHH
T ss_pred CCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHH
Confidence 99999999999986544322221111234678999999998889999999999999999998 9999975321 222
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. .+........ +. ..+..+.+|+.+||+.||++|||++++++
T Consensus 325 ~~---~~~~~~~~~~--~~--------~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 325 RE---FVEKGGRLPC--PE--------LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HH---HHHTTCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---HHHcCCCCCC--CC--------CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 22 2222221111 10 11233889999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=335.08 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=202.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|+ +..+++.||+|++.. ...........+.+|..+++.++||||++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~-~~~~~~~~AiK~~~k------------~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 133 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVR-HKSTRKVYAMKLLSK------------FEMIKRSDSAFFWEERDIMAFANSPWVVQ 133 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTCCCSTHHHHHHHHHHCCCTTBCC
T ss_pred CccccEEEEEEEcCCCEEEEEEE-ECCCCcEEEEEEEeh------------hhhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 56789999999999999999996 556789999999831 11111223345788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..|+||||++||+|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+||+++.++
T Consensus 134 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g 205 (410)
T 3v8s_A 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSG 205 (410)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTS
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCC
Confidence 99999999999999999999999999832 35889999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT----ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.+||+|||++......... .....+||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.... ...
T Consensus 206 ~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~ 280 (410)
T 3v8s_A 206 HLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVG 280 (410)
T ss_dssp CEEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS----HHH
T ss_pred CEEEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC----hhh
Confidence 9999999999876544321 222358999999999988765 7889999999999999999999996522 122
Q ss_pred HHHHHHHHh-hhCCCC-cccchhhcCCchHHHHHHHHHHHhhhcCCCCCC--CCChhhhhc
Q 040480 268 MVRWMRNVM-ASENPN-RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDE--RPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~ 324 (325)
....+.... ....+. ..+ +..+.+||.+||+.+|.+ ||+++||++
T Consensus 281 ~~~~i~~~~~~~~~p~~~~~------------s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 281 TYSKIMNHKNSLTFPDDNDI------------SKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHHTHHHHCCCCTTCCC------------CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHHHhccccccCCCcccc------------cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 222111111 111111 111 122899999999999988 999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=325.80 Aligned_cols=263 Identities=21% Similarity=0.296 Sum_probs=207.2
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ 103 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 103 (325)
.+....++|++.+.||+|+||.||+|++.. .+++.||+|.+... ........+.+|+.+++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~ 106 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--------------ASADMQADFQREAALMAE 106 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--------------CCHHHHHHHHHHHHHHHT
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--------------cCHHHHHHHHHHHHHHHh
Confidence 344467899999999999999999997653 34588999987321 122345678999999999
Q ss_pred cCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhccc--------------------ccccChhhHHHHHHHHHHH
Q 040480 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG--------------------RRELEWLSRHKIALAVASG 163 (325)
Q Consensus 104 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------------------~~~~~~~~~~~i~~~l~~~ 163 (325)
++||||+++++++...+..++||||+++++|.+++...... ...+++..++.++.|++.|
T Consensus 107 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~ 186 (343)
T 1luf_A 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186 (343)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999653211 2568899999999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHH
Q 040480 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFG 243 (325)
Q Consensus 164 l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG 243 (325)
|.||| ++|++|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||
T Consensus 187 l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 263 (343)
T 1luf_A 187 MAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263 (343)
T ss_dssp HHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHH---hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHH
Confidence 99999 889999999999999999999999999999765443322222334678899999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhh
Q 040480 244 VLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322 (325)
Q Consensus 244 ~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (325)
+++|+|++ |..||.... . ......+........ +. ..+..+.+|+.+||+.||.+|||+.++
T Consensus 264 ~il~el~t~g~~p~~~~~----~---~~~~~~~~~~~~~~~--~~--------~~~~~l~~li~~~l~~~p~~Rps~~~~ 326 (343)
T 1luf_A 264 VVLWEIFSYGLQPYYGMA----H---EEVIYYVRDGNILAC--PE--------NCPLELYNLMRLCWSKLPADRPSFCSI 326 (343)
T ss_dssp HHHHHHHTTTCCTTTTSC----H---HHHHHHHHTTCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhcCCCcCCCCC----h---HHHHHHHhCCCcCCC--CC--------CCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 99999999 999996522 1 122222222222111 10 112338999999999999999999998
Q ss_pred hc
Q 040480 323 RC 324 (325)
Q Consensus 323 l~ 324 (325)
++
T Consensus 327 ~~ 328 (343)
T 1luf_A 327 HR 328 (343)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=319.74 Aligned_cols=261 Identities=22% Similarity=0.322 Sum_probs=207.1
Q ss_pred HhhhcCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR 105 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 105 (325)
....++|.+.+.||+|+||.||+|.+. ..++..||+|.+... ........+.+|+.+++.++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~ 84 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--------------ASPSELRDLLSEFNVLKQVN 84 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--------------CCHHHHHHHHHHHHHHTTCC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--------------CCHHHHHHHHHHHHHHhhCC
Confidence 345689999999999999999999753 234588999987321 12234567889999999999
Q ss_pred CCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc--------------------cccccChhhHHHHHHHHHHHHH
Q 040480 106 HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK--------------------GRRELEWLSRHKIALAVASGLE 165 (325)
Q Consensus 106 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~~l~ 165 (325)
||||+++++++...+..++||||+++++|.+++..... ....++...+..++.|++.||.
T Consensus 85 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 164 (314)
T 2ivs_A 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164 (314)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHH
T ss_pred CCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999965322 1234888999999999999999
Q ss_pred HHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHH
Q 040480 166 YLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVL 245 (325)
Q Consensus 166 ~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~i 245 (325)
||| ++|++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||++
T Consensus 165 ~lH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 241 (314)
T 2ivs_A 165 YLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241 (314)
T ss_dssp HHH---HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHH
T ss_pred HHH---HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHH
Confidence 999 78999999999999999999999999999987755443333333467788999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 246 LAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 246 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+|+|++ |..||..... ........ ....... + ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 242 l~el~t~g~~p~~~~~~----~~~~~~~~---~~~~~~~--~--------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 242 LWEIVTLGGNPYPGIPP----ERLFNLLK---TGHRMER--P--------DNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp HHHHHTTSCCSSTTCCG----GGHHHHHH---TTCCCCC--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCCH----HHHHHHhh---cCCcCCC--C--------ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999 9999975322 22222221 1111111 1 011233899999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=335.79 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=194.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.. ...........+.+|+.+++.++||||++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 212 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVK-EKATGRYYAMKILKK------------EVIVAKDEVAHTLTENRVLQNSRHPFLTA 212 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEH------------HHHC-------------CCCCCSCTTSCC
T ss_pred ChHHcEEeEEEeeCcCEEEEEEE-EcCCCCEEEEEEEEh------------hhhhhhHHHHHHHHHHHHHHhCCCCeEee
Confidence 34789999999999999999995 567889999999831 11122344566788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEecCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~nil~~~~ 190 (325)
+++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.||| + +||+||||||+||+++.+
T Consensus 213 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~ 285 (446)
T 4ejn_A 213 LKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKD 285 (446)
T ss_dssp EEEEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSS
T ss_pred EEEEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCC
Confidence 99999999999999999999999999843 456899999999999999999999 6 799999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ....
T Consensus 286 ~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~-- 357 (446)
T 4ejn_A 286 GHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKL-- 357 (446)
T ss_dssp SCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH--
T ss_pred CCEEEccCCCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHH--
Confidence 99999999999754332221 223589999999999999999999999999999999999999996522 1122
Q ss_pred HHHHHhhhCCC-CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 271 WMRNVMASENP-NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
...+...... +... +..+.+||.+||+.||.+|| |++|+++
T Consensus 358 -~~~i~~~~~~~p~~~------------~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 358 -FELILMEEIRFPRTL------------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -HHHHHHCCCCCCTTS------------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -HHHHHhCCCCCCccC------------CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 2222222111 1111 12389999999999999999 9999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=339.06 Aligned_cols=258 Identities=26% Similarity=0.353 Sum_probs=206.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.||+|++.. ...........+.+|+.+++.++||||++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~-~~~tg~~vAvK~l~k------------~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~ 248 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQ-VRATGKMYACKKLEK------------KRIKKRKGEAMALNEKQILEKVNSRFVVS 248 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccceEEEEEEeeCCCEEEEEEE-ECCCCCEEEEEEEEh------------HhhhhhHHHHHHHHHHHHHHHcCCCCEee
Confidence 45679999999999999999996 556789999999831 11112234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..|+||||++|++|.+++.. .....+++..+..++.|++.||.||| ++||+||||||+||+++.++
T Consensus 249 l~~~~~~~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g 323 (576)
T 2acx_A 249 LAYAYETKDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHG 323 (576)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTS
T ss_pred EEEEEeeCCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCC
Confidence 99999999999999999999999999843 22345899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++......... ...+||+.|+|||++.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 324 ~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~- 399 (576)
T 2acx_A 324 HIRISDLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER- 399 (576)
T ss_dssp CEEECCCTTCEECCTTCCE---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-
T ss_pred CeEEEecccceecccCccc---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-
Confidence 9999999999876544322 225899999999999998999999999999999999999999976433222222222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
.+....... +. ..+..+.+||.+||+.||.+|| +++|+++
T Consensus 400 --~i~~~~~~~---p~--------~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 400 --LVKEVPEEY---SE--------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --HHHHCCCCC---CT--------TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --HhhcccccC---Cc--------cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 222211111 11 0112389999999999999999 6788864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=319.53 Aligned_cols=263 Identities=20% Similarity=0.267 Sum_probs=207.7
Q ss_pred HHhhhcCcccccccccCcceeEEEEEe----cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAEL----PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI 104 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 104 (325)
+....++|++.+.||+|+||.||+|++ +..+++.||+|.+.... .....+.+.+|+.+++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~E~~~l~~l 83 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--------------HLTEREALMSELKVLSYL 83 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------------CHHHHHHHHHHHHHHHHH
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--------------hHHHHHHHHHHHHHHhhc
Confidence 344668999999999999999999975 44567899999984211 123456789999999999
Q ss_pred -CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc--------------cccccChhhHHHHHHHHHHHHHHHHh
Q 040480 105 -RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK--------------GRRELEWLSRHKIALAVASGLEYLHM 169 (325)
Q Consensus 105 -~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~l~~lh~ 169 (325)
+||||+++++++...+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||
T Consensus 84 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH- 162 (313)
T 1t46_A 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA- 162 (313)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred ccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-
Confidence 899999999999999999999999999999999965321 1235889999999999999999999
Q ss_pred cCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHH
Q 040480 170 HHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVL 249 (325)
Q Consensus 170 ~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~l 249 (325)
++|++|+||||+||+++.++.++|+|||.+................+++.|+|||.+.+..++.++||||||+++|+|
T Consensus 163 --~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 240 (313)
T 1t46_A 163 --SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240 (313)
T ss_dssp --HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHH
Confidence 789999999999999999999999999999877654433333334567889999999988999999999999999999
Q ss_pred Hh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 250 VM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 250 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++ |..||..... .......... ...... + ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 241 lt~g~~p~~~~~~---~~~~~~~~~~---~~~~~~--~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 241 FSLGSSPYPGMPV---DSKFYKMIKE---GFRMLS--P--------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HTTTCCSSTTCCS---SHHHHHHHHH---TCCCCC--C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCcccc---hhHHHHHhcc---CCCCCC--c--------ccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 98 9999975322 1112222111 111110 0 011233899999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=323.02 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=188.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.||+|.+... ...+.+.+|+.+++.++||||++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~ 112 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKT-----------------VDKKIVRTEIGVLLRLSHPNIIK 112 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEC---------------------------CHHHHHCCCTTBCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEE-ECCCCcEEEEEEeccc-----------------hhHHHHHHHHHHHHhCCCCCCcc
Confidence 34679999999999999999996 4567889999998321 12345778999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC--
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-- 189 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~-- 189 (325)
+++++...+..++||||+++++|.+++ .....++...+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 113 ~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~ 185 (349)
T 2w4o_A 113 LKEIFETPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPA 185 (349)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHH----TTCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSS
T ss_pred eeeeEecCCeEEEEEEeCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCC
Confidence 999999999999999999999999998 34456899999999999999999999 789999999999999975
Q ss_pred -CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 190 -DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
++.++|+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 186 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~-- 256 (349)
T 2w4o_A 186 PDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG----D-- 256 (349)
T ss_dssp TTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC----H--
T ss_pred CCCCEEEccCccccccCccccc---ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc----c--
Confidence 789999999999865443221 225789999999999998999999999999999999999999965221 1
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+....... .... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 257 ~~~~~~i~~~~~~~---~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 257 QFMFRRILNCEYYF---ISPW----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHHTTCCCC---CTTT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCcc---CCch----hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122222222111 0000 1112234899999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=308.83 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=202.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..++..+|+|++... .......+.+|+.+++.++||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~a~k~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~i~~~ 71 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAV-QKGTRIRRAAKKIPKY---------------FVEDVDRFKQEIEIMKSLDHPNIIRL 71 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEGG---------------GCSCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhEEeeeEEeecCCEEEEEEE-eCCCCcEEEEEeehhh---------------ccchHHHHHHHHHHHHhCCCCCEeeE
Confidence 5789999999999999999995 5567789999988321 12345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---cC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DD 189 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~---~~ 189 (325)
++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.||| ++|++|+||+|+||++ +.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 144 (277)
T 3f3z_A 72 YETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSP 144 (277)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSST
T ss_pred EEEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCC
Confidence 9999999999999999999999998843 455899999999999999999999 8899999999999999 77
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||.+.......... ...||+.|+|||.+.+. ++.++||||||+++|+|++|..||.... ...
T Consensus 145 ~~~~~l~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~-- 214 (277)
T 3f3z_A 145 DSPLKLIDFGLAARFKPGKMMR---TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT----DSE-- 214 (277)
T ss_dssp TCCEEECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHH--
T ss_pred CCcEEEEecccceeccCccchh---ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC----HHH--
Confidence 8899999999998765443322 24789999999998764 8999999999999999999999996522 111
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+....... +.... ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 215 -~~~~~~~~~~~~---~~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 215 -VMLKIREGTFTF---PEKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -HHHHHHHCCCCC---CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -HHHHHHhCCCCC---Cchhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122222222111 11100 012234899999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=319.12 Aligned_cols=264 Identities=22% Similarity=0.296 Sum_probs=197.2
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|. +..+++.||+|++.... ........+.+|+.++++++||||++++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 68 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCR-NRDTGQIVAIKKFLESE-------------DDPVIKKIALREIRMLKQLKHPNLVNLL 68 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEECCCC-------------C-HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeeEEeecCCeEEEEEE-eCCCCcEEEEEEeeccc-------------cchHHHHHHHHHHHHHHhCCCCCccchh
Confidence 689999999999999999996 55678999999884321 1112345678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..++||||+++++|.+++ .....++...+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~ 141 (311)
T 4agu_A 69 EVFRRKRRLHLVFEYCDHTVLHELD----RYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVI 141 (311)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHH----HTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred heeecCCeEEEEEEeCCCchHHHHH----hhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCE
Confidence 9999999999999999998888887 33456899999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||.+.......... ....||..|+|||++.+ ..++.++|+||||+++|+|++|..||..... .+.....
T Consensus 142 kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~ 215 (311)
T 4agu_A 142 KLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD----VDQLYLI 215 (311)
T ss_dssp EECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHH
T ss_pred EEeeCCCchhccCccccc--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 999999998765433221 22478999999999876 5679999999999999999999999965321 1222111
Q ss_pred HHHhhhCC-----------------CCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASEN-----------------PNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ .................+..+.+|+.+||+.||.+|||++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 216 RKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11111000 00000000000001123344889999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=323.43 Aligned_cols=263 Identities=20% Similarity=0.254 Sum_probs=203.8
Q ss_pred HHhhhcCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI 104 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 104 (325)
+....++|++.+.||+|+||.||+|.+. ..++..||+|.+... ........+.+|+.+++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l 105 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--------------ADSSEREALMSELKMMTQL 105 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------------CHHHHHHHHHHHHH
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc--------------cCHHHHHHHHHHHHHHHhh
Confidence 4446689999999999999999999752 335678999998421 1123346788999999999
Q ss_pred -CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhccc-------------------ccccChhhHHHHHHHHHHHH
Q 040480 105 -RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG-------------------RRELEWLSRHKIALAVASGL 164 (325)
Q Consensus 105 -~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~~~~i~~~l~~~l 164 (325)
.||||+++++++...+..++||||+++++|.+++...... ...+++..+..++.|++.||
T Consensus 106 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 185 (344)
T 1rjb_A 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185 (344)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHH
T ss_pred cCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHH
Confidence 8999999999999999999999999999999999543211 13478889999999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHH
Q 040480 165 EYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGV 244 (325)
Q Consensus 165 ~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~ 244 (325)
.||| ++|++|+||||+||+++.++.++|+|||++................||+.|+|||.+.+..++.++||||||+
T Consensus 186 ~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 262 (344)
T 1rjb_A 186 EFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262 (344)
T ss_dssp HHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHH---hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHH
Confidence 9999 7899999999999999999999999999998665443322233346788999999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 245 LLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 245 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
++|+|++ |..||..... ......... ....... +. ..+..+.+|+.+||+.||.+|||+.+++
T Consensus 263 il~el~t~g~~p~~~~~~---~~~~~~~~~---~~~~~~~--~~--------~~~~~l~~li~~~l~~dp~~Rps~~~l~ 326 (344)
T 1rjb_A 263 LLWEIFSLGVNPYPGIPV---DANFYKLIQ---NGFKMDQ--PF--------YATEEIYIIMQSCWAFDSRKRPSFPNLT 326 (344)
T ss_dssp HHHHHTTTSCCSSTTCCC---SHHHHHHHH---TTCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCCCCcccCCc---HHHHHHHHh---cCCCCCC--CC--------CCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 9999998 9999976322 111222111 1111110 00 1123389999999999999999999997
Q ss_pred c
Q 040480 324 C 324 (325)
Q Consensus 324 ~ 324 (325)
+
T Consensus 327 ~ 327 (344)
T 1rjb_A 327 S 327 (344)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=326.76 Aligned_cols=263 Identities=23% Similarity=0.332 Sum_probs=189.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~ 111 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|++... .........+.+|+.+++.+. ||||++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~i~~~-------------~~~~~~~~~~~~E~~~l~~l~~h~niv~ 73 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSI-DRRTGEVVAVKKIFDA-------------FQNSTDAQRTFREIMILTELSGHENIVN 73 (388)
T ss_dssp HTTEEEEEC-------CEEEEE-ETTTCCEEEEEEECC---------------CCHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred cCceEEEEEeeeCCCeEEEEEE-ECCCCCEEEEEEeccc-------------ccChHHHHHHHHHHHHHHhccCCCCCCe
Confidence 4789999999999999999995 6678899999988321 122244567789999999997 999999
Q ss_pred cccceecCC--ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 112 LLAHMVRPD--SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 112 ~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++...+ ..|+||||+++ +|.+.+.. ..++...+..++.|++.||.||| ++||+||||||+||+++.
T Consensus 74 l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~ 144 (388)
T 3oz6_A 74 LLNVLRADNDRDVYLVFDYMET-DLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNA 144 (388)
T ss_dssp EEEEEECTTSSCEEEEEECCSE-EHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECT
T ss_pred eeeEEecCCCCEEEEEecccCc-CHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcC
Confidence 999987544 68999999975 89988832 46888999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCc-------------------cccceeecCCccccccccccc-CCCCCccchhhHHHHHHHH
Q 040480 190 DMEARISGFDLAILMPDGLT-------------------QIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVL 249 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~-------------------~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~l 249 (325)
++.+||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 145 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 224 (388)
T 3oz6_A 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224 (388)
T ss_dssp TCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred CCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHH
Confidence 99999999999986543111 111222578999999999876 5689999999999999999
Q ss_pred HhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccc----------------------hhhcCCchH------------
Q 040480 250 VMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAID----------------------SKLLGNGYE------------ 295 (325)
Q Consensus 250 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~------------ 295 (325)
++|+.||.+.. ..+....+..... .+..... .........
T Consensus 225 l~g~~pf~~~~----~~~~~~~i~~~~~--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (388)
T 3oz6_A 225 LCGKPIFPGSS----TMNQLERIIGVID--FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298 (388)
T ss_dssp HHSSCSCCCSS----HHHHHHHHHHHHC--CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTT
T ss_pred HhCCCCCCCCC----HHHHHHHHHHhcC--CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccc
Confidence 99999997532 1121111111111 1100000 000000000
Q ss_pred -HHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 296 -EQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 296 -~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+.+|+.+||+.||++|||++|+++
T Consensus 299 ~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 299 ADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 12334899999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=332.42 Aligned_cols=261 Identities=24% Similarity=0.285 Sum_probs=194.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|. +..+++.||||++... .........+.+|+.+++.++||||+++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~vAiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpnIv~l 126 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAY-DAVLDRNVAIKKLSRP-------------FQNQTHAKRAYRELVLMKCVNHKNIISL 126 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEE-ETTTTEEEEEEEEESG-------------GGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred cCCeEEEEEeecCCCeEEEEEE-ECCCCCEEEEEEECcc-------------ccChHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 4789999999999999999995 6678899999998321 1233446678899999999999999999
Q ss_pred ccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++.... ..|+||||+++ +|.+.+. ..++...+..++.|++.||.||| ++||+||||||+||+
T Consensus 127 ~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIl 196 (464)
T 3ttj_A 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 196 (464)
T ss_dssp SEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred EEEEccCCccccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEE
Confidence 99986553 56999999976 5776662 23888899999999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..
T Consensus 197 l~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~----~~ 269 (464)
T 3ttj_A 197 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YI 269 (464)
T ss_dssp ECTTSCEEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HH
T ss_pred EeCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC----HH
Confidence 99999999999999986654322 222588999999999999999999999999999999999999997532 11
Q ss_pred hHHHHHHHHhhhCC-------------------C-CcccchhhcCC--------chHHHHHHHHHHHhhhcCCCCCCCCC
Q 040480 267 DMVRWMRNVMASEN-------------------P-NRAIDSKLLGN--------GYEEQMLLVLKLACFCTLADPDERPN 318 (325)
Q Consensus 267 ~~~~~~~~~~~~~~-------------------~-~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rps 318 (325)
+....+......+. . .....+..... ........+.+|+.+||+.||++|||
T Consensus 270 ~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 349 (464)
T 3ttj_A 270 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349 (464)
T ss_dssp HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC
Confidence 11111111110000 0 00000000000 01222456899999999999999999
Q ss_pred hhhhhc
Q 040480 319 SKDVRC 324 (325)
Q Consensus 319 ~~ell~ 324 (325)
++|+++
T Consensus 350 a~e~L~ 355 (464)
T 3ttj_A 350 VDDALQ 355 (464)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=320.03 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=188.3
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCC--cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
...++|++.+.||+|+||.||+|++...++ ..||+|.+.. ..........+.+|+.+++.++|||
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~h~~ 86 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-------------DIIASSDIEEFLREAACMKEFDHPH 86 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------------------CHHHHHHHHHHHHHTTCCCTT
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecc-------------cccCHHHHHHHHHHHHHHHHCCCCc
Confidence 356799999999999999999997543322 3799998732 1122344677899999999999999
Q ss_pred ccccccceecCCce------EEEEEcccCCCHHHHHhhhcc--cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 040480 109 ILPLLAHMVRPDSH------LLVYDFMKNGSLQAVLYDVSK--GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDI 180 (325)
Q Consensus 109 i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl 180 (325)
|+++++++...... ++||||+.+++|.+++..... ....++...+..++.|++.||.||| ++|++|+||
T Consensus 87 iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Di 163 (323)
T 3qup_A 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDL 163 (323)
T ss_dssp BCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred eehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCC
Confidence 99999999877655 999999999999999955332 2225889999999999999999999 889999999
Q ss_pred CCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCc
Q 040480 181 KPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDF 259 (325)
Q Consensus 181 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~ 259 (325)
||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 164 kp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 164 AARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp SGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999987654433333333456788999999999899999999999999999999 99999753
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ..... .......... +. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 244 ~~----~~~~~---~~~~~~~~~~--~~--------~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 244 EN----AEIYN---YLIGGNRLKQ--PP--------ECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp CG----GGHHH---HHHTTCCCCC--CT--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred Ch----HHHHH---HHhcCCCCCC--CC--------ccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22 22222 1222221111 11 11233899999999999999999888764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=330.40 Aligned_cols=259 Identities=21% Similarity=0.265 Sum_probs=202.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.++||+|+||+||+|+ ...+++.||+|++.. ...........+.+|..++..++||||++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~-~~~~~~~vAvK~~~~------------~~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 138 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVK-LKNADKVFAMKILNK------------WEMLKRAETACFREERDVLVNGDSKWITT 138 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEEH------------HHHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred ChhheEEEEEEEeCCCEEEEEEE-EcCCCcEEEEEEEEH------------HHhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 45799999999999999999996 456788999999831 11111223344788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..|+||||+++|+|.+++.. ....+++..+..++.|++.||.||| ++||+||||||+|||++.++
T Consensus 139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNG 212 (437)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTS
T ss_pred EEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCC
Confidence 99999999999999999999999999943 2456999999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
.+||+|||++......... .....+||+.|+|||++. ...++.++||||||+++|+|++|+.||.... ..
T Consensus 213 ~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~----~~ 287 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES----LV 287 (437)
T ss_dssp CEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS----HH
T ss_pred CEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC----hh
Confidence 9999999999776543322 122258999999999987 4568999999999999999999999997522 22
Q ss_pred hHHHHHHHHh-hhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCC--CCChhhhhc
Q 040480 267 DMVRWMRNVM-ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDE--RPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~ 324 (325)
+....+.... ....+... ......+.+||.+||+.+|+. ||+++|+++
T Consensus 288 ~~~~~i~~~~~~~~~p~~~----------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 288 ETYGKIMNHKERFQFPTQV----------TDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHHHTHHHHCCCCSSC----------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHHHhhhhccccccCCccc----------ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 2222111111 11111110 011223899999999998888 999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=315.17 Aligned_cols=262 Identities=21% Similarity=0.314 Sum_probs=198.4
Q ss_pred hhcCcccccccccCcceeEEEEEe---cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAEL---PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
..++|++.+.||+|+||+||+|++ +..+++.||+|++.. ........+.+|+.+++.++|||
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~ 72 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---------------STEEHLRDFEREIEILKSLQHDN 72 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC---------------CCHHHHHHHHHHHHHHHTCCCTT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc---------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence 458999999999999999999975 455789999999832 12234567889999999999999
Q ss_pred ccccccceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 109 ILPLLAHMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 109 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
|+++++++.. ....++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+
T Consensus 73 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil 146 (295)
T 3ugc_A 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 146 (295)
T ss_dssp BCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred EeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEE
Confidence 9999998854 3568999999999999999954 2345899999999999999999999 789999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc----
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS---- 261 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~---- 261 (325)
++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..|+.....
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~ 226 (295)
T 3ugc_A 147 VENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 226 (295)
T ss_dssp EEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH
T ss_pred EcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh
Confidence 999999999999999876543221 111123467789999999999999999999999999999999999864210
Q ss_pred ----C-CCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 ----H-TGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ..................... + ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 227 MIGNDKQGQMIVFHLIELLKNNGRLPR--P--------DGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCCCCC--C--------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhcCccccchhHHHHHHHHhccCcCCC--C--------cCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 011111111222222211111 1 112234899999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=309.94 Aligned_cols=251 Identities=26% Similarity=0.319 Sum_probs=203.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..++..||+|.+.. ...........+.+|+.+++.++||||++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 78 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAR-EKQNKFIMALKVLFK------------SQLEKEGVEHQLRREIEIQSHLRHPNILR 78 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhhceeeheecCCCCeEEEEEE-EcCCCcEEEEEEEcc------------cccchHHHHHHHHHHHHHHhcCCCCCEee
Confidence 34789999999999999999996 556788999999831 11112234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||+|+||+++.++
T Consensus 79 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~ 151 (284)
T 2vgo_A 79 MYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKG 151 (284)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTC
T ss_pred EEEEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCC
Confidence 99999999999999999999999999843 345889999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||.+........ ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .. ..
T Consensus 152 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~---~~ 220 (284)
T 2vgo_A 152 ELKIADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS----HT---ET 220 (284)
T ss_dssp CEEECCCTTCEECSSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HH---HH
T ss_pred CEEEecccccccCccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC----Hh---HH
Confidence 999999999876544322 22478999999999999889999999999999999999999996522 11 11
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+...... .+. ..+..+.+++.+||+.||.+|||++++++
T Consensus 221 ~~~~~~~~~~---~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 221 HRRIVNVDLK---FPP--------FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHTTCCC---CCT--------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccC---CCC--------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 2222222111 111 01223889999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=326.50 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=189.7
Q ss_pred hcCcccc-cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHh-ccCCCCcc
Q 040480 33 EDCFASL-EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITAS-QIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~ 110 (325)
.++|.+. +.||.|+||+||+|. +..+++.||||++. ....+.+|+.++. ..+||||+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~-~~~~~~~vAiK~~~--------------------~~~~~~~E~~~~~~~~~hp~iv 118 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIF-NKRTQEKFALKMLQ--------------------DCPKARREVELHWRASQCPHIV 118 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEE--------------------CSHHHHHHHHHHHHHTTSTTBC
T ss_pred cccceeccceeeeccCeEEEEEE-ECCCCCEEEEEEeC--------------------cchhHHHHHHHHHHhcCCCCcc
Confidence 3567776 689999999999995 56788999999982 1234566777764 45799999
Q ss_pred ccccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 111 PLLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 111 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++++.. ....|+||||+++++|.+++.. .....+++..+..++.|++.||.||| ++||+||||||+||+
T Consensus 119 ~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nil 193 (400)
T 1nxk_A 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLL 193 (400)
T ss_dssp CEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred eEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEE
Confidence 99998865 5678999999999999999943 22346899999999999999999999 789999999999999
Q ss_pred ecC---CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 187 IDD---DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 187 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
++. ++.+||+|||++........ ....+||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 194 l~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 270 (400)
T 1nxk_A 194 YTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_dssp ESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS
T ss_pred EecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 997 78899999999986654322 223578999999999999999999999999999999999999997644332
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+. ...... +... ....+..+.+||.+||+.||++|||+.++++
T Consensus 271 ~~~~~~~~i~---~~~~~~---~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 271 ISPGMKTRIR---MGQYEF---PNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp SCCSHHHHHH---HTCCCC---CTTT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHH---cCcccC---CCcc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222222222 111110 0000 0112233899999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=328.80 Aligned_cols=293 Identities=16% Similarity=0.192 Sum_probs=205.8
Q ss_pred CceeeccccchhHHHHHhhhcCcccccccccCcceeEEEEEecCC----CCcEEEEEEEcccCCCcHHHHHHHHHhhCcc
Q 040480 14 GLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGS----NGKMIAVKKVIIYSPMSAAELIDAYSELGEG 89 (325)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~ 89 (325)
.....++....++.......++|++.+.||+|+||.||+|.+... .++.||+|.+..... ............
T Consensus 15 ~~~~~~~~~~~g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~~~~~ 90 (364)
T 3op5_A 15 AKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG----PLFTELKFYQRA 90 (364)
T ss_dssp ------CCCCTTCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH----HHHHHHHHHHHH
T ss_pred hhhhcchhcCCCcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch----hHHHHHHHHHhh
Confidence 333344444444433334567999999999999999999976433 357899999753321 111111111122
Q ss_pred hHHHHHHHHHHHhccCCCCccccccceecC----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHH
Q 040480 90 KLTEIRSQIITASQIRHRNILPLLAHMVRP----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLE 165 (325)
Q Consensus 90 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~ 165 (325)
.......++..++.++||||+++++++... ...++||||+ +++|.+++.. ....+++..+..++.|++.||.
T Consensus 91 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~ 166 (364)
T 3op5_A 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILE 166 (364)
T ss_dssp CCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHH
Confidence 233466778888999999999999998765 4589999999 8899999954 3456999999999999999999
Q ss_pred HHHhcCCCCeEecCCCCCceEec--CCCCceeeccccceecCCCCccc-----cceeecCCcccccccccccCCCCCccc
Q 040480 166 YLHMHHSARVIHRDIKPANVLID--DDMEARISGFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTLTISEKCD 238 (325)
Q Consensus 166 ~lh~~~~~~ivH~dl~~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~~D 238 (325)
||| ++||+||||||+||+++ .++.++|+|||++.......... ......||+.|+|||++.+..++.++|
T Consensus 167 ~lH---~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 243 (364)
T 3op5_A 167 YIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGD 243 (364)
T ss_dssp HHH---HTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHH
T ss_pred HHH---HCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhh
Confidence 999 88999999999999999 88999999999998765432211 112245899999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC
Q 040480 239 IYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN 318 (325)
Q Consensus 239 vwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (325)
|||||+++|+|++|..||..... ................ ....+..... ...+..+.+++..||..||.+|||
T Consensus 244 i~slG~~l~el~~g~~Pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~ 316 (364)
T 3op5_A 244 LEILGYCMIQWLTGHLPWEDNLK---DPKYVRDSKIRYRENI-ASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPL 316 (364)
T ss_dssp HHHHHHHHHHHHHSCCTTGGGTT---CHHHHHHHHHHHHHCH-HHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred HHHHHHHHHHHHhCCCCcccccc---CHHHHHHHHHHhhhhH-HHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999975322 1112211111111110 0000000000 111234899999999999999999
Q ss_pred hhhhhc
Q 040480 319 SKDVRC 324 (325)
Q Consensus 319 ~~ell~ 324 (325)
+.++++
T Consensus 317 ~~~l~~ 322 (364)
T 3op5_A 317 YENLRD 322 (364)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=323.11 Aligned_cols=258 Identities=19% Similarity=0.268 Sum_probs=194.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|.+.... .........+.+|+.+++.++||||+++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~------------~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 77 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLAR-DLRDHRDVAVKVLRADL------------ARDPSFYLRFRREAQNAAALNHPAIVAV 77 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECTTT------------TTSHHHHHHHHHHHTTCCCCCCTTBCCE
T ss_pred cCcEEEEEEEccCCCEEEEEEE-ECCCCceEEEEEeCccc------------cCCHHHHHHHHHHHHHHHcCCCCCcceE
Confidence 4789999999999999999996 55678999999984321 1122345678899999999999999999
Q ss_pred ccceecCCce----EEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 113 LAHMVRPDSH----LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 113 ~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++++...... |+||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||||+||+++
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~ 150 (311)
T 3ork_A 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMIS 150 (311)
T ss_dssp EEEEEEEETTEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE
T ss_pred EEeeeccCCCCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEc
Confidence 9988766543 999999999999999943 346899999999999999999999 78999999999999999
Q ss_pred CCCCceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.++.++|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 151 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------ 224 (311)
T 3ork_A 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------ 224 (311)
T ss_dssp TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------
T ss_pred CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------
Confidence 9999999999999866543221 122235689999999999999999999999999999999999999965221
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............. +..... ..+..+.+|+.+||+.||++||++.++++
T Consensus 225 -~~~~~~~~~~~~~~----~~~~~~---~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 225 -VSVAYQHVREDPIP----PSARHE---GLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp -HHHHHHHHHCCCCC----HHHHST---TCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -HHHHHHHhcCCCCC----cccccC---CCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 11111222221111 110011 12233889999999999999999888763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=311.36 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=204.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..+++.+|+|.+.... .......+.+.+|+.+++.++||||++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~a~K~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~iv~ 79 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEIS-DADTKEVFAGKIVPKSL------------LLKPHQREKMSMEISIHRSLAHQHVVG 79 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEGGG------------CCSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cccceEEEEEEeecCCEEEEEEE-ECCCCceEEEEEechhh------------ccCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 45789999999999999999996 55678899999883221 112234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||+|+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~ 152 (294)
T 2rku_A 80 FHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 152 (294)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTC
T ss_pred eeeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCC
Confidence 99999999999999999999999998843 346899999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||.+......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...
T Consensus 153 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~ 223 (294)
T 2rku_A 153 EVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KET 223 (294)
T ss_dssp CEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHH
T ss_pred CEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHH
Confidence 9999999999876543222 1225789999999999998899999999999999999999999965221 111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... .+. .....+.+++.+||+.||++|||++++++
T Consensus 224 ~~~~~~~~~~---~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 224 YLRIKKNEYS---IPK--------HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHHTTCCC---CCT--------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHhhccCC---Ccc--------ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1222221111 111 01123889999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=315.64 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=205.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|.+........ ........+.+|+.++++++||||+++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 80 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRAS---------RRGVSREEIEREVSILRQVLHHNVITL 80 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEBCSSSSC---------SSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hccEEEeeEeeecCCEEEEEEE-ECCCCeEEEEEEEeccccccc---------ccchhHHHHHHHHHHHHhCCCCCcceE
Confidence 4679999999999999999996 556789999999854321110 011235678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC-
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM- 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~- 191 (325)
++++...+..++||||+++++|.+++. ....++...+..++.|++.||.||| ++|++|+||+|+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~ 153 (321)
T 2a2a_A 81 HDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNI 153 (321)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTS
T ss_pred EEEEecCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCC
Confidence 999999999999999999999999993 3456899999999999999999999 78999999999999999887
Q ss_pred ---CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 ---EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ---~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~--- 223 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----K--- 223 (321)
T ss_dssp SSCCEEECCCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----H---
T ss_pred CcCCEEEccCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC----H---
Confidence 7999999999876554322 22478999999999999899999999999999999999999996522 1
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+...... .+..... ..+..+.+|+.+||+.||++|||++|+++
T Consensus 224 ~~~~~~i~~~~~~---~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 224 QETLANITSVSYD---FDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHHTTCCC---CCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhcccc---cChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1222222222111 1111111 12233889999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=309.50 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=203.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||+|+||.||+|. +..+++.||+|.+.... .......+.+|+.+++.++||||++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~i~~ 69 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAV-NRVTEEAVAVKIVDMKR--------------AVDCPENIKKEICINKMLNHENVVK 69 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEE-ETTTCCEEEEEEEEGGG--------------CTTHHHHHHHHHHHHHTCCCTTBCC
T ss_pred eecceEEEEEeecCCCcEEEEEE-ECCCCcEEEEEEeeecc--------------chhhhHHHHHHHHHHHhcCCCCcee
Confidence 35789999999999999999995 55678899999983211 1234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++|+||+++++|.+++ .....++...+..++.|++.||.+|| ++|++|+||+|+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~ 142 (276)
T 2yex_A 70 FYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERD 142 (276)
T ss_dssp EEEEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTC
T ss_pred eeeEEEcCCEEEEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCC
Confidence 999999999999999999999999888 34456899999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+................|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...... ......
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~ 220 (276)
T 2yex_A 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSD 220 (276)
T ss_dssp CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHH
T ss_pred CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHH
Confidence 999999999986543322222233578999999999987765 77899999999999999999999763321 111111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+ ......... ....+..+.+|+.+||+.||.+|||++++++
T Consensus 221 ~----~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 221 W----KEKKTYLNP---------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp H----HTTCTTSTT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h----hhcccccCc---------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1 111111000 0112233889999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=316.97 Aligned_cols=268 Identities=21% Similarity=0.271 Sum_probs=196.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc---CCCCc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI---RHRNI 109 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i 109 (325)
.++|++.+.||+|+||+||+|+ +..+++.||+|.+........ .......+.+|+.+++.+ .||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~h~ni 76 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKAR-DPHSGHFVALKSVRVPNGGGG----------GGGLPISTVREVALLRRLEAFEHPNV 76 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEE-CTTTCCEEEEEEEEEECCCTT----------SSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred ccceEEEEEEecCCCeEEEEEE-ECCCCcEEEEEEEeccccccc----------ccccchhHHHHHHHHHHHhhcCCCCe
Confidence 5799999999999999999995 567889999999854321110 111123445566665555 59999
Q ss_pred cccccceecCC-----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040480 110 LPLLAHMVRPD-----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 110 ~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~n 184 (325)
+++++++.... ..++||||+.+ +|.+++.. .....+++..+..++.|++.||.||| ++|++|+||||+|
T Consensus 77 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~N 150 (308)
T 3g33_A 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPEN 150 (308)
T ss_dssp CCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTT
T ss_pred EEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHH
Confidence 99999987765 47999999975 99999854 22334899999999999999999999 8899999999999
Q ss_pred eEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 185 VLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
|+++.++.++|+|||.+......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 151 il~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---- 223 (308)
T 3g33_A 151 ILVTSGGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---- 223 (308)
T ss_dssp EEECTTSCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS----
T ss_pred EEEcCCCCEEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC----
Confidence 99999999999999999766543322 22578999999999999899999999999999999999999996522
Q ss_pred cchHHHHHHHHhhhCCCCcccch-----hhc--------CCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDS-----KLL--------GNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+....+...........+... ... .....+....+.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 224 EADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 22222222222111111100000 000 0001122344889999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=312.97 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=199.6
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
....++|++.+.||+|+||.||+|++. ++..||+|++... ......+.+|+.+++.++||||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~----------------~~~~~~~~~E~~~l~~l~h~~i 81 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG----------------SMSEDEFIEEAKVMMNLSHEKL 81 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTT----------------SBCHHHHHHHHHHHHTCCCTTB
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCC----------------CCCHHHHHHHHHHHhcCCCCCE
Confidence 345689999999999999999999764 6778999998321 1234568899999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++...+..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~ 155 (283)
T 3gen_A 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVND 155 (283)
T ss_dssp CCEEEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECT
T ss_pred eeEEEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcC
Confidence 9999999999999999999999999999943 2456899999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 268 (325)
++.++|+|||.+......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~- 229 (283)
T 3gen_A 156 QGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SE- 229 (283)
T ss_dssp TSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HH-
T ss_pred CCCEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hH-
Confidence 999999999999765443211 1112356778999999998899999999999999999998 9999975321 11
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+........+ . ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 230 --~~~~~~~~~~~~~~--~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 273 (283)
T 3gen_A 230 --TAEHIAQGLRLYRP--H--------LASEKVYTIMYSCWHEKADERPTFKILLS 273 (283)
T ss_dssp --HHHHHHTTCCCCCC--T--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred --HHHHHhcccCCCCC--C--------cCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12222222111111 0 01123889999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=319.95 Aligned_cols=266 Identities=23% Similarity=0.265 Sum_probs=201.1
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.-.++|++.+.||+|+||.||+|. +..+++.||+|.+... ............+.+|+.+++.++||||+
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~~----------~~~~~~~~~~~~~~~E~~~l~~l~hpniv 91 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAI-ENQTRAIRAIKIMNKN----------KIRQINPKDVERIKTEVRLMKKLHHPNIA 91 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEHH----------HHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhheeecceeeecCCeEEEEEE-ECCCCceEEEeehhhh----------hhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 445889999999999999999995 5677889999998321 11122345667899999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcc------------------------------------cccccChhhHH
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------------------------------GRRELEWLSRH 154 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------~~~~~~~~~~~ 154 (325)
++++++.+.+..++||||+++++|.+++..... ....+++..+.
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 999999999999999999999999999842111 02234567788
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC--CceeeccccceecCCCCcc--ccceeecCCccccccccccc
Q 040480 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM--EARISGFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQT 230 (325)
Q Consensus 155 ~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~ 230 (325)
.++.|++.||.||| ++|++|+||||+||+++.++ .++|+|||++......... .......||+.|+|||++.+
T Consensus 172 ~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 172 NIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 89999999999999 78999999999999998766 8999999999865432211 12223578999999999875
Q ss_pred --CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhh
Q 040480 231 --LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFC 308 (325)
Q Consensus 231 --~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 308 (325)
..++.++||||||+++|+|++|..||..... . .....+.......... .....+..+.+||.+|
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND----A---DTISQVLNKKLCFENP-------NYNVLSPLARDLLSNL 314 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H---HHHHHHHHCCCCTTSG-------GGGGSCHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh----H---HHHHHHHhcccccCCc-------ccccCCHHHHHHHHHH
Confidence 5688999999999999999999999965321 1 1122222222111110 0011223389999999
Q ss_pred cCCCCCCCCChhhhhc
Q 040480 309 TLADPDERPNSKDVRC 324 (325)
Q Consensus 309 l~~dP~~Rps~~ell~ 324 (325)
|+.||.+|||+.++++
T Consensus 315 l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 315 LNRNVDERFDAMRALQ 330 (345)
T ss_dssp SCSCTTTSCCHHHHHH
T ss_pred cCCChhHCCCHHHHhc
Confidence 9999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=320.59 Aligned_cols=254 Identities=21% Similarity=0.329 Sum_probs=195.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCc----EEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||+||+|++. .+++ .||+|.+.. .........+.+|+.++++++||
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~ 77 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELRE--------------ATSPKANKEILDEAYVMASVDNP 77 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEC-C----CCEEEEEEEC---------------------CHHHHHHHHHHHHHCCBT
T ss_pred CHHHcccceEEeeCCCeEEEEEEEc-CCCceEEEEEEEeeccc--------------ccCHHHHHHHHHHHHHHHhCCCC
Confidence 5678999999999999999999753 3333 468887621 11223456789999999999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
||+++++++... ..+++++|+.+++|.+++.. ....++...+..++.|++.||.||| ++|++||||||+||++
T Consensus 78 ~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll 150 (327)
T 3poz_A 78 HVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLV 150 (327)
T ss_dssp TBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CEeEEEEEEecC-CeEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEE
Confidence 999999998865 47899999999999999854 3456899999999999999999999 7899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcc
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEM 266 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~ 266 (325)
+.++.++|+|||++................+|..|+|||++.+..++.++||||||+++|+|++ |..||.... ..
T Consensus 151 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~ 226 (327)
T 3poz_A 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----AS 226 (327)
T ss_dssp EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----GG
T ss_pred CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC----HH
Confidence 9999999999999987655444333333466889999999999999999999999999999999 999997532 22
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... ....... +. ..+..+.+++.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~---~~~~~~~--~~--------~~~~~~~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 227 EISSILE---KGERLPQ--PP--------ICTIDVYMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp GHHHHHH---TTCCCCC--CT--------TBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred HHHHHHH---cCCCCCC--Cc--------cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2222222 1111111 11 11223889999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=317.42 Aligned_cols=255 Identities=19% Similarity=0.263 Sum_probs=192.6
Q ss_pred hhcCcccccccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|++.+.||+|+||.||+|+.. ..+++.+|+|++..... .........+.+|+.+++.++||||
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~hp~i 83 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-----------VRNAKDTAHTKAERNILEEVKHPFI 83 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------------HHHHHHHCCCTTB
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh-----------hhhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999999753 25788999999842210 0111234567889999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++...+..|+||||+++++|.+++.. ...++...+..++.|++.||.||| ++||+|+||||+||+++.
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~ 156 (327)
T 3a62_A 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNH 156 (327)
T ss_dssp CCEEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECT
T ss_pred cceeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECC
Confidence 9999999999999999999999999999843 345888999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||++......... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.... . .
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~---~ 227 (327)
T 3a62_A 157 QGHVKLTDFGLCKESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----R---K 227 (327)
T ss_dssp TSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----H---H
T ss_pred CCcEEEEeCCcccccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC----H---H
Confidence 999999999998754332221 122478999999999999889999999999999999999999996522 1 1
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
.....+....... +. .....+.+|+.+||+.||.+|| ++.++++
T Consensus 228 ~~~~~i~~~~~~~---p~--------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 228 KTIDKILKCKLNL---PP--------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHHTCCCC---CT--------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHhCCCCC---CC--------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 2222222222111 11 0122389999999999999999 6667764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=324.04 Aligned_cols=249 Identities=24% Similarity=0.279 Sum_probs=191.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHH-HhccCCCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIIT-ASQIRHRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~ 110 (325)
..++|++.+.||+|+||.||+|+ +..+++.||+|++.... .........+..|..+ ++.++||||+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~-~~~~~~~~AiK~~~~~~------------~~~~~~~~~~~~e~~~ll~~~~hp~Iv 102 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKA------------ILKKKEEKHIMSERNVLLKNVKHPFLV 102 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEE-ETTTCCEEEEEEEEGGG------------BC-------------CCBCCCCCTTBC
T ss_pred ChhheEEEEEEeeCCCeEEEEEE-EcCCCCEEEEEEEEHHH------------hhhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 45789999999999999999996 55678899999984221 1112233455666665 5678999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.+.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+||+++.+
T Consensus 103 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~ 175 (373)
T 2r5t_A 103 GLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQ 175 (373)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred CEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCC
Confidence 999999999999999999999999999843 345888999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||++........ .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... . ..
T Consensus 176 g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~---~~ 246 (373)
T 2r5t_A 176 GHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----T---AE 246 (373)
T ss_dssp SCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB----H---HH
T ss_pred CCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----H---HH
Confidence 9999999999975433222 1223589999999999999999999999999999999999999996522 1 22
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
....+....... ++. ....+.+||.+||+.||.+||++.
T Consensus 247 ~~~~i~~~~~~~---~~~--------~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 247 MYDNILNKPLQL---KPN--------ITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHHSCCCC---CSS--------SCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHhcccCC---CCC--------CCHHHHHHHHHHcccCHHhCCCCC
Confidence 222333222111 110 112389999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=317.37 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=204.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|.+.+.||+|+||.||+|. +..+++.+|+|.+.... .......+.+.+|+.+++.++||||++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~a~K~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~~iv~ 105 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEIS-DADTKEVFAGKIVPKSL------------LLKPHQREKMSMEISIHRSLAHQHVVG 105 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEGGG------------CCSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cCCceEEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEechhh------------hcCHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 45789999999999999999996 55678899999983211 112245567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..++||||+.+++|.+++.. ...++...+..++.|++.||.||| ++|++|+||+|+||+++.++
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~ 178 (335)
T 2owb_A 106 FHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 178 (335)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTC
T ss_pred EEEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCC
Confidence 99999999999999999999999998843 356899999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++......... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.... .. ..
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~---~~ 249 (335)
T 2owb_A 179 EVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LK---ET 249 (335)
T ss_dssp CEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS----HH---HH
T ss_pred CEEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC----HH---HH
Confidence 9999999999876543222 222578999999999999889999999999999999999999996522 11 11
Q ss_pred HHHHhhhCCC-CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENP-NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+...... .... ...+.+|+.+||+.||++|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 250 YLRIKKNEYSIPKHI------------NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHHTCCCCCTTS------------CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHhcCCCCCCccC------------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222222111 1111 123889999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=321.85 Aligned_cols=252 Identities=22% Similarity=0.275 Sum_probs=197.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|.+.... ....+|+.++.++ +||||++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~~avK~~~~~~-------------------~~~~~E~~~l~~~~~hp~iv~ 80 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCI-HKATNMEFAVKIIDKSK-------------------RDPTEEIEILLRYGQHPNIIT 80 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEETTT-------------------CCCHHHHHHHHHHTTSTTBCC
T ss_pred cccEEEEEEEeeCCCEEEEEEE-ECCCCCEEEEEEEEccc-------------------CChHHHHHHHHHhcCCCCcCe
Confidence 5789999999999999999995 56778999999983211 1124566677777 7999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC-
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD- 190 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~- 190 (325)
+++++.+.+..|+||||++|++|.+++. ....+++..+..++.|++.||.||| ++||+||||||+||++..+
T Consensus 81 ~~~~~~~~~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~ 153 (342)
T 2qr7_A 81 LKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDES 153 (342)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSS
T ss_pred EEEEEEcCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCC
Confidence 9999999999999999999999999983 3456899999999999999999999 8899999999999998543
Q ss_pred ---CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 191 ---MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 191 ---~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+.++|+|||++......... ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... ...
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~ 227 (342)
T 2qr7_A 154 GNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP----DDT 227 (342)
T ss_dssp CSGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST----TSC
T ss_pred CCcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC----cCC
Confidence 24999999999876543322 122578999999999988888999999999999999999999997521 112
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+........ .. .....+..+.+||.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~i~~~~~~~~---~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 228 PEEILARIGSGKFSLS---GG----YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHHHCCCCCC---ST----TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHccCCcccC---cc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2223333333222211 00 01112233899999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=320.64 Aligned_cols=267 Identities=22% Similarity=0.314 Sum_probs=207.3
Q ss_pred hhHHHHHhhhcCcccccccccCcceeEEEEEecC------CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHH
Q 040480 24 KEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPG------SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97 (325)
Q Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 97 (325)
+++-.+....++|++.+.||+|+||.||+|++.. .++..||+|.+... ........+.+|
T Consensus 25 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E 90 (334)
T 2pvf_A 25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--------------ATEKDLSDLVSE 90 (334)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--------------CCHHHHHHHHHH
T ss_pred CCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--------------CcHHHHHHHHHH
Confidence 4444455567899999999999999999997532 35678999987321 122345678899
Q ss_pred HHHHhcc-CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHH
Q 040480 98 IITASQI-RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGL 164 (325)
Q Consensus 98 ~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l 164 (325)
+.+++.+ +||||+++++++...+..++||||+++++|.+++..... ....++...+..++.|++.||
T Consensus 91 ~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 170 (334)
T 2pvf_A 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170 (334)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 9999999 899999999999999999999999999999999965321 123488889999999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHH
Q 040480 165 EYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGV 244 (325)
Q Consensus 165 ~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~ 244 (325)
.||| ++|++|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+
T Consensus 171 ~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 247 (334)
T 2pvf_A 171 EYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247 (334)
T ss_dssp HHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred HHHH---hCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHH
Confidence 9999 8899999999999999999999999999998776544333333346678899999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 245 LLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 245 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
++|+|++ |..||.... ..+.. ..+........ +. ..+..+.+++.+||+.||.+|||+.+++
T Consensus 248 il~ellt~g~~p~~~~~----~~~~~---~~~~~~~~~~~--~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell 310 (334)
T 2pvf_A 248 LMWEIFTLGGSPYPGIP----VEELF---KLLKEGHRMDK--PA--------NCTNELYMMMRDCWHAVPSQRPTFKQLV 310 (334)
T ss_dssp HHHHHHTTSCCSSTTCC----HHHHH---HHHHHTCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCcCcCC----HHHHH---HHHhcCCCCCC--Cc--------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999 999996521 12222 22222221111 10 1122389999999999999999999997
Q ss_pred c
Q 040480 324 C 324 (325)
Q Consensus 324 ~ 324 (325)
+
T Consensus 311 ~ 311 (334)
T 2pvf_A 311 E 311 (334)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=311.33 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=183.7
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|+ +..+++.||+|.+.. ...........+.+|+.++++++||||+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~------------~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 74 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAE-SIHTGLEVAIKMIDK------------KAMYKAGMVQRVQNEVKIHCQLKHPSIL 74 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHTTBCCTTBC
T ss_pred cccccceeeeeecCCCceEEEEEE-EccCCceEEEEEeeh------------hhhhhhhHHHHHHHHHHHHHhCCCCCeE
Confidence 355789999999999999999996 456788999999831 1111223456789999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.+.+..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||+|+||+++.+
T Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~ 148 (278)
T 3cok_A 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRN 148 (278)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTT
T ss_pred eEEEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCC
Confidence 999999999999999999999999999843 3356899999999999999999999 7899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||.+.......... ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ..
T Consensus 149 ~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~- 221 (278)
T 3cok_A 149 MNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN----TL- 221 (278)
T ss_dssp CCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------
T ss_pred CCEEEEeecceeeccCCCCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH----HH-
Confidence 999999999998765332211 12468999999999998889999999999999999999999997533211 00
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... ...+ . ..+..+.+|+.+||+.||++|||++++++
T Consensus 222 --~~~~~~~---~~~~-----~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 --NKVVLAD---YEMP-----S---FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CCSSC---CCCC-----T---TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --HHHhhcc---cCCc-----c---ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111000 0001 0 11223889999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.12 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=192.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|. +..+++.||+|.+.... ........+.+|+.+++.++||||++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv~ 97 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAI-DTVTNETVAIKRIRLEH-------------EEEGVPGTAIREVSLLKELQHRNIIE 97 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEE-ETTTTEEEEEEECCCCC---------------------CHHHHHHGGGCCCTTBCC
T ss_pred chhhEEEEEEEEecCCeEEEEEE-ECCCCceEEEEEEcccc-------------cccccchhHHHHHHHHHHcCCCCcce
Confidence 45799999999999999999995 56788999999984321 11223456678999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec---
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID--- 188 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~--- 188 (325)
+++++...+..++||||+++ +|.+++. ....++...+..++.|++.||.||| ++||+|+||||+||+++
T Consensus 98 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~ 169 (329)
T 3gbz_A 98 LKSVIHHNHRLHLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSD 169 (329)
T ss_dssp EEEEEEETTEEEEEEECCSE-EHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC--
T ss_pred EEEEEecCCEEEEEEecCCC-CHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCC
Confidence 99999999999999999976 9999984 3445899999999999999999999 78999999999999995
Q ss_pred --CCCCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 189 --DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 189 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
..+.++|+|||++......... .....||..|+|||++.+. .++.++||||||+++|+|++|..||.... .
T Consensus 170 ~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~ 243 (329)
T 3gbz_A 170 ASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS----E 243 (329)
T ss_dssp ---CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----H
T ss_pred CCccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC----H
Confidence 4445999999999866533222 1224679999999998874 48999999999999999999999996522 1
Q ss_pred chHHHHHHHHhhhCCCCcccc-----------hhhcCCchH-----HHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAID-----------SKLLGNGYE-----EQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....+...........+.. +........ .....+.+||.+||+.||.+|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 244 IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 122211111111111110000 000000000 12244889999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=317.82 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=197.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..+++.||+|++..... ........+.+|+.+++.++||||++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~------------~~~~~~~~~~~E~~~l~~l~h~~i~~ 96 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAA-CLLDGVPVALKKVQIFDL------------MDAKARADCIKEIDLLKQLNHPNVIK 96 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEE-ETTTCCEEEEEEECTTSS------------CCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cccceEEEEeecCCCCceEEEEE-EcCCCceEEEEeeehhhc------------cCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 45689999999999999999996 556788999999843211 12234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+.+++|.+++.........++...+..++.|++.||.||| ++|++|+||+|+||+++.++
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~ 173 (310)
T 2wqm_A 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATG 173 (310)
T ss_dssp EEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTS
T ss_pred EEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCC
Confidence 999999999999999999999999999765556677999999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++......... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.... ......
T Consensus 174 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~ 246 (310)
T 2wqm_A 174 VVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSL 246 (310)
T ss_dssp CEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCHHHH
T ss_pred CEEEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----hhHHHH
Confidence 9999999998765443221 122468899999999999889999999999999999999999996422 122222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.........+... . ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~------~---~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 247 CKKIEQCDYPPLP------S---DHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHTTCSCCCC------T---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhhcccCCCCc------c---cccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2222222221111 0 011223899999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=310.87 Aligned_cols=250 Identities=28% Similarity=0.365 Sum_probs=189.3
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|.+ ++..+|+|.+.... ........+.+.+|+.+++.++||||+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDP-----------DEDISQTIENVRQEAKLFAMLKHPNIIAL 71 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC---------------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCC-----------cccHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 47899999999999999999975 58899999873221 11112345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC---eEecCCCCCceEecC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR---VIHRDIKPANVLIDD 189 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~---ivH~dl~~~nil~~~ 189 (325)
++++...+..++||||+++++|.+++ ....++...+..++.|++.||.||| ++| ++|+||||+||+++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~ 143 (271)
T 3dtc_A 72 RGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQ 143 (271)
T ss_dssp EEEECCC--CEEEEECCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESS
T ss_pred EEEEecCCceEEEEEcCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEec
Confidence 99999999999999999999999998 3456899999999999999999999 667 999999999999986
Q ss_pred --------CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 190 --------DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 190 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
++.++|+|||.+......... ...|++.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 144 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (271)
T 3dtc_A 144 KVENGDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219 (271)
T ss_dssp CCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred ccccccccCcceEEccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 677999999999765543222 24789999999999998899999999999999999999999965221
Q ss_pred CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ............ ...+. ..+..+.+++.+||+.||.+|||+.|+++
T Consensus 220 ----~---~~~~~~~~~~~~-~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 220 ----L---AVAYGVAMNKLA-LPIPS--------TCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp ----H---HHHHHHHTSCCC-CCCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----H---HHHHhhhcCCCC-CCCCc--------ccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 111111111111 11111 11233899999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=321.70 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=202.2
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..-.++|++.+.||+|+||.||+|. +..+++.||+|.+........ ..........+.+|+.+++.++||||
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~-~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~h~~I 91 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAV-DKEKNKEVVVKFIKKEKVLED-------CWIEDPKLGKVTLEIAILSRVEHANI 91 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEE-ETTTTEEEEEEEEESTTSCTT-------SEEEETTTEEEEHHHHHHTTCCCTTB
T ss_pred cccccceEEEeEEEecCCEEEEEEE-ECCCCcEEEEEEEehhhcccc-------cccchHHHHHHHHHHHHHHhCCCCCE
Confidence 3456899999999999999999995 567889999999843221000 00011233456779999999999999
Q ss_pred cccccceecCCceEEEEEcccCC-CHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNG-SLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
+++++++.+.+..++||||+.++ +|.+++ .....+++..+..++.|++.||.||| ++|++|+||||+||+++
T Consensus 92 v~~~~~~~~~~~~~lv~e~~~~g~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~ 164 (335)
T 3dls_A 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIA 164 (335)
T ss_dssp CCEEEEEECSSEEEEEEECCTTSCBHHHHH----HTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred eeEEEEEeeCCEEEEEEEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEc
Confidence 99999999999999999998766 999998 34456999999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.++.++|+|||++......... ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 165 ~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---- 237 (335)
T 3dls_A 165 EDFTIKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---- 237 (335)
T ss_dssp TTSCEEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----
T ss_pred CCCcEEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----
Confidence 9999999999999876654332 22578999999999988776 789999999999999999999996522100
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+... +..+.+|+.+||+.||++|||++++++
T Consensus 238 --------~~~~~~~~~~------------~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 238 --------EAAIHPPYLV------------SKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp --------TTCCCCSSCC------------CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------hhccCCCccc------------CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011111111 123899999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=311.05 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=196.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc--cCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ--IRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~ 110 (325)
.++|++.+.||+|+||+||+|++ +++.||+|++.. .....+..|.+++.. ++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~------------------~~~~~~~~e~~~~~~~~l~h~niv 65 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSS------------------RDEKSWFRETELYNTVMLRHENIL 65 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECG------------------GGHHHHHHHHHHHHHTCCCCTTBC
T ss_pred cCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEecc------------------ccchhhHHHHHHHHHhhccCcCee
Confidence 57899999999999999999975 688999999831 123344555555555 7899999
Q ss_pred ccccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCC
Q 040480 111 PLLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH-----HSARVIHRDIK 181 (325)
Q Consensus 111 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-----~~~~ivH~dl~ 181 (325)
++++++.. ....++||||+++++|.+++ ....+++..+..++.|++.||.|||.. ++++++|+|||
T Consensus 66 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 140 (301)
T 3q4u_A 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140 (301)
T ss_dssp CEEEEEEEEETTEEEEEEEECCCTTCBHHHHH-----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCC
T ss_pred eEEEeeccccCCCceeEEehhhccCCCHHHHH-----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCC
Confidence 99998654 34589999999999999999 335699999999999999999999932 14589999999
Q ss_pred CCceEecCCCCceeeccccceecCCCCccc--cceeecCCcccccccccccC------CCCCccchhhHHHHHHHHHhC-
Q 040480 182 PANVLIDDDMEARISGFDLAILMPDGLTQI--DTMYVVGTPRYIAPEYHQTL------TISEKCDIYSFGVLLAVLVMG- 252 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~------~~~~~~DvwslG~il~~ll~g- 252 (325)
|+||+++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 141 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~ 220 (301)
T 3q4u_A 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220 (301)
T ss_dssp GGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhh
Confidence 999999999999999999997654433221 11224789999999998876 455789999999999999999
Q ss_pred ---------CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 253 ---------KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 253 ---------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
..||............. .............+.... ....+..+.+|+.+||+.||.+|||+.+++
T Consensus 221 ~~~~~~~~~~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 221 VSNGIVEDYKPPFYDVVPNDPSFEDM---RKVVCVDQQRPNIPNRWF---SDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHH---HHHHTTSCCCCCCCGGGG---GSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cCccccccccccccccCCCCcchhhh---hHHHhccCCCCCCChhhc---cCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 88886544322222211 121222222222222111 223455699999999999999999999998
Q ss_pred c
Q 040480 324 C 324 (325)
Q Consensus 324 ~ 324 (325)
+
T Consensus 295 ~ 295 (301)
T 3q4u_A 295 K 295 (301)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=325.88 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=200.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|+ ...+++.||+|++.. ...........+.+|..++..++||||++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~-~~~~~~~vAiK~l~k------------~~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 125 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVK-MKQTGQVYAMKIMNK------------WDMLKRGEVSCFREERDVLVNGDRRWITQ 125 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEH------------HHHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred ChhhEEEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEeH------------HHhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence 46789999999999999999996 456889999999831 11111223445788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..|+||||++|++|.+++... ...+++..+..++.|++.||.||| ++||+||||||+||+++.++
T Consensus 126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g 199 (412)
T 2vd5_A 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCG 199 (412)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTS
T ss_pred EEEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCC
Confidence 999999999999999999999999999542 346899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccc-------cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-------TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-------~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
.+||+|||++......... .....+||+.|+|||++. +..++.++|+||||+++|+|++|+.||....
T Consensus 200 ~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---- 274 (412)
T 2vd5_A 200 HIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---- 274 (412)
T ss_dssp CEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS----
T ss_pred CEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC----
Confidence 9999999999876543321 122358999999999987 3568999999999999999999999996522
Q ss_pred cchHHHHHHHHhh-hCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCC---CChhhhhc
Q 040480 265 EMDMVRWMRNVMA-SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDER---PNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~ell~ 324 (325)
..+....+..... ...+. .+ ...+..+.+||.+||+ +|.+| |+++|+++
T Consensus 275 ~~~~~~~i~~~~~~~~~p~--~~--------~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 275 TAETYGKIVHYKEHLSLPL--VD--------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHHHHTHHHHCCCC--------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHHHHhcccCcCCCc--cc--------cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1222211111111 11110 00 0112238999999999 99998 58988874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=313.94 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=203.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.... ........+.+|+.++++++||||++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~~e~~~l~~l~h~~i~~ 69 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIR-RKSDGKILVWKELDYGS-------------MTEAEKQMLVSEVNLLRELKHPNIVR 69 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEE-ETTTCCEEEEEEEECTT-------------CCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred chhheeeehhccCCCCcEEEEEE-ECCCCcEEEEEEEEccc-------------CCHHHHHHHHHHHHHHHhcCCCCCCe
Confidence 45799999999999999999996 55678999999984321 12234567899999999999999999
Q ss_pred ccccee--cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCc
Q 040480 112 LLAHMV--RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR-----VIHRDIKPAN 184 (325)
Q Consensus 112 ~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~-----ivH~dl~~~n 184 (325)
+++++. .....++||||+++++|.+++.........+++..++.++.|++.||.||| +++ ++|+||+|+|
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~N 146 (279)
T 2w5a_A 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPAN 146 (279)
T ss_dssp EEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGG
T ss_pred EEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhh
Confidence 999774 456789999999999999999765555566999999999999999999999 656 9999999999
Q ss_pred eEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 185 VLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
|+++.++.++|+|||.+.......... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 147 Il~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---- 220 (279)
T 2w5a_A 147 VFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---- 220 (279)
T ss_dssp EEECSSSCEEECCCCHHHHC---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred EEEcCCCCEEEecCchheeeccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC----
Confidence 999999999999999997665432211 12468999999999999889999999999999999999999997532
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... ...+........ +. ..+..+.+++.+||+.||.+|||+.|+++
T Consensus 221 ~~~~---~~~i~~~~~~~~--~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 221 QKEL---AGKIREGKFRRI--PY--------RYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HHHH---HHHHHHTCCCCC--CT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH---HHHHhhcccccC--Cc--------ccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1122 222222222111 10 11233899999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=309.14 Aligned_cols=267 Identities=32% Similarity=0.455 Sum_probs=206.6
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAH 115 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 115 (325)
|...+.||+|+||.||+|.+ ++..+|+|.+..... .........+.+|+.+++.++||||++++++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 98 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVD-----------ITTEELKQQFDQEIKVMAKCQHENLVELLGF 98 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTT-----------SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCccccCCCeEEEEEEE---CCceEEEEEEecccC-----------cchHHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 44448999999999999964 678999999843211 1122346678999999999999999999999
Q ss_pred eecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCcee
Q 040480 116 MVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARI 195 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l 195 (325)
+...+..++||||+++++|.+++... .....+++..+..++.|++.||.||| ++|++|+||+|+||+++.++.++|
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl 174 (307)
T 2nru_A 99 SSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKI 174 (307)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEE
Confidence 99999999999999999999998543 23456889999999999999999999 789999999999999999999999
Q ss_pred eccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHH
Q 040480 196 SGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275 (325)
Q Consensus 196 ~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 275 (325)
+|||.+................|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.. ..
T Consensus 175 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~ 250 (307)
T 2nru_A 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE---EI 250 (307)
T ss_dssp CCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH---HH
T ss_pred eecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH---Hh
Confidence 99999987654433323333578999999998876 578999999999999999999999976443322222222 11
Q ss_pred hhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......................+..+.+++.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp HTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1111111111111122334566677999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=320.45 Aligned_cols=256 Identities=20% Similarity=0.260 Sum_probs=201.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|.+... .....+.+|+.+++.+ +||||++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~-----------------~~~~~~~~E~~~l~~l~~h~~i~~ 69 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGK-NLYTNEYVAIKLEPMK-----------------SRAPQLHLEYRFYKQLGSGDGIPQ 69 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEE-ETTTTEEEEEEEEETT-----------------CSSCCHHHHHHHHHHHCSCTTSCC
T ss_pred cCCeEEEEEeeccCCceEEEEE-ECCCCcEEEEEEeccc-----------------cchHHHHHHHHHHHHhhCCCCCCE
Confidence 4789999999999999999996 5578899999987321 1123477899999999 8999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+ +++|.+++... ...+++..+..++.|++.||.||| ++||+|+||||+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~ 142 (330)
T 2izr_A 70 VYYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPG 142 (330)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGG
T ss_pred EEEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCC
Confidence 999999999999999999 88999999542 457999999999999999999999 78999999999999999887
Q ss_pred C-----ceeeccccceecCCCCccc-----cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 192 E-----ARISGFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 192 ~-----~~l~dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
. ++|+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 143 ~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 143 NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 6 9999999998765433221 11235789999999999999999999999999999999999999976432
Q ss_pred CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.........+....... +........ + .+.+++.+||+.||.+||+++++++
T Consensus 223 ----~~~~~~~~~i~~~~~~~---~~~~~~~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 223 ----DTLKERYQKIGDTKRAT---PIEVLCENF---P-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ----SSHHHHHHHHHHHHHHS---CHHHHTTTC---H-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----ccHHHHHHHHHhhhccC---CHHHHhccC---h-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 12222222211111100 011111111 1 3999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=319.74 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=196.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCc----EEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||+||+|.+. .++. .+|+|.+.... .......+.+|+.+++.++||
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~kv~~K~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~ 75 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWI-PEGESIKIPVCIKVIEDKS--------------GRQSFQAVTDHMLAIGSLDHA 75 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEEC-CTTCSCCEEEEEEEECCTT--------------SCSCBCSCCHHHHHHHTCCCT
T ss_pred CHhHceeeeeeeecCCceEEEEEEc-CCCceEEEEEEEEeccccc--------------cHHHHHHHHHHHHHHhcCCCC
Confidence 4578999999999999999999754 3443 37788763211 112234567788999999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
||+++++++. .+..++|+||+.+++|.+++.. ....+++..+..++.|++.||.||| ++|++|+||||+||++
T Consensus 76 ~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~ 148 (325)
T 3kex_A 76 HIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLL 148 (325)
T ss_dssp TBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEE
T ss_pred CcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEE
Confidence 9999999876 5678999999999999999843 3456899999999999999999999 7899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcc
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEM 266 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~ 266 (325)
+.++.++|+|||++................|+..|+|||++.+..++.++||||||+++|+|++ |..||.... ..
T Consensus 149 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~ 224 (325)
T 3kex_A 149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR----LA 224 (325)
T ss_dssp SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----TT
T ss_pred CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC----HH
Confidence 9999999999999987765444333344577889999999998899999999999999999999 999997632 22
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............. ....+. .+.+++.+||+.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~-~~~~~~------------~~~~li~~~l~~dp~~Rps~~el~~ 269 (325)
T 3kex_A 225 EVPDLLEKGERLAQ-PQICTI------------DVYMVMVKCWMIDENIRPTFKELAN 269 (325)
T ss_dssp HHHHHHHTTCBCCC-CTTBCT------------TTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred HHHHHHHcCCCCCC-CCcCcH------------HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22222221111111 111111 2788999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=316.23 Aligned_cols=269 Identities=20% Similarity=0.280 Sum_probs=208.4
Q ss_pred chhHHHHHhhhcCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHH
Q 040480 23 EKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98 (325)
Q Consensus 23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 98 (325)
..+...+....++|++.+.||+|+||.||+|++. ..+++.||+|.+... ........+.+|+
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~ 81 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--------------ATHSEHRALMSEL 81 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--------------CCHHHHHHHHHHH
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--------------CCcHHHHHHHHHH
Confidence 3445566667899999999999999999999752 356789999998321 1223445788999
Q ss_pred HHHhcc-CCCCccccccceecCC-ceEEEEEcccCCCHHHHHhhhccc------------ccccChhhHHHHHHHHHHHH
Q 040480 99 ITASQI-RHRNILPLLAHMVRPD-SHLLVYDFMKNGSLQAVLYDVSKG------------RRELEWLSRHKIALAVASGL 164 (325)
Q Consensus 99 ~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~l 164 (325)
.++..+ +||||+++++++...+ ..++||||+++++|.+++...... ...++...+..++.|++.||
T Consensus 82 ~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 161 (316)
T 2xir_A 82 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 161 (316)
T ss_dssp HHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHH
T ss_pred HHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHH
Confidence 999999 6899999999987655 489999999999999999543221 12278889999999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHH
Q 040480 165 EYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGV 244 (325)
Q Consensus 165 ~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~ 244 (325)
.||| ++|++|+||||+||+++.++.++|+|||++................||+.|+|||++.+..++.++||||||+
T Consensus 162 ~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 238 (316)
T 2xir_A 162 EFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238 (316)
T ss_dssp HHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHH---hCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHH
Confidence 9999 7899999999999999999999999999998765543333333356788999999999989999999999999
Q ss_pred HHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 245 LLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 245 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
++|+|++ |..||..... ....... .......... . ..+..+.+++.+||+.||.+|||+.+++
T Consensus 239 il~~l~t~g~~p~~~~~~---~~~~~~~---~~~~~~~~~~--~--------~~~~~l~~li~~~l~~dp~~Rps~~ell 302 (316)
T 2xir_A 239 LLWEIFSLGASPYPGVKI---DEEFCRR---LKEGTRMRAP--D--------YTTPEMYQTMLDCWHGEPSQRPTFSELV 302 (316)
T ss_dssp HHHHHHTTSCCSSTTCCC---SHHHHHH---HHHTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCCcccch---hHHHHHH---hccCccCCCC--C--------CCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9999998 9999965322 1112221 1112111100 0 0112389999999999999999999997
Q ss_pred c
Q 040480 324 C 324 (325)
Q Consensus 324 ~ 324 (325)
+
T Consensus 303 ~ 303 (316)
T 2xir_A 303 E 303 (316)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=318.93 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=199.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-----C
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-----H 106 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h 106 (325)
-.++|++.+.||+|+||+||+|+ +..+++.||+|++.. ..........|+.+++.+. |
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~h 95 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQ-HIDNKKYYAVKVVRN----------------IKKYTRSAKIEADILKKIQNDDINN 95 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEECS----------------CHHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred ecCEEEEEEEEcccCCeEEEEEE-ECCCCeEEEEEEecc----------------chhhhhhhHHHHHHHHHhcccCCCC
Confidence 35789999999999999999996 556788999999831 1233455677888888886 9
Q ss_pred CCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 107 RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 107 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
|||+++++++...+..++||||+ +++|.+++.. .....++...+..++.|++.||.||| ++||+|+||||+||+
T Consensus 96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl 169 (360)
T 3llt_A 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENIL 169 (360)
T ss_dssp GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCeecccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEE
Confidence 99999999999999999999999 8899999954 22345889999999999999999999 889999999999999
Q ss_pred ecC-------------------------CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhh
Q 040480 187 IDD-------------------------DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYS 241 (325)
Q Consensus 187 ~~~-------------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dvws 241 (325)
++. ++.++|+|||++....... ....||+.|+|||++.+..++.++||||
T Consensus 170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHH
Confidence 975 7889999999998654322 1247899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccc--------------------hhhcCC---------
Q 040480 242 FGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAID--------------------SKLLGN--------- 292 (325)
Q Consensus 242 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~--------- 292 (325)
||+++|+|++|+.||.... ..+....+..... ..+..... +.....
T Consensus 245 lG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 319 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHE----HMEHLAMMESIIQ-PIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHTC-CCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCc----HHHHHHHHHHhcC-CCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhh
Confidence 9999999999999997522 2222222221111 00000000 000000
Q ss_pred ----chHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 293 ----GYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 293 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+.+|+.+||+.||.+|||++|+|+
T Consensus 320 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00001144789999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.07 Aligned_cols=204 Identities=25% Similarity=0.292 Sum_probs=167.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||+|+||.||+|. +..+++.||||++... .........+.+|+.+++.++||||++
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~vAiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~nIv~ 89 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAY-DKNTEKNVAIKKVNRM-------------FEDLIDCKRILREITILNRLKSDYIIR 89 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEE-ETTTTEEEEEEEECST-------------TTSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEE-ECCCCcEEEEEEeCch-------------hcChHHHHHHHHHHHHHHHcCCCCcce
Confidence 35799999999999999999995 5678899999998321 112234567899999999999999999
Q ss_pred cccceecC-----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 112 LLAHMVRP-----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 112 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
+++++... ...|+||||+.+ +|.+++ .....++...+..++.|++.||.||| ++||+||||||+||+
T Consensus 90 l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NIL 161 (432)
T 3n9x_A 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLF----KTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCL 161 (432)
T ss_dssp EEEECCCSCTTTCCCEEEEEECCSE-EHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred EEEEEecCCCCcCCeEEEEEecCCc-CHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeE
Confidence 99998766 568999999965 999998 34566999999999999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcc--------------------ccceeecCCccccccccc-ccCCCCCccchhhHHHH
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQ--------------------IDTMYVVGTPRYIAPEYH-QTLTISEKCDIYSFGVL 245 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~--------------------~~~~~~~g~~~~~aPE~~-~~~~~~~~~DvwslG~i 245 (325)
++.++.+||+|||++......... ......+||+.|+|||++ .+..++.++|||||||+
T Consensus 162 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~i 241 (432)
T 3n9x_A 162 LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241 (432)
T ss_dssp ECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred ECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHH
Confidence 999999999999999876543221 112336889999999985 56669999999999999
Q ss_pred HHHHHhCCCCCC
Q 040480 246 LAVLVMGKFPFD 257 (325)
Q Consensus 246 l~~ll~g~~p~~ 257 (325)
+|+|++|..||.
T Consensus 242 l~ell~g~~p~~ 253 (432)
T 3n9x_A 242 FAELLNMLQSHI 253 (432)
T ss_dssp HHHHHTTCTTTC
T ss_pred HHHHHhcccccc
Confidence 999998655553
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=310.58 Aligned_cols=252 Identities=22% Similarity=0.359 Sum_probs=199.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
....|++.+.||+|+||.||+|. +..++..||+|.+... .........+.+|+.+++.++||||++
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~~va~k~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~iv~ 89 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGL-DTETTVEVAWCELQDR-------------KLTKSERQRFKEEAEMLKGLQHPNIVR 89 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEGG-------------GSCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred CceeEEeeeeccCCCCeEEEEeE-ecCCceEEEEEEecch-------------hhCHHHHHHHHHHHHHHHhCCCCCeee
Confidence 45569999999999999999995 5677889999988321 223345677899999999999999999
Q ss_pred cccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCce
Q 040480 112 LLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR--VIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~--ivH~dl~~~ni 185 (325)
+++++.. ....++||||+++++|.+++.. ...++...+..++.|++.||.||| +++ ++|+||+|+||
T Consensus 90 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Ni 162 (290)
T 1t4h_A 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNI 162 (290)
T ss_dssp EEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGE
T ss_pred eeeeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHE
Confidence 9998765 3558999999999999999943 355889999999999999999999 778 99999999999
Q ss_pred Eec-CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 186 LID-DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+++ .++.++|+|||++........ ....|++.|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 163 l~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~---- 233 (290)
T 1t4h_A 163 FITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ---- 233 (290)
T ss_dssp EESSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----
T ss_pred EEECCCCCEEEeeCCCccccccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC----
Confidence 998 788999999999975443322 22478999999998875 58999999999999999999999996522
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..............+ ...+.. .+..+.+|+.+||+.||.+|||++++++
T Consensus 234 --~~~~~~~~~~~~~~~-~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 234 --NAAQIYRRVTSGVKP-ASFDKV--------AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --SHHHHHHHHTTTCCC-GGGGGC--------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cHHHHHHHHhccCCc-cccCCC--------CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112222222222211 111111 1123899999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=320.83 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=199.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.||||.+...... .......+.+|+.+++.++||||++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~-~~~~~~~vaiK~~~~~~~~------------~~~~~~~~~~E~~~l~~l~hpniv~ 118 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSGKQ------------SNEKWQDIIKEVRFLQKLRHPNTIQ 118 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEESCSSC------------HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhheeeeeEEccCCCEEEEEEE-EccCCeEEEEEEEcccccc------------chHHHHHHHHHHHHHHhCCCCCEee
Confidence 44679999999999999999995 5568899999998432211 1133467889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+.| +|.+.+.. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 119 ~~~~~~~~~~~~lv~e~~~g-~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~ 191 (348)
T 1u5q_A 119 YRGCYLREHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPG 191 (348)
T ss_dssp EEEEEEETTEEEEEEECCSE-EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTT
T ss_pred EEEEEEECCeEEEEEecCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCC
Confidence 99999999999999999975 88887743 3456899999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||++....... ...||+.|+|||++. ...++.++||||||+++|+|++|..||.... .
T Consensus 192 ~~kL~DfG~a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~----~--- 258 (348)
T 1u5q_A 192 LVKLGDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----A--- 258 (348)
T ss_dssp EEEECCCTTCBSSSSBC------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----H---
T ss_pred CEEEeeccCceecCCCC------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----h---
Confidence 99999999997654322 247899999999884 4568999999999999999999999996522 1
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+... . . ..+..+.+||.+||+.||++|||++++++
T Consensus 259 ~~~~~~~~~~~~~~~~-~-----~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 259 MSALYHIAQNESPALQ-S-----G---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHHHHSCCCCCC-C-----T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCCCCCC-C-----C---CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1112222222221110 0 1 11223889999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=332.58 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=202.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|. +..+++.||+|++.. ..........+.+|+.++++++||||+++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 86 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCK-DRITQQEYAVKVINK-------------ASAKNKDTSTILREVELLKKLDHPNIMKL 86 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEE-ETTTCCEEEEEEEEH-------------HHHBCSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hcceEEeEEEeecCCEEEEEEE-ECCCCCEEEEEEEec-------------ccccchHHHHHHHHHHHHHhCCCCCcCeE
Confidence 4789999999999999999995 567789999999831 12223446778999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec---C
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID---D 189 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~---~ 189 (325)
++++.+.+..++||||+.+++|.+.+.. ...+++..+..++.|++.||.||| ++||+|+||||+||+++ .
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~ 159 (486)
T 3mwu_A 87 FEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEK 159 (486)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSST
T ss_pred EEEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCC
Confidence 9999999999999999999999998843 356899999999999999999999 88999999999999995 4
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||++......... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ..
T Consensus 160 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~--- 228 (486)
T 3mwu_A 160 DCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EY--- 228 (486)
T ss_dssp TCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HH---
T ss_pred CCCEEEEECCcCeECCCCCcc---CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HH---
Confidence 567999999999766543322 22578999999999887 58999999999999999999999996521 12
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+......... + .....+..+.+||.+||+.||.+|||+.++++
T Consensus 229 ~~~~~i~~~~~~~~~-~------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 229 DILKRVETGKYAFDL-P------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHHHHTCCCSCS-G------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhCCCCCCC-c------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 222233322222111 0 01112234899999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=311.57 Aligned_cols=257 Identities=18% Similarity=0.215 Sum_probs=201.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|.+... .....+.+|+.+++.+ +|+++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~-----------------~~~~~~~~e~~~~~~l~~~~~i~~ 70 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGT-NLLNNQQVAIKFEPRR-----------------SDAPQLRDEYRTYKLLAGCTGIPN 70 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEE-ETTTTEEEEEEEEECC-----------------TTSCCHHHHHHHHHHTTTCTTCCC
T ss_pred ccceEEEEEEeecCCEEEEEEE-ECCCCcEEEEEEeccC-----------------CccHHHHHHHHHHHHHhcCCCCCe
Confidence 4689999999999999999996 5568899999987321 1223467788889988 7999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++......++||||+ +++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 71 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~ 143 (298)
T 1csn_A 71 VYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPN 143 (298)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSS
T ss_pred EEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCC
Confidence 999999999999999999 8899999954 2345899999999999999999999 88999999999999998776
Q ss_pred C-----ceeeccccceecCCCCccc-----cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 192 E-----ARISGFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 192 ~-----~~l~dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
. ++|+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 144 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred CCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 5 9999999998765443221 12335789999999999999999999999999999999999999976432
Q ss_pred CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ......+......... .... ...+..+.+|+.+||+.||++|||++++++
T Consensus 224 ~~~-~~~~~~~~~~~~~~~~-----~~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 224 ATN-KQKYERIGEKKQSTPL-----RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp CCH-HHHHHHHHHHHHHSCH-----HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccc-HHHHHHHHhhccCccH-----HHHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 211 1111111111111110 0000 012234899999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=311.85 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=191.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.||+|.+.... ........+.++...++.++||||++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~-------------~~~~~~~~~~~~~~~~~~~~h~~iv~ 70 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMR-HVPSGQIMAVKRIRATV-------------NSQEQKRLLMDLDISMRTVDCPFTVT 70 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEC----------------CHHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cHHhhhhHHhcCCCCCeEEEEEE-ecCCCeEEEEEEeeccc-------------CcHHHHHHHHHHHHHHHhCCCCeEEE
Confidence 45899999999999999999996 55688999999984211 11122334555566688889999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEecCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA-RVIHRDIKPANVLIDDD 190 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~ivH~dl~~~nil~~~~ 190 (325)
+++++...+..++||||+++ +|.+++.........+++..+..++.|++.||.||| ++ |++|+||||+||+++.+
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~ 146 (290)
T 3fme_A 71 FYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINAL 146 (290)
T ss_dssp EEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTT
T ss_pred EeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCC
Confidence 99999999999999999975 898888665556678999999999999999999999 76 99999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCccccccccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYH----QTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~----~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+.++|+|||.+.......... ...||+.|+|||++ .+..++.++||||||+++|+|++|..||.... .
T Consensus 147 ~~~kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~ 218 (290)
T 3fme_A 147 GQVKMCDFGISGYLVDDVAKD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-----T 218 (290)
T ss_dssp CCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-----C
T ss_pred CCEEEeecCCccccccccccc---ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-----c
Confidence 999999999997665433222 24689999999995 55668899999999999999999999996421 1
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... .........+.... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 219 ~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 219 PFQQ-LKQVVEEPSPQLPA---------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHH-HHHHHHSCCCCCCT---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hHHH-HHHHhccCCCCccc---------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111 12222222211110 011223899999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=324.51 Aligned_cols=256 Identities=20% Similarity=0.330 Sum_probs=191.2
Q ss_pred hhcCcccccccccCcceeEEEEEecC--CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPG--SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|.+.+.||+|+||.||+|++.. .++..||+|.+... ........+.+|+.++++++||||
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~ni 108 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--------------YTEKQRRDFLGEASIMGQFDHPNI 108 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--------------CCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--------------cCHHHHHHHHHHHHHHHhCCCCCC
Confidence 45689999999999999999996542 35677999988321 122345678999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++...+..++||||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 182 (373)
T 2qol_A 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINS 182 (373)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred CeEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcC
Confidence 9999999999999999999999999999943 3446899999999999999999999 789999999999999999
Q ss_pred CCCceeeccccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
++.+||+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.... ...
T Consensus 183 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~----~~~ 258 (373)
T 2qol_A 183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQD 258 (373)
T ss_dssp TCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC----HHH
T ss_pred CCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC----HHH
Confidence 9999999999998765432211 1111244678999999999899999999999999999998 999996532 122
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ..+......... ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 259 ~~---~~i~~~~~~~~~----------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 259 VI---KAVDEGYRLPPP----------MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HH---HHHHTTEECCCC----------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---HHHHcCCCCCCC----------ccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 22 222221111110 012233899999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=310.03 Aligned_cols=251 Identities=26% Similarity=0.435 Sum_probs=204.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.... .......+.+|+.+++.++||||++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~i~~ 84 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEE--------------AEDEIEDIQQEITVLSQCDSPYVTK 84 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEE-ETTTCCEEEEEEEETTT--------------CSTTHHHHHHHHHHHHHCCCTTBCC
T ss_pred hHHHHHHhhhhcccCCeEEEEEE-ECCCCcEEEEEEecccc--------------cHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 55789999999999999999995 55678899999984221 1234667899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++......++||||+++++|.+++. ...++...+..++.|++.||.+|| ++|++|+||+|+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~ 156 (303)
T 3a7i_A 85 YYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHG 156 (303)
T ss_dssp EEEEEEETTEEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTS
T ss_pred EEEEEecCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCC
Confidence 9999999999999999999999999983 356899999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||.+.......... ....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .....
T Consensus 157 ~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~-- 228 (303)
T 3a7i_A 157 EVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH----PMKVL-- 228 (303)
T ss_dssp CEEECCCTTCEECBTTBCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH--
T ss_pred CEEEeecccceecCcccccc--CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC----HHHHH--
Confidence 99999999998765433221 22578999999999999899999999999999999999999996522 11111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+.....+. .+ . ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 229 -~~~~~~~~~~--~~-----~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 229 -FLIPKNNPPT--LE-----G---NYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp -HHHHHSCCCC--CC-----S---SCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHhhcCCCCC--Cc-----c---ccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111221111 01 0 11223899999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=315.42 Aligned_cols=262 Identities=21% Similarity=0.346 Sum_probs=195.4
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
....++|.+.+.||+|+||.||+|.+... ++..||+|.+... .........+.+|+.++++++||
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~ 96 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD-------------NSSQREIEEFLSEAACMKDFSHP 96 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC----------------CCCHHHHHHHHHHHHHHHTCCCT
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc-------------ccchhHHHHHHHHHHHHhcCCCC
Confidence 34668999999999999999999976543 4568999987321 12223456788999999999999
Q ss_pred CccccccceecCC-----ceEEEEEcccCCCHHHHHhhhc--ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 040480 108 NILPLLAHMVRPD-----SHLLVYDFMKNGSLQAVLYDVS--KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDI 180 (325)
Q Consensus 108 ~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl 180 (325)
||+++++++...+ ..++||||+.+++|.+++.... .....++...++.++.|++.||.||| ++|++|+||
T Consensus 97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~di 173 (313)
T 3brb_A 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDL 173 (313)
T ss_dssp TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCC
T ss_pred CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 9999999987655 3599999999999999985432 23456899999999999999999999 889999999
Q ss_pred CCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCc
Q 040480 181 KPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDF 259 (325)
Q Consensus 181 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~ 259 (325)
||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 174 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 174 AARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp SGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 99999999999999999999987654433222333467889999999999899999999999999999999 88999753
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ...... .........+ . ..+..+.+++.+||..||.+|||+.++++
T Consensus 254 ~~----~~~~~~---~~~~~~~~~~--~--------~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 254 QN----HEMYDY---LLHGHRLKQP--E--------DCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp CG----GGHHHH---HHTTCCCCCB--T--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CH----HHHHHH---HHcCCCCCCC--c--------cccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22 222222 1222111111 1 11233899999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=320.05 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=192.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC--CCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH--RNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i 109 (325)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ........+.+|+.+++.+.| |||
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~~~~~~i 71 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEE-------------ADNQTLDSYRNEIAYLNKLQQHSDKI 71 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC--TTSCEEEEEEEECTT-------------CCHHHHHHHHHHHHHHHHHTTTCTTB
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe--CCCCEEEEEEeeccc-------------cchHHHHHHHHHHHHHHhhhhcCCce
Confidence 457899999999999999999964 368889999984321 122345678899999999976 999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++...+..++|||+ .+++|.+++. ....++...+..++.|++.||.||| ++||+||||||+||+++
T Consensus 72 v~~~~~~~~~~~~~lv~e~-~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~- 142 (343)
T 3dbq_A 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV- 142 (343)
T ss_dssp CCEEEEEECSSEEEEEECC-CSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-
T ss_pred EEEeeeEeeCCEEEEEEeC-CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-
Confidence 9999999999999999995 5779999994 3456889999999999999999999 78999999999999997
Q ss_pred CCCceeeccccceecCCCCccccceeecCCccccccccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----------LTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----------~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
++.++|+|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 143 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 57899999999987654433333334579999999999865 5688999999999999999999999964
Q ss_pred cccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 259 FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ... ........... ...+. . ....+.+|+.+||+.||.+|||+.|+++
T Consensus 223 ~~~-----~~~-~~~~~~~~~~~-~~~~~-----~---~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 223 IIN-----QIS-KLHAIIDPNHE-IEFPD-----I---PEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CCS-----HHH-HHHHHHCTTSC-CCCCC-----C---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhh-----HHH-HHHHHhcCCcc-cCCcc-----c---CCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 221 111 12222211111 11110 0 0123889999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=320.02 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=194.7
Q ss_pred Cccc--ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 35 CFAS--LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 35 ~y~~--~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.|.+ .+.||+|+||.||+|. +..++..||+|++... .......+.+|+.++++++||||+++
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~-~~~~g~~vavK~~~~~---------------~~~~~~~~~~E~~~l~~l~hpnIv~~ 151 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTR---------------GMKDKEEVKNEISVMNQLDHANLIQL 151 (373)
T ss_dssp TEEEEEEEECC-----CEEEEE-ETTTCCEEEEEEEECC---------------SHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ceeeecceEEecCcCEEEEEEE-EcCCCcEEEEEEEccc---------------ccccHHHHHHHHHHHHhCCCCCCCeE
Confidence 4444 5689999999999995 5567899999998321 11345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe--cCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI--DDD 190 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~--~~~ 190 (325)
++++...+..++||||+++++|.+++.. ....+++..+..++.|++.||.||| ++||+|+||||+||++ +.+
T Consensus 152 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~ 225 (373)
T 2x4f_A 152 YDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDA 225 (373)
T ss_dssp EEEEECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTT
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCC
Confidence 9999999999999999999999998843 3346889999999999999999999 8899999999999999 466
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||++.......... ...||+.|+|||++.+..++.++||||||+++|+|++|..||.... . ..
T Consensus 226 ~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~---~~ 295 (373)
T 2x4f_A 226 KQIKIIDFGLARRYKPREKLK---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN----D---AE 295 (373)
T ss_dssp TEEEECCCSSCEECCTTCBCC---CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS----H---HH
T ss_pred CcEEEEeCCCceecCCccccc---cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----H---HH
Confidence 789999999998765443222 2478999999999999889999999999999999999999996522 1 12
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+........ ... ....+..+.+||.+||+.||.+|||+.|+++
T Consensus 296 ~~~~i~~~~~~~~---~~~----~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 296 TLNNILACRWDLE---DEE----FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHTCCCSC---SGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCC---hhh----hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2222222222111 000 1112234899999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=318.88 Aligned_cols=267 Identities=23% Similarity=0.340 Sum_probs=198.8
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|+ +..+++.||+|++.... ........+.+|+.+++.++||||+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv 87 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCR-NKDTGRIVAIKKFLESD-------------DDKMVKKIAMREIKLLKQLRHENLV 87 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEE-ETTTCCEEEEEEEESCS-------------SCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhheeeeEEeecCCEEEEEEE-ECCCCceEEEEEEecCC-------------CchHHHHHHHHHHHHHhhCCCCCEe
Confidence 356799999999999999999996 55678999999884321 1123345678899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++||||+++++|.++. .....++...+..++.|++.||.||| ++|++|+||||+||+++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~ 160 (331)
T 4aaa_A 88 NLLEVCKKKKRWYLVFEFVDHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQS 160 (331)
T ss_dssp CEEEEEEETTEEEEEEECCSEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred eEEEEeecCCEEEEEEecCCcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCC
Confidence 9999999999999999999998888876 34456899999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||.+......... .....|+..|+|||++.+. .++.++||||||+++|+|++|..||..... .+..
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~ 234 (331)
T 4aaa_A 161 GVVKLCDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD----IDQL 234 (331)
T ss_dssp SCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH
T ss_pred CcEEEEeCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHH
Confidence 99999999999765443221 1224789999999998875 689999999999999999999999975321 1111
Q ss_pred HHHHHHhhhC-----------------CCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASE-----------------NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... ..................+..+.+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111100000 000000000000001123345899999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=312.73 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=196.2
Q ss_pred hcCcccc-cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 33 EDCFASL-EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 33 ~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
.++|++. +.||+|+||.||+|. +..+++.||+|++... .......+.+|+.++.++ +||||+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~---------------~~~~~~~~~~E~~~l~~~~~h~~i~ 74 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCI-NLITSQEYAVKIIEKQ---------------PGHIRSRVFREVEMLYQCQGHRNVL 74 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEE-CSSSCCEEEEEEEECC---------------SSCCHHHHHHHHHHHHHTCCCTTBC
T ss_pred ceeEEecCceecCCceEEEEEEE-EcCCCcEEEEEEEeeC---------------cchhHHHHHHHHHHHHHhcCCCCee
Confidence 4679885 789999999999995 5677899999998321 223456788899999885 799999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.+.+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||||+||+++.+
T Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~ 147 (316)
T 2ac3_A 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHP 147 (316)
T ss_dssp CEEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCS
T ss_pred eEEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccC
Confidence 999999999999999999999999999943 346899999999999999999999 7899999999999999977
Q ss_pred CC---ceeeccccceecCCCCc-----cccceeecCCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCC
Q 040480 191 ME---ARISGFDLAILMPDGLT-----QIDTMYVVGTPRYIAPEYHQT-----LTISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 191 ~~---~~l~dfg~~~~~~~~~~-----~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
+. ++|+|||++........ ........||..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp SSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 65 99999999876542211 111122468999999999875 457899999999999999999999997
Q ss_pred CcccCCCcch--------HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 258 DFFSHTGEMD--------MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 258 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......... .......+....... +.... ...+..+.+|+.+||+.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~---~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEF---PDKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCCCSCSCC----CCHHHHHHHHHHHHHCCCCC---CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccccccccccchhHHHHHHHHHhccCccc---Cchhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 6432221111 111222222222111 11100 112234899999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=312.18 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=204.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|. +..++..||+|.+.. .......+.+|+.++++++||||++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~~ 73 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGV-WKKYSLTVAVKTLKE----------------DTMEVEEFLKEAAVMKEIKHPNLVQ 73 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEE-EGGGTEEEEEEEECS----------------CSTHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccceeEEeecCCCCceeEEEeE-ecCCCEEEEEEecCc----------------CHHHHHHHHHHHHHHHhCCCCCEee
Confidence 56889999999999999999996 445688999999832 2234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+.+..++||||+++++|.+++.. .....++...+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 74 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~ 148 (288)
T 3kfa_A 74 LLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENH 148 (288)
T ss_dssp EEEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGG
T ss_pred EEEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCC
Confidence 99999999999999999999999999954 23456899999999999999999999 77999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... ......
T Consensus 149 ~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~----~~~~~~ 223 (288)
T 3kfa_A 149 LVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYE 223 (288)
T ss_dssp CEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHH
T ss_pred CEEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH
Confidence 9999999999866543322 1122456788999999998899999999999999999999 999997532 222222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... ...... + ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 224 ~~~~---~~~~~~--~--------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 224 LLEK---DYRMER--P--------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHT---TCCCCC--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhc---cCCCCC--C--------CCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 2221 111110 0 011233899999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=319.73 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=196.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.++++++||||+++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~vavK~~~~~~--------------~~~~~~~~~~E~~~l~~l~hpniv~~ 69 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAK-NKVDDCNYAIKRIRLPN--------------RELAREKVMREVKALAKLEHPGIVRY 69 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEE-ETTTCCEEEEEEEECCS--------------TTTHHHHHHHHHHHHTSCCCTTBCCE
T ss_pred hhcCceeeEecCCCCeEEEEEE-EcCCCcEEEEEEeecCC--------------chhHHHHHHHHHHHHHhCCCCCEeeE
Confidence 4689999999999999999996 55678899999984321 22345678999999999999999999
Q ss_pred ccceecCC---------------------------------------------------------ceEEEEEcccCCCHH
Q 040480 113 LAHMVRPD---------------------------------------------------------SHLLVYDFMKNGSLQ 135 (325)
Q Consensus 113 ~~~~~~~~---------------------------------------------------------~~~lv~e~~~~~~L~ 135 (325)
++++.+.. ..++||||+++++|.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 149 (332)
T 3qd2_B 70 FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLK 149 (332)
T ss_dssp EEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHH
T ss_pred EEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHH
Confidence 99875543 279999999999999
Q ss_pred HHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCcc-----
Q 040480 136 AVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ----- 210 (325)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----- 210 (325)
+++.... .....+...+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++.........
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~ 225 (332)
T 3qd2_B 150 DWMNRRC-SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225 (332)
T ss_dssp HHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------
T ss_pred HHHhccc-CccchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc
Confidence 9995422 2233455568899999999999999 889999999999999999999999999999877654221
Q ss_pred -----ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCccc
Q 040480 211 -----IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAI 285 (325)
Q Consensus 211 -----~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (325)
.......||+.|+|||++.+..++.++||||||+++|+|++|..|+.. .............+
T Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~~~~~~~~~~~~---- 292 (332)
T 3qd2_B 226 PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVRIITDVRNLKFP---- 292 (332)
T ss_dssp ------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHHHHHHHHTTCCC----
T ss_pred cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHHHHHHhhccCCC----
Confidence 111224789999999999999999999999999999999998777532 11111111111111
Q ss_pred chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 286 DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.........+.+|+.+||+.||++|||++|+++
T Consensus 293 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 293 ------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 112233344789999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=316.40 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=192.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCc----EEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGK----MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||.||+|.+. .+++ .+|+|.+.. .........+.+|+.+++.++||
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~kv~iK~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp 77 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELRE--------------ATSPKANKEILDEAYVMASVDNP 77 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEEC-CTTCSCCEEEEEEEECC--------------CSSCCCHHHHHHHHHHHTTCCBT
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEc-CCCceEEEEEEEEeecc--------------ccCHHHHHHHHHHHHHHHhCCCC
Confidence 5689999999999999999999753 3443 357776621 11234567789999999999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
||+++++++.... .+++++++.+++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||++
T Consensus 78 ~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~ 150 (327)
T 3lzb_A 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLV 150 (327)
T ss_dssp TBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEE
Confidence 9999999888654 8899999999999999854 3456899999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcc
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEM 266 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~ 266 (325)
+.++.++|+|||++................+|..|+|||.+.+..++.++||||||+++|+|++ |..||..... .
T Consensus 151 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~ 226 (327)
T 3lzb_A 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----S 226 (327)
T ss_dssp EETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----G
T ss_pred cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH----H
Confidence 9999999999999987654443333333466788999999999999999999999999999999 9999975322 2
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... ....... +. ..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~---~~~~~~~--~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 227 EISSILE---KGERLPQ--PP--------ICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp GHHHHHH---TTCCCCC--CT--------TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH---cCCCCCC--Cc--------cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2222222 1111111 10 01123889999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=317.30 Aligned_cols=262 Identities=19% Similarity=0.284 Sum_probs=194.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|+ +..+++.||+|.+..... ......+.+|+.+++.++||||++++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 66 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGK-SKLTDNLVALKEIRLEHE--------------EGAPCTAIREVSLLKDLKHANIVTLH 66 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEECC--------------------CCCCCCCHHHHSCCCCTTBCCEE
T ss_pred CceEEEEEEcCCCCEEEEEEE-ECCCCcEEEEEEEecccc--------------cccchhHHHHHHHHHhcCCCCCCeee
Confidence 689999999999999999995 556788999998842210 01111234688999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..++||||+++ +|.+++.. ....++...+..++.|++.||.||| ++||+|+||||+||+++.++.+
T Consensus 67 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~ 139 (324)
T 3mtl_A 67 DIIHTEKSLTLVFEYLDK-DLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGEL 139 (324)
T ss_dssp EEEECSSCEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCE
T ss_pred eEEeeCCEEEEEeccccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCE
Confidence 999999999999999975 89888844 3446889999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+|+|||++......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||... ...+....+
T Consensus 140 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i 213 (324)
T 3mtl_A 140 KLADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS----TVEEQLHFI 213 (324)
T ss_dssp EECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHH
T ss_pred EEccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Confidence 99999999765433221 122477999999999876 56899999999999999999999999752 222333333
Q ss_pred HHHhhhCCCCcccchhhcC-----------------CchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLG-----------------NGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+.... ++..... .........+.+|+.+||+.||.+|||++|+++
T Consensus 214 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 214 FRILGTPTEET-WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHCCCCTTT-STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhCCCChHh-chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 33222221111 1100000 000112334889999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=306.55 Aligned_cols=257 Identities=24% Similarity=0.432 Sum_probs=197.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.||+|.+.......... .......+.+|+.+++.++||||++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~ 87 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGR-LVKDKSVVAIKSLILGDSEGETE--------MIEKFQEFQREVFIMSNLNHPNIVK 87 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEE-ETTTCCEEEEEECCCCTTTCCHH--------HHCCSHHHHHHHHHHTTCCCTTBCC
T ss_pred hhccceehhccccCCceeEEEEE-EcCCceEEEEEEeeccccccchh--------HHHHHHHHHHHHHHHHhCCCCCchh
Confidence 45789999999999999999996 55678999999985433211110 0012367889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEecC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR--VIHRDIKPANVLIDD 189 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~--ivH~dl~~~nil~~~ 189 (325)
+++++.+.. ++||||+++++|.+.+.. ....+++..+..++.|++.||.||| ++| ++|+||||+||+++.
T Consensus 88 ~~~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~ 159 (287)
T 4f0f_A 88 LYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQS 159 (287)
T ss_dssp EEEEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESC
T ss_pred hheeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEec
Confidence 999886654 799999999999988843 4456899999999999999999999 778 999999999999987
Q ss_pred CCC-----ceeeccccceecCCCCccccceeecCCcccccccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCcccC
Q 040480 190 DME-----ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ--TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSH 262 (325)
Q Consensus 190 ~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~--~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~ 262 (325)
++. ++|+|||++...... .....||+.|+|||.+. ...++.++||||||+++|+|++|..||.....
T Consensus 160 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 233 (287)
T 4f0f_A 160 LDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY- 233 (287)
T ss_dssp CCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC-
T ss_pred cCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc-
Confidence 776 999999999754332 22257899999999984 44578899999999999999999999975322
Q ss_pred CCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 263 TGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. .............. ..+. ..+..+.+|+.+||+.||.+|||++++++
T Consensus 234 ---~~-~~~~~~~~~~~~~~-~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 234 ---GK-IKFINMIREEGLRP-TIPE--------DCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ---CH-HHHHHHHHHSCCCC-CCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cH-HHHHHHHhccCCCC-CCCc--------ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 11112212111111 1111 11233899999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.98 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=197.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|+ +..++..+|+|.+.... ........+.+|+.+++.++||||+++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~hpniv~~ 101 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCR-DKVTHVERAIKIIRKTS-------------VSTSSNSKLLEEVAVLKLLDHPNIMKL 101 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEE-ETTTCCEEEEEEEEC------------------CTTHHHHHHHHHHTTCCCTTBCCE
T ss_pred hcCeEEeeEEecCCCEEEEEEE-ECCCCcEEEEEEEeccc-------------cCchHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3579999999999999999996 56778899999984221 112334678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC--
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD-- 190 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~-- 190 (325)
++++.+.+..|+||||+.+++|.+.+.. ...+++..+..++.|++.||.||| ++||+||||||+||+++..
T Consensus 102 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~ 174 (494)
T 3lij_A 102 YDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEK 174 (494)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSST
T ss_pred EEEEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCC
Confidence 9999999999999999999999998843 356899999999999999999999 8899999999999999754
Q ss_pred -CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 191 -MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 -~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||++......... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ..
T Consensus 175 ~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~--- 243 (494)
T 3lij_A 175 DALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT----DQ--- 243 (494)
T ss_dssp TCCEEECCCTTCEECBTTBCB---CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HH---
T ss_pred CCcEEEEECCCCeECCCCccc---cccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC----HH---
Confidence 45999999999876654322 22579999999999875 68999999999999999999999997532 12
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+......... .. ....+..+.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~~~i~~~~~~~~~---~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 244 EILRKVEKGKYTFDS---PE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHHHTCCCCCS---GG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCCCCCCc---hh----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 222233322222110 00 1112234899999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=319.40 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=193.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|++... .........+.+|+.+++.++||||+++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpnIv~l 89 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAV-DGRTGAKVAIKKLYRP-------------FQSELFAKRAYRELRLLKHMRHENVIGL 89 (367)
T ss_dssp BSSEEEEEEC------CEEEEE-ETTTCCEEEEEECSST-------------TSSHHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred cceEEEeEEeeecCCeEEEEEE-ECCCCCEEEEEEeCcc-------------ccCHHHHHHHHHHHHHHHhCCCcCCCCc
Confidence 4789999999999999999995 5678899999987321 1122345678899999999999999999
Q ss_pred ccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++.... ..|+||||+ +++|.+++.. ..++...+..++.|++.||.||| ++|++|+||||+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIl 160 (367)
T 1cm8_A 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLA 160 (367)
T ss_dssp SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred eeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEE
Confidence 99987653 459999999 7799999843 45889999999999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
++.++.+||+|||++....... ....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.... .
T Consensus 161 l~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~ 231 (367)
T 1cm8_A 161 VNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD----H 231 (367)
T ss_dssp ECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----H
T ss_pred EcCCCCEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC----H
Confidence 9999999999999998754321 22478999999999877 678999999999999999999999997522 1
Q ss_pred chHHHHHHHHhhhCCCCccc-------------------chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAI-------------------DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....+.... ..+.... ...............+.+|+.+||+.||.+|||++++++
T Consensus 232 ~~~l~~i~~~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 232 LDQLKEIMKVT--GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHHHHH--CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhc--CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11111111111 1110000 000001111122344899999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=311.22 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=188.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|++ ...+|+|.+..... .......+.+|+.++++++||||++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~----~~~vavK~~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAP-------------TPQQLQAFKNEVGVLRKTRHVNILL 84 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEES----SSEEEEEEESCSSC-------------CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred CccceeeeeEecCCCCeEEEEEEE----cCceEEEEEeccCC-------------CHHHHHHHHHHHHHHHhCCCCcEEE
Confidence 458999999999999999999964 33599999843321 2234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
++++ ......++||||+.+++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 85 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~ 157 (289)
T 3og7_A 85 FMGY-STAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDN 157 (289)
T ss_dssp EEEE-ECSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTT
T ss_pred EEee-ccCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCC
Confidence 9995 456678999999999999999843 3456899999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||++................||+.|+|||.+. +..++.++||||||+++|+|++|..||..... ....
T Consensus 158 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~ 234 (289)
T 3og7_A 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQI 234 (289)
T ss_dssp EEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC---HHHH
T ss_pred CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch---HHHH
Confidence 99999999998665433333333357899999999886 55678899999999999999999999975321 1112
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ............ ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 235 ~~---~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 235 IE---MVGRGSLSPDLS------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HH---HHHHTSCCCCTT------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---HhcccccCcchh------hccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22 222222111100 001112334899999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=311.66 Aligned_cols=247 Identities=17% Similarity=0.254 Sum_probs=194.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCC------cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNG------KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR 105 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 105 (325)
..++|++.+.||+|+||.||+|.+..... ..||+|.+. .......+.+.+|+.++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~---------------~~~~~~~~~~~~E~~~l~~l~ 70 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---------------KAHRNYSESFFEAASMMSKLS 70 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEEC---------------GGGGGGHHHHHHHHHHHHTSC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcc---------------cccHHHHHHHHHHHHHHHhCC
Confidence 45789999999999999999997543221 579999882 122345567899999999999
Q ss_pred CCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 106 HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 106 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
||||+++++++...+..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||
T Consensus 71 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI 144 (289)
T 4fvq_A 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNI 144 (289)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred CCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceE
Confidence 99999999999999999999999999999999954 3344889999999999999999999 88999999999999
Q ss_pred EecCCCC--------ceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCC-CC
Q 040480 186 LIDDDME--------ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGK-FP 255 (325)
Q Consensus 186 l~~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~-~p 255 (325)
+++.++. ++|+|||.+....... ...|+..|+|||++.+ ..++.++||||||+++|+|++|. .|
T Consensus 145 ll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 145 LLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp EEEECCBGGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEecCCcccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9998876 9999999986543321 1357889999999887 67899999999999999999955 45
Q ss_pred CCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 256 FDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|.... . .............+...+. .+.+|+.+||+.||.+|||+.++++
T Consensus 219 ~~~~~----~---~~~~~~~~~~~~~~~~~~~------------~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 219 LSALD----S---QRKLQFYEDRHQLPAPKAA------------ELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp TTTSC----H---HHHHHHHHTTCCCCCCSSC------------TTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccc----h---HHHHHHhhccCCCCCCCCH------------HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 43311 1 1111111112222222222 1889999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=307.12 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=196.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|++ .+..+|+|.+.... ........+.+|+.++++++||||++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv~ 71 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRD-------------WSTRKSRDFNEECPRLRIFSHPNVLP 71 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTT-------------CCHHHHHHHHHHGGGGCCCSCTTEEC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEecccc-------------cCHHHHHHHHHHHHHHHhcCCCchhh
Confidence 347899999999999999999976 48889999984321 12234567899999999999999999
Q ss_pred cccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEe
Q 040480 112 LLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR--VIHRDIKPANVLI 187 (325)
Q Consensus 112 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~--ivH~dl~~~nil~ 187 (325)
+++++.+. +..++||||+++++|.+++.. .....+++..+..++.|++.||.||| +++ ++|+||||+||++
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~ 146 (271)
T 3kmu_A 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMI 146 (271)
T ss_dssp EEEEECTTTSSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEE
T ss_pred eEEEEccCCCCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEE
Confidence 99999877 778999999999999999943 22335899999999999999999999 778 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCC---ccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISE---KCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~---~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+.++.+++.|||++...... ...||+.|+|||.+.+..++. ++||||||+++|+|++|..||.....
T Consensus 147 ~~~~~~~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--- 216 (271)
T 3kmu_A 147 DEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--- 216 (271)
T ss_dssp CTTSCEEEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---
T ss_pred cCCcceeEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---
Confidence 99999999999887543222 136789999999998765544 79999999999999999999965321
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ........... ..+. ..+..+.+++.+||+.||++|||++++++
T Consensus 217 -~~~---~~~~~~~~~~~-~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 217 -MEI---GMKVALEGLRP-TIPP--------GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -HHH---HHHHHHSCCCC-CCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH---HHHHHhcCCCC-CCCC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 11111111111 1111 11223899999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=322.73 Aligned_cols=253 Identities=21% Similarity=0.333 Sum_probs=192.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--CCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR--HRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~ 110 (325)
..+|++.+.||+|+||.||+|... +++.||||++.... ........+.+|+.+++.+. ||||+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~-------------~~~~~~~~~~~Ei~~l~~l~~~~~~iv 119 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEE-------------ADNQTLDSYRNEIAYLNKLQQHSDKII 119 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTT-------------CCHHHHHHHHHHHHHHHHHTTTCTTBC
T ss_pred CCceEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEeccc-------------ccHHHHHHHHHHHHHHHHcccCCCeEE
Confidence 346999999999999999999643 48899999984321 12234567899999999996 59999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..|+||| +.+++|.+++.. ...++...+..++.|++.||.||| ++||+||||||+||+++ +
T Consensus 120 ~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~ 190 (390)
T 2zmd_A 120 RLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-D 190 (390)
T ss_dssp CEEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-S
T ss_pred EEEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-C
Confidence 99999999999999999 557799999843 346888889999999999999999 88999999999999995 5
Q ss_pred CCceeeccccceecCCCCccccceeecCCccccccccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCc
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----------LTISEKCDIYSFGVLLAVLVMGKFPFDDF 259 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----------~~~~~~~DvwslG~il~~ll~g~~p~~~~ 259 (325)
+.+||+|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 191 GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 7899999999987654433222233579999999999865 36888999999999999999999999642
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. .......+....... ..+. .. ...+.+||.+||+.||.+|||+.|+++
T Consensus 271 ~~------~~~~~~~~~~~~~~~-~~~~-----~~---~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 271 IN------QISKLHAIIDPNHEI-EFPD-----IP---EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CC------HHHHHHHHHCTTSCC-CCCC-----CS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hH------HHHHHHHHhCccccC-CCCc-----cc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 21 111222222211111 1110 00 123889999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=317.25 Aligned_cols=263 Identities=20% Similarity=0.280 Sum_probs=204.4
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCC----CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSN----GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI 104 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 104 (325)
+....++|++.+.||+|+||.||+|.+.... ...||+|.+... ........+.+|+.+++.+
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l 106 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--------------AHADEKEALMSELKIMSHL 106 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT--------------CCHHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc--------------cChHHHHHHHHHHHHHHhh
Confidence 3445688999999999999999999754322 257999988321 1223456788999999999
Q ss_pred -CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc----------cccccChhhHHHHHHHHHHHHHHHHhcCCC
Q 040480 105 -RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK----------GRRELEWLSRHKIALAVASGLEYLHMHHSA 173 (325)
Q Consensus 105 -~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~ 173 (325)
+||||+++++++...+..++||||+++++|.+++..... ....++...+..++.|++.||.||| ++
T Consensus 107 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 183 (333)
T 2i1m_A 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SK 183 (333)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred cCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cC
Confidence 899999999999999999999999999999999965321 1345788999999999999999999 78
Q ss_pred CeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-C
Q 040480 174 RVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-G 252 (325)
Q Consensus 174 ~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g 252 (325)
|++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 184 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 263 (333)
T 2i1m_A 184 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 263 (333)
T ss_dssp TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999986644333222223456788999999998889999999999999999998 9
Q ss_pred CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 253 KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 253 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..||..... .......... ...... +. ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 264 ~~p~~~~~~---~~~~~~~~~~---~~~~~~--~~--------~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 264 LNPYPGILV---NSKFYKLVKD---GYQMAQ--PA--------FAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp CCSSTTCCS---SHHHHHHHHH---TCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccch---hHHHHHHHhc---CCCCCC--CC--------CCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999975322 1112222211 111110 00 01223899999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=331.19 Aligned_cols=254 Identities=21% Similarity=0.351 Sum_probs=201.6
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
+....++|++.+.||+|+||.||+|.+. ++..||||.+.. .....+.+.+|+.++++++|||
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~----------------~~~~~~~~~~E~~~l~~l~h~~ 244 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKP----------------GSMSVEAFLAEANVMKTLQHDK 244 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECT----------------TSBCHHHHHHHHHHHTTCCCTT
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecC----------------CCccHHHHHHHHHHHhhCCCCC
Confidence 3446678999999999999999999764 567899999832 1234667899999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++. .+..++||||+++++|.+++... ....++...+..++.|++.||.||| +++++||||||+||+++
T Consensus 245 iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~ 318 (454)
T 1qcf_A 245 LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVS 318 (454)
T ss_dssp BCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEEC
T ss_pred EeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEC
Confidence 999999876 66789999999999999999532 2235788889999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.... ..+
T Consensus 319 ~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~----~~~ 393 (454)
T 1qcf_A 319 ASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPE 393 (454)
T ss_dssp TTCCEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHH
T ss_pred CCCcEEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC----HHH
Confidence 9999999999999865432211 1112345778999999998899999999999999999999 999997532 222
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+... +........+ ...+..+.+||.+||+.||++|||+++|++
T Consensus 394 ~~~~---i~~~~~~~~~----------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 394 VIRA---LERGYRMPRP----------ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHH---HHHTCCCCCC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH---HHcCCCCCCC----------CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 2222 2222221111 112234899999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=311.00 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=199.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~---------------~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVK-QRLTGKLFALKCIKKSP---------------AFRDSSLENEIAVLKKIKHENIVTL 71 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEECC---------------------HHHHHHHHHHHCCCTTBCCE
T ss_pred hccceeeeeccCCCCceEEEEE-ECCCCCEEEEEEEeccc---------------ccchHHHHHHHHHHHhCCCCCeeeh
Confidence 4789999999999999999996 55678899999984221 1223467889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---cC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DD 189 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~---~~ 189 (325)
++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||+|+||++ +.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~ 144 (304)
T 2jam_A 72 EDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEE 144 (304)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSST
T ss_pred hhhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCC
Confidence 9999999999999999999999999843 345889999999999999999999 7899999999999999 67
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||.+........ ....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... ....
T Consensus 145 ~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~- 215 (304)
T 2jam_A 145 NSKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET----ESKL- 215 (304)
T ss_dssp TCCEEBCSCSTTCCCCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC----HHHH-
T ss_pred CCCEEEccCCcceecCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHH-
Confidence 88999999999875443221 12468999999999999899999999999999999999999996522 1122
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+....... +... ....+..+.+++.+||+.||++|||++++++
T Consensus 216 --~~~i~~~~~~~---~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 216 --FEKIKEGYYEF---ESPF----WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp --HHHHHHCCCCC---CTTT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred --HHHHHcCCCCC---Cccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22222222111 0000 0112234899999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=334.56 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=204.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|++.... .........+.+|+.++++++||||+++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~avK~~~~~~------------~~~~~~~~~~~~E~~~l~~l~hpniv~~ 91 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCK-DKITGQECAVKVISKRQ------------VKQKTDKESLLREVQLLKQLDHPNIMKL 91 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEETTT------------CCBSSCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cCceEEeeEEecCCCEEEEEEE-ECCCCCEEEEEEEEhhh------------cccchHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3689999999999999999995 56788999999984221 1112456778999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---cC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DD 189 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~---~~ 189 (325)
++++...+..++||||+.+++|.+.+. ....+++..+..++.|++.||.||| ++||+|+||||+||++ +.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~ 164 (484)
T 3nyv_A 92 YEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSK 164 (484)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSST
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCC
Confidence 999999999999999999999999983 4456999999999999999999999 8899999999999999 46
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
++.++|+|||++.......... ...||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ..+
T Consensus 165 ~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~-- 234 (484)
T 3nyv_A 165 DANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN----EYD-- 234 (484)
T ss_dssp TCCEEECCTTHHHHBCCCCSHH---HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH--
T ss_pred CCcEEEEeeeeeEEcccccccc---cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC----HHH--
Confidence 7889999999998765443222 2478999999999877 68999999999999999999999997522 222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+......... + .....+..+.+||.+||+.||.+|||+.|+++
T Consensus 235 -~~~~i~~~~~~~~~-~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 235 -ILKKVEKGKYTFEL-P------QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -HHHHHHHCCCCCCS-G------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHcCCCCCCC-c------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 22223322221110 0 01122334899999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=321.64 Aligned_cols=200 Identities=25% Similarity=0.448 Sum_probs=173.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..++..||+|.+... ........+.+|+.+++.++||||+++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~va~K~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 96 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLE--------------IKPAIRNQIIRELQVLHECNSPYIVGF 96 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEECC--------------CCHHHHHHHHHHHGGGGGCCCTTBCCE
T ss_pred cccceeeeeecCCCCeEEEEEE-ECCCCcEEEEEEeccc--------------cCHHHHHHHHHHHHHHHHCCCCCEEEE
Confidence 5689999999999999999996 5567899999998422 122345678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEecCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA-RVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~ivH~dl~~~nil~~~~~ 191 (325)
++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++ |++|+||||+||+++.++
T Consensus 97 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~ 169 (360)
T 3eqc_A 97 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRG 169 (360)
T ss_dssp EEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTC
T ss_pred eEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCC
Confidence 9999999999999999999999999943 345889999999999999999999 64 899999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
.++|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 170 ~~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 170 EIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CEEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred CEEEEECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999986543211 1224789999999999999999999999999999999999999965
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=310.02 Aligned_cols=262 Identities=20% Similarity=0.293 Sum_probs=203.7
Q ss_pred hcCcccccccccCcceeEEEEEe---cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAEL---PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..+|++.+.||+|+||.||+|++ +..+++.||+|.+... ........+.+|+.+++.++||||
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i 85 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--------------SGGNHIADLKKEIEILRNLYHENI 85 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------------CCHHHHHHHHHHHHTCCCTTB
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccc--------------ccchhHHHHHHHHHHHHhCCCCCe
Confidence 46799999999999999999975 4557899999998321 122345678999999999999999
Q ss_pred cccccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 110 LPLLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 110 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+++++++... ...++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||++
T Consensus 86 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~ 159 (302)
T 4e5w_A 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLV 159 (302)
T ss_dssp CCEEEEEEC---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred eeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEE
Confidence 9999999876 668999999999999999844 2345899999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcc------
Q 040480 188 DDDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF------ 260 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~------ 260 (325)
+.++.++|+|||.+......... .......||..|+|||.+.+..++.++||||||+++|+|++|..|+....
T Consensus 160 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 239 (302)
T 4e5w_A 160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239 (302)
T ss_dssp EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhc
Confidence 99999999999999876554321 11222467888999999999889999999999999999999999875321
Q ss_pred --cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 --SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....................... + ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 240 IGPTHGQMTVTRLVNTLKEGKRLPC--P--------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HCSCCGGGHHHHHHHHHHTTCCCCC--C--------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCCcccccCHHHHHHHHhccCCCCC--C--------CCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11122222222332222222111 1 112233899999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=308.79 Aligned_cols=255 Identities=21% Similarity=0.308 Sum_probs=190.1
Q ss_pred hhhcCcccccccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
...++|++.+.||+|+||.||+|.+... .+..||+|.+... ......+.+.+|+.++++++|||
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~ 77 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--------------TSDSVREKFLQEALTMRQFDHPH 77 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--------------TSHHHHHHHHHHHHHHHTCCCTT
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--------------CCHHHHHHHHHHHHHHHhCCCCc
Confidence 3457999999999999999999976432 3567999987321 12234567889999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++. ++..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++
T Consensus 78 iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~ 150 (281)
T 1mp8_A 78 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVS 150 (281)
T ss_dssp BCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred cceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEEC
Confidence 999999874 5678999999999999999943 2346889999999999999999999 78999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
.++.++|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .+
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~----~~ 225 (281)
T 1mp8_A 151 SNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----ND 225 (281)
T ss_dssp ETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GG
T ss_pred CCCCEEECccccccccCcccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH----HH
Confidence 99999999999998765432211 112356778999999998889999999999999999996 9999975322 22
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+ ....... .+. ..+..+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~i---~~~~~~~--~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 226 VIGRI---ENGERLP--MPP--------NCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHHH---HTTCCCC--CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHH---HcCCCCC--CCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22222 1221111 111 12233889999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=305.85 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=194.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.||+|.+.. ...........+.+|+.+++.++||||++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 75 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGE-HQLTGHKVAVKILNR------------QKIRSLDVVGKIKREIQNLKLFRHPHIIK 75 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred eeccEEEEeeecCCCCeEEEEEE-ECCCCceEEEEEecc------------ccccchhHHHHHHHHHHHHhcCCCCCEeE
Confidence 34789999999999999999996 456788999999831 11112234567899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.+|| ++|++|+||+|+||+++.++
T Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~ 148 (276)
T 2h6d_A 76 LYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHM 148 (276)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTS
T ss_pred EEEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCC
Confidence 99999999999999999999999999943 345889999999999999999999 77999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
.++|+|||.+......... ....|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.... ....
T Consensus 149 ~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~-- 219 (276)
T 2h6d_A 149 NAKIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----VPTL-- 219 (276)
T ss_dssp CEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH--
T ss_pred CEEEeecccccccCCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc----HHHH--
Confidence 9999999999876543221 22468899999999988765 689999999999999999999996521 1111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+....... +. . ....+.+++.+||+.||.+|||++++++
T Consensus 220 -~~~~~~~~~~~---~~-----~---~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 220 -FKKIRGGVFYI---PE-----Y---LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -HHHHHHCCCCC---CT-----T---SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHhhcCcccC---ch-----h---cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 22222221111 10 0 1123889999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=317.15 Aligned_cols=270 Identities=23% Similarity=0.297 Sum_probs=196.2
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|. +..+++.||+|.+..... ..........+.+|+.+++.++||||+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~iv 75 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKAR-DKNTNQIVAIKKIKLGHR----------SEAKDGINRTALREIKLLQELSHPNII 75 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEE-CSSCCSEEEEEEC----------------------CTHHHHHHHHHHHCCCTTBC
T ss_pred HHhcccEEEeEEeecCCEEEEEEE-ECCCCcEEEEEEEecCCc----------chhhhhhhHHHHHHHHHHhhCCCCCCC
Confidence 356899999999999999999995 556789999999842211 001111234678899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++||||+.+ +|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.+
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~ 148 (346)
T 1ua2_A 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDEN 148 (346)
T ss_dssp CEEEEECCTTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred eEEEEEeeCCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCC
Confidence 999999999999999999986 88888833 3456888999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||++......... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.... ..+..
T Consensus 149 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~----~~~~~ 222 (346)
T 1ua2_A 149 GVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQL 222 (346)
T ss_dssp CCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH
T ss_pred CCEEEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHHHH
Confidence 99999999999866433221 1225789999999998764 47899999999999999999999986521 22222
Q ss_pred HHHHHHhhhCCCCcccchhh---------cC-----CchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKL---------LG-----NGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~---------~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+...........+..... .. .........+.+||.+||+.||++|||++|+++
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 21221111111111100000 00 000122345899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=328.25 Aligned_cols=198 Identities=24% Similarity=0.344 Sum_probs=153.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|. +..+++.||||++... .........+.+|+.+++.++||||+++
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~i~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~l 117 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAY-DKLEKRVVAIKKILRV-------------FEDLIDCKRILREIAILNRLNHDHVVKV 117 (458)
T ss_dssp CTTEEECCC-------CEEEEE-ECC--CEEEEEEECST-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCeEEeeEeeecCCeEEEEEE-ECCCCcEEEEEEechh-------------hcCHHHHHHHHHHHHHHHhCCCCCCCce
Confidence 4789999999999999999995 5678899999998321 1122345678899999999999999999
Q ss_pred ccceec-----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 113 LAHMVR-----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 113 ~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
++++.. ....|+||||+. ++|.+++ .....+++..+..++.|++.||.||| ++||+||||||+|||+
T Consensus 118 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl 189 (458)
T 3rp9_A 118 LDIVIPKDVEKFDELYVVLEIAD-SDFKKLF----RTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLV 189 (458)
T ss_dssp EEECCCSCTTTCCCEEEEECCCS-EEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEE
T ss_pred EEEEecCCcccCceEEEEEeccc-cchhhhc----ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEE
Confidence 999843 356899999985 5899988 34566999999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCcc-------------------------ccceeecCCccccccccc-ccCCCCCccchhh
Q 040480 188 DDDMEARISGFDLAILMPDGLTQ-------------------------IDTMYVVGTPRYIAPEYH-QTLTISEKCDIYS 241 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~-------------------------~~~~~~~g~~~~~aPE~~-~~~~~~~~~Dvws 241 (325)
+.++.+||+|||++......... ......+||+.|+|||++ .+..++.++||||
T Consensus 190 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwS 269 (458)
T 3rp9_A 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWS 269 (458)
T ss_dssp CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHH
T ss_pred CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHH
Confidence 99999999999999876432211 112235789999999976 5567999999999
Q ss_pred HHHHHHHHHhC
Q 040480 242 FGVLLAVLVMG 252 (325)
Q Consensus 242 lG~il~~ll~g 252 (325)
|||++|+|++|
T Consensus 270 lG~il~elltg 280 (458)
T 3rp9_A 270 IGCIFAELLNM 280 (458)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHh
Confidence 99999999993
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=313.45 Aligned_cols=247 Identities=18% Similarity=0.224 Sum_probs=188.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc-cCCCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ-IRHRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~ 112 (325)
++|++.++||+|+||+||+|. +..+++.||||++..... ..........|+..+.. .+||||+++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~e~~~~~~~~~h~~iv~l 122 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVR-SKEDGRLYAVKRSMSPFR-------------GPKDRARKLAEVGSHEKVGQHPCCVRL 122 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEE-ETTTSCEEEEEEESSSCC-------------SHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hheeeeheeccCCCeEEEEEE-ECCCCeEEEEEEeccccc-------------ChHHHHHHHHHHHHHHHhcCCCcEEEE
Confidence 689999999999999999996 556789999998743211 11122233444444444 489999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+..++||||+ +++|.+++... ...+++..+..++.|++.||.||| +++|+|+||||+||+++.++.
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~ 195 (311)
T 3p1a_A 123 EQAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGR 195 (311)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGC
T ss_pred EEEEEeCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCC
Confidence 99999999999999999 56999988542 346999999999999999999999 789999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+||+|||++......... ....||+.|+|||++.+ .++.++||||||+++|+|++|..|+.... . .
T Consensus 196 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~----~ 261 (311)
T 3p1a_A 196 CKLGDFGLLVELGTAGAG---EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------G----W 261 (311)
T ss_dssp EEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------H----H
T ss_pred EEEccceeeeecccCCCC---cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------H----H
Confidence 999999999876543322 22468999999999887 78999999999999999999976654311 1 1
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ ++.... ..+..+.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~-----~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 262 QQLRQGYL-----PPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTTTCC-----CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhccCC-----Cccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111111 111111 12234899999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=338.28 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=203.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
..++|++++.||+|+||.||+|+ +..+++.||+|++.. ...........+..|..++..+ +||+|+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~-~~~~~~~vAvK~l~~------------~~~~~~~~~~~~~~E~~~l~~~~~~~~i~ 405 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSE-RKGTDELYAVKILKK------------DVVIQDDDVECTMVEKRVLALPGKPPFLT 405 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEE-ESSSCCEEEEEEEEH------------HHHHHTTTTHHHHHHHHHHTCTTCCTTBC
T ss_pred cccceEEEEEEccCCCEEEEEEE-ECCCCcEEEEEEEec------------cccccHHHHHHHHHHHHHHHhccCCCeEE
Confidence 45789999999999999999996 456788999999831 1112234456778889999887 689999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.+.+..|+||||+++++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+|||++.+
T Consensus 406 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~ 478 (674)
T 3pfq_A 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE 478 (674)
T ss_dssp CEEEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSS
T ss_pred EEEEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCC
Confidence 999999999999999999999999999943 346999999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.+||+|||++......... ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... . ..
T Consensus 479 g~ikL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~----~---~~ 549 (674)
T 3pfq_A 479 GHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----E---DE 549 (674)
T ss_dssp SCEEECCCTTCEECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----H---HH
T ss_pred CcEEEeecceeeccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC----H---HH
Confidence 99999999999864433222 233689999999999999999999999999999999999999997522 1 22
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh-----hhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS-----KDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~ 324 (325)
....+....... +. .....+.+||.+||+.||.+||++ ++|++
T Consensus 550 ~~~~i~~~~~~~---p~--------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 550 LFQSIMEHNVAY---PK--------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHSSCCCC---CT--------TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHhCCCCC---Cc--------cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 233333322111 11 112238999999999999999998 67654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=306.30 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=201.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.+|+|.+....... .........+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~avK~~~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 73 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSS---------SRRGVSREEIEREVNILREIRHPNIITL 73 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEBCSSTT---------CSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhhHHhhcccCceEEEEEE-EcCCCCeeehHHhhhccccc---------cccchHHHHHHHHHHHHHhCCCCCeeeh
Confidence 3679999999999999999996 55678899999985432111 0111246678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC-
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM- 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~- 191 (325)
++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.+|| ++|++|+||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 74 HDIFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSS
T ss_pred hheecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCC
Confidence 9999999999999999999999999943 346899999999999999999999 78999999999999998776
Q ss_pred ---CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 ---EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ---~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.++|+|||.+......... ....|++.|+|||++.+..++.++|+||||+++|+|++|..||.... .
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~--- 216 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET----K--- 216 (283)
T ss_dssp SSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS----H---
T ss_pred CCCceEEEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc----h---
Confidence 7999999999876543322 22468999999999999899999999999999999999999996522 1
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+...... .+..... ..+..+.+|+.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~---~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 217 QETLTNISAVNYD---FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHHHHTTCCC---CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhHhcccC---Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 1112222211111 1111111 12234899999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=310.04 Aligned_cols=257 Identities=21% Similarity=0.266 Sum_probs=192.4
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|+ +..+++.||+|.+... ..........+.+|+.+++.++||||+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~hp~iv 97 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAE-DTVRERIVALKLMSET------------LSSDPVFRTRMQREARTAGRLQEPHVV 97 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEE-ETTTTEEEEEEECGGG------------GGGSHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred cEeccEEEEEEEcCCCCeeEEEEE-EcCCCeEEEEEecCcc------------cccCHHHHHHHHHHHHHHhhcCCCCee
Confidence 345899999999999999999996 5567899999998321 112233457789999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++|+||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||+|+||+++.+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~ 170 (309)
T 2h34_A 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSAD 170 (309)
T ss_dssp CEEEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred EEEEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCC
Confidence 999999999999999999999999999943 346899999999999999999999 7899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||++......... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~--- 241 (309)
T 2h34_A 171 DFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----S--- 241 (309)
T ss_dssp SCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----H---
T ss_pred CCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----H---
Confidence 99999999999765443221 11224689999999999998999999999999999999999999965221 1
Q ss_pred HHHHHhhhCCCC-cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-Chhhhhc
Q 040480 271 WMRNVMASENPN-RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-NSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~ 324 (325)
..........+. ....+ ..+..+.+++.+||+.||++|| |++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 242 VMGAHINQAIPRPSTVRP--------GIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHSCCCCGGGTST--------TCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCCCccccCC--------CCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 111112111111 11111 1122388999999999999999 8888764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=332.50 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=203.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|.+. .++..||||.+.. .....+.+.+|+.++++++||||++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~----------------~~~~~~~~~~E~~~l~~l~hpniv~ 280 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKE----------------DTMEVEEFLKEAAVMKEIKHPNLVQ 280 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCS----------------SSSCHHHHHHHHHHHHHCCCTTBCC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecC----------------cccchHHHHHHHHHHHhcCCCCEee
Confidence 4578999999999999999999753 5578999999832 1234567899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++......++||||+++++|.+++... ....++...+..++.|++.||.||| +++|+||||||+||+++.++
T Consensus 281 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~ 355 (495)
T 1opk_A 281 LLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENH 355 (495)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred EEEEEecCCcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCC
Confidence 999999999999999999999999999542 3355888999999999999999999 88999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.... ...+..
T Consensus 356 ~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~----~~~~~~ 430 (495)
T 1opk_A 356 LVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYE 430 (495)
T ss_dssp CEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHH
T ss_pred cEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC----HHHHHH
Confidence 9999999999876543221 1112345678999999998889999999999999999999 999997632 222332
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+. ....... + ..++..+.+||.+||+.||++|||+.++++
T Consensus 431 ~~~---~~~~~~~--~--------~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 431 LLE---KDYRMER--P--------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHH---TTCCCCC--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH---cCCCCCC--C--------CCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 222 1111110 0 112233899999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=322.88 Aligned_cols=268 Identities=19% Similarity=0.266 Sum_probs=206.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
.+++|++.+.||+|+||+||+|. +..+++.||+|++... ........+.+|+.+++.++||||++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~-~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~hpnIv~ 71 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGR-HKKTGDLFAIKVFNNI--------------SFLRPVDVQMREFEVLKKLNHKNIVK 71 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEECGG--------------GGGSCHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCceEEEEEEEcCCCeEEEEEE-ECCCCcEEEEEEeccc--------------cccchHHHHHHHHHHHHhcCCCCCCe
Confidence 35789999999999999999996 5567899999998321 11233566789999999999999999
Q ss_pred cccceecCC--ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe--
Q 040480 112 LLAHMVRPD--SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI-- 187 (325)
Q Consensus 112 ~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~-- 187 (325)
+++++...+ ..++||||+++++|.+++.... ....++...+..++.|++.||.||| ++||+|+||||+||++
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 147 (396)
T 4eut_A 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVI 147 (396)
T ss_dssp EEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEE
T ss_pred EEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEee
Confidence 999987655 6799999999999999984422 2223899999999999999999999 8899999999999999
Q ss_pred --cCCCCceeeccccceecCCCCccccceeecCCccccccccccc--------CCCCCccchhhHHHHHHHHHhCCCCCC
Q 040480 188 --DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT--------LTISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 188 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~--------~~~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
+.++.+||+|||++.......... ...||+.|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 148 ~~~~~~~~kL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 148 GEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp CTTSCEEEEECCGGGCEECCCGGGSS---CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred cCCCceeEEEecCCCceEccCCCccc---cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 667779999999998765543222 2478999999998865 467889999999999999999999997
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCccc--------------chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAI--------------DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
.........+. ...+.......... ...............+.+++.+||+.||++|||+.+++
T Consensus 225 ~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l 301 (396)
T 4eut_A 225 PFEGPRRNKEV---MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (396)
T ss_dssp CTTCTTTCHHH---HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred CCCcccchHHH---HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHH
Confidence 64433333222 22333222211100 00011122356677799999999999999999999986
Q ss_pred c
Q 040480 324 C 324 (325)
Q Consensus 324 ~ 324 (325)
+
T Consensus 302 ~ 302 (396)
T 4eut_A 302 A 302 (396)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=306.66 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=201.5
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++||||+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~----------------~~~~~~~~~e~~~l~~l~h~~i~ 66 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREG----------------AMSEEDFIEEAEVMMKLSHPKLV 66 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTT----------------TBCHHHHHHHHHHHHTCCCTTBC
T ss_pred EchhheeeeeEecCCCceeEEEEEec--CCCeEEEEEcccc----------------CCCHHHHHHHHHHHHhCCCCCEe
Confidence 35679999999999999999999754 6778999998321 12335788999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++||||+++++|.+++.. ....++...+..++.|++.||.+|| ++|++|+||+|+||+++.+
T Consensus 67 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~ 140 (267)
T 3t9t_A 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGEN 140 (267)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGG
T ss_pred eEEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCC
Confidence 999999999999999999999999999944 3346889999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... . .
T Consensus 141 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~---~ 212 (267)
T 3t9t_A 141 QVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----N---S 212 (267)
T ss_dssp GCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----H---H
T ss_pred CCEEEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC----H---H
Confidence 99999999999765432211 1112356778999999998889999999999999999999 899996522 1 1
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+........+ . ..+..+.+++.+||+.||++|||+.++++
T Consensus 213 ~~~~~i~~~~~~~~~--~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 213 EVVEDISTGFRLYKP--R--------LASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp HHHHHHHTTCCCCCC--T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCcCCCC--c--------cCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222222222111110 0 01223889999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=315.32 Aligned_cols=260 Identities=18% Similarity=0.304 Sum_probs=204.2
Q ss_pred hhhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH 106 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 106 (325)
...++|++.+.||+|+||.||+|.+.. .+++.||+|.+... ........+.+|+.+++.++|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h 87 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--------------ASMRERIEFLNEASVMKEFNC 87 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--------------SCHHHHHHHHHHHHHGGGCCC
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--------------cCHHHHHHHHHHHHHHHhcCC
Confidence 456899999999999999999997542 35678999987311 112334568899999999999
Q ss_pred CCccccccceecCCceEEEEEcccCCCHHHHHhhhccc------ccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 040480 107 RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG------RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDI 180 (325)
Q Consensus 107 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl 180 (325)
|||+++++++...+..++||||+++++|.+++...... ...++...+..++.|++.||.||| ++|++|+||
T Consensus 88 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~di 164 (322)
T 1p4o_A 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDL 164 (322)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCC
T ss_pred CCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCC
Confidence 99999999999999999999999999999999653211 235688899999999999999999 789999999
Q ss_pred CCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCc
Q 040480 181 KPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDF 259 (325)
Q Consensus 181 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~ 259 (325)
||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 165 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 165 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp SGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 99999999999999999999976544332222222456888999999998889999999999999999999 89999652
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. . ......+......... ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 245 ~----~---~~~~~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~ 292 (322)
T 1p4o_A 245 S----N---EQVLRFVMEGGLLDKP----------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292 (322)
T ss_dssp C----H---HHHHHHHHTTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----H---HHHHHHHHcCCcCCCC----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2 1 1222222222211110 112233899999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=325.28 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=197.8
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|.+ .++.||||.+.. ......+.+|+.++++++||||+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~-----------------~~~~~~~~~E~~~l~~l~h~niv 249 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKN-----------------DATAQAFLAEASVMTQLRHSNLV 249 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESS-----------------CTTSHHHHHHHHHHHTCCCTTBC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCC-----------------chHHHHHHHHHHHHHhccCCCEE
Confidence 3567899999999999999999976 477999999831 12345788999999999999999
Q ss_pred ccccceecCC-ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 111 PLLAHMVRPD-SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 111 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++++++.... ..++||||+++++|.+++... ....++...+..++.|++.||.||| +++++||||||+||+++.
T Consensus 250 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~ 324 (450)
T 1k9a_A 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSE 324 (450)
T ss_dssp CEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred EEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECC
Confidence 9999987665 789999999999999999542 2334788899999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 268 (325)
++.+||+|||++........ ...++..|+|||++.+..++.++||||||+++|+|++ |..||..... .+.
T Consensus 325 ~~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~ 395 (450)
T 1k9a_A 325 DNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDV 395 (450)
T ss_dssp TSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----TTH
T ss_pred CCCEEEeeCCCccccccccc-----CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHH
Confidence 99999999999985443211 1256788999999999999999999999999999998 9999976432 222
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+ ..+..... + ..++..+.+||.+||+.||.+|||+.++++
T Consensus 396 ~~~i---~~~~~~~~--p--------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 396 VPRV---EKGYKMDA--P--------DGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHH---HTTCCCCC--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH---HcCCCCCC--C--------CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2222 22221111 1 112233899999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=307.73 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=198.1
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|. +..+++.||+|.+... .....+.+|+.+++.++||||+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~-----------------~~~~~~~~e~~~l~~l~h~~i~ 87 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAI-HKETGQIVAIKQVPVE-----------------SDLQEIIKEISIMQQCDSPHVV 87 (314)
T ss_dssp ----CEEEEEECC----CEEEEEE-ETTTCCEEEEEEEETT-----------------SCCHHHHHHHHHHHTCCCTTBC
T ss_pred cchhhhhhheeeccCCCeEEEEEE-ECCCCCEEEEEecCch-----------------HHHHHHHHHHHHHHhCCCCCCc
Confidence 456789999999999999999996 5567899999988321 2345688899999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++||||+++++|.+++.. ....++...+..++.|++.||.||| +.|++|+||+|+||+++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~ 161 (314)
T 3com_A 88 KYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTE 161 (314)
T ss_dssp CEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred cEEEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCC
Confidence 999999999999999999999999999842 3456899999999999999999999 7899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.++|+|||.+......... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ..
T Consensus 162 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~ 232 (314)
T 3com_A 162 GHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------MR 232 (314)
T ss_dssp CCEEECCCTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HH
T ss_pred CCEEEeecccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HH
Confidence 99999999999876543222 1224789999999999998899999999999999999999999965221 11
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..........+....+ ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 233 AIFMIPTNPPPTFRKP--------ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHSCCCCCSSG--------GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhcCCCcccCCc--------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111122221111111 111233899999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=327.99 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=201.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|+ +..++..+|+|.+......... . ...........+.+.+|+.++++++||||+++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~-~~~~~~~~aiK~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCK-EKNGHSEKAIKVIKKSQFDKGR-Y-SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEE-ETTTCCEEEEEEEEC------------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccceEEEeEecccCCeEEEEEE-ECCCCcEEEEEEEEhhhccccc-c-cccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4789999999999999999996 5567889999998533211100 0 00011112446788999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC-
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM- 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~- 191 (325)
++++.+....++||||+++++|.+.+.. ...+++..+..++.|++.||.||| ++||+|+||||+||+++.++
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCC
Confidence 9999999999999999999999999843 356999999999999999999999 88999999999999998765
Q ss_pred --CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 192 --EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 192 --~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
.++|+|||++......... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... . .
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~---~ 253 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN----D---Q 253 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS----H---H
T ss_pred CccEEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC----H---H
Confidence 6899999999876554322 22578999999999875 68999999999999999999999997522 1 2
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+....... +.... ...+..+.+||.+||+.||.+|||++|+++
T Consensus 254 ~~~~~i~~~~~~~---~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 254 DIIKKVEKGKYYF---DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHHCCCCC---CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCC---Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2222333222211 11111 112234899999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=314.88 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=205.8
Q ss_pred HHHhhhcCcccccccccCcceeEEEEEe---cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc
Q 040480 28 AFLKKEDCFASLEKIGSGGCGDVYKAEL---PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI 104 (325)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 104 (325)
..+...++|++.+.||+|+||.||+|++ +..+++.||+|.+... .......+.+|+.+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~~E~~~l~~l 81 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---------------GPDQQRDFQREIQILKAL 81 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---------------CHHHHHHHHHHHHHHHTC
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---------------CHHHHHHHHHHHHHHHhc
Confidence 3345678999999999999999999975 4567899999998321 223456788999999999
Q ss_pred CCCCcccccccee--cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 105 RHRNILPLLAHMV--RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 105 ~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
+||||+++++++. .....++||||+++++|.+++... ...++...+..++.|++.||.||| ++|++|+||||
T Consensus 82 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp 155 (327)
T 3lxl_A 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAA 155 (327)
T ss_dssp CCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred CCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCh
Confidence 9999999999876 456689999999999999999542 345899999999999999999999 88999999999
Q ss_pred CceEecCCCCceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
+||+++.++.++|+|||.+......... .......|+..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 156 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp GGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred hhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 9999999999999999999876543321 122224678889999999998899999999999999999999999864221
Q ss_pred C--------CCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 H--------TGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ..................... + ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 236 EFLRMMGCERDVPALSRLLELLEEGQRLPA--P--------PACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHCC----CCHHHHHHHHHHTTCCCCC--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhcccccccccHHHHHHHhhcccCCCC--C--------CcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 011111122222222211111 1 112233899999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=307.04 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=197.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|.+.... ........+.+|+..+..+ +||||++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~~e~~~~~~l~~h~~iv~ 75 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCV-KRLDGCIYAIKRSKKPL-------------AGSVDEQNALREVYAHAVLGQHSHVVR 75 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEECCC-------------TTSHHHHHHHHHHHHHHHSCSCTTBCC
T ss_pred cchhhhhhhhcCCCceEEEEEE-EcCCCceEEEEEecccc-------------cccHHHHHHHHHHHHHHHhCCCCCeee
Confidence 4789999999999999999995 55678999999984321 1123345677888888888 8999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC-
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD- 190 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~- 190 (325)
+++++.+.+..++||||+++++|.+++.........+++..+..++.|++.||.||| ++|++|+||||+||+++.+
T Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~ 152 (289)
T 1x8b_A 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTS 152 (289)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC---
T ss_pred eeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCC
Confidence 999999999999999999999999999665444467899999999999999999999 8899999999999999844
Q ss_pred ------------------CCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHh
Q 040480 191 ------------------MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVM 251 (325)
Q Consensus 191 ------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~ 251 (325)
..++|+|||.+........ ..||+.|+|||.+.+. .++.++||||||+++|+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (289)
T 1x8b_A 153 IPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226 (289)
T ss_dssp -----------------CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred CCcccccccccccccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence 4789999999987654332 3589999999998776 56689999999999999999
Q ss_pred CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 252 GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 252 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|..|+... ... ........+.. +. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~-------~~~---~~~~~~~~~~~--~~--------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 227 AEPLPRNG-------DQW---HEIRQGRLPRI--PQ--------VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCCSSS-------HHH---HHHHTTCCCCC--SS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCcch-------hHH---HHHHcCCCCCC--Cc--------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 99876431 111 11111211111 10 11223899999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=309.47 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=198.4
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|. +..+++.+|+|.+... .......+.+|+.+++.++||||+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~i~ 79 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAK-NKETGALAAAKVIETK---------------SEEELEDYIVEIEILATCDHPYIV 79 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEE-ETTTCCEEEEEEEC-------------------CCHHHHHHHHHHHHHCCCTTBC
T ss_pred CCccceeecceeccCCCeEEEEEE-EcCCCcEEEEEEecCC---------------CHHHHHHHHHHHHHHhcCCCCCEe
Confidence 356899999999999999999996 5567889999988321 223456788999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||+|+||+++.+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 153 (302)
T 2j7t_A 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLE 153 (302)
T ss_dssp CEEEEEECC-CEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTT
T ss_pred eeeeeeeeCCeEEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCC
Confidence 999999999999999999999999998844 2355899999999999999999999 7899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCccccccccc-----ccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYH-----QTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~-----~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
+.++|+|||++........ ......|+..|+|||++ .+..++.++||||||+++|+|++|..||.....
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---- 227 (302)
T 2j7t_A 154 GDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---- 227 (302)
T ss_dssp SCEEECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----
T ss_pred CCEEEEECCCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----
Confidence 9999999998753321111 11124689999999987 356788999999999999999999999965321
Q ss_pred chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+....+. ..+..+.+++.+||+.||.+|||++++++
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 228 ---MRVLLKIAKSDPPTLLTPS--------KWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---HHHHHHHHHSCCCCCSSGG--------GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---HHHHHHHhccCCcccCCcc--------ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122222222222111111 11233889999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=308.44 Aligned_cols=258 Identities=25% Similarity=0.386 Sum_probs=193.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc--CCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI--RHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i 109 (325)
-.++|++.+.||+|+||.||+|++ +++.||+|.+.. ........|.+++... +||||
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~------------------~~~~~~~~e~~~~~~~~~~h~~i 93 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFT------------------TEEASWFRETEIYQTVLMRHENI 93 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEG------------------GGHHHHHHHHHHHTSTTCCCTTB
T ss_pred cccceEEEeEeecCCCeEEEEEEE---CCceEEEEEEec------------------cccchhhhHHHHHHHHhhcCCCe
Confidence 347899999999999999999975 488999998831 1223334455555544 89999
Q ss_pred cccccceecC----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC--------CeEe
Q 040480 110 LPLLAHMVRP----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA--------RVIH 177 (325)
Q Consensus 110 ~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~--------~ivH 177 (325)
+++++++... ...++||||+++++|.+++.. ..++...+..++.|++.||.||| ++ |++|
T Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH 165 (337)
T 3mdy_A 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAH 165 (337)
T ss_dssp CCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEEC
T ss_pred eeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEe
Confidence 9999998877 678999999999999999932 35899999999999999999999 77 9999
Q ss_pred cCCCCCceEecCCCCceeeccccceecCCCCcccc--ceeecCCcccccccccccCCCCCc------cchhhHHHHHHHH
Q 040480 178 RDIKPANVLIDDDMEARISGFDLAILMPDGLTQID--TMYVVGTPRYIAPEYHQTLTISEK------CDIYSFGVLLAVL 249 (325)
Q Consensus 178 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~------~DvwslG~il~~l 249 (325)
+||||+||+++.++.+||+|||++........... .....||+.|+|||++.+...+.. +||||||+++|+|
T Consensus 166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 245 (337)
T 3mdy_A 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245 (337)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence 99999999999999999999999976654332211 123478999999999988766655 9999999999999
Q ss_pred HhC----------CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 250 VMG----------KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 250 l~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
++| ..||............. .............+.... ..+++..+.+|+.+||+.||.+|||+
T Consensus 246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDM---REIVCIKKLRPSFPNRWS---SDECLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHH---HHHHTTSCCCCCCCGGGG---GSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HhccCcccccccccccHhhhcCCCCchhhh---HHHHhhhccCccccccch---hhHHHHHHHHHHHHhhhhChhhCCCH
Confidence 999 66665543322221111 111222222222222111 22455669999999999999999999
Q ss_pred hhhhc
Q 040480 320 KDVRC 324 (325)
Q Consensus 320 ~ell~ 324 (325)
.++++
T Consensus 320 ~ell~ 324 (337)
T 3mdy_A 320 LRVKK 324 (337)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=303.18 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=198.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.+|+|.+... ...........+.+|+.+++.++||||+++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~-~~~~~~~~avK~~~~~-----------~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 71 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVL-DSETLCRRAVKILKKK-----------KLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEE-BTTTCCEEEEEEECHH-----------HHHHSTTHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccceeEeeEEecCCCeEEEEEE-ECCCCcEEEEEEeccc-----------cccccchhHHHHHHHHHHHHhcCCCCeeEE
Confidence 3789999999999999999995 6678899999998321 111123456788999999999999999999
Q ss_pred ccce--ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 113 LAHM--VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 113 ~~~~--~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++ ......++||||+.++ |.+.+... ....++...+..++.|++.||.||| ++|++|+||||+||+++.+
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~ 145 (305)
T 2wtk_C 72 VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTG 145 (305)
T ss_dssp EEEEECC---CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred EEEEEcCCCCeEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCC
Confidence 9988 4456789999999875 77777442 3456899999999999999999999 7899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT--ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
+.++|+|||.+................|+..|+|||++.+.. ++.++||||||+++|+|++|..||.... .
T Consensus 146 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~ 218 (305)
T 2wtk_C 146 GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------I 218 (305)
T ss_dssp CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------H
T ss_pred CcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------H
Confidence 999999999998765433333333457899999999987654 3779999999999999999999997521 1
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+....... +. +....+.+|+.+||+.||.+|||++++++
T Consensus 219 ~~~~~~i~~~~~~~---~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 219 YKLFENIGKGSYAI---PG--------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHHHHHCCCCC---CS--------SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhcCCCCC---CC--------ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22222222222111 10 11223889999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=318.63 Aligned_cols=264 Identities=19% Similarity=0.200 Sum_probs=200.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-------
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR------- 105 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------- 105 (325)
.++|++.+.||+|+||+||+|+ +..+++.||+|++.. .......+.+|+.+++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~----------------~~~~~~~~~~E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSW-DIQGKKFVAMKVVKS----------------AEHYTETALDEIRLLKSVRNSDPNDP 98 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHHSCTTCG
T ss_pred CCeEEEEEEeeecCCeeEEEEE-ecCCCeEEEEEEEec----------------CCcchHHHHHHHHHHHHHhhcCCCCC
Confidence 3789999999999999999995 567789999999831 1233456788899988885
Q ss_pred -CCCcccccccee----cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC-CeEecC
Q 040480 106 -HRNILPLLAHMV----RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA-RVIHRD 179 (325)
Q Consensus 106 -h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~ivH~d 179 (325)
||||+++++.+. .....++||||+ +++|.+.+.. .....++...+..++.|++.||.||| ++ ||+|||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrD 172 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTD 172 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCC
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCC
Confidence 788999999887 556789999999 5577777743 23356899999999999999999999 77 999999
Q ss_pred CCCCceEecCCC-------------------------------------------------CceeeccccceecCCCCcc
Q 040480 180 IKPANVLIDDDM-------------------------------------------------EARISGFDLAILMPDGLTQ 210 (325)
Q Consensus 180 l~~~nil~~~~~-------------------------------------------------~~~l~dfg~~~~~~~~~~~ 210 (325)
|||+||+++.++ .++|+|||.+.......
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-- 250 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-- 250 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS--
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC--
Confidence 999999998765 79999999998765331
Q ss_pred ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcc------
Q 040480 211 IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRA------ 284 (325)
Q Consensus 211 ~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 284 (325)
....||..|+|||++.+..++.++|||||||++|+|++|..||.........................+..
T Consensus 251 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 251 ---TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp ---CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred ---ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 22478999999999999999999999999999999999999997654433222222111111111111000
Q ss_pred -----cch-------------------hhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 285 -----IDS-------------------KLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 285 -----~~~-------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+.. .............+.+||.+||+.||++|||++|+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 0001123456667999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=312.65 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=199.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|+ +..+++.||+|.+... .......+.+|+.+++.++||||++
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~ 90 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVE-GLHDGHFYALKRILCH---------------EQQDREEAQREADMHRLFNHPNILR 90 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEE-ETTTCCEEEEEEEEES---------------SHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCeEEEEEEEecCCCCeEEEEEE-ecCCCcEEEEEEEecC---------------CHHHHHHHHHHHHHHhhcCCCCeee
Confidence 45799999999999999999996 5567899999987321 2234567889999999999999999
Q ss_pred ccccee----cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 112 LLAHMV----RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 112 ~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+++++. .....++|+||+.+++|.+++.........+++..+..++.|++.||.||| ++|++|+||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~ 167 (317)
T 2buj_A 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILL 167 (317)
T ss_dssp CCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred EEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 999886 344689999999999999999766556678999999999999999999999 7899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccc-------cceeecCCcccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQI-------DTMYVVGTPRYIAPEYHQTLT---ISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~-------~~~~~~g~~~~~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
+.++.++|+|||.+.......... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.
T Consensus 168 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 999999999999987654221110 011235789999999987654 6889999999999999999999996
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... ....... .....+ .. ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~--~~~~~~~---~~~~~~--~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 299 (317)
T 2buj_A 248 MVFQKGD--SVALAVQ---NQLSIP--QS--------PRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299 (317)
T ss_dssp HHHHTTS--CHHHHHH---CC--CC--CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhcccc--hhhHHhh---ccCCCC--cc--------ccCCHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 4222111 1111111 100000 00 011223899999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=314.65 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=201.4
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|+ +..+++.||+|++.... ........+.+|+.+++.++||||+
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv 79 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKVLMEN-------------EKEGFPITALREIKILQLLKHENVV 79 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEE-ETTTCCEEEEEECCCSS-------------CSSSSCHHHHHHHHHHHHCCCTTBC
T ss_pred ccccceeEEEEEecCCCcEEEEEE-ECCCCCEEEEEEEeccc-------------ccccchHHHHHHHHHHHhccCCCcc
Confidence 356899999999999999999996 55678899999874321 1222344677899999999999999
Q ss_pred ccccceec--------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 111 PLLAHMVR--------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 111 ~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
++++++.. .+..++||||+.+ +|.+.+.. ....++...+..++.|++.||.||| ++||+|+||||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp 152 (351)
T 3mi9_A 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKA 152 (351)
T ss_dssp CEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred cHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCH
Confidence 99999876 3468999999976 77777733 3356899999999999999999999 88999999999
Q ss_pred CceEecCCCCceeeccccceecCCCCcc--ccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCc
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDF 259 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~ 259 (325)
+||+++.++.++|+|||++......... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 153 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp GGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876532221 12223578999999998876 45799999999999999999999999752
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhc------------CCchHH------HHHHHHHHHhhhcCCCCCCCCChhh
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLL------------GNGYEE------QMLLVLKLACFCTLADPDERPNSKD 321 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~------~~~~l~~li~~~l~~dP~~Rps~~e 321 (325)
........+........+......... .....+ ....+.+||.+||+.||.+|||++|
T Consensus 233 ----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 233 ----TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp ----SHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ----ChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 222222222222222211111000000 000001 1234889999999999999999999
Q ss_pred hhc
Q 040480 322 VRC 324 (325)
Q Consensus 322 ll~ 324 (325)
+++
T Consensus 309 ~l~ 311 (351)
T 3mi9_A 309 ALN 311 (351)
T ss_dssp HHT
T ss_pred HhC
Confidence 985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=321.07 Aligned_cols=261 Identities=20% Similarity=0.276 Sum_probs=196.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|. +..+++.||+|++... .....+|+.+++.++||||++
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~-~~~~~~~vAiK~~~~~-------------------~~~~~~E~~il~~l~hpnIv~ 64 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVF-DIESGKRFALKKVLQD-------------------PRYKNRELDIMKVLDHVNIIK 64 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEE-ETTTCCEEEEEEEECC-------------------TTSCCHHHHHHTTCCCTTBCC
T ss_pred ccceEEEEEEEEeccCEEEEEEE-ECCCCCEEEEEEEecC-------------------cchHHHHHHHHHHcCCCCccc
Confidence 45799999999999999999995 5678899999988321 111236899999999999999
Q ss_pred cccceec--------------------------------------CCceEEEEEcccCCCHHHHHhhhcccccccChhhH
Q 040480 112 LLAHMVR--------------------------------------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153 (325)
Q Consensus 112 ~~~~~~~--------------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 153 (325)
+++++.. ....++||||+++ +|.+.+.........++...+
T Consensus 65 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~ 143 (383)
T 3eb0_A 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLI 143 (383)
T ss_dssp EEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHH
T ss_pred hhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHH
Confidence 9998843 3347899999985 888888766566778999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec-CCCCceeeccccceecCCCCccccceeecCCcccccccccccCC
Q 040480 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT 232 (325)
Q Consensus 154 ~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~ 232 (325)
..++.|++.||.||| ++||+|+||||+||+++ .++.++|+|||.+........... ..||..|+|||++.+..
T Consensus 144 ~~i~~qi~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~ 217 (383)
T 3eb0_A 144 SIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA---YICSRFYRAPELMLGAT 217 (383)
T ss_dssp HHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCC---CCCCSSCCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcC---cccCCCccCHHHhcCCC
Confidence 999999999999999 88999999999999998 678999999999987654433222 47799999999887754
Q ss_pred -CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCC-----------CCcccchhhcCCc-----hH
Q 040480 233 -ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASEN-----------PNRAIDSKLLGNG-----YE 295 (325)
Q Consensus 233 -~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~-----~~ 295 (325)
++.++|||||||++|+|++|..||.... ..+....+......+. ....++ ...... ..
T Consensus 218 ~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 292 (383)
T 3eb0_A 218 EYTPSIDLWSIGCVFGELILGKPLFSGET----SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP-TLKAKDWRKILPE 292 (383)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCC-CCCCCCHHHHSCT
T ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCCHHHHHHhCcccccccCC-ccCcccHHhhCCC
Confidence 8999999999999999999999997532 1111111111111000 000000 000000 01
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 296 EQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 296 ~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 293 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 293 GTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp TCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12334899999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=314.12 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=198.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..++..||+|++... ........+.+|+.++++++||||+++
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~niv~~ 90 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAY-DNLNKVRVAIKKISPF--------------EHQTYCQRTLREIKILLRFRHENIIGI 90 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECCT--------------TCHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred cccEEEEEEeecCCCeEEEEEE-ECCCCeEEEEEEeccc--------------cCcHHHHHHHHHHHHHHhcCCCCCccc
Confidence 5689999999999999999995 5678899999998321 122345678899999999999999999
Q ss_pred ccceecC-----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 113 LAHMVRP-----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 113 ~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
++++... ...++|+||+.+ +|.+++. ...++...+..++.|++.||.||| ++|++|+||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~ 161 (364)
T 3qyz_A 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLL 161 (364)
T ss_dssp CEEECCSSTTTCCCEEEEEECCSE-EHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred eeEEecCCccccceEEEEEcccCc-CHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEE
Confidence 9988654 368999999975 8999883 245899999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccc-cceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 188 DDDMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
+.++.++|+|||.+.......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... .
T Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~ 237 (364)
T 3qyz_A 162 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH----Y 237 (364)
T ss_dssp CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS----G
T ss_pred CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC----h
Confidence 999999999999998765432211 1223578999999998654 458999999999999999999999997532 2
Q ss_pred chHHHHHHHHhhhCCC--------------------Ccccc-hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENP--------------------NRAID-SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~--------------------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....+......... ....+ .... ......+.+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF----PNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhC----CCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2222222111111000 00000 0000 112234899999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=307.86 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=199.6
Q ss_pred hhcCccccc-ccccCcceeEEEEEec-CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLE-KIGSGGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~-~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|++.+ .||+|+||.||+|.+. ..+++.||+|.+... .........+.+|+.+++.++||||
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i 80 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-------------ANDPALKDELLAEANVMQQLDNPYI 80 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------------CHHHHHHHHHHHHHHTCCCTTB
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc-------------ccCHHHHHHHHHHHHHHHhCCCCCE
Confidence 457899998 9999999999999653 345688999998321 1122346678999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++ ..+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 81 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~ 152 (291)
T 1xbb_A 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVT 152 (291)
T ss_dssp CCEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEE
T ss_pred EEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeC
Confidence 9999988 66788999999999999999943 455899999999999999999999 789999999999999999
Q ss_pred CCCceeeccccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ...
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~ 228 (291)
T 1xbb_A 153 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSE 228 (291)
T ss_dssp TTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHH
T ss_pred CCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC----HHH
Confidence 9999999999998765443221 1122345788999999998889999999999999999999 999997532 122
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ..+........ + ...+..+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~---~~~~~~~~~~~--~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 229 VT---AMLEKGERMGC--P--------AGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HH---HHHHTTCCCCC--C--------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HH---HHHHcCCCCCC--C--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22 22222221111 1 112233899999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=306.67 Aligned_cols=257 Identities=24% Similarity=0.329 Sum_probs=196.4
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
....+|++.+.||+|+||.||+|.+...+ ...+|+|.+.. .........+.+|+.++++++|||
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~ 87 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--------------ITDIGEVSQFLTEGIIMKDFSHPN 87 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT--------------CCSHHHHHHHHHHHHHHHTCCCTT
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc--------------CCCHHHHHHHHHHHHHHHhCCCCC
Confidence 35578999999999999999999754333 34688998732 112234567889999999999999
Q ss_pred ccccccce-ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 109 ILPLLAHM-VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 109 i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
|+++++++ ..++..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||++
T Consensus 88 iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~ 161 (298)
T 3f66_A 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCML 161 (298)
T ss_dssp BCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEE
Confidence 99999985 456678999999999999999943 3456888999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCcc--ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTG 264 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~ 264 (325)
+.++.++|+|||.+......... .......+|+.|+|||.+.+..++.++|+||||+++|+|++ +.+||.....
T Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 238 (298)
T 3f66_A 162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--- 238 (298)
T ss_dssp CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---
T ss_pred CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---
Confidence 99999999999999866543321 11222466788999999999899999999999999999999 5666654221
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+..... ........+ . ..+..+.+++.+||+.||.+|||+.++++
T Consensus 239 -~~~~~~~---~~~~~~~~~--~--------~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 239 -FDITVYL---LQGRRLLQP--E--------YCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -TTHHHHH---HTTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHH---hcCCCCCCC--c--------cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2222211 111111110 0 01123899999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=316.65 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=190.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|++.... ........+.+|+.+++.++||||+++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~hpniv~~ 89 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAY-DAILERNVAIKKLSRPF-------------QNQTHAKRAYRELVLMKCVNHKNIIGL 89 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEECTT-------------SSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhheeEeeeeEecCCEEEEEEE-ECCCCceEEEEEecccc-------------CChHHHHHHHHHHHHHHhcCCCCccce
Confidence 4789999999999999999995 56778999999984211 122345678899999999999999999
Q ss_pred ccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++...+ ..|+||||+++ +|.+.+. ..++...+..++.|++.||.||| ++||+|+||||+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl 159 (371)
T 2xrw_A 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 159 (371)
T ss_dssp EEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred EEeeccccccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEE
Confidence 99987665 67999999976 7888872 24888899999999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
++.++.++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 160 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~ 232 (371)
T 2xrw_A 160 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----I 232 (371)
T ss_dssp ECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred EcCCCCEEEEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence 99999999999999986543322 1225789999999999998999999999999999999999999965321 1
Q ss_pred hHHHHHHHHhhh-CCC--------------------C-cc------cchhhcC---CchHHHHHHHHHHHhhhcCCCCCC
Q 040480 267 DMVRWMRNVMAS-ENP--------------------N-RA------IDSKLLG---NGYEEQMLLVLKLACFCTLADPDE 315 (325)
Q Consensus 267 ~~~~~~~~~~~~-~~~--------------------~-~~------~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~ 315 (325)
+ .+ ..+... ..+ . .. .+....+ .........+.+|+.+||+.||++
T Consensus 233 ~--~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 233 D--QW-NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp H--HH-HHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred H--HH-HHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence 1 11 111110 000 0 00 0000000 011233556999999999999999
Q ss_pred CCChhhhhc
Q 040480 316 RPNSKDVRC 324 (325)
Q Consensus 316 Rps~~ell~ 324 (325)
|||++|+++
T Consensus 310 R~t~~e~l~ 318 (371)
T 2xrw_A 310 RISVDEALQ 318 (371)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhC
Confidence 999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=306.44 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=196.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+|+.+++.++|++++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~-----------------~~~~~~~~e~~~l~~l~~~~~i~ 68 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGT-DIAAGEEVAIKLECVK-----------------TKHPQLHIESKIYKMMQGGVGIP 68 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEE-ETTTTEEEEEEEEEC--------------------CCCHHHHHHHHHHHTTSTTCC
T ss_pred cCCceEEeeeecCCCCeEEEEEE-EcCCCceEEEEeeccc-----------------ccchHHHHHHHHHHHhcCCCCCC
Confidence 45789999999999999999995 5568899999986321 11224678899999999877766
Q ss_pred cccce-ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---
Q 040480 112 LLAHM-VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI--- 187 (325)
Q Consensus 112 ~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~--- 187 (325)
.+..+ ...+..++||||+ +++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||++
T Consensus 69 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~ 141 (296)
T 4hgt_A 69 TIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLG 141 (296)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCG
T ss_pred eeeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeecc
Confidence 66555 5667789999999 8899999843 2446899999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccc-----cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSH 262 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~ 262 (325)
+.++.++|+|||.+.......... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 142 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 142 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred CCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 788999999999998765543211 122357899999999999999999999999999999999999999875443
Q ss_pred CCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 263 TGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.................. ..... ..+..+.+|+.+||+.||++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 222 TKRQKYERISEKKMSTPI-------EVLCK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SSSSHHHHHHHHHHHSCH-------HHHTT---TSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhhhhcccccchh-------hhhhc---cCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 333333322222211110 00000 11223899999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=312.92 Aligned_cols=256 Identities=17% Similarity=0.276 Sum_probs=199.2
Q ss_pred hcCcccc-cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 33 EDCFASL-EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 33 ~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
.++|.+. +.||+|+||.||+|. +..+++.||+|.+... .........+.+|+.++..+. ||||+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~~iv 92 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKR-------------RRGQDCRAEILHEIAVLELAKSCPRVI 92 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEESE-------------ETTEECHHHHHHHHHHHHHTTTCTTBC
T ss_pred hhEEeeccceeCCCCCeEEEEEE-ECCCCCEEEEEEEehh-------------hcchHHHHHHHHHHHHHHhccCCCCEE
Confidence 4678887 899999999999995 5677899999998422 122344567889999999985 69999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC-
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD- 189 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~- 189 (325)
++++++...+..++||||+.+++|.+++.. .....+++..+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 93 NLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSI 167 (327)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCB
T ss_pred EEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecC
Confidence 999999999999999999999999988732 23456899999999999999999999 889999999999999987
Q ss_pred --CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 190 --DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 --~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
++.++|+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ...
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~ 240 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED----NQE 240 (327)
T ss_dssp TTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH
T ss_pred CCCCcEEEeeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chH
Confidence 789999999999876543322 22478999999999999999999999999999999999999996522 111
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... .+....... ... .....+..+.+||.+||+.||.+|||++++++
T Consensus 241 ~~~---~i~~~~~~~---~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 241 TYL---NISQVNVDY---SEE----TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHH---HHHHTCCCC---CTT----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHH---HHHhccccc---Cch----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111 111111111 000 01112233889999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=314.19 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=197.0
Q ss_pred hhcCcccccccccCcceeEEEEEe----cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAEL----PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||.||+|++ +..++..||+|.+... ........+.+|+.++++++||
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~ 93 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--------------CSEQDELDFLMEALIISKFNHQ 93 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--------------CCHHHHHHHHHHHHHHHHCCCT
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--------------cchhhHHHHHHHHHHHhhCCCC
Confidence 458999999999999999999974 3346778999987311 1123445688899999999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhcc---cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK---GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~n 184 (325)
||+++++++......++||||+++++|.+++..... ....++...+..++.|++.||.||| ++|++|+||||+|
T Consensus 94 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~N 170 (327)
T 2yfx_A 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARN 170 (327)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred CCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhH
Confidence 999999999999999999999999999999965332 1245888899999999999999999 8899999999999
Q ss_pred eEecC---CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcc
Q 040480 185 VLIDD---DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFF 260 (325)
Q Consensus 185 il~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~ 260 (325)
|+++. +..++|+|||++................|++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 171 Ili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 171 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp EEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 99984 44699999999975543332222223467889999999988889999999999999999998 999996522
Q ss_pred cCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... ...+......... ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 251 ----~~~~---~~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 297 (327)
T 2yfx_A 251 ----NQEV---LEFVTSGGRMDPP----------KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297 (327)
T ss_dssp ----HHHH---HHHHHTTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHH---HHHHhcCCCCCCC----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1122 2222222221110 011223899999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=317.20 Aligned_cols=274 Identities=16% Similarity=0.178 Sum_probs=196.4
Q ss_pred hhcCcccccccccCcceeEEEEEecC--CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPG--SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|++.+.||+|+||.||+|.+.. .++..+|+|.+......... .. ..........+.+|+..++.++||||
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~-e~---~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-EL---KFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHH-HH---HHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHH-HH---HHHHHHhhhHHHHHHHhhccccccCc
Confidence 45789999999999999999997542 15678999988543221111 11 11111223457788999999999999
Q ss_pred cccccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 110 LPLLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 110 ~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++++++.. ....|+||||+ +++|.+++. ....+++..+..++.|++.||.||| ++|++|+||||+||
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 182 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANL 182 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHE
Confidence 999999887 67899999999 889999983 3337999999999999999999999 78999999999999
Q ss_pred EecCCC--CceeeccccceecCCCCcc-----ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 186 LIDDDM--EARISGFDLAILMPDGLTQ-----IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 186 l~~~~~--~~~l~dfg~~~~~~~~~~~-----~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+++.++ .++|+|||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999777 9999999999876432211 111235789999999999998899999999999999999999999964
Q ss_pred cccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 259 FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ................+... ...... ...+..+.+++.+||+.||++|||++++++
T Consensus 263 ~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 263 NLK---DPVAVQTAKTNLLDELPQSV-LKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp GTT---CHHHHHHHHHHHHHTTTHHH-HHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccc---ccHHHHHHHHhhcccccHHH-Hhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 221 11111111111111111100 000000 012223999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=310.65 Aligned_cols=256 Identities=21% Similarity=0.368 Sum_probs=195.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCCC---CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSN---GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
..++|.+.+.||+|+||.||+|.+...+ +..||+|.+... ........+.+|+.+++.++|||
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~ 107 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--------------YTEKQRVDFLGEAGIMGQFSHHN 107 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--------------CCHHHHHHHHHHHHHHHTCCCTT
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC--------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence 4578999999999999999999765333 346999998321 12234557889999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++...+..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~ 181 (333)
T 1mqb_A 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVN 181 (333)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred CCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEEC
Confidence 99999999999999999999999999999843 3456899999999999999999999 78999999999999999
Q ss_pred CCCCceeeccccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcc
Q 040480 189 DDMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEM 266 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~ 266 (325)
.++.++|+|||.+.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ..
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~----~~ 257 (333)
T 1mqb_A 182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NH 257 (333)
T ss_dssp TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HH
T ss_pred CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC----HH
Confidence 99999999999998765432211 1112345778999999998899999999999999999998 999996522 12
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+. ...+......... . ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 258 ~~---~~~~~~~~~~~~~--~--------~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 258 EV---MKAINDGFRLPTP--M--------DCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp HH---HHHHHTTCCCCCC--T--------TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HH---HHHHHCCCcCCCc--c--------cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22 2222222221111 0 11233899999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=310.39 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=193.8
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
...++|++.+.||+|+||.||+|+ +..+++.||+|.+... ......+.+|+.+++.+ +||||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~----------------~~~~~~~~~e~~~l~~l~~h~~i 83 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGR-HVKTGQLAAIKVMDVT----------------GDEEEEIKQEINMLKKYSHHRNI 83 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEECC----------------SSTTHHHHHHHHHHHHHCCSTTB
T ss_pred CCCCcEEEEEEeccCCCEEEEEEE-ECCCCCeEEEEEEecC----------------cccHHHHHHHHHHHHhccCCCCe
Confidence 367899999999999999999996 4567889999998322 12345678899999998 79999
Q ss_pred cccccceec------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 110 LPLLAHMVR------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 110 ~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+++++++.. .+..++||||+++++|.+++... ....++...+..++.|++.||.||| ++|++|+||+|+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~ 158 (326)
T 2x7f_A 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQ 158 (326)
T ss_dssp CCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGG
T ss_pred eeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHH
Confidence 999999876 46789999999999999999542 2356888999999999999999999 789999999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
||+++.++.++|+|||++......... .....|++.|+|||++. +..++.++||||||+++|+|++|..||..
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp GEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HEEEcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999765433221 12247899999999987 45688999999999999999999999965
Q ss_pred cccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 259 FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... . ...........+.. .. .. .+..+.+||.+||..||.+|||++++++
T Consensus 237 ~~~----~---~~~~~~~~~~~~~~-~~-----~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 237 MHP----M---RALFLIPRNPAPRL-KS-----KK---WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCH----H---HHHHHHHHSCCCCC-SC-----SC---SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CcH----H---HHHHHhhcCccccC-Cc-----cc---cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 221 1 11112222221111 00 11 1223899999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=305.84 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=191.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|++ .++.||+|.+. .......+.+|+.++++++||||++
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~-----------------~~~~~~~~~~E~~~l~~l~hp~iv~ 65 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIE-----------------SESERKAFIVELRQLSRVNHPNIVK 65 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECS-----------------STTHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CHhHeeeeeEeecCCCceEEEEEE---CCeeEEEEEec-----------------ChhHHHHHHHHHHHHhcCCCCCcCe
Confidence 347899999999999999999976 47889999872 1234567889999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++.+ ..++||||+++++|.+++... .....++...+..++.|++.||.|||..+.+|++|+||||+||+++.++
T Consensus 66 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 142 (307)
T 2eva_A 66 LYGACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 142 (307)
T ss_dssp EEEBCTT--TTEEEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT
T ss_pred EEEEEcC--CcEEEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC
Confidence 9998773 589999999999999999432 1123467888899999999999999944338999999999999999888
Q ss_pred C-ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 192 E-ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~-~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
. ++|+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ....
T Consensus 143 ~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~ 212 (307)
T 2eva_A 143 TVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG-----PAFR 212 (307)
T ss_dssp TEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-----SHHH
T ss_pred CEEEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-----cHHH
Confidence 7 7999999997554321 124689999999999998999999999999999999999999975321 1112
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..........+... ...+..+.+|+.+||+.||.+|||++++++
T Consensus 213 ~~~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 213 IMWAVHNGTRPPLI----------KNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHTTCCCCCB----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCcc----------cccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22222222221111 011233889999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=309.94 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=197.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
..++|++.+.||+|+||.||+|. +..+++.||+|++. ......+.+|+.+++.++ ||||+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~------------------~~~~~~~~~E~~~l~~l~~~~~i~ 94 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAI-NITNNEKVVVKILK------------------PVKKKKIKREIKILENLRGGPNII 94 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEC------------------SCCHHHHHHHHHHHHHHTTSTTBC
T ss_pred CCCceEEEEEecccCCeEEEEEE-ECCCCcEEEEEEec------------------ccchHHHHHHHHHHHHcCCCCCEE
Confidence 45789999999999999999995 55678999999982 123467889999999997 99999
Q ss_pred ccccceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 111 PLLAHMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 111 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++++++.+ ....++||||+.+++|.+++. .++...+..++.|++.||.||| ++|++|+||||+||+++
T Consensus 95 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~ 164 (330)
T 3nsz_A 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMID 164 (330)
T ss_dssp CEEEEEECTTTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEE
T ss_pred EeeeeeccCCCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEc
Confidence 99999987 667899999999999998872 3888899999999999999999 88999999999999999
Q ss_pred CCC-CceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 189 DDM-EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 189 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
.++ .++|+|||++.......... ...|+..|+|||.+.+ ..++.++||||||+++|+|++|..||..... ...
T Consensus 165 ~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~ 239 (330)
T 3nsz_A 165 HEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYD 239 (330)
T ss_dssp TTTTEEEECCCTTCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHH
T ss_pred CCCCEEEEEeCCCceEcCCCCccc---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHH
Confidence 766 89999999998765443322 2478999999999877 5689999999999999999999999954221 111
Q ss_pred hHHHHHHH---------HhhhCCC-------------CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRN---------VMASENP-------------NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~---------~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+...... ....... ...................+.+||.+||+.||.+|||++|+++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 240 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111000 0000000 0000000001111112345899999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=305.23 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=200.1
Q ss_pred hhcCccccc-ccccCcceeEEEEEec-CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLE-KIGSGGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~-~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|.+.+ .||+|+||.||+|.+. ..++..||+|.+... ........+.+|+.+++.++||||
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i 72 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--------------TEKADTEEMMREAQIMHQLDNPYI 72 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--------------CCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--------------cchhHHHHHHHHHHHHHhCCCCCE
Confidence 346777777 9999999999999753 346788999998421 122345678899999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++ ..+..++||||+++++|.+++.. ....++...+..++.|++.||.+|| ++|++|+||+|+||+++.
T Consensus 73 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~ 145 (287)
T 1u59_A 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVN 145 (287)
T ss_dssp CCEEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEE
T ss_pred eEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcC
Confidence 9999988 55679999999999999999842 3456899999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
++.++|+|||++.......... ......+|+.|+|||++.+..++.++|+||||+++|+|++ |..||..... .+
T Consensus 146 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~ 221 (287)
T 1u59_A 146 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PE 221 (287)
T ss_dssp TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HH
T ss_pred CCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HH
Confidence 9999999999998765433221 1122356788999999998889999999999999999998 9999975321 22
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... .+....... .+. ..+..+.+++.+||+.||.+|||+.++++
T Consensus 222 ~~~---~i~~~~~~~--~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 265 (287)
T 1u59_A 222 VMA---FIEQGKRME--CPP--------ECPPELYALMSDCWIYKWEDRPDFLTVEQ 265 (287)
T ss_dssp HHH---HHHTTCCCC--CCT--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHH---HHhcCCcCC--CCC--------CcCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222 222222111 111 12233899999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=317.03 Aligned_cols=260 Identities=24% Similarity=0.343 Sum_probs=182.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||||++... .........+.+|+.+++.++||||+++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 93 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAF-DTKTGLRVAVKKLSRP-------------FQSIIHAKRTYRELRLLKHMKHENVIGL 93 (367)
T ss_dssp ETTEEEEEECC----CCEEEEE-ETTTTEEEEEEECSST-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CCceEEeeEEeecCCeEEEEEE-ECCCCCEEEEEEeCcc-------------ccCHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 4799999999999999999995 5678899999987321 1122345678899999999999999999
Q ss_pred ccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++... ...|+|+|++ +++|.+++. ...++...+..++.|++.||.||| ++||+|+||||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIl 164 (367)
T 2fst_X 94 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLA 164 (367)
T ss_dssp SEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred EEEEecCCccccCCeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEE
Confidence 9988654 5679999999 679998883 256899999999999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
++.++.++|+|||++...... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. .
T Consensus 165 l~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~ 235 (367)
T 2fst_X 165 VNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD----H 235 (367)
T ss_dssp ECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS----H
T ss_pred ECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC----H
Confidence 999999999999999765432 122578999999999877 678999999999999999999999997532 1
Q ss_pred chHHHHHHHHhhhCCCC-----------------cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPN-----------------RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....+......+... ...+..............+.+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 236 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 22222221111110000 000000000001112334899999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=310.62 Aligned_cols=272 Identities=25% Similarity=0.384 Sum_probs=185.7
Q ss_pred HHHHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC
Q 040480 27 LAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH 106 (325)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 106 (325)
+.+....++|++.+.||+|+||.||+|. +..+++.||+|.+.... .......+.+|+.+++.++|
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h 72 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAY-CAPKKEKVAIKRINLEK--------------CQTSMDELLKEIQAMSQCHH 72 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEE-C----CEEEEECCC------------------------------CCCCCCC
T ss_pred cccccchhhhhhhheeccccceEEEEEE-ECCCCcEEEEEEEEhhh--------------cchhHHHHHHHHHHHhhcCC
Confidence 3455567899999999999999999995 55678899999873211 11234567889999999999
Q ss_pred CCccccccceecCCceEEEEEcccCCCHHHHHhhhcc----cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 107 RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK----GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 107 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
|||+++++++...+..++||||+++++|.+++..... ....++...+..++.|++.||.||| ++|++|+||+|
T Consensus 73 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p 149 (303)
T 2vwi_A 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKA 149 (303)
T ss_dssp TTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSG
T ss_pred CCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCCh
Confidence 9999999999999999999999999999999864322 2445889999999999999999999 78999999999
Q ss_pred CceEecCCCCceeeccccceecCCCCc---cccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDGLT---QIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+||+++.++.++|+|||.+........ ........||+.|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 150 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 150 GNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp GGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999999976543321 111223578999999999876 4689999999999999999999999975
Q ss_pred cccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 259 FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ..... .......+... ............+..+.+|+.+||+.||.+|||+.++++
T Consensus 230 ~~~----~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 230 YPP----MKVLM---LTLQNDPPSLE-TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCG----GGHHH---HHHTSSCCCTT-C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cch----hhHHH---HHhccCCCccc-cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 322 11111 11111111100 000000001112234889999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=318.01 Aligned_cols=198 Identities=20% Similarity=0.280 Sum_probs=167.3
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc------CC
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI------RH 106 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h 106 (325)
..+|++.+.||+|+||.||+|. +..+++.||||++.. .......+.+|+.+++.+ .|
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~-~~~~~~~vAvK~~~~----------------~~~~~~~~~~E~~~l~~l~~~~~~~~ 158 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAY-DHKVHQHVALKMVRN----------------EKRFHRQAAEEIRILEHLRKQDKDNT 158 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEE-ETTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHTTCTTSC
T ss_pred cCcEEEEEEcccCccEEEEEEE-ECCCCcEEEEEEECC----------------ccchHHHHHHHHHHHHHHhhccccCC
Confidence 4579999999999999999995 567789999999832 112234556666666665 57
Q ss_pred CCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 107 RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 107 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
+||+++++.+...+..++||||+. ++|.+++... ....+++..+..++.|++.||.||| ++||+||||||+||+
T Consensus 159 ~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIL 232 (429)
T 3kvw_A 159 MNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENIL 232 (429)
T ss_dssp SCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEE
T ss_pred cCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeE
Confidence 799999999999999999999996 5999998542 2345889999999999999999999 779999999999999
Q ss_pred ecCCCC--ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 187 IDDDME--ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 187 ~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
++.++. ++|+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 233 l~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 233 LKQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp ESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 998877 9999999997654322 124789999999999999999999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=326.41 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=195.1
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|.+. .+..||||.+... ....+.+.+|+.++++++||||+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~----------------~~~~~~~~~E~~~l~~l~hp~iv 242 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPG----------------TMSPEAFLQEAQVMKKLRHEKLV 242 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTT----------------SSCHHHHHHHHHHHHHCCCTTBC
T ss_pred cChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccC----------------CCCHHHHHHHHHHHHhCCCCCEe
Confidence 35678999999999999999999764 4567999988321 12345789999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.. +..++||||+++++|.+++... ....++...+..++.|++.||.||| ++|++|+||||+||+++.+
T Consensus 243 ~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~ 316 (452)
T 1fmk_A 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGEN 316 (452)
T ss_dssp CEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred eEEEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCC
Confidence 99998866 6789999999999999999532 2345888999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
+.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ..+..
T Consensus 317 ~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~----~~~~~ 391 (452)
T 1fmk_A 317 LVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVL 391 (452)
T ss_dssp GCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHH
T ss_pred CCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC----HHHHH
Confidence 99999999999866433221 1112356788999999998899999999999999999999 999996532 12222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+........ +. .++..+.+||.+||+.||++|||++++++
T Consensus 392 ---~~i~~~~~~~~--~~--------~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 392 ---DQVERGYRMPC--PP--------ECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ---HHHHTTCCCCC--CT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHcCCCCCC--CC--------CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22222222111 11 12234899999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=303.31 Aligned_cols=254 Identities=19% Similarity=0.285 Sum_probs=196.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|++.+.||+|+||.||+|.+.... +..||+|.+... ........+.+|+.+++.++||||
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i 75 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--------------CTLDNKEKFMSEAVIMKNLDHPHI 75 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--------------SCHHHHHHHHHHHHHHHHHCCTTB
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--------------cCchHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999999765433 356999987321 122345678899999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.+ +..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 76 ~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~ 148 (281)
T 3cc6_A 76 VKLIGIIEE-EPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVAS 148 (281)
T ss_dssp CCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEE
T ss_pred ceEEEEEcC-CCCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECC
Confidence 999998764 467999999999999999954 2345889999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 268 (325)
++.++|+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ..+.
T Consensus 149 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~----~~~~ 223 (281)
T 3cc6_A 149 PECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----NKDV 223 (281)
T ss_dssp TTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----GGGH
T ss_pred CCcEEeCccCCCcccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC----hHHH
Confidence 9999999999998665432211 122456788999999998889999999999999999998 999996532 2222
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ...... +. ..+..+.+++.+||+.||.+|||+.++++
T Consensus 224 ~~~~~~---~~~~~~--~~--------~~~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 224 IGVLEK---GDRLPK--PD--------LCPPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp HHHHHH---TCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhc---CCCCCC--CC--------CCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 222221 111110 00 01223899999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=317.46 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=199.6
Q ss_pred hcCcccccccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
.++|++.+.||+|+||.||+|+.. ..+++.||+|++..... .........+.+|+.+++.+ .||||
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~~h~~i 121 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI-----------VQKAKTTEHTRTERQVLEHIRQSPFL 121 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEE-----------EEEESSGGGCCCHHHHHHHHHTCTTB
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHh-----------hhhhhHHHHHHHHHHHHHHccCCCce
Confidence 478999999999999999999753 24789999999842110 00112234566788888888 69999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++||+|+||||+||+++.
T Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDS 194 (355)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred eEEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECC
Confidence 9999999999999999999999999999943 346899999999999999999999 789999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
++.++|+|||++......... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||........
T Consensus 195 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--- 270 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--- 270 (355)
T ss_dssp TSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---
T ss_pred CCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---
Confidence 999999999999866433221 22235789999999998863 478899999999999999999999975432222
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
............... +. .....+.+||.+||..||.+|| |++++++
T Consensus 271 ~~~~~~~~~~~~~~~---~~--------~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 271 QAEISRRILKSEPPY---PQ--------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHHHHHHHHHCCCCC---CT--------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHHHhccCCCC---Cc--------ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 222222222222111 11 1122388999999999999999 8999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=304.84 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=199.4
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
....++|++.+.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++||||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~----------------~~~~~~~~~E~~~l~~l~h~~i 70 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQG----------------SMSPDAFLAEANLMKQLQHQRL 70 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTT----------------SSCHHHHHHHHHHHHHCCCTTB
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCC----------------cccHHHHHHHHHHHHhCCCcCc
Confidence 345689999999999999999999753 5678999988321 1234578899999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++. .+..++||||+++++|.+++... ....++...+..++.|++.||.+|| ++|++|+||+|+||+++.
T Consensus 71 ~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~ 144 (279)
T 1qpc_A 71 VRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSD 144 (279)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred ceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcC
Confidence 99999876 45689999999999999998431 1235889999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 268 (325)
++.++|+|||.+........... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ..+.
T Consensus 145 ~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~ 219 (279)
T 1qpc_A 145 TLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEV 219 (279)
T ss_dssp TSCEEECCCTTCEECSSSCEECC-TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHH
T ss_pred CCCEEECCCcccccccCcccccc-cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC----HHHH
Confidence 99999999999987654332211 12356778999999998889999999999999999999 999996522 1122
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............ + ...+..+.+|+.+||+.||++|||+.++++
T Consensus 220 ---~~~~~~~~~~~~--~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 220 ---IQNLERGYRMVR--P--------DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ---HHHHHTTCCCCC--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHhcccCCCC--c--------ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222222211111 0 011234899999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=308.21 Aligned_cols=258 Identities=23% Similarity=0.289 Sum_probs=198.4
Q ss_pred CcccccccccCcceeEEEEEec---CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 35 CFASLEKIGSGGCGDVYKAELP---GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
.|++.+.||+|+||+||++.+. ..+++.||+|++... ........+.+|+.+++.++||||++
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~ 97 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--------------AGPQHRSGWKQEIDILRTLYHEHIIK 97 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--------------CCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--------------cChHHHHHHHHHHHHHHhCCCcchhh
Confidence 3599999999999999988653 346789999998321 12234567899999999999999999
Q ss_pred cccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 112 LLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 112 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++.+. ...++||||+++++|.+++. ...++...+..++.|++.||.+|| ++|++|+||||+||+++.
T Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~ 169 (318)
T 3lxp_A 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDN 169 (318)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred EEEEEecCCCceEEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcC
Confidence 99999874 56899999999999999983 234899999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccC------
Q 040480 190 DMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSH------ 262 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~------ 262 (325)
++.++|+|||.+......... .......++..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 170 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~ 249 (318)
T 3lxp_A 170 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249 (318)
T ss_dssp TCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC
T ss_pred CCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc
Confidence 999999999999877654322 1122246788899999999988999999999999999999999998642110
Q ss_pred --CCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 263 --TGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 263 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.................... .+ ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~--~~--------~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 250 IAQGQMTVLRLTELLERGERLP--RP--------DKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp SCCHHHHHHHHHHHHHTTCCCC--CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccchhHHHHHHHHhcccCCC--CC--------ccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01111111112111111111 11 112234899999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=322.87 Aligned_cols=247 Identities=13% Similarity=0.160 Sum_probs=186.3
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHH---HHHhccCCCCc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI---ITASQIRHRNI 109 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i 109 (325)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... .......+.+.+|+ .++++++||||
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~vavK~~~~~~------------~~~~~~~~~~~~E~~~l~~l~~l~hpni 138 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTE------------RPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEE-C-CCCCEEEEEEEEECC-------------CCTTHHHHHHHHHHGGGGSTTCCSHHH
T ss_pred CceEEEcceeecCCCEEEEEEE-ECCCCcEEEEEEEeecc------------ccchHHHHHHHHHHHHHHhccccCCHHH
Confidence 5789999999999999999996 45678999999984321 11223456788898 55556689999
Q ss_pred cccc-------cceecCC-----------------ceEEEEEcccCCCHHHHHhhhcc---cccccChhhHHHHHHHHHH
Q 040480 110 LPLL-------AHMVRPD-----------------SHLLVYDFMKNGSLQAVLYDVSK---GRRELEWLSRHKIALAVAS 162 (325)
Q Consensus 110 ~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~ 162 (325)
++++ +++...+ ..|+||||+ +|+|.+++..... ....+++..+..++.|++.
T Consensus 139 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~ 217 (377)
T 3byv_A 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217 (377)
T ss_dssp HHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHH
Confidence 9998 4444443 378999999 5699999964321 1123445778889999999
Q ss_pred HHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccC-----------
Q 040480 163 GLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL----------- 231 (325)
Q Consensus 163 ~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~----------- 231 (325)
||.||| ++||+|+||||+||+++.++.+||+|||++..... ......| +.|+|||++.+.
T Consensus 218 aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 288 (377)
T 3byv_A 218 LLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRT 288 (377)
T ss_dssp HHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred HHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccc
Confidence 999999 78999999999999999999999999999986433 1222467 899999999887
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCC
Q 040480 232 TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLA 311 (325)
Q Consensus 232 ~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 311 (325)
.++.++||||||+++|+|++|..||............ .. ... ..+..+.+||.+||+.
T Consensus 289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~-------~~---~~~------------~~~~~~~~li~~~L~~ 346 (377)
T 3byv_A 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-------FR---SCK------------NIPQPVRALLEGFLRY 346 (377)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG-------GS---SCC------------CCCHHHHHHHHHHTCS
T ss_pred cCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh-------hh---hcc------------CCCHHHHHHHHHHcCC
Confidence 7999999999999999999999999653321111000 00 001 1122389999999999
Q ss_pred CCCCCCChhhhhc
Q 040480 312 DPDERPNSKDVRC 324 (325)
Q Consensus 312 dP~~Rps~~ell~ 324 (325)
||++|||+.++++
T Consensus 347 dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 347 PKEDRLLPLQAME 359 (377)
T ss_dssp SGGGCCCHHHHHT
T ss_pred CchhCCCHHHHhh
Confidence 9999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=310.18 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=204.0
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
.-.++|++.+.||.|+||.||+|. +..+++.||||++........... .......+.+|+.+++.+ .||||
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~-~~~~g~~vavK~~~~~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~i 162 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQ-------LEEVREATRRETHILRQVAGHPHI 162 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEETTSSCCCHHH-------HHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred hhhhhcccceEEecCCCEEEEEEE-ECCCCcEEEEEEEEccccccCHHH-------HHHHHHHHHHHHHHHHHhcCCCCE
Confidence 345789999999999999999996 456789999999854332111110 112355788999999999 79999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++......++||||+++++|.+++.. ...++...+..++.|++.||.||| +.|++|+||+|+||+++.
T Consensus 163 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDD 235 (365)
T ss_dssp CCEEEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred eEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 9999999999999999999999999999843 346899999999999999999999 789999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCccccccccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT------LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
++.++|+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 236 ~~~ikl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--- 309 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--- 309 (365)
T ss_dssp TCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred CCCEEEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---
Confidence 999999999999876644322 22578999999998863 357889999999999999999999996521
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ......+........ ..... ..+..+.+|+.+||+.||++|||++++++
T Consensus 310 -~---~~~~~~i~~~~~~~~---~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 310 -Q---ILMLRMIMEGQYQFS---SPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -H---HHHHHHHHHTCCCCC---HHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -H---HHHHHHHHhCCCCCC---Ccccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 112222222221110 00001 11233889999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=306.21 Aligned_cols=258 Identities=24% Similarity=0.307 Sum_probs=193.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCc--EEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGK--MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|++.+.||+|+||.||+|++...++. .||+|.+... ..........+.+|+.++++++||||
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i 83 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD------------VLSQPEAMDDFIREVNAMHSLDHRNL 83 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------------CHHHHHHHHHHHHHHHCCCTTB
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccC------------ccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 457899999999999999999986554443 6899987321 11123456788999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.... .++|+||+.+++|.+++... ...++...+..++.|++.||.+|| ++|++|+||+|+||+++.
T Consensus 84 ~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~ 156 (291)
T 1u46_A 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLAT 156 (291)
T ss_dssp CCEEEEECSSS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEE
T ss_pred ccEEEEEccCC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcC
Confidence 99999887754 89999999999999999542 345889999999999999999999 789999999999999999
Q ss_pred CCCceeeccccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
++.++|+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.... ..
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~- 231 (291)
T 1u46_A 157 RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GS- 231 (291)
T ss_dssp TTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HH-
T ss_pred CCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC----HH-
Confidence 9999999999998765433221 1222456778999999998889999999999999999999 999996532 11
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+....... ..+ ...+..+.+++.+||..||.+|||+.++++
T Consensus 232 --~~~~~~~~~~~~~-~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 232 --QILHKIDKEGERL-PRP--------EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --HHHHHHHTSCCCC-CCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHccCCCC-CCC--------cCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2222222211111 111 112234899999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=326.20 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=191.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|.+.+.||+|+||.||+|. +..+++.||+|++........ ..........+.+|+.++++++||||++
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~-~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~hpniv~ 204 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIG-------SAREADPALNVETEIEILKKLNHPCIIK 204 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEE-ETTTCCEEEEEEEEGGGGTTC---------------CCHHHHHHHHHHCCCTTBCC
T ss_pred hhccEEEEeEEeeCCCeEEEEEE-ECCCCcEEEEEEEEechhccc-------ccccchhHHHHHHHHHHHHhCCCCCEee
Confidence 35789999999999999999995 667889999999843210000 0001122335788999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++. .+..++||||+++++|.+++ .....+++..+..++.|++.||.||| ++||+|+||||+||+++.++
T Consensus 205 l~~~~~-~~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 205 IKNFFD-AEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp CCEEEE-SSEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSS
T ss_pred EEEEEe-cCceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCC
Confidence 999875 45689999999999998887 44567999999999999999999999 78999999999999997544
Q ss_pred ---CceeeccccceecCCCCccccceeecCCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 192 ---EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT---LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 192 ---~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 277 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--- 350 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--- 350 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS---
T ss_pred CcceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch---
Confidence 599999999987654322 223578999999999864 56788999999999999999999999753221
Q ss_pred chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........ ...... .+... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 351 ~~~~~~i~---~~~~~~---~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 351 VSLKDQIT---SGKYNF---IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCHHHHHH---TTCCCC---CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHh---cCCCCC---Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 12222111 111111 11111 112234899999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=302.96 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=199.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
-.++|++.+.||+|+||.||+|+ +..+++.||+|.+... .....+.+|+.+++.++|++++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~-----------------~~~~~~~~e~~~l~~l~~~~~i~ 68 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGT-DIAAGEEVAIKLECVK-----------------TKHPQLHIESKIYKMMQGGVGIP 68 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEE-ETTTTEEEEEEEEESC-----------------SSCCHHHHHHHHHHHHTTSTTCC
T ss_pred eccEEEEEEEEccCCCeEEEEEE-EcCCCcEEEEEEecCC-----------------cchhHHHHHHHHHHHhhcCCCCC
Confidence 35789999999999999999996 5568899999987322 12235788999999999887666
Q ss_pred cccce-ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec--
Q 040480 112 LLAHM-VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID-- 188 (325)
Q Consensus 112 ~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~-- 188 (325)
.+..+ ...+..++||||+ +++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++
T Consensus 69 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~ 141 (296)
T 3uzp_A 69 TIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLG 141 (296)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCG
T ss_pred ccccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecC
Confidence 65555 5566789999999 8899999943 3456999999999999999999999 88999999999999994
Q ss_pred -CCCCceeeccccceecCCCCccc-----cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccC
Q 040480 189 -DDMEARISGFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSH 262 (325)
Q Consensus 189 -~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~ 262 (325)
.++.++|+|||.+.......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 142 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 3uzp_A 142 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred CCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch
Confidence 78899999999998765543211 122357899999999999999999999999999999999999999865433
Q ss_pred CCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 263 TGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
................... .... ..+..+.+++.+||+.||.+|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~-------~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 222 TKRQKYERISEKKMSTPIE-------VLCK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SSSSHHHHHHHHHHHSCHH-------HHTT---TSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhhhcccccCCchH-------HHHh---hCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 3322222222221111100 0000 11223899999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=307.60 Aligned_cols=260 Identities=20% Similarity=0.291 Sum_probs=200.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC-----
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR----- 107 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~----- 107 (325)
.++|++.+.||+|+||.||+|.+...+++.||+|++.. .......+.+|+.+++.++|+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~~~ 76 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----------------VDRYCEAARSEIQVLEHLNTTDPNST 76 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----------------SHHHHHHHHHHHHHHHHHHHHCTTCT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----------------CCchhHHHHHHHHHHHHhhhcCCCCc
Confidence 46899999999999999999975466889999999831 113345677888888887655
Q ss_pred -CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 108 -NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 108 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
+++++++++...+..++||||+ +++|.+++.. .....++...+..++.|++.||.||| ++|++|+||||+||+
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil 150 (339)
T 1z57_A 77 FRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENIL 150 (339)
T ss_dssp TCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred eeeEeeecccccCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEE
Confidence 4999999999999999999999 7899999854 23346888999999999999999999 789999999999999
Q ss_pred ecC-------------------CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHH
Q 040480 187 IDD-------------------DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLA 247 (325)
Q Consensus 187 ~~~-------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~ 247 (325)
++. ++.++|+|||.+....... ....||+.|+|||++.+..++.++||||||+++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (339)
T 1z57_A 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225 (339)
T ss_dssp ESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHH
T ss_pred EeccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHH
Confidence 987 6689999999998654322 1247899999999999989999999999999999
Q ss_pred HHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCccc-------------------------------chhhcCCchHH
Q 040480 248 VLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAI-------------------------------DSKLLGNGYEE 296 (325)
Q Consensus 248 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~ 296 (325)
+|++|..||.... ..+.......... ..+.... ...........
T Consensus 226 el~~g~~pf~~~~----~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (339)
T 1z57_A 226 EYYLGFTVFPTHD----SKEHLAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300 (339)
T ss_dssp HHHHSSCSCCCSC----HHHHHHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSH
T ss_pred HHHhCCCCCCCCC----hHHHHHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchh
Confidence 9999999997532 1222222222111 1000000 00000111223
Q ss_pred HHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 297 QMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 297 ~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+.+|+.+||+.||.+|||+.|+++
T Consensus 301 ~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 301 EHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 4566999999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=304.47 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=196.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
....|.+.+.||+|+||+||+|.+... ++..+|+|.+... ......+.+.+|+.+++.++||||
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i 84 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--------------TEMQQVEAFLREGLLMRGLNHPNV 84 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--------------CSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--------------ccHHHHHHHHHHHHHHHhCCCCCe
Confidence 445677889999999999999975332 3347999988321 122345678899999999999999
Q ss_pred cccccceecCCce-EEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 110 LPLLAHMVRPDSH-LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 110 ~~~~~~~~~~~~~-~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
+++++++...+.. ++++||+.+++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++
T Consensus 85 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~ 158 (298)
T 3pls_A 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLD 158 (298)
T ss_dssp CCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEc
Confidence 9999999876665 999999999999999943 3456888999999999999999999 78999999999999999
Q ss_pred CCCCceeeccccceecCCCCc--cccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCC-CCCcccCCCc
Q 040480 189 DDMEARISGFDLAILMPDGLT--QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP-FDDFFSHTGE 265 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p-~~~~~~~~~~ 265 (325)
.++.++|+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++|..| |... ..
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----~~ 234 (298)
T 3pls_A 159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DP 234 (298)
T ss_dssp TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CG
T ss_pred CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----CH
Confidence 999999999999976543321 1112224678899999999999999999999999999999995555 4332 22
Q ss_pred chHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+...... ....... +. ..+..+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~---~~~~~~~--~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 235 FDLTHFLA---QGRRLPQ--PE--------YCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp GGHHHHHH---TTCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhh---cCCCCCC--Cc--------cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22222222 1111111 00 01123899999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=302.22 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=204.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
-.++|++.+.||+|+||.||+|. +..+++.||+|.+.......... .......+.+.+|+.+++++. ||||+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSA------EEVQELREATLKEVDILRKVSGHPNII 87 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEETTCSTTCCH------HHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred hhhccceeeeecCCCceEEEEEE-EcCcCceEEEEEEecccccccCH------HHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 45799999999999999999995 55678999999985433211100 011133567889999999996 99999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++||||+++++|.+++.. ...++...+..++.|++.||.||| ++|++|+||+|+||+++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDD 160 (298)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred eeeeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCC
Confidence 999999999999999999999999999943 356899999999999999999999 7899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ------TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~------~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+.++|+|||.+......... ....|++.|+|||++. ...++.++|+||||+++|+|++|..||....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---- 233 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---- 233 (298)
T ss_dssp CCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred CcEEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc----
Confidence 99999999999876543322 2247899999999875 4467889999999999999999999996521
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ......+......... ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~---~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 234 Q---MLMLRMIMSGNYQFGS-------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H---HHHHHHHHHTCCCCCT-------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H---HHHHHHHhcCCcccCc-------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 1122222222211110 001122334899999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=311.09 Aligned_cols=262 Identities=25% Similarity=0.334 Sum_probs=188.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHH--HHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQ--IITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e--~~~l~~l~h~~i 109 (325)
..++|++.+.||+|+||.||+|++ +++.||+|++... ....+..| +..+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~------------------~~~~~~~e~~~~~~~~~~h~~i 69 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFA------------------NRQNFINEKNIYRVPLMEHDNI 69 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGG------------------GHHHHHHHHHHHTSTTCCCTTB
T ss_pred ChHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeecc------------------chhhHHHHHHHHHHHhccCcch
Confidence 458999999999999999999975 6889999998321 12223333 334556899999
Q ss_pred ccccccee-----cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC---------Ce
Q 040480 110 LPLLAHMV-----RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA---------RV 175 (325)
Q Consensus 110 ~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~---------~i 175 (325)
+++++.+. .....++||||+++++|.+++.. ...++..+..++.|++.||.||| +. ||
T Consensus 70 ~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~i 141 (336)
T 3g2f_A 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAI 141 (336)
T ss_dssp CCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCE
T ss_pred hhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHH---hhhccccccccce
Confidence 99987432 33357899999999999999932 34578888999999999999999 77 99
Q ss_pred EecCCCCCceEecCCCCceeeccccceecCCCCc------cccceeecCCccccccccccc-------CCCCCccchhhH
Q 040480 176 IHRDIKPANVLIDDDMEARISGFDLAILMPDGLT------QIDTMYVVGTPRYIAPEYHQT-------LTISEKCDIYSF 242 (325)
Q Consensus 176 vH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~g~~~~~aPE~~~~-------~~~~~~~Dvwsl 242 (325)
+|+||||+||+++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||
T Consensus 142 vH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 221 (336)
T 3g2f_A 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221 (336)
T ss_dssp ECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred eecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHH
Confidence 9999999999999999999999999987654321 111222468999999999887 356778999999
Q ss_pred HHHHHHHHhCCCCCCCcccCCC-cchH---------HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCC
Q 040480 243 GVLLAVLVMGKFPFDDFFSHTG-EMDM---------VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLAD 312 (325)
Q Consensus 243 G~il~~ll~g~~p~~~~~~~~~-~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 312 (325)
|+++|+|++|..||........ .... .................+.. .......+..+.+||.+||+.|
T Consensus 222 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 222 GLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCC
Confidence 9999999999776643221111 1000 01111111111111111111 1112234556999999999999
Q ss_pred CCCCCChhhhhc
Q 040480 313 PDERPNSKDVRC 324 (325)
Q Consensus 313 P~~Rps~~ell~ 324 (325)
|++|||+.|+++
T Consensus 300 P~~Rps~~e~l~ 311 (336)
T 3g2f_A 300 AEARLTAQXAEE 311 (336)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcchHHHHH
Confidence 999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=312.28 Aligned_cols=270 Identities=20% Similarity=0.257 Sum_probs=189.6
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
.....++|++.+.||+|+||.||+|+ +..+++.||||++.... .......+++..++.++|||
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~----------------~~~~~~~~~~~~l~~l~h~n 80 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGK-EKSTGMSVAIKKVIQDP----------------RFRNRELQIMQDLAVLHHPN 80 (360)
T ss_dssp HHHHHTTEEEC----------CEEEE-ETTTCCEEEEEEEECCT----------------TCCCHHHHHHHHHHHHCCTT
T ss_pred chhhccceEEEEEEecCCCeEEEEEE-ECCCCCEEEEEEEecCc----------------cccHHHHHHHHHHHhcCCCC
Confidence 34556899999999999999999996 55678899999873211 12234566777788889999
Q ss_pred ccccccceecCCc-------eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040480 109 ILPLLAHMVRPDS-------HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181 (325)
Q Consensus 109 i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~ 181 (325)
|+++++++...+. .++||||+++ +|.+.+.........++...+..++.|++.||.|||.+ ++||+|+|||
T Consensus 81 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlk 158 (360)
T 3e3p_A 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIK 158 (360)
T ss_dssp BCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCC
T ss_pred cccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCC
Confidence 9999999865443 7899999976 67666655445667789999999999999999999944 6799999999
Q ss_pred CCceEecC-CCCceeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCc
Q 040480 182 PANVLIDD-DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDF 259 (325)
Q Consensus 182 ~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~ 259 (325)
|+||+++. ++.++|+|||++.......... ...||+.|+|||++.+.. ++.++||||||+++|+|++|..||...
T Consensus 159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp GGGEEEETTTTEEEECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEEeCCCCcEEEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 99999996 8899999999998765443322 247899999999986654 899999999999999999999999753
Q ss_pred ccCCCcchHHHHHHHHhhhCC---------CCcccc---------hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhh
Q 040480 260 FSHTGEMDMVRWMRNVMASEN---------PNRAID---------SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (325)
. .......+........ .....+ ..............+.+|+.+||+.||.+|||+.|
T Consensus 236 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 311 (360)
T 3e3p_A 236 N----SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311 (360)
T ss_dssp S----HHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C----hHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence 2 1122211111110000 000000 00011111113455999999999999999999999
Q ss_pred hhc
Q 040480 322 VRC 324 (325)
Q Consensus 322 ll~ 324 (325)
+++
T Consensus 312 ~l~ 314 (360)
T 3e3p_A 312 ALC 314 (360)
T ss_dssp HTT
T ss_pred Hhc
Confidence 985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=312.25 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=196.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcE--EEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKM--IAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
++|++.+.||+|+||.||+|++. .++.. +|+|.+... ........+.+|+.+++++ +||||+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~~v~iK~~~~~--------------~~~~~~~~~~~E~~~l~~l~~hp~iv 89 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEY--------------ASKDDHRDFAGELEVLCKLGHHPNII 89 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEE-ETTEEEEEEEEEEECC--------------------CHHHHHHHHHTTCCCCTTBC
T ss_pred HHccceeeeecCCCceEEEEEEc-cCCcccceeeeeeccc--------------cchHHHHHHHHHHHHHHhccCCCchh
Confidence 78999999999999999999753 44554 588887321 1123345688999999999 899999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhc------------ccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS------------KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
++++++...+..++||||+++++|.+++.... .....++...++.++.|++.||.||| ++|++|+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 166 (327)
T 1fvr_A 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHR 166 (327)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred hhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCC
Confidence 99999999999999999999999999995532 22346899999999999999999999 8899999
Q ss_pred CCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 040480 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFD 257 (325)
Q Consensus 179 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~ 257 (325)
||||+||+++.++.++|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 167 dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 167 DLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCccceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999874332211 122356788999999998889999999999999999998 999996
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... ......+........+ . ..+..+.+|+.+||+.||.+|||++++++
T Consensus 244 ~~~~-------~~~~~~~~~~~~~~~~--~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 293 (327)
T 1fvr_A 244 GMTC-------AELYEKLPQGYRLEKP--L--------NCDDEVYDLMRQCWREKPYERPSFAQILV 293 (327)
T ss_dssp TCCH-------HHHHHHGGGTCCCCCC--T--------TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcH-------HHHHHHhhcCCCCCCC--C--------CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 5221 1222222222111111 0 11233899999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=315.38 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=188.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCC--cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...|.+.+.||+|+||.||+|.+...++ ..+|+|.+.. .........+.+|+.++++++||||+
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~il~~l~hpnIv 153 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--------------ITDIGEVSQFLTEGIIMKDFSHPNVL 153 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS--------------CSCSHHHHHHHHHHTTSTTCCCTTBC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC--------------CCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3468889999999999999997643333 4688998731 11224466789999999999999999
Q ss_pred cccccee-cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 111 PLLAHMV-RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 111 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++++++. .++..++||||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~ 227 (373)
T 3c1x_A 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDE 227 (373)
T ss_dssp CCCEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred eEEEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECC
Confidence 9999865 45678999999999999999943 3445788889999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCcc--ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcc
Q 040480 190 DMEARISGFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEM 266 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~ 266 (325)
++.+||+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||..... .
T Consensus 228 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~----~ 303 (373)
T 3c1x_A 228 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----F 303 (373)
T ss_dssp TCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS----S
T ss_pred CCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH----H
Confidence 999999999999865432211 11122456788999999999899999999999999999999 7788865322 2
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+..... ........+ . ..+..+.+++.+||+.||++|||+.++++
T Consensus 304 ~~~~~~---~~~~~~~~p--~--------~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 304 DITVYL---LQGRRLLQP--E--------YCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp CHHHHH---HTTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHH---HcCCCCCCC--C--------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222221 122211110 0 11223899999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=303.50 Aligned_cols=242 Identities=22% Similarity=0.370 Sum_probs=195.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|.+... ...+.+|+.+++.++||||+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~-------------------~~~~~~e~~~l~~l~h~~i~~~ 69 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAK-HRIDGKTYVIKRVKYN-------------------NEKAEREVKALAKLDHVNIVHY 69 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEE-ETTTCCEEEEEEEECC-------------------SGGGHHHHHHHHHCCCTTBCCE
T ss_pred ccccceeeeeccCCceEEEEEE-EcCCCeEEEEEEeccc-------------------cHHHHHHHHHHHhCCCCCEEEE
Confidence 4689999999999999999996 4567889999998321 1245688999999999999999
Q ss_pred ccceec----------------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 040480 113 LAHMVR----------------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVI 176 (325)
Q Consensus 113 ~~~~~~----------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~iv 176 (325)
++++.. ....++||||+++++|.+++... ....+++..+..++.|++.||.||| ++|++
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~ 144 (284)
T 2a19_B 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIH---SKKLI 144 (284)
T ss_dssp EEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred eeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 998754 34579999999999999999542 2356889999999999999999999 78999
Q ss_pred ecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 040480 177 HRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 177 H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~ 256 (325)
|+||+|+||+++.++.++|+|||.+.......... ...|++.|+|||.+.+..++.++|+||||+++|+|++|..|+
T Consensus 145 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred eccCCHHHEEEcCCCCEEECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 99999999999999999999999998766543222 246899999999999988999999999999999999999887
Q ss_pred CCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 257 DDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ......... .......+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~~---------~~~~~~~~~-~~~~~~~~------------~~~~~li~~~l~~dp~~Rps~~e~l~ 267 (284)
T 2a19_B 222 FET---------SKFFTDLRD-GIISDIFD------------KKEKTLLQKLLSKKPEDRPNTSEILR 267 (284)
T ss_dssp HHH---------HHHHHHHHT-TCCCTTSC------------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhH---------HHHHHHhhc-ccccccCC------------HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 421 111111111 11111111 22889999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=311.10 Aligned_cols=246 Identities=13% Similarity=0.083 Sum_probs=193.1
Q ss_pred hhcCcccccccccCcceeEEEEEe----cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAEL----PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-- 105 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-- 105 (325)
..++|++.+.||+|+||+||+|.+ +..+++.||+|.+.. .....+..|..+++.++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~------------------~~~~~~~~e~~~~~~l~~~ 124 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP------------------ANPWEFYIGTQLMERLKPS 124 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS------------------CCHHHHHHHHHHHHHSCGG
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC------------------CChhHHHHHHHHHHHhhhh
Confidence 457899999999999999999952 345788999999831 22345666667777665
Q ss_pred -CCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc-cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 106 -HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK-GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 106 -h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
|+||+++++.+...+..++||||+++++|.+++..... ....+++..+..++.|++.||.||| ++||+||||||+
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~ 201 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPD 201 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGG
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHH
Confidence 89999999999999999999999999999999965433 3566999999999999999999999 889999999999
Q ss_pred ceEecC-----------CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhC
Q 040480 184 NVLIDD-----------DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMG 252 (325)
Q Consensus 184 nil~~~-----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g 252 (325)
|||++. ++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 999998 899999999999866533333333446799999999999999999999999999999999999
Q ss_pred CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 253 KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 253 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
+.||......... ....... .. ..+.+.+++..||+.+|.+|++..
T Consensus 282 ~~pf~~~~~~~~~------------~~~~~~~-------~~---~~~~~~~~~~~~l~~~p~~r~~~~ 327 (365)
T 3e7e_A 282 TYMKVKNEGGECK------------PEGLFRR-------LP---HLDMWNEFFHVMLNIPDCHHLPSL 327 (365)
T ss_dssp SCCCEEEETTEEE------------ECSCCTT-------CS---SHHHHHHHHHHHHCCCCTTCCCCH
T ss_pred CCccccCCCCcee------------echhccc-------cC---cHHHHHHHHHHHcCCCCCCcchHH
Confidence 9999643221000 0000000 00 122377899999999999996543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=299.76 Aligned_cols=254 Identities=25% Similarity=0.310 Sum_probs=194.2
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|.....||+|+||.||+|. +..++..||+|.+... .......+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~~ 85 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGR-DLSNQVRIAIKEIPER---------------DSRYSQPLHEEIALHKHLKHKNIVQYL 85 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEE-ETTTCCEEEEEEEECC---------------CC---HHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCCCcEEEeecCcEEEEEEE-ECCCCeEEEEEEccCC---------------chHHHHHHHHHHHHHHhCCCCCEeeEe
Confidence 345555699999999999996 5567889999988321 223456788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC-CCC
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-DME 192 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~-~~~ 192 (325)
+++...+..++||||+++++|.+++... .....++...+..++.|++.||.||| ++|++|+||+|+||+++. ++.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 161 (295)
T 2clq_A 86 GSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGV 161 (295)
T ss_dssp EEEEETTEEEEEEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCC
T ss_pred eEEEeCCcEEEEEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCC
Confidence 9999999999999999999999999542 12234667888899999999999999 789999999999999987 899
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT--ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
++|+|||.+......... .....|+..|+|||++.+.. ++.++|+||||+++|+|++|..||..... ....
T Consensus 162 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~- 234 (295)
T 2clq_A 162 LKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE----PQAA- 234 (295)
T ss_dssp EEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS----HHHH-
T ss_pred EEEeecccccccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc----hhHH-
Confidence 999999999876543221 12247899999999987653 78899999999999999999999964221 1111
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..........+. .+. ..+..+.+|+.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~--~~~--------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 235 MFKVGMFKVHPE--IPE--------SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHCCCCC--CCT--------TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHhhcccccccc--ccc--------cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111111 110 11223889999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=318.78 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=194.1
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
...+|++.+.||+|+||+||+|+ +..+++.||||++... .....+|+.+++.++||||++
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~~vaiK~~~~~-------------------~~~~~~E~~il~~l~hpniv~ 111 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQD-------------------KRFKNRELQIMRKLDHCNIVR 111 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEECC-------------------TTSCCHHHHHHHTCCCTTBCC
T ss_pred ccceEEeeeEEeeCCCEEEEEEE-ECCCCcEEEEEEeccc-------------------chhHHHHHHHHHHcCCCCccc
Confidence 34579999999999999999996 4567899999988321 011246899999999999999
Q ss_pred cccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++++... ...++||||+++ +|.+.+.........++...+..++.|++.||.||| ++||+||||||+||
T Consensus 112 l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NI 187 (420)
T 1j1b_A 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNL 187 (420)
T ss_dssp EEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGE
T ss_pred eeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhE
Confidence 99887432 236799999976 777777655555677999999999999999999999 88999999999999
Q ss_pred EecCC-CCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 186 LIDDD-MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 186 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
|++.+ +.+||+|||++.......... ...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 188 Ll~~~~~~~kl~DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-- 262 (420)
T 1j1b_A 188 LLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-- 262 (420)
T ss_dssp EEETTTTEEEECCCTTCEECCTTCCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EEeCCCCeEEeccchhhhhcccCCCce---eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--
Confidence 99965 567999999998765443222 24789999999998765 689999999999999999999999975321
Q ss_pred CcchHHHHHHHH--------hhh-CCCCcccchhhcCCch-----HHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNV--------MAS-ENPNRAIDSKLLGNGY-----EEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~--------~~~-~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+...+... ... ........+......+ ...+..+.+||.+||+.||.+|||+.|+++
T Consensus 263 -~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 263 -VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp -HHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 11122221110 000 0000000000000001 112344899999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=310.55 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=195.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|.+........ ..........+.+|+.+++.++||||+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIG-------SAREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECC----------------------CHHHHHHHHHHCCCTTBCCE
T ss_pred hhceeEeeEEecCCCEEEEEEE-EcCCCcEEEEEEeehhhhhhc-------ccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 4689999999999999999995 556789999999843211000 00111233457889999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.... .++||||+++++|.+++ .....++...+..++.|++.||.||| ++|++|+||||+||+++.++.
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHH----STTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSS
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCC
Confidence 99886654 89999999999999998 34567899999999999999999999 789999999999999987654
Q ss_pred ---ceeeccccceecCCCCccccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 193 ---ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 193 ---~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
++|+|||++......... ....||+.|+|||++. ...++.++||||||+++|+|++|..||...... .
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~ 226 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ---V 226 (322)
T ss_dssp SCCEEECCCTTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS---S
T ss_pred CCeEEEccCccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH---H
Confidence 999999999876543221 2246899999999864 456889999999999999999999999753321 1
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... ...... .+... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~---~~~~~~---~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 SLKDQIT---SGKYNF---IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CHHHHHH---HTCCCC---CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHH---hCcccc---Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 2222111 111111 11111 112234899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=310.97 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=193.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|.+.+.||+|+||.||+|. +..+++.||+|++.... ........+.+|+.+++.++||||+++
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~niv~~ 106 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAI-DKRSGEKVAIKKLSRPF-------------QSEIFAKRAYRELLLLKHMQHENVIGL 106 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECSTT-------------SSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred cccEEEEeEEecCCCeEEEEEE-ECCCCCEEEEEEecccc-------------cchhHHHHHHHHHHHHHhcCCCCchhh
Confidence 4789999999999999999995 56788999999984211 122345678899999999999999999
Q ss_pred ccceecCCce------EEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRPDSH------LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++...+.. ++||||+.+ +|.+.+ ...++...+..++.|++.||.||| ++|++|+||||+||+
T Consensus 107 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl 176 (371)
T 4exu_A 107 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM------GMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLA 176 (371)
T ss_dssp SEEECSCSSSTTCCCCEEEEECCCE-EHHHHT------TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred hhheeccCCcccceeEEEEEccccc-cHHHHh------hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeE
Confidence 9999877665 999999974 888776 234899999999999999999999 789999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
++.++.++|+|||++....... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... .
T Consensus 177 l~~~~~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~ 247 (371)
T 4exu_A 177 VNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD----Y 247 (371)
T ss_dssp ECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS----H
T ss_pred ECCCCCEEEEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----h
Confidence 9999999999999997654321 22467999999999887 678999999999999999999999996522 1
Q ss_pred chHHHHHHHHhhhCCCCcccc-------------------hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRAID-------------------SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....+.... ..+..... ..............+.+||.+||+.||.+|||++|+++
T Consensus 248 ~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 248 LDQLTQILKVT--GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHHHHHH--CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHHh--CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 11111111111 11000000 00000000112344899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=315.64 Aligned_cols=271 Identities=24% Similarity=0.287 Sum_probs=183.4
Q ss_pred hcCccc-ccccccCcceeEEEEEec-CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFAS-LEKIGSGGCGDVYKAELP-GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~-~~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.+.|++ .++||+|+||+||+|++. ..+++.||+|.+.. ......+.+|+.+++.++||||+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----------------~~~~~~~~~E~~~l~~l~hpniv 81 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG-----------------TGISMSACREIALLRELKHPNVI 81 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSS-----------------SSCCHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECC-----------------CCCCHHHHHHHHHHHhcCCCCee
Confidence 345777 458999999999999753 24678899998731 12234578899999999999999
Q ss_pred cccccee--cCCceEEEEEcccCCCHHHHHhhhcc-----cccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 111 PLLAHMV--RPDSHLLVYDFMKNGSLQAVLYDVSK-----GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 111 ~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
++++++. .....++||||+.+ +|.+++..... ....+++..+..++.|++.||.||| ++||+||||||+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~ 157 (405)
T 3rgf_A 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPA 157 (405)
T ss_dssp CCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGG
T ss_pred eEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHH
Confidence 9999994 46789999999975 88888753221 1224889999999999999999999 889999999999
Q ss_pred ceEe----cCCCCceeeccccceecCCCCcc-ccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 040480 184 NVLI----DDDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 184 nil~----~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
||++ +.++.++|+|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 158 NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 158 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp GEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999 67789999999999876543211 122235789999999998874 48999999999999999999999996
Q ss_pred CcccCC-----CcchHHHHHHHHhhhCCCCcccchhhcCCc----------------hH--------HHHHHHHHHHhhh
Q 040480 258 DFFSHT-----GEMDMVRWMRNVMASENPNRAIDSKLLGNG----------------YE--------EQMLLVLKLACFC 308 (325)
Q Consensus 258 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~--------~~~~~l~~li~~~ 308 (325)
...... ...+....+......+....+......... .. .....+.+||.+|
T Consensus 238 ~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~ 317 (405)
T 3rgf_A 238 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317 (405)
T ss_dssp CCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHH
T ss_pred CccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHH
Confidence 532211 111222222222211111111100000000 00 0023488999999
Q ss_pred cCCCCCCCCChhhhhc
Q 040480 309 TLADPDERPNSKDVRC 324 (325)
Q Consensus 309 l~~dP~~Rps~~ell~ 324 (325)
|+.||.+|||++|+|+
T Consensus 318 L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 318 LTMDPIKRITSEQAMQ 333 (405)
T ss_dssp SCSSGGGSCCHHHHHT
T ss_pred ccCCcccCCCHHHHhc
Confidence 9999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=313.09 Aligned_cols=260 Identities=14% Similarity=0.149 Sum_probs=195.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCC-------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGS-------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI 104 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 104 (325)
..++|++.+.||+|+||.||+|++... .++.||+|.+.. ...+.+|+.+++.+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~--------------------~~~~~~E~~~l~~l 99 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK--------------------DGRLFNEQNFFQRA 99 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEET--------------------TSTHHHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecc--------------------cchHHHHHHHHHHh
Confidence 358999999999999999999975432 478999999821 13577889999999
Q ss_pred CCCCccc---------------cccceec-CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHH
Q 040480 105 RHRNILP---------------LLAHMVR-PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLH 168 (325)
Q Consensus 105 ~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh 168 (325)
+||||++ +++++.. ....++||||+ +++|.+++... ....+++..+..++.|++.||.|||
T Consensus 100 ~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH 176 (352)
T 2jii_A 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLH 176 (352)
T ss_dssp CCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999888 4445544 67789999999 88999999542 2367999999999999999999999
Q ss_pred hcCCCCeEecCCCCCceEecCCC--CceeeccccceecCCCCccc-----cceeecCCcccccccccccCCCCCccchhh
Q 040480 169 MHHSARVIHRDIKPANVLIDDDM--EARISGFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTLTISEKCDIYS 241 (325)
Q Consensus 169 ~~~~~~ivH~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~~Dvws 241 (325)
++|++|+||||+||+++.++ .++|+|||++.......... ......||+.|+|||++.+..++.++||||
T Consensus 177 ---~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 253 (352)
T 2jii_A 177 ---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQS 253 (352)
T ss_dssp ---HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred ---hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHH
Confidence 78999999999999999988 89999999997664322111 112247899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhh
Q 040480 242 FGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321 (325)
Q Consensus 242 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (325)
||+++|+|++|..||..... ............. ....... ...... ...+..+.+|+.+||+.||++|||+++
T Consensus 254 lG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~-~~~~~~~-~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 254 LGYCMLKWLYGFLPWTNCLP--NTEDIMKQKQKFV-DKPGPFV-GPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAM 326 (352)
T ss_dssp HHHHHHHHHHSCCTTGGGTT--CHHHHHHHHHHHH-HSCCCEE-CTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred HHHHHHHHHhCCCCcccCCc--CHHHHHHHHHhcc-CChhhhh-hhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence 99999999999999976431 1122222222221 1211111 000000 011223899999999999999999999
Q ss_pred hhc
Q 040480 322 VRC 324 (325)
Q Consensus 322 ll~ 324 (325)
+++
T Consensus 327 l~~ 329 (352)
T 2jii_A 327 LRN 329 (352)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=302.63 Aligned_cols=246 Identities=27% Similarity=0.374 Sum_probs=190.2
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|++ +++.||+|.+.. ....+.+.+|+.+++.++||||++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~-----------------~~~~~~~~~E~~~l~~l~h~~iv~ 78 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKN-----------------DATAQAFLAEASVMTQLRHSNLVQ 78 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCC-----------------CC--HHHHHTHHHHTTCCCTTBCC
T ss_pred ChhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecc-----------------hhHHHHHHHHHHHHHhCCCCCEee
Confidence 458999999999999999999975 588999998731 124567889999999999999999
Q ss_pred cccceecC-CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 112 LLAHMVRP-DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 112 ~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
+++++... +..++||||+++++|.+++... ....++...+..++.|++.||.+|| ++|++|+||+|+||+++.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 153 (278)
T 1byg_A 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSED 153 (278)
T ss_dssp EEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred EEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCC
Confidence 99986544 5789999999999999999542 2234788889999999999999999 7899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
+.++|+|||.+........ ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .+..
T Consensus 154 ~~~~l~Dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~ 224 (278)
T 1byg_A 154 NVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVV 224 (278)
T ss_dssp SCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHH
T ss_pred CcEEEeecccccccccccc-----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 9999999999875543221 1356788999999998889999999999999999998 9999975321 2222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. .+....... .+ ...+..+.+++.+||+.||.+|||+.++++
T Consensus 225 ~---~~~~~~~~~--~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 225 P---RVEKGYKMD--AP--------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp H---HHTTTCCCC--CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H---HHhcCCCCC--Cc--------ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 2 111111111 01 111233899999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=305.49 Aligned_cols=262 Identities=20% Similarity=0.304 Sum_probs=201.4
Q ss_pred hhcCcccccccccCcceeEEEEEe---cCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAEL---PGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
..++|++.+.||+|+||.||+|++ +..+++.||+|.+.. ........+.+|+.+++.++|||
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~ 103 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---------------STEEHLRDFEREIEILKSLQHDN 103 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS---------------CCSHHHHHHHHHHHHHHTCCCTT
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc---------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence 567899999999999999999975 345789999999832 12344567899999999999999
Q ss_pred ccccccceecCC--ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 109 ILPLLAHMVRPD--SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 109 i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
|+++++++...+ ..++||||+++++|.+++.. ....++...+..++.|++.||.+|| ++|++|+||||+||+
T Consensus 104 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIl 177 (326)
T 2w1i_A 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 177 (326)
T ss_dssp BCCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred eeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEE
Confidence 999999886654 68999999999999999954 2345889999999999999999999 789999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcccc-ceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcc-----
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQID-TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF----- 260 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~----- 260 (325)
++.++.++|+|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+....
T Consensus 178 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~ 257 (326)
T 2w1i_A 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 257 (326)
T ss_dssp EEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHH
T ss_pred EcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 99999999999999987654432211 122356778999999998889999999999999999999999986421
Q ss_pred ---cCCC-cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 261 ---SHTG-EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 261 ---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... .................. .+ ...+..+.+|+.+||+.||++|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--------~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 258 MIGNDKQGQMIVFHLIELLKNNGRLP--RP--------DGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCCCC--CC--------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhccccchhhhHHHHHHHhhcCCCCC--CC--------CcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 001111111111111111 11 112234899999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=309.44 Aligned_cols=269 Identities=22% Similarity=0.327 Sum_probs=197.7
Q ss_pred HhhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc---CC
Q 040480 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI---RH 106 (325)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h 106 (325)
....++|++.+.||+|+||.||+|.+...+++.||+|.+...... ......+.+|+.+++.+ .|
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~h 73 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-------------EGMPLSTIREVAVLRHLETFEH 73 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-------------TSCBCTHHHHHHHHHHHHHTCC
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-------------ccCCchhhHHHHHHHhhhccCC
Confidence 345689999999999999999999764567899999998533211 11112344555555555 89
Q ss_pred CCcccccccee-----cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040480 107 RNILPLLAHMV-----RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIK 181 (325)
Q Consensus 107 ~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~ 181 (325)
|||+++++++. .....++||||+. ++|.+++... ....++...+..++.|++.||.||| ++|++|+||+
T Consensus 74 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlk 147 (326)
T 1blx_A 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLK 147 (326)
T ss_dssp TTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred CCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCC
Confidence 99999999887 5567899999997 5999998542 2345889999999999999999999 7899999999
Q ss_pred CCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 182 PANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
|+||+++.++.++|+|||.+........ .....|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 148 p~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~- 223 (326)
T 1blx_A 148 PQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS- 223 (326)
T ss_dssp GGGEEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-
T ss_pred HHHeEEcCCCCEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-
Confidence 9999999999999999999976543221 223578999999999999899999999999999999999999997532
Q ss_pred CCCcchHHHHHHHHhhhCCCCccc-----ch--------hhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAI-----DS--------KLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+...........+. +. ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus 224 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 224 ---DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp ---HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112221111111110000000 00 0000001122344889999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=300.62 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=201.4
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.-.++|++.+.||+|+||.||+|+ +..+++.||+|.+... .........+.+|+.++++++||||+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~-~~~~~~~valK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~ 84 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCK-DRITQQEYAVKVINKA-------------SAKNKDTSTILREVELLKKLDHPNIM 84 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEGG-------------GBSSSCHHHHHHHHHHHHTCCCTTBC
T ss_pred HHhhcceeeEEEcCCCCEEEEEEE-EcCCCcEEEEEEeccc-------------ccchHHHHHHHHHHHHHHhccCCCcc
Confidence 345799999999999999999996 5567889999998321 12234567788999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++|+||+.+++|.+.+.. ...++...+..++.|++.||.+|| ++|++|+||+|+||+++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~ 157 (287)
T 2wei_A 85 KLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESK 157 (287)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCS
T ss_pred EEEEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecC
Confidence 999999999999999999999999998843 345899999999999999999999 7899999999999999754
Q ss_pred ---CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 191 ---MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 191 ---~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+.++|+|||++.......... ...|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... ..
T Consensus 158 ~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~- 228 (287)
T 2wei_A 158 EKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EY- 228 (287)
T ss_dssp STTCCEEECSTTGGGTBCCCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HH-
T ss_pred CCcccEEEeccCcceeecCCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC----HH-
Confidence 469999999997665433221 1357889999999876 48999999999999999999999996522 11
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+......... + . ....+..+.+++.+||+.||++|||+.++++
T Consensus 229 --~~~~~~~~~~~~~~~-~--~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 229 --DILKRVETGKYAFDL-P--Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --HHHHHHHHCCCCCCS-G--G----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHcCCCCCCc-h--h----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 222222222221110 0 0 0112233899999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=314.37 Aligned_cols=260 Identities=21% Similarity=0.311 Sum_probs=191.4
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
...+|++.+.||+|+||+||+|++. .+..+|+|++.... ....+|+.+++.++||||++
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~-------------------~~~~~E~~il~~l~h~niv~ 96 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDK-------------------RFKNRELQIMRIVKHPNVVD 96 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCT-------------------TSCCHHHHHHHTCCCTTBCC
T ss_pred ccceEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCc-------------------chHHHHHHHHHhCCCCCcce
Confidence 4568999999999999999999753 33458999873211 11236889999999999999
Q ss_pred cccceecCCc------eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 112 LLAHMVRPDS------HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
+++++...+. .++||||+++ ++.+.+.........++...+..++.|++.||.||| ++||+||||||+||
T Consensus 97 l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Ni 172 (394)
T 4e7w_A 97 LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNL 172 (394)
T ss_dssp EEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred EEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHE
Confidence 9999855433 7899999987 555555444445667999999999999999999999 88999999999999
Q ss_pred Eec-CCCCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 186 LID-DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 186 l~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
+++ .++.+||+|||++........... ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 173 ll~~~~~~~kL~DFG~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-- 247 (394)
T 4e7w_A 173 LLDPPSGVLKLIDFGSAKILIAGEPNVS---YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-- 247 (394)
T ss_dssp EEETTTTEEEECCCTTCEECCTTCCCCS---SCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EEcCCCCcEEEeeCCCcccccCCCCCcc---cccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 999 789999999999987654433222 4789999999998765 589999999999999999999999975321
Q ss_pred CcchHHHHHHHHhhhCC-----------CCcccchhhcCCch-----HHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASEN-----------PNRAIDSKLLGNGY-----EEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+..... ....+. .....+ ....... ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 248 -~~~l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 248 -IDQLVEIIK-VLGTPSREQIKTMNPNYMEHKFP-QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp -HHHHHHHHH-HHCCCCHHHHHHHCGGGSSSCCC-CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHH-HhCCCCHHHHHhhChhhhhhccc-cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 111111111 110000 000000 0000000 012334899999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=309.43 Aligned_cols=275 Identities=19% Similarity=0.252 Sum_probs=201.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHH--HHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELI--DAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|++.+.||+|+||.||+|++ +++.||+|.+............ .............+.+|+.+++.++||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 47999999999999999999975 8899999998421100000000 000000001227889999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhh----hcccccccChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCce
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYD----VSKGRRELEWLSRHKIALAVASGLEYLHMHHS-ARVIHRDIKPANV 185 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~~ivH~dl~~~ni 185 (325)
++++++...+..++||||+++++|.+++.. .......++...+..++.|++.||.||| + +|++|+||+|+||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNI 183 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhE
Confidence 999999999999999999999999988321 0112567999999999999999999999 6 7999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCC-ccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISE-KCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~-~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
+++.++.++|+|||.+....... .....|+..|+|||++.+. .++. ++||||||+++|+|++|..||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred EEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence 99999999999999998765431 2224789999999999887 5655 999999999999999999999753221
Q ss_pred CcchHHHHHHHHhhhCCCCcccchh---------hcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSK---------LLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... ...+....... +.... .........+..+.+|+.+||+.||.+|||++|+++
T Consensus 259 --~~~---~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --VEL---FNNIRTKNIEY-PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHH---HHHHTSCCCCC-CCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHH---HHHHhccCcCC-ccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 22222221111 10000 000000222334899999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=304.54 Aligned_cols=260 Identities=17% Similarity=0.249 Sum_probs=197.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC----
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN---- 108 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~---- 108 (325)
.++|++.+.||+|+||+||+|.....++..||+|.+.. .......+.+|+.+++.++|++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----------------~~~~~~~~~~E~~~l~~l~~~~~~~~ 81 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----------------VGKYREAARLEINVLKKIKEKDKENK 81 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHHHCTTSC
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----------------cccchhHHHHHHHHHHHHhhcCCCCc
Confidence 47899999999999999999975444557899999831 1233456778888888887655
Q ss_pred --ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 109 --ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 109 --i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++.+++++...+..++||||+ +++|.+.+.. .....++...+..++.|++.||.||| ++||+|+||||+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIl 155 (355)
T 2eu9_A 82 FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENIL 155 (355)
T ss_dssp SCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEE
T ss_pred eeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEE
Confidence 888999999999999999999 5578777744 23346899999999999999999999 889999999999999
Q ss_pred e-------------------cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHH
Q 040480 187 I-------------------DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLA 247 (325)
Q Consensus 187 ~-------------------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~ 247 (325)
+ +.++.++|+|||++....... ....||+.|+|||++.+..++.++||||||+++|
T Consensus 156 l~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 230 (355)
T 2eu9_A 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 230 (355)
T ss_dssp ESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred EecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHH
Confidence 9 567899999999998644322 2247899999999999989999999999999999
Q ss_pred HHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCccc----------------c---------------hhhcCCchHH
Q 040480 248 VLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAI----------------D---------------SKLLGNGYEE 296 (325)
Q Consensus 248 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~---------------~~~~~~~~~~ 296 (325)
+|++|..||.... ..+....+..... ..+.... + ..........
T Consensus 231 el~~g~~pf~~~~----~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (355)
T 2eu9_A 231 EYYRGFTLFQTHE----NREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305 (355)
T ss_dssp HHHHSSCSCCCSS----HHHHHHHHHHHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSH
T ss_pred HHHhCCCCCCCCC----HHHHHHHHHHHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccch
Confidence 9999999997532 1222222222211 1100000 0 0000011123
Q ss_pred HHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 297 QMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 297 ~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+...+.+|+.+||+.||++|||++|+++
T Consensus 306 ~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 306 EHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 3456899999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=329.16 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=199.1
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|.+. .+..||||++... ....+.+.+|+.++++++||||+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~----------------~~~~~~~~~E~~~l~~l~hpniv 325 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPG----------------TMSPEAFLQEAQVMKKLRHEKLV 325 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTT----------------SSCHHHHHHHHHHHHHCCCTTBC
T ss_pred cchhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCC----------------CCCHHHHHHHHHHHHhCCCCCEe
Confidence 35578999999999999999999764 4567999998321 12345789999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.+ +..++||||+.+++|.+++... ....++...+..++.|++.||.||| +++|+|+||||+|||++.+
T Consensus 326 ~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~ 399 (535)
T 2h8h_A 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGEN 399 (535)
T ss_dssp CEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred eEEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCC
Confidence 99998866 6789999999999999999532 2245888999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
+.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.... ..++.
T Consensus 400 ~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~----~~~~~ 474 (535)
T 2h8h_A 400 LVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVL 474 (535)
T ss_dssp GCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC----HHHHH
T ss_pred CcEEEcccccceecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHH
Confidence 99999999999765432111 1112346778999999998899999999999999999999 999996532 12222
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+........ + ..++..+.+||.+||+.||++|||+++|++
T Consensus 475 ---~~i~~~~~~~~--~--------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 475 ---DQVERGYRMPC--P--------PECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp ---HHHHTTCCCCC--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHcCCCCCC--C--------CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22222221111 1 112233899999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.02 Aligned_cols=257 Identities=11% Similarity=0.020 Sum_probs=177.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHH---HHHhccCCCCc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI---ITASQIRHRNI 109 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i 109 (325)
...|.+.+.||+|+||.||+|+ +..+++.||+|++...... .......+.+|+ .+++. +||||
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~E~~~~~~l~~-~hp~i 126 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVR-DVERLEDFALKVFTMGAEN------------SRSELERLHEATFAAARLLG-ESPEE 126 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEECCSTT------------HHHHHHHHHHHHHHHHHHHC------
T ss_pred ceeeeeeeeccCCCCEEEEEEE-ECCCCceeEEEEEEecccc------------cccHHHHHHHHHHHHHHhcc-cChhh
Confidence 3459999999999999999996 5567899999998543211 112344566774 45555 69998
Q ss_pred ccccc-------ceecC-----------------CceEEEEEcccCCCHHHHHhhhcccccccChhhH------HHHHHH
Q 040480 110 LPLLA-------HMVRP-----------------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR------HKIALA 159 (325)
Q Consensus 110 ~~~~~-------~~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~------~~i~~~ 159 (325)
++++. ++... ...|+||||++ ++|.+++... +..++...+ ..++.|
T Consensus 127 v~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~q 202 (371)
T 3q60_A 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQ 202 (371)
T ss_dssp -----CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHH
T ss_pred hhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHH
Confidence 88553 33222 33799999998 7999999653 223455555 678899
Q ss_pred HHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCccccccccccc--CCCCCcc
Q 040480 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT--LTISEKC 237 (325)
Q Consensus 160 l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~--~~~~~~~ 237 (325)
++.||+||| ++||+||||||+||+++.++.+||+|||++........ ...+|+.|+|||++.+ ..++.++
T Consensus 203 i~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~ 274 (371)
T 3q60_A 203 LIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHAL 274 (371)
T ss_dssp HHHHHHHHH---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHH
T ss_pred HHHHHHHHH---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccc
Confidence 999999999 88999999999999999999999999999987643221 2356799999999987 6789999
Q ss_pred chhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC
Q 040480 238 DIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317 (325)
Q Consensus 238 DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (325)
||||||+++|+|++|+.||........... . .............. ......+..+.+||.+||+.||++||
T Consensus 275 DiwSlG~il~elltg~~Pf~~~~~~~~~~~-~----~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rp 345 (371)
T 3q60_A 275 NAWQLGLSIYRVWCLFLPFGLVTPGIKGSW-K----RPSLRVPGTDSLAF----GSCTPLPDFVKTLIGRFLNFDRRRRL 345 (371)
T ss_dssp HHHHHHHHHHHHHHSSCSTTBCCTTCTTCC-C----BCCTTSCCCCSCCC----TTSSCCCHHHHHHHHHHTCSSTTTCC
T ss_pred cHHHHHHHHHHHHhCCCCCCCcCcccccch-h----hhhhhhccccccch----hhccCCCHHHHHHHHHHcCCChhhCC
Confidence 999999999999999999976432111100 0 00000000000000 00012233489999999999999999
Q ss_pred Chhhhhc
Q 040480 318 NSKDVRC 324 (325)
Q Consensus 318 s~~ell~ 324 (325)
|+.++++
T Consensus 346 t~~e~l~ 352 (371)
T 3q60_A 346 LPLEAME 352 (371)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=306.08 Aligned_cols=200 Identities=21% Similarity=0.310 Sum_probs=167.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CC----
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HR---- 107 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~---- 107 (325)
.++|++.+.||+|+||+||+|. +..+++.||||++.. .......+..|+.+++.+. |+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~~~ 115 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAY-DRVEQEWVAIKIIKN----------------KKAFLNQAQIEVRLLELMNKHDTEMK 115 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEE-ETTTTEEEEEEEECS----------------SHHHHHHHHHHHHHHHHHHHCSSGGG
T ss_pred eeeEEEEEEEeecCCEEEEEEE-EcCCCcEEEEEEEec----------------cHHHHHHHHHHHHHHHHHHhcccccc
Confidence 4789999999999999999995 567789999999831 1123445667777777764 44
Q ss_pred -CccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 108 -NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 108 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
+|+++++.+...+..++||||+.+ +|.+++... ....+++..+..++.|++.||.|||.+ ..||+||||||+||+
T Consensus 116 ~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIl 191 (382)
T 2vx3_A 116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENIL 191 (382)
T ss_dssp GGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEE
T ss_pred eeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEE
Confidence 489999999999999999999965 999998542 224588999999999999999999943 469999999999999
Q ss_pred ec--CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 187 ID--DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 187 ~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
++ .++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 192 l~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 192 LCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp ESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 95 46789999999998765322 124789999999999999999999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=306.02 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=180.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 110 (325)
...+|++.+.||+|+||.||+|+ +..+++.||+|.+... .......+.+|+.+++++. ||||+
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~---------------~~~~~~~~~~e~~~l~~l~~h~~iv 89 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQ-DVGSGREYALKRLLSN---------------EEEKNRAIIQEVCFMKKLSGHPNIV 89 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEE-ETTTCCEEEEEEEEES---------------SHHHHHHHHHHHHHHHHHTTSTTBC
T ss_pred cCceEEEEEEEccCCceEEEEEE-ECCCCcEEEEEEecCC---------------chHHHHHHHHHHHHHHHhccCCChh
Confidence 34699999999999999999996 5567889999987321 2234556788999999996 99999
Q ss_pred cccccee--------cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCC
Q 040480 111 PLLAHMV--------RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR--VIHRDI 180 (325)
Q Consensus 111 ~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~--ivH~dl 180 (325)
++++++. .....++++||+. ++|.+++.... ....+++..+..++.|++.||.||| ++| ++|+||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Di 164 (337)
T 3ll6_A 90 QFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDL 164 (337)
T ss_dssp CEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCC
T ss_pred hccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccC
Confidence 9999883 3445799999996 59999885432 3446999999999999999999999 778 999999
Q ss_pred CCCceEecCCCCceeeccccceecCCCCccc----------cceeecCCccccccccc---ccCCCCCccchhhHHHHHH
Q 040480 181 KPANVLIDDDMEARISGFDLAILMPDGLTQI----------DTMYVVGTPRYIAPEYH---QTLTISEKCDIYSFGVLLA 247 (325)
Q Consensus 181 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~g~~~~~aPE~~---~~~~~~~~~DvwslG~il~ 247 (325)
||+||+++.++.++|+|||++.......... ......||+.|+|||++ .+..++.++||||||+++|
T Consensus 165 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~ 244 (337)
T 3ll6_A 165 KVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244 (337)
T ss_dssp CGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHH
T ss_pred CcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHH
Confidence 9999999999999999999998765432211 11124689999999998 5667889999999999999
Q ss_pred HHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 248 VLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 248 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+|++|..||...... ......... ....... ..+.+|+.+||+.||.+|||+.|+++
T Consensus 245 el~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~------------~~~~~li~~~l~~~p~~Rps~~e~l~ 301 (337)
T 3ll6_A 245 LLCFRQHPFEDGAKL-------RIVNGKYSI-PPHDTQY------------TVFHSLIRAMLQVNPEERLSIAEVVH 301 (337)
T ss_dssp HHHHSSCCC-------------------CCC-CTTCCSS------------GGGHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCcchhHH-------HhhcCcccC-Ccccccc------------hHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999652211 111111111 1111111 11789999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=309.88 Aligned_cols=265 Identities=20% Similarity=0.247 Sum_probs=196.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC------
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR------ 105 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------ 105 (325)
..++|++.+.||+|+||.||+|+ +..+++.||+|.+.. .......+.+|+.+++.+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~~ 79 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAK-DMVNNTHVAMKIVRG----------------DKVYTEAAEDEIKLLQRVNDADNTK 79 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHHTCCSH
T ss_pred cCCeEEEEEeeeecCCeEEEEEE-ecCCCcEEEEEEecC----------------CccchhhhhHHHHHHHHhhcccccc
Confidence 45799999999999999999995 556789999999831 1123455677888888775
Q ss_pred -----CCCccccccceecCC----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC-Ce
Q 040480 106 -----HRNILPLLAHMVRPD----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA-RV 175 (325)
Q Consensus 106 -----h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~i 175 (325)
||||+++++++...+ ..++|||++ +++|.+++... ....++...+..++.|++.||.||| ++ ||
T Consensus 80 ~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~i 153 (373)
T 1q8y_A 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMH---RRCGI 153 (373)
T ss_dssp HHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCE
T ss_pred hhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHH---hcCCE
Confidence 889999999987654 689999999 78999999542 2345889999999999999999999 77 99
Q ss_pred EecCCCCCceEecC------CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHH
Q 040480 176 IHRDIKPANVLIDD------DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVL 249 (325)
Q Consensus 176 vH~dl~~~nil~~~------~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~l 249 (325)
+|+||||+||+++. .+.++|+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|
T Consensus 154 vH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 228 (373)
T 1q8y_A 154 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 228 (373)
T ss_dssp ECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHH
T ss_pred EecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHH
Confidence 99999999999953 3479999999998764322 124789999999999999999999999999999999
Q ss_pred HhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccc---------------------------h---hhcCCchHHHHH
Q 040480 250 VMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAID---------------------------S---KLLGNGYEEQML 299 (325)
Q Consensus 250 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~~ 299 (325)
++|..||.........................+.... . ............
T Consensus 229 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (373)
T 1q8y_A 229 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308 (373)
T ss_dssp HHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHH
T ss_pred HhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHH
Confidence 9999999764332221111111111111111000000 0 000112245667
Q ss_pred HHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 300 LVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 300 ~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+.+||.+||+.||.+|||++|+++
T Consensus 309 ~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 309 EISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHHHhccCccccCCHHHHhh
Confidence 7999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=303.09 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=199.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhc--cCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQ--IRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~ 110 (325)
.++|++.+.||+|+||.||+|++ +++.||+|.+.. .....+.+|.+++.. ++||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~------------------~~~~~~~~e~~~~~~~~l~h~ni~ 99 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSS------------------REERSWFREAEIYQTVMLRHENIL 99 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECG------------------GGHHHHHHHHHHHHHSCCCCTTBC
T ss_pred cccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCc------------------hhHHHHHHHHHHHHHhhcCCCcEE
Confidence 47899999999999999999975 588999999821 223456777788776 7899999
Q ss_pred ccccceecCC----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCC
Q 040480 111 PLLAHMVRPD----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH-----HSARVIHRDIK 181 (325)
Q Consensus 111 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-----~~~~ivH~dl~ 181 (325)
++++++.... ..++||||+++++|.+++.. ..+++..+..++.|++.||.|||.. ++++++|+|||
T Consensus 100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 174 (342)
T 1b6c_B 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174 (342)
T ss_dssp CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred EEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence 9999998776 78999999999999999943 3588999999999999999999932 13589999999
Q ss_pred CCceEecCCCCceeeccccceecCCCCccc--cceeecCCcccccccccccCC------CCCccchhhHHHHHHHHHhC-
Q 040480 182 PANVLIDDDMEARISGFDLAILMPDGLTQI--DTMYVVGTPRYIAPEYHQTLT------ISEKCDIYSFGVLLAVLVMG- 252 (325)
Q Consensus 182 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~------~~~~~DvwslG~il~~ll~g- 252 (325)
|+||+++.++.++|+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~ 254 (342)
T 1b6c_B 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 254 (342)
T ss_dssp GGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred HHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence 999999999999999999998765443221 122347899999999987752 34689999999999999999
Q ss_pred ---------CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 253 ---------KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 253 ---------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
..||....... .....+......... ....+... ...+....+.+|+.+||+.||++|||+.+++
T Consensus 255 ~~~~~~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 255 SIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKL-RPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp CBTTBCCCCCCTTTTTSCSS--CCHHHHHHHHTTSCC-CCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CcCCcccccccCccccCcCc--ccHHHHHHHHHHHHh-CCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 77886543322 122222232222211 11111111 1234555699999999999999999999997
Q ss_pred c
Q 040480 324 C 324 (325)
Q Consensus 324 ~ 324 (325)
+
T Consensus 329 ~ 329 (342)
T 1b6c_B 329 K 329 (342)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=308.08 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=195.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|.+... ........+.+|+.+++.++||||+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 74 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSAT-HKPTGEIVAIKKIEPF--------------DKPLFALRTLREIKILKHFKHENIITI 74 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECCC--------------SSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEE-ECCCCcEEEEEeeccc--------------ccchHHHHHHHHHHHHHhCcCCCcCCe
Confidence 5789999999999999999996 5567899999998321 112334567889999999999999999
Q ss_pred ccceecC-----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 113 LAHMVRP-----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 113 ~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
++++... ...++||||+.+ +|.+++.. ..++...+..++.|++.||.||| ++|++|+||||+||++
T Consensus 75 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~ 145 (353)
T 2b9h_A 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLI 145 (353)
T ss_dssp EEECCCSCSTTCCCEEEEECCCSE-EHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred eeeecccccCccceEEEEEeccCc-cHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEE
Confidence 9987654 678999999975 89998833 46899999999999999999999 7899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccc--------cceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQI--------DTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~--------~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+.++.++|+|||++.......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999998765332211 1122468999999998754 6789999999999999999999999975
Q ss_pred cccCCCcchHHHHHHHHhhhCCCCccc------------------chhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh
Q 040480 259 FFSHTGEMDMVRWMRNVMASENPNRAI------------------DSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (325)
... ......+............. +...........+..+.+|+.+||+.||++|||++
T Consensus 226 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (353)
T 2b9h_A 226 RDY----RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301 (353)
T ss_dssp SSH----HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCc----HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence 321 11111111111111000000 00000000012234488999999999999999999
Q ss_pred hhhc
Q 040480 321 DVRC 324 (325)
Q Consensus 321 ell~ 324 (325)
|+++
T Consensus 302 ell~ 305 (353)
T 2b9h_A 302 EALE 305 (353)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=308.93 Aligned_cols=274 Identities=20% Similarity=0.216 Sum_probs=193.3
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|... ++..||+|++.......... ...........+.+|+.++++++||||+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTV----NILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCE----EGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HhccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchh----hhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 46789999999999999999999643 48899999985433211100 0001123357889999999999999999
Q ss_pred ccccceec-----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 040480 111 PLLAHMVR-----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185 (325)
Q Consensus 111 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ni 185 (325)
++++++.. ....++||||+.+ +|.+.+. .....++...+..++.|++.||.||| ++|++|+||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCCC-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence 99999843 3457999999975 8888874 23456899999999999999999999 78999999999999
Q ss_pred EecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+++.++.++|+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---- 238 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---- 238 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----
T ss_pred EEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC----
Confidence 9999999999999999754433222 22478899999998877 678999999999999999999999997532
Q ss_pred cchHHHHHHHHhhhCC------------------CCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASEN------------------PNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+....+........ .....+..............+.+|+.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111111111110000 00000000000001112334889999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=300.51 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=188.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|.+... .......+.+|+.+++.++||||+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~ 73 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAV-DNDCDKRVAIKKIVLT---------------DPQSVKHALREIKIIRRLDHDNIVKV 73 (320)
T ss_dssp TTTEEEEEECC-----CEEEEE-ETTTTEEEEEEEEECC---------------SHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCceeEEEEeccCCCeEEEEEE-ECCCCeEEEEEEEecC---------------ChHHHHHHHHHHHHHHhcCCCCeeEE
Confidence 5789999999999999999995 5567899999988322 22345678899999999999999999
Q ss_pred cccee--------------cCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 113 LAHMV--------------RPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 113 ~~~~~--------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
++++. .....++||||+.+ +|.+++. ...++...+..++.|++.||.||| ++|++|+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 144 (320)
T 2i6l_A 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLLEEHARLFMYQLLRGLKYIH---SANVLHR 144 (320)
T ss_dssp EEEECTTSCBCCC----CCSCSEEEEEEECCSE-EHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred EEeccccccccccccccccccCceeEEeeccCC-CHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 98763 34678999999975 9999982 356889999999999999999999 8899999
Q ss_pred CCCCCceEec-CCCCceeeccccceecCCCCcc-ccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCC
Q 040480 179 DIKPANVLID-DDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFP 255 (325)
Q Consensus 179 dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p 255 (325)
||||+||+++ +++.++|+|||.+......... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..|
T Consensus 145 dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (320)
T 2i6l_A 145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence 9999999997 5678999999999866432111 11222467889999998765 6789999999999999999999999
Q ss_pred CCCcccCCCcchHHHHHHHHhhhCCCCcccc-------------hhh------cCCchHHHHHHHHHHHhhhcCCCCCCC
Q 040480 256 FDDFFSHTGEMDMVRWMRNVMASENPNRAID-------------SKL------LGNGYEEQMLLVLKLACFCTLADPDER 316 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~------~~~~~~~~~~~l~~li~~~l~~dP~~R 316 (325)
|..... .... ..+........... ... ........+..+.+|+.+||+.||++|
T Consensus 225 f~~~~~----~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 225 FAGAHE----LEQM---QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp SCCSSH----HHHH---HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred CCCCCH----HHHH---HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcccc
Confidence 975321 1111 11111110000000 000 000001123448999999999999999
Q ss_pred CChhhhhc
Q 040480 317 PNSKDVRC 324 (325)
Q Consensus 317 ps~~ell~ 324 (325)
||++++++
T Consensus 298 pt~~ell~ 305 (320)
T 2i6l_A 298 LTAEEALS 305 (320)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhC
Confidence 99999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=305.00 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=169.6
Q ss_pred hhcCccccc-ccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 32 KEDCFASLE-KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 32 ~~~~y~~~~-~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
-.++|++.+ .||+|+||+||+|. +..+++.||+|++... .....+....++.+.||||+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~-------------------~~~~~e~~~~~~~~~h~~i~ 85 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECF-HRRTGQKCALKLLYDS-------------------PKARQEVDHHWQASGGPHIV 85 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEESS-------------------HHHHHHHHHHHHHTTSTTBC
T ss_pred ccceeEecceeeeeCCCeEEEEEE-ECCCCCEEEEEEecCc-------------------HHHHHHHHHHHHhcCCCChH
Confidence 357899965 69999999999995 5677899999998310 11112222335566899999
Q ss_pred ccccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 111 PLLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 111 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++++.. ....++||||+++++|.+++.. .....+++..+..++.|++.||.||| ++|++|+||||+||+
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIl 160 (336)
T 3fhr_A 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLL 160 (336)
T ss_dssp CEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred HHHHHHhhccCCCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 99999876 4458999999999999999954 23346999999999999999999999 889999999999999
Q ss_pred ecC---CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 187 IDD---DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 187 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
++. ++.++|+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 161 l~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (336)
T 3fhr_A 161 YTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA 236 (336)
T ss_dssp ESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred EEecCCCceEEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence 985 45599999999986654322 12467999999999988889999999999999999999999996533211
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........... .... .+... ....+..+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~---~~~~---~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 237 ISPGMKRRIRL---GQYG---FPNPE----WSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----------------C---CCTTT----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhhHHHhhhc---cccc---cCchh----hccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111110 0000 00000 0112233899999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=301.26 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=191.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--CCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR--HRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i 109 (325)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ........+.+|+.+++.+. ||||
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~~~~~~i 90 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEE-------------ADNQTLDSYRNEIAYLNKLQQHSDKI 90 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSS-------------CCHHHHHHHHHHHHHHHHHGGGCTTB
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEecccc-------------ccccchHHHHHHHHHHHhccccCCce
Confidence 5578999999999999999999643 58889999984321 12234567889999999997 5999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++...+..++||| +.+++|.+++.. ...++...+..++.|++.||.||| ++|++|+||||+||++++
T Consensus 91 v~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~ 162 (313)
T 3cek_A 91 IRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD 162 (313)
T ss_dssp CCEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET
T ss_pred EEEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC
Confidence 999999999999999999 557799999943 356888999999999999999999 789999999999999965
Q ss_pred CCCceeeccccceecCCCCccccceeecCCccccccccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-----------LTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----------~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+.++|+|||++................|++.|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 163 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 163 -GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp -TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 7899999999987654433222233578999999999875 4678899999999999999999999965
Q ss_pred cccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 259 FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
... .. ............. ..+. . .+..+.+++.+||+.||.+|||+.++++
T Consensus 242 ~~~-----~~-~~~~~~~~~~~~~-~~~~-----~---~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 242 IIN-----QI-SKLHAIIDPNHEI-EFPD-----I---PEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CCS-----HH-HHHHHHHCTTSCC-CCCC-----C---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH-----HH-HHHHHHHhccccc-CCcc-----c---chHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 321 11 1122222111110 1110 0 0123889999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=328.63 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=191.6
Q ss_pred cccccCcceeEEEEEecC-CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPG-SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 118 (325)
+.||+|+||.||+|.+.. .+++.||||++.. ..........+.+|+.++++++||||+++++++.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~-------------~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~- 440 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-------------EANDPALKDELLAEANVMQQLDNPYIVRMIGICE- 440 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECG-------------GGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecc-------------ccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 479999999999996532 3568899999832 1222344678999999999999999999999886
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
.+..++||||+.+++|.+++. ....+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+||
T Consensus 441 ~~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DF 513 (635)
T 4fl3_A 441 AESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDF 513 (635)
T ss_dssp SSSEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCT
T ss_pred cCCEEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEc
Confidence 456899999999999999993 3456899999999999999999999 789999999999999999999999999
Q ss_pred ccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHh
Q 040480 199 DLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVM 276 (325)
Q Consensus 199 g~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 276 (325)
|++......... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||..... ..+. ..+.
T Consensus 514 Gla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~---~~i~ 586 (635)
T 4fl3_A 514 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVT---AMLE 586 (635)
T ss_dssp THHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHH---HHHH
T ss_pred CCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHH---HHHH
Confidence 999876543321 11222356788999999999899999999999999999998 9999975322 2222 2222
Q ss_pred hhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.......+ ...+..+.+||.+||+.||++|||++++++
T Consensus 587 ~~~~~~~p----------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 587 KGERMGCP----------AGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp TTCCCCCC----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCCCC----------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 22221111 012234899999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=326.36 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=193.7
Q ss_pred Cccccc-ccccCcceeEEEEEecCC-CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 35 CFASLE-KIGSGGCGDVYKAELPGS-NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 35 ~y~~~~-~lg~G~~g~v~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
++.+.+ .||+|+||.||+|.+... ++..||||.+... ......+.+.+|+.++++++||||+++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--------------~~~~~~~~~~~E~~il~~l~hpniv~l 401 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--------------TEKADTEEMMREAQIMHQLDNPYIVRL 401 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC--------------CSSTTHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--------------CChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 444444 799999999999976433 4567999998321 122356788999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.. +..++||||+.+++|.+++.. ....+++..+..++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 402 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~ 474 (613)
T 2ozo_A 402 IGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHY 474 (613)
T ss_dssp EEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTE
T ss_pred EEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCc
Confidence 999876 569999999999999999843 3456899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 193 ARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||..... .++..
T Consensus 475 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~ 550 (613)
T 2ozo_A 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMA 550 (613)
T ss_dssp EEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----HHHHH
T ss_pred EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHH
Confidence 999999999865433221 11111245678999999998899999999999999999998 9999976322 22222
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+..+..... +. .++..+.+||.+||+.||++|||+.++++
T Consensus 551 ---~i~~~~~~~~--p~--------~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 551 ---FIEQGKRMEC--PP--------ECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ---HHHTTCCCCC--CT--------TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ---HHHcCCCCCC--CC--------cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2222222111 11 12233899999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.31 Aligned_cols=257 Identities=22% Similarity=0.293 Sum_probs=197.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC-CCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH-RNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~ 111 (325)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... ....+..|+.+++.+.| +++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~-~~~~~~~vAvK~~~~~~-----------------~~~~~~~E~~il~~L~~~~~i~~ 67 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKT-----------------KHPQLLYESKIYRILQGGTGIPN 67 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEE-ETTTCCEEEEEEEETTC-----------------SSCCHHHHHHHHHHTTTSTTCCC
T ss_pred CCcEEEEEEEeeCCCEEEEEEE-ECCCCcEEEEEEecccc-----------------ccHHHHHHHHHHHHhcCCCCCCe
Confidence 4789999999999999999996 55678999999873221 12246788999999987 56666
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---c
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---D 188 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~---~ 188 (325)
+..++...+..++||||+ +++|.+++.. ....+++..++.++.|++.||.||| ++||+|+||||+|||+ +
T Consensus 68 i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~ 140 (483)
T 3sv0_A 68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGR 140 (483)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGG
T ss_pred EEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCC
Confidence 666667778889999999 8899999953 2456999999999999999999999 7899999999999999 5
Q ss_pred CCCCceeeccccceecCCCCccc-----cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 189 DDMEARISGFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
.++.++|+|||++.......... ......||..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence 88999999999998765543221 1123578999999999999999999999999999999999999997643322
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............. .... .. ....+..+.+|+.+||+.||++||++.+|++
T Consensus 221 ~~~~~~~i~~~~~~-~~~~-----~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 221 KKQKYEKISEKKVA-TSIE-----AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHHHHHHH-SCHH-----HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhcccc-ccHH-----HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11112211111111 0000 00 0111234899999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=303.75 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=178.1
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHH-HHhccCCCCc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII-TASQIRHRNI 109 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i 109 (325)
...++|++.+.||+|+||.||+|. +..+++.||+|.+.... .......+..|+. +++.++||||
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~e~~~~~~~~~h~ni 83 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMV-HKPSGQIMAVKRIRSTV--------------DEKEQKQLLMDLDVVMRSSDCPYI 83 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEE-ETTTTEEEEEEEEECCC--------------CHHHHHHHHHHHHHHHSSCCCTTB
T ss_pred cCHHHhhehheeccCCCEEEEEEE-EcCCCCEEEEEEeeccc--------------CchHHHHHHHHHHHHHHcCCCCcE
Confidence 355899999999999999999995 55678999999984221 1122233444444 7778899999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhc-ccccccChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEe
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS-KGRRELEWLSRHKIALAVASGLEYLHMHHSA-RVIHRDIKPANVLI 187 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~ivH~dl~~~nil~ 187 (325)
+++++++...+..++||||+.+ +|.+++.... .....++...+..++.|++.||.||| +. |++|+||||+||++
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll 159 (327)
T 3aln_A 84 VQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILL 159 (327)
T ss_dssp CCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEE
T ss_pred eeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEE
Confidence 9999999999999999999986 8888875322 23567899999999999999999999 77 99999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCccccccccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYH----QTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~----~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
+.++.++|+|||++......... ....|++.|+|||++ .+..++.++||||||+++|+|++|..||......
T Consensus 160 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 235 (327)
T 3aln_A 160 DRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV- 235 (327)
T ss_dssp ETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----
T ss_pred cCCCCEEEccCCCceeccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-
Confidence 99999999999999766443222 224689999999998 4566899999999999999999999999753210
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
............+. .. .......+..+.+|+.+||+.||.+|||+.++++
T Consensus 236 -----~~~~~~~~~~~~~~--~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 236 -----FDQLTQVVKGDPPQ--LS----NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---------CCCCCSCCCC--CC----CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----HHHHHHHhcCCCCC--CC----CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 01111111111110 00 0000112233899999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=297.32 Aligned_cols=253 Identities=23% Similarity=0.420 Sum_probs=190.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|+ +..+++.||+|.+.. .......+.+|+.+++.++||||+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~~~ 67 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKIRH----------------TEEKLSTILSEVMLLASLNHQYVVRY 67 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEE----------------EHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccchhhheeccCCcEEEEEEE-EcCCCeEEEEEEEec----------------cHHHHHHHHHHHHHHHhcCchHHHHH
Confidence 4789999999999999999995 556789999998831 12345678899999999999999999
Q ss_pred ccceec-------------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 040480 113 LAHMVR-------------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179 (325)
Q Consensus 113 ~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~d 179 (325)
++++.+ ....++||||+++++|.+++.. ....++...++.++.|++.||.||| ++|++|+|
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~d 141 (303)
T 1zy4_A 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRD 141 (303)
T ss_dssp EEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred HHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence 998754 3567999999999999999954 3445778889999999999999999 78999999
Q ss_pred CCCCceEecCCCCceeeccccceecCCCCc------------cccceeecCCcccccccccccC-CCCCccchhhHHHHH
Q 040480 180 IKPANVLIDDDMEARISGFDLAILMPDGLT------------QIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLL 246 (325)
Q Consensus 180 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il 246 (325)
|+|+||+++.++.++|+|||.+........ ........|+..|+|||.+.+. .++.++||||||+++
T Consensus 142 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221 (303)
T ss_dssp CCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHH
T ss_pred CCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHH
Confidence 999999999999999999999976543211 1112234688999999998865 689999999999999
Q ss_pred HHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 247 AVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 247 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|+|++ ||... .+............. ..++.. ....+..+.+++.+||+.||.+|||+.++++
T Consensus 222 ~~l~~---p~~~~------~~~~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 222 FEMIY---PFSTG------MERVNILKKLRSVSI---EFPPDF----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHS---CCSSH------HHHHHHHHHHHSTTC---CCCTTC----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHh---ccCCc------hhHHHHHHhcccccc---ccCccc----cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 99998 55321 111222222222111 111111 1122233889999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.16 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=193.3
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|.+.+.||+|+||.||+|. +..+++.||||.+... .........+.+|+.+++.++||||+++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 88 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAI-DKRSGEKVAIKKLSRP-------------FQSEIFAKRAYRELLLLKHMQHENVIGL 88 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEESST-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CceEEEeeeEecCCCeEEEEEE-ECCCCCEEEEEEeccc-------------ccchHHHHHHHHHHHHHHhcCCCCcccH
Confidence 4789999999999999999995 5678899999998321 1122345678899999999999999999
Q ss_pred ccceecCCc------eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRPDS------HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++..... .++||||+.+ +|.+++ ...++...+..++.|++.||.||| ++|++|+||||+||+
T Consensus 89 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl 158 (353)
T 3coi_A 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM------GLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLA 158 (353)
T ss_dssp SEEECSCSSGGGCCCCEEEEECCSE-EGGGTT------TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEE
T ss_pred hheEecccccccceeEEEEeccccC-CHHHHh------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEe
Confidence 999887654 4999999975 887766 124889999999999999999999 789999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
++.++.++|+|||.+...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 159 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---- 229 (353)
T 3coi_A 159 VNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---- 229 (353)
T ss_dssp ECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH----
T ss_pred ECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 999999999999999764432 122478999999998877 6789999999999999999999999975321
Q ss_pred chHHHHHHHHhhhCCC-----------------CcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENP-----------------NRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....+......... ................+..+.+|+.+||+.||++|||++++++
T Consensus 230 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 230 LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111111111000000 0000000001111122344899999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.97 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=195.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--CCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR--HRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i 109 (325)
-.++|++.+.||+|+||.||+|. +..+++.||+|.+......... .......+.+|+.+++.+. ||||
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWG---------ELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEE-ETTTTEEEEEEEEEGGGCCCEE---------ECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred ccCceEEEEEEeeCCCeEEEEEE-ECCCCcEEEEEEEecccchhhh---------hhhhhhHHHHHHHHHHhhccCCCCc
Confidence 45789999999999999999995 5567899999998432111000 0012234567888888886 5999
Q ss_pred cccccceecCCceEEEEEcccC-CCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKN-GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
+++++++...+..++|+|++.+ ++|.+++.. ...++...+..++.|++.||.||| ++|++|+||||+||+++
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILID 183 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEE
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEe
Confidence 9999999999999999999975 899999843 456889999999999999999999 88999999999999999
Q ss_pred -CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 189 -DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 189 -~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+++.++|+|||++........ ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------ 253 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 253 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred CCCCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------
Confidence 778999999999987654322 12468999999999887665 688999999999999999999996421
Q ss_pred hHHHHHHHHhhhCC-CCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASEN-PNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ...... .... .+..+.+|+.+||+.||.+|||++++++
T Consensus 254 ~-------~~~~~~~~~~~------------~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 E-------IIRGQVFFRQR------------VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp H-------HHHCCCCCSSC------------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h-------hhccccccccc------------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 111111 1111 1123889999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=297.88 Aligned_cols=256 Identities=21% Similarity=0.316 Sum_probs=180.6
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|++.+.||+|+||.||+|. +..+++.||+|.+..... .......+.++..+++.++||||+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~~~~~~~~~h~~i~ 87 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMR-FRKTGHVIAVKQMRRSGN-------------KEENKRILMDLDVVLKSHDCPYIV 87 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEE-ETTTCCEEEEEEEETTSC-------------HHHHHHHHHHHHHHHHTTTCTTBC
T ss_pred hhhccccccceeeecCCeeEEEEE-EecCCeEEEEEEeccccc-------------chHHHHHHHHHHHHHHhcCCCcee
Confidence 345889999999999999999996 456788999999843210 111233445555678888999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEecC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA-RVIHRDIKPANVLIDD 189 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~ivH~dl~~~nil~~~ 189 (325)
++++++...+..++||||+ ++.+...... ....++...+..++.|++.||.||| ++ |++|+||+|+||+++.
T Consensus 88 ~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~ 160 (318)
T 2dyl_A 88 QCFGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDE 160 (318)
T ss_dssp CEEEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECT
T ss_pred eEEEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECC
Confidence 9999999999999999999 5466555532 2456899999999999999999999 64 9999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
++.++|+|||.+......... ....|++.|+|||++. +..++.++||||||+++|+|++|..||.....
T Consensus 161 ~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--- 234 (318)
T 2dyl_A 161 RGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--- 234 (318)
T ss_dssp TSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---
T ss_pred CCCEEEEECCCchhccCCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---
Confidence 999999999999765443222 2246899999999984 45678899999999999999999999965221
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............+...... ..+..+.+|+.+||+.||.+|||++++++
T Consensus 235 ---~~~~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 235 ---DFEVLTKVLQEEPPLLPGHM--------GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---HHHHHHHHHHSCCCCCCSSS--------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---cHHHHHHHhccCCCCCCccC--------CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11222222222222111100 11223889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=305.25 Aligned_cols=253 Identities=21% Similarity=0.322 Sum_probs=191.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||.||+|.+. ..+|+|.+.... ........+.+|+.++++++||||++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~-------------~~~~~~~~~~~e~~~l~~l~h~~iv~ 93 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIER-------------DNEDQLKAFKREVMAYRQTRHENVVL 93 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCS-------------CCCCCCCCCCTTGGGGTTCCCTTBCC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCC-------------CCHHHHHHHHHHHHHHhcCCCCCEeE
Confidence 4589999999999999999999753 349999874322 11222345677889999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++...+..++|+||+++++|.+++.. ....++...+..++.|++.||.||| ++|++|+||+|+||+++ ++
T Consensus 94 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~ 166 (319)
T 2y4i_B 94 FMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NG 166 (319)
T ss_dssp CCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---
T ss_pred EEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CC
Confidence 99999999999999999999999999833 3346899999999999999999999 78999999999999998 67
Q ss_pred CceeeccccceecCCCC---ccccceeecCCccccccccccc---------CCCCCccchhhHHHHHHHHHhCCCCCCCc
Q 040480 192 EARISGFDLAILMPDGL---TQIDTMYVVGTPRYIAPEYHQT---------LTISEKCDIYSFGVLLAVLVMGKFPFDDF 259 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~---~~~~~~~~~g~~~~~aPE~~~~---------~~~~~~~DvwslG~il~~ll~g~~p~~~~ 259 (325)
.++|+|||++....... .........|++.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 167 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999987543211 1112222468899999998875 34788999999999999999999999652
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. .. ...........+... ... .+..+.+|+.+||..||.+|||+.++++
T Consensus 247 ~----~~---~~~~~~~~~~~~~~~-~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 247 P----AE---AIIWQMGTGMKPNLS-QIG--------MGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp C----HH---HHHHHHHTTCCCCCC-CSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred C----HH---HHHHHhccCCCCCCC-cCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2 11 112222222221111 000 1112889999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=322.74 Aligned_cols=254 Identities=21% Similarity=0.309 Sum_probs=196.7
Q ss_pred hhcCcccccccccCcceeEEEEEecCC--CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGS--NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|++.+.||+|+||.||+|.+... .+..+|+|.+... ......+.+.+|+.++++++||||
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~HpnI 453 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--------------TSDSVREKFLQEALTMRQFDHPHI 453 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--------------TCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--------------CCHHHHHHHHHHHHHHHhCCCCCC
Confidence 457899999999999999999976432 3567999987321 122345678899999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++. ++..++||||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++||||||+||+++.
T Consensus 454 v~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~ 526 (656)
T 2j0j_A 454 VKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSS 526 (656)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEE
T ss_pred CeEEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeC
Confidence 99999874 4678999999999999999943 3345888999999999999999999 789999999999999999
Q ss_pred CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 268 (325)
++.++|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... ..+.
T Consensus 527 ~~~vkL~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~----~~~~ 601 (656)
T 2j0j_A 527 NDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDV 601 (656)
T ss_dssp TTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH
T ss_pred CCCEEEEecCCCeecCCCccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC----HHHH
Confidence 9999999999998765432211 122356788999999998899999999999999999997 999997532 2222
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. .+........ +. ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 602 ~~---~i~~~~~~~~--~~--------~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 602 IG---RIENGERLPM--PP--------NCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HH---HHHHTCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---HHHcCCCCCC--Cc--------cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22 2222222111 11 11233899999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=308.98 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=184.3
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
.+.|.+.+.||+|+||+||.+.. .+++.||||.+.. ...+.+.+|+.++..+ +||||++
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~------------------~~~~~~~~E~~~l~~l~~HpnIv~ 73 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLI------------------DFCDIALMEIKLLTESDDHPNVIR 73 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEE--SSSSEEEEEEEEG------------------GGHHHHHHHHHHHHHHTTSTTBCC
T ss_pred hheeeccCeEeeCCCeEEEEEEE--ECCeEEEEEEEcH------------------HHHHHHHHHHHHHHhccCCCCcCe
Confidence 35677789999999999986633 4689999998731 1234567889999876 8999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccc---cChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE---LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
+++++.+.+..|+||||++ ++|.+++......... .+...+..++.|++.||.||| ++||+|+||||+||+++
T Consensus 74 ~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~ 149 (434)
T 2rio_A 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVS 149 (434)
T ss_dssp EEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEE
T ss_pred EEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEe
Confidence 9999999999999999996 4999999543221111 133456789999999999999 88999999999999997
Q ss_pred CC-------------CCceeeccccceecCCCCccc--cceeecCCccccccccccc-------CCCCCccchhhHHHHH
Q 040480 189 DD-------------MEARISGFDLAILMPDGLTQI--DTMYVVGTPRYIAPEYHQT-------LTISEKCDIYSFGVLL 246 (325)
Q Consensus 189 ~~-------------~~~~l~dfg~~~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~-------~~~~~~~DvwslG~il 246 (325)
.+ +.++|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il 229 (434)
T 2rio_A 150 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229 (434)
T ss_dssp CCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHH
T ss_pred cCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHH
Confidence 54 479999999998776543221 1223578999999999875 5688999999999999
Q ss_pred HHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 247 AVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 247 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|+|++ |..||..... .... +.......... ........+..+.+||.+||+.||.+|||+.++++
T Consensus 230 ~ellt~g~~Pf~~~~~-----~~~~----i~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 230 YYILSKGKHPFGDKYS-----RESN----IIRGIFSLDEM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTTSCCTTCSTTT-----HHHH----HHHTCCCCCCC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCCCCCchh-----hHHH----HhcCCCCcccc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 99999 9999965321 1111 11111111110 01112344556999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=319.51 Aligned_cols=264 Identities=21% Similarity=0.272 Sum_probs=195.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||.||+|. +..+++.||+|.+... ........+.+|+.+++.++||||+++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~-~~~tg~~VAVKvi~~~--------------~~~~~~~~~~~Ei~iL~~L~HpnIV~l 77 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWI-HQDTGEQVAIKQCRQE--------------LSPKNRERWCLEIQIMKKLNHPNVVSA 77 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCC-CTTTTCCEEECCCCSC--------------CCHHHHHHHHHHHHHHHHCCBTTBCCE
T ss_pred CCCeEEEEEEeeCCCeEEEEEE-ECCCCcEEEEEEeccc--------------CCHHHHHHHHHHHHHHHhCCCCCCCce
Confidence 3789999999999999999995 5577899999987321 122345678899999999999999999
Q ss_pred ccceec------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVR------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++.. .+..++||||+++++|.+++.... ....+++..+..++.|++.||.||| +.|++|+||+|+||+
T Consensus 78 ~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NIL 153 (676)
T 3qa8_A 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIV 153 (676)
T ss_dssp EECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEE
T ss_pred eeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeE
Confidence 998765 667899999999999999995422 2235889999999999999999999 789999999999999
Q ss_pred ecCCCC---ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 187 IDDDME---ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 187 ~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
++.++. ++|+|||.+......... ....||..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 154 l~~~g~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-- 228 (676)
T 3qa8_A 154 LQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-- 228 (676)
T ss_dssp EECCSSSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH--
T ss_pred eecCCCceeEEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc--
Confidence 997665 899999999876554332 225789999999999999999999999999999999999999964211
Q ss_pred CcchHHHHHHHH--------hhhCC--CCcccch--hhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNV--------MASEN--PNRAIDS--KLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~--------~~~~~--~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...|.... ..... ....+.. ..........+..+.+|+.+||..||++|||++++++
T Consensus 229 ----~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 229 ----PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp ----HHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred ----hhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 01000000 00000 0000000 0011122334556999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=297.02 Aligned_cols=248 Identities=21% Similarity=0.279 Sum_probs=186.6
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc----CCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI----RHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l----~h~ 107 (325)
-.++|++.+.||+|+||.||+|+ +..+++.||+|.+......... .......+.+|+.++.++ +||
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~~h~ 98 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWS---------PLSDSVTCPLEVALLWKVGAGGGHP 98 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEE-CTTTCCEEEEEECCSTTTC-----------------CCCCHHHHHHHHHHSSCCCS
T ss_pred hhhceEEeeEEEcCCCEEEEEEE-EccCCeEEEEEEEecccccccc---------cchhhHHHHHHHHHHHhhcccCCCC
Confidence 45789999999999999999995 5667889999998433211110 001223345677777777 899
Q ss_pred CccccccceecCCceEEEEEc-ccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 108 NILPLLAHMVRPDSHLLVYDF-MKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
||+++++++...+..++|+|+ +.+++|.+++.. ...+++..+..++.|++.||.||| ++|++|+||+|+||+
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil 171 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENIL 171 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEE
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEE
Confidence 999999999999999999999 788999999943 345899999999999999999999 779999999999999
Q ss_pred ec-CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 187 ID-DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 187 ~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
++ .++.++|+|||++........ ....|+..|+|||++.+..+ +.++||||||+++|+|++|+.||....
T Consensus 172 ~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 243 (312)
T 2iwi_A 172 IDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---- 243 (312)
T ss_dssp EETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred EeCCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----
Confidence 99 788999999999987654332 22468999999999877665 458999999999999999999996421
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
. ....... .+. .....+.+++.+||+.||++|||++|+++
T Consensus 244 --~-------~~~~~~~---~~~--------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 --E-------ILEAELH---FPA--------HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --H-------HHHTCCC---CCT--------TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --H-------HhhhccC---Ccc--------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1111110 000 11223889999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=304.77 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=183.6
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNI 109 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 109 (325)
....+|.+.+.||+|+||+||.... .+++.||||++... ....+.+|+.+++.+ +||||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~------------------~~~~~~~E~~~l~~l~~HpnI 80 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPE------------------CFSFADREVQLLRESDEHPNV 80 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEE--SSSSEEEEEEECTT------------------TEEECHHHHHHHHHSCCCTTB
T ss_pred EccEEEecCCeeecCcCEEEEEEEE--eCCeEEEEEEECHH------------------HHHHHHHHHHHHHhccCCCCc
Confidence 3556899999999999998654322 37889999988311 112245788899988 79999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.+....|+||||+.+ +|.+++.. .........+..++.|++.||.||| ++||+||||||+||+++.
T Consensus 81 v~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~ 153 (432)
T 3p23_A 81 IRYFCTEKDRQFQYIAIELCAA-TLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISM 153 (432)
T ss_dssp CCEEEEEEETTEEEEEEECCSE-EHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECC
T ss_pred CeEEEEEecCCEEEEEEECCCC-CHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEec
Confidence 9999999999999999999965 99999843 2334555667889999999999999 889999999999999953
Q ss_pred ---C--CCceeeccccceecCCCCcc-ccceeecCCcccccccccc---cCCCCCccchhhHHHHHHHHHh-CCCCCCCc
Q 040480 190 ---D--MEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQ---TLTISEKCDIYSFGVLLAVLVM-GKFPFDDF 259 (325)
Q Consensus 190 ---~--~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~---~~~~~~~~DvwslG~il~~ll~-g~~p~~~~ 259 (325)
+ ..++|+|||++......... .......||+.|+|||++. +..++.++|||||||++|+|++ |..||...
T Consensus 154 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp CBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 2 35779999999876543221 1222357899999999987 4567889999999999999999 99999642
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ... .... .........+ .......+.+||.+||+.||.+|||++++++
T Consensus 234 ~~-----~~~---~~~~-~~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 234 LQ-----RQA---NILL-GACSLDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TT-----HHH---HHHT-TCCCCTTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hH-----HHH---HHHh-ccCCccccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 21 111 1111 1111111111 1122334789999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=284.58 Aligned_cols=232 Identities=19% Similarity=0.275 Sum_probs=175.5
Q ss_pred hcCcccc-cccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHH-hccCCCCcc
Q 040480 33 EDCFASL-EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITA-SQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~ 110 (325)
.++|.+. +.||+|+||.||+|. +..+++.||+|.+. ......+|+.++ +..+||||+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~--------------------~~~~~~~e~~~~~~~~~h~~i~ 74 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIF-NKRTQEKFALKMLQ--------------------DCPKARREVELHWRASQCPHIV 74 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEE--------------------CSHHHHHHHHHHHHHTTSTTBC
T ss_pred ccchhhcCcccccCCCeEEEEEE-EcCCCcEEEEEEec--------------------ccHHHHHHHHHHHHhccCCCch
Confidence 3678887 789999999999995 55778999999982 123456777776 556899999
Q ss_pred ccccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 111 PLLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 111 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++++.. ....++||||+++++|.+++.. .....++...+..++.|++.||.||| ++|++|+||||+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil 149 (299)
T 3m2w_A 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLL 149 (299)
T ss_dssp CEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred hHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEE
Confidence 99999876 6778999999999999999954 23346899999999999999999999 889999999999999
Q ss_pred ecC---CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 187 IDD---DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 187 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
++. ++.++|+|||++..... ..++.++||||||+++|+|++|..||.......
T Consensus 150 ~~~~~~~~~~kl~Dfg~a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 205 (299)
T 3m2w_A 150 YTSKRPNAILKLTDFGFAKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205 (299)
T ss_dssp ESSSSTTCCEEECCCTTCEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred EecCCCCCcEEEecccccccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence 997 78899999999854321 245788999999999999999999996532211
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...... ..........+... ....+..+.+|+.+||+.||.+|||++|+++
T Consensus 206 ~~~~~~------~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 206 ISPGMK------TRIRMGQYEFPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp --CCSC------CSSCTTCCSSCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHHHH------HHHhhccccCCchh----cccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 00000000111100 0122334899999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=314.94 Aligned_cols=235 Identities=20% Similarity=0.262 Sum_probs=188.2
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|.+...+++.||||.+... ........+.+|+.+++.++||||++++
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 145 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--------------GDAEAQAMAMAERQFLAEVVHPSIVQIF 145 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--------------CCHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--------------CCHHHHHHHHHHHHHHHhcCCCCcCeEe
Confidence 78999999999999999999765557899999987321 1123445678999999999999999999
Q ss_pred cceecCCc-----eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 114 AHMVRPDS-----HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 114 ~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
+++...+. .|+||||++|++|.+++. ..+++..+..++.|++.+|.||| ++||+|+||||+||+++
T Consensus 146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~ 216 (681)
T 2pzi_A 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLT 216 (681)
T ss_dssp EEEEEECTTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred eeEeecCCCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEe
Confidence 99987665 799999999999988762 16899999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.+ .+||+|||++...... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||........
T Consensus 217 ~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---- 284 (681)
T 2pzi_A 217 EE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---- 284 (681)
T ss_dssp SS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----
T ss_pred CC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----
Confidence 75 8999999999876543 2247899999999987754 8899999999999999999998864221100
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
+. ..........+.+||.+||+.||.+||+..+.+
T Consensus 285 ------------~~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l 319 (681)
T 2pzi_A 285 ------------PE--------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319 (681)
T ss_dssp ------------CT--------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred ------------cc--------cccccccCHHHHHHHhhhccCChhhCCCHHHHH
Confidence 00 000111223488999999999999999766654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=278.74 Aligned_cols=228 Identities=16% Similarity=0.144 Sum_probs=175.1
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|. +..+++.||+|.+...... .......+.+|+.+++.++||||++++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~-~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~e~~~l~~l~hp~iv~~~ 97 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVL------------PDDVLQETLSRTLRLSRIDKPGVARVL 97 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEE-ETTTTEEEEEEESCTTCCS------------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcEEEEEEEcccCCeEEEEEE-ecCCCceEEEEEECccccc------------CHHHHHHHHHHHHHHhcCCCCCcceee
Confidence 789999999999999999995 5567899999998432211 123456788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++...+..|+||||++|++|.+++.. . .....+..++.|++.||.||| ++||+|+||||+||+++.++.+
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~ 168 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDV 168 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCE
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCE
Confidence 999999999999999999999999832 2 345567889999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
+|++++. ++ +++.++||||||+++|+|++|+.||.............
T Consensus 169 kl~~~~~----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---- 215 (286)
T 3uqc_A 169 VLAYPAT----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---- 215 (286)
T ss_dssp EECSCCC----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----
T ss_pred EEEeccc----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----
Confidence 9874432 22 35889999999999999999999997643321110000
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..... ......... .+.+..+.+|+.+||+.||++| |+.|+++
T Consensus 216 ---~~~~~-~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 216 ---RDTAG-QPIEPADID---RDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp ---BCTTS-CBCCHHHHC---TTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ---HHhcc-CCCChhhcc---cCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00000 000000001 1122338999999999999999 9999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=294.70 Aligned_cols=246 Identities=15% Similarity=0.172 Sum_probs=180.5
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC-CCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH-RNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~ 112 (325)
..|...+.||+|+||+||+|+ +..+++.||||++..... ......+.+.+|+.+++.+.| ++...+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~-~~~~g~~vAvK~~~~~~~------------~~~~~~~~~~~E~~~~~~l~~~~~~~~~ 144 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTER------------PPSNAIKQMKEEVLRLRLLRGIKNQKQA 144 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEECCSCC----------------CCHHHHHHHHGGGGSTTCCSHHHH
T ss_pred eeEEEecccccCCCEEEEEEE-ecCCCCceEEEEEecCCC------------ccHHHHHHHHHHHHHHHhhccCCCHHHH
Confidence 458889999999999999996 556788999998842221 111234568889999998876 332222
Q ss_pred ccc---------------------eec-----CCceEEEEEcccCCCHHHHHhhh---cccccccChhhHHHHHHHHHHH
Q 040480 113 LAH---------------------MVR-----PDSHLLVYDFMKNGSLQAVLYDV---SKGRRELEWLSRHKIALAVASG 163 (325)
Q Consensus 113 ~~~---------------------~~~-----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~ 163 (325)
..+ +.. ....+++|+++ +++|.+++... ......+++..+..++.|++.|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~a 223 (413)
T 3dzo_A 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223 (413)
T ss_dssp HHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred HHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHH
Confidence 111 111 12357777766 56999998533 2335567888899999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCccccccccc----------ccCCC
Q 040480 164 LEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYH----------QTLTI 233 (325)
Q Consensus 164 l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~----------~~~~~ 233 (325)
|.||| ++||+||||||+|||++.++.+||+|||++...... .....| +.|+|||++ .+..+
T Consensus 224 L~~LH---~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~ 294 (413)
T 3dzo_A 224 LASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM 294 (413)
T ss_dssp HHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred HHHHH---hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC
Confidence 99999 889999999999999999999999999998765433 222467 899999998 55568
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCC
Q 040480 234 SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADP 313 (325)
Q Consensus 234 ~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 313 (325)
+.++||||||+++|+|++|+.||........... ... .. . ..+..+.+||.+||+.||
T Consensus 295 ~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~-------~~~-~~--~------------~~~~~~~~li~~~l~~dP 352 (413)
T 3dzo_A 295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW-------IFR-SC--K------------NIPQPVRALLEGFLRYPK 352 (413)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG-------GGS-SC--C------------CCCHHHHHHHHHHTCSSG
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH-------HHh-hc--c------------cCCHHHHHHHHHHccCCh
Confidence 8899999999999999999999976432111110 000 00 0 112338999999999999
Q ss_pred CCCCChhhhhc
Q 040480 314 DERPNSKDVRC 324 (325)
Q Consensus 314 ~~Rps~~ell~ 324 (325)
++|||+.++++
T Consensus 353 ~~Rpt~~~~l~ 363 (413)
T 3dzo_A 353 EDRLLPLQAME 363 (413)
T ss_dssp GGSCCHHHHTT
T ss_pred hhCcCHHHHHh
Confidence 99999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=283.69 Aligned_cols=251 Identities=17% Similarity=0.169 Sum_probs=184.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC------
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR------ 105 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------ 105 (325)
..++|++.+.||+|+||+||+|++ +++.||+|++........ ..........+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLV-------NGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCB-------TTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred ccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCcccc-------ccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 457899999999999999999975 679999999854321100 0012234467788888888776
Q ss_pred --------------------CCCccccccceec-------------CCceEEEEEcccCCCHHHHHhhhcccccccChhh
Q 040480 106 --------------------HRNILPLLAHMVR-------------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152 (325)
Q Consensus 106 --------------------h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 152 (325)
||||+++++++.. .+..|+||||+++|++.+.+. +..+++..
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~ 162 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLAT 162 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHH
Confidence 5666666666665 788999999999987666652 24589999
Q ss_pred HHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceEecCCC--------------------CceeeccccceecCCCCccc
Q 040480 153 RHKIALAVASGLEYLH-MHHSARVIHRDIKPANVLIDDDM--------------------EARISGFDLAILMPDGLTQI 211 (325)
Q Consensus 153 ~~~i~~~l~~~l~~lh-~~~~~~ivH~dl~~~nil~~~~~--------------------~~~l~dfg~~~~~~~~~~~~ 211 (325)
+..++.|++.||.||| .. ||+||||||+|||++.++ .+||+|||++......
T Consensus 163 ~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---- 235 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----
T ss_pred HHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----
Confidence 9999999999999999 44 899999999999999887 8999999999866532
Q ss_pred cceeecCCcccccccccccCCCCCccchhhHHHH-HHHHHhCCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhc
Q 040480 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVL-LAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLL 290 (325)
Q Consensus 212 ~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~i-l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
...||+.|+|||++.+.. +.++|||||+++ .+++++|..||.... ................... .
T Consensus 236 ---~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~----~ 301 (336)
T 2vuw_A 236 ---IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMTFKTKC----N 301 (336)
T ss_dssp ---EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCCCSSCC----C
T ss_pred ---cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhccCccc----c
Confidence 247899999999999876 889999998777 777888999984310 0001111111111111111 1
Q ss_pred CCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 291 GNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 291 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
.......+..+.+||.+||+.| |++|+|
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 1123456667999999999977 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-33 Score=255.88 Aligned_cols=194 Identities=19% Similarity=0.112 Sum_probs=129.8
Q ss_pred cCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccccccceecCCce
Q 040480 44 SGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHMVRPDSH 122 (325)
Q Consensus 44 ~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 122 (325)
.|++|.+..++ ....|+.+++|.+.......... ....+...+++.+|+++|+++ .|+||+++++++.+++..
T Consensus 244 ~~~~~~h~~~r-r~~fg~~~~~K~~~~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 244 AGAGLAHKRSR-RYFFGEDYVCKFFYYDMPHGILT-----AEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp --------CCE-EEEECSSEEEEEEESSCSTTCSC-----HHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred cCCcccccccc-cccccceeEEEEEecccccccch-----hhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 44444443332 22356789999985433222111 111224456799999999999 699999999999999999
Q ss_pred EEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 123 LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 123 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
|+||||++|++|.+.+. ....++. ..|+.|++.||.|+| ++|||||||||+|||++.++.+||+|||+++
T Consensus 318 yLVMEyv~G~~L~d~i~----~~~~l~~---~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr 387 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLA----AGEEIDR---EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIV 387 (569)
T ss_dssp EEEEECCCSEEHHHHHH----TTCCCCH---HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred EEEEecCCCCcHHHHHH----hCCCCCH---HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCe
Confidence 99999999999999994 3445554 358999999999999 8899999999999999999999999999998
Q ss_pred ecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 040480 203 LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~ 256 (325)
........ ....+||+.|+|||++.+. +..++|+||+|++++.+.++..++
T Consensus 388 ~~~~~~~~--~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 388 TTPQDCSW--PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp SCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred eCCCCCcc--ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 76544332 2235899999999998874 577899999999988776665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=224.24 Aligned_cols=193 Identities=15% Similarity=0.117 Sum_probs=146.3
Q ss_pred ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccce
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHM 116 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 116 (325)
...+.||+|+||.||+|++ .+..+++|............ ......+.+.+|+.++++++||||+++..+.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~-------~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 408 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERL-------DENIRKSRTAREARYLALVKDFGIPAPYIFD 408 (540)
T ss_dssp ---------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHH-------HHHHHHHHHHHHHHHHHHGGGGTCCCCCEEE
T ss_pred CCCCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhh-------hhHHHHHHHHHHHHHHHhcCCCCcCceEEEE
Confidence 4466899999999999954 57789999875432221110 1112356789999999999999999766666
Q ss_pred ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceee
Q 040480 117 VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS 196 (325)
Q Consensus 117 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~ 196 (325)
...+..|+||||+++++|.+++.. ...++.|++.+|.||| ++||+||||||+||+++. .+||+
T Consensus 409 ~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~ 471 (540)
T 3en9_A 409 VDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYII 471 (540)
T ss_dssp EETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEEC
T ss_pred EeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEE
Confidence 677888999999999999999832 4579999999999999 889999999999999998 99999
Q ss_pred ccccceecCCCCccc-----cceeecCCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCC
Q 040480 197 GFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQT--LTISEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 197 dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~ 256 (325)
|||++.......... ......||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 472 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 472 DFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999998876532211 1123578999999999987 56788899999988888877777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=182.85 Aligned_cols=161 Identities=11% Similarity=0.064 Sum_probs=117.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcH-----HHHHHHHHhhCcchHHHHHHHHHHHhccCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSA-----AELIDAYSELGEGKLTEIRSQIITASQIRH 106 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 106 (325)
....|.+.+.||+|+||.||+|.+ .+++.||+|.+........ .+.. ...........+.+|+.+++.++
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~--~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYG--DLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC---------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCeEEEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhc--chhhHHHHHHHHHHHHHHHHhcc-
Confidence 455566779999999999999975 6789999999843221000 0000 00000023567889999999998
Q ss_pred CCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 107 RNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 107 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
| +++.+.+. .+..|+||||++|++|.+ + . ......++.|++.||.+|| ++|++|+||||+||+
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l----~------~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-V----R------VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-C----C------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-c----c------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEE
Confidence 4 66666543 356799999999999987 4 1 1234579999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCccccccccccc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT 230 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~ 230 (325)
++ ++.++|+|||++.. +..+.|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99 99999999999853 234567887653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-19 Score=149.75 Aligned_cols=156 Identities=17% Similarity=0.157 Sum_probs=107.3
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcE--EEEEEEcccCCCcHHHHHH----------HHHhhCcchHHHHHHHHH
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKM--IAVKKVIIYSPMSAAELID----------AYSELGEGKLTEIRSQII 99 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~e~~ 99 (325)
...-|++.+.||+|+||.||+|.+ ..+++. ||||++..... ....... ............+.+|+.
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~-~~~g~~~~vAvK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 122 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADG-VFDGKPVAMAVKIYRIETS-EFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR 122 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEE-EETTEEEEEEEEEECCC--------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEE-cCCCcEeeEEEEEEECCcc-chhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence 334478999999999999999964 246778 99998743211 0000000 000000112346788999
Q ss_pred HHhccCCCCc--cccccceecCCceEEEEEcccC-C----CHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCC
Q 040480 100 TASQIRHRNI--LPLLAHMVRPDSHLLVYDFMKN-G----SLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHS 172 (325)
Q Consensus 100 ~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~ 172 (325)
++..+.|+++ +.++.. +..++||||+.+ | +|.+.... .+...+..++.|++.+|.+||. +
T Consensus 123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~--~ 189 (258)
T 1zth_A 123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQ--E 189 (258)
T ss_dssp HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHH--T
T ss_pred HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHH--H
Confidence 9999988764 333331 367899999942 3 67665421 2355678899999999999993 2
Q ss_pred CCeEecCCCCCceEecCCCCceeeccccceec
Q 040480 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILM 204 (325)
Q Consensus 173 ~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~ 204 (325)
.|++|+||||+|||++. .++|+|||++...
T Consensus 190 ~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 190 AELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 38999999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.5e-19 Score=155.13 Aligned_cols=157 Identities=15% Similarity=0.146 Sum_probs=99.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHH--------HHHHHHHHhc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE--------IRSQIITASQ 103 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~e~~~l~~ 103 (325)
+..-|++.+.||.|++|.||+|.. .+|+.||||++..... +.+................ ...|...+.+
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d--~~G~~vAvKi~r~~~~-sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVAD--EKGKQKVLKIHRLGRI-SFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEC--TTCCEEEEEEECTTEE-CCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEEC--CCCCEEEEEEEecccc-cHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 445699999999999999999964 3689999998743211 0000000000000011111 2334455555
Q ss_pred cCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040480 104 IRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 104 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~ 183 (325)
+.+.++.-..- +. ....++||||++|++|.+.. .......++.|++.+|.+|| ..|||||||||.
T Consensus 170 L~~~gv~vp~p-~~-~~~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~ 234 (397)
T 4gyi_A 170 LYEEGFPVPEP-IA-QSRHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLA---KHGLIHGDFNEF 234 (397)
T ss_dssp HHHTTCSCCCE-EE-EETTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred HHhcCCCCCee-ee-ccCceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHH
Confidence 53333221111 11 12347999999998875432 12244678899999999999 779999999999
Q ss_pred ceEecCCCC----------ceeeccccceecCC
Q 040480 184 NVLIDDDME----------ARISGFDLAILMPD 206 (325)
Q Consensus 184 nil~~~~~~----------~~l~dfg~~~~~~~ 206 (325)
|||+++++. ++|+||+-+.....
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence 999987763 79999998876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=4.7e-13 Score=112.07 Aligned_cols=142 Identities=11% Similarity=0.044 Sum_probs=108.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~ 111 (325)
-..|++...++.|+.+.||++.. .+..+++|...... ......+.+|..+++.+. +.++++
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~---------------~~~~~~~~~E~~~l~~l~~~~~vP~ 74 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRY---------------KGTTYDVEREKDMMLWLEGKLPVPK 74 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGG---------------TTSTTCHHHHHHHHHHHTTTSCCCC
T ss_pred hccceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCccc---------------CCCHHHHHHHHHHHHHHhcCCCCCe
Confidence 35799999999999999999953 46789999873110 011224778888888874 577888
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcC--------------------
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHH-------------------- 171 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~-------------------- 171 (325)
++++....+..|+|||+++|.+|.+.+ .+......++.+++.++..||...
T Consensus 75 v~~~~~~~~~~~lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~ 145 (263)
T 3tm0_A 75 VLHFERHDGWSNLLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL 145 (263)
T ss_dssp EEEEEEETTEEEEEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHH
T ss_pred EEEEEecCCceEEEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHH
Confidence 999888888999999999999987763 122334578889999999999621
Q ss_pred ------------------------------------CCCeEecCCCCCceEecCCCCceeeccccc
Q 040480 172 ------------------------------------SARVIHRDIKPANVLIDDDMEARISGFDLA 201 (325)
Q Consensus 172 ------------------------------------~~~ivH~dl~~~nil~~~~~~~~l~dfg~~ 201 (325)
...++|+|++|.||+++++..+.|+||+.+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 145999999999999987655679999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=1.6e-10 Score=96.26 Aligned_cols=137 Identities=12% Similarity=0.090 Sum_probs=93.5
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC--ccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN--ILP 111 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~ 111 (325)
..|.+....+.|..+.||++.. .++..+++|..... ....+..|..+++.+.+.+ +++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~--~~g~~~vlK~~~~~------------------~~~~~~~E~~~l~~l~~~~~~vP~ 79 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA--QGRPVLFVKTDLSG------------------ALNELQDEAARLSWLATTGVPCAA 79 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC--TTSCCEEEEEECSC------------------TTSCHHHHHHHHHHHHTTTCCBCC
T ss_pred CCCceEecccCCCCceEEEEec--CCCCeEEEEeCCcc------------------cchhhhHHHHHHHHHHhCCCCCCe
Confidence 4566555545666799999953 35677999986211 1134567777777775433 566
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcC--------------------
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHH-------------------- 171 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~-------------------- 171 (325)
++.+....+..++||||++|.+|. .. . . ....++.+++..+..||...
T Consensus 80 ~~~~~~~~~~~~~v~e~i~G~~l~--~~----~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~ 147 (264)
T 1nd4_A 80 VLDVVTEAGRDWLLLGEVPGQDLL--SS----H---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTR 147 (264)
T ss_dssp EEEEEECSSCEEEEEECCSSEETT--TS----C---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHH
T ss_pred EEEeccCCCCCEEEEEecCCcccC--cC----c---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHH
Confidence 888877777899999999998774 20 0 1 12245666666777777431
Q ss_pred -----------------------------------CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 -----------------------------------SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 -----------------------------------~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..+++|+|++|.||++++++.+.|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 148 MEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999876556799998873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.5e-10 Score=98.95 Aligned_cols=146 Identities=12% Similarity=0.120 Sum_probs=103.0
Q ss_pred CcccccccccCcceeEEEEEecCCCCcEEEEEEEc--ccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--CCCcc
Q 040480 35 CFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVI--IYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR--HRNIL 110 (325)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~ 110 (325)
.....+.|+.|.++.||++.. .+..+++|+.. ... .......+.+|..+++.+. +.+++
T Consensus 39 ~~~~~~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~--------------~~~~~~~~~~E~~~l~~L~~~~vpvP 101 (359)
T 3dxp_A 39 GPLSVEQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSK--------------LLPSAHAIEREYRVMDALAGTDVPVA 101 (359)
T ss_dssp CCCEEEECCC-CCSCEEEEEC---SSCEEEEECCCC------------------------CHHHHHHHHHHHTTSSSCCC
T ss_pred CCceEEEcCCcccceEEEEEE---CCceEEEEeCCCCCCC--------------CCCcHHHHHHHHHHHHHhhcCCCCCC
Confidence 344567889999999999964 34678888652 100 0012235677888888886 35678
Q ss_pred ccccceecC---CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcC----------------
Q 040480 111 PLLAHMVRP---DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHH---------------- 171 (325)
Q Consensus 111 ~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~---------------- 171 (325)
+++.++.+. +..|+||||++|..+.+.. ...++......++.+++..|..||...
T Consensus 102 ~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3dxp_A 102 KMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYF 175 (359)
T ss_dssp CEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHH
T ss_pred cEEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCch
Confidence 888877666 4589999999987764321 123566677788999999999999631
Q ss_pred ---------------------------------------CCCeEecCCCCCceEecCCCC--ceeecccccee
Q 040480 172 ---------------------------------------SARVIHRDIKPANVLIDDDME--ARISGFDLAIL 203 (325)
Q Consensus 172 ---------------------------------------~~~ivH~dl~~~nil~~~~~~--~~l~dfg~~~~ 203 (325)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 176 QRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=8.9e-10 Score=94.11 Aligned_cols=188 Identities=18% Similarity=0.157 Sum_probs=114.7
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CC--Cccccccc
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HR--NILPLLAH 115 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~--~i~~~~~~ 115 (325)
.+.++.|....||++. ..+++|... .......+.+|..+++.+. +. .+++++..
T Consensus 25 i~~~~~G~~n~v~~v~------~~~vlR~~~-----------------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~ 81 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN------RDFIFKFPK-----------------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFT 81 (304)
T ss_dssp CCEEEECSSEEEEEST------TSEEEEEES-----------------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEE
T ss_pred eEecCCCCcceEEEEC------CEEEEEecC-----------------CcchHHHHHHHHHHHHHHHhcCCCCCCceEee
Confidence 4568999999999873 458888751 1123456788888888773 32 24444444
Q ss_pred eecCC---ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc----------------------
Q 040480 116 MVRPD---SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH---------------------- 170 (325)
Q Consensus 116 ~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~---------------------- 170 (325)
....+ ..|+||++++|.++..... ..++......++.+++..+..||..
T Consensus 82 ~~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~ 155 (304)
T 3sg8_A 82 GMPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNK 155 (304)
T ss_dssp CCCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHH
T ss_pred cCCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHH
Confidence 33332 3589999999988765431 1245555566666666666666641
Q ss_pred ---------------------------------CCCCeEecCCCCCceEecC--CCCceeeccccceecCCCCcccccee
Q 040480 171 ---------------------------------HSARVIHRDIKPANVLIDD--DMEARISGFDLAILMPDGLTQIDTMY 215 (325)
Q Consensus 171 ---------------------------------~~~~ivH~dl~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~ 215 (325)
....++|+|++|.||++++ ...+.++||+.+........-.....
T Consensus 156 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~ 235 (304)
T 3sg8_A 156 KIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLME 235 (304)
T ss_dssp HHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCC
T ss_pred HHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHh
Confidence 1235899999999999997 45578999999865432111000000
Q ss_pred ------------ecCCccccc-ccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 040480 216 ------------VVGTPRYIA-PEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFD 257 (325)
Q Consensus 216 ------------~~g~~~~~a-PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~ 257 (325)
....+.... |+.... .....+.|+++.++|.+.+|..+|-
T Consensus 236 ~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 236 DDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred hccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 000000011 111111 1123689999999999999988863
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.9e-07 Score=76.92 Aligned_cols=135 Identities=16% Similarity=0.147 Sum_probs=92.4
Q ss_pred ccccCcce-eEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccccccceec
Q 040480 41 KIGSGGCG-DVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPLLAHMVR 118 (325)
Q Consensus 41 ~lg~G~~g-~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 118 (325)
.+..|..+ .||+.. ....+..+++|.-. ......+.+|...++.+. +-.+.+++.++.+
T Consensus 31 ~~~~G~S~~~v~rl~-~~~~~~~~~lk~~~------------------~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~ 91 (272)
T 4gkh_A 31 RDNVGQSGATIYRLY-GKPNAPELFLKHGK------------------GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT 91 (272)
T ss_dssp EEECSSSSCEEEEEE-CCTTCCCEEEEEEE------------------THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred EccCCCcCCeEEEEE-ecCCCeEEEEEECC------------------CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE
Confidence 34445554 689884 44456778999752 112345677777777764 3347788888888
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcC---------------------------
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHH--------------------------- 171 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--------------------------- 171 (325)
.+..++||++++|.++.+.... .......+..++...|..||...
T Consensus 92 ~~~~~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (272)
T 4gkh_A 92 PDDAWLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVD 163 (272)
T ss_dssp TTEEEEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCC
T ss_pred CCeEEEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhh
Confidence 8999999999999888776521 11223345566666666666430
Q ss_pred ----------------------------CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 ----------------------------SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ----------------------------~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 164 ASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1138999999999999987666799998873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2e-06 Score=73.33 Aligned_cols=75 Identities=12% Similarity=0.035 Sum_probs=52.5
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC---Cccccccc
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR---NILPLLAH 115 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~ 115 (325)
.+.++.|....||+. +..+++|+-. .......+.+|..+++.+.+. .+.+++.+
T Consensus 24 v~~l~~G~~n~v~~v------g~~~VlR~~~-----------------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~ 80 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------NGDWVFRFPK-----------------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYI 80 (306)
T ss_dssp EEEEEECSSEEEEEE------TTTEEEEEES-----------------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEE
T ss_pred eeecCCCcceeEEEE------CCEEEEEecC-----------------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEee
Confidence 456788888899988 3567888741 112345688899999988642 35566655
Q ss_pred ee-cCCceEEEEEcccCCCHHH
Q 040480 116 MV-RPDSHLLVYDFMKNGSLQA 136 (325)
Q Consensus 116 ~~-~~~~~~lv~e~~~~~~L~~ 136 (325)
.. ..+..++||++++|.++..
T Consensus 81 ~~~~~g~~~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 81 GKRSDGNPFVGYRKVQGQILGE 102 (306)
T ss_dssp EECTTSCEEEEEECCCSEECHH
T ss_pred cccCCCceEEEEeccCCeECch
Confidence 53 4556899999999988765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=2.7e-05 Score=67.18 Aligned_cols=31 Identities=19% Similarity=0.351 Sum_probs=27.9
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
...++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999877889999998774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=3.4e-06 Score=73.44 Aligned_cols=86 Identities=3% Similarity=-0.057 Sum_probs=49.8
Q ss_pred ccccc-ccCcceeEEEEEecC--C---CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-C--CC
Q 040480 38 SLEKI-GSGGCGDVYKAELPG--S---NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-H--RN 108 (325)
Q Consensus 38 ~~~~l-g~G~~g~v~~~~~~~--~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~~ 108 (325)
..+.| +.|....+|+..... . ++..+++|.-.... .........+.+|..+++.+. + -.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~------------~~~~~~~~~~~~E~~~l~~L~~~~~vp 91 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAE------------DVPVFPTYRLDHQFEVIRLVGELTDVP 91 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGG------------GCCSSSCCCHHHHHHHHHHHHHHCCSC
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCC------------ccccCchhHHHHHHHHHHHHhhcCCCC
Confidence 34667 888889999986420 0 15678888642100 000000123456666666553 2 35
Q ss_pred ccccccceecC---CceEEEEEcccCCCHH
Q 040480 109 ILPLLAHMVRP---DSHLLVYDFMKNGSLQ 135 (325)
Q Consensus 109 i~~~~~~~~~~---~~~~lv~e~~~~~~L~ 135 (325)
+.+++.+..+. +..++|||+++|.++.
T Consensus 92 vP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 92 VPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred CCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 66777666554 3578999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.3e-05 Score=70.72 Aligned_cols=84 Identities=11% Similarity=0.136 Sum_probs=47.4
Q ss_pred cccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC--C-Ccccccc
Q 040480 38 SLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH--R-NILPLLA 114 (325)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~-~i~~~~~ 114 (325)
-.+.+|.|..+.||++... .++..+++|....... . ...........+..|..+++.+.. | .+++++.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~-~~~~~~vvK~~~~~~r-----~---~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~ 104 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAK-----V---VGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY 104 (397)
T ss_dssp EEEECCSSSSEEEEEEEC-----CEEEEEEECCC---------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred EEEECCCCceEEEEEEEEC-CCCcEEEEEecchhhc-----c---cCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE
Confidence 3568899999999999532 3467899997632110 0 000001122345667777776632 3 3445554
Q ss_pred ceecCCceEEEEEcccCC
Q 040480 115 HMVRPDSHLLVYDFMKNG 132 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~ 132 (325)
+ +.+..++|||++++.
T Consensus 105 ~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 105 S--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp E--ETTTTEEEECCCTTS
T ss_pred E--cCCccEEEEEeCCCc
Confidence 3 445568999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00015 Score=61.65 Aligned_cols=76 Identities=12% Similarity=0.067 Sum_probs=56.0
Q ss_pred cccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC---CCCcccccc
Q 040480 38 SLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR---HRNILPLLA 114 (325)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~ 114 (325)
-.+.|+.|....+|+... ++..+++|.... .....+..|...|+.+. ...+++++.
T Consensus 40 ~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~------------------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~ 98 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND---EVQTVFVKINER------------------SYRSMFRAEADQLALLAKTNSINVPLVYG 98 (312)
T ss_dssp EEEEECCSSSSEEEEEES---SSCEEEEEEEEG------------------GGHHHHHHHHHHHHHHHHTTSSBCCCEEE
T ss_pred eeEEeCCccceeeeEEEE---CCCeEEEEeCCc------------------ccHHHHHHHHHHHHHHHhhCCCCcceEEE
Confidence 346789999999999963 467888997621 12445677777777663 356788888
Q ss_pred ceecCCceEEEEEcccCCCH
Q 040480 115 HMVRPDSHLLVYDFMKNGSL 134 (325)
Q Consensus 115 ~~~~~~~~~lv~e~~~~~~L 134 (325)
.....+..++||||++|..+
T Consensus 99 ~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 99 IGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECSSEEEEEEECCCCCCC
T ss_pred EeecCCceEEEEEeccCCCC
Confidence 87777889999999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00013 Score=64.95 Aligned_cols=32 Identities=16% Similarity=0.389 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccceec
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAILM 204 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~ 204 (325)
...++|+|+.+.||+++.++ +.++||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 67899999999999998776 999999888643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00052 Score=57.60 Aligned_cols=80 Identities=14% Similarity=0.172 Sum_probs=51.1
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC---CCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH---RNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~ 110 (325)
....-.+.+|.|..+.||+.+.. +|+.+++|+-.... ......+..|...|+.+.. -.++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~---------------~~~~~~~~~Ea~~L~~L~~~~~vpvP 77 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA--DGTPLFVKALPDDA---------------PALDGLFRAEALGLDWLGRSFGSPVP 77 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET--TSCEEEEEECCTTC---------------CCCTTHHHHHHHHHHHHTCSTTCCSC
T ss_pred CCeEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeCCCC---------------cchhhHHHHHHHHHHHHHhhCCCCcc
Confidence 34566778999999999999764 77899999752111 1112235667777776632 2344
Q ss_pred ccccceecCCceEEEEEcccCCCH
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSL 134 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L 134 (325)
+++.. +..++||||+.+...
T Consensus 78 ~v~~~----~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 78 QVAGW----DDRTLAMEWVDERPP 97 (288)
T ss_dssp CEEEE----ETTEEEEECCCCCCC
T ss_pred eEEec----cCceEEEEeecccCC
Confidence 44443 234789999976543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.43 E-value=0.001 Score=52.57 Aligned_cols=103 Identities=15% Similarity=0.061 Sum_probs=65.6
Q ss_pred CCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccc
Q 040480 132 GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI 211 (325)
Q Consensus 132 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 211 (325)
.+|.+.+.. .++++++.++|.++.|.+.+|.-+-. .+.-...=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 488998854 46679999999999999888776521 11111233456889999998887663 1110
Q ss_pred cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 040480 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFP 255 (325)
Q Consensus 212 ~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p 255 (325)
.....+.|||... ...+++.=|||||+++|..+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123567888753 2446788899999999999875544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00049 Score=58.15 Aligned_cols=31 Identities=19% Similarity=0.173 Sum_probs=26.0
Q ss_pred CCCeEecCCCCCceEecCCCCceeecccccee
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~ 203 (325)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 446899999999999 5667789999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0012 Score=56.31 Aligned_cols=31 Identities=32% Similarity=0.358 Sum_probs=26.2
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4579999999999999877555799998774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0013 Score=58.63 Aligned_cols=73 Identities=7% Similarity=0.099 Sum_probs=43.2
Q ss_pred ccccccCcceeEEEEEecCC------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC-ccc
Q 040480 39 LEKIGSGGCGDVYKAELPGS------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN-ILP 111 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~ 111 (325)
.+.|+.|....+|++..... ++..+++|+.... .....+..|..+++.+...+ .++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----------------~~~~~li~E~~~l~~L~~~g~~P~ 140 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----------------ETESHLVAESVIFTLLSERHLGPK 140 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----------------CCHHHHHHHHHHHHHHHHTTSSSC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----------------CcHHHHHHHHHHHHHHHhCCCCCc
Confidence 45677888899999975321 2467888876110 01123445667776664222 345
Q ss_pred cccceecCCceEEEEEcccCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNG 132 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~ 132 (325)
+++.+.+ .+|++|++|.
T Consensus 141 l~~~~~~----g~v~e~l~G~ 157 (429)
T 1nw1_A 141 LYGIFSG----GRLEEYIPSR 157 (429)
T ss_dssp EEEEETT----EEEECCCCEE
T ss_pred EEEEeCC----CEEEEEeCCc
Confidence 5554432 3889999863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0014 Score=56.19 Aligned_cols=33 Identities=24% Similarity=0.292 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCceEecCC----CCceeeccccceec
Q 040480 172 SARVIHRDIKPANVLIDDD----MEARISGFDLAILM 204 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~----~~~~l~dfg~~~~~ 204 (325)
...++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999864 67899999988653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0027 Score=55.41 Aligned_cols=145 Identities=9% Similarity=0.116 Sum_probs=77.5
Q ss_pred ccccccCcceeEEEEEecC------CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccc
Q 040480 39 LEKIGSGGCGDVYKAELPG------SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILP 111 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~ 111 (325)
.+.|..|-...+|++.... .++..+++|+.-. .......+.+|..+++.+. +.-..+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~----------------~~~~~~~~~rE~~vl~~L~~~gv~P~ 118 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA----------------ILQGVDSLVLESVMFAILAERSLGPQ 118 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------------------CCHHHHHHHHHHHHHHHHTTSSCC
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC----------------ccchHHHHHHHHHHHHHHHhcCCCCe
Confidence 3456678788999996531 1346788887410 0112344557777777664 222355
Q ss_pred cccceecCCceEEEEEcccCCCHH--------------HHHhhhcccc----cccC--hhhHHHHHHHHHH---------
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQ--------------AVLYDVSKGR----RELE--WLSRHKIALAVAS--------- 162 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~--------------~~~~~~~~~~----~~~~--~~~~~~i~~~l~~--------- 162 (325)
+++.+.+ .+|+||++|.+|. +.+....... .... +..+.++..++..
T Consensus 119 ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~ 194 (379)
T 3feg_A 119 LYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEM 194 (379)
T ss_dssp EEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSC
T ss_pred EEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchh
Confidence 5655443 2899999875442 1111111111 1111 2333444433321
Q ss_pred ----------HHHH----HHhc-CCCCeEecCCCCCceEecCC----CCceeecccccee
Q 040480 163 ----------GLEY----LHMH-HSARVIHRDIKPANVLIDDD----MEARISGFDLAIL 203 (325)
Q Consensus 163 ----------~l~~----lh~~-~~~~ivH~dl~~~nil~~~~----~~~~l~dfg~~~~ 203 (325)
.+.. |... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 195 ~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 195 NLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1222 2211 23469999999999999876 6899999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.011 Score=50.39 Aligned_cols=30 Identities=23% Similarity=0.238 Sum_probs=25.8
Q ss_pred CCCeEecCCCCCceEecCCCCceeecccccee
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~ 203 (325)
...++|+|+.+.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 55789999999999999 4 889999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.018 Score=49.33 Aligned_cols=32 Identities=28% Similarity=0.439 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCceEecCCCCceeecccccee
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~ 203 (325)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999878899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0072 Score=52.51 Aligned_cols=31 Identities=16% Similarity=0.365 Sum_probs=25.4
Q ss_pred CCCeEecCCCCCceEecCCCCceeecccccee
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~ 203 (325)
...++|+|+.+.||+++.++ +.++||..+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 45799999999999998654 89999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.01 Score=53.22 Aligned_cols=75 Identities=12% Similarity=0.099 Sum_probs=42.0
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc-ccccccee
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI-LPLLAHMV 117 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~ 117 (325)
.+.|+.|-...+|++... .++..+++|+.-... ...-...+|..+++.+...++ +++++.+.
T Consensus 113 i~~lsgG~tN~~y~v~~~-~~~~~~vLRi~g~~~----------------~~~idR~~E~~vl~~L~~~gl~P~ll~~~~ 175 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDM-SKQAKYLIRLYGPKT----------------DEIINREREKKISCILYNKNIAKKIYVFFT 175 (458)
T ss_dssp EEEECC--CEEEEEEEET-TTTEEEEEEEECC-C----------------CSCSCHHHHHHHHHHHTTSSSBCCEEEEET
T ss_pred EEEcCCCeEeEEEEEEEC-CCCceEEEEECCCCh----------------hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC
Confidence 456777888999999753 124778888751100 000011466777777754333 45665552
Q ss_pred cCCceEEEEEcccCCCH
Q 040480 118 RPDSHLLVYDFMKNGSL 134 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L 134 (325)
+ .+|++|++|.+|
T Consensus 176 --~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 176 --N--GRIEEFMDGYAL 188 (458)
T ss_dssp --T--EEEEECCCSEEC
T ss_pred --C--eEEEEeeCCccC
Confidence 2 359999987433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.022 Score=50.39 Aligned_cols=31 Identities=19% Similarity=0.415 Sum_probs=26.9
Q ss_pred CCCeEecCCCCCceEecCCCCceeecccccee
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~ 203 (325)
...++|+|+.+.||+ +.++.+.++||..+..
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 346999999999999 7778899999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.32 E-value=0.75 Score=36.34 Aligned_cols=116 Identities=17% Similarity=0.172 Sum_probs=75.5
Q ss_pred CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 040480 105 RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLE-YLHMHHSARVIHRDIKPA 183 (325)
Q Consensus 105 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~-~lh~~~~~~ivH~dl~~~ 183 (325)
.||++ -..+-.+++.+.+.++.-+++.-...+ ...+...+++++.+++.... +++ .-+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 46777 344446666766666655444333344 23778888889888876555 444 5689999999
Q ss_pred ceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 184 NVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 184 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
|++++.++.+++.-.|+-.. ++|.- .++..=+-++=|++..++.++..|.+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred eEEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999987776421 22221 11111123466778888888888854
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.87 E-value=0.56 Score=36.92 Aligned_cols=118 Identities=14% Similarity=0.104 Sum_probs=75.9
Q ss_pred CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040480 105 RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPAN 184 (325)
Q Consensus 105 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~n 184 (325)
.||+.+.. .+-.+.+.+.+.++.-+.+ ..+- .-...+...+++++.+++....+++ .-+|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPFD-----NIKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTS--EEGG-----GGGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCccc--CCHH-----HHHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecce
Confidence 46777765 4555556555555543322 1111 1234777888899999887765555 45799999999
Q ss_pred eEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q 040480 185 VLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~ 259 (325)
++++.++.+++.--|+... ++|. ..++..=+-++=+++..+++++..|...
T Consensus 110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9999999999987766421 1221 1122222334677888899999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.14 E-value=0.44 Score=41.73 Aligned_cols=30 Identities=17% Similarity=0.370 Sum_probs=25.1
Q ss_pred CeEecCCCCCceEe------cCCCCceeecccccee
Q 040480 174 RVIHRDIKPANVLI------DDDMEARISGFDLAIL 203 (325)
Q Consensus 174 ~ivH~dl~~~nil~------~~~~~~~l~dfg~~~~ 203 (325)
.++|+|+.+.||++ +++..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 3457799999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.99 E-value=0.14 Score=45.83 Aligned_cols=64 Identities=9% Similarity=0.038 Sum_probs=17.4
Q ss_pred ccccccccCcceeEEEEEecCCCCcEEEE------EEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNGKMIAV------KKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.+.+.|| ||.||++.+.. ...+||+ |... ...........+.++..++..++|||++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~-~~~~Vav~~~~~~K~~~-------------~~~~~~e~~~~~~rea~l~~~~~H~niv 207 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK-KHMPVLKETHDERDSTG-------------QDGVSEKRLTSLVRRATLKENEQIPKYE 207 (463)
T ss_dssp CSTTTSS---BCCC----------CCBGGGC------------------------------------------------C
T ss_pred cccccCC---chhhhcccccc-cCCchhhhhccCccccc-------------cccccccccccccccccccccccccccC
Confidence 4556666 99999998753 2346777 5441 0112233445677788888888999999
Q ss_pred cccccee
Q 040480 111 PLLAHMV 117 (325)
Q Consensus 111 ~~~~~~~ 117 (325)
+.+++..
T Consensus 208 ~~h~f~~ 214 (463)
T 3cxl_A 208 KIHNFKV 214 (463)
T ss_dssp BCCCEEE
T ss_pred CCcceEE
Confidence 9887654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 325 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-51
Identities = 64/290 (22%), Positives = 119/290 (41%), Gaps = 39/290 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
++IGSG G VYK + G +AVK + + + +L ++++
Sbjct: 13 GQRIGSGSFGTVYKGKWHGD----VAVKMLNV-------------TAPTPQQLQAFKNEV 55
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ RH NIL + + P +V + + SL L+ + E + IA
Sbjct: 56 GVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIAR 111
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
A G++YLH +IHRD+K N+ + +D+ +I F LA + + G
Sbjct: 112 QTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 219 TPRYIAPEYHQTLT---ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275
+ ++APE + S + D+Y+FG++L L+ G+ P+ + ++ + +
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-------INNRDQIIFM 221
Query: 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+ SK+ N + + +L C DERP +
Sbjct: 222 VG-RGYLSPDLSKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-50
Identities = 56/259 (21%), Positives = 106/259 (40%), Gaps = 25/259 (9%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL 91
K+D F + ++G+G G V+K +G ++A K + + E+
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLI--------------HLEIKPAIR 48
Query: 92 TEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWL 151
+I ++ + I+ + + M GSL VL +
Sbjct: 49 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQ 104
Query: 152 SRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQI 211
K+++AV GL YL +++HRD+KP+N+L++ E ++ F ++ + D +
Sbjct: 105 ILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162
Query: 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271
VGT Y++PE Q S + DI+S G+ L + +G++P + E+
Sbjct: 163 F----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218
Query: 272 MRNVMASENPNRAIDSKLL 290
+ A P + L
Sbjct: 219 VEGDAAETPPRPRTPGRPL 237
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-49
Identities = 64/296 (21%), Positives = 121/296 (40%), Gaps = 38/296 (12%)
Query: 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK 90
+ ED + L IG+G G K S+GK++ K++ Y + E +
Sbjct: 2 RAED-YEVLYTIGTGSYGRCQKIRRK-SDGKILVWKEL-------------DYGSMTEAE 46
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLL--VYDFMKNGSLQAVLYDVSKGRREL 148
+ S++ +++H NI+ ++ + L V ++ + G L +V+ +K R+ L
Sbjct: 47 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 106
Query: 149 EWLSRHKIALAVASGLEYLHMHH--SARVIHRDIKPANVLIDDDMEARISGFDLAILMPD 206
+ ++ + L+ H V+HRD+KPANV +D ++ F LA ++
Sbjct: 107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166
Query: 207 GLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266
+ TP Y++PE ++ +EK DI+S G LL L PF F +
Sbjct: 167 DTSFAKAFVG--TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF----SQK 220
Query: 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
++ +R P R D + ++ RP+ +++
Sbjct: 221 ELAGKIREGKFRRIPYRYSDE-------------LNEIITRMLNLKDYHRPSVEEI 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-48
Identities = 64/298 (21%), Positives = 119/298 (39%), Gaps = 44/298 (14%)
Query: 30 LKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEG 89
L ED + + ++G G G VYKA+ + A K + E
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVI---------------DTKSEE 51
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELE 149
+L + +I + H NI+ LL ++ ++ +F G++ AV+ + R L
Sbjct: 52 ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPLT 108
Query: 150 WLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
+ L YLH ++IHRD+K N+L D + +++ F ++ +
Sbjct: 109 ESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165
Query: 210 QIDTMYVVGTPRYIAPEYHQTLT-----ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264
+ D+ +GTP ++APE T K D++S G+ L + + P +
Sbjct: 166 RRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE------ 217
Query: 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
++ +R + + SE P A S+ N + + K C + D R + +
Sbjct: 218 -LNPMRVLLKIAKSEPPTLAQPSRWSSNFKD----FLKK----CLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 2e-47
Identities = 66/305 (21%), Positives = 120/305 (39%), Gaps = 50/305 (16%)
Query: 21 LIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELI 80
L K+D E F+ L +IG G G VY A N +++A+KK +
Sbjct: 7 LFFKDDP-----EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKK------------M 48
Query: 81 DAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD 140
+ K +I ++ ++RH N + +R + LV ++ + +
Sbjct: 49 SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE-- 106
Query: 141 VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
++ L+ + + GL YLH H+ +IHRD+K N+L+ + ++ F
Sbjct: 107 --VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 161
Query: 201 AILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT---ISEKCDIYSFGVLLAVLVMGKFPFD 257
A +M VGTP ++APE + K D++S G+ L K P
Sbjct: 162 ASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
Query: 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317
+ M+ + + ++ +E+P L + E + C P +RP
Sbjct: 216 N-------MNAMSALYHIAQNESP------ALQSGHWSEYFRNFVDS---CLQKIPQDRP 259
Query: 318 NSKDV 322
S+ +
Sbjct: 260 TSEVL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-46
Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 42/284 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+G G G+VY A + ++A+K + A+L G ++R ++
Sbjct: 11 GRPLGKGKFGNVYLAREK-QSKFILALKV------LFKAQLEK------AGVEHQLRREV 57
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
S +RH NIL L + L+ ++ G++ L +SK +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYIT 113
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+A+ L Y H S RVIHRDIKP N+L+ E +I+ F ++ P + G
Sbjct: 114 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCG 166
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
T Y+ PE + EK D++S GVL ++GK PF+ + +
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-------NTYQETYKRISRV 219
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
E ++ L +P +RP ++V
Sbjct: 220 EFTFPDFVTEGA-----------RDLISRLLKHNPSQRPMLREV 252
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-46
Identities = 57/292 (19%), Positives = 118/292 (40%), Gaps = 41/292 (14%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ +E++G+G G+V+ G +AVK + + G
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSL----------------KQGSMSPDA 54
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
++ Q++H+ ++ L A + + + ++ ++M+NGSL L +L
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKL 111
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+A +A G+ ++ + IHRD++ AN+L+ D + +I+ F LA L+ D
Sbjct: 112 LDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273
++ APE T + K D++SFG+LL +V + ++++ +
Sbjct: 169 G-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVIQNLE 224
Query: 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
P+ + + +L C P++RP +R +
Sbjct: 225 RGYRMVRPDNCPEE-------------LYQLMRLCWKERPEDRPTFDYLRSV 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-45
Identities = 62/286 (21%), Positives = 112/286 (39%), Gaps = 38/286 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
++ +G G G+V A + +AVK V + + E I+ +I
Sbjct: 10 VQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 54
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ H N++ H + L ++ G L +D + + +
Sbjct: 55 CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH 110
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+ +G+ YLH + HRDIKP N+L+D+ +IS F LA + + + G
Sbjct: 111 QLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 219 TPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277
T Y+APE + +E D++S G++L ++ G+ P+D + +
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKT 224
Query: 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323
NP + IDS L L+ K+ +P R D++
Sbjct: 225 YLNPWKKIDSAPLA--------LLHKILVE----NPSARITIPDIK 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-45
Identities = 56/292 (19%), Positives = 112/292 (38%), Gaps = 41/292 (14%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ K+G G G+V+ G +A+K + + G
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTL----------------KPGTMSPEA 58
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
+ ++RH ++ L A +V + +V ++M GSL + + + L
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLL--DFLKGETGKYLRLPQL 115
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+A +ASG+ Y+ + +HRD++ AN+L+ +++ +++ F LA L+ D
Sbjct: 116 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273
++ APE + K D++SFG+LL L + +++ +
Sbjct: 173 G-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVE 228
Query: 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
P +S + L C C +P+ERP + ++
Sbjct: 229 RGYRMPCPPECPES-------------LHDLMCQCWRKEPEERPTFEYLQAF 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 4e-45
Identities = 55/296 (18%), Positives = 116/296 (39%), Gaps = 39/296 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
C + IG+G G+V L + I V + S + E + +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT------------EKQRRD 73
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
S+ Q H N++ L + + +++ +FM+NGSL + L ++ +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV-- 131
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+ +A+G++YL + +HRD+ N+L++ ++ ++S F L+ + D +
Sbjct: 132 -GMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187
Query: 214 MYVVG---TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269
+G R+ APE Q + D++S+G+++ ++ G+ P+ D D++
Sbjct: 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----TNQDVI 243
Query: 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+ P + + +L C D + RP +
Sbjct: 244 NAIEQDYRLPPPMDCPSA-------------LHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-45
Identities = 65/308 (21%), Positives = 114/308 (37%), Gaps = 45/308 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
E IG G G+V++ + G+ +AVK E + ++I
Sbjct: 8 QESIGKGRFGEVWRGKW---RGEEVAVKIF----------------SSREERSWFREAEI 48
Query: 99 ITASQIRHRNILPLLAHMVRPDSHL----LVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
+RH NIL +A + + LV D+ ++GSL L R +
Sbjct: 49 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMI 103
Query: 155 KIALAVASGLEYLHMH-----HSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLT 209
K+AL+ ASGL +LHM + HRD+K N+L+ + I+ LA+
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163
Query: 210 QIDTMY--VVGTPRYIAPEY------HQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261
ID VGT RY+APE + ++ DIY+ G++ +
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
Query: 262 HTG---EMDMVRWMRNVMASENPNRAIDSKLLGNGYE-EQMLLVLKLACFCTLADPDERP 317
+ ++ M + + + E + ++ K+ C A+ R
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 318 NSKDVRCM 325
+ ++
Sbjct: 284 TALRIKKT 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-44
Identities = 54/293 (18%), Positives = 105/293 (35%), Gaps = 38/293 (12%)
Query: 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK 90
K+ + F + +G G V A + + A+K ++ + E K
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKI------------LEKRHIIKENK 51
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
+ + + S++ H + L + + KNG L + +
Sbjct: 52 VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------- 104
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
A + L H +IHRD+KP N+L+++DM +I+ F A ++ Q
Sbjct: 105 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164
Query: 211 IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270
VGT +Y++PE + + D+++ G ++ LV G PF + +
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLI 218
Query: 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323
+ + + + K LV KL D +R +++
Sbjct: 219 FQKIIKLEYDFPEKFFPKARD--------LVEKLLVL----DATKRLGCEEME 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 1e-44
Identities = 54/285 (18%), Positives = 100/285 (35%), Gaps = 43/285 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L+++G+G G V + G +A+K + + G E +
Sbjct: 9 LKELGTGQFGVVKYGKWRG--QYDVAIKMI----------------KEGSMSEDEFIEEA 50
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ H ++ L + ++ ++M NG L L + R + ++
Sbjct: 51 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCK 107
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
V +EYL +HRD+ N L++D ++S F L+ + D
Sbjct: 108 DVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKF 163
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277
R+ PE S K DI++FGVL+ + +GK P++ F + + + +R
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 223
Query: 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ + C DERP K +
Sbjct: 224 HLASEKVYT-----------------IMYSCWHEKADERPTFKIL 251
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 2e-44
Identities = 55/316 (17%), Positives = 108/316 (34%), Gaps = 57/316 (18%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEG 89
+ + IG G G V++A PG M+AVK + E
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--------------KEEASAD 58
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------ 143
+ + + ++ + NI+ LL L++++M G L L +S
Sbjct: 59 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 144 --------------GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189
G L + IA VA+G+ YL + +HRD+ N L+ +
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGE 175
Query: 190 DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVL 249
+M +I+ F L+ + R++ PE + + D++++GV+L +
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235
Query: 250 VMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCT 309
+ +++ ++R+ P + L C
Sbjct: 236 FSYGLQ---PYYGMAHEEVIYYVRDGNILACPENCPLE-------------LYNLMRLCW 279
Query: 310 LADPDERPNSKDVRCM 325
P +RP+ + +
Sbjct: 280 SKLPADRPSFCSIHRI 295
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-44
Identities = 63/284 (22%), Positives = 122/284 (42%), Gaps = 41/284 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
EKIG G G VY A + G+ +A++++ + + K I ++I
Sbjct: 25 FEKIGQGASGTVYTAMDV-ATGQEVAIRQM---------------NLQQQPKKELIINEI 68
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ + ++ NI+ L + D +V +++ GSL V+ ++ +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCR 123
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
LE+LH S +VIHRDIK N+L+ D +++ F + ++ TM VG
Sbjct: 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VG 178
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
TP ++APE K DI+S G++ ++ G+ P+ + + +R + + +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-------ENPLRALYLIATN 231
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
P KL + + + C D ++R ++K++
Sbjct: 232 GTPELQNPEKLSAIFRD----FLNR----CLDMDVEKRGSAKEL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-44
Identities = 53/288 (18%), Positives = 110/288 (38%), Gaps = 44/288 (15%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+IG G VYK +A ++ +L + + + +
Sbjct: 15 IEIGRGSFKTVYKGLDTE-TTVEVAWCELQD-------------RKLTKSERQRFKEEAE 60
Query: 100 TASQIRHRNILPLLAHMVRPDSH----LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
++H NI+ +LV + M +G+L+ L K + ++
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRS 116
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-DMEARISGFDLAILMPDGLTQIDTM 214
+ GL++LH +IHRD+K N+ I +I LA L +
Sbjct: 117 WCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---- 171
Query: 215 YVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274
V+GTP ++APE ++ E D+Y+FG+ + + ++P+ + + + R + +
Sbjct: 172 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRRVTS 227
Query: 275 VMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ + ++ ++ ++ C + DER + KD+
Sbjct: 228 GVKPASFDKVAIPEV------------KEIIEGCIRQNKDERYSIKDL 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 9e-44
Identities = 66/288 (22%), Positives = 109/288 (37%), Gaps = 47/288 (16%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L+ IG G GDV + G +AVK + + ++
Sbjct: 12 LQTIGKGEFGDVMLGDY---RGNKVAVKCIK-----------------NDATAQAFLAEA 51
Query: 99 ITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
+Q+RH N++ LL +V L +V ++M GSL L S+GR L K +
Sbjct: 52 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFS 109
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVV 217
L V +EYL ++ +HRD+ NVL+ +D A++S F L
Sbjct: 110 LDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGK 161
Query: 218 GTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277
++ APE + S K D++SFG+LL + + D+V +
Sbjct: 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYK 218
Query: 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+ P+ + V ++ C D RP+ +R
Sbjct: 219 MDAPDGCPPA-------------VYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-43
Identities = 62/342 (18%), Positives = 116/342 (33%), Gaps = 58/342 (16%)
Query: 9 GSRDRGLTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN----GKMIA 64
GS D + DL + + + +GSG G V A G + +A
Sbjct: 12 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71
Query: 65 VKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHMVRPDSHL 123
VK + + + + S++ +Q+ H NI+ LL
Sbjct: 72 VKMLK--------------EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117
Query: 124 LVYDFMKNGSLQAVLYDVSKGRRE-------------------LEWLSRHKIALAVASGL 164
L++++ G L L + E L + A VA G+
Sbjct: 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177
Query: 165 EYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIA 224
E+L +HRD+ NVL+ +I F LA + + +++A
Sbjct: 178 EFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234
Query: 225 PEYHQTLTISEKCDIYSFGVLLAVLV-MGKFPFDDFFSHTGEMDMVRWMRNVMASENPNR 283
PE + K D++S+G+LL + +G P+ + + + ++N + P
Sbjct: 235 PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI---PVDANFYKLIQNGFKMDQPFY 291
Query: 284 AIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
A + + + C D +RP+ ++
Sbjct: 292 ATEE-------------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-43
Identities = 60/289 (20%), Positives = 106/289 (36%), Gaps = 37/289 (12%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
E IG G G VY L ++GK I + G++++ ++ I
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------------IGEVSQFLTEGI 80
Query: 100 TASQIRHRNILPLLAHMVRPDSH-LLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
H N+L LL +R + L+V +MK+G L+ + + L
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGL 137
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY--V 216
VA G+ S + +HRD+ N ++D+ +++ F LA M D
Sbjct: 138 QVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 217 VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVM 276
+++A E QT + K D++SFGVLL L+ P + D+ ++
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVYLLQGR 251
Query: 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
P D + ++ C + RP+ ++
Sbjct: 252 RLLQPEYCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-43
Identities = 55/299 (18%), Positives = 111/299 (37%), Gaps = 39/299 (13%)
Query: 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGE 88
FLK+++ + ++G G G V + ++ KV+ +
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-------------KQGTEK 50
Query: 89 GKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
E+ + Q+ + I+ L+ + + ++ +LV + G L L R E+
Sbjct: 51 ADTEEMMREAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLV---GKREEI 106
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDG 207
+ ++ V+ G++YL + +HRD+ NVL+ + A+IS F L+ L D
Sbjct: 107 PVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 208 LTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLA-VLVMGKFPFDDFFSHTGEM 266
++ APE S + D++S+GV + L G+ P+
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK----MKGP 219
Query: 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+++ ++ E P + L C + ++RP+ V
Sbjct: 220 EVMAFIEQGKRMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQR 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-43
Identities = 53/284 (18%), Positives = 100/284 (35%), Gaps = 41/284 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+++IGSG G V+ N +A+K + G + +
Sbjct: 10 VQEIGSGQFGLVHLGYWL--NKDKVAIKTI----------------REGAMSEEDFIEEA 51
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
++ H ++ L + LV++FM++G L + R + + L
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCL 108
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
V G+ YL VIHRD+ N L+ ++ ++S F + + D +
Sbjct: 109 DVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKF 164
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
++ +PE S K D++SFGVL+ + + S ++V +
Sbjct: 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRL 221
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
P A V ++ C P++RP +
Sbjct: 222 YKPRLASTH-------------VYQIMNHCWKERPEDRPAFSRL 252
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 8e-43
Identities = 57/287 (19%), Positives = 107/287 (37%), Gaps = 39/287 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
K+G G G+VY+ +AVK + + ++ E +
Sbjct: 22 KHKLGGGQYGEVYEGVWKK-YSLTVAVKTL----------------KEDTMEVEEFLKEA 64
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+I+H N++ LL R ++ +FM G+L L + R+E+ + +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMAT 122
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
++S +EYL + IHRD+ N L+ ++ +++ F L+ LM
Sbjct: 123 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKF 178
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
++ APE S K D+++FGVLL + + + +
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRM 235
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
E P + V +L C +P +RP+ ++
Sbjct: 236 ERPEGCPEK-------------VYELMRACWQWNPSDRPSFAEIHQA 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-42
Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 41/300 (13%)
Query: 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSN-GKMIAVKKVIIYSPMSAAELIDAYSELG 87
+L ++ +++GSG G V K K +AVK +
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-------------KNEAND 48
Query: 88 EGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRE 147
E+ ++ Q+ + I+ ++ + +S +LV + + G L L R
Sbjct: 49 PALKDELLAEANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQ----NRH 103
Query: 148 LEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDG 207
++ + ++ V+ G++YL + +HRD+ NVL+ A+IS F L+ +
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160
Query: 208 LTQIDTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLL-AVLVMGKFPFDDFFSHTGE 265
++ APE S K D++SFGVL+ G+ P+
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG------- 213
Query: 266 MDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
M + E G +M L C D + RP V
Sbjct: 214 MKGSEVTAMLEKGERMG-------CPAGCPREM---YDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-42
Identities = 52/296 (17%), Positives = 116/296 (39%), Gaps = 40/296 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKM---IAVKKVIIYSPMSAAELIDAYSELGEGK 90
C + IG+G G+VYK L S+GK +A+K + + E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------------KAGYTEKQ 52
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
+ + Q H NI+ L + + +++ ++M+NG+ + + + E
Sbjct: 53 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSV 109
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
L + +A+G++Y + +HRD+ N+L++ ++ ++S F L+ ++ D
Sbjct: 110 LQLVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166
Query: 211 IDTMY-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269
T R+ APE + D++SFG+++ ++ + +++
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---PYWELSNHEVM 223
Query: 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
+ + + P + + +L C + RP D+ +
Sbjct: 224 KAINDGFRLPTP-------------MDCPSAIYQLMMQCWQQERARRPKFADIVSI 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-41
Identities = 52/302 (17%), Positives = 105/302 (34%), Gaps = 49/302 (16%)
Query: 39 LEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +G+G G V +A G +AVK + + ++ E + ++E+
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL----------MSEL 77
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYD-------------- 140
+ + + H NI+ LL L++ ++ G L L
Sbjct: 78 K---VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 141 VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
+ L+ + VA G+ +L + IHRD+ N+L+ +I F L
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGL 191
Query: 201 AILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF 260
A + + + +++APE + + D++S+G+ L L +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--YP 249
Query: 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320
+ + ++ +P A + + C ADP +RP K
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAE-------------MYDIMKTCWDADPLKRPTFK 296
Query: 321 DV 322
+
Sbjct: 297 QI 298
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 6e-41
Identities = 63/320 (19%), Positives = 108/320 (33%), Gaps = 58/320 (18%)
Query: 16 TIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKM-IAVKKVIIYSPM 74
TI+ P+++ D+ F + IG G G V KA + +M A+K++ Y+
Sbjct: 2 TIY-PVLDWNDIKFQ---------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK 51
Query: 75 SAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSL 134
E+ + H NI+ LL L ++ +G+L
Sbjct: 52 DDHRDF----------AGELE---VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 98
Query: 135 QAVLYD------------VSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182
L + L A VA G++YL + IHRD+
Sbjct: 99 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAA 155
Query: 183 ANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSF 242
N+L+ ++ A+I+ F L+ + R++A E + D++S+
Sbjct: 156 RNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212
Query: 243 GVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVL 302
GVLL +V + ++ + E P D V
Sbjct: 213 GVLLWEIVSLGGT---PYCGMTCAELYEKLPQGYRLEKPLNCDDE-------------VY 256
Query: 303 KLACFCTLADPDERPNSKDV 322
L C P ERP+ +
Sbjct: 257 DLMRQCWREKPYERPSFAQI 276
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-40
Identities = 57/301 (18%), Positives = 109/301 (36%), Gaps = 44/301 (14%)
Query: 28 AFLK--KEDCFASLEKIGSGGCGDVYKAELPGSNGKM---IAVKKVIIYSPMSAAELIDA 82
A L+ KE F ++ +GSG G VYK K+ +A+K++
Sbjct: 1 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-------------- 46
Query: 83 YSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS 142
EI + + + + ++ LL + + L+ M G L L V
Sbjct: 47 REATSPKANKEILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCL---LDYVR 102
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
+ + + + +A G+ YL ++HRD+ NVL+ +I+ F LA
Sbjct: 103 EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159
Query: 203 LMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLV-MGKFPFDDFFS 261
L+ + +++A E + + D++S+GV + L+ G P+D
Sbjct: 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--- 216
Query: 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321
+ + E + + V + C + D D RP ++
Sbjct: 217 ----IPASEISSILEKGERLPQP----------PICTIDVYMIMVKCWMIDADSRPKFRE 262
Query: 322 V 322
+
Sbjct: 263 L 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-40
Identities = 65/317 (20%), Positives = 117/317 (36%), Gaps = 52/317 (16%)
Query: 25 EDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSN------GKMIAVKKVIIYSPMSAAE 78
ED + D + +G G G V AE G + +AVK +
Sbjct: 4 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---------- 53
Query: 79 LIDAYSELGEGKLTEIRSQIITASQI-RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAV 137
S+ E L+++ S++ I +H+NI+ LL + ++ ++ G+L+
Sbjct: 54 ----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109
Query: 138 LY------------DVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANV 185
L +L A VA G+EYL S + IHRD+ NV
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166
Query: 186 LIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVL 245
L+ +D +I+ F LA + T +++APE + + D++SFGVL
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 246 LAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLA 305
L + + ++ + ++ + P+ + + +
Sbjct: 227 LWEIFTLGGS---PYPGVPVEELFKLLKEGHRMDKPSNCTNE-------------LYMMM 270
Query: 306 CFCTLADPDERPNSKDV 322
C A P +RP K +
Sbjct: 271 RDCWHAVPSQRPTFKQL 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 9e-40
Identities = 46/299 (15%), Positives = 105/299 (35%), Gaps = 43/299 (14%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEG 89
+ ++G G G VY+ G +A+K V
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--------------NEAASMR 65
Query: 90 KLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKG----- 144
+ E ++ + +++ LL + + L++ + M G L++ L +
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 145 -RRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAIL 203
++A +A G+ YL+ + +HRD+ N ++ +D +I F +
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 204 MPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263
+ + + R+++PE + + D++SFGV+L + +
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGL 239
Query: 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
++R++ + P+ D + +L C +P RP+ ++
Sbjct: 240 SNEQVLRFVMEGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMRPSFLEI 285
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 140 bits (355), Expect = 9e-40
Identities = 58/286 (20%), Positives = 106/286 (37%), Gaps = 41/286 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
E++G+G G V++ + G A K V+ E +R +I
Sbjct: 31 HEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPH---------------ESDKETVRKEI 74
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
T S +RH ++ L + +++Y+FM G L + ++ +
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMR 131
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLI--DDDMEARISGFDLAILMPDGLTQIDTMYV 216
V GL ++H ++ +H D+KP N++ E ++ F L + +
Sbjct: 132 QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVT 185
Query: 217 VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVM 276
GT + APE + + D++S GVL +L+ G PF + +RNV
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-------ENDDETLRNVK 238
Query: 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ + +D E+ + KL DP+ R
Sbjct: 239 ---SCDWNMDDSAFSGISEDGKDFIRKLLLA----DPNTRMTIHQA 277
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-39
Identities = 63/290 (21%), Positives = 110/290 (37%), Gaps = 37/290 (12%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVK-KVIIYSPMSAAELIDAYSELGEGKLTEIRSQ 97
LEK+G G G V + E +GK ++V K + +S E +D + +
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----------DFIRE 61
Query: 98 IITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIA 157
+ + HRN++ L ++ P +V + GSL L + K + + + A
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYA 117
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID-TMYV 216
+ VA G+ YL S R IHRD+ N+L+ +I F L +P +
Sbjct: 118 VQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 217 VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNV 275
+ APE +T T S D + FGV L + G+ P+ ++ + + +
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-------LNGSQILHKI 227
Query: 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
E+ + + C P++RP +R
Sbjct: 228 DKEGERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (348), Expect = 1e-38
Identities = 55/291 (18%), Positives = 105/291 (36%), Gaps = 41/291 (14%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
D + LE++GSG G V++ + G++ K + P+
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYT--------------- 72
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
++++I +Q+ H ++ L +L+ +F+ G L + + ++
Sbjct: 73 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEV 129
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLID--DDMEARISGFDLAILMPDGLTQI 211
GL+++H H ++H DIKP N++ + +I F LA +
Sbjct: 130 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 184
Query: 212 DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271
T + APE + D+++ GVL VL+ G PF D +
Sbjct: 185 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-------EDDLET 236
Query: 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
++NV + D + E + L +P +R D
Sbjct: 237 LQNVKRCDWE---FDEDAFSSVSPEAKDFIKNLLQK----EPRKRLTVHDA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-38
Identities = 58/303 (19%), Positives = 110/303 (36%), Gaps = 27/303 (8%)
Query: 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGK 90
+ + + + +IG G G V+KA + G+ +A+K+V + + E+ +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLR 62
Query: 91 LTEIRSQIITASQIRHRNILPLLAHMV--RPDSHLLVYDFMKNGSLQAVLYDVSKGRREL 148
H N++ L R D + ++ Y +
Sbjct: 63 H---------LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 113
Query: 149 EWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGL 208
+ + + GL++LH S RV+HRD+KP N+L+ + +++ F LA +
Sbjct: 114 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-- 168
Query: 209 TQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD---------F 259
Q+ VV T Y APE + + D++S G + A + K F
Sbjct: 169 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
Query: 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319
G W R+V + ++ + + L L C +P +R ++
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 320 KDV 322
Sbjct: 288 YSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-38
Identities = 56/283 (19%), Positives = 107/283 (37%), Gaps = 39/283 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+ +G G G V+ AE + A+K + + ++ E + E R
Sbjct: 7 HKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDV--------ECTMVEKR--- 54
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ + H + + ++ V +++ G L + + + + A
Sbjct: 55 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAA 110
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+ GL++LH +++RD+K N+L+D D +I+ F + G + +T G
Sbjct: 111 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CG 165
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
TP YIAPE + D +SFGVLL +++G+ PF +R
Sbjct: 166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPR 224
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321
A D L++K + +P++R +
Sbjct: 225 WLEKEAKD-------------LLVK----LFVREPEKRLGVRG 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 133 bits (336), Expect = 1e-37
Identities = 71/290 (24%), Positives = 113/290 (38%), Gaps = 36/290 (12%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
E +G G V + K AVK II + + EL E L E+
Sbjct: 8 KEILGRGVSSVVRRCIHK-PTCKEYAVK--IIDVTGGGSFSAEEVQELREATLKEVD--- 61
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
I H NI+ L LV+D MK G L +D + L KI
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 117
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
A+ + LH + ++HRD+KP N+L+DDDM +++ F + + G V G
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCG 171
Query: 219 TPRYIAPEYHQT------LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272
TP Y+APE + ++ D++S GV++ L+ G PF + +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-------RKQMLML 224
Query: 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
R +M + N S + + LV + P +R +++
Sbjct: 225 RMIM---SGNYQFGSPEWDDYSDTVKDLVSRFLVV----QPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 2e-37
Identities = 66/303 (21%), Positives = 117/303 (38%), Gaps = 47/303 (15%)
Query: 23 EKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDA 82
+ ED+ D + + +G+G +V AE K++A+K +
Sbjct: 3 QAEDI-----RDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCI-------------- 42
Query: 83 YSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS 142
+ EGK + ++I +I+H NI+ L L+ + G L +D
Sbjct: 43 AKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRI 98
Query: 143 KGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFD 199
+ ++ V ++YLH ++HRD+KP N+L D+D + IS F
Sbjct: 99 VEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFG 155
Query: 200 LAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDF 259
L+ + G GTP Y+APE S+ D +S GV+ +L+ G PF D
Sbjct: 156 LSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD- 211
Query: 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319
+ + ++ +E DS + + + L DP++R
Sbjct: 212 ------ENDAKLFEQILKAEYE---FDSPYWDDISDSAKDFIRHLMEK----DPEKRFTC 258
Query: 320 KDV 322
+
Sbjct: 259 EQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-37
Identities = 60/286 (20%), Positives = 103/286 (36%), Gaps = 42/286 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
E +G G G V++ S+ K K V ++ ++ +I
Sbjct: 10 AEDLGRGEFGIVHRCVET-SSKKTYMAKFV----------------KVKGTDQVLVKKEI 52
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ RHRNIL L + +++++F+ + + + EL
Sbjct: 53 SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVH 109
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLID--DDMEARISGFDLAILMPDGLTQIDTMYV 216
V L++LH H+ + H DI+P N++ +I F A + G +
Sbjct: 110 QVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLL 163
Query: 217 VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVM 276
P Y APE HQ +S D++S G L+ VL+ G PF + + N+M
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-------ETNQQIIENIM 216
Query: 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
N D + E M V +L + R + +
Sbjct: 217 ---NAEYTFDEEAFKEISIEAMDFVDRLLVK----ERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-37
Identities = 50/305 (16%), Positives = 99/305 (32%), Gaps = 50/305 (16%)
Query: 39 LEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94
+ +G G G V +A+ G + + +AVK + + +
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--------------KEGATHSEHRAL 63
Query: 95 RSQIITASQIRHRNILPLLAHMVRPDSH--LLVYDFMKNGSLQAVLYDVSK--------- 143
S++ I H + L +++ +F K G+L L
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 144 ---GRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDL 200
+ L + VA G+E+L IHRD+ N+L+ + +I F L
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGL 180
Query: 201 AILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFF 260
A + + +++APE + + D++SFGVLL + +
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YP 238
Query: 261 SHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK 320
+ + R ++ P+ + + C +P +RP
Sbjct: 239 GVKIDEEFCRRLKEGTRMRAPDYTTPE-------------MYQTMLDCWHGEPSQRPTFS 285
Query: 321 DVRCM 325
++
Sbjct: 286 ELVEH 290
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (330), Expect = 8e-37
Identities = 55/286 (19%), Positives = 108/286 (37%), Gaps = 39/286 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
E +G GG +V+ A + +AVK + A R +
Sbjct: 12 GEILGFGGMSEVHLARDL-RLHRDVAVKV------------LRADLARDPSFYLRFRREA 58
Query: 99 ITASQIRHRNILPLLAHMVRPDSHL----LVYDFMKNGSLQAVLYDVSKGRRELEWLSRH 154
A+ + H I+ + +V +++ +L D+ +
Sbjct: 59 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAI 114
Query: 155 KIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTM 214
++ L + H + +IHRD+KPAN++I ++ F +A + D +
Sbjct: 115 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 215 Y-VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273
V+GT +Y++PE + ++ + D+YS G +L ++ G+ PF G+ + +
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQ 225
Query: 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319
+V P A L + +VLK +P+ R +
Sbjct: 226 HVREDPIPPSARHEGLSADLDA----VVLK----ALAKNPENRYQT 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (334), Expect = 1e-36
Identities = 64/240 (26%), Positives = 93/240 (38%), Gaps = 23/240 (9%)
Query: 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIR 95
F+ IG GG G+VY GKM A+K + + + GE R
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCL---------DKKRIKMKQGETLALNER 55
Query: 96 SQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+ S I+ + PD + D M G L Y +S+ E R
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEADMRF- 111
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
A + GLE++H V++RD+KPAN+L+D+ RIS LA
Sbjct: 112 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHA 164
Query: 216 VVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274
VGT Y+APE Q + D +S G +L L+ G PF + ++ R
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLT 223
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (330), Expect = 2e-36
Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 43/281 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L +G+G G V+ NG+ A+K + + ++ +
Sbjct: 9 LRTLGTGSFGRVHLIRSR-HNGRYYAMKV------------LKKEIVVRLKQVEHTNDER 55
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ S + H I+ + ++ D+++ G L+ + + + A
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG----ELFSLLRKSQRFPNPVAKFYAA 111
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
V LEYLH +I+RD+KP N+L+D + +I+ F A +PD T + G
Sbjct: 112 EVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCG 163
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
TP YIAPE T ++ D +SFG+L+ ++ G PF D + ++ ++ +
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-------SNTMKTYEKILNA 216
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319
E ++ + + L+ +L D +R +
Sbjct: 217 ELRFPPFFNEDVKD-------LLSRLITR----DLSQRLGN 246
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-36
Identities = 62/299 (20%), Positives = 109/299 (36%), Gaps = 39/299 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L+ +G G VYKA + +++A+KK+ + SE +G +I
Sbjct: 3 LDFLGEGQFATVYKARDK-NTNQIVAIKKI----------KLGHRSEAKDGINRTALREI 51
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
++ H NI+ LL + LV+DFM+ + L L
Sbjct: 52 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV----IIKDNSLVLTPSHIKAYML 107
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
GLEYLH H ++HRD+KP N+L+D++ +++ F LA + V
Sbjct: 108 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVV 162
Query: 219 TPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277
T Y APE D+++ G +LA L++ ++D + + +
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG----DSDLDQLTRIFETLG 218
Query: 278 SENPNRAIDSKLLGNGYEEQMLLVLKLACF--------------CTLADPDERPNSKDV 322
+ + D L + + + L L +P R +
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 3e-35
Identities = 59/293 (20%), Positives = 104/293 (35%), Gaps = 42/293 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
KIGSG GD+Y + G+ +A+K + + K ++ +
Sbjct: 12 GRKIGSGSFGDIYLGTDI-AAGEEVAIKLECV-----------------KTKHPQLHIES 53
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
++ +P + + ++ + SL + R+ + +A
Sbjct: 54 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLAD 110
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLI---DDDMEARISGFDLAILMPDGLTQIDTMY 215
+ S +EY+H + IHRD+KP N L+ I F LA D T Y
Sbjct: 111 QMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 216 -----VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270
+ GT RY + H + S + D+ S G +L +G P+ + T R
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
Query: 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323
M + ++L GY + L C D++P+ +R
Sbjct: 228 ISEKKM-------STPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLR 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-35
Identities = 52/287 (18%), Positives = 99/287 (34%), Gaps = 36/287 (12%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
IG G GDV++ +AV + S + + +
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS------------DSVREKFLQEA 59
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+T Q H +I+ L+ + + ++ + G L++ L + L+ S A
Sbjct: 60 LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAY 115
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+++ L YL +HRDI NVL+ + ++ F L+ M D T
Sbjct: 116 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKL 171
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
+++APE + D++ FGV + ++M + D++ + N
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERL 228
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
P + + L C DP RP +++
Sbjct: 229 PMPPNCPPT-------------LYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-34
Identities = 61/303 (20%), Positives = 115/303 (37%), Gaps = 42/303 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L IG G G V A N +A+KK+ + + +I
Sbjct: 13 LSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFE--------------HQTYCQRTLREI 57
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ RH NI+ + + P + ++ + A LY + K + L
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLY 116
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLA-ILMPDGLTQIDTMYVV 217
+ GL+Y+H + V+HRD+KP+N+L++ + +I F LA + PD V
Sbjct: 117 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 218 GTPRYIAPEY-HQTLTISEKCDIYSFGVLLAVLVMGKFPFDD-----------------F 259
T Y APE + ++ DI+S G +LA ++ + F
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233
Query: 260 FSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319
+ ++ +++ + N+ ++L N + + L+ K+ F +P +R
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF----NPHKRIEV 289
Query: 320 KDV 322
+
Sbjct: 290 EQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-34
Identities = 62/311 (19%), Positives = 118/311 (37%), Gaps = 47/311 (15%)
Query: 16 TIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMS 75
T+F +E++ +D + + E++GSG V K S G A K +
Sbjct: 1 TVFR----QENV-----DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFI------- 43
Query: 76 AAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQ 135
+ S +I ++ +I+H N++ L +L+ + + G
Sbjct: 44 --KKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--- 98
Query: 136 AVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEAR- 194
L+D + L + + +G+ + HS ++ H D+KP N+++ D +
Sbjct: 99 -ELFDFLAEKESLTEEEATEFLKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKP 154
Query: 195 ---ISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251
I F LA + G + GTP ++APE + + D++S GV+ +L+
Sbjct: 155 RIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
Query: 252 GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLA 311
G PF T + + E+ + S L + + +L
Sbjct: 212 GASPFLG---DTKQETLANVSAVNYEFEDEYFSNTSALAKD-------FIRRLLVK---- 257
Query: 312 DPDERPNSKDV 322
DP +R +D
Sbjct: 258 DPKKRMTIQDS 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-33
Identities = 45/225 (20%), Positives = 80/225 (35%), Gaps = 22/225 (9%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ F L+ +G G G V + G+ A+K + + + ++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKI------------LRKEVIIAKDEVAH 51
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
++ RH + L D V ++ G L L +
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTE 104
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+ A + L HS V++RDIK N+++D D +I+ F L
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 162
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
GTP Y+APE + D + GV++ ++ G+ PF +
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (308), Expect = 2e-33
Identities = 46/297 (15%), Positives = 100/297 (33%), Gaps = 44/297 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+IG G G +++ N + +A+K ++R +
Sbjct: 10 GRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPR-----------------RSDAPQLRDEY 51
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
T + +P + + + H ++ + SL+ +L R+ + A
Sbjct: 52 RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAK 108
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDME-----ARISGFDLAILMPDGLTQIDT 213
+ + ++ +H +++RDIKP N LI + F + D +T+
Sbjct: 109 QMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 214 MY-----VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268
Y + GT RY++ H S + D+ + G + + G P+ + T +
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
Query: 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325
R + + L G+ E+ + D P+ ++ +
Sbjct: 226 ERIGEKKQ-------STPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGL 272
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-32
Identities = 60/287 (20%), Positives = 102/287 (35%), Gaps = 44/287 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+GSGG G VY S+ +A+K V + I + EL G + +
Sbjct: 9 GPLLGSGGFGSVYSGIRV-SDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVL 60
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+ ++ LL RPDS +L+ + + L+D R L+
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFW 117
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLAILMPDGLTQIDTMYVV 217
V + + H V+HRDIK N+LID + E ++ F L+ D
Sbjct: 118 QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFD 170
Query: 218 GTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVM 276
GT Y PE+ + ++S G+LL +V G PF+ + + +
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVFF 223
Query: 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323
+ L+ C P +RP ++++
Sbjct: 224 RQRVSSECQH-------------LIRW----CLALRPSDRPTFEEIQ 253
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-32
Identities = 70/305 (22%), Positives = 119/305 (39%), Gaps = 42/305 (13%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
+ F +EKIG G G VYKA G+++A+KK+ + EG +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRL-------------DTETEGVPST 47
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
+I ++ H NI+ LL + + LV++F+ + + + +
Sbjct: 48 AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLI 104
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
+ GL + H H V+HRD+KP N+LI+ + +++ F LA +
Sbjct: 105 KSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 214 MYVVGTPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD---------FFSHT 263
V T Y APE S DI+S G + A +V + F F
Sbjct: 162 E--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
Query: 264 GEMDMVRWMRNVMASE------NPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP 317
G D V W + R SK++ E+ L+ ++ + DP++R
Sbjct: 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY----DPNKRI 275
Query: 318 NSKDV 322
++K
Sbjct: 276 SAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 9e-32
Identities = 49/287 (17%), Positives = 96/287 (33%), Gaps = 39/287 (13%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ +G G G V + + A+K + + E+ +
Sbjct: 18 QVLGLGINGKVLQIFNK-RTQEKFALKML----------------QDCPKARREVE---L 57
Query: 100 TASQIRHRNILPLL----AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+ +I+ ++ L+V + + G L + + D +G + +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASE 115
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
I ++ ++YLH + + HRD+KP N+L I + +
Sbjct: 116 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
Query: 216 VVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275
TP Y+APE + CD++S GV++ +L+ G PF M +R
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-- 230
Query: 276 MASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+ EE +L+ L +P +R +
Sbjct: 231 ----MGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEF 269
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (299), Expect = 9e-32
Identities = 44/241 (18%), Positives = 89/241 (36%), Gaps = 29/241 (12%)
Query: 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTE 93
D F ++ +G+G G V + +G A+K +D + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKI------------LDKQKVVKLKQIEH 87
Query: 94 IRSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSR 153
++ + ++ L + +V +++ G + + L
Sbjct: 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHA 143
Query: 154 HKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDT 213
A + EYLH +I+RD+KP N+LID +++ F A + T
Sbjct: 144 RFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 214 MYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273
+ GTP +APE + ++ D ++ GVL+ + G PF + + +
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIV 251
Query: 274 N 274
+
Sbjct: 252 S 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 116 bits (292), Expect = 2e-31
Identities = 70/296 (23%), Positives = 117/296 (39%), Gaps = 36/296 (12%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
LEKIG G G VYKA+ G+ A+KK+ + + EG + +I
Sbjct: 7 LEKIGEGTYGVVYKAQNN--YGETFALKKIRL-------------EKEDEGIPSTTIREI 51
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+++H NI+ L + +LV++ + + LE ++ L
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK----KLLDVCEGGLESVTAKSFLL 107
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+ +G+ Y H RV+HRD+KP N+LI+ + E +I+ F LA + + + +
Sbjct: 108 QLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIV 162
Query: 219 TPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277
T Y AP+ + S DI+S G + A +V G F M + R + +
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 278 SENPNRAIDSKLLGNGYEEQMLL-----------VLKLACFCTLADPDERPNSKDV 322
PN K N + L + L DP++R +K
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 9e-31
Identities = 58/297 (19%), Positives = 110/297 (37%), Gaps = 40/297 (13%)
Query: 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKL 91
+E + + IG+G G VY+A+L +G+++A+KKV+ E
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKRFKNRE------------- 63
Query: 92 TEIRSQIITASQIRHRNILPLLAHMVRPDSH------LLVYDFMKNGSLQAVLYDVSKGR 145
+ ++ H NI+ L LV D++ + V S+ +
Sbjct: 64 ------LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAK 116
Query: 146 RELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD-MEARISGFDLAILM 204
+ L + + L Y+H S + HRDIKP N+L+D D ++ F A +
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 205 PDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264
G + + Y+ + D++S G +LA L++G+ F
Sbjct: 174 VRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG----DS 227
Query: 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKD 321
+D + + V+ + + + Y E +K + + P P +
Sbjct: 228 GVDQLVEIIKVLGTPTREQIREMN---PNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 7e-30
Identities = 57/299 (19%), Positives = 109/299 (36%), Gaps = 40/299 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
LEKIG G G V+KA+ +++A+K+V + + EG + +I
Sbjct: 7 LEKIGEGTYGTVFKAKNR-ETHEIVALKRVRL-------------DDDDEGVPSSALREI 52
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+++H+NI+ L + LV++F Q + +L+
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+ GL + H + V+HRD+KP N+LI+ + E +++ F LA + + VV
Sbjct: 109 QLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVT 164
Query: 219 TPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMAS 278
S D++S G + A L P F D ++ + ++ +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGT 221
Query: 279 ENPNRAIDSKLLGNGYEEQMLLVLK---------------LACFCTLADPDERPNSKDV 322
+ L + M L +P +R ++++
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-29
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 38/299 (12%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L+ +GSG G V A G +A+KK+ E ++
Sbjct: 23 LQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYR-------------PFQSELFAKRAYREL 68
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
+RH N++ LL ++ DF +L +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY 128
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+ GL Y+H +IHRD+KP N+ +++D E +I F LA +T V
Sbjct: 129 QMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-----VV 180
Query: 219 TPRYIAPE-YHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277
T Y APE + ++ DI+S G ++A ++ GK F H ++ + +
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG-SDHLDQLKEIMKVTGTPP 239
Query: 278 SENPNRA--------------IDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDV 322
+E R ++ K + L + L + D ++R + +
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-29
Identities = 64/313 (20%), Positives = 107/313 (34%), Gaps = 54/313 (17%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L KIG G G+V+KA G+ +A+KKV++ EG +I
Sbjct: 15 LAKIGQGTFGEVFKARHR-KTGQKVALKKVLM-------------ENEKEGFPITALREI 60
Query: 99 ITASQIRHRNILPLL--------AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEW 150
++H N++ L+ + S LV+DF ++ + L
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVK 113
Query: 151 LSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQ 210
+ +I + L L+ H +++HRD+K ANVLI D +++ F LA
Sbjct: 114 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173
Query: 211 IDTMY--VVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDD--------- 258
Y V T Y PE D++ G ++A +
Sbjct: 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233
Query: 259 --------FFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQML-LVLKLACFCT 309
+D + + R + +L + L L+ KL
Sbjct: 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL-- 291
Query: 310 LADPDERPNSKDV 322
DP +R +S D
Sbjct: 292 --DPAQRIDSDDA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 4e-28
Identities = 61/286 (21%), Positives = 111/286 (38%), Gaps = 38/286 (13%)
Query: 39 LEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRS 96
L+ +G+G G V+ + GK+ A+K + + + A+ + R+
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE-----------HTRT 77
Query: 97 QIITASQIRHRNILPLLAHMVRPDSHL-LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK 155
+ IR L L + + ++ L L+ D++ G L L + + H+
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHE 130
Query: 156 IALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMY 215
+ + V + L H +I+RDIK N+L+D + ++ F L+ T+
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYD 189
Query: 216 VVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273
GT Y+AP+ + + D +S GVL+ L+ G PF + R
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV---DGEKNSQAEISR 246
Query: 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319
++ SE P S L + L+ +L DP +R
Sbjct: 247 RILKSEPPYPQEMSALAKD-------LIQRLLMK----DPKKRLGC 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (269), Expect = 2e-27
Identities = 55/266 (20%), Positives = 98/266 (36%), Gaps = 12/266 (4%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+ K+G G V+ A+ N +A+K ++ + D L + +
Sbjct: 18 VRKLGWGHFSTVWLAKDM-VNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHK-IA 157
+ +IL LL H + + + + +L + K L K I+
Sbjct: 76 S----MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 158 LAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLAILMPDGLTQIDTMYV 216
+ GL+Y+H +IH DIKP NVL++ D + +A L
Sbjct: 132 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 217 VGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPF--DDFFSHTGEMDMVRWMRN 274
+ T Y +PE DI+S L+ L+ G F F D+ S+T + D + +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 275 VMASENPNRAIDSKLLGNGYEEQMLL 300
++ + K + + LL
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLL 275
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (267), Expect = 2e-27
Identities = 54/252 (21%), Positives = 98/252 (38%), Gaps = 38/252 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
+ K+G G +V++A +N + + VK + P+ ++ EI+
Sbjct: 40 VRKLGRGKYSEVFEAINI-TNNEKVVVKIL---KPVKKKKI-----------KREIK--- 81
Query: 99 ITASQIRHRNILPLLAHMVRPDSHL--LVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKI 156
I + NI+ L + P S LV++ + N + + + L
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFY 134
Query: 157 ALAVASGLEYLHMHHSARVIHRDIKPANVLID-DDMEARISGFDLAILMPDGLTQIDTMY 215
+ L+Y H ++HRD+KP NV+ID + + R+ + LA G
Sbjct: 135 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NV 188
Query: 216 VVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRN 274
V + + PE D++S G +LA ++ K P FF D + +
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAK 245
Query: 275 VMASENPNRAID 286
V+ +E+ ID
Sbjct: 246 VLGTEDLYDYID 257
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (245), Expect = 4e-24
Identities = 51/226 (22%), Positives = 86/226 (38%), Gaps = 33/226 (14%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L+ IGSG G V A + +A+KK+ + + ++
Sbjct: 22 LKPIGSGAQGIVCAAYDA-VLDRNVAIKKL-------------SRPFQNQTHAKRAYREL 67
Query: 99 ITASQIRHRNILPLLAHMVRPDS------HLLVYDFMKNGSLQAVLYDVSKGRRELEWLS 152
+ + H+NI+ LL + LV + M Q + + EL+
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHER 120
Query: 153 RHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQID 212
+ + G+++LH +IHRD+KP+N+++ D +I F LA
Sbjct: 121 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--- 174
Query: 213 TMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258
V T Y APE + E DI+S G ++ +V K F
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 1e-23
Identities = 58/303 (19%), Positives = 105/303 (34%), Gaps = 46/303 (15%)
Query: 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQI 98
L +GSG G V A G +AVKK+ + ++
Sbjct: 23 LSPVGSGAYGSVCAAFDT-KTGLRVAVKKL-------------SRPFQSIIHAKRTYREL 68
Query: 99 ITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIAL 158
++H N++ LL S D L + ++L +
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 159 AVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVG 218
+ GL+Y+H +IHRD+KP+N+ +++D E +I F LA + V
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVA 180
Query: 219 TPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNVMA 277
T Y APE ++ DI+S G ++A L+ G+ F H ++ ++ +
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG-TDHIDQLKLILRLVGTPG 239
Query: 278 SENPNRAID------------------SKLLGNGYEEQMLLVLKLACFCTLADPDERPNS 319
+E + + + + L+ K+ D D+R +
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL----DSDKRITA 295
Query: 320 KDV 322
Sbjct: 296 AQA 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 62.5 bits (151), Expect = 3e-12
Identities = 21/163 (12%), Positives = 50/163 (30%), Gaps = 18/163 (11%)
Query: 40 EKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQII 99
+ +G G V+ VK ++ + + + G+ I
Sbjct: 6 KLMGEGKESAVFNCYSE--KFGECVVK--FHKVGHTSFKKVKEKRDYGD---LHFSVLAI 58
Query: 100 TASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALA 159
+++ R + L V Y + N L +K + + ++
Sbjct: 59 RSARNEFRALQKLQGLAVPKV-----YAWEGNAVLME--LIDAKELYRVRVENPDEVLDM 111
Query: 160 VASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAI 202
+ + + ++H D+ NVL+ + I F ++
Sbjct: 112 ILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.89 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.77 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.51 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=380.54 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=206.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|+ +..+++.||+|++... .....+.+.+|+.++++++||||+++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~-~~~~~~~vAvK~~~~~---------------~~~~~~~~~~E~~il~~l~HpnIv~~ 82 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAM-DVATGQEVAIRQMNLQ---------------QQPKKELIINEILVMRENKNPNIVNY 82 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEE-BTTTCCEEEEEEEEGG---------------GCSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccEEEEEEecCcCcEEEEEE-ECCCCCEEEEEEEecc---------------cChHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3589999999999999999995 5678899999998321 12345678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..|+||||++||+|.+++. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~ivmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~ 154 (293)
T d1yhwa1 83 LDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGS 154 (293)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCC
T ss_pred eEEEEECCEEEEEEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCc
Confidence 999999999999999999999999873 245899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. . ....
T Consensus 155 vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~---~~~~ 225 (293)
T d1yhwa1 155 VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----P---LRAL 225 (293)
T ss_dssp EEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----H---HHHH
T ss_pred Eeeccchhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC----H---HHHH
Confidence 999999999876543322 223589999999999999999999999999999999999999996422 1 1222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+.....+....+. ..+..+.+||.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~--------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 226 YLIATNGTPELQNPE--------KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHCSCCCSSGG--------GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCCCCCcc--------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233333322222211 12233899999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=375.45 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=205.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|+ +..+++.||+|++.. ...........+.+|+.+++.++||||++++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~-~~~~~~~vAiK~i~~------------~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~ 72 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAR-EKQSKFILALKVLFK------------AQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hHeEEEEEEecCCCcEEEEEE-ECCCCcEEEEEEEch------------HHccChHHHHHHHHHHHHHHhcCCCCCCeEE
Confidence 579999999999999999996 557789999999831 1112234566789999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+++..|+||||+++|+|.+++. ....+++..+..++.|++.||.||| ++||+||||||+|||++.++.+
T Consensus 73 ~~~~~~~~~~ivmEy~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~ 145 (263)
T d2j4za1 73 GYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 145 (263)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEeecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCE
Confidence 99999999999999999999999994 3456999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
||+|||++........ ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......
T Consensus 146 kl~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~ 214 (263)
T d2j4za1 146 KIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYK 214 (263)
T ss_dssp EECCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHH
T ss_pred eecccceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-------HHHHHH
Confidence 9999999976554322 23579999999999999999999999999999999999999996421 122223
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....... +. ..++.+.+|+.+||+.||++|||++|+++
T Consensus 215 ~i~~~~~~~---p~--------~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 215 RISRVEFTF---PD--------FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHTTCCCC---CT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCC---Cc--------cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 333222211 11 11233899999999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-57 Score=379.50 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=202.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|+ +..+++.||+|++.... .....+.+.+|+.++++++||||+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~-~~~~~~~vAiK~i~~~~--------------~~~~~~~~~~Ei~~l~~l~HpnIv~~ 68 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAV-NRVTEEAVAVKIVDMKR--------------AVDCPENIKKEICINKMLNHENVVKF 68 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEECC---------------------CHHHHHHHHHTCCCTTBCCE
T ss_pred CcceEEEEEEecCcCeEEEEEE-ECCCCCEEEEEEEehhh--------------cchHHHHHHHHHHHHHhCCCCCEeeE
Confidence 4679999999999999999996 55678999999984321 11223467899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..|+||||+++|+|.+++ .....+++..+..++.|++.||.||| ++||+||||||+|||+++++.
T Consensus 69 ~~~~~~~~~~~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~ 141 (271)
T d1nvra_ 69 YGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDN 141 (271)
T ss_dssp EEEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCC
T ss_pred eeeeccCceeEEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCC
Confidence 99999999999999999999999988 34567999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
+||+|||++...............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ......
T Consensus 142 ~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~- 217 (271)
T d1nvra_ 142 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYS- 217 (271)
T ss_dssp EEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST---TSHHHH-
T ss_pred EEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh---HHHHHH-
Confidence 99999999987654433333334689999999999988776 6789999999999999999999965322 111111
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........... ....+..+.+|+.+||+.||++|||++|+++
T Consensus 218 --~~~~~~~~~~~---------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 218 --DWKEKKTYLNP---------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --HHHTTCTTSTT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHhcCCCCCCc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111110 0111233889999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=379.48 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=204.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|+ +..+++.||||++.. ...........+.+|+.++++++||||+++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~-~~~~~~~vAvK~i~~------------~~~~~~~~~~~~~~E~~il~~l~HpnIv~l 73 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLAR-ELATSREYAIKILEK------------RHIIKENKVPYVTRERDVMSRLDHPFFVKL 73 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHHCCSTTBCCE
T ss_pred CCCCEEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEeh------------HHccCHHHHHHHHHHHHHHHHcCCCCeeEE
Confidence 3679999999999999999996 556789999999831 111223456789999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..|+||||++||+|.+++. ....+++..+..++.|++.||.||| ++||+||||||+||++++++.
T Consensus 74 ~~~~~~~~~~~ivmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~ 146 (288)
T d1uu3a_ 74 YFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH 146 (288)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCce
Confidence 999999999999999999999999884 3456999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|..||... .. ....
T Consensus 147 vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~---~~~~ 219 (288)
T d1uu3a_ 147 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NE---YLIF 219 (288)
T ss_dssp EEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SH---HHHH
T ss_pred EEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc----CH---HHHH
Confidence 9999999998876554444444468999999999999999999999999999999999999999652 11 2222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+...... ++.. .+..+.+||.+||+.||++|||++|+++
T Consensus 220 ~~i~~~~~~---~p~~--------~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 220 QKIIKLEYD---FPEK--------FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHTTCCC---CCTT--------CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHcCCCC---CCcc--------CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 333322211 1111 1223899999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-57 Score=378.50 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=197.8
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
+.++|++.+.||+|+||+||+|+ +..+++.||+|.+... ...+...+.+.+|+.++++++||||++
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~-~~~~~~~vAvK~i~~~-------------~~~~~~~~~~~~E~~il~~l~HpnIv~ 67 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIR-RKSDGKILVWKELDYG-------------SMTEAEKQMLVSEVNLLRELKHPNIVR 67 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEECCT-------------TSCHHHHHHHHHHHHHTTSCCCTTBCC
T ss_pred CchhCEEeEEEecCCCeEEEEEE-ECCCCCEEEEEEEChh-------------hCCHHHHHHHHHHHHHHHHCCCCCEee
Confidence 35789999999999999999996 5577899999998432 122334567899999999999999999
Q ss_pred cccceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEe
Q 040480 112 LLAHMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHH--SARVIHRDIKPANVLI 187 (325)
Q Consensus 112 ~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~~ivH~dl~~~nil~ 187 (325)
+++++.+ .+..|+||||+++|+|.+++......+..+++..++.++.|++.||.|||+.. ..+|+||||||+|||+
T Consensus 68 ~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll 147 (269)
T d2java1 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 147 (269)
T ss_dssp EEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE
T ss_pred EEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc
Confidence 9998865 45689999999999999999766556678999999999999999999999431 1349999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..
T Consensus 148 ~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~----~~- 220 (269)
T d2java1 148 DGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QK- 220 (269)
T ss_dssp CTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HH-
T ss_pred CCCCcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC----HH-
Confidence 99999999999999876543322 123588999999999999999999999999999999999999996522 12
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+........ +.. .++.+.+||.+||+.||++|||++|+++
T Consensus 221 --~~~~~i~~~~~~~~--~~~--------~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 221 --ELAGKIREGKFRRI--PYR--------YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --HHHHHHHHTCCCCC--CTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHcCCCCCC--Ccc--------cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 22233333322211 111 1223899999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=376.53 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=203.9
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.+.|++++.||+|+||+||+|+ +..+++.||+|++... .....+.+.+|+.++++++||||+++
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~-~~~~~~~vAvK~i~~~---------------~~~~~~~~~~E~~il~~l~HpnIv~l 74 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQ-NKETSVLAAAKVIDTK---------------SEEELEDYMVEIDILASCDHPNIVKL 74 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEECS---------------SSGGGGGTHHHHHHHHHCCCTTBCCE
T ss_pred ccCeEEeEEEeeCCCcEEEEEE-ECCCCeEEEEEEECcC---------------CHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4679999999999999999996 5577899999998422 22334567899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| ++||+||||||+|||++.++.
T Consensus 75 ~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~ 148 (288)
T d2jfla1 75 LDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGD 148 (288)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred EEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCC
Confidence 9999999999999999999999998743 2346999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-----TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+... .+
T Consensus 149 ~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----~~ 222 (288)
T d2jfla1 149 IKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----MR 222 (288)
T ss_dssp EEECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG----GG
T ss_pred EEEEechhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH----HH
Confidence 99999999976543221 122357999999999874 45578999999999999999999999975322 22
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ..+.....+....+. ..+..+.+||.+||+.||++|||++|+++
T Consensus 223 ~~---~~i~~~~~~~~~~~~--------~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 223 VL---LKIAKSEPPTLAQPS--------RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HH---HHHHHSCCCCCSSGG--------GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HH---HHHHcCCCCCCCccc--------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 222333322221111 12234899999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=364.55 Aligned_cols=251 Identities=23% Similarity=0.369 Sum_probs=198.0
Q ss_pred hcCc-ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 33 EDCF-ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 33 ~~~y-~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
+++| ++.++||+|+||+||+|+ +..++..||+|.+... .......+.+.+|+.++++++||||++
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~-~~~~~~~va~K~i~~~-------------~~~~~~~~~~~~E~~il~~l~HpnIv~ 72 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGL-DTETTVEVAWCELQDR-------------KLTKSERQRFKEEAEMLKGLQHPNIVR 72 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEGG-------------GSCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred CCCEEEeeeEEecCcCcEEEEEE-ECCCCeEEEEEEEchh-------------hCCHHHHHHHHHHHHHHHhCCCCCeee
Confidence 3455 677889999999999996 5577889999998421 223344567899999999999999999
Q ss_pred cccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCce
Q 040480 112 LLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSAR--VIHRDIKPANV 185 (325)
Q Consensus 112 ~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~--ivH~dl~~~ni 185 (325)
+++++.+ +...|+||||+++++|.+++.. ...+++..+..++.|++.||.||| +++ |+||||||+||
T Consensus 73 ~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NI 145 (270)
T d1t4ha_ 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNI 145 (270)
T ss_dssp EEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGE
T ss_pred EEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhc
Confidence 9998864 3457999999999999999943 456899999999999999999999 777 99999999999
Q ss_pred Eec-CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 186 LID-DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 186 l~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
|++ +++.+||+|||++....... .....||+.|+|||++.+ +++.++|||||||++|+|++|+.||.+..
T Consensus 146 Ll~~~~~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~---- 216 (270)
T d1t4ha_ 146 FITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ---- 216 (270)
T ss_dssp EESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----
T ss_pred eeeCCCCCEEEeecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc----
Confidence 997 57899999999997544322 223589999999999876 58999999999999999999999996421
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........+.....+ ...+. . ....+.+||.+||+.||++|||++|+++
T Consensus 217 --~~~~~~~~i~~~~~~-~~~~~----~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 217 --NAAQIYRRVTSGVKP-ASFDK----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --SHHHHHHHHTTTCCC-GGGGG----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cHHHHHHHHHcCCCC-cccCc----c----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 122222333322222 11111 1 1123889999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=379.79 Aligned_cols=201 Identities=25% Similarity=0.451 Sum_probs=176.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
.+++|++++.||+|+||+||+|+ +..+++.||+|++... ........+.+|+.++++++||||++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~-~~~~~~~vAiK~i~~~--------------~~~~~~~~~~~Ei~il~~l~HpnIv~ 68 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVS-HKPSGLVMARKLIHLE--------------IKPAIRNQIIRELQVLHECNSPYIVG 68 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEE-ETTTTEEEEEEEEECC--------------CCTTHHHHHHHHGGGGGGCCCTTBCC
T ss_pred CccCCEEEEEEecCCCeEEEEEE-ECCCCcEEEEEEEChh--------------hCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 46789999999999999999995 5678899999998432 12234567899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEecCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSA-RVIHRDIKPANVLIDDD 190 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~-~ivH~dl~~~nil~~~~ 190 (325)
+++++.+++..|+||||++||+|.+++.. ...+++..+..++.|++.||.||| ++ ||+||||||+|||++.+
T Consensus 69 l~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~ 141 (322)
T d1s9ja_ 69 FYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSR 141 (322)
T ss_dssp EEEEEECSSEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTT
T ss_pred EEEEEEECCEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCC
Confidence 99999999999999999999999999943 346999999999999999999999 53 89999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDD 258 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~ 258 (325)
+.+||+|||+|....... ....+||+.|+|||++.+.+++.++|||||||++|+|++|+.||..
T Consensus 142 ~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 142 GEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CCEEEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999998653321 1235899999999999999999999999999999999999999965
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-55 Score=374.78 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=201.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
++.|++++.||+|+||+||+|+ +..+++.||||++..... ......+.+.+|+.++++++||||+++
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~-~~~~~~~vAvK~i~~~~~------------~~~~~~~~~~~Ei~il~~l~HpnIv~~ 80 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSGK------------QSNEKWQDIIKEVRFLQKLRHPNTIQY 80 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEE-ETTTTEEEEEEEEECCSS------------CHHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred HHhcEeeEEEecCCCeEEEEEE-ECCCCcEEEEEEEchhhc------------cCHHHHHHHHHHHHHHHHCCCCCEeeE
Confidence 4579999999999999999995 557789999999843221 112345678899999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..|+||||+.+++|..++ .....+++..+..++.|++.||.||| ++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~iv~E~~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~ 153 (309)
T d1u5ra_ 81 RGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 153 (309)
T ss_dssp EEEEEETTEEEEEEECCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTE
T ss_pred EEEEEECCEEEEEEEecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCC
Confidence 99999999999999999998887665 33456999999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT---LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 269 (325)
+||+|||++....... ...||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.. . .
T Consensus 154 ~Kl~DFG~a~~~~~~~------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~---~ 220 (309)
T d1u5ra_ 154 VKLGDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----A---M 220 (309)
T ss_dssp EEECCCTTCBSSSSBC------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----H---H
T ss_pred EEEeecccccccCCCC------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC----H---H
Confidence 9999999997654322 2579999999999864 358899999999999999999999996521 1 1
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+.....+... +. ..+..+.+||.+||+.||++|||++|+++
T Consensus 221 ~~~~~i~~~~~~~~~-~~--------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 221 SALYHIAQNESPALQ-SG--------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHSCCCCCS-CT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhCCCCCCC-CC--------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 222233332222111 10 11223899999999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=365.89 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=195.9
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|++ +..||||++.... ......+.+.+|+.++++++||||++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~----~~~vAvK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~HpnIv~ 68 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTA-------------PTPQQLQAFKNEVGVLRKTRHVNILL 68 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES----SSEEEEEECCCSS-------------CCTTHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE----CCEEEEEEEEccc-------------CCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 357899999999999999999974 2369999984322 22345678899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++. .+..++||||+++|+|.+++.. .+..+++..+..++.|++.||+||| +++|+||||||+|||++.++
T Consensus 69 ~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~ 141 (276)
T d1uwha_ 69 FMGYST-APQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDL 141 (276)
T ss_dssp EEEEEC-SSSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTS
T ss_pred eeEEEe-ccEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCC
Confidence 999765 4578999999999999999843 3456999999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL---TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.+||+|||++................||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+... ..
T Consensus 142 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----~~- 216 (276)
T d1uwha_ 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RD- 216 (276)
T ss_dssp SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HH-
T ss_pred CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----HH-
Confidence 9999999999876554433333446799999999998653 478899999999999999999999975321 11
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+......+.. .. ...+.++.+.+|+.+||+.||++|||++|+++
T Consensus 217 -~~~~~~~~~~~~p~~--~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~ 265 (276)
T d1uwha_ 217 -QIIFMVGRGYLSPDL--SK----VRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265 (276)
T ss_dssp -HHHHHHHHTSCCCCG--GG----SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHhcCCCCCcc--hh----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 111112222211111 00 01112334899999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-54 Score=370.48 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=189.6
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
+.|++.+.||+|+||+||+|+ +..+++.||||.+.... .......+.+|+.++++++||||++++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~-~~~~~~~vAvK~i~~~~--------------~~~~~~~~~~Ei~il~~l~HpnIv~l~ 73 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAE-DKRTQKLVAIKCIAKKA--------------LEGKEGSMENEIAVLHKIKHPNIVALD 73 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEE-ETTTCCEEEEEEEEC------------------------CHHHHHHHTCCCTTBCCEE
T ss_pred cceEEEEEEeeccCeEEEEEE-ECCCCCEEEEEEEchHH--------------hhhHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 679999999999999999996 55778999999984221 112234678899999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec---CC
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID---DD 190 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~---~~ 190 (325)
+++.+++..|+||||++|++|.+++. ....+++..+..++.|++.||.||| ++||+||||||+||++. ++
T Consensus 74 ~~~~~~~~~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~ 146 (307)
T d1a06a_ 74 DIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDED 146 (307)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTT
T ss_pred EEEEECCEEEEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCC
Confidence 99999999999999999999999993 4567999999999999999999999 88999999999999995 57
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 270 (325)
+.+||+|||++......... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .. .
T Consensus 147 ~~vkl~DFG~a~~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~---~ 216 (307)
T d1a06a_ 147 SKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DA---K 216 (307)
T ss_dssp CCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HH---H
T ss_pred ceEEEeccceeEEccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC----HH---H
Confidence 88999999999865543322 22579999999999999999999999999999999999999996521 11 2
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+......... ... .+.+..+.+||.+||+.||++|||++|+++
T Consensus 217 ~~~~i~~~~~~~~~---~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 217 LFEQILKAEYEFDS---PYW----DDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHTTCCCCCT---TTT----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCCCC---ccc----cCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 22233332221111 000 112233899999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=368.25 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=205.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|++++.||+|+||.||+|+ +..+++.||+|++. ............+.+|+.+++.++||||+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~-~~~~~~~~AiK~i~------------k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l 70 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVR-EKATGRYYAMKILR------------KEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEE------------HHHHHHTTCHHHHHHHHHHHHSCCCTTBCCE
T ss_pred hHhcEEEEEEecCcCeEEEEEE-ECCCCCEEEEEEEc------------hhhccCHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3689999999999999999995 56788999999983 1112223456778999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+.+|+||||++||+|.+++. ....+++..+..++.|++.||.||| ++||+||||||+|||++.+|.
T Consensus 71 ~~~~~~~~~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~ 143 (337)
T d1o6la_ 71 KYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 143 (337)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred EeeeccccccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCC
Confidence 999999999999999999999999984 3456899999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+||+|||++......... ....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.... ...+ .
T Consensus 144 vkl~DFG~a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~---~ 214 (337)
T d1o6la_ 144 IKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERL---F 214 (337)
T ss_dssp EEECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---H
T ss_pred EEEeecccccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----HHHH---H
Confidence 999999999865443222 223689999999999999999999999999999999999999997522 2222 2
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
..+...... ++.. .+..+.+||.+||+.||.+||+ ++|+++
T Consensus 215 ~~i~~~~~~---~p~~--------~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 215 ELILMEEIR---FPRT--------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHCCCC---CCTT--------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHhcCCCC---CCcc--------CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 222222211 1111 1223889999999999999995 677764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=361.71 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=192.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|++. ++..||||++.. .....+.+.+|+.++++++||||+++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~----------------~~~~~~~~~~E~~~l~~l~HpnIv~~ 65 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIRE----------------GAMSEEDFIEEAEVMMKLSHPKLVQL 65 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCS----------------SSSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECC----------------CcCcHHHHHHHHHHHHhcCCCCcccc
Confidence 468999999999999999999764 567899999732 22334578999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++..++..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++|+||||||+||++++++.
T Consensus 66 ~g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~ 139 (263)
T d1sm2a_ 66 YGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQV 139 (263)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGC
T ss_pred cceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCC
Confidence 9999999999999999999999999843 3456888999999999999999999 789999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMG-KFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~ 271 (325)
+||+|||++.......... .....||+.|+|||++.+..++.++||||||+++|+|+++ .+||... ...++.
T Consensus 140 ~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~~~~~~-- 212 (263)
T d1sm2a_ 140 IKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVV-- 212 (263)
T ss_dssp EEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----CHHHHH--
T ss_pred eEecccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----CHHHHH--
Confidence 9999999998765433222 2224789999999999999999999999999999999995 5555431 222222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+........+. .++..+.+|+.+||+.||++|||++|+++
T Consensus 213 -~~i~~~~~~~~p~----------~~~~~l~~li~~cl~~~p~~Rps~~~il~ 254 (263)
T d1sm2a_ 213 -EDISTGFRLYKPR----------LASTHVYQIMNHCWKERPEDRPAFSRLLR 254 (263)
T ss_dssp -HHHHHTCCCCCCT----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHhcCCCCCcc----------ccCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 2222322222110 11223899999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.5e-54 Score=371.75 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=205.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.++++++||||++++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~-~~~~g~~vAvK~i~~~---------------~~~~~~~~~~E~~il~~l~HpnIv~~~ 89 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVT-ERATGNNFAAKFVMTP---------------HESDKETVRKEIQTMSVLRHPTLVNLH 89 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEE-ETTTTEEEEEEEECCC---------------SHHHHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred cCeEEEEEEecCcCeEEEEEE-ECCCCCEEEEEEEccc---------------chhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 589999999999999999995 5678899999998421 122346788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC--CC
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD--DM 191 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~--~~ 191 (325)
+++.+++..|+||||++||+|.+++.. ....+++..+..++.|++.||.||| ++||+||||||+|||++. ++
T Consensus 90 ~~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~ 163 (350)
T d1koaa2 90 DAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSN 163 (350)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSC
T ss_pred EEEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCC
Confidence 999999999999999999999999832 3456999999999999999999999 889999999999999964 57
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||... .. ...
T Consensus 164 ~vkL~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~---~~~ 233 (350)
T d1koaa2 164 ELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----ND---DET 233 (350)
T ss_dssp CEEECCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SH---HHH
T ss_pred eEEEeecchheeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC----CH---HHH
Confidence 8999999999877654332 2368999999999999999999999999999999999999999652 11 222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+......... .. ....++.+.+||.+||+.||++|||++|+++
T Consensus 234 ~~~i~~~~~~~~~---~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 234 LRNVKSCDWNMDD---SA----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHHTCCCSCC---GG----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCc---cc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2333332221111 00 1112234899999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-53 Score=371.03 Aligned_cols=252 Identities=19% Similarity=0.270 Sum_probs=204.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||+|+||+||+|+ +..+++.||+|++... .......+.+|+.++++++||||++++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~-~~~~~~~vAiK~i~~~---------------~~~~~~~~~~Ei~il~~l~HpnIv~~~ 92 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCV-EKATGRVFVAKFINTP---------------YPLDKYTVKNEISIMNQLHHPKLINLH 92 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEECC---------------SHHHHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred cceEEEEEEecCCCeEEEEEE-ECCCCCEEEEEEECCc---------------chhHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 579999999999999999995 5577899999998421 112345678999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec--CCC
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID--DDM 191 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~--~~~ 191 (325)
+++.+++..|+||||++||+|.+.+. .....+++..+..++.|++.||.||| ++||+||||||+|||++ .++
T Consensus 93 ~~~~~~~~~~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~ 166 (352)
T d1koba_ 93 DAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKAS 166 (352)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCC
T ss_pred EEEEECCEEEEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCC
Confidence 99999999999999999999998873 23456999999999999999999999 88999999999999998 568
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+ .
T Consensus 167 ~vkL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~---~ 236 (352)
T d1koba_ 167 SVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLE---T 236 (352)
T ss_dssp CEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHH---H
T ss_pred eEEEeecccceecCCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHH---H
Confidence 9999999999887654332 23588999999999999999999999999999999999999996522 122 2
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+........ ... ....+..+.+||.+||+.||.+|||++|+++
T Consensus 237 ~~~i~~~~~~~~---~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 237 LQNVKRCDWEFD---EDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHCCCCCC---SST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCCCC---ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223332222111 100 1112233899999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-54 Score=356.58 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=204.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.++||+|+||+||+|++. ++..||||++.. .....+.+.+|+.++++++||||+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~----------------~~~~~~~~~~Ev~~~~~l~HpnIv~~ 64 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKE----------------GSMSEDEFIEEAKVMMNLSHEKLVQL 64 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEES----------------SSSCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECc----------------CcCCHHHHHHHHHHHHhcCCCceeeE
Confidence 478999999999999999999863 678899999842 12334578999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..++||||+++|+|.+++.. ....+++..+.+++.|++.||.||| +.||+||||||+||+++.++.
T Consensus 65 ~g~~~~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~ 138 (258)
T d1k2pa_ 65 YGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGV 138 (258)
T ss_dssp EEEECCSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCC
T ss_pred EEEEeeCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCc
Confidence 9999999999999999999999999743 4456888999999999999999999 789999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 271 (325)
+||+|||++......... ......||..|+|||.+.+..++.++||||||+++|+|+| |+.||.... ..++
T Consensus 139 ~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~----~~~~--- 210 (258)
T d1k2pa_ 139 VKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT----NSET--- 210 (258)
T ss_dssp EEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----HHHH---
T ss_pred EEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC----HHHH---
Confidence 999999999866543322 2223578999999999999999999999999999999998 899997532 2222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+........+ . ..+..+.+||.+||+.||++|||++++++
T Consensus 211 ~~~i~~~~~~~~p---~-------~~~~~l~~li~~cl~~dP~~RPt~~eil~ 253 (258)
T d1k2pa_ 211 AEHIAQGLRLYRP---H-------LASEKVYTIMYSCWHEKADERPTFKILLS 253 (258)
T ss_dssp HHHHHTTCCCCCC---T-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCc---c-------cccHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 2333332222111 1 11234899999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=362.68 Aligned_cols=258 Identities=23% Similarity=0.322 Sum_probs=207.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
+++|++.+.||+|+||+||+|+ +..+++.||||++....... .......+.+.+|+.++++++||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~-~~~~~~~~AvK~i~~~~~~~---------~~~~~~~~~~~~E~~il~~l~HpnIv~~ 78 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKS---------SRRGVSREDIEREVSILKEIQHPNVITL 78 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEE-ETTTCCEEEEEEEEBCSSTT---------CSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccCEEEeEEEecCCCeEEEEEE-ECCCCCEEEEEEEEhhhcch---------hhhhHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3689999999999999999996 55788999999985332111 1112346788999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC-
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM- 191 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~- 191 (325)
++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~ 151 (293)
T d1jksa_ 79 HEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 151 (293)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSS
T ss_pred EEEEEECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCC
Confidence 9999999999999999999999999943 356999999999999999999999 88999999999999998765
Q ss_pred ---CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 192 ---EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 192 ---~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
.+|++|||++.......... ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .
T Consensus 152 ~~~~vkl~DfG~a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~--- 221 (293)
T d1jksa_ 152 PKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----K--- 221 (293)
T ss_dssp SSCCEEECCCTTCEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----H---
T ss_pred cccceEecchhhhhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC----H---
Confidence 48999999998776543322 2578999999999999999999999999999999999999996522 1
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+....... +..... +.+..+.+||.+||+.||++|||++|+++
T Consensus 222 ~~~~~~i~~~~~~~---~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 QETLANVSAVNYEF---EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHHTTCCCC---CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCC---CchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222333222211 111111 12234889999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-54 Score=364.35 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=203.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|.+ ..+++.||||++.. .....+.+.+|+.++++++||||+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~-~~~~~~vAvK~i~~----------------~~~~~~~~~~E~~il~~l~HpnIv~~ 78 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKE----------------DTMEVEEFLKEAAVMKEIKHPNLVQL 78 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEE-GGGTEEEEEEECCT----------------TCSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEE-CCCCeEEEEEEECC----------------ccchHHHHHHHHHHHHhCCCCCEecC
Confidence 46899999999999999999964 45688999998731 12345678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+.+..++||||+++|+|.+++.. .....+++..+..++.|++.||+||| ++||+||||||+|||+++++.
T Consensus 79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~ 153 (287)
T d1opja_ 79 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHL 153 (287)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred CccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCc
Confidence 9999999999999999999999999854 34457899999999999999999999 789999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+||+|||++.......... .....|++.|+|||++.+..++.++||||||+++|+|++|..|+.... ....+.
T Consensus 154 ~Kl~DFG~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~~~~~~--- 226 (287)
T d1opja_ 154 VKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVY--- 226 (287)
T ss_dssp EEECCCCCTTTCCSSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHH---
T ss_pred EEEccccceeecCCCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---hHHHHH---
Confidence 9999999998765433222 222467889999999999999999999999999999999776654311 112222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+.....+.. +. ..+..+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~i~~~~~~~~--~~--------~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 227 ELLEKDYRMER--PE--------GCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHTTCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCC--Cc--------cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 22222222111 11 11233899999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-54 Score=364.61 Aligned_cols=255 Identities=20% Similarity=0.354 Sum_probs=192.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCC--cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|++.+.||+|+||+||+|++...++ ..||||.+... ......+.+.+|+.++++++||||+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~HpnIv 90 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--------------YTEKQRRDFLSEASIMGQFDHPNVI 90 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--------------CCHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--------------cCHHHHHHHHHHHHHHHhCCCCCCc
Confidence 4789999999999999999997643322 36888876321 1223456789999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++...+..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++++||||||+|||++.+
T Consensus 91 ~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~ 164 (299)
T d1jpaa_ 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSN 164 (299)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred cEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCC
Confidence 999999999999999999999999998843 3456899999999999999999999 7899999999999999999
Q ss_pred CCceeeccccceecCCCCccc---cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcc
Q 040480 191 MEARISGFDLAILMPDGLTQI---DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEM 266 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~ 266 (325)
+.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|+|+| |..||.+.. ..
T Consensus 165 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~----~~ 240 (299)
T d1jpaa_ 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT----NQ 240 (299)
T ss_dssp CCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HH
T ss_pred CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC----HH
Confidence 999999999998765432221 1122457889999999999999999999999999999998 899997532 22
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++ ...+......+.+. +.+..+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~---~~~i~~~~~~~~~~----------~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 241 DV---INAIEQDYRLPPPM----------DCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp HH---HHHHHTTCCCCCCT----------TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HH---HHHHHcCCCCCCCc----------cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 22 22333332222111 12234899999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-53 Score=361.75 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=204.6
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||+|+||+||+|+ +..+++.||||++.. .........+.+.+|+.+++.++||||++++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~-~~~~g~~vAvK~i~~------------~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 70 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIR-SRHNGRYYAMKVLKK------------EIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHSCCBTTBCCEE
T ss_pred hHeEEEEEEecCcCcEEEEEE-ECCCCCEEEEEEEch------------HHccCHHHHHHHHHHHHHHHhccCcChhhee
Confidence 579999999999999999996 557789999999831 1112234567889999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+.+..|+||||+.|++|...+ .....++...+..++.|++.||.||| ++||+||||||+|||++.++.+
T Consensus 71 ~~~~~~~~~~ivmE~~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~v 143 (316)
T d1fota_ 71 GTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHI 143 (316)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCE
T ss_pred eeEeeCCeeeeEeeecCCccccccc----cccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCE
Confidence 9999999999999999999999988 34556888888999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... . .....
T Consensus 144 kL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~---~~~~~ 211 (316)
T d1fota_ 144 KITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----T---MKTYE 211 (316)
T ss_dssp EECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----H---HHHHH
T ss_pred EEecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC----H---HHHHH
Confidence 999999998765432 23589999999999999999999999999999999999999996521 1 22223
Q ss_pred HHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 274 NVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
.+....... ++. .+..+.+++.+||+.||.+|| |++++++
T Consensus 212 ~i~~~~~~~---p~~--------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 212 KILNAELRF---PPF--------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHCCCCC---CTT--------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHcCCCCC---CCC--------CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 333322211 111 112389999999999999996 8888874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-54 Score=369.09 Aligned_cols=263 Identities=20% Similarity=0.264 Sum_probs=203.3
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCCC----cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSNG----KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI 104 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 104 (325)
|-...++|++.+.||+|+||+||+|++...++ ..||+|.+... ........+.+|+.+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l 97 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--------------ADSSEREALMSELKMMTQL 97 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------------CHHHHHHHHHHHHH
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc--------------cCHHHHHHHHHHHHHHHHh
Confidence 33345789999999999999999997643322 46899987321 1123345688999999988
Q ss_pred -CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc-------------------cccccChhhHHHHHHHHHHHH
Q 040480 105 -RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK-------------------GRRELEWLSRHKIALAVASGL 164 (325)
Q Consensus 105 -~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~i~~~l~~~l 164 (325)
+||||+++++++.+.+..|+||||+++|+|.+++..... ....+++..+..++.|++.||
T Consensus 98 ~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl 177 (325)
T d1rjba_ 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177 (325)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHH
T ss_pred cCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999954321 123588889999999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHH
Q 040480 165 EYLHMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGV 244 (325)
Q Consensus 165 ~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~ 244 (325)
+||| +++|+||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||
T Consensus 178 ~yLH---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gv 254 (325)
T d1rjba_ 178 EFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 254 (325)
T ss_dssp HHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHH---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhH
Confidence 9999 8899999999999999999999999999998765544333333357899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhh
Q 040480 245 LLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVR 323 (325)
Q Consensus 245 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (325)
++|+|++ |..||.+... ...+...+. ....... +. ..++.+.+||.+||+.||++|||++||+
T Consensus 255 il~emlt~g~~Pf~~~~~---~~~~~~~~~---~~~~~~~--p~--------~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 255 LLWEIFSLGVNPYPGIPV---DANFYKLIQ---NGFKMDQ--PF--------YATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp HHHHHTTTSCCSSTTCCC---SHHHHHHHH---TTCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCCCCCCH---HHHHHHHHh---cCCCCCC--CC--------cCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999998 8999975322 112222221 2211111 10 1123489999999999999999999998
Q ss_pred c
Q 040480 324 C 324 (325)
Q Consensus 324 ~ 324 (325)
+
T Consensus 319 ~ 319 (325)
T d1rjba_ 319 S 319 (325)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=359.30 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=199.0
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccc
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILP 111 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 111 (325)
..++|++.+.||+|+||+||+|++. ++..||||++.. .....+.+.+|+.++++++||||++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~----------------~~~~~~~~~~E~~~l~~l~HpnIv~ 72 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQ----------------GSMSPDAFLAEANLMKQLQHQRLVR 72 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECT----------------TSSCHHHHHHHHHHHHHCCCTTBCC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEcc----------------CcCCHHHHHHHHHHHHhCCCCCEeE
Confidence 3478999999999999999999864 567899999831 1233467899999999999999999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
+++++. ++..++||||+++|+|.+++.. .....+++..+..++.|++.||.||| +++|+||||||+||++++++
T Consensus 73 ~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~ 146 (272)
T d1qpca_ 73 LYAVVT-QEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTL 146 (272)
T ss_dssp EEEEEC-SSSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTS
T ss_pred EEeeec-cCCeEEEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeeccc
Confidence 999765 4567999999999999998743 23345899999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.+||+|||+++......... .....||+.|+|||++.+..++.++||||||+++|+|+||..|+... ... ...
T Consensus 147 ~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~---~~~---~~~ 219 (272)
T d1qpca_ 147 SCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG---MTN---PEV 219 (272)
T ss_dssp CEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT---CCH---HHH
T ss_pred ceeeccccceEEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC---CCH---HHH
Confidence 99999999998776443222 22246889999999999889999999999999999999965554321 111 222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+.....+..+ . ..+..+.+|+.+||+.||++|||++++++
T Consensus 220 ~~~i~~~~~~~~p--~--------~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 220 IQNLERGYRMVRP--D--------NCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp HHHHHTTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCc--c--------cChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2233332222211 1 12233899999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=359.04 Aligned_cols=247 Identities=22% Similarity=0.277 Sum_probs=194.5
Q ss_pred cccccCcceeEEEEEecC-CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccceec
Q 040480 40 EKIGSGGCGDVYKAELPG-SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHMVR 118 (325)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 118 (325)
++||+|+||+||+|.+.. .+++.||||++... .......+.+.+|+.++++++||||+++++++..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-------------~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~ 79 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-------------ANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 79 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh-------------hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc
Confidence 469999999999997643 34578999998321 1223445679999999999999999999998854
Q ss_pred CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceeecc
Q 040480 119 PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARISGF 198 (325)
Q Consensus 119 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~df 198 (325)
+..++||||+++|+|.+++. ....+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+||
T Consensus 80 -~~~~lvmE~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DF 151 (277)
T d1xbba_ 80 -ESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDF 151 (277)
T ss_dssp -SSEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred -CCEEEEEEcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccch
Confidence 56799999999999999983 4456999999999999999999999 789999999999999999999999999
Q ss_pred ccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHHHHHHHh
Q 040480 199 DLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVRWMRNVM 276 (325)
Q Consensus 199 g~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 276 (325)
|++.......... ......||+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.. ..++. ..+.
T Consensus 152 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----~~~~~---~~i~ 224 (277)
T d1xbba_ 152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSEVT---AMLE 224 (277)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHH---HHHH
T ss_pred hhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC----HHHHH---HHHH
Confidence 9998765443322 2223578999999999999999999999999999999998 899997532 22222 2233
Q ss_pred hhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 277 ASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+..+..+ . ..+..+.+|+.+||+.||++|||+++|++
T Consensus 225 ~~~~~~~p--~--------~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 225 KGERMGCP--A--------GCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp TTCCCCCC--T--------TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCCCC--c--------ccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 33222211 1 12234899999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-53 Score=366.19 Aligned_cols=247 Identities=19% Similarity=0.246 Sum_probs=204.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||+|+||+||+|+ +..+++.||||++.. .........+.+.+|+.+++.++||||++++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~-~~~~g~~~AvK~i~~------------~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~ 107 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVK-HKESGNHYAMKILDK------------QKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCeEEEEEeecCcCcEEEEEE-ECCCCCEEEEEEEch------------HHccCHHHHHHHHHHHHHHHHcCCCcEeecc
Confidence 579999999999999999996 567889999999831 1112234567789999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+....++||||+.+|+|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++.+
T Consensus 108 ~~~~~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~i 180 (350)
T d1rdqe_ 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred cccccccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCE
Confidence 999999999999999999999999843 346999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMR 273 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 273 (325)
||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||... . ......
T Consensus 181 kL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~---~~~~~~ 248 (350)
T d1rdqe_ 181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----Q---PIQIYE 248 (350)
T ss_dssp EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----S---HHHHHH
T ss_pred Eeeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc----C---HHHHHH
Confidence 999999998765432 2257899999999999999999999999999999999999999642 1 222233
Q ss_pred HHhhhCCCC-cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-----Chhhhhc
Q 040480 274 NVMASENPN-RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-----NSKDVRC 324 (325)
Q Consensus 274 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 324 (325)
.+....... ... +..+.+||.+||+.||.+|+ |++++++
T Consensus 249 ~i~~~~~~~p~~~------------s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 249 KIVSGKVRFPSHF------------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHCCCCCCTTC------------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhcCCCCCCccC------------CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 333322211 111 22389999999999999995 8999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=358.16 Aligned_cols=255 Identities=20% Similarity=0.263 Sum_probs=201.5
Q ss_pred hhcCcccccc-cccCcceeEEEEEecCC-CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 32 KEDCFASLEK-IGSGGCGDVYKAELPGS-NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 32 ~~~~y~~~~~-lg~G~~g~v~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
..++|.+.+. ||+|+||+||+|.+... ++..||||.+... ......+.+.+|+.++++++||||
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--------------~~~~~~~~~~~E~~il~~l~HpnI 71 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--------------TEKADTEEMMREAQIMHQLDNPYI 71 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--------------CCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--------------cCHHHHHHHHHHHHHHHhCCCCCE
Confidence 3467888884 99999999999976433 4567999998321 122345678999999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.. +..|+||||+++|+|.+++.. .+..+++..+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 72 v~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~ 144 (285)
T d1u59a_ 72 VRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVN 144 (285)
T ss_dssp CCEEEEEES-SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEE
T ss_pred eeEeeeecc-CeEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeecc
Confidence 999998864 568999999999999998732 3456999999999999999999999 889999999999999999
Q ss_pred CCCceeeccccceecCCCCcc-ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 190 DMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.. ..+
T Consensus 145 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~----~~~ 220 (285)
T d1u59a_ 145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPE 220 (285)
T ss_dssp TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----THH
T ss_pred CCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC----HHH
Confidence 999999999999877554322 22223468899999999999899999999999999999998 899997532 222
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+. ..+..+..+..+ + ..+..+.+||.+||+.||++|||+.+|++
T Consensus 221 ~~---~~i~~~~~~~~p--~--------~~~~~l~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 221 VM---AFIEQGKRMECP--P--------ECPPELYALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp HH---HHHHTTCCCCCC--T--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HH---HHHHcCCCCCCC--C--------cCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 22 223333322211 1 12234899999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-52 Score=364.82 Aligned_cols=255 Identities=26% Similarity=0.302 Sum_probs=199.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||.||+|+ +..+++.||+|.+.... ...............++.+++.++||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~-~~~t~~~vAiK~i~~~~---------~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~ 73 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCR-KADTGKMYAMKCLDKKR---------IKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEEHHH---------HHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred HhCeeeeEEecCCCeEEEEEE-ECCCCCEEEEEEEchHH---------cchhhHHHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence 689999999999999999995 56788999999983210 01111112223344557788888999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+.+..|+||||++||+|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~i 146 (364)
T d1omwa3 74 YAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHV 146 (364)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCE
T ss_pred EEEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcE
Confidence 999999999999999999999999943 456888999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQ-TLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
||+|||++........ ....||+.|+|||++. +..++.++|||||||++|+|++|+.||..... .+.....
T Consensus 147 Kl~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~ 218 (364)
T d1omwa3 147 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEID 218 (364)
T ss_dssp EECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHHHH
T ss_pred EEeeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 9999999987665432 2247999999999986 45689999999999999999999999975322 1222222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
........ ..+.. .+..+.+||.+||+.||++||| ++|+++
T Consensus 219 ~~~~~~~~---~~~~~--------~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 219 RMTLTMAV---ELPDS--------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHSSSCCC---CCCSS--------SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HhcccCCC---CCCCC--------CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 22111111 11111 1223899999999999999999 577764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=359.04 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=201.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHh-ccCCCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITAS-QIRHRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~ 112 (325)
++|++.+.||+|+||+||+|+ +..+++.||||++.. ...........+..|..++. .++||||+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~-~~~t~~~vAvK~i~k------------~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~ 68 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAE-FKKTNQFFAIKALKK------------DVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEE-ETTTTEEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred CCeEEeeEEecCCCcEEEEEE-ECCCCCEEEEEEEch------------hhccChHHHHHHHHHHHHHHHhCCCCcEEEE
Confidence 579999999999999999996 567889999999831 11122234455666666654 6899999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..|+||||+++|+|.+++. ....+++..+..++.|++.||.||| +++|+||||||+|||+++++.
T Consensus 69 ~~~~~~~~~~yivmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~ 141 (320)
T d1xjda_ 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGH 141 (320)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred EEEEccCCceeEEEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCc
Confidence 999999999999999999999999994 3456889999999999999999999 889999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ...+ .
T Consensus 142 ~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~----~~~~---~ 212 (320)
T d1xjda_ 142 IKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEEL---F 212 (320)
T ss_dssp EEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---H
T ss_pred eeccccchhhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----HHHH---H
Confidence 999999999865543322 223589999999999999999999999999999999999999996521 2222 2
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChh-hhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSK-DVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 324 (325)
..+....... +. ..+..+.+||.+||+.||.+|||+. ++++
T Consensus 213 ~~i~~~~~~~---p~--------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 213 HSIRMDNPFY---PR--------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHCCCCC---CT--------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHcCCCCC---Cc--------cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2222222111 11 1122389999999999999999996 6764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.6e-52 Score=349.29 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=205.8
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~ 112 (325)
++|++.+.||+|+||+||+|+ +..+++.||||++.......... .......+.+.+|+.+++++. ||||+++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~~~AvK~i~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 75 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSA------EEVQELREATLKEVDILRKVSGHPNIIQL 75 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEEETTCSTTCCH------HHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred ccCEEceEEecCcCeEEEEEE-ECCCCCEEEEEEEecccccchhH------HHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 689999999999999999996 55688999999985443221100 001123457889999999997 9999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++.+++..|+||||+++++|.+++. ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.
T Consensus 76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 76 KDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred EeecccCcceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCC
Confidence 999999999999999999999999994 3456999999999999999999999 789999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCccccccccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT------LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+||+|||++......... ....||+.|.|||.+.+ ..++.++||||+||++|+|++|+.||.... .
T Consensus 149 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~----~- 220 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----Q- 220 (277)
T ss_dssp EEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----H-
T ss_pred eEEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC----H-
Confidence 999999999887654332 22579999999998763 346789999999999999999999997521 1
Q ss_pred hHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......+........... ..+.+..+.+|+.+||+.||++|||++|+++
T Consensus 221 --~~~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 221 --MLMLRMIMSGNYQFGSPE-------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --HHHHHHHHHTCCCCCTTT-------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHHHHHHHhCCCCCCCcc-------cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112223333322111100 1112234899999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=352.05 Aligned_cols=256 Identities=21% Similarity=0.334 Sum_probs=194.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCC---cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNG---KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI 109 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 109 (325)
.++|++.+.||+|+||.||+|.+...++ ..||||.+... ........+.+|+.++++++||||
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--------------~~~~~~~~~~~E~~il~~l~H~nI 71 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--------------YTEKQRVDFLGEAGIMGQFSHHNI 71 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--------------CCHHHHHHHHHHHHHHHTCCCTTB
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--------------cChHHHHHHHHHHHHHHhcCCCCE
Confidence 3679999999999999999998764433 47999988321 122344568899999999999999
Q ss_pred cccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 110 LPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 110 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++++.+.+..++||||+.++++.+.+.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.
T Consensus 72 v~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~ 145 (283)
T d1mqba_ 72 IRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNS 145 (283)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred eeeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECC
Confidence 9999999999999999999999999988743 3456899999999999999999999 789999999999999999
Q ss_pred CCCceeeccccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 190 DMEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 190 ~~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|+|+++..|+.... ...++
T Consensus 146 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~~~~ 222 (283)
T d1mqba_ 146 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEV 222 (283)
T ss_dssp TCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH
T ss_pred CCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---CHHHH
Confidence 9999999999998765432221 2222468999999999999999999999999999999999666553311 12222
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+..+..++.+. +.+..+.+|+.+||+.||++|||+.||++
T Consensus 223 ---~~~i~~~~~~~~~~----------~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 223 ---MKAINDGFRLPTPM----------DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ---HHHHHTTCCCCCCT----------TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---HHHHhccCCCCCch----------hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 23333332222111 12233899999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=356.47 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=203.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++.+.||+|+||+||+|. +..+++.||+|.+... ......+.+|+.+++.++||||++++
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~-~~~~~~~~AiK~i~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~~~ 67 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVK----------------GTDQVLVKKEISILNIARHRNILHLH 67 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECCC----------------THHHHHHHHHHHHHHHSCCTTBCCEE
T ss_pred cceEEEEEEecCCCeEEEEEE-ECCCCcEEEEEEEcCC----------------cccHHHHHHHHHHHHhCCCCCCCeEE
Confidence 679999999999999999995 5678899999998422 12234578999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC--C
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD--M 191 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~--~ 191 (325)
+++.+++..|+||||++|++|.+++.. ....+++..+..++.|++.||.||| ++||+||||||+|||++.+ .
T Consensus 68 ~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~ 141 (321)
T d1tkia_ 68 ESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSS 141 (321)
T ss_dssp EEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCce
Confidence 999999999999999999999999932 3346899999999999999999999 8899999999999999844 5
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
.++|+|||++........ .....||+.|+|||...+..++.++|||||||++|+|++|..||.... . ...
T Consensus 142 ~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~----~---~~~ 211 (321)
T d1tkia_ 142 TIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----N---QQI 211 (321)
T ss_dssp CEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----H---HHH
T ss_pred EEEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC----H---HHH
Confidence 789999999987654432 223578999999999999999999999999999999999999997522 1 222
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+....... +..... ..+..+.+||.+||+.||++|||++|+++
T Consensus 212 ~~~i~~~~~~~---~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 212 IENIMNAEYTF---DEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHTCCCC---CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCC---Chhhcc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23333322211 111111 11233889999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-52 Score=353.53 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=195.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|+ +..+++.||||++..... ........+.+|+.+++.++||||+++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~-~~~~~~~vAiK~i~~~~~------------~~~~~~~~~~~E~~~l~~~~hpniv~~ 72 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLAR-DLRLHRDVAVKVLRADLA------------RDPSFYLRFRREAQNAAALNHPAIVAV 72 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECSTTT------------TCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cceeEEeEEEeeCCCeEEEEEE-ECCCCCEEEEEEEchhhc------------cCHHHHHHHHHHHHHHHhcCCCCCCcc
Confidence 3689999999999999999995 557899999999843211 122345678999999999999999999
Q ss_pred ccceecCCc----eEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 113 LAHMVRPDS----HLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 113 ~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++++...+. .|+||||++|++|.+++. ....+++..+..++.|++.||.||| ++||+||||||+||+++
T Consensus 73 ~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~ 145 (277)
T d1o6ya_ 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMIS 145 (277)
T ss_dssp EEEEEEECSSSEEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEE
T ss_pred cceeeeccCCCceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccC
Confidence 999876543 799999999999999884 3456999999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCc-cccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLT-QIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
.++..+++|||.+........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 146 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------ 219 (277)
T d1o6ya_ 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------ 219 (277)
T ss_dssp TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------
T ss_pred ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------
Confidence 999999999999876543322 1222335799999999999999999999999999999999999999965221
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCC-Chhhhh
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERP-NSKDVR 323 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell 323 (325)
................ .... +.+..+.++|.+||+.||.+|| |+++++
T Consensus 220 -~~~~~~~~~~~~~~~~----~~~~---~~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 220 -VSVAYQHVREDPIPPS----ARHE---GLSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp -HHHHHHHHHCCCCCGG----GTSS---SCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -HHHHHHHHhcCCCCCc----hhcc---CCCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 2222222222221111 0011 1223389999999999999999 777765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=359.87 Aligned_cols=252 Identities=20% Similarity=0.293 Sum_probs=196.1
Q ss_pred cCccccc-ccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCccc
Q 040480 34 DCFASLE-KIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNILP 111 (325)
Q Consensus 34 ~~y~~~~-~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 111 (325)
++|++.. .||+|+||+||+|+ +..+++.||||++. ....+.+|+.++.++ +||||++
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~-~~~~~~~vAiK~i~--------------------~~~~~~~E~~~~~~~~~hpnIv~ 69 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIF-NKRTQEKFALKMLQ--------------------DCPKARREVELHWRASQCPHIVR 69 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEE-ETTTCCEEEEEEEE--------------------CSHHHHHHHHHHHHHTTSTTBCC
T ss_pred cCEEEeeEEeeeccCeEEEEEE-ECCCCCEEEEEEEC--------------------CcHHHHHHHHHHHHhcCCCCCCe
Confidence 6899875 59999999999996 55678999999982 234567788886554 7999999
Q ss_pred cccceec----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 112 LLAHMVR----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 112 ~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+++++.+ +...|+|||||+||+|.+++.. .....+++..+..++.|++.||+||| ++||+||||||+||++
T Consensus 70 l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll 144 (335)
T d2ozaa1 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLY 144 (335)
T ss_dssp EEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred EEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccc
Confidence 9998865 4568999999999999999943 23456999999999999999999999 8899999999999999
Q ss_pred cC---CCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 188 DD---DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 188 ~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
+. .+.+||+|||++.......... ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....
T Consensus 145 ~~~~~~~~~Kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~- 220 (335)
T d2ozaa1 145 TSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA- 220 (335)
T ss_dssp SCSSTTCCEEECCCTTCEECCCCCCCC---CCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred ccccccccccccccceeeeccCCCccc---cccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-
Confidence 85 4679999999998766543322 2589999999999999999999999999999999999999997533211
Q ss_pred cchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
......... .......+ .......+..+.+||.+||+.||++|||+.|+++
T Consensus 221 ---~~~~~~~~i--~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 221 ---ISPGMKTRI--RMGQYEFP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----------CC--CSCSSSCC----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHHH--hcCCCCCC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111111 11111111 1112234455999999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=350.96 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=194.6
Q ss_pred hcCcccccccccCcceeEEEEEecCCCC--cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|++.+.||+|+||.||+|++...++ ..||||++.. .........+.+.+|+.++++++||||+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~------------~~~~~~~~~~~~~~Ei~~l~~l~H~nIv 74 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP------------DVLSQPEAMDDFIREVNAMHSLDHRNLI 74 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------------CHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEECh------------hhcCCHHHHHHHHHHHHHHHhCCCCCEE
Confidence 4679999999999999999998765554 4689998721 1122334567899999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++.+ ...++||||++++++.+.+.. ....+++..+..++.|++.||.||| +++|+||||||+||+++.+
T Consensus 75 ~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~ 147 (273)
T d1u46a_ 75 RLYGVVLT-PPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATR 147 (273)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEET
T ss_pred EEEEEEee-cchheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccc
Confidence 99999965 567899999999999998854 3345999999999999999999999 7899999999999999999
Q ss_pred CCceeeccccceecCCCCccc-cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchH
Q 040480 191 MEARISGFDLAILMPDGLTQI-DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 268 (325)
+.+||+|||++.......... ......|+..|+|||.+.+..++.++||||||+++|+|++ |..||... ...+
T Consensus 148 ~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~----~~~~- 222 (273)
T d1u46a_ 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQ- 222 (273)
T ss_dssp TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHH-
T ss_pred cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc----CHHH-
Confidence 999999999999875543322 2223467889999999999999999999999999999998 89999652 1222
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+....... ..+. ..+..+.+|+.+||+.||++|||+.+|++
T Consensus 223 --~~~~i~~~~~~~-~~~~--------~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 223 --ILHKIDKEGERL-PRPE--------DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp --HHHHHHTSCCCC-CCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHhCCCCC-CCcc--------cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 222332222111 1111 11223899999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=355.42 Aligned_cols=255 Identities=21% Similarity=0.313 Sum_probs=197.5
Q ss_pred hhcCcccccccccCcceeEEEEEecCCCC---cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPGSNG---KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRN 108 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 108 (325)
+.++|++++.||+|+||+||+|++...+. ..||+|.+.. .......+.+.+|+.++++++|||
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~Hpn 72 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--------------ATSPKANKEILDEAYVMASVDNPH 72 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------------------CTHHHHHHHHHHHHHCCCTT
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecc--------------ccCHHHHHHHHHHHHHHHhCCCCC
Confidence 44679999999999999999997543222 3688998731 112234667899999999999999
Q ss_pred ccccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 109 ILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 109 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
|+++++++.+ +..+++++++.+++|.+.+.. ....+++..+..++.|++.||.||| +++|+||||||+||+++
T Consensus 73 Iv~l~g~~~~-~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~ 145 (317)
T d1xkka_ 73 VCRLLGICLT-STVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVK 145 (317)
T ss_dssp BCCEEEEEES-SSEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred EeeEEEEEec-CCeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeC
Confidence 9999999876 467788899999999998743 4567999999999999999999999 78999999999999999
Q ss_pred CCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcch
Q 040480 189 DDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMD 267 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~ 267 (325)
.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.... ..+
T Consensus 146 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~----~~~ 221 (317)
T d1xkka_ 146 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASE 221 (317)
T ss_dssp ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----GGG
T ss_pred CCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC----HHH
Confidence 999999999999987765544433344578999999999999999999999999999999998 889987532 223
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+...+. .+...+.+ + ..+..+.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~~~i~---~~~~~~~p--~--------~~~~~~~~li~~cl~~dP~~RPs~~eil~ 265 (317)
T d1xkka_ 222 ISSILE---KGERLPQP--P--------ICTIDVYMIMVKCWMIDADSRPKFRELII 265 (317)
T ss_dssp HHHHHH---HTCCCCCC--T--------TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHH---cCCCCCCC--c--------ccCHHHHHHHHHhCCCChhhCcCHHHHHH
Confidence 333332 22222111 0 11223899999999999999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=354.41 Aligned_cols=264 Identities=23% Similarity=0.276 Sum_probs=196.3
Q ss_pred ccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccccce
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLAHM 116 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 116 (325)
+.++.||+|+||+||+|+ +..+++.||||++.... ...........+.+|+.++++++||||+++++++
T Consensus 1 E~l~~lG~G~fg~Vy~~~-~~~~~~~vAvK~i~~~~----------~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~ 69 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKAR-DKNTNQIVAIKKIKLGH----------RSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 69 (299)
T ss_dssp CEEEEEEEETTEEEEEEE-CSSCCSEEEEEEC----------------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcceEeccCcCeEEEEEE-ECCCCcEEEEEEEehhh----------hhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee
Confidence 356899999999999995 56788999999983221 0111112235688999999999999999999999
Q ss_pred ecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCceee
Q 040480 117 VRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEARIS 196 (325)
Q Consensus 117 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~~l~ 196 (325)
..++..|+||||+.++++.... .....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+
T Consensus 70 ~~~~~~~ivmE~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~ 142 (299)
T d1ua2a_ 70 GHKSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLA 142 (299)
T ss_dssp CCTTCCEEEEECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCceeehhhhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccc
Confidence 9999999999999887666554 44567999999999999999999999 8899999999999999999999999
Q ss_pred ccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHHHHH
Q 040480 197 GFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWMRNV 275 (325)
Q Consensus 197 dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 275 (325)
|||.+........... ..+||+.|+|||++.+. .++.++|||||||++|+|++|..||... ...+....+...
T Consensus 143 DFG~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~----~~~~~l~~i~~~ 216 (299)
T d1ua2a_ 143 DFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD----SDLDQLTRIFET 216 (299)
T ss_dssp CCGGGSTTTSCCCCCC--CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHH
T ss_pred cCccccccCCCccccc--ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC----CHHHHHHHHHHh
Confidence 9999976654332222 24789999999988654 5799999999999999999999999652 222222222222
Q ss_pred hhhCCCCcccchhh---------c-----CCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 276 MASENPNRAIDSKL---------L-----GNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 276 ~~~~~~~~~~~~~~---------~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............. . ..........+.+|+.+||+.||++|||++|+|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 217 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 21111110000000 0 0001122345899999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=347.93 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=191.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCC--CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSN--GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
.++|++.+.||+|+||.||+|.+...+ +..||+|.+.. .........+.+|+.++++++||||+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~--------------~~~~~~~~~~~~E~~~l~~l~HpnIv 71 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--------------CTSDSVREKFLQEALTMRQFDHPHIV 71 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT--------------TTSHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc--------------ccCHHHHHHHHHHHHHHHhCCCCCEe
Confidence 368999999999999999999765433 35688887621 11234456789999999999999999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++++. ++..|+||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++++||||||+||+++.+
T Consensus 72 ~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~ 144 (273)
T d1mp8a_ 72 KLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSN 144 (273)
T ss_dssp CEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEET
T ss_pred eEEEEEe-cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCC
Confidence 9999885 5678999999999999998743 3456899999999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMV 269 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 269 (325)
+.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.... ..++.
T Consensus 145 ~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~----~~~~~ 219 (273)
T d1mp8a_ 145 DCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVI 219 (273)
T ss_dssp TEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHH
T ss_pred CcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC----HHHHH
Confidence 99999999999876543322 2223467899999999999999999999999999999998 899997632 23333
Q ss_pred HHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 270 RWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. +..+...+ .++ +.+..+.+||.+||+.||++|||++||++
T Consensus 220 ~~---i~~~~~~~--~~~--------~~~~~~~~li~~cl~~dp~~Rps~~ei~~ 261 (273)
T d1mp8a_ 220 GR---IENGERLP--MPP--------NCPPTLYSLMTKCWAYDPSRRPRFTELKA 261 (273)
T ss_dssp HH---HHTTCCCC--CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---HHcCCCCC--CCC--------CCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 22 22222221 111 12234899999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=347.47 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=192.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++.+.||+|+||+||+|.+. ++..||||++.. .....+.+.+|+.++++++||||+++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~----------------~~~~~~~~~~E~~~l~~l~h~nIv~~ 77 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKP----------------GTMSPEAFLQEAQVMKKLRHEKLVQL 77 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCT----------------TSSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECc----------------ccCCHHHHHHHHHHHHhcccCCEeEE
Confidence 368999999999999999999764 446799999832 11234678999999999999999999
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCC
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDME 192 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~ 192 (325)
++++. ++..++||||+++|+|..++... ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.
T Consensus 78 ~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~ 151 (285)
T d1fmka3 78 YAVVS-EEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLV 151 (285)
T ss_dssp EEEEC-SSSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEe-cCCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCc
Confidence 99885 45689999999999999998542 3345899999999999999999999 789999999999999999999
Q ss_pred ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 193 ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 193 ~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
+||+|||+++........ ......||+.|+|||++....++.++||||||+++|+|++|..|+... .. .....
T Consensus 152 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~---~~---~~~~~ 224 (285)
T d1fmka3 152 CKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG---MV---NREVL 224 (285)
T ss_dssp EEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT---CC---HHHHH
T ss_pred EEEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC---CC---HHHHH
Confidence 999999999866433322 222357899999999999999999999999999999999966555331 11 22222
Q ss_pred HHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+......+ .+. ..++.+.+|+.+||+.||++|||+++|++
T Consensus 225 ~~i~~~~~~~--~~~--------~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 225 DQVERGYRMP--CPP--------ECPESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp HHHHTTCCCC--CCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCC--CCc--------ccCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 3333222211 111 12234899999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=352.34 Aligned_cols=259 Identities=21% Similarity=0.305 Sum_probs=205.2
Q ss_pred hhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCC
Q 040480 32 KEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHR 107 (325)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 107 (325)
..++|++.+.||+|+||+||+|++.. .+++.||||++... ........+.+|+.++++++||
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--------------~~~~~~~~~~~E~~il~~l~h~ 76 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--------------ASADMQADFQREAALMAEFDNP 76 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--------------CCHHHHHHHHHHHHHHHTCCCT
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--------------cChHHHHHHHHHHHHHHhcCCC
Confidence 45689999999999999999998643 35678999987321 1223456789999999999999
Q ss_pred CccccccceecCCceEEEEEcccCCCHHHHHhhhc--------------------ccccccChhhHHHHHHHHHHHHHHH
Q 040480 108 NILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS--------------------KGRRELEWLSRHKIALAVASGLEYL 167 (325)
Q Consensus 108 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~~l~~l 167 (325)
||+++++++...+..+++|||+.+++|.+++.... .....+++..+..++.|++.||+||
T Consensus 77 niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl 156 (301)
T d1lufa_ 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156 (301)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred CcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc
Confidence 99999999999999999999999999999986422 1133478889999999999999999
Q ss_pred HhcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHH
Q 040480 168 HMHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLA 247 (325)
Q Consensus 168 h~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~ 247 (325)
| +++++||||||+||+++.++.+||+|||++................|++.|+|||.+.+..++.++||||||+++|
T Consensus 157 H---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ 233 (301)
T d1lufa_ 157 S---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233 (301)
T ss_dssp H---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred c---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHH
Confidence 9 8899999999999999999999999999998665444433334457889999999999999999999999999999
Q ss_pred HHHhCC-CCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 248 VLVMGK-FPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 248 ~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+|++|. +||... .. .+....+.....+..+ . ..+..+.+|+.+||+.||++|||+.||++
T Consensus 234 ell~~~~~p~~~~----~~---~e~~~~v~~~~~~~~p--~--------~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 234 EIFSYGLQPYYGM----AH---EEVIYYVRDGNILACP--E--------NCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHTTTCCTTTTS----CH---HHHHHHHHTTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCCCCC----CH---HHHHHHHHcCCCCCCC--c--------cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999985 577542 22 2223333333332211 1 11223899999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=345.42 Aligned_cols=245 Identities=27% Similarity=0.369 Sum_probs=191.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
-++|++.+.||+|+||.||+|++ .+..||||++.. ....+.+.+|+.++++++||||+++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~-----------------~~~~~~~~~E~~~l~~l~HpnIv~~ 65 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKN-----------------DATAQAFLAEASVMTQLRHSNLVQL 65 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCC-----------------CC--HHHHHTHHHHTTCCCTTBCCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECc-----------------HHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 46799999999999999999986 577899999831 2344678899999999999999999
Q ss_pred ccceec-CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCC
Q 040480 113 LAHMVR-PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDM 191 (325)
Q Consensus 113 ~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~ 191 (325)
++++.+ .+..++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 66 ~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~ 140 (262)
T d1byga_ 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDN 140 (262)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTS
T ss_pred EEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCC
Confidence 998854 46689999999999999999542 2345899999999999999999999 78999999999999999999
Q ss_pred CceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCcccCCCcchHHH
Q 040480 192 EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM-GKFPFDDFFSHTGEMDMVR 270 (325)
Q Consensus 192 ~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 270 (325)
.++++|||++........ ...++..|+|||.+.+..++.++||||||+++|+|++ |.+||... ...++..
T Consensus 141 ~~kl~dfg~s~~~~~~~~-----~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~----~~~~~~~ 211 (262)
T d1byga_ 141 VAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVP 211 (262)
T ss_dssp CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHH
T ss_pred CEeecccccceecCCCCc-----cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC----CHHHHHH
Confidence 999999999976543221 2367889999999999899999999999999999998 78887652 2223333
Q ss_pred HHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 271 WMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+ ..+..++. +. ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 212 ~i---~~~~~~~~--~~--------~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 212 RV---EKGYKMDA--PD--------GCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HH---TTTCCCCC--CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---HcCCCCCC--Cc--------cCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22 22222221 11 11123899999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=348.16 Aligned_cols=265 Identities=25% Similarity=0.310 Sum_probs=198.4
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||+|+||+||+|. +..+++.||||++... .........+.+|+.++++++||||++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~-~~~~~~~vAvK~i~~~-------------~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~ 67 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKIRLD-------------TETEGVPSTAIREISLLKELNHPNIVKLL 67 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEE-ETTTCCEEEEEEEC--------------------CCHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCCEeccEEecCcCeEEEEEE-ECCCCCEEEEEEEehh-------------hcChHHHHHHHHHHHHHHhCCCCcEEEec
Confidence 589999999999999999995 5677889999998321 11223346788999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+.+..|+||||+.+ ++.+.+.. .....+++..+..++.|++.||.||| ++||+||||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~iv~e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~ 141 (298)
T d1gz8a_ 68 DVIHTENKLYLVFEFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 141 (298)
T ss_dssp EEEEETTEEEEEEECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred cccccccceeEEEeecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcc
Confidence 999999999999999976 45554422 34556999999999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
||+|||.+.......... ....||+.|+|||...... ++.++|+||||+++|+|++|+.||.... ..+.....
T Consensus 142 kl~DFG~a~~~~~~~~~~--~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~----~~~~~~~i 215 (298)
T d1gz8a_ 142 KLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRI 215 (298)
T ss_dssp EECSTTHHHHHCCCSBCT--TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHH
T ss_pred eeccCCcceeccCCcccc--eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC----HHHHHHHH
Confidence 999999998765433222 2257899999999877665 5789999999999999999999996521 11111111
Q ss_pred HHHhhhCCCCcccc----hh-------hcCC----chHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAID----SK-------LLGN----GYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~----~~-------~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............. +. .... ........+.+|+.+||+.||++|||++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111111000000 00 0000 01122245899999999999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=349.66 Aligned_cols=262 Identities=24% Similarity=0.311 Sum_probs=202.7
Q ss_pred HHhhhcCcccccccccCcceeEEEEEecCCC------CcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHh
Q 040480 29 FLKKEDCFASLEKIGSGGCGDVYKAELPGSN------GKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITAS 102 (325)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 102 (325)
|....++|++.+.||+|+||.||+|++...+ +..||||++... ........+.+|...+.
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--------------~~~~~~~~~~~e~~~l~ 73 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--------------ATEKDLSDLISEMEMMK 73 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--------------CCHHHHHHHHHHHHHHH
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--------------cChHHHHHHHHHHHHHH
Confidence 4455679999999999999999999754322 257999987321 22234567788888888
Q ss_pred cc-CCCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHh
Q 040480 103 QI-RHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHM 169 (325)
Q Consensus 103 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~ 169 (325)
++ +||||+++++++.+++..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||
T Consensus 74 ~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH- 152 (299)
T d1fgka_ 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA- 152 (299)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred HhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh-
Confidence 88 799999999999999999999999999999999964321 2356899999999999999999999
Q ss_pred cCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHH
Q 040480 170 HHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVL 249 (325)
Q Consensus 170 ~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~l 249 (325)
+++++||||||+|||++.++.+||+|||.+................|++.|+|||.+.+..++.++||||||+++|+|
T Consensus 153 --~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 153 --SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp --HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --hCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHh
Confidence 889999999999999999999999999999877655444444445789999999999999999999999999999999
Q ss_pred Hh-CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 250 VM-GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 250 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
++ |..||.+.. ...+. ..+..+..+..+ . ..+..+.+||.+||+.||++|||+.||++
T Consensus 231 l~~g~~p~~~~~----~~~~~---~~i~~~~~~~~p--~--------~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 231 FTLGGSPYPGVP----VEELF---KLLKEGHRMDKP--S--------NCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HTTSCCSSTTCC----HHHHH---HHHHTTCCCCCC--S--------SCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCCCCC----HHHHH---HHHHcCCCCCCC--c--------cchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 98 788886422 22222 222222222211 1 11233899999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=344.25 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=192.9
Q ss_pred hhhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-C
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-R 105 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 105 (325)
...++|++.+.||+|+||.||+|++.. .+++.||||++.. .......+.+.+|..++.++ +
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--------------~~~~~~~~~~~~e~~~l~~~~~ 75 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--------------GATHSEHRALMSELKILIHIGH 75 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------------------CHHHHHHHHHHHHHHHHHCC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcc--------------ccCcHHHHHHHHHHHHHHhhcC
Confidence 344789999999999999999997643 2457899998731 11223345667777777776 5
Q ss_pred CCCccccccceecC-CceEEEEEcccCCCHHHHHhhhcc------------cccccChhhHHHHHHHHHHHHHHHHhcCC
Q 040480 106 HRNILPLLAHMVRP-DSHLLVYDFMKNGSLQAVLYDVSK------------GRRELEWLSRHKIALAVASGLEYLHMHHS 172 (325)
Q Consensus 106 h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~ 172 (325)
|+||+.+++.+... ...++||||+++|+|.+++..... ....+++..+..++.|++.||+||| +
T Consensus 76 h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~ 152 (299)
T d1ywna1 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---S 152 (299)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---h
Confidence 88999999987654 468999999999999999965322 1345888999999999999999999 8
Q ss_pred CCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhC
Q 040480 173 ARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMG 252 (325)
Q Consensus 173 ~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g 252 (325)
++|+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 153 ~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~ 232 (299)
T d1ywna1 153 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232 (299)
T ss_dssp TTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhC
Confidence 89999999999999999999999999999876554444344446799999999999999999999999999999999986
Q ss_pred -CCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 253 -KFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 253 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..||..... .......+ ..+..+..+ . ..+..+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~p~~~~~~---~~~~~~~~---~~~~~~~~~--~--------~~~~~l~~li~~cl~~dP~~Rpt~~eil~ 289 (299)
T d1ywna1 233 GASPYPGVKI---DEEFCRRL---KEGTRMRAP--D--------YTTPEMYQTMLDCWHGEPSQRPTFSELVE 289 (299)
T ss_dssp SCCSSTTCCC---SHHHHHHH---HHTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCH---HHHHHHHH---hcCCCCCCC--c--------cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 567754321 11222222 222222111 1 11223899999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=344.51 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=194.7
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--CCCcc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR--HRNIL 110 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~ 110 (325)
+++|++.+.||+|+||+||+|+ +..+++.||||++........ .......++.+|+.++++++ ||||+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~-~~~~~~~vAvK~i~~~~~~~~---------~~~~~~~~~~~E~~il~~l~~~h~nIv 72 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDW---------GELPNGTRVPMEVVLLKKVSSGFSGVI 72 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEEGGGCCCE---------EECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred CCeEEEeEEEeeCCCeEEEEEE-ECCCCCEEEEEEEehHHccch---------hhhhHHHHHHHHHHHHHHhccCCCCcc
Confidence 5789999999999999999995 567789999999843211110 00011233567899999886 89999
Q ss_pred ccccceecCCceEEEEEcccC-CCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKN-GSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
++++++.+.+..++||||+.+ +++.+++. ....+++..+..++.|++.||.||| ++||+||||||+||+++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~ 145 (273)
T d1xwsa_ 73 RLLDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDL 145 (273)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEET
T ss_pred EEEEEEeeCCeEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEec
Confidence 999999999999999999975 57777773 3456999999999999999999999 889999999999999985
Q ss_pred -CCCceeeccccceecCCCCccccceeecCCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 190 -DMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTI-SEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
++.+||+|||++........ ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 146 ~~~~vkl~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------- 214 (273)
T d1xwsa_ 146 NRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------- 214 (273)
T ss_dssp TTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred CCCeEEECccccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------
Confidence 47899999999987554322 23579999999999987765 577999999999999999999996421
Q ss_pred HHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+...... ++.. .+.++.+||.+||+.||++|||++|+++
T Consensus 215 ------~i~~~~~~---~~~~--------~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 ------EIIRGQVF---FRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------HHHHCCCC---CSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHhhcccC---CCCC--------CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111111 1110 1223899999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=348.95 Aligned_cols=267 Identities=21% Similarity=0.306 Sum_probs=195.4
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc---CCC
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI---RHR 107 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ 107 (325)
..+++|++++.||+|+||+||+|++...+++.||||++..... .......+.+|+.+++.+ +||
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-------------~~~~~~~~~~E~~~l~~l~~~~Hp 70 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-------------EEGMPLSTIREVAVLRHLETFEHP 70 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-------------TTSCBCTHHHHHHHHHHHHHTCCT
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-------------cchHHHHHHHHHHHHHHHhhcCCC
Confidence 3568999999999999999999975555678899999843221 111122344566665554 799
Q ss_pred Cccccccceec-----CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 108 NILPLLAHMVR-----PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 108 ~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
||+++++++.. ....++++||+.++++..... .....+++..+..++.|++.||.||| +++|+||||||
T Consensus 71 nIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp 144 (305)
T d1blxa_ 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKP 144 (305)
T ss_dssp TBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred CcceeeeeecccccccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCc
Confidence 99999998853 346799999998866654432 34566889999999999999999999 88999999999
Q ss_pred CceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccC
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSH 262 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~ 262 (325)
+|||++.++.++|+|||.+........ .....||+.|+|||++.+.+++.++|||||||++|+|++|+.||....
T Consensus 145 ~NILi~~~~~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-- 219 (305)
T d1blxa_ 145 QNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-- 219 (305)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred cEEEEcCCCCeeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC--
Confidence 999999999999999999876543322 233689999999999999999999999999999999999999996522
Q ss_pred CCcchHHHHHHHHhhhCCCCcccchh--------------hcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 263 TGEMDMVRWMRNVMASENPNRAIDSK--------------LLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
..+....+........ ...++.. ..........+.+.+||.+||+.||++|||++|+|+
T Consensus 220 --~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 220 --DVDQLGKILDVIGLPG-EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp --HHHHHHHHHHHHCCCC-GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHHHHhhCCCc-hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 2222221211111110 0000000 000001122334889999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=347.76 Aligned_cols=262 Identities=20% Similarity=0.262 Sum_probs=206.7
Q ss_pred hhhcCcccccccccCcceeEEEEEec----CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-C
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELP----GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-R 105 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 105 (325)
...++|++.+.||+|+||.||+|++. ..+++.||||++.... .......+.+|+.+++.+ +
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--------------~~~~~~~~~~E~~~~~~l~~ 85 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--------------HLTEREALMSELKVLSYLGN 85 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------------CHHHHHHHHHHHHHHHHHCC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--------------CHHHHHHHHHHHHHHHhccC
Confidence 44579999999999999999999763 3466789999984221 223455788999999999 6
Q ss_pred CCCccccccceecCCceEEEEEcccCCCHHHHHhhhcc--------------cccccChhhHHHHHHHHHHHHHHHHhcC
Q 040480 106 HRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSK--------------GRRELEWLSRHKIALAVASGLEYLHMHH 171 (325)
Q Consensus 106 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~ 171 (325)
||||+++++++.+.+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||
T Consensus 86 HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--- 162 (311)
T d1t46a_ 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--- 162 (311)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred CCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---
Confidence 99999999999999999999999999999999865321 2336888999999999999999999
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHh
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVM 251 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~ 251 (325)
+++++||||||+||+++.++.++++|||.+................||+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 163 ~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt 242 (311)
T d1t46a_ 163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (311)
T ss_dssp HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHh
Confidence 88999999999999999999999999999987765544444444688999999999999899999999999999999999
Q ss_pred -CCCCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhcC
Q 040480 252 -GKFPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRCM 325 (325)
Q Consensus 252 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (325)
|.+||.... ....+...+.. +..+..+ . ..+..+.+||.+||+.||++|||+++|+++
T Consensus 243 ~g~p~~~~~~---~~~~~~~~i~~---~~~~~~~--~--------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 243 LGSSPYPGMP---VDSKFYKMIKE---GFRMLSP--E--------HAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp TTCCSSTTCC---SSHHHHHHHHH---TCCCCCC--T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCC---HHHHHHHHHhc---CCCCCCc--c--------cccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555554322 11222222222 1111111 0 112238999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-50 Score=342.95 Aligned_cols=263 Identities=25% Similarity=0.326 Sum_probs=198.1
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|+++++||+|+||+||+|++. +++.||||++.... ........+.+|+.++++++||||++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~-------------~~~~~~~~~~~E~~il~~l~hpnIv~~~ 66 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEK-------------EDEGIPSTTIREISILKELKHSNIVKLY 66 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSS-------------GGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred CCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhh-------------cChHHHHHHHHHHHHHHhCCCCcEEeee
Confidence 58999999999999999999753 77899999984321 1223356789999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+.+..++..+++++++.++.+..+. .....+++..+..++.|++.||.||| ++||+||||||+||+++.++.+
T Consensus 67 ~~~~~~~~~~i~~e~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~ 139 (286)
T d1ob3a_ 67 DVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGEL 139 (286)
T ss_dssp EEEECSSCEEEEEECCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred eecccCCceeEEEEeehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCE
Confidence 9999999999999999886666665 44567999999999999999999999 7899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
|++|||.+......... .....|++.|.|||.+.+. .++.++|+||||+++|+|++|+.||.+.. ..+.....
T Consensus 140 kl~DfG~a~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~----~~~~~~~i 213 (286)
T d1ob3a_ 140 KIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRI 213 (286)
T ss_dssp EECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHH
T ss_pred EecccccceecccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC----HHHHHHHH
Confidence 99999999876543322 2224688999999988754 46899999999999999999999996522 12222111
Q ss_pred HHHhhhCCCCcccchhh---------------cCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAIDSKL---------------LGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
................. ...........+.+|+.+||+.||++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111110000000 00001112234889999999999999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=345.89 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=197.6
Q ss_pred cCcccccccccCcceeEEEEEecCCCCc--EEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhcc-CCCCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGK--MIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQI-RHRNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 110 (325)
++|++.+.||+|+||+||+|++.. ++. .||||.+... ......+.+.+|+.+++++ +||||+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~~HpnIv 74 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEY--------------ASKDDHRDFAGELEVLCKLGHHPNII 74 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC--------------------CHHHHHHHHHTTCCCCTTBC
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcc--------------cChHHHHHHHHHHHHHHhccCCCCEe
Confidence 689999999999999999997643 443 5778876321 1122345789999999998 699999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhh------------cccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDV------------SKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHR 178 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~ 178 (325)
++++++.+++..++||||+++|+|.+++... ......+++..+..++.|++.||.|+| +++++||
T Consensus 75 ~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHr 151 (309)
T d1fvra_ 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHR 151 (309)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred eEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCcccc
Confidence 9999999999999999999999999998542 123467899999999999999999999 8899999
Q ss_pred CCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCC-CCCC
Q 040480 179 DIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK-FPFD 257 (325)
Q Consensus 179 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~-~p~~ 257 (325)
||||+|||++.++.+||+|||++.......... ...||..|+|||.+.+..++.++||||||+++|+|++|. +||.
T Consensus 152 Dlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 152 DLAARNILVGENYVAKIADFGLSRGQEVYVKKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccceEEEcCCCceEEcccccccccccccccc---ceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 999999999999999999999997554332221 246899999999999999999999999999999999975 5664
Q ss_pred CcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 258 DFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.. ...+....+.....+..+. +.+..+.+||.+||+.||++|||++|+++
T Consensus 229 ~~-------~~~~~~~~i~~~~~~~~~~----------~~~~~~~~li~~cl~~dP~~RPs~~eil~ 278 (309)
T d1fvra_ 229 GM-------TCAELYEKLPQGYRLEKPL----------NCDDEVYDLMRQCWREKPYERPSFAQILV 278 (309)
T ss_dssp TC-------CHHHHHHHGGGTCCCCCCT----------TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-------CHHHHHHHHHhcCCCCCCc----------cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 32 2222333333333222111 11233899999999999999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=336.95 Aligned_cols=263 Identities=24% Similarity=0.302 Sum_probs=192.9
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
.+|.+.+.||+|+||.||+|++ +++.||||++... .........|+..+.+++||||++++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~----------------~~~~~~~e~ei~~~~~~~HpnIv~~~ 63 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR----------------EERSWFREAEIYQTVMLRHENILGFI 63 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGG----------------GHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECcc----------------chhHHHHHHHHHHHhhCCCCcCcceE
Confidence 5788999999999999999986 6889999988311 11111223455566678999999999
Q ss_pred cceecCC----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCc
Q 040480 114 AHMVRPD----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH-----HSARVIHRDIKPAN 184 (325)
Q Consensus 114 ~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-----~~~~ivH~dl~~~n 184 (325)
+++.+.+ ..++||||+++|+|.+++.. ..+++..+..++.|++.||+|+|.. +++||+||||||+|
T Consensus 64 ~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~N 138 (303)
T d1vjya_ 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp EEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGG
T ss_pred EEEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccc
Confidence 9997654 47999999999999999943 3588999999999999999999942 24699999999999
Q ss_pred eEecCCCCceeeccccceecCCCCcc--ccceeecCCcccccccccccCC------CCCccchhhHHHHHHHHHhCCCCC
Q 040480 185 VLIDDDMEARISGFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQTLT------ISEKCDIYSFGVLLAVLVMGKFPF 256 (325)
Q Consensus 185 il~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~------~~~~~DvwslG~il~~ll~g~~p~ 256 (325)
||++.++.+||+|||++......... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 139 ILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~ 218 (303)
T d1vjya_ 139 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred eEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence 99999999999999999876543322 1223367999999999987643 567899999999999999999887
Q ss_pred CCcccCC--------CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 257 DDFFSHT--------GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 257 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....... .............. .......+... ...+....+.+|+.+||+.||++|||+.||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCE-QKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTT-SCCCCCCCGGG---GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred CcccccccchhhcccccchHHHHHHHHhc-cccCCCCCccc---CChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 5322111 11122222222222 11111111111 12234455899999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=342.20 Aligned_cols=270 Identities=17% Similarity=0.284 Sum_probs=211.1
Q ss_pred ccccchhHHHHHhhhcCcccccccccCcceeEEEEEecC----CCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHH
Q 040480 19 SPLIEKEDLAFLKKEDCFASLEKIGSGGCGDVYKAELPG----SNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEI 94 (325)
Q Consensus 19 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 94 (325)
+.+..+++ |....++|++.+.||+|+||+||+|.+.. .++..||||++... ........+
T Consensus 7 ~~~~~~~~--~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--------------~~~~~~~~~ 70 (308)
T d1p4oa_ 7 ADVYVPDE--WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--------------ASMRERIEF 70 (308)
T ss_dssp CSCCCCCT--TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--------------SCHHHHHHH
T ss_pred ccCcCccc--eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--------------cChHHHHHH
Confidence 34444443 33345899999999999999999997642 23578999988311 122334568
Q ss_pred HHHHHHHhccCCCCccccccceecCCceEEEEEcccCCCHHHHHhhhc------ccccccChhhHHHHHHHHHHHHHHHH
Q 040480 95 RSQIITASQIRHRNILPLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVS------KGRRELEWLSRHKIALAVASGLEYLH 168 (325)
Q Consensus 95 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~~l~~lh 168 (325)
.+|+.++++++||||+++++.+..++..++||||+++|+|.+++.... .....++...+..++.|++.||.|||
T Consensus 71 ~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH 150 (308)
T d1p4oa_ 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 150 (308)
T ss_dssp HHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 899999999999999999999999999999999999999999985432 12234678889999999999999999
Q ss_pred hcCCCCeEecCCCCCceEecCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHH
Q 040480 169 MHHSARVIHRDIKPANVLIDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAV 248 (325)
Q Consensus 169 ~~~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ 248 (325)
+++|+||||||+|||+++++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|+
T Consensus 151 ---~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~E 227 (308)
T d1p4oa_ 151 ---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227 (308)
T ss_dssp ---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ---hCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHH
Confidence 77999999999999999999999999999987655444443444578999999999999999999999999999999
Q ss_pred HHhCC-CCCCCcccCCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 249 LVMGK-FPFDDFFSHTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 249 ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
|++|. .||... ...+....+..+..+..+ . ..+..+.+||.+||+.||++|||+++|++
T Consensus 228 l~t~~~~p~~~~-------~~~~~~~~i~~~~~~~~p--~--------~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 228 IATLAEQPYQGL-------SNEQVLRFVMEGGLLDKP--D--------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHTSCCTTTTS-------CHHHHHHHHHTTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCCC-------CHHHHHHHHHhCCCCCCc--c--------cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99985 777542 222333333333332211 1 11233999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=336.62 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=194.7
Q ss_pred ccccccccCcceeEEEEEecCCCC--cEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccccc
Q 040480 37 ASLEKIGSGGCGDVYKAELPGSNG--KMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLLA 114 (325)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 114 (325)
.+.++||+|+||+||+|.+...++ ..||||.+... ......+.+.+|++++++++||||+++++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--------------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g 95 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--------------TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 95 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--------------CCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--------------cCHHHHHHHHHHHHHHHhCCCCCEeEEeE
Confidence 346789999999999998654433 46899987311 12345678999999999999999999999
Q ss_pred ceec-CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 115 HMVR-PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 115 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
++.. ++..++||||+++++|.+++.. .....+...+..++.|++.||.|+| +.+|+||||||+|||+++++.+
T Consensus 96 ~~~~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~ 169 (311)
T d1r0pa_ 96 ICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTV 169 (311)
T ss_dssp EEEETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCE
Confidence 8765 5678999999999999998843 4445777888999999999999999 8899999999999999999999
Q ss_pred eeeccccceecCCCCccc--cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHH
Q 040480 194 RISGFDLAILMPDGLTQI--DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRW 271 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 271 (325)
||+|||+++......... ......||..|+|||.+.+..++.++||||||+++|+|++|..||..... ..+ .
T Consensus 170 kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~---~~~---~ 243 (311)
T d1r0pa_ 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFD---I 243 (311)
T ss_dssp EECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------C
T ss_pred EEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC---HHH---H
Confidence 999999998765433222 12224688999999999999999999999999999999998888754221 111 2
Q ss_pred HHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 272 MRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
...+..+..+..+ . ..++.+.+||.+||+.||++|||+.||++
T Consensus 244 ~~~i~~g~~~~~p--~--------~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 286 (311)
T d1r0pa_ 244 TVYLLQGRRLLQP--E--------YCPDPLYEVMLKCWHPKAEMRPSFSELVS 286 (311)
T ss_dssp HHHHHTTCCCCCC--T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCc--c--------cCcHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2222333332211 0 11233899999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=337.44 Aligned_cols=269 Identities=22% Similarity=0.271 Sum_probs=198.2
Q ss_pred hhhcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 31 KKEDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
...++|+++++||+|+||+||+|+ +..+++.||||++.. ..........+.+|+.+++.++||||+
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~-~~~~~~~vAvK~i~~-------------~~~~~~~~~~~~~E~~il~~l~h~nii 72 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKVLM-------------ENEKEGFPITALREIKILQLLKHENVV 72 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEE-ETTTCCEEEEEEC-----------------CTTSSCHHHHHHHHHHHHCCCTTBC
T ss_pred CccCCEEEEEEEecCcCeEEEEEE-ECCCCCEEEEEEEeh-------------hhcchHHHHHHHHHHHHHHHhcCCCcc
Confidence 346899999999999999999995 557889999998732 122234456788999999999999999
Q ss_pred ccccceec--------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040480 111 PLLAHMVR--------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKP 182 (325)
Q Consensus 111 ~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~ 182 (325)
++++++.. .+..|+||||+.++.+.... .....++...+..++.|++.||.||| ++||+||||||
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp 145 (318)
T d3blha1 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKA 145 (318)
T ss_dssp CEEEEEEC----------CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred ceEeeeecccccccccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCc
Confidence 99998755 34689999999876555443 44566888999999999999999999 88999999999
Q ss_pred CceEecCCCCceeeccccceecCCCCcc--ccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCc
Q 040480 183 ANVLIDDDMEARISGFDLAILMPDGLTQ--IDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDF 259 (325)
Q Consensus 183 ~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~ 259 (325)
+||+++.++.++++|||++......... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 146 ~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 146 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp GGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 9999999999999999999866543221 122225789999999998765 5899999999999999999999999642
Q ss_pred ccCCCcchHHHHHHHHhhhCCCCcccchh------------hcCCch------HHHHHHHHHHHhhhcCCCCCCCCChhh
Q 040480 260 FSHTGEMDMVRWMRNVMASENPNRAIDSK------------LLGNGY------EEQMLLVLKLACFCTLADPDERPNSKD 321 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (325)
........+................ ...... ......+.+||.+||+.||++|||++|
T Consensus 226 ----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 226 ----TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp ----SHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ----CHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 2222222222222111111000000 000000 011234789999999999999999999
Q ss_pred hhc
Q 040480 322 VRC 324 (325)
Q Consensus 322 ll~ 324 (325)
+++
T Consensus 302 lL~ 304 (318)
T d3blha1 302 ALN 304 (318)
T ss_dssp HHH
T ss_pred HHc
Confidence 985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=340.79 Aligned_cols=258 Identities=25% Similarity=0.365 Sum_probs=191.5
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++++.||+|+||+||+|. +..+++.||||++... .......+.+.+|+.+|++++||||+++
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~-~~~~~~~vAiK~i~~~-------------~~~~~~~~~~~~Ei~il~~l~hpniv~l 82 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAV-DGRTGAKVAIKKLYRP-------------FQSELFAKRAYRELRLLKHMRHENVIGL 82 (346)
T ss_dssp BSSEEEEEEC------CEEEEE-ETTTCCEEEEEECSST-------------TSSHHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred CCcEEEEEEEecCCCeEEEEEE-ECCCCCEEEEEEEchh-------------hcChHHHHHHHHHHHHHHhcCCCCeeEE
Confidence 4789999999999999999995 5678999999998321 1223445678999999999999999999
Q ss_pred ccceecCC------ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRPD------SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++...+ ..|+||||+ +.+|...+ ....+++..+..++.|++.||.||| ++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL 153 (346)
T d1cm8a_ 83 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLA 153 (346)
T ss_dssp SEEECSCSSTTTCCCCEEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred EEEeccCccccccceEEEEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhh
Confidence 99987654 469999999 55787776 2356999999999999999999999 889999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccccceeecCCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCc
Q 040480 187 IDDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL-TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGE 265 (325)
Q Consensus 187 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~ 265 (325)
++.++.++++|||.+....... +...||+.|+|||.+.+. .++.++|||||||++|+|++|..||.... .
T Consensus 154 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~----~ 224 (346)
T d1cm8a_ 154 VNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD----H 224 (346)
T ss_dssp ECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----H
T ss_pred cccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC----h
Confidence 9999999999999998765432 235789999999988764 56899999999999999999999996531 1
Q ss_pred chHHHHHHHHhhhCCCCcc-------------------cchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 266 MDMVRWMRNVMASENPNRA-------------------IDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
........... ..+... ................+.+||.+||+.||.+|||++|+|+
T Consensus 225 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 225 LDQLKEIMKVT--GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHHHHHH--CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhcc--CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11111111100 000000 0000000011122234889999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=336.00 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=193.4
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
+++|++++.||+|+||+||+|. +..+++.||||++... ......+.+.+|+.+|++++||||+++
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~-~~~~~~~vAvK~i~~~--------------~~~~~~~~~~~Ei~il~~l~hp~iv~~ 71 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAY-DNVNKVRVAIKKISPF--------------EHQTYCQRTLREIKILLRFRHENIIGI 71 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEE-ETTTCSEEEEEEECCT--------------TCHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEE-ECCCCcEEEEEEEehh--------------cChHHHHHHHHHHHHHHHcCCCCCCcE
Confidence 4689999999999999999995 6678999999998321 122345678899999999999999999
Q ss_pred ccceecCC----ceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec
Q 040480 113 LAHMVRPD----SHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID 188 (325)
Q Consensus 113 ~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~ 188 (325)
++++.... ..+++++++.+++|.+++. ...+++..+..++.|++.||.||| ++||+||||||+|||++
T Consensus 72 ~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~ 143 (345)
T d1pmea_ 72 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLN 143 (345)
T ss_dssp CEEECCSSTTTCCCEEEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEC
T ss_pred EEEEeeccccccceEEEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEEC
Confidence 99986543 2345556677889999983 246999999999999999999999 88999999999999999
Q ss_pred CCCCceeeccccceecCCCCcc-ccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 189 DDMEARISGFDLAILMPDGLTQ-IDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
.++.+||+|||++......... ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.... ..
T Consensus 144 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~----~~ 219 (345)
T d1pmea_ 144 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH----YL 219 (345)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS----HH
T ss_pred CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC----HH
Confidence 9999999999999876443222 12233578999999998744 457899999999999999999999996532 11
Q ss_pred hHHHHHHHHhhhCC---------------------CCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASEN---------------------PNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
+............. ........... .....+.+|+.+||+.||++|||++|+|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP----NADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111110000 00000000011 11224889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=330.05 Aligned_cols=265 Identities=22% Similarity=0.261 Sum_probs=204.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|++++.||+|+||+||+|+ +..+++.||||++.... ........+.+|+.+++.++||||++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~-~~~~~~~vAvK~i~~~~-------------~~~~~~~~~~~E~~il~~l~h~niv~~~ 67 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAK-NRETHEIVALKRVRLDD-------------DDEGVPSSALREICLLKELKHKNIVRLH 67 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEE-ETTTCCEEEEEEEESSC-------------SSTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCCEeeeEEecCcCeEEEEEE-ECCCCcEEEEEEEehhh-------------CChHHHHHHHHHHHHHHhcCcCCEEeec
Confidence 589999999999999999996 56788999999984321 2234567889999999999999999999
Q ss_pred cceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCCCCc
Q 040480 114 AHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDDMEA 193 (325)
Q Consensus 114 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~~~~ 193 (325)
+++.+....+++++++.+++|..++ .....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~iv~~~~~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~ 140 (292)
T d1unla_ 68 DVLHSDKKLTLVFEFCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGEL 140 (292)
T ss_dssp EEEECSSEEEEEEECCSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCE
T ss_pred cccccccceeEEeeecccccccccc----ccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCce
Confidence 9999999999999999998888777 34567889999999999999999999 7899999999999999999999
Q ss_pred eeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchHHHHH
Q 040480 194 RISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDMVRWM 272 (325)
Q Consensus 194 ~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 272 (325)
||+|||.+........... ...++..|.|||.+.+.. ++.++|||||||++|+|++|+.||.... ...+....+
T Consensus 141 kl~DFG~a~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~---~~~~~~~~~ 215 (292)
T d1unla_ 141 KLANFGLARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRI 215 (292)
T ss_dssp EECCCTTCEECCSCCSCCC--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHH
T ss_pred eeeecchhhcccCCCccce--eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC---CHHHHHHHH
Confidence 9999999987655433222 235678899999887665 6899999999999999999999974311 222222222
Q ss_pred HHHhhhCCCCcccc---------------hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 273 RNVMASENPNRAID---------------SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 273 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.............. ..............+.+|+.+||+.||++|||++|+|+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22221111100000 00001111222344889999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=340.20 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=192.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
..+|..+++||+|+||+||+|+ +..+++.||||++.... ....+|+.++++++||||+++
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~-~~~~~~~vAiK~i~~~~-------------------~~~~~Ei~il~~l~h~niv~~ 78 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDK-------------------RFKNRELQIMRKLDHCNIVRL 78 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEEEECCS-------------------SSCCHHHHHHHHCCCTTBCCE
T ss_pred cCCcEeeeEEeeCcCeEEEEEE-ECCCCCEEEEEEECccc-------------------hHHHHHHHHHHhcCCCCCCcE
Confidence 3479999999999999999996 55778999999983211 122468999999999999999
Q ss_pred ccceecC------CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 040480 113 LAHMVRP------DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVL 186 (325)
Q Consensus 113 ~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil 186 (325)
++++... ...++||||++++ +.+.+.........+++..+..++.|++.||+||| ++||+||||||+|||
T Consensus 79 ~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NIL 154 (350)
T d1q5ka_ 79 RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 154 (350)
T ss_dssp EEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEE
T ss_pred EEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEE
Confidence 9988532 3478999999764 55555444455667999999999999999999999 889999999999999
Q ss_pred ecCCC-CceeeccccceecCCCCccccceeecCCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCcccCCC
Q 040480 187 IDDDM-EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQT-LTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTG 264 (325)
Q Consensus 187 ~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 264 (325)
++.++ .+||+|||++........... ..|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.....
T Consensus 155 l~~~~~~~kl~DFG~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~--- 228 (350)
T d1q5ka_ 155 LDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--- 228 (350)
T ss_dssp ECTTTCCEEECCCTTCEECCTTSCCCS---CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---
T ss_pred EecCCCceeEecccchhhccCCccccc---ccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---
Confidence 99765 889999999987755433222 478999999998765 4689999999999999999999999965221
Q ss_pred cchHHHHHHHHhhhC-----------CCCcccc----hhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 265 EMDMVRWMRNVMASE-----------NPNRAID----SKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 265 ~~~~~~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.+....+....... ......+ .............++.+|+.+||+.||++|||+.|+|+
T Consensus 229 -~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 229 -VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111100000 0000000 00000001112334899999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.9e-48 Score=333.92 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=195.0
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~ 111 (325)
.++|+++++||+|+||+||+|+ +..+++.||||++.. .....+.+|+.+++++. ||||++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~-~~~~~~~vAiK~i~~------------------~~~~~~~~Ei~il~~l~~hpnIv~ 94 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAI-NITNNEKVVVKILKP------------------VKKKKIKREIKILENLRGGPNIIT 94 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECS------------------SCHHHHHHHHHHHHHHTTSTTBCC
T ss_pred CcCeEEEEEEecCcCeEEEEEE-ECCCCCEEEEEEECH------------------HHHHHHHHHHHHHHhccCCCCCcE
Confidence 4689999999999999999996 567889999999821 23456789999999996 999999
Q ss_pred cccceec--CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC
Q 040480 112 LLAHMVR--PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD 189 (325)
Q Consensus 112 ~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~ 189 (325)
+++++.. ....++||||+.+++|.... ..+++..+..++.|++.||.||| ++||+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~ 164 (328)
T d3bqca1 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDH 164 (328)
T ss_dssp EEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEET
T ss_pred EEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcC
Confidence 9999874 45689999999999987654 35899999999999999999999 889999999999999986
Q ss_pred CC-CceeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 190 DM-EARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 190 ~~-~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
++ .++|+|||++.......... ...+|..|+|||.+.+.. ++.++|+||+||++|+|++|..||..... ..+
T Consensus 165 ~~~~vkl~DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~---~~~ 238 (328)
T d3bqca1 165 EHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---NYD 238 (328)
T ss_dssp TTTEEEECCGGGCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS---HHH
T ss_pred CCCeeeecccccceeccCCCccc---ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch---hHH
Confidence 55 58999999998766543322 257899999999987654 79999999999999999999999965321 111
Q ss_pred HHHHHHHHhh----------hCCC-C------------cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 268 MVRWMRNVMA----------SENP-N------------RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 268 ~~~~~~~~~~----------~~~~-~------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
....+..... .... . .................++.+||.+||+.||++|||++|+|+
T Consensus 239 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111100 0000 0 000000001111223345899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=336.82 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=189.5
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCccccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPLL 113 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 113 (325)
++|+++++||+|+||+||+|. +..+++.||||++... .........+.+|+.++++++||||++++
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~-d~~t~~~vAvK~i~~~-------------~~~~~~~~~~~~Ei~il~~l~hpnIv~~~ 82 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAY-DAVLDRNVAIKKLSRP-------------FQNQTHAKRAYRELVLMKCVNHKNIISLL 82 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEE-ETTTTEEEEEEEEEST-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred CCeEEEEEeecCcCeEEEEEE-ECCCCCEEEEEEEChh-------------hcCHHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence 689999999999999999995 6678999999998422 12234456789999999999999999999
Q ss_pred cceec------CCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 114 AHMVR------PDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 114 ~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
+++.. ....|+||||+.++ +.+.+ ...+++..+..++.|++.||.||| ++||+||||||+||++
T Consensus 83 ~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~------~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~ 152 (355)
T d2b1pa1 83 NVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVV 152 (355)
T ss_dssp EEECSCCSTTTCCEEEEEEECCSEE-HHHHH------TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred EEEecccccccCceeEEEEeccchH-HHHhh------hcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCcccccc
Confidence 99864 36789999999774 54444 134889999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcch
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMD 267 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~ 267 (325)
+.++.++++|||.+......... ....||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ...
T Consensus 153 ~~~~~~kl~df~~~~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~----~~~ 225 (355)
T d2b1pa1 153 KSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YID 225 (355)
T ss_dssp CTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHH
T ss_pred ccccceeeechhhhhcccccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC----HHH
Confidence 99999999999998766554332 23578999999999999999999999999999999999999996422 111
Q ss_pred HHHHHHHHh-------------------hhCCCCccc-ch-----hh---cCCchHHHHHHHHHHHhhhcCCCCCCCCCh
Q 040480 268 MVRWMRNVM-------------------ASENPNRAI-DS-----KL---LGNGYEEQMLLVLKLACFCTLADPDERPNS 319 (325)
Q Consensus 268 ~~~~~~~~~-------------------~~~~~~~~~-~~-----~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (325)
....+.... ......... .+ .. ...........+.+|+.+||+.||++|||+
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta 305 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 111111000 110000000 00 00 011123456679999999999999999999
Q ss_pred hhhhc
Q 040480 320 KDVRC 324 (325)
Q Consensus 320 ~ell~ 324 (325)
+|+|+
T Consensus 306 ~elL~ 310 (355)
T d2b1pa1 306 DDALQ 310 (355)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=334.50 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=199.9
Q ss_pred cCcccccccccCcceeEEEEEec--CCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC-CCcc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELP--GSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH-RNIL 110 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~ 110 (325)
++|++.+.||+|+||+||+|... ..+++.||||.+..... .......+.+.+|+.++++++| |||+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~-----------~~~~~~~~~~~~E~~il~~l~h~pnIv 92 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI-----------VQKAKTTEHTRTERQVLEHIRQSPFLV 92 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEE-----------EEEESSGGGCCCHHHHHHHHHTCTTBC
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHh-----------ccchHHHHHHHHHHHHHHhccCCCeEE
Confidence 67999999999999999999652 34688999998832110 0112234567889999999977 8999
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
++++.+.+....+++|||+.+++|.+++. ....+++..+..++.|++.||.|+| +++|+||||||+||+++.+
T Consensus 93 ~~~~~~~~~~~~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 93 TLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN 165 (322)
T ss_dssp CEEEEEEETTEEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred EeeeeeccCCceeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCC
Confidence 99999999999999999999999999984 3445788889999999999999999 8899999999999999999
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCcccCCCcchH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTL--TISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEMDM 268 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~ 268 (325)
+.++|+|||++.......... .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+
T Consensus 166 ~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i 244 (322)
T d1vzoa_ 166 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244 (322)
T ss_dssp SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred CCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999998765443322 2235789999999988764 4678999999999999999999999764332222222
Q ss_pred HHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCC-----hhhhhc
Q 040480 269 VRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPN-----SKDVRC 324 (325)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 324 (325)
. ........+. +. ..+..+.+|+.+||+.||.+||| ++|+++
T Consensus 245 ~---~~~~~~~~~~---~~--------~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 245 S---RRILKSEPPY---PQ--------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp H---HHHHHCCCCC---CT--------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred H---HhcccCCCCC---cc--------cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2 2222221111 10 11223899999999999999995 788875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-47 Score=326.52 Aligned_cols=257 Identities=23% Similarity=0.296 Sum_probs=191.8
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCc-cc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNI-LP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~ 111 (325)
.++|++.+.||+|+||+||+|+ +..+++.||||++... .....+..|+.+++.++|+++ +.
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~-~~~~~~~vAvK~~~~~-----------------~~~~~~~~E~~i~~~l~~~~~i~~ 67 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGT-DIAAGEEVAIKLECVK-----------------TKHPQLHIESKIYKMMQGGVGIPT 67 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEE-ETTTTEEEEEEEEESC-----------------TTSCCHHHHHHHHHHSTTSTTCCC
T ss_pred CCEEEEeEEEeeCCCcEEEEEE-ECCCCCEEEEEEEchh-----------------ccCHHHHHHHHHHHHccCCCcccE
Confidence 3689999999999999999996 5567899999987321 112346789999999987664 55
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEec---
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLID--- 188 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~--- 188 (325)
+..++...+..++||||+. +++.+.+.. ....++...+..++.|++.||+||| ++||+||||||+||+++
T Consensus 68 ~~~~~~~~~~~~ivme~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~ 140 (299)
T d1ckia_ 68 IRWCGAEGDYNVMVMELLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGK 140 (299)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGG
T ss_pred EEEEEecCCEEEEEEEEcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccC
Confidence 5566677788899999995 577766633 4456999999999999999999999 88999999999999986
Q ss_pred CCCCceeeccccceecCCCCccc-----cceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCcccCC
Q 040480 189 DDMEARISGFDLAILMPDGLTQI-----DTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFSHT 263 (325)
Q Consensus 189 ~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 263 (325)
.+..++++|||++.......... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus 141 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 141 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp GTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred CCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 34579999999999775433221 1223579999999999999999999999999999999999999997644332
Q ss_pred CcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 264 GEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
................ . .... .+.+..+.+++.+||+.||++||+++++.+
T Consensus 221 ~~~~~~~~~~~~~~~~--~-----~~~~---~~~p~~~~~li~~cl~~~p~~RP~~~~i~~ 271 (299)
T d1ckia_ 221 KRQKYERISEKKMSTP--I-----EVLC---KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271 (299)
T ss_dssp ----HHHHHHHHHHSC--H-----HHHT---TTSCHHHHHHHHHHHHSCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcccCCCC--h-----hHhc---cCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 2222222222111111 0 0000 112233899999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-46 Score=320.31 Aligned_cols=257 Identities=18% Similarity=0.227 Sum_probs=197.2
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCC-CCccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRH-RNILP 111 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~ 111 (325)
.++|++.+.||+|+||+||+|+ +..+++.||||++... .....+.+|++.++.+.| +|++.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~-~~~~~~~vAvK~~~~~-----------------~~~~~~~~e~~~~~~l~~~~~i~~ 65 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGT-NLLNNQQVAIKFEPRR-----------------SDAPQLRDEYRTYKLLAGCTGIPN 65 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEE-ETTTTEEEEEEEEECC-----------------TTSCCHHHHHHHHHHTTTCTTCCC
T ss_pred CCceEEEEEEecCCCeEEEEEE-ECCCCCEEEEEEEccc-----------------cCcHHHHHHHHHHHHhcCCCCCCE
Confidence 4789999999999999999996 5567899999987321 112245677888888875 89999
Q ss_pred cccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecC--
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDD-- 189 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~-- 189 (325)
+++++......++||||+ +++|.+++.. ....++..+...++.|++.||.||| ++||+||||||+||+++.
T Consensus 66 ~~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~ 138 (293)
T d1csna_ 66 VYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPN 138 (293)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSS
T ss_pred EEEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcc
Confidence 999999999999999999 6799998843 3456899999999999999999999 899999999999999974
Q ss_pred ---CCCceeeccccceecCCCCcc-----ccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCccc
Q 040480 190 ---DMEARISGFDLAILMPDGLTQ-----IDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGKFPFDDFFS 261 (325)
Q Consensus 190 ---~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 261 (325)
++.++|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 139 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 567999999999876543221 122335799999999999999999999999999999999999999976433
Q ss_pred CCCcchHHHHHHHHhhhCCCCcccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 262 HTGEMDMVRWMRNVMASENPNRAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.... .....+....... +. ..... +.++.+.+++..|+..+|++||+++.+.+
T Consensus 219 ~~~~-~~~~~i~~~~~~~-~~----~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 219 ATNK-QKYERIGEKKQST-PL----RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CCHH-HHHHHHHHHHHHS-CH----HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhHH-HHHHHHHhccCCC-Ch----HHhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 2221 1111111111111 10 11111 11233889999999999999999887654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=330.63 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=192.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcccc
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIRHRNILPL 112 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 112 (325)
.++|++++.||+|+||+||+|+ +..+++.||||++... .........+.+|+.++++++||||+++
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~-~~~~~~~vAiK~i~~~-------------~~~~~~~~~~~~Ei~il~~l~h~~iv~~ 82 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAF-DTKTGLRVAVKKLSRP-------------FQSIIHAKRTYRELRLLKHMKHENVIGL 82 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEE-ETTTTEEEEEEECSCT-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CCCeEEEEEEecCCCeEEEEEE-ECCCCCEEEEEEECch-------------hcChHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 4689999999999999999995 6678999999998321 1122345678899999999999999999
Q ss_pred ccceecC-----CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 040480 113 LAHMVRP-----DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLI 187 (325)
Q Consensus 113 ~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~ 187 (325)
++++... ...+++++++.+++|.+++ ....+++..+..++.|++.||.||| ++||+||||||+||++
T Consensus 83 ~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~-----~~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi 154 (348)
T d2gfsa1 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 154 (348)
T ss_dssp SEEECSCSSTTTCCCCEEEEECCSEEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred EEEEeeccccccCceEEEEEeecCCchhhhc-----ccccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccc
Confidence 9988533 3446667778899999998 3346999999999999999999999 8899999999999999
Q ss_pred cCCCCceeeccccceecCCCCccccceeecCCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCcccCCCcc
Q 040480 188 DDDMEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLT-ISEKCDIYSFGVLLAVLVMGKFPFDDFFSHTGEM 266 (325)
Q Consensus 188 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 266 (325)
+.++.++++|||.+....... ....|+..|+|||...+.. ++.++|||||||++|+|++|..||.... ..
T Consensus 155 ~~~~~~kl~dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~----~~ 225 (348)
T d2gfsa1 155 NEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD----HI 225 (348)
T ss_dssp CTTCCEEECCC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS----HH
T ss_pred cccccccccccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC----HH
Confidence 999999999999997554322 2246788999999876654 6889999999999999999999996522 11
Q ss_pred hHHHHHHHHhhhCCCC-----------------cccchhhcCCchHHHHHHHHHHHhhhcCCCCCCCCChhhhhc
Q 040480 267 DMVRWMRNVMASENPN-----------------RAIDSKLLGNGYEEQMLLVLKLACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 267 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (325)
.....+.......... ..................+.+||.+||+.||++|||++|+|+
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 1111111111100000 000000000001112334889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-42 Score=300.62 Aligned_cols=267 Identities=20% Similarity=0.213 Sum_probs=187.1
Q ss_pred hcCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-------
Q 040480 33 EDCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR------- 105 (325)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------- 105 (325)
+++|+++++||+|+||+||+|+ +..+++.||||++.. .....+.+.+|+.+++.+.
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~-~~~~g~~vAvKvi~~----------------~~~~~~~~~~Ei~~l~~l~~~~~~~~ 74 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAK-DMVNNTHVAMKIVRG----------------DKVYTEAAEDEIKLLQRVNDADNTKE 74 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHHTCCSHH
T ss_pred CCcEEEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEec----------------cccchHHHHHHHHHHHHhcchhhhhh
Confidence 4679999999999999999995 667899999999832 1123345667777776664
Q ss_pred ----CCCccccccceecC--CceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 040480 106 ----HRNILPLLAHMVRP--DSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRD 179 (325)
Q Consensus 106 ----h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~d 179 (325)
|+||+++++++... ...++++.++.......... .......++...+..++.|++.||.|||. ..||+|||
T Consensus 75 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrD 151 (362)
T d1q8ya_ 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTD 151 (362)
T ss_dssp HHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSC
T ss_pred hhcCcCceEEEEEEeeeccccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCccccc
Confidence 57899998887543 45566666665443332221 12445668888999999999999999993 26999999
Q ss_pred CCCCceEecCCCC------ceeeccccceecCCCCccccceeecCCcccccccccccCCCCCccchhhHHHHHHHHHhCC
Q 040480 180 IKPANVLIDDDME------ARISGFDLAILMPDGLTQIDTMYVVGTPRYIAPEYHQTLTISEKCDIYSFGVLLAVLVMGK 253 (325)
Q Consensus 180 l~~~nil~~~~~~------~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~DvwslG~il~~ll~g~ 253 (325)
|||+|||++.++. ++++|||.+....... ....||+.|+|||++.+..++.++|+||+||++++|++|+
T Consensus 152 lKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226 (362)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCC
Confidence 9999999986543 8999999997654322 2257899999999999999999999999999999999999
Q ss_pred CCCCCcccCCCcchHHHHHHHHhhhCCCCc--------------------ccc----------hhhcCCchHHHHHHHHH
Q 040480 254 FPFDDFFSHTGEMDMVRWMRNVMASENPNR--------------------AID----------SKLLGNGYEEQMLLVLK 303 (325)
Q Consensus 254 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~----------~~~~~~~~~~~~~~l~~ 303 (325)
.||.........................+. ... ..............+.+
T Consensus 227 ~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 306 (362)
T d1q8ya_ 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306 (362)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHH
Confidence 999754332222222211111111110000 000 00011223556677999
Q ss_pred HHhhhcCCCCCCCCChhhhhc
Q 040480 304 LACFCTLADPDERPNSKDVRC 324 (325)
Q Consensus 304 li~~~l~~dP~~Rps~~ell~ 324 (325)
|+.+||+.||.+|||++|+|+
T Consensus 307 ll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 307 FLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.1e-24 Score=169.74 Aligned_cols=175 Identities=12% Similarity=0.105 Sum_probs=119.6
Q ss_pred cccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCC-----cHHHHHHHHHhhCcchHHHHHHHHHHHhccCCCCcc
Q 040480 36 FASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPM-----SAAELIDAYSELGEGKLTEIRSQIITASQIRHRNIL 110 (325)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 110 (325)
+.+.++||+|+||+||+|.. .+++.||||++...... ..... ...............|...+.++.|++++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~--~~g~~vAvKi~r~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~~~~v~ 77 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDY--GDLHFSVLAIRSARNEFRALQKLQGLAVP 77 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC---------CHHHHHHHHHHHHHHHHHHTTTSSSC
T ss_pred chhCCEeeeCcceEEEEEEC--CCCCEEEEEEEecccchhhhhhhhhhh--ccHHHHHHHHHHHHHHHHHHHHccCCCcc
Confidence 45789999999999999965 36889999987532110 00000 00001112234556788889999999998
Q ss_pred ccccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEecCC
Q 040480 111 PLLAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMHHSARVIHRDIKPANVLIDDD 190 (325)
Q Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~~ivH~dl~~~nil~~~~ 190 (325)
..++.. ..+++|||+++..+. .++......++.|++.++.+|| ++|++|+||||+|||++++
T Consensus 78 ~~~~~~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~ 139 (191)
T d1zara2 78 KVYAWE----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE 139 (191)
T ss_dssp CEEEEE----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT
T ss_pred eEEEec----CCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC
Confidence 877542 237999999875432 2555667789999999999999 7899999999999999965
Q ss_pred CCceeeccccceecCCCCccccceeecCCcccccc------cccccCCCCCccchhhHHH
Q 040480 191 MEARISGFDLAILMPDGLTQIDTMYVVGTPRYIAP------EYHQTLTISEKCDIYSFGV 244 (325)
Q Consensus 191 ~~~~l~dfg~~~~~~~~~~~~~~~~~~g~~~~~aP------E~~~~~~~~~~~DvwslG~ 244 (325)
.++|+|||.+......... .|... +.+ ...|+.++|+||+.-
T Consensus 140 -~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp -EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHH
Confidence 4899999999765433211 11111 111 245788899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=1.8e-08 Score=81.94 Aligned_cols=142 Identities=11% Similarity=0.040 Sum_probs=92.0
Q ss_pred cCcccccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCcccc
Q 040480 34 DCFASLEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILPL 112 (325)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~ 112 (325)
+.|++.+..+-++.+.||+... ++..+++|+..... ......+.+|...+..+. +-.+.++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~---~~~~~vlk~~~~~~---------------~~~~~~~~~E~~~l~~l~~~vpvP~v 75 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRY---------------KGTTYDVEREKDMMLWLEGKLPVPKV 75 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC---SSCEEEEEEECGGG---------------TTSTTCHHHHHHHHHHHTTTSCCCCE
T ss_pred hceEEEEcCCCCCCCcEEEEEe---CCCeEEEEEcCCCc---------------ccchhhHHHHHHHHHHHhccCCCCcE
Confidence 5677777765566678999852 56678888763211 111223566666666553 3346677
Q ss_pred ccceecCCceEEEEEcccCCCHHHHHhhhcccccccChhhHHHHHHHHHHHHHHHHhc----------------------
Q 040480 113 LAHMVRPDSHLLVYDFMKNGSLQAVLYDVSKGRRELEWLSRHKIALAVASGLEYLHMH---------------------- 170 (325)
Q Consensus 113 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~---------------------- 170 (325)
+.+...++..++||++++|.++.+... +......+..++...+..||+.
T Consensus 76 l~~~~~~~~~~lv~~~l~G~~~~~~~~---------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T d1j7la_ 76 LHFERHDGWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEEEEETTEEEEEEECCSSEEHHHHTT---------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEEecCCceEEEEEeccccccccccc---------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence 777778888999999999987765541 1112223444444555555532
Q ss_pred ----------------------------------CCCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 171 ----------------------------------HSARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 171 ----------------------------------~~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01248999999999999987666799998873
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=4.3e-06 Score=67.05 Aligned_cols=74 Identities=14% Similarity=0.144 Sum_probs=46.4
Q ss_pred ccccCcc-eeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC--CCCcccccccee
Q 040480 41 KIGSGGC-GDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR--HRNILPLLAHMV 117 (325)
Q Consensus 41 ~lg~G~~-g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 117 (325)
.+..|.. +.||+... .++..+++|..... ....+..|...++.+. .-.+.+++....
T Consensus 17 ~~~~G~s~~~v~r~~~--~~~~~~vlK~~~~~------------------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~ 76 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA--QGRPVLFVKTDLSG------------------ALNELQDEAARLSWLATTGVPCAAVLDVVT 76 (255)
T ss_dssp ECSCTTSSCEEEEEEC--TTSCCEEEEEECSC------------------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE
T ss_pred EcCCcccCCeEEEEEe--CCCCEEEEEeCCcc------------------CHhHHHHHHHHHHHHHhcCCCCCceeeecc
Confidence 3445554 67899854 35666888875211 1122445555555443 234677787777
Q ss_pred cCCceEEEEEcccCCCH
Q 040480 118 RPDSHLLVYDFMKNGSL 134 (325)
Q Consensus 118 ~~~~~~lv~e~~~~~~L 134 (325)
+.+..++||++++|.++
T Consensus 77 ~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 77 EAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSSCEEEEEECCSSEET
T ss_pred cccceEEEEEeeecccc
Confidence 88889999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.89 E-value=2.5e-05 Score=66.70 Aligned_cols=84 Identities=12% Similarity=0.159 Sum_probs=46.7
Q ss_pred ccccccCcceeEEEEEecCCCCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-C--CCccccccc
Q 040480 39 LEKIGSGGCGDVYKAELPGSNGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-H--RNILPLLAH 115 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~ 115 (325)
.+.+|.|....||++. +..+++.+++|.-..... ...........+...|...++.+. + ..+++++.
T Consensus 31 ~~eig~G~~N~vfrV~-~~~~~~svivKqa~p~~r--------~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~- 100 (392)
T d2pula1 31 CQEIGDGNLNYVFHIY-DQEHDRALIIKQAVPYAK--------VVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY- 100 (392)
T ss_dssp EEECCSSSSEEEEEEE-C----CEEEEEEECCGGG--------C--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-
T ss_pred EEEeCCCceEeEEEEE-eCCCCeEEEEecCCchhc--------ccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE-
Confidence 4568999999999995 445677899996422110 000000112334456666666552 2 34555554
Q ss_pred eecCCceEEEEEcccCCC
Q 040480 116 MVRPDSHLLVYDFMKNGS 133 (325)
Q Consensus 116 ~~~~~~~~lv~e~~~~~~ 133 (325)
.+....++|||++.+..
T Consensus 101 -~d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 101 -SDTEMAVTVMEDLSHLK 117 (392)
T ss_dssp -EETTTTEEEECCCTTSE
T ss_pred -EcCCCCEEEEeccCCcc
Confidence 35556789999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.09 E-value=0.00087 Score=55.29 Aligned_cols=30 Identities=23% Similarity=0.248 Sum_probs=24.5
Q ss_pred CCCeEecCCCCCceEecCCCCceeecccccee
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAIL 203 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~~ 203 (325)
..+++|+|+.+.||+++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4679999999999999743 56899988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.77 E-value=0.0063 Score=51.37 Aligned_cols=74 Identities=5% Similarity=0.074 Sum_probs=43.3
Q ss_pred ccccccCcceeEEEEEecCC------CCcEEEEEEEcccCCCcHHHHHHHHHhhCcchHHHHHHHHHHHhccC-CCCccc
Q 040480 39 LEKIGSGGCGDVYKAELPGS------NGKMIAVKKVIIYSPMSAAELIDAYSELGEGKLTEIRSQIITASQIR-HRNILP 111 (325)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~ 111 (325)
++.|+-|---.+|++..... ..+.|++++.-. ........+|..+++.+. +.-.++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-----------------~~~~idr~~E~~i~~~ls~~gl~Pk 109 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-----------------PETESHLVAESVIFTLLSERHLGPK 109 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-----------------CCCHHHHHHHHHHHHHHHHTTSSSC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-----------------cchhhHHHHHHHHHHHHHhCCCCCe
Confidence 45678888889999976432 235577776511 011122345666666664 333456
Q ss_pred cccceecCCceEEEEEcccCCC
Q 040480 112 LLAHMVRPDSHLLVYDFMKNGS 133 (325)
Q Consensus 112 ~~~~~~~~~~~~lv~e~~~~~~ 133 (325)
+++++.+ .+|++|++|.+
T Consensus 110 ll~~~~~----g~I~efi~g~~ 127 (395)
T d1nw1a_ 110 LYGIFSG----GRLEEYIPSRP 127 (395)
T ss_dssp EEEEETT----EEEECCCCEEE
T ss_pred EEEEcCC----ceEEEEecccc
Confidence 6665542 68899997643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.51 E-value=0.0057 Score=49.80 Aligned_cols=31 Identities=32% Similarity=0.358 Sum_probs=27.6
Q ss_pred CCCeEecCCCCCceEecCCCCceeeccccce
Q 040480 172 SARVIHRDIKPANVLIDDDMEARISGFDLAI 202 (325)
Q Consensus 172 ~~~ivH~dl~~~nil~~~~~~~~l~dfg~~~ 202 (325)
..|++|+|+.++|++++.+...-+.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5689999999999999988777899999885
|